PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hummel, D; Rudolf, AK; Untch, KH; Grabhorn, R; Mohr, HM				Hummel, Dennis; Rudolf, Anne K.; Untch, Karl-Heinz; Grabhorn, Ralph; Mohr, Harald M.			Visual Adaptation to Thin and Fat Bodies Transfers across Identity	PLOS ONE			English	Article							EXTRASTRIATE BODY AREA; EATING-DISORDERS; FACE ADAPTATION; PERCEPTION; EXPRESSION; IMAGE; REPRESENTATIONS; DISSATISFACTION; SELECTIVITY	Visual perception is highly variable and can be influenced by the surrounding world. Previous research has revealed that body perception can be biased due to adaptation to thin or fat body shapes. The aim of the present study was to show that adaptation to certain body shapes and the resulting perceptual biases transfer across different identities of adaptation and test stimuli. We designed two similar adaptation experiments in which healthy female participants adapted to pictures of either thin or fat bodies and subsequently compared more or less distorted pictures of their own body to their actual body shape. In the first experiment (n = 16) the same identity was used as adaptation and test stimuli (i.e. pictures of the participant's own body) while in the second experiment (n = 16) we used pictures of unfamiliar thin or fat bodies as adaptation stimuli. We found comparable adaptation effects in both experiments: After adaptation to a thin body, participants rated a thinner than actual body picture to be the most realistic and vice versa. We therefore assume that adaptation to certain body shapes transfers across different identities. These results raise the questions of whether some type of natural adaptation occurs in everyday life. Natural and predominant exposure to certain bodily features like body shape - especially the thin ideal in Western societies - could bias perception for these features. In this regard, further research might shed light on aspects of body dissatisfaction and the development of body image disturbances in terms of eating disorders.	[Hummel, Dennis; Rudolf, Anne K.; Untch, Karl-Heinz] Goethe Univ Frankfurt, Inst Psychol, Dept Neurocognit Psychol, Frankfurt, Germany; [Grabhorn, Ralph; Mohr, Harald M.] Goethe Univ Hosp, Dept Psychiat Psychosomat & Psychotherapy, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Hummel, D (corresponding author), Goethe Univ Frankfurt, Inst Psychol, Dept Neurocognit Psychol, Frankfurt, Germany.	hummel@psych.uni-frankfurt.de			German Research Foundation (Deutsche Forschungsgemeinschaft) [MO2014/1-2]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, MO2014/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addams J, 1834, LONDON EDINBURGH PHI, V5, P373, DOI [DOI 10.1080/14786443408648481, 10.1080/14786443408648481]; AKAN GE, 1995, INT J EAT DISORDER, V18, P181, DOI 10.1002/1098-108X(199509)18:2&lt;181::AID-EAT2260180211&gt;3.0.CO;2-M; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Benton CP, 2009, PERCEPTION, V38, P1267, DOI 10.1068/p6468; Calder AJ, 2007, CURR BIOL, V17, P20, DOI 10.1016/j.cub.2006.10.052; Campbell J, 2009, VISION RES, V49, P1532, DOI 10.1016/j.visres.2009.03.009; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Ellamil M, 2008, COGN AFFECT BEHAV NE, V8, P273, DOI 10.3758/CABN.8.3.273; Evans PC, 2003, PSYCHOL WOMEN QUART, V27, P209, DOI 10.1111/1471-6402.00100; Fox CJ, 2007, BRAIN RES, V1127, P80, DOI 10.1016/j.brainres.2006.09.104; Fox CJ, 2008, J VISION, V8, DOI 10.1167/8.3.11; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Glauert R, 2009, INT J EAT DISORDER, V42, P443, DOI 10.1002/eat.20640; Groesz LM, 2002, INT J EAT DISORDER, V31, P1, DOI 10.1002/eat.10005; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hummel D, HUM BRAIN M IN PRESS; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Lai M, 2012, CORTEX, V48, P477, DOI 10.1016/j.cortex.2010.11.014; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; MCCOLLOUGH C, 1965, AM J PSYCHOL, V78, P362, DOI 10.2307/1420571; Minnebusch DA, 2009, NEUROSCI BIOBEHAV R, V33, P1133, DOI 10.1016/j.neubiorev.2009.05.008; Mohr HM, 2011, NEUROIMAGE, V56, P1822, DOI 10.1016/j.neuroimage.2011.02.069; MOHR HM, 2009, PSYCHOL MED, V17, P1; Ng M, 2006, P NATL ACAD SCI USA, V103, P19552, DOI 10.1073/pnas.0605358104; Ng M, 2008, J VISION, V8, DOI 10.1167/8.1.1; PATE JE, 1992, J AM ACAD CHILD PSY, V31, P802, DOI 10.1097/00004583-199209000-00005; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Sands R, 2004, J PSYCHOL, V138, P325, DOI 10.3200/JRLP.138.4.325-338; SILBERSTEIN LR, 1988, SEX ROLES, V19, P219, DOI 10.1007/BF00290156; Skinner AL, 2012, J VISION, V12, DOI 10.1167/12.2.12; STICE E, 1994, CLIN PSYCHOL REV, V14, P633, DOI 10.1016/0272-7358(94)90002-7; Stice E, 2002, PSYCHOL BULL, V128, P825, DOI 10.1037//0033-2909.128.5.825; Taylor JC, 2007, J NEUROPHYSIOL, V98, P1626, DOI 10.1152/jn.00012.2007; Urgesi C, 2004, CURR BIOL, V14, P2130, DOI 10.1016/j.cub.2004.11.031; Urgesi C, 2007, NAT NEUROSCI, V10, P30, DOI 10.1038/nn1815; Watson TL, 2003, PERCEPTION, V32, P1109, DOI 10.1068/p5082; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Williamson DA, 1999, BEHAV MODIF, V23, P556, DOI 10.1177/0145445599234003; Winkler C, 2005, BRIT J PSYCHOL, V96, P141, DOI 10.1348/000712605X36343; Zhao L, 2001, VISION RES, V41, P2979, DOI 10.1016/S0042-6989(01)00202-4	42	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43195	10.1371/journal.pone.0043195	http://dx.doi.org/10.1371/journal.pone.0043195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AG	22905232	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600057
J	McDaniel, LD; Young, EC; Ritchie, KB; Paul, JH				McDaniel, Lauren D.; Young, Elizabeth C.; Ritchie, Kimberly B.; Paul, John H.			Environmental Factors Influencing Gene Transfer Agent (GTA) Mediated Transduction in the Subtropical Ocean	PLOS ONE			English	Article							MARINE-BACTERIA; POPULATIONS; BACTERIOPHAGES; ENUMERATION; EXPRESSION	Microbial genomic sequence analyses have indicated widespread horizontal gene transfer (HGT). However, an adequate mechanism accounting for the ubiquity of HGT has been lacking. Recently, high frequencies of interspecific gene transfer have been documented, catalyzed by Gene Transfer Agents (GTAs) of marine alpha-Proteobacteria. It has been proposed that the presence of bacterial genes in highly purified viral metagenomes may be due to GTAs. However, factors influencing GTA-mediated gene transfer in the environment have not yet been determined. Several genomically sequenced strains containing complete GTA sequences similar to Rhodobacter capsulatus (RcGTA, type strain) were screened to ascertain if they produced putative GTAs, and at what abundance. Five of nine marine strains screened to date spontaneously produced virus-like particles (VLP's) in stationary phase. Three of these strains have demonstrated gene transfer activity, two of which were documented by this lab. These two strains Roseovarius nubinhibens ISM and Nitratireductor 44B9s, were utilized to produce GTAs designated RnGTA and NrGTA and gene transfer activity was verified in culture. Cell-free preparations of purified RnGTA and NrGTA particles from marked donor strains were incubated with natural microbial assemblages to determine the level of GTA-mediated gene transfer. In conjunction, several ambient environmental parameters were measured including lysogeny indicated by prophage induction. GTA production in culture systems indicated that approximately half of the strains produced GTA-like particles and maximal GTA counts ranged from 10-30% of host abundance. Modeling of GTA-mediated gene transfer frequencies in natural samples, along with other measured environmental variables, indicated a strong relationship between GTA mediated gene transfer and the combined factors of salinity, multiplicity of infection (MOI) and ambient bacterial abundance. These results indicate that GTA-mediated HGT in the marine environment with the strains examined is favored during times of elevated bacterial and GTA abundance as well as in areas of higher salinity.	[McDaniel, Lauren D.; Young, Elizabeth C.; Paul, John H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Ritchie, Kimberly B.] Mote Marine Lab, Sarasota, FL 34236 USA	State University System of Florida; University of South Florida; Mote Marine Laboratory & Aquarium	McDaniel, LD (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	mcdaniel@marine.usf.edu			U.S. National Science Foundation, Microbial Interactions and Processes (NSF-MIP) [EF 0801593]; State of Florida Mote "Protect Our Reefs" (POR) License Plate Grant [MML197-656]; Florida Institute of Oceanography	U.S. National Science Foundation, Microbial Interactions and Processes (NSF-MIP)(National Science Foundation (NSF)); State of Florida Mote "Protect Our Reefs" (POR) License Plate Grant; Florida Institute of Oceanography	Funding was provided by U.S. National Science Foundation, Microbial Interactions and Processes (NSF-MIP) grant, award number EF 0801593 to JHP and LM; a grant from the State of Florida Mote "Protect Our Reefs" (POR) License Plate Grant MML197-656to KBR and JHP; and a Florida Institute of Oceanography Shiptime award to JHP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON B, 1994, MOL MICROBIOL, V13, P67, DOI 10.1111/j.1365-2958.1994.tb00402.x; Bertani G, 1999, J BACTERIOL, V181, P2992, DOI 10.1128/JB.181.10.2992-3002.1999; Biers EJ, 2008, APPL ENVIRON MICROB, V74, P2933, DOI 10.1128/AEM.02129-07; Brussaard Corina P. D., 2009, V501, P97, DOI 10.1007/978-1-60327-164-6_11; Eiserling F, 1999, J GEN VIROL, V80, P3305, DOI 10.1099/0022-1317-80-12-3305; Fu YY, 2010, AQUAT MICROB ECOL, V59, P283, DOI 10.3354/ame01398; Huang S, 2011, VIROLOGY J, P8; Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003; Lan RT, 1996, MOL BIOL EVOL, V13, P47, DOI 10.1093/oxfordjournals.molbev.a025569; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Lang AS, 2010, NUCLEIC ACIDS MOL BI, V25, P15, DOI 10.1007/978-3-642-12617-8_2; Lang AS, 2000, P NATL ACAD SCI USA, V97, P859, DOI 10.1073/pnas.97.2.859; Lang AS, 2002, J MOL EVOL, V55, P534, DOI 10.1007/s00239-002-2348-7; Long A, 2008, ISME J, V2, P132, DOI 10.1038/ismej.2007.102; MARRS B, 1974, P NATL ACAD SCI USA, V71, P971, DOI 10.1073/pnas.71.3.971; Matson EG, 2005, J BACTERIOL, V187, P5885, DOI 10.1128/JB.187.17.5885-5892.2005; MAZODIER P, 1985, NUCLEIC ACIDS RES, V13, P195, DOI 10.1093/nar/13.1.195; McDaniel L, 2012, PLOS ONE IN PRESS; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; Patel A, 2007, NAT PROTOC, V2, P269, DOI 10.1038/nprot.2007.6; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Paul John H., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P45; RAPP BJ, 1987, P NATL ACAD SCI USA, V84, P9128, DOI 10.1073/pnas.84.24.9128; Ritchie K.B., 2011, BENEFICIAL MICROORGA, P139, DOI DOI 10.1007/978-3-642-21680-0_9; Sambrook J., 2001, MOL CLONING LAB MANU; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Vicente M, 2008, ENVIRON MICROBIOL, V10, P1663, DOI 10.1111/j.1462-2920.2008.01635.x; Williams HG, 1997, MOL MAR BIOL BIOTECH, V6, P238; Young EC, 2012, APPL ENV MICRO UNPUB; Zhao YL, 2010, APPL ENVIRON MICROB, V76, P589, DOI 10.1128/AEM.01450-09; Zhao YL, 2009, ISME J, V3, P364, DOI 10.1038/ismej.2008.115; Zobell CE, 1941, J MAR RES, V4, P42	32	15	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43506	10.1371/journal.pone.0043506	http://dx.doi.org/10.1371/journal.pone.0043506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905268	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600077
J	Martinez-Gonzalez, MA; Garcia-Arellano, A; Toledo, E; Salas-Salvado, J; Buil-Cosiales, P; Corella, D; Covas, MI; Schroder, H; Aros, F; Gomez-Gracia, E; Fiol, M; Ruiz-Gutierrez, V; Lapetra, J; Lamuela-Raventos, RM; Serra-Majem, L; Pinto, X; Munoz, MA; Warnberg, J; Ros, E; Estruch, R				Angel Martinez-Gonzalez, Miguel; Garcia-Arellano, Ana; Toledo, Estefania; Salas-Salvado, Jordi; Buil-Cosiales, Pilar; Corella, Dolores; Isabel Covas, Maria; Schroeder, Helmut; Aros, Fernando; Gomez-Gracia, Enrique; Fiol, Miquel; Ruiz-Gutierrez, Valentina; Lapetra, Jose; Maria Lamuela-Raventos, Rosa; Serra-Majem, Lluis; Pinto, Xavier; Angel Munoz, Miguel; Waernberg, Julia; Ros, Emilio; Estruch, Ramon		PREDIMED Study Investigators	A 14-Item Mediterranean Diet Assessment Tool and Obesity Indexes among High-Risk Subjects: The PREDIMED Trial	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; BODY-MASS INDEX; WEIGHT-GAIN; LOW-FAT; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; LIFE-STYLE; ADHERENCE; METAANALYSIS; ASSOCIATION	Objective: Independently of total caloric intake, a better quality of the diet (for example, conformity to the Mediterranean diet) is associated with lower obesity risk. It is unclear whether a brief dietary assessment tool, instead of full-length comprehensive methods, can also capture this association. In addition to reduced costs, a brief tool has the interesting advantage of allowing immediate feedback to participants in interventional studies. Another relevant question is which individual items of such a brief tool are responsible for this association. We examined these associations using a 14-item tool of adherence to the Mediterranean diet as exposure and body mass index, waist circumference and waist-to-height ratio (WHtR) as outcomes. Design: Cross-sectional assessment of all participants in the "PREvencion con DIeta MEDiterranea'' (PREDIMED) trial. Subjects: 7,447 participants (55-80 years, 57% women) free of cardiovascular disease, but with either type 2 diabetes or >= 3 cardiovascular risk factors. Trained dietitians used both a validated 14-item questionnaire and a full-length validated 137-item food frequency questionnaire to assess dietary habits. Trained nurses measured weight, height and waist circumference. Results: Strong inverse linear associations between the 14-item tool and all adiposity indexes were found. For a two-point increment in the 14-item score, the multivariable-adjusted differences in WHtR were -0.0066 (95% confidence interval, -0.0088 to -0.0049) for women and -0.0059 (-0.0079 to -0.0038) for men. The multivariable-adjusted odds ratio for a WHtR>0.6 in participants scoring >= 10 points versus <= 7 points was 0.68 (0.57 to 0.80) for women and 0.66 (0.54 to 0.80) for men. High consumption of nuts and low consumption of sweetened/carbonated beverages presented the strongest inverse associations with abdominal obesity. Conclusions: A brief 14-item tool was able to capture a strong monotonic inverse association between adherence to a good quality dietary pattern (Mediterranean diet) and obesity indexes in a population of adults at high cardiovascular risk.	[Angel Martinez-Gonzalez, Miguel; Garcia-Arellano, Ana; Toledo, Estefania; Salas-Salvado, Jordi; Buil-Cosiales, Pilar; Aros, Fernando; Gomez-Gracia, Enrique; Ruiz-Gutierrez, Valentina; Maria Lamuela-Raventos, Rosa; Serra-Majem, Lluis; Pinto, Xavier; Waernberg, Julia; Estruch, Ramon] Spanish Govt, ISCIII, PREDIMED Prevenc Con Dieta Mediterranea Network R, Madrid, Spain; [Angel Martinez-Gonzalez, Miguel; Garcia-Arellano, Ana; Toledo, Estefania; Buil-Cosiales, Pilar; Waernberg, Julia] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Salas-Salvado, Jordi; Corella, Dolores; Isabel Covas, Maria; Schroeder, Helmut; Fiol, Miquel; Lapetra, Jose; Maria Lamuela-Raventos, Rosa; Ros, Emilio; Estruch, Ramon] Spanish Govt, ISCIII, CIBER Ctr Biomed Network Res Fisiopatol Obesidad, Madrid, Spain; [Corella, Dolores] Univ Valencia, Dept Prevent Med, Valencia, Spain; [Salas-Salvado, Jordi] Univ Rovira & Virgili, IISPV, Dept Human Nutr, E-43201 Reus, Spain; [Isabel Covas, Maria; Schroeder, Helmut] Inst Recerca Hosp Mar, Cardiovasc & Nutr Res Grp, Barcelona, Spain; [Aros, Fernando] Univ Hosp Alava, Dept Cardiol, Vitoria, Spain; [Gomez-Gracia, Enrique; Waernberg, Julia] Univ Malaga, Dept Prevent Med, E-29071 Malaga, Spain; [Fiol, Miquel] Univ Balearic Isl, Inst Hlth Sci IUNICS, Palma de Mallorca, Spain; [Fiol, Miquel] Hosp Son Espases, Palma de Mallorca, Spain; [Ruiz-Gutierrez, Valentina] CSIC, Inst Grasa, Seville, Spain; [Lapetra, Jose] San Pablo Hlth Ctr, Primary Care Div Sevilla, Dept Family Med, Seville, Spain; [Maria Lamuela-Raventos, Rosa] Univ Barcelona, INSA, XaRTA, Dept Nutr & Food Sci,Sch Pharm, Barcelona, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Pinto, Xavier] Hosp Llobregat, Hosp Univ Bellvitge, Lipids & Vasc Risk Unit, Barcelona, Spain; [Angel Munoz, Miguel] Catalonian Inst Hlth, Primary Care Div, Barcelona, Spain; [Ros, Emilio] Univ Barcelona, Hosp Clin, Dept Endocrinol & Nutr, Inst Invest Biomed August Pi Sunyer IDIBAPS,Lipid, Barcelona, Spain; [Estruch, Ramon] Univ Barcelona, Hosp Clin, Dept Internal Med, Inst Invest Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain	Instituto de Salud Carlos III; University of Navarra; Instituto de Salud Carlos III; University of Valencia; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universidad de Malaga; Universitat de les Illes Balears; Hospital Universitari Son Espases; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG); University of Barcelona; Universidad de Las Palmas de Gran Canaria; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Martinez-Gonzalez, MA (corresponding author), Spanish Govt, ISCIII, PREDIMED Prevenc Con Dieta Mediterranea Network R, Madrid, Spain.	mamartinez@unav.es	IBIS, ATENCION PRIMARIA/I-3524-2016; Warnberg, Julia/G-1390-2011; Schroder, Helmut/G-2586-2015; Muñoz, Miguel Angel/X-3511-2019; Toledo, Estefania/H-6211-2014; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Fiol, Miguel/F-6793-2016; Estruch, Ramon/AAZ-3723-2020; Salas-Salvado, Jordi/C-7229-2017; Serra-Majem, Lluis/I-6708-2019; Pintó, Xavier/AGI-4297-2022; perez, miguel/GXF-5077-2022; Stefanadis, Christodoulos/ABH-2232-2020; Lamuela-Raventos, Rosa M/F-3986-2016	Warnberg, Julia/0000-0002-8408-316X; Schroder, Helmut/0000-0003-2231-5081; Muñoz, Miguel Angel/0000-0002-4083-3248; Toledo, Estefania/0000-0002-6263-4434; Fiol, Miguel/0000-0002-5370-1391; Salas-Salvado, Jordi/0000-0003-2700-7459; Serra-Majem, Lluis/0000-0002-9658-9061; Pintó, Xavier/0000-0002-2216-2444; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; GARCIA ARELLANO, ANA/0000-0003-1491-9627; Stefanadis, Christodoulos/0000-0001-5974-6454; Ros, Emilio/0000-0002-2573-1294; Buil-Cosiales, Pilar/0000-0002-8586-577X; Lamuela-Raventos, Rosa M/0000-0002-1287-4560	Biomedical Research of the Spanish Government; Instituto de Salud Carlos III (ISCIII) [RTIC G03/140, CIBERobn, RD 06/0045, PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407, PI11/01647]; Rio-Hortega post-residency fellowship	Biomedical Research of the Spanish Government; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Rio-Hortega post-residency fellowship	The Official funding agency for Biomedical Research of the Spanish Government, Instituto de Salud Carlos III (ISCIII), provided the grants for his study: RTIC G03/140, CIBERobn, RD 06/0045, PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407 and PI11/01647. CIBERobn and RTIC RD 06/0045 are initiatives of ISCIII, Spain. RT is supported by a Rio-Hortega post-residency fellowship of the Instituto de Salud Carlos III, Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Buckland G, 2008, OBES REV, V9, P582, DOI 10.1111/j.1467-789X.2008.00503.x; Bullo M, 2011, PREV MED, V53, P155, DOI 10.1016/j.ypmed.2011.06.008; Calder PC, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511005460; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011; Esposito K, 2011, METAB SYNDR RELAT D, V9, P1, DOI 10.1089/met.2010.0031; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Estruch R, 2010, P NUTR SOC, V69, P333, DOI 10.1017/S0029665110001539; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Field AE, 2007, OBESITY, V15, P967, DOI 10.1038/oby.2007.616; Fuentes F, 2008, BRIT J NUTR, V100, P159, DOI 10.1017/S0007114508888708; Gao SK, 2008, AM J CLIN NUTR, V88, P64; Beunza JJ, 2010, AM J CLIN NUTR, V92, P1484, DOI 10.3945/ajcn.2010.29764; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Kimokoti RW, 2010, J NUTR, V140, P1287, DOI 10.3945/jn.109.120808; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719; Lassale C, 2012, INT J OBESITY, V36, P1455, DOI 10.1038/ijo.2011.264; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Ludwig DS, 2012, JAMA-J AM MED ASSOC, V307, P498, DOI 10.1001/jama.2011.2011; Maillot M, 2011, AM J CLIN NUTR, V94, P1127, DOI 10.3945/ajcn.111.016501; Martinez-Gonzalez MA, 2004, EUR J CLIN NUTR, V58, P1550, DOI 10.1038/sj.ejcn.1602004; Martinez-Gonzalez MA, 2002, EUR J NUTR, V41, P153, DOI 10.1007/s00394-002-0370-6; McManus K, 2001, INT J OBESITY, V25, P1503, DOI 10.1038/sj.ijo.0801796; Mena MP, 2009, AM J CLIN NUTR, V89, P248, DOI 10.3945/ajcn.2008.26094; Mendez MA, 2006, J NUTR, V136, P2934, DOI 10.1093/jn/136.11.2934; Hermsdorff HHM, 2009, ENDOCRINE, V36, P445, DOI 10.1007/s12020-009-9248-1; Mombelli G, 2009, METAB SYNDR RELAT D, V7, P477, DOI 10.1089/met.2008.0101; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Nordmann AJ, 2011, AM J MED, V124, P841, DOI 10.1016/j.amjmed.2011.04.024; Panagiotakos DB, 2006, NUTRITION, V22, P449, DOI 10.1016/j.nut.2005.11.004; Quatromoni PA, 2006, OBESITY, V14, P1383, DOI 10.1038/oby.2006.157; Romaguera D, 2010, AM J CLIN NUTR, V92, P912, DOI 10.3945/ajcn.2010.29482; Romaguera D, 2009, J NUTR, V139, P1728, DOI 10.3945/jn.109.108902; Sanchez-Tainta A, 2008, EUR J CARDIOV PREV R, V15, P589, DOI 10.1097/HJR.0b013e328308ba61; Sanchez-Villegas A, 2006, INT J OBESITY, V30, P350, DOI 10.1038/sj.ijo.0803118; Schneider Harald J, 2011, Diabetes Care, V34, pe7, DOI 10.2337/dc10-1794; Schroder H, 2004, J NUTR, V134, P3355, DOI 10.1093/jn/134.12.3355; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Schroder H, 2010, INT J PEDIATR OBES, V5, P516, DOI 10.3109/17477161003777417; Serra-Majem L, 2009, BRIT J NUTR, V101, pS21, DOI 10.1017/S0007114509990559; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Trichopoulou A, 2005, AM J CLIN NUTR, V82, P935, DOI 10.1093/ajcn/82.5.935; Zamora D, 2010, AM J CLIN NUTR, V92, P784, DOI 10.3945/ajcn.2010.29161; Zazpe I, 2008, J AM DIET ASSOC, V108, P1134, DOI 10.1016/j.jada.2008.04.011	46	470	477	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43134	10.1371/journal.pone.0043134	http://dx.doi.org/10.1371/journal.pone.0043134			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905215	Green Published, gold			2022-12-27	WOS:000307500800049
J	Chen, H; Yu, KD; Xu, GZ				Chen, Han; Yu, Ke-Da; Xu, Ge-Zhi			Association between Variant Y402H in Age-Related Macular Degeneration (AMD) Susceptibility Gene CFH and Treatment Response of AMD: A Meta-Analysis	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; PHOTODYNAMIC THERAPY; INTRAVITREAL RANIBIZUMAB; LOC387715 GENOTYPES; POLYMORPHISM; BEVACIZUMAB; RISK	Purpose: To investigate the association between polymorphism rs1061170 (T1277C, Y402H) in age-related macular degeneration (AMD) susceptibility gene Complement Factor H (CFH) and treatment response of neovascular AMD. Methods: We performed a literature-based meta-analysis including 10 published association studies involving 1,510 patients. Treatments included anti-VEGF (bevacizumab and ranibizumab) or photodynamic therapy. Summary odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using fixed- and random-effects models. Q-statistic test was used to assess heterogeneity. Results: Polymorphism rs1061170 showed a significant summary OR of 1.68 (95% CI, 1.09 to 2.60; P = 0.020; CC versus TT; random-effects) for treatment response of neovascular AMD with heterogeneity of 0.09. In subgroup analysis, rs1061170 was more likely to be a predictor of response to anti-VEGF therapy (P = 0.011). However, heterozygous TC genotype was not associated with altered treatment response (OR = 1.18, 95% CI, 0.95 to 1.47; P = 0.145; fixed-effects). Influence analysis indicated the robustness of our findings. Conclusions: rs1061170 might be associated with treatment response of neovascular AMD, especially for the anti-VEGF agents. It might be the first meta-analytically confirmed genetic marker predictive for AMD treatment response though a further validation in larger studies is needed.	[Chen, Han; Xu, Ge-Zhi] Fudan Univ, Dept Ophthalmol, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China; [Yu, Ke-Da] Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Yu, Ke-Da] Fudan Univ, Inst Canc, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Chen, H (corresponding author), Fudan Univ, Dept Ophthalmol, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China.	fudanchenhan@gmail.com; yukd@shca.org.cn; xugezhi@gmail.com			National Basic Research grants of China [81170857]; Program Of Shanghai Subject Chief Scientist [09XD1400900]	National Basic Research grants of China; Program Of Shanghai Subject Chief Scientist	This work was supported by National Basic Research grants of China (81170857, 2011) and Program Of Shanghai Subject Chief Scientist (A type, 09XD1400900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brantley MA, 2009, EYE, V23, P626, DOI 10.1038/eye.2008.28; Brantley MA, 2007, OPHTHALMOLOGY, V114, P2168, DOI 10.1016/j.ophtha.2007.09.008; Cheung C.M., 2011, ARCH OPHTHALMOL; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Feng XF, 2009, OPHTHALMOLOGY, V116, P1908, DOI 10.1016/j.ophtha.2009.03.011; Goverdhan SV, 2008, EYE, V22, P849, DOI 10.1038/sj.eye.6702830; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Imai Daisuke, 2010, J Ocul Biol Dis Infor, V3, P53, DOI 10.1007/s12177-010-9055-1; Klein ML, 2008, OPHTHALMOLOGY, V115, P1019, DOI 10.1016/j.ophtha.2008.01.036; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kloeckener-Gruissem B, 2011, INVEST OPHTH VIS SCI, V52, P4694, DOI 10.1167/iovs.10-6080; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Lee AY, 2009, BRIT J OPHTHALMOL, V93, P610, DOI 10.1136/bjo.2008.150995; McKibbin M, 2012, BRIT J OPHTHALMOL, V96, P208, DOI 10.1136/bjo.2010.193680; Mori K, 2010, OPHTHALMOLOGY, V117, P928, DOI 10.1016/j.ophtha.2009.10.001; Nischler C, 2011, ACTA OPHTHALMOL, V89, pE344, DOI 10.1111/j.1755-3768.2010.02080.x; Orlin A, 2012, RETINA-J RET VIT DIS, V32, P4, DOI 10.1097/IAE.0b013e31822a2c7c; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Seitsonen SP, 2007, EUR J OPHTHALMOL, V17, P943, DOI 10.1177/112067210701700612; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Teper SJ, 2010, MOL VIS, V16, P2598; Thakkinstian A, 2011, AM J EPIDEMIOL, V173, P1365, DOI 10.1093/aje/kwr025; Ting AYC, 2009, CURR OPIN OPHTHALMOL, V20, P369, DOI 10.1097/ICU.0b013e32832f8016; Tsuchihashi T, 2011, OPHTHALMOLOGY, V118, P93, DOI 10.1016/j.ophtha.2010.04.007; Yachimski P, 2009, GASTROINTEST ENDOSC, V69, P205, DOI 10.1016/j.gie.2008.05.032; Yu KD, 2011, BREAST CANCER RES TR, V127, P577, DOI 10.1007/s10549-011-1361-1; Zhou P, 2011, FASEB J, V25, P3489, DOI 10.1096/fj.11-189258; Ziegler A, 2011, BREAST CANCER RES TR, V128, P197, DOI 10.1007/s10549-010-1295-z	30	40	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42464	10.1371/journal.pone.0042464	http://dx.doi.org/10.1371/journal.pone.0042464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905135	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800012
J	Jaillet, J; Genty, M; Cambefort, J; Rouault, JD; Auge-Gouillou, C				Jaillet, Jerome; Genty, Murielle; Cambefort, Jeanne; Rouault, Jacques-Deric; Auge-Gouillou, Corinne			Regulation of Mariner Transposition: The Peculiar Case of Mos1	PLOS ONE			English	Article							TRANSPOSABLE ELEMENT MARINER; RECENT HORIZONTAL TRANSFER; SYNAPTIC COMPLEX; GERM-LINE; IN-VITRO; DROSOPHILA; EVOLUTION; BINDING; ARCHITECTURE; CELLS	Background: Mariner elements represent the most successful family of autonomous DNA transposons, being present in various plant and animal genomes, including humans. The introduction and co-evolution of mariners within host genomes imply a strict regulation of the transposon activity. Biochemical data accumulated during the past decade have led to a convergent picture of the transposition cycle of mariner elements, suggesting that mariner transposition does not rely on host-specific factors. This model does not account for differences of transposition efficiency in human cells between mariners. We thus wondered whether apparent similarities in transposition cycle could hide differences in the intrinsic parameters that control mariner transposition. Principal Findings: We find that Mos1 transposase concentrations in excess to the Mos1 ends prevent the paired-end complex assembly. However, we observe that Mos1 transposition is not impaired by transposase high concentration, dismissing the idea that transposase over production plays an obligatory role in the down-regulation of mariner transposition. Our main finding is that the paired-end complex is formed in a cooperative way, regardless of the transposase concentration. We also show that an element framed by two identical ITRs (Inverted Terminal Repeats) is more efficient in driving transposition than an element framed by two different ITRs (i.e. the natural Mos1 copy), the latter being more sensitive to transposase concentration variations. Finally, we show that the current Mos1 ITRs correspond to the ancestral ones. Conclusions: We provide new insights on intrinsic properties supporting the self-regulation of the Mos1 element. These properties (transposase specific activity, aggregation, ITR sequences, transposase concentration/transposon copy number ratio.) could have played a role in the dynamics of host-genomes invasion by Mos1, accounting (at least in part) for the current low copy number of Mos1 within host genomes.	[Jaillet, Jerome; Genty, Murielle; Cambefort, Jeanne; Auge-Gouillou, Corinne] Univ Tours, EA 6306, Tours, France; [Rouault, Jacques-Deric] CNRS, Lab Evolut Genomes & Speciat, UPR9034, Gif Sur Yvette, France; [Rouault, Jacques-Deric] Univ Paris 11, Orsay, France	Universite de Tours; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Jaillet, J (corresponding author), Univ Tours, EA 6306, Parc Grandmont, Tours, France.	auge@univ-tours.fr	GOUILLOU, Corinne AUGE/T-2346-2018	GOUILLOU, Corinne AUGE/0000-0002-3340-5560	Universite Francois Rabelais (Tours); Centre National de la Recherche Scientifique (CNRS); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Agence Nationale de la recherche (ANR project Elegineer) [ANR 2010 BLAN 1618 02]	Universite Francois Rabelais (Tours); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Agence Nationale de la recherche (ANR project Elegineer)(French National Research Agency (ANR))	This research was supported by grants from the Universite Francois Rabelais (Tours), the Centre National de la Recherche Scientifique (CNRS), the Ministere de l'Education Nationale, de la Recherche et de la Technologie and from the Agence Nationale de la recherche (ANR project Elegineer, # ANR 2010 BLAN 1618 02). This work was sustained by the GIS mariner of the french CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge-Gouillou C, 2005, J MOL BIOL, V351, P117, DOI 10.1016/j.jmb.2005.05.019; Auge-Gouillou C, 2005, MOL CELL BIOL, V25, P2861, DOI 10.1128/MCB.25.7.2861-2870.2005; Auge-Gouillou C, 2001, MOL GENET GENOMICS, V265, P51, DOI 10.1007/s004380000385; BEACHY PA, 1993, MOL CELL BIOL, V13, P6941, DOI 10.1128/MCB.13.11.6941; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Bouuaert CC, 2011, MOL CELL BIOL, V31, P317, DOI 10.1128/MCB.01066-10; Bouuaert CC, 2010, NUCLEIC ACIDS RES, V38, P190, DOI 10.1093/nar/gkp891; Brunet F, 1999, J MOL EVOL, V49, P760, DOI 10.1007/PL00006598; Butler MG, 2006, GENETICA, V127, P351, DOI 10.1007/s10709-006-6250-x; Carpentier G, 2011, J MOL BIOL, V405, P892, DOI 10.1016/j.jmb.2010.11.032; Casteret S, 2009, MOL GENET GENOMICS, V282, P531, DOI 10.1007/s00438-009-0484-0; CRENES G, 2010, MOSL GENETICA, V138, P509, DOI DOI 10.1007/S10709-009-9387-6; Crenes G, 2009, MOL GENET GENOMICS, V281, P315, DOI 10.1007/s00438-008-0414-6; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; Germon S, 2009, GENETICA, V137, P265, DOI 10.1007/s10709-009-9375-x; Gueiros FJ, 1997, SCIENCE, V276, P1716, DOI 10.1126/science.276.5319.1716; Hartl DL, 1997, TRENDS GENET, V13, P197, DOI 10.1016/S0168-9525(97)01087-1; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Lampe DJ, 1998, GENETICS, V149, P179; Lipkow K, 2004, MOL CELL BIOL, V24, P8301, DOI 10.1128/MCB.24.18.8301-8311.2004; Liu N, 2004, INSECT MOL BIOL, V13, P443, DOI 10.1111/j.0962-1075.2004.00500.x; Lohe AR, 1996, MOL BIOL EVOL, V13, P549, DOI 10.1093/oxfordjournals.molbev.a025615; MARUYAMA K, 1991, J MOL EVOL, V33, P514, DOI 10.1007/BF02102804; MARUYAMA K, 1991, GENETICS, V128, P319; Ogura K, 2003, GENETICA, V119, P229, DOI 10.1023/B:GENE.0000003602.98863.67; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; ROBERTSON HM, 1995, MOL BIOL EVOL, V12, P850; Rouault JD, 2009, GENE, V448, P227, DOI 10.1016/j.gene.2009.08.009; Sinzelle L, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-106; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; Wang W, 2000, INSECT MOL BIOL, V9, P145, DOI 10.1046/j.1365-2583.2000.00172.x; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Zhang L, 2001, NUCLEIC ACIDS RES, V29, P3566, DOI 10.1093/nar/29.17.3566	37	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43365	10.1371/journal.pone.0043365	http://dx.doi.org/10.1371/journal.pone.0043365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905263	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800081
J	Bozdagi, O; Sakurai, T; Dorr, N; Pilorge, M; Takahashi, N; Buxbaum, JD				Bozdagi, Ozlem; Sakurai, Takeshi; Dorr, Nathan; Pilorge, Marion; Takahashi, Nagahide; Buxbaum, Joseph D.			Haploinsufficiency of Cyfip1 Produces Fragile X-Like Phenotypes in Mice	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; LONG-TERM POTENTIATION; PRADER-WILLI-SYNDROME; COPY NUMBER VARIATION; SYNAPTIC PLASTICITY; MOUSE MODEL; SOCIAL APPROACH; CRITICAL REGION; 4 GENES; SCHIZOPHRENIA	Background: Copy number variation (CNV) at the 15q11.2 region, which includes a gene that codes for CYFIP1 (cytoplasmic FMR1 interacting protein 1), has been implicated in autism, intellectual disability and additional neuropsychiatric phenotypes. In the current study we studied the function of Cyfip1 in synaptic physiology and behavior, using mice with a disruption of the Cyfip1 gene. Methodology/Principal Findings: We observed that in Cyfip1 heterozygous mice metabotropic glutamate receptor (mGluR)-dependent long-term depression (LTD) induced by paired-pulse low frequency stimulation (PP-LFS) was significantly increased in comparison to wildtype mice. In addition, mGluR-LTD was not affected in the presence of protein synthesis inhibitor in the Cyfip1 heterozygous mice, while the same treatment inhibited LTD in wildtype littermate controls. mGluR-agonist (RS)-3,5-dihydroxyphenylglycine (DHPG)-induced LTD was also significantly increased in hippocampal slices from Cyfip1 heterozygous mice and again showed independence from protein synthesis only in the heterozygous animals. Furthermore, we observed that the mammalian Target of Rapamycin (mTOR) inhibitor rapamycin was only effective at reducing mGluR-LTD in wildtype animals. Behaviorally, Cyfip1 heterozygous mice showed enhanced extinction of inhibitory avoidance. Application of both mGluR5 and mGluR1 antagonist to slices from Cyfip1 heterozygous mice reversed the increase in DHPG-induced LTD in these mice. Conclusions/Significance: These results demonstrate that haploinsufficiency of Cyfip1 mimics key aspects of the phenotype of Fmr1 knockout mice and are consistent with the hypothesis that these effects are mediated by interaction of Cyfip1 and Fmrp in regulating activity-dependent translation. The data provide support for a model where CYFIP1 haploinsufficiency in patients results in intermediate phenotypes increasing risk for neuropsychiatric disorders.	[Bozdagi, Ozlem; Sakurai, Takeshi; Dorr, Nathan; Pilorge, Marion; Takahashi, Nagahide; Buxbaum, Joseph D.] Mt Sinai Sch Med, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Bozdagi, Ozlem; Sakurai, Takeshi; Dorr, Nathan; Pilorge, Marion; Takahashi, Nagahide; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bozdagi, O (corresponding author), Mt Sinai Sch Med, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA.	joseph.buxbaum@mssm.edu	Takahashi, Nagahide/AAR-6268-2020; Buxbaum, Joseph D/G-6001-2010	Takahashi, Nagahide/0000-0002-7711-0297; Buxbaum, Joseph/0000-0001-8898-8313	Seaver Foundation	Seaver Foundation	This work was supported by the Seaver Foundation. OB and TS are Seaver Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bittel DC, 2006, PEDIATRICS, V118, pE1276, DOI 10.1542/peds.2006-0424; Botzolakis EJ, 2011, MOL CELL NEUROSCI, V46, P122, DOI 10.1016/j.mcn.2010.08.012; Bozdagi O, 2010, J NEUROSCI, V30, P9984, DOI 10.1523/JNEUROSCI.1223-10.2010; Burnside R, 2011, HUM GENET, V130, P517, DOI 10.1007/s00439-011-0970-4; Butler MG, 2004, PEDIATRICS, V113, P565, DOI 10.1542/peds.113.3.565; Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Doornbos M, 2009, EUR J MED GENET, V52, P108, DOI 10.1016/j.ejmg.2009.03.010; Elder GA, 2008, BEHAV BRAIN RES, V191, P256, DOI 10.1016/j.bbr.2008.03.036; Ferrari F, 2007, MOL CELL NEUROSCI, V34, P343, DOI 10.1016/j.mcn.2006.11.015; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Godfraind JM, 1996, AM J MED GENET, V64, P246; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Heyser Charles J, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0818s25; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Izumi N, 2008, J BIOL CHEM, V283, P12981, DOI 10.1074/jbc.M710282200; James AP, 2006, BIOCHIM BIOPHYS ACTA, V1762, p[11, 986]; Kirov G, 2010, EXPERT REV NEUROTHER, V10, P25, DOI [10.1586/ern.09.133, 10.1586/ERN.09.133]; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Murthy SK, 2007, CYTOGENET GENOME RES, V116, P135, DOI 10.1159/000097433; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; Peters SU, 2011, J CHILD PSYCHOL PSYC; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Sahoo T, 2006, J MED GENET, V43, P512, DOI 10.1136/jmg.2005.036913; Sakurai T, 2011, AUTISM RES, V4, P28, DOI 10.1002/aur.169; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; van der Zwaag B, 2010, AM J MED GENET B, V153B, P960, DOI 10.1002/ajmg.b.31055; von der Lippe C, 2011, EUR J MED GENET, V54, P357, DOI 10.1016/j.ejmg.2010.12.008; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101	48	73	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42422	10.1371/journal.pone.0042422	http://dx.doi.org/10.1371/journal.pone.0042422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900020	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900037
J	Coombs, GW; Goering, RV; Chua, KYL; Monecke, S; Howden, BP; Stinear, TP; Ehricht, R; O'Brien, FG; Christiansen, KJ				Coombs, Geoffrey W.; Goering, Richard V.; Chua, Kyra Y. L.; Monecke, Stefan; Howden, Benjamin P.; Stinear, Timothy P.; Ehricht, Ralf; O'Brien, Frances G.; Christiansen, Keryn J.			The Molecular Epidemiology of the Highly Virulent ST93 Australian Community Staphylococcus aureus Strain	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; UNITED-STATES; WESTERN-AUSTRALIA; GENES; ELECTROPHORESIS; HOSPITALS; LINEAGES; DATABASE; CLONES	In Australia the PVL - positive ST93-IV [2B], colloquially known as "Queensland CA-MRSA" has become the dominant CA-MRSA clone. First described in the early 2000s, ST93-IV [2B] is associated with skin and severe invasive infections including necrotizing pneumonia. A singleton by multilocus sequence typing (MLST) eBURST analysis ST93 is distinct from other S aureus clones. To determine if the increased prevalence of ST93-IV [2B] is due to the widespread transmission of a single strain of ST93-IV [2B] the genetic relatedness of 58 S. aureus ST93 isolated throughout Australia over an extended period were studied in detail using a variety of molecular methods including pulsed-field gel electrophoresis, spa typing, MLST, microarray DNA, SCCmec typing and dru typing. Identification of the phage harbouring the lukS-PV/lukF-PV Panton Valentine leucocidin genes, detection of allelic variations in lukS-PV/lukF-PV, and quantification of LukF-PV expression was also performed. Although ST93-IV [2B] is known to have an apparent enhanced clinical virulence, the isolates harboured few known virulence determinants. All PVL-positive isolates carried the PVL-encoding phage Phi Sa2USA and the lukS-PV/lukF-PV genes had the same R variant SNP profile. The isolates produced similar expression levels of LukF-PV. Although multiple rearrangements of the spa sequence have occurred, the core genome in ST93 is very stable. The emergence of ST93-MRSA is due to independent acquisitions of different dru-defined type IV and type V SCCmec elements in several spa-defined ST93-MSSA backgrounds. Rearrangement of the spa sequence in ST93-MRSA has subsequently occurred in some of these strains. Although multiple ST93-MRSA strains were characterised, little genetic diversity was identified for most isolates, with PVL-positive ST93-IVa [2B]-t202-dt10 predominant across Australia. Whether ST93-IVa [2B] t202-dt10 arose from one PVL-positive ST93-MSSA-t202, or by independent acquisitions of SCCmec-IVa [2B]-dt10 into multiple PVL-positive ST93-MSSA-t202 strains is not known.	[Coombs, Geoffrey W.; Christiansen, Keryn J.] Royal Perth Hosp, PathWest Lab Med Western Australia, Australian Collaborating Ctr Enterococcus & Staph, Western Australia, Australia; [Coombs, Geoffrey W.; O'Brien, Frances G.; Christiansen, Keryn J.] Curtin Univ, Sch Biomed Sci, Western Australia, Australia; [Goering, Richard V.] Creighton Univ, Dept Med Microbiol, Omaha, NE 68178 USA; [Chua, Kyra Y. L.; Howden, Benjamin P.; Stinear, Timothy P.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Chua, Kyra Y. L.; Howden, Benjamin P.] Austin Hlth, Dept Infect Dis, ACIR, Heidelberg, Vic, Australia; [Chua, Kyra Y. L.; Howden, Benjamin P.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Chua, Kyra Y. L.; Howden, Benjamin P.; Stinear, Timothy P.] Austin Hlth, Dept Microbiol, Heidelberg, Vic, Australia; [Monecke, Stefan; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany	Royal Perth Hospital; Curtin University; Creighton University; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Alere; Technische Universitat Dresden	Coombs, GW (corresponding author), Royal Perth Hosp, PathWest Lab Med Western Australia, Australian Collaborating Ctr Enterococcus & Staph, Western Australia, Australia.	Geoffrey.coombs@health.wa.gov.au		Goering, Richard/0000-0001-7502-7185; Stinear, Timothy/0000-0003-0150-123X; Chua, Kyra Yu Lin/0000-0001-8826-7137; Howden, Benjamin/0000-0003-0237-1473; Coombs, Geoffrey/0000-0003-1635-6506	PathWest Laboratory Medicine - WA; Curtin University; Western Australian Department of Health; National Health and Medical Research Council of Australia [1008656]	PathWest Laboratory Medicine - WA; Curtin University; Western Australian Department of Health; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by PathWest Laboratory Medicine - WA, Curtin University, the Western Australian Department of Health and the National Health and Medical Research Council of Australia Project Grant 1008656. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkhoucha SN, 2009, EUR J CLIN MICROBIOL, V28, P553, DOI 10.1007/s10096-008-0660-x; Benson G, 1997, J COMPUT BIOL, V4, P351, DOI 10.1089/cmb.1997.4.351; Boakes E, 2011, J CLIN MICROBIOL, V49, P684, DOI 10.1128/JCM.01917-10; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; CA-SFM, 1996, CLIN MICROBIOL INFEC, V2; Chua K, 2010, J BACTERIOL, V192, P5556, DOI 10.1128/JB.00878-10; Chua KYL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025887; CLSI, 2009, M100S18 CLSI; Collignon P, 1998, LANCET, V352, P145, DOI 10.1016/S0140-6736(98)85051-4; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; Coombs GW, 2009, COMMUN DIS INTELL, V33, P10; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Coombs GW, 2006, EMERG INFECT DIS, V12, P241; Costa AM, 2005, DIAGN MICR INFEC DIS, V51, P13, DOI 10.1016/j.diagmicrobio.2004.08.014; Ellington MJ, 2010, CLIN MICROBIOL INFEC, V16, P1009, DOI 10.1111/j.1469-0691.2009.02994.x; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P46, DOI 10.1093/jac/dkp386; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Finlay JE, 1997, ANTIMICROB AGENTS CH, V41, P1137, DOI 10.1128/AAC.41.5.1137; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Ma XX, 2008, J CLIN MICROBIOL, V46, P3246, DOI 10.1128/JCM.00136-08; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Munckhof WJ, 2008, EUR J CLIN MICROBIOL, V27, P355, DOI 10.1007/s10096-007-0449-3; Munckhof Wendy J., 2003, International Journal of Infectious Diseases, V7, P259, DOI 10.1016/S1201-9712(03)90104-4; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; O'Brien FG, 2009, J ANTIMICROB CHEMOTH, V64, P684, DOI 10.1093/jac/dkp285; O'Brien FG, 2006, NAT PROTOC, V1, P3028, DOI 10.1038/nprot.2006.382; Peleg AY, 2005, EUR J CLIN MICROBIOL, V24, P384, DOI 10.1007/s10096-005-1329-3; Riley D, 1998, NEW ZEAL MED J, V111, P59; Risson DC, 2007, MED J AUSTRALIA, V186, P479, DOI 10.5694/j.1326-5377.2007.tb01002.x; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P1324, DOI 10.1128/AAC.05804-11; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Tong SYC, 2009, CLIN MICROBIOL INFEC, V15, P1126, DOI 10.1111/j.1469-0691.2009.02732.x; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Udo EE, 2008, J CLIN MICROBIOL, V46, P3514, DOI 10.1128/JCM.00966-08; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wolter DJ, 2007, CLIN MICROBIOL INFEC, V13, P827, DOI 10.1111/j.1469-0691.2007.01763.x	44	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43037	10.1371/journal.pone.0043037	http://dx.doi.org/10.1371/journal.pone.0043037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900085	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900103
J	Herrera-Aguilar, JL; Larralde, H; Aldana, M				Herrera-Aguilar, Jose L.; Larralde, Hernan; Aldana, Maximino			Pattern Recognition in Neural Networks with Competing Dynamics: Coexistence of Fixed-Point and Cyclic Attractors	PLOS ONE			English	Article							STATE-DEPENDENT SYNAPSES; LONG-TERM-MEMORY; STORAGE CAPACITY; MODEL	We study the properties of the dynamical phase transition occurring in neural network models in which a competition between associative memory and sequential pattern recognition exists. This competition occurs through a weighted mixture of the symmetric and asymmetric parts of the synaptic matrix. Through a generating functional formalism, we determine the structure of the parameter space at non-zero temperature and near saturation (i.e., when the number of stored patterns scales with the size of the network), identifying the regions of high and weak pattern correlations, the spin-glass solutions, and the order-disorder transition between these regions. This analysis reveals that, when associative memory is dominant, smooth transitions appear between high correlated regions and spurious states. In contrast when sequential pattern recognition is stronger than associative memory, the transitions are always discontinuous. Additionally, when the symmetric and asymmetric parts of the synaptic matrix are defined in terms of the same set of patterns, there is a discontinuous transition between associative memory and sequential pattern recognition. In contrast, when the symmetric and asymmetric parts of the synaptic matrix are defined in terms of independent sets of patterns, the network is able to perform both associative memory and sequential pattern recognition for a wide range of parameter values.	[Herrera-Aguilar, Jose L.; Larralde, Hernan; Aldana, Maximino] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico; [Herrera-Aguilar, Jose L.] Univ Autonoma Estado Morelos, Fac Ciencias, Cuernavaca, Morelos, Mexico; [Aldana, Maximino] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Aldana, Maximino] Harvard Univ, David Rockefeller Ctr Latin Amer Studies, Cambridge, MA 02138 USA	Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Harvard University; Harvard University	Herrera-Aguilar, JL (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico.	jlherrera@uach.mx	Aldana, Maximino/D-9372-2017	Aldana, Maximino/0000-0002-3419-6641; Larralde, Hernan/0000-0002-6037-2629	PAPIIT-UNAM [IN109111]; SEP-CONACyT [129471]; David Rockefeller Center at Harvard University; CONACyT [177241]; Fundacion BBVA Bancomer-UAEM	PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); David Rockefeller Center at Harvard University; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion BBVA Bancomer-UAEM	This work was partially supported by PAPIIT-UNAM grant IN109111 and the SEP-CONACyT grant no. 129471. MA acknowledges David Rockefeller Center at Harvard University for the Madero/ Fundacion Mexico Fellowship. JLHA also thanks CONACyT for a Ph.D. grant under contract No. 177241 and Fundacion BBVA Bancomer-UAEM for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AMIT DJ, 1985, PHYS REV A, V32, P1007, DOI 10.1103/PhysRevA.32.1007; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; AMIT DJ, 1987, ANN PHYS-NEW YORK, V173, P30, DOI 10.1016/0003-4916(87)90092-3; COOLEN ACC, 1992, J PHYS A-MATH GEN, V25, P5493, DOI 10.1088/0305-4470/25/21/011; During A, 1998, J PHYS A-MATH GEN, V31, P8607, DOI 10.1088/0305-4470/31/43/005; Fukai T, 1999, J PHYS A-MATH GEN, V32, P5551, DOI 10.1088/0305-4470/32/30/303; GRINIASTY M, 1993, NEURAL COMPUT, V5, P1, DOI 10.1162/neco.1993.5.1.1; Hebb Donald O., 1949, ORG BEHAV; Hertz J, 1991, SANTA FE I SCI COMPL, VI; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kawamura M, 2002, J PHYS A-MATH GEN, V35, P253, DOI 10.1088/0305-4470/35/2/306; LAUGHTON SN, 1994, J PHYS A-MATH GEN, V27, P8011, DOI 10.1088/0305-4470/27/24/013; LITTLE W A, 1974, Mathematical Biosciences, V19, P101, DOI 10.1016/0025-5564(74)90031-5; LITTLE WA, 1975, BEHAV BIOL, V14, P115, DOI 10.1016/S0091-6773(75)90122-4; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; Metz FL, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/38/385001; Metz FL, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041907; Metz FL, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021908; Mimura K, 2004, J PHYS A-MATH GEN, V37, P6437, DOI 10.1088/0305-4470/37/25/002; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; WHYTE W, 1995, J PHYS A-MATH GEN, V28, P3421, DOI 10.1088/0305-4470/28/12/016; ZERTUCHE F, 1994, J PHYS A-MATH GEN, V27, P5879, DOI 10.1088/0305-4470/27/17/020; ZERTUCHE F, 1994, J PHYS A-MATH GEN, V27, P1575, DOI 10.1088/0305-4470/27/5/021	24	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42348	10.1371/journal.pone.0042348	http://dx.doi.org/10.1371/journal.pone.0042348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900014	Green Published, gold			2022-12-27	WOS:000307380900031
J	Howard, J; Battaglini, M; Babb, JS; Arienzo, D; Holst, B; Omari, M; De Stefano, N; Herbert, J; Inglese, M				Howard, Jonathan; Battaglini, Marco; Babb, James Scott; Arienzo, Donatello; Holst, Brigitte; Omari, Mirza; De Stefano, Nicola; Herbert, Joseph; Inglese, Matilde			MRI Correlates of Disability in African-Americans with Multiple Sclerosis	PLOS ONE			English	Article								Objectives: Multiple sclerosis (MS) in African-Americans (AAs) is characterized by more rapid disease progression and poorer response to treatment than in Caucasian-Americans (CAs). MRI provides useful and non-invasive tools to investigate the pathological substrate of clinical progression. The aim of our study was to compare MRI measures of brain damage between AAs and CAs with MS. Methods: Retrospective analysis of 97 AAs and 97 CAs with MS matched for age, gender, disease duration and age at MRI examination. Results: AA patients had significantly greater T2- (p = 0.001) and T1-weighted (p = 0.0003) lesion volumes compared to CA patients. In contrast, measurements of global and regional brain volume did not significantly differ between the two ethnic groups (p>0.1). Conclusions: By studying a quite large sample of well demographically and clinically matched CA and AA patients with a homogeneous MRI protocol we showed that higher lesion accumulation, rather than pronounced brain volume decrease might explain the early progress to ambulatory assistance of AAs with MS.	[Howard, Jonathan; Omari, Mirza; Herbert, Joseph; Inglese, Matilde] Langone Med Ctr, Dept Neurol, New York, NY USA; [Babb, James Scott; Arienzo, Donatello; Holst, Brigitte; Inglese, Matilde] Langone Med Ctr, Dept Radiol, New York, NY USA; [Battaglini, Marco; De Stefano, Nicola] Univ Siena, Dept Neurol & Behav Sci, I-53100 Siena, Italy; [Holst, Brigitte] Univ Med Ctr Hamburg Eppendorf, Dept Neuroradiol, Hamburg, Germany; [Inglese, Matilde] Mt Sinai Sch Med, Dept Neurol, New York, NY USA	NYU Langone Medical Center; NYU Langone Medical Center; University of Siena; University of Hamburg; University Medical Center Hamburg-Eppendorf; Icahn School of Medicine at Mount Sinai	Howard, J (corresponding author), Langone Med Ctr, Dept Neurol, New York, NY USA.	matilde.inglese@mssm.edu	Inglese, Matilde/AAH-3189-2020; De Stefano, Nicola/AHE-3052-2022	Inglese, Matilde/0000-0002-9610-0297; De Stefano, Nicola/0000-0003-4930-7639; Howard, Jonathan/0000-0003-2658-3219	National institute of health (NIH) [R01 NS051623]; Merck Serono; Novartis; Teva Pharmaceutical Industries ltd.; Biogen; Teva; Bayer; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051623] Funding Source: NIH RePORTER	National institute of health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Serono(Merck & Company); Novartis(Novartis); Teva Pharmaceutical Industries ltd.(Teva Pharmaceutical Industries); Biogen(Biogen); Teva(Teva Pharmaceutical Industries); Bayer(Bayer AG); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded in part by National institute of health (NIH) [grant R01 NS051623 to Mirza Omari]. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Nicola De Stefano serves on the scientific advisory boards for Merck Serono and Novartis; he has received funding for travel from Merck Serono, Novartis and Teva Pharmaceutical Industries ltd.; he has received speaker honoraria from Novartis, Teva Pharmaceutical Industries ltd., Biogen-Dompe, Schering-Bayer, Sanofi-Aventis, and Merck Serono. Joseph Herbert has received grants from Biogen, Teva, Merk Serono and Bayer. Mirza Omari is funded by NIH grant R01 NS051623. Mirza Omari serves on the scientific advisory board of Celgene and she has served as consultant for Vaccinex and Biogen. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Battaglini M., 2011, HUM BRAIN MAPP; Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D; Gelfand JM, 2011, NEUROLOGY, V76, P1824, DOI 10.1212/WNL.0b013e31821cccf5; Inglese M, 2010, BRAIN, V133, P847, DOI 10.1093/brain/awp334; Isamah N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013642; Kister I, 2010, NEUROLOGY, V75, P217, DOI 10.1212/WNL.0b013e3181e8e72a; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Naismith RT, 2006, MULT SCLER J, V12, P775, DOI 10.1177/1352458506070923; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rinker JR, 2007, NEUROLOGY, V69, P68, DOI 10.1212/01.wnl.0000265057.79843.d9; Wallin MT, 2004, ANN NEUROL, V55, P65, DOI 10.1002/ana.10788; Weinstock-Guttman B, 2010, NEUROLOGY, V74, P538, DOI 10.1212/WNL.0b013e3181cff6fb	12	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43061	10.1371/journal.pone.0043061	http://dx.doi.org/10.1371/journal.pone.0043061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900088	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900106
J	Kuhn, PC; Horimoto, ARVR; Sanches, JM; Vieira, JPB; Franco, L; Dal Fabbro, A; Franco, LJ; Pereira, AC; Moises, RS				Kuhn, Patricia C.; Russo Horimoto, Andrea R. V.; Sanches, Jose Mauricio; Vieira Filho, Joao Paulo B.; Franco, Luciana; Dal Fabbro, Amaury; Franco, Laercio Joel; Pereira, Alexandre C.; Moises, Regina S.			Genome-Wide Analysis in Brazilian Xavante Indians Reveals Low Degree of Admixture	PLOS ONE			English	Article							GENETIC-STRUCTURE; PATTERNS; POPULATIONS; HISTORY; ORIGIN	Characterization of population genetic variation and structure can be used as tools for research in human genetics and population isolates are of great interest. The aim of the present study was to characterize the genetic structure of Xavante Indians and compare it with other populations. The Xavante, an indigenous population living in Brazilian Central Plateau, is one of the largest native groups in Brazil. A subset of 53 unrelated subjects was selected from the initial sample of 300 Xavante Indians. Using 86,197 markers, Xavante were compared with all populations of HapMap Phase III and HGDP-CEPH projects and with a Southeast Brazilian population sample to establish its population structure. Principal Components Analysis showed that the Xavante Indians are concentrated in the Amerindian axis near other populations of known Amerindian ancestry such as Karitiana, Pima, Surui and Maya and a low degree of genetic admixture was observed. This is consistent with the historical records of bottlenecks experience and cultural isolation. By calculating pair-wise F-st statistics we characterized the genetic differentiation between Xavante Indians and representative populations of the HapMap and from HGDP-CEPH project. We found that the genetic differentiation between Xavante Indians and populations of Ameridian, Asian, European, and African ancestry increased progressively. Our results indicate that the Xavante is a population that remained genetically isolated over the past decades and can offer advantages for genome-wide mapping studies of inherited disorders.	[Kuhn, Patricia C.; Vieira Filho, Joao Paulo B.; Franco, Luciana; Moises, Regina S.] Univ Fed Sao Paulo, Disciplina Endocrinol, Escola Paulista Med, Sao Paulo, Brazil; [Russo Horimoto, Andrea R. V.; Sanches, Jose Mauricio; Pereira, Alexandre C.] Univ Sao Paulo, Sch Med, Lab Genet & Mol Cardiol, Inst Heart, Sao Paulo, Brazil; [Dal Fabbro, Amaury; Franco, Laercio Joel] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Social Med, Ribeirao Preto, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Kuhn, PC (corresponding author), Univ Fed Sao Paulo, Disciplina Endocrinol, Escola Paulista Med, Sao Paulo, Brazil.	rmoises@unifesp.br	Pereira, Alexandre/HHN-1038-2022; Dal-Fabbro, Amaury/H-7307-2012; Moises, Regina/AAP-8918-2021	Dal-Fabbro, Amaury/0000-0002-0824-4603; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); INCT- Obesidade e Diabetes	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT- Obesidade e Diabetes	This study was funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and INCT- Obesidade e Diabetes. The funders have no rule in study design, data coletion and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Coimbra Jr CEA, 2002, XAVANT TRANSITION HL; Friedrich DC, 2012, AM J PHYS ANTHROPOL, V147, P427, DOI 10.1002/ajpa.22010; Garfield Seth, 2001, INDIGENOUS STRUGGLE; Giolo SR, 2012, EUR J HUM GENET, V20, P111, DOI 10.1038/ejhg.2011.144; Jorde LB, 2000, HUM HERED, V50, P57, DOI 10.1159/000022891; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kolman CJ, 1996, GENETICS, V142, P1321; Kristiansson K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-109; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Pereira NDM, 2009, HUM ORGAN, V68, P166; Mulligan CJ, 2004, ANNU REV GENOM HUM G, V5, P295, DOI 10.1146/annurev.genom.5.061903.175920; NEEL JV, 1964, AM J HUM GENET, V16, P52; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Salzano FM, 1997, AM J PHYS ANTHROPOL, V104, P23, DOI 10.1002/(SICI)1096-8644(199709)104:1<23::AID-AJPA2>3.0.CO;2-E; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Sheffield VC, 1998, TRENDS GENET, V14, P391, DOI 10.1016/S0168-9525(98)01556-X; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	27	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42702	10.1371/journal.pone.0042702	http://dx.doi.org/10.1371/journal.pone.0042702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900041	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900058
J	Lee, DN; Papes, M; Van Den Bussche, RA				Lee, Dana N.; Papes, Monica; Van Den Bussche, Ronald A.			Present and Potential Future Distribution of Common Vampire Bats in the Americas and the Associated Risk to Cattle	PLOS ONE			English	Article							CLIMATE-CHANGE; GEOGRAPHIC DISTRIBUTIONS; DESMODUS-ROTUNDUS; SPECIES DISTRIBUTIONS; TRANSMITTED RABIES; SPATIAL-PATTERNS; LIVESTOCK; DISEASE; MODELS; PREDICTION	Success of the cattle industry in Latin America is impeded by the common vampire bat, Desmodus rotundus, through decreases in milk production and mass gain and increased risk of secondary infection and rabies. We used ecological niche modeling to predict the current potential distribution of D. rotundus and the future distribution of the species for the years 2030, 2050, and 2080 based on the A2, A1B, and B1 climate scenarios from the Intergovernmental Panel on Climate Change. We then combined the present day potential distribution with cattle density estimates to identify areas where cattle are at higher risk for the negative impacts due to D. rotundus. We evaluated our risk prediction by plotting 17 documented outbreaks of cattle rabies. Our results indicated highly suitable habitat for D. rotundus occurs throughout most of Mexico and Central America as well as portions of Venezuela, Guyana, the Brazilian highlands, western Ecuador, northern Argentina, and east of the Andes in Peru, Bolivia, and Paraguay. With future climate projections suitable habitat for D. rotundus is predicted in these same areas and additional areas in French Guyana, Suriname, Venezuela and Columbia; however D. rotundus are not likely to expand into the U.S. because of inadequate 'temperature seasonality.' Areas with large portions of cattle at risk include Mexico, Central America, Paraguay, and Brazil. Twelve of 17 documented cattle rabies outbreaks were represented in regions predicted at risk. Our present day and future predictions can help authorities focus rabies prevention efforts and inform cattle ranchers which areas are at an increased risk of cattle rabies because it has suitable habitat for D. rotundus.	[Lee, Dana N.; Papes, Monica; Van Den Bussche, Ronald A.] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Lee, DN (corresponding author), Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA.	dana.lee10@okstate.edu		Van Den Bussche, Ronald/0000-0002-6481-3209				Acha P. N., 1988, Natural history of vampire bats., P207; Aguiar LMS, 2010, ACTA CHIROPTEROL, V12, P275, DOI 10.3161/150811010X537855; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; ARELLANOSOTA C, 1988, REV INFECT DIS, V10, pS615; ARELLANOSOTA C, 1988, REV INFECT DIS, V10, pS707; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; Bradley BA, 2010, BIOL INVASIONS, V12, P1855, DOI 10.1007/s10530-009-9597-y; Coen CE, 2002, THESIS CORNELL U ITH, P11; DELPIETRO HA, 1992, PREV VET MED, V14, P13, DOI 10.1016/0167-5877(92)90080-Y; ELIAS DJ, 1978, B ENVIRON CONTAM TOX, V20, P71, DOI 10.1007/BF01683488; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; ESRI, 2011, ARCGIS DESKT REL 10; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Flores-Crespo R., 1991, P461; Gibbons RV, 2002, ANN EMERG MED, V39, P528, DOI 10.1067/mem.2002.121521; Gomes MN, 2010, PREV VET MED, V93, P139, DOI 10.1016/j.prevetmed.2009.10.006; GONZALEZ R, 1976, Proceedings of the Vertebrate Pest Conference, V7, P254; GREENHALL A M, 1983, Mammalian Species, P1, DOI 10.2307/3503895; GREENHALL A M, 1971, Biotropica, V3, P136, DOI 10.2307/2989817; GREENHALL AM, 1972, J ZOOL, V168, P451; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Jones P.G., 2009, GENERATING CHARACTER; Kobayashi Y, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-44; KUZMIN IV, 2007, RABIES, P259; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Leedom JM, 2006, CLIN INFECT DIS, V43, P610, DOI 10.1086/507035; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lord R.D., 1980, Proceedings of the Vertebrate Pest Conference, V9, P170; Machado-Machado EA, 2012, APPL GEOGR, V33, P82, DOI 10.1016/j.apgeog.2011.06.011; MartinezBurnes J, 1997, CAN VET J, V38, P175; Massad E, 2001, THEOR POPUL BIOL, V60, P265, DOI 10.1006/tpbi.2000.1494; Mayen F, 2003, J VET MED B, V50, P469, DOI 10.1046/j.1439-0450.2003.00713.x; MCNAB BK, 1973, J MAMMAL, V54, P131, DOI 10.2307/1378876; Meltzer MI, 1998, PHARMACOECONOMICS, V14, P481, DOI 10.2165/00019053-199814050-00003; Mistry S, 2008, BATS, V26, P8; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Neerinckx SB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-54; Nel L., 2009, MICROBE, V4, P61; [Pan American Health Organization Veterinary Public Health Program], 1993, EP SURV RAB AM; Pan American Health Organization Veterinary Public Health Program, 2007, EP SURV RAB AM; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, SYNTH AM MUS NAT HIS, V50; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson A Townsend, 2007, Vet Ital, V43, P393; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Peterson AT, 2001, ECOL MODEL, V144, P21, DOI 10.1016/S0304-3800(01)00345-3; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; ProMED-mail, RAB VIR COWS MEX CEN; Rebelo H, 2010, GLOBAL CHANGE BIOL, V16, P561, DOI 10.1111/j.1365-2486.2009.02021.x; Rios NE, 2010, GEOLOCATE VERSION 3; Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836; Saupe EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017731; SCHMIDT K M, 1979, Proceedings of the Oklahoma Academy of Science, V59, P112; SIKES RK, 1970, AM J PUBLIC HEALTH N, V60, P1133, DOI 10.2105/AJPH.60.6.1133; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sterner RT, 2004, P VERTEBR PEST C, V390, P185; THOMPSON RD, 1977, J WILDLIFE MANAGE, V41, P736, DOI 10.2307/3799998; THOMPSON RD, 1972, SCIENCE, V177, P806, DOI 10.1126/science.177.4051.806; Turner DC, 1995, VAMPIRE BAT FIELD ST; Voigt CC, 2006, J MAMMAL, V87, P1, DOI 10.1644/05-MAMM-F-276R1.1; Wint G. R. W., 2007, GRIDDED LIVESTOCK WO; Zijpp J. van der, 2003, Archivos Latinoamericanos de Produccion Animal, V11, P50	73	80	83	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42466	10.1371/journal.pone.0042466	http://dx.doi.org/10.1371/journal.pone.0042466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900023	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900039
J	Yeo, J; Hong, S; Lee, D; Hotz, N; Lee, MT; Grigoropoulos, CP; Ko, SH				Yeo, Junyeob; Hong, Sukjoon; Lee, Daehoo; Hotz, Nico; Lee, Ming-Tsang; Grigoropoulos, Costas P.; Ko, Seung Hwan			Next Generation Non-Vacuum, Maskless, Low Temperature Nanoparticle Ink Laser Digital Direct Metal Patterning for a Large Area Flexible Electronics	PLOS ONE			English	Article							STRETCHABLE ELECTRONICS; ELASTIC CONDUCTORS; ARRAYS; GOLD; TRANSISTORS; SUBSTRATE; DISPLAYS	Flexible electronics opened a new class of future electronics. The foldable, light and durable nature of flexible electronics allows vast flexibility in applications such as display, energy devices and mobile electronics. Even though conventional electronics fabrication methods are well developed for rigid substrates, direct application or slight modification of conventional processes for flexible electronics fabrication cannot work. The future flexible electronics fabrication requires totally new low-temperature process development optimized for flexible substrate and it should be based on new material too. Here we present a simple approach to developing a flexible electronics fabrication without using conventional vacuum deposition and photolithography. We found that direct metal patterning based on laser-induced local melting of metal nanoparticle ink is a promising low-temperature alternative to vacuum deposition- and photolithography-based conventional metal patterning processes. The "digital" nature of the proposed direct metal patterning process removes the need for expensive photomask and allows easy design modification and short turnaround time. This new process can be extremely useful for current small-volume, large-variety manufacturing paradigms. Besides, simple, scalable, fast and low-temperature processes can lead to cost-effective fabrication methods on a large-area polymer substrate. The developed process was successfully applied to demonstrate high-quality Ag patterning (2.1 mu Omega.cm) and high-performance flexible organic field effect transistor arrays.	[Yeo, Junyeob; Hong, Sukjoon; Ko, Seung Hwan] Korea Adv Inst Sci & Technol, Appl Nano Technol & Sci Lab, Dept Mech Engn, Taejon 305701, South Korea; [Lee, Daehoo; Grigoropoulos, Costas P.] Univ Calif Berkeley, Laser Thermal Lab, Berkeley, CA 94720 USA; [Hotz, Nico] Duke Univ, Dept Mech Engn & Mat Sci, Thermodynam & Sustainable Energy Lab, Durham, NC 27706 USA; [Lee, Ming-Tsang] Natl Chung Hsing Univ, Dept Mech Engn, Taichung 40227, Taiwan	Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California Berkeley; Duke University; National Chung Hsing University	Yeo, J (corresponding author), Korea Adv Inst Sci & Technol, Appl Nano Technol & Sci Lab, Dept Mech Engn, Taejon 305701, South Korea.	cgrigoro@me.berkeley.edu; maxko@kaist.ac.kr	Ko, Seung Hwan/B-5448-2008; Hotz, Nico/A-5624-2013; Yeo, Junyeob/I-1287-2013; Lee, Daeho/M-2734-2017; Ko, Seung Hwan/B-5448-2008	Ko, Seung Hwan/0000-0002-7477-0820; Yeo, Junyeob/0000-0001-7422-3467; Lee, Daeho/0000-0002-8119-9677; Lee, Ming-Tsang/0000-0002-5715-6044; Ko, Seung Hwan/0000-0001-5614-4773; Grigoropoulos, Costas/0000-0002-8505-4037	National Research Foundation of Korea [2011-0005321, 2011-0028662]; Ministry of Education Science of Korea; King Abdullah University of Science and Technology; U.S. National Science Foundation Small Business Technology Transfer Program through AppliFlex LLC [0930594]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education Science of Korea; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); U.S. National Science Foundation Small Business Technology Transfer Program through AppliFlex LLC	This study was partially supported by Basic Science Research Program (2011-0005321, 2011-0028662) from the National Research Foundation of Korea funded by the Ministry of Education Science of Korea to Korea Advanced Institute of Science and Technology, and by a grant from King Abdullah University of Science and Technology to UC Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests to declare. This study was partially supported by the U.S. National Science Foundation Small Business Technology Transfer Program (0930594) through AppliFlex LLC. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Ding L, 2010, EUR J INORG CHEM, P4357, DOI 10.1002/ejic.201000563; Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061; Hu LB, 2009, P NATL ACAD SCI USA, V106, P21490, DOI 10.1073/pnas.0908858106; Khairy M, 2010, ELECTROANAL, V22, P2496, DOI 10.1002/elan.201000226; Ko SH, 2008, APPL PHYS A-MATER, V92, P579, DOI 10.1007/s00339-008-4597-9; Ko SH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345202; Ko SH, 2007, J APPL PHYS, V102, DOI 10.1063/1.2802302; Ko SH, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/12/125010; Ko SH, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.05EC03; Korgel BA, 1998, ADV MATER, V10, P661, DOI 10.1002/(SICI)1521-4095(199806)10:9<661::AID-ADMA661>3.0.CO;2-L; Lacour SP, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2201874; Link S, 1999, J PHYS CHEM B, V103, P8410, DOI 10.1021/jp9917648; Lipomi DJ, 2011, ADV MATER, V23, P1771, DOI 10.1002/adma.201004426; Murphy AR, 2005, CHEM MATER, V17, P4892, DOI 10.1021/cm050911d; Pan H, 2008, APPL PHYS A-MATER, V90, P247, DOI 10.1007/s00339-007-4320-2; Pan H, 2010, SMALL, V6, P1812, DOI 10.1002/smll.201000345; Pan H, 2008, J HEAT TRANS-T ASME, V130, DOI 10.1115/1.2943303; Pan H, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3082095; Pan H, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3043583; Park I, 2008, ADV MATER, V20, P489, DOI 10.1002/adma.200702326; Ridley BA, 1999, SCIENCE, V286, P746, DOI 10.1126/science.286.5440.746; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Santhanam V, 2004, NANO LETT, V4, P41, DOI 10.1021/nl034851r; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/NMAT2459, 10.1038/nmat2459]; Sirringhaus H, 2003, MRS BULL, V28, P802, DOI 10.1557/mrs2003.228; Son Y, 2012, THERMOCHIM ACTA, V542, P52, DOI 10.1016/j.tca.2012.03.004; Son Y, 2011, ADV MATER, V23, P3176, DOI 10.1002/adma.201100717; Sun YG, 2006, NAT NANOTECHNOL, V1, P201, DOI 10.1038/nnano.2006.131; Takei K, 2010, NAT MATER, V9, P821, DOI [10.1038/nmat2835, 10.1038/NMAT2835]; Yamada T, 2011, NAT NANOTECHNOL, V6, P296, DOI [10.1038/nnano.2011.36, 10.1038/NNANO.2011.36]; Yin WW, 2008, KOREAN J CHEM ENG, V25, P1358, DOI 10.1007/s11814-008-0223-y	34	91	93	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42315	10.1371/journal.pone.0042315	http://dx.doi.org/10.1371/journal.pone.0042315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900011	gold, Green Published, Green Submitted			2022-12-27	WOS:000307380900028
J	Collins, D; Luxton, T; Kumar, N; Shah, S; Walker, VK; Shah, V				Collins, Daniel; Luxton, Todd; Kumar, Niraj; Shah, Shreya; Walker, Virginia K.; Shah, Vishal			Assessing the Impact of Copper and Zinc Oxide Nanoparticles on Soil: A Field Study	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL DIVERSITY; SPECIATION; SILVER; AGGREGATION; COMMUNITY; FECES; XAFS; ZN; PH	It is not known if the annual production of tonnes of industrial nanoparticles (NPs) has the potential to impact terrestrial microbial communities, which are so necessary for ecosystem functioning. Here, we have examined the consequences of adding zero valent copper and zinc oxide NPs to soil in pots that were then maintained under field conditions. The fate of these NPs, as well as changes in the microbial communities, was monitored over 162 days. Both NP types traveled through the soil matrix, albeit at differential rates, with Cu NPs retained in the soil matrix at a higher rate compared to ZnO NPs. Leaching of Cu and Zn ions from the parent NPs was also observed as a function of time. Analysis of microbial communities using culture-dependent and independent methods clearly indicated that Cu and ZnO NPs altered the microbial community structure. In particular, two orders of organisms found in rhizosphere, Flavobacteriales and Sphingomonadales, appeared to be particularly susceptible to the presence of NPs. Together, the migration of NPs through soil matrix and the ability of these potential pollutants to influence the composition of microbial community in this field study, cannot help but raise some environmental concerns.	[Collins, Daniel; Shah, Shreya; Shah, Vishal] Dowling Coll, Dept Biol, Oakdale, NY USA; [Luxton, Todd] US EPA, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA; [Kumar, Niraj; Walker, Virginia K.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Kumar, Niraj; Walker, Virginia K.] Queens Univ, Sch Environm Studies, Kingston, ON, Canada	United States Environmental Protection Agency; Queens University - Canada; Queens University - Canada	Collins, D (corresponding author), Dowling Coll, Dept Biol, Oakdale, NY USA.	ShahV@dowling.edu	luxton, todd/AAA-7671-2020; Shah, Shreya/HDN-1499-2022		National Science Foundation grant [966741]; NSERC (Canada) grant; Queen's Research Chair award; Div Of Chem, Bioeng, Env, & Transp Sys [0966741] Funding Source: National Science Foundation	National Science Foundation grant(National Science Foundation (NSF)); NSERC (Canada) grant; Queen's Research Chair award; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The work was funded by National Science Foundation grant # 966741, NSERC (Canada) grant, and a Queen's Research Chair award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010463; Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878; Ben-Moshe T, 2010, CHEMOSPHERE, V81, P387, DOI 10.1016/j.chemosphere.2010.07.007; Biswas P, 2005, J AIR WASTE MANAGE, V55, P708, DOI 10.1080/10473289.2005.10464656; Bystrzejewska-Piotrowska G, 2009, WASTE MANAGE, V29, P2587, DOI 10.1016/j.wasman.2009.04.001; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Colwell RR, 1997, J IND MICROBIOL BIOT, V18, P302, DOI 10.1038/sj.jim.2900390; Cullen LG, 2011, CHEMOSPHERE, V82, P1675, DOI 10.1016/j.chemosphere.2010.11.009; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Feare CJ, 1999, J R SOC PROMO HEALTH, V119, P146, DOI 10.1177/146642409911900303; Ge YG, 2011, ENVIRON SCI TECHNOL, V45, P1659, DOI 10.1021/es103040t; GLUNDER G, 1981, AVIAN DIS, V25, P195, DOI 10.2307/1589841; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Haggstrom JA, 2010, NANOSCALE, V2, P399, DOI 10.1039/b9nr00245f; Hansch M, 2010, J PLANT NUTR SOIL SC, V173, P554, DOI 10.1002/jpln.200900358; Hill GT, 2000, APPL SOIL ECOL, V15, P25, DOI 10.1016/S0929-1393(00)00069-X; Jacquat O, 2009, GEOCHIM COSMOCHIM AC, V73, P5554, DOI 10.1016/j.gca.2009.05.069; Jacquat O, 2009, GEOCHIM COSMOCHIM AC, V73, P5256, DOI 10.1016/j.gca.2009.05.066; Jacquat O, 2009, GEOCHIM COSMOCHIM AC, V73, P348, DOI 10.1016/j.gca.2008.10.026; Jeong SW, 2009, J ENVIRON MONITOR, V11, P1595, DOI 10.1039/b907658a; Kanel SR, 2011, J NANOPART RES, V13, P4035, DOI 10.1007/s11051-011-0345-8; Kato S, 2010, ENVIRON MICROBIOL, V12, P3114, DOI 10.1111/j.1462-2920.2010.02284.x; Kosmulski M, 2009, ADV COLLOID INTERFAC, V152, P14, DOI 10.1016/j.cis.2009.08.003; Kumar N, 2012, ENVIRON TOXICOL CHEM, V31, P131, DOI 10.1002/etc.721; Kumar N, 2011, J HAZARD MATER, V190, P816, DOI 10.1016/j.jhazmat.2011.04.005; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Liu Y, 2009, J APPL MICROBIOL, V107, P1193, DOI 10.1111/j.1365-2672.2009.04303.x; Lu JR, 2008, APPL ENVIRON MICROB, V74, P3969, DOI 10.1128/AEM.00019-08; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Nishimura S, 2010, LANGMUIR, V26, P4473, DOI 10.1021/la904248z; Pampulha ME, 2007, J BASIC MICROB, V47, P325, DOI 10.1002/jobm.200610274; Peterson SB, 2008, THESIS U WISCONSIN M; Petosa AR, 2010, ENVIRON SCI TECHNOL, V44, P6532, DOI 10.1021/es100598h; Pisz JM, 2007, J MICROBIOL METH, V71, P312, DOI 10.1016/j.mimet.2007.09.015; Ramyadevi J, 2012, MATER LETT, V71, P114, DOI 10.1016/j.matlet.2011.12.055; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rispoli F, 2010, J HAZARD MATER, V180, P212, DOI 10.1016/j.jhazmat.2010.04.016; Scheckel KG, 2010, ENVIRON SCI TECHNOL, V44, P1307, DOI 10.1021/es9032265; Shah V, 2009, WATER AIR SOIL POLL, V197, P143, DOI 10.1007/s11270-008-9797-6; Simonet BM, 2009, ANAL BIOANAL CHEM, V393, P17, DOI 10.1007/s00216-008-2484-z; Strawn DG, 2008, ENVIRON SCI TECHNOL, V42, P37, DOI 10.1021/es071605z; Strawn DG, 2009, ENVIRON POLLUT, V157, P2813, DOI 10.1016/j.envpol.2009.04.018; Thill A, 2006, ENVIRON SCI TECHNOL, V40, P6151, DOI 10.1021/es060999b; USEPA, 1986, AC DIG SED SLUDG SOI, V1; Voegelin A, 2011, ENVIRON SCI TECHNOL, V45, P255, DOI 10.1021/es101189d; Yan F, 2000, GEODERMA, V96, P321, DOI 10.1016/S0016-7061(00)00018-5; Yoon KY, 2007, SCI TOTAL ENVIRON, V373, P572, DOI 10.1016/j.scitotenv.2006.11.007; Zelazny L.W., 1996, METHODS SOIL ANAL, P1231, DOI DOI 10.2136/SSSABOOKSER5.3.C41; Zhou DX, 2010, WATER RES, V44, P2948, DOI 10.1016/j.watres.2010.02.025	49	92	95	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42663	10.1371/journal.pone.0042663	http://dx.doi.org/10.1371/journal.pone.0042663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905159	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100055
J	Orshinsky, AM; Hu, JN; Opiyo, SO; Reddyvari-Channarayappa, V; Mitchell, TK; Boehm, MJ				Orshinsky, Angela M.; Hu, Jinnan; Opiyo, Stephen O.; Reddyvari-Channarayappa, Venu; Mitchell, Thomas K.; Boehm, Michael J.			RNA-Seq Analysis of the Sclerotinia homoeocarpa - Creeping Bentgrass Pathosystem	PLOS ONE			English	Article							ABC TRANSPORTER BCATRB; DOLLAR SPOT; BOTRYTIS-CINEREA; TRANSPOSABLE ELEMENTS; GENETIC-VARIATION; RESISTANCE; ACID; SENSITIVITY; EXPRESSION; TOOL	Sclerotinia homoeocarpa causes dollar spot disease, the predominate disease on highly-maintained turfgrass. Currently, there are major gaps in our understanding of the molecular interactions between S. homoeocarpa and creeping bentgrass. In this study, 454 sequencing technology was used in the de novo assembly of S. homoeocarpa and creeping bentgrass transcriptomes. Transcript sequence data obtained using Illumina's first generation sequencing-by-synthesis (SBS) were mapped to the transcriptome assemblies to estimate transcript representation in different SBS libraries. SBS libraries included a S. homoeocarpa culture control, a creeping bentgrass uninoculated control, and a library for creeping bentgrass inoculated with S. homoeocarpa and incubated for 96 h. A Fisher's exact test was performed to determine transcripts that were significantly different during creeping bentgrass infection with S. homoeocarpa. Fungal transcripts of interest included glycosyl hydrolases, proteases, and ABC transporters. Of particular interest were the large number of glycosyl hydrolase transcripts that target a wide range of plant cell wall compounds, corroborating the suggested wide host range and saprophytic abilities of S. homoeocarpa. Several of the multidrug resistance ABC transporters may be important for resistance to both fungicides and plant defense compounds. Creeping bentgrass transcripts of interest included germins, ubiquitin transcripts involved in proteasome degradation, and cinnamoyl reductase, which is involved in lignin production. This analysis provides an extensive overview of the S. homoeocarpa-turfgrass pathosystem and provides a starting point for the characterization of potential virulence factors and host defense responses. In particular, determination of important host defense responses may assist in the development of highly resistant creeping bentgrass varieties.	[Orshinsky, Angela M.; Hu, Jinnan; Mitchell, Thomas K.; Boehm, Michael J.] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA; [Opiyo, Stephen O.] Ohio State Univ, Mol & Cellular Imaging Ctr Columbus, Columbus, OH 43210 USA; [Reddyvari-Channarayappa, Venu] Dale Bumpers Natl Rice Res Ctr, Stuttgart, AZ USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Orshinsky, AM (corresponding author), Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA.	aorshinsky@gmail.com	Opiyo, Stephen/A-9385-2013	Boehm, Michael/0000-0001-5592-1710	Ohio State University; Ohio Agricultural Research and Development Center	Ohio State University(Ohio State University); Ohio Agricultural Research and Development Center	This study was supported with state and federal dollars appropriated to The Ohio State University and the Ohio Agricultural Research and Development Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; BALL AM, 1991, PHYSIOL MOL PLANT P, V38, P147, DOI 10.1016/S0885-5765(05)80132-8; Birch P, 2000, NEW TECHNOLOGIES LIF, V0, P1471; Bonos SA, 2007, INTEGRATED APPROACH; Bonos SA, 2006, PHYTOPATHOLOGY, V96, P808, DOI 10.1094/PHYTO-96-0808; BURPEE LL, 1986, CAN J PLANT SCI, V66, P345, DOI 10.4141/cjps86-049; Chakraborty N, 2006, CROP SCI, V46, P1237, DOI 10.2135/cropsci2005.04-0031; Chipps TJ, 2005, PHYTOPATHOLOGY, V95, P292, DOI 10.1094/PHYTO-95-0292; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COUCH HB, 1960, PHYTOPATHOLOGY, V50, P761; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; DaRoche A.B., 2004, PHYTOPATHOLOGY, V94S, P157; Davidson RM, 2009, PLANT SCI, V177, P499, DOI 10.1016/j.plantsci.2009.08.012; de Waard MA, 2006, PEST MANAG SCI, V62, P195, DOI 10.1002/ps.1150; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; DETWEILER AR, 1983, PLANT DIS, V67, P627, DOI 10.1094/PD-67-627; Dobinson KF, 1997, CAN J MICROBIOL, V43, P227, DOI 10.1139/m97-031; ENDO RM, 1963, PHYTOPATHOLOGY, V53, P857; ENDO RM, 1966, PHYTOPATHOLOGY, V56, P877; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; GOLEMBIEWSKI RC, 1995, PLANT DIS, V79, P491, DOI 10.1094/PD-79-0491; Grandbastien MA, 1998, TRENDS PLANT SCI, V3, P181, DOI 10.1016/S1360-1385(98)01232-1; Guo ZF, 2003, MOL BREEDING, V11, P95, DOI 10.1023/A:1022458101221; HALL R, 1984, CAN J PLANT SCI, V64, P167, DOI 10.4141/cjps84-021; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Herath HMTB, 2009, J NAT PROD, V72, P2091, DOI 10.1021/np900334k; Hsiang T, 1999, PLANT PATHOL, V48, P83, DOI 10.1046/j.1365-3059.1999.00306.x; Hu X, 2003, PLANT PHYSIOL, V133, P170, DOI 10.1104/pp.103.024026; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Kars I, 2007, EXTRACELLULAR ENZYME; Kejnovsky E, 2012, PLANT GENOME DIVERSI, P18; Kretschmer M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000696; Latin R, 2009, TURFGRASS DIS PROFIL; LEHTINEN U, 1993, PHYSIOL MOL PLANT P, V43, P121, DOI 10.1006/pmpp.1993.1045; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li J, 2010, BMC EVOL BIOL, V10, DOI [10.1186/1471-2148-10-68, 10.1186/1471-2407-10-354]; Lu Guihua, 2003, African Journal of Biotechnology, V2, P509; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MONTEITH J., 1932, Bull. U.S. Golf Ass. Green Sec., V12, P85; Orshinsky AM, 2011, CAN J MICROBIOL, V57, P398, DOI [10.1139/w11-019, 10.1139/W11-019]; Orshinsky AM, 2010, CHARACTERIZATION GRO; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pigati RL, 2010, PLANT DIS, V94, P596, DOI 10.1094/PDIS-94-5-0596; Rotter D, 2007, MOL GENET GENOMICS, V278, P197, DOI 10.1007/s00438-007-0240-2; Rowe HC, 2007, MOL PLANT MICROBE IN, V20, P1126, DOI 10.1094/MPMI-20-9-1126; Sabot F, 2004, EUPHYTICA, V139, P227, DOI 10.1007/s10681-004-3179-y; Schoonbeek H, 2001, MOL PLANT MICROBE IN, V14, P562, DOI 10.1094/MPMI.2001.14.4.562; Sreedhar L, 1999, GENE, V235, P121, DOI 10.1016/S0378-1119(99)00201-2; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; StLeger RJ, 1997, MICROBIOL-UK, V143, P1983, DOI 10.1099/00221287-143-6-1983; Venu R.C., 2009, INT TURFGRASS SOC RE, V11, P263; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vermeulen T, 2001, PEST MANAG SCI, V57, P393, DOI 10.1002/ps.309; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Walsh B, 1999, HORTSCIENCE, V34, P13, DOI 10.21273/HORTSCI.34.1.13; Walz A, 2008, PLANT PATHOLOGY, P57; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Zhou T, 1999, CAN J PLANT PATHOL, V21, P93, DOI 10.1080/07060661.1999.10600090	62	33	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41150	10.1371/journal.pone.0041150	http://dx.doi.org/10.1371/journal.pone.0041150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905098	Green Published, gold			2022-12-27	WOS:000307331100010
J	Toxopeus, CM; Maurits, NM; Valsan, G; Conway, BA; Leenders, KL; de Jong, BM				Toxopeus, Carolien M.; Maurits, Natasha M.; Valsan, Gopal; Conway, Bernard A.; Leenders, Klaus L.; de Jong, Bauke M.			Cerebral Activations Related to Ballistic, Stepwise Interrupted and Gradually Modulated Movements in Parkinson Patients	PLOS ONE			English	Article							BASAL GANGLIA CIRCUITS; MOTOR CONTROL; FUNCTIONAL-ANATOMY; RHESUS-MONKEY; ARM MOVEMENTS; DISEASE; INHIBITION; CEREBELLUM; BRAIN; CUES	Patients with Parkinson's disease (PD) experience impaired initiation and inhibition of movements such as difficulty to start/stop walking. At single-joint level this is accompanied by reduced inhibition of antagonist muscle activity. While normal basal ganglia (BG) contributions to motor control include selecting appropriate muscles by inhibiting others, it is unclear how PD-related changes in BG function cause impaired movement initiation and inhibition at single-joint level. To further elucidate these changes we studied 4 right-hand movement tasks with fMRI, by dissociating activations related to abrupt movement initiation, inhibition and gradual movement modulation. Initiation and inhibition were inferred from ballistic and stepwise interrupted movement, respectively, while smooth wrist circumduction enabled the assessment of gradually modulated movement. Task-related activations were compared between PD patients (N = 12) and healthy subjects (N = 18). In healthy subjects, movement initiation was characterized by antero-ventral striatum, substantia nigra (SN) and premotor activations while inhibition was dominated by subthalamic nucleus (STN) and pallidal activations, in line with the known role of these areas in simple movement. Gradual movement mainly involved antero-dorsal putamen and pallidum. Compared to healthy subjects, patients showed reduced striatal/SN and increased pallidal activation for initiation, whereas for inhibition STN activation was reduced and striatal-thalamo-cortical activation increased. For gradual movement patients showed reduced pallidal and increased thalamo-cortical activation. We conclude that PD-related changes during movement initiation fit the (rather static) model of alterations in direct and indirect BG pathways. Reduced STN activation and regional cortical increased activation in PD during inhibition and gradual movement modulation are better explained by a dynamic model that also takes into account enhanced responsiveness to external stimuli in this disease and the effects of hyper-fluctuating cortical inputs to the striatum and STN in particular.	[Toxopeus, Carolien M.; Maurits, Natasha M.; Leenders, Klaus L.; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Valsan, Gopal; Conway, Bernard A.] Univ Strathclyde, Bioengn Unit, Glasgow, Lanark, Scotland	University of Groningen; University of Strathclyde	Toxopeus, CM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	c.m.toxopeus@umcg.nl	Conway, Bernard/A-9625-2016	Conway, Bernard/0000-0002-0069-0131; Maurits, Natasha/0000-0001-6231-7044; de Jong, Bauke M./0000-0002-6568-5739	International Parkinson Foundation	International Parkinson Foundation	This study was sponsored with a grant from the International Parkinson Foundation, grant title: "Initiation and Inhibition of Movement in patients with Parkinson's disease: New Insights Using a Direct Coupling Between Movement, Muscle and Brain Activity". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Amick MM, 2006, NEUROPSYCHOLOGIA, V44, P339, DOI 10.1016/j.neuropsychologia.2005.06.002; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; BENECKE R, 1987, J NEUROL NEUROSUR PS, V50, P296, DOI 10.1136/jnnp.50.3.296; Berardelli A, 1996, BRAIN, V119, P661, DOI 10.1093/brain/119.2.661; BERARDELLI A, 1986, J NEUROL NEUROSUR PS, V49, P1273, DOI 10.1136/jnnp.49.11.1273; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; Beudel M, 2008, NEUROREPORT, V19, P1055, DOI 10.1097/WNR.0b013e328303b7b9; Boecker H, 2008, NEUROIMAGE, V39, P1356, DOI 10.1016/j.neuroimage.2007.09.069; Bostan AC, 2010, NEUROPSYCHOL REV, V20, P261, DOI 10.1007/s11065-010-9143-9; Castiello U, 2009, NEUROPSYCHOLOGIA, V47, P835, DOI 10.1016/j.neuropsychologia.2008.12.016; Cerminara NL, 2005, PROG BRAIN RES, V148, P213, DOI 10.1016/S0079-6123(04)48018-2; Coxon JP, 2009, J COGNITIVE NEUROSCI, V21, P1193, DOI 10.1162/jocn.2009.21081; Crossman AR, 2000, J ANAT, V196, P519, DOI 10.1046/j.1469-7580.2000.19640519.x; de Jong BM, 2007, BRAIN RES, V1132, P139, DOI 10.1016/j.brainres.2006.11.017; de Jong BM, 1999, COGNITIVE BRAIN RES, V8, P45, DOI 10.1016/S0926-6410(99)00005-1; DeLong M, 2009, PARKINSONISM RELAT D, V15, pS237, DOI 10.1016/S1353-8020(09)70822-3; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; Donovan S, 2011, PARKINSONISM RELAT D, V17, P240, DOI 10.1016/j.parkreldis.2010.08.010; Dounskaia N, 2005, EXP BRAIN RES, V164, P311, DOI 10.1007/s00221-005-2251-8; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; EBERSBACH G, 1994, NEUROPSYCHOLOGIA, V32, P799, DOI 10.1016/0028-3932(94)90018-3; EIDELBERG D, 1994, J CEREBR BLOOD F MET, V14, P783, DOI 10.1038/jcbfm.1994.99; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; FREEMAN JS, 1993, J NEUROL NEUROSUR PS, V56, P1078, DOI 10.1136/jnnp.56.10.1078; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; Giladi N, 2001, ADV NEUROL, V87, P191; Gowen E, 2007, NEUROIMAGE, V36, P396, DOI 10.1016/j.neuroimage.2007.03.005; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Hauber W, 1998, PROG NEUROBIOL, V56, P507, DOI 10.1016/S0301-0082(98)00041-0; Hirano S, 2009, MOVEMENT DISORD, V24, pS725, DOI 10.1002/mds.22541; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; HORE J, 1980, EXP BRAIN RES, V39, P217; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jahanshahi M, 2006, J NEUROSCI, V26, P12266, DOI 10.1523/JNEUROSCI.2540-06.2006; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Jiang Y, 2006, CLIN REHABIL, V20, P36, DOI 10.1191/0269215506cr925oa; Josephs KA, 2006, ARCH NEUROL-CHICAGO, V63, P354, DOI 10.1001/archneur.63.3.354; Joti P, 2007, EXP BRAIN RES, V177, P447, DOI 10.1007/s00221-006-0687-0; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Kaneda K, 2002, J NEUROPHYSIOL, V88, P1420, DOI 10.1152/jn.2002.88.3.1420; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Knill DC, 2005, J VISION, V5, P103, DOI 10.1167/5.2.2; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kropotov JD, 1999, INT J PSYCHOPHYSIOL, V31, P197, DOI 10.1016/S0167-8760(98)00051-8; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Luzzi S, 2011, J NEUROL NEUROSURG P; Ma YL, 2007, J CEREBR BLOOD F MET, V27, P597, DOI 10.1038/sj.jcbfm.9600358; MARSDEN CD, 1994, J NEUROL NEUROSUR PS, V57, P672, DOI 10.1136/jnnp.57.6.672; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; Meunier S, 2000, BRAIN, V123, P1017, DOI 10.1093/brain/123.5.1017; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mink J W, 1993, Curr Opin Neurobiol, V3, P950, DOI 10.1016/0959-4388(93)90167-W; MINK JW, 1991, J NEUROPHYSIOL, V65, P330, DOI 10.1152/jn.1991.65.2.330; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Nambu A, 2005, J NEUROL, V252, P1, DOI 10.1007/s00415-005-4002-y; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Obeso JA, 2008, ANN NEUROL, V64, pS30, DOI 10.1002/ana.21481; Ohyama T, 2003, TRENDS NEUROSCI, V26, P222, DOI 10.1016/S0166-2236(03)00054-7; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Praamstra P, 1998, BRAIN, V121, P167, DOI 10.1093/brain/121.1.167; Raptis H, 2010, J PHYSIOL-LONDON, V588, P1551, DOI 10.1113/jphysiol.2009.186858; Rascol O, 1997, BRAIN, V120, P103, DOI 10.1093/brain/120.1.103; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; ROMO R, 1992, EXP BRAIN RES, V91, P396, DOI 10.1007/BF00227836; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; ROTHWELL JC, 2003, HAND CLIN N, V1, P417; Rubchinsky LL, 2003, P NATL ACAD SCI USA, V100, P14427, DOI 10.1073/pnas.2036283100; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Samuel M, 1997, BRAIN, V120, P963, DOI 10.1093/brain/120.6.963; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Shires J, 2010, CURR OPIN NEUROBIOL, V20, P717, DOI 10.1016/j.conb.2010.08.008; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Teune LK, 2010, MOVEMENT DISORD, V25, P2395, DOI 10.1002/mds.23291; Toxopeus CM, 2007, NEUROREPORT, V18, P1557, DOI 10.1097/WNR.0b013e3282efa0a2; Toxopeus CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024572; Turner RS, 1997, J NEUROPHYSIOL, V77, P1051, DOI 10.1152/jn.1997.77.3.1051; WISE SP, 1988, SCIENCE, V242, P736, DOI 10.1126/science.3187520; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; YETERIAN EH, 1995, J COMP NEUROL, V352, P436, DOI 10.1002/cne.903520309; YETERIAN EH, 1978, BRAIN RES, V139, P43, DOI 10.1016/0006-8993(78)90059-8; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047; Zatsiorsky VM, 2008, J MOTOR BEHAV, V40, P446, DOI 10.3200/JMBR.40.5.446-476	99	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41042	10.1371/journal.pone.0041042	http://dx.doi.org/10.1371/journal.pone.0041042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911738	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700036
J	Traina, F; Visconte, V; Jankowska, AM; Makishima, H; O'Keefe, CL; Elson, P; Han, YC; Hsieh, FH; Sekeres, MA; Mali, RS; Kalaycio, M; Lichtin, AE; Advani, AS; Duong, HK; Copelan, E; Kapur, R; Saad, STO; Maciejewski, JP; Tiu, RV				Traina, Fabiola; Visconte, Valeria; Jankowska, Anna M.; Makishima, Hideki; O'Keefe, Christine L.; Elson, Paul; Han, Yingchun; Hsieh, Fred H.; Sekeres, Mikkael A.; Mali, Raghuveer Singh; Kalaycio, Matt; Lichtin, Alan E.; Advani, Anjali S.; Duong, Hien K.; Copelan, Edward; Kapur, Reuben; Olalla Saad, Sara T.; Maciejewski, Jaroslaw P.; Tiu, Ramon V.			Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis	PLOS ONE			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; MAST-CELL NEOPLASMS; C-KIT; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE NEOPLASMS; MYELOID MALIGNANCIES; PROGENITOR-CELL; SPECTRUM; CRITERIA; IDENTIFICATION	We hypothesized that analysis of single nucleotide polymorphism arrays (SNP-A) and new molecular defects may provide new insight in the pathogenesis of systemic mastocytosis (SM). SNP-A karyotyping was applied to identify recurrent areas of loss of heterozygosity and bidirectional sequencing was performed to evaluate the mutational status of TET2, DNMT3A, ASXL1, EZH2, IDH1/IDH2 and the CBL gene family. Overall survival (OS) was analyzed using the Kaplan-Meier method. We studied a total of 26 patients with SM. In 67% of SM patients, SNP-A karyotyping showed new chromosomal abnormalities including uniparental disomy of 4q and 2p spanning TET2/KIT and DNMT3A. Mutations in TET2, DNMT3A, ASXL1 and CBL were found in 23%, 12%, 12%, and 4% of SM patients, respectively. No mutations were observed in EZH2 and IDH1/IDH2. Significant differences in OS were observed for SM mutated patients grouped based on the presence of combined TET2/DNMT3A/ASXL1 mutations independent of KIT (P = 0.04) and sole TET2 mutations (P<0.001). In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.	[Traina, Fabiola; Visconte, Valeria; Jankowska, Anna M.; Makishima, Hideki; O'Keefe, Christine L.; Sekeres, Mikkael A.; Maciejewski, Jaroslaw P.; Tiu, Ramon V.] Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44106 USA; [Traina, Fabiola; Olalla Saad, Sara T.] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, INCT Sangue, Sao Paulo, Brazil; [Elson, Paul] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Han, Yingchun; Hsieh, Fred H.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44106 USA; [Han, Yingchun; Hsieh, Fred H.] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA; [Sekeres, Mikkael A.; Kalaycio, Matt; Lichtin, Alan E.; Advani, Anjali S.; Duong, Hien K.; Copelan, Edward; Maciejewski, Jaroslaw P.; Tiu, Ramon V.] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44106 USA; [Mali, Raghuveer Singh; Kapur, Reuben] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA	Cleveland Clinic Foundation; Universidade Estadual de Campinas; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Indiana University System; Indiana University Bloomington	Traina, F (corresponding author), Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44106 USA.	tiur@ccf.org	Traina, Fabiola/U-1451-2019; Traina, Fabiola/L-3809-2014	Traina, Fabiola/0000-0003-4258-289X; Traina, Fabiola/0000-0003-4258-289X; Sekeres, Mikkael/0000-0003-2009-6524	Celgene Future Leaders of Hematology Award; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL077522, R01HL077177] Funding Source: NIH RePORTER	Celgene Future Leaders of Hematology Award(Bristol-Myers SquibbCelgene Corporation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from Celgene Future Leaders of Hematology Award and Cleveland Clinic Seed Support (RVT), Howard Hughes Medical Institute Career Grant (FHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2010, LEUKEMIA, V24, P1656, DOI 10.1038/leu.2010.144; Akin C, 2000, EXP HEMATOL, V28, P140, DOI 10.1016/S0301-472X(99)00145-9; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; Gelsi-Boyer V, 2010, BRIT J HAEMATOL, V151, P365, DOI 10.1111/j.1365-2141.2010.08381.x; Gondek LP, 2008, BLOOD, V111, P1534, DOI 10.1182/blood-2007-05-092304; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Horny HP, 2001, LEUKEMIA RES, V25, P543, DOI 10.1016/S0145-2126(01)00021-2; Horny HP AC, 2008, WHO CLASSIFICATION T, P54; Huh J, 2010, GENE CHROMOSOME CANC, V49, P390, DOI 10.1002/gcc.20748; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; Lee SW, 2010, J BIOL CHEM, V285, P18, DOI 10.1074/jbc.M109.065862; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Pardanani A, 2003, LEUKEMIA RES, V27, P739, DOI 10.1016/S0145-2126(02)00303-X; Sugimoto Y, 2010, BRIT J HAEMATOL, V150, P83, DOI 10.1111/j.1365-2141.2010.08196.x; Tefferi A, 2004, CURR OPIN HEMATOL, V11, P58, DOI 10.1097/00062752-200401000-00009; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Tefferi A, 2009, LEUKEMIA, V23, P900, DOI 10.1038/leu.2009.37; Tiu R, 2007, LEUKEMIA, V21, P1648, DOI 10.1038/sj.leu.2404757; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2004, EUR J CLIN INVEST, V34, P41, DOI 10.1111/j.0960-135X.2004.01369.x; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Yavuz AS, 2002, BLOOD, V100, P661, DOI 10.1182/blood-2002-01-0203; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120	34	83	84	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43090	10.1371/journal.pone.0043090	http://dx.doi.org/10.1371/journal.pone.0043090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905207	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600045
J	Huynh, TT; McDougald, D; Klebensberger, J; Al Qarni, B; Barraud, N; Rice, SA; Kjelleberg, S; Schleheck, D				Huynh, Tran T.; McDougald, Diane; Klebensberger, Janosch; Al Qarni, Budoor; Barraud, Nicolas; Rice, Scott A.; Kjelleberg, Staffan; Schleheck, David			Glucose Starvation-Induced Dispersal of Pseudomonas aeruginosa Biofilms Is cAMP and Energy Dependent	PLOS ONE			English	Article							DIFFERENTIAL REGULATION; CELLULAR DETACHMENT; TWITCHING MOTILITY; PUTIDA; EXPRESSION; RESISTANCE; VIRULENCE	Carbon starvation has been shown to induce a massive dispersal event in biofilms of the opportunistic pathogen Pseudomonas aeruginosa; however, the molecular pathways controlling this dispersal response remain unknown. We quantified changes in the proteome of P. aeruginosa PAO1 biofilm and planktonic cells during glucose starvation by differential peptide-fingerprint mass-spectrometry (iTRAQ). In addition, we monitored dispersal photometrically, as a decrease in turbidity/opacity of biofilms pre-grown and starved in continuous flow-cells, in order to evaluate treatments (e. g. inhibitors CCCP, arsenate, chloramphenicol, L-serine hydroxamate) and key mutants altered in biofilm development and dispersal (e.g. nirS, vfr, bdlA, rpoS, lasRrhlR, Pf4-bacteriophage and cyaA). In wild-type biofilms, dispersal started within five minutes of glucose starvation, was maximal after 2 h, and up to 60% of the original biomass had dispersed after 24 h of starvation. The changes in protein synthesis were generally not more than two fold and indicated that more than 100 proteins belonging to various classes, including carbon and energy metabolism, stress adaptation, and motility, were differentially expressed. For the different treatments, only the proton-ionophore CCCP or arsenate, an inhibitor of ATP synthesis, prevented dispersal of the biofilms. For the different mutants tested, only cyaA, the synthase of the intracellular second messenger cAMP, failed to disperse; complementation of the cyaA mutation restored the wild-type phenotype. Hence, the pathway for carbon starvation-induced biofilm dispersal in P. aeruginosa PAO1 involves ATP production via direct ATP synthesis and proton-motive force dependent step(s) and is mediated through cAMP, which is likely to control the activity of proteins involved in remodeling biofilm cells in preparation for planktonic survival.	[Huynh, Tran T.; McDougald, Diane; Klebensberger, Janosch; Al Qarni, Budoor; Barraud, Nicolas; Rice, Scott A.; Kjelleberg, Staffan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [McDougald, Diane] Nanyang Technol Univ, Adv Environm Biotechnol Ctr, Singapore, Singapore; [Rice, Scott A.; Kjelleberg, Staffan] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore; [Schleheck, David] Univ Konstanz, Dept Biol Sci, Constance, Germany; [Schleheck, David] Univ Konstanz, Res Sch Chem Biol, Constance, Germany	University of New South Wales Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Konstanz; University of Konstanz	Huynh, TT (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia.	d.mcdougald@unsw.edu.au	Kjelleberg, Staffan/AAB-4641-2020; McDougald, Diane/B-5564-2009; Rice, Scott/A-6084-2019; Barraud, Nicolas/D-1569-2010; McDougald, Diane/AAF-4799-2020; Kjelleberg, Staffan/C-9229-2015	Kjelleberg, Staffan/0000-0003-4271-6413; McDougald, Diane/0000-0001-5827-8441; Rice, Scott/0000-0002-9486-2343; Barraud, Nicolas/0000-0002-1807-7765; McDougald, Diane/0000-0001-5827-8441; Kjelleberg, Staffan/0000-0003-4271-6413; Klebensberger, Janosch/0000-0003-2740-3769	Centre for Marine Bio-Innovation, the School of Biotechnology and Biomolecular Sciences, University of New South Wales (UNSW); Australian Research Council (ARC) [DP110104525]; Environmental Biotechnology Cooperative Research Centre (EB-CRC); UNSW; University of Konstanz	Centre for Marine Bio-Innovation, the School of Biotechnology and Biomolecular Sciences, University of New South Wales (UNSW); Australian Research Council (ARC)(Australian Research Council); Environmental Biotechnology Cooperative Research Centre (EB-CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); UNSW; University of Konstanz	The project was funded by the Centre for Marine Bio-Innovation, the School of Biotechnology and Biomolecular Sciences, University of New South Wales (UNSW), and by the Australian Research Council (ARC Discovery Project DP110104525). The work of T. T. H. was supported by a postgraduate scholarship from the Environmental Biotechnology Cooperative Research Centre (EB-CRC). The work of D. S. was supported by a UNSW Vice-Chancellor's Postdoctoral Research Fellowship and by the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Barraud N, 2009, J BACTERIOL, V191, P7333, DOI 10.1128/JB.00975-09; Beatson SA, 2002, J BACTERIOL, V184, P3605, DOI 10.1128/JB.184.13.3605-3613.2002; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; BOOMINATHAN K, 1992, P NATL ACAD SCI USA, V89, P5586, DOI 10.1073/pnas.89.12.5586; BOYD A, 1994, APPL ENVIRON MICROB, V60, P2355, DOI 10.1128/AEM.60.7.2355-2359.1994; Buhmann M, 2012, ENV MICROBIOL REP, V4, P133, DOI 10.1111/j.1758-2229.2011.00315.x; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; DELAQUIS PJ, 1989, MICROBIAL ECOL, V18, P199, DOI 10.1007/BF02075808; Denkhaus E, 2007, MICROCHIM ACTA, V158, P1, DOI 10.1007/s00604-006-0688-5; DOIG P, 1988, INFECT IMMUN, V56, P1641, DOI 10.1128/IAI.56.6.1641-1646.1988; Endoh T, 2009, J BACTERIOL, V191, P7193, DOI 10.1128/JB.00970-09; Erickson DL, 2004, INFECT IMMUN, V72, P5638, DOI 10.1128/IAI.72.10.5638-5645.2004; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fuchs EL, 2010, J BACTERIOL, V192, P2779, DOI 10.1128/JB.00168-10; GHOUL M, 1989, APPL ENVIRON MICROB, V55, P1040, DOI 10.1128/AEM.55.4.1040-1043.1989; Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Harmsen M, 2010, FEMS IMMUNOL MED MIC, V59, P253, DOI 10.1111/j.1574-695X.2010.00690.x; Hunt SM, 2004, APPL ENVIRON MICROB, V70, P7418, DOI 10.1128/AEM.70.12.7418-7425.2004; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; KENNEDY SIT, 1968, BIOCHEM J, V107, P497, DOI 10.1042/bj1070497; Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0; Klebensberger J, 2007, ENVIRON MICROBIOL, V9, P2247, DOI 10.1111/j.1462-2920.2007.01339.x; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; MAZON MJ, 1982, EUR J BIOCHEM, V127, P605; Merighi M, 2010, PSEUDOMONAS, VOL 6: MOLECULAR MICROBIOLOGY, INFECTION AND BIODIVERSITY, P97, DOI 10.1007/978-90-481-3909-5_4; Monteiro C, 2009, ENVIRON MICROBIOL, V11, P1105, DOI 10.1111/j.1462-2920.2008.01840.x; Morgan R, 2006, J BACTERIOL, V188, P7335, DOI 10.1128/JB.00599-06; Musk DJ, 2005, CHEM BIOL, V12, P789, DOI 10.1016/j.chembiol.2005.05.007; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; NG EYW, 1994, ANTIMICROB AGENTS CH, V38, P1345, DOI 10.1128/AAC.38.6.1345; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sauer K, 2001, J BACTERIOL, V183, P6579, DOI 10.1128/JB.183.22.6579-6589.2001; Schleheck D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005513; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; STEFANOVICH V, 1979, NEUROCHEM RES, V4, P587, DOI 10.1007/BF00964436; Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; WRANGSTADH M, 1989, CAN J MICROBIOL, V35, P309, DOI 10.1139/m89-046	54	49	51	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42874	10.1371/journal.pone.0042874	http://dx.doi.org/10.1371/journal.pone.0042874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905180	gold, Green Published			2022-12-27	WOS:000307500800025
J	Willing, EM; Dreyer, C; van Oosterhout, C				Willing, Eva-Maria; Dreyer, Christine; van Oosterhout, Cock			Estimates of Genetic Differentiation Measured by F-ST Do Not Necessarily Require Large Sample Sizes When Using Many SNP Markers	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; STRUCTURED POPULATIONS; CONSERVATION; ECOLOGY; HISTORY; POWER; BIAS	Population genetic studies provide insights into the evolutionary processes that influence the distribution of sequence variants within and among wild populations. F-ST is among the most widely used measures for genetic differentiation and plays a central role in ecological and evolutionary genetic studies. It is commonly thought that large sample sizes are required in order to precisely infer F-ST and that small sample sizes lead to overestimation of genetic differentiation. Until recently, studies in ecological model organisms incorporated a limited number of genetic markers, but since the emergence of next generation sequencing, the panel size of genetic markers available even in non-reference organisms has rapidly increased. In this study we examine whether a large number of genetic markers can substitute for small sample sizes when estimating F-ST. We tested the behavior of three different estimators that infer F-ST and that are commonly used in population genetic studies. By simulating populations, we assessed the effects of sample size and the number of markers on the various estimates of genetic differentiation. Furthermore, we tested the effect of ascertainment bias on these estimates. We show that the population sample size can be significantly reduced (as small as n = 4-6) when using an appropriate estimator and a large number of bi-allelic genetic markers (k > 1,000). Therefore, conservation genetic studies can now obtain almost the same statistical power as studies performed on model organisms using markers developed with next-generation sequencing.	[Willing, Eva-Maria; Dreyer, Christine] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [van Oosterhout, Cock] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Max Planck Society; University of East Anglia	Willing, EM (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.	willing@mpipz.mpg.de		van Oosterhout, Cock/0000-0002-5653-738X	Deutsche Forschungsgemeinschaft; Max Planck Society; ELSA, The Earth and Life Sciences Alliance	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); ELSA, The Earth and Life Sciences Alliance	Supported by a Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft to Detlef Weigel at the Max Planck Institute for Developmental Biology, and the Max Planck Society. CvO was funded by ELSA, The Earth and Life Sciences Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Excoffier L, 2007, HDB STAT GENETICS; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; LEWONTIN RC, 1973, GENETICS, V74, P175; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; Narum SR, 2008, MOL ECOL, V17, P3464, DOI 10.1111/j.1365-294X.2008.03851.x; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Raufaste N, 2000, THEOR POPUL BIOL, V57, P285, DOI 10.1006/tpbi.2000.1457; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rosenblum EB, 2007, J HERED, V98, P331, DOI 10.1093/jhered/esm031; Seddon JM, 2005, MOL ECOL, V14, P503, DOI 10.1111/j.1365-294X.2005.02435.x; Tautz D, 2010, MOL ECOL, V19, P1, DOI 10.1111/j.1365-294X.2009.04489.x; Weir B. S., 1996, GENETIC DATA ANAL; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x	19	265	265	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42649	10.1371/journal.pone.0042649	http://dx.doi.org/10.1371/journal.pone.0042649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905157	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000307500800019
J	Zhang, YF; Xie, QG; Robertson, JB; Johnson, CH				Zhang, Yunfei; Xie, Qiguang; Robertson, J. Brian; Johnson, Carl Hirschie			pHlash: A New Genetically Encoded and Ratiometric Luminescence Sensor of Intracellular pH	PLOS ONE			English	Article							ENERGY-TRANSFER BRET; PROTEIN INTERACTIONS; CA2+; PLANT; OSCILLATIONS; HOMEOSTASIS; DYNAMICS; CALCIUM; GLUCOSE; SYSTEM	We report the development of a genetically encodable and ratiometic pH probe named "pHlash'' that utilizes Bioluminescence Resonance Energy Transfer (BRET) rather than fluorescence excitation. The pHlash sensor-composed of a donor luciferase that is genetically fused to a Venus fluorophore-exhibits pH dependence of its spectral emission in vitro. When expressed in either yeast or mammalian cells, pHlash reports basal pH and cytosolic acidification in vivo. Its spectral ratio response is H+ specific; neither Ca++, Mg++, Na+, nor K+ changes the spectral form of its luminescence emission. Moreover, it can be used to image pH in single cells. This is the first BRET-based sensor of H+ ions, and it should allow the approximation of pH in cytosolic and organellar compartments in applications where current pH probes are inadequate.	[Zhang, Yunfei] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Zhang, YF (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA.	carl.h.johnson@vanderbilt.edu	Xu, Xiaodong/HGD-8082-2022; Johnson, Carl H/I-4655-2014		National Science Foundation (NSF SGER) [IOS-0854942]; National Institute of Mental Health [R21 MH 080035]; National Institute of General Medical Sciences [R01 GM 065467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH080035] Funding Source: NIH RePORTER	National Science Foundation (NSF SGER)(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from the National Science Foundation (NSF SGER # IOS-0854942), the National Institute of Mental Health (R21 MH 080035), and the National Institute of General Medical Sciences (R01 GM 065467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS RJ, 1985, CELL, V43, P653, DOI 10.1016/0092-8674(85)90237-5; Agulhon C, 2007, J PHYSIOL-LONDON, V583, P945, DOI 10.1113/jphysiol.2007.135715; Audet M, 2010, FASEB J, V24, P2829, DOI 10.1096/fj.09-144816; Boonsirichai K, 2003, PLANT CELL, V15, P2612, DOI 10.1105/tpc.015560; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; BUSA WB, 1983, SCIENCE, V221, P366, DOI 10.1126/science.221.4608.366; Dreosti E, 2011, EXP PHYSIOL, V96, P4, DOI 10.1113/expphysiol.2009.051953; Eklund SE, 2004, ANAL CHEM, V76, P519, DOI 10.1021/ac034641z; Fernandez NA, 2011, AM J PHYSIOL-CELL PH, V300, pC1513, DOI 10.1152/ajpcell.00433.2010; Fricker MD., 1999, FLUORESCENT LUMINESC, P569; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; GRAINGER JL, 1979, DEV BIOL, V68, P396, DOI 10.1016/0012-1606(79)90213-6; Hoshino H, 2007, NAT METHODS, V4, P637, DOI 10.1038/NMETH1069; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; LEE HC, 1983, DEV BIOL, V95, P31, DOI 10.1016/0012-1606(83)90004-0; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Plieth C, 1999, PLANT J, V18, P643, DOI 10.1046/j.1365-313x.1999.00492.x; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Rogers KL, 2005, EUR J NEUROSCI, V21, P597, DOI 10.1111/j.1460-9568.2005.03871.x; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SATROUTDINOV AD, 1992, FEMS MICROBIOL LETT, V98, P261, DOI 10.1016/0378-1097(92)90167-M; Schulte A, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-7; SIKORSKI RS, 1989, GENETICS, V122, P19; Subramanian C, 2004, P NATL ACAD SCI USA, V101, P6798, DOI 10.1073/pnas.0307964101; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Xie QG, 2011, METHODS MOL BIOL, V680, P3, DOI 10.1007/978-1-60761-901-7_1; Xu XD, 2007, P NATL ACAD SCI USA, V104, P10264, DOI 10.1073/pnas.0701987104; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535	36	20	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43072	10.1371/journal.pone.0043072	http://dx.doi.org/10.1371/journal.pone.0043072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905204	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500800043
J	Smeti, I; Assou, S; Savary, E; Masmoudi, S; Zine, A				Smeti, Ibtihel; Assou, Said; Savary, Etienne; Masmoudi, Saber; Zine, Azel			Transcriptomic Analysis of the Developing and Adult Mouse Cochlear Sensory Epithelia	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; NOTCH SIGNALING PATHWAY; AUDITORY HAIR-CELLS; INNER-EAR; ANDROGEN RECEPTOR; STEM-CELLS; POSTMITOTIC STATE; CDNA MICROARRAYS; ACOUSTIC TRAUMA; GROWTH-HORMONE	The adult mammalian cochlea lacks regenerative ability and the irreversible degeneration of cochlear sensory hair cells leads to permanent hearing loss. Previous data show that early postnatal cochlea harbors stem/progenitor-like cells and shows a limited regenerative/repair capacity. These properties are progressively lost later during the postnatal development. Little is known about the genes and pathways that are potentially involved in this difference of the regenerative/repair potentialities between early postnatal and adult mammalian cochlear sensory epithelia (CSE). The goal of our study is to investigate the transcriptomic profiles of these two stages. We used Mouse Genome 430 2.0 microarray to perform an extensive analysis of the genes expressed in mouse postnatal day-3 (P3) and adult CSE. Statistical analysis of microarray data was performed using SAM (Significance Analysis of Microarrays) software. We identified 5644 statistically significant differentially expressed transcripts with a fold change (FC) >2 and a False Discovery Rate (FDR) <= 0.05. The P3 CSE signature included 3,102 transcripts, among which were known genes in the cochlea, but also new transcripts such as, Hmga2 (high mobility group AT-hook 2) and Nrarp (Notch-regulated ankyrin repeat protein). The adult CSE overexpressed 2,542 transcripts including new transcripts, such as Prl (Prolactin) and Ar (Androgen receptor), that previously were not known to be expressed in the adult cochlea. Our comparative study revealed important genes and pathways differentially expressed between the developing and adult CSE. The identification of new candidate genes would be useful as potential markers of the maintenance or the loss of stem cells and regenerative/repair ability during mammalian cochlear development.	[Smeti, Ibtihel; Savary, Etienne; Zine, Azel] UMR 7260 Aix Marseille Univ, CNRS, Marseille, France; [Smeti, Ibtihel; Zine, Azel] Univ Montpellier I, Fac Pharm, Montpellier, France; [Assou, Said] Univ Montpellier I, CHU Montpellier, Inst Res Biotherapy, INSERM,U1040, Montpellier, France; [Smeti, Ibtihel; Masmoudi, Saber] Ctr Biotechnol, Lab Microorganismes & Biomol, Sfax, Tunisia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Centre de Biotechnologie de Borj Cedria; Centre de Biotechnologie de Sfax; Universite de Sfax	Smeti, I (corresponding author), UMR 7260 Aix Marseille Univ, CNRS, Marseille, France.	azel.zine@univ-montp1.fr	Masmoudi, Saber/W-1478-2019	Saber, Masmoudi/0000-0002-1076-5256; assou, said/0000-0001-6448-7995	ANR (Agence Nationale de Recherche) [ANR-2010-BLAN-1107-01-b]; Fondation de France Fonds; Averroes program/University Montpellier I	ANR (Agence Nationale de Recherche)(French National Research Agency (ANR)); Fondation de France Fonds; Averroes program/University Montpellier I	Funding was provided by the ANR (Agence Nationale de Recherche; ANR-2010-BLAN-1107-01-b to AZ), The Fondation de France Fonds, and the Averroes program/University Montpellier I (doctoral fellowship to IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chen FQ, 2009, J NEUROCHEM, V108, P1226, DOI 10.1111/j.1471-4159.2009.05871.x; Chen P, 2003, NAT CELL BIOL, V5, P422, DOI 10.1038/ncb976; Chen ZY, 2002, JARO-J ASSOC RES OTO, V3, P140, DOI 10.1007/s101620020029; Cho YS, 2002, JARO, V3, P54, DOI 10.1007/s101620010042; Cho YS, 2004, MOL BRAIN RES, V130, P134, DOI 10.1016/j.molbrainres.2004.07.017; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Diensthuber M, 2009, JARO-J ASSOC RES OTO, V10, P173, DOI 10.1007/s10162-009-0161-3; Drayton M, 2006, HEARING RES, V212, P128, DOI 10.1016/j.heares.2005.11.006; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falkenius-Schmidt K, 2005, HEARING RES, V203, P154, DOI 10.1016/j.heares.2004.11.015; Forlano PM, 2010, J COMP NEUROL, V518, P493, DOI 10.1002/cne.22233; Fritzsch B, 2011, HEARING RES, V276, P16, DOI 10.1016/j.heares.2011.01.007; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Hawkins RD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000525; Hawkins RD, 2003, HUM MOL GENET, V12, P1261, DOI 10.1093/hmg/ddg150; Hirning-Folz U, 1998, GENE CHROMOSOME CANC, V23, P350, DOI 10.1002/(SICI)1098-2264(199812)23:4<350::AID-GCC10>3.0.CO;2-E; Horner KC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1224, DOI 10.1152/ajpendo.00279.2007; Horner KC, 2002, NEUROPSYCHOPHARMACOL, V26, P135, DOI 10.1016/S0893-133X(01)00356-6; Hudspeth AJ, 1997, NEURON, V19, P947, DOI 10.1016/S0896-6273(00)80385-2; Kaur T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.63; Kopecky B, 2011, PHARMACEUTICALS, V4, P848, DOI 10.3390/ph4060848; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Laine H, 2007, J NEUROSCI, V27, P1434, DOI 10.1523/JNEUROSCI.4956-06.2007; Laine H, 2010, DEV BIOL, V337, P134, DOI 10.1016/j.ydbio.2009.10.027; Lenoir M, 1997, INT J DEV NEUROSCI, V15, P487, DOI 10.1016/S0736-5748(96)00105-0; Li O, 2007, FEBS LETT, V581, P3533, DOI 10.1016/j.febslet.2007.06.072; Lin JH, 2003, HEARING RES, V175, P2, DOI 10.1016/S0378-5955(02)00704-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantela J, 2005, DEVELOPMENT, V132, P2377, DOI 10.1242/dev.01834; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Morris KA, 2005, JARO-J ASSOC RES OTO, V6, P75, DOI 10.1007/s10162-004-5046-x; Nagashima R, 2005, J PHARMACOL SCI, V99, P301, DOI 10.1254/jphs.CPJ05004X; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; National Center for Biotechnology Information, GUID CAR US LAB AN; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Ogita K, 2000, NEUROREPORT, V11, P859, DOI 10.1097/00001756-200003200-00040; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Paxton CN, 2010, GENE EXPR PATTERNS, V10, P31, DOI 10.1016/j.gep.2009.11.002; Pfannkuche K, 2009, STEM CELL REV REP, V5, P224, DOI 10.1007/s12015-009-9078-9; Pirot P, 2004, BIOCHEM BIOPH RES CO, V322, P526, DOI 10.1016/j.bbrc.2004.07.157; Price K, 2009, HEARING RES, V252, P29, DOI 10.1016/j.heares.2009.02.010; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; REITER E, 1992, MOL CELL ENDOCRINOL, V88, P77, DOI 10.1016/0303-7207(92)90011-T; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Sajan SA, 2007, GENETICS, V177, P631, DOI 10.1534/genetics.107.078584; Sato T, 2009, ACTA OTO-LARYNGOL, V129, P12, DOI 10.1080/00016480902926464; Savary E, 2007, STEM CELLS, V25, P332, DOI 10.1634/stemcells.2006-0303; Schuck JB, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-88; Slattery EL, 2009, JARO-J ASSOC RES OTO, V10, P341, DOI 10.1007/s10162-009-0166-y; Smeti I, 2011, GENE EXPR PATTERNS, V11, P22, DOI 10.1016/j.gep.2010.08.008; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Staecker H, 1998, CURR OPIN NEUROBIOL, V8, P480, DOI 10.1016/S0959-4388(98)80035-4; Sun HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028372; Trevino V, 2007, MOL MED, V13, P527, DOI 10.2119/2006-00107.Trevino; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004; Zine A, 1998, NEUROREPORT, V9, P263, DOI 10.1097/00001756-199801260-00016	62	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42987	10.1371/journal.pone.0042987	http://dx.doi.org/10.1371/journal.pone.0042987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900075	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900093
J	Ying, XJ; Dong, P; Shen, B; Xu, CZ; Xu, HM; Zhao, SW				Ying, Xin-Jiang; Dong, Pin; Shen, Bin; Xu, Cheng-Zhi; Xu, Hong-Ming; Zhao, Shu-Wei			Glutathione S-Transferase M1 Gene Polymorphism and Laryngeal Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GSTM1 POLYMORPHISMS; NAT2 POLYMORPHISMS; T1 GENOTYPES; LUNG-CANCER; GSTT1; TOBACCO; CYP1A1; HEAD; ALCOHOL	Background and Objectives: Studies investigating the association between glutathione S-transferase M1 (GSTM1) gene polymorphism and laryngeal cancer risk have reported conflicting results. The aim of the present study was to conduct a meta-analysis assessing the possible associations of GSTM1 gene polymorphism with laryngeal cancer risk. Methods: The relevant studies were identified through a search of PubMed, Embase, ISI Web of Knowledge and Chinese National Knowledge Infrastructure until May 2011 and selected on the basis of the established inclusion criteria for publications, then a meta-analysis was performed to quantitatively summarize association of GSTM1 polymorphism with laryngeal cancer susceptibility. Results: Seventeen studies were included in the present meta-analysis (2,180 cases and 2,868 controls). The combined results based on all studies showed that GSTM1 null genotype was associated with increased laryngeal cancer risk (OR = 1.17, 95% CI = 1.04 similar to 1.31). When stratifying for race, GSTM1 null genotype exhibited increased laryngeal cancer risk in Caucasians (OR = 1.15, 95% CI = 1.01 similar to 1.31), while no significant association was detected in Asians (OR = 1.25, 95% CI = 0.80 similar to 1.96). In the subgroup analysis based on source of controls, significant associations were observed in the population-based studies (OR = 1.15, 95% CI = 1.01 similar to 1.31) yet not in the hospital-based studies (OR = 1.25, 95% CI = 0.93 similar to 1.67). Furthermore, in the subgroup analysis based on sample size, significant associations were also found in studies with at least 50 cases and 50 controls (OR = 1.15, 95% CI = 1.02 similar to 1.30) but not in studies with fewer than 50 cases or 50 controls (OR = 1.46, 95% CI = 0.87 similar to 2.46). Conclusions: This meta-analysis supported that the GSTM1 gene polymorphism was associated with laryngeal cancer, particularly in Caucasians, and these associations varied in different subgroup, which indicated that population-based study with larger sample size was more appropriate in design of future study.	[Ying, Xin-Jiang; Dong, Pin; Shen, Bin; Xu, Cheng-Zhi; Xu, Hong-Ming] Shanghai Jiao Tong Univ, Dept Otolaryngol Head & Neck Surg, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Zhao, Shu-Wei] Second Mil Med Univ, Dept Otolaryngol, Changzheng Hosp, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University	Ying, XJ (corresponding author), Shanghai Jiao Tong Univ, Dept Otolaryngol Head & Neck Surg, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	yingxinjiang@126.com; dongpin64@yahoo.com.cn; zhaoshw1@yahoo.com.cn						Acar H, 2006, CANCER GENET CYTOGEN, V169, P89, DOI 10.1016/j.cancergencyto.2005.12.007; Bardakci F, 2003, J CELL MOL MED, V7, P307, DOI 10.1111/j.1582-4934.2003.tb00231.x; Becher H, 2005, INT J CANCER, V116, P451, DOI 10.1002/ijc.21049; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bennett DA, 2004, J CLIN EPIDEMIOL, V57, P349, DOI 10.1016/j.jclinepi.2003.09.015; Boccia S, 2008, J CANCER RES CLIN, V134, P93, DOI 10.1007/s00432-007-0254-5; Bolt HM, 2006, CURR DRUG METAB, V7, P613, DOI 10.2174/138920006778017786; Cabelguenne A, 2001, INT J CANCER, V93, P725, DOI 10.1002/ijc.1392; Carlsten C, 2008, AM J EPIDEMIOL, V167, P759, DOI 10.1093/aje/kwm383; Chatzimichalis M, 2010, J LARYNGOL OTOL, V124, P318, DOI 10.1017/S002221510999154X; Cotton SC, 2000, AM J EPIDEMIOL, V151, P7, DOI 10.1093/oxfordjournals.aje.a010124; Coutelle C, 1997, HUM GENET, V99, P319, DOI 10.1007/s004390050365; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Frank SA, 2004, NAT REV GENET, V5, P764, DOI 10.1038/nrg1450; Gajecka M, 2005, MUTAT RES-FUND MOL M, V574, P112, DOI 10.1016/j.mrfmmm.2005.01.027; Gronau S, 2003, OTOLARYNG HEAD NECK, V128, P674, DOI 10.1016/S0194-5998(03)00176-1; Hanna E, 2001, AM J OTOLARYNG, V22, P121, DOI 10.1053/ajot.2001.22571; Hashibe M, 2003, CANCER EPIDEM BIOMAR, V12, P1509; Hashibe M, 2007, AM J EPIDEMIOL, V165, P814, DOI 10.1093/aje/kwk066; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong YJ, 2000, CLIN CHEM LAB MED, V38, P917, DOI 10.1515/CCLM.2000.134; Jahnke V, 1996, AM J SURG, V172, P671, DOI 10.1016/S0002-9610(96)00298-X; Jahnke V, 1997, EUR ARCH OTO-RHINO-L, V254, pS147, DOI 10.1007/BF02439747; JAHNKE V, 1995, LARYNGO RHINO OTOL, V74, P691, DOI 10.1055/s-2007-997826; Jourenkova N, 1998, CANCER EPIDEM BIOMAR, V7, P19; Kihara M, 1997, CANCER LETT, V112, P257, DOI 10.1016/S0304-3835(96)04584-3; Koskinen WJ, 2007, J CANCER RES CLIN, V133, P673, DOI 10.1007/s00432-007-0219-8; La Torre G, 2005, CANCER LETT, V217, P53, DOI 10.1016/j.canlet.2004.08.020; Li Li, 2004, Zhonghua Er Bi Yan Hou Ke Za Zhi, V39, P2; Matthias C, 1998, PHARMACOGENETICS, V8, P91; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Morita S, 1999, INT J CANCER, V80, P685, DOI 10.1002/(SICI)1097-0215(19990301)80:5<685::AID-IJC9>3.0.CO;2-W; Ntais C, 2005, CANCER EPIDEM BIOMAR, V14, P176; Olshan AF, 2000, CANCER EPIDEM BIOMAR, V9, P185; Peters ES, 2006, CANCER EPIDEM BIOMAR, V15, P2196, DOI 10.1158/1055-9965.EPI-06-0503; Risch A, 2003, PHARMACOGENETICS, V13, P225, DOI 10.1097/00008571-200304000-00007; Shi XQ, 2008, LUNG CANCER, V59, P155, DOI 10.1016/j.lungcan.2007.08.004; Sull JW, 2004, YONSEI MED J, V45, P683, DOI 10.3349/ymj.2004.45.4.683; To-Figueras J, 2002, CANCER LETT, V187, P95, DOI 10.1016/S0304-3835(02)00406-8; Unal M, 2004, AM J OTOLARYNG, V25, P318, DOI 10.1016/j.amjoto.2004.04.003; White DL, 2008, AM J EPIDEMIOL, V167, P377, DOI 10.1093/aje/kwm315; Yang CX, 2005, WORLD J GASTROENTERO, V11, P2531, DOI 10.3748/wjg.v11.i17.2531; Zhuo WL, 2009, J CANCER RES CLIN, V135, P1081, DOI 10.1007/s00432-009-0548-x	43	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42826	10.1371/journal.pone.0042826	http://dx.doi.org/10.1371/journal.pone.0042826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900055	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900073
J	King, AV; Welter, BH; Koushik, AB; Gordon, LN; Temesvari, LA				King, Ada V.; Welter, Brenda H.; Koushik, Amrita B.; Gordon, Lindsay N.; Temesvari, Lesly A.			A Genome-Wide Over-Expression Screen Identifies Genes Involved in Phagocytosis in the Human Protozoan Parasite, Entamoeba histolytica	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; LARGE-SCALE ANALYSIS; OVEREXPRESSION SCREEN; PROTEOMIC ANALYSIS; CAENORHABDITIS-ELEGANS; MOLECULAR-MECHANISMS; IONIZING-RADIATION; RNA INTERFERENCE; LIM PROTEIN; DNA-DAMAGE	Functional genomics and forward genetics seek to assign function to all known genes in a genome. Entamoeba histolytica is a protozoan parasite for which forward genetics approaches have not been extensively applied. It is the causative agent of amoebic dysentery and liver abscess, and infection is prevalent in developing countries that cannot prevent its fecal-oral spread. It is responsible for considerable global morbidity and mortality. Given that the E. histolytica genome has been sequenced, it should be possible to apply genomic approaches to discover gene function. We used a genome-wide overexpression screen to uncover genes regulating an important virulence function of E. histolytica, namely phagocytosis. We developed an episomal E. histolytica cDNA over-expression library, transfected the collection of plasmids into trophozoites, and applied a high-throughput screen to identify phagocytosis mutants in the population of over-expressing cells. The screen was based on the phagocytic uptake of human red blood cells loaded with the metabolic toxin, tubercidin. Expression plasmids were isolated from trophozoites that survived exposure to tubercidin-charged erythrocytes (phagocytosis mutants), and the cDNAs were sequenced. We isolated the gene encoding profilin, a well-characterized cytoskeleton-regulating protein with a known role in phagocytosis. This supports the validity of our approach. Furthermore, we assigned a phagocytic role to several genes not previously known to function in this manner. To our knowledge, this is the first genome-wide forward genetics screen to be applied to this pathogen. The study demonstrates the power of forward genetics in revealing genes regulating virulence in E. histolytica. In addition, the study validates an E. histolytica cDNA over-expression library as a valuable tool for functional genomics.	[King, Ada V.; Welter, Brenda H.; Temesvari, Lesly A.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Koushik, Amrita B.; Gordon, Lindsay N.] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA	Clemson University; Clemson University	King, AV (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	ltemesv@clemson.edu			National Institute of Allergy and Infectious Diseases, National Institutes of Health [R21 AI081100-01]; NIFA/USDA [SC-1700312]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081100] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIFA/USDA(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by grant no. R21 AI081100-01 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health to L.A.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This material is based upon work supported by NIFA/USDA, under project number SC-1700312 (Technical Contribution No. 6026 of the Clemson University Experiment Station). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, or the USDA.	Abhyankar MM, 2009, PARASITOL INT, V58, P95, DOI 10.1016/j.parint.2008.08.004; ACS G, 1964, P NATL ACAD SCI USA, V52, P493, DOI 10.1073/pnas.52.2.493; Anderson JB, 2003, GENETICS, V163, P1287; Arlt H, 2011, TRAFFIC, V12, P1592, DOI 10.1111/j.1600-0854.2011.01252.x; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Biller L, 2009, PROTEOMICS, V9, P4107, DOI 10.1002/pmic.200900022; Birrell GW, 2001, P NATL ACAD SCI USA, V98, P12608, DOI 10.1073/pnas.231366398; Butcher RA, 2003, CHEM BIOL, V10, P521, DOI 10.1016/S1074-5521(03)00108-X; Byekova YA, 2010, INFECT IMMUN, V78, P125, DOI 10.1128/IAI.00719-09; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chavez-Rios R, 2003, MOL BIOCHEM PARASIT, V127, P151, DOI 10.1016/S0166-6851(02)00332-8; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Drew ME, 2003, J BIOL CHEM, V278, P46596, DOI 10.1074/jbc.M309320200; Ehrenkaufer GM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-216; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Game JC, 2003, RADIAT RES, V160, P14, DOI 10.1667/RR3019; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hanway D, 2002, P NATL ACAD SCI USA, V99, P10605, DOI 10.1073/pnas.152264899; Hart CP, 2005, DRUG DISCOV TODAY, V10, P513, DOI 10.1016/S1359-6446(05)03415-X; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Khurana T, 2005, EMBO J, V24, P2254, DOI 10.1038/sj.emboj.7600716; KNIGHT R, 1980, J ANTIMICROB CHEMOTH, V6, P577, DOI 10.1093/jac/6.5.577; Laughlin Richard C., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009622; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Luesch H, 2005, CHEM BIOL, V12, P55, DOI 10.1016/j.chembiol.2004.10.015; Luesch Hendrik, 2008, V477, P343, DOI 10.1007/978-1-60327-517-0_26; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Marion S, 2006, INT J PARASITOL, V36, P131, DOI 10.1016/j.ijpara.2005.10.007; Marion S, 2005, CELL MICROBIOL, V7, P1504, DOI 10.1111/j.1462-5822.2005.00573.x; MUSCHEL RJ, 1977, J EXP MED, V145, P175, DOI 10.1084/jem.145.1.175; Okada M, 2006, MOL BIOCHEM PARASIT, V145, P171, DOI 10.1016/j.molbiopara.2005.10.001; Okada M, 2006, ARCH MED RES, V37, P244, DOI 10.1016/j.arcmed.2005.10.003; Okada M, 2005, EUKARYOT CELL, V4, P827, DOI 10.1128/EC.4.4.827-831.2005; Olivos-Garcia A, 2004, PARASITOLOGY, V129, P19, DOI 10.1017/S0031182004005116; Page N, 2003, GENETICS, V163, P875; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pimenta PEP, 2002, J EUKARYOT MICROBIOL, V49, P209, DOI 10.1111/j.1550-7408.2002.tb00525.x; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Prassler J, 1998, MOL BIOL CELL, V9, P545, DOI 10.1091/mbc.9.3.545; Ramakrishnan G, 1997, MOL BIOCHEM PARASIT, V84, P93, DOI 10.1016/S0166-6851(96)02784-3; Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122; RODRIGUEZ MA, 1986, J INFECT DIS, V154, P27, DOI 10.1093/infdis/154.1.27; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Samarawickrema NA, 1997, J ANTIMICROB CHEMOTH, V40, P833, DOI 10.1093/jac/40.6.833; Sateriale Adam, 2011, Journal of Parasitology Research, P926706, DOI 10.1155/2011/926706; Schneider N, 2003, CELL MOTIL CYTOSKEL, V56, P130, DOI 10.1002/cm.10139; Seifert K, 2000, ARCH MED RES, V31, pS6, DOI 10.1016/S0188-4409(00)00139-9; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; SMITH CG, 1970, CANCER RES, V30, P69; Sokal R. R., 1981, BIOMETRY; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; SUN HQ, 1995, CURR OPIN CELL BIOL, V7, P102, DOI 10.1016/0955-0674(95)80051-4; Tallada VA, 2002, YEAST, V19, P1139, DOI 10.1002/yea.902; Temesvari L, 2000, MOL BIOL CELL, V11, P2019, DOI 10.1091/mbc.11.6.2019; Tseng ASK, 2002, GENETICS, V162, P229; Voigt H, 1999, J CELL SCI, V112, P1191; Welter BH, 2006, EXP PARASITOL, V113, P91, DOI 10.1016/j.exppara.2005.12.012; Welter BH, 2009, EUKARYOT CELL, V8, P1014, DOI 10.1128/EC.00030-09; Wender N, 2007, EUKARYOT CELL, V6, P1646, DOI 10.1128/EC.00177-07; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zewail A, 2003, P NATL ACAD SCI USA, V100, P3345, DOI 10.1073/pnas.0530118100	75	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43025	10.1371/journal.pone.0043025	http://dx.doi.org/10.1371/journal.pone.0043025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905196	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800038
J	Dovzhenok, A; Kuznetsov, AS				Dovzhenok, Andrey; Kuznetsov, Alexey S.			Exploring Neuronal Bistability at the Depolarization Block	PLOS ONE			English	Article							BISTABLE BEHAVIOR; MEMBRANE; MODEL; AXON	Many neurons display bistability-coexistence of two firing modes such as bursting and tonic spiking or tonic spiking and silence. Bistability has been proposed to endow neurons with richer forms of information processing in general and to be involved in short-term memory in particular by allowing a brief signal to elicit long-lasting changes in firing. In this paper, we focus on bistability that allows for a choice between tonic spiking and depolarization block in a wide range of the depolarization levels. We consider the spike-producing currents in two neurons, models of which differ by the parameter values. Our dopaminergic neuron model displays bistability in a wide range of applied currents at the depolarization block. The Hodgkin-Huxley model of the squid giant axon shows no bistability. We varied parameter values for the model to analyze transitions between the two parameter sets. We show that bistability primarily characterizes the inactivation of the Na+ current. Our study suggests a connection between the amount of the Na+ window current and the length of the bistability range. For the dopaminergic neuron we hypothesize that bistability can be linked to a prolonged action of antipsychotic drugs.	[Dovzhenok, Andrey] Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA; Indiana Univ Purdue Univ, Ctr Math Biosci, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Dovzhenok, A (corresponding author), Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA.	adovzhen@iupui.edu	Kuznetsov, Alexey/L-1128-2017					Boye SM, 2000, J NEUROSCI, V20, P1229, DOI 10.1523/JNEUROSCI.20-03-01229.2000; Cymbalyuk G, 2005, J COMPUT NEUROSCI, V18, P255, DOI 10.1007/s10827-005-0354-7; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Grace AA, 1997, TRENDS NEUROSCI, V20, P31, DOI 10.1016/S0166-2236(96)10064-3; GUTTMAN R, 1980, J PHYSIOL-LONDON, V305, P377, DOI 10.1113/jphysiol.1980.sp013370; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOUNSGAARD J, 1984, EXP BRAIN RES, V55, P391; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Kuznetsov AS, 2006, J NEUROPHYSIOL, V95, P932, DOI 10.1152/jn.00691.2004; Le T, 2006, J NEUROPHYSIOL, V95, P1356, DOI 10.1152/jn.00893.2005; Lechner HA, 1996, J NEUROPHYSIOL, V75, P957, DOI 10.1152/jn.1996.75.2.957; Lee RH, 1996, J NEUROPHYSIOL, V76, P2107, DOI 10.1152/jn.1996.76.3.2107; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; RINZEL J, 1978, FED PROC, V37, P2793; Shilnikov A, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056214; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Valenti O, 2011, J NEUROSCI, V31, P12330, DOI 10.1523/JNEUROSCI.2808-11.2011	19	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42811	10.1371/journal.pone.0042811	http://dx.doi.org/10.1371/journal.pone.0042811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900051	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900069
J	Kursu, O; Tuukkanen, T; Rahkonen, T; Vahasoyrinki, M				Kursu, Olli; Tuukkanen, Tuomas; Rahkonen, Timo; Vahasoyrinki, Mikko			3D Active Stabilization System with Sub-Micrometer Resolution	PLOS ONE			English	Article							SENSOR	Stable positioning between a measurement probe and its target from sub- to few micrometer scales has become a prerequisite in precision metrology and in cellular level measurements from biological tissues. Here we present a 3D stabilization system based on an optoelectronic displacement sensor and custom piezo-actuators driven by a feedback control loop that constantly aims to zero the relative movement between the sensor and the target. We used simulations and prototyping to characterize the developed system. Our results show that 95 % attenuation of movement artifacts is achieved at 1 Hz with stabilization performance declining to ca. 70 % attenuation at 10 Hz. Stabilization bandwidth is limited by mechanical resonances within the displacement sensor that occur at relatively low frequencies, and are attributable to the sensor's high force sensitivity. We successfully used brain derived micromotion trajectories as a demonstration of complex movement stabilization. The micromotion was reduced to a level of similar to 1 mu m with nearly 100 fold attenuation at the lower frequencies that are typically associated with physiological processes. These results, and possible improvements of the system, are discussed with a focus on possible ways to increase the sensor's force sensitivity without compromising overall system bandwidth.	[Kursu, Olli; Rahkonen, Timo] Univ Oulu, Dept Elect & Informat Engn, Oulu, Finland; [Kursu, Olli; Rahkonen, Timo] Univ Oulu, Infotech Oulu, Elect Lab, Oulu, Finland; [Tuukkanen, Tuomas; Vahasoyrinki, Mikko] Univ Oulu, Dept Phys, FIN-90570 Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Kursu, O (corresponding author), Univ Oulu, Dept Elect & Informat Engn, Oulu, Finland.	mikko.vahasoyrinki@oulu.fi	Rahkonen, Timo E/H-9249-2012; Kursu, Olli/ABB-6597-2021	Kursu, Olli/0000-0002-8490-7069; Rahkonen, Timo/0000-0002-1343-1120	Academy of Finland [118480, 129762]; Sigrid Juselius Foundation; Infotech Oulu Graduate School; Tauno Tonning foundation; Emil Aaltonen foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Infotech Oulu Graduate School; Tauno Tonning foundation; Emil Aaltonen foundation	The work was supported by the Academy of Finland grants 118480 and 129762 (to MV), Sigrid Juselius Foundation (to MV and TT), Infotech Oulu Graduate School (to OK), Tauno Tonning foundation (to OK) and Emil Aaltonen foundation (to OK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkelman PJ, 2003, IEEE T ROBOTIC AUTOM, V19, P917, DOI 10.1109/TRA.2003.817526; BRITT RH, 1982, J NEUROSCI METH, V6, P219, DOI 10.1016/0165-0270(82)90085-1; Cham JG, 2005, J NEUROPHYSIOL, V93, P570, DOI 10.1152/jn.00369.2004; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Fauver ME, 1998, IEEE T BIO-MED ENG, V45, P891, DOI 10.1109/10.686797; Fee MS, 2000, NEURON, V27, P461, DOI 10.1016/S0896-6273(00)00057-X; Laffray S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019928; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Muntwyler S, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/2/025011; Rind FC, 2008, J NEUROPHYSIOL, V100, P670, DOI 10.1152/jn.01055.2007; Saif MTA, 2003, ANN BIOMED ENG, V31, P950, DOI 10.1114/1.1591189; Stenlund L, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/7/075102; Strang W. G., 1973, ANAL FINITE ELEMENT; Vahasoyrinki M, 2009, J NEUROSCI METH, V180, P290, DOI 10.1016/j.jneumeth.2009.04.004	14	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42733	10.1371/journal.pone.0042733	http://dx.doi.org/10.1371/journal.pone.0042733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900045	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900062
J	Nakanishi, W; Imura, T; Inagaki, A; Nakamura, Y; Sekiguchi, S; Fujimori, K; Satomi, S; Goto, M				Nakanishi, Wataru; Imura, Takehiro; Inagaki, Akiko; Nakamura, Yasuhiro; Sekiguchi, Satoshi; Fujimori, Keisei; Satomi, Susumu; Goto, Masafumi			Ductal Injection Does Not Increase the Islet Yield or Function after Cold Storage in a Vascular Perfusion Model	PLOS ONE			English	Article							ISOLATED PANCREATIC-ISLETS; ISCHEMIC STRESS; TRANSPLANTATION; PRESERVATION; CULTURE; QUALITY; IMPACT	Several studies have reported that pancreatic ductal preservation greatly improved the islet yield and function after cold storage. However, these studies were devoid of appropriate controls, such as vascular perfusion, which is routinely performed to preserve organs in the clinical setting. In this study, we created a vascular perfusion model using inbred rats, and investigated the effect of ductal injection on the islet yield and function after cold storage. Rat pancreases after 10 h cold ischemia were classified as follows: without ductal/vascular perfusion; with ductal injection; with vascular perfusion; and with ductal/vascular perfusion. The islet yield, function, viability, release of inflammatory mediators, and pathological changes in the exocrine tissues were assessed in the Hanks' Balanced Salt Solution (HBSS) model. The islet yield was also assesed by introducing University of Wisconsin Solution (UWS) and Histidine-Tryptophan-Ketoglutarate solution (HTK), which are the standard clinical preservation solutions. In the HBSS model, ductal injection and vascular perfusion significantly improved the islet yield compared with the control group. However, ductal injection showed no additional effects on the islet yield, function, viability and suppressing the release of inflammatory mediators when vascular perfusion was performed. Although ductal injection significantly decreased the apoptosis of exocrine cells, no beneficial effect on vacuolation was observed. In contrast, vascular perfusion significantly suppressed vacuolation in the exocrine tissues. Likewise, in the UWS and HTK model, ductal injection and vascular perfusion improved the islet yield compared with the control group. Nevertheless, the combination group showed no additional effects. These data suggest that ductal injection has no additional effect on islet yield and function after cold storage in a vascular perfusion model. We propose that ductal injection can be an effective and simple alternative for vascular perfusion prior to pancreas harvest, but is not necessary in most cases, since vascular perfusion is routinely performed.	[Nakanishi, Wataru; Sekiguchi, Satoshi; Fujimori, Keisei; Satomi, Susumu; Goto, Masafumi] Tohoku Univ, Div Adv Surg Sci & Technol, Sendai, Miyagi 980, Japan; [Imura, Takehiro; Inagaki, Akiko; Goto, Masafumi] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 980, Japan; [Nakamura, Yasuhiro] Tohoku Univ, Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Nakanishi, W (corresponding author), Tohoku Univ, Div Adv Surg Sci & Technol, Sendai, Miyagi 980, Japan.	gotokichi@aol.com	Goto, Masafumi/GPF-7677-2022; Nakamura, Yasuhiro/AAR-7367-2020		Innovation Plaza Miyagi of Japan Science and Technology Agency (JST); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23791479] Funding Source: KAKEN	Innovation Plaza Miyagi of Japan Science and Technology Agency (JST); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from Innovation Plaza Miyagi of Japan Science and Technology Agency (JST), the Japanese Grant-in-Aid for Scientific Research (B), the Mochida Memorial Foundation for Medical and Pharmaceutical Research and the Takeda Science Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne K, 1996, PHYSIOLOGIST, V39, P199; Goto M, 2005, TRANSPLANT P, V37, P1315, DOI 10.1016/j.transproceed.2004.11.042; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Goto M, 2010, TRANSPL P, V42, P2040, DOI 10.1016/j.transproceed.2010.05.101; Goto M, 2009, TRANSPL P, V41, P311, DOI 10.1016/j.transproceed.2008.10.075; Kin T, 2008, TRANSPL INT, V21, P1029, DOI 10.1111/j.1432-2277.2008.00719.x; Matsumoto S, 2006, TRANSPLANTATION, V82, P460, DOI 10.1097/01.tp.0000231710.37981.64; Matsumoto S, 2010, CELL TRANSPLANT, V19, P291, DOI 10.3727/096368909X481773; Monbaliu D, 2005, TRANSPLANTATION, V79, P1226, DOI 10.1097/01.TP.0000153508.71684.99; Movahedi B, 2004, DIABETOLOGIA, V47, P998, DOI 10.1007/s00125-004-1426-3; Noguchi H, 2008, CELL TRANSPLANT, V17, P69, DOI 10.3727/000000008783907062; Pileggi A, 2009, TRANSPLANTATION, V87, P1442, DOI 10.1097/TP.0b013e3181a36b1e; Saito Y, 2010, CELL TRANSPLANT, V19, P775, DOI 10.3727/096368910X508889; Sawada T, 2003, TRANSPLANTATION, V75, P1965, DOI 10.1097/01.TP.0000068871.09469.E0; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Takita Morihito, 2010, Proc (Bayl Univ Med Cent), V23, P341; Toso C, 2002, TRANSPLANT P, V34, P826, DOI 10.1016/S0041-1345(01)02925-6; Wennberg L, 2001, TRANSPLANTATION, V71, P1024, DOI 10.1097/00007890-200104270-00002	18	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42319	10.1371/journal.pone.0042319	http://dx.doi.org/10.1371/journal.pone.0042319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900012	gold, Green Submitted, Green Published			2022-12-27	WOS:000307380900029
J	Baird, TA; Baird, TD; Shine, R				Baird, Troy A.; Baird, Teresa D.; Shine, Richard			Aggressive Transition between Alternative Male Social Tactics in a Long-Lived Australian Dragon (Physignathus lesueurii) Living at High Density	PLOS ONE			English	Article							MALE COLLARED LIZARDS; AMPHIBOLURUS-MURICATUS; TERRITORY ACQUISITION; SEXUAL SELECTION; REPRODUCTIVE SUCCESS; CROTAPHYTUS-COLLARIS; FIGHTING ABILITY; VISUAL-DISPLAYS; MARINE IGUANAS; JACKY DRAGON	Theory predicts the evolution of alternative male social tactics when intense competition coupled with the superior competitive ability of some individuals limits access to reproductive opportunities by others. How selection has shaped alternative social tactics may be especially interesting in long-lived species where size among sexually mature males varies markedly. We conducted experimental studies on long-lived eastern Australian water dragons living where competition was intense to test the hypotheses that mature males adopt alternative social tactics that are plastic, and that large size and body condition determine resource-holding potential. Approximately one-half of mature males (N = 14) defended territories using high rates of patrol and advertisement display, whereas 16 smaller mature males having lower body condition indices utilized non-territorial social tactics. Although territorial males were larger in absolute size and head dimensions, their heads were not allometrically larger. Territorial males advertised very frequently using displays involving stereotypical movements of the head and dewlap. More aggressive displays were given infrequently during baseline social conditions, but increased during periods of social instability. Female home ranges overlapped those of several territorial and non-territorial males, but females interacted more frequently with territorial males. The extreme plasticity of social tactics in this species that are dependent on body size was confirmed by two instances when relatively large non-territorial males spontaneously evicted territory owners, and by marked shifts in tactics by non-territorial males in response to temporary experimental removals of territory owners, followed (usually) by their expulsion when original owners were reinstated. The high level of social plasticity in this population where same-sex competitors are densely concentrated in preferred habitat suggests that chronic high energetic costs of defense may select for males to cycle between territorial and non-territorial social tactics depending upon their changing energetic status and their current capacity for competition with rivals.	[Baird, Troy A.; Baird, Teresa D.] Univ Cent Oklahoma, Dept Biol, Edmond, OK USA; [Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Central Oklahoma; University of Sydney	Baird, TA (corresponding author), Univ Cent Oklahoma, Dept Biol, Edmond, OK USA.	tbaird@uco.edu			Australian Research Council Grant [FF056365]	Australian Research Council Grant(Australian Research Council)	Australian Research Council Grant FF056365 to Richard Shine. The funders had no role in sudy design, data collection and analysis, descision to publish, or preparation of the manuscript.	Alonzo SH, 2004, BEHAV ECOL, V15, P278, DOI 10.1093/beheco/arh007; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ANDERSON RA, 1990, OECOLOGIA, V84, P145, DOI 10.1007/BF00318265; Anibaldi C, 1998, AFR J ECOL, V36, P199, DOI 10.1046/j.1365-2028.1998.00119.x; Aragon P, 2004, ETHOLOGY, V110, P1001, DOI 10.1111/j.1439-0310.2004.01046.x; ARCESE P, 1989, ANIM BEHAV, V37, P45, DOI 10.1016/0003-3472(89)90005-5; Baird TA, 2003, LIZARD SOCIAL BEHAVIOR, P7; Baird TA, 2008, BEHAV ECOL, V19, P589, DOI 10.1093/beheco/arn014; Baird TA, 2007, BEHAV ECOL, V18, P1146, DOI 10.1093/beheco/arm092; Baird TA, 2010, BEHAV ECOL, V21, P753, DOI 10.1093/beheco/arq049; BAUGH JR, 1994, BEHAVIOUR, V131, P207, DOI 10.1163/156853994X00442; BERRY K H, 1974, University of California Publications in Zoology, V101, P1; Buston PM, 2004, P ROY SOC B-BIOL SCI, V271, pS252, DOI 10.1098/rsbl.2003.0156; Calsbeek R, 2002, OECOLOGIA, V132, P468, DOI 10.1007/s00442-002-0975-8; CARPENTER CC, 1970, COPEIA, P497; CENSKY EJ, 1995, BEHAVIOUR, V132, P529, DOI 10.1163/156853995X00199; COGGER HG, 1978, AUST J ZOOL, V26, P653, DOI 10.1071/ZO9780653; COURTICE GP, 1981, COMP BIOCHEM PHYS A, V68, P429, DOI 10.1016/0300-9629(81)90072-4; Cuervo JJ, 2007, J ZOOL, V273, P298, DOI 10.1111/j.1469-7998.2007.00328.x; Earley RL, 2002, AMPHIBIA-REPTILIA, V23, P469, DOI 10.1163/15685380260462374; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FOX SF, 1992, ANIM BEHAV, V44, P780, DOI 10.1016/S0003-3472(05)80306-9; Fretwell SD, 1985, ACTA BIOTHEOR, V19, P16; Gier PJ, 2003, LIZARD SOCIAL BEHAVIOR, P278; Hacklander K, 1999, BEHAV ECOL, V10, P592, DOI 10.1093/beheco/10.5.592; Harlow PS, 2001, THESIS MACQUARIE U; Heideman Neil J.L., 1993, Journal of the Herpetological Association of Africa, V42, P28; Hews DK, 2003, LIZARD SOCIAL BEHAVIOR, P253; Hews DK, 1997, BEHAV ECOL SOCIOBIOL, V41, P371, DOI 10.1007/s002650050398; Husak JF, 2003, ANIM BEHAV, V65, P391, DOI 10.1006/anbe.2003.2058; Hussein H.K., 2000, PAKISTAN J BIOL SCI, V3, P1700; Jenssen TA, 2005, ANIM BEHAV, V69, P1325, DOI 10.1016/j.anbehav.2004.07.023; Karsten KB, 2009, BEHAV ECOL, V20, P1079, DOI 10.1093/beheco/arp100; Lappin AK, 2006, AM NAT, V168, P100, DOI 10.1086/505161; Lebas NR, 2001, MOL ECOL, V10, P193, DOI 10.1046/j.1365-294X.2001.01174.x; Martin J, 2007, FUNCT ECOL, V21, P568, DOI 10.1111/j.1365-2435.2007.01262.x; MILES DB, 1994, LIZARD ECOLOGY, P207; OLSSON M, 1994, ANIM BEHAV, V48, P607, DOI 10.1006/anbe.1994.1280; ONEILL KM, 1983, BEHAVIOUR, V86, P295, DOI 10.1163/156853983X00408; Ord TJ, 2003, BEHAVIOUR, V140, P1495, DOI 10.1163/156853903771980684; Pal Arttatrana, 2011, Taprobanica, V3, P31; Partecke J, 2002, BEHAV ECOL SOCIOBIOL, V51, P579, DOI 10.1007/s00265-002-0469-z; Paruk JD, 1999, WILSON BULL, V111, P116; Peters RA, 2003, AUSTRAL ECOL, V28, P499, DOI 10.1046/j.1442-9993.2003.01306.x; PICMAN J, 1987, AUK, V104, P405, DOI 10.2307/4087537; Piper WH, 2000, ANIM BEHAV, V59, P385, DOI 10.1006/anbe.1999.1295; PRATT NC, 1994, ANIM BEHAV, V47, P1101, DOI 10.1006/anbe.1994.1148; Radder RS, 2006, J ETHOL, V24, P275, DOI 10.1007/s10164-006-0192-8; ROSE B, 1982, J HERPETOL, V16, P253, DOI 10.2307/1563718; Schwartz AM, 2007, ETHOLOGY, V113, P9, DOI 10.1111/j.1439-0310.2006.01297.x; SHINE R, 1990, BIOL J LINN SOC, V40, P11, DOI 10.1111/j.1095-8312.1990.tb00531.x; SHUSTER SM, 1989, EVOLUTION, V43, P1683, DOI 10.1111/j.1558-5646.1989.tb02618.x; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; SMITH SM, 1978, AM NAT, V112, P571, DOI 10.1086/283298; Stone PA, 2002, J HERPETOL, V36, P427, DOI 10.2307/1566187; Stuart-Fox D, 2006, P ROY SOC B-BIOL SCI, V273, P1555, DOI 10.1098/rspb.2006.3468; Stuart-Fox DM, 2005, BEHAVIOUR, V142, P329, DOI 10.1163/1568539053778265; STUTCHBURY BJ, 1991, ANIM BEHAV, V42, P435, DOI 10.1016/S0003-3472(05)80042-9; Switzer PV, 2002, ANN ENTOMOL SOC AM, V95, P628, DOI 10.1603/0013-8746(2002)095[0628:IVITDO]2.0.CO;2; THOMPSON MB, 1993, WILDLIFE RES, V20, P613, DOI 10.1071/WR9930613; Tibbetts EA, 2009, BEHAV ECOL SOCIOBIOL, V63, P1377, DOI 10.1007/s00265-009-0764-z; TRILLMICH F, 1984, BIOL J LINN SOC, V21, P209; Turner F. B., 1971, Herpetological Review, V3, P77; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; VITT LJ, 1985, CAN J ZOOL, V63, P995, DOI 10.1139/z85-148; WASER PM, 1985, ECOLOGY, V66, P1170, DOI 10.2307/1939169; Watkins GG, 1996, ECOLOGY, V77, P1473, DOI 10.2307/2265544; Watt MJ, 2003, BRAIN BEHAV EVOLUT, V61, P172, DOI 10.1159/000070701; Whiting MJ, 2003, LIZARD SOCIAL BEHAVIOR, P47; Wikelski M, 2005, BEHAV ECOL, V16, P260, DOI 10.1093/beheco/arh160; ZACK S, 1992, BEHAVIOUR, V123, P194, DOI 10.1163/156853992X00020; Zamudio KR, 2003, LIZARD SOCIAL BEHAVIOR, P83	72	33	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41819	10.1371/journal.pone.0041819	http://dx.doi.org/10.1371/journal.pone.0041819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905109	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100019
J	Roe, OD; Szulkin, A; Anderssen, E; Flatberg, A; Sandeck, H; Amundsen, T; Erlandsen, SE; Dobra, K; Sundstrom, SH				Roe, Oluf Dimitri; Szulkin, Adam; Anderssen, Endre; Flatberg, Arnar; Sandeck, Helmut; Amundsen, Tore; Erlandsen, Sten Even; Dobra, Katalin; Sundstrom, Stein Harald			Molecular Resistance Fingerprint of Pemetrexed and Platinum in a Long-Term Survivor of Mesothelioma	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; SQUAMOUS-CELL CARCINOMA; MESSENGER-RNA EXPRESSION; FALSE DISCOVERY RATE; CANCER-CELLS; GENE-EXPRESSION; BREAST-CANCER; THYMIDYLATE SYNTHASE; LUNG-CANCER; DNA-REPAIR	Background: Pemetrexed, a multi-folate inhibitor combined with a platinum compound is the first-line treatment of malignant mesothelioma, but median survival is still one year. Intrinsic and acquired resistance to pemetrexed is common, but its biological basis is obscure. Here we report for the first time a genome-wide profile of acquired resistance in the tumour from an exceptional case with advanced pleural mesothelioma and almost six years survival after 39 cycles of second-line pemetrexed/carboplatin treatment. Methodology and Principal Findings: Genome-wide analysis with Illumina BeadChip Kit of 25,000 genes was performed on mRNA from pre-treatment and post-resistance biopsies from this individual as well on case and control samples from our previously published study (in total 17 samples). Cell specific expression of proteins encoded by selected genes were analysed by immunohistochemistry. Serial serum levels of CA125, CYFRA21-1 and SMRP levels were examined. TS protein, the main target of pemetrexed was overexpressed. Proteins and genes related to DNA damage response, elongation and telomere extension and repair related directly and indirectly to platinum resistance were overexpressed, as the CHK1 protein and the genes CHEK2, LIG3, POLD1, POLA2, FANCD2, PRPF19, RECQ5 respectively, the last two not previously described in mesothelioma. We observed a down-regulation of leukocyte transendothelial migration and cell adhesion molecules pathways. Silencing of NT5C in two mesothelioma cell lines did not sensitize the cells to Pemetrexed. Proposed resistance markers are TS, KRT7/ CK7, TYMP/ thymidine phosphorylase and down-regulated SPARCL1 and CDKN1B. Moreover, comparison of the primary expression of the sensitive versus a primary resistant case showed multi-fold overexpressed DNA repair, cell cycle, cytokinesis, and spindle formation in the latter. Serum CA125 and SMRP reflected the clinical and radiological course and tumour burden. Conclusions: Genome-wide microarray of mesothelioma pre- and post-resistance biopsies indicated a novel resistance signature to pemetrexed/carboplatin that deserve validation in a larger cohort.	[Roe, Oluf Dimitri; Flatberg, Arnar; Erlandsen, Sten Even] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Canc Res & Mol Med IKM, Trondheim, Norway; [Roe, Oluf Dimitri; Sundstrom, Stein Harald] Nord Trondelag Hlth Trust, Levanger Hosp, Canc Clin, Levanger, Norway; [Szulkin, Adam; Dobra, Katalin] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Szulkin, Adam; Dobra, Katalin] Huddinge Univ Hosp, Stockholm, Sweden; [Anderssen, Endre] Univ Tromso, Inst Clin Med, Lab Mol Med Res, Tromso, Norway; [Sandeck, Helmut] St Olavs Hosp, Dept Pathol & Med Genet, Trondheim, Norway; [Amundsen, Tore] St Olavs Hosp, Dept Thorac Med, Trondheim, Norway; [Amundsen, Tore] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Karolinska Institutet; Karolinska Institutet; UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Roe, OD (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Canc Res & Mol Med IKM, Trondheim, Norway.	oluf.roe@ntnu.no		Roe, Oluf Dimitri/0000-0002-4870-5822	functional genomics program (FUGE) in the Research Council of Norway	functional genomics program (FUGE) in the Research Council of Norway(Research Council of Norway)	The Illumina Beadchip and hybridization service was provided by NMC at the national technology platform, and supported by the functional genomics program (FUGE) in the Research Council of Norway. Thanks to Dr. Kristin Nesgard for valuable clinical and radiological service and to Unn Granli and Borgny Ytterhus for excellent immunohistochemical stainings.	Ahmed KM, 2008, FREE RADICAL BIO MED, V44, P1, DOI 10.1016/j.freeradbiomed.2007.09.022; Akiyama S, 2004, CANCER SCI, V95, P851, DOI 10.1111/j.1349-7006.2004.tb02193.x; Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Arora S, 2010, GYNECOL ONCOL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atienza JM, 2005, MOL CANCER THER, V4, P361; Azorsa DO, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-43; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bongiovanni M, 2001, CANCER-AM CANCER SOC, V92, P1245, DOI 10.1002/1097-0142(20010901)92:5<1245::AID-CNCR1444>3.0.CO;2-G; Briassouli P, 2007, CANCER RES, V67, P1689, DOI 10.1158/0008-5472.CAN-06-2272; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Cao DF, 2007, MODERN PATHOL, V20, P570, DOI 10.1038/modpathol.3800772; Castro M, 2003, J CLIN ONCOL, V21, P4066, DOI 10.1200/JCO.2003.99.092; Catto JWF, 2010, EUR UROL, V57, P398, DOI 10.1016/j.eururo.2009.10.029; Ceppi P, 2010, INT J CLIN PHARM TH, V48, P481; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chen CH, 2009, ONCOGENE, V28, P2723, DOI 10.1038/onc.2009.128; Chen H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-29; Cho SH, 2009, BLOOD, V113, P2416, DOI 10.1182/blood-2008-03-144121; Corson TW, 2007, CLIN CANCER RES, V13, P3229, DOI 10.1158/1078-0432.CCR-07-0393; De Angelis PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-20; Delgermaa V, 2011, B WORLD HEALTH ORGAN, V89, P716, DOI 10.2471/BLT.11.086678; Devlin HL, 2008, MOL CANCER RES, V6, P808, DOI 10.1158/1541-7786.MCR-07-2027; Esposito I, 2007, NEOPLASIA, V9, P8, DOI 10.1593/neo.06646; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Fu J, 2010, CELL RES; Fuhler GM, 2010, EXP CELL RES, V316, P1816, DOI 10.1016/j.yexcr.2010.03.013; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Garate M, 2010, FREE RADICAL BIO MED, V48, P1601, DOI 10.1016/j.freeradbiomed.2010.03.003; Garnis C, 2005, HUM MOL GENET, V14, P475, DOI 10.1093/hmg/ddi043; Gelmini S, 2007, CLIN CHEM LAB MED, V45, P862, DOI 10.1515/CCLM.2007.133; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Gordon GJ, 2007, J PATHOL, V211, P447, DOI 10.1002/path.2121; Gresner P, 2009, LUNG CANCER, V65, P34, DOI 10.1016/j.lungcan.2008.10.023; Han S, 2003, J SURG ONCOL, V83, P241, DOI 10.1002/jso.10268; Hassan KA, 2002, CANCER RES, V62, P6414; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Hu YD, 2009, MOL BIOL CELL, V20, P114, DOI 10.1091/mbc.E08-06-0565; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; HUANG AP, 1994, ONCOGENE, V9, P491; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanwar RK, 2010, CURR MED CHEM, V17, P1509, DOI 10.2174/092986710790979935; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Li DH, 2009, CLIN CANCER RES, V15, P740, DOI 10.1158/1078-0432.CCR-08-1607; Li YZ, 2003, P NATL ACAD SCI USA, V100, P2674, DOI 10.1073/pnas.0538044100; Long XH, 2007, INT J MOL MED, V19, P607; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; Lu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030880; Ludwig RJ, 2005, J INVEST DERMATOL, V125, P969, DOI 10.1111/j.0022-202X.2005.23912.x; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; MacDermed DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-16; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Martin LP, 2008, CLIN CANCER RES, V14, P1291, DOI 10.1158/1078-0432.CCR-07-2238; Masuda T, 2003, CLIN CANCER RES, V9, P5693; Min SH, 2008, CANCER CHEMOTH PHARM, V61, P819, DOI 10.1007/s00280-007-0539-z; Mirchandani KD, 2006, EXP CELL RES, V312, P2647, DOI 10.1016/j.yexcr.2006.06.014; Mo ML, 2010, INT J BIOL MARKER, V25, P236, DOI 10.5301/JBM.2010.6088; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Mountzios G, 2008, CANCER TREAT REV, V34, P175, DOI 10.1016/j.ctrv.2007.09.005; Muhale FA, 2011, PHARMACOGENOMICS, V12, P341, DOI [10.2217/pgs.10.188, 10.2217/PGS.10.188]; Nakajima Y, 2009, ANTI-CANCER AGENT ME, V9, P239, DOI 10.2174/187152009787313846; Nelson ES, 2011, MOL CANCER RES, V9, P712, DOI 10.1158/1541-7786.MCR-10-0599; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Ooi AT, 2010, CANCER RES, V70, P6639, DOI 10.1158/0008-5472.CAN-10-0455; Osanai M, 2006, CANCER RES, V66, P9125, DOI 10.1158/0008-5472.CAN-06-1864; PELINENLUND K, 1990, CARCINOGENESIS, V11, P673, DOI 10.1093/carcin/11.4.673; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Righi L, 2010, J CLIN ONCOL, V28, P1534, DOI 10.1200/JCO.2009.25.9275; ROE OD, 2009, LUNG CANC; Roe OD, 2008, LUNG CANCER, V61, P235, DOI 10.1016/j.lungcan.2007.12.025; Roe OD, 2010, LUNG CANCER, V67, P57, DOI 10.1016/j.lungcan.2009.03.016; Roe OD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006554; Romagnoli S, 2009, AM J PATHOL, V174, P762, DOI 10.2353/ajpath.2009.080721; Sandeck HP, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-47; Sato J, 2011, J HEPATO-BIL-PAN SCI, V18, P700, DOI 10.1007/s00534-011-0376-7; SCHMITTER D, 1992, INT J CANCER, V51, P296, DOI 10.1002/ijc.2910510220; Schultz RM, 1999, SEMIN ONCOL, V26, P68; Smid K, 2006, NUCLEOS NUCLEOT NUCL, V25, P1001, DOI 10.1080/15257770600890269; Soini Y, 2006, J CLIN PATHOL, V59, P250, DOI 10.1136/jcp.2005.028589; TAKADA Y, 1994, BIOCHEM BIOPH RES CO, V205, P1345, DOI 10.1006/bbrc.1994.2813; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Timson DJ, 2000, MUTAT RES-DNA REPAIR, V460, P301, DOI 10.1016/S0921-8777(00)00033-1; Tot T, 2001, CANCER, V92, P2727, DOI 10.1002/1097-0142(20011115)92:10<2727::AID-CNCR1627>3.0.CO;2-B; Toziu-Kara S, 2007, J MOL ENDOCRINOL, V39, P305, DOI 10.1677/JME-07-0001; Turton NJ, 2001, ONCOGENE, V20, P1300, DOI 10.1038/sj.onc.1204235; van der Wilt CL, 2001, CANCER RES, V61, P3675; Vare P, 2008, ONCOL REP, V19, P25; Vecchi M, 2008, ONCOGENE, V27, P2148, DOI 10.1038/sj.onc.1210858; Visnes T, 2008, DNA REPAIR, V7, P1869, DOI 10.1016/j.dnarep.2008.07.012; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wang CL, 2009, J PROTEOME RES, V8, P4428, DOI 10.1021/pr900160h; Wegmann F, 2006, J EXP MED, V203, P1671, DOI 10.1084/jem.20060565; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wu MF, 2010, J THORAC ONCOL, V5, P1143, DOI 10.1097/JTO.0b013e3181e0b954; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; Yamamoto G, 2006, VIRCHOWS ARCH, V448, P435, DOI 10.1007/s00428-005-0132-y; Yamamoto Y, 2007, CANCER GENET CYTOGEN, V174, P42, DOI 10.1016/j.cancergencyto.2006.11.012; Yang HJ, 2010, CANCER INVEST, V28, P127, DOI 10.3109/07357900903147184; Zalmas LP, 2008, EMBO REP, V9, P252, DOI 10.1038/sj.embor.7401158; Zhao RB, 2005, CLIN CANCER RES, V11, P1294; Zucali PA, 2010, ANN ONCOL, V21, P1560, DOI 10.1093/annonc/mdq253; Zucali PA, 2011, CLIN CANCER RES, V17, P2581, DOI 10.1158/1078-0432.CCR-10-2873	106	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e40521	10.1371/journal.pone.0040521	http://dx.doi.org/10.1371/journal.pone.0040521			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905093	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100005
J	Taranto, GH; Kvile, KO; Pitcher, TJ; Morato, T				Taranto, Gerald H.; Kvile, Kristina O.; Pitcher, Tony J.; Morato, Telmo			An Ecosystem Evaluation Framework for Global Seamount Conservation and Management	PLOS ONE			English	Article							SPECIES RICHNESS; DEEP; ENDEMISM; PATTERNS; CORALS; AREAS; FAUNA; VULNERABILITY; BIODIVERSITY; BIOGEOGRAPHY	In the last twenty years, several global targets for protection of marine biodiversity have been adopted but have failed. The Convention on Biological Diversity (CBD) aims at preserving 10% of all the marine biomes by 2020. For achieving this goal, ecologically or biologically significant areas (EBSA) have to be identified in all biogeographic regions. However, the methodologies for identifying the best suitable areas are still to be agreed. Here, we propose a framework for applying the CBD criteria to locate potential ecologically or biologically significant seamount areas based on the best information currently available. The framework combines the likelihood of a seamount constituting an EBSA and its level of human impact and can be used at global, regional and local scales. This methodology allows the classification of individual seamounts into four major portfolio conservation categories which can help optimize management efforts toward the protection of the most suitable areas. The framework was tested against 1000 dummy seamounts and satisfactorily assigned seamounts to proper EBSA and threats categories. Additionally, the framework was applied to eight case study seamounts that were included in three out of four portfolio categories: areas highly likely to be identified as EBSA with high degree of threat; areas highly likely to be EBSA with low degree of threat; and areas with a low likelihood of being EBSA with high degree of threat. This framework will allow managers to identify seamount EBSAs and to prioritize their policies in terms of protecting undisturbed areas, disturbed areas for recovery of habitats and species, or both based on their management objectives. It also identifies seamount EBSAs and threats considering different ecological groups in both pelagic and benthic communities. Therefore, this framework may represent an important tool to mitigate seamount biodiversity loss and to achieve the 2020 CBD goals.	[Taranto, Gerald H.; Kvile, Kristina O.; Morato, Telmo] Univ Acores, Dept Oceanografia & Pescas, IMAR, LARSYS, Horta, Portugal; [Pitcher, Tony J.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	Universidade dos Acores; University of British Columbia	Taranto, GH (corresponding author), Univ Acores, Dept Oceanografia & Pescas, IMAR, LARSYS, Horta, Portugal.	telmo@uac.pt	Morato, Telmo/A-4548-2009; Kvile, Kristina/AAO-6084-2020	Morato, Telmo/0000-0003-2393-4773; Kvile, Kristina/0000-0003-2771-9077; Taranto, Gerald Hechter/0000-0002-7968-1982	European Community Seventh Framework Programme (FP7) under the CoralFISH project [213144]; Marine Conservation Institute through the Mia J. Tegner Memorial Research Grant Program in Marine Environmental History and Historical Marine Ecology; POPH; QREN; European Social Fund; Portuguese Ministry for Science and Education; Natural Science and Engineering Research Council of Canada; HERMIONE project [226354]	European Community Seventh Framework Programme (FP7) under the CoralFISH project; Marine Conservation Institute through the Mia J. Tegner Memorial Research Grant Program in Marine Environmental History and Historical Marine Ecology; POPH; QREN; European Social Fund(European Social Fund (ESF)); Portuguese Ministry for Science and Education(Portuguese Foundation for Science and Technology); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); HERMIONE project	This research has received funding from the European Community Seventh Framework Programme (FP7/2007-2013) under the CoralFISH project, grant agreement no 213144 and HERMIONE project, grant agreement no 226354. Additional funding was received from the Marine Conservation Institute through the Mia J. Tegner Memorial Research Grant Program in Marine Environmental History and Historical Marine Ecology. TM was funded by POPH, QREN, European Social Fund and the Portuguese Ministry for Science and Education. TJP was funded in part by the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Ardron J, 2009, DEFINING ECOLOGICALL; Ardron J, 2008, MAR POLICY, V32, P832, DOI 10.1016/j.marpol.2008.03.018; Auster PJ, 2005, ERLANGEN EARTH C SER, P747, DOI 10.1007/3-540-27673-4_39; Auster PJ, 1998, AM FISH S S, V22, P150; Bachraty C, 2009, DEEP-SEA RES PT I, V56, P1371, DOI 10.1016/j.dsr.2009.01.009; Baker KD, 2009, ENVIRON BIOL FISH, V85, P79, DOI 10.1007/s10641-009-9465-8; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Boehlert G.W., 1987, WILEY, V43, P319, DOI [DOI 10.1029/GM043P0319, 10.1029/GM043P0319]; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Castelin M, 2011, DEEP-SEA RES PT I, V58, P637, DOI 10.1016/j.dsr.2011.03.008; CBD, 2009, AZ SCI CRIT GUID ID; Charles A, 2009, ICES J MAR SCI, V66, P6, DOI 10.1093/icesjms/fsn182; Chuenpagdee R, 2003, FRONT ECOL ENVIRON, V1, P517; Clark M. R., 2007, SEAMOUNTS ECOLOGY FI, P413, DOI 10.1002/9780470691953.; Clark MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029232; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Collie JS, 2000, J ANIM ECOL, V69, P785, DOI 10.1046/j.1365-2656.2000.00434.x; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; Dunn DC, 2011, ECOLOGICALLY BIOL SI; Etnoyer PJ, 2010, OCEANOGRAPHY, V23, P206, DOI 10.5670/oceanog.2010.96; Ferreira Rogerio L., 2001, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V18A, P75; Food and Agriculture Organization, 2009, INT GUID MAN DEEP SE; Freese JL, 2001, MAR FISH REV, V63, P38; Freiwald A., 2004, COLD WATER CORAL REE, V22; Fuller S., 2008, WE FISH MATTERS ADDR; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Gilman E, 2011, BIODIVERS CONSERV, V20, P3363, DOI 10.1007/s10531-011-0116-y; Grantham HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016552; Gregr EJ, 2012, MAR POLICY, V36, P716, DOI 10.1016/j.marpol.2011.10.009; Halfar J, 2007, SCIENCE, V316, P987, DOI 10.1126/science.1138289; HALLSPENCER J, 2007, BULLMARSCI, P135; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Haury L, 2000, PROG OCEANOGR, V45, P69, DOI 10.1016/S0079-6611(99)00051-8; He GW, 2011, ACTA OCEANOL SIN, V30, P63, DOI 10.1007/s13131-011-0120-9; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Hogg MM, 2010, DEEP SEA SPONGE GROU; ICES, 2008, REP ICES NAFO JOINT; Ince R, 2007, ESTUAR COAST SHELF S, V74, P77, DOI 10.1016/j.ecss.2007.03.029; IUCN World Commission on Protected Areas, 2008, EST RES MAR PROT AR; Kaplan DM, 2010, TRENDS ECOL EVOL, V25, P62, DOI 10.1016/j.tree.2009.09.003; Kaschner Kristin, 2007, Fish and Aquatic Resources Series, V12, P230; Kelly NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013832; Kim SS, 2011, GEOPHYS J INT, V186, P615, DOI 10.1111/j.1365-246X.2011.05076.x; KLIMLEY AP, 1984, BEHAV ECOL SOCIOBIOL, V15, P45, DOI 10.1007/BF00310214; KLITGAARD AB, 1995, SARSIA, V80, P1; Koslow JA, 1996, J FISH BIOL, V49, P54, DOI 10.1111/j.1095-8649.1996.tb06067.x; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; Kvile KO, 2011, SEAMOUNT ECOSYSTEM E; Litvinov Feodor, 2007, Fish and Aquatic Resources Series, V12, P202; LUTZ RA, 1993, REV GEOPHYS, V31, P211, DOI 10.1029/93RG01280; Malakoff D, 2004, SCIENCE, V304, P1104, DOI 10.1126/science.304.5674.1104; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marques da Silva Helder, 2007, Fish and Aquatic Resources Series, V12, P335; Maxwell SM, 2011, MARINE MAMM IN PRESS; McArthur AG, 1998, GEOL SOC SPEC PUBL, V148, P271, DOI 10.1144/GSL.SP.1998.148.01.15; McClain CR, 2007, J BIOGEOGR, V34, P2001, DOI 10.1111/j.1365-2699.2007.01783.x; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; McDonald MA, 2009, J ACOUST SOC AM, V125, P624, DOI 10.1121/1.3050317; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Morato T, 2006, J FISH BIOL, V68, P209, DOI 10.1111/j.0022-1112.2006.00894.x; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Morato T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014453; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Morato T, 2009, DEEP-SEA RES PT II, V56, P2713, DOI 10.1016/j.dsr2.2008.12.029; Norse EA, 2006, MPA NEWS, V7, P4; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; OSPAR, 2008, 20086 OSPAR; Pitcher Tony J., 2007, Fish and Aquatic Resources Series, V12, P282; Pitcher TJ, 2010, OCEANOGRAPHY, V23, P123, DOI 10.5670/oceanog.2010.90; Pitcher TJ, 2010, OCEANOGRAPHY, V23, P134, DOI 10.5670/oceanog.2010.66; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Roberts CM, 2003, ECOL APPL, V13, pS199; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Robison BH, 2009, CONSERV BIOL, V23, P847, DOI 10.1111/j.1523-1739.2009.01219.x; Rogers A.D., 2007, SEAMOUNTS ECOLOGY FI, P3343; Rogers A.D., 2008, SCI GUIDELINES SCI G; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Rogers Alex D., 2007, Fish and Aquatic Resources Series, V12, P141; Rowden AA, 2005, NEW ZEAL J MAR FRESH, V39, P1039, DOI 10.1080/00288330.2005.9517374; Rowden AA, 2010, MAR ECOL S, V31, P1226; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; Santos Marco A., 2007, Fish and Aquatic Resources Series, V12, P239; Santos RS, 2009, DEEP-SEA RES PT II, V56, P2720, DOI 10.1016/j.dsr2.2008.12.031; Sautya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016162; Sedberry GR, 2001, MAR BIOL, V139, P355; Silva MA, 2011, AQUAT CONSERV, V21, P17, DOI 10.1002/aqc.1158; Staudigel H, 2010, OCEANOGRAPHY, V23, P20, DOI 10.5670/oceanog.2010.85; Thomaz Sidinei Magela, 2010, Acta Limnol. Bras., V22, P218, DOI 10.4322/actalb.02202011; Thompson David R., 2007, Fish and Aquatic Resources Series, V12, P245; Toropova C., 2010, GLOBAL OCEAN PROTECT; UNESCO, 2009, IOC TECHN SER, V84; Van den Hove S, 2007, ECOSYSTEMS BIODIVERS; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2011, ICES J MAR SCI, V68, P341, DOI 10.1093/icesjms/fsq086; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2010.00385.x; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Young JW, 2011, DEEP-SEA RES PT II, V58, P720, DOI 10.1016/j.dsr2.2010.10.005; Zezina ON, 1997, ADV MAR BIOL, V32, P389	114	29	30	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42950	10.1371/journal.pone.0042950	http://dx.doi.org/10.1371/journal.pone.0042950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905190	gold, Green Submitted, Green Published			2022-12-27	WOS:000307331100077
J	Kigozi, R; Baxi, SM; Gasasira, A; Sserwanga, A; Kakeeto, S; Nasr, S; Rubahika, D; Dissanayake, G; Kamya, MR; Filler, S; Dorsey, G				Kigozi, Ruth; Baxi, Sanjiv M.; Gasasira, Anne; Sserwanga, Asadu; Kakeeto, Stella; Nasr, Sussann; Rubahika, Denis; Dissanayake, Gunawardena; Kamya, Moses R.; Filler, Scott; Dorsey, Grant			Indoor Residual Spraying of Insecticide and Malaria Morbidity in a High Transmission Intensity Area of Uganda	PLOS ONE			English	Article							TOME-AND-PRINCIPE; ANOPHELES-GAMBIAE; TREATED NETS; RESISTANCE; MOZAMBIQUE; AFRICA; BENIN	Background: Recently the use of indoor residual spraying of insecticide (IRS) has greatly increased in Africa; however, limited data exist on the quantitative impacts of IRS on health outcomes in highly malaria endemic areas. Methodology/Principal Findings: Routine data were collected on more than 90,000 patient visits at a single health facility over a 56 month period covering five rounds of IRS using three different insecticides. Temporal associations between the timing of IRS and the probability of a patient referred for microscopy having laboratory confirmed malaria were estimated controlling for seasonality and age. Considering patients less than five years of age there was a modest decrease in the odds of malaria following the 1st round of IRS using DDT (OR = 0.76, p<0.001) and the 2nd round using alpha-cypermethrin (OR = 0.83, p = 0.002). Following rounds 3-5 using bendiocarb there was a much greater decrease in the odds of malaria (ORs 0.34, 0.16, 0.17 respectively, p<0.001 for all comparisons). Overall, the impact of IRS was less pronounced among patients 5 years or older. Conclusions/Significance: IRS was associated with a reduction in malaria morbidity in an area of high transmission intensity in Uganda and the benefits appeared to be greatest after switching to a carbamate class of insecticide.	[Kigozi, Ruth; Gasasira, Anne; Sserwanga, Asadu; Kakeeto, Stella] Uganda Malaria Surveillance Project, Kampala, Uganda; [Baxi, Sanjiv M.; Dorsey, Grant] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Nasr, Sussann; Filler, Scott] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA; [Rubahika, Denis] Uganda Minist Hlth, Kampala, Uganda; [Dissanayake, Gunawardena] Presidents Malaria Initiat, Kampala, Uganda; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda	University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; Makerere University	Kigozi, R (corresponding author), Uganda Malaria Surveillance Project, Kampala, Uganda.	gdorsey@medsfgh.ucsf.edu			U.S. President's Malaria Initiative; Centers for Disease Control and Prevention [1U51CK000117]; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [U19AI089674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER	U.S. President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. President's Malaria Initiative through a cooperative agreement with the Centers for Disease Control and Prevention (1U51CK000117) and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (U19AI089674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilio AP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-110; Akogbeto M, 2011, AM J TROP MED HYG, V85, P586, DOI 10.4269/ajtmh.2011.10-0668; [Anonymous], 2008, GLOB MAL ACT PLAN; Bukirwa H, 2009, AM J TROP MED HYG, V81, P611, DOI 10.4269/ajtmh.2009.09-0126; Curtis CF, 2000, B WORLD HEALTH ORGAN, V78, P1389; Curtis CF, 1998, TROP MED INT HEALTH, V3, P619, DOI 10.1046/j.1365-3156.1998.00281.x; Hamel MJ, 2011, AM J TROP MED HYG, V85, P1080, DOI 10.4269/ajtmh.2011.10-0684; Hunt RH, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-107; Jensen TP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-213; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Kouznetsov R L, 1977, Trop Doct, V7, P81; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Mnzava AEP, 2001, SAMJ S AFR MED J, V91, P978; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Sharp B, 2002, TROP MED INT HEALTH, V7, P732, DOI 10.1046/j.1365-3156.2002.00928.x; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; Tseng LF, 2008, AM J TROP MED HYG, V78, P248, DOI 10.4269/ajtmh.2008.78.248; Verhaeghen K, 2010, AM J TROP MED HYG, V82, P566, DOI 10.4269/ajtmh.2010.08-0668; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2006, US IND RES SPRAYING; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83; Yeka A, 2012, ACTA TROP, V342, pd1617	28	62	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42857	10.1371/journal.pone.0042857	http://dx.doi.org/10.1371/journal.pone.0042857			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880123	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000078
J	Burgess, STG; Greer, A; Frew, D; Wells, B; Marr, EJ; Nisbet, AJ; Huntley, JF				Burgess, Stewart T. G.; Greer, Andrew; Frew, David; Wells, Beth; Marr, Edward J.; Nisbet, Alasdair J.; Huntley, John F.			Transcriptomic Analysis of Circulating Leukocytes Reveals Novel Aspects of the Host Systemic Inflammatory Response to Sheep Scab Mites	PLOS ONE			English	Article							ENDOTHELIAL CELL RECOGNITION; GENE-EXPRESSION PROFILES; PSOROPTES-OVIS; LYMPHOCYTE RECIRCULATION; COMPLEMENT-SYSTEM; TRAFFIC SIGNALS; INNATE IMMUNITY; S100 PROTEINS; DISEASE; BLOOD	Infestation of ovine skin with the ectoparasitic mite Psoroptes ovis results in the development of a rapid cutaneous inflammatory response, leading to the crusted skin lesions characteristic of sheep scab. To facilitate the identification of novel diagnostic and therapeutic targets, a better understanding of the host-parasite relationship in sheep scab is essential. Although our knowledge of the host's local cutaneous inflammatory response to sheep scab has increased in recent years, we still know relatively little about the mechanisms of this response at the systemic level. This study used a combined network and pathway analysis of the in vivo transcriptomic response of circulating leukocytes to infestation with P. ovis, during a 6 week period. Network graph analysis identified six temporally-associated gene clusters, which separated into two distinct sub-networks within the graph, representing those genes either up or down-regulated during the time course. Functional and pathway analysis of these clusters identified novel insights into the host systemic response to P. ovis infestation, including roles for the complement system, clotting cascade and fibrinolysis. These analyses also highlighted potential mechanisms by which the systemic immune response to sheep scab can influence local tissue responses via enhanced leukocyte activation and extravasation. By analysing the transcriptomic responses of circulating leukocytes in sheep following infestation with P. ovis, this study has provided key insights into the inflammatory response to infestation and has also demonstrated the utility of these cells as a proxy of events occurring at local tissue sites, providing insight into the mechanisms by which a local allergen-induced inflammatory response may be controlled.	[Burgess, Stewart T. G.; Frew, David; Wells, Beth; Marr, Edward J.; Nisbet, Alasdair J.; Huntley, John F.] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland; [Greer, Andrew] Lincoln Univ, Fac Agr & Life Sci, Canterbury, New Zealand	Moredun Research Institute; Lincoln University - New Zealand	Burgess, STG (corresponding author), Moredun Res Inst, Pentlands Sci Pk, Edinburgh EH17 7JH, Midlothian, Scotland.	stewart.burgess@moredun.ac.uk	Greer, Andrew W/S-5846-2018	Greer, Andrew W/0000-0002-1479-3297; Nisbet, Alasdair/0000-0002-4965-5396; burgess, stewart/0000-0002-9268-7641	Department for Environment, Food and Rural Affairs, United Kingdom [OD0553]; Scottish Government's Rural and Environment Science and Analytical Services Division	Department for Environment, Food and Rural Affairs, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Scottish Government's Rural and Environment Science and Analytical Services Division	This study was funded by the Department for Environment, Food and Rural Affairs, United Kingdom under project OD0553 and also supported by The Scottish Government's Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergstrom FC, 2009, J IMMUNOL, V182, P7809, DOI 10.4049/jimmunol.0804205; Burgess STG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-624; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; COCHRANE CG, 1982, ADV IMMUNOL, V33, P241, DOI 10.1016/S0065-2776(08)60837-8; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; DAFFERN PJ, 1995, J EXP MED, V181, P2119, DOI 10.1084/jem.181.6.2119; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; Fleming-Waddell JN, 2007, ANIM GENET, V38, P28, DOI 10.1111/j.1365-2052.2006.01562.x; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Guyer DA, 1996, BLOOD, V88, P2415, DOI 10.1182/blood.V88.7.2415.bloodjournal8872415; Hamilton JA, 2004, GROWTH FACTORS, V22, P225, DOI 10.1080/08977190412331279881; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Ji SQ, 1998, ANIM BIOTECHNOL, V9, P1, DOI 10.1080/10495399809525887; Kenyon F, 2002, VET PARASITOL, V105, P317, DOI 10.1016/S0304-4017(02)00015-8; Kijas JW, 2006, ANIM GENET, V37, P171, DOI 10.1111/j.1365-2052.2005.01399.x; Kim BE, 2008, CLIN IMMUNOL, V126, P332, DOI 10.1016/j.clim.2007.11.006; KIRKWOOD AC, 1986, PARASITOL TODAY, V2, P302, DOI 10.1016/0169-4758(86)90124-9; Kitayama J, 1998, J CLIN INVEST, V101, P2017, DOI 10.1172/JCI2688; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liu WG, 2006, VET IMMUNOL IMMUNOP, V110, P11, DOI 10.1016/j.vetimm.2005.08.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Maruo K, 1997, J ALLERGY CLIN IMMUN, V100, P253, DOI 10.1016/S0091-6749(97)70233-1; MARUO K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P62, DOI 10.1016/0304-4165(91)90040-N; MARUO K, 1993, J BIOL CHEM, V268, P17711; Menzies M, 2006, VET IMMUNOL IMMUNOP, V109, P23, DOI 10.1016/j.vetimm.2005.06.014; Min JL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-96; Mitsudo K, 2003, BIOCHEMISTRY-US, V42, P3874, DOI 10.1021/bi027029v; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nisbet AJ, 2006, PARASITE IMMUNOL, V28, P165, DOI 10.1111/j.1365-3024.2006.00803.x; NUSRAT AR, 1991, J CLIN INVEST, V87, P1091, DOI 10.1172/JCI115070; Pahl A, 2002, BLOOD, V100, P1094, DOI 10.1182/blood-2002-03-0813; Peng Qi, 2009, Inflammation & Allergy Drug Targets, V8, P236; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Prendergast GC, 2011, CURR MED CHEM, V18, P2257, DOI 0929-8673/11 $58.00+.00; Raghavachari N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006484; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; ROTH J, 1992, INT ARCH ALLERGY IMM, V98, P140, DOI 10.1159/000236177; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; Samitas K, 2011, EUR RESPIR J, V37, P331, DOI 10.1183/09031936.00017810; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SEOW HF, 1994, IMMUNOL CELL BIOL, V72, P398, DOI 10.1038/icb.1994.59; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; STETLER G, 1986, NUCLEIC ACIDS RES, V14, P7883, DOI 10.1093/nar/14.20.7883; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; van den Broek AH, 2003, J COMP PATHOL, V128, P79, DOI 10.1053/jcpa.2002.0627; van den Broek AHM, 2004, J COMP PATHOL, V131, P318, DOI 10.1016/j.jcpa.2004.05.005; van den Broek AHM, 2000, PARASITE IMMUNOL, V22, P407, DOI 10.1046/j.1365-3024.2000.00318.x; VanDongen S., 2000, THESIS U UTRECHT UTR, P169; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wu K., 2007, GLOBIN REDUCTION PRO; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	64	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42778	10.1371/journal.pone.0042778	http://dx.doi.org/10.1371/journal.pone.0042778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880105	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100169
J	Ackermann, M; Clement-Ziza, M; Michaelson, JJ; Beyer, A				Ackermann, Marit; Clement-Ziza, Mathieu; Michaelson, Jacob J.; Beyer, Andreas			Teamwork: Improved eQTL Mapping Using Combinations of Machine Learning Methods	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; STATISTICAL-METHODS; SELECTION; EPISTASIS	Expression quantitative trait loci (eQTL) mapping is a widely used technique to uncover regulatory relationships between genes. A range of methodologies have been developed to map links between expression traits and genotypes. The DREAM (Dialogue on Reverse Engineering Assessments and Methods) initiative is a community project to objectively assess the relative performance of different computational approaches for solving specific systems biology problems. The goal of one of the DREAM5 challenges was to reverse-engineer genetic interaction networks from synthetic genetic variation and gene expression data, which simulates the problem of eQTL mapping. In this framework, we proposed an approach whose originality resides in the use of a combination of existing machine learning algorithms (committee). Although it was not the best performer, this method was by far the most precise on average. After the competition, we continued in this direction by evaluating other committees using the DREAM5 data and developed a method that relies on Random Forests and LASSO. It achieved a much higher average precision than the DREAM best performer at the cost of slightly lower average sensitivity.	[Ackermann, Marit; Clement-Ziza, Mathieu; Michaelson, Jacob J.; Beyer, Andreas] Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany; [Beyer, Andreas] Ctr Regenerat Therapy Dresden, Dresden, Germany	Technische Universitat Dresden	Ackermann, M (corresponding author), Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany.	andreas.beyer@biotec.tu-dresden.de	Beyer, Andreas/AAQ-5519-2020; Clément-Ziza, Mathieu/J-4146-2012; Beyer, Andreas/A-3352-2009	Beyer, Andreas/0000-0002-3891-2123; Clément-Ziza, Mathieu/0000-0003-2763-249X; Beyer, Andreas/0000-0002-3891-2123; Michaelson, Jacob/0000-0001-9713-0992	Klaus Tschira Foundation; CRTD Seed Grant [043 261581]; European Union [FP7-223539, FP7-200720]	Klaus Tschira Foundation; CRTD Seed Grant; European Union(European Commission)	This work was funded by the Klaus Tschira Foundation http://www.klaus-tschira-stiftung.de/english/index.html, a CRTD Seed Grant (Grant ID 043 261581) http://www.crt-dresden.de/, and the European Union FP7 projects PhenOxiGEn (Grant ID FP7-223539) http://www.phenoxigen.eu/and EuroSyStem (Grant ID FP7-200720) http://www.eurosystemproject.eu/.]jmm 6/21/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broman KW, 2002, J R STAT SOC B, V64, P641, DOI 10.1111/1467-9868.00354; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Drummond C., 2000, P 17 INT C MACH LEAR, P239; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Goadrich M, 2004, LECT NOTES ARTIF INT, V3194, P98; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Kendziorski CM, 2006, BIOMETRICS, V62, P19, DOI 10.1111/j.1541-0420.2005.00437.x; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Loguercio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013920; Marbach D, 2009, ANN NY ACAD SCI, V1158, P102, DOI 10.1111/j.1749-6632.2008.03945.x; Michaelson JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-502; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Norel R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.70; Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364, DOI 10.2214/ajr.184.2.01840364; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pinna A, 2011, BIOINFORMATICS, V27, P2459, DOI 10.1093/bioinformatics/btr407; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Provost F., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P43; R Core Team, 2021, R LANGUAGE ENV STAT; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Suthram S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.4; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Vignes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029165; Yilmaz E, 2006, ESTIMATING AVERAGE P, P102, DOI DOI 10.1145/1183614.1183633; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	35	12	13	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40916	10.1371/journal.pone.0040916	http://dx.doi.org/10.1371/journal.pone.0040916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911718	gold, Green Published, Green Submitted			2022-12-27	WOS:000306751300017
J	Featherstone, RE; Phillips, JM; Thieu, T; Ehrlichman, RS; Halene, TB; Leiser, SC; Christian, E; Johnson, E; Lerman, C; Siegel, SJ				Featherstone, Robert E.; Phillips, Jennifer M.; Thieu, Tony; Ehrlichman, Richard S.; Halene, Tobias B.; Leiser, Steven C.; Christian, Edward; Johnson, Edwin; Lerman, Caryn; Siegel, Steven J.			Nicotine Receptor Subtype-Specific Effects on Auditory Evoked Oscillations and Potentials	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; GAMMA-BAND RESPONSES; ACETYLCHOLINE-RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; NEUROPHYSIOLOGICAL EVIDENCE; INDUCED ENHANCEMENT; GATING DEFICITS; MICE; SCHIZOPHRENIA; MOUSE	Background: Individuals with schizophrenia show increased smoking rates which may be due to a beneficial effect of nicotine on cognition and information processing. Decreased amplitude of the P50 and N100 auditory event-related potentials (ERPs) is observed in patients. Both measures show normalization following administration of nicotine. Recent studies identified an association between deficits in auditory evoked gamma oscillations and impaired information processing in schizophrenia, and there is evidence that nicotine normalizes gamma oscillations. Although the role of nicotine receptor subtypes in augmentation of ERPs has received some attention, less is known about how these receptor subtypes regulate the effect of nicotine on evoked gamma activity. Methodology/Principal Findings: We examined the effects of nicotine, the alpha 7 nicotine receptor antagonist methyllycaconitine (MLA) the alpha 4 beta 4/alpha 4 beta 2 nicotine receptor antagonist dihydro-beta-erythroidine (DH beta E), and the alpha 4 beta 2 agonist AZD3480 on P20 and N40 amplitude as well as baseline and event-related gamma oscillations in mice, using electrodes in hippocampal CA3. Nicotine increased P20 amplitude, while DHbE blocked nicotine-induced enhancements in P20 amplitude. Conversely, MLA did not alter P20 amplitude either when presented alone or with nicotine. Administration of the alpha 4 beta 2 specific agonist AZD3480 did not alter any aspect of P20 response, suggesting that DHbE blocks the effects of nicotine through a non-alpha 4 beta 2 receptor specific mechanism. Nicotine and AZD3480 reduced N40 amplitude, which was blocked by both DHbE and MLA. Finally, nicotine significantly increased event-related gamma, as did AZD3480, while DHbE but not MLA blocked the effect of nicotine on event-related gamma. Conclusions/Significance: These results support findings showing that nicotine-induced augmentation of P20 amplitude occurs via a DHbE sensitive mechanism, but suggests that this does not occur through activation of alpha 4 beta 2 receptors. Event-related gamma is strongly influenced by activation of alpha 4 beta 2, but not a7, receptor subtypes, while disruption of N40 amplitude requires the activation of multiple receptor subtypes.	[Featherstone, Robert E.; Thieu, Tony; Ehrlichman, Richard S.; Halene, Tobias B.; Lerman, Caryn; Siegel, Steven J.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Phillips, Jennifer M.] Mt St Marys Univ, Dept Psychol, Emmitsburg, MD USA; [Leiser, Steven C.; Christian, Edward; Johnson, Edwin] AstraZeneca, Wilmington, DE USA	University of Pennsylvania; AstraZeneca	Featherstone, RE (corresponding author), Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA.	siegels@upenn.edu	Lerman, Caryn/AHC-5180-2022	Leiser, Steven/0000-0002-4680-2012; Siegel, Steven/0000-0001-8058-9713	National Cancer Institute [P50-CA/DA-084718]; National Institute of Drug Abuse [R01DA023210]; AstraZeneca; NuPathe; Merck; Glaxo SmithKline; Novartis; Pfizer; NATIONAL CANCER INSTITUTE [P50CA084718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023210] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); AstraZeneca(AstraZeneca); NuPathe; Merck(Merck & Company); Glaxo SmithKline(GlaxoSmithKline); Novartis(Novartis); Pfizer(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by P50-CA/DA-084718, (National Cancer Institute and National Institute of Drug Abuse, Caryn Lerman, PI) and R01DA023210 (National Institute of Drug Abuse, Steven Siegel, PI). No additional external funding received for this study.; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We have the following interests. Steven Leiser, Edward Christian and Edwin Johnson are former employees of AstraZeneca who provided a pilot grant for this study. Steven Siegel has been a consultant and/or has received grant support from the following companies that develop and/or market medications: NuPathe, AstraZeneca, and Merck, all unrelated to the current manuscript. Caryn Lerman has been a consultant and/or has received grant support from the following companies that develop and/or market smoking cessation medications: AstraZeneca, Glaxo SmithKline, Novartis and Pfizer, all unrelated to the current manuscript. AstraZeneca supplied AZD3480 for use in this study. There are no other patents, products in development or other marketed products to declare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189, DOI 10.1093/oxfordjournals.schbul.a033320; ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Amann LC, 2008, BEHAV NEUROSCI, V122, P982, DOI 10.1037/a0012995; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; BasarEroglu C, 1996, INT J PSYCHOPHYSIOL, V24, P101, DOI 10.1016/S0167-8760(96)00051-7; Benchenane K, 2011, CURR OPIN NEUROBIOL, V21, P475, DOI 10.1016/j.conb.2011.01.004; BOUTROS N, 1993, PSYCHIAT RES, V47, P243, DOI 10.1016/0165-1781(93)90082-R; BOUTROS NN, 1991, CLIN ELECTROENCEPHAL, V22, P40, DOI 10.1177/155005949102200109; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Connolly PM, 2003, BRAIN RES, V992, P85, DOI 10.1016/j.brainres.2003.08.035; Connolly PM, 2004, NEUROCHEM RES, V29, P1179, DOI 10.1023/B:NERE.0000023605.68408.fb; Crawford HJ, 2002, NEUROSCI LETT, V317, P151, DOI 10.1016/S0304-3940(01)02454-5; Damaj MI, 1999, J PHARMACOL EXP THER, V291, P1284; Davis JA, 2006, PSYCHOPHARMACOLOGY, V184, P345, DOI 10.1007/s00213-005-0047-y; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demiralp T, 1996, INT J NEUROSCI, V84, P1, DOI 10.3109/00207459608987246; Demiralp T, 2007, INT J PSYCHOPHYSIOL, V64, P24, DOI 10.1016/j.ijpsycho.2006.07.005; Dunbar G, 2007, PSYCHOPHARMACOLOGY, V191, P919, DOI 10.1007/s00213-006-0675-x; Ehrlichman RS, 2008, J COGNITIVE NEUROSCI, V20, P1403, DOI 10.1162/jocn.2008.20097; FREEDMAN R, 1983, BIOL PSYCHIAT, V18, P537; Gandal MJ, 2011, NEUROPHARMACOLOGY; Gatto GJ, 2004, CNS DRUG REV, V10, P147; Gommans J, 2000, NEUROPHARMACOLOGY, V39, P2840, DOI 10.1016/S0028-3908(00)00130-1; Griffith JM, 1998, BIOL PSYCHIAT, V44, P98, DOI 10.1016/S0006-3223(97)00362-4; Hajos M, 2005, J PHARMACOL EXP THER, V312, P1213, DOI 10.1124/jpet.104.076968; Hashimoto K, 2005, PSYCHOPHARMACOLOGY, V183, P13, DOI 10.1007/s00213-005-0142-0; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lippiello P, 2006, J MOL NEUROSCI, V30, P19, DOI 10.1385/JMN:30:1:19; Maxwell CR, 2004, NEUROPSYCHOPHARMACOL, V29, P739, DOI 10.1038/sj.npp.1300376; Maxwell CR, 2004, NEUROSCIENCE, V129, P101, DOI 10.1016/j.neuroscience.2004.07.038; Maxwell CR, 2006, NEUROPSYCHOPHARMACOL, V31, P897, DOI 10.1038/sj.npp.1300879; Maxwell CR, 2006, J PHARMACOL EXP THER, V316, P315, DOI 10.1124/jpet.105.091199; Metzger KL, 2007, BIOL PSYCHIAT, V61, P23, DOI 10.1016/j.biopsych.2005.12.011; Olincy A, 2006, ARCH GEN PSYCHIAT, V63, P630, DOI 10.1001/archpsyc.63.6.630; PANTEV C, 1991, ACTA OTO-LARYNGOL, P106; Pantev C, 1991, ACTA OTO-LARYNGOL, V491, P115; Patterson F, 2009, BIOL PSYCHIAT, V65, P144, DOI 10.1016/j.biopsych.2008.08.028; PETERSEN DR, 1984, DRUG METAB DISPOS, V12, P725; Phillips JM, 2007, NEUROSCIENCE, V144, P1314, DOI 10.1016/j.neuroscience.2006.11.003; Rudnick ND, 2010, NICOTINE TOB RES, V12, P589, DOI 10.1093/ntr/ntq049; Rudnick N, 2009, PSYCHOPHARMACOLOGY, V202, P745, DOI 10.1007/s00213-008-1358-6; Siegel S, 2003, NEUROPSYCHOPHARMACOL, V28, P675, DOI 10.1038/sj.npp.1300087; Siegel SJ, 2005, NEUROSCIENCE, V133, P729, DOI 10.1016/j.neuroscience.2005.03.027; Stegelmeier BL, 2003, J ANIM SCI, V81, P1237; Stevens KE, 1998, PSYCHOPHARMACOLOGY, V136, P320, DOI 10.1007/s002130050573; TUREK JW, 1995, J NEUROSCI METH, V61, P113, DOI 10.1016/0165-0270(95)00032-P; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Umbricht D, 2004, BRAIN RES, V1019, P189, DOI 10.1016/j.brainres.2004.05.097; Walters CL, 2006, PSYCHOPHARMACOLOGY, V184, P339, DOI 10.1007/s00213-005-0295-x; Wildeboer KM, 2008, BRAIN RES, V1224, P29, DOI 10.1016/j.brainres.2008.06.007	53	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39775	10.1371/journal.pone.0039775	http://dx.doi.org/10.1371/journal.pone.0039775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911690	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600009
J	Macdonald, TA; Burd, BJ; van Roodselaar, A				Macdonald, Tara A.; Burd, Brenda J.; van Roodselaar, Albert			Size Structure of Marine Soft-Bottom Macrobenthic Communities across Natural Habitat Gradients: Implications for Productivity and Ecosystem Function	PLOS ONE			English	Article							TRAWLING DISTURBANCE; BRISSOPSIS LYRIFERA; TROPHIC STRUCTURE; BIOMASS SPECTRA; ORGANIC-CARBON; SEDIMENT; STRAIT; ABUNDANCE; GEORGIA; INVERTEBRATES	Size distributions of biotic assemblages are important modifiers of productivity and function in marine sediments. We investigated the distribution of proportional organic biomass among logarithmic size classes (2(-6) J to 2(16) J) in the soft-bottom macrofaunal communities of the Strait of Georgia, Salish Sea on the west coast of Canada. The study examines how size structure is influenced by 3 fundamental habitat descriptors: depth, sediment percent fines, and organic flux (modified by quality). These habitat variables are uncorrelated in this hydrographically diverse area, thus we examine their effects in combination and separately. Cluster analyses and cumulative biomass size spectra reveal clear and significant responses to each separate habitat variable. When combined, habitat factors result in three distinct assemblages: (1) communities with a high proportion of biomass in small organisms, typical of shallow areas (, 10 m) with coarse sediments (<10% fines) and low accumulation of organic material (<3.0 g C/m(2)/yr/delta N-15); (2) communities with high proportion of biomass in the largest organisms found in the Strait, typical of deep, fine sediments with high modified organic flux (>3 g C/m(2)/yr/delta 15N) from the Fraser River; and (3) communities with biomass dominated by moderately large organisms, but lacking the smallest and largest size classes, typical of deep, fine sediments experiencing low modified organic flux (<3.0 gC/m(2)/yr/delta N-15). The remaining assemblages had intermediate habitat types and size structures. Sediment percent fines and flux appear to elicit threshold responses in size structure, whereas depth has the most linear influence on community size structure. The ecological implications of size structure in the Strait of Georgia relative to environmental conditions, secondary production and sediment bioturbation are discussed.	[Macdonald, Tara A.; Burd, Brenda J.] Inst Ocean Sci, Dept Fisheries & Oceans, Sidney, BC V8L 4B2, Canada; [Macdonald, Tara A.] Biol Environm Serv, Victoria, BC, Canada; [Burd, Brenda J.] Ecostat Res Ltd, N Saanich, BC, Canada; [van Roodselaar, Albert] Metro Vancouver, Burnaby, BC, Canada	Fisheries & Oceans Canada	Macdonald, TA (corresponding author), Inst Ocean Sci, Dept Fisheries & Oceans, Sidney, BC V8L 4B2, Canada.	tara@biologica.bc.ca			Metro Vancouver	Metro Vancouver	This work is part of the Strait of Georgia Ambient Monitoring Program, which is a collaborative research program with two partners: Fisheries and Oceans Canada and Metro Vancouver (formerly the Greater Vancouver Regional District). Metro Vancouver supplied the funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro T, 2010, BIOGEOSCIENCES, V7, P2419, DOI 10.5194/bg-7-2419-2010; Austen MC, 1998, J EXP MAR BIOL ECOL, V222, P219, DOI 10.1016/S0022-0981(97)00146-9; BOUDREAU PR, 1991, J THEOR BIOL, V152, P329, DOI 10.1016/S0022-5193(05)80198-5; Braeckman U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018078; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; BREY T, 1988, J EXP MAR BIOL ECOL, V117, P271, DOI 10.1016/0022-0981(88)90062-7; Brey T., 2001, POPULATION DYNAMICS; Bromley R.G., 1990, TRACE FOSSILS BIOL T; Burd B. J., 2009, Canadian Technical Report of Fisheries and Aquatic Sciences, V2859, pV; Burd BJ, 2008, MAR ENVIRON RES, V66, pS3, DOI 10.1016/j.marenvres.2008.09.004; Burd BJ, 2008, MAR ENVIRON RES, V66, pS62, DOI 10.1016/j.marenvres.2008.08.009; Burd BJ, 2012, PLOS ONE IN PRESS; Clarke K.R., 2006, PRIMER E V6 USER MAN; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cusson M, 2005, MAR ECOL PROG SER, V297, P1, DOI 10.3354/meps297001; Dashtgard SE, 2008, PALAEOGEOGR PALAEOCL, V257, P224, DOI 10.1016/j.palaeo.2007.10.024; Duplisea DE, 1999, MAR ECOL PROG SER, V177, P73, DOI 10.3354/meps177073; Duplisea DE, 2000, LIMNOL OCEANOGR, V45, P558, DOI 10.4319/lo.2000.45.3.0558; Duplisea DE, 2002, CAN J FISH AQUAT SCI, V59, P1785, DOI 10.1139/F02-148; Gaston GR, 1996, ESTUARIES, V19, P674, DOI 10.2307/1352527; GORDON K, 1997, THESIS U BRIT COLUMB; GRAY JS, 1982, NETH J SEA RES, V16, P424, DOI 10.1016/0077-7579(82)90048-5; GRAY JS, 1989, BIOL J LINN SOC, V37, P19, DOI 10.1111/j.1095-8312.1989.tb02003.x; Hill PR, 2008, MAR ENVIRON RES, V66, pS39, DOI 10.1016/j.marenvres.2008.09.003; Isaaks EH, 1989, APPL GEOSTATISTICS; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 2001, MAR ECOL PROG SER, V213, P127, DOI 10.3354/meps213127; Johannessen SC, 2012, MAR POLLUT BULL, V64, P675, DOI 10.1016/j.marpolbul.2012.01.026; Johannessen SC, 2008, MAR ENVIRON RES, V66, pS1, DOI 10.1016/j.marenvres.2008.10.001; Johannessen SC, 2005, ENVIRON SCI TECHNOL, V39, P4361, DOI 10.1021/es040535i; Johannessen SC, 2003, ESTUAR COAST SHELF S, V56, P845, DOI 10.1016/S0272-7714(02)00303-7; Kristensen K, 1999, BIOGEOCHEMISTRY, V45, P147, DOI 10.1007/BF01106779; Levinton J, 1995, BIOTURBATORS ECOSYST, P29; Lin L., 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; Macdonald RW, 2008, MAR ENVIRON RES, V66, pS87, DOI 10.1016/j.marenvres.2008.08.001; Macdonald T.A., 2010, CAN TECH REP FISH AQ, V2874, P63; Macdonald TA, 2012, MAR ECOL PROG SER, V445, P129, DOI 10.3354/meps09478; Masson D, 2002, ESTUAR COAST SHELF S, V54, P115, DOI 10.1006/ecss.2001.0833; Needham HR, 2011, ECOSYSTEMS, V14, P1096, DOI 10.1007/s10021-011-9468-0; NEMEC AFL, 1988, CAN J FISH AQUAT SCI, V45, P965, DOI 10.1139/f88-118; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; PLATT T, 1977, HELGOLAND WISS MEER, V30, P575, DOI 10.1007/BF02207862; Queiros AM, 2006, J EXP MAR BIOL ECOL, V335, P91, DOI 10.1016/j.jembe.2006.03.001; ROMEROWETZEL MB, 1991, MEERESFORSCHUNG, V33, P247; Saiz-Salinas JI, 1999, MAR ECOL PROG SER, V178, P221, DOI 10.3354/meps178221; Sakamaki T, 2009, MAR FRESHWATER RES, V60, P160, DOI 10.1071/MF08173; Sakamaki T, 2007, ESTUAR COAST SHELF S, V73, P781, DOI 10.1016/j.ecss.2007.03.019; SCHWINGHAMER P, 1981, CAN J FISH AQUAT SCI, V38, P1255, DOI 10.1139/f81-167; SCHWINGHAMER P, 1983, MAR ECOL PROG SER, V13, P151, DOI 10.3354/meps013151; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; SPRULES WG, 1986, CAN J FISH AQUAT SCI, V43, P1789, DOI 10.1139/f86-222; Vanaverbeke J, 2003, MAR ECOL PROG SER, V249, P157, DOI 10.3354/meps249157; Vopel K, 2007, MAR ECOL PROG SER, V333, P161, DOI 10.3354/meps333161; WACASEY JW, 1987, MAR ECOL PROG SER, V39, P243, DOI 10.3354/meps039243; WARWICK RM, 1984, OECOLOGIA, V61, P32, DOI 10.1007/BF00379085; WARWICK RM, 1994, MAR BIOL, V118, P739, DOI 10.1007/BF00347523; WESTON DP, 1990, MAR ECOL PROG SER, V61, P233, DOI 10.3354/meps061233; Wethey DS, 2008, J MAR RES, V66, P255, DOI 10.1357/002224008785837121; Wetzel MA, 2005, HELGOLAND MAR RES, V59, P206, DOI 10.1007/s10152-005-0220-z; Widdicombe S, 2004, MAR ECOL PROG SER, V275, P1, DOI 10.3354/meps275001; Widdicombe S, 2000, HYDROBIOLOGIA, V440, P369, DOI 10.1023/A:1004120621842; Widdicombe S, 1998, J EXP MAR BIOL ECOL, V228, P241, DOI 10.1016/S0022-0981(98)00032-X; WIGLEY RL, 1964, LIMNOL OCEANOGR, V9, P485, DOI 10.4319/lo.1964.9.4.0485; Wlodarska-Kowalczuk M, 2005, MAR ECOL PROG SER, V303, P31, DOI 10.3354/meps303031; Yvon-Durocher G, 2011, GLOBAL CHANGE BIOL, V17, P1681, DOI 10.1111/j.1365-2486.2010.02321.x	67	13	13	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40071	10.1371/journal.pone.0040071	http://dx.doi.org/10.1371/journal.pone.0040071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911694	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600013
J	Stucki, D; Malla, B; Hostettler, S; Huna, T; Feldmann, J; Yeboah-Manu, D; Borrell, S; Fenner, L; Comas, I; Coscolla, M; Gagneux, S				Stucki, David; Malla, Bijaya; Hostettler, Simon; Huna, Thembela; Feldmann, Julia; Yeboah-Manu, Dorothy; Borrell, Sonia; Fenner, Lukas; Comas, Inaki; Coscolla, Mireia; Gagneux, Sebastien			Two New Rapid SNP-Typing Methods for Classifying Mycobacterium tuberculosis Complex into the Main Phylogenetic Lineages	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LARGE SEQUENCE POLYMORPHISMS; REAL-TIME PCR; STRAIN DIFFERENTIATION; BEIJING GENOTYPE; MULTIPLEX ASSAY; GENOME; IDENTIFICATION; RESISTANCE; DIVERSITY	There is increasing evidence that strain variation in Mycobacterium tuberculosis complex (MTBC) might influence the outcome of tuberculosis infection and disease. To assess genotype-phenotype associations, phylogenetically robust molecular markers and appropriate genotyping tools are required. Most current genotyping methods for MTBC are based on mobile or repetitive DNA elements. Because these elements are prone to convergent evolution, the corresponding genotyping techniques are suboptimal for phylogenetic studies and strain classification. By contrast, single nucleotide polymorphisms (SNP) are ideal markers for classifying MTBC into phylogenetic lineages, as they exhibit very low degrees of homoplasy. In this study, we developed two complementary SNP-based genotyping methods to classify strains into the six main human-associated lineages of MTBC, the "Beijing" sublineage, and the clade comprising Mycobacterium bovis and Mycobacterium caprae. Phylogenetically informative SNPs were obtained from 22 MTBC whole-genome sequences. The first assay, referred to as MOL-PCR, is a ligation-dependent PCR with signal detection by fluorescent microspheres and a Luminex flow cytometer, which simultaneously interrogates eight SNPs. The second assay is based on six individual TaqMan real-time PCR assays for singleplex SNP-typing. We compared MOL-PCR and TaqMan results in two panels of clinical MTBC isolates. Both methods agreed fully when assigning 36 well-characterized strains into the main phylogenetic lineages. The sensitivity in allele-calling was 98.6% and 98.8% for MOL-PCR and TaqMan, respectively. Typing of an additional panel of 78 unknown clinical isolates revealed 99.2% and 100% sensitivity in allele-calling, respectively, and 100% agreement in lineage assignment between both methods. While MOL-PCR and TaqMan are both highly sensitive and specific, MOL-PCR is ideal for classification of isolates with no previous information, whereas TaqMan is faster for confirmation. Furthermore, both methods are rapid, flexible and comparably inexpensive.	[Stucki, David; Malla, Bijaya; Hostettler, Simon; Feldmann, Julia; Borrell, Sonia; Coscolla, Mireia; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Stucki, David; Malla, Bijaya; Hostettler, Simon; Feldmann, Julia; Borrell, Sonia; Coscolla, Mireia; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Huna, Thembela] Natl Inst Med Res, Div Mycobacterial Res, Med Res Council, London NW7 1AA, England; [Yeboah-Manu, Dorothy] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Comas, Inaki] Ctr Publ Hlth Res, Genom & Hlth Unit, Valencia, Spain; [Comas, Inaki] CIBER Epidemiol & Salud Publ, Madrid, Spain	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Ghana; University of Bern; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Stucki, D (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	Sebastien.Gagneux@unibas.ch	Comas, Iñaki/F-1185-2011; Comas, Iñaki/AAA-1155-2019; Coscolla, Mireia/ABD-7942-2021; Gagneux, Sebastien/ABE-7909-2020; Yeboah-Manu, Dorothy/A-1933-2016	Comas, Iñaki/0000-0001-5504-9408; Comas, Iñaki/0000-0001-5504-9408; Fenner, Lukas/0000-0003-3309-4835; Gagneux, Sebastien/0000-0001-7783-9048; Stucki, David/0000-0003-0131-9980; Coscolla, Mireia/0000-0003-0752-0538; Yeboah-Manu, Dorothy/0000-0002-1663-6287	Swiss National Science Foundation [PP00A-119205]; National Institutes of Health [AI090928, HHSN266200700022C]; Leverhulme-Royal Society Africa Award [AA080019]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090928] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leverhulme-Royal Society Africa Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swiss National Science Foundation (grant number PP00A-119205), the National Institutes of Health (AI090928 and HHSN266200700022C), and the Leverhulme-Royal Society Africa Award (AA080019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Ben Shabat M, 2010, J CLIN MICROBIOL, V48, P2909, DOI 10.1128/JCM.00699-10; Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552; Bergal IL, 2008, J CLIN MICROBIOL, V46, P689, DOI 10.1128/JCM.01821-07; Bouakaze C, 2011, J CLIN MICROBIOL, V49, P3292, DOI 10.1128/JCM.00744-11; Bouakaze C, 2010, J CLIN MICROBIOL, V48, P1758, DOI 10.1128/JCM.02255-09; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Caws M, 2006, J CLIN MICROBIOL, V44, P3934, DOI 10.1128/JCM.01181-06; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Clotilde LM, 2011, J FOOD PROTECT, V74, P373, DOI 10.4315/0362-028X.JFP-10-344; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; de los Monteros LEE, 1998, J CLIN MICROBIOL, V36, P239, DOI 10.1128/JCM.36.1.239-242.1998; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Deshpande A, 2010, J MICROBIOL METH, V80, P155, DOI 10.1016/j.mimet.2009.12.001; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Fenner L, 2012, J CLIN MICROBIOL, V50, P388, DOI 10.1128/JCM.05392-11; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Halse TA, 2011, J CLIN MICROBIOL, V49, P2562, DOI 10.1128/JCM.00467-11; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Kaderali L, 2003, NUCLEIC ACIDS RES, V31, P1796, DOI 10.1093/nar/gkg267; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI 10.2217/FMB.10.165; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Lee SH, 2004, THEOR APPL GENET, V110, P167, DOI 10.1007/s00122-004-1827-1; Maddison WP, 2009, MESQUITE MODULAR SYS; McEvoy CRE, 2007, TUBERCULOSIS, V87, P393, DOI 10.1016/j.tube.2007.05.010; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Milner DA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-35; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Nuebel U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032698; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schurch AC, 2012, INFECT GENET EVOL, V12, P602, DOI 10.1016/j.meegid.2011.08.032; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Song JA, 2010, ADV EXP MED BIOL, V680, P455, DOI 10.1007/978-1-4419-5913-3_51; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Wang L, 2007, ADV EXP MED BIOL, V593, P105; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906; Yesilkaya H, 2006, J CLIN MICROBIOL, V44, P3826, DOI 10.1128/JCM.00225-06; Zhi Jizu, 2010, BMC Res Notes, V3, P137, DOI 10.1186/1756-0500-3-137; Zhi JZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-407	72	91	92	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41253	10.1371/journal.pone.0041253	http://dx.doi.org/10.1371/journal.pone.0041253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911768	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000306644600062
J	Kobayashi, H; Hatada, Y; Tsubouchi, T; Nagahama, T; Takami, H				Kobayashi, Hideki; Hatada, Yuji; Tsubouchi, Taishi; Nagahama, Takahiko; Takami, Hideto			The Hadal Amphipod Hirondellea gigas Possessing a Unique Cellulase for Digesting Wooden Debris Buried in the Deepest Seafloor	PLOS ONE			English	Article							SCAVENGING AMPHIPODS; MARIANA TRENCH; BODY-SIZE; TERMITE; OCEAN; LYSIANASSOIDEA; METABOLISM; GASTROPODA; PATTERNS; ORIGIN	The Challenger Deep in the Mariana Trench is the deepest point in the ocean (10,994 m). Certain deep-sea animals can withstand the extreme pressure at this great depth. The amphipod Hirondellea gigas is a resident of the Challenger Deep. Amphipods are common inhabitants at great depths and serve as scavengers. However, there is relatively little information available regarding the physiology of H. gigas or this organism's ecological interactions in the hadopelagic zone. To understand the feeding behavior of this scavenger in the deepest oligotrophic hadal zone, we analyzed the digestive enzymes in whole-body extracts. We describe the detection of amylase, cellulase, mannanase, xylanase, and alpha-glycosidase activities that are capable of digesting plant-derived polysaccharides. Our identification of glucose, maltose, and cellobiose in the H. gigas extracts indicated that these enzymes function under great pressure in situ. In fact, the glucose content of H. gigas averaged 0.4% (w/dry-w). The purified H. gigas cellulase (HGcel) converted cellulose to glucose and cellobiose at an exceptional molar ratio of 2:1 and efficiently produced glucose from dried wood, a natural cellulosic biomass, at 35 degrees C. The enzyme activity increased under a high hydrostatic pressure of 100 MPa at 2 degrees C, conditions equivalent to those found in the Challenger Deep. An analysis of the amino acid sequence of HGcel supported its classification as a family 31 glycosyl hydrolase. However, none of the enzymes of this family had previously been shown to possess cellulase activity. These results strongly suggested that H. gigas adapted to its extreme oligotrophic hadal oceanic environment by evolving digestive enzymes capable of digesting sunken wooden debris.	[Kobayashi, Hideki; Hatada, Yuji; Tsubouchi, Taishi; Nagahama, Takahiko; Takami, Hideto] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Biogeosci, Yokosuka, Kanagawa, Japan; [Nagahama, Takahiko] Higashi Chikushi Jr Coll, Dept Food & Nutr, Fukuoka, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Kobayashi, H (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Biogeosci, Yokosuka, Kanagawa, Japan.	hidekik@jamstec.go.jp	Takami, Hideto/D-4200-2012	Takami, Hideto/0000-0003-3433-7018; Tsubouchi, Taishi/0000-0002-1635-2604	Japan Society for the Promotion of Science [24580153]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research (C) 24580153 from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ISO82451999 AM NAT S; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; Beliaev G. M., 1989, DEEP SEA OCEAN TRENC; Blankenship LE, 2006, DEEP-SEA RES PT I, V53, P48, DOI 10.1016/j.dsr.2005.09.006; Blankenship LE, 2007, LIMNOL OCEANOGR, V52, P1685, DOI 10.4319/lo.2007.52.4.1685; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Davison A, 2005, MOL BIOL EVOL, V22, P1273, DOI 10.1093/molbev/msi107; FRANCE SC, 1993, MAR ECOL PROG SER, V92, P277, DOI 10.3354/meps092277; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; GEORGE RY, 1979, AMBIO SPECIAL REPORT, V6, P51; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Hargrave BT, 1995, DEEP-SEA RES PT 1, V42, P11; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Henry AR, 2008, P NATL ACAD SCI USA, V105, P17006; HESSLER RR, 1978, DEEP-SEA RES, V25, P1029, DOI 10.1016/0146-6291(78)90585-4; Ise Y, 2008, DEEP SEA LIFE BIOL O; Jamieson AJ, 2010, TRENDS ECOL EVOL, V25, P190, DOI 10.1016/j.tree.2009.09.009; Kaariainen JI, 2006, J MAR BIOL ASSOC UK, V86, P1339, DOI 10.1017/S0025315406014366; Kobayashi H, 1998, EXTREMOPHILES, V2, P401, DOI 10.1007/s007920050085; Kobayashi Hideki, 2000, JAMSTEC Journal of Deep Sea Research, V17, P19; Labropoulos KC, 2002, CARBOHYD POLYM, V50, P393, DOI 10.1016/S0144-8617(02)00084-X; Leal JH, 1999, INVERTEBR BIOL, V118, P116, DOI 10.2307/3227054; Lemche H., 1976, Videnskabelige Meddr dansk naturh Foren, V139, P263; Lorenz M. G., 1959, ANAL CHEM, V31, P426; MOORE DR, 1963, SCIENCE, V139, P1234; Nyssen F, 2002, POLAR BIOL, V25, P280, DOI 10.1007/s00300-001-0340-0; ODELSON DA, 1985, APPL ENVIRON MICROB, V49, P614, DOI 10.1128/AEM.49.3.614-621.1985; Perrone FM, 2002, J MAR BIOL ASSOC UK, V82, P419, DOI 10.1017/S0025315402005672; PICCARD J, 1960, NATL GEOGR, V118, P224; PRATT RM, 1962, SCIENCE, V138, P492, DOI 10.1126/science.138.3539.492; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; SMITH KL, 1982, MAR BIOL, V68, P287, DOI 10.1007/BF00409595; Strong EE, 1999, INVERTEBR BIOL, V118, P137, DOI 10.2307/3227055; Takami H, 1999, EXTREMOPHILES, V3, P97, DOI 10.1007/s007920050104; THIEL H, 1975, HYDROBIOLOGY, V60, P576; Treude T, 2002, DEEP-SEA RES PT I, V49, P1281, DOI 10.1016/S0967-0637(02)00023-7; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watanabe H, 1998, NATURE, V394, P330, DOI 10.1038/28527; Watanabe H, 2001, CELL MOL LIFE SCI, V58, P1167, DOI 10.1007/PL00000931; WOLFF T, 1976, Aquatic Botany, V2, P161, DOI 10.1016/0304-3770(76)90017-6; YAMIN MA, 1981, SCIENCE, V211, P58, DOI 10.1126/science.211.4477.58; YAYANOS AA, 1978, SCIENCE, V200, P1056, DOI 10.1126/science.200.4345.1056; YAYANOS AA, 1981, P NATL ACAD SCI-BIOL, V78, P5212, DOI 10.1073/pnas.78.8.5212; YOKOE Y, 1964, COMP BIOCHEM PHYSIOL, V13, P323, DOI 10.1016/0010-406X(64)90027-1; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	47	53	58	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42727	10.1371/journal.pone.0042727	http://dx.doi.org/10.1371/journal.pone.0042727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905166	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600026
J	Park, JE; Kim, MJ; Ha, SK; Hong, SG; Oh, HJ; Kim, GA; Park, J; Kang, T; Saadeldin, IM; Jang, G; Lee, BC				Park, Jung Eun; Kim, Min Jung; Ha, Seung Kwon; Hong, So Gun; Oh, Hyun Ju; Kim, Geon A.; Park, Jung; Kang, Taek; Saadeldin, Islam M.; Jang, Goo; Lee, Byeong Chun			Altered Cell Cycle Gene Expression and Apoptosis in Post-Implantation Dog Parthenotes	PLOS ONE			English	Article							CONTROL PRIMER SYSTEM; PARTHENOGENETIC MOUSE EMBRYOS; NUCLEAR TRANSFER; IMPRINTED GENES; IN-VITRO; STEM-CELLS; DEVELOPMENTAL COMPETENCE; PREIMPLANTATION EMBRYOS; SOMATIC-CELLS; OOCYTES	Mature oocytes can be parthenogenetically activated by a variety of methods and the resulting embryos are valuable for studies of the respective roles of paternal and maternal genomes in early mammalian development. In the present study, we report the first successful development of parthenogenetic canine embryos to the post-implantation stage. Nine out of ten embryo transfer recipients became pregnant and successful in utero development of canine parthenotes was confirmed. For further evaluation of these parthenotes, their fetal development was compared with artificially inseminated controls and differentially expressed genes (DEGs) were compared using ACP RT-PCR, histological analysis and immunohistochemistry. We found formation of the limb-bud and no obvious differences in histological appearance of the canine parthenote recovered before degeneration occurred; however canine parthenotes were developmentally delayed with different cell cycle regulating-, mitochondria-related and apoptosis-related gene expression patterns compared with controls. In conclusion, our protocols were suitable for activating canine oocytes artificially and supported early fetal development. We demonstrated that the developmental abnormalities in canine parthenotes may result from defective regulation of apoptosis and aberrant gene expression patterns, and provided evidence that canine parthenotes can be a useful tool for screening and for comparative studies of imprinted genes.	[Park, Jung Eun; Kim, Min Jung; Hong, So Gun; Oh, Hyun Ju; Kim, Geon A.; Park, Jung; Kang, Taek; Saadeldin, Islam M.; Jang, Goo; Lee, Byeong Chun] Seoul Natl Univ, Dept Theriogenol & Biotechnol, Coll Vet Med, Seoul, South Korea; [Ha, Seung Kwon] SK Chem, Life Sci R&D Ctr, Seoul, South Korea; [Saadeldin, Islam M.] Zagazig Univ, Dept Physiol, Fac Vet Med, Zagazig, Sharkia, Egypt	Seoul National University (SNU); SK Group; Egyptian Knowledge Bank (EKB); Zagazig University	Park, JE (corresponding author), Seoul Natl Univ, Dept Theriogenol & Biotechnol, Coll Vet Med, Seoul, South Korea.	bclee@snu.ac.kr	Saadeldin, Islam M./J-6729-2013; Lee, Byeong Chun/C-5707-2014	Saadeldin, Islam M./0000-0002-7633-730X; Kang, Jung-Taek/0000-0001-9185-165X	National Research Foundation of Korea Grant; Korean Government [NRF 550-20110039]; Rural Development Administration [PJ0089752012]; RNL Bio [550-20120006]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries [311062-04-1-SB010]; Research Institute for Veterinary Science; Nestle Purina Korea; Nestle Purina PetCare	National Research Foundation of Korea Grant(National Research Foundation of Korea); Korean Government(Korean Government); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); RNL Bio; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries; Research Institute for Veterinary Science; Nestle Purina Korea(Nestle SA); Nestle Purina PetCare(Nestle SA)	This study was supported by National Research Foundation of Korea Grant funded by Korean Government (NRF 550-20110039), Rural Development Administration (#PJ0089752012), RNL Bio (#550-20120006), Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (#311062-04-1-SB010), Research Institute for Veterinary Science and Nestle Purina Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Nestle Purina PetCare provided financial support, and Seung Kwon Ha is an employee of ORIENT CRO. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alberio R, 2001, INT J DEV BIOL, V45, P797; Alexander B, 2006, MOL REPROD DEV, V73, P20, DOI 10.1002/mrd.20372; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Brevini IAL, 2008, CELL PROLIFERAT, V41, P20, DOI 10.1111/j.1365-2184.2008.00485.x; Brevini TAL, 2012, THERIOGENOLOGY, V77, P766, DOI 10.1016/j.theriogenology.2011.11.010; Brill A, 1999, J ASSIST REPROD GEN, V16, P512, DOI 10.1023/A:1020541019347; Chen B, 2003, MOL ENDOCRINOL, V17, P1368, DOI 10.1210/me.2003-0036; Chen ZS, 2009, STEM CELLS, V27, P2136, DOI 10.1002/stem.158; Cheng WM, 2007, ANIM BIOTECHNOL, V18, P131, DOI 10.1080/10495390601096148; Cibelli JB, 2006, METHOD ENZYMOL, V418, P117, DOI 10.1016/S0076-6879(06)18008-8; Cui XS, 2007, MOL REPROD DEV, V74, P133, DOI 10.1002/mrd.20483; Cui XS, 2005, MOL REPROD DEV, V70, P278, DOI 10.1002/mrd.20210; Dobenecker B, 2006, J ANIM PHYSIOL AN N, V90, P394, DOI 10.1111/j.1439-0396.2006.00618.x; Gomez E, 2009, REPRODUCTION, V137, P285, DOI 10.1530/REP-08-0220; Hong SG, 2009, ANIM REPROD SCI, V115, P334, DOI 10.1016/j.anireprosci.2008.12.005; Hong SG, 2009, GENESIS, V47, P314, DOI 10.1002/dvg.20504; Hossein MS, 2009, CLONING STEM CELLS, V11, P123, DOI 10.1089/clo.2008.0029; Hwang IT, 2003, BIOTECHNIQUES, V35, P1180, DOI 10.2144/03356st03; Hwang KC, 2004, MOL REPROD DEV, V69, P43, DOI 10.1002/mrd.20156; Jang G, 2008, THERIOGENOLOGY, V69, P146, DOI 10.1016/j.theriogenology.2007.08.022; Jang G, 2007, THERIOGENOLOGY, V67, P941, DOI 10.1016/j.theriogenology.2006.11.006; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Ka H, 2009, MOL REPROD DEV, V76, P75, DOI 10.1002/mrd.20935; KAUFMAN MH, 1977, NATURE, V265, P53, DOI 10.1038/265053a0; Kim HJ, 2007, J VET SCI, V8, P75, DOI 10.4142/jvs.2007.8.1.75; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Kobayashi S, 2000, GENES CELLS, V5, P1029, DOI 10.1046/j.1365-2443.2000.00390.x; Kono T, 2006, CYTOGENET GENOME RES, V113, P31, DOI 10.1159/000090812; KUBIAK J, 1991, DEVELOPMENT, V111, P763; Kure-Bayashi S, 2000, THERIOGENOLOGY, V53, P1105, DOI 10.1016/S0093-691X(00)00256-9; Lee BC, 2005, NATURE, V436, P641, DOI 10.1038/436641a; Lee JH, 2009, PATHOLOGY, V41, P229, DOI 10.1080/00313020902756279; Liu N, 2010, J MOL CELL BIOL, V2, P333, DOI 10.1093/jmcb/mjq029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loi P, 1998, BIOL REPROD, V58, P1177, DOI 10.1095/biolreprod58.5.1177; Luvoni GC, 2006, REPROD DOMEST ANIM, V41, P286, DOI 10.1111/j.1439-0531.2006.00704.x; Marshall VS, 1998, BIOL REPROD, V59, P1491, DOI 10.1095/biolreprod59.6.1491; McElroy SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010979; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; O'Sullivan FM, 2007, EVOL DEV, V9, P579, DOI 10.1111/j.1525-142X.2007.00198.x; Ogawa H, 2006, FEBS LETT, V580, P5377, DOI 10.1016/j.febslet.2006.08.087; Oh HJ, 2008, THERIOGENOLOGY, V70, P638, DOI 10.1016/j.theriogenology.2008.04.032; Oh HJ, 2009, THERIOGENOLOGY, V72, P461, DOI 10.1016/j.theriogenology.2009.03.016; Oh HJ, 2011, THERIOGENOLOGY, V75, P1221, DOI 10.1016/j.theriogenology.2010.11.035; OZIL JP, 1990, DEVELOPMENT, V109, P117; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Radaelli T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.019; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rodrigues BD, 2007, ZYGOTE, V15, P43, DOI 10.1017/S0967199406003960; Saikhun J, 2008, THERIOGENOLOGY, V69, P1104, DOI 10.1016/j.theriogenology.2008.01.024; Spanos S, 2002, REPRODUCTION, V124, P353, DOI 10.1530/reprod/124.3.353; Stelzer Y, 2011, NAT STRUCT MOL BIOL, V18, P735, DOI 10.1038/nsmb.2050; STURM KS, 1994, DEV DYNAM, V201, P11, DOI 10.1002/aja.1002010103; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; VARMUZA S, 1993, DEV GENET, V14, P239, DOI 10.1002/dvg.1020140310; WALSH C, 1994, MECH DEVELOP, V46, P55, DOI 10.1016/0925-4773(94)90037-X; Wayne RK, 2007, TRENDS GENET, V23, P557, DOI 10.1016/j.tig.2007.08.013; Wianny F, 1998, DEV DYNAM, V212, P49, DOI 10.1002/(SICI)1097-0177(199805)212:1<49::AID-AJA5>3.0.CO;2-2; Zeng FY, 2003, BIOL REPROD, V68, P31, DOI 10.1095/biolreprod.102.007674	61	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e41256	10.1371/journal.pone.0041256	http://dx.doi.org/10.1371/journal.pone.0041256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905100	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600004
J	Wu, P; Su, Y; Guan, XH; Liu, XW; Zhang, JK; Dong, XW; Huang, WH; Hu, YZ				Wu, Peng; Su, Yi; Guan, Xianghong; Liu, Xiaowen; Zhang, Jiankang; Dong, Xiaowu; Huang, Wenhai; Hu, Yongzhou			Identification of Novel Piperazinylquinoxaline Derivatives as Potent Phosphoinositide 3-Kinase (PI3K) Inhibitors	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; CANCER; KINASE; PI3K-ALPHA; DISCOVERY; PATHWAY	Background: Development of small-molecule inhibitors targeting phosphoinositide 3-kinase (PI3K) has been an appealing strategy for the treatment of various types of cancers. Methodology/Principal Finding: Our approach was to perform structural modification and optimization based on previously identified morpholinoquinoxaline derivative WR1 and piperidinylquinoxaline derivative WR23 with a total of forty-five novel piperazinylquinoxaline derivatives synthesized. Most target compounds showed low micromolar to nanomolar antiproliferative potency against five human cancer cell lines using MTT method. Selected compounds showed potent PI3K alpha inhibitory activity in a competitive fluorescent polarization assay, such as compound 22 (IC50 40 nM) and 41 (IC50: 24 nM), which induced apoptosis in PC3 cells. Molecular docking analysis was performed to explore possible binding modes between target compounds and PI3K. Conclusions/Significance: The identified novel piperazinylquinoxaline derivatives that showed potent PI3K alpha inhibitory activity and cellular antiproliferative potency may be promising agents for potential applications in cancer treatment.	[Wu, Peng; Guan, Xianghong; Zhang, Jiankang; Dong, Xiaowu; Huang, Wenhai; Hu, Yongzhou] Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Univ Ecole Normale Super Joint Lab Med C, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Yi; Liu, Xiaowen] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, P (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Univ Ecole Normale Super Joint Lab Med C, Hangzhou 310003, Zhejiang, Peoples R China.	huyz@zju.edu.cn	Wu, Peng/N-4377-2018	Wu, Peng/0000-0002-0186-1086; Guan, Xianghong/0000-0002-7874-8065	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	PW was supported by the European Commission Eramus Mundus LiSUM project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Denley A, 2008, ONCOGENE, V27, P2561, DOI 10.1038/sj.onc.1210918; DESAI M, 1976, ORG PREP PROCED INT, V8, P85, DOI 10.1080/00304947609355594; Drees BE, 2003, COMB CHEM HIGH T SCR, V6, P321; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; HALL HK, 1956, J AM CHEM SOC, V78, P2570, DOI 10.1021/ja01592a066; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Hu Y, 2009, CN 2009/101560179, Patent No. 2009101560179; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wu P, 2010, CURR MED CHEM, V17, P4326, DOI 10.2174/092986710793361234; Wu P, 2012, MEDCHEMCOMM, V3, P1337, DOI 10.1039/c2md20044a; Wu P, 2012, MEDCHEMCOMM, V3, P659, DOI 10.1039/c2md00255h; Wu P, 2012, BIOORGAN MED CHEM, V20, P2837, DOI 10.1016/j.bmc.2012.03.026; Wu P, 2011, EUR J MED CHEM, V46, P5540, DOI 10.1016/j.ejmech.2011.09.015; Wu P, 2009, CURR MED CHEM, V16, P916, DOI 10.2174/092986709787581905	25	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43171	10.1371/journal.pone.0043171	http://dx.doi.org/10.1371/journal.pone.0043171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905224	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800056
J	Zeng, Y; Ebong, EE; Fu, BMM; Tarbell, JM				Zeng, Ye; Ebong, Eno E.; Fu, Bingmei M.; Tarbell, John M.			The Structural Stability of the Endothelial Glycocalyx after Enzymatic Removal of Glycosaminoglycans	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; CHONDROITIN SULFATE; GLOMERULAR CHARGE; CELL GLYCOCALYX; SHEAR-STRESS; CAROTID-ARTERY; BARRIER; HYALURONAN; GLUCOSE; PERMEABILITY	Rationale: It is widely believed that glycosaminoglycans (GAGs) and bound plasma proteins form an interconnected gel-like structure on the surface of endothelial cells (the endothelial glycocalyx layer-EGL) that is stabilized by the interaction of its components. However, the structural organization of GAGs and proteins and the contribution of individual components to the stability of the EGL are largely unknown. Objective: To evaluate the hypothesis that the interconnected gel-like glycocalyx would collapse when individual GAG components were almost completely removed by a specific enzyme. Methods and Results: Using confocal microscopy, we observed that the coverage and thickness of heparan sulfate (HS), chondroitin sulfate (CS), hyaluronic acid (HA), and adsorbed albumin were similar, and that the thicknesses of individual GAGs were spatially nonuniform. The individual GAGs were degraded by specific enzymes in a dose-dependent manner, and decreased much more in coverage than in thickness. Removal of HS or HA did not result in cleavage or collapse of any of the remaining components. Simultaneous removal of CS and HA by chondroitinase did not affect HS, but did reduce adsorbed albumin, although the effect was not large. Conclusion: All GAGs and adsorbed proteins are well inter-mixed within the structure of the EGL, but the GAG components do not interact with one another. The GAG components do provide binding sites for albumin. Our results provide a new view of the organization of the endothelial glycocalyx layer and provide the first demonstration of the interaction between individual GAG components.	[Zeng, Ye; Fu, Bingmei M.; Tarbell, John M.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA; [Ebong, Eno E.] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); Yeshiva University	Zeng, Y (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	tarbell@ccny.cuny.edu	Zeng, Ye/E-3010-2010; Fu, Bingmei M/I-3295-2013	Zeng, Ye/0000-0001-5440-6194; 	National Institutes of Health [HL 094889]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health RO1 Grant HL 094889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON RH, 1992, J PHYSIOL-LONDON, V445, P473, DOI 10.1113/jphysiol.1992.sp018934; Barker AL, 2004, PHYS CHEM CHEM PHYS, V6, P1006, DOI 10.1039/b312189e; Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Chappell D, 2008, BIOL CHEM, V389, P79, DOI 10.1515/BC.2008.005; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Curry FE, 2012, ANN BIOMED ENG, V40, P828, DOI 10.1007/s10439-011-0429-8; Dancu MB, 2007, ATHEROSCLEROSIS, V192, P9, DOI 10.1016/j.atherosclerosis.2006.05.042; DELVOS U, 1985, THROMB HAEMOSTASIS, V53, P26; DERBY MA, 1978, HISTOCHEM J, V10, P529, DOI 10.1007/BF01003135; DESJARDINS C, 1990, AM J PHYSIOL, V258, pH647, DOI 10.1152/ajpheart.1990.258.3.H647; Duan WL, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-16; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; EGGLI PS, 1995, J HISTOCHEM CYTOCHEM, V43, P689, DOI 10.1177/43.7.7608523; Friden V, 2011, KIDNEY INT, V79, P1322, DOI 10.1038/ki.2011.58; Gao LJ, 2010, MICROVASC RES, V80, P394, DOI 10.1016/j.mvr.2010.06.005; Grondahl F, 2011, CARBOHYD RES, V346, P50, DOI 10.1016/j.carres.2010.10.025; HALDENBY KA, 1994, J VASC RES, V31, P2, DOI 10.1159/000159025; Hamai A, 1997, J BIOL CHEM, V272, P9123; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Koshiishi I, 1998, ANAL BIOCHEM, V265, P49, DOI 10.1006/abio.1998.2883; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lipowsky Herbert H, 2011, Drug Discov Today Dis Models, V8, P57; Lipowsky HH, 2012, ANN BIOMED ENG, V40, P840, DOI 10.1007/s10439-011-0427-x; MARCUM JA, 1985, BIOCHEM BIOPH RES CO, V126, P365, DOI 10.1016/0006-291X(85)90615-1; Marechal X, 2008, SHOCK, V29, P572, DOI 10.1097/SHK.0b013e318157e926; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Nelson A, 2008, SHOCK, V30, P623, DOI 10.1097/SHK.0b013e3181777da3; Nikmanesh M, 2012, BIOTECHNOL BIOENG, V109, P583, DOI 10.1002/bit.23302; Ohlson M, 2001, AM J PHYSIOL-RENAL, V280, pF396, DOI 10.1152/ajprenal.2001.280.3.F396; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; RAPRAEGER A, 1989, J CELL BIOL, V109, P2509, DOI 10.1083/jcb.109.5.2509; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Reitsma S, 2011, J VASC RES, V48, P297, DOI 10.1159/000322176; Shi ZD, 2011, ANN BIOMED ENG, V39, P1608, DOI 10.1007/s10439-011-0309-2; Singh A, 2011, AM J PHYSIOL-RENAL, V300, pF40, DOI 10.1152/ajprenal.00103.2010; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Sorensson J, 1998, ACTA PHYSIOL SCAND, V163, P83, DOI 10.1046/j.1365-201x.1998.00315.x; Sorensson J, 2001, AM J PHYSIOL-RENAL, V280, pF646, DOI 10.1152/ajprenal.2001.280.4.F646; Stevens AP, 2007, AM J PHYSIOL-LUNG C, V293, pL328, DOI 10.1152/ajplung.00390.2006; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; Tarbell JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.140pt8; TENNYSON VM, 1990, J COMP NEUROL, V291, P345, DOI 10.1002/cne.902910303; Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101; van den Berg BM, 2009, PFLUG ARCH EUR J PHY, V457, P1199, DOI 10.1007/s00424-008-0590-6; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; Vogl-Willis CA, 2004, BBA-GEN SUBJECTS, V1672, P36, DOI 10.1016/j.bbagen.2004.02.005; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; WITTE S, 1988, THROMB RES, V52, P111, DOI 10.1016/0049-3848(88)90089-8; WRIGHT CS, 1984, J MOL BIOL, V178, P91, DOI 10.1016/0022-2836(84)90232-8; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yen WY, 2012, MICROVASC RES, V83, P337, DOI 10.1016/j.mvr.2012.02.005	56	82	82	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43168	10.1371/journal.pone.0043168	http://dx.doi.org/10.1371/journal.pone.0043168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905223	gold, Green Published			2022-12-27	WOS:000307500800055
J	Briggs, AA; Young, HS; McCauley, DJ; Hathaway, SA; Dirzo, R; Fisher, RN				Briggs, Amy A.; Young, Hillary S.; McCauley, Douglas J.; Hathaway, Stacie A.; Dirzo, Rodolfo; Fisher, Robert N.			Effects of Spatial Subsidies and Habitat Structure on the Foraging Ecology and Size of Geckos	PLOS ONE			English	Article							FOOD-CHAIN LENGTH; HEMIDACTYLUS-FRENATUS; REPRODUCTIVE SUCCESS; MARINE SUBSIDIES; BODY CONDITION; HOUSE GECKOS; WEB; LIZARDS; ISLAND; COMPETITION	While it is well established that ecosystem subsidies-the addition of energy, nutrients, or materials across ecosystem boundaries-can affect consumer abundance, there is less information available on how subsidy levels may affect consumer diet, body condition, trophic position, and resource partitioning among consumer species. There is also little information on whether changes in vegetation structure commonly associated with spatial variation in subsidies may play an important role in driving consumer responses to subsidies. To address these knowledge gaps, we studied changes in abundance, diet, trophic position, size, and body condition of two congeneric gecko species (Lepidodactylus spp.) that coexist in palm dominated and native (hereafter dicot dominated) forests across the Central Pacific. These forests differ strongly both in the amount of marine subsidies that they receive from seabird guano and carcasses, and in the physical structure of the habitat. Contrary to other studies, we found that subsidy level had no impact on the abundance of either gecko species; it also did not have any apparent effects on resource partitioning between species. However, it did affect body size, dietary composition, and trophic position of both species. Geckos in subsidized, dicot forests were larger, had higher body condition and more diverse diets, and occupied a much higher trophic position than geckos found in palm dominated, low subsidy level forests. Both direct variation in subsidy levels and associated changes in habitat structure appear to play a role in driving these responses. These results suggest that variation in subsidy levels may drive important behavioral responses in predators, even when their numerical response is limited. Strong changes in trophic position of consumers also suggest that subsidies may drive increasingly complex food webs, with longer overall food chain length.	[Briggs, Amy A.; Young, Hillary S.; McCauley, Douglas J.; Dirzo, Rodolfo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Hathaway, Stacie A.; Fisher, Robert N.] US Geol Survey, Western Ecol Res Ctr, San Diego Field Stn, San Diego, CA USA	Stanford University; United States Department of the Interior; United States Geological Survey	Briggs, AA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	hyoung@fas.harvard.edu	Fisher, Robert/AAA-7301-2022; Young, Hillary/S-1514-2017	Fisher, Robert/0000-0002-2956-3240; Briggs, Amy/0000-0002-5782-7928	National Science Foundation; National Geographic Society; Woods Institute for the Environment; Stanford University	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Woods Institute for the Environment; Stanford University(Stanford University)	This work was supported by funding from the National Science Foundation, the National Geographic Society, the Woods Institute for the Environment, and Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo L, 2006, BIOL CONSERV, V131, P402, DOI 10.1016/j.biocon.2006.02.015; Anderson WB, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P82; Arim M, 2007, AM NAT, V169, P62, DOI 10.1086/510210; Barrett K, 2005, OIKOS, V109, P145, DOI 10.1111/j.0030-1299.2005.13728.x; Barrett K, 2003, J BIOGEOGR, V30, P1575, DOI 10.1046/j.1365-2699.2003.00936.x; Brehme CS, 2009, J ARID ENVIRON, V73, P811, DOI 10.1016/j.jaridenv.2009.03.002; BUSTARD HR, 1970, COPEIA, P173; BUSTARD HR, 1970, ECOLOGY, V51, P724; CASE TJ, 1994, ECOLOGY, V75, P464, DOI 10.2307/1939550; CASE TJ, 1991, TRENDS ECOL EVOL, V6, P135, DOI 10.1016/0169-5347(91)90093-D; Catenazzi A, 2007, OIKOS, V116, P75, DOI 10.1111/j.2006.0030-1299.15230.x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; CHAO A, 1989, BIOMETRICS, V45, P427, DOI 10.2307/2531487; CLARKE KR, 1994, MAR BIOL, V118, P167, DOI 10.1007/BF00699231; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Deenik JL, 2008, SOIL SCI, V173, P54, DOI 10.1097/ss.0b013e31815a668c; Ellis JC, 2005, PLANT ECOL, V181, P227, DOI 10.1007/s11258-005-7147-y; Ellis JC, 2011, SEABIRD ISLANDS ECOL, P212; FRANKENBERG E, 1981, J HERPETOL, V15, P373, DOI 10.2307/1563445; Halaj J, 2000, OIKOS, V90, P139, DOI 10.1034/j.1600-0706.2000.900114.x; HANLEY KA, 1994, EVOL ECOL, V8, P438, DOI 10.1007/BF01238194; HANLEY KA, 1995, EVOLUTION, V49, P418, DOI [10.2307/2410266, 10.1111/j.1558-5646.1995.tb02274.x]; Helfield JM, 2001, ECOLOGY, V82, P2403, DOI 10.1890/0012-9658(2001)082[2403:EOSDNO]2.0.CO;2; Hines J, 2006, ECOLOGY, V87, P1542, DOI 10.1890/0012-9658(2006)87[1542:NSTBMI]2.0.CO;2; HUEY RB, 1979, OECOLOGIA, V38, P249, DOI 10.1007/BF00345186; Hurlbert AH, 2004, ECOL LETT, V7, P714, DOI 10.1111/j.1461-0248.2004.00630.x; Huxel GR, 2002, ECOL RES, V17, P419, DOI 10.1046/j.1440-1703.2002.00501.x; IASON GR, 1986, J ANIM ECOL, V55, P507, DOI 10.2307/4734; Ineich I., 1992, B COLL SCI U RYUKYUS, V53, P31; Kauzinger CMK, 1998, NATURE, V395, P495; Kolb G.S., 2011, P212; Kolb GS, 2010, ECOSYSTEMS, V13, P353, DOI 10.1007/s10021-010-9323-8; KUO S, 1996, METHODS SOIL ANAL 3, P898; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; Markwell TJ, 2002, ECOSCIENCE, V9, P293, DOI 10.1080/11956860.2002.11682715; MORITZ C, 1993, BIOL J LINN SOC, V48, P113, DOI 10.1006/bijl.1993.1010; Petren K, 1998, P NATL ACAD SCI USA, V95, P11739, DOI 10.1073/pnas.95.20.11739; Petren K, 1996, ECOLOGY, V77, P118, DOI 10.2307/2265661; Piovia-Scott J, 2011, SCIENCE, V331, P461, DOI 10.1126/science.1200282; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; POLIS GA, 1995, P NATL ACAD SCI USA, V92, P4382, DOI 10.1073/pnas.92.10.4382; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; RADTKEY RR, 1995, P ROY SOC B-BIOL SCI, V259, P145, DOI 10.1098/rspb.1995.0022; Rand TA, 2006, CONSERV BIOL, V20, P1720, DOI 10.1111/j.1523-1739.2006.00507.x; Rose MD, 1998, ECOLOGY, V79, P998, DOI 10.2307/176595; Salvador A, 2008, BEHAV ECOL, V19, P169, DOI 10.1093/beheco/arm118; Schmidt S, 2004, FUNCT PLANT BIOL, V31, P517, DOI 10.1071/FP04024; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; SCHOENER TW, 1980, J ANIM ECOL, V49, P19, DOI 10.2307/4276; Shine R, 2001, EVOLUTION, V55, P598, DOI 10.1554/0014-3820(2001)055[0598:BITSDE]2.0.CO;2; Short KH, 2008, ANIM BEHAV, V76, P429, DOI 10.1016/j.anbehav.2008.04.008; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Thompson RM, 2005, OIKOS, V108, P137, DOI 10.1111/j.0030-1299.2005.11600.x; VANBERKUM FH, 1989, FUNCT ECOL, V3, P97; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Werth M, 2010, SOIL BIOL BIOCHEM, V42, P1372, DOI 10.1016/j.soilbio.2010.04.009; Young HS, 2010, J VEG SCI, V21, P1058, DOI 10.1111/j.1654-1103.2010.01219.x; Young HS, 2010, MAR ECOL PROG SER, V403, P291, DOI 10.3354/meps08478; Young HS, 2010, P NATL ACAD SCI USA, V107, P2072, DOI 10.1073/pnas.0914169107	62	21	24	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41364	10.1371/journal.pone.0041364	http://dx.doi.org/10.1371/journal.pone.0041364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899995	Green Submitted, gold, Green Published			2022-12-27	WOS:000307380900010
J	Castle, MD; Gilligan, CA				Castle, Matthew D.; Gilligan, Christopher A.			An Epidemiological Framework for Modelling Fungicide Dynamics and Control	PLOS ONE			English	Article							PLANT PATHOGEN POPULATIONS; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; CONTROL STRATEGIES; CHEMICAL CONTROL; DISEASE; INVASION; SCALE; PERSISTENCE; SIMULATION	Defining appropriate policies for controlling the spread of fungal disease in agricultural landscapes requires appropriate theoretical models. Most existing models for the fungicidal control of plant diseases do not explicitly include the dynamics of the fungicide itself, nor do they consider the impact of infection occurring during the host growth phase. We introduce a modelling framework for fungicide application that allows us to consider how "explicit" modelling of fungicide dynamics affects the invasion and persistence of plant pathogens. Specifically, we show that "explicit" models exhibit bistability zones for values of the basic reproductive number (R-0) less than one within which the invasion and persistence threshold depends on the initial infection levels. This is in contrast to classical models where invasion and persistence thresholds are solely dependent on R-0. In addition if initial infection occurs during the growth phase then an additional "invasion zone" can exist for even smaller values of R-0. Within this region the system will experience an epidemic that is not able to persist. We further show that ideal fungicides with high levels of effectiveness, low rates of application and low rates of decay lead to the existence of these bistability zones. The results are robust to the inclusion of demographic stochasticity.	[Castle, Matthew D.; Gilligan, Christopher A.] Univ Cambridge, Dept Plant Sci, Cambridge, England	University of Cambridge	Castle, MD (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	mdc31@cam.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/B502379/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MDC acknowledges the support of a Biotechnology and Biological Sciences Research Council (BBSRC) PhD studentship. CAG acknowledges the support of a BBSRC Professorial Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham I.J., 2006, BARLEY GROWTH GUIDE, P3; Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Blake J, 2012, 20041068 USGS; Brauer F, 2004, J MATH ANAL APPL, V298, P418, DOI 10.1016/j.jmaa.2004.05.045; Brent KJ, 2007, 20041068 USGS; CHIN KM, 1987, PHYTOPATHOLOGY, V77, P666, DOI 10.1094/Phyto-77-666; Cunniffe NJ, 2010, J R SOC INTERFACE, V7, P439, DOI 10.1098/rsif.2009.0226; DEWAARD MA, 1993, ANNU REV PHYTOPATHOL, V31, P403, DOI 10.1146/annurev.py.31.090193.002155; Dybiec B, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066145; Dybiec B, 2005, ACTA PHYS POL B, V36, P1509; Forster GA, 2007, P NATL ACAD SCI USA, V104, P4984, DOI 10.1073/pnas.0607900104; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gilligan CA, 2002, ADV BOT RES, V38, P1, DOI 10.1016/S0065-2296(02)38027-3; Gilligan CA, 2007, J R SOC INTERFACE, V4, P925, DOI 10.1098/rsif.2007.1019; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; HADELER KP, 1995, MATH BIOSCI, V128, P41, DOI 10.1016/0025-5564(94)00066-9; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; Holt J, 1999, PLANT PATHOL, V48, P453, DOI 10.1046/j.1365-3059.1999.00360.x; Kribs-Zaleta CM, 2000, MATH BIOSCI, V164, P183, DOI 10.1016/S0025-5564(00)00003-1; LEVY Y, 1983, PHYTOPATHOLOGY, V73, P1475, DOI 10.1094/Phyto-73-1475; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley N, 2012, 20041068 USGS; Reinink K, 1986, EUROPEAN J PLANT PAT, V92, P3; Russell PE, 2005, J AGR SCI-CAMBRIDGE, V143, P11, DOI 10.1017/S0021859605004971; Safan M, 2006, J MATH BIOL, V53, P703, DOI 10.1007/s00285-006-0028-8; SHAW MW, 1989, CROP PROT, V8, P405, DOI 10.1016/0261-2194(89)90065-3; Sylvester-Bradley R, 2008, 20041068 USGS; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; ZILBERMAN D, 1991, SCIENCE, V253, P518, DOI 10.1126/science.253.5019.518	33	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e40941	10.1371/journal.pone.0040941	http://dx.doi.org/10.1371/journal.pone.0040941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899992	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900007
J	Charbaji, N; Schafer-Korting, M; Kuchler, S				Charbaji, Nada; Schaefer-Korting, Monika; Kuechler, Sarah			Morphine Stimulates Cell Migration of Oral Epithelial Cells by Delta-Opioid Receptor Activation	PLOS ONE			English	Article							MU-OPIATE RECEPTOR; TGF-BETA; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; MAP KINASES; PAIN; SKIN; PROLIFERATION; KERATINOCYTES; ANALGESIA	Oral mucositis is one of the most common side effects of chemoradiation regimens and manifestation can be dose-limiting for the therapy, can impair the patient's nutritional condition and quality of life due to severe pain. The therapeutic options are limited; often only an alleviation of the symptoms such as pain reduction by using systemic opioids is possible. Stimulating opioid receptors on peripheral neurons and dermal tissue, potent analgesic effects are induced e.g. in skin grafted patients. Advantageous effects on the cell migration and, thus, on the wound healing process are described, too. In this study, we investigated whether opioid receptors are also expressed on oral epithelial cells and if morphine can modulate their cell migration behavior. The expression of the opioid receptors MOR, DOR and KOR on primary human oral epithelial cells was verified. Furthermore, a significantly accelerated cell migration was observed following incubation with morphine. The effect even slightly exceeded the cell migration stimulating effect of TGF-beta: After 14 h of morphine treatment about 86% of the wound area was closed, whereas TGF-beta application resulted in a closed wound area of 80%. With respect to morphine stimulated cell migration we demonstrate that DOR plays a key role and we show the involvement of the MAPK members Erk 1/2 and p38 using Western blot analysis. Further studies in more complex systems in vitro and in vivo are required. Nevertheless, these findings might open up a new therapeutic option for the treatment of oral mucositis.	[Charbaji, Nada; Schaefer-Korting, Monika; Kuechler, Sarah] Free Univ Berlin, Inst Pharm, Berlin, Germany	Free University of Berlin	Charbaji, N (corresponding author), Free Univ Berlin, Inst Pharm, Berlin, Germany.	sarah.kuechler@cup.uni-muenchen.de		Hedtrich (nee Kuchler), Sarah/0000-0001-6770-3657	European Funding for Regional Development (EFRE)	European Funding for Regional Development (EFRE)	Nada Charbaji was funded partly by the European Funding for Regional Development (EFRE). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellm LA, 2000, SUPPORT CARE CANCER, V8, P33; Bigliardi PL, 2009, EXP DERMATOL, V18, P424, DOI 10.1111/j.1600-0625.2009.00844.x; Bigliardi PL, 1998, J INVEST DERMATOL, V111, P297, DOI 10.1046/j.1523-1747.1998.00259.x; Bigliardi-Qi M, 2006, DIFFERENTIATION, V74, P174, DOI 10.1111/j.1432-0436.2006.00065.x; Bigliardi-Qi M, 2004, DERMATOLOGY, V209, P183, DOI 10.1159/000079887; Cerchietti LCA, 2003, PAIN, V105, P265, DOI 10.1016/S0304-3959(03)00227-6; Cerchietti LCA, 2002, CANCER, V95, P2230, DOI 10.1002/cncr.10938; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cheng B, 2008, BRIT J DERMATOL, V158, P713, DOI 10.1111/j.1365-2133.2008.08449.x; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Farooqui M, 2007, BRIT J CANCER, V97, P1523, DOI 10.1038/sj.bjc.6604057; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FERREIRA SH, 1979, PROSTAGLANDINS, V18, P191, DOI 10.1016/0090-6980(79)90104-7; Flock P, 2003, J PAIN SYMPTOM MANAG, V25, P547, DOI 10.1016/S0885-3924(03)00140-4; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gysler A, 1997, PHARMACEUT RES, V14, P793, DOI 10.1023/A:1012162708675; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Ibrahim AS, DIABETES, V60, P1122; Kuchler S, 2010, J BIOTECHNOL, V148, P24, DOI 10.1016/j.jbiotec.2010.01.001; LeBon B, 2009, J PAIN SYMPTOM MANAG, V37, P913, DOI 10.1016/j.jpainsymman.2008.06.007; Li W, 2001, J INVEST DERMATOL, V117, P1601, DOI 10.1046/j.0022-202x.2001.01608.x; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203; Moon SE, 2002, BRIT J CANCER, V87, P457, DOI 10.1038/sj.bjc.6600478; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ohshima M, 2002, EUR J ORAL SCI, V110, P130, DOI 10.1034/j.1600-0722.2002.11179.x; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; PASI A, 1991, GEN PHARMACOL, V22, P1077, DOI 10.1016/0306-3623(91)90580-Y; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Platzer M, 2005, SCHMERZ, V19, P296, DOI 10.1007/s00482-004-0372-9; Poonawala T, 2005, WOUND REPAIR REGEN, V13, P165, DOI 10.1111/j.1067-1927.2005.130207.x; PRATHER PL, 1994, J PHARMACOL EXP THER, V270, P177; Rachinger-Adam B, 2011, CURR OPIN ANESTHESIO, V24, P408, DOI 10.1097/ACO.0b013e32834873e5; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Salemi S, 2005, BIOCHEM BIOPH RES CO, V338, P1012, DOI 10.1016/j.bbrc.2005.10.072; SCHAFER M, 1995, EUR J PHARMACOL, V279, P165, DOI 10.1016/0014-2999(95)00150-J; Silverman Sol Jr, 2007, J Support Oncol, V5, P13; Sonis Stephen T, 2007, J Support Oncol, V5, P3; STEIN C, 1990, P NATL ACAD SCI USA, V87, P5935, DOI 10.1073/pnas.87.15.5935; Stein C, 2003, ADV EXP MED BIOL, V521, P69; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; STEIN C, 1993, ANESTH ANALG, V76, P182; STEIN C, 1995, NEW ENGL J MED, V332, P1685, DOI 10.1056/NEJM199506223322506; Stone Rebecca, 2005, Eur J Oncol Nurs, V9 Suppl 1, pS24, DOI 10.1016/j.ejon.2005.08.004; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wolf NB, 2009, EUR J PHARM BIOPHARM, V73, P34, DOI 10.1016/j.ejpb.2009.03.009; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; ZADINA JE, 1994, J PHARMACOL EXP THER, V270, P1086; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	51	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42616	10.1371/journal.pone.0042616	http://dx.doi.org/10.1371/journal.pone.0042616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900034	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900050
J	Jiang, Q; Thiffault, C; Kramer, BC; Ding, GL; Zhang, L; Nejad-Davarani, SP; Li, L; Arbab, AS; Lu, M; Navia, B; Victor, SJ; Hong, K; Li, QJ; Wang, SY; Li, Y; Chopp, M				Jiang, Quan; Thiffault, Christine; Kramer, Brian C.; Ding, Guang Liang; Zhang, Li; Nejad-Davarani, Siamak P.; Li, Lian; Arbab, Ali S.; Lu, Mei; Navia, Brad; Victor, Stephen J.; Hong, Klaudyne; Li, Qing Jiang; Wang, Shi Yang; Li, Yi; Chopp, Michael			MRI Detects Brain Reorganization after Human Umbilical Tissue-Derived Cells (hUTC) Treatment of Stroke in Rat	PLOS ONE			English	Article							MARROW STROMAL CELLS; ENDOTHELIAL GROWTH-FACTOR; FUNCTIONAL RECOVERY; EMBOLIC STROKE; ENHANCES ANGIOGENESIS; THERAPEUTIC BENEFIT; CEREBRAL-ISCHEMIA; NEUROGENESIS; VEGF; PERMEABILITY	Human umbilical tissue-derived cells (hUTC) represent an attractive cell source and a potential technology for neurorestoration and improvement of functional outcomes following stroke. Male Wistar rats were subjected to a transient middle cerebral artery occlusion (tMCAo) and were intravenously administered hUTC (N = 11) or vehicle (N = 10) 48 hrs after stroke. White matter and vascular reorganization was monitored over a 12-week period using MRI and histopathology. MRI results were correlated with neurological functional and histology outcomes to demonstrate that MRI can be a useful tool to measure structural recovery after stroke. MRI revealed a significant reduction in the ventricular volume expansion and improvement in cerebral blood flow (CBF) in the hUTC treated group compared to vehicle treated group. Treatment with hUTC resulted in histological and functional improvements as evidenced by enhanced expression of vWF and synaptophysin, and improved outcomes on behavioral tests. Significant correlations were detected between MRI ventricular volumes and histological lesion volume as well as number of apoptotic cells. A positive correlation was also observed between MRI CBF or cerebral blood volume (CBV) and histological synaptic density. Neurological functional tests were also significantly correlated with MRI ventricular volume and CBV. Our data demonstrated that MRI measurements can detect the effect of hUTC therapy on the brain reorganization and exhibited positive correlation with histological measurements of brain structural changes and functional behavioral tests after stroke. MRI ventricular volumes provided the most sensitive index in monitoring brain remodeling and treatment effects and highly correlated with histological and functional measurements.	[Jiang, Quan; Ding, Guang Liang; Zhang, Li; Nejad-Davarani, Siamak P.; Li, Lian; Li, Qing Jiang; Wang, Shi Yang; Li, Yi; Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA; [Lu, Mei] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Arbab, Ali S.] Henry Ford Hlth Syst, Dept Radiol, Detroit, MI USA; [Thiffault, Christine; Kramer, Brian C.; Hong, Klaudyne] Adv Technol & Regenerat Med LLC, Somerville, NJ USA; [Navia, Brad; Victor, Stephen J.] Johnson & Johnson Pharmaceut Res & Dev, Titusville, NJ USA; [Jiang, Quan; Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Johnson & Johnson; Johnson & Johnson USA; Oakland University	Jiang, Q (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA.	qjiang1@hfhs.org	Arbab, Ali/AAS-1933-2020; Wang, Shiyang/C-1729-2012; Nejad-Davarani, Siamak/AAH-8399-2021	Ding, Guangliang/0000-0003-1286-5901; Nejad-Davarani, Siamak/0000-0002-2415-6689; Li, Lian/0000-0003-0097-1184	Advanced Technologies and Regenerative Medicine, LLC. [08-0320-TR]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064134, P50NS023393, R01NS048349] Funding Source: NIH RePORTER	Advanced Technologies and Regenerative Medicine, LLC.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research presented herein was funded by Advanced Technologies and Regenerative Medicine, LLC. 08-0320-TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; BRIX G, 1990, MAGN RESON IMAGING, V8, P351, DOI 10.1016/0730-725X(90)90041-Y; CHEN H, 1992, J CEREBR BLOOD F MET, V12, P621, DOI 10.1038/jcbfm.1992.86; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen JL, 2004, BRAIN RES, V1005, P21, DOI 10.1016/j.brainres.2003.11.080; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; DERYCK M, 1992, BRAIN RES, V573, P44; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Ding GL, 2010, J NEUROSCI RES, V88, P3206, DOI 10.1002/jnr.22470; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Institution S, 2004, SAS ATAT 9 1 SOFTW; Jiang Q, 2005, NEUROIMAGE, V28, P698, DOI 10.1016/j.neuroimage.2005.06.063; Jiang Q, 2005, J CEREBR BLOOD F MET, V25, P583, DOI 10.1038/sj.jcbfm.9600053; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; Jin KL, 2004, J CEREBR BLOOD F MET, V24, P399, DOI 10.1097/00004647-200404000-00005; Johansen-Berg H, 2007, INT J STROKE, V2, P7, DOI 10.1111/j.1747-4949.2007.00093.x; KNIGHT RA, 1991, STROKE, V22, P802, DOI 10.1161/01.STR.22.6.802; Kraemer M, 2004, J NEUROIMAGING, V14, P265, DOI 10.1177/1051228404264950; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Li L, 2006, J CEREBR BLOOD F MET, V26, P1366, DOI 10.1038/sj.jcbfm.9600288; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Look D. C., 1970, Review of Scientific Instruments, V41, P250, DOI 10.1063/1.1684482; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MATSON GB, 1994, MAGN RESON IMAGING, V12, P1205, DOI 10.1016/0730-725X(94)90086-7; Mintzopoulos D, 2009, NEUROIMAGE, V47, pT90, DOI 10.1016/j.neuroimage.2009.03.007; Navaratna D, 2009, CELL ADHES MIGR, V3, P216, DOI 10.4161/cam.3.2.8396; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Pourabdollah-Nejad S, 2009, P 17 ANN M INT SOC M, P3206; Pourabdollah-Nejad S, 2008, P 16 ANN M INT SOC M, P3332; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Slevin M, 2000, STROKE, V31, P1863, DOI 10.1161/01.STR.31.8.1863; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Walters RJL, 2003, J NEUROL NEUROSUR PS, V74, P213, DOI 10.1136/jnnp.74.2.213; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; WEILLER C, 1993, ANN NEUROL, V33, P181; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang L, 2005, STROKE UNPUB; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhang ZG, 2002, TRENDS CARDIOVAS MED, V12, P62, DOI 10.1016/S1050-1738(01)00149-9; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	59	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42845	10.1371/journal.pone.0042845	http://dx.doi.org/10.1371/journal.pone.0042845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900057	gold, Green Published, Green Submitted			2022-12-27	WOS:000307380900075
J	Kakimoto, Y; Tsuruyama, T; Yamamoto, T; Furuta, M; Kotani, H; Ozeki, M; Yoshizawa, A; Haga, H; Tamaki, K				Kakimoto, Yu; Tsuruyama, Tatsuaki; Yamamoto, Takushi; Furuta, Masaru; Kotani, Hirokazu; Ozeki, Munetaka; Yoshizawa, Akihiko; Haga, Hironori; Tamaki, Keiji			Novel In Situ Pretreatment Method for Significantly Enhancing the Signal In MALDI-TOF MS of Formalin-Fixed Paraffin-Embedded Tissue Sections	PLOS ONE			English	Article							ANTIGEN RETRIEVAL; MASS-SPECTROMETRY; PROTEIN EXTRACTION; PROTEOMIC ANALYSIS; CANCER; SURFACTANTS; EXPRESSION; DIGESTION	The application of matrix-assisted laser desorption/ionization (MALDI)-based mass spectrometry (MS) to the proteomic analysis of formalin-fixed paraffin-embedded (FFPE) tissue presents significant technical challenges. In situ enzymatic digestion is frequently used to unlock formalin-fixed tissues for analysis, but the results are often unsatisfactory. Here, we report a new, simplified in situ pretreatment method for preparing tissue sections for MS that involves heating with vapor containing acetonitrile in a small airtight pressurized space. The utility of the novel method is shown using FFPE tissue of human colon carcinoma. The number and intensity of MALDI peaks obtained from analysis of pretreated tissue was significantly higher than control tissue not subjected to pretreatment. A prominent peak (m/z 850) apparently specific to cancerous tissue was identified as a fragment of histone H2A in FFPE tissue pretreated using our method. This highly sensitive treatment may enable MALDI-MS analysis of archived pathological FFPE samples, thus leading to the identification of new biomarkers.	[Kakimoto, Yu; Tsuruyama, Tatsuaki; Kotani, Hirokazu; Ozeki, Munetaka; Tamaki, Keiji] Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Kyoto, Japan; [Yamamoto, Takushi; Furuta, Masaru] Shimadzu Co Ltd, Kyoto Applicat Dev Ctr, Analyt & Measuring Instruments Div, Kyoto, Japan; [Yoshizawa, Akihiko] Shinshu Univ Hosp, Grad Sch Med, Dept Diagnost Pathol, Matsumoto, Nagano, Japan; [Haga, Hironori] Kyoto Univ Hosp, Grad Sch Med, Dept Diagnost Pathol, Kyoto 606, Japan	Kyoto University; Shimadzu Corporation; Shinshu University; Kyoto University	Kakimoto, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Kyoto, Japan.	tsuruyama@kuhp.kyoto-u.ac.jp	Yoshizawa, Akihiko/AAM-9519-2020	Haga, Hironori/0000-0003-4322-9561	Ministry of Education, Culture, Science and Technology, Japan; Ministry of Health, Welfare, and Labor, Japan	Ministry of Education, Culture, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Culture, Science and Technology, Japan, and by a grant from the Ministry of Health, Welfare, and Labor, Japan. The funding agencies had no role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Bornsen KO, 2000, METH MOL B, V146, P387, DOI 10.1385/1-59259-045-4:387; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Gustafsson JOR, 2010, J PROTEOME RES, V9, P4315, DOI 10.1021/pr9011766; HELANDER KG, 1994, BIOTECH HISTOCHEM, V69, P177, DOI 10.3109/10520299409106282; Hood BL, 2005, MOL CELL PROTEOMICS, V4, P1741, DOI 10.1074/mcp.M500102-MCP200; Kahveci Z, 2003, BIOTECH HISTOCHEM, V78, P119, DOI 10.1080/10520290310001593775; LEE TD, 1990, METHOD ENZYMOL, V193, P361, DOI 10.1016/0076-6879(90)93427-M; Lemaire R, 2006, ANAL CHEM, V78, P7145, DOI 10.1021/ac060565z; Mandal SM, 2010, EUR J MASS SPECTROM, V16, P567, DOI 10.1255/ejms.1097; Maneta-Peyret L, 1999, HISTOCHEM J, V31, P541, DOI 10.1023/A:1003844107756; Naldi M, 2006, J CHROMATOGR A, V1129, P73, DOI 10.1016/j.chroma.2006.06.100; Nirmalan NJ, 2009, J PATHOL, V217, P497, DOI 10.1002/path.2504; Palmer-Toy DE, 2005, J PROTEOME RES, V4, P2404, DOI 10.1021/pr050208p; Rodriguez-Rigueiro T, 2011, PROTEOMICS, V11, P2555, DOI 10.1002/pmic.201000809; Ronci M, 2008, PROTEOMICS, V8, P3702, DOI 10.1002/pmic.200701143; SHANRONG S, 2000, ANTIGEN RETRIEVAL TE; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Sugiura Y., 2006, J MASS SPECTROM SOC, V54, P45, DOI DOI 10.5702/MASSSPEC.54.45; SUTTON CW, 1995, ELECTROPHORESIS, V16, P308, DOI 10.1002/elps.1150160151; Werner M, 1996, HISTOCHEM CELL BIOL, V105, P253, DOI 10.1007/BF01463928; Zhang N, 2004, RAPID COMMUN MASS SP, V18, P889, DOI 10.1002/rcm.1423	22	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41607	10.1371/journal.pone.0041607	http://dx.doi.org/10.1371/journal.pone.0041607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899997	gold, Green Published, Green Submitted			2022-12-27	WOS:000307380900012
J	Kim, L; Hoe, KL; Yu, YM; Yeon, JH; Maeng, PJ				Kim, Lila; Hoe, Kwang-Lae; Yu, Yeong Man; Yeon, Ji-Hyun; Maeng, Pil Jae			The Fission Yeast GATA Factor, Gaf1, Modulates Sexual Development via Direct Down-Regulation of ste11(+) Expression in Response to Nitrogen Starvation	PLOS ONE			English	Article							ATF1 TRANSCRIPTION FACTOR; ZINC-FINGER PROTEIN; SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; MAP KINASE; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; ECTOPIC MEIOSIS; G(1) ARREST; PHEROMONE	Gaf1 is the first GATA family zinc-finger transcription factor identified in Schizosaccharomyces pombe. Here, we report that Gaf1 functions as a negatively acting transcription factor of ste11(+), delaying the entrance of cells exposed to transient nitrogen starvation into the meiotic cycle. gaf1 Delta strains exhibited accelerated G(1)-arrest upon nitrogen starvation. Moreover, gaf1 Delta mutation caused increased mating and sporulation frequency under both nitrogen-starved and unstarved conditions, while overexpression of gaf1(+) led to a significant impairment of sporulation. By microarray analysis, we found that approximately 63% (116 genes) of the 183 genes up-regulated in unstarved gaf1 Delta cells were nitrogen starvation-responsive genes, and furthermore that 25 genes among the genes up-regulated by gaf1 Delta mutation are Ste11 targets (e.g., gpa1(+), ste4(+), spk1(+), ste11(+), and mei2(+)). The phenotype caused by gaf1 Delta mutation was masked by ste11 Delta mutation, indicating that ste11(+) is epistatic to gaf1(+) with respect to sporulation efficiency, and accordingly that gaf1(+) functions upstream of ste11(+) in the signaling pathway governing sexual development. gaf1 Delta strains showed accelerated ste11(+) expression under nitrogen starvation and increased ste11(+) expression even under normal conditions. Electrophoretic mobility shift assay analysis demonstrated that Gaf1 specifically binds to the canonical GATA motif (5'-HGATAR-3') spanning from -371 to -366 in ste11(+) promoter. Consequently, Gaf1 provides the prime example for negative regulation of ste11(+) transcription through direct binding to a cis-acting motif of its promoter.	[Kim, Lila; Yu, Yeong Man; Yeon, Ji-Hyun; Maeng, Pil Jae] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon, South Korea; [Hoe, Kwang-Lae] Chungnam Natl Univ, Grad Sch New Drug Discovery & Dev, Taejon, South Korea	Chungnam National University; Chungnam National University	Kim, L (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon, South Korea.	pjmaeng@cnu.ac.kr		Hoe, Kwang Lae/0000-0002-3943-4549; Maeng, Pil Jae/0000-0002-7677-3208	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [313-2008-2-C00778]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST) (No. 313-2008-2-C00778). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C, 1993, EXPT FISSION YEAST L; Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Charron F, 1999, MOL CELL BIOL, V19, P4355; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Davey J, 1998, YEAST, V14, P1529, DOI 10.1002/(SICI)1097-0061(199812)14:16<1529::AID-YEA357>3.0.CO;2-0; DAVEY J, 1994, CURR GENET, V26, P105, DOI 10.1007/BF00313796; Davidson MK, 2004, J BIOL CHEM, V279, P50857, DOI 10.1074/jbc.M409079200; EGEL R, 1973, MOL GEN GENET, V122, P339, DOI 10.1007/BF00269434; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Hoe KL, 1998, GENE, V215, P319, DOI 10.1016/S0378-1119(98)00301-1; IMAI Y, 1994, GENE DEV, V8, P328, DOI 10.1101/gad.8.3.328; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; Kjaerulff S, 2005, MOL CELL BIOL, V25, P2045, DOI 10.1128/MCB.25.5.2045-2059.2005; Kunitomo H, 2000, MOL BIOL CELL, V11, P3205, DOI 10.1091/mbc.11.9.3205; KUNITOMO H, 1995, CURR GENET, V28, P32, DOI 10.1007/BF00311879; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Li P, 1996, CELL, V87, P869, DOI 10.1016/S0092-8674(00)81994-7; Martin-Castellanos C, 2005, CURR BIOL, V15, P2056, DOI 10.1016/j.cub.2005.10.038; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MOCHIZUKI N, 1992, MOL GEN GENET, V233, P17, DOI 10.1007/BF00587556; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakashima A, 2006, CURR GENET, V49, P403, DOI 10.1007/s00294-006-0067-0; Ohmiya R, 2000, MOL GEN GENET, V264, P441, DOI 10.1007/s004380000305; Pearson BM, 1998, YEAST, V14, P391, DOI 10.1002/(SICI)1097-0061(19980315)14:4<391::AID-YEA235>3.0.CO;2-O; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pelletier B, 2003, NUCLEIC ACIDS RES, V31, P4332, DOI 10.1093/nar/gkg647; Perlman H, 1998, J BIOL CHEM, V273, P13713, DOI 10.1074/jbc.273.22.13713; Scazzocchio C, 2000, CURR OPIN MICROBIOL, V3, P126, DOI 10.1016/S1369-5274(00)00063-1; Shieh JC, 1998, J CELL SCI, V111, P2799; Shiozaki K, 1997, MOL BIOL CELL, V8, P409, DOI 10.1091/mbc.8.3.409; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Siam R, 2004, METHODS, V33, P189, DOI 10.1016/j.ymeth.2003.11.013; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Wang LL, 2005, GENETICS, V171, P1523, DOI 10.1534/genetics.105.047233; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Won M, 1999, BIOCHEM CELL BIOL, V77, P127, DOI 10.1139/bcb-77-2-127; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yamada H, 1997, J GEN APPL MICROBIOL, V43, P209, DOI 10.2323/jgam.43.209; Yamamoto M, 1996, CELL STRUCT FUNCT, V21, P431, DOI 10.1247/csf.21.431; Yamamoto TG, 2004, J CELL SCI, V117, P3875, DOI 10.1242/jcs.01248	50	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42409	10.1371/journal.pone.0042409	http://dx.doi.org/10.1371/journal.pone.0042409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900017	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900034
J	Xu, XF; Zhou, YQ; Xie, CG; Wei, SM; Gan, HZ; He, SL; Wang, F; Xu, L; Lu, J; Dai, WQ; He, L; Chen, P; Wang, XP; Guo, CY				Xu, Xuanfu; Zhou, Yingqun; Xie, Chuangao; Wei, Shu-mei; Gan, Huizhong; He, Shengli; Wang, Fan; Xu, Ling; Lu, Jie; Dai, Weiqi; He, Lei; Chen, Ping; Wang, Xingpeng; Guo, Chuanyong			Genome-Wide Screening Reveals an EMT Molecular Network Mediated by Sonic Hedgehog-Gli1 Signaling in Pancreatic Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; REGULATORY NETWORKS; UP-REGULATION; TARGET GENES; METASTASIS; INVASION; INHIBITION; EXPRESSION; S100A4	Aims: The role of sonic hedgehog (SHH) in epithelial mesenchymal transition (EMT) of pancreatic cancer (PC) is known, however, its mechanism is unclear. Because SHH promotes tumor development predominantly through Gli1, we sought to understand its mechanism by identifying Gli1 targets in pancreatic cancer cells. Methods: First, we investigated invasion, migration, and EMT in PC cells transfected with lentiviral Gli1 interference vectors or SHH over-expression vectors in vitro and in vivo. Next, we determined the target gene profiles of Gli1 in PC cells using cDNA microarray assays. Finally, the primary regulatory networks downstream of SHH-Gli1 signaling in PC cells were studied through functional analyses of these targets. Results: Our results indicate there is decreased E-cadherin expression upon increased expression of SHH/Gli1. Migration of PC cells increased significantly in a dose-dependent manner within 24 hours of Gli1 expression (P<0.05). The ratio of liver metastasis and intrasplenic miniature metastasis increased markedly upon activation of SHH-Gli1 signals in nude mice. Using cDNA microarray, we identified 278 upregulated and 59 downregulated genes upon Gli1 expression in AsPC-1 cells. The data indicate that SHH-Gli1 signals promote EMT by mediating a complex signaling network including TGF beta, Ras, Wnt, growth factors, PI3K/AKT, integrins, transmembrane 4 superfamily (TM4SF), and S100A4. Conclusion: Our results suggest that targeting the molecular connections established between SHH-Gli1 signaling and EMT could provide effective therapies for PC.	[Xu, Xuanfu; Zhou, Yingqun; Wang, Fan; Xu, Ling; Lu, Jie; Dai, Weiqi; He, Lei; Chen, Ping; Wang, Xingpeng; Guo, Chuanyong] Tongji Univ, Dept Gastroenterol, Peoples Hosp Shanghai 10, Shanghai 200092, Peoples R China; [Xie, Chuangao; Wei, Shu-mei] Zhejiang Univ, Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Gan, Huizhong] Anhui Med Univ, Peoples Hosp Hefei 1, Dept Gastroenterol, Hefei, Anhui, Peoples R China; [He, Shengli] Fudan Univ, Dept Integrat Oncol, Minhang Branch, Shanghai Canc Ctr, Shanghai 200433, Peoples R China	Tongji University; Zhejiang University; Anhui Medical University; Fudan University	Xu, XF (corresponding author), Tongji Univ, Dept Gastroenterol, Peoples Hosp Shanghai 10, Shanghai 200092, Peoples R China.	guochuanyong@yahoo.com.cn		Guo, Chuanyong/0000-0002-6527-4673	National Natural Science Foundation of China [81072005, 81172312]; Shanghai Science and Technology Committee [10ZR1423300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was funded by grants from the National Natural Science Foundation of China (81072005 and 81172312) and Shanghai Science and Technology Committee (10ZR1423300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Botta GP, 2012, MOL CANCER RES, V10, P183, DOI 10.1158/1541-7786.MCR-11-0399; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Chen L, 2009, WORLD J GASTROENTERO, V15, P2270, DOI 10.3748/wjg.15.2270; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Cui WJ, 2012, FEBS LETT, V586, P766, DOI 10.1016/j.febslet.2012.01.039; Dai JT, 2011, PANCREAS, V40, P233, DOI 10.1097/MPA.0b013e3181f7e09f; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Feldmann G, 2008, GUT, V57, P1420, DOI 10.1136/gut.2007.148189; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2009, INT J ONCOL, V35, P187, DOI 10.3892/ijo_00000328; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Lin Kimberly, 2010, Genes Cancer, V1, P409; Luncsford PJ, 2010, J MOL BIOL, V403, P351, DOI 10.1016/j.jmb.2010.08.045; Mfopou JK, 2007, STEM CELLS, V25, P1156, DOI 10.1634/stemcells.2006-0720; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Nishio R, 2002, CANCER SCI, V102, P622; Partecke IL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-40; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sasaki T, 2011, DRUG METAB PHARMACOK, V26, P374, DOI 10.2133/dmpk.DMPK-10-RG-103; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Strobel O, 2010, GASTROENTEROLOGY, V138, P1166, DOI 10.1053/j.gastro.2009.12.005; Walker E, 2011, CELL CYCLE, V10, P45, DOI 10.4161/cc.10.1.14389; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yu J, 2012, CLIN CANCER RES, V18, P981, DOI 10.1158/1078-0432.CCR-11-2347; Yu M, 2009, J BIOL CHEM, V284, P5620, DOI 10.1074/jbc.M809172200; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zhang HY, 2012, MOL BIOL REP, V39, P199, DOI 10.1007/s11033-011-0726-1	34	41	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43119	10.1371/journal.pone.0043119	http://dx.doi.org/10.1371/journal.pone.0043119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900095	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900113
J	Sciorra, VA; Sanchez, MA; Kunibe, A; Wurmser, AE				Sciorra, Vicki A.; Sanchez, Michael A.; Kunibe, Akemi; Wurmser, Andrew E.			Suppression of Glioma Progression by Egln3	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; STEM-CELLS; TUMOR VASCULATURE; GENE-EXPRESSION; ANGIOGENESIS; GLIOBLASTOMA; TUMORIGENESIS; NORMALIZATION; PHD2; HYDROXYLASE	Grade IV astrocytoma or glioblastoma has a poor clinical outcome that can be linked to hypoxia, invasiveness and active vascular remodeling. It has recently been suggested that hypoxia-inducible factors, Hifs, increase glioma growth and aggressiveness [1,2,3]. Here, we tested the hypothesis that Egl 9 homolog 3 (Egln3), a prolyl-hydroxylase that promotes Hif degradation, suppresses tumor progression of human and rodent glioma models. Through intracranial tumorigenesis and in vitro assays, we demonstrate for the first time that Egln3 was sufficient to decrease the kinetics of tumor progression and increase survival. We also find that Klf5, a transcription factor important to vascular remodeling, was regulated by hypoxia in glioma. An analysis of the tumor vasculature revealed that elevated Egln3 normalized glioma capillary architecture, consistent with a role for Egln3 in eliciting decreases in the production of Hif-regulated, angiogenic factors. We also find that the hydroxylase-deficient mutant, Egln3(H196A) partially maintained tumor suppressive activity. These results highlight a bifurcation of Egln3 signaling and suggest that Egln3 has a non-hydroxylase-dependent function in glioma. We conclude that Egln3 is a critical determinant of glioma formation and tumor vascular functionality.	[Sciorra, Vicki A.; Sanchez, Michael A.; Kunibe, Akemi; Wurmser, Andrew E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Cell & Dev Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sciorra, VA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Cell & Dev Biol, Berkeley, CA 94720 USA.	aewurmser@yahoo.com			Berkeley Chancellor's Fellowship; Ellison Medical Foundation [AG-NS-0340-06]; Hellman Family Faculty Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	Berkeley Chancellor's Fellowship; Ellison Medical Foundation(Lawrence Ellison Foundation); Hellman Family Faculty Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.A.S. is supported by a Berkeley Chancellor's Fellowship. The authors thank the Ellison Medical Foundation for its financial support (Grant # AG-NS-0340-06; http://www.ellisonfoundation.org/index.jsp) and the Hellman Family Faculty Fund (http://vpaafw.chance.berkeley.edu/hellman.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bordoli MR, 2011, ONCOGENE, V30, P548, DOI 10.1038/onc.2010.433; Chan DA, 2010, BRIT J CANCER, V103, P1, DOI 10.1038/sj.bjc.6605682; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Du ZH, 2009, GLIA, V57, P724, DOI 10.1002/glia.20800; Erez N, 2003, CANCER RES, V63, P8777; Garcia JA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.296pe70; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hatzimichael E, 2010, EUR J HAEMATOL, V84, P47, DOI 10.1111/j.1600-0609.2009.01344.x; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kashiwagi S, 2008, NAT MED, V14, P255, DOI 10.1038/nm1730; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zhang Q, 2009, CANCER CELL, V16, P413, DOI 10.1016/j.ccr.2009.09.029	52	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e40053	10.1371/journal.pone.0040053	http://dx.doi.org/10.1371/journal.pone.0040053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905089	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100002
J	Cimino, M; Thomas, C; Namouchi, A; Dubrac, S; Gicquel, B; Gopaul, DN				Cimino, Mena; Thomas, Christophe; Namouchi, Amine; Dubrac, Sarah; Gicquel, Brigitte; Gopaul, Deshmukh N.			Identification of DNA Binding Motifs of the Mycobacterium tuberculosis PhoP/PhoR Two-Component Signal Transduction System	PLOS ONE			English	Article							DENDRITIC CELLS; REGULATOR PHOP; IN-VIVO; VIRULENCE; EXPRESSION; TRANSCRIPTION; RECOGNITION; STRAIN; GENES; PHOSPHORYLATION	Background: The Mycobacterium tuberculosis PhoP/PhoR two-component signal transduction system controls the expression of about 2% of the genome and plays a major role in pathogenicity. However, its regulon has not been well characterized. Methodology/Principal Findings: The binding site of PhoP transcription regulator was identified in the upstream regions of msl3, pks2, lipF and fadD21 genes, by using gene fusions, electrophoretic mobility shift assays and DNase I footprinting experiments. A consensus sequence for PhoP binding was deduced. It consists of two direct repeats, DR1/DR2, associated with a third repeat, DR3, important in some cases for PhoP binding to DR1/DR2 but located at a variable distance from these direct repeats. DR1/DR2 and DR3 consensus sequences were used to screen the whole-genome sequence for other putative binding sites potentially corresponding to genes directly regulated by PhoP. The identified 87 genes, encoding transcription regulators, and proteins involved in secondary metabolites biosynthesis, transport and catabolism are proposed to belong to the PhoP regulon. Conclusions/Significance: A consensus sequence derived from the analysis of PhoP binding to four gene promoter regions is proposed. We show for the first time the involvement of a third direct repeat motif in this binding reaction. The consensus sequence was instrumented to study the global regulation mediated by PhoP in M. tuberculosis. This analysis leads to the identification of several genes that are potentially regulated by this key player.	[Cimino, Mena; Namouchi, Amine; Gicquel, Brigitte] Inst Pasteur, Unit Genet Mycobacterienne, Paris, France; [Thomas, Christophe; Gopaul, Deshmukh N.] Inst Pasteur, CNRS UMR 3525, Unite Plasticite Genome Bacterien, Paris, France; [Dubrac, Sarah] Inst Pasteur, Unite Rech Biol Bacteries Pathogenes Gram Positif, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cimino, M (corresponding author), Inst Pasteur, Unit Genet Mycobacterienne, Paris, France.	brigitte.gicquel@pasteur.fr		GOPAUL, Deshmukh/0000-0003-1631-3303; Sarah, Dubrac/0000-0002-9810-5390	7th Framework Program NEWTBVAC contract [HEALTH-F3-2009-241745]; FP7-REGPOT EUMEDNET; TB project [ANR-09-MIEN-024-02]; Institut Pasteur Starter grant [CNRS URA 2185]	7th Framework Program NEWTBVAC contract; FP7-REGPOT EUMEDNET; TB project; Institut Pasteur Starter grant	This study received funding from the 7th Framework Program NEWTBVAC contract, HEALTH-F3-2009-241745, the FP7-REGPOT EUMEDNET vs TB project, the ANR-09-MIEN-024-02 project and the Institut Pasteur Starter grant/CNRS URA 2185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri CJ, 2011, MOL MICROBIOL, V82, P145, DOI 10.1111/j.1365-2958.2011.07804.x; ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Birck C, 2003, J BACTERIOL, V185, P254, DOI 10.1128/JB.185.1.254-261.2003; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Chang C, 1998, PLANT PHYSIOL, V117, P723, DOI 10.1104/pp.117.3.723; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dove SL, 2003, MOL MICROBIOL, V48, P863, DOI 10.1046/j.1365-2958.2003.03467.x; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gonzalo-Asensio J, 2008, J BACTERIOL, V190, P7068, DOI 10.1128/JB.00712-08; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Goyal R, 2011, J BIOL CHEM, V286, P45197, DOI 10.1074/jbc.M111.307447; Groisman EA, 2006, COLD SPRING HARB SYM, V71, P251, DOI 10.1101/sqb.2006.71.005; Gupta S, 2006, FEBS LETT, V580, P5328, DOI 10.1016/j.febslet.2006.09.004; Gupta S, 2009, J BACTERIOL, V191, P7466, DOI 10.1128/JB.00669-09; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; MILLER SI, 1990, INFECT IMMUN, V58, P3706, DOI 10.1128/IAI.58.11.3706-3710.1990; MURRAY A, 1992, MOL MICROBIOL, V6, P3331, DOI 10.1111/j.1365-2958.1992.tb02201.x; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Saviola B, 2003, INFECT IMMUN, V71, P1379, DOI 10.1128/IAI.71.3.1379-1388.2003; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	42	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42876	10.1371/journal.pone.0042876	http://dx.doi.org/10.1371/journal.pone.0042876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880126	Green Published, Green Submitted, gold			2022-12-27	WOS:000307437900057
J	Agosta, F; Valsasina, P; Riva, N; Copetti, M; Messina, MJ; Prelle, A; Comi, G; Filippi, M				Agosta, Federica; Valsasina, Paola; Riva, Nilo; Copetti, Massimiliano; Messina, Maria Jose; Prelle, Alessandro; Comi, Giancarlo; Filippi, Massimo			The Cortical Signature of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MILD AD DEMENTIA; BRAIN ATROPHY; MOTOR CORTEX; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; TRACT DAMAGE; WHOLE-BRAIN; ALS; THICKNESS	The aim of this study was to explore the pattern of regional cortical thickness in patients with non-familial amyotrophic lateral sclerosis (ALS) and to investigate whether cortical thinning is associated with disease progression rate. Cortical thickness analysis was performed in 44 ALS patients and 26 healthy controls. Group differences in cortical thickness and the age-by-group effects were assessed using vertex-by-vertex and multivariate linear models. The discriminatory ability of MRI variables in distinguishing patients from controls was estimated using the Concordance Statistics (C-statistic) within logistic regression analyses. Correlations between cortical thickness measures and disease progression rate were tested using the Pearson coefficient. Relative to controls, ALS patients showed a bilateral cortical thinning of the primary motor, prefrontal and ventral frontal cortices, cingulate gyrus, insula, superior and inferior temporal and parietal regions, and medial and lateral occipital areas. There was a significant age-by-group effect in the sensorimotor cortices bilaterally, suggesting a stronger association between age and cortical thinning in ALS patients compared to controls. The mean cortical thickness of the sensorimotor cortices distinguished patients with ALS from controls (C-statistic >= 0.74). Cortical thinning of the left sensorimotor cortices was related to a faster clinical progression (r = -0.33, p = 0.03). Cortical thickness measurements allowed the detection and quantification of motor and extramotor involvement in patients with ALS. Cortical thinning of the precentral gyrus might offer a marker of upper motor neuron involvement and disease progression.	[Agosta, Federica; Valsasina, Paola; Filippi, Massimo] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Div Neurosci, Neuroimaging Res Unit,Inst Expt Neurol, Milan, Italy; [Riva, Nilo; Messina, Maria Jose; Comi, Giancarlo; Filippi, Massimo] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Div Neurosci, Dept Neurol,Inst Expt Neurol, Milan, Italy; [Copetti, Massimiliano] IRCCS Osped Casa Sollievo Sofferenza, Biostat Unit, San Giovanni Rotondo, Italy; [Prelle, Alessandro] Osped Maggiore Crema, Neurol Unit, Crema, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Casa Sollievo Della Sofferenza	Agosta, F (corresponding author), Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Div Neurosci, Neuroimaging Res Unit,Inst Expt Neurol, Milan, Italy.	filippi.massimo@hsr.it	Riva, Nilo/J-7187-2012; Agosta, Federica/J-9908-2016; Valsasina, Paola/K-5820-2016; Filippi, Massimo/K-1755-2018; COPETTI, MASSIMILIANO/K-3186-2016	Riva, Nilo/0000-0002-0513-9517; prelle, alessandro/0000-0002-7019-5291; Agosta, Federica/0000-0003-3121-4979; Valsasina, Paola/0000-0001-5390-2655; Filippi, Massimo/0000-0002-5485-0479; COPETTI, MASSIMILIANO/0000-0002-7960-5947				Agosta F, 2007, HUM BRAIN MAPP, V28, P1430, DOI 10.1002/hbm.20364; Agosta F, 2010, AM J NEURORADIOL, V31, P1769, DOI 10.3174/ajnr.A2043; Agosta F, 2010, AM J NEURORADIOL, V31, P1457, DOI 10.3174/ajnr.A2105; Bakkour A, 2009, NEUROLOGY, V72, P1048, DOI 10.1212/01.wnl.0000340981.97664.2f; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Ciccarelli O, 2006, BRAIN, V129, P1859, DOI 10.1093/brain/awl100; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Eisen A, 2001, MUSCLE NERVE, V24, P564, DOI 10.1002/mus.1042; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558; Gredal O, 2000, J NEUROSCI METH, V95, P171, DOI 10.1016/S0165-0270(99)00175-2; Greenland S, 1983, Stat Med, V2, P243, DOI 10.1002/sim.4780020219; Grosskreutz J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-17; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hardan AY, 2006, AM J PSYCHIAT, V163, P1290, DOI 10.1176/appi.ajp.163.7.1290; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Ince PG, 1998, NEUROPATH APPL NEURO, V24, P104, DOI 10.1046/j.1365-2990.1998.00108.x; Jubault T, 2011, NEUROIMAGE, V55, P462, DOI 10.1016/j.neuroimage.2010.12.043; Kassubek J, 2005, AMYOTROPH LATERAL SC, V6, P213, DOI 10.1080/14660820510038538; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Maekawa S, 2004, BRAIN, V127, P1237, DOI 10.1093/brain/awh132; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Roccatagliata L, 2009, AMYOTROPH LATERAL SC, V10, P47, DOI 10.1080/17482960802267530; TSERMENTSELI S, 2011, CORTEX; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Verstraete E, 2011, J NEUROL NEUROSURG P; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664	41	89	92	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42816	10.1371/journal.pone.0042816	http://dx.doi.org/10.1371/journal.pone.0042816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880116	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000075
J	Kim, ST; Adair-Kirk, TL; Senior, RM; Miner, JH				Kim, Sung Tae; Adair-Kirk, Tracy L.; Senior, Robert M.; Miner, Jeffrey H.			Functional Consequences of Cell Type-Restricted Expression of Laminin alpha 5 in Mouse Placental Labyrinth and Kidney Glomerular Capillaries	PLOS ONE			English	Article							MUTANT MICE; BASEMENT-MEMBRANE; CHAIN; MORPHOGENESIS; LAMININ-ALPHA-5; ABNORMALITIES; LOCALIZATION; MATURATION; MIGRATION; DELETION	The labyrinth is the highly vascularized part of the rodent placenta that allows efficient transfer of gases, nutrients, wastes, and other molecules between the maternal and embryonic circulations. These two blood compartments are separated by blastocyst-derived trophoblasts and endothelial cells with an intervening basement membrane that contains laminin and other typical basement membrane components. Previously we reported that the labyrinth of laminin alpha 5 knockout (LM alpha 5-/-) embryos exhibits reduced vascularization and detachment of endothelial cells from the basement membrane, which normally contains LM alpha 5. As very little is known about the origin of this vascular basement membrane, we investigated the cellular requirements for LM alpha 5 expression in the mouse placental labyrinth. By fluorescence-activated cell sorting and RTPCR we confirmed that both endothelial cells and trophoblasts normally express LM alpha 5. Using Cre-loxP technology and doxycycline-mediated gene expression, we generated genetically mosaic placentas in which either the trophoblasts or the endothelial cells, but not both, expressed LM alpha 5. We found that the overall architecture of the labyrinth was normal as long as one of these two cell types expressed LM alpha 5, even if it was transgene-derived human laminin alpha 5. These results suggest that laminin trimers containing alpha 5 that are synthesized and secreted by endothelium or by trophoblasts are capable of integrating into the basement membrane and promoting normal vascularization of the placenta. Additional studies showed that endothelium-expressed human LM alpha 5 can support vascularization of the kidney glomerulus, consistent with previous studies using a tissue grafting approach.	[Kim, Sung Tae; Miner, Jeffrey H.] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA; [Adair-Kirk, Tracy L.; Senior, Robert M.] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Senior, Robert M.; Miner, Jeffrey H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kim, ST (corresponding author), Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA.	minerj@wustl.edu			National Institutes of Health [R01GM060432, R01DK078314, P01HL029594]; Washington University George M. O'Brien Center for Kidney Disease Research [NIH P30DK079333]; Washington University Department of Otolaryngology, Research Center for Auditory and Visual Studies [NIH P30DC004665]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079333, R01DK078314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University George M. O'Brien Center for Kidney Disease Research; Washington University Department of Otolaryngology, Research Center for Auditory and Visual Studies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	These studies were supported by grants from the National Institutes of Health (R01GM060432 and R01DK078314 to JHM; P01HL029594 to RMS). Imaging and transgenic mouse studies were supported by the Washington University George M. O'Brien Center for Kidney Disease Research (NIH P30DK079333) and by the Washington University Department of Otolaryngology, Research Center for Auditory and Visual Studies (NIH P30DC004665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2007, J AM SOC NEPHROL, V18, P2285, DOI 10.1681/ASN.2007020207; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Coles EG, 2006, DEV BIOL, V289, P218, DOI 10.1016/j.ydbio.2005.10.031; ENGVALL E, 1986, J CELL BIOL, V103, P2457, DOI 10.1083/jcb.103.6.2457; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; Goldberg S, 2010, J AM SOC NEPHROL, V21, P579, DOI 10.1681/ASN.2009091004; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Jarad G, 2006, J CLIN INVEST, V116, P2272, DOI 10.1172/JCI28414; Kikkawa Y, 2006, DEV BIOL, V296, P265, DOI 10.1016/j.ydbio.2006.04.463; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Korhonen M, 2001, J HISTOCHEM CYTOCHEM, V49, P313, DOI 10.1177/002215540104900305; Mahoney ZX, 2008, J CELL SCI, V121, P2493, DOI 10.1242/jcs.025528; Miner JH, 2006, DEVELOPMENT, V133, P967, DOI 10.1242/dev.02270; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; MINER JH, 1995, J BIOL CHEM, V270, P28523, DOI 10.1074/jbc.270.48.28523; Miner JH, 2000, DEV BIOL, V217, P278, DOI 10.1006/dbio.1999.9546; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Nguyen NM, 2002, DEV BIOL, V246, P231, DOI 10.1006/dbio.2002.0658; Nguyet NM, 2005, DEV BIOL, V282, P111, DOI 10.1016/j.ydbio.2005.02.031; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Rebustini IT, 2007, DEV BIOL, V308, P15, DOI 10.1016/j.ydbio.2007.04.031; Shaut CAE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000073; Simmons DG, 2008, DEVELOPMENT, V135, P2083, DOI 10.1242/dev.020099; St John PL, 2001, KIDNEY INT, V60, P1037, DOI 10.1046/j.1523-1755.2001.0600031037.x; Steenhard BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023926; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Tiger CF, 1997, J BIOL CHEM, V272, P28590, DOI 10.1074/jbc.272.45.28590; Wang JM, 2006, J BIOL CHEM, V281, P213, DOI 10.1074/jbc.M505061200; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wulff C, 2003, REPRODUCTION, V126, P569, DOI 10.1530/rep.0.1260569	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41348	10.1371/journal.pone.0041348	http://dx.doi.org/10.1371/journal.pone.0041348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911783	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600073
J	Whiston, E; Wise, HZ; Sharpton, TJ; Jui, G; Cole, GT; Taylor, JW				Whiston, Emily; Wise, Hua Zhang; Sharpton, Thomas J.; Jui, Ginger; Cole, Garry T.; Taylor, John W.			Comparative Transcriptomics of the Saprobic and Parasitic Growth Phases in Coccidioides pp	PLOS ONE			English	Article							HISTOPLASMA-CAPSULATUM; FUNGAL PATHOGEN; POSADASII CONTRIBUTES; CANDIDA-ALBICANS; IMMITIS; VIRULENCE; GENE; EXPRESSION; PROTEIN; ALPHA-(1,3)-GLUCAN	Coccidioides immitis and C. posadasii, the causative agents of coccidioidomycosis, are dimorphic fungal pathogens, which grow as hyphae in the saprobic phase in the environment and as spherules in the parasitic phase in the mammalian host. In this study, we use comparative transcriptomics to identify gene expression differences between the saprobic and parasitic growth phases. We prepared Illumina mRNA sequencing libraries for saprobic-phase hyphae and parasitic-phase spherules in vitro for C. immitis isolate RS and C. posadasii isolate C735 in biological triplicate. Of 9,910 total predicted genes in Coccidioides, we observed 1,298 genes up-regulated in the saprobic phase of both C. immitis and C. posadasii and 1,880 genes up-regulated in the parasitic phase of both species. Comparing the saprobic and parasitic growth phases, we observed considerable differential expression of cell surface-associated genes, particularly chitin-related genes. We also observed differential expression of several virulence factors previously identified in Coccidioides and other dimorphic fungal pathogens. These included alpha (1,3) glucan synthase, SOWgp, and several genes in the urease pathway. Furthermore, we observed differential expression in many genes predicted to be under positive selection in two recent Coccidioides comparative genomics studies. These results highlight a number of genes that may be crucial to dimorphic phase-switching and virulence in Coccidioides. These observations will impact priorities for future genetics-based studies in Coccidioides and provide context for studies in other fungal pathogens.	[Whiston, Emily; Jui, Ginger; Taylor, John W.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Wise, Hua Zhang; Cole, Garry T.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Sharpton, Thomas J.] Univ Calif San Francisco, J David Gladstone Inst, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of Texas System; University of Texas at San Antonio (UTSA); University of California System; University of California San Francisco; The J David Gladstone Institutes	Whiston, E (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	whiston@berkeley.edu	Pacific-Southwest, RCE/B-6155-2009	Sharpton, Thomas/0000-0002-5996-7764	National Institutes of Health [NIH-NIAID 1R01AI070891, NIH-U54-AI65359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070891, U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors received funding from the National Institutes of Health with grants NIH-NIAID 1R01AI070891 and NIH-U54-AI65359. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampel NM, 2010, MYCOPATHOLOGIA, V169, P425, DOI 10.1007/s11046-010-9285-6; ANDERS S, 2010, GENOME BIOL, V11; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bayram OS, 2010, LAEA CONTROL VELVET; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Borchers AT, 2010, AUTOIMMUN REV, V10, P94, DOI 10.1016/j.autrev.2010.08.010; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Center for Disease Control, 2010, CDC COCC GEN INF NCZ; Chanda A, 2009, P NATL ACAD SCI USA, V106, P19533, DOI 10.1073/pnas.0907416106; Cole GT., 1985, FUNGAL DIMORPHISM, P281, DOI [10.1007/978-1-4684-4982-2_12, DOI 10.1007/978-1-4684-4982-2_12]; Delgado N, 2003, INFECT IMMUN, V71, P3010, DOI 10.1128/IAI.71.6.3010-3019.2003; DEWEY C, 2006, WHOLE GENOME ALIGNME; Dewey Colin N., 2007, V395, P221; Dixon DM, 2001, J APPL MICROBIOL, V91, P602, DOI 10.1046/j.1365-2672.2001.01496.x; Fisher BT, 2010, PEDIATR INFECT DIS J, V29, P243, DOI 10.1097/INF.0b013e3181bcfd7f; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Fisher MC, 2000, J CLIN MICROBIOL, V38, P807, DOI 10.1128/JCM.38.2.807-813.2000; Grumbt M, 2011, FEMS MICROBIOL LETT, V320, P79, DOI 10.1111/j.1574-6968.2011.02276.x; Guevara-Olvera L, 2000, GENE, V242, P437, DOI 10.1016/S0378-1119(99)00496-5; Hashizume K, 2009, MOL BIOL CELL, V20, P4673, DOI 10.1091/mbc.E09-02-0172; Hector RF, 2011, INT J ENV RES PUB HE, V8, P1150, DOI 10.3390/ijerph8041150; Herr RA, 2007, INFECT IMMUN, V75, P5777, DOI 10.1128/IAI.00807-07; HOGAN LH, 1994, INFECT IMMUN, V62, P3543, DOI 10.1128/IAI.62.8.3543-3546.1994; Huang GH, 2006, P NATL ACAD SCI USA, V103, P12813, DOI 10.1073/pnas.0605270103; Hung CY, 2005, INFECT IMMUN, V73, P6689, DOI 10.1128/IAI.73.10.6689-6703.2005; Hung CY, 2000, INFECT IMMUN, V68, P584, DOI 10.1128/IAI.68.2.584-593.2000; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; Jedd G, 2000, NAT CELL BIOL, V2, P226, DOI 10.1038/35008652; Johannesson H, 2006, FUNGAL GENET BIOL, V43, P545, DOI 10.1016/j.fgb.2006.02.003; Johannesson H, 2005, GENETICS, V171, P109, DOI 10.1534/genetics.105.040923; KIRKLAND TN, 1991, INFECT IMMUN, V59, P3952, DOI 10.1128/IAI.59.11.3952-3961.1991; Klein BS, 2007, CURR OPIN MICROBIOL, V10, P314, DOI 10.1016/j.mib.2007.04.002; KLIMPEL KR, 1988, INFECT IMMUN, V56, P2997, DOI 10.1128/IAI.56.11.2997-3000.1988; LEVINE HB, 1961, J IMMUNOL, V87, P218; Martin R, 2011, INT J MED MICROBIOL, V301, P417, DOI 10.1016/j.ijmm.2011.04.009; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; Mirbod-Donovan F, 2006, INFECT IMMUN, V74, P504, DOI 10.1128/IAI.74.1.504-515.2006; Mulder HJ, 2004, MOL GENET GENOMICS, V271, P130, DOI 10.1007/s00438-003-0965-5; Neafsey DE, 2010, GENOME RES, V20, P938, DOI 10.1101/gr.103911.109; Nemecek JC, 2006, SCIENCE, V312, P583, DOI 10.1126/science.1124105; Nguyen VQ, 2008, P NATL ACAD SCI USA, V105, P4880, DOI 10.1073/pnas.0710448105; Nunes LR, 2005, EUKARYOT CELL, V4, P2115, DOI 10.1128/EC.4.12.2115-2128.2005; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Rappleye CA, 2006, ANNU REV MICROBIOL, V60, P281, DOI 10.1146/annurev.micro.59.030804.121055; Ruiz-Herrera J., 2003, Current Drug Targets - Infectious Disorders, V3, P77, DOI 10.2174/1568005033342064; SANBLAS G, 1977, INFECT IMMUN, V15, P343, DOI 10.1128/IAI.15.2.343-346.1977; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Smit A, 1996, REPEATMASKER OPEN 30; Sudhof TC, 2009, MEMBRANE FUSION GRAP; Tan KC, 2009, MOL PLANT PATHOL, V10, P703, DOI [10.1111/J.1364-3703.2009.00565.X, 10.1111/j.1364-3703.2009.00565.x]; Taylor JW, 2003, CURR OPIN MICROBIOL, V6, P351, DOI 10.1016/S1369-5274(03)00088-2; Tenney K, 2000, FUNGAL GENET BIOL, V31, P205, DOI 10.1006/fgbi.2000.1230; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Viriyakosol S., 2005, INFECT IMMUN, V73, P1553; Webster RH, 2008, P NATL ACAD SCI USA, V105, P14573, DOI 10.1073/pnas.0806221105; Wu X, 2001, MOL GENET GENOMICS, V265, P622, DOI 10.1007/s004380100455; WYCKOFF EE, 1995, GENE, V161, P107, DOI 10.1016/0378-1119(95)00250-A; Zaragoza O, 2010, PLOS PATHOG, V6, P18	62	50	50	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41034	10.1371/journal.pone.0041034	http://dx.doi.org/10.1371/journal.pone.0041034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911737	Green Submitted, gold, Green Published			2022-12-27	WOS:000306644600041
J	Benslimane, N; Hassan, GS; Yacoub, D; Mourad, W				Benslimane, Nadir; Hassan, Ghada S.; Yacoub, Daniel; Mourad, Walid			Requirement of Transmembrane Domain for CD154 Association to Lipid Rafts and Subsequent Biological Events	PLOS ONE			English	Article							CELL ANTIGEN RECEPTOR; CD4(+) T-LYMPHOCYTES; CD40 LIGAND; SIGNALING PATHWAYS; ACTIVATION; CHOLESTEROL; TRIGGERS; PHOSPHORYLATION; INTEGRIN	Interaction of CD40 with CD154 leads to recruitment of both molecules into lipid rafts, resulting in bi-directional cell activation. The precise mechanism by which CD154 is translocated into lipid rafts and its impact on CD154 signaling remain largely unknown. Our aim is to identify the domain of CD154 facilitating its association to lipid rafts and the impact of such association on signaling events and cytokine production. Thus, we generated Jurkat cell lines expressing truncated CD154 lacking the cytoplasmic domain or chimeric CD154 in which the transmembrane domain was replaced by that of transferrin receptor I, known to be excluded from lipid rafts. Our results show that cell stimulation with soluble CD40 leads to the association of CD154 wild-type and CD154-truncated, but not CD154-chimera, with lipid rafts. This is correlated with failure of CD154-chimera to activate Akt and p38 MAP kinases, known effectors of CD154 signaling. We also found that CD154-chimera lost the ability to promote IL-2 production upon T cell stimulation with anti-CD3/CD28 and soluble CD40. These results demonstrate the implication of the transmembrane domain of CD154 in lipid raft association, and that this association is necessary for CD154-mediated Akt and p38 activation with consequent enhancement of IL-2 production.	[Benslimane, Nadir; Hassan, Ghada S.; Yacoub, Daniel; Mourad, Walid] CHU Montreal, Hop St Luc, Lab Immunol Cellulaire & Mol, Montreal, PQ, Canada	Universite de Montreal	Benslimane, N (corresponding author), CHU Montreal, Hop St Luc, Lab Immunol Cellulaire & Mol, Montreal, PQ, Canada.	mw.mourad@umontreal.ca		Mourad, Walid/0000-0002-1859-9387; Hassan, Ghada S./0000-0002-1391-5248	Canadian Institutes of Health Research; Canadian Arthritis Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network	This work was supported by the Canadian Institutes of Health Research (www.cihr.ca) and the Canadian Arthritis Network (www.arthritisnetwork.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Blair PJ, 2000, J EXP MED, V191, P651, DOI 10.1084/jem.191.4.651; Blotta MH, 1996, J IMMUNOL, V156, P3133; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Bouillon M, 2003, J BIOL CHEM, V278, P7099, DOI 10.1074/jbc.M211566200; Brenner B, 1997, BIOCHEM BIOPH RES CO, V239, P11, DOI 10.1006/bbrc.1997.7415; Brenner B, 1997, FEBS LETT, V417, P301, DOI 10.1016/S0014-5793(97)01306-9; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; CAYABYAB M, 1994, J IMMUNOL, V152, P1523; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; El Fakhry Y, 2010, EUR J IMMUNOL, V40, P770, DOI 10.1002/eji.200939646; Grassme H, 2002, J BIOL CHEM, V277, P30289, DOI 10.1074/jbc.M200494200; Hassan Ghada S., 2009, Current Immunology Reviews, V5, P285; Hassan GS, 2009, TRENDS IMMUNOL, V30, P165, DOI 10.1016/j.it.2009.01.004; Hassan GS, 2011, IMMUNOBIOLOGY; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kabouridis PS, 2008, FEBS LETT, V582, P3711, DOI 10.1016/j.febslet.2008.10.006; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kiani-Alikhan S, 2011, J CLIN IMMUNOL; Langlet C, 2000, CURR OPIN IMMUNOL, V12, P250, DOI 10.1016/S0952-7915(00)00084-4; Leveille C, 2007, J BIOL CHEM, V282, P5143, DOI 10.1074/jbc.M608342200; Mahammad S, 2008, BBA-BIOMEMBRANES, V1778, P1251, DOI 10.1016/j.bbamem.2008.02.010; Matsuda S, 1998, J BIOL CHEM, V273, P12378, DOI 10.1074/jbc.273.20.12378; Mikolajczak SA, 2004, J EXP MED, V199, P1025, DOI 10.1084/jem.20031705; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Nadiri A, 2011, EUR J IMMUNOL, V41, P2358, DOI 10.1002/eji.201041143; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; PERSCHL A, 1995, J CELL SCI, V108, P1033; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Reyes-Moreno C, 2007, J BIOL CHEM, V282, P19473, DOI 10.1074/jbc.M701076200; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yu TC, 2004, ACTA BIOCH BIOPH SIN, V36, P741, DOI 10.1093/abbs/36.11.741; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43070	10.1371/journal.pone.0043070	http://dx.doi.org/10.1371/journal.pone.0043070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905203	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500800042
J	Morrison, GJ; Ganesan, R; Qin, ZX; Aswad, DW				Morrison, Gareth J.; Ganesan, Ranjani; Qin, Zhenxia; Aswad, Dana W.			Considerations in the Identification of Endogenous Substrates for Protein L-Isoaspartyl Methyltransferase: The Case of Synuclein	PLOS ONE			English	Article							CARBOXYL METHYLTRANSFERASE; O-METHYLTRANSFERASE; REPAIR ENZYME; ASPARTYL RESIDUES; DAMAGED PROTEINS; HISTONE H2B; DEAMIDATION; METHYLATION; MICE; PEPTIDES	Protein L-isoaspartyl methyltransferase (PIMT) repairs abnormal isoaspartyl peptide bonds in age-damaged proteins. It has been reported that synuclein, a protein implicated in neurodegenerative diseases, is a major target of PIMT in mouse brain. To extend this finding and explore its possible relevance to neurodegenerative diseases, we attempted to determine the stoichiometry of isoaspartate accumulation in synuclein in vivo and in vitro. Brain proteins from PIMT knockout mice were separated by 2D electrophoresis followed by on-blot [H-3]-methylation to label isoaspartyl proteins, and by immunoblotting to confirm the coincident presence of synuclein. On-blot H-3-methylation revealed numerous isoaspartyl proteins, but no signal in the position of synuclein. This finding was corroborated by immunoprecipitation of synuclein followed by on-blot H-3-methylation. To assess the propensity of synuclein to form isoaspartyl sites in vitro, samples of recombinant mouse and human alpha-synucleins were aged for two weeks by incubation at pH 7.5 and 37 degrees C. The stoichiometries of isoaspartate accumulation were extremely low at 0.02 and 0.07 mol of isoaspartate per mol of protein respectively. Using a simple mathematical model based on the first order kinetics of isoaspartyl protein methyl ester hydrolysis, we ascribe the discrepancy between our results and the previous report to methodological limitations of the latter stemming from an inherent, and somewhat counterintuitive, relationship between the propensity of proteins to form isoaspartyl sites and the instability of the H-3-methyl esters used to tag them. The results presented here indicate that synuclein is not a major target of PIMT in vivo, and emphasize the need to minimize methyl ester hydrolysis when using methylation to assess the abundance of isoaspartyl sites in proteins.	[Morrison, Gareth J.; Ganesan, Ranjani; Qin, Zhenxia; Aswad, Dana W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	University of California System; University of California Irvine	Morrison, GJ (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	dwaswad@uci.edu			National Institutes of Health [NS-17269]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grant NS-17269 to Dana W. Aswad. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro JF, 2008, ANAL CHEM, V80, P3882, DOI 10.1021/ac800251q; ASWAD DW, 1984, J BIOL CHEM, V259, P714; AXELROD J, 1965, SCIENCE, V150, P892, DOI 10.1126/science.150.3698.892; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Diepold K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030295; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; Doyle HA, 2007, AUTOIMMUNITY, V40, P131, DOI 10.1080/08916930601165180; Furuchi T, 2010, CHEM BIODIVERS, V7, P1337, DOI 10.1002/cbdv.200900273; GALLETTI P, 1988, BIOCHEMISTRY-US, V27, P1752, DOI 10.1021/bi00405a055; GEIGER T, 1987, J BIOL CHEM, V262, P785; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1993, J BIOL CHEM, V268, P6174; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; JOHNSON BA, 1985, BIOCHEMISTRY-US, V24, P2581, DOI 10.1021/bi00331a028; JOHNSON BA, 1989, ARCH BIOCHEM BIOPHYS, V268, P276, DOI 10.1016/0003-9861(89)90589-4; JOHNSON BA, 1989, J BIOL CHEM, V264, P14262; Khoury MK, 2010, ANAL BIOCHEM, V397, P129, DOI 10.1016/j.ab.2009.09.041; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kim E, 1999, J BIOL CHEM, V274, P20671, DOI 10.1074/jbc.274.29.20671; Lees JE, 1999, ELECTROPHORESIS, V20, P2139, DOI 10.1002/(SICI)1522-2683(19990701)20:10<2139::AID-ELPS2139>3.0.CO;2-R; Lindner H, 2001, EXP GERONTOL, V36, P1551, DOI 10.1016/S0531-5565(01)00140-1; LINDQUIST JA, 1994, J PROTEIN CHEM, V13, P553, DOI 10.1007/BF01901537; Liu M, 2012, ANAL CHEM, V84, P1056, DOI 10.1021/ac202652z; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; MURRAY ED, 1984, J BIOL CHEM, V259, P722; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; Robinson NE, 2004, J PEPT RES, V63, P426, DOI 10.1111/j.1399-3011.2004.00151.x; Robinson NE, 2009, PROTEIN SCI, V18, P1766, DOI 10.1002/pro.183; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Vigneswara V, 2006, J BIOL CHEM, V281, P32619, DOI 10.1074/jbc.M605421200; Vitali R, 2004, BEHAV BRAIN RES, V153, P129, DOI 10.1016/j.bbr.2003.11.007; Volkin DB, 1997, MOL BIOTECHNOL, V8, P105, DOI 10.1007/BF02752255; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Young AL, 2001, J BIOL CHEM, V276, P37161, DOI 10.1074/jbc.M106682200; Young GW, 2005, J BIOL CHEM, V280, P26094, DOI 10.1074/jbc.M503624200; Zhu JX, 2007, ANAL BIOCHEM, V364, P1, DOI 10.1016/j.ab.2007.02.013; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	41	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43288	10.1371/journal.pone.0043288	http://dx.doi.org/10.1371/journal.pone.0043288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905247	Green Published, gold			2022-12-27	WOS:000307500800072
J	Birkett, EE; Talcott, JB				Birkett, Emma E.; Talcott, Joel B.			Interval Timing in Children: Effects of Auditory and Visual Pacing Stimuli and Relationships with Reading and Attention Variables	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; DEFICIT/HYPERACTIVITY DISORDER; DEVELOPMENTAL DYSLEXIA; PARKINSONS-DISEASE; FUNCTIONAL MRI; MOTOR; RHYTHMS; SYNCHRONIZATION; COORDINATION; VARIABILITY	Motor timing tasks have been employed in studies of neurodevelopmental disorders such as developmental dyslexia and ADHD, where they provide an index of temporal processing ability. Investigations of these disorders have used different stimulus parameters within the motor timing tasks that are likely to affect performance measures. Here we assessed the effect of auditory and visual pacing stimuli on synchronised motor timing performance and its relationship with cognitive and behavioural predictors that are commonly used in the diagnosis of these highly prevalent developmental disorders. Twenty-one children (mean age 9.6 years) completed a finger tapping task in two stimulus conditions, together with additional psychometric measures. As anticipated, synchronisation to the beat (ISI 329 ms) was less accurate in the visually paced condition. Decomposition of timing variance indicated that this effect resulted from differences in the way that visual and auditory paced tasks are processed by central timekeeping and associated peripheral implementation systems. The ability to utilise an efficient processing strategy on the visual task correlated with both reading and sustained attention skills. Dissociations between these patterns of relationship across task modality suggest that not all timing tasks are equivalent.	[Birkett, Emma E.; Talcott, Joel B.] Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Aston University	Birkett, EE (corresponding author), Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	j.b.talcott@aston.ac.uk	Hassan, Randa/AAW-3624-2021; Birkett, Emma/J-7398-2017	Birkett, Emma/0000-0001-8358-3085	Economic and Social Research Council [ES/G013845/1]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Economic and Social Research Council (grant number ES/G013845/1, www.esrc.ac.uk). The funders had no role in study design, data collection, data analysis, decision to publish, nor preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barkley RA, 2006, ATTENTION DEFICIT HY; Ben-Pazi H, 2006, NEUROPSYCHOLOGIA, V44, P412, DOI 10.1016/j.neuropsychologia.2005.05.022; Ben-Pazi H, 2003, DEV MED CHILD NEUROL, V45, P743, DOI 10.1017/S0012162203001385; Bridgeman B, 1998, PSYCHOL SCI, V9, P232, DOI 10.1111/1467-9280.00045; Collier GL, 2004, J EXP PSYCHOL HUMAN, V30, P853, DOI 10.1037/0096-1523.30.5.853; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Duchek J.M., 1994, NEUROPSYCHOLOGY, V8, P218, DOI [DOI 10.1037/0894-4105.8.2.218, 10.1037/0894-4105.8.2.218]; Elliott MT, 2010, EUR J NEUROSCI, V31, P1828, DOI 10.1111/j.1460-9568.2010.07205.x; Elze T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012792; Farmer ME, 1995, PSYCHON B REV, V2, P460, DOI 10.3758/BF03210983; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Forsman LJ, 2009, PERS INDIV DIFFER, V47, P229, DOI 10.1016/j.paid.2009.02.020; Freeman J S, 1996, Parkinsonism Relat Disord, V2, P81, DOI 10.1016/1353-8020(96)00009-0; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Grahn JA, 2012, EXP BRAIN RES, V220, P51, DOI 10.1007/s00221-012-3114-8; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Heron J, 2010, EUR J NEUROSCI, V31, P1755, DOI 10.1111/j.1460-9568.2010.07194.x; Hulslander J, 2004, J EXP CHILD PSYCHOL, V88, P274, DOI 10.1016/j.jecp.2004.03.006; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P51, DOI 10.1016/S0926-6410(00)00022-7; Jantzen KJ, 2005, NEUROIMAGE, V25, P1031, DOI 10.1016/j.neuroimage.2004.12.029; Kato M, 2006, BRAIN RES, V1084, P115, DOI 10.1016/j.brainres.2006.02.019; Klein R. M., 2002, READING WRITING INTE, V15, P207, DOI [DOI 10.1023/A:1013828723016, 10.1023/A:1013828723016]; KOLERS PA, 1985, J EXP PSYCHOL HUMAN, V11, P150, DOI 10.1037/0096-1523.11.2.150; Kooistra L, 1997, ACTA PSYCHOL, V96, P61, DOI 10.1016/S0001-6918(96)00047-9; Loras H, 2012, EXP BRAIN RES, V220, P335, DOI 10.1007/s00221-012-3142-4; Madison G, 2001, J EXP PSYCHOL HUMAN, V27, P411, DOI 10.1037/0096-1523.27.2.411; Madison G, 2011, NATURE REV NEUROSCIE, P175, DOI [10.1007/s00221-011-2817-6, DOI 10.1007/S00221-011-2817-6]; Madison G, 2009, INTELLIGENCE, V37, P68, DOI 10.1016/j.intell.2008.07.006; Manly T., 1999, TEST EVERYDAY ATTENT; McAuley JD, 2010, ATTEN PERCEPT PSYCHO, V72, P1377, DOI 10.3758/APP.72.5.1377; McGrath LM, 2011, J CHILD PSYCHOL PSYC, V52, P547, DOI 10.1111/j.1469-7610.2010.02346.x; Overy K, 2003, DYSLEXIA, V9, P18, DOI 10.1002/dys.233; PASTOR MA, 1992, BRAIN, V115, P875, DOI 10.1093/brain/115.3.875; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Pauc R, 2005, CLIN CHIROPR, V8, P189, DOI [10.1016/j.clch.2005.09.007, DOI 10.1016/J.CLCH.2005.09.007]; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Pitcher TM, 2002, HUM MOVEMENT SCI, V21, P919, DOI 10.1016/S0167-9457(02)00167-7; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Rubia K, 2003, J ABNORM CHILD PSYCH, V31, P301, DOI 10.1023/A:1023233630774; Rubia K, 2001, BRIT J PSYCHIAT, V179, P138, DOI 10.1192/bjp.179.2.138; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Rubia K, 2009, PHILOS T R SOC B, V364, P1919, DOI 10.1098/rstb.2009.0014; Schneider W, 2002, E PRIME; Share DL, 2002, PERCEPTION, P151; Tabachnick B. G., 2001, USING MULTIVARIATE S; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Thomson JM, 2008, J PHYSIOL-PARIS, V102, P120, DOI 10.1016/j.jphysparis.2008.03.007; Thomson JM, 2006, J RES READ, V29, P334, DOI 10.1111/j.1467-9817.2006.00312.x; Toplak ME, 2006, J NEUROSCI METH, V151, P15, DOI 10.1016/j.jneumeth.2005.09.018; Toplak ME, 2005, PERCEPT MOTOR SKILL, V100, P659, DOI 10.2466/PMS.100.3.659-675; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; Waber DP, 2000, DEV NEUROPSYCHOL, V17, P181, DOI 10.1207/S15326942DN1702_03; Wechsler D., 2009, WECHSLER INDIVIDUAL, V3rd; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Willcutt EG, 2000, J LEARN DISABIL, V33, P179, DOI 10.1177/002221940003300206; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3; Wolff P.H., 2002, READ WRIT, V15, P179, DOI [10.1023/A:1013880723925, DOI 10.1023/A:1013880723925, 10.1023/a:1013880723925]; WOLFF PH, 1984, NEUROPSYCHOLOGIA, V22, P587, DOI 10.1016/0028-3932(84)90023-X; WOLFF PH, 1990, DEV PSYCHOL, V26, P349, DOI 10.1037/0012-1649.26.3.349; Zelaznik HN, 2012, HUM MOVEMENT SCI, V31, P255, DOI 10.1016/j.humov.2011.05.003	65	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42820	10.1371/journal.pone.0042820	http://dx.doi.org/10.1371/journal.pone.0042820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986XO	22900054	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000307380900072
J	Hasan, MZ; Kamil, AA; Mustafa, A; Baten, MA				Hasan, Md. Zobaer; Kamil, Anton Abdulbasah; Mustafa, Adli; Baten, Md. Azizul			A Cobb Douglas Stochastic Frontier Model on Measuring Domestic Bank Efficiency in Malaysia	PLOS ONE			English	Article							FUTURE-RESEARCH; INDUSTRY	Banking system plays an important role in the economic development of any country. Domestic banks, which are the main components of the banking system, have to be efficient; otherwise, they may create obstacle in the process of development in any economy. This study examines the technical efficiency of the Malaysian domestic banks listed in the Kuala Lumpur Stock Exchange (KLSE) market over the period 2005-2010. A parametric approach, Stochastic Frontier Approach (SFA), is used in this analysis. The findings show that Malaysian domestic banks have exhibited an average overall efficiency of 94 percent, implying that sample banks have wasted an average of 6 percent of their inputs. Among the banks, RHBCAP is found to be highly efficient with a score of 0.986 and PBBANK is noted to have the lowest efficiency with a score of 0.918. The results also show that the level of efficiency has increased during the period of study, and that the technical efficiency effect has fluctuated considerably over time.	[Hasan, Md. Zobaer; Kamil, Anton Abdulbasah] Univ Sains Malaysia, Sch Distance Educ, Math Sect, George Town, Malaysia; [Mustafa, Adli] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia; [Baten, Md. Azizul] Univ Utara Malaysia, Sch Quantitat Sci, Dept Decis Sci, Darul Aman, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Utara Malaysia	Hasan, MZ (corresponding author), Univ Sains Malaysia, Sch Distance Educ, Math Sect, George Town, Malaysia.	jubaerha09@gmail.com	Kamil, Anton Abdulbasah/A-9795-2011	Kamil, Anton Abdulbasah/0000-0001-5410-812X; Baten, Md. Azizul/0000-0001-9786-6369; Mustafa, Adli/0000-0003-0989-674X; HASAN, MD ZOBAER/0000-0002-6378-6333				Aigner D, 1977, J ECONOMETRICS, V6, P21, DOI DOI 10.1016/0304-4076(77)90052-5; ALY HY, 1990, REV ECON STAT, V72, P211, DOI 10.2307/2109710; [Anonymous], APPL FINANCIAL EC; Battese GE., 1992, J PROD ANAL, V3, P153, DOI DOI 10.1007/BF00158774; Berger A. N., 1992, MEASUREMENT EFFICIEN; Berger AN, 1997, EUR J OPER RES, V98, P175, DOI 10.1016/S0377-2217(96)00342-6; Boscia V., 1999, RES PAPERS BANKING F; Coelli T., 1996, GUIDE FRONTIER VERSI; Coelli TJ, 1998, ITNRO EFFICIENCY PRO; Das A., 2005, EC POLIT WKLY, V40, P1190; Das A., 1997, RBI OCCASIONAL PAPER, V18, P279; De PK, 2004, INDIAN ECON REV, V34, P261; ELYASIANI E, 1990, APPL ECON, V22, P539, DOI 10.1080/00036849000000010; Fadzlan S., 2005, ICFAI J BANK MANAGEM, V4, P16; Karim M. Z. A., 2001, ASEAN EC B, P289, DOI DOI 10.2307/25773688; Katib MN, 2000, SINGAP ECON REV, V44, P89; KIRKLEY JE, 1995, AM J AGR ECON, V77, P686, DOI 10.2307/1243235; Koetter M., 2005, DISCUSSION PAPER SER, V2; Kumbhakar SC, 2003, J MONEY CREDIT BANK, V35, P403, DOI 10.1353/mcb.2003.0020; Kwan SH, 1996, FEDERAL RESERVE BANK; Lovell C.A.K., 1993, MEASUREMENT PRODUCTI; Lovell Knox C.A., 2000, STOCHASTIC FRONTIER; Lozano-Vivas A, 1997, EUR J OPER RES, V98, P381; Mahesh HP, 2006, LIBERALIZATION PRODU; Olesen OB, 1996, J PROD ANAL, V7, P87, DOI 10.1007/BF00157036; Ray, 2004, EC POLIT WKLY, V39, P1271; Satish V., 2003, PRAJNAN, V21, P275; Sensarma R., 2005, ECON POLIT WEEKLY, P1198; Shanmugam KR, 2001, ASIA AFR J EC ECONOM, V1, P211; Sherman H. D., 1985, J BANK FINANC, V9, P279; Sufian F., 2004, INT J APPL EC QUANT, V1, P53	31	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42215	10.1371/journal.pone.0042215	http://dx.doi.org/10.1371/journal.pone.0042215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986XO	22900009	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000307380900025
J	Richey, EA; Qin, HM				Richey, Elizabeth A.; Qin, Hongmin			Dissecting the Sequential Assembly and Localization of Intraflagellar Transport Particle Complex B in Chlamydomonas	PLOS ONE			English	Article							SENSORY CILIA; CAENORHABDITIS-ELEGANS; IFT PARTICLES; CELLS ANTENNA; DISEASE GENE; KINESIN-II; BASAL BODY; C-ELEGANS; PROTEIN; REINHARDTII	Intraflagellar transport (IFT), the key mechanism for ciliogenesis, involves large protein particles moving bi-directionally along the entire ciliary length. IFT particles contain two large protein complexes, A and B, which are constructed with proteins in a core and several peripheral proteins. Prior studies have shown that in Chlamydomonas reinhardtii, IFT46, IFT52, and IFT88 directly interact with each other and are in a subcomplex of the IFT B core. However, ift46, bld1, and ift88 mutants differ in phenotype as ift46 mutants are able to form short flagella, while the other two lack flagella completely. In this study, we investigated the functional differences of these individual IFT proteins contributing to complex B assembly, stability, and basal body localization. We found that complex B is completely disrupted in bld1 mutant, indicating an essential role of IFT52 for complex B core assembly. Ift46 mutant cells are capable of assembling a relatively intact complex B, but such complex is highly unstable and prone to degradation. In contrast, in ift88 mutant cells the complex B core still assembles and remains stable, but the peripheral proteins no longer attach to the B core. Moreover, in ift88 mutant cells, while complex A and the anterograde IFT motor FLA10 are localized normally to the transition fibers, complex B proteins instead are accumulated at the proximal ends of the basal bodies. In addition, in bld2 mutant, the IFT complex B proteins still localize to the proximal ends of defective centrioles which completely lack transition fibers. Taken together, these results revealed a step-wise assembly process for complex B, and showed that the complex first localizes to the proximal end of the centrioles and then translocates onto the transition fibers via an IFT88-dependent mechanism.	[Richey, Elizabeth A.; Qin, Hongmin] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Richey, EA (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	hqin@bio.tamu.edu		Qin, Hongmin/0000-0002-0045-5780	National Science Foundation [MCB-0923835]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation Grant MCB-0923835 to H. Qin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Behal RH, 2012, J BIOL CHEM, V287, P11689, DOI 10.1074/jbc.M111.287102; Bell LR, 2006, GENETICS, V173, P1275, DOI 10.1534/genetics.106.056721; Bhogaraju S, 2011, EMBO J; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Dave D, 2009, EUKARYOT CELL, V8, P1397, DOI 10.1128/EC.00378-08; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Delaval B, 2011, NAT CELL BIOL, V13, P461, DOI 10.1038/ncb2202; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; Dutcher SK, 2012, G3-GENES GENOM GENET, V2, P15, DOI 10.1534/g3.111.000919; Engel BD, 2009, J CELL BIOL, V187, P81, DOI 10.1083/jcb.200812084; Fan ZC, 2010, MOL BIOL CELL, V21, P2696, DOI 10.1091/mbc.E10-03-0191; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Kobayashi T, 2007, GENES CELLS, V12, P593, DOI 10.1111/j.1365-2443.2007.01076.x; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; LUCKER BF, 2010, J BIOL CHEM; Mueller J, 2005, MOL BIOL CELL, V16, P1341, DOI 10.1091/mbc.E04-10-0931; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pedersen LB, 2005, CURR BIOL, V15, P262, DOI 10.1016/j.cub.2005.01.037; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pigino G, 2009, J CELL BIOL, V187, P135, DOI 10.1083/jcb.200905103; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Silva DA, 2012, CYTOSKELETON, V69, P33, DOI 10.1002/cm.20546; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Taschner M, 2011, J BIOL CHEM, V286, P26344, DOI 10.1074/jbc.M111.254920; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Williamson SM, 2011, PROTOPLASMA	43	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43118	10.1371/journal.pone.0043118	http://dx.doi.org/10.1371/journal.pone.0043118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900094	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900112
J	Ruiz, XD; Mlakar, LR; Yamaguchi, Y; Su, YY; Larregina, AT; Pilewski, JM; Feghali-Bostwick, CA				Ruiz, Ximena D.; Mlakar, Logan R.; Yamaguchi, Yukie; Su, Yunyun; Larregina, Adriana T.; Pilewski, Joseph M.; Feghali-Bostwick, Carol A.			Syndecan-2 Is a Novel Target of Insulin-Like Growth Factor Binding Protein-3 and Is Over-Expressed in Fibrosis	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; HEPARAN-SULFATE PROTEOGLYCANS; INITIATION-FACTOR 4E; BREAST-CANCER CELLS; FACTOR-BETA; CYTOKINE REGULATION; GENE-EXPRESSION; RETINOIC ACID; ADHESION; FIBROBLASTS	Extracellular matrix deposition and tissue scarring characterize the process of fibrosis. Transforming growth factor beta (TGF beta) and Insulin-like growth factor binding protein-3 (IGFBP-3) have been implicated in the pathogenesis of fibrosis in various tissues by inducing mesenchymal cell proliferation and extracellular matrix deposition. We identified Syndecan-2 (SDC2) as a gene induced by TGF beta in an IGFBP-3-dependent manner. TGF beta induction of SDC2 mRNA and protein required IGFBP-3. IGFBP-3 independently induced production of SDC2 in primary fibroblasts. Using an ex-vivo model of human skin in organ culture expressing IGFBP-3, we demonstrate that IGFBP-3 induces SDC2 ex vivo in human tissue. We also identified Mitogen-activated protein kinase-interacting kinase (Mknk2) as a gene induced by IGFBP-3. IGFBP-3 triggered Mknk2 phosphorylation resulting in its activation. Mknk2 independently induced SDC2 in human skin. Since IGFBP-3 is over-expressed in fibrotic tissues, we examined SDC2 levels in skin and lung tissues of patients with systemic sclerosis (SSc) and lung tissues of patients with idiopathic pulmonary fibrosis (IPF). SDC2 levels were increased in fibrotic dermal and lung tissues of patients with SSc and in lung tissues of patients with IPF. This is the first report describing elevated levels of SDC2 in fibrosis. Increased SDC2 expression is due, at least in part, to the activity of two pro-fibrotic factors, TGF beta and IGFBP-3.	[Ruiz, Ximena D.; Mlakar, Logan R.; Yamaguchi, Yukie; Su, Yunyun; Pilewski, Joseph M.; Feghali-Bostwick, Carol A.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Larregina, Adriana T.] Univ Pittsburgh, Sch Med, Dept Dermatol, Pittsburgh, PA 15261 USA; [Feghali-Bostwick, Carol A.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ruiz, XD (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	feghalica@upmc.edu	Pilewski, Joseph/AAF-5149-2021	Yamaguchi, Yukie/0000-0002-0297-6627	National Institutes of Health [AR050840, P30 DK072506]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health grant AR050840 (CFB) and grant P30 DK072506 (JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTON C, 1995, AM J RESP CRIT CARE, V151, P1597, DOI 10.1164/ajrccm.151.5.7537587; Bayer-Garner IB, 2001, MODERN PATHOL, V14, P1052, DOI 10.1038/modpathol.3880435; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cevikbas F, 2008, MATRIX BIOL, V27, P42, DOI 10.1016/j.matbio.2007.07.003; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Choi S, 2009, BIOCHEM BIOPH RES CO, V384, P231, DOI 10.1016/j.bbrc.2009.04.093; Essner JJ, 2006, INT J BIOCHEM CELL B, V38, P152, DOI 10.1016/j.biocel.2005.08.012; Frangogiannis NG, 2010, HYPERTENSION, V55, P233, DOI 10.1161/HYPERTENSIONAHA.109.147256; Fujishima S, 2010, ARCH PATHOL LAB MED, V134, P1136, DOI 10.1043/2009-0144-OA.1; Galante LL, 2007, J CELL BIOL, V179, P999, DOI 10.1083/jcb.200707150; Gucev ZS, 1996, CANCER RES, V56, P1545; Huang CC, 2005, MODERN PATHOL, V18, P941, DOI 10.1038/modpathol.3800374; Hwa V, 1997, ENDOCRINE, V6, P235, DOI 10.1007/BF02820498; Jiang DH, 2010, J CLIN INVEST, V120, P2049, DOI 10.1172/JCI38644; Klass CM, 2000, J CELL SCI, V113, P493; Kliment CR, 2009, J BIOL CHEM, V284, P3537, DOI 10.1074/jbc.M807001200; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Kuemmerle JF, 2004, AM J PHYSIOL-GASTR L, V287, pG795, DOI 10.1152/ajpgi.00009.2004; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Martin JL, 2006, ENDOCRINOLOGY, V147, P4400, DOI 10.1210/en.2006-0094; MARTIN JL, 1991, ENDOCRINOLOGY, V128, P1425, DOI 10.1210/endo-128-3-1425; Munesue S, 2007, J BIOL CHEM, V282, P28164, DOI 10.1074/jbc.M609812200; OH Y, 1995, J BIOL CHEM, V270, P13589, DOI 10.1074/jbc.270.23.13589; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Ryu HY, 2009, J BIOL CHEM, V284, P35692, DOI 10.1074/jbc.M109.054254; Sadikot RT, 2004, CURR DRUG TARGETS, V5, P581, DOI 10.2174/1389450043345281; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Sebestyen A, 2000, CYTOKINE, V12, P1557, DOI 10.1006/cyto.2000.0754; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Venkatesan N, 2002, AM J PHYSIOL-LUNG C, V283, pL806, DOI 10.1152/ajplung.00061.2002; Villena J, 2003, CELL BIOL INT, V27, P1005, DOI 10.1016/j.cellbi.2003.09.004; Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Worapamorn W, 2002, J PERIODONTAL RES, V37, P273, DOI 10.1034/j.1600-0765.2002.01610.x; Worapamorn W, 2001, J CELL PHYSIOL, V186, P448, DOI 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1047>3.0.CO;2-V; Yasuoka H, 2006, ARTHRITIS RHEUM-US, V54, P3001, DOI 10.1002/art.22084; Yasuoka Hidekata, 2008, Open Rheumatol J, V2, P17, DOI 10.2174/1874312900802010017	44	27	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43049	10.1371/journal.pone.0043049	http://dx.doi.org/10.1371/journal.pone.0043049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900087	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000307380900105
J	Sengupta, A; Foster, SD; Patterson, TA; Bravington, M				Sengupta, Aritra; Foster, Scott D.; Patterson, Toby A.; Bravington, Mark			Accounting for Location Error in Kalman Filters: Integrating Animal Borne Sensor Data into Assimilation Schemes	PLOS ONE			English	Article							TRACKING; FISH	Data assimilation is a crucial aspect of modern oceanography. It allows the future forecasting and backward smoothing of ocean state from the noisy observations. Statistical methods are employed to perform these tasks and are often based on or related to the Kalman filter. Typically Kalman filters assumes that the locations associated with observations are known with certainty. This is reasonable for typical oceanographic measurement methods. Recently, however an alternative and abundant source of data comes from the deployment of ocean sensors on marine animals. This source of data has some attractive properties: unlike traditional oceanographic collection platforms, it is relatively cheap to collect, plentiful, has multiple scientific uses and users, and samples areas of the ocean that are often difficult of costly to sample. However, inherent uncertainty in the location of the observations is a barrier to full utilisation of animal-borne sensor data in data-assimilation schemes. In this article we examine this issue and suggest a simple approximation to explicitly incorporate the location uncertainty, while staying in the scope of Kalman-filter-like methods. The approximation stems from a Taylor-series approximation to elements of the updating equation.	[Sengupta, Aritra] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Foster, Scott D.; Bravington, Mark] CSIRO Math & Informat Sci, Hobart, Tas, Australia; [Patterson, Toby A.] CSIRO Wealth Oceans Res Flagship, Castray Esplanade, Hobart, Tas, Australia	University System of Ohio; Ohio State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sengupta, A (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	sengupta.11@osu.edu	Foster, Scott D/E-9311-2010; Sengupta, Aritra/AAV-4492-2021; Patterson, Toby/B-3836-2011	Foster, Scott D/0000-0002-6719-8002; Sengupta, Aritra/0000-0001-6268-010X; Patterson, Toby/0000-0002-7150-9205	CSIRO Centre for Mathematics, Informatics, and Statistics, Australia	CSIRO Centre for Mathematics, Informatics, and Statistics, Australia	This research was carried out as an internship project for the first author (Aritra Sengupta). The internship was supported by CSIRO Centre for Mathematics, Informatics, and Statistics, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B.D.O., 1979, OPTIMAL FILTERING; Boehme L, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004647; Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105; Costa DP, 2010, P OCEANOBS, V9, P21; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Evensen G., 2003, OCEAN DYNAM, V53, P343, DOI [DOI 10.1007/S10236-003-0036-9, 10.1007/s10236-003-0036-9]; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; Gunn J., 2001, TUNA PHYSL ECOLOGY E, P167, DOI 10.1016/S1546-5098(01)19006-0; Harvey A. C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; Ide K, 1997, J METEOROL SOC JPN, V75, P181, DOI 10.2151/jmsj1965.75.1B_181; Lydersen C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015462; MEINHOLD RJ, 1983, AM STAT, V37, P123, DOI 10.2307/2685871; Menard R, 1996, TELLUS A, V48, P221, DOI 10.1034/j.1600-0870.1996.t01-1-00003.x; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Musyl M, 2001, ELECT TAGGING TRACKI, P343, DOI [10.1007/978-94-017-1402-0_19, DOI 10.3354/MEPS09899]; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; NIILER PP, 1995, J PHYS OCEANOGR, V25, P2819, DOI 10.1175/1520-0485(1995)025<2819:WDMITN>2.0.CO;2; Oke PR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031549; Pedersen MW, 2007, THESIS DTU; Poulain PM, 1996, J GEOPHYS RES-OCEANS, V101, P18237, DOI 10.1029/96JC00506; Press W.H., 1988, NUMERICAL RECIPIES C; Royer F, 2009, REV-METHODS TECHNOL, V9, P323, DOI 10.1007/978-1-4020-9640-2_20; Sibert JR, 2009, REV-METHODS TECHNOL, V9, P311, DOI 10.1007/978-1-4020-9640-2_19; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x	25	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42093	10.1371/journal.pone.0042093	http://dx.doi.org/10.1371/journal.pone.0042093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900005	Green Submitted, gold, Green Published			2022-12-27	WOS:000307380900020
J	Sun, LF; Wu, XJ; Peng, Y; Goh, JY; Liou, YC; Lin, DH; Zhao, YF				Sun, Lifang; Wu, Xueji; Peng, Yu; Goh, Jian Yuan; Liou, Yih-Cherng; Lin, Donghai; Zhao, Yufen			Solution Structural Analysis of the Single-Domain Parvulin TbPin1	PLOS ONE			English	Article							PROLYL CIS/TRANS-ISOMERASE; MITOTIC REGULATOR HPIN1; CIS-TRANS-ISOMERIZATION; N-15 NMR RELAXATION; ROTATIONAL DIFFUSION; CATALYTIC MECHANISM; ESSENTIAL ESS1; PIN1; PHOSPHORYLATION; RECOGNITION	Background: Pin1-type parvulins are phosphorylation-dependent peptidyl-prolyl cis-trans isomerases. Their functions have been widely reported to be involved in a variety of cellular responses or processes, such as cell division, transcription, and apoptosis, as well as in human diseases including Alzheimer's disease and cancers. TbPin1 was identified as a novel class of Pin1-type parvulins from Trypanosoma brucei, containing a unique PPIase domain, which can catalyze the isomerization of phosphorylated Ser/Thr-Pro peptide bond. Methodology/Principal Findings: We determined the solution structure of TbPin1 and performed N-15 relaxation measurements to analyze its backbone dynamics using multi-dimensional heteronuclear NMR spectroscopy. The average RMSD values of the 20 lowest energy structures are 0.50+/-0.05 angstrom for backbone heavy atoms and 0.85+/-0.08 angstrom for all heavy atoms. TbPin1 adopts the typical catalytic tertiary structure of Pin1-type parvulins, which comprises a globular fold with a four-stranded anti-parallel beta-sheet core surrounded by three alpha-helices and one 3(10)-helix. The global structure of TbPin1 is relatively rigid except the active site. The 2D EXSY spectra illustrate that TbPin1 possesses a phosphorylation-dependent PPIase activity. The binding sites of TbPin1 for a phosphorylated peptide substrate {SSYFSG[p]TPLEDDSD} were determined by the chemical shift perturbation approach. Residues Ser15, Arg18, Asn19, Val21, Ser22, Val32, Gly66, Ser67, Met83, Asp105 and Gly107 are involved in substantial contact with the substrate. Conclusions/Significance: The solution structure of TbPin1 and the binding sites of the phosphorylated peptide substrate on TbPin1 were determined. The work is helpful for further understanding the molecular basis of the substrate specificity for Pin1-type parvulin family and enzyme catalysis.	[Sun, Lifang; Wu, Xueji; Lin, Donghai; Zhao, Yufen] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China; [Peng, Yu] Chinese Acad Sci, Shanghai Inst Mat Med, NMR Lab, Shanghai 200031, Peoples R China; [Goh, Jian Yuan; Liou, Yih-Cherng] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Liou, Yih-Cherng] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Xiamen University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National University of Singapore; National University of Singapore	Sun, LF (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China.	dhlin@xmu.edu.cn; yfzhao@xmu.edu.cn	Zhao, Yufen/G-3445-2010	Peng, Yu/0000-0003-2039-9015	Chinese National Science Foundation [20972130, 91129713, 31170717]; Major State Basic Research Development Program of China (973 Program) [2012CB821600]; Program of Shanghai Subject Chief Scientist [09XD1405100]; Biomedical Research Council, the Agency for Science, Research and Technology, Singapore [06/1/21/19/473]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Program of Shanghai Subject Chief Scientist; Biomedical Research Council, the Agency for Science, Research and Technology, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Chinese National Science Foundation (Nos. 20972130, 91129713, 31170717), the Major State Basic Research Development Program of China (973 Program, No. 2012CB821600) and the Program of Shanghai Subject Chief Scientist (No. 09XD1405100). Y-CL was supported by a grant (06/1/21/19/473) from the Biomedical Research Council, the Agency for Science, Research and Technology, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey ML, 2008, BIOCHEMISTRY-US, V47, P11481, DOI 10.1021/bi800964q; Bayer E, 2003, J BIOL CHEM, V278, P26183, DOI 10.1074/jbc.M300721200; Behrsin CD, 2007, J MOL BIOL, V365, P1143, DOI 10.1016/j.jmb.2006.10.078; Bialik S, 2011, MOL CELL, V42, P139, DOI 10.1016/j.molcel.2011.04.002; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Daum S, 2006, BIOCHEMISTRY-US, V45, P12125, DOI 10.1021/bi0608820; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doreleijers JF, 1998, J MOL BIOL, V281, P149, DOI 10.1006/jmbi.1998.1808; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Erben ED, 2007, MOL BIOCHEM PARASIT, V153, P186, DOI 10.1016/j.molbiopara.2007.03.004; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Goh JY, 2010, FEBS LETT, V584, P2901, DOI 10.1016/j.febslet.2010.04.077; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Heikkinen O, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-17; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsu T, 2001, NAT CELL BIOL, V3, P538, DOI 10.1038/35078508; Ishima R, 2012, TOP CURR CHEM, V326, P99, DOI 10.1007/128_2011_212; Jaremko L, 2011, J BIOL CHEM, V286, P6554, DOI 10.1074/jbc.M110.160713; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kouri ED, 2009, PLANT PHYSIOL, V150, P1160, DOI 10.1104/pp.108.132415; Kuhlewein A, 2004, PROTEIN SCI, V13, P2378, DOI 10.1110/ps.04756704; Labeikovsky W, 2007, J MOL BIOL, V367, P1370, DOI 10.1016/j.jmb.2007.01.049; Landrieu I, 2002, J MOL BIOL, V320, P321, DOI 10.1016/S0022-2836(02)00429-1; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li Z, 2005, BIOCHEMISTRY-US, V44, P6180, DOI 10.1021/bi050115l; Lim JN, 2005, BBA-MOL BASIS DIS, V1739, P311, DOI 10.1016/j.bbadis.2004.10.003; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lippens G, 2007, FEBS J, V274, P5211, DOI 10.1111/j.1742-4658.2007.06057.x; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Metzner M, 2001, J BIOL CHEM, V276, P13524, DOI 10.1074/jbc.M007005200; Mueller JW, 2011, J AM CHEM SOC, V133, P20096, DOI 10.1021/ja2086195; Mueller JW, 2008, PERSPECT MED CHEM, V2, P11; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; PARK ST, 1992, J BIOL CHEM, V267, P3316; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sekerina E, 2000, J MOL BIOL, V301, P1003, DOI 10.1006/jmbi.2000.4013; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Terada T, 2001, J MOL BIOL, V305, P917, DOI 10.1006/jmbi.2000.4293; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Velazquez HA, 2011, BIOCHEMISTRY-US, V50, P9605, DOI 10.1021/bi2009954; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang Y, 2010, MOL CELL, V37, P112, DOI 10.1016/j.molcel.2009.12.020; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yang QY, 2009, J BIOL CHEM, V284, P23980, DOI 10.1074/jbc.M109.022814; Yao JL, 2001, J BIOL CHEM, V276, P13517, DOI 10.1074/jbc.M007006200; Zerbe O, 2003, BIONMR DRUG RES; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026	65	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43017	10.1371/journal.pone.0043017	http://dx.doi.org/10.1371/journal.pone.0043017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900083	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900101
J	Park, JK; Askin, F; Giles, JT; Halushka, MK; Rosen, A; Levine, SM				Park, Jin Kyun; Askin, Frederic; Giles, Jon T.; Halushka, Marc K.; Rosen, Antony; Levine, Stuart M.			Increased Generation of TRAP Expressing Multinucleated Giant Cells in Patients with Granulomatosis with Polyangiitis	PLOS ONE			English	Article							WEGENERS-GRANULOMATOSIS; OSTEOCLAST PRECURSORS; PSORIATIC-ARTHRITIS; IDENTIFICATION; BONE; VASCULITIS; RELAPSE; BLOOD	Background: Tissue-infiltrating multinucleated giant cells (MNGs) within geographic necrosis are pathologic hallmarks of granulomatosis with polyangiitis (GPA). However, the origin, phenotype, and function of these cells in GPA remain undefined. Methodology/Principal Findings: MNG phenotype in GPA lung tissue was examined by immunohistochemistry using antibody directed against cathepsin K and calcitonin-receptor. Tartrate-resistant-acid-phosphatase (TRAP) expression was assessed using enzymatic color reaction. Peripheral blood mononuclear cells (PBMCs) from 13 GPA patients (5 with localized and 8 with systemic disease) and 11 healthy controls were cultured in the presence of RANKL and M-CSF for 9 days, and TRAP+ MNGs containing 3 or more nuclei were identified. GPA lung granulomata contained numerous MNGs that expressed osteoclastic TRAP and cathepsin K but not calcitonin receptors. In the presence of RANKL and M-CSF, PBMCs of GPA patients formed significantly more MNGs than healthy controls (114 +/- 29 MNG/well vs. 22 +/- 9 MNG/well, P=0.02). In a subgroup analysis, patients with systemic disease generated significantly more MNGs than patients with localized disease (161 +/- 35 MNG/well vs. 39 +/- 27 MNG/well, P<0.01) or healthy controls (P<0.01). MNG production did not differ between localized GPA and control subjects (P=0.96). Conclusions/Significance: MNGs in granulomata in the GPA lung express osteoclastic enzymes TRAP and cathepsin K. GPA patients have a higher propensity to form TRAP+ MNGs from peripheral blood than healthy controls. These data suggest that (i) the tendency to form MNGs is a component of the GPA phenotype itself, and (ii) that lesional MNGs might participate in the destructive process through their proteolytic enzymes.	[Park, Jin Kyun; Rosen, Antony; Levine, Stuart M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA; [Askin, Frederic; Halushka, Marc K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Giles, Jon T.] Columbia Univ Coll Phys & Surg, Dept Med, Div Rheumatol, New York, NY 10032 USA	Johns Hopkins University; Johns Hopkins University; Columbia University	Park, JK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA.	jinkyunpark@gmail.com		Park, Jin Kyun/0000-0003-2167-9393; Halushka, Marc/0000-0002-7112-7389	Brian & Bettina Finn and Family; Trish and Edward Savides and Family; Johns Hopkins Center for Innovative Medicine and Lowe Family Scholar program; Brian Finn and Family; Trish and Ed Savides and family; Dr. Ira T. Fine Discovery fund; Johns Hopkins RDRCC Award [P30AR053503]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053503] Funding Source: NIH RePORTER	Brian & Bettina Finn and Family; Trish and Edward Savides and Family; Johns Hopkins Center for Innovative Medicine and Lowe Family Scholar program; Brian Finn and Family; Trish and Ed Savides and family; Dr. Ira T. Fine Discovery fund; Johns Hopkins RDRCC Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Levine's work was supported by Brian & Bettina Finn and Family, and Trish and Edward Savides and Family, Johns Hopkins Center for Innovative Medicine and Lowe Family Scholar program, Brian Finn and Family, Trish and Ed Savides and family, Dr. Ira T. Fine Discovery fund, and the Johns Hopkins RDRCC Award # P30AR053503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bossard MJ, 1996, J BIOL CHEM, V271, P12517, DOI 10.1074/jbc.271.21.12517; BURSTONE MS, 1959, J HISTOCHEM CYTOCHEM, V7, P39, DOI 10.1177/7.1.39; Cheadle C, 2010, ARTHRITIS RHEUM-US, V62, P1744, DOI 10.1002/art.27398; Chiu YG, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2915; da Costa CET, 2005, J EXP MED, V201, P687, DOI 10.1084/jem.20041785; DEVANEY KO, 1990, AM J SURG PATHOL, V14, P555, DOI 10.1097/00000478-199006000-00006; Falk RJ, 2011, ARTHRITIS RHEUM-US, V63, P863, DOI 10.1002/art.30286; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Hayman AR, 2001, J HISTOCHEM CYTOCHEM, V49, P675, DOI 10.1177/002215540104900601; Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Holle JU, 2011, ARTHRITIS RHEUM-US, V63, P257, DOI 10.1002/art.27763; Hopkins J, 2003, ARTHRITIS RHEUM-US, V48, P2299, DOI 10.1002/art.11075; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Mensah KA, 2010, J CELL PHYSIOL, V223, P76, DOI 10.1002/jcp.22012; Muto A, 2011, J BONE MINER RES, V26, P2978, DOI 10.1002/jbmr.490; Popa ER, 2007, RHEUMATOLOGY, V46, P1029, DOI 10.1093/rheumatology/kem022; Quinn JMW, 1999, BONE, V25, P1, DOI 10.1016/S8756-3282(99)00094-0; Ritchlin CT, 2003, J CLIN INVEST, V111, P821, DOI 10.1172/JCI200316069; Shen ZX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1938; STEGEMAN CA, 1994, ANN INTERN MED, V120, P12, DOI 10.7326/0003-4819-120-1-199401010-00003; Sullivan EJ, 1998, CLIN CHEST MED, V19, P759, DOI 10.1016/S0272-5231(05)70115-5; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122	23	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42659	10.1371/journal.pone.0042659	http://dx.doi.org/10.1371/journal.pone.0042659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905158	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100054
J	Paterson, KB; McGowan, VA; Jordan, TR				Paterson, Kevin B.; McGowan, Victoria A.; Jordan, Timothy R.			Eye Movements Reveal Effects of Visual Content on Eye Guidance and Lexical Access during Reading	PLOS ONE			English	Article							E-Z READER; FOVEAL PROCESSING DIFFICULTY; PARAFOVEAL WORD-LENGTH; CONTRAST SENSITIVITY; SPATIAL-FREQUENCY; INTEGRATING INFORMATION; FIXATION DURATIONS; MODEL; ATTENTION; IDENTIFICATION	Background: Normal reading requires eye guidance and activation of lexical representations so that words in text can be identified accurately. However, little is known about how the visual content of text supports eye guidance and lexical activation, and thereby enables normal reading to take place. Methods and Findings: To investigate this issue, we investigated eye movement performance when reading sentences displayed as normal and when the spatial frequency content of text was filtered to contain just one of 5 types of visual content: very coarse, coarse, medium, fine, and very fine. The effect of each type of visual content specifically on lexical activation was assessed using a target word of either high or low lexical frequency embedded in each sentence Results: No type of visual content produced normal eye movement performance but eye movement performance was closest to normal for medium and fine visual content. However, effects of lexical frequency emerged early in the eye movement record for coarse, medium, fine, and very fine visual content, and were observed in total reading times for target words for all types of visual content. Conclusion: These findings suggest that while the orchestration of multiple scales of visual content is required for normal eye-guidance during reading, a broad range of visual content can activate processes of word identification independently. Implications for understanding the role of visual content in reading are discussed.	[Paterson, Kevin B.; McGowan, Victoria A.; Jordan, Timothy R.] Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England	University of Leicester	Paterson, KB (corresponding author), Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England.	kbp3@le.ac.uk; proftimjordan@gmail.com		McGowan, Victoria/0000-0003-1956-1599; Paterson, Kevin/0000-0002-8150-8628				ALLEN PA, 1990, J EXP PSYCHOL HUMAN, V16, P48, DOI 10.1037/0096-1523.16.1.48; Allen PA, 2009, ATTEN PERCEPT PSYCHO, V71, P281, DOI 10.3758/APP.71.2.281; Baayen R. H, 1995, CELEX LEXICAL DATABA; BALOTA DA, 1985, COGNITIVE PSYCHOL, V17, P364, DOI 10.1016/0010-0285(85)90013-1; BECKMANN PJ, 1991, SID 91, P106; Blais C, 2005, J VIS, V5, p813a; Blakemore C, 1969, J PHYSL, V2000, P11; Boden C, 2009, BRAIN COGNITION, V69, P580, DOI 10.1016/j.bandc.2008.12.002; BRIIHL D, 1995, J EXP PSYCHOL LEARN, V21, P55, DOI 10.1037/0278-7393.21.1.55; Chung STL, 2009, J VISION, V9, DOI 10.1167/9.9.16; CRASSINI B, 1988, PERCEPTION, V17, P315, DOI 10.1068/p170315; Drieghe D, 2005, J EXP PSYCHOL HUMAN, V31, P954, DOI 10.1037/0096-1523.31.5.954; Drieghe D, 2004, EUR J COGN PSYCHOL, V16, P79, DOI 10.1080/09541440340000141; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Fiset D, 2009, COGN NEUROPSYCHOL, V26, P23, DOI 10.1080/02643290802421160; GINSBURG AP, 1986, HDB PERCEPTION HUMAN, V2, P1; Gollan TH, 2011, J EXP PSYCHOL GEN, V140, P186, DOI 10.1037/a0022256; GUZMAN O, 1985, VISION RES, V25, P137, DOI 10.1016/0042-6989(85)90087-2; HENDERSON JM, 1990, J EXP PSYCHOL LEARN, V16, P417, DOI 10.1037/0278-7393.16.3.417; INHOFF AW, 1986, PERCEPT PSYCHOPHYS, V40, P431, DOI 10.3758/BF03208203; Jordan TR, 2003, J EXP PSYCHOL LEARN, V29, P900, DOI 10.1037/0278-7393.29.5.900; JORDAN TR, 1990, J EXP PSYCHOL HUMAN, V16, P893, DOI 10.1037/0096-1523.16.4.893; JORDAN TR, 1995, J EXP PSYCHOL HUMAN, V21, P512, DOI 10.1037/0096-1523.21.3.512; Juhasz BJ, 2006, Q J EXP PSYCHOL, V59, P1614, DOI 10.1080/17470210500497722; Juhasz BJ, 2008, J EXP PSYCHOL HUMAN, V34, P1560, DOI 10.1037/a0012319; Juhasz BJ, 2003, J EXP PSYCHOL LEARN, V29, P1312, DOI 10.1037/0278-7393.29.6.1312; KENNISON SM, 1995, J EXP PSYCHOL LEARN, V21, P68, DOI 10.1037/0278-7393.21.1.68; Leat SJ, 1994, TECHNICAL DIGEST SER, V2, P250; LEGGE GE, 1985, VISION RES, V25, P239, DOI 10.1016/0042-6989(85)90117-8; Levy-Schoen A., 1981, EYE MOVEMENTS COGNIT, P299; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; MASON A, 1993, CLIN VISION SCI, V8, P345; Patching GR, 2005, MEM COGNITION, V33, P961, DOI 10.3758/BF03193205; Patching GR, 2005, INVEST OPHTH VIS SCI, V46, P2219, DOI 10.1167/iovs.03-1247; Paterson KB, 2010, MEM COGNITION, V38, P502, DOI 10.3758/MC.38.4.502; Paterson KB, 2009, PSYCHON B REV, V16, P43, DOI 10.3758/PBR.16.1.43; Pelli DG, 2003, NATURE, V423, P752, DOI 10.1038/nature01516; Plummer P, 2012, ATTEN PERCEPT PSYCHO, V74, P950, DOI 10.3758/s13414-012-0286-z; Pollatsek A, 2006, COGNITIVE PSYCHOL, V52, P1, DOI 10.1016/j.cogpsych.2005.06.001; POLLATSEK A, 1982, J EXP PSYCHOL HUMAN, V8, P817, DOI 10.1037/0096-1523.8.6.817; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 1996, J EXP PSYCHOL HUMAN, V22, P1188, DOI 10.1037/0096-1523.22.5.1188; Rayner K, 1998, VISION RES, V38, P1129, DOI 10.1016/S0042-6989(97)00274-5; RAYNER K, 1980, COGNITIVE PSYCHOL, V12, P206, DOI 10.1016/0010-0285(80)90009-2; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; RAYNER K, 1979, PERCEPTION, V8, P21, DOI 10.1068/p080021; RAYNER K, 1982, PERCEPT PSYCHOPHYS, V31, P537, DOI 10.3758/BF03204186; Rayner K., 1989, PSYCHOL READING; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reichle ED, 2006, COGN SYST RES, V7, P4, DOI 10.1016/j.cogsys.2005.07.002; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125; Reichle ED, 2011, PSYCHOPHYSIOLOGY, V48, P993, DOI 10.1111/j.1469-8986.2011.01169.x; Reichle ED, 2009, PSYCHON B REV, V16, P1, DOI 10.3758/PBR.16.1.1; Reingold EM, 2010, J EXP PSYCHOL HUMAN, V36, P1677, DOI 10.1037/a0019959; ROBSON JG, 1966, J OPT SOC AM, V56, P1141, DOI 10.1364/JOSA.56.001141; Schroyens W, 1999, Q J EXP PSYCHOL-A, V52, P1021, DOI 10.1080/713755859; White Sarah J., 2007, P409, DOI 10.1016/B978-008044980-7/50020-3; White SJ, 2006, Q J EXP PSYCHOL, V59, P760, DOI 10.1080/02724980543000024; White SJ, 2006, VISION RES, V46, P426, DOI 10.1016/j.visres.2005.07.006; White SJ, 2005, PSYCHON B REV, V12, P466, DOI 10.3758/BF03193789; White SJ, 2004, EUR J COGN PSYCHOL, V16, P52, DOI 10.1080/09541440340000204; Young LK, 2011, J VISION, V11, DOI 10.1167/11.13.20	62	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41766	10.1371/journal.pone.0041766	http://dx.doi.org/10.1371/journal.pone.0041766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905106	Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100017
J	von Wyl, V; Cambiano, V; Jordan, MR; Bertagnolio, S; Miners, A; Pillay, D; Lundgren, J; Phillips, AN				von Wyl, Viktor; Cambiano, Valentina; Jordan, Michael R.; Bertagnolio, Silvia; Miners, Alec; Pillay, Deenan; Lundgren, Jens; Phillips, Andrew N.			Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring	PLOS ONE			English	Article							HIV-1 DRUG-RESISTANCE; TREATMENT-NAIVE PATIENTS; DISOPROXIL FUMARATE; REVERSE-TRANSCRIPTASE; INFECTED PATIENTS; K65R MUTATION; SOUTH-AFRICA; VIRAL LOAD; EFAVIRENZ; EMTRICITABINE	Background: The most recent World Health Organization (WHO) antiretroviral treatment guidelines recommend the inclusion of zidovudine (ZDV) or tenofovir (TDF) in first-line therapy. We conducted a cost-effectiveness analysis with emphasis on emerging patterns of drug resistance upon treatment failure and their impact on second-line therapy. Methods: We used a stochastic simulation of a generalized HIV-1 epidemic in sub-Saharan Africa to compare two strategies for first-line combination antiretroviral treatment including lamivudine, nevirapine and either ZDV or TDF. Model input parameters were derived from literature and, for the simulation of resistance pathways, estimated from drug resistance data obtained after first-line treatment failure in settings without virological monitoring. Treatment failure and cost effectiveness were determined based on WHO definitions. Two scenarios with optimistic (no emergence; base) and pessimistic (extensive emergence) assumptions regarding occurrence of multidrug resistance patterns were tested. Results: In the base scenario, cumulative proportions of treatment failure according to WHO criteria were higher among first-line ZDV users (median after six years 36% [95% simulation interval 32%; 39%]) compared with first-line TDF users (31% [29%; 33%]). Consequently, a higher proportion initiated second-line therapy (including lamivudine, boosted protease inhibitors and either ZDV or TDF) in the first-line ZDV user group 34% [31%; 37%] relative to first-line TDF users (30% [27%; 32%]). At the time of second-line initiation, a higher proportion (16%) of first-line ZDV users harboured TDF-resistant HIV compared with ZDV-resistant viruses among first-line TDF users (0% and 6% in base and pessimistic scenarios, respectively). In the base scenario, the incremental cost effectiveness ratio with respect to quality adjusted life years (QALY) was US$83 when TDF instead of ZDV was used in first-line therapy (pessimistic scenario: US$ 315), which was below the WHO threshold for high cost effectiveness (US$ 2154). Conclusions: Using TDF instead of ZDV in first-line treatment in resource-limited settings is very cost-effective and likely to better preserve future treatment options in absence of virological monitoring.	[von Wyl, Viktor; Cambiano, Valentina; Phillips, Andrew N.] UCL, Res Dept Infect & Populat Hlth, London, England; [von Wyl, Viktor] CSS Inst Empir Hlth Econ, Luzern, Switzerland; [Jordan, Michael R.; Bertagnolio, Silvia] World Hlth Org, Geneva, Switzerland; [Jordan, Michael R.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Miners, Alec] London Sch Hyg & Trop Med, London WC1, England; [Pillay, Deenan] UCL, Div Infect & Immun, London, England; [Lundgren, Jens] Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark	University of London; University College London; World Health Organization; Tufts University; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Rigshospitalet; University of Copenhagen	von Wyl, V (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	viktor.vonwyl@css-institut.ch	Phillips, Andrew N/B-4427-2008; Lundgren, Jens/AAE-6876-2019	Phillips, Andrew N/0000-0003-2384-4807; Lundgren, Jens/0000-0001-8901-7850; von Wyl, Viktor/0000-0002-8754-9797	European Community's Seventh Framework Programme under the project 'Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)' [223131]; Swiss National Science Foundation (SNF) Grant for Prospective Researchers [PBEZP3-125726]; National Institutes of Health [NIH K23 AI074423-05]	European Community's Seventh Framework Programme under the project 'Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)'; Swiss National Science Foundation (SNF) Grant for Prospective Researchers(Swiss National Science Foundation (SNSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research leading to these results has received partial funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project 'Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)' - grant agreement no 223131. VvW was supported by a Swiss National Science Foundation (SNF) Grant for Prospective Researchers (PBEZP3-125726), and MRJ has received a grant from the National Institutes of Health (NIH K23 AI074423-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; BENDAVID E, 2011, 17 INT AIDS C MEX CI, V25, P211, DOI DOI 10.1097/QAD.0B013E328340FDF8; Bender MA, 2010, CLIN INFECT DIS, V50, P416, DOI 10.1086/649884; Boucher S, 2006, HIV MED, V7, P294, DOI 10.1111/j.1468-1293.2006.00379.x; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Bygrave H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017609; Bygrave H, 2011, JAIDS-J ACQ IMM DEF, V56, pE75, DOI 10.1097/QAI.0b013e3182097505; Chappell BJ, 2007, AIDS, V21, P761, DOI 10.1097/QAD.0b013e3280187533; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Chi BH, 2010, JAIDS-J ACQ IMM DEF, V54, P63, DOI 10.1097/QAI.0b013e3181c6c65c; Clinton Health Access Initiative, 2010, ANT ARV PRIC LIST VE; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Grant PM, 2010, ANTIMICROB AGENTS CH, V54, P1520, DOI 10.1128/AAC.01380-09; Hamers RL, 2011, LANCET INFECT DIS; Hawkins CA, 2009, JAIDS-J ACQ IMM DEF, V52, P228, DOI 10.1097/QAI.0b013e3181b06125; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Jouquet G., 2011, J ACQUIR IMMUNE DEFI; Kauf TL, 2008, VALUE HEALTH, V11, P1144, DOI 10.1111/j.1524-4733.2008.00326.x; KEISER O, 2009, 17 INT AIDS C MEX CI, V23, P1867, DOI DOI 10.1097/QAD.0B013E32832E05B2; Koyalta D, 2009, CLIN INFECT DIS, V49, P155, DOI 10.1086/599611; Lyagoba F, 2010, JAIDS-J ACQ IMM DEF, V55, P277, DOI 10.1097/QAI.0b013e3181ea0df8; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; Margot NA, 2009, JAIDS-J ACQ IMM DEF, V52, P209, DOI 10.1097/QAI.0b013e3181b05f7c; Miller MD, 2007, AIDS, V21, P265, DOI 10.1097/QAD.0b013e32801199ee; Ndembi N, 2010, J INFECT DIS, V201, P106, DOI 10.1086/648590; PHILLIPS AN, 2011, 17 INT AIDS C MEX CI, V25, P843, DOI DOI 10.1097/QAD.0B013E328344037A; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; Sanchez-de la Rosa R, 2008, CLIN THER, V30, P372, DOI 10.1016/j.clinthera.2008.02.009; Scherrer AU, 2012, JAIDS-J ACQ IMM DEF, V59, P105, DOI 10.1097/QAI.0b013e31823c8b69; Trotta MP, 2006, J MED VIROL, V78, P535, DOI 10.1002/jmv.20573; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; von Wyl V, 2012, CLIN INFECT DIS, V54, P131, DOI 10.1093/cid/cir728; Wallis CL, 2010, JAIDS-J ACQ IMM DEF, V53, P480, DOI 10.1097/QAI.0b013e3181bc478b; WHO, 2010, ANT THER HIV INF AD	41	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42834	10.1371/journal.pone.0042834	http://dx.doi.org/10.1371/journal.pone.0042834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905175	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100067
J	Verma, M; Sharma, A; Naidu, S; Bhadra, AK; Kukreti, R; Taneja, V				Verma, Meenakshi; Sharma, Abhishek; Naidu, Swarna; Bhadra, Ankan Kumar; Kukreti, Ritushree; Taneja, Vibha			Curcumin Prevents Formation of Polyglutamine Aggregates by Inhibiting Vps36, a Component of the ESCRT-II Complex	PLOS ONE			English	Article							AMYLOID PATHOLOGY; ALPHA-SYNUCLEIN; SMALL MOLECULES; TOXICITY; YEAST; PROTEIN; PRION; FIBRILS; ENHANCE; PLAQUES	Small molecules with antioxidative properties have been implicated in amyloid disorders. Curcumin is the active ingredient present in turmeric and known for several biological and medicinal effects. Adequate evidence substantiates the importance of curcumin in Alzheimer's disease and recent evidence suggests its role in Prion and Parkinson's disease. However, contradictory effects have been suggested for Huntington's disease. This difference provided a compelling reason to investigate the effect of curcumin on glutamine-rich (Q-rich) and non-glutamine-rich (non Q-rich) amyloid aggregates in the well established yeast model system. Curcumin significantly inhibited the formation of htt72Q-GFP (a Q-rich) and Het-s-GFP (a non Q-rich) aggregates in yeast. We show that curcumin prevents htt72Q-GFP aggregation by down regulating Vps36, a component of the ESCRT-II (Endosomal sorting complex required for transport). Moreover, curcumin disrupted the htt72Q-GFP aggregates that were pre-formed in yeast and cured the yeast prion, [PSI+].	[Verma, Meenakshi; Kukreti, Ritushree] Inst Genom & Integrat Biol CSIR, Delhi, India; [Sharma, Abhishek] Ruhr Univ Bochum, Fac Chem & Biochem, Bochum, Germany; [Naidu, Swarna; Taneja, Vibha] Sir Ganga Ram Hosp, Dept Res, Delhi, India; [Bhadra, Ankan Kumar] Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Sas Nagar, Punjab, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Ruhr University Bochum; National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Verma, M (corresponding author), Inst Genom & Integrat Biol CSIR, Mall Rd, Delhi, India.	vibha17@yahoo.com	Bhadra, Ankan/AAJ-6115-2021	Bhadra, Ankan/0000-0002-8679-0984; Sharma, Abhishek/0000-0003-3699-5460; BHADRA, ANKAN KUMAR/0000-0001-8729-9153	Department of Biotechnology, Government of India, India; Department of Biotechnology, India; Indian Council of Medical Research	Department of Biotechnology, Government of India, India(Department of Biotechnology (DBT) India); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	Innovative Young Biotechnology Award, Department of Biotechnology, Government of India, India. VT acknowledges fellowship from Innovative Young Biotechnologist Award, Department of Biotechnology, India. MV acknowledges senior research fellowship from Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Davies JE, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S2; Dikshit P, 2006, BIOCHEM BIOPH RES CO, V342, P1323, DOI 10.1016/j.bbrc.2006.02.104; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gong EJ, 2011, NEUROBIOL DIS, V44, P223, DOI 10.1016/j.nbd.2011.07.005; Hafner-Bratkovic I, 2008, J NEUROCHEM, V104, P1553, DOI 10.1111/j.1471-4159.2007.05105.x; Hickey MA, 2012, MOL NEURODEGENER, P7; INGEVECHTOMOV SG, 1988, GENETIKA+, V24, P1159; Jagota S, 2012, NEUROCHEM RES, V37, P40, DOI 10.1007/s11064-011-0580-5; Kaganovich D, 2006, BIOCH BIOPHYSICAL RE, V342, P1323; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lin JK, 2007, ADV EXP MED BIOL, V595, P227; Mathur V, 2010, MOL BIOL CELL, V21, P1449, DOI 10.1091/mbc.E09-11-0927; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; Noor H, 2012, PROTEIN SCI, V21, P373, DOI 10.1002/pro.2023; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Pandey N, 2008, ACTA NEUROPATHOL, V115, P479, DOI 10.1007/s00401-007-0332-4; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Roberts BE, 2009, NAT CHEM BIOL, V5, P936, DOI 10.1038/nchembio.246; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Sherman MY, 2003, NEUROMOL MED, V4, P133, DOI 10.1385/NMM:4:1-2:133; Shkundina IS, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1519, DOI 10.1134/S0006297907130081; Taneja V, 2007, MOL CELL, V27, P67, DOI 10.1016/j.molcel.2007.05.027; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Upadhya SC, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S12; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yilmaz R, 2012, AFR J BIOTECHNOL, V11, P1046; Zabrocki P, 2005, FEBS J, V272, P1386, DOI 10.1111/j.1742-4658.2005.04571.x; Zhang C, 2010, J BIOL CHEM, V285, P28472, DOI 10.1074/jbc.M110.133520; Zhang X, 2011, PHARMACOL REP, V63, P1101, DOI 10.1016/S1734-1140(11)70629-6; Zhang X, 2011, EUR J PHARM SCI, V42, P540, DOI 10.1016/j.ejps.2011.02.009	40	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42923	10.1371/journal.pone.0042923	http://dx.doi.org/10.1371/journal.pone.0042923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880132	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900062
J	Guo, W; Li, YH; Liang, W; Wong, S; Apovian, C; Kirkland, JL; Corkey, BE				Guo, Wen; Li, Yahui; Liang, Wentao; Wong, Siu; Apovian, Caroline; Kirkland, James L.; Corkey, Barbara E.			Beta-Mecaptoethanol Suppresses Inflammation and Induces Adipogenic Differentiation in 3T3-F442A Murine Preadipocytes	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED RECEPTOR-GAMMA; NECROSIS-FACTOR-ALPHA; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; PPAR-GAMMA; DIETARY 2-MERCAPTOETHANOL; OXIDATIVE STRESS; NORMAL-WEIGHT; REDOX STATUS	Preadipocytes are present in adipose tissues throughout adult life that can proliferate and differentiate into mature adipocytes in response to environmental cues. Abnormal increase in adipocyte number or size leads to fat tissue expansion. However, it is now recognized that adipocyte hypertrophy is a greater risk factor for metabolic syndrome whereas fat tissue that continues to produce newer and smaller fat cells through preadipocyte differentiation is "metabolically healthy". Because adipocyte hypertrophy is often associated with increased oxidant stress and low grade inflammation, both are linked to disturbed cellular redox, we tested how preadipocyte differentiation may be regulated by beta-mercaptoethanol (BME), a pharmacological redox regulator and radical scavenger, using murine 3T3-F442A preadipocytes as the cell model. Effects of BME on adipogenesis were measured by microphotography, real-time PCR, and Western analysis. Our data demonstrated that preadipocyte differentiation could be regulated by extracellular BME. At an optimal concentration, BME enhanced expression of adipogenic gene markers and lipid accumulation. This effect was associated with BME-mediated down-regulation of inflammatory cytokine expression during early differentiation. BME also attenuated TNFalpha-induced activation of NFkappaB in differentiating preadipocytes and partially restored TNFalpha-mediated suppression on adipogenesis. Using a non-adipogenic HEK293 cell line transfected with luciferase reporter genes, we demonstrated that BME reduced basal and TNFalpha-induced NFkappaB activity and increased basal and ciglitazone-induced PPARgamma activity; both may contribute to the pro-adipogenic effect of BME in differentiating F442A preadipocytes.	[Guo, Wen; Li, Yahui; Liang, Wentao; Wong, Siu; Apovian, Caroline; Corkey, Barbara E.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Kirkland, James L.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA	Boston University; Mayo Clinic	Guo, W (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	wguo@bu.edu	Kirkland, James/F-9159-2016	Guo, Wen/0000-0002-4474-2837; Apovian, Caroline/0000-0002-8029-1922; Liang, Wentao/0000-0002-0609-6280	National Institutes of Health [AG013925, DK56690, AG037859]; Department of Medicine Bridge Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456, R01DK056690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013925, R21AG037859, R37AG013925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine Bridge Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by National Institutes of Health funding AG013925 (JLK), DK56690 (BEC, WG), AG037859 (WG) and the Department of Medicine Bridge Fund (WG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe D, 2010, BIOFACTORS, V36, P52, DOI 10.1002/biof.70; Abeydeera LR, 1998, THERIOGENOLOGY, V50, P747, DOI 10.1016/S0093-691X(98)00180-0; Antonopoulos Alexios S, 2011, Recent Pat Cardiovasc Drug Discov, V6, P78; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Berg AH, 2004, AM J PHYSIOL-ENDOC M, V287, pE1178, DOI 10.1152/ajpendo.00002.2004; Beyer I, 2012, CURR OPIN CLIN NUTR, V15, P12, DOI 10.1097/MCO.0b013e32834dd297; Bird SD, 2011, CELL BIOL INT, V35, P857, DOI 10.1042/CBI20100593; Blanquicett C, 2010, FREE RADICAL BIO MED, V48, P1618, DOI 10.1016/j.freeradbiomed.2010.03.007; BRIDGEMAN MME, 1994, THORAX, V49, P670, DOI 10.1136/thx.49.7.670; Briggs DB, 2009, BIOCHEMISTRY-US, V48, P12345, DOI 10.1021/bi9015555; Brodsky M, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-3; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Chiarugi P, 2010, EXPERT OPIN THER TAR, V14, P193, DOI 10.1517/14728220903530712; Cho KJ, 2003, J BIOL CHEM, V278, P34823, DOI 10.1074/jbc.M210747200; Cho S, 1998, BIOCHEM BIOPH RES CO, V253, P104, DOI 10.1006/bbrc.1998.9697; Chung SW, 2000, J BIOL CHEM, V275, P32681, DOI 10.1074/jbc.M002577200; Click RE, 2010, VIRULENCE, V1, P509, DOI 10.4161/viru.1.6.13803; Click RE, 2010, VIRULENCE, V1, P516, DOI 10.4161/viru.1.6.13805; Coskun H, 2010, J THEOR BIOL, V265, P87, DOI 10.1016/j.jtbi.2010.03.047; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Diaz-Velasquez CE, 2008, J CELL BIOCHEM, V105, P147, DOI 10.1002/jcb.21810; Elbrecht A, 1999, J BIOL CHEM, V274, P7913, DOI 10.1074/jbc.274.12.7913; Finck BN, 2000, AM J PHYSIOL-REG I, V278, pR537, DOI 10.1152/ajpregu.2000.278.2.R537; Finck BN, 1998, ENDOCRINOLOGY, V139, P2278, DOI 10.1210/en.139.5.2278; Fink T, 2011, METHODS MOL BIOL, V698, P243, DOI 10.1007/978-1-60761-999-4_19; Fisette PL, 2003, J BIOL CHEM, V278, P46252, DOI 10.1074/jbc.M306587200; Fukuyama R, 2007, MOL CARCINOGEN, V46, P402, DOI 10.1002/mc.20288; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; Gummersbach C, 2009, DIFFERENTIATION, V77, P115, DOI 10.1016/j.diff.2008.09.009; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; HEIDRICK ML, 1984, MECH AGEING DEV, V27, P341, DOI 10.1016/0047-6374(84)90057-5; Higa A, 2012, CELL SIGNAL, V24, P1548, DOI 10.1016/j.cellsig.2012.03.011; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Imhoff BR, 2011, CELL MOL BIOL LETT, V16, P149, DOI 10.2478/s11658-010-0042-0; Imhoff BR, 2010, DIFFERENTIATION, V80, P31, DOI 10.1016/j.diff.2010.04.005; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kaur S, 2008, BRIT J DERMATOL, V159, P1364, DOI 10.1111/j.1365-2133.2008.08759.x; Kil IS, 2008, BIOCHEM BIOPH RES CO, V373, P169, DOI 10.1016/j.bbrc.2008.06.007; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Kobayashi H, 2009, AM J PHYSIOL-ENDOC M, V296, pE1326, DOI 10.1152/ajpendo.90921.2008; Koutnikova H, 2001, ANN MED, V33, P556, DOI 10.3109/07853890108995966; Lechpammer S, 2005, EXP HEMATOL, V33, P1201, DOI 10.1016/j.exphem.2005.06.026; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee JH, 2007, INT J MOL MED, V20, P59; Lee OH, 2010, BIOFACTORS, V36, P459, DOI 10.1002/biof.119; Lijnen HR, 2011, J PHARMACOL EXP THER, V337, P457, DOI 10.1124/jpet.110.178046; Lin YC, 2012, FREE RADICAL BIO MED, V52, P1844, DOI 10.1016/j.freeradbiomed.2012.02.028; MACDOUGALD OA, 1995, CURR BIOL, V5, P618, DOI 10.1016/S0960-9822(95)00125-4; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; Moghe SS, 2012, J MED FOOD, V15, P448, DOI 10.1089/jmf.2011.0234; Moon MK, 2012, APPL PHYSL NUTR META; O'Connell J, 2011, J CLIN ENDOCR METAB, V96, pE680, DOI 10.1210/jc.2010-2026; Park HT, 2012, CLIN ENDOCRINOL, V76, P59, DOI 10.1111/j.1365-2265.2011.04141.x; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Relic B, 2009, LAB INVEST, V89, P811, DOI 10.1038/labinvest.2009.41; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Samuni Y, 2010, FREE RADICAL BIO MED, V49, P667, DOI 10.1016/j.freeradbiomed.2010.05.028; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Simone RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019652; Singh Sarvjeet, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P259, DOI 10.2174/187152006776930918; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Sundar IK, 2010, METHOD ENZYMOL, V474, P213, DOI 10.1016/S0076-6879(10)74013-1; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Vallespi MG, 2004, INT IMMUNOPHARMACOL, V4, P1343, DOI 10.1016/j.intimp.2004.05.019; van Tienen FHJ, 2011, INT J OBESITY, V35, P1154, DOI 10.1038/ijo.2010.275; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; Vincent HK, 2009, METABOLISM, V58, P254, DOI 10.1016/j.metabol.2008.09.022; Zembron-Lacny A, 2010, PHYSIOL RES, V59, P239, DOI 10.33549/physiolres.931774; Zhou QG, 2010, J CELL PHYSIOL, V225, P42, DOI 10.1002/jcp.22189	78	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40958	10.1371/journal.pone.0040958	http://dx.doi.org/10.1371/journal.pone.0040958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911724	Green Submitted, gold, Green Published			2022-12-27	WOS:000306687700028
J	Guirola, M; Perez-Rafael, S; Capdevila, M; Palacios, O; Atrian, S				Guirola, Maria; Perez-Rafael, Silvia; Capdevila, Merce; Palacios, Oscar; Atrian, Silvia			Metal Dealing at the Origin of the Chordata Phylum: The Metallothionein System and Metal Overload Response in Amphioxus	PLOS ONE			English	Article							BINDING ABILITIES; MESSENGER-RNA; EVOLUTION; FEATURES; ZINC; DIFFERENTIATION; SPECIFICITY; CADMIUM(II); EXPRESSION; SEQUENCE	Non-vertebrate chordates, specifically amphioxus, are considered of the utmost interest for gaining insight into the evolutionary trends, i.e. differentiation and specialization, of gene/protein systems. In this work, MTs (metallothioneins), the most important metal binding proteins, are characterized for the first time in the cephalochordate subphylum at both gene and protein level, together with the main features defining the amphioxus response to cadmium and copper overload. Two MT genes (BfMT1 and BfMT2) have been identified in a contiguous region of the genome, as well as several ARE (antioxidant response element) and MRE (metal response element) located upstream the transcribed region. Their corresponding cDNAs exhibit identical sequence in the two lancelet species (B. floridae and B. lanceolatum), BfMT2 cDNA resulting from an alternative splicing event. BfMT1 is a polyvalent metal binding peptide that coordinates any of the studied metal ions (Zn, Cd or Cu) rendering complexes stable enough to last in physiological environments, which is fully concordant with the constitutive expression of its gene, and therefore, with a metal homeostasis housekeeping role. On the contrary, BfMT2 exhibits a clear ability to coordinate Cd(II) ions, while it is absolutely unable to fold into stable Cu (I) complexes, even as mixed species. This identifies it as an essential detoxification agent, which is consequently only induced in emergency situations. The cephalochordate MTs are not directly related to vertebrate MTs, neither by gene structure, protein similarity nor metal-binding behavior of the encoded peptides. The closest relative is the echinoderm MT, which confirm proposed phylogenetic relationships between these two groups. The current findings support the existence in most organisms of two types of MTs as for their metal binding preferences, devoted to different biological functions: multivalent MTs for housekeeping roles, and specialized MTs that evolve either as Cd-thioneins or Cu-thioneins, according to the ecophysiological needs of each kind of organisms.	[Guirola, Maria; Atrian, Silvia] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Perez-Rafael, Silvia; Capdevila, Merce; Palacios, Oscar] Univ Autonoma Barcelona, Dept Quim, Fac Ciencies, E-08193 Barcelona, Spain	University of Barcelona; Autonomous University of Barcelona	Guirola, M (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain.	satrian@ub.edu	Guirola, Maria/AAA-8752-2019; Capdevila, Mercè/ABG-4588-2020; Guirola, Maria/N-3734-2015; Palacios, Òscar/AAJ-3492-2021; Capdevila, Mercè/F-5374-2015; Palacios, Oscar/C-8974-2009	Guirola, Maria/0000-0003-1381-4567; Capdevila, Mercè/0000-0002-2246-0994; Guirola, Maria/0000-0003-1381-4567; Palacios, Òscar/0000-0002-2987-7303; Capdevila, Mercè/0000-0002-2246-0994; Palacios, Oscar/0000-0002-2987-7303	Spanish "Ministerio de Ciencia e Innovacion" (MICINN) [BIO2009-12513-C02-01, BIO2009-12513-C02-02]; European Union; "Ministerio de Asuntos Exteriores-Agencia Espanola de Cooperacion Internacional para el Desarrollo" (MAE-AECID) fellowship	Spanish "Ministerio de Ciencia e Innovacion" (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); "Ministerio de Asuntos Exteriores-Agencia Espanola de Cooperacion Internacional para el Desarrollo" (MAE-AECID) fellowship	This work was supported by the Spanish "Ministerio de Ciencia e Innovacion" (MICINN) grants BIO2009-12513-C02-01 to Silvia Atrian and BIO2009-12513-C02-02 to Merce Capdevila. These coordinated projects were co-financed by the European Union, through the "Fondo Europeo de Desarrollo Regional" (FEDER) program. The authors from the Universitat de Barcelona and the Universitat Autonoma de Barcelona are members of the 2009SGR-1457 "Grup de Recerca de la Generalitat de Catalunya". Maria Guirola is recipient of an "Ministerio de Asuntos Exteriores-Agencia Espanola de Cooperacion Internacional para el Desarrollo" (MAE-AECID) fellowship for PhD studies in Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GK, 1996, J NUTR, V126, pS1317, DOI 10.1093/jn/126.suppl_4.1317S; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Binz PA, 1999, METALLOTHIONEIN IV, P7; Bofill R, 1999, J INORG BIOCHEM, V73, P57, DOI 10.1016/S0162-0134(98)10091-0; Bofill R, 2009, FEBS J, V276, P7040, DOI 10.1111/j.1742-4658.2009.07417.x; Bofill R, 2009, METALLOMICS, V1, P229, DOI 10.1039/b904953c; BONGERS J, 1988, ANAL CHEM, V60, P2683, DOI 10.1021/ac00175a008; Canestro C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-208; Canestro C, 2012, BRIEF FUNCT GENOMICS, V11, P131, DOI 10.1093/bfgp/els010; Capdevila M, 2005, ANGEW CHEM INT EDIT, V44, P4618, DOI 10.1002/anie.200501183; Capdevila M, 2012, COORDIN CHEM REV, V256, P46, DOI 10.1016/j.ccr.2011.07.006; Capdevila M, 1997, CELL MOL LIFE SCI, V53, P681, DOI 10.1007/s000180050088; Capdevila M, 2011, J BIOL INORG CHEM, V16, P977, DOI 10.1007/s00775-011-0798-3; Cohen M, 1900, BIOL EFFECTS HEAVY M, P19; Cols N, 1997, J INORG BIOCHEM, V68, P157, DOI 10.1016/S0162-0134(97)00085-8; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Domenech J, 2007, J BIOL INORG CHEM, V12, P867, DOI 10.1007/s00775-007-0241-y; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2002, PHYLIP PHYLOGENETIC; Ferre F, 2006, NUCLEIC ACIDS RES, V1, P82; Franchi N, 2011, J EXP ZOOL PART A, V315A, P90, DOI 10.1002/jez.653; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Henikoff JG, 2000, ELECTROPHORESIS, V21, P1700, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1700::AID-ELPS1700>3.3.CO;2-M; Hockner M, 2011, BIOMETALS, V24, P1079, DOI 10.1007/s10534-011-9466-x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lippi M, 2008, BIOINFORMATICS, V24, P2094, DOI 10.1093/bioinformatics/btn371; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; MULLER JP, 1993, DNA CELL BIOL, V12, P341, DOI 10.1089/dna.1993.12.341; Nam DH, 2007, COMP BIOCHEM PHYS C, V145, P295, DOI 10.1016/j.cbpc.2006.10.012; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orihuela R, 2010, CHEM-EUR J, V16, P12363, DOI 10.1002/chem.201001125; Oulion S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036554; Pagani A, 2007, MOL MICROBIOL, V63, P256, DOI 10.1111/j.1365-2958.2006.05510.x; Pagani MA, 2007, MOL MICROBIOL, V65, P521, DOI 10.1111/j.1365-2958.2007.05807.x; Palacios O, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-4; Perez-Rafael S, 2012, METALLOMICS, V4, P342, DOI 10.1039/c2mt00182a; Perez-Rafael S, 2012, J INORG BIOCHEM, V108, P84, DOI 10.1016/j.jinorgbio.2011.11.025; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Riggio M, 2003, MOL REPROD DEV, V66, P374, DOI 10.1002/mrd.10365; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Sigel A., 2009, METAL IONS LIFE SCI, V5; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Tio L, 2004, J BIOL CHEM, V279, P24403, DOI 10.1074/jbc.M401346200; Valls M, 2001, J BIOL CHEM, V276, P32835, DOI 10.1074/jbc.M102151200; Vasak M, 2000, CURR OPIN CHEM BIOL, V4, P177, DOI 10.1016/S1367-5931(00)00082-X; Vasak M, 2011, J BIOL INORG CHEM, V16, P1067, DOI 10.1007/s00775-011-0799-2; Vergani Laura, 2009, V5, P199, DOI 10.1039/9781847558992-00199; Villarreal L, 2006, FEBS J, V273, P523, DOI 10.1111/j.1742-4658.2005.05086.x; Yu JK, 2008, DEV GENES EVOL, V218, P723, DOI 10.1007/s00427-008-0228-x; Zdobnov EM, 2002, BIOINFORMATICS, V18, P368, DOI 10.1093/bioinformatics/18.2.368; Zeitoun-Ghandour S, 2010, FEBS J, V277, P2531, DOI 10.1111/j.1742-4658.2010.07667.x	51	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43299	10.1371/journal.pone.0043299	http://dx.doi.org/10.1371/journal.pone.0043299			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905252	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500800074
J	Liu, L; Zhang, Q; Hu, LL; Tang, JJ; Xu, LG; Yang, XT; Yong, JWH; Chen, X				Liu, Ling; Zhang, Qian; Hu, Liangliang; Tang, Jianjun; Xu, Ligen; Yang, Xiantian; Yong, Jean W. H.; Chen, Xin			Legumes Can Increase Cadmium Contamination in Neighboring Crops	PLOS ONE			English	Article							SEQUENTIAL EXTRACTION; FOOD SECURITY; SOIL; PRODUCTIVITY; AVAILABILITY; RESTORATION; NITROGEN; PLANTS; MAIZE	Legumes are widely used in many cropping systems because they share their nitrogen fixation products and phosphorus mobilization activities with their neighbors. In the current study, however, we showed that co-cultivation with legumes increased cadmium (Cd) contamination in the adjacent crops. Both field and mesocosm experiments indicated that legumes increased Cd levels in edible parts and shoots of four neighboring crops and five maize varieties tested, regardless of the Cd levels in the soil. This enhanced Cd accumulation in crops was attributed to root interactions that alter the rhizosphere environment. Co-cultivation with legumes reduced soil pH, which somewhat increased the exchangeable forms of Cd. Our results have demonstrated the inevitable increases in Cd levels of crops as a direct result of co-cultivation with legumes even under situations when these levels are below the permissible threshold. With this new revelation, we need to consider carefully the current cropping systems involving legumes and perhaps to re-design the current and future cropping systems in view of avoiding food contamination by Cd.	[Liu, Ling; Zhang, Qian; Hu, Liangliang; Tang, Jianjun; Xu, Ligen; Chen, Xin] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Yong, Jean W. H.] Singapore Univ Technol & Design, Singapore, Singapore; [Yang, Xiantian] Taizhou Acad Agr Sci, Taizhou, Peoples R China	Zhejiang University; Singapore University of Technology & Design; Jiangsu Academy of Agricultural Sciences	Liu, L (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	chen-tang@zju.edu.cn	Yong, Jean/B-9976-2019; Yong, Jean W. H./H-4671-2012	Yong, Jean/0000-0003-3325-8254; Yong, Jean W. H./0000-0003-3325-8254	Natural Science Foundation of China [30970477]; Natural Science Foundation of Zhejiang Province [Y307418]; Key Laboratory of Ministry of Agriculture of the People's Republic of China [KYJD09021]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Key Laboratory of Ministry of Agriculture of the People's Republic of China	The work was supported by the Natural Science Foundation of China (no. 30970477), the Natural Science Foundation of Zhejiang Province (no. Y307418) and the Key Laboratory of Ministry of Agriculture of the People's Republic of China (no. 278 KYJD09021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada I, 1999, COMMUN SOIL SCI PLAN, V30, P1507, DOI 10.1080/00103629909370303; Bromley DW, 2010, SCIENCE, V328, P169, DOI 10.1126/science.328.5975.169-d; Chaer GM, 2011, TREE PHYSIOL, V31, P139, DOI 10.1093/treephys/tpq116; Ghosh PK, 2007, J SUSTAIN AGR, V30, P59, DOI 10.1300/J064v30n01_07; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Hauggaard-Nielsen H, 2009, NUTR CYCL AGROECOSYS, V85, P141, DOI 10.1007/s10705-009-9254-y; Krishnamurti GSR, 1997, J ENVIRON QUAL, V26, P271, DOI 10.2134/jeq1997.00472425002600010038x; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Li NY, 2009, WATER AIR SOIL POLL, V199, P45, DOI 10.1007/s11270-008-9858-x; Liu L, 2012, J ENVIRON MANAGE, V93, P22, DOI 10.1016/j.jenvman.2011.08.021; Liu L, 2011, J ENVIRON SCI, V23, P453, DOI 10.1016/S1001-0742(10)60430-5; Luo SM, 2010, PRINCIPLE TECHNOLOGY; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Mench MJ, 1998, AGR ECOSYST ENVIRON, V67, P175, DOI 10.1016/S0167-8809(97)00117-5; Ministry of Health of the People's Republic of China, 2005, GB27622005 MIN HLTH; Mulvaney RL, 2009, J ENVIRON QUAL, V38, P2295, DOI 10.2134/jeq2008.0527; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; Omondi EC, 2010, J SUSTAIN AGR, V34, P244, DOI 10.1080/10440041003613230; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Padilla FM, 2009, BASIC APPL ECOL, V10, P640, DOI 10.1016/j.baae.2009.03.003; Rao MR, 2000, AGR ECOSYST ENVIRON, V78, P123, DOI 10.1016/S0167-8809(99)00125-5; Sappin-Didier V, 2005, PLANT SOIL, V270, P189, DOI 10.1007/s11104-004-1494-7; Siddique I, 2008, BIOGEOCHEMISTRY, V88, P89, DOI 10.1007/s10533-008-9196-5; State Environmental Protection Administration of China, 1995, GB156181995 STAT ENV; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; [杨忠芳 Yang Zhongfang], 2005, [地学前缘, Earth science frontiers], V12, P252	27	24	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42944	10.1371/journal.pone.0042944	http://dx.doi.org/10.1371/journal.pone.0042944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905189	gold, Green Submitted, Green Published			2022-12-27	WOS:000307500800032
J	Bill, MA; Nicholas, C; Mace, TA; Etter, JP; Li, CL; Schwartz, EB; Fuchs, JR; Young, GS; Lin, L; Lin, JY; He, L; Phelps, M; Li, PK; Lesinski, GB				Bill, Matthew A.; Nicholas, Courtney; Mace, Thomas A.; Etter, Jonathan P.; Li, Chenglong; Schwartz, Eric B.; Fuchs, James R.; Young, Gregory S.; Lin, Li; Lin, Jiayuh; He, Lei; Phelps, Mitch; Li, Pui-Kai; Lesinski, Gregory B.			Structurally Modified Curcumin Analogs Inhibit STAT3 Phosphorylation and Promote Apoptosis of Human Renal Cell Carcinoma and Melanoma Cell Lines	PLOS ONE			English	Article							FLUORESCENCE POLARIZATION ASSAY; TUMOR-SUPPRESSOR GENE; TARGETING STAT3; SIGNAL TRANSDUCER; INTERFERON-ALPHA; T-CELLS; IMMUNE CELLS; IFN-ALPHA; CANCER; EXPRESSION	The Janus kinase-2 (Jak2)-signal transducer and activator of transcription-3 (STAT3) pathway is critical for promoting an oncogenic and metastatic phenotype in several types of cancer including renal cell carcinoma (RCC) and melanoma. This study describes two small molecule inhibitors of the Jak2-STAT3 pathway, FLLL32 and its more soluble analog, FLLL62. These compounds are structurally distinct curcumin analogs that bind selectively to the SH2 domain of STAT3 to inhibit its phosphorylation and dimerization. We hypothesized that FLLL32 and FLLL62 would induce apoptosis in RCC and melanoma cells and display specificity for the Jak2-STAT3 pathway. FLLL32 and FLLL62 could inhibit STAT3 dimerization in vitro. These compounds reduced basal STAT3 phosphorylation (pSTAT3), and induced apoptosis in four separate human RCC cell lines and in human melanoma cell lines as determined by Annexin V/PI staining. Apoptosis was also confirmed by immunoblot analysis of caspase-3 processing and PARP cleavage. Pre-treatment of RCC and melanoma cell lines with FLLL32/62 did not inhibit IFN-gamma-induced pSTAT1. In contrast to FLLL32, curcumin and FLLL62 reduced downstream STAT1-mediated gene expression of IRF1 as determined by Real Time PCR. FLLL32 and FLLL62 significantly reduced secretion of VEGF from RCC cell lines in a dose-dependent manner as determined by ELISA. Finally, each of these compounds inhibited in vitro generation of myeloid-derived suppressor cells. These data support further investigation of FLLL32 and FLLL62 as lead compounds for STAT3 inhibition in RCC and melanoma.	[Bill, Matthew A.; Nicholas, Courtney; Mace, Thomas A.; Lesinski, Gregory B.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Etter, Jonathan P.; Li, Chenglong; Schwartz, Eric B.; Fuchs, James R.; He, Lei; Phelps, Mitch; Li, Pui-Kai] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Young, Gregory S.] Ohio State Univ, Arthur G James Canc Hosp, Ctr Biostat, Columbus, OH 43210 USA; [Young, Gregory S.] Ohio State Univ, Richard J Solove Res Inst, Columbus, OH 43210 USA; [Lin, Li; Lin, Jiayuh] Nationwide Childrens Hosp, Coll Med, Dept Pediat, Ctr Childhood Canc,Res Inst, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Bill, MA (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	Gregory.Lesinski@osumc.edu	nicholas, courtney/AAU-3887-2021; Lin, Jiayuh/E-3515-2011; Phelps, Mitch A/H-3941-2013; Li, Chenglong/E-7182-2010	Phelps, Mitch A/0000-0002-1615-5280; Li, Chenglong/0000-0003-3174-8719; Nicholas, Courtney/0000-0001-8596-0200; Li, Pui Kai/0000-0002-4831-7213; Fuchs, James/0000-0002-8743-6389	National Institutes of Health (NIH) [CA84402, 1R21 CA141434, K22CA134551]; Valvano Foundation for Cancer Research; American Cancer Society [IRG 67 003-44]; National Center for Research Resources [UL1RR025755]; Office of the Director, NIH (OD); NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA016058, R21CA141434, R21CA084402, K22CA134551] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Valvano Foundation for Cancer Research; American Cancer Society(American Cancer Society); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Director, NIH (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health (NIH) grants CA84402, 1R21 CA141434 (Lesinski), K22CA134551 (Lesinski) (http://www.nih.gov/); The Valvano Foundation for Cancer Research (Lesinski) (http://www.jimmyv.org/); and grant IRG 67 003-44 from the American Cancer Society (Fuchs) (http://www.cancer.org/). The project described was supported by award mumber UL1RR025755 from the National Center for Research Resources, funded by the Office of the Director, NIH (OD) and supported by the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bill MA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-165; Bill MA, 2009, MOL CANCER THER, V8, P2726, DOI 10.1158/1535-7163.MCT-09-0377; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Clifford SC, 1998, GENE CHROMOSOME CANC, V22, P200, DOI 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#; Du YH, 2007, J BIOMOL SCREEN, V12, P915, DOI 10.1177/1087057107306067; Fletcher S, 2008, CHEMMEDCHEM, V3, P1159, DOI 10.1002/cmdc.200800123; Glienke W, 2010, CANCER INVEST, V28, P166, DOI 10.3109/07357900903287006; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Hao WS, 2008, BIOORG MED CHEM LETT, V18, P4988, DOI 10.1016/j.bmcl.2008.08.032; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Herrmann A, 2010, CANCER RES, V70, P7455, DOI 10.1158/0008-5472.CAN-10-0736; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hoechst B, 2009, HEPATOLOGY, V50, P799, DOI 10.1002/hep.23054; Horiguchi A, 2002, J UROLOGY, V168, P762, DOI 10.1016/S0022-5347(05)64741-6; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Hutson TE, 2011, ONCOLOGIST, V16, P14, DOI 10.1634/theoncologist.2011-S2-14; Ito N, 2007, J CLIN ONCOL, V25, P2785, DOI 10.1200/JCO.2006.09.8897; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Kong LY, 2010, CLIN CANCER RES, V16, P2550, DOI 10.1158/1078-0432.CCR-10-0279; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Kujawski M, 2010, CANCER RES, V70, P9599, DOI 10.1158/0008-5472.CAN-10-1293; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lechner MG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-90; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Lee JW, 2010, KOREAN J UROL, V51, P870, DOI 10.4111/kju.2010.51.12.870; Lesinski GB, 2004, JNCI-J NATL CANCER I, V96, P1331, DOI 10.1093/jnci/djh252; Lesinski GB, 2008, CANCER RES, V68, P8351, DOI 10.1158/0008-5472.CAN-08-0426; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Lin L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-217; Masuda A, 2009, BIOMED RES-TOKYO, V30, P171, DOI 10.2220/biomedres.30.171; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; Motzer RJ, 2002, J CLIN ONCOL, V20, P2376, DOI 10.1200/JCO.2002.11.123; Mundy-Bosse BL, 2011, CANCER IMMUNOL IMMUN, V60, P1269, DOI 10.1007/s00262-011-1029-z; Nieto M, 2011, CLIN CANCER RES, V17, P6608, DOI 10.1158/1078-0432.CCR-11-1734; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Prakobwong S, 2011, CARCINOGENESIS, V32, P1372, DOI 10.1093/carcin/bgr032; Ramsauer K, 2002, P NATL ACAD SCI USA, V99, P12859, DOI 10.1073/pnas.192264999; Saradhi UVRV, 2010, J CHROMATOGR B, V878, P3045, DOI 10.1016/j.jchromb.2010.08.039; Sarkar FH, 2010, CURR PHARM DESIGN, V16, P1801, DOI 10.2174/138161210791208956; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schust J, 2004, ANAL BIOCHEM, V330, P114, DOI 10.1016/j.ab.2004.03.024; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001; Zimmerer JM, 2007, J IMMUNOL, V178, P4832, DOI 10.4049/jimmunol.178.8.4832	55	68	71	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e40724	10.1371/journal.pone.0040724	http://dx.doi.org/10.1371/journal.pone.0040724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899991	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900006
J	Kraneveld, EA; Buijs, MJ; Bonder, MJ; Visser, M; Keijser, BJF; Crielaard, W; Zaura, E				Kraneveld, Eefje A.; Buijs, Mark J.; Bonder, Marc J.; Visser, Marjolein; Keijser, Bart J. F.; Crielaard, Wim; Zaura, Egija			The Relation between Oral Candida Load and Bacterial Microbiome Profiles in Dutch Older Adults	PLOS ONE			English	Article							ALKALI PRODUCTION; ACID PRODUCTION; PCR ASSAYS; ALBICANS; DIVERSITY; EPIDEMIOLOGY; COMMUNITIES; SALIVARY; CARIES; STREPTOCOCCI	Currently there are no evidence-based ecological measures for prevention of overgrowth and subsequent infection by fungi in the oral cavity. The aim of this study was to increase our knowledge on fungal-bacterial ecological interactions. Salivary Candida abundance of 82 Dutch adults aged 58-80 years was established relative to the bacterial load by quantitative PCR analysis of the Internal Transcribed (ITS) region (Candida) and 16S rDNA gene (bacteria). The salivary microbiome was assessed using barcoded pyrosequencing of the bacterial hypervariable regions V5-V7 of 16S rDNA. Sequencing data was preprocessed by denoising and chimera removal, clustered in Operational Taxonomic Units (OTUs) and assigned to taxonomy. Both OTU-based (PCA, diversity statistics) and phylogeny-based analyses (UniFrac, PCoA) were performed. Saliva of Dutch older adults contained 0-4 x 10(8) CFU/mL Candida with a median Candida load of 0.06%. With increased Candida load the diversity of the salivary microbiome decreased significantly (p<0.001). Increase in the Candida load correlated positively with class Bacilli, and negatively with class Fusobacteria, Flavobacteria, and Bacteroidia. Microbiomes with high Candida load were less diverse and had a distinct microbial composition towards dominance by saccharolytic and acidogenic bacteria - streptococci. The control of the acidification of the oral environment may be a potential preventive measure for Candida outgrowth that should be evaluated in longitudinal clinical intervention trials.	[Kraneveld, Eefje A.; Buijs, Mark J.; Bonder, Marc J.; Crielaard, Wim; Zaura, Egija] Univ Amsterdam, Dept Prevent Dent, Acad Ctr Dent Amsterdam, Amsterdam, Netherlands; [Visser, Marjolein] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Keijser, Bart J. F.] TNO Earth Environm & Life Sci, Zeist, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research	Kraneveld, EA (corresponding author), Univ Amsterdam, Dept Prevent Dent, Acad Ctr Dent Amsterdam, Amsterdam, Netherlands.	e.zaura@acta.nl	Visser, Marjolein/AAP-3224-2020	Bonder, Marc Jan/0000-0002-8431-3180; Visser, Marjolein/0000-0002-5136-298X; Zaura, Egija/0000-0003-1432-6194	Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care	Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care	The Longitudinal Aging Study Amsterdam is largely supported by a grant from the Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbeele AV, 2008, GERODONTOLOGY, V25, P222, DOI 10.1111/j.1741-2358.2007.00247.x; Acevedo Ana Maria, 2005, J Clin Dent, V16, P63; Bodineau Agnes, 2009, Curr Aging Sci, V2, P109; Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0; Brandt BW, 2012, NUCLEIC ACIDS RES, V40, pW82, DOI 10.1093/nar/gks418; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Deeg DJH, 1994, AUTONOMY WELL BEING; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gordan VV, 2010, CARIES RES, V44, P547, DOI 10.1159/000321139; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holmes AR, 2006, ORAL SURG ORAL MED O, V102, P488, DOI 10.1016/j.tripleo.2005.10.052; Holmes AR, 1996, INFECT IMMUN, V64, P4680, DOI 10.1128/IAI.64.11.4680-4685.1996; Huisman M, 2011, INT J EPIDEMIOL, V40, P868, DOI 10.1093/ije/dyq219; JENKINSON HF, 1990, INFECT IMMUN, V58, P1429, DOI 10.1128/IAI.58.5.1429-1436.1990; Jenkinson HF, 2002, POLYMICROBIAL DIS; Klinke T, 2009, CARIES RES, V43, P83, DOI 10.1159/000204911; Li Y, 2005, J DENT RES, V84, P559, DOI 10.1177/154405910508400614; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Morales DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000886; Muenz R., 2007, AGING DEMOGRAPHIC CH; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nair RG, 2001, APMIS, V109, P147, DOI 10.1034/j.1600-0463.2001.d01-116.x; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; O'Sullivan JM, 2000, MICROBIOL-UK, V146, P41, DOI 10.1099/00221287-146-1-41; PERCIVAL RS, 1991, J MED MICROBIOL, V35, P5, DOI 10.1099/00222615-35-1-5; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Pham LC, 2009, ARCH ORAL BIOL, V54, P132, DOI 10.1016/j.archoralbio.2008.09.007; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pybus V, 1998, FEMS IMMUNOL MED MIC, V22, P317, DOI 10.1016/S0928-8244(98)00103-5; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; RICHARDS S, 1987, J APPL BACTERIOL, V62, P421, DOI 10.1111/j.1365-2672.1987.tb02671.x; Gusmao JMR, 2011, GERODONTOLOGY, V28, P283, DOI 10.1111/j.1741-2358.2010.00390.x; Ryu M, 2010, J ORAL REHABIL, V37, P194, DOI 10.1111/j.1365-2842.2009.02042.x; SAMARANAYAKE LP, 1986, J ORAL PATHOL MED, V15, P251, DOI 10.1111/j.1600-0714.1986.tb00617.x; Schabereiter-Gurtner C, 2007, J CLIN MICROBIOL, V45, P906, DOI 10.1128/JCM.01344-06; Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; ten Cate JM, 2009, J DENT RES, V88, P105, DOI 10.1177/0022034508329273; Thein ZM, 2006, ARCH ORAL BIOL, V51, P672, DOI 10.1016/j.archoralbio.2006.02.005; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	54	78	80	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42770	10.1371/journal.pone.0042770	http://dx.doi.org/10.1371/journal.pone.0042770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900048	gold, Green Published			2022-12-27	WOS:000307380900066
J	Li, YY; Zhang, H; Xu, J; Qian, Y; Lu, XZ; Yang, B; Chen, ML; Yang, ZJ; Cao, KJ				Li, Yan-yan; Zhang, Hui; Xu, Jian; Qian, Yun; Lu, Xin-zheng; Yang, Bing; Chen, Minglong; Yang, Zhi-jian; Cao, Ke-jiang			Bradykinin beta(2) Receptor-58T/C Gene Polymorphism and Essential Hypertension: A Meta-Analysis	PLOS ONE			English	Article							PROMOTER POLYMORPHISM; ASSOCIATION; REGION; BIAS; B2	Background: Research has shown that bradykinin beta(2) receptor (BDKRB2) -58T/C gene polymorphism is correlated with the risk of essential hypertension (EH), but the results remain inconclusive. Objective and Methods: The objective of this study was to explore the association between BDKRB2-58T/C gene polymorphism and EH. A meta-analysis of 11 studies with 3882 subjects was conducted. Pooled odds ratios (ORs) for the association between BDKRB2-58T/C gene polymorphism and EH and their corresponding 95% confidence intervals (CIs) were estimated using the random effects model. Results: The BDKRB2-58T/C gene polymorphism was significantly correlated with EH under an allelic genetic model (OR = 1.24, 95% CI = 1.05-1.46; P = 0.01), a dominant genetic model (OR = 0.65, 95% CI = 0.47-0.90; P = 0.01), a recessive genetic model (OR = 1.146, 95% CI = 1.035-1.269; P = 0.009), a homozygote genetic model (OR = 1.134, 95% CI = 1.048-1.228; P = 0.002), and a heterozygote genetic model (OR = 1.060, 95% CI = 1.009-1.112; P = 0.019). Conclusions: The BDKRB2-58T/C gene polymorphism is associated with increased EH risk. The results of this study suggest that carriers of the -58C allele are susceptible to EH.	[Li, Yan-yan; Xu, Jian; Qian, Yun; Yang, Bing; Chen, Minglong; Yang, Zhi-jian] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China; [Zhang, Hui; Lu, Xin-zheng; Yang, Zhi-jian; Cao, Ke-jiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Li, YY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China.	lyynjmu123@126.com; kjcao@njmu.edu.cn			National Natural Science Foundation of China [NSFC 81100073]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was funded by the National Natural Science Foundation of China (NSFC 81100073 to Dr Yan-yan Li) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfie ME, 1997, HYPERTENSION, V29, P483, DOI 10.1161/01.HYP.29.1.483; Aoki S, 2001, JPN CIRC J, V65, P621, DOI 10.1253/jcj.65.621; Bhupatiraju C, 2012, CLIN EXP HYPERTENS, V34, P230, DOI 10.3109/10641963.2011.631653; Braun A, 1996, HUM GENET, V97, P688; Braun A, 1996, IMMUNOPHARMACOLOGY, V33, P32, DOI 10.1016/0162-3109(96)00079-3; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; Cui J, 2005, J HYPERTENS, V23, P55, DOI 10.1097/00004872-200501000-00013; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; [董会奕 Dong Huiyi], 2006, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V28, P1252; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fu Y, 2004, HYPERTENS RES, V27, P933, DOI 10.1291/hypres.27.933; Gainer JV, 2000, AM J HYPERTENS, V13, P1268, DOI 10.1016/S0895-7061(00)01215-2; Katori M, 1996, JPN J PHARMACOL, V70, P95, DOI 10.1254/jjp.70.95; [李南方 LI Nanfang], 2008, [医学分子生物学杂志, Journal of Medical Molecular Biology], V5, P110; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030214; MANTEL N, 1959, J NATL CANCER I, V22, P719; Milan A, 2005, J HYPERTENS, V23, P63, DOI 10.1097/00004872-200501000-00014; Mukae S, 1999, JPN CIRC J, V63, P759, DOI 10.1253/jcj.63.759; Niu WQ, 2010, CLIN CHIM ACTA, V411, P324, DOI 10.1016/j.cca.2009.12.015; SIRAGY HM, 1993, AM J PHYSIOL, V265, pE648, DOI 10.1152/ajpendo.1993.265.4.E648; Wang B, 2001, HYPERTENS RES, V24, P299, DOI 10.1291/hypres.24.299; [邹力 ZOU Li], 2011, [中国老年学杂志, Chinese Journal of Gerontology], V31, P2609	22	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43068	10.1371/journal.pone.0043068	http://dx.doi.org/10.1371/journal.pone.0043068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900090	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900108
J	Minot, S; Wu, GD; Lewis, JD; Bushman, FD				Minot, Samuel; Wu, Gary D.; Lewis, James D.; Bushman, Frederic D.			Conservation of Gene Cassettes among Diverse Viruses of the Human Gut	PLOS ONE			English	Article							DE-NOVO ASSEMBLER; MODULAR EVOLUTION; PHAGE; DNA; BACTERIOPHAGES; PROTEINS; GENOMICS; SEQUENCE; FEATURES; LAMBDA	Viruses are a crucial component of the human microbiome, but large population sizes, high sequence diversity, and high frequencies of novel genes have hindered genomic analysis by high-throughput sequencing. Here we investigate approaches to metagenomic assembly to probe genome structure in a sample of 5.6 Gb of gut viral DNA sequence from six individuals. Tests showed that a new pipeline based on DeBruijn graph assembly yielded longer contigs that were able to recruit more reads than the equivalent non-optimized, single-pass approach. To characterize gene content, the database of viral RefSeq proteins was compared to the assembled viral contigs, generating a bipartite graph with functional cassettes linking together viral contigs, which revealed a high degree of connectivity between diverse genomes involving multiple genes of the same functional class. In a second step, open reading frames were grouped by their co-occurrence on contigs in a database-independent manner, revealing conserved cassettes of co-oriented ORFs. These methods reveal that free-living bacteriophages, while usually dissimilar at the nucleotide level, often have significant similarity at the level of encoded amino acid motifs, gene order, and gene orientation. These findings thus connect contemporary metagenomic analysis with classical studies of bacteriophage genomic cassettes. Software is available at https://sourceforge.net/projects/optitdba/.	[Minot, Samuel; Bushman, Frederic D.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wu, Gary D.] Univ Penn, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lewis, James D.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Minot, S (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu		Bushman, Frederic/0000-0003-4740-4056; Minot, Samuel/0000-0003-1639-3905	Human Microbiome Roadmap Demonstration Project [UH2DK083981]; NIH [T32AI060516]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083981] Funding Source: NIH RePORTER	Human Microbiome Roadmap Demonstration Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Human Microbiome Roadmap Demonstration Project UH2DK083981 (Wu, Bushman, Lewis, Co-PIs). SM was supported by NIH Training Grant T32AI060516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Botstein D, 1980, Ann N Y Acad Sci, V354, P484, DOI 10.1111/j.1749-6632.1980.tb27987.x; BOTSTEIN D, 1974, NATURE, V251, P584, DOI 10.1038/251584a0; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/j.resmic.2008.04.006; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Charuvaka A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S8; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Hendrix R. W, 1983, LAMBDA, VII; Hershey A. D., 1971, BACTERIOPHAGE LAMBDA; Hoffmann KH, 2007, FEMS MICROBIOL LETT, V273, P224, DOI 10.1111/j.1574-6968.2007.00790.x; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lima-Mendez G, 2011, RES MICROBIOL, V162, P737, DOI 10.1016/j.resmic.2011.06.006; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Lucchini S, 1999, J VIROL, V73, P8647, DOI 10.1128/JVI.73.10.8647-8656.1999; Luo C, 2011, ISME J; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Minot S, 2012, P NATL ACAD SCI US; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; OHLENDORF DH, 1983, J MOL BIOL, V169, P757, DOI 10.1016/S0022-2836(83)80169-7; Peng Y, 2011, BIOINFORMATICS, V27, pI94, DOI 10.1093/bioinformatics/btr216; Peng Y, 2010, LECT N BIOINFORMAT, V6044, P426, DOI 10.1007/978-3-642-12683-3_28; Petrov VM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-292; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pignatelli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019984; Pruitt K, 2011, NCBI HDB; Ptashne M, 1986, GENETIC SWITCH; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rao Venigalla B., 2005, P40; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rohwer F, 2003, CELL, V113, P141, DOI 10.1016/S0092-8674(03)00276-9; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; SAUER RT, 1982, NATURE, V298, P447, DOI 10.1038/298447a0; Shah SA, 2011, RES MICROBIOL, V162, P27, DOI 10.1016/j.resmic.2010.09.001; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; WILGUS GS, 1973, VIROLOGY, V56, P46, DOI 10.1016/0042-6822(73)90286-9; Willner D, 2011, P NATL ACAD SCI USA, V108, P4547, DOI 10.1073/pnas.1000089107; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	49	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42342	10.1371/journal.pone.0042342	http://dx.doi.org/10.1371/journal.pone.0042342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900013	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900030
J	Bouso, JC; Gonzalez, D; Fondevila, S; Cutchet, M; Fernandez, X; Barbosa, PCR; Alcazar-Corcoles, MA; Araujo, WS; Barbanoj, MJ; Fabregas, JM; Riba, J				Carlos Bouso, Jose; Gonzalez, Debora; Fondevila, Sabela; Cutchet, Marta; Fernandez, Xavier; Ribeiro Barbosa, Paulo Cesar; Angel Alcazar-Corcoles, Miguel; Sena Araujo, Wladimyr; Barbanoj, Manel J.; Maria Fabregas, Josep; Riba, Jordi			Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study	PLOS ONE			English	Article							PSYCHOACTIVE BEVERAGE AYAHUASCA; DRUG-USE; ADDICTION SEVERITY; RECEPTOR; 5-HT2A; PHARMACOLOGY; SPIRITUALITY; ADOLESCENCE; IMPULSIVITY; MECHANISMS	Ayahuasca is an Amazonian psychoactive plant beverage containing the serotonergic 5-HT2A agonist N,N-dimethyltryptamine (DMT) and monoamine oxidase-inhibiting alkaloids (harmine, harmaline and tetrahydroharmine) that render it orally active. Ayahuasca ingestion is a central feature in several Brazilian syncretic churches that have expanded their activities to urban Brazil, Europe and North America. Members of these groups typically ingest ayahuasca at least twice per month. Prior research has shown that acute ayahuasca increases blood flow in prefrontal and temporal brain regions and that it elicits intense modifications in thought processes, perception and emotion. However, regular ayahuasca use does not seem to induce the pattern of addiction-related problems that characterize drugs of abuse. To study the impact of repeated ayahuasca use on general psychological well-being, mental health and cognition, here we assessed personality, psychopathology, life attitudes and neuropsychological performance in regular ayahuasca users (n = 127) and controls (n = 115) at baseline and 1 year later. Controls were actively participating in non-ayahuasca religions. Users showed higher Reward Dependence and Self-Transcendence and lower Harm Avoidance and Self-Directedness. They scored significantly lower on all psychopathology measures, showed better performance on the Stroop test, the Wisconsin Card Sorting Test and the Letter-Number Sequencing task from the WAIS-III, and better scores on the Frontal Systems Behavior Scale. Analysis of life attitudes showed higher scores on the Spiritual Orientation Inventory, the Purpose in Life Test and the Psychosocial Well-Being test. Despite the lower number of participants available at follow-up, overall differences with controls were maintained one year later. In conclusion, we found no evidence of psychological maladjustment, mental health deterioration or cognitive impairment in the ayahuasca-using group.	[Carlos Bouso, Jose; Riba, Jordi] IIB St Pau, Barcelona, Spain; [Carlos Bouso, Jose; Barbanoj, Manel J.; Riba, Jordi] Univ Autonoma Barcelona, Ctr Invest Medicaments, Serv Farmacol Clin, Dept Farmacol & Terapeut, E-08193 Barcelona, Spain; [Carlos Bouso, Jose] ICEERS, Halsteren, Netherlands; [Gonzalez, Debora] Univ Autonoma Barcelona, Unidad Farmacol Humana & Neurociencias, Inst Invest Hosp Mar IMIM, E-08193 Barcelona, Spain; [Fondevila, Sabela] Ctr UCM ISCIII Human Evolut & Behav, Madrid, Spain; [Cutchet, Marta; Maria Fabregas, Josep] IDEAA, Barcelona, Spain; [Ribeiro Barbosa, Paulo Cesar] Univ Estadual Santa Cruz, Dept Filosofia & Ciencias Humanas, Ilheus, Bahia, Brazil; [Angel Alcazar-Corcoles, Miguel] Univ Autonoma Madrid, Dept Psicol Biol & Salud, Fac Psicol, Madrid, Spain; [Sena Araujo, Wladimyr] Conselho Estadual Educac Estado Acre, Prefeitura Municipal Rio Branco, Rio Branco, Acre, Brazil; [Riba, Jordi] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universidade Estadual de Santa Cruz; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona	Bouso, JC (corresponding author), IIB St Pau, Barcelona, Spain.	jbouso@santpau.cat	Alcázar-Córcoles, Miguel Ángel/AAE-5735-2020; Alcázar-Córcoles, Miguel Ángel/C-4012-2011	Alcázar-Córcoles, Miguel Ángel/0000-0003-1650-2606; Alcázar-Córcoles, Miguel Ángel/0000-0003-1650-2606; Riba, Jordi/0000-0002-9375-8421; Bouso, Jose Carlos/0000-0003-1115-9407	IDEAA, Instituto de Estopsicologia Amazonica Aplicada, Barcelona (Spain)/Prato Raso (Brazil); International Center for Ethnobotanical Education, Research & Service (ICEERS Foundation)	IDEAA, Instituto de Estopsicologia Amazonica Aplicada, Barcelona (Spain)/Prato Raso (Brazil); International Center for Ethnobotanical Education, Research & Service (ICEERS Foundation)	Funding for this study was provided by IDEAA, Instituto de Estopsicologia Amazonica Aplicada, Barcelona (Spain)/Prato Raso (Brazil). We also would like to thank the International Center for Ethnobotanical Education, Research & Service (ICEERS Foundation; www.iceers.org) for funding the edition costs of this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, INT NARC CONTR BOARD; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Barbosa PCR, 2005, J PSYCHOACTIVE DRUGS, V37, P193, DOI 10.1080/02791072.2005.10399801; Beique JC, 2007, P NATL ACAD SCI USA, V104, P9870, DOI 10.1073/pnas.0700436104; Bouso JC, 2011, ETHNOPHARMACOLOGY AY, P55; Cami J, 2003, NEW ENGL J MED, V349, P975, DOI 10.1056/NEJMra023160; Casullo M. M, 2000, REV PSICOLOGIA LIMA, VXVIII, P35; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Colzato LS, 2009, PSYCHOPHARMACOLOGY, V207, P225, DOI 10.1007/s00213-009-1650-0; Crumbaugh JC, 1976, PURPOSE LIFE TEST; Da Silveira DX, 2005, J PSYCHOACTIVE DRUGS, V37, P129, DOI 10.1080/02791072.2005.10399792; de Araujo DB, 2012, HUM BRAIN MAPP, V33, P2550, DOI 10.1002/hbm.21381; Derogatis L. R., 1994, SCL 90 R SYMPT CHECK; Derogatis LR, 2001, CUESTIONARIO 90 SINT; Doering-Silveira E, 2005, J PSYCHOACTIVE DRUGS, V37, P123, DOI 10.1080/02791072.2005.10399791; dos Santos RG, 2012, PSYCHOPHARMACOLOGY, V219, P1039, DOI 10.1007/s00213-011-2434-x; dos Santos RG, 2011, J CLIN PSYCHOPHARM, V31, P717, DOI 10.1097/JCP.0b013e31823607f6; ELKINS DN, 1988, J HUMANIST PSYCHOL, V28, P5, DOI 10.1177/0022167888284002; Fantegrossi WE, 2008, BIOCHEM PHARMACOL, V75, P17, DOI 10.1016/j.bcp.2007.07.018; Francis L, 2001, RES SOCIAL SCI STUDY, V12, P53; Fuentes D., 2000, ESCALAS AVALIA O 150, P363; Goldberg E., 2001, EXECUTIVE BRAIN FRON; Golden C.J., 1994, STROOP TEST COLORES; Grace J., 2001, FRSBE FRONTAL SYSTEM; Grob CS, 1996, J NERV MENT DIS, V184, P86, DOI 10.1097/00005053-199602000-00004; Halpern JH, 2005, BIOL PSYCHIAT, V58, P624, DOI 10.1016/j.biopsych.2005.06.038; Halpern JH, 2008, MED SCI MONITOR, V14, pSR15; Heaton RK, 2001, WCST TEST CLASIFICAC; Jocham G, 2009, NEUROSCI BIOBEHAV R, V33, P48, DOI 10.1016/j.neubiorev.2008.08.011; Fernandez-Serrano MJ, 2012, PSYCHOPHARMACOLOGY, V219, P673, DOI 10.1007/s00213-011-2485-z; Fernandez-Serrano MJ, 2010, J PSYCHOPHARMACOL, V24, P1317, DOI 10.1177/0269881109349841; Labate B.C., 2008, AYAHUASCA RELIG COMP; Lane HY, 2008, J PSYCHIATR NEUROSCI, V33, P47; Le Berre AP, 2010, ALCOHOL CLIN EXP RES, V34, P1888, DOI 10.1111/j.1530-0277.2010.01277.x; Lima F, 2002, REV BRAS PSIQUIAT S2, V24; Macher RB, 2012, J CLIN EXP NEUROPSYC, V34, P405, DOI 10.1080/13803395.2011.646957; MacLean KA, 2011, J PSYCHOPHARMACOL, V25, P1453, DOI 10.1177/0269881111420188; MacRae E., 1992, GUIDED MOON SHAMANIS; Fabregas JM, 2010, DRUG ALCOHOL DEPEN, V111, P257, DOI 10.1016/j.drugalcdep.2010.03.024; McIlhenny EH, 2011, BIOMED CHROMATOGR, V25, P970, DOI 10.1002/bmc.1551; McKenna DJ, 2004, PHARMACOL THERAPEUT, V102, P111, DOI 10.1016/j.pharmathera.2004.03.002; McLellan AT, 2006, AM J ADDICTION, V15, P113, DOI 10.1080/10550490500528316; Melcher T, 2008, BRAIN RES REV, V59, P96, DOI 10.1016/j.brainresrev.2008.06.003; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moreno JL, 2011, NEUROSCI LETT, V493, P76, DOI 10.1016/j.neulet.2011.01.046; Nestor LJ, 2011, PSYCHIAT RES-NEUROIM, V194, P287, DOI 10.1016/j.pscychresns.2011.04.010; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Oberauer K, 2005, PSYCHOL BULL, V131, P61, DOI 10.1037/0033-2909.131.1.61; Passetti F, 2003, PSYCHOPHARMACOLOGY, V165, P136, DOI 10.1007/s00213-002-1227-7; Passie T, 2008, CNS NEUROSCI THER, V14, P295, DOI 10.1111/j.1755-5949.2008.00059.x; Pedrero-Perez E. J., 2006, ADICCIONES, V18, P135; PIERCE PA, 1989, PSYCHOPHARMACOLOGY, V97, P118, DOI 10.1007/BF00443425; Riba J, 2006, PSYCHOPHARMACOLOGY, V186, P93, DOI 10.1007/s00213-006-0358-7; Riba J, 2001, PSYCHOPHARMACOLOGY, V154, P85, DOI 10.1007/s002130000606; Riba J, 2003, J PHARMACOL EXP THER, V306, P73, DOI 10.1124/jpet.103.049882; Riba J, 2002, BRIT J CLIN PHARMACO, V53, P613, DOI 10.1046/j.1365-2125.2002.01609.x; Barbosa PCR, 2009, J PSYCHOACTIVE DRUGS, V41, P205, DOI 10.1080/02791072.2009.10400530; Santos RG, 2007, J ETHNOPHARMACOL, V112, P507, DOI 10.1016/j.jep.2007.04.012; Santos RG, 2008, BR J PSYCHIAT; Schultes R., 1979, PLANTS GODS ORIGINS; Smith RL, 1998, PHARMACOL BIOCHEM BE, V61, P323, DOI 10.1016/S0091-3057(98)00110-5; Spinella M, 2003, ADDICT BIOL, V8, P67, DOI 10.1080/1355621031000069909; Stenner K., 2005, AUTHORITARIAN DYNAMI; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tosello D, 2001, THESIS U CATOLICA CA; Trichter S, 2009, J PSYCHOACTIVE DRUGS, V41, P121, DOI 10.1080/02791072.2009.10399905; Tupper KW, 2008, INT J DRUG POLICY, V19, P297, DOI 10.1016/j.drugpo.2006.11.001; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Verdejo-Garcia A, 2006, ADDICT BEHAV, V31, P1373, DOI 10.1016/j.addbeh.2005.11.003; Vollenweider FX, 1999, NEUROPSYCHOPHARMACOL, V20, P424, DOI 10.1016/S0893-133X(98)00108-0; Wechsler D., 1997, WECHSLER ADULT INTEL; Williams GV, 2002, J NEUROSCI, V22, P2843, DOI 10.1523/JNEUROSCI.22-07-02843.2002; Yucel M, 2007, AUST NZ J PSYCHIAT, V41, P957, DOI 10.1080/00048670701689444	77	158	160	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42421	10.1371/journal.pone.0042421	http://dx.doi.org/10.1371/journal.pone.0042421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905130	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100037
J	Gupta, GK; Agrawal, T; Del Core, MG; Hunter, WJ; Agrawal, DK				Gupta, Gaurav K.; Agrawal, Tanupriya; Del Core, Michael G.; Hunter, William J., III; Agrawal, Devendra K.			Decreased Expression of Vitamin D Receptors in Neointimal Lesions following Coronary Artery Angioplasty in Atherosclerotic Swine	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BALLOON ANGIOPLASTY; D DEFICIENCY; CARDIOVASCULAR-DISEASE; BARE-METAL; RESTENOSIS; MODEL; 1,25-DIHYDROXYVITAMIN-D3; INFLAMMATION; ASSOCIATION	Background: Inflammatory cytokines, such as TNF-alpha, play a key role in the pathogenesis of occlusive vascular diseases. Activation of vitamin D receptors (VDR) elicits both growth-inhibitory and anti-inflammatory effects. Here, we investigated the expression of TNF-alpha and VDR in post-angioplasty coronary artery neointimal lesions of hypercholesterolemic swine and examined the effect of vitamin D deficiency on the development of coronary restenosis. We also examined the effect of calcitriol on cell proliferation and effect of TNF-alpha on VDR activity and expression in porcine coronary artery smooth muscle cells (PCASMCs) in-vitro. Methodology/Principal Findings: Expression of VDR and TNF-alpha and the effect of vitamin D deficiency in post-angioplasty coronary arteries were analyzed by immunohistochemistry and histomorphometry. Cell proliferation was examined by thymidine and BrdU incorporation assays in cultured PCASMCs. Effect of TNF-alpha-stimulation on the activity and expression of VDR was analyzed by luciferase assay, immunoblotting and immunocytochemistry. In-vivo, morphometric analysis of the tissues revealed typical lesions with significant neointimal proliferation. Histological evaluation showed expression of smooth muscle alpha-actin and significantly increased expression of TNF-alpha in neointimal lesions. Interestingly, there was significantly decreased expression of VDR in PCASMCs of neointimal region compared to normal media. Indeed, post-balloon angioplasty restenosis was significantly higher in vitamin D-deficient hypercholesterolemic swine compared to vitamin D-sufficient group. In-vitro, calcitriol inhibited both serum- and PDGF-BB-induced proliferation in PCASMCs and TNF-alpha-stimulation significantly decreased the expression and activity of VDR in PCASMCs. Conclusions/Significance:These data suggest that significant downregulation of VDR in proliferating smooth muscle cells in neointimal lesions could be due to atherogenic cytokines, including TNF-alpha. Vitamin D deficiency potentiates the development of coronary restenosis. Calcitriol has anti-proliferative properties in PCASMCs and these actions are mediated through VDR. This could be a potential mechanism for uncontrolled growth of neointimal cells in injured arteries leading to restenosis.	[Gupta, Gaurav K.; Agrawal, Tanupriya; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Gupta, Gaurav K.; Agrawal, Tanupriya; Agrawal, Devendra K.] Creighton Univ, Sch Med, Ctr Clin & Translat Sci, Omaha, NE 68178 USA; [Del Core, Michael G.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Internal Med, Omaha, NE 68178 USA; [Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Hunter, William J., III] Creighton Univ, Sch Med, Dept Pathol, Omaha, NE 68178 USA	Creighton University; Creighton University; Creighton University; Creighton University; Creighton University	Gupta, GK (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	dkagr@creighton.edu	Agrawal, Devendra/GLR-3925-2022; Stefanadis, Christodoulos/ABH-2232-2020	Agrawal, Devendra/0000-0001-5445-0013; Agrawal, Tanupriya/0000-0002-7649-2828; Stefanadis, Christodoulos/0000-0001-5974-6454	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL104516, R01HL116042]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104516, R01HL116042, R01HL112597, R01HL120659] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award numbers R01HL104516 and R01HL116042 to DKA. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Cardus A, 2003, NEFROLOGIA, V23, P117; Carlberg C, 2001, STEROIDS, V66, P213, DOI 10.1016/S0039-128X(00)00150-1; Carrelli AL, 2011, STROKE, V42, P2240, DOI 10.1161/STROKEAHA.110.608539; Chen SC, 2010, J STEROID BIOCHEM, V118, P135, DOI 10.1016/j.jsbmb.2009.11.002; DOKOH S, 1984, CANCER RES, V44, P2103; Donners MMPC, 2003, ANN MED, V35, P523, DOI 10.1080/07853890310014876; Fernandez-Martin JL, 1998, MOL CELL ENDOCRINOL, V141, P65, DOI 10.1016/S0303-7207(98)00094-X; Garg P, 2008, J AM COLL CARDIOL, V51, P1844, DOI 10.1016/j.jacc.2008.01.042; Gupta GK, 2011, EXP MOL PATHOL, V91, P346, DOI 10.1016/j.yexmp.2011.04.004; HALLORAN BP, 1981, J BIOL CHEM, V256, P7338; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Jia GH, 2007, J SURG RES, V142, P137, DOI 10.1016/j.jss.2006.11.007; Jovinge S, 1997, ARTERIOSCL THROM VAS, V17, P490, DOI 10.1161/01.ATV.17.3.490; Kenagy RD, 1997, CIRCULATION, V96, P3555; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Michos ED, 2008, CURR OPIN CLIN NUTR, V11, P7, DOI 10.1097/MCO.0b013e3282f2f4dd; MITSUHASHI T, 1991, J CLIN INVEST, V87, P1889, DOI 10.1172/JCI115213; Monraats PS, 2005, FASEB J, V19, P1998, DOI 10.1096/fj.05-4634com; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Pilz S, 2008, J CLIN ENDOCR METAB, V93, P3927, DOI 10.1210/jc.2008-0784; Rajasree S, 2002, LIFE SCI, V70, P1777, DOI 10.1016/S0024-3205(02)01473-X; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; SCHWARTZ RS, 1990, CIRCULATION, V82, P2190, DOI 10.1161/01.CIR.82.6.2190; Seol Sang-Hoon, 2009, Korean Circ J, V39, P439, DOI 10.4070/kcj.2009.39.10.439; Shah PK, 2003, CIRCULATION, V107, P2175, DOI 10.1161/01.CIR.0000069943.41206.BD; Somjen D, 2005, CIRCULATION, V111, P1666, DOI 10.1161/01.CIR.0000160353.27927.70; STEELE PM, 1985, CIRC RES, V57, P105, DOI 10.1161/01.RES.57.1.105; Toutouzas K, 2004, EUR HEART J, V25, P1679, DOI 10.1016/j.ehj.2004.06.011; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Williams S, 2009, ETHN DIS S5, V19; Wu-Wong JR, 2007, J CELL BIOCHEM, V100, P1395, DOI 10.1002/jcb.21133; Wu-Wong JR, 2006, ATHEROSCLEROSIS, V186, P20, DOI 10.1016/j.atherosclerosis.2005.06.046; Zhou ZM, 2002, ATHEROSCLEROSIS, V161, P153, DOI 10.1016/S0021-9150(01)00640-2	33	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42789	10.1371/journal.pone.0042789	http://dx.doi.org/10.1371/journal.pone.0042789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880111	gold, Green Published, Green Submitted			2022-12-27	WOS:000307810000071
J	Jones, JE; Kroll, AJ; Giovanini, J; Duke, SD; Ellis, TM; Betts, MG				Jones, Jay E.; Kroll, Andrew J.; Giovanini, Jack; Duke, Steven D.; Ellis, Tana M.; Betts, Matthew G.			Avian Species Richness in Relation to Intensive Forest Management Practices in Early Seral Tree Plantations	PLOS ONE			English	Article							PACIFIC-NORTHWEST; DOUGLAS-FIR; COASTAL OREGON; BIRD ABUNDANCE; UNITED-STATES; VEGETATION; COMMUNITIES; LANDSCAPE; DIVERSITY; HABITAT	Background: Managers of landscapes dedicated to forest commodity production require information about how practices influence biological diversity. Individual species and communities may be threatened if management practices truncate or simplify forest age classes that are essential for reproduction and survival. For instance, the degradation and loss of complex diverse forest in young age classes have been associated with declines in forest-associated Neotropical migrant bird populations in the Pacific Northwest, USA. These declines may be exacerbated by intensive forest management practices that reduce hardwood and broadleaf shrub cover in order to promote growth of economically valuable tree species in plantations. Methodology and Principal Findings: We used a Bayesian hierarchical model to evaluate relationships between avian species richness and vegetation variables that reflect stand management intensity (primarily via herbicide application) on 212 tree plantations in the Coast Range, Oregon, USA. Specifically, we estimated the influence of broadleaf hardwood vegetation cover, which is reduced through herbicide applications, on bird species richness and individual species occupancy. Our model accounted for imperfect detection. We used average predictive comparisons to quantify the degree of association between vegetation variables and species richness. Both conifer and hardwood cover were positively associated with total species richness, suggesting that these components of forest stand composition may be important predictors of alpha diversity. Estimates of species richness were 35-80% lower when imperfect detection was ignored (depending on covariate values), a result that has critical implications for previous efforts that have examined relationships between forest composition and species richness. Conclusion and Significance: Our results revealed that individual and community responses were positively associated with both conifer and hardwood cover. In our system, patterns of bird community assembly appear to be associated with stand management strategies that retain or increase hardwood vegetation while simultaneously regenerating the conifer cover in commercial tree plantations.	[Jones, Jay E.; Giovanini, Jack; Duke, Steven D.] Weyerhaeuser NR, Stat Math & Operat Res, Washington, DC USA; [Kroll, Andrew J.] Weyerhaeuser NR, Timberlands Technol, Washington, DC USA; [Ellis, Tana M.; Betts, Matthew G.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA	Oregon State University	Jones, JE (corresponding author), Weyerhaeuser NR, Stat Math & Operat Res, Fed Way, Washington, DC USA.	jay.jones@weyerhaeuser.com	Kroll, Andrew/ABB-3724-2020; Betts, Matthew G/Q-2978-2019	Kroll, Andrew/0000-0001-7747-830X; Betts, Matthew G/0000-0002-7100-2551	National Science Foundation [NSF-ARC-0941748]; United States Department of Agriculture Food and Research Initiative [AFRI-2009-04457]; National Council for Air and Stream Improvement; Directorate For Geosciences [0941748] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture Food and Research Initiative; National Council for Air and Stream Improvement; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially supported by grants from the National Science Foundation (NSF-ARC-0941748), the United States Department of Agriculture Food and Research Initiative (AFRI-2009-04457), and the National Council for Air and Stream Improvement to M.G. Betts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Arnett EB, 2010, FOREST ECOL MANAG, V260, P1773, DOI 10.1016/j.foreco.2010.08.021; Berlik MM, 2002, J BIOGEOGR, V29, P1557, DOI 10.1046/j.1365-2699.2002.00768.x; Beschta RL, 2004, CONSERV BIOL, V18, P957, DOI 10.1111/j.1523-1739.2004.00495.x; Betts MG, 2010, ECOL APPL, V20, P2116, DOI 10.1890/09-1305.1; BIBBY CJ, 1987, ACTA OECOL-OEC GEN, V8, P103; Binkley CS, 2005, J FOREST, V103, P61; Bunnell Fred L., 1999, Environmental Reviews, V7, P97, DOI 10.1139/a99-010; Cam E, 2000, ECOL APPL, V10, P1196, DOI 10.2307/2641026; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; DeGraaf RM, 2003, FOREST ECOL MANAG, V185, P179, DOI 10.1016/S0378-1127(03)00254-8; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Ellis TM, 2012, CAN J FOREST RES, V42, P918, DOI [10.1139/x2012-035, 10.1139/X2012-035]; Ellis TM, 2011, FOREST ECOL MANAG, V261, P1372, DOI 10.1016/j.foreco.2011.01.018; ENOKSSON B, 1995, LANDSCAPE ECOL, V10, P267, DOI 10.1007/BF00128994; Etterson MA, 2009, ECOL APPL, V19, P2049, DOI 10.1890/08-1317.1; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A, 2007, SOCIOL METHODOL, V37, P23, DOI 10.1111/j.1467-9531.2007.00181.x; Hagar JC, 2007, FOREST ECOL MANAG, V246, P108, DOI 10.1016/j.foreco.2007.03.054; HARRINGTON TB, 1995, FOREST ECOL MANAG, V76, P55, DOI 10.1016/0378-1127(95)03558-R; Harrington TB, 2005, PRODUCTIVITY W FORES, P27; Harvey CA, 2007, BIODIVERS CONSERV, V16, P2257, DOI 10.1007/s10531-007-9194-2; Hayes JP, 2005, J FOREST, V103, P83; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Kennedy RSH, 2005, BIOL CONSERV, V122, P363, DOI 10.1016/j.biocon.2004.07.022; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P327, DOI 10.1111/j.1466-8238.2007.00379.x; Kroll AJ, 2010, FOREST ECOL MANAG, V260, P1599, DOI 10.1016/j.foreco.2010.08.009; Lesak AA, 2011, REMOTE SENS ENVIRON, V115, P2823, DOI 10.1016/j.rse.2011.01.025; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Linden DW, FOREST ECOL IN PRESS; Lindh BC, 2004, FOREST ECOL MANAG, V192, P285, DOI 10.1016/j.foreco.2004.01.018; Maas B, 2009, BIOL CONSERV, V142, P2665, DOI 10.1016/j.biocon.2009.06.018; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Marshall MR, 2003, FOREST ECOL MANAG, V183, P127, DOI 10.1016/S0378-1127(03)00101-4; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; MARTIN TE, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P455; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; MORRISON ML, 1984, J WILDLIFE MANAGE, V48, P14, DOI 10.2307/3808449; Nagy LR, 2005, ECOLOGY, V86, P675, DOI 10.1890/04-0155; Najera A, 2010, CONSERV BIOL, V24, P319, DOI 10.1111/j.1523-1739.2009.01350.x; Oliver C.D., 1996, FOREST STAND DYNAMIC; Paquet JY, 2006, FOREST ECOL MANAG, V227, P59, DOI 10.1016/j.foreco.2006.02.009; Pearman PB, 2002, ECOL MONOGR, V72, P19, DOI 10.1890/0012-9615(2002)072[0019:TSOCSH]2.0.CO;2; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Ralph CJ, 1995, PSWGTR149 USDA FOR S; RICH TD, 2004, PARTNERS FLIGHT N AM; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Sauer J.R., 2008, N AM BREEDING BIRD S; Schieck J, 1997, CONDOR, V99, P179, DOI 10.2307/1370236; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Spies TA, 2007, ECOL APPL, V17, P5, DOI 10.1890/1051-0761(2007)017[0005:CEASEO]2.0.CO;2; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Tappeiner JC, 2001, CAN J FOREST RES, V31, P1629, DOI 10.1139/cjfr-31-9-1629; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; TERBORGH J, 1975, ECOLOGY, V56, P562, DOI 10.2307/1935491; van Dorp D, 1987, LANDSCAPE ECOL, V1, P59, DOI 10.1007/BF02275266; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WILLSON MF, 1974, ECOLOGY, V55, P1017, DOI 10.2307/1940352; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	66	22	22	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43290	10.1371/journal.pone.0043290	http://dx.doi.org/10.1371/journal.pone.0043290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905249	Green Published, gold			2022-12-27	WOS:000307823600065
J	Malcevschi, S; Marchini, A; Savini, D; Facchinetti, T				Malcevschi, Sergio; Marchini, Agnese; Savini, Dario; Facchinetti, Tullio			Opportunities for Web-Based Indicators in Environmental Sciences	PLOS ONE			English	Article							GOOGLE; INFORMATION; MANAGEMENT; GOVERNANCE; SCALE	This paper proposes a set of web-based indicators for quantifying and ranking the relevance of terms related to key-issues in Ecology and Sustainability Science. Search engines that operate in different contexts (e.g. global, social, scientific) are considered as web information carriers (WICs) and are able to analyse; (i) relevance on different levels: global web, individual/personal sphere, on-line news, and culture/science; (ii) time trends of relevance; (iii) relevance of keywords for environmental governance. For the purposes of this study, several indicators and specific indices (relational indices and dynamic indices) were applied to a test-set of 24 keywords. Outputs consistently show that traditional study topics in environmental sciences such as water and air have remained the most quantitatively relevant keywords, while interest in systemic issues (i.e. ecosystem and landscape) has grown over the last 20 years. Nowadays, the relevance of new concepts such as resilience and ecosystem services is increasing, but the actual ability of these concepts to influence environmental governance needs to be further studied and understood. The proposed approach, which is based on intuitive and easily replicable procedures, can support the decision-making processes related to environmental governance.	[Malcevschi, Sergio; Marchini, Agnese; Savini, Dario] Univ Pavia, Dipartimento Sci Terra & Ambiente, I-27100 Pavia, Italy; [Facchinetti, Tullio] Univ Pavia, Dipartimento Ingn Ind & Informaz, I-27100 Pavia, Italy	University of Pavia; University of Pavia	Malcevschi, S (corresponding author), Univ Pavia, Dipartimento Sci Terra & Ambiente, Via Palestro 3, I-27100 Pavia, Italy.	dario.savini@unipv.it	Marchini, Agnese/J-9256-2012	Marchini, Agnese/0000-0003-4580-0522; Facchinetti, Tullio/0000-0003-0221-6123	Regione Lombardia	Regione Lombardia(Regione Lombardia)	The study has been funded by Regione Lombardia, commissioning the Department of Earth and Environmental Sciences of the University of Pavia for studying ecological webs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal P, 2009, J RETAILING, V85, P145, DOI 10.1016/j.jretai.2009.03.001; Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Apic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020902; ARROW K, 1995, SCIENCE, V268, P520, DOI 10.1126/science.268.5210.520; Berners-Lee T, 2006, SCIENCE, V313, P769, DOI 10.1126/science.1126902; Bollen J, 2006, SCIENTOMETRICS, V69, P227, DOI 10.1007/s11192-006-0151-8; Borja A, 2008, ECOL INDIC, V8, P331, DOI 10.1016/j.ecolind.2007.05.004; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Buizer M, 2011, ECOL SOC, V16; Caliman A, 2010, BIODIVERS CONSERV, V19, P651, DOI 10.1007/s10531-009-9725-0; Cooley R, 1997, PROC INT C TOOLS ART, P558, DOI 10.1109/TAI.1997.632303; Cortese J., 2007, INTERNET LEARNING BU; Entwistle A, 2000, PRIORITIES CONSERVAT; Evans JA, 2011, SCIENCE, V331, P721, DOI 10.1126/science.1201765; Fazey I, 2010, ECOL SOC, V15; Fergus R, 2004, LECT NOTES COMPUT SC, V3021, P242; Fuchs Christian, 2008, INTERNET SOC SOCIAL; Gaikwad J., 2008, CKWB WEB BASED PROTO; Gorley C.K., 2006, GETTING STARTED PRIM; Hengl T, 2009, SCIENTOMETRICS, V80, P491, DOI 10.1007/s11192-009-0073-3; Hood WW, 2001, SCIENTOMETRICS, V52, P291, DOI 10.1023/A:1017919924342; Introna LD, 2000, INFORM SOC, V16, P169, DOI 10.1080/01972240050133634; Kemp-Benedict EJ, 2010, ECOL SOC, V15; Kousha K, 2009, J AM SOC INF SCI TEC, V60, P1537, DOI 10.1002/asi.21085; Learned E.P., 1965, BUSINESS POLICY TEXT; Leydesdorff L, 2007, J AM SOC INF SCI TEC, V58, P1303, DOI 10.1002/asi.20614; Malcevschi S, 2005, VALUTAZIONE AMBIENTA, V8, P11; Malcevschi S, 2005, VALUTAZIONE AMBIENTA, V8, P47; Malcevschi S, 2009, VALUTAZIONE AMBIENTA, V16, P87; Malcevschi S, 2010, ENV CULTURAL WEB PRO; Malcevschi S, 2010, VALUTAZIONE AMBIENTA, V17, P105; Malcevschi S, 2008, VALUTAZIONE AMBIENTA, V14, P85; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Moed HF., 2004, HDB QUANTITATIVE SCI; Nobis M, 2004, OIKOS, V106, P411, DOI 10.1111/j.0030-1299.2004.13496.x; Noruzi A, 2005, LIBRI, V55, P170, DOI 10.1515/LIBR.2005.170; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Ostendorf B, 2011, ECOL INDIC, V11, P97, DOI 10.1016/j.ecolind.2010.10.003; Perz SG, 2010, ENVIRON CONSERV, V37, P419, DOI 10.1017/S0376892910000810; Rametsteiner E, 2011, ECOL INDIC, V11, P61, DOI 10.1016/j.ecolind.2009.06.009; Reid WV, 2010, SCIENCE, V330, P916, DOI 10.1126/science.1196263; Schwarz CJ, 2007, INT STAT REV, V75, P348, DOI 10.1111/j.1751-5823.2007.00035.x; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sheate WR, 2010, ENVIRON IMPACT ASSES, V30, P278, DOI 10.1016/j.eiar.2009.10.003; Shields D., 2002, ECOL INDIC, V2, P149, DOI [DOI 10.1016/S1470-160X(02)00042-0, 10.1016/S1470-160X(02)00042-0]; Slevin J., 2000, INTERNET SOC; Termeer CJAM, 2010, ECOL SOC, V15; Varian, 2009, PREDICTING PRESENT G; Vaughan L, 2005, J AM SOC INF SCI TEC, V56, P1075, DOI 10.1002/asi.20199; White RM, 2009, LAND USE POLICY, V26, P242, DOI 10.1016/j.landusepol.2008.03.005; Yang GB, 2003, ASIAN SURV, V43, P405, DOI 10.1525/as.2003.43.3.405	52	10	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42128	10.1371/journal.pone.0042128	http://dx.doi.org/10.1371/journal.pone.0042128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AG	22905118	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600010
J	Russell, CL; Semerdjieva, S; Empson, RM; Austen, BM; Beesley, PW; Alifragis, P				Russell, Claire L.; Semerdjieva, Sophia; Empson, Ruth M.; Austen, Brian M.; Beesley, Philip W.; Alifragis, Pavlos			Amyloid-beta Acts as a Regulator of Neurotransmitter Release Disrupting the Interaction between Synaptophysin and VAMP2	PLOS ONE			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; PRECURSOR PROTEIN; RAT HIPPOCAMPUS; VESICLE ENDOCYTOSIS; SOLUBLE OLIGOMERS; NATURAL OLIGOMERS; RECEPTOR	Background: It is becoming increasingly evident that deficits in the cortex and hippocampus at early stages of dementia in Alzheimer's disease (AD) are associated with synaptic damage caused by oligomers of the toxic amyloid-beta peptide (A beta 42). However, the underlying molecular and cellular mechanisms behind these deficits are not fully understood. Here we provide evidence of a mechanism by which A beta 42 affects synaptic transmission regulating neurotransmitter release. Methodology/Findings: We first showed that application of 50 nM A beta 42 in cultured neurones is followed by its internalisation and translocation to synaptic contacts. Interestingly, our results demonstrate that with time, A beta 42 can be detected at the presynaptic terminals where it interacts with Synaptophysin. Furthermore, data from dissociated hippocampal neurons as well as biochemical data provide evidence that A beta 42 disrupts the complex formed between Synaptophysin and VAMP2 increasing the amount of primed vesicles and exocytosis. Finally, electrophysiology recordings in brain slices confirmed that A beta 42 affects baseline transmission. Conclusions/Significance: Our observations provide a necessary and timely insight into cellular mechanisms that underlie the initial pathological events that lead to synaptic dysfunction in Alzheimer's disease. Our results demonstrate a new mechanism by which A beta 42 affects synaptic activity.	[Russell, Claire L.; Semerdjieva, Sophia; Empson, Ruth M.; Beesley, Philip W.; Alifragis, Pavlos] Royal Holloway Univ London, Sch Biol Sci, Surrey, England; [Empson, Ruth M.] Univ Otago, Sch Med Sci, Dept Physiol, Dunedin, New Zealand; [Austen, Brian M.] Univ London, Neurodegenerat Unit, London, England	University of London; Royal Holloway University London; University of Otago; University of London	Russell, CL (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Surrey, England.	pavlos.alifragis@rhul.ac.uk		Alifragis, Pavlos/0000-0003-0844-2316; Empson, Ruth/0000-0002-0415-6083	Southwest Academic Network (SWAN); Biotechnology and Biological Sciences Research Council (BBSRC)	Southwest Academic Network (SWAN); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	C.L.R. was supported by the Southwest Academic Network (SWAN) and S. S. was funded by the Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; ARIAS C, 1995, J NEUROSCI RES, V41, P561, DOI 10.1002/jnr.490410416; Arthur CP, 2007, STRUCTURE, V15, P707, DOI 10.1016/j.str.2007.04.011; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cuevas ME, 2011, J ALZHEIMERS DIS; Cullen WK, 1997, NEUROREPORT, V8, P3213, DOI 10.1097/00001756-199710200-00006; Dougherty JJ, 2003, J NEUROSCI, V23, P6740; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; El-Agnaf OMA, 2000, BIOCHEM BIOPH RES CO, V273, P1003, DOI 10.1006/bbrc.2000.3051; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gordon SL, 2011, J NEUROSCI, V31, P14032, DOI 10.1523/JNEUROSCI.3162-11.2011; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x; HARRIS ME, 1995, NEUROREPORT, V6, P1875, DOI 10.1097/00001756-199510020-00013; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Kabogo D, 2010, NEUROBIOL AGING, V31, P1164, DOI 10.1016/j.neurobiolaging.2008.08.009; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Kelly BL, 2007, NEUROSCIENCE, V147, P60, DOI 10.1016/j.neuroscience.2007.03.047; Kim JH, 2001, J NEUROSCI, V21, P1327; Klyubin I, 2011, NEUROBIOL AGING, V32, P614, DOI 10.1016/j.neurobiolaging.2009.04.005; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; Li M, 2007, PROG NEUROBIOL, V83, P131, DOI 10.1016/j.pneurobio.2007.08.002; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Mezler M, 2011, BR J PHARM; Molnar Z, 2004, NEUROREPORT, V15, P1649, DOI 10.1097/01.wnr.0000134471.06244.d2; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Parodi J, 2010, J BIOL CHEM, V285, P2506, DOI 10.1074/jbc.M109.030023; Pellistri F, 2008, J BIOL CHEM; Pennuto M, 2002, MOL BIOL CELL, V13, P2706, DOI 10.1091/mbc.E02-01-0036; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Puangthong U, 2009, NEUROPSYCH DIS TREAT, V5, P553; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Scholtzova H, 2008, J NEUROSCI RES; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Sian AK, 2000, BIOCHEM J, V349, P299, DOI 10.1042/0264-6021:3490299; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Spiwoks-Becker I, 2001, NEUROSCIENCE, V107, P127, DOI 10.1016/S0306-4522(01)00345-1; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200	75	75	90	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43201	10.1371/journal.pone.0043201	http://dx.doi.org/10.1371/journal.pone.0043201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905234	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600058
J	Creanza, N; Fogarty, L; Feldman, MW				Creanza, Nicole; Fogarty, Laurel; Feldman, Marcus W.			Models of Cultural Niche Construction with Selection and Assortative Mating	PLOS ONE			English	Article							MARRIAGE FORM; SEX-RATIOS; EVOLUTION; TRANSMISSION; INHERITANCE; COEVOLUTION; WAR	Niche construction is a process through which organisms modify their environment and, as a result, alter the selection pressures on themselves and other species. In cultural niche construction, one or more cultural traits can influence the evolution of other cultural or biological traits by affecting the social environment in which the latter traits may evolve. Cultural niche construction may include either gene-culture or culture-culture interactions. Here we develop a model of this process and suggest some applications of this model. We examine the interactions between cultural transmission, selection, and assorting, paying particular attention to the complexities that arise when selection and assorting are both present, in which case stable polymorphisms of all cultural phenotypes are possible. We compare our model to a recent model for the joint evolution of religion and fertility and discuss other potential applications of cultural niche construction theory, including the evolution and maintenance of large-scale human conflict and the relationship between sex ratio bias and marriage customs. The evolutionary framework we introduce begins to address complexities that arise in the quantitative analysis of multiple interacting cultural traits.	[Creanza, Nicole; Feldman, Marcus W.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Fogarty, Laurel] Univ St Andrews, Sch Biol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland	Stanford University; University of St Andrews	Creanza, N (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	creanza@stanford.edu		Creanza, Nicole/0000-0001-8821-7383	National Institutes of Health [GM28016]; Biotechnology and Biological Sciences Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health grant GM28016 and a Biotechnology and Biological Sciences Research Council studentship to LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI K, 1986, P NATL ACAD SCI USA, V83, P2929, DOI 10.1073/pnas.83.9.2929; Boyd R., 1985, CULTURE EVOLUTIONARY; Brown MJ, 2009, P NATL ACAD SCI USA, V106, P22139, DOI 10.1073/pnas.0907520106; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; CAVALLIS.LL, 1973, AM J HUM GENET, V25, P618; CAVALLISFORZA LL, 1976, P NATL ACAD SCI USA, V73, P1689, DOI 10.1073/pnas.73.5.1689; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Durham WH., 1991, COEVOLUTION GENES CU; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Feldman M.W., 1989, MATH EVOLUTIONARY TH; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; GUGLIELMINO CR, 1995, P NATL ACAD SCI USA, V92, P7585, DOI 10.1073/pnas.92.16.7585; Halperin E, 2011, SCIENCE, V333, P1767, DOI 10.1126/science.1202925; HEATON TB, 1990, SOCIOL ANAL, V51, P363, DOI 10.2307/3711077; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; Hinde R. A., 1987, INDIVIDUALS RELATION; Hinde RA, 1997, INTERDISCIPL SCI REV, V22, P229; Ihara Y, 2004, THEOR POPUL BIOL, V65, P105, DOI 10.1016/j.tpb.2003.07.003; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KUMM J, 1994, THEOR POPUL BIOL, V46, P249, DOI 10.1006/tpbi.1994.1027; Kumm J, 1997, THEOR POPUL BIOL, V52, P1, DOI 10.1006/tpbi.1997.1304; Laland Kevin., 2002, SENSE NONSENSE EVOLU; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Laland KN, 1996, J EVOLUTION BIOL, V9, P293, DOI 10.1046/j.1420-9101.1996.9030293.x; Laland KN, 2000, BEHAV BRAIN SCI, V23, P131, DOI 10.1017/S0140525X00002417; Lehmann L, 2008, P ROY SOC B-BIOL SCI, V275, P2877, DOI 10.1098/rspb.2008.0842; Lewontin R.C., 1983, P273; Lewontin R.C., 1982, LEARNING DEV CULTURE, P151; Li N., 2000, MATH POPUL STUD, V8, P91, DOI [DOI 10.1080/08898480009525475, 10.1080/08898480009525475]; Li SZ, 2001, SOC BIOL, V48, P125; Lipatov M, 2011, PHILOS T R SOC B, V366, P901, DOI 10.1098/rstb.2010.0303; Odling-Smee F. J., 2009, PREHISTORY LANGUAGE, P99, DOI DOI 10.1093/ACPROF:OSO/9780199545872.003.0006; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Odling-Smee John, 2010, P175; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Rowthorn R, 2011, P ROY SOC B-BIOL SCI, V278, P2519, DOI 10.1098/rspb.2010.2504; Saunders MA, 2002, GENETICS, V162, P1849; Sosis R, 2003, EVOL ANTHROPOL, V12, P264, DOI 10.1002/evan.10120; TULJAPURKAR S, 1995, SCIENCE, V267, P874, DOI 10.1126/science.7846529	39	30	31	1	240	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42744	10.1371/journal.pone.0042744	http://dx.doi.org/10.1371/journal.pone.0042744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905167	Green Published, gold			2022-12-27	WOS:000307500800020
J	Svensson, PA; Lehtonen, TK; Wong, BBM				Svensson, P. Andreas; Lehtonen, Topi K.; Wong, Bob B. M.			A High Aggression Strategy for Smaller Males	PLOS ONE			English	Article							ESCALATING FIGHTS; ROUND GOBIES; BODY-SIZE; FEMALE; INFORMATION; EVOLUTION; DOMINANCE; SELECTION; DURATION; SPIDER	Male-male conflict is common among animals, but questions remain as to when, how and by whom aggression should be initiated. Factors that affect agonistic strategies include residency, the value of the contested resource and the fighting ability of the two contestants. We quantified initiation of aggression in a fish, the desert goby, Chlamydogobius eremius, by exposing nest-holding males to a male intruder. The perceived value of the resource ( the nest) was manipulated by exposing half of the residents to sexually receptive females for two days before the trial. Resident male aggression, however, was unaffected by perceived mating opportunities. It was also unaffected by the absolute and relative size of the intruder. Instead resident aggression was negatively related to resident male size. In particular, smaller residents attacked sooner and with greater intensity compared to larger residents. These results suggest that resident desert goby males used set, rather than conditional, strategies for initiating aggression. If intruders are more likely to flee than retaliate, small males may benefit from attacking intruders before these have had an opportunity to assess the resident and/or the resource.	[Svensson, P. Andreas] Linnaeus Univ, Dept Nat Sci, Kalmar, Sweden; [Svensson, P. Andreas; Lehtonen, Topi K.; Wong, Bob B. M.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Lehtonen, Topi K.] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland	Linnaeus University; Monash University; University of Turku	Svensson, PA (corresponding author), Linnaeus Univ, Dept Nat Sci, Kalmar, Sweden.	andreas.svensson@lnu.se	Lehtonen, Topi/A-6679-2010; Svensson, P Andreas/D-2517-2015	Lehtonen, Topi/0000-0002-1372-9509; Svensson, P Andreas/0000-0002-1426-0036; Wong, Bob/0000-0001-9352-6500	Australian Research Council Discovery Project [DP0771070]; Deakin University; Academy of Finland; Department of Biology, University of Turku	Australian Research Council Discovery Project(Australian Research Council); Deakin University; Academy of Finland(Academy of Finland); Department of Biology, University of Turku	Funding was provided by the Australian Research Council Discovery Project, grant number DP0771070 (to BBMW), an Alfred Deakin Postdoctoral Research Fellowship from Deakin University (to PAS), and the Academy of Finland and Department of Biology, University of Turku (to TKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balshine S, 2005, J GREAT LAKES RES, V31, P68, DOI 10.1016/S0380-1330(05)70238-0; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Bergman M, 2010, P ROY SOC B-BIOL SCI, V277, P3027, DOI 10.1098/rspb.2010.0646; Brown WD, 2007, ETHOLOGY, V113, P457, DOI 10.1111/j.1439-0310.2007.01357.x; Cooper William E. Jr., 1997, Amphibia-Reptilia, V18, P59, DOI 10.1163/156853897X00314; Crawley M.J., 2007, R BOOK; Dubs DOL, 1996, J GREAT LAKES RES, V22, P838, DOI 10.1016/S0380-1330(96)71005-5; DUGATKIN LA, 1990, ANIM BEHAV, V39, P802, DOI 10.1016/S0003-3472(05)80394-X; FRANCK D, 1989, BEHAV ECOL SOCIOBIOL, V24, P133, DOI 10.1007/BF00292096; Glover CJM, 1971, THESIS U ADELAIDE; Goldsmith SK, 1996, J INSECT BEHAV, V9, P719, DOI 10.1007/BF02213552; GROSSMAN GD, 1980, OECOLOGIA, V45, P261, DOI 10.1007/BF00346467; Hack MA, 1997, ETHOLOGY, V103, P488; Hsu YY, 2001, ANIM BEHAV, V61, P777, DOI 10.1006/anbe.2000.1650; JANSSEN J, 1990, COPEIA, P349, DOI 10.2307/1446340; Johnsson JI, 2002, BEHAV ECOL SOCIOBIOL, V51, P282, DOI 10.1007/S00265-001-0430-6; Just W, 2003, EVOL ECOL, V17, P509, DOI 10.1023/B:EVEC.0000005629.54152.83; Just W, 2000, IEEE C EVOL COMPUTAT, P851, DOI 10.1109/CEC.2000.870727; Just W, 2007, BEHAV PROCESS, V74, P342, DOI 10.1016/j.beproc.2006.12.005; Lehtonen TK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-233; Lindstrom K, 2001, AM NAT, V158, P64, DOI 10.1086/320867; Magnhagen C, 2006, ANIM BEHAV, V71, P879, DOI 10.1016/j.anbehav.2005.07.017; Maynard Smith J., 1982, pi; McPhee MV, 1998, ENVIRON BIOL FISH, V51, P369, DOI 10.1023/A:1007432928783; Mehlis M, 2010, P ROY SOC B-BIOL SCI, V277, P2627, DOI 10.1098/rspb.2010.0234; Morrell LJ, 2005, P ROY SOC B-BIOL SCI, V272, P1235, DOI 10.1098/rspb.2005.3085; MORRIS MR, 1995, BEHAV ECOL SOCIOBIOL, V37, P303, DOI 10.1007/BF00174134; Nijman V, 2011, NEOTROP ICHTHYOL, V9, P543, DOI 10.1590/S1679-62252011005000031; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; R Core Team, 2020, R LANG ENV STAT COMP; Raftery AE, 2010, BMA BAYESIAN MODEL A; RIBOWSKI A, 1993, ETHOLOGY, V93, P265; RIBOWSKI A, 1993, AGGRESSIVE BEHAV, V19, P223, DOI 10.1002/1098-2337(1993)19:3<223::AID-AB2480190307>3.0.CO;2-T; SIGURJONSDOTTIR H, 1981, BEHAV ECOL SOCIOBIOL, V8, P219, DOI 10.1007/BF00299834; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Svensson PA, 2010, BEHAV ECOL SOCIOBIOL, V64, P1967, DOI 10.1007/s00265-010-1007-z; Taylor PW, 2001, BEHAV ECOL SOCIOBIOL, V50, P403, DOI 10.1007/s002650100390; TEMELES EJ, 1990, ANIM BEHAV, V40, P361, DOI 10.1016/S0003-3472(05)80931-5; Therneau T., 2009, SURVIVAL SURVIVAL AN; Thunken T, 2011, BEHAV ECOL, V22, P358, DOI 10.1093/beheco/arq217; Van Tassell JL, 2012, BIOLOGY OF GOBIES, P3; Viallefont V, 2001, STAT MED, V20, P3215, DOI 10.1002/sim.976.abs; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Wong BBM, 2009, BEHAV ECOL SOCIOBIOL, V63, P543, DOI 10.1007/s00265-008-0689-y	45	21	21	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43121	10.1371/journal.pone.0043121	http://dx.doi.org/10.1371/journal.pone.0043121			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OQ	22905213	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800047
J	Bridges, D; Chang, L; Lodhi, IJ; Clark, NA; Saltiel, AR				Bridges, Dave; Chang, Louise; Lodhi, Irfan J.; Clark, Natalie A.; Saltiel, Alan R.			TC10 Is Regulated by Caveolin in 3T3-L1 Adipocytes	PLOS ONE			English	Article							STIMULATED GLUT4 TRANSLOCATION; NUCLEOTIDE-EXCHANGE FACTORS; RHO-GTPASES; TYROSINE PHOSPHORYLATION; SIGNALING PATHWAYS; GLUCOSE-TRANSPORT; EXOCYST COMPLEX; G-PROTEINS; INSULIN; MEMBRANE	Background: TC10 is a small GTPase found in lipid raft microdomains of adipocytes. The protein undergoes activation in response to insulin, and plays a key role in the regulation of glucose uptake by the hormone. Methodology/Principal Findings: TC10 requires high concentrations of magnesium in order to stabilize guanine nucleotide binding. Kinetic analysis of this process revealed that magnesium acutely decreased the nucleotide release and exchange rates of TC10, suggesting that the G protein may behave as a rapidly exchanging, and therefore active protein in vivo. However, in adipocytes, the activity of TC10 is not constitutive, indicating that mechanisms must exist to maintain the G protein in a low activity state in untreated cells. Thus, we searched for proteins that might bind to and stabilize TC10 in the inactive state. We found that Caveolin interacts with TC10 only when GDP-bound and stabilizes GDP binding. Moreover, knockdown of Caveolin 1 in 3T3-L1 adipocytes increased the basal activity state of TC10. Conclusions/Significance: Together these data suggest that TC10 is intrinsically active in vivo, but is maintained in the inactive state by binding to Caveolin 1 in 3T3-L1 adipocytes under basal conditions, permitting its activation by insulin.	[Bridges, Dave; Chang, Louise; Lodhi, Irfan J.; Clark, Natalie A.; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bridges, D (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	saltiel@lsi.umich.edu	Saltiel, Alan/L-3632-2019; Bridges, Dave/A-8825-2010	Bridges, Dave/0000-0002-5334-972X; Lodhi, Irfan/0000-0002-6246-9862; Chang, Louise/0000-0001-5501-4774; Saltiel, Alan/0000-0002-9726-9828	National Institutes of Health [DK01618]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (www.nih.gov) grant DK01618 and an American Diabetes Association (www.diabetes.org) Mentor Based Postdoctoral Fellowship (to DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chang L, 2002, P NATL ACAD SCI USA, V99, P12835, DOI 10.1073/pnas.202495599; Chang L, 2007, ENDOCRINOLOGY, V148, P27, DOI 10.1210/en.2006-1167; Cheng ZJ, 2010, J BIOL CHEM, V285, P15119, DOI 10.1074/jbc.M109.069427; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Chiang SH, 2002, J BIOL CHEM, V277, P13067, DOI 10.1074/jbc.M109471200; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Gingras D, 1998, BIOCHEM BIOPH RES CO, V247, P888, DOI 10.1006/bbrc.1998.8885; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Kanzaki M, 2004, J CELL BIOL, V164, P279, DOI 10.1083/jcb.200306152; Kepner EM, 2011, AM J PHYSIOL-ENDOC M, V301, pE1072, DOI 10.1152/ajpendo.00312.2011; Kimura A, 2002, J BIOL CHEM, V277, P30153, DOI 10.1074/jbc.M203375200; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523; Neudauer CL, 2000, METHOD ENZYMOL, V325, P3; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; Wu SK, 1996, TRENDS BIOCHEM SCI, V21, P472, DOI 10.1016/S0968-0004(96)10062-1; Ye M, 2005, J BIOL CHEM, V280, P31267, DOI 10.1074/jbc.M505503200	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42451	10.1371/journal.pone.0042451	http://dx.doi.org/10.1371/journal.pone.0042451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900022	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900038
J	Ma, L; Ranganathan, R				Ma, Lan; Ranganathan, Rama			Quantifying the Rhythm of KaiB-C Interaction for In Vitro Cyanobacterial Circadian Clock	PLOS ONE			English	Article							SYNECHOCOCCUS-ELONGATUS; PROTEIN INTERACTIONS; FLUORESCENT PROTEIN; ATPASE ACTIVITY; PHOSPHORYLATION; DYNAMICS; OSCILLATION; MODEL; DETERMINES; FEEDBACK	An oscillator consisting of KaiA, KaiB, and KaiC proteins comprises the core of cyanobacterial circadian clock. While one key reaction in this process-KaiC phosphorylation-has been extensively investigated and modeled, other key processes, such as the interactions among Kai proteins, are not understood well. Specifically, different experimental techniques have yielded inconsistent views about Kai A, B, and C interactions. Here, we first propose a mathematical model of cyanobacterial circadian clock that explains the recently observed dynamics of the four phospho-states of KaiC as well as the interactions among the three Kai proteins. Simulations of the model show that the interaction between KaiB and KaiC oscillates with the same period as the phosphorylation of KaiC, but displays a phase delay of similar to 8 hr relative to the total phosphorylated KaiC. Secondly, this prediction on KaiB-C interaction are evaluated using a novel FRET (Fluorescence Resonance Energy Transfer)based assay by tagging fluorescent proteins Cerulean and Venus to KaiC and KaiB, respectively, and reconstituting fluorescent protein-labeled in vitro clock. The data show that the KaiB: KaiC interaction indeed oscillates with similar to 24 hr periodicity and similar to 8 hr phase delay relative to KaiC phosphorylation, consistent with model prediction. Moreover, it is noteworthy that our model indicates that the interlinked positive and negative feedback loops are the underlying mechanism for oscillation, with the serine phosphorylated-state (the "S-state") of KaiC being a hub for the feedback loops. Because the kinetics of the KaiB-C interaction faithfully follows that of the S-state, the FRET measurement may provide an important real-time probe in quantitative study of the cyanobacterial circadian clock.	[Ma, Lan] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA; [Ma, Lan; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Ma, Lan; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ma, L (corresponding author), Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA.	lan.ma@utdallas.edu						Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Brettschneider C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.44; Clodong S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100128; Dong GG, 2010, CURR OPIN GENET DEV, V20, P619, DOI 10.1016/j.gde.2010.09.002; Dong GG, 2008, CURR OPIN MICROBIOL, V11, P541, DOI 10.1016/j.mib.2008.10.003; Goda K, 2012, J BIOL CHEM, V287, P3241, DOI 10.1074/jbc.M111.265777; Golden SS, 2003, NAT REV MICROBIOL, V1, P191, DOI 10.1038/nrmicro774; Golden SS, 2007, NAT STRUCT MOL BIOL, V14, P362, DOI 10.1038/nsmb0507-362; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwasaki H, 1999, EMBO J, V18, P1137, DOI 10.1093/emboj/18.5.1137; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Kondo T, 2007, COLD SPRING HARB SYM, V72, P47, DOI 10.1101/sqb.2007.72.029; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Kurosawa G, 2006, BIOPHYS J, V91, P2015, DOI 10.1529/biophysj.105.076554; Li CX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000568; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Mehra A, 2006, PLOS COMPUT BIOL, V2, P816, DOI 10.1371/journal.pcbi.0020096; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Murakami R, 2008, GENES CELLS, V13, P387, DOI 10.1111/j.1365-2443.2008.01174.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Pattanayek R, 2008, EMBO J, V27, P1767, DOI 10.1038/emboj.2008.104; Pattanayek R, 2006, EMBO J, V25, P2017, DOI 10.1038/sj.emboj.7601086; Poon AC, 2007, SCIENCE, V318, P757, DOI 10.1126/science.1150740; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; van Zon JS, 2007, P NATL ACAD SCI USA, V104, P7420, DOI 10.1073/pnas.0608665104; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Yang Q, 2010, SCIENCE, V327, P1522, DOI 10.1126/science.1181759; Yoda M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000408	42	8	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42581	10.1371/journal.pone.0042581	http://dx.doi.org/10.1371/journal.pone.0042581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900029	gold, Green Submitted, Green Published			2022-12-27	WOS:000307380900045
J	Liang, YJ; Luo, J; Lu, Q; Zhou, Y; Wu, HW; Zheng, D; Ren, YY; Sun, KY; Wang, Y; Zhang, ZS				Liang, Yue-jin; Luo, Jie; Lu, Qiao; Zhou, Ying; Wu, Hai-wei; Zheng, Dan; Ren, Yong-ya; Sun, Ke-yi; Wang, Yong; Zhang, Zhao-song			Gene Profile of Chemokines on Hepatic Stellate Cells of Schistosome-Infected Mice and Antifibrotic Roles of CXCL9/10 on Liver Non-Parenchymal Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; RECEPTOR CXCR3; FIBROSIS; INFLAMMATION; ACTIVATION; EXPRESSION; HUMANS; MODEL; IMMUNOPATHOLOGY; IDENTIFICATION	Hepatic stellate cells (HSCs) play a key role in the development of liver fibrosis caused by schistosomiasis. Chemokines were widely expressed and involved in cellular activation, proliferation and migration in inflammatory and infectious diseases. However, little is known about the expressions of chemokines on HSCs in the schistosoma infection. In addition, the roles of chemokines in pathogenesis of liver fibrosis are not totally clear. In our study, we used microarray to analyze the temporal gene expressions of primary HSCs isolated from mice with both acute and chronic schistosomiasis. Our microarray data showed that most of the chemokines expressed on HSCs were upregulated at 3 weeks post-infection (p.i) when the egg granulomatous response was not obviously evoked in the liver. However, some of them like CXCL9, CXCL10 and CXCL11 were subsequently decreased at 6 weeks p.i when the granulomatous response reached the peak. In the chronic stage, most of the differentially expressed chemokines maintained persistent high-abundances. Furthermore, several chemokines including CCR2, CCR5, CCR7, CXCR3, CXCR4, CCL2, CCL5, CCL21, CXCL9 and CXCL10 were expressed by HCSs and the abundances of them were changed following the praziquantel treatment in the chronic stage, indicating that chemokines were possibly necessary for the persistence of the chronic stage. In vitro experiments, hepatic non-parenchymal cells, primary HSCs and human HSCs line LX-2 were stimulated by chemokines. The results showed that CXCL9 and CXCL10, but not CXCL11 or CXCL4, significantly inhibited the gene expressions of Col1 alpha 1, Col3 alpha 1 and alpha-SMA, indicating the potential anti-fibrosis effect of CXCL9 and CXCL10 in schistosomiasis. More interestingly, soluble egg antigen (SEA) of Schistosoma japonicum was able to inhibit transcriptional expressions of some chemokines by LX-2 cells, suggesting that SEA was capable of regulating the expression pattern of chemokine family and modulating the hepatic immune microenvironment in schistosomiasis.	[Liang, Yue-jin; Luo, Jie; Lu, Qiao; Zhou, Ying; Zheng, Dan; Wang, Yong; Zhang, Zhao-song] Nanjing Med Univ, Dept Pathogen Biol, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Wu, Hai-wei] Brown Univ, Rhode Isl Hosp, Ctr Int Hlth Res, Providence, RI 02903 USA; [Ren, Yong-ya] Nanjing Med Univ, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Sun, Ke-yi] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Nanjing Medical University; Nanjing Medical University	Liang, YJ (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.	yongwsh@njmu.edu.cn	Liang, Yuejin/X-5250-2019	Liang, Yuejin/0000-0002-9557-1847	National Basic Research Program of China (973 Program) [2007CB513102]; Basic Research Program of Jiangsu Higher Education Institutions [11KJA330003]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Basic Research Program of Jiangsu Higher Education Institutions; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (973 Program) (No. 2007CB513102). The Basic Research Program of Jiangsu Higher Education Institutions (No. 11KJA330003) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony B, 2010, EXP PARASITOL, V124, P409, DOI 10.1016/j.exppara.2009.12.009; Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bonacchi A, 2003, GASTROENTEROLOGY, V125, P1060, DOI 10.1016/S0016-5085(03)01194-6; Bonacchi A, 2001, J BIOL CHEM, V276, P9945, DOI 10.1074/jbc.M010303200; Booth V, 2004, PROTEIN SCI, V13, P2022, DOI 10.1110/ps.04791404; Bourd-Boittin K, 2009, J CELL MOL MED, V13, P1526, DOI 10.1111/j.1582-4934.2009.00787.x; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000598; Campanella GSV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012700; Efsen E, 2002, J HEPATOL, V37, P39, DOI 10.1016/S0168-8278(02)00065-X; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Garcia-Lopez MA, 2001, LAB INVEST, V81, P409, DOI 10.1038/labinvest.3780248; GRAVES DT, 1989, SCIENCE, V245, P1490, DOI 10.1126/science.2781291; Hasegawa H, 2008, GENE THER, V15, P171, DOI 10.1038/sj.gt.3303051; Hintermann E, 2010, J AUTOIMMUN, V35, P424, DOI 10.1016/j.jaut.2010.09.003; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Liang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020247; Marra F, 2002, FRONT BIOSCI, V7, pD1899, DOI 10.2741/marra; Morais CNL, 2006, MEM I OSWALDO CRUZ, V101, P353, DOI 10.1590/S0074-02762006000900057; Nakaya I, 2007, NEPHRON EXP NEPHROL, V107, pE12, DOI 10.1159/000106505; Osterreicher CH, 2009, HEPATOLOGY, V50, P929, DOI 10.1002/hep.23104; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Perney P, 2009, CLIN IMMUNOL, V132, P55, DOI 10.1016/j.clim.2009.03.521; Peterson TC, 1998, BIOCHEM PHARMACOL, V55, P703, DOI 10.1016/S0006-2952(97)00593-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rutitzky LI, 2001, P NATL ACAD SCI USA, V98, P13243, DOI 10.1073/pnas.231258498; Santodomingo-Garzon T, 2009, HEPATOLOGY, V49, P1267, DOI 10.1002/hep.22761; Shimizu I, 1999, GUT, V44, P127, DOI 10.1136/gut.44.1.127; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Tao FF, 2009, VACCINE, V27, P4110, DOI 10.1016/j.vaccine.2009.04.073; Wasmuth HE, 2010, Z GASTROENTEROL, V48, P38, DOI 10.1055/s-0028-1109933; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zeremski M, 2009, J INFECT DIS, V200, P1774, DOI 10.1086/646614	42	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42490	10.1371/journal.pone.0042490	http://dx.doi.org/10.1371/journal.pone.0042490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905138	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100042
J	Link, A; Becker, V; Goel, A; Wex, T; Malfertheiner, P				Link, Alexander; Becker, Verena; Goel, Ajay; Wex, Thomas; Malfertheiner, Peter			Feasibility of Fecal MicroRNAs as Novel Biomarkers for Pancreatic Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; COLON-CANCER; EXPRESSION; ADENOCARCINOMA; TUMORS; STOOL; STRATEGIES; SIGNATURE; SURVIVAL; FEATURES	Introduction: Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rates. Majority of PCA patients are diagnosed usually at late tumor stages when the therapeutic options are limited. MicroRNAs (miRNA) are involved in tumor development and are commonly dysregulated in PCA. As a proof-of-principle study, we aimed to evaluate the potential of fecal miRNAs as biomarkers for pancreatic cancer. Materials and Methods: Total RNA was extracted from feces using Qiagen's miRNA Mini Kit. For miRNA expression analyses we selected a subset of 7 miRNAs that are frequently dysregulated in PCA (miR-21, -143, -155, -196a, -210, -216a, -375). Subsequently, expression levels of these miRNAs were determined in fecal samples from controls (n = 15), chronic pancreatitis (n = 15) and PCA patients (n = 15) using quantitative TaqMan-PCR assays. Results: All selected miRNAs were detectable in fecal samples with high reproducibility. Four of seven miRNAs (miR-216a, -196a, -143 und -155) were detected at lower concentrations in feces of PCA patients when compared to controls (p < 0.05). Analysis of fecal miRNA expression in controls and patients with chronic pancreatitis and PCA revealed that the expression of miR-216a, -196a, -143 und -155 were highest in controls and lowest in PCA. The expression of the remaining three miRNAs (miR-21, -210 and -375) remained unchanged among controls and the patients with either chronic pancreatitis or PCA. Conclusion: Our data provide novel evidence for the differential expression of miRNAs in feces of patients with PCA. If successfully validated in large-scale prospective studies, the fecal miRNA biomarkers may offer novel tools for PCA screening research.	[Link, Alexander; Becker, Verena; Wex, Thomas; Malfertheiner, Peter] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Goel, Ajay] Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab, Div Gastroenterol,Baylor Res Inst, Dallas, TX USA	Otto von Guericke University; Baylor Scott & White Health; Baylor University; Baylor University Medical Center	Link, A (corresponding author), Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany.	alinkmail@gmail.com		Goel, Ajay/0000-0003-1396-6341; Link, Alexander/0000-0002-9514-4562				Ahmed Farid E., 2009, Cancer Genomics & Proteomics, V6, P281; Ali S, 2011, AM J TRANSL RES, V3, P28; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bhatti I, 2011, J GASTROINTEST SURG, V15, P199, DOI 10.1007/s11605-010-1381-x; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Buchholz M, 2008, PANCREATOLOGY, V8, P551, DOI 10.1159/000159213; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Canto MI, 2007, SEMIN ONCOL, V34, P295, DOI 10.1053/j.seminoncol.2007.05.008; Chang Y, 2012, GASTROENTEROLOGY; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Furukawa H, 1996, CANCER, V78, P986, DOI 10.1002/(SICI)1097-0142(19960901)78:5<986::AID-CNCR7>3.0.CO;2-A; Ghaneh P, 2008, POSTGRAD MED J, V84, P478, DOI 10.1136/gut.2006.103333; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Greenhalf W, 2009, PANCREATOLOGY, V9, P215, DOI 10.1159/000210262; Greenhalf W, 2006, NAT CLIN PRACT ONCOL, V3, P346, DOI 10.1038/ncponc0483; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Haug U, 2008, EXPERT REV MOL DIAGN, V8, P753, DOI 10.1586/14737159.8.6.753; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kalimutho M, 2011, J GASTROENTEROL, V46, P1391, DOI 10.1007/s00535-011-0456-0; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kong XY, 2011, DIGEST DIS SCI, V56, P602, DOI 10.1007/s10620-010-1285-3; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; LaConti JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020687; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; Melnikov AA, 2009, J SURG ONCOL, V99, P119, DOI 10.1002/jso.21208; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Pramanik D, 2011, MOL CANCER THER, V10, P1470, DOI 10.1158/1535-7163.MCT-11-0152; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sadakari Y, 2010, J PANCREAS, V11, P587; Stan SD, 2010, NAT REV GASTRO HEPAT, V7, P347, DOI 10.1038/nrgastro.2010.61; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wu CW, 2012, GUT, V61, P739, DOI 10.1136/gut.2011.239236; Zhang HG, 2011, CLIN CANCER RES, V17, P959, DOI 10.1158/1078-0432.CCR-10-1489	49	65	71	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42933	10.1371/journal.pone.0042933	http://dx.doi.org/10.1371/journal.pone.0042933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905187	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100076
J	Wei, CF; Hsu, ST; Deng, WL; Wen, YD; Huang, HC				Wei, Chia-Fong; Hsu, Shih-Tien; Deng, Wen-Ling; Wen, Yu-Der; Huang, Hsiou-Chen			Plant Innate Immunity Induced by Flagellin Suppresses the Hypersensitive Response in Non-Host Plants Elicited by Pseudomonas syringae pv. averrhoi	PLOS ONE			English	Article							III SECRETION SYSTEM; TOMATO; DEFENSE; ARABIDOPSIS; PERCEPTION; RESISTANCE; VIRULENCE; EFFECTORS; MOTILITY; GLYCINEA	A new pathogen, Pseudomonas syringae pv. averrhoi (Pav), which causes bacterial spot disease on carambola was identified in Taiwan in 1997. Many strains of this pathovar have been isolated from different locations and several varieties of hosts. Some of these strains, such as HL1, are nonmotile and elicit a strong hypersensitive response (HR) in nonhost tobacco leaves, while other strains, such as PA5, are motile and elicit a weak HR. Based on the image from a transmission electron microscope, the results showed that HL1 is flagellum-deficient and PA5 has normal flagella. Here we cloned and analyzed the fliC gene and glycosylation island from Pav HL1 and PA5. The amino acid sequences of FliC from HL1 and PA5 are identical to P. s. pvs. tabaci (Pta), glycinea and phaseolicola and share very high similarity with other pathovars of P. syringae. In contrast to the flagellin mutant Pta Delta fliC, PA5 Delta fliC grows as well as wild type in the host plant, but it elicits stronger HR than wild type does in non-host plants. Furthermore, the purified Pav flagellin, but not the divergent flagellin from Agrobacterium tumefaciens, is able to impair the HR induced by PA5 Delta fliC. PA5 Delta fgt1 possessing nonglycosylated flagella behaved as its wild type in both bacterial growth in host and HR elicitation. Flagellin was infiltrated into tobacco leaves either simultaneously with flagellum-deficient HL1 or prior to the inoculation of wild type HL1, and both treatments impaired the HR induced by HL1. Moreover, the HR elicited by PA5 and PA5 Delta fliC was enhanced by the addition of cycloheximide, suggesting that the flagellin is one of the PAMPs (pathogen-associated molecular patterns) contributed to induce the PAMP-triggered immunity (PTI). Taken together, the results shown in this study reveal that flagellin in Pav is capable of suppressing HR via PTI induction during an incompatible interaction.	[Wei, Chia-Fong; Huang, Hsiou-Chen] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Hsu, Shih-Tien; Deng, Wen-Ling] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Wen, Yu-Der] Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan	National Chung Hsing University; National Chung Hsing University; National Changhua University of Education	Wei, CF (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan.	hchuang@dragon.nchu.edu.tw			Interchange Association-Japan; NSC-Taiwan (National Science Council);  [NSC97-2317-B-005-001]	Interchange Association-Japan(Interchange Association, Japan); NSC-Taiwan (National Science Council); 	This work was supported by grant NSC97-2317-B-005-001 and the Ph.D. summer program financed by Interchange Association-Japan and NSC-Taiwan (National Science Council) (for C-FW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Bahar O, 2011, MOL PLANT MICROBE IN, V24, P1040, DOI 10.1094/MPMI-02-11-0041; BAKER CJ, 1987, PHYTOPATHOLOGY, V77, P1268, DOI 10.1094/Phyto-77-1268; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bozso Z, 1999, PHYSIOL MOL PLANT P, V55, P215, DOI 10.1006/pmpp.1999.0225; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Charkowski AO, 1998, J BACTERIOL, V180, P5211, DOI 10.1128/JB.180.19.5211-5217.1998; Crabill E, 2010, PLANT PHYSIOL, V154, P233, DOI 10.1104/pp.110.159723; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Hanahan D, 1985, DNA CLONING PRACTICA; Harlow E., 1988, ANTIBODIES LAB MANUA; HATTERMANN DR, 1989, PHYTOPATHOLOGY, V79, P284, DOI 10.1094/Phyto-79-284; He P, 2004, PLANT J, V37, P589, DOI 10.1111/j.1365-313X.2003.01986.x; HUYNH TV, 1992, CIRC RES, V70, P508, DOI 10.1161/01.RES.70.3.508; Ichinose Yuki, 2003, Journal of General Plant Pathology, V69, P244, DOI 10.1007/s10327-003-0045-z; Ishiga Yasuhiro, 2005, Journal of General Plant Pathology, V71, P302, DOI 10.1007/s10327-005-0201-8; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KING EO, 1954, J LAB CLIN MED, V44, P301; Klement Z, 2003, PEST MANAG SCI, V59, P465, DOI 10.1002/ps.694; Klement Z, 1999, J PHYTOPATHOL, V147, P467, DOI 10.1111/j.1439-0434.1999.tb03852.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Lin Y-C, 2006, THESIS NATL CHUNG HS; Lin YuanChuen, 2006, Plant Pathology Bulletin, V15, P139; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Naito K, 2008, MOL PLANT MICROBE IN, V21, P1165, DOI 10.1094/MPMI-21-9-1165; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Newman MA, 2000, MOL PLANT PATHOL, V1, P25, DOI 10.1046/j.1364-3703.2000.00004.x; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Oh HS, 2005, PLANT J, V44, P348, DOI 10.1111/j.1365-313X.2005.02529.x; Oh HS, 2010, MOL PLANT MICROBE IN, V23, P727, DOI 10.1094/MPMI-23-6-0727; Pallen MJ, 2005, TRENDS MICROBIOL, V13, P143, DOI 10.1016/j.tim.2005.02.008; PANOPOULOS NJ, 1974, PHYTOPATHOLOGY, V64, P1389, DOI 10.1094/Phyto-64-1389; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shimizu R, 2003, MOL GENET GENOMICS, V269, P21, DOI 10.1007/s00438-003-0817-3; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Taguchi F, 2003, PLANT CELL PHYSIOL, V44, P342, DOI 10.1093/pcp/pcg042; Taguchi F, 2006, CELL MICROBIOL, V8, P923, DOI 10.1111/j.1462-5822.2005.00674.x; Taguchi F, 2003, PLANT PHYSIOL BIOCH, V41, P165, DOI 10.1016/S0981-9428(02)00018-9; Taguchi F, 2009, PHYSIOL MOL PLANT P, V74, P11, DOI 10.1016/j.pmpp.2009.08.001; Takeuchi K, 2003, J BACTERIOL, V185, P6658, DOI 10.1128/JB.185.22.6658-6665.2003; Tans-Kersten J, 2001, J BACTERIOL, V183, P3597, DOI 10.1128/JB.183.12.3597-3605.2001; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; TOTTEN PA, 1990, J BACTERIOL, V172, P7188, DOI 10.1128/jb.172.12.7188-7199.1990; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; TURNER JG, 1974, PHYTOPATHOLOGY, V64, P885, DOI 10.1094/Phyto-64-885; Wei CF, 2005, MOL MICROBIOL, V57, P520, DOI 10.1111/j.1365-2958.2005.04704.x; WILSON DR, 1993, CAN J MICROBIOL, V39, P451, DOI 10.1139/m93-066; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P3339; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	59	39	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41056	10.1371/journal.pone.0041056	http://dx.doi.org/10.1371/journal.pone.0041056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911741	Green Submitted, Green Published, gold			2022-12-27	WOS:000306687700038
J	Lerret, NM; Rogozinska, M; Jaramillo, A; Marzo, AL				Lerret, Nadine M.; Rogozinska, Magdalena; Jaramillo, Andres; Marzo, Amanda L.			Adoptive Transfer of Mammaglobin-A Epitope Specific CD8 T Cells Combined with a Single Low Dose of Total Body Irradiation Eradicates Breast Tumors	PLOS ONE			English	Article							POORLY IMMUNOGENIC TUMOR; IL-7 RECEPTOR-ALPHA; IN-VIVO; ANTITUMOR IMMUNITY; TRANSFER THERAPY; TRANSGENIC MICE; CENTRAL MEMORY; EFFECTOR; CANCER; LYMPHOCYTES	Adoptive T cell therapy has proven to be beneficial in a number of tumor systems by targeting the relevant tumor antigen. The tumor antigen targeted in our model is Mammaglobin-A, expressed by approximately 80% of human breast tumors. Here we evaluated the use of adoptively transferred Mammaglobin-A specific CD8 T cells in combination with low dose irradiation to induce breast tumor rejection and prevent relapse. We show Mammaglobin-A specific CD8 T cells generated by DNA vaccination with all epitopes (Mammaglobin-A2.1, A2.2, A2.4 and A2.6) and full-length DNA in vivo resulted in heterogeneous T cell populations consisting of both effector and central memory CD8 T cell subsets. Adoptive transfer of spleen cells from all Mammaglobin-A2 immunized mice into tumor-bearing SCID/beige mice induced tumor regression but this anti-tumor response was not sustained long-term. Additionally, we demonstrate that only the adoptive transfer of Mammaglobin-A2 specific CD8 T cells in combination with a single low dose of irradiation prevents tumors from recurring. More importantly we show that this single dose of irradiation results in the down regulation of the macrophage scavenger receptor 1 on dendritic cells within the tumor and reduces lipid uptake by tumor resident dendritic cells potentially enabling the dendritic cells to present tumor antigen more efficiently and aid in tumor clearance. These data reveal the potential for adoptive transfer combined with a single low dose of total body irradiation as a suitable therapy for the treatment of established breast tumors and the prevention of tumor recurrence.	[Lerret, Nadine M.; Rogozinska, Magdalena; Marzo, Amanda L.] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Jaramillo, Andres] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Jaramillo, Andres] Gift Hope Organ & Tissue Donor Network, Histocompatibil Lab, Itasca, IL USA	Rush University; Rush University	Lerret, NM (corresponding author), Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA.	Amanda_Marzo@rush.edu	Jaramillo, Andrés/AAG-8461-2020	Jaramillo, Andrés/0000-0002-0910-1460; Marzo, amanda/0000-0002-5839-0430	Susan G. Komen for the Cure [BCTR0600731]; Prevent Cancer Foundation; Brian Piccolo/Gavers Cancer Research Foundation; Rush UCR grant	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Prevent Cancer Foundation; Brian Piccolo/Gavers Cancer Research Foundation; Rush UCR grant	This work was supported by the Susan G. Komen for the Cure (Grant# BCTR0600731; A. L. M. and A.J.), the Prevent Cancer Foundation (A.L.M. and A.J.), the Brian Piccolo/Gavers Cancer Research Foundation (A.L.M.), and a Rush UCR grant (A.L.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Beverley PC, 2008, NAT CLIN PRACT RHEUM, V4, P43, DOI 10.1038/ncprheum0671; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Dudley ME, 2003, NAT REV CANCER, V3, P666, DOI 10.1038/nrc1167; Fallarino F, 2000, J IMMUNOL, V165, P5495, DOI 10.4049/jimmunol.165.10.5495; Gallez-Hawkins G, 2003, J VIROL, V77, P4457, DOI 10.1128/JVI.77.7.4457-4462.2003; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jaramillo A, 2004, BREAST CANCER RES TR, V88, P29, DOI 10.1007/s10549-004-8918-1; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Lacey SF, 2011, BLOOD, V118, P2159, DOI 10.1182/blood-2011-04-349951; Marzo AL, 2000, J IMMUNOL, V165, P6047, DOI 10.4049/jimmunol.165.11.6047; Marzo AL, 2007, J IMMUNOL, V179, P36, DOI 10.4049/jimmunol.179.1.36; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Narayanan K, 2004, JNCI-J NATL CANCER I, V96, P1388, DOI 10.1093/jnci/djh261; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Paulos CM, 2007, CLIN CANCER RES, V13, P5280, DOI 10.1158/1078-0432.CCR-07-1378; Perret R, 2008, EUR J IMMUNOL, V38, P2886, DOI 10.1002/eji.200838483; Powell DJ, 2005, BLOOD, V105, P241, DOI 10.1182/blood-2004-06-2482; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SHIRAI M, 1995, J IMMUNOL, V154, P2733; Sussman JJ, 2004, CANCER RES, V64, P9124, DOI 10.1158/0008-5472.CAN-03-0376; SUSSMAN JJ, 1994, ANN SURG ONCOL, V1, P296, DOI 10.1007/BF02303568; Thomas WD, 1998, J IMMUNOL, V161, P2195; VITIELLO A, 1991, J EXP MED, V173, P1007, DOI 10.1084/jem.173.4.1007; Watson MA, 1999, CANCER RES, V59, P3028; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wong SBJ, 2008, J IMMUNOL, V180, P3122, DOI 10.4049/jimmunol.180.5.3122; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Zhang PS, 2007, CANCER RES, V67, P6468, DOI 10.1158/0008-5472.CAN-07-1264	38	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41240	10.1371/journal.pone.0041240	http://dx.doi.org/10.1371/journal.pone.0041240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911764	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600059
J	Ort, BS; Bantay, RM; Pantoja, NA; O'Grady, PM				Ort, Brian S.; Bantay, Roxanne M.; Pantoja, Norma A.; O'Grady, Patrick M.			Fungal Diversity Associated with Hawaiian Drosophila Host Plants	PLOS ONE			English	Article							NONPARAMETRIC-ESTIMATION; FOOD PREFERENCES; GENE-EXPRESSION; YOSEMITE REGION; YEAST; LARVAL; ORIGIN; COEVOLUTION; PHYLOGENY; COMMUNITY	Hawaiian Drosophila depend primarily, sometimes exclusively, on specific host plants for oviposition and larval development, and most specialize further on a particular decomposing part of that plant. Differences in fungal community between host plants and substrate types may establish the basis for host specificity in Hawaiian Drosophila. Fungi mediate decomposition, releasing plant micronutrients and volatiles that can indicate high quality substrates and serve as cues to stimulate oviposition. This study addresses major gaps in our knowledge by providing the first culture-free, DNA-based survey of fungal diversity associated with four ecologically important tree genera in the Hawaiian Islands. Three genera, Cheirodendron, Clermontia, and Pisonia, are important host plants for Drosophila. The fourth, Acacia, is not an important drosophilid host but is a dominant forest tree. We sampled fresh and rotting leaves from all four taxa, plus rotting stems from Clermontia and Pisonia. Based on sequences from the D1/D2 domain of the 26S rDNA gene, we identified by BLAST search representatives from 113 genera in 13 fungal classes. A total of 160 operational taxonomic units, defined on the basis of >= 97% genetic similarity, were identified in these samples, but sampling curves show this is an underestimate of the total fungal diversity present on these substrates. Shannon diversity indices ranged from 2.0 to 3.5 among the Hawaiian samples, a slight reduction compared to continental surveys. We detected very little sharing of fungal taxa among the substrates, and tests of community composition confirmed that the structure of the fungal community differed significantly among the substrates and host plants. Based on these results, we hypothesize that fungal community structure plays a central role in the establishment of host preference in the Hawaiian Drosophila radiation.	[Ort, Brian S.; Bantay, Roxanne M.; Pantoja, Norma A.; O'Grady, Patrick M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ort, BS (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	ort@berkeley.edu	O'Grady, Patrick/J-3421-2019	O'Grady, Patrick/0000-0002-6075-8951	University of California, Berkeley; UC Berkeley's Sponsored Projects for Undergraduate Research (SPUR); UC Berkeley's Undergraduate Research Apprenticeship Program (URAP)	University of California, Berkeley(University of California System); UC Berkeley's Sponsored Projects for Undergraduate Research (SPUR); UC Berkeley's Undergraduate Research Apprenticeship Program (URAP)	This work was funded in part by University of California, Berkeley start up funds to PMO. Other funding was from UC Berkeley's Sponsored Projects for Undergraduate Research (SPUR) and Undergraduate Research Apprenticeship Program (URAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anagnostou C, 2010, ENTOMOL EXP APPL, V136, P1, DOI 10.1111/j.1570-7458.2010.00997.x; Anderson TM, 2004, AM NAT, V164, P709, DOI 10.1086/425372; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Barker J.S.F., 1982, ECOLOGICAL GENETICS; BARKER JSF, 1994, HEREDITY, V72, P384, DOI 10.1038/hdy.1994.55; Barker JSF, 1999, HEREDITAS, V130, P145, DOI 10.1111/j.1601-5223.1999.00145.x; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; COOPER DM, 1960, EVOLUTION, V14, P41, DOI 10.2307/2405921; Currie CR, 2006, SCIENCE, V311, P81, DOI 10.1126/science.1119744; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; DACUNHA AB, 1951, EVOLUTION, V5, P97, DOI 10.1111/j.1558-5646.1951.tb02766.x; DESALLE R, 1992, MOL BIOL EVOL, V9, P905; DOBZHANSKY T, 1956, ECOLOGY, V37, P544, DOI 10.2307/1930178; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; EXCOFFIER L, 1992, GENETICS, V131, P479; Fellous S, 2010, MOL ECOL, V19, P1462, DOI 10.1111/j.1365-294X.2010.04567.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; FOGLEMAN JC, 1982, OECOLOGIA, V52, P187, DOI 10.1007/BF00363835; FOGLEMAN JC, 1981, P NATL ACAD SCI-BIOL, V78, P4435, DOI 10.1073/pnas.78.7.4435; Fricke C, 2008, EVOLUTION, V62, P3170, DOI 10.1111/j.1558-5646.2008.00515.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HEED W B, 1971, Taxon, V20, P115, DOI 10.2307/1218539; Heed WB, 1968, ECOLOGY HAWAIIAN DRO, P387; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; KANESHIRO KY, 1973, AM NAT, V107, P766, DOI 10.1086/282874; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kopp A, 2008, MOL BIOL EVOL, V25, P1081, DOI 10.1093/molbev/msn055; Kurtzman CP, 2006, TOP CURR GENET, V15, P29, DOI 10.1007/b106654; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Lachance MA, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P1, DOI 10.1007/3-540-30985-3_1; LACHANCE MA, 1989, YEAST, V5, P501; Lachance MA, 2001, FEMS YEAST RES, V1, P1; Lapoint RT, 2011, MOL PHYLOGENET EVOL, V58, P492, DOI 10.1016/j.ympev.2010.12.015; LINDSAY SL, 1958, AM NAT, V92, P279, DOI 10.1086/282036; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Magnacca KN, 2008, ZOOTAXA, P1; Magnacca KN, 2012, ZOOTAXA, P1; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Markow TA, 2005, ANNU REV GENET, V39, P263, DOI 10.1146/annurev.genet.39.073003.112454; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Northrop JH, 1917, J BIOL CHEM, V30, P0181; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; O'Grady P, RAPIDLY EVO IN PRESS; O'Grady P.M., 2010, Bishop Museum Occasional Papers, V108, P1; O'Grady P, 2008, BIOL LETTERS, V4, P195, DOI 10.1098/rsbl.2007.0575; O'Grady PM, 2011, MOL PHYLOGENET EVOL, V58, P244, DOI 10.1016/j.ympev.2010.11.022; Pellmyr O, 2003, ANN MO BOT GARD, V90, P35, DOI 10.2307/3298524; PHAFF HJ, 1956, ECOLOGY, V37, P533, DOI 10.2307/1930176; Phaff HJ, 2000, INT J SYST EVOL MICR, V50, P1683, DOI 10.1099/00207713-50-4-1683; Remsen J, 2002, MOL PHYLOGENET EVOL, V24, P249, DOI 10.1016/S1055-7903(02)00226-9; Remsen J, 1998, MOL PHYLOGENET EVOL, V9, P225, DOI 10.1006/mpev.1997.0484; Roderick GK, 1998, MOL ECOL, V7, P519, DOI 10.1046/j.1365-294x.1998.00309.x; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; STARMER WT, 1982, EVOL BIOL, V14, P269; Starmer WT, 2003, FEMS YEAST RES, V3, P441, DOI 10.1016/S1567-1356(03)00056-4; STARMER WT, 1981, EVOLUTION, V35, P38, DOI 10.1111/j.1558-5646.1981.tb04856.x; STARMER WT, 1990, EVOL BIOL, V24, P253; Stewart CN, 1996, J EVOLUTION BIOL, V9, P153, DOI 10.1046/j.1420-9101.1996.9020153.x; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; THOMAS RH, 1993, MOL BIOL EVOL, V10, P362; WAGNER RP, 1944, U TEXAS PUBL, V4445, P104; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wisotsky Z, 2011, NAT NEUROSCI, V14, P1534, DOI 10.1038/nn.2944	77	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40550	10.1371/journal.pone.0040550	http://dx.doi.org/10.1371/journal.pone.0040550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911703	Green Published, Green Submitted, gold			2022-12-27	WOS:000306644600021
J	Schroll, JB; Maund, E; Gotzsche, PC				Schroll, Jeppe Bennekou; Maund, Emma; Gotzsche, Peter C.			Challenges in Coding Adverse Events in Clinical Trials: A Systematic Review	PLOS ONE			English	Review							MEDICAL DICTIONARY; MEDDRA	Background: Misclassification of adverse events in clinical trials can sometimes have serious consequences. Therefore, each of the many steps involved, from a patient's adverse experience to presentation in tables in publications, should be as standardised as possible, minimising the scope for interpretation. Adverse events are categorised by a predefined dictionary, e.g. MedDRA, which is updated biannually with many new categories. The objective of this paper is to study interobserver variation and other challenges of coding. Methods: Systematic review using PRISMA. We searched PubMed, EMBASE and The Cochrane Library. All studies were screened for eligibility by two authors. Results: Our search returned 520 unique studies of which 12 were included. Only one study investigated interobserver variation. It reported that 12% of the codes were evaluated differently by two coders. Independent physicians found that 8% of all the codes deviated from the original description. Other studies found that product summaries could be greatly affected by the choice of dictionary. With the introduction of MedDRA, it seems to have become harder to identify adverse events statistically because each code is divided in subgroups. To account for this, lumping techniques have been developed but are rarely used, and guidance on when to use them is vague. An additional challenge is that adverse events are censored if they already occurred in the run-in period of a trial. As there are more than 26 ways of determining whether an event has already occurred, this can lead to bias, particularly because data analysis is rarely performed blindly. Conclusion: There is a lack of evidence that coding of adverse events is a reliable, unbiased and reproducible process. The increase in categories has made detecting adverse events harder, potentially compromising safety. It is crucial that readers of medical publications are aware of these challenges. Comprehensive interobserver studies are needed.	[Schroll, Jeppe Bennekou; Maund, Emma; Gotzsche, Peter C.] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Schroll, JB (corresponding author), Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark.	js@cochrane.dk		Schroll, Jeppe Bennekou/0000-0002-1776-0562				Brown DR, 1997, INT J PHARM MED, V11, P85; Brown E. G., 1996, Pharmaceutical Medicine (London), V10, P111; Brown EG, 2004, DRUG SAFETY, V27, P591, DOI 10.2165/00002018-200427080-00010; Brown EG, 2003, DRUG SAFETY, V26, P145, DOI 10.2165/00002018-200326030-00002; Brown EG, 2002, DRUG SAFETY, V25, P445, DOI 10.2165/00002018-200225060-00009; Corrigan OP, 2002, SOC SCI MED, V55, P497, DOI 10.1016/S0277-9536(01)00183-6; Fescharek DR., 2004, INT J PHARM MED, V18, P259, DOI [10.2165/00124363-200418050-00001, DOI 10.2165/00124363-200418050-00001]; Furukawa TA, 2004, BRIT MED J, V329, P626, DOI 10.1136/bmj.329.7466.626-a; Gotzsche PC, 1996, CONTROL CLIN TRIALS, V17, P285, DOI 10.1016/0197-2456(95)00263-4; ICH Secretariat, 2011, MEDDRA TERM SEL POIN; ICH Secretariat, 2011, MEDDRA DAT RETR PRES; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Journot V, 2008, CONTEMP CLIN TRIALS, V29, P95, DOI 10.1016/j.cct.2007.05.007; Kondro W, 2004, CAN MED ASSOC J, V170, P783, DOI 10.1503/cmaj.1040213; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; MOZZICATO P, 2009, PHARM MED, V23, P65; Nilsson ME, 2001, DRUG INF J, V35, P1289, DOI 10.1177/009286150103500425; Toneatti C, 2006, CONTEMP CLIN TRIALS, V27, P13, DOI 10.1016/j.cct.2005.09.009; White CA, 1998, DRUG INF J, V32, P347, DOI 10.1177/009286159803200204; Wood K., 1994, PHARMACOEPIDEM DR S, V3, P7, DOI [10.1002/pds.2630030105, DOI 10.1002/PDS.2630030105]; Zhao-Wong AC, 2006, DRUG INF J, V40, P291, DOI 10.1177/009286150604000308	21	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41174	10.1371/journal.pone.0041174	http://dx.doi.org/10.1371/journal.pone.0041174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911755	gold, Green Submitted, Green Published			2022-12-27	WOS:000306644600051
J	Wisniewski, MG; Mercado, E; Gramann, K; Makeig, S				Wisniewski, Matthew G.; Mercado, Eduardo, III; Gramann, Klaus; Makeig, Scott			Familiarity with Speech Affects Cortical Processing of Auditory Distance Cues and Increases Acuity	PLOS ONE			English	Article							PHASE PATTERNS; EEG DYNAMICS; PERCEPTION; DISCRIMINATION; INFORMATION; RESPONSES; SOUNDS; CORTEX	Several acoustic cues contribute to auditory distance estimation. Nonacoustic cues, including familiarity, may also play a role. We tested participants' ability to distinguish the distances of acoustically similar sounds that differed in familiarity. Participants were better able to judge the distances of familiar sounds. Electroencephalographic (EEG) recordings collected while participants performed this auditory distance judgment task revealed that several cortical regions responded in different ways depending on sound familiarity. Surprisingly, these differences were observed in auditory cortical regions as well as other cortical regions distributed throughout both hemispheres. These data suggest that learning about subtle, distance-dependent variations in complex speech sounds involves processing in a broad cortical network that contributes both to speech recognition and to how spatial information is extracted from speech.	[Wisniewski, Matthew G.; Mercado, Eduardo, III] SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA; [Gramann, Klaus; Makeig, Scott] Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA; [Gramann, Klaus] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California San Diego; University Osnabruck	Wisniewski, MG (corresponding author), SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA.	mgw@buffalo.edu	Gramann, Klaus/AAD-7313-2019	Gramann, Klaus/0000-0003-2673-1832	NSF [SBE 0542013, SBE 0835976]; Office of Naval Research	NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research)	This work was supported in part by NSF Grants SBE 0542013 to the Temporal Dynamics of Learning Center, SBE 0835976 to CELEST, a BRC grant from the Office of Naval Research (SM) and by a gift from The Swartz Foundation (Old Field NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	At A, 2011, NEUROPSYCHOLOGIA, V49, P2794, DOI 10.1016/j.neuropsychologia.2011.05.024; BERGER KW, 1964, J ACOUST SOC AM, V36, P1888, DOI 10.1121/1.1919287; Brungart DS, 2001, J ACOUST SOC AM, V110, P425, DOI 10.1121/1.1379730; BUZSAKI G, 1982, J EXP ANAL BEHAV, V37, P461, DOI 10.1901/jeab.1982.37-461; Cheyne HA, 2009, J ACOUST SOC AM, V126, P2052, DOI 10.1121/1.3205400; COLEMAN PD, 1963, PSYCHOL BULL, V60, P302, DOI 10.1037/h0045716; COLEMAN PD, 1962, J ACOUST SOC AM, V34, P345, DOI 10.1121/1.1928121; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Hall DA, 2003, CURR BIOL, V13, pR91, DOI 10.1016/S0960-9822(03)00034-4; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Howard MF, 2010, J NEUROPHYSIOL, V104, P2500, DOI 10.1152/jn.00251.2010; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Krause CM, 1999, BRAIN RES COGN GRAIN, V5, P295; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; Liu EH, 2011, ATTEN PERCEPT PSYCHO, V73, P2624, DOI 10.3758/s13414-011-0190-y; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Mathiak K, 2003, NEUROREPORT, V14, P307, DOI 10.1097/01.wnr.0000059775.23521.fe; MCGREGOR P, 1985, PERCEPT MOTOR SKILL, V61, P1082, DOI 10.2466/pms.1985.61.3f.1082; Mills W, 1972, MODERN AUDITORY THEO; NACHSHON I, 1986, INT J PSYCHOL, V21, P617, DOI 10.1080/00207598608247609; Nasir SM, 2009, P NATL ACAD SCI USA, V106, P20470, DOI 10.1073/pnas.0907032106; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Onton J, 2006, PROG BRAIN RES, V159, P99, DOI 10.1016/S0079-6123(06)59007-7; Orr JM, 2009, CEREB CORTEX, V19, P703, DOI 10.1093/cercor/bhn119; Paquette C, 1997, CORTEX, V33, P689, DOI 10.1016/S0010-9452(08)70726-3; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; SIMPSON WE, 1973, AM J PSYCHOL, V86, P151, DOI 10.2307/1421856; Talati A, 2005, J COGNITIVE NEUROSCI, V17, P981, DOI 10.1162/0898929054475226; Tzourio N, 1997, NEUROIMAGE, V5, P63, DOI 10.1006/nimg.1996.0252; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088; Zahorik P, 2002, J ACOUST SOC AM, V111, P1832, DOI 10.1121/1.1458027; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409; Zahorik P, 2002, J ACOUST SOC AM, V112, P2110, DOI 10.1121/1.1506692	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41025	10.1371/journal.pone.0041025	http://dx.doi.org/10.1371/journal.pone.0041025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911734	Green Published, gold			2022-12-27	WOS:000306644600038
J	Marks, LR; Clementi, EA; Hakansson, AP				Marks, Laura R.; Clementi, Emily A.; Hakansson, Anders P.			The Human Milk Protein-Lipid Complex HAMLET Sensitizes Bacterial Pathogens to Traditional Antimicrobial Agents	PLOS ONE			English	Article							PENICILLIN-RESISTANT PNEUMOCOCCI; CONJUGATE VACCINE FORMULATION; HUMAN ALPHA-LACTALBUMIN; STREPTOCOCCUS-PNEUMONIAE; OTITIS-MEDIA; BINDING PROTEINS; TUMOR-CELLS; MIDDLE-EAR; VANCOMYCIN TOLERANCE; EPITHELIAL-CELLS	The fight against antibiotic resistance is one of the most significant challenges to public health of our time. The inevitable development of resistance following the introduction of novel antibiotics has led to an urgent need for the development of new antibacterial drugs with new mechanisms of action that are not susceptible to existing resistance mechanisms. One such compound is HAMLET, a natural complex from human milk that kills Streptococcus pneumoniae (the pneumococcus) using a mechanism different from common antibiotics and is immune to resistance-development. In this study we show that sublethal concentrations of HAMLET potentiate the effect of common antibiotics (penicillins, macrolides, and aminoglycosides) against pneumococci. Using MIC assays and short-time killing assays we dramatically reduced the concentrations of antibiotics needed to kill pneumococci, especially for antibiotic-resistant strains that in the presence of HAMLET fell into the clinically sensitive range. Using a biofilm model in vitro and nasopharyngeal colonization in vivo, a combination of HAMLET and antibiotics completely eradicated both biofilms and colonization in mice of both antibiotic-sensitive and resistant strains, something each agent alone was unable to do. HAMLET-potentiation of antibiotics was partially due to increased accessibility of antibiotics to the bacteria, but relied more on calcium import and kinase activation, the same activation pathway HAMLET uses when killing pneumococci by itself. Finally, the sensitizing effect was not confined to species sensitive to HAMLET. The HAMLET-resistant respiratory species Acinetobacter baumanii and Moraxella catarrhalis were all sensitized to various classes of antibiotics in the presence of HAMLET, activating the same mechanism as in pneumococci. Combined these results suggest the presence of a conserved HAMLET-activated pathway that circumvents antibiotic resistance in bacteria. The ability to activate this pathway may extend the lifetime of the current treatment arsenal.	[Marks, Laura R.; Clementi, Emily A.; Hakansson, Anders P.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Hakansson, Anders P.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA; [Hakansson, Anders P.] New York State Ctr Excellence Bioinformat & Life, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Marks, LR (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	andersh@buffalo.edu	Hakansson, Anders P/AAX-1225-2020; Hakansson, Anders/H-8190-2014	Hakansson, Anders P/0000-0002-2834-6009; Hakansson, Anders/0000-0002-2834-6009; Marks, Laura/0000-0002-5317-443X	Bill and Melinda Gates Foundation [53085]; JR Oishei Foundation; American Lung Association [RG-123721-N]; NIH (NIDCR) [F31DC011218]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011218] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); JR Oishei Foundation; American Lung Association; NIH (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Bill and Melinda Gates Foundation (Grant 53085), the JR Oishei Foundation, and The American Lung Association (Grant RG-123721-N) to APH, and NIH (NIDCR) fellowship F31DC011218 to EAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; ANDERSSON B, 1983, J EXP MED, V158, P559, DOI 10.1084/jem.158.2.559; ANIANSSON G, 1994, PEDIATR INFECT DIS J, V13, P183, DOI 10.1097/00006454-199403000-00003; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bachrach VRG, 2003, ARCH PEDIAT ADOL MED, V157, P237, DOI 10.1001/archpedi.157.3.237; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Butler JC, 1999, CLIN INFECT DIS, V28, P730, DOI 10.1086/515220; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; Clementi EA, 2012, J BIOL CHEM; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cottagnoud P, 2000, ANTIMICROB AGENTS CH, V44, P2179, DOI 10.1128/AAC.44.8.2179-2181.2000; Cottagnoud P, 2003, ANTIMICROB AGENTS CH, V47, P144, DOI 10.1128/AAC.47.1.144-147.2003; DarrasJoly C, 1996, ANTIMICROB AGENTS CH, V40, P2147, DOI 10.1128/AAC.40.9.2147; Drago L, 2011, J ANTIMICROB CHEMOTH, V66, P845, DOI 10.1093/jac/dkr016; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Gee KR, 2001, ELECTROPHORESIS, V22, P960, DOI 10.1002/1522-2683()22:5<960::AID-ELPS960>3.0.CO;2-9; German JB, 2002, CURR OPIN CLIN NUTR, V5, P653, DOI 10.1097/00075197-200211000-00007; Ginsburg I, 2002, APMIS, V110, P753, DOI 10.1034/j.1600-0463.2002.1101101.x; GROSS ME, 1995, ANTIMICROB AGENTS CH, V39, P1166, DOI 10.1128/AAC.39.5.1166; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; HAKENBECK R, 1991, J INFECT DIS, V164, P313, DOI 10.1093/infdis/164.2.313; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hanson Lars A, 2002, Semin Neonatol, V7, P275, DOI 10.1016/S1084-2756(02)90124-7; Harrison CJ, 2009, J ANTIMICROB CHEMOTH, V63, P511, DOI 10.1093/jac/dkn538; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P122, DOI 10.1086/313609; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; Hoa M, 2009, ANN OTO RHINOL LARYN, V118, P292, DOI 10.1177/000348940911800410; Jain R, 2004, ANN PHARMACOTHER, V38, P1449, DOI 10.1345/aph.1D592; Johnsborg O, 2008, MOL MICROBIOL, V69, P245, DOI 10.1111/j.1365-2958.2008.06288.x; Joloba ML, 2001, CLIN INFECT DIS, V33, P1489, DOI 10.1086/323027; Kadurugamuwa JL, 1997, J ANTIMICROB CHEMOTH, V40, P615, DOI 10.1093/jac/40.5.615; Kuhn F, 2003, ANTIMICROB AGENTS CH, V47, P2487, DOI 10.1128/AAC.47.8.2487-2491.2003; Lepper PM, 2002, INTENS CARE MED, V28, P824, DOI 10.1007/s00134-002-1330-6; Levin BR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000601; Lonnerdal B, 2004, ADV EXP MED BIOL, V554, P11; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Marks L. R., 2012, INFECT IMMU IN PRESS; Marriott HM, 2008, CURR MOL MED, V8, P497, DOI 10.2174/156652408785747924; MARSHALL KJ, 1993, J CLIN MICROBIOL, V31, P1246, DOI 10.1128/JCM.31.5.1246-1250.1993; Mattie H, 2005, J ANTIMICROB CHEMOTH, V56, P154, DOI 10.1093/jac/dki176; MCDANIEL LS, 1987, J EXP MED, V165, P381, DOI 10.1084/jem.165.2.381; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Nau R, 2002, CLIN MICROBIOL REV, V15, P95, DOI 10.1128/CMR.15.1.95-110.2002; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; Reid SD, 2009, J INFECT DIS, V199, P786, DOI 10.1086/597042; Robertson GT, 2002, J BACTERIOL, V184, P6987, DOI 10.1128/JB.184.24.6987-7000.2002; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Sader HS, 1998, DIAGN MICR INFEC DIS, V32, P289, DOI 10.1016/S0732-8893(98)00124-2; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Sanchez-Tatay D, 2008, CLIN MICROBIOL INFEC, V14, P797, DOI 10.1111/j.1469-0691.2008.02025.x; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; Schneider Aline Petter, 2007, J. bras. pneumol., V33, P454, DOI 10.1590/S1806-37132007000400016; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; TOMASZ A, 1975, P NATL ACAD SCI USA, V72, P4162, DOI 10.1073/pnas.72.10.4162; TUOMANEN E, 1985, J INFECT DIS, V151, P535, DOI 10.1093/infdis/151.3.535; Tuomanen E, 1999, CURR OPIN MICROBIOL, V2, P35, DOI 10.1016/S1369-5274(99)80006-X; Tyx RE, 2011, J BACTERIOL, V193, P3512, DOI 10.1128/JB.01410-10; Van Looveren M, 2004, CLIN MICROBIOL INFEC, V10, P684, DOI 10.1111/j.1469-0691.2004.00942.x; Varon E, 2010, CLIN MICROBIOL INFEC, V16, P401, DOI 10.1111/j.1469-0691.2010.03190.x; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	70	39	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43514	10.1371/journal.pone.0043514	http://dx.doi.org/10.1371/journal.pone.0043514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905269	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600078
J	Xu, B; Chelikani, P; Bhullar, RP				Xu, Bing; Chelikani, Prashen; Bhullar, Rajinder P.			Characterization and Functional Analysis of the Calmodulin-Binding Domain of Rac1 GTPase	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RHO-GTPASES; CDC42 ACTIVATION; H-RAS; K-RAS; CA2+/CALMODULIN; MEMBRANE; PROTEIN; PLATELET; ELEMENTS	Rac1, a member of the Rho family of small GTPases, has been shown to promote formation of lamellipodia at the leading edge of motile cells and affect cell migration. We previously demonstrated that calmodulin can bind to a region in the C-terminal of Rac1 and that this interaction is important in the activation of platelet Rac1. Now, we have analyzed amino acid residue(s) in the Rac1-calmodulin binding domain that are essential for the interaction and assessed their functional contribution in Rac1 activation. The results demonstrated that region 151-164 in Rac1 is essential for calmodulin binding. Within the 151-164 region, positively-charged amino acids K153 and R163 were mutated to alanine to study impact on calmodulin binding. Mutant form of Rac1 (K153A) demonstrated significantly reduced binding to calmodulin while the double mutant K153A/R163A demonstrated complete lack of binding to calmodulin. Thrombin or EGF resulted in activation of Rac1 in CHRF-288-11 or HeLa cells respectively and W7 inhibited this activation. Immunoprecipitation studies demonstrated that higher amount of CaM was associated with Rac1 during EGF dependent activation. In cells expressing mutant forms of Rac1 (K153A or K153A/R163A), activation induced by EGF was significantly decreased in comparison to wild type or the R163A forms of Rac1. The lack of Rac1 activation in mutant forms was not due to an inability of GDP-GTP exchange or a change in subcelllular distribution. Moreover, Rac1 activation was decreased in cells where endogenous level of calmodulin was reduced using shRNA knockdown and increased in cells where calmodulin was overexpressed. Docking analysis and modeling demonstrated that K153 in Rac1 interacts with Q41 in calmodulin. These results suggest an important role for calmodulin in the activation of Rac1 and thus, in cytoskeleton reorganization and cell migration.	[Xu, Bing; Chelikani, Prashen; Bhullar, Rajinder P.] Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada; [Bhullar, Rajinder P.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Xu, B (corresponding author), Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada.	bhullar@cc.umanitoba.ca	Xu, Bing/AAB-6608-2019	Chelikani, Prashen/0000-0003-1129-7957	Heart & Stroke Foundation of Manitoba	Heart & Stroke Foundation of Manitoba	The work is supported by the Heart & Stroke Foundation of Manitoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar H, 2007, J THROMB HAEMOST, V5, P1747, DOI 10.1111/j.1538-7836.2007.02646.x; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clough RR, 2002, J BIOL CHEM, V277, P28972, DOI 10.1074/jbc.M201504200; Elsaraj SM, 2008, BBA-MOL CELL RES, V1783, P770, DOI 10.1016/j.bbamcr.2008.01.022; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Guo F, 2008, J ELECTRON MATER, V37, P1, DOI 10.1007/s11664-007-0302-6; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kawashima T, 2006, J CELL BIOL, V175, P937, DOI 10.1083/jcb.200604073; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Lee JH, 2008, P NATL ACAD SCI USA, V105, P12575, DOI 10.1073/pnas.0712033105; Lian JP, 2001, J IMMUNOL, V166, P2643, DOI 10.4049/jimmunol.166.4.2643; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; MacDougall DA, 2009, J BIOL CHEM, V284, P15573, DOI 10.1074/jbc.M809585200; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Moreto J, 2008, CELL SIGNAL, V20, P1092, DOI 10.1016/j.cellsig.2008.01.022; Pang ZP, 2010, J BIOL CHEM, V285, P33930, DOI 10.1074/jbc.M110.150151; Quatela SE, 2006, CURR OPIN CELL BIOL, V18, P162, DOI 10.1016/j.ceb.2006.02.004; Rashid A, 2004, BIOCHEM BIOPH RES CO, V317, P363, DOI 10.1016/j.bbrc.2004.03.051; Ray RM, 2007, CELL MOTIL CYTOSKEL, V64, P143, DOI 10.1002/cm.20172; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Samson T, 2010, MOL BIOL CELL, V21, P1629, DOI 10.1091/mbc.E09-09-0809; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Sehn X, 2005, P NATL ACAD SCI USA, V102, P5969; Sidhu RS, 2005, BIOCHEM BIOPH RES CO, V336, P105, DOI 10.1016/j.bbrc.2005.08.053; Sidhu RS, 2001, BIOCHEM BIOPH RES CO, V289, P1039, DOI 10.1006/bbrc.2001.6113; Soulet C, 2001, FEBS LETT, V507, P253, DOI 10.1016/S0014-5793(01)02984-2; Vidal-Quadras M, 2011, TRAFFIC, V12, P1879, DOI 10.1111/j.1600-0854.2011.01274.x; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wang KL, 1999, J BIOL CHEM, V274, P14525, DOI 10.1074/jbc.274.21.14525; Wang KL, 1997, J BIOL CHEM, V272, P16002, DOI 10.1074/jbc.272.25.16002; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xu B, 2011, MOL CELL BIOCHEM, V353, P73, DOI 10.1007/s11010-011-0776-7; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33	40	13	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42975	10.1371/journal.pone.0042975	http://dx.doi.org/10.1371/journal.pone.0042975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905193	Green Submitted, gold, Green Published			2022-12-27	WOS:000307823600037
J	Ishida, K; Nishizuka, SS; Chiba, T; Ikeda, M; Kume, K; Endo, F; Katagiri, H; Matsuo, T; Noda, H; Iwaya, T; Yamada, N; Fujiwara, H; Takahashi, M; Itabashi, T; Uesugi, N; Maesawa, C; Tamura, G; Sugai, T; Otsuka, K; Koeda, K; Wakabayashi, G				Ishida, Kazushige; Nishizuka, Satoshi S.; Chiba, Takehiro; Ikeda, Miyuki; Kume, Kohei; Endo, Fumitaka; Katagiri, Hirokatsu; Matsuo, Teppei; Noda, Hironobu; Iwaya, Takeshi; Yamada, Noriyuki; Fujiwara, Hisataka; Takahashi, Masanori; Itabashi, Tetsuya; Uesugi, Noriyuki; Maesawa, Chihaya; Tamura, Gen; Sugai, Tamotsu; Otsuka, Koki; Koeda, Keisuke; Wakabayashi, Go			Molecular Marker Identification for Relapse Prediction in 5-FU-Based Adjuvant Chemotherapy in Gastric and Colorectal Cancers	PLOS ONE			English	Article							NF-KAPPA-B; LYSATE MICROARRAYS; GENE-EXPRESSION; JNK ACTIVATION; COLON-CANCER; CELL-LINES; CARCINOMA; INHIBITION; ALPHA; CHEMORESISTANCE	To confirm the clinical significance of NF-kappa B and JNK protein expression from experimentally identified candidates for predicting prognosis for patients with 5-FU treatment, we evaluated the protein expression of surgically removed specimens. A total of 79 specimens were obtained from 30 gastric and 49 colorectal cancer patients who underwent R0 resection followed by postoperative 5-FU based adjuvant chemotherapy. Immunohistochemical examinations of NF-kappa B and JNK on tissue microarrays (TMAs) revealed that significantly shorter time-to-relapse (TTR) in both NF-kappa B(+) and JNK(-) subgroups in both gastric (NF-kappa B(+), p = 0.0002, HR11.7. 95% CI3 3.2-43.4; JNK(-), p = 0.0302, HR4.4, 95% CI 1.2-16.6) and colon (NF-kappa B(+), p = 0.0038, HR36.9, 95% CI 3.2-426.0; JNK(-), p = 0.0098, HR3.2, 95% CI 1.3-7.7) cancers. These protein expression patterns also show strong discriminately power in gastric cancer patients for overall survival rate, suggesting a potential utility as prognostic or chemosensitivity markers. Baseline expression of these proteins using gastric cancer cell lines demonstrated the reciprocal patterns between NF-kappa B and JNK, while 5-FU exposure of these cell lines only induced NF-kappa B, suggesting that NF-kappa B plays a dominant role in the response to 5-FU. Subsequent siRNA experiments confirmed that gene knockdown of NF-kappa B increased 5-FU-specific sensitivity, whereas that of JNK did not affect the chemosensitivity. These results suggest that the expression of these proteins may aid in the decisions involved with adjuvant chemotherapy for gastrointestinal tract cancers.	[Ishida, Kazushige; Nishizuka, Satoshi S.; Chiba, Takehiro; Ikeda, Miyuki; Kume, Kohei; Endo, Fumitaka; Katagiri, Hirokatsu; Matsuo, Teppei; Noda, Hironobu; Iwaya, Takeshi; Fujiwara, Hisataka; Takahashi, Masanori; Itabashi, Tetsuya; Otsuka, Koki; Koeda, Keisuke; Wakabayashi, Go] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 020, Japan; [Nishizuka, Satoshi S.; Kume, Kohei; Uesugi, Noriyuki; Maesawa, Chihaya; Wakabayashi, Go] Iwate Med Univ, MIAST, Morioka, Iwate 020, Japan; [Iwaya, Takeshi] Kyushu Univ, Med Inst Bioregulat, Dept Surg, Beppu, Oita, Japan; [Kume, Kohei; Maesawa, Chihaya] Iwate Med Univ, Ctr Adv Med Sci, Dept Tumor Biol, Yahaba, Iwate, Japan; [Yamada, Noriyuki; Uesugi, Noriyuki; Sugai, Tamotsu] Iwate Med Univ, Sch Med, Dept Pathol, Div Diagnost Mol Pathol, Morioka, Iwate 020, Japan; [Tamura, Gen] Yamagata Prefectural Cent Hosp, Dept Pathol & Lab Med, Yamagata, Japan	Iwate Medical University; Iwate Medical University; Kyushu University; Iwate Medical University; Iwate Medical University; Yamagata Prefectural Central Hospital	Ishida, K (corresponding author), NCI, Chem Immunol Sect, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	snishizu@iwate-med.ac.jp			Keiryokai Research Foundation [101]; KAKENHI [21591676]; MIAST (Medical Innovation by Advanced Science and Technology) project of the Ministry of Education, Culture, Sports, Science and Technology, JAPAN; Grants-in-Aid for Scientific Research [24591917] Funding Source: KAKEN	Keiryokai Research Foundation(Keiryokai Research Foundation); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MIAST (Medical Innovation by Advanced Science and Technology) project of the Ministry of Education, Culture, Sports, Science and Technology, JAPAN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by: Keiryokai Research Foundation (101) by S.S.N.; KAKENHI (21591676); Grant-in-Aid for Scientific Research(C) by S.S.N; and MIAST (Medical Innovation by Advanced Science and Technology) project of the Ministry of Education, Culture, Sports, Science and Technology, JAPAN by S.S.N, K. K, N.U., C. M., T. S., and G. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2011, GASTRIC CANC; Aoyama T, 2011, GASTRIC CANCER, V14, P150, DOI 10.1007/s10120-011-0020-x; Bednarski BK, 2008, MOL CANCER THER, V7, P1827, DOI 10.1158/1535-7163.MCT-08-0321; Bourgarel-Rey V, 2001, MOL PHARMACOL, V59, P1165, DOI 10.1124/mol.59.5.1165; Brennan DJ, 2010, NAT REV CANCER, V10, P605, DOI 10.1038/nrc2902; Bubici C, 2004, CELL CYCLE, V3, P1524, DOI 10.4161/cc.3.12.1321; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Cunningham D, 2007, LANCET, V370, P1980, DOI 10.1016/S0140-6736(07)61841-8; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Grem JL, 2001, CLIN CANCER RES, V7, P999; Honda T, 2005, JPN J CLIN ONCOL, V35, P580, DOI 10.1093/jjco/hyi166; Ishida K, 2010, J IWATE MED ASS, V62, P363; Ito N, 1997, JPN J GASTROENTEROL, V30, P741; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kojima M, 2004, ANTICANCER RES, V24, P675; Krueger S, 2006, J BIOL CHEM, V281, P2868, DOI 10.1074/jbc.m511053200; Levidou G, 2007, VIRCHOWS ARCH, V450, P519, DOI 10.1007/s00428-007-0396-5; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Matsuyama R, 2006, INT J CANCER, V119, P406, DOI 10.1002/ijc.21843; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Nishizuka S, 2003, CANCER RES, V63, P5243; Nishizuka S, 2008, CURR OPIN BIOTECH, V19, P41, DOI 10.1016/j.copbio.2007.11.007; Nishizuka S, 2008, J PROTEOME RES, V7, P803, DOI 10.1021/pr0702971; O'Connell MJ, 1998, J CLIN ONCOL, V16, P295, DOI 10.1200/JCO.1998.16.1.295; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Ross JS, 2010, AM J CLIN PATHOL, V134, P478, DOI 10.1309/AJCP2Y8KTDPOAORH; Roxburgh C, 2011, INT J COLORECTAL DIS, V26, P483, DOI 10.1007/s00384-010-1120-5; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sargent D, 2009, J CLIN ONCOL, V27, P872, DOI 10.1200/JCO.2008.19.5362; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Scartozzi M, 2007, J CLIN ONCOL, V25, P3930, DOI 10.1200/JCO.2007.11.5022; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Uen YH, 2008, ANN SURG ONCOL, V15, P2120, DOI 10.1245/s10434-008-9961-7; Uetsuka H, 2003, EXP CELL RES, V289, P27, DOI 10.1016/S0014-4827(03)00223-4; Voboril R, 2007, NEOPLASMA, V54, P495; Voboril R, 2004, J SURG RES, V120, P178, DOI 10.1016/j.jss.2003.11.023; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Yamanaka N, 2004, ANTICANCER RES, V24, P1071	52	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43236	10.1371/journal.pone.0043236	http://dx.doi.org/10.1371/journal.pone.0043236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905237	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800062
J	Kitab, B; El Feydi, AE; Afifi, R; Trepo, C; Benazzouz, M; Essamri, W; Zoulim, F; Chemin, I; Alj, HS; Ezzikouri, S; Benjelloun, S				Kitab, Bouchra; El Feydi, Abdellah Essaid; Afifi, Rajaa; Trepo, Christian; Benazzouz, Mustapha; Essamri, Wafaa; Zoulim, Fabien; Chemin, Isabelle; Alj, Hanane Salih; Ezzikouri, Sayeh; Benjelloun, Soumaya			Variability in the Precore and Core Promoter Regions of HBV Strains in Morocco: Characterization and Impact on Liver Disease Progression	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; E-ANTIGEN; GENOTYPE-D; NATURAL-HISTORY; MUTATIONS; RISK; MUTANTS; INFECTION; INCREASE	Background: Hepatitis B virus (HBV) is one of the most common human pathogens that cause aggressive hepatitis and advanced liver disease (AdLD), including liver cirrhosis and Hepatocellular Carcinoma. The persistence of active HBV replication and liver damage after the loss of hepatitis B e antigen (HBeAg) has been frequently associated with mutations in the pre-core (pre-C) and core promoter (CP) regions of HBV genome that abolish or reduce HBeAg expression. The purpose of this study was to assess the prevalence of pre-C and CP mutations and their impact on the subsequent course of liver disease in Morocco. Methods/Principal Findings: A cohort of 186 patients with HBeAg-negative chronic HBV infection was studied (81 inactive carriers, 69 with active chronic hepatitis, 36 with AdLD). Pre-C and CP mutations were analyzed by PCR-direct sequencing method. The pre-C stop codon G1896A mutation was the most frequent (83.9%) and was associated with a lower risk of AdLD development (OR, 0.4; 95% CI, 0.15-1.04; p = 0.04). HBV-DNA levels in patients with G1896A were not significantly different from the other patients carrying wild-type strains (p = 0.84). CP mutations C1653T, T1753V, A1762T/G1764A, and C1766T/T1768A were associated with higher HBV-DNA level and increased liver disease severity. Multiple logistic regression analysis showed that older age (>= 40 years), male sex, high viral load (>4.3 log(10) IU/mL) and CP mutations C1653T, T1753V, A1762T/G1764A, and C1766T/T1768A were independent risk factors for AdLD development. Combination of these mutations was significantly associated with AdLD (OR, 7.52; 95% CI, 4.8-8; p<0.0001). Conclusions: This study shows for the first time the association of HBV viral load and CP mutations with the severity of liver disease in Moroccan HBV chronic carriers. The examination of CP mutations alone or in combination could be helpful for prediction of the clinical outcome.	[Kitab, Bouchra; Ezzikouri, Sayeh; Benjelloun, Soumaya] Inst Pasteur Maroc, Lab Hepatites Virales, Casablanca, Morocco; [El Feydi, Abdellah Essaid; Afifi, Rajaa; Benazzouz, Mustapha; Essamri, Wafaa] CHU Ibn Sina, Serv Med C, Rabat, Morocco; [Trepo, Christian; Zoulim, Fabien; Chemin, Isabelle] INSERM, U1052, F-69008 Lyon, France; [Kitab, Bouchra; Alj, Hanane Salih] Univ Hassan 2, CNRST, Lab Rech Lipoprot & Atherosclerose, Unite Associee,CNRST,URAC 34,Fac Sci Ben Msik, Casablanca, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique & Technologique (CNRST); Hassan II University of Casablanca	Kitab, B (corresponding author), Inst Pasteur Maroc, Lab Hepatites Virales, Casablanca, Morocco.	soumaya.benjelloun@pasteur.ma	Zoulim, Fabien/ABD-5594-2021; Ezzikouri, Sayeh/Q-8116-2019; Chemin, Isabelle/I-3032-2016	Zoulim, Fabien/0000-0002-2245-0083; Chemin, Isabelle/0000-0002-7188-5489; Ezzikouri, Sayeh/0000-0002-3982-6163; Benjelloun, Soumaya/0000-0001-5573-8684	Novartis Pharma Morocco; Pasteur Institute of Morocco	Novartis Pharma Morocco; Pasteur Institute of Morocco	This study was supported in part by a research grant from Novartis Pharma Morocco and the additional part was supported by Pasteur Institute of Morocco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interest. The study was supported by Novartis Pharma Morocco and Pasteur Institute of Morocco; there are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PloS ONE policies on sharing data and materials.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P405; Baha W, 2012, INFECT GENET EVOL, V12, P1157, DOI 10.1016/j.meegid.2012.04.026; Bahri O, 2006, J MED VIROL, V78, P353, DOI 10.1002/jmv.20554; Bai X, 2011, CARCINOGENESIS, V32, P63, DOI 10.1093/carcin/bgq195; Baumert TF, 1996, J CLIN INVEST, V98, P2268, DOI 10.1172/JCI119037; BENJELLOUN S, 1993, RES VIROLOGY, V144, P159, DOI 10.1016/S0923-2516(06)80024-5; Bozdayi AM, 2001, J CLIN VIROL, V21, P91, DOI 10.1016/S1386-6532(01)00148-2; Bozdayi AM, 1999, INFECTION, V27, P357, DOI 10.1007/s150100050043; CARMAN WF, 1989, LANCET, V2, P588; Chan HLY, 1999, HEPATOLOGY, V29, P976, DOI 10.1002/hep.510290352; Chen CH, 2008, J INFECT DIS, V198, P1634, DOI 10.1086/592990; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Ducancelle A, 2011, PATHOL BIOL PARIS, V59, P21; Elkady A, 2008, J GASTROEN HEPATOL, V23, P474, DOI 10.1111/j.1440-1746.2008.05321.x; Ezzikouri S, 2008, INFECT GENET EVOL, V8, P306, DOI 10.1016/j.meegid.2008.01.010; Ezzikouri S, 2007, HEPATOL RES, V37, P748, DOI 10.1111/j.1872-034X.2007.00126.x; Funk ML, 2002, J VIRAL HEPATITIS, V9, P52, DOI 10.1046/j.1365-2893.2002.00304.x; Gandhe SS, 2003, J VIRAL HEPATITIS, V10, P367, DOI 10.1046/j.1365-2893.2003.00445.x; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guo X, 2008, J HEPATOL, V49, P718, DOI 10.1016/j.jhep.2008.06.026; Hadziyannis SJ, 2011, J HEPATOL, V55, P183, DOI 10.1016/j.jhep.2010.12.030; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Jardi R, 2004, J HEPATOL, V40, P507, DOI 10.1016/j.jhep.2003.11.015; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Khelifa F, 2009, PATHOL BIOL, V57, P107, DOI 10.1016/j.patbio.2008.07.031; Kim TH, 2006, J KOREAN MED SCI, V21, P279, DOI 10.3346/jkms.2006.21.2.279; Kitab B, 2011, J INFECTION, V63, P66, DOI 10.1016/j.jinf.2011.05.007; Kramvis A, 1998, J VIRAL HEPATITIS, V5, P357, DOI 10.1046/j.1365-2893.1998.00124.x; Kramvis A, 1999, J VIRAL HEPATITIS, V6, P415, DOI 10.1046/j.1365-2893.1999.00189.x; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kurosaki M, 1996, J MED VIROL, V49, P115; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARZUL D, 1990, J VIROL METHODS, V27, P49, DOI 10.1016/0166-0934(90)90145-6; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lindh M, 1996, HEPATOLOGY, V24, P494, DOI 10.1053/jhep.1996.v24.pm0008781313; Liu CJ, 2009, J INFECT DIS, V199, P742, DOI 10.1086/596655; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Lusida MI, 2008, J CLIN MICROBIOL, V46, P2160, DOI 10.1128/JCM.01681-07; Mrani S, 2002, CAH MED, V4, P87; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; Parekh S, 2003, J VIROL, V77, P6601, DOI 10.1128/JVI.77.12.6601-6612.2003; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Sbai A, 2011, PATHOL BIOL PARIS; Sebti M F, 1984, IARC Sci Publ, P227; Tanaka Y, 2004, HEPATOLOGY, V40, P747, DOI 10.1002/hep.20365; Tanaka Y, 2006, J HEPATOL, V45, P646, DOI 10.1016/j.jhep.2006.06.018; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Tong MJ, 2007, LIVER INT, V27, P1356, DOI 10.1111/j.1478-3231.2007.01585.x; Wang Y, 2004, ONCOGENE, V23, P142, DOI 10.1038/sj.onc.1206889; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yoo BC, 2003, J HEPATOL, V38, P98, DOI 10.1016/S0168-8278(02)00349-5; Yotsuyanagi H, 2002, J HEPATOL, V37, P355, DOI 10.1016/S0168-8278(02)00180-0	53	35	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42891	10.1371/journal.pone.0042891	http://dx.doi.org/10.1371/journal.pone.0042891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905181	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500800027
J	Wong, FY; Silas, R; Hew, S; Samarasinghe, T; Walker, AM				Wong, Flora Y.; Silas, Reshma; Hew, Simon; Samarasinghe, Thilini; Walker, Adrian M.			Cerebral Oxygenation Is Highly Sensitive to Blood Pressure Variability in Sick Preterm Infants	PLOS ONE			English	Article							SPATIALLY-RESOLVED SPECTROSCOPY; BIRTH-WEIGHT INFANTS; PREMATURE-INFANTS; NEWBORN LAMBS; FLOW; AUTOREGULATION; CIRCULATION; PASSIVITY; FETAL	Objectives: The significance of blood pressure variability (BPV) for cerebral oxygenation in extremely preterm infants has not been explored, though BPV may well be associated with end organ injury. We hypothesized that increased BPV in sick preterm infants, by exceeding the cerebral autoregulatory capacity, is associated with cerebral oxygenation changes which closely follow the blood pressure fluctuations. We assessed the autoregulatory capacity in the early postnatal period, by determining the correlation between BPV (mmHg(2)) and coherence of mean arterial blood pressure (MABP mmHg) and cerebral oxygenation (tissue oxygenation index, TOI %). Study Design: Thirty-two preterm infants of mean gestational age of 26.3 (+/- 1.5) weeks were studied on the first 3 postnatal days. Spectral analysis (Coherence and transfer-function gain analysis) was used to calculate coherence of MABP and TOI; BPV was quantified using power spectral density of MABP. Results: Overall, maximum Coherence showed a trend for positive correlation with BPV (n = 32, p = 0.06). Infants identified as clinically unstable with documented brain injury (n = 7) had high Coherence values at low BPV. Separate analysis of stable infants (excluding the 7 critically ill infants) revealed a significant association between maximum Coherence and BPV (n = 25, p = 0.006). Conclusions: Fluctuation in cerebral oxygenation is closely associated with increased BPV in preterm infants undergoing intensive care. Moreover, in the critically sick preterm infant, blood pressure-dependent variations in cerebral oxygenation occur even with relatively lower BPV, suggesting they have severely impaired autoregulation, and placing them at greater vulnerability to cerebral injury arising from blood pressure fluctuations.	[Wong, Flora Y.; Silas, Reshma; Hew, Simon; Samarasinghe, Thilini; Walker, Adrian M.] Monash Univ, Ritchie Ctr, Melbourne, Vic 3004, Australia; [Wong, Flora Y.; Silas, Reshma] Monash Med Ctr, Melbourne, Vic, Australia; [Wong, Flora Y.] Monash Univ, Dept Paediat, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University	Wong, FY (corresponding author), Monash Univ, Ritchie Ctr, Melbourne, Vic 3004, Australia.	Flora.Wong@monash.edu			Ritchie Centre, Monash University; Kathleen Tinsley Fellowship	Ritchie Centre, Monash University; Kathleen Tinsley Fellowship	Internal funding provided by the Ritchie Centre, Monash University. Dr. Wong was supported by the Kathleen Tinsley Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, GUIDELINES GOOD PRAC; Bassan H, 2006, PEDIATRICS, V117, P2111, DOI 10.1542/peds.2005-1570; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Borch K, 2010, ACTA PAEDIATR, V99, P1489, DOI 10.1111/j.1651-2227.2010.01856.x; Boylan GB, 2000, PEDIATR RES, V48, P12, DOI 10.1203/00006450-200007000-00005; Grant DA, 1998, J CEREBR BLOOD F MET, V18, P639, DOI 10.1097/00004647-199806000-00006; Greisen G, 2005, EARLY HUM DEV, V81, P423, DOI 10.1016/j.earlhumdev.2005.03.005; Hahn GH, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3426323; Kuo TBJ, 1998, J CEREBR BLOOD F MET, V18, P311, DOI 10.1097/00004647-199803000-00010; Liu JG, 2003, J HYPERTENS, V21, P1961, DOI 10.1097/00004872-200310000-00025; Munro MJ, 2004, PEDIATRICS, V114, P1591, DOI 10.1542/peds.2004-1073; Musini VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005673; O'Leary H, 2009, PEDIATRICS, V124, P302, DOI 10.1542/peds.2008-2004; Omboni S, 1996, CLIN AUTON RES, V6, P171, DOI 10.1007/BF02281905; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; PAPILE LA, 1985, PEDIATR RES, V19, P159, DOI 10.1203/00006450-198502000-00001; Parati G, 2005, J HYPERTENS, V23, pS19, DOI 10.1097/01.hjh.0000165624.79933.d3; PRYDS O, 1989, J PEDIATR-US, V115, P638, DOI 10.1016/S0022-3476(89)80301-4; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Suzuki S, 1999, P SOC PHOTO-OPT INS, V3597, P582, DOI 10.1117/12.356862; SZYMONOWICZ W, 1988, AM J PHYSIOL, V254, pH52, DOI 10.1152/ajpheart.1988.254.1.H52; Tsuji M, 2000, PEDIATRICS, V106, P625, DOI 10.1542/peds.106.4.625; Volpe JJ., 2001, NEUROLOGY NEWBORN, P428; Wilson-Costello D, 2007, PEDIATRICS, V119, P37, DOI 10.1542/peds.2006-1416; Wong FY, 2008, PEDIATRICS, V121, pE604, DOI 10.1542/peds.2007-1487; Wong FY, 2009, INTENS CARE MED, V35, P1464, DOI 10.1007/s00134-009-1486-4; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	27	43	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43165	10.1371/journal.pone.0043165	http://dx.doi.org/10.1371/journal.pone.0043165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905222	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500800054
J	Conrad, JL; Balcarcel, AM; Mehling, CM				Conrad, Jack L.; Balcarcel, Ana M.; Mehling, Carl M.			Earliest Example of a Giant Monitor Lizard (Varanus, Varanidae, Squamata)	PLOS ONE			English	Article							BODY-SIZE; EVOLUTION; REPTILIA; PHYLOGENY; MOSASAURS; ECOLOGY; AMPHISBAENIANS; SYSTEMATICS; VARANOIDEA; OLIGOCENE	Background: Varanidae is a clade of tiny (<20 mm pre-caudal length [PCL]) to giant (>600 mm PCL) lizards first appearing in the Cretaceous. True monitor lizards (Varanus) are known from diagnostic remains beginning in the early Miocene (Varanus rusingensis), although extremely fragmentary remains have been suggested as indicating earlier Varanus. The paleobiogeographic history of Varanus and timing for origin of its gigantism remain uncertain. Methodology/Principal Findings: A new Varanus from the Mytilini Formation (Turolian, Miocene) of Samos, Greece is described. The holotype consists of a partial skull roof, right side of a braincase, partial posterior mandible, fragment of clavicle, and parts of six vertebrae. A cladistic analysis including 83 taxa coded for 5733 molecular and 489 morphological characters (71 previously unincluded) demonstrates that the new fossil is a nested member of an otherwise exclusively East Asian Varanus clade. The new species is the earliest-known giant (>600 mm PCL) terrestrial lizard. Importantly, this species co-existed with a diverse continental mammalian fauna. Conclusions/Significance: The new monitor is larger (longer) than 99% of known fossil and living lizards. Varanus includes, by far, the largest limbed squamates today. The only extant non-snake squamates that approach monitors in maximum size are the glass-snake Pseudopus and the worm-lizard Amphisbaena. Mosasauroids were larger, but exclusively marine, and occurred only during the Late Cretaceous. Large, extant, non-Varanus, lizards are limbless and/or largely isolated from mammalian competitors. By contrast, our new Varanus achieved gigantism in a continental environment populated by diverse eutherian mammal competitors.	[Conrad, Jack L.] New York Coll Osteopath Med, Dept Anat, Old Westbury, NY USA; [Conrad, Jack L.; Balcarcel, Ana M.; Mehling, Carl M.] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA	New York Institute Technology; American Museum of Natural History (AMNH)	Conrad, JL (corresponding author), New York Coll Osteopath Med, Dept Anat, Old Westbury, NY USA.	jack.conrad@gmail.com						Ast JC, 2001, CLADISTICS, V17, P211, DOI 10.1111/j.1096-0031.2001.tb00118.x; Ast JC, 2002, THESIS U MICHIGAN AN; Auffenberg W., 1981, BEHAV ECOLOGY KOMODO; Bakker RT., 1986, DINOSAUR HERESIES; Balsai M.J., 2001, THESIS U PENNSYLVANI; Bell GL, 2005, NETH J GEOSCI, V84, P177, DOI 10.1017/S0016774600020965; Bever G.S., 2005, PALAEONT ELECT, V8, P1, DOI DOI 10.1080/08912960600679570; Bever GS, 2005, SHINISAURUS CROCODIL; Burnell A, 2012, B SOC GEOL FR, V183, P151, DOI 10.2113/gssgfbull.183.2.151; Caldwell MW, 2000, J VERTEBR PALEONTOL, V20, P720, DOI 10.1671/0272-4634(2000)020[0720:OTASDL]2.0.CO;2; Case T.J., 1982, P184; CASE TJ, 1978, ECOLOGY, V59, P1, DOI 10.2307/1936628; Colli GR, 1999, COPEIA, P733, DOI 10.2307/1447606; Conrad J, 2004, J VERTEBR PALEONTOL, V24, p47A; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Conrad JL, 2006, HIST BIOL, V18, P405, DOI 10.1080/08912960600679570; Conrad JL, 2011, B AM MUS NAT HIST, P1; Conrad JL, 2011, CLADISTICS, V27, P230, DOI 10.1111/j.1096-0031.2010.00330.x; Conrad JL, 2008, AM MUS NOVIT, P1, DOI 10.1206/596.1; Conrad JL, 2008, AM MUS NOVIT, P1, DOI 10.1206/586.1; Conrad JL, 2004, ZOOL J LINN SOC-LOND, V141, P399, DOI 10.1111/j.1096-3642.2004.00128.x; de Fejervary GJ, 1918, ANN HIST NATURALES M, V16, P341; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; Espinoza RE, 2004, P NATL ACAD SCI USA, V101, P16819, DOI 10.1073/pnas.0401226101; Estes R, 1983, SAURIA TERRESTRIA AM; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; Falconer H. P., 1868, PALEONTOLOGICAL MEMO; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; Fuller S, 1998, MOL PHYLOGENET EVOL, V9, P294, DOI 10.1006/mpev.1997.0476; Gao K., 1996, B CARNEGIE MUSEUM NA, V33, P1; Gao KQ, 2000, B AM MUS NAT HIST, P1; Gilmore C. W., 1928, Mem Nat Acad Sci Washington, V22, P1; Goloboff P.A., 2003, T N T TREE ANAL USIN; Goloboff PA, 2010, T N T TREE ANAL USIN; Goloboff P, 2008, CLADISTICS, V24, P91; Haber A, 2005, NETH J GEOSCI, V84, P247, DOI 10.1017/S001677460002103X; Head JJ, 2009, ZOOL J LINN SOC-LOND, V155, P445, DOI 10.1111/j.1096-3642.2008.00448.x; Head JJ, 2009, NATURE, V457, P715, DOI 10.1038/nature07671; HECHT M K, 1975, Proceedings of the Royal Society of Victoria, V87, P239; Hocknull SA, 2009, PLOS ONE, V4, p[e7241, 7241]; Holmes RB, 2010, PALAEONTOLOGY, V53, P1099, DOI 10.1111/j.1475-4983.2010.00994.x; Kearney M, 2003, J VERTEBR PALEONTOL, V23, P263, DOI 10.1671/0272-4634(2003)023[0263:PDTMDI]2.0.CO;2; King D, 1999, MERTENSIELLA ADV MON, P43; KING M, 1990, ADV LIF SCI, P153; KING M, 1975, AUST J BIOL SCI, V28, P89, DOI 10.1071/BI9750089; Koch Andre, 2010, Bonn Zoological Bulletin, V57, P127; Lee MSY, 2000, J PALEONTOL, V74, P915, DOI 10.1666/0022-3360(2000)074<0915:AATAOM>2.0.CO;2; LINGHAMSOLIAR T, 1995, PHILOS T ROY SOC B, V347, P155, DOI 10.1098/rstb.1995.0019; MADDISON WP, 2006, MESQUITE MODULAR SYS; Maisano JA, 2001, HERPETOL MONOGR, V15, P135, DOI 10.2307/1467041; Meiri S, 2010, J ZOOL, P1; Mertens R, 1942, ABHANDLUNGEN SENCKEN, V465, P117; MOLNAR R E, 1990, Memoirs of the Queensland Museum, V29, P437; Molnar RE, 2004, VARANOID LIZARDS OF THE WORLD, P10; Molnar RE, 2004, VARANOID LIZARDS OF THE WORLD, P68; Molnar RE., 2004, DRAGONS DUST PALEOBI; Murphy J. C., 1997, TALES GIANT SNAKES H; Norell Mark A., 1997, American Museum Novitates, V3211, P1; Norell MA, 2008, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2008)3605[1:ANPLDS]2.0.CO;2; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Page R. D. M., 2001, NDE NEXUS DATA EDITO; Palci A, 2007, J VERTEBR PALEONTOL, V27, P1, DOI 10.1671/0272-4634(2007)27[1:VFAAEI]2.0.CO;2; Pepin David J., 1999, Mertensiella, V11, P11; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; PIANKA ER, 1994, AUST J ECOL, V19, P395, DOI 10.1111/j.1442-9993.1994.tb00505.x; Pianka ER, 2004, VARANOID LIZARDS OF THE WORLD, P3; PIANKA ER, 1995, AM NAT, V146, P398, DOI 10.1086/285806; Pianka ER, 2004, VARANOID LIZARDS WOR; Polcyn MJ, 2005, NETH J GEOSCI, V84, P321, DOI 10.1017/S0016774600021107; Pregill GK, 2003, HERPETOLOGICA, V59, P57, DOI 10.1655/0018-0831(2003)059[0057:ANILSI]2.0.CO;2; Rieppel O, 2001, NEUES JAHRB GEOL P-A, V221, P111; RIEPPEL O, 1983, Z ZOOL SYST EVOL, V21, P142; Rieppel O, 2000, ZOOL J LINN SOC-LOND, V129, P489, DOI 10.1006/zjls.1999.0215; RIEPPEL O, 1980, PHYLOGENY ANGUINIMOR; Rieppel O, 2007, J PALEONTOL, V81, P643, DOI 10.1666/pleo0022-3360(2007)081[0643:TAOTFV]2.0.CO;2; SCHWARTZ A., 1991, AMPHIBIANS REPTILES; Smith KT, 2008, J VERTEBR PALEONTOL, V28, P909, DOI 10.1671/0272-4634(2008)28[909:EAROTV]2.0.CO;2; Solounias N., 1981, CONTRIBUTIONS TO VERTEBRATE EVOLUTION, V6, P1; SOLOUNIAS N, 1981, Annals of Carnegie Museum, V50, P231; Soulinias N, 2007, J VIRTUAL EXPLORER; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Turner AH, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3557[1:ASDTFS]2.0.CO;2; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Vidal N, 2009, CR BIOL, V332, P129, DOI 10.1016/j.crvi.2008.07.010; Weithoffer K., 1888, BEITRAGE PALAONTOLOG, V6, P225; Welton L. J., 2010, BIOL LETT, V6, P1; Wroe S, 2002, AUST J ZOOL, V50, P1, DOI 10.1071/ZO01053; Zug G. R., 2001, HERPETOLOGY, P57; [No title captured]	91	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41767	10.1371/journal.pone.0041767	http://dx.doi.org/10.1371/journal.pone.0041767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900001	Green Submitted, gold, Green Published			2022-12-27	WOS:000307380900016
J	Santamaria, ME; Martinez, ICM; Pozancos, C; Gonzalez-Melendi, P; Grbic, V; Castanera, P; Ortego, F; Diaz, I				Estrella Santamaria, Maria; Manuel Martinez, Ines Cambra; Pozancos, Clara; Gonzalez-Melendi, Pablo; Grbic, Vojislava; Castanera, Pedro; Ortego, Felix; Diaz, Isabel			Gene Pyramiding of Peptidase Inhibitors Enhances Plant Resistance to the Spider Mite Tetranychus urticae	PLOS ONE			English	Article							COLORADO POTATO BEETLE; PROTEINASE-INHIBITORS; INSECT RESISTANCE; BARLEY; CYSTEINE; EXPRESSION; ACARI; CME; PHYTOSEIIDAE; LEPIDOPTERA	The two-spotted spider mite Tetranychus urticae is a damaging pest worldwide with a wide range of host plants and an extreme record of pesticide resistance. Recently, the complete T. urticae genome has been published and showed a proliferation of gene families associated with digestion and detoxification of plant secondary compounds which supports its polyphagous behaviour. To overcome spider mite adaptability a gene pyramiding approach has been developed by co-expressing two barley proteases inhibitors, the cystatin Icy6 and the trypsin inhibitor Itr1 genes in Arabidopsis plants by Agrobacterium-mediated transformation. The presence and expression of both transgenes was studied by conventional and quantitative real time RT-PCR assays and by indirect ELISA assays. The inhibitory activity of cystatin and trypsin inhibitor was in vitro analysed using specific substrates. Single and double transformants were used to assess the effects of spider mite infestation. Double transformed lines showed the lowest damaged leaf area in comparison to single transformants and non-transformed controls and different accumulation of H2O2 as defence response in the leaf feeding site, detected by diaminobenzidine staining. Additionally, an impact on endogenous mite cathepsin B-and L-like activities was observed after feeding on Arabidopsis lines, which correlates with a significant increase in the mortality of mites fed on transformed plants. These effects were analysed in view of the expression levels of the target mite protease genes, C1A cysteine peptidase and S1 serine peptidase, identified in the four developmental mite stages (embryo, larvae, nymphs and adults) performed using the RNA-seq information available at the BOGAS T. urticae database. The potential of pyramiding different classes of plant protease inhibitors to prevent plant damage caused by mites as a new tool to prevent pest resistance and to improve pest control is discussed.	[Estrella Santamaria, Maria; Manuel Martinez, Ines Cambra; Pozancos, Clara; Gonzalez-Melendi, Pablo; Diaz, Isabel] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas UPM INIA, Madrid, Spain; [Estrella Santamaria, Maria; Castanera, Pedro; Ortego, Felix] CSIC, Ctr Invest Biol, Dpto Biol Medioambiental, Madrid, Spain; [Estrella Santamaria, Maria; Grbic, Vojislava] Western Univ, Dept Biol, Ottawa, ON, Canada	Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Santamaria, ME (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas UPM INIA, Campus Montegancedo,Autopista M40,Km 38, Madrid, Spain.	i.diaz@upm.es	Diaz, Isabel/I-8840-2014; SANTAMARIA, M ESTRELLA/I-9337-2014; Martinez, Manuel/I-8743-2014; Ortego, Félix/F-9402-2011; de León, Pablo González-Melendi/K-1604-2014; , risueno/AAD-3993-2019; castanera, pedro/G-2165-2015	Diaz, Isabel/0000-0001-9865-902X; SANTAMARIA, M ESTRELLA/0000-0003-4999-6227; Martinez, Manuel/0000-0002-7826-5872; Ortego, Félix/0000-0002-7778-8508; de León, Pablo González-Melendi/0000-0003-4355-4495; 	Ministerio de Economia y Competitividad [AGL2011-23650]; CSIC [2010-40E049]; Government of Canada through Genome Canada; Ontario Genomics Institute [OGI-046]; Ontario Research Fend-Global Leadership in Genomics and Life Sciences [GL2-01-035]	Ministerio de Economia y Competitividad(Spanish Government); CSIC; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Ontario Research Fend-Global Leadership in Genomics and Life Sciences	Financial support from the Ministerio de Economia y Competitividad (project AGL2011-23650), from CSIC (project 2010-40E049) and the Government of Canada through Genome Canada and the Ontario Genomics Institute (project OGI-046) and Ontario Research Fend-Global Leadership in Genomics and Life Sciences (project GL2-01-035), are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JE, 2007, FEBS J, V274, P2800, DOI 10.1111/j.1472-4658.2007.05816.x; Alfonso-Rubi J, 2003, TRANSGENIC RES, V12, P23, DOI 10.1023/A:1022176207180; Altpeter F, 1999, MOL BREEDING, V5, P53, DOI 10.1023/A:1009659911798; Alvarez-Alfageme F, 2007, TRANSGENIC RES, V16, P1, DOI 10.1007/s11248-006-9022-6; Azzouz H, 2005, J INSECT PHYSIOL, V51, P75, DOI 10.1016/j.jinsphys.2004.11.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrillo L, 2011, PLANT PHYSIOL BIOCH, V49, P1191, DOI 10.1016/j.plaphy.2011.03.012; Carrillo L, 2011, TRANSGENIC RES, V20, P305, DOI 10.1007/s11248-010-9417-2; Carrillo L, 2011, PLANT CELL REP, V30, P101, DOI 10.1007/s00299-010-0948-z; Castagnoli M, 2003, EXP APPL ACAROL, V31, P177, DOI 10.1023/B:APPA.0000010387.48323.ee; Charity JA, 2005, FUNCT PLANT BIOL, V32, P35, DOI 10.1071/FP04105; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cui JJ, 2011, J ECON ENTOMOL, V104, P673, DOI 10.1603/EC09228; de Ilarduya OM, 2003, MOL PLANT MICROBE IN, V16, P699, DOI 10.1094/MPMI.2003.16.8.699; Down RE, 1999, PARASITOLOGY, V119, P157, DOI 10.1017/S0031182099004515; Dunse KM, 2010, P NATL ACAD SCI USA, V107, P15011, DOI 10.1073/pnas.1009241107; Esteves AB, 2010, NEOTROP ENTOMOL, V39, P338, DOI 10.1590/S1519-566X2010000300005; Filimonova SA, 2009, ARTHROPOD STRUCT DEV, V38, P303, DOI 10.1016/j.asd.2009.01.002; Golmirzaie A., 1997, Hortscience, V32, P435; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Hamilton KA, 2003, INT J PARASITOL, V33, P773, DOI 10.1016/S0020-7519(03)00089-4; Hnasko R, 2011, BIOCHEM BIOPH RES CO, V410, P726, DOI 10.1016/j.bbrc.2011.06.005; Khajehali J, 2011, PEST MANAG SCI, V67, P1424, DOI 10.1002/ps.2191; Lara P, 2000, TRANSGENIC RES, V9, P169, DOI 10.1023/A:1008905631440; Li GY, 2005, PEST MANAG SCI, V61, P390, DOI 10.1002/ps.990; McCafferty HRK, 2008, PLANT SCI, V175, P385, DOI 10.1016/j.plantsci.2008.05.007; McCafferty HRK, 2006, TRANSGENIC RES, V15, P337, DOI 10.1007/s11248-006-0005-4; Michaud D, 1996, ELECTROPHORESIS, V17, P74, DOI 10.1002/elps.1150170113; Migeon A., 2011, SPIDER MITES WEB COM; Navarro M, 2011, ICAR 22 INT C AR RES; Nisbet AJ, 2000, INT J PARASITOL, V30, P19, DOI 10.1016/S0020-7519(99)00169-1; Novillo C, 1997, ARCH INSECT BIOCHEM, V36, P181, DOI 10.1002/(SICI)1520-6327(1997)36:3<181::AID-ARCH3>3.0.CO;2-X; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Ortego F, 2001, J INSECT PHYSIOL, V47, P1291, DOI 10.1016/S0022-1910(01)00118-4; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rodriguez-Herva JJ, 2012, CELL MICROBIOL, V14, P669, DOI 10.1111/j.1462-5822.2012.01749.x; Rovenska GZ, 2005, BIOL CONTROL, V33, P293, DOI 10.1016/j.biocontrol.2005.03.017; Royo J, 1996, PLANT MOL BIOL, V31, P1051, DOI 10.1007/BF00040723; Sambrook J., 2001, MOL CLONING LAB MANU; Senthilkumar R, 2010, PLANT BIOTECHNOL J, V8, P65, DOI 10.1111/j.1467-7652.2009.00466.x; Van Leeuween T., 2012, P NATL ACAD SCI USA, V105, P598; Zhu-Salzman K, 2008, PLANT PHYSIOL, V146, P852, DOI 10.1104/pp.107.112177	44	59	59	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43011	10.1371/journal.pone.0043011	http://dx.doi.org/10.1371/journal.pone.0043011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900081	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900099
J	McCormick, MI; Weaver, CJ				McCormick, Mark I.; Weaver, Christine J.			It Pays to Be Pushy: Intracohort Interference Competition between Two Reef Fishes	PLOS ONE			English	Article							CORAL-DWELLING FISHES; GREAT-BARRIER-REEF; INTERSPECIFIC COMPETITION; SELECTIVE MORTALITY; INTRASPECIFIC COMPETITION; TERRITORIAL DAMSELFISHES; PREDATOR RECOGNITION; DENSITY-DEPENDENCE; HUMBUG DAMSELFISH; DASCYLLUS-ARUANUS	Competition is often most intense between similar sized organisms that have similar ecological requirements. Many coral reef fish species settle preferentially to live coral at the end of their larval phase where they interact with other species that recruited to the same habitat patch at a similar time. Mortality is high and usually selective and individuals must compete for low risk space. This study examined the competitive interactions between two species of juvenile damselfish and the extent to which interactions that occurred within a recruitment cohort established the disjunct distribution patterns that were displayed in later life stages. Censuses and field experiments with juveniles found that one species, the ambon damsel, was dominant immediately after settlement and pushed the subordinate species higher up the reef and further from shelter. Presence of a competitor resulted in reduced growth for both species. Juvenile size was the best predictor of competitive success and outweighed the effects of short term prior residency. Size at settlement also dramatically influenced survival, with slightly larger individuals displaying higher aggression, pushing the subordinate species into higher risk habitats. While subordinates had higher feeding rates, they also sustained higher mortality. The study highlights the importance of interaction dynamics between species within a recruitment cohort to patterns of growth and distribution of species within communities.	[McCormick, Mark I.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	McCormick, MI (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	mark.mccormick@jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645	Australian Research Council	Australian Research Council(Australian Research Council)	Research was funded through the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RA, 1985, ECOLOGY, V66, P1097, DOI 10.2307/1939161; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; BENKE AC, 1978, J ANIM ECOL, V47, P335, DOI 10.2307/3787; Bonin MC, 2009, CORAL REEFS, V28, P265, DOI 10.1007/s00338-008-0451-y; BOOTH DJ, 1995, ECOLOGY, V76, P91, DOI 10.2307/1940634; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; BUCHHEIM JR, 1992, J EXP MAR BIOL ECOL, V164, P45, DOI 10.1016/0022-0981(92)90135-W; CHAMBERS RC, 1987, CAN J FISH AQUAT SCI, V44, P1936, DOI 10.1139/f87-238; CLARKE RD, 1992, CORAL REEFS, V11, P199, DOI 10.1007/BF00301994; COATES D, 1980, J ANIM ECOL, V49, P335, DOI 10.2307/4292; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; CROWLEY PH, 1987, OECOLOGIA, V71, P447, DOI 10.1007/BF00378720; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; DOHERTY PJ, 1988, OCEANOGR MAR BIOL, V26, P487; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; DOHERTY PJ, 1982, J EXP MAR BIOL ECOL, V65, P249, DOI 10.1016/0022-0981(82)90057-0; DOHERTY PJ, 1983, ECOLOGY, V64, P176, DOI 10.2307/1937339; EBERSOLE JP, 1985, ECOLOGY, V66, P14, DOI 10.2307/1941302; Eitam A, 2005, OECOLOGIA, V146, P36, DOI 10.1007/s00442-005-0185-2; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; FIGLER MH, 1976, BEHAVIOUR, V58, P254, DOI 10.1163/156853976X00181; Figueira WF, 2008, OECOLOGIA, V156, P215, DOI 10.1007/s00442-008-0985-2; FORRESTER GE, 1991, ANIM BEHAV, V42, P701, DOI 10.1016/S0003-3472(05)80116-2; Forrester GE, 2006, OECOLOGIA, V148, P632, DOI 10.1007/s00442-006-0397-0; Fuiman LA, 2010, OECOLOGIA, V164, P99, DOI 10.1007/s00442-010-1712-3; Geange SW, 2009, ECOLOGY, V90, P2868, DOI 10.1890/08-0630.1; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Hawkins LA, 2004, BEHAVIOUR, V141, P1249, DOI 10.1163/1568539042729694; Hobbs JPA, 2004, MAR ECOL PROG SER, V278, P253, DOI 10.3354/meps278253; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Jones G.P., 1991, P294; Jones Geoffrey P., 2002, P221, DOI 10.1016/B978-012615185-5/50013-X; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; JONES GP, 1987, ECOLOGY, V68, P1534, DOI 10.2307/1939237; Kerrigan BA, 1996, MAR ECOL PROG SER, V135, P27, DOI 10.3354/meps135027; Knight CM, 2009, BIOL INVASIONS, V11, P1033, DOI 10.1007/s10530-008-9314-2; LAWLER SP, 1993, ECOLOGY, V74, P174, DOI 10.2307/1939512; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; Louette G, 2007, OIKOS, V116, P419, DOI 10.1111/j.2006.0030-1299.15381.x; Manassa RP, 2012, ANIM COGN, V15, P559, DOI 10.1007/s10071-012-0484-z; Mathis A, 1996, ANIM BEHAV, V51, P185, DOI 10.1006/anbe.1996.0016; McCormick MI, 2010, CORAL REEFS, V29, P537, DOI 10.1007/s00338-010-0620-7; McCormick MI, 2007, ECOLOGY, V88, P1562, DOI 10.1890/06-0830; McCormick MI, 2010, MAR ECOL PROG SER, V407, P173, DOI 10.3354/meps08583; McCormick MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007096; McCormick MI, 1997, MAR ECOL PROG SER, V153, P247, DOI 10.3354/meps153247; MCCORMICK MI, 1994, MAR ECOL PROG SER, V103, P1, DOI 10.3354/meps103001; McCormick MI, 2002, MAR BIOL, V141, P841, DOI 10.1007/s00227-002-0883-9; Meekan MG, 2010, ANIM BEHAV, V79, P803, DOI 10.1016/j.anbehav.2009.12.002; Meekan MG, 2001, MAR BIOL, V139, P373; Metcalfe NB, 2003, J APPL ECOL, V40, P535, DOI 10.1046/j.1365-2664.2003.00815.x; MILICICH MJ, 1994, MAR ECOL PROG SER, V110, P121, DOI 10.3354/meps110121; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; Munday PL, 2004, ECOLOGY, V85, P623, DOI 10.1890/03-3100; Munday PL, 2001, ECOLOGY, V82, P2177, DOI 10.1890/0012-9658(2001)082[2177:ICACIA]2.0.CO;2; Nilsson GE, 2007, P ROY SOC B-BIOL SCI, V274, P79, DOI 10.1098/rspb.2006.3706; PATTERSON JW, 1989, HYDROBIOLOGIA, V171, P121, DOI 10.1007/BF00008172; Perez-Dominguez R., 2010, EVOLUTION, V64, P2450, DOI DOI 10.1111/J.1558-5646.2010.00994.X; Rauch TJ, 2007, ENVIRON BIOL FISH, V78, P347, DOI 10.1007/s10641-006-9158-5; ROBERTSON DR, 1995, OECOLOGIA, V103, P180, DOI 10.1007/BF00329078; ROBERTSON DR, 1984, ECOLOGY, V65, P1121, DOI 10.2307/1938320; Robertson DR, 1996, ECOLOGY, V77, P885, DOI 10.2307/2265509; Ruggerone GT, 2003, FISH OCEANOGR, V12, P209, DOI 10.1046/j.1365-2419.2003.00239.x; SALE PF, 1976, J EXP MAR BIOL ECOL, V24, P297, DOI 10.1016/0022-0981(76)90061-7; Samhouri JF, 2009, ECOLOGY, V90, P1009, DOI 10.1890/07-1161.1; Schmitt RJ, 1999, ECOLOGY, V80, P35, DOI 10.1890/0012-9658(1999)080[0035:MOJDIF]2.0.CO;2; Schmitt RJ, 1999, OECOLOGIA, V118, P76, DOI 10.1007/s004420050705; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Shand J, 1997, ENVIRON BIOL FISH, V49, P307, DOI 10.1023/A:1007353003066; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; THOMPSON P, 1993, OIKOS, V67, P264, DOI 10.2307/3545471; Vail AL, 2011, BIOL LETTERS, V7, P921, DOI 10.1098/rsbl.2011.0380; van Gremberghe I, 2009, ENVIRON MICROBIOL, V11, P2564, DOI 10.1111/j.1462-2920.2009.01981.x; WALDNER R. E., 1980, B MAR SCI, V30, P171; Webster MS, 2004, ECOLOGY, V85, P986, DOI 10.1890/02-0576; Webster MS, 2000, MAR ECOL PROG SER, V196, P187, DOI 10.3354/meps196187; WELLINGTON GM, 1989, MAR BIOL, V101, P557, DOI 10.1007/BF00541659; Whiteman EA, 2004, ANIM BEHAV, V67, P239, DOI 10.1016/j.anbehav.2003.04.006; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; Wilson DT, 1997, MAR ECOL PROG SER, V153, P259, DOI 10.3354/meps153259; Wilson JA, 2005, J EXP MAR BIOL ECOL, V327, P144, DOI 10.1016/j.jembe.2005.06.013; [No title captured]	84	56	56	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42590	10.1371/journal.pone.0042590	http://dx.doi.org/10.1371/journal.pone.0042590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900030	Green Accepted, gold, Green Published			2022-12-27	WOS:000307380900046
J	Zahler, AM; Neeb, ZT; Lin, A; Katzman, S				Zahler, Alan M.; Neeb, Zachary T.; Lin, Athena; Katzman, Sol			Mating of the Stichotrichous Ciliate Oxytricha trifallax Induces Production of a Class of 27 nt Small RNAs Derived from the Parental Macronucleus	PLOS ONE			English	Article							PROGRAMMED GENOME REARRANGEMENTS; DICER-LIKE PROTEIN; DNA ELIMINATION; STERKIELLA-HISTRIOMUSCORUM; TETRAHYMENA-THERMOPHILA; CODING PROPERTIES; GENE; NOVA; PIWI; MECHANISM	Ciliated protozoans possess two types of nuclei; a transcriptionally silent micronucleus, which serves as the germ line nucleus, and a transcriptionally active macronucleus, which serves as the somatic nucleus. The macronucleus is derived from a new diploid micronucleus after mating, with epigenetic information contributed by the parental macronucleus serving to guide the formation of the new macronucleus. In the stichotrichous ciliate Oxytricha trifallax, the macronuclear DNA is highly processed to yield gene-sized nanochromosomes with telomeres at each end. Here we report that soon after mating of Oxytricha trifallax, abundant 27 nt small RNAs are produced that are not present prior to mating. We performed next generation sequencing of Oxytricha small RNAs from vegetative and mating cells. Using sequence comparisons between macronuclear and micronuclear versions of genes, we found that the 27 nt RNA class derives from the parental macronucleus, not the developing macronucleus. These small RNAs are produced equally from both strands of macronuclear nanochromosomes, but in a highly non-uniform distribution along the length of the nanochromosome, and with a particular depletion in the 30 nt telomere-proximal positions. This production of small RNAs from the parental macronucleus during macronuclear development stands in contrast to the mechanism of epigenetic control in the distantly related ciliate Tetrahymena. In that species, 28-29 nt scanRNAs are produced from the micronucleus and these micronuclear-derived RNAs serve as epigenetic controllers of macronuclear development. Unlike the Tetrahymena scanRNAs, the Oxytricha macronuclear-derived 27 mers are not modified by 2'O-methylation at their 3' ends. We propose models for the role of these "27macRNAs" in macronuclear development.	[Zahler, Alan M.; Neeb, Zachary T.; Lin, Athena] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Zahler, Alan M.; Neeb, Zachary T.; Lin, Athena] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Katzman, Sol] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Zahler, AM (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	zahler@ucsc.edu		Neeb, Zachary T./0000-0001-8930-3574; Zahler, Alan/0000-0003-0027-1647	National Science Foundation [MCB-1121290]; University of California Institute for Quantitative Biology [QB3]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); University of California Institute for Quantitative Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the National Science Foundation (MCB-1121290) to AMZ. SK is supported in part by the University of California Institute for Quantitative Biology (QB3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2000, J EUKARYOT MICROBIOL, V47, P443, DOI 10.1111/j.1550-7408.2000.tb00073.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cavalcanti ARO, 2004, CHROMOSOMA, V113, P69, DOI 10.1007/s00412-004-0295-3; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; Chalker DL, 2011, ANNU REV GENET, V45, P227, DOI 10.1146/annurev-genet-110410-132432; Chang WJ, 2004, PROTIST, V155, P245, DOI 10.1078/143446104774199628; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; GRESLIN AF, 1989, P NATL ACAD SCI USA, V86, P6264, DOI 10.1073/pnas.86.16.6264; Heyse G, 2010, P NATL ACAD SCI USA, V107, P22134, DOI 10.1073/pnas.1009284107; Hoffman DC, 1996, NUCLEIC ACIDS RES, V24, P3337, DOI 10.1093/nar/24.17.3337; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Jahn CL, 2002, ANNU REV MICROBIOL, V56, P489, DOI 10.1146/annurev.micro.56.012302.160916; Jung S, 2011, NUCLEIC ACIDS RES, V39, P7529, DOI 10.1093/nar/gkr501; Kataoka K, 2011, ADV EXP MED BIOL, V722, P156, DOI 10.1007/978-1-4614-0332-6_10; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAUTH MR, 1976, CELL, V7, P67, DOI 10.1016/0092-8674(76)90256-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin H, 2008, COLD SH Q B, V73, P273, DOI 10.1101/sqb.2008.73.056; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; MITCHAM JL, 1992, GENE DEV, V6, P788, DOI 10.1101/gad.6.5.788; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Nowacki M, 2011, ANNU REV GENOM HUM G, V12, P367, DOI 10.1146/annurev-genom-082410-101420; Nowacki M, 2010, P NATL ACAD SCI USA, V107, P22140, DOI 10.1073/pnas.1012236107; Nowacki M, 2009, CURR OPIN MICROBIOL, V12, P638, DOI 10.1016/j.mib.2009.09.012; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Postberg J, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-3; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; Prescott DM, 1996, J EUKARYOT MICROBIOL, V43, P432, DOI 10.1111/j.1550-7408.1996.tb04502.x; Prescott DM, 2002, PROTIST, V153, P71, DOI 10.1078/1434-4610-00084; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; SWANTON MT, 1980, CHROMOSOMA, V77, P217, DOI 10.1007/BF00329546; Swart EC, 2012, GENOME BIOL EVOL, V4, P136, DOI 10.1093/gbe/evr136; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; WILLIAMS K, 1993, EMBO J, V12, P4593, DOI 10.1002/j.1460-2075.1993.tb06148.x; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; ZAHLER AM, 1989, NUCLEIC ACIDS RES, V17, P6299, DOI 10.1093/nar/17.15.6299; Zoller SD, 2012, PROTIST	46	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42371	10.1371/journal.pone.0042371	http://dx.doi.org/10.1371/journal.pone.0042371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900016	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900033
J	Tennie, C; Call, J; Tomasello, M				Tennie, Claudio; Call, Josep; Tomasello, Michael			Untrained Chimpanzees (Pan troglodytes schweinfurthii) Fail to Imitate Novel Actions	PLOS ONE			English	Article							TOOL-USE; TRADITIONS; CHILDREN; CULTURE; APES; TRANSMISSION; EVOLUTION; COGNITION; BEHAVIOR; HUMANS	Background: Social learning research in apes has focused on social learning in the technical (problem solving) domain - an approach that confounds action and physical information. Successful subjects in such studies may have been able to perform target actions not as a result of imitation learning but because they had learnt some technical aspect, for example, copying the movements of an apparatus (i.e., different forms of emulation learning). Methods: Here we present data on action copying by non-enculturated and untrained chimpanzees when physical information is removed from demonstrations. To date, only one such study (on gesture copying in a begging context) has been conducted - with negative results. Here we have improved this methodology and have also added non-begging test situations (a possible confound of the earlier study). Both familiar and novel actions were used as targets. Prior to testing, a trained conspecific demonstrator was rewarded for performing target actions in view of observers. All but one of the tested chimpanzees already failed to copy familiar actions. When retested with a novel target action, also the previously successful subject failed to copy - and he did so across several contexts. Conclusion: Chimpanzees do not seem to copy novel actions, and only some ever copy familiar ones. Due to our having tested only non-enculturated and untrained chimpanzees, the performance of our test subjects speak more than most other studies of the general (dis-)ability of chimpanzees to copy actions, and especially novel actions.	[Tennie, Claudio; Call, Josep; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany	Max Planck Society	Tennie, C (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.	tennie@eva.mpg.de		Call Balaguer, Josep/0000-0002-8597-8336; Tennie, Claudio/0000-0002-5302-4925				Acerbi A, 2011, LEARN BEHAV, V39, P104, DOI 10.3758/s13420-010-0009-z; Boesch C, 2009, J HUM EVOL, V56, P560, DOI 10.1016/j.jhevol.2009.04.001; Bonnie KE, 2007, P ROY SOC B-BIOL SCI, V274, P367, DOI 10.1098/rspb.2006.3733; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; Buttelmann D, 2007, DEVELOPMENTAL SCI, V10, pF31, DOI 10.1111/j.1467-7687.2007.00630.x; Byrne R., 2006, INT J PSYCHOL PSYCHO, V6, P215; Byrne R.W., 1994, P223; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; Byrne RW, 2005, PERSPECTIVES IMITATI, P255; Caldwell CA, 2009, PSYCHOL SCI, V20, P1478, DOI 10.1111/j.1467-9280.2009.02469.x; Call J, 2002, FROM ANIM ANIMAT, P211; Call J, 2001, CYBERNET SYST, V32, P97, DOI 10.1080/019697201300001821; CUSTANCE DM, 1995, BEHAVIOUR, V132, P837, DOI 10.1163/156853995X00036; DAWKINS R, 2006, CLIMBING MOUNT IMPRO; de Waal F., 2001, APE SUSHI MASTER CUL; Dean LG, 2012, SCIENCE, V335, P1114, DOI 10.1126/science.1213969; Dindo M, 2009, AM J PRIMATOL, V71, P419, DOI 10.1002/ajp.20669; Enquist M, 2007, AM ANTHROPOL, V109, P727, DOI 10.1525/AA.2007.109.4.727; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Galef B G, 1992, Hum Nat, V3, P157, DOI 10.1007/BF02692251; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Gergely G., 2005, INTERACT STUD, V6, P463, DOI [10.1075/is.6.3.10ger, DOI 10.1075/IS.6.3.10GER]; Gruber T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00128; Hanus D, 2008, CURR BIOL, V18, pR370, DOI 10.1016/j.cub.2008.02.039; Hanus D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019555; Hare B, 2001, Anim Cogn, V4, P269, DOI 10.1007/s100710100084; HAYES KJ, 1952, J COMP PHYSIOL PSYCH, V45, P450, DOI 10.1037/h0053609; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Heyes CM, SIGNALLING COMMITMEN; Hobaiter C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011959; Hopper LM, 2008, P ROY SOC B-BIOL SCI, V275, P835, DOI 10.1098/rspb.2007.1542; Hopper LM, 2007, ANIM BEHAV, V73, P1021, DOI 10.1016/j.anbehav.2006.07.016; Hopper Lydia M., 2012, P99; Hopper LM, 2012, AM J PRIMATOL, V74, P442, DOI 10.1002/ajp.22001; Hopper LM, 2011, ANIM BEHAV, V81, P1195, DOI 10.1016/j.anbehav.2011.03.002; Horner V, 2007, J COMP PSYCHOL, V121, P12, DOI 10.1037/0735-7036.121.1.12; Hrubesch C, 2009, ANIM COGN, V12, P209, DOI 10.1007/s10071-008-0183-y; Huber L, 2009, PHILOS T R SOC B, V364, P2299, DOI 10.1098/rstb.2009.0060; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Laland K. N., 2009, QUESTION ANIMAL CULT; Laland KN, 2004, LEARN BEHAV, V32, P4; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; Marshall-Pescini S, 2008, ANIM COGN, V11, P449, DOI 10.1007/s10071-007-0135-y; Marshall-Pescini S, 2008, J COMP PSYCHOL, V122, P186, DOI 10.1037/0735-7036.122.2.186; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Moll H, 2007, PHILOS T R SOC B, V362, P639, DOI 10.1098/rstb.2006.2000; Morgan BJ, 2006, CURR BIOL, V16, pR632, DOI 10.1016/j.cub.2006.07.045; Nielsen M, 2006, DEV PSYCHOL, V42, P555, DOI 10.1037/0012-1649.42.3.555; Over H, 2011, J COMP PSYCHOL; Price EE, 2009, P ROY SOC B-BIOL SCI, V276, P3377, DOI 10.1098/rspb.2009.0640; Pryor K, 1999, DONT SHOOT DOG NEW A; Rakoczy H, 2008, DEV PSYCHOL, V44, P875, DOI 10.1037/0012-1649.44.3.875; Ray E, 2011, DEVELOPMENTAL SCI, V14, P92, DOI 10.1111/j.1467-7687.2010.00961.x; Rendell L, 2011, TRENDS COGN SCI, V15, P68, DOI 10.1016/j.tics.2010.12.002; Richerson PJ., 2005, NOT GENES ALONE CULT; Sanz C, 2009, BIOL LETTERS, V5, P293, DOI 10.1098/rsbl.2008.0786; Tennie C, BEHAV BRAIN IN PRESS; Tennie C, 2008, AM J PRIMATOL, V70, P584, DOI 10.1002/ajp.20532; Tennie C, 2006, ETHOLOGY, V112, P1159, DOI 10.1111/j.1439-0310.2006.01269.x; Tennie C, 2009, ANIM SCI ISSUES PROF, P95; Tennie C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010544; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; TOMASELLO M, 1993, CHILD DEV, V64, P1688, DOI 10.1111/j.1467-8624.1993.tb04207.x; Tomasello M, 2004, ANIM COGN, V7, P213, DOI 10.1007/s10071-004-0227-x; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Tomasello M, 1999, CULTURAL ORIGINS HUM, pvi; Tomasello M., 1997, EVOLUTION COMMUNICAT, V1, P223, DOI [DOI 10.1075/EOC.1.2.04TOM, 10.1075/eoc.1.2.04tom]; van Schaik CP, 2003, J HUM EVOL, V44, P645, DOI 10.1016/S0047-2484(03)00041-1; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2007, CURR BIOL, V17, P1038, DOI 10.1016/j.cub.2007.05.031	75	66	67	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41548	10.1371/journal.pone.0041548	http://dx.doi.org/10.1371/journal.pone.0041548			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905102	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100013
J	Magadan, AH; Dupuis, ME; Villion, M; Moineau, S				Magadan, Alfonso H.; Dupuis, Marie-Eve; Villion, Manuela; Moineau, Sylvain			Cleavage of Phage DNA by the Streptococcus thermophilus CRISPR3-Cas System	PLOS ONE			English	Article							CRISPR/CAS SYSTEM; IMMUNE-SYSTEM; BACTERIA; BACTERIOPHAGES; RESISTANCE; SEQUENCES; DIVERSITY; EVOLUTION; RNA	Streptococcus thermophilus, similar to other Bacteria and Archaea, has developed defense mechanisms to protect cells against invasion by foreign nucleic acids, such as virus infections and plasmid transformations. One defense system recently described in these organisms is the CRISPR-Cas system (Clustered Regularly Interspaced Short Palindromic Repeats loci coupled to CRISPR-associated genes). Two S. thermophilus CRISPR-Cas systems, CRISPR1-Cas and CRISPR3-Cas, have been shown to actively block phage infection. The CRISPR1-Cas system interferes by cleaving foreign dsDNA entering the cell in a length-specific and orientation-dependant manner. Here, we show that the S. thermophilus CRISPR3-Cas system acts by cleaving phage dsDNA genomes at the same specific position inside the targeted protospacer as observed with the CRISPR1-Cas system. Only one cleavage site was observed in all tested strains. Moreover, we observed that the CRISPR1-Cas and CRISPR3-Cas systems are compatible and, when both systems are present within the same cell, provide increased resistance against phage infection by both cleaving the invading dsDNA. We also determined that overall phage resistance efficiency is correlated to the total number of newly acquired spacers in both CRISPR loci.	[Magadan, Alfonso H.; Dupuis, Marie-Eve; Villion, Manuela; Moineau, Sylvain] Univ Laval, Fac Sci & Genie, Grp Rech Ecol Buccale, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ G1K 7P4, Canada; [Moineau, Sylvain] Univ Laval, Felix dHerelle Reference Ctr Bacterial Viruses, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Magadan, AH (corresponding author), Univ Laval, Fac Sci & Genie, Grp Rech Ecol Buccale, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ G1K 7P4, Canada.	Sylvain.Moineau@bcm.ulaval.ca	Magadán, Alfonso Hernández/K-4455-2012; Moineau, Sylvain/I-7231-2019; Moineau, Sylvain/N-3578-2013; Magadan, Alfonso Hernandez/M-5994-2019	Magadán, Alfonso Hernández/0000-0003-2556-7890; Moineau, Sylvain/0000-0002-2832-5101; Magadan, Alfonso Hernandez/0000-0003-2556-7890	Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	S.M. acknowledges funding from the Natural Sciences and Engineering Research Council (NSERC) of Canada (Discovery program). S. M. holds a Tier 1 Canada Research Chair in Bacteriophages. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Delorme C, 2011, J BACTERIOL, V193, P5581, DOI 10.1128/JB.05404-11; Delorme C, 2010, APPL ENVIRON MICROB, V76, P451, DOI 10.1128/AEM.01018-09; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Duplessis M, 2005, VIROLOGY, V340, P192, DOI 10.1016/j.virol.2005.05.033; Fortier LC, 2007, APPL ENVIRON MICROB, V73, P7358, DOI 10.1128/AEM.00582-07; Garneau JE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S20; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Khan MA, 2004, ENV BIOTECHNOLOGY AD, P349; Levesque C, 2005, APPL ENVIRON MICROB, V71, P4057, DOI 10.1128/AEM.71.7.4057-4068.2005; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mills S, 2010, J APPL MICROBIOL, V108, P945, DOI 10.1111/j.1365-2672.2009.04486.x; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Sambrook J., 2001, MOL CLONING LAB MANU; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sun ZH, 2011, J BACTERIOL, V193, P793, DOI 10.1128/JB.01374-10; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	27	72	96	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40913	10.1371/journal.pone.0040913	http://dx.doi.org/10.1371/journal.pone.0040913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911717	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600028
J	Molesini, B; Pandolfini, T; Pii, Y; Korte, A; Spena, A				Molesini, Barbara; Pandolfini, Tiziana; Pii, Youry; Korte, Arthur; Spena, Angelo			Arabidopsis thaliana AUCSIA-1 Regulates Auxin Biology and Physically Interacts with a Kinesin-Related Protein	PLOS ONE			English	Article							PRECURSOR INDOLE-3-BUTYRIC ACID; CLATHRIN-DEPENDENT ENDOCYTOSIS; LATERAL ROOT DEVELOPMENT; GENE-EXPRESSION; FLAVIN MONOOXYGENASES; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; FRUIT-DEVELOPMENT; PLANT DEVELOPMENT; ABC TRANSPORTERS	Aucsia is a green plant gene family encoding 44-54 amino acids long miniproteins. The sequenced genomes of most land plants contain two Aucsia genes. RNA interference of both tomato (Solanum lycopersicum) Aucsia genes (SlAucsia-1 and SlAucsia-2) altered auxin sensitivity, auxin transport and distribution; it caused parthenocarpic development of the fruit and other auxin-related morphological changes. Here we present data showing that the Aucsia-1 gene of Arabidopsis thaliana alters, by itself, root auxin biology and that the AtAUCSIA-1 miniprotein physically interacts with a kinesin-related protein. The AtAucsia-1 gene is ubiquitously expressed, although its expression is higher in roots and inflorescences in comparison to stems and leaves. Two allelic mutants for AtAucsia-1 gene did not display visible root morphological alterations; however both basipetal and acropetal indole-3-acetic acid (IAA) root transport was reduced as compared with wild-type plants. The transcript steady state levels of the auxin efflux transporters ATP BINDING CASSETTE subfamily B (ABCB) ABCB1, ABCB4 and ABCB19 were reduced in ataucsia-1 plants. In ataucsia-1 mutant, lateral root growth showed an altered response to i) exogenous auxin, ii) an inhibitor of polar auxin transport and iii) ethylene. Overexpression of AtAucsia-1 inhibited primary root growth. In vitro and in vivo protein-protein interaction experiments showed that AtAUCSIA-1 interacts with a 185 amino acids long fragment belonging to a 2712 amino acids long protein of unknown function (At4g31570). Bioinformatics analysis indicates that the AtAUCSIA-1 interacting protein (AtAUCSIA-1IP) clusters with a group of CENP-E kinesin-related proteins. Gene ontology predictions for the two proteins are consistent with the hypothesis that the AtAUCSIA-1/AtAUCSIA-1IP complex is involved in the regulation of the cytoskeleton dynamics underlying auxin biology.	[Molesini, Barbara; Pandolfini, Tiziana; Pii, Youry; Spena, Angelo] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy; [Korte, Arthur] WeihenstephanTech Univ Muenchen, Wissensch Zentrum, Freising Weihenstephan, Germany	University of Verona	Molesini, B (corresponding author), Univ Verona, Dept Biotechnol, I-37100 Verona, Italy.	angelo.spena@univr.it	Korte, Arthur/H-3190-2019; Pii, Youry/N-1151-2016	Korte, Arthur/0000-0003-0831-1463; Pii, Youry/0000-0002-1613-851X; MOLESINI, Barbara/0000-0002-4324-4908; Pandolfini, Tiziana/0000-0002-1658-2231	MIUR (Ministry for University and Research)	MIUR (Ministry for University and Research)(Ministry of Education, Universities and Research (MIUR))	Supported by a MIUR (Ministry for University and Research) grant to AS (from 2005 to 2007). No other financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Alonso JM, 2004, SCIENCE, V306, P1513, DOI 10.1126/science.1104812; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bandyopadhyay A, 2007, BIOCHEM SOC T, V35, P137, DOI 10.1042/BST0350137; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bhalerao RP, 2003, NAT CELL BIOL, V5, P939, DOI 10.1038/ncb1103-939; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Bohn-Courseau I, 2010, CR BIOL, V333, P290, DOI 10.1016/j.crvi.2010.01.004; Bradford JR, 2010, PLANT J, V61, P713, DOI 10.1111/j.1365-313X.2009.04097.x; Calderon-Villalobos LI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005546; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Cecchetti V, 2008, PLANT CELL, V20, P1760, DOI 10.1105/tpc.107.057570; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Dhonukshe P, 2008, P NATL ACAD SCI USA, V105, P4489, DOI 10.1073/pnas.0711414105; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Fei HM, 2004, PLANTA, V219, P649, DOI 10.1007/s00425-004-1270-1; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Frey N, 2010, J EXP BOT, V61, P3423, DOI 10.1093/jxb/erq164; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Fuentes S, 2010, ANNU PLANT REV, V38, P107, DOI 10.1002/9781444314557.ch4; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Gao XW, 2008, MOL PLANT, V1, P899, DOI 10.1093/mp/ssn069; Garzon M, 2007, FEBS LETT, V581, P3189, DOI 10.1016/j.febslet.2007.06.005; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Gustafson FG, 1936, P NATL ACAD SCI USA, V22, P628, DOI 10.1073/pnas.22.11.628; Harrison BR, 2008, PLANT J, V53, P380, DOI 10.1111/j.1365-313X.2007.03351.x; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Ivanchenko MG, 2008, PLANT J, V55, P335, DOI 10.1111/j.1365-313X.2008.03528.x; Iwai S, 2004, J BIOL CHEM, V279, P4696, DOI 10.1074/jbc.M308022200; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Kleine-Vehn J, 2006, PLANT CELL, V18, P3171, DOI 10.1105/tpc.106.042770; Knapp S, 2002, J EXP BOT, V53, P2001, DOI 10.1093/jxb/erf068; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kuriyama R, 2002, J CELL BIOL, V156, P783, DOI 10.1083/jcb.200109090; Lewis DR, 2009, NAT PROTOC, V4, P437, DOI 10.1038/nprot.2009.1; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Ljung K, 2001, PLANT J, V28, P465, DOI 10.1046/j.1365-313X.2001.01173.x; Lobello G, 2000, J EXP BOT, V51, P1403, DOI 10.1093/jexbot/51.349.1403; Lynch M, 2000, GENETICS, V154, P459; Lynch M, 2002, SCIENCE, V297, P945, DOI 10.1126/science.1075472; Marsch-Martinez N, 2002, PLANT PHYSIOL, V129, P1544, DOI 10.1104/pp.003327; Martinez-Laborda A., 2009, ARABIDOPSIS FRUIT DE, P172; Molesini B, 2009, PLANT PHYSIOL, V149, P534, DOI 10.1104/pp.108.131367; Mravec J, 2009, NATURE, V459, P1136, DOI 10.1038/nature08066; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Negi S, 2008, PLANT J, V55, P175, DOI 10.1111/j.1365-313X.2008.03495.x; Nick P, 2009, PLANT PHYSIOL, V151, P155, DOI 10.1104/pp.109.140111; Noh B, 2003, NATURE, V423, P999, DOI 10.1038/nature01716; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Peer WA, 2011, MOL PLANT, V4, P487, DOI 10.1093/mp/ssr034; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Pii Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-21; Preuss ML, 2004, PLANT PHYSIOL, V136, P3945, DOI 10.1104/pp.104.052340; Rahman A, 2007, PLANT J, V50, P514, DOI 10.1111/j.1365-313X.2007.03068.x; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Reed RC, 1998, PLANT PHYSIOL, V118, P1369, DOI 10.1104/pp.118.4.1369; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Rotino GL, 1997, NAT BIOTECHNOL, V15, P1398, DOI 10.1038/nbt1297-1398; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Ruzicka K, 2010, P NATL ACAD SCI USA, V107, P10749, DOI 10.1073/pnas.1005878107; Samaj J, 2004, PLANT PHYSIOL, V135, P1150, DOI 10.1104/pp.104.040683; SANCHEZBRAVO J, 1992, PLANT PHYSIOL, V100, P108, DOI 10.1104/pp.100.1.108; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schulz B, 2006, FEBS LETT, V580, P1010, DOI 10.1016/j.febslet.2006.01.002; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Strader LC, 2009, PLANT CELL, V21, P1992, DOI 10.1105/tpc.109.065821; Suetsugu N, 2010, P NATL ACAD SCI USA, V107, P8860, DOI 10.1073/pnas.0912773107; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Titapiwatanakun B, 2009, J EXP BOT, V60, P1093, DOI 10.1093/jxb/ern240; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woodward C, 2005, PLANT PHYSIOL, V139, P192, DOI 10.1104/pp.105.063495; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; Zazimalova E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001552; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Zourelidou M, 2009, DEVELOPMENT, V136, P627, DOI 10.1242/dev.028365	103	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41327	10.1371/journal.pone.0041327	http://dx.doi.org/10.1371/journal.pone.0041327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911780	Green Submitted, Green Published, gold			2022-12-27	WOS:000306644600071
J	Vadrot, N; Ghanem, S; Braut, F; Gavrilescu, L; Pilard, N; Mansouri, A; Moreau, R; Reyl-Desmars, F				Vadrot, Nathalie; Ghanem, Sarita; Braut, Francoise; Gavrilescu, Laura; Pilard, Nathalie; Mansouri, Abdellah; Moreau, Richard; Reyl-Desmars, Florence			Mitochondrial DNA Maintenance Is Regulated in Human Hepatoma Cells by Glycogen Synthase Kinase 3 beta and p53 in Response to Tumor Necrosis Factor alpha	PLOS ONE			English	Article							TRANSCRIPTION-FACTOR-A; BASE EXCISION-REPAIR; CANCER; KINASE-3-BETA; PROTEIN; INFLAMMATION; HEPATOCYTES; INDUCTION; APOPTOSIS; DEPLETION	During chronic liver inflammation, up-regulated Tumor Necrosis Factor alpha (TNF-alpha) targets hepatocytes and induces abnormal reactive oxygen species (ROS) production responsible for mitochondrial DNA (mtDNA) alterations. The serine/threonine Glycogen Synthase Kinase 3 beta (GSK3 beta) plays a pivotal role during inflammation but its involvement in the maintenance of mtDNA remains unknown. The aim of this study was to investigate its involvement in TNF-alpha induced mtDNA depletion and its interrelationship with p53 a protein known to maintain mtDNA copy numbers. Using quantitative polymerase chain reaction (qPCR) we found that at 30 min in human hepatoma HepG2 cells TNF-alpha induced 0.55 +/- 0.10 mtDNA lesions per 10 Kb and a 52.4 +/- 2.8% decrease in mtDNA content dependent on TNF-R1 receptor and ROS production. Both lesions and depletion returned to baseline from 1 to 6 h after TNF-alpha exposure. Luminol-amplified chemiluminescence (LAC) was used to measure the rapid (10 min) and transient TNF-alpha induced increase in ROS production (168 +/- 15%). A transient 8-oxo-dG level of 1.4 +/- 0.3 ng/mg DNA and repair of abasic sites were also measured by ELISA assays. Translocation of p53 to mitochondria was observed by Western Blot and co-immunoprecipitations showed that TNF-alpha induced p53 binding to GSK3 beta and mitochondrial transcription factor A (TFAM). In addition, mitochondrial D-loop immunoprecipitation (mtDIP) revealed that TNF-alpha induced p53 binding to the regulatory D-loop region of mtDNA. The knockdown of p53 by siRNAs, inhibition by the phosphoSer(15) p53 antibody or transfection of human mutant active GSK3 beta S9A pcDNA3 plasmid inhibited recovery of mtDNA content while blockade of GSK3 beta activity by SB216763 inhibitor or knockdown by siRNAs suppressed mtDNA depletion. This study is the first to report the involvement of GSK3 beta in TNF-alpha induced mtDNA depletion. We suggest that p53 binding to GSK3 beta, TFAM and D-loop could induce recovery of mtDNA content through mtDNA repair.	[Vadrot, Nathalie; Ghanem, Sarita; Gavrilescu, Laura; Pilard, Nathalie; Mansouri, Abdellah; Moreau, Richard; Reyl-Desmars, Florence] Univ Paris 07, Equipe Moreau, INSERM U773, Fac Med Bichat 10,CRB3, Paris, France; [Braut, Francoise] Univ Paris 07, Equipe El Benna, INSERM U773, Fac Med Bichat 10,CRB3, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Vadrot, N (corresponding author), Univ Paris 07, Equipe Moreau, INSERM U773, Fac Med Bichat 10,CRB3, Paris, France.	florence.reyl-desmars@inserm.fr	Abdellah, Mansouri/B-3002-2017; Moreau, Richard/S-1300-2019; Moreau, Richard/N-2197-2017	Abdellah, Mansouri/0000-0003-3856-5771; Moreau, Richard/0000-0003-0862-403X; Moreau, Richard/0000-0003-0862-403X				Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Appella E, 2000, PATHOL BIOL, V48, P227; Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Canugovi C, 2010, DNA REPAIR, V9, P1080, DOI 10.1016/j.dnarep.2010.07.009; Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043; Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103; Chinnery PF, 2005, J HEPATOL, V43, P207, DOI 10.1016/j.jhep.2005.05.012; Choumar A, 2011, ANTIOXID REDOX SIGN, V15, P2837, DOI 10.1089/ars.2010.3713; Coant N, 2011, J HEPATOL, V55, P784, DOI 10.1016/j.jhep.2010.12.039; Cotgreave I A, 1997, Adv Pharmacol, V38, P205; de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Farina AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004797; Gensler S, 2001, NUCLEIC ACIDS RES, V29, P3657, DOI 10.1093/nar/29.17.3657; Huang M, 2011, MOL PHARMACOL, V80, P40, DOI 10.1124/mol.110.070284; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Jelkmann W, 1999, EXP HEMATOL, V27, P224, DOI 10.1016/S0301-472X(98)00054-X; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kai Y, 2006, MITOCHONDRION, V6, P299, DOI 10.1016/j.mito.2006.10.002; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kobayashi H, 2001, J ANDROL, V22, P568; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Kulawiec M, 2009, J CARCINOGEN, V8, P1; Larosche I, 2010, J PHARMACOL EXP THER, V332, P886, DOI 10.1124/jpet.109.160879; Lasfer M, 2005, J HEPATOL, V42, P230, DOI 10.1016/j.jhep.2004.10.014; Lasfer M, 2006, FEBS LETT, V580, P2547, DOI 10.1016/j.febslet.2006.03.089; Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004; Lim KS, 2005, ANN NY ACAD SCI, V1042, P210, DOI 10.1196/annals.1338.023; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Nagakawa Y, 2005, HEPATOLOGY, V42, P208, DOI 10.1002/hep.20755; O'Dowd Y, 2004, BIOCHEM PHARMACOL, V68, P2003, DOI 10.1016/j.bcp.2004.06.023; Pessayre Dominique, 2010, Handb Exp Pharmacol, P311, DOI 10.1007/978-3-642-00663-0_11; Sadji-Ouatas Z, 2002, BIOCHEM J, V364, P881, DOI 10.1042/BJ20020349; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2339; Staib F, 2005, CANCER RES, V65, P10255, DOI 10.1158/0008-5472.CAN-05-1714; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Tazi KA, 2006, J HEPATOL, V45, P280, DOI 10.1016/j.jhep.2006.02.013; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Yang ES, 2011, NEURO-ONCOLOGY, V13, P459, DOI 10.1093/neuonc/nor016; Yoshida Y, 2003, CANCER RES, V63, P3729; Yoshida Y, 2002, BIOCHEM BIOPH RES CO, V295, P945, DOI 10.1016/S0006-291X(02)00757-X	53	16	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40879	10.1371/journal.pone.0040879	http://dx.doi.org/10.1371/journal.pone.0040879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911714	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600025
J	Frock, RL; Chen, SC; Da, DF; Frett, E; Lau, C; Brown, C; Pak, DN; Wang, YX; Muchir, A; Worman, HJ; Santana, LF; Ladiges, WC; Rabinovitch, PS; Kennedy, BK				Frock, Richard L.; Chen, Steven C.; Da, Dao-Fu; Frett, Ellie; Lau, Carmen; Brown, Christina; Pak, Diana N.; Wang, Yuexia; Muchir, Antoine; Worman, Howard J.; Santana, Luis F.; Ladiges, Warren C.; Rabinovitch, Peter S.; Kennedy, Brian K.			Cardiomyocyte-Specific Expression of Lamin A Improves Cardiac Function in Lmna(-/-) Mice	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; A-TYPE LAMINS; JUNCTIONAL INTERCELLULAR COMMUNICATION; CONDUCTION-SYSTEM DISEASE; ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; GAP-JUNCTION; DILATED CARDIOMYOPATHY; A/C GENE; NUCLEAR-ENVELOPE	Lmna(-/-) mice display multiple tissue defects and die by 6-8 weeks of age reportedly from dilated cardiomyopathy with associated conduction defects. We sought to determine whether restoration of lamin A in cardiomyocytes improves cardiac function and extends the survival of Lmna(-/-) mice. We observed increased total desmin protein levels and disorganization of the cytoplasmic desmin network in,20% of Lmna(-/-) ventricular myocytes, rescued in a cell-autonomous manner in Lmna(-/-) mice expressing a cardiac-specific lamin A transgene (Lmna(-/-); Tg). Lmna(-/-); Tg mice displayed significantly increased contractility and preservation of myocardial performance compared to Lmna(-/-) mice. Lmna(-/-); Tg mice attenuated ERK1/2 phosphorylation relative to Lmna(-/-) mice, potentially underlying the improved localization of connexin43 to the intercalated disc. Electrocardiographic recordings from Lmna(-/-) mice revealed arrhythmic events and increased frequency of PR interval prolongation, which is partially rescued in Lmna(-/-); Tg mice. These findings support our observation that Lmna(-/-); Tg mice have a 12% median extension in lifespan compared to Lmna(-/-) mice. While significant, Lmna(-/-); Tg mice only have modest improvement in cardiac function and survival likely stemming from the observation that only 40% of Lmna(-/-); Tg cardiomyocytes have detectable lamin A expression. Cardiomyocyte-specific restoration of lamin A in Lmna(-/-) mice improves heart-specific pathology and extends lifespan, demonstrating that the cardiac pathology of Lmna(-/-) mice limits survival. The expression of lamin A is sufficient to rescue certain cellular defects associated with loss of A-type lamins in cardiomyocytes in a cell-autonomous fashion.	[Frock, Richard L.; Chen, Steven C.; Lau, Carmen; Brown, Christina; Pak, Diana N.; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Da, Dao-Fu; Rabinovitch, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Santana, Luis F.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Ladiges, Warren C.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Frett, Ellie] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY USA; [Kennedy, Brian K.] Buck Inst Age Res, Novato, CA USA; [Wang, Yuexia; Muchir, Antoine; Worman, Howard J.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA; [Wang, Yuexia; Muchir, Antoine; Worman, Howard J.] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Rochester; Buck Institute for Research on Aging; Columbia University; Columbia University	Frock, RL (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	bkennedy@buckinstitute.org	Dai, Dao-Fu/AAB-7547-2022; Frock, Richard/I-6934-2019; Dai, Dao-Fu/AAM-4396-2021; Pak, Diana/GWZ-8091-2022; Santana, Luis/AAF-9298-2019	Frock, Richard/0000-0001-6963-4931; Dai, Dao-Fu/0000-0001-7724-321X; Santana, Luis/0000-0002-4297-8029; Kennedy, Brian/0000-0002-5754-1874; Muchir, Antoine/0000-0002-4780-9275	NICHD; National Institute on Aging at the National Institutes of Health [R01 AG024287]; National Institutes of Health [T32 HL007312, HL085686]; National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health [R01 AR048997]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085686, T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024287] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank Sara Mamman, Rubysue Mangalindan, Ashot Safarli and other members of the Ladiges lab in the Department of Comparative Medicine for handling and maintenance of mouse colonies. The MF20 myosin antibody (Fischman) was obtained from the Developmental Studies Hybridoma Bank under the auspices of the NICHD, maintained by University of Iowa (Biological Sciences, Iowa City, IA 52242).; Contract grant sponsor: National Institute on Aging at the National Institutes of Health; Contract grant number: R01 AG024287. Contract grant sponsor: National Institutes of Health; Contract grant number: T32 HL007312. Contract grant sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health; Contract grant number: R01 AR048997. Contract grant sponsor: National Institutes of Health; Contract grant number: HL085686. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P296, DOI 10.1111/j.1742-7843.2007.00064.x; Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Danik SB, 2004, CIRC RES, V95, P1035, DOI 10.1161/01.RES.0000148664.33695.2a; Davies BSJ, 2010, HUM MOL GENET, V19, P2682, DOI 10.1093/hmg/ddq158; Eckardt D, 2004, J MOL CELL CARDIOL, V36, P101, DOI 10.1016/j.yjmcc.2003.10.006; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Faureau C, 2008, EXP CELL RES, V314, P1392, DOI 10.1016/j.yexcr.2008.01.018; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Gard JJ, 2005, CARDIOVASC RES, V67, P539, DOI 10.1016/j.cardiores.2005.04.004; Gary-Bobo G, 2008, EUR J HEART FAIL, V10, P635, DOI 10.1016/j.ejheart.2008.04.014; Gonzalez S, 2011, AUTOIMMUN REV, V10, P175, DOI 10.1016/j.autrev.2010.09.022; Guerrero PA, 1997, J CLIN INVEST, V99, P1991, DOI 10.1172/JCI119367; Gutstein DE, 2005, AM J PHYSIOL-HEART C, V289, pH1091, DOI 10.1152/ajpheart.00095.2005; Gutstein DE, 2001, CELL COMMUN ADHES, V8, P345, DOI 10.3109/15419060109080751; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Kodama H, 2000, AM J PHYSIOL-HEART C, V279, pH1635, DOI 10.1152/ajpheart.2000.279.4.H1635; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lee DC, 2009, EXP CELL RES, V315, P996, DOI 10.1016/j.yexcr.2009.01.003; Lu G, 2010, CARDIOVASC RES, V88, P277, DOI 10.1093/cvr/cvq293; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Mounkes LC, 2005, HUM MOL GENET, V14, P2167, DOI 10.1093/hmg/ddi221; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343; Muchir A, 2009, BBA-MOL BASIS DIS, V1792, P75, DOI 10.1016/j.bbadis.2008.10.012; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Polontchouk L, 2001, FASEB J, V15, P87, DOI 10.1096/fj.01-0381fje; Rodriguez J, 2010, J CELL BIOL, V191, P967, DOI 10.1083/jcb.201004067; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; Rottlaender D, 2010, J CLIN INVEST, V120, P1441, DOI 10.1172/JCI40927; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Shumaker DK, 2008, J CELL BIOL, V181, P269, DOI 10.1083/jcb.200708155; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Wang YX, 2006, HUM MOL GENET, V15, P2479, DOI 10.1093/hmg/ddl170; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Wu W, 2011, CIRCULATION, V123, P53, DOI 10.1161/CIRCULATIONAHA.110.970673	45	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42918	10.1371/journal.pone.0042918	http://dx.doi.org/10.1371/journal.pone.0042918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905185	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600034
J	Abo, R; Jenkins, GD; Wang, LW; Fridley, BL				Abo, Ryan; Jenkins, Gregory D.; Wang, Liewei; Fridley, Brooke L.			Identifying the Genetic Variation of Gene Expression Using Gene Sets: Application of Novel Gene Set eQTL Approach to PharmGKB and KEGG	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BIOLOGICAL PATHWAYS; VARIANTS; RISK; PHARMACOGENOMICS; GEMCITABINE; DISCOVERY; DISEASE; LOCI; SNPS	Genetic variation underlying the regulation of mRNA gene expression in humans may provide key insights into the molecular mechanisms of human traits and complex diseases. Current statistical methods to map genetic variation associated with mRNA gene expression have typically applied standard linkage and/or association methods; however, when genome-wide SNP and mRNA expression data are available performing all pair wise comparisons is computationally burdensome and may not provide optimal power to detect associations. Consideration of different approaches to account for the high dimensionality and multiple testing issues may provide increased efficiency and statistical power. Here we present a novel approach to model and test the association between genetic variation and mRNA gene expression levels in the context of gene sets (GSs) and pathways, referred to as gene set - expression quantitative trait loci analysis (GS-eQTL). The method uses GSs to initially group SNPs and mRNA expression, followed by the application of principal components analysis (PCA) to collapse the variation and reduce the dimensionality within the GSs. We applied GS-eQTL to assess the association between SNP and mRNA expression level data collected from a cell-based model system using PharmGKB and KEGG defined GSs. We observed a large number of significant GS-eQTL associations, in which the most significant associations arose between genetic variation and mRNA expression from the same GS. However, a number of associations involving genetic variation and mRNA expression from different GSs were also identified. Our proposed GS-eQTL method effectively addresses the multiple testing limitations in eQTL studies and provides biological context for SNP-expression associations.	[Abo, Ryan; Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Rochester, MN 55905 USA; [Jenkins, Gregory D.; Fridley, Brooke L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Abo, R (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Rochester, MN 55905 USA.	fridley.brooke@mayo.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956	National Institutes of Health (NIH) [GM61388, CA140879, GM86689, CA130828, CA138461, CA102701]; Minnesota Partnership; Mayo Foundation; NATIONAL CANCER INSTITUTE [K22CA130828, P50CA102701, P20CA102701, R21CA140879, R01CA138461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM086689, U01GM061388, U19GM061388] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (NIH grants GM61388, CA140879, GM86689, CA130828, CA138461, CA102701), the Minnesota Partnership, and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballard DH, 2010, GENET EPIDEMIOL, V34, P201, DOI 10.1002/gepi.20448; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Chai HS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-102; Chen L, 2009, GENOMICS, V93, P501, DOI 10.1016/j.ygeno.2009.01.011; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duarte CW, 2011, GENETICS, V187, P955, DOI 10.1534/genetics.110.124685; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Franke L, 2009, METHODS MOL BIOL, V573, P311, DOI 10.1007/978-1-60761-247-6_17; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Grieve IC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004033; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li J, 2005, HUM MOL GENET, V14, pR163, DOI 10.1093/hmg/ddi267; Li L, 2008, CANCER RES, V68, P7050, DOI 10.1158/0008-5472.CAN-08-0405; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007765; Li SY, 2011, STAT INTERFACE, V4, P389; Li SY, 2010, J BIOPHARM STAT, V20, P373, DOI 10.1080/10543400903572803; Loguercio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013920; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Plenge RM, 2010, NAT GENET, V42, P281, DOI 10.1038/ng0410-281; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Scholkopf B., 2002, LEARNING KERNELS; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suthram S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.4; Team RDC, 2010, R LANG ENV STAT COMP; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Vapnik V., 1998, STAT LEARNING THEORY; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5	60	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43301	10.1371/journal.pone.0043301	http://dx.doi.org/10.1371/journal.pone.0043301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905253	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800075
J	Bartee, E; Meacham, A; Wise, E; Cogle, CR; McFadden, G				Bartee, Eric; Meacham, Amy; Wise, Elizabeth; Cogle, Christopher R.; McFadden, Grant			Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells	PLOS ONE			English	Article							T-CELLS; GVHD; STRATEGIES; LEUKEMIA; FAILURE	Graft-versus-host disease (GVHD) is a potentially lethal clinical complication arising from the transfer of alloreactive T lymphocytes into immunocompromised recipients. Despite conventional methods of T cell depletion, GVHD remains a major challenge in allogeneic hematopoietic cell transplant. Here, we demonstrate a novel method of preventing GVHD by ex vivo treatment of primary human hematopoietic cell sources with myxoma virus, a rabbit specific poxvirus currently under development for oncolytic virotherapy. This pretreatment dramatically increases post-transplant survival of immunocompromised mice injected with primary human bone marrow or peripheral blood cells and prevents the expansion of human CD3(+) lymphocytes in major recipient organs. Similar viral treatment also prevents human-human mixed alloreactive T lymphocyte reactions in vitro. Our data suggest that ex vivo virotherapy with myxoma virus can be a simple and effective method for preventing GVHD following infusion of hematopoietic products containing alloreactive T lymphocytes such as: allogeneic hematopoietic stem and progenitor cells, donor leukocyte infusions and blood transfusions.	[Bartee, Eric; McFadden, Grant] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32603 USA; [Meacham, Amy; Wise, Elizabeth; Cogle, Christopher R.] Univ Florida, Coll Med, Dept Med, Div Hematol Oncol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bartee, E (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32603 USA.	grantmcf@ufl.edu	Cogle, Christopher/H-1746-2016	Cogle, Christopher/0000-0001-5422-6863; McFadden, Grant/0000-0002-2556-3526; Bartee, Eric/0000-0003-1793-446X	National Institutes of Health, National Cancer Institute [R01 CA138541, R21 CA149869]; Florida Department of Health Bankhead Coley Research Program Team Science grant [1BT02]; Leukemia & Lymphoma Society; STOP! Children's Cancer, Inc; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health Bankhead Coley Research Program Team Science grant; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); STOP! Children's Cancer, Inc; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by funding to GM from National Institutes of Health R01 CA138541 and R21 CA149869 from National Cancer Institute (www.nih.gov). GM and CRC are supported by the Florida Department of Health Bankhead Coley Research Program Team Science grant 1BT02 (http://floridabiomed.com/funding_bc.html). CRC is supported by a Scholar in Clinical Research Award from the Leukemia & Lymphoma Society (www.lss.org). EB is supported by STOP! Children's Cancer, Inc (http://www.stopchildrenscancer.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar Masood, 2003, J Ayub Med Coll Abbottabad, V15, P56; Bais S, 2011, ADV VIROL; Bartee E, 2012, BIOL BLOOD MARROW TR; Blazar BR, 1997, IMMUNOL REV, V157, P79, DOI 10.1111/j.1600-065X.1997.tb00976.x; Chahroudi A, 2005, J VIROL, V79, P10397, DOI 10.1128/JVI.79.16.10397-10407.2005; Chao N, 2012, BLOOD, V119, P1102, DOI 10.1182/blood-2011-12-395905; Chao NJ, 2008, BEST PRACT RES CL HA, V21, P93, DOI 10.1016/j.beha.2007.11.012; Choi SW, 2010, IMMUNOL ALLERGY CLIN, V30, P75, DOI 10.1016/j.iac.2009.10.001; Davies JK, 2011, JOVE-J VIS EXP, DOI 10.3791/2673; DELAIN M, 1993, LEUKEMIA LYMPHOMA, V11, P359, DOI 10.3109/10428199309067927; FENNER F, 1965, MYXOMATOSIS; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003; Kim M, 2009, LEUKEMIA, V23, P2313, DOI 10.1038/leu.2009.219; Li JM, 2009, IMMUNOTHERAPY-UK, V1, P599, DOI 10.2217/IMT.09.32; Madlambayan GJ, 2012, LEUKEMIA RES, V36, P619, DOI 10.1016/j.leukres.2012.01.020; Maeda Y, 2005, BLOOD, V105, P2023, DOI 10.1182/blood-2004-08-3036; MARTIN PJ, 1988, BONE MARROW TRANSPL, V3, P445; MOSS B, 2007, FIELDS VIROLOGY, P2849; Murphy WJ, 1999, CURR OPIN IMMUNOL, V11, P509, DOI 10.1016/S0952-7915(99)00002-3; O'Shaughnessy MJ, 2009, AM J TRANSPLANT, V9, P452, DOI 10.1111/j.1600-6143.2008.02533.x; Paczesny S, 2009, CURR OPIN HEMATOL, V16, P427, DOI 10.1097/MOH.0b013e3283319a6f; Pasquini MC, 2010, CURRENT USE OUTCOME; Rahman MM, 2010, CYTOKINE GROWTH F R, V21, P169, DOI 10.1016/j.cytogfr.2010.02.010; Socie G, 2009, BLOOD, V114, P4327, DOI 10.1182/blood-2009-06-204669; Stanford MM, 2007, EXPERT OPIN BIOL TH, V7, P1415, DOI 10.1517/14712598.7.9.1415; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319	28	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43298	10.1371/journal.pone.0043298	http://dx.doi.org/10.1371/journal.pone.0043298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905251	gold, Green Submitted, Green Published			2022-12-27	WOS:000307500800073
J	Mauleon, G; Fall, CP; Eddington, DT				Mauleon, Gerardo; Fall, Christopher P.; Eddington, David T.			Precise Spatial and Temporal Control of Oxygen within In Vitro Brain Slices via Microfluidic Gas Channels	PLOS ONE			English	Article							HIPPOCAMPAL SLICES; NETWORK ACTIVITY; HYPOXIA; CALCIUM; DEPRIVATION; NEURONS; CA1; ACCUMULATION; DECREASES; CHAMBER	The acute brain slice preparation is an excellent model for studying the details of how neurons and neuronal tissue respond to a variety of different physiological conditions. But open slice chambers ideal for electrophysiological and imaging access have not allowed the precise spatiotemporal control of oxygen in a way that might realistically model stroke conditions. To address this problem, we have developed a microfluidic add-on to a commercially available perfusion chamber that diffuses oxygen throughout a thin membrane and directly to the brain slice. A microchannel enables rapid and efficient control of oxygen and can be modified to allow different regions of the slice to experience different oxygen conditions. Using this novel device, we show that we can obtain a stable and homogeneous oxygen environment throughout the brain slice and rapidly alter the oxygen tension in a hippocampal slice. We also show that we can impose different oxygen tensions on different regions of the slice preparation and measure two independent responses, which is not easily obtainable with current techniques.	[Mauleon, Gerardo; Fall, Christopher P.; Eddington, David T.] Univ Illinois, Dept Bioengn, Chicago, IL 60680 USA; [Fall, Christopher P.] Georgetown Univ, Dept Comp Sci, Washington, DC USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Georgetown University	Mauleon, G (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60680 USA.	dte@uic.edu			National Institute of Mental Health Neurotechnology program [R21MH085073]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085073] Funding Source: NIH RePORTER	National Institute of Mental Health Neurotechnology program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors are grateful for the support of the National Institute of Mental Health Neurotechnology program through R21MH085073 to CPF and DTE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleisa AM, 2011, HIPPOCAMPUS, V21, P899, DOI 10.1002/hipo.20806; Beierlein M, 2002, J NEUROSCI, V22, P9885; BICKLER PE, 1992, STROKE, V23, P1617, DOI 10.1161/01.STR.23.11.1617; Bickler PE, 1998, DEV BRAIN RES, V106, P57, DOI 10.1016/S0165-3806(97)00189-2; BICKLER PE, 1994, BRAIN RES, V665, P269, DOI 10.1016/0006-8993(94)91347-1; BINGMANN D, 1982, EXP BRAIN RES, V48, P89; Blake AJ, 2007, LAB CHIP, V7, P842, DOI 10.1039/b704754a; BONNEKOH P, 1992, NEUROSCI LETT, V146, P75, DOI 10.1016/0304-3940(92)90176-8; Caicedo HH, 2010, BIOMED MICRODEVICES, V12, P761, DOI 10.1007/s10544-010-9430-5; Choi Y, 2007, BIOMED MICRODEVICES, V9, P7, DOI 10.1007/s10544-006-9004-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hajos N, 2009, J NEUROSCI METH, V183, P107, DOI 10.1016/j.jneumeth.2009.06.005; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; Hambrecht VS, 2007, HIPPOCAMPUS, V17, P934, DOI 10.1002/hipo.20312; Hoffmann U, 2006, BRAIN RES, V1069, P207, DOI 10.1016/j.brainres.2005.11.025; Huang Y, 2012, LAB CHIP, V12, P2103, DOI 10.1039/c2lc21142d; Huchzermeyer C, 2008, J NEUROSCI, V28, P1153, DOI 10.1523/JNEUROSCI.4105-07.2008; Lo JF, 2012, ANAL CHEM, V84, P1987, DOI 10.1021/ac2030909; Lo JF, 2010, LAB CHIP, V10, P2394, DOI 10.1039/c004660d; Medvedeva YV, 2009, J NEUROSCI, V29, P1105, DOI 10.1523/JNEUROSCI.4604-08.2009; Mohammed JS, 2008, LAB CHIP, V8, P1048, DOI 10.1039/b802037j; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Mulkey DK, 2001, J APPL PHYSIOL, V90, P1887, DOI 10.1152/jappl.2001.90.5.1887; Nakamura I, 1996, TOHOKU J EXP MED, V179, P291, DOI 10.1620/tjem.179.291; Nolan PC, 1996, DEV BRAIN RES, V91, P111, DOI 10.1016/0165-3806(95)00166-2; Oppegard SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006891; Papazisis G, 2008, PHARMACOL RES, V57, P73, DOI 10.1016/j.phrs.2007.12.003; Passeraub PA, 2003, BIOMED MICRODEVICES, V5, P147, DOI 10.1023/A:1024547413721; Peterson BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031568; Queval A, 2010, LAB CHIP, V10, P326, DOI 10.1039/b916669f; Rambani K, 2009, J NEUROSCI METH, V180, P243, DOI 10.1016/j.jneumeth.2009.03.016; Rochefort NL, 2008, TRENDS MOL MED, V14, P389, DOI 10.1016/j.molmed.2008.07.005; Stork CJ, 2009, J CEREBR BLOOD F MET, V29, P1399, DOI 10.1038/jcbfm.2009.64; Taylor CP, 1999, J NEUROSCI, V19, P619; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; Wu CP, 2009, HIPPOCAMPUS, V19, P205, DOI 10.1002/hipo.20497; Wu JB, 2008, J NEUROL SCI, V264, P50, DOI 10.1016/j.jns.2007.06.057; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xue J, 2008, AM J PHYSIOL-REG I, V294, pR451, DOI 10.1152/ajpregu.00528.2007	39	33	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43309	10.1371/journal.pone.0043309	http://dx.doi.org/10.1371/journal.pone.0043309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905255	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800076
J	Christopherson, MR; Lambrecht, JA; Downs, D; Downs, DM				Christopherson, Melissa R.; Lambrecht, Jennifer A.; Downs, Deanna; Downs, Diana M.			Suppressor Analyses Identify Threonine as a Modulator of ridA Mutant Phenotypes in Salmonella enterica	PLOS ONE			English	Article							HOMOSERINE DEHYDROGENASE-I; ESCHERICHIA-COLI K-12; SACCHAROMYCES-CEREVISIAE; ISOLEUCINE BIOSYNTHESIS; PROTEIN; YJGF; TYPHIMURIUM; ENZYME; FAMILY; ACID	The RidA (YjgF/YER057c/UK114) family of proteins is broadly conserved in the three domains of life yet the functional understanding of these proteins is at an early stage. Physiological studies of ridA mutant strains of Salmonella enterica provided a framework to inform in vitro studies and led to the description of a conserved biochemical activity for this family. ridA mutant strains of S. enterica have characteristic phenotypes including new synthesis of thiamine biosynthetic intermediate phosphoribosylamine (PRA), inability to grow on pyruvate as a sole carbon and energy source or when serine is present in the minimal growth medium, and a decreased specific activity of transaminase B (IlvE). Secondary mutations restoring growth to a ridA mutant in the presence of serine were in dapA (encoding dihydrodipicolinate synthase) and thrA (encoding homoserine dehydrogenase). These mutations suppressed multiple ridA mutant phenotypes by increasing the synthesis of threonine. The ability of threonine to suppress the metabolic defects of a ridA mutant is discussed in the context of recent biochemical data and in vivo results presented here.	[Christopherson, Melissa R.; Lambrecht, Jennifer A.; Downs, Deanna; Downs, Diana M.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Christopherson, MR (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	downs@bact.wisc.edu			National Institutes of Health (NIH) [GM47296, GM95837, T32 GM07215]; National Science Foundation; Department of Bacteriology; Hilldale Competition; Merck and Co.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM047296, R01GM095837] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Bacteriology; Hilldale Competition; Merck and Co.(Merck & Company); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by competitive grants GM47296 and GM95837 from the National Institutes of Health (NIH) to DMD and a National Science Foundation Graduate Research Fellowship to MRC. JAL was supported as a trainee on the Molecular Biosciences Training Grant from the NIH (T32 GM07215). DD was the recipient of undergraduate research fellowships from the Department of Bacteriology, the Hilldale Competition, and Merck and Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acord J, 2004, FEMS MICROBIOL LETT, V235, P131, DOI 10.1016/j.femsle.2004.04.022; ANGELES TS, 1989, BIOCHEMISTRY-US, V28, P8771, DOI 10.1021/bi00448a014; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browne BA, 2006, J BACTERIOL, V188, P6786, DOI 10.1128/JB.00745-06; BURNS RO, 1979, J BIOL CHEM, V254, P1074; Burns RO, 1971, METHOD ENZYMOL, P555; CAETANOANOLLES G, 1993, PCR METH APPL, V3, P85; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; Christopherson MR, 2008, J BACTERIOL, V190, P3057, DOI 10.1128/JB.01700-07; D'Inca R, 2010, J PROTEOMICS, V73, P1542, DOI 10.1016/j.jprot.2010.03.017; DOWNS DM, 1994, J BACTERIOL, V176, P4858, DOI 10.1128/jb.176.16.4858-4864.1994; DUGGAN DE, 1973, ANAL BIOCHEM, V51, P67, DOI 10.1016/0003-2697(73)90453-3; Enos-Berlage JL, 1998, J BACTERIOL, V180, P6519, DOI 10.1128/JB.180.24.6519-6528.1998; Farkas A, 2004, BIOCHEM J, V383, P165, DOI 10.1042/BJ20040668; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; GoupilFeuillerat N, 1997, J BACTERIOL, V179, P6285, DOI 10.1128/JB.179.20.6285-6293.1997; HOFLER JG, 1978, J BIOL CHEM, V253, P1245; JAGUSZTYNKRYNICKA EK, 1982, J GEN MICROBIOL, V128, P1135; Kim JM, 2001, GENES CELLS, V6, P507, DOI 10.1046/j.1365-2443.2001.00443.x; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; Leitner-Dagan Y, 2006, PLANTA, V225, P89, DOI 10.1007/s00425-006-0332-y; Marchini A, 2002, YEAST, V19, P703, DOI 10.1002/yea.868; Morishita R, 1999, J BIOL CHEM, V274, P20688, DOI 10.1074/jbc.274.29.20688; OMORI K, 1993, J BACTERIOL, V175, P785, DOI 10.1128/JB.175.3.785-794.1993; Oxelmark E, 2000, MOL CELL BIOL, V20, P7784, DOI 10.1128/MCB.20.20.7784-7797.2000; Paris S, 2003, J BIOL CHEM, V278, P5361, DOI 10.1074/jbc.M207379200; Schmiedeknecht G, 1996, EUR J BIOCHEM, V242, P339, DOI 10.1111/j.1432-1033.1996.0339r.x; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schmitz G, 2004, J BACTERIOL, V186, P803, DOI 10.1128/JB.186.3.803-810.2004; SZCZESIUL M, 1976, BIOCHEMISTRY-US, V15, P2236, DOI 10.1021/bi00655a033; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; YUGARI YASUMI, 1965, J BIOL CHEM, V240, P4710	38	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43082	10.1371/journal.pone.0043082	http://dx.doi.org/10.1371/journal.pone.0043082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900093	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900111
J	Gaissert, N; Waterkamp, S; Fleming, RW; Bulthoff, I				Gaissert, Nina; Waterkamp, Steffen; Fleming, Roland W.; Buelthoff, Isabelle			Haptic Categorical Perception of Shape	PLOS ONE			English	Article							OBJECT RECOGNITION; NEURAL MECHANISMS; SIMILARITY; CATEGORIZATION; TOUCH; DISCRIMINATION; ORIENTATION; VISION; FACES	Categorization and categorical perception have been extensively studied, mainly in vision and audition. In the haptic domain, our ability to categorize objects has also been demonstrated in earlier studies. Here we show for the first time that categorical perception also occurs in haptic shape perception. We generated a continuum of complex shapes by morphing between two volumetric objects. Using similarity ratings and multidimensional scaling we ensured that participants could haptically discriminate all objects equally. Next, we performed classification and discrimination tasks. After a short training with the two shape categories, both tasks revealed categorical perception effects. Training leads to between-category expansion resulting in higher discriminability of physical differences between pairs of stimuli straddling the category boundary. Thus, even brief training can alter haptic representations of shape. This suggests that the weights attached to various haptic shape features can be changed dynamically in response to top-down information about class membership.	[Gaissert, Nina; Waterkamp, Steffen; Fleming, Roland W.; Buelthoff, Isabelle] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Fleming, Roland W.] Univ Giessen, Giessen, Germany; [Buelthoff, Isabelle] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Justus Liebig University Giessen; Korea University	Gaissert, N (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.	Nina.Gaissert@tuebingen.mpg.de; Isabelle.Buelthoff@tuebingen.mpg.de	Fleming, Roland William/GLV-1534-2022	Fleming, Roland William/0000-0001-5033-5069	Max Planck Society; German Federal Ministry of Education and Research (BMBF) [FKZ: 01GQ1002]; WCU (World Class University) program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-2008-000-10008-0]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); WCU (World Class University) program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a PhD stipend from the Max Planck Society. Part of this research was conducted as part of the research program of the Bernstein Center for Computational Neuroscience, Tubingen, funded by the German Federal Ministry of Education and Research (BMBF; FKZ: 01GQ1002). Part of this research was also supported by the WCU (World Class University) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-2008-000-10008-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; Bornstein MH, 1987, CATEGORICAL PERCEPTI, P535; Calder AJ, 1996, VIS COGN, V3, P81, DOI 10.1080/713756735; Cooke T, 2007, NEUROPSYCHOLOGIA, V45, P484, DOI 10.1016/j.neuropsychologia.2006.02.009; Craddock M, 2010, ATTEN PERCEPT PSYCHO, V72, P1975, DOI 10.3758/APP.72.7.1975; Damper RI, 2000, PERCEPT PSYCHOPHYS, V62, P843, DOI 10.3758/BF03206927; Desain P, 2003, PERCEPTION, V32, P341, DOI 10.1068/p3370; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gaissert N, 2012, EXP BRAIN RES, V216, P123, DOI 10.1007/s00221-011-2916-4; Gaissert N, 2011, ACTA PSYCHOL, V138, P219, DOI 10.1016/j.actpsy.2011.06.007; Gaissert N, 2010, J VISION, V10, DOI 10.1167/10.11.2; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; GOLDSTONE RL, 1994, COGNITION, V52, P125, DOI 10.1016/0010-0277(94)90065-5; Haag S, 2011, COGN PROCESS, V12, P33, DOI 10.1007/s10339-010-0369-5; Harnad S., 1987, CATEGORICAL PERCEPTI, P29; Homa D, 2012, HAPTICS RENDERING AP, P3; Homa D, 2009, ATTEN PERCEPT PSYCHO, V71, P690, DOI 10.3758/APP.71.4.690; HOWARD D, 1992, MUSIC PERCEPT, V10, P205; James TW, 2007, CAN J EXP PSYCHOL, V61, P219, DOI 10.1037/cjep2007023; KLATZKY RL, 1985, PERCEPT PSYCHOPHYS, V37, P299, DOI 10.3758/BF03211351; Lacey S, 2009, BRAIN TOPOGR, V21, P269, DOI 10.1007/s10548-009-0087-4; Lawson R, 2011, SEEING PERCEIVING, V24, P293, DOI 10.1163/187847511X579052; Lederman SJ, 2009, ATTEN PERCEPT PSYCHO, V71, P1439, DOI 10.3758/APP.71.7.1439; LEDERMAN SJ, 1990, COGNITIVE PSYCHOL, V22, P421, DOI 10.1016/0010-0285(90)90009-S; Levin DT, 2000, PERCEPT PSYCHOPHYS, V62, P386, DOI 10.3758/BF03205558; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Livingston KR, 1998, J EXP PSYCHOL LEARN, V24, P732, DOI 10.1037/0278-7393.24.3.732; Miquee A, 2008, NEUROSCIENCE, V152, P29, DOI 10.1016/j.neuroscience.2007.12.021; Newell FN, 2001, PSYCHOL SCI, V12, P37, DOI 10.1111/1467-9280.00307; Norman JF, 2004, PERCEPT PSYCHOPHYS, V66, P342, DOI 10.3758/BF03194883; Op de Beeck HP, 2008, J NEUROSCI, V28, P10111, DOI 10.1523/JNEUROSCI.2511-08.2008; Pastore RE, 1987, CATEGORICAL PERCEPTI, P29; PEPPERBERG IM, 1987, ANIM LEARN BEHAV, V15, P423, DOI 10.3758/BF03205051; Regan DM, 1987, CATEGORICAL PERCEPTI, P444; Regier T, 2009, TRENDS COGN SCI, V13, P439, DOI 10.1016/j.tics.2009.07.001; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Schwarzer G, 1999, MEM COGNITION, V27, P868, DOI 10.3758/BF03198539	38	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43062	10.1371/journal.pone.0043062	http://dx.doi.org/10.1371/journal.pone.0043062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900089	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900107
J	Reininger, V; Sieber, TN				Reininger, Vanessa; Sieber, Thomas N.			Mycorrhiza Reduces Adverse Effects of Dark Septate Endophytes (DSE) on Growth of Conifers	PLOS ONE			English	Article							APPLANATA SPECIES COMPLEX; PHIALOCEPHALA-FORTINII; ECTOMYCORRHIZAL FUNGI; LACCARIA-BICOLOR; ARBUSCULAR MYCORRHIZAL; DOUGLAS-FIR; COMMUNITY STRUCTURE; SPRUCE SEEDLINGS; ROOT ENDOPHYTES; BLACK SPRUCE	Mycorrhizal roots are frequently colonized by fungi of the Phialocephala fortinii s.l. - Acephala applanata species complex (PAC). These ascomycetes are common and widespread colonizers of tree roots. Some PAC strains reduce growth increments of their hosts but are beneficial in protecting roots against pathogens. Nothing is known about the effects of PAC on mycorrhizal fungi and the PAC-mycorrhiza association on plant growth, even though these two fungal groups occur closely together in natural habitats. We expect reduced colonization rates and reduced negative effects of PAC on host plants if roots are co-colonized by an ectomycorrhizal fungus (ECM). Depending on the temperature regime interactions among the partners in this tripartite ECM-PAC-plant system might also change. To test our hypotheses, effects of four PAC genotypes (two pathogenic and two non-pathogenic on the Norway spruce), mycorrhization by Laccaria bicolor (strain S238N) and two temperature regimes (19 degrees C and 25 degrees C) on the biomass of the Douglas-fir (Pseudotsuga menziesii) and Norway spruce (Picea abies) seedlings were studied. Mycorrhization compensated the adverse effects of PAC on the growth of the Norway spruce at both temperatures. The growth of the Douglas-fir was not influenced either by PAC or mycorrhization at 19 degrees C, but at 25 degrees C mycorrhization had a similar protective effect as in the Norway spruce. The compensatory effects probably rely on the reduction of the PAC-colonization density by mycorrhizae. Temperature and the PAC strain only had a differential effect on the biomass of the Norway spruce but not on the Douglas-fir. Higher temperature reduced mycorrhization of both hosts. We conclude that ectomycorrhizae form physical and/or physiological barriers against PAC leading to reduced PAC-colonization of the roots. Additionally, our results indicate that global warming could cause a general decrease of mycorrhization making primary roots more accessible to other symbionts and pathogens.	[Reininger, Vanessa; Sieber, Thomas N.] ETH, Dept Environm Syst Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Reininger, V (corresponding author), ETH, Dept Environm Syst Sci, Zurich, Switzerland.	Vanessa.Reininger@env.ethz.ch	Trilety, Roman/I-8225-2014; Reininger, Vanessa/F-7014-2011	Trilety, Roman/0000-0002-3778-0368; 	Competence Center Environment and Sustainability (CCES); Competence Center Environment and Sustainability (CCES) of the Swiss Federal Institute of Technology (ETH) Domain	Competence Center Environment and Sustainability (CCES); Competence Center Environment and Sustainability (CCES) of the Swiss Federal Institute of Technology (ETH) Domain	Funding came from Competence Center Environment and Sustainability (CCES), GEDIHAP Work Package 1B. http://www.cces.ethz.ch/projects/feh/gedihap. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study represents part of the research project GEDIHAP funded by the Competence Center Environment and Sustainability (CCES) of the Swiss Federal Institute of Technology (ETH) Domain. We wish to thank the Genetic Diversity Centre (GDC) of ETH Zurich for providing the necessary laboratory facilities to perform microsatellite analyses and Sophie Stroheker for taking care of the experiment, help with harvesting and measuring the plants' dry weight. We also would like to thank Sebastian Leuzinger for his help with the software R.	Ahlich K, 1996, NEW PHYTOL, V132, P259, DOI 10.1111/j.1469-8137.1996.tb01845.x; Alabouvette C, 2009, NEW PHYTOL, V184, P529, DOI 10.1111/j.1469-8137.2009.03014.x; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bonello P, 2001, FOREST PATHOL, V31, P99, DOI 10.1046/j.1439-0329.2001.00230.x; Branzanti MB, 1999, MYCORRHIZA, V9, P103, DOI 10.1007/s005720050007; Christophe C, 2010, PLANT SOIL, V328, P145, DOI 10.1007/s11104-009-0092-0; CHUCHOU M, 1992, SOIL BIOL BIOCHEM, V24, P633, DOI 10.1016/0038-0717(92)90041-U; Crawley M.J., 2007, R BOOK; CURRAH RS, 1993, CAN J BOT, V71, P1639, DOI 10.1139/b93-199; DiBattista C, 1996, MYCOL RES, V100, P1315, DOI 10.1016/S0953-7562(96)80058-X; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Girlanda M, 2002, NEW PHYTOL, V155, P481, DOI 10.1046/j.1469-8137.2002.00474.x; Grunig CR, 2008, BOTANY, V86, P1355, DOI 10.1139/B08-108; Grunig CR, 2007, FUNGAL GENET BIOL, V44, P773, DOI 10.1016/j.fgb.2006.12.008; HOLDENRIEDER O, 1992, MYCOL RES, V96, P151, DOI 10.1016/S0953-7562(09)80932-5; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jumpponen A, 1998, MYCORRHIZA, V7, P261, DOI 10.1007/s005720050190; Kennedy P, 2010, NEW PHYTOL, V187, P895, DOI 10.1111/j.1469-8137.2010.03399.x; Kennedy PG, 2007, J ECOL, V95, P1338, DOI 10.1111/j.1365-2745.2007.01306.x; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Kennedy PG, 2005, NEW PHYTOL, V166, P631, DOI 10.1111/j.1469-8137.2005.01355.x; Larimer AL, 2010, SYMBIOSIS, V51, P139, DOI 10.1007/s13199-010-0083-1; Liu QH, 2011, FUNCT ECOL, V25, P910, DOI 10.1111/j.1365-2435.2011.01853.x; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Mahmood S, 2003, FEMS MICROBIOL LETT, V221, P81, DOI 10.1016/S0378-1097(03)00166-6; Mandyam K, 2008, MYCORRHIZA, V18, P145, DOI 10.1007/s00572-008-0165-6; Marler M, 1999, CAN J FOREST RES, V29, P1317, DOI 10.1139/cjfr-29-9-1317; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; MELIN E., 1923, Mykologische Untersuchungen und Berichte, V2, P73; Menkis A, 2004, MYCOL RES, V108, P965, DOI 10.1017/S0953756204000668; Morin C, 1999, CAN J BOT, V77, P169, DOI 10.1139/cjb-77-1-169; Muller J, 2003, FUNCT PLANT BIOL, V30, P419, DOI 10.1071/FP02189; Oikawa, 2000, MICROBES ENVIRON, V15, P197; PARLADE J, 1993, MYCORRHIZA, V3, P93, DOI 10.1007/BF00210699; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Queloz V, 2010, MOL ECOL RESOUR, V10, P348, DOI 10.1111/j.1755-0998.2009.02757.x; Queloz V, 2008, MOL ECOL RESOUR, V8, P1322, DOI 10.1111/j.1755-0998.2008.02279.x; Reininger V, 2012, ENVIRON MICROBIOL, V14, P1064, DOI 10.1111/j.1462-2920.2011.02686.x; Reininger V, 2011, MICROB ECOL, V61, P676, DOI 10.1007/s00248-010-9798-z; Richard C, 1971, CAN J FOREST RES, V1, P246; ROGERS SO, 1989, CAN J BOT, V67, P1235, DOI 10.1139/b89-161; Rogers SO, 1994, PLANT MOL BIOL MANUA, P1; Rygiewicz PT, 2000, OECOLOGIA, V124, P299, DOI 10.1007/s004420000385; Scherrer D, 2010, GLOBAL CHANGE BIOL, V16, P2602, DOI 10.1111/j.1365-2486.2009.02122.x; Sieber T. N., 2002, Plant roots: the hidden half, P887; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; STOYKE G, 1992, CAN J BOT, V70, P2009, DOI 10.1139/b92-250; STROBEL NE, 1991, PHYTOPATHOLOGY, V81, P420, DOI 10.1094/Phyto-81-420; Sturz AV, 2000, APPL SOIL ECOL, V15, P183, DOI 10.1016/S0929-1393(00)00094-9; Summerbell RC, 2005, STUD MYCOL, P191, DOI 10.3114/sim.53.1.191; Summerbell RC, 2005, STUD MYCOL, P121; Tellenbach C, 2011, THESIS ETH ZURICH, P104; Tellenbach C, 2011, ENVIRON MICROBIOL, V13, P2508, DOI 10.1111/j.1462-2920.2011.02523.x; Tucci M, 2011, MOL PLANT PATHOL, V12, P341, DOI 10.1111/j.1364-3703.2010.00674.x; Wagg C, 2008, MYCORRHIZA, V18, P103, DOI 10.1007/s00572-007-0157-y; Xu G, 2011, RUSS J PLANT PHYSL+, V58, P491, DOI 10.1134/S1021443711030216; ZAK BRATISLAV, 1964, ANN REV PHYTOPATHOL, V2, P377, DOI 10.1146/annurev.py.02.090164.002113; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	60	44	47	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42865	10.1371/journal.pone.0042865	http://dx.doi.org/10.1371/journal.pone.0042865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900058	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900076
J	Ricardi, MM; Guaimas, FF; Gonzalez, RM; Burrieza, HP; Lopez-Fernandez, MP; Jares-Erijman, EA; Estevez, JM; Iusem, ND				Ricardi, Martiniano M.; Guaimas, Francisco F.; Gonzalez, Rodrigo M.; Burrieza, Hernan P.; Lopez-Fernandez, Maria P.; Jares-Erijman, Elizabeth A.; Estevez, Jose M.; Iusem, Norberto D.			Nuclear Import and Dimerization of Tomato ASR1, a Water Stress-Inducible Protein Exclusive to Plants	PLOS ONE			English	Article							DNA-BINDING; LOCALIZATION SIGNAL; BINARY VECTORS; GENE; PORE; TRANSFORMATION; EXPRESSION; TRANSPORT; FAMILY; GRAPE	The ASR (for ABA/water stress/ripening) protein family, first described in tomato as nuclear and involved in adaptation to dry climates, is widespread in the plant kingdom, including crops of high agronomic relevance. We show both nuclear and cytosolic localization for ASR1 (the most studied member of the family) in histological plant samples by immunodetection, typically found in small proteins readily diffusing through nuclear pores. Indeed, a nuclear localization was expected based on sorting prediction software, which also highlight a monopartite nuclear localization signal (NLS) in the primary sequence. However, here we prove that such an "NLS" of ASR1 from tomato is dispensable and non-functional, being the transport of the protein to the nucleus due to simple diffusion across nuclear pores. We attribute such a targeting deficiency to the misplacing in that cryptic NLS of two conserved contiguous lysine residues. Based on previous in vitro experiments regarding quaternary structure, we also carried out live cell imaging assays through confocal microscopy to explore dimer formation in planta. We found homodimers in both the cytosol and the nucleus and demonstrated that assembly of both subunits together can occur in the cytosol, giving rise to translocation of preformed dimers. The presence of dimers was further corroborated by means of in vivo crosslinking of nuclei followed by SDS-PAGE.	[Ricardi, Martiniano M.; Gonzalez, Rodrigo M.; Estevez, Jose M.; Iusem, Norberto D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias, IFIByNE CONICET, Buenos Aires, DF, Argentina; [Guaimas, Francisco F.; Jares-Erijman, Elizabeth A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Dept Quim Organ, Buenos Aires, DF, Argentina; [Guaimas, Francisco F.; Jares-Erijman, Elizabeth A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, CIHIDECAR, Buenos Aires, DF, Argentina; [Burrieza, Hernan P.; Lopez-Fernandez, Maria P.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina; [Iusem, Norberto D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular FBMC, LFBM, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Ricardi, MM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias, IFIByNE CONICET, Buenos Aires, DF, Argentina.	norbius@fbmc.fcen.uba.ar	Estevez, Jose Manuel/AAZ-9261-2020; Estevez, Jose Manuel/C-2915-2018	Estevez, Jose Manuel/0000-0001-6332-7738; Estevez, Jose Manuel/0000-0001-6332-7738; Ricardi, Martiniano/0000-0002-7904-6305; Iusem, Norberto/0000-0002-3052-2489	Universidad de Buenos Aires (UBA); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET), Argentina	Universidad de Buenos Aires (UBA)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Universidad de Buenos Aires (UBA), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), and Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassova R, 2003, PLANT PHYSIOL, V131, P326, DOI 10.1104/pp.009522; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Cakir B, 2003, PLANT CELL, V15, P2165, DOI 10.1105/tpc.013854; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Frankel N, 2003, MOL BIOL EVOL, V20, P1955, DOI 10.1093/molbev/msg214; Frankel N, 2007, PLANT MOL BIOL, V63, P719, DOI 10.1007/s11103-006-9120-0; Frankel N, 2006, GENE, V378, P74, DOI 10.1016/j.gene.2006.05.010; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; Grebenok RJ, 1997, PLANT J, V11, P573, DOI 10.1046/j.1365-313X.1997.11030573.x; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; HARRIS KF, 1995, MICROSC RES TECHNIQ, V32, P264, DOI 10.1002/jemt.1070320312; Hawkins J, 2007, J PROTEOME RES, V6, P1402, DOI 10.1021/pr060564n; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; IUSEM ND, 1993, PLANT PHYSIOL, V102, P1353, DOI 10.1104/pp.102.4.1353; Kalifa Y, 2004, BIOCHEM J, V381, P373, DOI 10.1042/BJ20031800; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Konrad Z, 2008, PLANTA, V227, P1213, DOI 10.1007/s00425-008-0693-5; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Maskin L, 2007, BIOCHEM BIOPH RES CO, V352, P831, DOI 10.1016/j.bbrc.2006.11.115; McBride Kevin M, 2003, Sci STKE, V2003, pRE13; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Ricardi MM, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-11; Rom S, 2006, BIOCHIMIE, V88, P621, DOI 10.1016/j.biochi.2005.11.008; Urtasun Nicolas, 2010, Open Biochem J, V4, P68, DOI 10.2174/1874091X01004010068; Vogt M, 2011, J CELL SCI, V124, P900, DOI 10.1242/jcs.072520; Wang HJ, 2005, PHYSIOL PLANTARUM, V123, P314, DOI 10.1111/j.1399-3054.2005.00454.x; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082	33	23	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41008	10.1371/journal.pone.0041008	http://dx.doi.org/10.1371/journal.pone.0041008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899993	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900008
J	Sarabdjitsingh, RA; Kofink, D; Karst, H; de Kloet, ER; Joels, M				Sarabdjitsingh, Ratna Angela; Kofink, Daniel; Karst, Henk; de Kloet, E. Ron; Joels, Marian			Stress-Induced Enhancement of Mouse Amygdalar Synaptic Plasticity Depends on Glucocorticoid and beta-Adrenergic Activity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CORTICOTROPIN-RELEASING-FACTOR; BASOLATERAL AMYGDALA; DENTATE GYRUS; EMOTIONAL MEMORY; NORADRENERGIC ACTIVATION; FREQUENCY STIMULATION; PREFRONTAL CORTEX; PRESYNAPTIC LTP; DIETHYL-ETHER	Background: Glucocorticoid hormones, in interaction with noradrenaline, enable the consolidation of emotionally arousing and stressful experiences in rodents and humans. Such interaction is thought to occur at least partly in the basolateral nucleus of the amygdala (BLA) which is crucially involved in emotional memory formation. Extensive evidence points to long-term synaptic potentiation (LTP) as a mechanism contributing to memory formation. Here we determined in adolescent C57/Bl6 mice the effects of stress on LTP in the LA-BLA pathway and the specific roles of corticosteroid and beta-adrenergic receptor activation in this process. Principal Findings: Exposure to 20 min of restraint stress (compared to control treatment) prior to slice preparation enhanced subsequent LTP induction in vitro, without affecting baseline fEPSP responses. The role of glucocorticoid receptors, mineralocorticoid receptors and beta 2-adrenoceptors in the effects of stress was studied by treating mice with the antagonists mifepristone, spironolactone or propranolol respectively (or the corresponding vehicles) prior to stress or control treatment. In undisturbed controls, mifepristone and propranolol administration in vivo did not influence LTP induced in vitro. By contrast, spironolactone caused a gradually attenuating form of LTP, both in unstressed and stressed mice. Mifepristone treatment prior to stress strongly reduced the ability to induce LTP in vitro. Propranolol normalized the stress-induced enhancement of LTP to control levels during the first 10 min after high frequency stimulation, after which synaptic responses further declined. Conclusions: Acute stress changes BLA electrical properties such that subsequent LTP induction is facilitated. Both beta-adrenergic and glucocorticoid receptors are involved in the development of these changes. Mineralocorticoid receptors are important for the maintenance of LTP in the BLA, irrespective of stress-induced changes in the circuit. The prolonged changes in BLA network function after stress may contribute to effective memory formation of emotional and stressful events.	[Sarabdjitsingh, Ratna Angela; Kofink, Daniel; Karst, Henk; Joels, Marian] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [de Kloet, E. Ron] Leiden Univ, Leiden Univ Med Ctr, Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sarabdjitsingh, RA (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands.	r.a.sarabdjitsingh@gmail.com	Karst, Henk/AAD-9281-2021; Joëls, Marian/P-6415-2016	de Kloet, Ron/0000-0001-9176-1830; Joels, Marian/0000-0002-4826-6209	Royal Netherlands Academy of Arts and Sciences	Royal Netherlands Academy of Arts and Sciences	RAS was supported in part by the Royal Netherlands Academy of Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec R, 2007, BEHAV BRAIN RES, V179, P192, DOI 10.1016/j.bbr.2007.02.001; Ahmed T, 2006, J NEUROSCI, V26, P3951, DOI 10.1523/JNEUROSCI.4901-05.2006; Akirav I, 2002, J NEUROSCI, V22, P9912; Akirav I, 1999, J NEUROSCI, V19, P10530; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bremner JD, 1996, SYNAPSE, V23, P28, DOI 10.1002/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.0.CO;2-J; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P4888, DOI 10.1073/pnas.0900835106; Connor SA, 2011, LEARN MEMORY, V18, P207, DOI 10.1101/lm.2043811; Datson NA, 2008, EUR J PHARMACOL, V583, P272, DOI 10.1016/j.ejphar.2007.11.070; de Haan M, 2002, LAB ANIM-UK, V36, P105, DOI 10.1258/0023677021912316; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; Duvarci S, 2007, J NEUROSCI, V27, P4482, DOI 10.1523/JNEUROSCI.0680-07.2007; Ferry B, 1999, J NEUROSCI, V19, P5119; Ferry B, 1997, EUR J NEUROSCI, V9, P1356, DOI 10.1111/j.1460-9568.1997.tb01490.x; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Gelinas JN, 2008, LEARN MEMORY, V15, P281, DOI 10.1101/lm.829208; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Henckens MJAG, 2010, J NEUROSCI, V30, P12725, DOI 10.1523/JNEUROSCI.3112-10.2010; Herman JP, 1998, J NEUROSCI, V18, P7462; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Huang CC, 1996, J NEUROSCI, V16, P1026; Huang CC, 1998, J NEUROSCI, V18, P2276; Huang YY, 2007, LEARN MEMORY, V14, P497, DOI 10.1101/lm.593407; Huge V, 2009, EUR J PAIN, V13, P124, DOI 10.1016/j.ejpain.2008.03.010; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; IKEGAYA Y, 1995, NEUROSCI RES, V22, P203, DOI 10.1016/0168-0102(95)00894-7; Joels M, 2012, PHARM REV IN PRESS; Joels M, 2011, TRENDS COGN SCI, V15, P280, DOI 10.1016/j.tics.2011.04.004; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2002, EUR J NEUROSCI, V16, P1083, DOI 10.1046/j.1460-9568.2002.02172.x; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kavushansky A, 2006, HIPPOCAMPUS, V16, P35, DOI 10.1002/hipo.20130; Kavushansky A, 2006, J NEUROSCI RES, V84, P1580, DOI 10.1002/jnr.21058; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Liebmann L, 2008, J NEUROPHYSIOL, V99, P958, DOI 10.1152/jn.01137.2007; Liebmann L, 2009, EUR J NEUROSCI, V30, P800, DOI 10.1111/j.1460-9568.2009.06882.x; Manzanares PAR, 2005, J NEUROSCI, V25, P8725, DOI 10.1523/JNEUROSCI.2260-05.2005; Maroun M, 2003, J NEUROSCI, V23, P4406; Maroun M, 2006, EUR J NEUROSCI, V24, P2917, DOI 10.1111/j.1460-9568.2006.05169.x; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McIntyre CK, 2002, EUR J NEUROSCI, V16, P1223, DOI 10.1046/j.1460-9568.2002.02188.x; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Nakao K, 2004, P NATL ACAD SCI USA, V101, P14270, DOI 10.1073/pnas.0405709101; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Pare D, 2003, PROG NEUROBIOL, V70, P409, DOI 10.1016/S0301-0082(03)00104-7; PITKANEN A, 1995, J COMP NEUROL, V356, P288, DOI 10.1002/cne.903560211; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Pu Zhenwei, 2009, Learn Mem, V16, P155, DOI 10.1101/lm.1272409; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Rainnie DG, 2004, J NEUROSCI, V24, P3471, DOI 10.1523/JNEUROSCI.5740-03.2004; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Richter-Levin G, 2004, NEUROSCIENTIST, V10, P31, DOI 10.1177/1073858403259955; Richter-Levin G, 2010, CEREB CORTEX, V20, P2433, DOI 10.1093/cercor/bhp311; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Roozendaal B, 2004, J NEUROSCI, V24, P8161, DOI 10.1523/JNEUROSCI.2574-04.2004; Roozendaal B, 2002, EUR J NEUROSCI, V15, P553, DOI 10.1046/j.0953-816x.2001.01876.x; Roozendaal B, 2008, J NEUROSCI, V28, P6642, DOI 10.1523/JNEUROSCI.1336-08.2008; Roozendaal B, 2006, NEUROBIOL LEARN MEM, V86, P249, DOI 10.1016/j.nlm.2006.03.003; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; SHORS TJ, 1994, BRAIN RES, V666, P232, DOI 10.1016/0006-8993(94)90777-3; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; SPENCER RL, 1990, BRAIN RES, V514, P37, DOI 10.1016/0006-8993(90)90433-C; Strange BA, 2004, P NATL ACAD SCI USA, V101, P11454, DOI 10.1073/pnas.0404282101; Vouimba RM, 2005, CEREB CORTEX, V15, P1815, DOI 10.1093/cercor/bhi058; Vouimba RM, 2004, EUR J NEUROSCI, V19, P1887, DOI 10.1111/j.1460-9568.2004.03294.x; Vouimba RM, 2007, NEUROPHARMACOLOGY, V52, P244, DOI 10.1016/j.neuropharm.2006.07.007; Vouimba RM, 2006, STRESS, V9, P29, DOI 10.1080/10253890600610973; Wiegert O, 2006, LEARN MEMORY, V13, P110, DOI 10.1101/lm.87706; Zardooz H, 2010, PHYSIOL RES, V59, P973, DOI 10.33549/physiolres.931896; Zhou M, 2010, NEUROBIOL LEARN MEM, V94, P530, DOI 10.1016/j.nlm.2010.09.005	80	26	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42143	10.1371/journal.pone.0042143	http://dx.doi.org/10.1371/journal.pone.0042143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900007	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900022
J	Schlitter, AM; Dorneburg, C; Barth, TFE; Wahl, J; Schulte, JH; Bruuderlein, S; Debatin, KM; Beltinger, C				Schlitter, Anne-Marie; Dorneburg, Carmen; Barth, Thomas F. E.; Wahl, Joachim; Schulte, Johannes H.; Bruederlein, Silke; Debatin, Klaus-Michael; Beltinger, Christian			CD57(high) Neuroblastoma Cells Have Aggressive Attributes Ex Situ and an Undifferentiated Phenotype in Patients	PLOS ONE			English	Article							NEURAL CREST MIGRATION; CARBOHYDRATE; EXPRESSION; ADHESION; TUMORS; DIFFERENTIATION; PREDICTS; CRITERIA	Background: Neuroblastoma is thought to originate from neural crest-derived cells. CD57 defines migratory neural crest cells in normal development and is expressed in neuroblastoma. Methodology and Principal Findings: We investigated the role of CD57 expression in neuroblastoma cells ex situ and in situ. Compared to CD57(low) U-NB1 neuroblastoma cells, CD57(high) cells developed tumors with decreased latency after orthotopic transplantation into adrenal glands of mice. In addition, CD57(high) U-NB1 and SK-N-BE(2)-C neuroblastoma cells were also more clonogenic, induced more spheres and were less lineage-restricted. CD57(high) cells attached better to endothelial cells and showed enhanced invasiveness. While invasion of U-NB1 cells was inhibited by blocking antibodies against CD57, neither invasion of SK-N-BE(2)-C cells nor adhesion of U-NB1 and SK-N-BE(2)-C cells was attenuated. After tail vein injection only CD57(high) cells generated liver metastases, while overall metastatic rate was not increased as compared to CD57(low) cells. In stroma-poor neuroblastoma of patients CD57(high) cells were associated with undifferentiated tumor cells across all stages and tended to be more frequent after chemotherapy. Conclusion: Strong expression of CD57 correlates with aggressive attributes of U-NB1 and SK-N-BE(2)-C neuroblastoma cells and is linked with undifferentiated neuroblastoma cells in patients.	[Schlitter, Anne-Marie; Dorneburg, Carmen; Wahl, Joachim; Debatin, Klaus-Michael; Beltinger, Christian] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany; [Barth, Thomas F. E.; Bruederlein, Silke] Univ Med Ctr Ulm, Inst Pathol, Ulm, Germany; [Schulte, Johannes H.] Univ Childrens Hosp Essen, Essen, Germany	Ulm University; Ulm University; University of Duisburg Essen	Schlitter, AM (corresponding author), Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany.	christian.beltinger@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014; Schulte, Johannes H./V-2474-2018; Schulte, Johannes H/G-3981-2010	Debatin, Klaus-Michael/0000-0002-8397-1886; Schulte, Johannes Hubertus/0000-0003-0671-1201	Wilhelm Sander-Stiftung; Deutsche Krebshilfe	Wilhelm Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported in part by grants from the Wilhelm Sander-Stiftung and the Deutsche Krebshilfe (to C.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABO T, 1981, J IMMUNOL, V127, P1024; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; BRONNERFRASER M, 1987, DEV BIOL, V123, P321, DOI 10.1016/0012-1606(87)90390-3; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; COOPER MJ, 1992, J CLIN INVEST, V90, P2402, DOI 10.1172/JCI116131; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; GRIFFITH LS, 1992, J NEUROSCI RES, V33, P639, DOI 10.1002/jnr.490330417; Hall H, 1997, EUR J BIOCHEM, V246, P233, DOI 10.1111/j.1432-1033.1997.t01-1-00233.x; Hall H, 1997, J NEUROCHEM, V68, P544; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CAN-07-0718; HARMS D, 1979, KLIN PADIATR, V191, P228; Hoehner JC, 1998, LAB INVEST, V78, P29; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Nakagawara A, 2004, CANCER LETT, V204, P213, DOI 10.1016/S0304-3835(03)00457-9; Ross RA, 2007, SEMIN CANCER BIOL, V17, P241, DOI 10.1016/j.semcancer.2006.04.006; Shimada H, 1999, CANCER, V86, P349, DOI 10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.3.CO;2-P; Suzuki-Anekoji M, 2011, J BIOL CHEM, V286, P32824, DOI 10.1074/jbc.M111.245886; Thies A, 2004, J PATHOL, V203, P933, DOI 10.1002/path.1595; Tweddle DA, 2001, CANCER RES, V61, P8; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985	23	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42025	10.1371/journal.pone.0042025	http://dx.doi.org/10.1371/journal.pone.0042025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900004	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900019
J	Shiga, A; Ishihara, T; Miyashita, A; Kuwabara, M; Kato, T; Watanabe, N; Yamahira, A; Kondo, C; Yokoseki, A; Takahashi, M; Kuwano, R; Kakita, A; Nishizawa, M; Takahashi, H; Onodera, O				Shiga, Atsushi; Ishihara, Tomohiko; Miyashita, Akinori; Kuwabara, Misaki; Kato, Taisuke; Watanabe, Norihiro; Yamahira, Akie; Kondo, Chigusa; Yokoseki, Akio; Takahashi, Masuhiro; Kuwano, Ryozo; Kakita, Akiyoshi; Nishizawa, Masatoyo; Takahashi, Hitoshi; Onodera, Osamu			Alteration of POLDIP3 Splicing Associated with Loss of Function of TDP-43 in Tissues Affected with ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; CELL-GROWTH; IN-VIVO; INCLUSIONS; MUTATIONS; DEPLETION; GENE; NEURODEGENERATION; HETEROGENEITY	Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease caused by selective loss of motor neurons. In the ALS motor neurons, TAR DNA-binding protein of 43 kDa (TDP-43) is dislocated from the nucleus to cytoplasm and forms inclusions, suggesting that loss of a nuclear function of TDP-43 may underlie the pathogenesis of ALS. TDP-43 functions in RNA metabolism include regulation of transcription, mRNA stability, and alternative splicing of pre-mRNA. However, a function of TDP-43 in tissue affected with ALS has not been elucidated. We sought to identify the molecular indicators reflecting on a TDP-43 function. Using exon array analysis, we observed a remarkable alteration of splicing in the polymerase delta interacting protein 3 (POLDIP3) as a result of the depletion of TDP-43 expression in two types of cultured cells. In the cells treated with TDP-43 siRNA, wild-type POLDIP3 (variant-1) decreased and POLDIP3 lacking exon 3 (variant-2) increased. The RNA binding ability of TDP-43 was necessary for inclusion of POLDIP3 exon 3. Moreover, we found an increment of POLDIP3 variant-2 mRNA in motor cortex, spinal cord and spinal motor neurons collected by laser capture microdissection with ALS. Our results suggest a loss of TDP-43 function in tissues affected with ALS, supporting the hypothesis that a loss of function of TDP-43 underlies the pathogenesis of ALS.	[Shiga, Atsushi; Takahashi, Hitoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan; [Ishihara, Tomohiko; Kuwabara, Misaki; Kato, Taisuke; Kondo, Chigusa; Yokoseki, Akio; Nishizawa, Masatoyo] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; [Miyashita, Akinori; Kuwano, Ryozo] Niigata Univ, Brain Res Inst, Ctr Bioresource Based Res, Dept Mol Genet,Genome Sci Branch, Niigata, Japan; [Watanabe, Norihiro; Yamahira, Akie; Takahashi, Masuhiro] Niigata Univ, Grad Sch Hlth Sci, Lab Hematol & Oncol, Niigata, Japan; [Kakita, Akiyoshi] Niigata Univ, Brain Res Inst, Dept Pathol Neurosci, Resource Branch Brain Dis Res, Niigata, Japan; [Onodera, Osamu] Niigata Univ, Brain Res Inst, Dept Mol Neurosci, Resource Branch Brain Dis Res, Niigata, Japan	Niigata University; Niigata University; Niigata University; Niigata University; Niigata University; Niigata University	Shiga, A (corresponding author), Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan.	onodera@bri.niigata-u.ac.jp	Onodera, Osamu/K-7327-2013; Ishihara, Tomohiko/AAJ-8742-2020	Onodera, Osamu/0000-0003-3354-5472; Ishihara, Tomohiko/0000-0001-9915-8665; Kato, Taisuke/0000-0001-5696-7104; Kato, Taisuke/0000-0003-0738-4951	Japan Society for the Promotion of Science [23240049, 22249036, 22659169]; Ministry of Education, Culture, Sports, Sceience and Technology, Japan [22113506]; Ministry of Health, Labor and Welfare, Japan [201024015A]; Grants-in-Aid for Scientific Research [24510275] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Sceience and Technology, Japan; Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-1 in-Aid for Scientific Research (A) (23240049, 22249036) and Grant-in-Aid for challenging Exploratory Research (22659169) from Japan Society for the Promotion of Science, and Grant-in-Aid for Scientific Research on Innovative Areas (22113506) from Ministry of Education, Culture, Sports, Sceience and Technology, Japan, and Grant-in-Aid for the Research Committee of CNS Degenerative Diseases (201024015A) form Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Fiesel FC, 2012, NUCLEIC ACIDS RES, V40, P2668, DOI 10.1093/nar/gkr1082; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Mackenzie IRA, 2006, ACTA NEUROPATHOL, V112, P539, DOI 10.1007/s00401-006-0138-9; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Mori F, 2010, NEUROPATH APPL NEURO, V36, P345, DOI 10.1111/j.1365-2990.2010.01081.x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishihira Y, 2008, ACTA NEUROPATHOL, V116, P169, DOI 10.1007/s00401-008-0385-z; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Smyk A, 2006, FEBS J, V273, P4728, DOI 10.1111/j.1742-4658.2006.05477.x; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; Tollervey JR, 2011, GENOME RES, V21, P1572, DOI 10.1101/gr.122226.111; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392	33	53	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43120	10.1371/journal.pone.0043120	http://dx.doi.org/10.1371/journal.pone.0043120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900096	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900114
J	Stephenne, X; Nicastro, E; Eeckhoudt, S; Hermans, C; Nyabi, O; Lombard, C; Najimi, M; Sokal, E				Stephenne, Xavier; Nicastro, Emanuele; Eeckhoudt, Stephane; Hermans, Cedric; Nyabi, Omar; Lombard, Catherine; Najimi, Mustapha; Sokal, Etienne			Bivalirudin in Combination with Heparin to Control Mesenchymal Cell Procoagulant Activity	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; TISSUE FACTOR EXPRESSION; SMOOTH-MUSCLE-CELLS; RECOMBINANT HIRUDIN; VEIN THROMBOSIS; STEM-CELLS; FACTOR XA; TRANSPLANTATION; HEPATOCYTES; FIBROBLASTS	Islet and hepatocyte transplantation are associated with tissue factor-dependent activation of coagulation which elicits instant blood mediated inflammatory reaction, thereby contributing to a low rate of engraftment. The aim of this study was i) to evaluate the procoagulant activity of human adult liver-derived mesenchymal progenitor cells (hALPCs), ii) to compare it to other mesenchymal cells of extra-hepatic (bone marrow mesenchymal stem cells and skin fibroblasts) or liver origin (liver myofibroblasts), and iii) to determine the ways this activity could be modulated. Using a whole blood coagulation test (thromboelastometry), we demonstrated that all analyzed cell types exhibit procoagulant activity. The hALPCs pronounced procoagulant activity was associated with an increased tissue factor and a decreased tissue factor pathway inhibitor expression as compared with hepatocytes. At therapeutic doses, the procoagulant effect of hALPCs was inhibited by neither antithrombin activators nor direct factor Xa inhibitor or direct thrombin inhibitors individually. However, concomitant administration of an antithrombin activator or direct factor Xa inhibitor and direct thrombin inhibitor proved to be a particularly effective combination for controlling the procoagulant effects of hALPCs both in vitro and in vivo. The results suggest that this dual antithrombotic therapy should also improve the efficacy of cell transplantation in humans.	[Stephenne, Xavier; Nicastro, Emanuele; Nyabi, Omar; Lombard, Catherine; Najimi, Mustapha; Sokal, Etienne] Catholic Univ Louvain, Inst Rech Expt & Clin, Unite Rech PEDI, B-1200 Brussels, Belgium; [Stephenne, Xavier; Nicastro, Emanuele; Sokal, Etienne] Clin Univ St Luc, Serv Gastroenterol & Hepatol Pediat, B-1200 Brussels, Belgium; [Eeckhoudt, Stephane] Clin Univ St Luc, Lab Hematol Hemostase, B-1200 Brussels, Belgium; [Hermans, Cedric] Clin Univ St Luc, Serv Hematol, Unite Hemostase Thrombose, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Stephenne, X (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Unite Rech PEDI, B-1200 Brussels, Belgium.	xavier.stephenne@uclouvain.be	Nicastro, Emanuele/AAJ-2274-2020; Nicastro, Emanuele/K-1260-2018; Hermans, Cedric/AAK-9433-2020	Nicastro, Emanuele/0000-0002-4518-9375; Sokal, Etienne/0000-0001-5597-4708; Lombard, Catherine/0000-0002-5653-9545	Belgian National Fund for Medical Research (FRSM); Belgian National Fund for Scientific Research [FNRS-3.4521.09]	Belgian National Fund for Medical Research (FRSM)(Fonds de la Recherche Scientifique - FNRS); Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS)	Research was supported by the Belgian National Fund for Medical Research (FRSM). X. Stephenne is recipient of a grant from the Belgian National Fund for Scientific Research (FNRS-3.4521.09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban S, 2001, THROMB HAEMOSTASIS, V85, P824; Baccarani U, 2005, TRANSPLANT INT, V18, P750, DOI 10.1111/j.1432-2277.2005.00127.x; Bajaj MS, 1999, THROMB HAEMOSTASIS, V82, P1663; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Beuneu C, 2004, DIABETES, V53, P1407, DOI 10.2337/diabetes.53.6.1407; BIEMOND BJ, 1994, THROMB HAEMOSTASIS, V72, P377; Khuu DN, 2011, CELL TRANSPLANT, V20, P287, DOI 10.3727/096368910X516655; Feng LM, 2009, CLIN THER, V31, P1559, DOI 10.1016/j.clinthera.2009.07.017; Fisher RA, 2000, TRANSPLANTATION, V69, P303, DOI 10.1097/00007890-200001270-00018; Forbes TJ, 2011, CATHETER CARDIO INTE, V77, P671, DOI 10.1002/ccd.22817; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Furlani D, 2009, MICROVASC RES, V77, P370, DOI 10.1016/j.mvr.2009.02.001; Garg HG, 2000, AM J PHYSIOL-LUNG C, V279, pL779, DOI 10.1152/ajplung.2000.279.5.L779; GAST A, 1994, BLOOD COAGUL FIBRIN, V5, P879, DOI 10.1097/00001721-199412000-00003; Gerotziafas GT, 2004, THROMB HAEMOSTASIS, V92, P1296, DOI 10.1160/TH03-11-0694; Guimaraes ELM, 2010, J HEPATOL, V52, P389, DOI 10.1016/j.jhep.2009.12.007; Gustafson EK, 2011, TRANSPLANTATION, V91, P632, DOI 10.1097/TP.0b013e31820ae459; Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755; Koutouzis M, 2011, HEART, V97, P1484, DOI 10.1136/hrt.2011.224709; Lysy PA, 2008, CELL PROLIFERAT, V41, P36, DOI 10.1111/j.1365-2184.2007.00507.x; Lysy PA, 2008, WORLD J GASTROENTERO, V14, P864, DOI 10.3748/wjg.14.864; Lysy PA, 2007, HEPATOLOGY, V46, P1574, DOI 10.1002/hep.21839; Meddahi S, 2009, BLOOD COAGUL FIBRIN, V20, P207, DOI 10.1097/MBC.0b013e3283273529; Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4; Mrabat H, 2009, J CELL PHYSIOL, V221, P603, DOI 10.1002/jcp.21891; Najimi M, 2005, Minerva Pediatr, V57, P243; Najimi M, 2007, CELL TRANSPLANT, V16, P717, DOI 10.3727/000000007783465154; PATTON WA, 1995, BIOCHEM J, V311, P461, DOI 10.1042/bj3110461; Pepke W, 2011, CARDIOVASC THER; POUPLARD C, 1995, THROMB RES, V80, P527, DOI 10.1016/0049-3848(95)00208-1; Samama MM, 2010, THROMB HAEMOSTASIS, V103, P815, DOI 10.1160/TH09-03-0176; Savage JM, 2001, J CELL PHYSIOL, V187, P283, DOI 10.1002/jcp.1076; Sokal EM, 2003, TRANSPLANTATION, V76, P735, DOI 10.1097/01.TP.0000077420.81365.53; Stephenne X, 2005, AM J TRANSPLANT, V5, P2058, DOI 10.1111/j.1600-6143.2005.00935.x; Stephenne X, 2006, GASTROENTEROLOGY, V130, P1317, DOI 10.1053/j.gastro.2006.01.008; Stephenne X, 2007, LIVER TRANSPLANT, V13, P599, DOI 10.1002/lt.21128; TAUBMAN MB, 1993, J CLIN INVEST, V91, P547, DOI 10.1172/JCI116234; Wang J, 2009, BBA-GEN SUBJECTS, V1790, P1689, DOI 10.1016/j.bbagen.2009.09.002; Xuereb JM, 1999, THROMB HAEMOSTASIS, V81, P151	39	46	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42819	10.1371/journal.pone.0042819	http://dx.doi.org/10.1371/journal.pone.0042819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900053	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900071
J	Drion, G; Franci, A; Seutin, V; Sepulchre, R				Drion, Guillaume; Franci, Alessio; Seutin, Vincent; Sepulchre, Rodolphe			A Novel Phase Portrait for Neuronal Excitability	PLOS ONE			English	Article							PIG THALAMIC NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; IONIC BASIS; BURST; MODEL; SPIKE; OSCILLATIONS; CHANNELS; CURRENTS; CELLS	Fifty years ago, FitzHugh introduced a phase portrait that became famous for a twofold reason: it captured in a physiological way the qualitative behavior of Hodgkin-Huxley model and it revealed the power of simple dynamical models to unfold complex firing patterns. To date, in spite of the enormous progresses in qualitative and quantitative neural modeling, this phase portrait has remained a core picture of neuronal excitability. Yet, a major difference between the neurophysiology of 1961 and of 2011 is the recognition of the prominent role of calcium channels in firing mechanisms. We show that including this extra current in Hodgkin-Huxley dynamics leads to a revision of FitzHugh-Nagumo phase portrait that affects in a fundamental way the reduced modeling of neural excitability. The revisited model considerably enlarges the modeling power of the original one. In particular, it captures essential electrophysiological signatures that otherwise require non-physiological alteration or considerable complexification of the classical model. As a basic illustration, the new model is shown to highlight a core dynamical mechanism by which calcium channels control the two distinct firing modes of thalamocortical neurons.	[Drion, Guillaume; Seutin, Vincent] Univ Liege, Neurophysiol Unit, Liege, Belgium; [Drion, Guillaume; Seutin, Vincent] Univ Liege, GIGA Neurosci, Liege, Belgium; [Drion, Guillaume; Sepulchre, Rodolphe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Drion, Guillaume; Sepulchre, Rodolphe] Univ Liege, GIGA Res, Liege, Belgium; [Franci, Alessio] Univ Paris 11, L2S, Gif Sur Yvette, France	University of Liege; University of Liege; University of Liege; University of Liege; UDICE-French Research Universities; Universite Paris Saclay	Drion, G (corresponding author), Univ Liege, Neurophysiol Unit, Liege, Belgium.	R.Sepulchre@ulg.ac.be		Drion, Guillaume/0000-0002-8076-9500	European Union Seventh Framework Programme [FP7] HYCON2 Network of excellence [n 257462]; F.R.S.-FNRS [9.4560.03]; Belgian Science Policy [IAP6/31, IAP6/4]; Fonds Leon Fredericq	European Union Seventh Framework Programme [FP7] HYCON2 Network of excellence; F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy(Belgian Federal Science Policy Office); Fonds Leon Fredericq	The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under grant agreement n 257462 HYCON2 Network of excellence, from grant 9.4560.03 from the F.R.S.-FNRS (VS), from two grants from the Belgian Science Policy (IAP6/31 (VS) and IAP6/4 (RS)), and from the Fonds Leon Fredericq (GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; Beurrier C, 1999, J NEUROSCI, V19, P599, DOI 10.1523/jneurosci.19-02-00599.1999; Canavier CC, 2006, J NEUROPHYSIOL, V96, P2549, DOI 10.1152/jn.00704.2006; Chen S, 2008, J PHYSIOL-LONDON, V586, P1351, DOI 10.1113/jphysiol.2007.148171; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; CRUNELLI V, 1989, J PHYSIOL-LONDON, V413, P543, DOI 10.1113/jphysiol.1989.sp017668; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Drion G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002050; Ermentrout G. B., 2002, SIMULATING ANAL ANIM; Ermentrout G.B., 2010, INTERDISCIPLINARY AP; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Franci A, 2011, ARXIV11122588V1; Ghazanfar AA, 1997, J NEUROPHYSIOL, V78, P506, DOI 10.1152/jn.1997.78.1.506; GUIDO W, 1992, J NEUROPHYSIOL, V68, P2199, DOI 10.1152/jn.1992.68.6.2199; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; GUIDO W, 1995, VISUAL NEUROSCI, V12, P723, DOI 10.1017/S0952523800008993; Halnes G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002160; Hille B., 1991, IONIC CHANNELS EXCIT; Hirsh M. V., 1977, LECT NOTES MATH; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huguenard J R, 1999, Adv Neurol, V79, P991; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Izhikevich EM, 2010, PHILOS T R SOC A, V368, P5061, DOI 10.1098/rsta.2010.0130; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; KOKOZ YM, 1973, BIOFIZIKA+, V18, P878; KRINSKII VI, 1973, BIOFIZIKA+, V18, P506; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; Molineux ML, 2005, J NEUROSCI, V25, P10863, DOI 10.1523/JNEUROSCI.3436-05.2005; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Pospischil M, 2011, BIOL CYBERN, V105, P167, DOI 10.1007/s00422-011-0458-2; Rekling JC, 1997, J NEUROPHYSIOL, V78, P2483, DOI 10.1152/jn.1997.78.5.2483; Richert M, 2011, FRONT NEUROINFORM, V5, P19, DOI [10.3389/fninf.2011.00019, DOI 10.3389/FNINF.2011.00019]; RINZEL J, 1985, FED PROC, V44, P2944; Rinzel J, 1989, ANAL NEURAL EXCITABI, P135; Seydel R., 2010, PRACTICAL BIFURCATIO, DOI [10.1007/978-1-4419-1740-9, DOI 10.1007/978-1-4419-1740-9]; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Shin HS, 2006, CELL CALCIUM, V40, P191, DOI 10.1016/j.ceca.2006.04.023; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Touboul J, 2009, SIAM J APPL DYN SYST, V8, P1462, DOI 10.1137/080742762; WANG XJ, 1991, J NEUROPHYSIOL, V66, P839, DOI 10.1152/jn.1991.66.3.839; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x; Zaman T, 2011, NEURON, V70, P95, DOI 10.1016/j.neuron.2011.02.042; Zhan XJ, 1999, J NEUROPHYSIOL, V81, P2360, DOI 10.1152/jn.1999.81.5.2360; Zhou Q, 1997, J NEUROPHYSIOL, V77, P2816, DOI 10.1152/jn.1997.77.5.2816	51	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41806	10.1371/journal.pone.0041806	http://dx.doi.org/10.1371/journal.pone.0041806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905107	Green Published, gold			2022-12-27	WOS:000307331100018
J	Filippi-Chiela, EC; Oliveira, MM; Jurkovski, B; Callegari-Jacques, SM; da Silva, VD; Lenz, G				Filippi-Chiela, Eduardo C.; Oliveira, Manuel M.; Jurkovski, Bruno; Callegari-Jacques, Sidia Maria; da Silva, Vinicius Duval; Lenz, Guido			Nuclear Morphometric Analysis (NMA): Screening of Senescence, Apoptosis and Nuclear Irregularities	PLOS ONE			English	Article							CYTOTOXICITY; RESVERATROL; INHIBITORS; DEATH; CELLS	Several cellular mechanisms affect nuclear morphology which can therefore be used to assess certain processes. Here, we present an analytic tool to quantify the number of cells in a population that present characteristics of senescence, apoptosis or nuclear irregularities through nuclear morphometric analysis. The tool presented here is based on nuclear image analysis and evaluation of size and regularity of adhered cells in culture. From 46 measurements of nuclear morphometry, principal component analysis filtered four measurements that best separated regular from irregular nuclei. These measurements, namely aspect, area box, radius ratio and roundness were combined into a single nuclear irregularity index (NII). Normal nuclei are used to set the parameters for a given cell type, and different nuclear phenotypes are separated in an area versus NII plot. The tool was validated with beta-gal staining for senescence and annexin or caspases inhibitor for apoptosis as well as several treatments that induce different cellular phenotypes. This method provides a direct and objective way of screening normal, senescent, apoptotic and nuclear irregularities which may occur during failed mitosis or mitotic catastrophe, which may be very useful in basic and clinical research.	[Filippi-Chiela, Eduardo C.; Lenz, Guido] Univ Fed Rio Grande do Sul, Dept Biophys, Porto Alegre, RS, Brazil; [Lenz, Guido] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Porto Alegre, RS, Brazil; [Oliveira, Manuel M.; Jurkovski, Bruno] Univ Fed Rio Grande do Sul, Inst Informat, Porto Alegre, RS, Brazil; [Callegari-Jacques, Sidia Maria] Univ Fed Rio Grande do Sul, Grad Program Genet & Mol Biol, Dept Stat, Porto Alegre, RS, Brazil; [da Silva, Vinicius Duval] Pontificia Univ Catolica Rio Grande do Sul, Sao Lucas Hosp, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Filippi-Chiela, EC (corresponding author), Univ Fed Rio Grande do Sul, Dept Biophys, Porto Alegre, RS, Brazil.	lenz@ufrgs.br	Lenz, Guido/A-7618-2008; da Silva, Vinicius Duval/AAE-9220-2021; da Silva, Vinicius D/C-5289-2013; Oliveira, Manuel M/H-1508-2011; Filippi-Chiela, Eduardo/F-1959-2014; Callegari-Jacques, Sidia M/H-1774-2016	da Silva, Vinicius Duval/0000-0003-3515-0263; da Silva, Vinicius D/0000-0003-3515-0263; Oliveira, Manuel M/0000-0003-4957-9984; Filippi-Chiela, Eduardo/0000-0001-8192-3779; CALLEGARI JACQUES, SIDIA M./0000-0002-2489-2539	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [476491/2008-8, 472512/20110]; Pronex-Fapergs/CNPq [10/0044-3]; Pronem/FAPERGS [11/2072-2]; CNPq	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pronex-Fapergs/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Pronem/FAPERGS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), grant numbers 476491/2008-8 and 472512/20110, Pronex-Fapergs/CNPq no: 10/0044-3 and Pronem/FAPERGS 11/2072-2. ECFC, MMO, BJ, VDS and GL are recipients of CNPq fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2010, ONCOGENE; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; Jung HJ, 2000, PLANTA MED, V66, P74, DOI 10.1055/s-0029-1243113; KONDO S, 1995, CANCER RES, V55, P6166; Rello-Varona S, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.6; Roninson IB, 2003, CANCER RES, V63, P2705; Saraste A, 1999, HERZ, V24, P189, DOI 10.1007/BF03044961; Sekhar KR, 2007, CANCER RES, V67, P695, DOI 10.1158/0008-5472.CAN-06-3212; Shao RG, 2004, ACTA PHARMACOL SIN, V25, P756; Stevens FE, 2008, ONCOGENE, V27, P1345, DOI 10.1038/sj.onc.1210779; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Xia L, 2008, BRIT J PHARMACOL, V155, P387, DOI 10.1038/bjp.2008.272; Zamin LL, 2009, CANCER SCI, V100, P1655, DOI 10.1111/j.1349-7006.2009.01215.x	17	115	117	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42522	10.1371/journal.pone.0042522	http://dx.doi.org/10.1371/journal.pone.0042522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905142	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100045
J	Iniguez, G; Taguena-Martinez, J; Kaski, KK; Barrio, RA				Iniguez, Gerardo; Tagueena-Martinez, Julia; Kaski, Kimmo K.; Barrio, Rafael A.			Are Opinions Based on Science: Modelling Social Response to Scientific Facts	PLOS ONE			English	Article							EVOLUTION; PHYSICS; PERCEPTIONS; ATTITUDES	As scientists we like to think that modern societies and their members base their views, opinions and behaviour on scientific facts. This is not necessarily the case, even though we are all (over-) exposed to information flow through various channels of media, i.e. newspapers, television, radio, internet, and web. It is thought that this is mainly due to the conflicting information on the mass media and to the individual attitude (formed by cultural, educational and environmental factors), that is, one external factor and another personal factor. In this paper we will investigate the dynamical development of opinion in a small population of agents by means of a computational model of opinion formation in a co-evolving network of socially linked agents. The personal and external factors are taken into account by assigning an individual attitude parameter to each agent, and by subjecting all to an external but homogeneous field to simulate the effect of the media. We then adjust the field strength in the model by using actual data on scientific perception surveys carried out in two different populations, which allow us to compare two different societies. We interpret the model findings with the aid of simple mean field calculations. Our results suggest that scientifically sound concepts are more difficult to acquire than concepts not validated by science, since opposing individuals organize themselves in close communities that prevent opinion consensus.	[Iniguez, Gerardo; Kaski, Kimmo K.] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Helsinki, Finland; [Tagueena-Martinez, Julia] Univ Nacl Autonoma Mexico, Ctr Invest Energa, Temixco, Morelos, Mexico; [Barrio, Rafael A.] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City 01000, DF, Mexico	Aalto University; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Iniguez, G (corresponding author), Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Helsinki, Finland.	gerardo.iniguez@aalto.fi	Iñiguez, Gerardo/F-9464-2012; Kaski, Kimmo K K/G-8067-2012; Kaski, Kimmo/AAO-4320-2021	Iñiguez, Gerardo/0000-0001-7181-5520; Kaski, Kimmo/0000-0002-3805-9687; Taguena-Martinez, J./0000-0002-8312-285X	EU's FP7 FET Open STREP Project ICTeCollective [238597]; Conacyt [79641]	EU's FP7 FET Open STREP Project ICTeCollective; Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	GI and KK acknowledge the Academy of Finland, the Finnish Center of Excellence program 2006-2011, under Project No. 129670. KK acknowledges support from EU's FP7 FET Open STREP Project ICTeCollective No. 238597. KK and RAB want to acknowledge financial support from Conacyt through Project No. 79641. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum N, 2008, PUBLIC UNDERST SCI, V17, P35, DOI 10.1177/0963662506070159; [Anonymous], 2010, INFORM GEN ESTADO CI; Bauer MW, 2007, PUBLIC UNDERST SCI, V16, P79, DOI 10.1177/0963662506071287; Bauer MW, 2005, INT J PUBLIC OPIN R, V17, P63, DOI 10.1093/ijpor/edh057; Baumeister R. F., 2011, SOCIAL PSYCHOL HUMAN; Bennett D.J., 2011, SUCCESSFUL SCI COMMU; Cacciatore MA, 2011, PUBLIC UNDERST SCI, V20, P385, DOI 10.1177/0963662509347815; Caldarelli G., 2007, SCALE FREE NETWORKS; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Dorogovtsev S, 2010, COMPLEX NETWORKS; Fiske S. T., 2010, SOCIAL COGNITION BRA; Gross T, 2009, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-01284-6; HOLLEY RA, 1975, ANN PROBAB, V3, P643, DOI 10.1214/aop/1176996306; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; Holyst JA, 2001, ANN REV COMP PHYS, V9, P253; Iniguez G, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066119; Iniguez G, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016111; Iniguez G, 2011, COMPUT PHYS COMMUN, V182, P1866, DOI 10.1016/j.cpc.2010.11.020; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Kuperman M, 2002, EUR PHYS J B, V26, P387, DOI 10.1140/epjb/e20020104; Miller JD, 2004, PUBLIC UNDERST SCI, V13, P273, DOI 10.1177/0963662504044908; Nardini C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158701; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Nisbet MC, 2007, PUBLIC UNDERST SCI, V16, P421, DOI 10.1177/0963662506065558; Park HJ, 2001, PUBLIC UNDERST SCI, V10, P173, DOI 10.1088/0963-6625/10/2/302; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Schiele B., 2012, SCI COMMUNICATION WO; Sobkowicz P, 2009, INT J MOD PHYS C, V20, P1645, DOI 10.1142/S0129183109014655; Sobkowicz P, 2009, JASSS-J ARTIF SOC S, V12; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Vazquez F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108702; WEIDLICH W, 1991, PHYS REP, V204, P1, DOI 10.1016/0370-1573(91)90024-G	33	6	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42122	10.1371/journal.pone.0042122	http://dx.doi.org/10.1371/journal.pone.0042122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905117	Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100027
J	Ying, SW; Kanda, VA; Hu, ZY; Purtell, K; King, EC; Abbott, GW; Goldstein, PA				Ying, Shui-Wang; Kanda, Vikram A.; Hu, Zhaoyang; Purtell, Kerry; King, Elizabeth C.; Abbott, Geoffrey W.; Goldstein, Peter A.			Targeted Deletion of Kcne2 Impairs HCN Channel Function in Mouse Thalamocortical Circuits	PLOS ONE			English	Article							ACTIVATED CATION CHANNELS; RETICULAR THALAMIC NEURONS; MINK-RELATED PEPTIDE-1; POTASSIUM CHANNELS; I-H; PACEMAKER CHANNELS; RELAY NEURONS; ABSENCE EPILEPSY; PHYSIOLOGICAL-FUNCTION; PROPOFOL-BLOCK	Background: Hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels generate the pacemaking current, I-h, which regulates neuronal excitability, burst firing activity, rhythmogenesis, and synaptic integration. The physiological consequence of HCN activation depends on regulation of channel gating by endogenous modulators and stabilization of the channel complex formed by principal and ancillary subunits. KCNE2 is a voltage-gated potassium channel ancillary subunit that also regulates heterologously expressed HCN channels; whether KCNE2 regulates neuronal HCN channel function is unknown. Methodology/Principal Findings: We investigated the effects of Kcne2 gene deletion on Ih properties and excitability in ventrobasal (VB) and cortical layer 6 pyramidal neurons using brain slices prepared from Kcne2(+/+) and Kcne2(-/-) mice. Kcne2 deletion shifted the voltage-dependence of Ih activation to more hyperpolarized potentials, slowed gating kinetics, and decreased Ih density. Kcne2 deletion was associated with a reduction in whole-brain expression of both HCN1 and HCN2 (but not HCN4), although co-immunoprecipitation from whole-brain lysates failed to detect interaction of KCNE2 with HCN1 or 2. Kcne2 deletion also increased input resistance and temporal summation of subthreshold voltage responses; this increased intrinsic excitability enhanced burst firing in response to 4-aminopyridine. Burst duration increased in corticothalamic, but not thalamocortical, neurons, suggesting enhanced cortical excitatory input to the thalamus; such augmented excitability did not result from changes in glutamate release machinery since miniature EPSC frequency was unaltered in Kcne2(-/-) neurons. Conclusions/Significance: Loss of KCNE2 leads to downregulation of HCN channel function associated with increased excitability in neurons in the cortico-thalamo-cortical loop. Such findings further our understanding of the normal physiology of brain circuitry critically involved in cognition and have implications for our understanding of various disorders of consciousness.	[Ying, Shui-Wang; Goldstein, Peter A.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA; [Kanda, Vikram A.; Purtell, Kerry; King, Elizabeth C.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Hu, Zhaoyang; Abbott, Geoffrey W.] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Hu, Zhaoyang; Abbott, Geoffrey W.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA	Cornell University; Cornell University; University of California System; University of California Irvine; University of California System; University of California Irvine	Ying, SW (corresponding author), Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA.	pag2014@med.cornell.edu		Goldstein, Peter/0000-0002-5973-9104; Abbott, Geoffrey/0000-0003-4552-496X	Dept. of Anesthesiolgy; National Institutes of Health [R01 HL079275, R01HL101190]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275, R01HL101190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER	Dept. of Anesthesiolgy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Dept. of Anesthesiolgy and by the National Institutes of Health (R01 HL079275 and R01HL101190, both to GWA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas SY, 2006, NEUROSCIENCE, V141, P1811, DOI 10.1016/j.neuroscience.2006.05.034; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Amendola J, 2012, J NEUROSCI, V32, P2166, DOI 10.1523/JNEUROSCI.5297-11.2012; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Biel M, 1999, REV PHYSIOL BIOCH P, V136, P165, DOI 10.1007/BFb0032324; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x; Brandt MC, 2009, AM J PHYSIOL-HEART C, V297, pH355, DOI 10.1152/ajpheart.00154.2009; Budde T, 2005, J NEUROSCI, V25, P9871, DOI 10.1523/JNEUROSCI.2590-05.2005; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Deschenes I, 2002, FEBS LETT, V528, P183, DOI 10.1016/S0014-5793(02)03296-9; Faivre JF, 1999, CARDIOVASC RES, V41, P188, DOI 10.1016/S0008-6363(98)00215-6; Golshani P, 1999, J NEUROSCI, V19, P2865; Gonzalez-Sulser A, 2011, NEUROPHARMACOLOGY, V60, P1142, DOI 10.1016/j.neuropharm.2010.10.007; HOFFMAN SN, 1995, DEV BRAIN RES, V85, P64, DOI 10.1016/0165-3806(94)00196-7; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Huang Z, 2009, J NEUROSCI, V29, P10979, DOI 10.1523/JNEUROSCI.1531-09.2009; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; HUGUENARD JR, 1991, J NEUROPHYSIOL, V66, P1304, DOI 10.1152/jn.1991.66.4.1304; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Jung S, 2010, J NEUROSCI, V30, P6678, DOI 10.1523/JNEUROSCI.1290-10.2010; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; Kanda VA, 2011, BIOPHYS J, V101, P1364, DOI 10.1016/j.bpj.2011.08.014; Kanyshkova T, 2012, NEUROBIOL DIS, V45, P450, DOI 10.1016/j.nbd.2011.08.032; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Lam YW, 2010, CEREB CORTEX, V20, P13, DOI 10.1093/cercor/bhp077; Le Roux N, 2006, EUR J NEUROSCI, V24, P3507, DOI 10.1111/j.1460-9568.2006.05203.x; Ledergerber D, 2010, J NEUROSCI, V30, P13031, DOI 10.1523/JNEUROSCI.2254-10.2010; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; McCrossan ZA, 2003, J NEUROSCI, V23, P8077; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2011, FASEB J, V25, P4264, DOI 10.1096/fj.11-187609; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Salah A, 2011, EPILEPSY RES, V94, P163, DOI 10.1016/j.eplepsyres.2011.01.017; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Timofeev I, 2004, NEUROSCIENCE, V123, P299, DOI 10.1016/j.neuroscience.2003.08.051; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tinel N, 2000, FEBS LETT, V480, P137, DOI 10.1016/S0014-5793(00)01918-9; Tsaur ML, 1997, FEBS LETT, V400, P215, DOI 10.1016/S0014-5793(96)01388-9; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Whyment AD, 2011, NEUROSCIENCE, V178, P68, DOI 10.1016/j.neuroscience.2010.12.061; Wierschke S, 2010, EPILEPSIA, V51, P404, DOI 10.1111/j.1528-1167.2009.02275.x; Ying SW, 2007, J NEUROSCI, V27, P8719, DOI 10.1523/JNEUROSCI.1630-07.2007; Ying SW, 2011, J NEUROSCI, V31, P10412, DOI 10.1523/JNEUROSCI.0021-11.2011; Ying SW, 2006, EUR J NEUROSCI, V23, P465, DOI 10.1111/j.1460-9568.2005.04587.x; Ying SW, 2005, J NEUROPHYSIOL, V93, P1935, DOI 10.1152/jn.01058.2004; Ying SW, 2011, NEUROSCIENCE; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	76	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42756	10.1371/journal.pone.0042756	http://dx.doi.org/10.1371/journal.pone.0042756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880098	Green Published, gold			2022-12-27	WOS:000307284100164
J	Zou, SR; Wu, F; Guo, CY; Song, J; Huang, CH; Zhu, ZN; Yu, HT; Guo, YF; Lu, X; Ruan, Y				Zou, Shurong; Wu, Fan; Guo, Changyi; Song, Jun; Huang, Cuihua; Zhu, Zhenni; Yu, Huiting; Guo, Yanfei; Lu, Xi; Ruan, Ye			Iodine Nutrition and the Prevalence of Thyroid Disease after Salt Iodization: A Cross-Sectional Survey in Shanghai, a Coastal Area in China	PLOS ONE			English	Article							NODULES; GOITER	Background: Both insufficient and excess iodine may produce thyroid disease. After salt iodization in China, the median urine iodine concentration (UIC) of children aged 8-10 years appeared adequate. However, it is unknown whether dietary changes due to rapid economic development in Shanghai have affected whole population iodine nutrition. Objective: To assess dietary iodine intake, UIC and the prevalence of thyroid disease in the general population of Shanghai. Design: A cross-sectional survey was conducted with general participants aged 5-69 years (n = 7,904) plus pregnant and lactating women (n = 380 each) selected by stratified multistage sampling. The iodine concentrations in their salt, drinking water and urine were measured. Daily iodine intake was estimated using the total diet study approach. Serum thyroid hormone concentrations and thyroid-related antibodies were measured and thyroid ultrasonography was performed. Results: The median iodine concentration in salt was 29.5 mg/kg, and 12.8 mu g/L in drinking water. Iodized salt, used by 95.3% of participants, contributed 63.5% of total dietary iodine. Estimated daily iodine intake was 225.96 mu g. The median UIC of general participants was 146.7 mu g/L; UIC <100 mu g/L (iodine insufficiency) was seen in 28.6%; UIC >300 mg/L (iodine excess) in 10.1%. Pregnant women had a median UIC of 135.9 mu g/L, with UIC <150 mu g/L in 55.4%. Thyroid nodules and subclinical hypothyroidism were found in 27.44% and 9.17%, respectively. Conclusions: According to published criteria, the current dietary iodine intake in Shanghai was generally sufficient and safe, but insufficient in pregnant women. Thyroid nodules and subclinical hypothyroidism were the commonest thyroid diseases identified.	[Zou, Shurong; Wu, Fan; Guo, Changyi; Song, Jun; Huang, Cuihua; Zhu, Zhenni] Shanghai Municipal Ctr Dis Control & Prevent, Dept Nutr Hyg, Shanghai, Peoples R China; [Yu, Huiting] Shanghai Municipal Ctr Dis Control & Prevent, Dept Hlth Stat, Shanghai, Peoples R China; [Guo, Yanfei] Shanghai Municipal Ctr Dis Control & Prevent, Dept Environm Hlth, Shanghai, Peoples R China; [Lu, Xi] Shanghai Municipal Ctr Dis Control & Prevent, Dept Sch Hlth, Shanghai, Peoples R China; [Ruan, Ye] Shanghai Municipal Ctr Dis Control & Prevent, Dept Diabet Mellitus Control & Prevent, Shanghai, Peoples R China	Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Zou, SR (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Dept Nutr Hyg, Shanghai, Peoples R China.	fanwu@scdc.sh.cn						[Anonymous], 2007, ASS IOD DEF DIS MON; [Anonymous], 2001, CHIN J ENDOCRINOL; BRANDER A, 1991, RADIOLOGY, V181, P683, DOI 10.1148/radiology.181.3.1947082; BRUNETON JN, 1994, J ULTRAS MED, V13, P87; Caldwell KL, 2011, THYROID, V21, P419, DOI 10.1089/thy.2010.0077; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Chen JX, 2000, CHINA NATL IODINE DE, P27; Chen JX, 1997, CHINA NATL IODINE DE, P16; Chen X., 2003, CHINA NATL IODINE DE; Chen XY, 2002, CHINA NATL IODINE DE, P39; Dunn JT, 1998, J CLIN ENDOCR METAB, V83, P3398, DOI 10.1210/jc.83.10.3398; FAO/WHO/UNU, 2004, FAO FOOD NUTR TECH R, V1, P103; Gharib H, 1997, ENDOCRIN METAB CLIN, V26, P777, DOI 10.1016/S0889-8529(05)70282-6; HELSEL DR, 1990, ENVIRON SCI TECHNOL, V24, P1766, DOI 10.1021/es00082a001; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; HULL OH, 1955, ARCH PATHOL, V59, P291; Leech JV, 1928, AM J PATHOL, V4, P481; Li QS, 2009, SERIES ULTRASOUND PH, P61; Liao EY, 2001, ENDOCRINOLOGY, P619; MATOVINOVIC J, 1965, J AMER MED ASSOC, V192, P234, DOI 10.1001/jama.1965.03080160054014; MORTENSEN JD, 1955, J CLIN ENDOCR METAB, V15, P1270, DOI 10.1210/jcem-15-10-1270; OERTEL J E, 1965, Med Ann Dist Columbia, V34, P75; Bonet-Manso MP, 2007, ENFERM CLIN, V17, P293; RALLISON ML, 1975, JAMA-J AM MED ASSOC, V233, P1069, DOI 10.1001/jama.233.10.1069; ROJESKI MT, 1985, NEW ENGL J MED, V313, P428, DOI 10.1056/NEJM198508153130707; Teng WP, 2003, FOREIGN MED SCI SEC, V23, P370; The Chinese Nutrition Society, 2000, CHIN DIET REF INT 20; Travers CA, 2006, MED J AUSTRALIA, V184, P617, DOI 10.5694/j.1326-5377.2006.tb00417.x; TROWBRIDGE FL, 1975, PEDIATRICS, V56, P82; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; US Environmental Protection Agency, 2006, DAT QUAL ASS STAT ME; VANDER JB, 1968, ANN INTERN MED, V69, P537, DOI 10.7326/0003-4819-69-3-537; WOESTYN J, 1985, BRIT J RADIOL, V58, P1179, DOI 10.1259/0007-1285-58-696-1179; World Health Organization, 2009, 72 WHO INT CLASS PAT, P5; Xiao DL, 2007, CHINA NATL IODINE DE, P43; [阎玉芹 Yan Yuqin], 2003, [中国地方病学杂志, Chinese Journal of Endemiology], V22, P141; Yang F, 2001, CHINESE J ENDOCRINOL, V17, P197	37	48	60	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40718	10.1371/journal.pone.0040718	http://dx.doi.org/10.1371/journal.pone.0040718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22911705	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200028
J	Brandi, G; Tavolari, S; De Rosa, F; Di Girolamo, S; Agostini, V; Barbera, MA; Frega, G; Biasco, G				Brandi, Giovanni; Tavolari, Simona; De Rosa, Francesco; Di Girolamo, Stefania; Agostini, Valentina; Barbera, Maria Aurelia; Frega, Giorgio; Biasco, Guido			Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; CETUXIMAB RESISTANCE; TARGETED THERAPIES; GENE-MUTATIONS; GROWTH; ANGIOGENESIS; SIMVASTATIN; BIOMARKERS; APOPTOSIS; INVASION	The employment of anti-epidermal growth factor receptor (EGFR) antibodies represents a backbone of the therapeutic options for the treatment of metastatic colorectal cancer (mCRC). However, this therapy is poorly effective or ineffective in unselected patients. Mutations in KRAS, BRAF and PIK3CA genes have recently emerged as the best predictive factors of low/absent response to EGFR-targeted therapy. Due to the need for efficacious treatment options for mCRC patients bearing these mutations, in this short report we examined the antitumoral activity of the protease inhibitor gabexate mesilate, alone and in combination with the anti-EGFR monoclonal antibody cetuximab, in a panel of human CRC cell lines harbouring a different expression pattern of wild-type/mutated KRAS, BRAF and PIK3CA genes. Results obtained showed that gabexate mesilate significantly inhibited the growth, invasive potential and tumour-induced angiogenesis in all the CRC cells employed in this study (including those ones harbouring dual KRAS/PIK3CA or BRAF/PIK3CA mutation), while cetuximab affected these parameters only in CRC cells with KRAS, BRAF and PIK3CA wild-type. Notably, the antitumoral efficacy of gabexate mesilate and cetuximab in combination was found to be not superior than that observed with gabexate mesilate as single agent. Overall, these preliminary findings suggest that gabexate mesilate could represent a promising therapeutic option for mCRC patients, particularly for those harbouring KRAS, BRAF and PIK3CA mutations, either as mono-therapy or in addition to standard chemotherapy regimens. Further studies to better elucidate gabexate mesilate mechanism of action in CRC cells are therefore warranted.	[Brandi, Giovanni; De Rosa, Francesco; Di Girolamo, Stefania; Agostini, Valentina; Barbera, Maria Aurelia; Frega, Giorgio; Biasco, Guido] Univ Bologna, St Orsola Malpighi Hosp, L&A Seragnoli Dept Hematol & Oncol Sci, Bologna, Italy; [Brandi, Giovanni; Tavolari, Simona; Biasco, Guido] Univ Bologna, G Prodi Interdept Ctr Canc Res CIRC, Bologna, Italy; [Tavolari, Simona] Univ Bologna, St Orsola Malpighi Hosp, Ctr Appl Biomed Res CRBA, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Brandi, G (corresponding author), Univ Bologna, St Orsola Malpighi Hosp, L&A Seragnoli Dept Hematol & Oncol Sci, Bologna, Italy.	giovanni.brandi@unibo.it	de Rosa, Francesco/AAC-5935-2022; Tavolari, Simona/K-3540-2018; Frega, Giorgio/W-8099-2019; Brandi, Giovanni/AAD-6327-2021; agostini, valentina/K-3945-2016	de Rosa, Francesco/0000-0003-0511-1298; Frega, Giorgio/0000-0001-9153-0557; Brandi, Giovanni/0000-0003-0013-2858; agostini, valentina/0000-0001-5540-2371; di girolamo, stefania/0000-0001-5156-7400				Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Barendsz-Janson AF, 1998, J VASC RES, V35, P109, DOI 10.1159/000025572; Brandi G, 2011, J NATL CANCER I, V103, P1278, DOI 10.1093/jnci/djr266; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; De Mattos-Arruda L, 2011, CLIN COLORECTAL CANC, V10, P279, DOI 10.1016/j.clcc.2011.03.030; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lee J, 2011, JNCI-J NATL CANCER I, V103, P674, DOI 10.1093/jnci/djr070; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; OHTA N, 1986, INT J PHARM, V29, P137, DOI 10.1016/0378-5173(86)90111-0; Ozeki T, 2010, INT J CLIN EXP PATHO, V3, P710; Prenen H, 2010, CLIN CANCER RES, V16, P2921, DOI 10.1158/1078-0432.CCR-09-2029; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Seta T, 2004, EUR J GASTROEN HEPAT, V16, P1287, DOI 10.1097/00042737-200412000-00009; Seta T, 2011, GASTROINTEST ENDOSC, V73, P700, DOI 10.1016/j.gie.2010.09.022; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Soares R, 2004, MOL ENDOCRINOL, V18, P2333, DOI 10.1210/me.2003-0362; Takahashi H, 2007, DIGEST DIS SCI, V52, P2646, DOI 10.1007/s10620-006-9654-7; Van Cutsem E, 2010, ANN ONCOL, V21, pv93, DOI 10.1093/annonc/mdq222; Yoon WH, 2004, CLIN CANCER RES, V10, P4517, DOI 10.1158/1078-0432.CCR-04-0084	26	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41347	10.1371/journal.pone.0041347	http://dx.doi.org/10.1371/journal.pone.0041347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911782	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300033
J	Nielsen, R; Korneliussen, T; Albrechtsen, A; Li, YR; Wang, J				Nielsen, Rasmus; Korneliussen, Thorfinn; Albrechtsen, Anders; Li, Yingrui; Wang, Jun			SNP Calling, Genotype Calling, and Sample Allele Frequency Estimation from New-Generation Sequencing Data	PLOS ONE			English	Article							ASSOCIATION; INFERENCE; IMPUTATION; SITES	We present a statistical framework for estimation and application of sample allele frequency spectra from New-Generation Sequencing (NGS) data. In this method, we first estimate the allele frequency spectrum using maximum likelihood. In contrast to previous methods, the likelihood function is calculated using a dynamic programming algorithm and numerically optimized using analytical derivatives. We then use a Bayesian method for estimating the sample allele frequency in a single site, and show how the method can be used for genotype calling and SNP calling. We also show how the method can be extended to various other cases including cases with deviations from Hardy-Weinberg equilibrium. We evaluate the statistical properties of the methods using simulations and by application to a real data set.	[Nielsen, Rasmus; Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Nielsen, Rasmus; Korneliussen, Thorfinn; Albrechtsen, Anders; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Beijing Genomics Institute (BGI); University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Copenhagen	Nielsen, R (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	rasmus_nielsen@berkeley.edu; wangj@genomics.org.cn	Korneliussen, Thorfinn Sand/ABB-7656-2021; Albrechtsen, Anders/K-4281-2013; Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; Korneliussen, Thorfinn Sand/F-6421-2014; Nielsen, Rasmus/D-4405-2009; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Albrechtsen, Anders/0000-0001-7306-031X; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Nielsen, Rasmus/0000-0003-0513-6591; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	United States National Institutes of Health [R01-HG003229]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; Villum Fonden [00007171] Funding Source: researchfish	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Villum Fonden(Villum Fonden)	Funding was provided by United States National Institutes of Health grant R01-HG003229. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; CASELLA G, 1985, AM STAT, V39, P83, DOI 10.2307/2682801; Dai JY, 2006, GENET EPIDEMIOL, V30, P690, DOI 10.1002/gepi.20180; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Hellmann I, 2008, GENOME RES, V18, P1020, DOI 10.1101/gr.074187.107; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Johnson PLF, 2008, MOL BIOL EVOL, V25, P199, DOI 10.1093/molbev/msm239; Johnson PLF, 2006, GENOME RES, V16, P1320, DOI 10.1101/gr.5431206; Keightley PD, 2011, GENETICS, V188, P931, DOI 10.1534/genetics.111.128355; Kim SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-231; Kim SY, 2010, GENET EPIDEMIOL, V34, P479, DOI 10.1002/gepi.20501; Le SQ, 2011, GENOME RES, V21, P952, DOI 10.1101/gr.113084.110; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lynch M, 2008, MOL BIOL EVOL, V25, P2409, DOI 10.1093/molbev/msn185; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martin ER, 2010, BIOINFORMATICS, V26, P2803, DOI 10.1093/bioinformatics/btq526; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Nordby J.J., 2000, DEAD RECKONING ART F; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; TAJIMA F, 1989, GENETICS, V123, P585; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	35	222	226	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e37558	10.1371/journal.pone.0037558	http://dx.doi.org/10.1371/journal.pone.0037558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911679	Green Published, gold			2022-12-27	WOS:000306751300001
J	Jung, J; Kim, HY; Kim, T; Shin, BH; Park, GS; Park, S; Chwae, YJ; Shin, HJ; Kim, K				Jung, Jaesung; Kim, Hee-Young; Kim, Taeyeung; Shin, Bo-Hye; Park, Gil-Soon; Park, Sun; Chwae, Yong-Joon; Shin, Ho-Joon; Kim, Kyongmin			C-Terminal Substitution of HBV Core Proteins with Those from DHBV Reveals That Arginine-Rich (167)RRRSQSPRR(175) Domain Is Critical for HBV Replication	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CAPSID PROTEIN; REVERSE TRANSCRIPTION; NUCLEAR-LOCALIZATION; NUCLEOTIDE-SEQUENCE; PHOSPHORYLATION; RNA; DUCK; ENCAPSIDATION; PARTICLES	To investigate the contributions of carboxyl-terminal nucleic acid binding domain of HBV core (C) protein for hepatitis B virus (HBV) replication, chimeric HBV C proteins were generated by substituting varying lengths of the carboxyl-terminus of duck hepatitis B virus (DHBV) C protein for the corresponding regions of HBV C protein. All chimeric C proteins formed core particles. A chimeric C protein with 221-262 amino acids of DHBV C protein, in place of 146-185 amino acids of the HBV C protein, supported HBV pregenomic RNA (pgRNA) encapsidation and DNA synthesis: 40% amino acid sequence identity or 45% homology in the nucleic-acid binding domain of HBV C protein was sufficient for pgRNA encapsidation and DNA synthesis, although we predominantly detected spliced DNA. A chimeric C protein with 221-241 and 251-262 amino acids of DHBV C, in place of HBV C 146-166 and 176-185 amino acids, respectively, could rescue full-length DNA synthesis. However, a reciprocal C chimera with 242-250 of DHBV C ((242)RAGSPLPRS(250)) introduced in place of 167-175 of HBV C ((167)RRRSQSPRR(175)) significantly decreased pgRNA encapsidation and DNA synthesis, and full-length DNA was not detected, demonstrating that the arginine-rich (167)RRRSQSPRR(175) domain may be critical for efficient viral replication. Five amino acids differing between viral species (underlined above) were tested for replication rescue; R169 and R175 were found to be important.	[Jung, Jaesung; Kim, Hee-Young; Kim, Taeyeung; Shin, Bo-Hye; Park, Gil-Soon; Park, Sun; Chwae, Yong-Joon; Shin, Ho-Joon; Kim, Kyongmin] Ajou Univ, Sch Med, Dept Microbiol, Suwon 441749, South Korea	Ajou University	Jung, J (corresponding author), Ajou Univ, Sch Med, Dept Microbiol, Suwon 441749, South Korea.	kimkm@ajou.ac.kr		Park, Sun/0000-0003-3254-4064; Kim, Kyongmin/0000-0001-9539-3051	Korea Research Foundation; Korean Government [KRF-2005-E00086, KRF-2006-E00017, KRF-2008-E00164]; Korean Ministry of Education	Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); Korean Ministry of Education(Ministry of Education (MOE), Republic of Korea)	This work was supported by Korea Research Foundation Grants funded by the Korean Government (KRF-2005-E00086, KRF-2006-E00017, and KRF-2008-E00164). Jaesung Jung, Taeyeung Kim, and Bo-Hye Shin were supported by the BK21 program, Korean Ministry of Education. The authors thank Dr. William Mason (Fox Chase Cancer Center) for providing the DHBV construct. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAMES B, 1993, VIROLOGY, V194, P597, DOI 10.1006/viro.1993.1299; BERKOWITZ RD, 1995, J VIROL, V69, P6445, DOI 10.1128/JVI.69.10.6445-6456.1995; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Brechot C, 2004, GASTROENTEROLOGY, V127, pS56, DOI 10.1053/j.gastro.2004.09.016; Certo JL, 1999, J VIROL, V73, P9170, DOI 10.1128/JVI.73.11.9170-9177.1999; Chua PK, 2010, J VIROL, V84, P2340, DOI 10.1128/JVI.01666-09; Daub H, 2002, J VIROL, V76, P8124, DOI 10.1128/JVI.76.16.8124-8137.2002; Enomoto M, 2006, FEBS LETT, V580, P894, DOI 10.1016/j.febslet.2006.01.011; GALLINA A, 1989, J VIROL, V63, P4645, DOI 10.1128/JVI.63.11.4645-4652.1989; Gazina EV, 2000, J VIROL, V74, P4721, DOI 10.1128/JVI.74.10.4721-4728.2000; Gunther S, 1997, VIROLOGY, V238, P363, DOI 10.1006/viro.1997.8863; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; HUANG JK, 1993, MOL CELL BIOL, V13, P7476, DOI 10.1128/MCB.13.12.7476; KANN M, 1994, J VIROL, V68, P7993, DOI 10.1128/JVI.68.12.7993-8000.1994; Kau JH, 1998, J VIROL, V72, P3796, DOI 10.1128/JVI.72.5.3796-3803.1998; Kaye JF, 1998, J VIROL, V72, P5877, DOI 10.1128/JVI.72.7.5877-5885.1998; KENNEY JM, 1995, STRUCTURE, V3, P1009, DOI 10.1016/S0969-2126(01)00237-4; Kim HY, 2004, VIROLOGY, V322, P22, DOI 10.1016/j.virol.2004.01.009; Kim KH, 2000, J VIROL, V74, P2663, DOI 10.1128/JVI.74.6.2663-2670.2000; Kock J, 2004, J VIROL, V78, P13812, DOI 10.1128/JVI.78.24.13812-13818.2004; Kock J, 1998, J VIROL, V72, P9116; KODAMA K, 1985, J VIROL, V56, P978, DOI 10.1128/JVI.56.3.978-986.1985; Konig S, 1998, J VIROL, V72, P4997; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Le Pogam S, 2005, J VIROL, V79, P1871, DOI 10.1128/JVI.79.3.1871-1887.2005; Lewellyn EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017202; Lewellyn EB, 2011, J VIROL, V85, P1298, DOI 10.1128/JVI.01957-10; LIAO W, 1995, J VIROL, V69, P1025, DOI 10.1128/JVI.69.2.1025-1029.1995; MACHIDA A, 1991, J VIROL, V65, P6024, DOI 10.1128/JVI.65.11.6024-6030.1991; MANDART E, 1984, J VIROL, V49, P782, DOI 10.1128/JVI.49.3.782-792.1984; Melegari M, 2005, J VIROL, V79, P9810, DOI 10.1128/JVI.79.15.9810-9820.2005; Mueller-Hill K, 2002, J VIROL, V76, P4260, DOI 10.1128/JVI.76.9.4260-4266.2002; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Newman M, 2003, J VIROL, V77, P12950, DOI 10.1128/JVI.77.24.12950-12960.2003; OKAMOTO H, 1990, J GEN VIROL, V71, P959, DOI 10.1099/0022-1317-71-4-959; Ostrow KM, 2004, J VIROL, V78, P8780, DOI 10.1128/JVI.78.16.8780-8787.2004; Ostrow KM, 2002, J VIROL, V76, P9087, DOI 10.1128/JVI.76.18.9087-9095.2002; Park GS, 2008, VIRUS RES, V136, P166, DOI 10.1016/j.virusres.2008.05.005; Perlman DH, 2005, P NATL ACAD SCI USA, V102, P9020, DOI 10.1073/pnas.0502138102; YEH CT, 1993, P NATL ACAD SCI USA, V90, P6459, DOI 10.1073/pnas.90.14.6459; YEH CT, 1991, J VIROL, V65, P2327, DOI 10.1128/JVI.65.5.2327-2331.1991; YU MS, 1994, J VIROL, V68, P2965, DOI 10.1128/JVI.68.5.2965-2969.1994; ZHOU S, 1992, P NATL ACAD SCI USA, V89, P10046, DOI 10.1073/pnas.89.21.10046; Ziermann R, 1996, VIROLOGY, V219, P350, DOI 10.1006/viro.1996.0260	44	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41087	10.1371/journal.pone.0041087	http://dx.doi.org/10.1371/journal.pone.0041087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911745	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600045
J	Edwards, AM; Bowden, MG; Brown, EL; Laabei, M; Massey, RC				Edwards, Andrew M.; Bowden, Maria Gabriela; Brown, Eric L.; Laabei, Maisem; Massey, Ruth C.			Staphylococcus aureus Extracellular Adherence Protein Triggers TNF alpha Release, Promoting Attachment to Endothelial Cells via Protein A	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; NECROSIS-FACTOR-ALPHA; FIBRINOGEN RECEPTOR; SECRETED PROTEIN; CLUMPING FACTOR; EAP-PROTEIN; EXPRESSION; IDENTIFICATION; GC1QR/P33; INVASION	Staphylococcus aureus is a leading cause of bacteraemia, which frequently results in complications such as infective endocarditis, osteomyelitis and exit from the bloodstream to cause metastatic abscesses. Interaction with endothelial cells is critical to these complications and several bacterial proteins have been shown to be involved. The S. aureus extracellular adhesion protein (Eap) has many functions, it binds several host glyco-proteins and has both pro-and anti-inflammatory activity. Unfortunately its role in vivo has not been robustly tested to date, due to difficulties in complementing its activity in mutant strains. We previously found Eap to have pro-inflammatory activity, and here show that purified native Eap triggered TNF alpha release in whole human blood in a dose-dependent manner. This level of TNF alpha increased adhesion of S. aureus to endothelial cells 4-fold via a mechanism involving protein A on the bacterial surface and gC1qR/p33 on the endothelial cell surface. The contribution this and other Eap activities play in disease severity during bacteraemia was tested by constructing an isogenic set of strains in which the eap gene was inactivated and complemented by inserting an intact copy elsewhere on the bacterial chromosome. Using a murine bacteraemia model we found that Eap expressing strains cause a more severe infection, demonstrating its role in invasive disease.	[Edwards, Andrew M.; Laabei, Maisem; Massey, Ruth C.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Bowden, Maria Gabriela] Texas A&M Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Houston, TX USA; [Brown, Eric L.] Univ Texas Houston, Sch Publ Hlth, Ctr Infect Dis, Houston, TX USA	University of Bath; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Edwards, AM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mol Bacteriol & Infect, London, England.	r.c.massey@bath.ac.uk	Laabei, Maisem/AAH-6383-2021; Massey, Ruth/AAT-6415-2021	Laabei, Maisem/0000-0002-8425-3704; Massey, Ruth/0000-0002-8154-4039; Edwards, Andrew/0000-0002-7173-7355	Medical Research Council (UK) [G0700836]; MRC [G0700836] Funding Source: UKRI; Medical Research Council [G0700836] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (UK) # G0700836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasopoulos AN, 2006, BLOOD, V107, P2720, DOI 10.1182/blood-2005-08-3140; BONE RC, 1994, ARCH INTERN MED, V154, P26, DOI 10.1001/archinte.154.1.26; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Carnicer-Pont D, 2006, EPIDEMIOL INFECT, V134, P1167, DOI 10.1017/S0950268806006327; Chavakis T, 2002, NAT MED, V8, P687, DOI 10.1038/nm728; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; CHEUNG AL, 1991, INFECT IMMUN, V59, P3827, DOI 10.1128/IAI.59.10.3827-3831.1991; Collins J, 2008, J CLIN MICROBIOL, V46, P2112, DOI 10.1128/JCM.00156-08; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Geisbrecht BV, 2005, J BIOL CHEM, V280, P17243, DOI 10.1074/jbc.M412311200; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Haggar A, 2004, INFECT IMMUN, V72, P6164, DOI 10.1128/IAI.72.10.6164-6167.2004; Haggar A, 2003, INFECT IMMUN, V71, P2310, DOI 10.1128/IAI.71.5.2310-2317.2003; Haggar A, 2010, CLIN MICROBIOL INFEC, V16, P1155, DOI 10.1111/j.1469-0691.2009.03058.x; Harraghy N, 2005, MICROBIOL-SGM, V151, P1789, DOI 10.1099/mic.0.27902-0; Hartleib J, 2000, BLOOD, V96, P2149; Hussain M, 2001, CLIN DIAGN LAB IMMUN, V8, P1271, DOI 10.1128/CDLI.8.6.1271-1276.2001; Hussain M, 2002, INFECT IMMUN, V70, P2933, DOI 10.1128/IAI.70.6.2933-2940.2002; Hussain M, 2008, INFECT IMMUN, V76, P5615, DOI 10.1128/IAI.00480-08; Hussain M, 2008, J CLIN MICROBIOL, V46, P470, DOI 10.1128/JCM.01425-07; Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07; Joost I, 2011, FEMS IMMUNOL MED MIC, V62, P23, DOI 10.1111/j.1574-695X.2011.00783.x; Joost I, 2009, J INFECT DIS, V199, P1471, DOI 10.1086/598484; Kerdudou S, 2006, THROMB HAEMOSTASIS, V96, P183, DOI 10.1160/TH-06-02-0116; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luong TT, 2007, J MICROBIOL METH, V70, P186, DOI 10.1016/j.mimet.2007.04.007; Madge LA, 2001, EXP MOL PATHOL, V70, P317, DOI 10.1006/exmp.2001.2368; Massey RC, 2007, INFECT IMMUN, V75, P5711, DOI 10.1128/IAI.00875-07; MCDEVITT D, 1992, INFECT IMMUN, V60, P1514, DOI 10.1128/IAI.60.4.1514-1523.1992; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; Nguyen T, 2000, INFECT IMMUN, V68, P2061, DOI 10.1128/IAI.68.4.2061-2068.2000; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Oviedo-Boyso J, 2008, SCAND J IMMUNOL, V67, P169, DOI 10.1111/j.1365-3083.2007.02056.x; Oviedo-Boyso J, 2008, FEMS IMMUNOL MED MIC, V54, P53, DOI 10.1111/j.1574-695X.2008.00447.x; Palma M, 1999, J BACTERIOL, V181, P2840, DOI 10.1128/JB.181.9.2840-2845.1999; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; Peerschke EIB, 2006, INFECT IMMUN, V74, P4418, DOI 10.1128/IAI.01794-05; Sau S, 1997, MICROBIOL-UK, V143, P2395, DOI 10.1099/00221287-143-7-2395; Scriba TJ, 2008, INFECT IMMUN, V76, P2164, DOI 10.1128/IAI.01699-07; Sethi S, 2011, MICROVASC RES, V82, P66, DOI 10.1016/j.mvr.2011.04.007; Spentzas T, 2011, CELL IMMUNOL, V269, P46, DOI 10.1016/j.cellimm.2011.03.009; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; Wang JE, 2000, INFECT IMMUN, V68, P3965, DOI 10.1128/IAI.68.7.3965-3970.2000; Xie CP, 2006, J EXP MED, V203, P985, DOI 10.1084/jem.20051681	54	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43046	10.1371/journal.pone.0043046	http://dx.doi.org/10.1371/journal.pone.0043046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905199	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600042
J	Hernadi, A; Anna, K; Turcsan, B; Topal, J				Hernadi, Anna; Kis, Anna; Turcsan, Borbala; Topal, Jozsef			Man's Underground Best Friend: Domestic Ferrets, Unlike the Wild Forms, Show Evidence of Dog-Like Social-Cognitive Skills	PLOS ONE			English	Article							HUMAN POINTING GESTURES; CANIS-FAMILIARIS; STRANGE SITUATION; MUSTELA-PUTORIUS; HUMANS; CUES; COMMUNICATION; ATTACHMENT; GAZE; RECOGNITION	Recent research has shown that dogs' possess surprisingly sophisticated human-like social communication skills compared to wolves or chimpanzees. The effects of domestication on the emergence of socio-cognitive skills, however, are still highly debated. One way to investigate this is to compare socialized individuals from closely related domestic and wild species. In the present study we tested domestic ferrets (Mustela furo) and compared their performance to a group of wild Mustela hybrids and to domestic dogs (Canis familiaris). We found that, in contrast to wild Mustela hybrids, both domestic ferrets and dogs tolerated eye-contact for a longer time when facing their owners versus the experimenter and they showed a preference in a two-way choice task towards their owners. Furthermore, domestic ferrets, unlike the wild hybrids, were able to follow human directional gestures (sustained touching; momentary pointing) and could reach the success rate of dogs. Our study provides the first evidence that domestic ferrets, in a certain sense, are more dog-like than their wild counterparts. These findings support the hypothesis that domestic species may share basic socio-cognitive skills that enable them to engage in effectively orchestrated social interactions with humans.	[Hernadi, Anna; Topal, Jozsef] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Hernadi, Anna; Kis, Anna; Turcsan, Borbala] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Kis, Anna] HAS ELTE Comparat Ethol Res Grp, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; MTA-ELTE Comparative Ethology Research Group	Hernadi, A (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary.	kisanna12@gmail.com	Turcsán, Borbála/I-7983-2018	Turcsán, Borbála/0000-0002-0197-5243; Kis, Anna/0000-0001-8728-4795	Hungarian Scientific Research Fund [K 84036, K 100695]; Hungarian Academy of Sciences [MTA 01 031]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This research was supported by the Hungarian Scientific Research Fund (K 84036, K 100695) and the Hungarian Academy of Sciences (MTA 01 031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 1997, EVOL HUM BEHAV, V18, P237, DOI 10.1016/S0162-3095(99)80001-4; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Gacsi M, 2005, DEV PSYCHOBIOL, V47, P111, DOI 10.1002/dev.20082; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Gaunet F, 2010, ANIM COGN, V13, P311, DOI 10.1007/s10071-009-0279-z; Grossmann T, 2008, P ROY SOC B-BIOL SCI, V275, P2803, DOI 10.1098/rspb.2008.0986; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Herman LM, 1999, J COMP PSYCHOL, V113, P347, DOI 10.1037/0735-7036.113.4.347; Ittyerah M, 2009, ANIM COGN, V12, P257, DOI 10.1007/s10071-008-0188-6; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; Kirchhofer KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030913; Kumashiro M, 2002, CAH PSYCHOL COGN, V21, P3; Lode T, 1999, Z SAUGETIERKD, V64, P110; Lode T, 2008, CR BIOL, V331, P248, DOI 10.1016/j.crvi.2007.12.006; Maros K, 2008, ANIM COGN, V11, P457, DOI 10.1007/s10071-008-0136-5; Miklosi A, 2005, J COMP PSYCHOL, V119, P179, DOI 10.1037/0735-7036.119.2.179; Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 2011, LEARN BEHAV, V39, P310, DOI 10.3758/s13420-011-0038-2; Mulcahy NJ, 2012, ANIM BEHAV, V83, P313, DOI 10.1016/j.anbehav.2011.11.019; Pongracz P, 2005, J COMP PSYCHOL, V119, P136, DOI 10.1037/0735-7036.119.2.136; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; Price E.O., 2002, ANIMAL DOMESTICATION; Racca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036076; Scheumann M, 2004, ANIM COGN, V7, P224, DOI 10.1007/s10071-004-0216-0; Soproni K, 2002, J COMP PSYCHOL, V116, P27, DOI 10.1037//0735-7036.116.1.27; THOMSON ALEXANDER P. D., 1951, JOUR HIST MED AND ALLIED SCI, V6, P471; Topal J, 2005, ANIM BEHAV, V70, P1367, DOI 10.1016/j.anbehav.2005.03.025; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Udell MAR, 2011, LEARN BEHAV, V39, P289, DOI 10.3758/s13420-011-0034-6; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Vinke CM, 2012, APPL ANIM BEHAV SCI, V139, P155, DOI 10.1016/j.applanim.2012.03.016; Viranyi Z, 2004, BEHAV PROCESS, V66, P161, DOI 10.1016/j.beproc.2004.01.012	36	47	47	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43267	10.1371/journal.pone.0043267	http://dx.doi.org/10.1371/journal.pone.0043267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905244	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000307823600063
J	Ferraro, L; Iani, C; Mariani, M; Nicoletti, R; Gallese, V; Rubichi, S				Ferraro, Luca; Iani, Cristina; Mariani, Michele; Nicoletti, Roberto; Gallese, Vittorio; Rubichi, Sandro			Look What I Am Doing: Does Observational Learning Take Place in Evocative Task-Sharing Situations?	PLOS ONE			English	Article							SIMON; COMPATIBILITY; RECOGNITION; INFORMATION	Two experiments were conducted to investigate whether physical and observational practice in task-sharing entail comparable implicit motor learning. To this end, the social-transfer-of-learning (SToL) effect was assessed when both participants performed the joint practice task (Experiment 1 - complete task-sharing), or when one participant observed the other performing half of the practice task (Experiment 2 - evocative task-sharing). Since the inversion of the spatial relations between responding agent and stimulus position has been shown to prevent SToL, in the present study we assessed it in both complete and evocative task-sharing conditions either when spatial relations were kept constant or changed from the practice to the transfer session. The same pattern of results was found for both complete and evocative task-sharing, thus suggesting that implicit motor learning in evocative task-sharing is equivalent to that obtained in complete task-sharing. We conclude that this motor learning originates from the simulation of the complementary (rather than the imitative) action.	[Ferraro, Luca; Iani, Cristina; Mariani, Michele; Rubichi, Sandro] Univ Modena & Reggio Emilia, Dept Commun & Econ, Emilia, Italy; [Nicoletti, Roberto] Univ Bologna, Dept Commun, Bologna, Italy; [Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy	Universita di Modena e Reggio Emilia; University of Bologna; University of Parma	Ferraro, L (corresponding author), Univ Modena & Reggio Emilia, Dept Commun & Econ, Emilia, Italy.	rubichi@unimore.it	Gallese, Vittorio/ABD-5097-2021; Iani, Cristina/D-1652-2009; Rubichi, Sandro/A-3265-2011	Gallese, Vittorio/0000-0003-4815-3607; Iani, Cristina/0000-0002-7220-6337; RUBICHI, Sandro/0000-0002-0279-3353	Italian Ministry of Education [2008ZN5J5S]	Italian Ministry of Education	This work was supported by the Italian Ministry of Education (grant number 2008ZN5J5S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura Albert, 1977, SOCIAL LEARNING THEO; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Ferraro L, 2011, EXP BRAIN RES, V211, P337, DOI 10.1007/s00221-011-2711-2; Figliozzi F, 2010, NEUROPSYCHOLOGIA, V48, P1011, DOI 10.1016/j.neuropsychologia.2009.11.025; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2011, PERSPECT PSYCHOL SCI, V6, P369, DOI 10.1177/1745691611413392; Iani C, 2011, EXP BRAIN RES, V211, P439, DOI 10.1007/s00221-011-2651-x; Iani C, 2009, CONSCIOUS COGN, V18, P856, DOI 10.1016/j.concog.2009.07.002; Iani C, 2009, MEM COGNITION, V37, P358, DOI 10.3758/MC.37.3.358; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Marini M, 2011, EXP PSYCHOL, V58, P473, DOI 10.1027/1618-3169/a000115; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Milanese N, 2011, EXP BRAIN RES, V211, P415, DOI 10.1007/s00221-011-2679-y; Milanese N, 2010, COGNITION, V116, P15, DOI 10.1016/j.cognition.2010.03.010; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Ocampo B, 2010, EXP BRAIN RES, V201, P743, DOI 10.1007/s00221-009-2089-6; Proctor R.W., 2006, STIMULUS RESPONSE CO; Proctor RW, 1999, MEM COGNITION, V27, P63, DOI 10.3758/BF03201214; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; ROGERS JL, 1993, PSYCHOL BULL, V113, P553, DOI 10.1037/0033-2909.113.3.553; Rubichi S, 2004, EUR J COGN PSYCHOL, V16, P825, DOI 10.1080/09541440340000367; Rubichi S, 2004, PERCEPT PSYCHOPHYS, V66, P255, DOI 10.3758/BF03194877; Rubichi S, 2000, PSYCHOL RES-PSYCH FO, V63, P129, DOI 10.1007/PL00008171; Rubichi S, 2006, PSYCHON B REV, V13, P201, DOI 10.3758/BF03193832; Sartori L, 2012, SOC NEUROSCI-UK, V7, P146, DOI 10.1080/17470919.2011.586579; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schneider W., 2002, E PRIME USERS GUIDE; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; SHEFFIELD FD, 1961, STUDENT RESPONSE PRO, P13, DOI DOI 10.17226/21290; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Torriero S, 2007, NEUROPSYCHOLOGIA, V45, P1208, DOI 10.1016/j.neuropsychologia.2006.10.007; Wenke D, 2011, REV PHILOS PSYCHOL, V2, P147, DOI 10.1007/s13164-011-0057-0	34	12	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43311	10.1371/journal.pone.0043311	http://dx.doi.org/10.1371/journal.pone.0043311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OQ	22905256	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500800077
J	Alves-Guerra, MC; Aheng, C; Pecqueur, C; Masscheleyn, S; Tharaux, PL; Druilhe, A; Ricquier, D; Challet, E; Miroux, B				Alves-Guerra, Marie-Clotilde; Aheng, Caroline; Pecqueur, Claire; Masscheleyn, Sandrine; Tharaux, Pierre Louis; Druilhe, Anne; Ricquier, Daniel; Challet, Etienne; Miroux, Bruno			Analysis of Uncoupling Protein 2-Deficient Mice upon Anaesthesia and Sedation Revealed a Role for UCP2 in Locomotion	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; OXIDATIVE STRESS; BROWN ADIPOCYTES; EXPRESSION; OBESITY; DYSFUNCTION; SECRETION; SURVIVAL; CELLS; MODEL	General anaesthesia is associated with hypothermia, oxidative stress, and immune depression. Uncoupling Protein (UCP2) is a member of the mitochondrial carrier family present in many organs including the spleen, the lung and the brain. A role of UCP2 in the activation of the inflammatory/immune cells, in the secretion of hormones, and in the excitability of neurons by regulating the production of reactive oxygen species has been discussed. Because of the side effects of anaesthesia listed above, we aimed to question the expression and the function of UCP2 during anaesthesia. Induction of anaesthesia with ketamine (20 mg/kg) or isoflurane (3.6%) and induction of sedation with the alpha 2 adrenergic receptor agonist medetomidine (0.2 mg/kg) stimulated infiltration of immune cells in the lung and increased UCP2 protein content in the lung, in both immune and non-immune cells. UCP2 content in the lung inversely correlated with body temperature decrease induced by medetomidine treatment. Challenge of the Ucp2(-/-) mice with isoflurane and medetomidine revealed an earlier behavioral recovery phenotype. Transponder analysis of body temperature and activity showed no difference between Ucp2(-/-) and control mice in basal conditions. However, upon an acute decrease of body temperature induced by medetomidine, Ucp2(-/-) mice exhibited increased locomotion activity. Together, these results show that UCP2 is rapidly mobilized during anaesthesia and sedation in immune cells, and suggest a role of UCP2 in locomotion.	[Alves-Guerra, Marie-Clotilde; Aheng, Caroline; Pecqueur, Claire; Ricquier, Daniel] Inst Cochin, CNRS, UMR8104, INSERM,U1016, Paris, France; [Alves-Guerra, Marie-Clotilde; Aheng, Caroline; Pecqueur, Claire; Tharaux, Pierre Louis; Druilhe, Anne; Ricquier, Daniel] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Masscheleyn, Sandrine; Miroux, Bruno] IBPC, CNRS, UMR7099, Lab Biol Physicochim Prot Membranaires, Paris, France; [Masscheleyn, Sandrine; Miroux, Bruno] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Tharaux, Pierre Louis] Paris Ctr Rech Cardiovasc, INSERM, U970, Paris, France; [Druilhe, Anne] Ctr Rech Croissance & Signalisat, INSERM, U845, Paris, France; [Challet, Etienne] Inst Neurosci Cellulaires & Integrat, CNRS, UPR3212, Dept Neurobiol Rythmes, Strasbourg, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Alves-Guerra, MC (corresponding author), Inst Cochin, CNRS, UMR8104, INSERM,U1016, Paris, France.	bruno.miroux@ibpc.fr	Pecqueur, Claire/L-3073-2015; Alves-Guerra, Marie-Clotilde/P-4356-2017; Druilhe, Anne/T-1296-2019; Challet, Etienne/ABF-7553-2020; Druilhe, Anne/O-8684-2016; Miroux, Bruno/E-9267-2017; Tharaux, Pierre-Louis/A-9155-2009	Pecqueur, Claire/0000-0002-7612-1672; Alves-Guerra, Marie-Clotilde/0000-0002-7918-1216; Druilhe, Anne/0000-0003-0064-110X; Challet, Etienne/0000-0001-9416-9496; Druilhe, Anne/0000-0003-3024-5001; Tharaux, Pierre-Louis/0000-0002-6062-5905; Miroux, Bruno/0000-0002-3066-4700	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [05-JCJC-0092-01]; Institut de Recherche Servier; European Community [LSHM-CT-2003-503041]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut de Recherche Servier; European Community(European Commission)	This work was supported by the Centre National de la Recherche Scientifique, the Agence Nationale de la Recherche (grant #05-JCJC-0092-01 to BM), the Institut de Recherche Servier (to DR), and the European Community (grant FP6 No LSHM-CT-2003-503041 to DR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaouchiche B, 2001, ANESTH ANALG, V93, P981, DOI 10.1097/00000539-200110000-00036; Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Alves-Guerra MC, SIGNALLING CELL ADAP, P257; Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Delogu G, 2001, ARCH SURG-CHICAGO, V136, P1190, DOI 10.1001/archsurg.136.10.1190; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gnanalingham MG, 2006, J ENDOCRINOL, V188, P375, DOI 10.1677/joe.1.06530; Grasshoff C, 2006, CURR PHARM DESIGN, V12, P3665, DOI 10.2174/138161206778522038; Hurtaud C, 2007, CELL MOL LIFE SCI, V64, P1853, DOI 10.1007/s00018-007-7039-5; Irifune M, 1997, ANESTHESIOLOGY, V86, P464, DOI 10.1097/00000542-199702000-00022; Juttler E, 2007, J NEUROIMMUNOL, V189, P41, DOI 10.1016/j.jneuroim.2007.06.020; KOTANI N, 1995, ANESTH ANALG, V81, P1255, DOI 10.1097/00000539-199512000-00023; Lahdesmaki J, 2003, NEUROPHARMACOLOGY, V44, P882, DOI 10.1016/S0028-3908(03)00080-7; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Ohlson KBE, 2004, BIOCHEM PHARMACOL, V68, P463, DOI 10.1016/j.bcp.2004.03.028; OHLSON KBE, 1994, ANESTHESIOLOGY, V81, P176, DOI 10.1097/00000542-199407000-00024; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Richard D, 1999, INT J OBESITY, V23, pS53, DOI 10.1038/sj.ijo.0800947; Rousset S, 2007, FEBS LETT, V581, P479, DOI 10.1016/j.febslet.2007.01.010; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Walder K, 1998, HUM MOL GENET, V7, P1431, DOI 10.1093/hmg/7.9.1431; Yamada S, 2003, J NEUROCHEM, V87, P461, DOI 10.1046/j.1471-4159.2003.02005.x; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	29	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41846	10.1371/journal.pone.0041846	http://dx.doi.org/10.1371/journal.pone.0041846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900002	Green Published, gold			2022-12-27	WOS:000307380900017
J	Herrmann, L; Ionescu, IA; Henes, K; Golub, Y; Wang, NXR; Buell, DR; Holsboer, F; Wotjak, CT; Schmidt, U				Herrmann, Leonie; Ionescu, Irina A.; Henes, Kathrin; Golub, Yulia; Wang, Nancy Xin Ru; Buell, Dominik R.; Holsboer, Florian; Wotjak, Carsten T.; Schmidt, Ulrike			Long-Lasting Hippocampal Synaptic Protein Loss in a Mouse Model of Posttraumatic Stress Disorder	PLOS ONE			English	Article							SYNAPSIN-I; PREFRONTAL CORTEX; RAT HIPPOCAMPUS; GENE-EXPRESSION; MESSENGER-RNA; DEPRESSION; BRAIN; MARKERS; VOLUME; SCHIZOPHRENIA	Despite intensive research efforts, the molecular pathogenesis of posttraumatic stress disorder (PTSD) and especially of the hippocampal volume loss found in the majority of patients suffering from this anxiety disease still remains elusive. We demonstrated before that trauma-induced hippocampal shrinkage can also be observed in mice exhibiting a PTSD-like syndrome. Aiming to decipher the molecular correlates of these trans-species posttraumatic hippocampal alterations, we compared the expression levels of a set of neurostructural marker proteins between traumatized and control mice at different time points after their subjection to either an electric footshock or mock treatment which was followed by stressful re-exposure in several experimental groups. To our knowledge, this is the first systematic in vivo study analyzing the long-term neuromolecular sequelae of acute traumatic stress combined with re-exposure. We show here that a PTSD-like syndrome in mice is accompanied by a long-lasting reduction of hippocampal synaptic proteins which interestingly correlates with the strength of the generalized and conditioned fear response but not with the intensity of hyperarousal symptoms. Furthermore, we demonstrate that treatment with the serotonin reuptake inhibitor (SSRI) fluoxetine is able to counteract both the PTSD-like syndrome and the posttraumatic synaptic protein loss. Taken together, this study demonstrates for the first time that a loss of hippocampal synaptic proteins is associated with a PTSD-like syndrome in mice. Further studies will have to reveal whether these findings are transferable to PTSD patients.	[Herrmann, Leonie; Ionescu, Irina A.; Henes, Kathrin; Golub, Yulia; Wang, Nancy Xin Ru; Buell, Dominik R.; Holsboer, Florian; Wotjak, Carsten T.; Schmidt, Ulrike] Max Planck Inst Psychiat, Munich, Germany; [Golub, Yulia] Univ Clin Erlangen, Dept Child & Adolescent Mental Hlth, Erlangen, Germany	Max Planck Society; University of Erlangen Nuremberg	Herrmann, L (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	uschmidt@mpipsykl.mpg.de	Wotjak, Carsten T./S-3200-2019; Golub, Yulia/AHC-3528-2022		private Horst Kubler foundation, Bad Ragaz	private Horst Kubler foundation, Bad Ragaz	Part of the study (consumables) was funded by the private Horst Kubler foundation, Bad Ragaz. The Horst Kubler foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alfonso J, 2006, BIOL PSYCHIAT, V59, P244, DOI 10.1016/j.biopsych.2005.06.036; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Ary AW, 2007, SYNAPSE, V61, P938, DOI 10.1002/syn.20439; Beasley CL, 2005, BIPOLAR DISORD, V7, P449, DOI 10.1111/j.1399-5618.2005.00239.x; Bowirrat A, 2010, CURR NEUROPHARMACOL, V8, P335, DOI 10.2174/157015910793358123; Briones A, 2012, BRIT J PHARMACOL, V165, P897, DOI 10.1111/j.1476-5381.2011.01602.x; Chang YC, 2006, NEUROBIOL DIS, V24, P101, DOI 10.1016/j.nbd.2006.06.001; Chen Q, 2004, AM J HUM GENET, V75, P873, DOI 10.1086/425588; Cole J, 2011, J AFFECT DISORDERS, V134, P483, DOI 10.1016/j.jad.2011.05.057; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; Czeh B, 2007, EUR ARCH PSY CLIN N, V257, P250, DOI 10.1007/s00406-007-0728-0; Dagyte G, 2011, J NEUROSCI RES, V89, P1646, DOI 10.1002/jnr.22697; DeCarolis NA, 2010, NEUROPHARMACOLOGY, V58, P884, DOI 10.1016/j.neuropharm.2009.12.013; Diehl LA, 2012, NEUROCHEM RES, V37, P700, DOI 10.1007/s11064-011-0660-6; Elizalde N, 2010, J NEUROCHEM, V114, P1302, DOI 10.1111/j.1471-4159.2010.06854.x; Fasani F, 2004, J CELL SCI, V117, P861, DOI 10.1242/jcs.00940; Felmingham K, 2009, NEUROREPORT, V20, P1402, DOI 10.1097/WNR.0b013e3283300fbc; Foa EB, 1997, ANNU REV PSYCHOL, V48, P449, DOI 10.1146/annurev.psych.48.1.449; Gamo NJ, 2011, BEHAV NEUROSCI, V125, P282, DOI 10.1037/a0023165; Gao Y, 2006, NEUROSCIENCE, V141, P1139, DOI 10.1016/j.neuroscience.2006.04.066; Garcia-Caceres C, 2010, PSYCHONEUROENDOCRINO, V35, P1525, DOI 10.1016/j.psyneuen.2010.05.006; Geske FJ, 2001, CELL DEATH DIFFER, V8, P182, DOI 10.1038/sj.cdd.4400786; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Golub Y, 2011, J PSYCHIATR RES, V45, P650, DOI 10.1016/j.jpsychires.2010.10.014; Grillo CA, 2005, NEUROSCIENCE, V136, P477, DOI 10.1016/j.neuroscience.2005.08.019; Guest KA, 2010, SCHIZOPHR RES, V120, P229, DOI 10.1016/j.schres.2010.03.029; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI 10.1586/ERN.10.198; Ionescu IA, 2012, NEUROPSYCHOPHARMACOL; Larsen MH, 2008, EUR J PHARMACOL, V578, P114, DOI 10.1016/j.ejphar.2007.08.050; Law AJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1381, DOI 10.1038/npp.2008.106; Liu W, 2011, PSYCHIAT RES-NEUROIM, V194, P385, DOI 10.1016/j.pscychresns.2011.02.007; Llorente R, 2011, J NEUROENDOCRINOL, V23, P329, DOI 10.1111/j.1365-2826.2011.02109.x; Lui CC, 2011, NEUROCHEM INT, V58, P434, DOI 10.1016/j.neuint.2011.01.002; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Martenyi F, 2006, EUR NEUROPSYCHOPHARM, V16, P340, DOI 10.1016/j.euroneuro.2005.10.007; Matrisciano F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016447; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mehta D, 2012, NEUROPHARMACOLOGY, V62, P654, DOI 10.1016/j.neuropharm.2011.03.009; MELLONI RH, 1993, J COMP NEUROL, V327, P507, DOI 10.1002/cne.903270404; MOBLEY P, 1985, P NATL ACAD SCI USA, V82, P945, DOI 10.1073/pnas.82.3.945; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nowicka D, 2003, ACTA NEUROBIOL EXP, V63, P185; Pamplona FA, 2011, J PSYCHIATR RES, V45, P354, DOI 10.1016/j.jpsychires.2010.06.015; Pitman RK, 2006, ANN NY ACAD SCI, V1071, P242, DOI 10.1196/annals.1364.019; Qi C, 2010, GENES BRAIN BEHAV, V9, P974, DOI 10.1111/j.1601-183X.2010.00636.x; Rapp S, 2004, PHARMACOGENOMICS J, V4, P110, DOI 10.1038/sj.tpj.6500229; Reines A, 2008, NEUROPSYCHOPHARMACOL, V33, P1896, DOI 10.1038/sj.npp.1301596; Revest JM, 2010, MOL PSYCHIATR, V15, P1140, DOI 10.1038/mp.2010.40; Sananbenesi F, 2007, NAT NEUROSCI, V10, P1012, DOI 10.1038/nn1943; Schmidt U, 2011, DIS MARKERS, V30, P77, DOI [10.1155/2011/343616, 10.3233/DMA-2011-0749]; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; SIEGEL SJ, 1993, BRAIN RES, V619, P299, DOI 10.1016/0006-8993(93)91624-2; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Sterlemann V, 2010, HIPPOCAMPUS, V20, P540, DOI 10.1002/hipo.20655; Thome J, 2001, BIOL PSYCHIAT, V50, P809, DOI 10.1016/S0006-3223(01)01229-X; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Wu LM, 2007, NEUROPSYCHOPHARMACOL, V32, P2500, DOI 10.1038/sj.npp.1301386; Yan J, 2010, BRAIN RES, V1347, P132, DOI 10.1016/j.brainres.2010.05.074; Yang C, 2009, BEHAV BRAIN RES, V205, P518, DOI 10.1016/j.bbr.2009.08.008; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Zink M, 2010, NEUROPHARMACOLOGY, V58, P465, DOI 10.1016/j.neuropharm.2009.09.005	65	38	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42603	10.1371/journal.pone.0042603	http://dx.doi.org/10.1371/journal.pone.0042603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900032	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900048
J	Zach, GJ; Peneder, S; Strodl, MA; Schausberger, P				Zach, Gernot J.; Peneder, Stefan; Strodl, Markus A.; Schausberger, Peter			Social Familiarity Governs Prey Patch-Exploitation, - Leaving and Inter-Patch Distribution of the Group-Living Predatory Mite Phytoseiulus persimilis	PLOS ONE			English	Article							PRIOR ASSOCIATION; KIN RECOGNITION; ADULT FEMALES; DISPERSAL; CONSEQUENCES; BEHAVIOR; ACARI; CANNIBALISM; COMPETITION; TETRANYCHIDAE	Background: In group-living animals, social interactions and their effects on other life activities such as foraging are commonly determined by discrimination among group members. Accordingly, many group-living species evolved sophisticated social recognition abilities such as the ability to recognize familiar individuals, i.e. individuals encountered before. Social familiarity may affect within-group interactions and between-group movements. In environments with patchily distributed prey, group-living predators must repeatedly decide whether to stay with the group in a given prey patch or to leave and search for new prey patches and groups. Methodology/Principal Findings: Based on the assumption that in group-living animals social familiarity allows to optimize the performance in other tasks, as for example predicted by limited attention theory, we assessed the influence of social familiarity on prey patch exploitation, patch-leaving, and inter-patch distribution of the group-living, plant-inhabiting predatory mite Phytoseiulus persimilis. P. persimilis is highly specialized on herbivorous spider mite prey such as the two-spotted spider mite Tetranychus urticae, which is patchily distributed on its host plants. We conducted two experiments with (1) groups of juvenile P. persimilis under limited food on interconnected detached leaflets, and (2) groups of adult P. persimilis females under limited food on whole plants. Familiar individuals of both juvenile and adult predator groups were more exploratory and dispersed earlier from a given spider mite patch, occupied more leaves and depleted prey more quickly than individuals of unfamiliar groups. Moreover, familiar juvenile predators had higher survival chances than unfamiliar juveniles. Conclusions/Significance: We argue that patch-exploitation and -leaving, and inter-patch dispersion were more favorably coordinated in groups of familiar than unfamiliar predators, alleviating intraspecific competition and improving prey utilization and suppression.	[Zach, Gernot J.; Peneder, Stefan; Strodl, Markus A.; Schausberger, Peter] Univ Nat Resources & Life Sci, Grp Arthropod Ecol & Behav, Div Plant Protect, Dept Crop Sci, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Zach, GJ (corresponding author), Univ Nat Resources & Life Sci, Grp Arthropod Ecol & Behav, Div Plant Protect, Dept Crop Sci, Vienna, Austria.	peter.schausberger@boku.ac.at		Schausberger, Peter/0000-0002-1529-3198	Austrian Science Fund (FWF) [P20743-B17]; Austrian Science Fund (FWF) [P 20743] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financially supported by the Austrian Science Fund (FWF): P20743-B17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELETSKY LD, 1989, P NATL ACAD SCI USA, V86, P7933, DOI 10.1073/pnas.86.20.7933; Bhat A, 2006, J FISH BIOL, V68, P759, DOI 10.1111/j.1095-8649.2006.00963.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chittenden AR, 2001, J ETHOL, V19, P55, DOI 10.1007/s101640170018; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; CRISTOL DA, 1995, ANIM BEHAV, V50, P151, DOI 10.1006/anbe.1995.0228; Dugatkin LA, 1997, BIOSCIENCE, V47, P355, DOI 10.2307/1313150; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; FELS D, 1995, BEHAVIOUR, V132, P49, DOI 10.1163/156853995X00270; FRETWELL S D, 1972, P217; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Giraldeau Luc-Alain, 2008, P233; GODFRAY HCJ, 1988, NATURE, V331, P211, DOI 10.1038/331211a0; Gompper ME, 1996, BEHAV ECOL, V7, P254, DOI 10.1093/beheco/7.3.254; GRIGOR PN, 1995, APPL ANIM BEHAV SCI, V45, P97, DOI 10.1016/0168-1591(95)00596-K; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Hojesjo J, 1998, BEHAV ECOL, V9, P445, DOI 10.1093/beheco/9.5.445; HOOGLAND JL, 1979, BEHAVIOUR, V69, P1, DOI 10.1163/156853979X00377; Jones RB, 2002, ANIM BEHAV, V63, P659, DOI 10.1006/anbe.2001.1943; KACELNIK A, 1992, TRENDS ECOL EVOL, V7, P50, DOI 10.1016/0169-5347(92)90106-L; KATZIR G, 1982, BEHAVIOUR, V81, P231, DOI 10.1163/156853982X00157; Koenig A, 2002, INT J PRIMATOL, V23, P759, DOI 10.1023/A:1015524931226; Krause J, 2002, LIVING GROUPS; KREBS JR, 1974, ANIM BEHAV, V22, P953, DOI 10.1016/0003-3472(74)90018-9; LAWRENCE WS, 1987, BEHAV ECOL SOCIOBIOL, V21, P367, DOI 10.1007/BF00299931; Lena JP, 1998, BEHAV ECOL, V9, P500, DOI 10.1093/beheco/9.5.500; Liebgold EB, 2011, ANIM BEHAV, V82, P1059, DOI 10.1016/j.anbehav.2011.07.041; LINDSTROM A, 1989, AUK, V106, P225; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Madden JR, 2011, BEHAV ECOL SOCIOBIOL, V65, P1857, DOI 10.1007/s00265-011-1194-2; Mateo JM, 2009, ANIM BEHAV, V77, P115, DOI 10.1016/j.anbehav.2008.09.015; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; Mayland H, 2000, ENTOMOL EXP APPL, V96, P245, DOI 10.1023/A:1004047722647; Milinski M, 1990, BEHAV ECOL, V1, P7, DOI 10.1093/beheco/1.1.7; Mitteldorf J, 2000, J THEOR BIOL, V204, P481, DOI 10.1006/jtbi.2000.2007; NAGELKERKE CJ, 1994, AM NAT, V144, P262, DOI 10.1086/285674; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Patriquin KJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P899, DOI 10.1007/s00265-010-0905-4; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Ranta Esa, 1994, Ecoscience, V1, P99; Sabelis M.W., 1985, P141; Schausberger P, 1997, EXP APPL ACAROL, V21, P131, DOI 10.1023/A:1018478418010; Schausberger P, 2005, BEHAV ECOL SOCIOBIOL, V58, P53, DOI 10.1007/s00265-004-0898-y; Schausberger P, 2004, ANIM BEHAV, V67, P1031, DOI 10.1016/j.anbehav.2003.10.006; Schausberger P, 2003, EXP APPL ACAROL, V29, P173, DOI 10.1023/A:1025839206394; Schausberger P, 2001, ANIM BEHAV, V61, P459, DOI 10.1006/anbe.2000.1611; Schausberger P, 2007, BEHAV ECOL SOCIOBIOL, V62, P119, DOI 10.1007/s00265-007-0444-9; Seppa T, 2001, CAN J FISH AQUAT SCI, V58, P1380, DOI 10.1139/cjfas-58-7-1380; Sibly RM, 2007, ECOL LETT, V10, P970, DOI 10.1111/j.1461-0248.2007.01092.x; Slavik O, 2011, AQUACULTURE, V313, P73, DOI 10.1016/j.aquaculture.2011.01.002; Stephens D.W., 1986, pi; Strodl MA, 2012, NATURWISSENSCHAFTEN, V99, P303, DOI 10.1007/s00114-012-0903-7; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Utne-Palm AC, 2000, OIKOS, V91, P225, DOI 10.1034/j.1600-0706.2000.910203.x; Vanas V, 2006, EXP APPL ACAROL, V39, P1, DOI 10.1007/s10493-006-0024-0; vanBaalen M, 1995, OIKOS, V74, P391, DOI 10.2307/3545984; Walzer A, 2006, J INSECT BEHAV, V19, P305, DOI 10.1007/s10905-006-9025-4; Walzer A, 2011, BIOL J LINN SOC, V102, P650, DOI 10.1111/j.1095-8312.2010.01593.x; Webster MM, 2007, ANIM BEHAV, V74, P253, DOI 10.1016/j.anbehav.2006.07.021; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; Zemek R, 1998, EXP APPL ACAROL, V22, P259, DOI 10.1023/A:1006022500205; ZHANG ZQ, 1992, ENVIRON ENTOMOL, V21, P799, DOI 10.1093/ee/21.4.799	69	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42889	10.1371/journal.pone.0042889	http://dx.doi.org/10.1371/journal.pone.0042889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900062	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900080
J	Qiao, T; Ma, RH; Luo, XB; Luo, ZL; Zheng, PM				Qiao, Tie; Ma, Rui-hong; Luo, Xiao-bing; Luo, Zhen-liang; Zheng, Pei-ming			Cholecystolithiasis Is Associated with Clonorchis sinensis Infection	PLOS ONE			English	Article							OPISTHORCHIS-VIVERRINI INFECTION; GALLSTONE; CHOLESTEROL; BILE; PREVALENCE; DISEASE; INTENSITY; COMMUNITY; RISK	Background: The objective of this study was to analyze gallbladder stones for direct evidence of a relationship between Clonorchis sinensis infection and gallbladder stones formation. Methodology: We investigated one hundred eighty-three gallbladder stones for the presence of Clonorchis sinensis eggs using microscopy, and analyzed their composition using Fourier transform infrared spectroscopy. We confirmed the presence of Clonorchis sinensis eggs in the gallbladder stones using real-time fluorescent PCR and scanning electron microscopy. Principal Findings: Clonorchis sinensis eggs were detected in 122 of 183 gallbladder stones based on morphologic characteristics and results from real-time fluorescent PCR. The proportion of pigment stones, cholesterol stones and mixed gallstones in the egg-positive stones was 79.5% (97/122), 3.3% (4/122) and 17.2% (21/122), respectively, while 29.5% (18/61), 31.1% (19/61) and 39.3% (24/61) in the egg-negative stones. The proportion of pigment stone in the Clonorchis sinensis egg-positive stones was higher than in egg-negative stones (P < 0.0001). In the 30 egg-positive stones examined by scanning electron microscopy, dozens or even hundreds of Clonorchis sinensis eggs were visible (x400) showing a distinct morphology. Many eggs were wrapped with surrounding particles, and in some, muskmelon wrinkles was seen on the surface of the eggs. Also visible were pieces of texture shed from some of the eggs. Some eggs were depressed or without operculum while most eggs were adhered to or wrapped with amorphous particles or mucoid matter (x3000). Conclusion: Clonorchis sinensis eggs were detected in the gallbladder stones which suggests an association between Clonorchis sinensis infection and gallbladder stones formation, especially pigment stones.	[Qiao, Tie; Ma, Rui-hong; Luo, Xiao-bing; Luo, Zhen-liang; Zheng, Pei-ming] Inst Gallbladder Dis Panyu, Lab Gallbladder Dis, Guangzhou, Guangdong, Peoples R China; [Qiao, Tie; Ma, Rui-hong; Luo, Xiao-bing; Luo, Zhen-liang; Zheng, Pei-ming] Second Peoples Hosp Panyu, Lab Gallbladder Dis, Guangzhou, Guangdong, Peoples R China		Qiao, T (corresponding author), Inst Gallbladder Dis Panyu, Lab Gallbladder Dis, Guangzhou, Guangdong, Peoples R China.	fqj1958@163.com						ABDUSSALAM M, 1995, WHO TECH REP SER, V849, P1; AKERLUND JE, 1991, GASTROENTEROLOGY, V100, P1046, DOI 10.1016/0016-5085(91)90281-O; Chen ZuZe, 1997, Chinese Journal of Parasitic Disease Control, V10, P31; Choi D, 2008, J GASTROEN HEPATOL, V23, pE399, DOI 10.1111/j.1440-1746.2007.05242.x; Coordinating Office of the National Survey on the Important Human Parasitic Diseases, 2005, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V23, P332; Djessou PS, 2010, ANN BIOL CLIN-PARIS, V68, P39; EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501; Fang YueYi, 2008, Chinese Journal of Parasitology and Parasitic Diseases, V26, P99; FLAVELL DJ, 1981, T ROY SOC TROP MED H, V75, P814, DOI 10.1016/0035-9203(81)90419-3; HARINASUTA T, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1167; HOU MF, 1989, J TROP MED HYG, V92, P108; Jang Ji Sun, 2007, Korean Journal of Parasitology, V45, P301, DOI 10.3347/kjp.2007.45.4.301; JONGSUKSUNTIGUL P, 1996, J TROP MED PARASITOL, V19, P24; Joo KR, 2005, YONSEI MED J, V46, P794, DOI 10.3349/ymj.2005.46.6.794; Kaewpitoon N, 2008, WORLD J GASTROENTERO, V14, P2297, DOI 10.3748/wjg.14.2297; Kim HG, 2009, WORLD J GASTROENTERO, V15, P86, DOI 10.3748/wjg.15.86; Kratzer W, 1999, J CLIN ULTRASOUND, V27, P1, DOI 10.1002/(SICI)1097-0096(199901)27:1<1::AID-JCU1>3.0.CO;2-H; Lee Soo-Ung, 2004, Korean Journal of Parasitology, V42, P145, DOI 10.3347/kjp.2004.42.3.145; Li XM, 2011, SE ASIAN J TROP MED, V42, P248; LIM JH, 1990, AM J ROENTGENOL, V155, P1001, DOI 10.2214/ajr.155.5.2120925; LIM JH, 1991, AM J ROENTGENOL, V157, P1; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Mairiang E, 2003, ACTA TROP, V88, P221, DOI 10.1016/j.actatropica.2003.03.001; McManus DP, 2004, INT J PARASITOL, V34, P153, DOI 10.1016/j.ijpara.2003.11.003; Pae WK, 1968, J KOREAN SURG SOC, V10, P377; Park GM, 2007, PARASITOL RES, V100, P351, DOI 10.1007/s00436-006-0269-x; Pereira SP, 2003, ALIMENT PHARM THER, V17, P923, DOI 10.1046/j.1365-2036.2003.01529.x; Rahman SMM, 2011, PARASITOL RES, V109, P297, DOI 10.1007/s00436-011-2253-3; Rana Surinder Singh, 2007, Curr Gastroenterol Rep, V9, P156, DOI 10.1007/s11894-007-0011-6; Rim Han-Jong, 1996, Korean Journal of Parasitology, V34, P7, DOI 10.3347/kjp.1996.34.1.7; Rim HJ, 2005, J HELMINTHOL, V79, P269, DOI 10.1079/JOH2005300; Schirmer Bruce D, 2005, J Long Term Eff Med Implants, V15, P329, DOI 10.1615/JLongTermEffMedImplants.v15.i3.90; Shi JS, 2001, WORLD J GASTROENTERO, V7, P593; Shin HR, 1996, INT J EPIDEMIOL, V25, P933, DOI 10.1093/ije/25.5.933; Stewart L, 2006, AM J SURG, V192, P598, DOI 10.1016/j.amjsurg.2006.08.001; Stolk MFJ, 2001, DIGEST DIS SCI, V46, P1328, DOI 10.1023/A:1010635901414; STOLK MFJ, 1995, GASTROENTEROLOGY, V108, P1882, DOI 10.1016/0016-5085(95)90153-1; UPATHAM ES, 1984, B WORLD HEALTH ORGAN, V62, P451; UPATHAM ES, 1982, AM J TROP MED HYG, V31, P1156, DOI 10.4269/ajtmh.1982.31.1156; Volzke H, 2005, DIGESTION, V71, P97, DOI 10.1159/000084525; WETTER LA, 1994, LANCET, V343, P444, DOI 10.1016/S0140-6736(94)92691-3; Wu JP, 2000, HUANG JIASI SURG, P1226; Xie Qiong-Jun, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P106; Yoo EH, 2008, CLIN CHEM LAB MED, V46, P376, DOI 10.1515/CCLM.2008.074	44	32	46	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42471	10.1371/journal.pone.0042471	http://dx.doi.org/10.1371/journal.pone.0042471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905137	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100041
J	Rosenthal, DT; Zhang, J; Bao, LW; Zhu, L; Wu, ZF; Toy, K; Kleer, CG; Merajver, SD				Rosenthal, Devin T.; Zhang, Jie; Bao, Liwei; Zhu, Lian; Wu, Zhifen; Toy, Kathy; Kleer, Celina G.; Merajver, Sofia D.			RhoC Impacts the Metastatic Potential and Abundance of Breast Cancer Stem Cells	PLOS ONE			English	Article							ACTIN STRESS FIBERS; PROSPECTIVE IDENTIFICATION; ALDEHYDE DEHYDROGENASE; BINDING PROTEIN; GTPASE; GROWTH; CORRELATE	Cancer stem cells (CSCs) have been shown to promote tumorigenesis of many tumor types, including breast, although their relevance to cancer metastasis remains unclear. While subpopulations of CSCs required for metastasis have been identified, to date there are no known molecular regulators of breast CSC (BCSC) metastasis. Here we identify RhoC GTPase as an important regulator of BCSC metastasis, and present evidence suggesting that RhoC also modulates the frequency of BCSCs within a population. Using an orthotopic xenograft model of spontaneous metastasis we discover that RhoC is both necessary and sufficient to promote SUM149 and MCF-10A BCSC metastasis-often independent from primary tumor formation-and can even induce metastasis of non-BCSCs within these cell lines. The relationship between RhoC and BCSCs persists in breast cancer patients, as expression of RhoC and the BCSC marker ALDH1 are highly correlated in clinical specimens. These results suggest new avenues to combating the deadliest cells driving the most lethal stage of breast cancer progression.	[Rosenthal, Devin T.; Kleer, Celina G.; Merajver, Sofia D.] Univ Michigan, Mol & Cellular Biol Program, Ann Arbor, MI 48109 USA; [Toy, Kathy; Kleer, Celina G.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Kleer, Celina G.; Merajver, Sofia D.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Rosenthal, Devin T.; Zhang, Jie; Bao, Liwei; Zhu, Lian; Wu, Zhifen; Merajver, Sofia D.] Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rosenthal, DT (corresponding author), Tufts Univ, Dept Anat, Boston, MA 02111 USA.	smerajve@med.umich.edu			Department of Defense Breast Cancer Research Program through a Predoctoral Traineeship award [BC083262]; NIH Cellular and Molecular Biology Training Grant [T32-GM07315]; Burroughs Wellcome Fund; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA107469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program through a Predoctoral Traineeship award(United States Department of Defense); NIH Cellular and Molecular Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Department of Defense Breast Cancer Research Program through a Predoctoral Traineeship award (BC083262) (D. T. R.), an NIH Cellular and Molecular Biology Training Grant (T32-GM07315) (D. T. R.), the Burroughs Wellcome Fund (S. D. M.), and the Breast Cancer Research Foundation (S. D. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dietrich KA, 2009, BIOL CHEM, V390, P1063, DOI 10.1515/BC.2009.110; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Ikoma T, 2004, CLIN CANCER RES, V10, P1192, DOI 10.1158/1078-0432.CCR-03-0275; Islam M, 2009, MOL CANCER RES, V7, P1771, DOI 10.1158/1541-7786.MCR-08-0512; JONES RJ, 1995, BLOOD, V85, P2742, DOI 10.1182/blood.V85.10.2742.bloodjournal85102742; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nocito A, 2001, INT J CANCER, V94, P1, DOI 10.1002/ijc.1385; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pavlidis N, 2012, LANCET; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rosenthal DT, 2010, RHO GTPASES IN CANCER, P29, DOI 10.1007/978-1-4419-1111-7_2; Singh SK, 2003, CANCER RES, V63, P5821; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; van Golen KL, 2000, CANCER RES, V60, P5832; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012	33	56	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40979	10.1371/journal.pone.0040979	http://dx.doi.org/10.1371/journal.pone.0040979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911725	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700031
J	Holland, J; Silva, AS; Mace, R				Holland, Jo; Silva, Antonio S.; Mace, Ruth			Lost Letter Measure of Variation in Altruistic Behaviour in 20 Neighbourhoods	PLOS ONE			English	Article							CONTEXT	Altruistic behaviour varies across human populations and this variation is likely to be partly explained by variation in the ecological context of the populations. We hypothesise that area level socio-economic characteristics will determine the levels of altruism found in individuals living in an area and we use a lost letter experiment to measure altruism across 20 neighbourhoods with a wide range of income deprivation scores in London, UK. The results show a strong negative effect of neighbourhood income deprivation on altruistic behaviour, with letters dropped in the poorest neighbourhoods having 91% lower odds of being returned than letters dropped in the wealthiest neighbourhoods. We suggest that measures of altruism are strongly context dependant.	[Holland, Jo; Silva, Antonio S.; Mace, Ruth] UCL, Dept Anthropol, London, England	University of London; University College London	Holland, J (corresponding author), UCL, Dept Anthropol, London, England.	antonio.silva.09@ucl.ac.uk		Mace, Ruth/0000-0002-6137-7739	European Research Council; Fundacao para a Ciencia e a Tecnologia	European Research Council(European Research Council (ERC)European Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	RM was funded by the European Research Council and ASS was funded by the Fundacao para a Ciencia e a Tecnologia. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M, 2011, SCIENCE, V334, P1392, DOI 10.1126/science.1202599; BETZIG LL, 1986, CURR ANTHROPOL, V27, P397, DOI 10.1086/203457; Bornstein G, 2003, PERS SOC PSYCHOL REV, V7, P129, DOI 10.1207/S15327957PSPR0702_129-145; DCLG (Department for Communities and Local Government), 2010, ENGL IND DEPR 2010; Gintis H., 2005, MORAL SENTIMENTS MAT, P3; Laurence J., 2008, PREDICTORS COMMUNITY; Lynam DR, 2000, J ABNORM PSYCHOL, V109, P563, DOI 10.1037//0021-843X.109.4.563; MILGRAM S, 1965, PUBLIC OPIN QUART, V29, P437, DOI 10.1086/267344; Nettle D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026922; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; ONS, 2011, SUP OUTP AR SOAS; Piff PK, 2012, P NATL ACAD SCI USA, P1; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; SHOTLAND RL, 1970, PUBLIC OPIN QUART, V34, P278, DOI 10.1086/267799; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; VOA, 2010, COUNC TAX VAL LIST; Wilson DS, 2009, EVOL HUM BEHAV, V30, P190, DOI 10.1016/j.evolhumbehav.2008.12.002	17	56	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43294	10.1371/journal.pone.0043294	http://dx.doi.org/10.1371/journal.pone.0043294			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AG	22905250	gold, Green Submitted, Green Published			2022-12-27	WOS:000307823600066
J	Bermudez-Brito, M; Munoz-Quezada, S; Gomez-Llorente, C; Matencio, E; Bernal, MJ; Romero, F; Gil, A				Bermudez-Brito, Miriam; Munoz-Quezada, Sergio; Gomez-Llorente, Carolina; Matencio, Esther; Bernal, Maria J.; Romero, Fernando; Gil, Angel			Human Intestinal Dendritic Cells Decrease Cytokine Release against Salmonella Infection in the Presence of Lactobacillus paracasei upon TLR Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSE; REGULATORY T-CELLS; PROBIOTIC STRAINS; EPITHELIAL-CELLS; CACO-2 CELLS; KAPPA-B; EXPRESSION; GUT; INFLAMMATION	Probiotic bacteria have been shown to modulate immune responses and could have therapeutic effects in allergic and inflammatory disorders. However, little is known about the signalling pathways that are engaged by probiotics. Dendritic cells (DCs) are antigen-presenting cells that are involved in immunity and tolerance. Monocyte-derived dendritic cells (MoDCs) and murine DCs are different from human gut DCs; therefore, in this study, we used human DCs generated from CD34+ progenitor cells (hematopoietic stem cells) harvested from umbilical cord blood; those DCs exhibited surface antigens of dendritic Langerhans cells, similar to the lamina propria DCs in the gut. We report that both a novel probiotic strain isolated from faeces of exclusively breast-fed newborn infants, Lactobacillus paracasei CNCM I-4034, and its cell-free culture supernatant (CFS) decreased pro-inflammatory cytokines and chemokines in human intestinal DCs challenged with Salmonella. Interestingly, the supernatant was as effective as the bacteria in reducing pro-inflammatory cytokine expression. In contrast, the bacterium was a potent inducer of TGF-beta 2 secretion, whereas the supernatant increased the secretion of TGF-beta 1 in response to Salmonella. We also showed that both the bacteria and its supernatant enhanced innate immunity through the activation of Toll-like receptor (TLR) signalling. These treatments strongly induced the transcription of the TLR9 gene. In addition, upregulation of the CASP8 and TOLLIP genes was observed. This work demonstrates that L. paracasei CNCM I-4034 enhanced innate immune responses, as evidenced by the activation of TLR signalling and the downregulation of a broad array of pro-inflammatory cytokines. The use of supernatants like the one described in this paper could be an effective and safe alternative to using live bacteria in functional foods.	[Bermudez-Brito, Miriam; Munoz-Quezada, Sergio; Gomez-Llorente, Carolina; Gil, Angel] Univ Granada, Dept Biochem & Mol Biol 2, Inst Nutr & Food Technol Jose Mataix, Biomed Res Ctr, Granada, Spain; [Matencio, Esther; Bernal, Maria J.; Romero, Fernando] Hero Spain, Hero Inst Infant Nutr, Murcia, Spain	University of Granada	Bermudez-Brito, M (corresponding author), Univ Granada, Dept Biochem & Mol Biol 2, Inst Nutr & Food Technol Jose Mataix, Biomed Res Ctr, Granada, Spain.	agil@ugr.es	Gil, Angel/L-2275-2014; Gil, Angel/ABA-7621-2020; Llorente, Carolina Gomez/K-7484-2015	Gil, Angel/0000-0001-7663-0939; Gil, Angel/0000-0001-7663-0939; Llorente, Carolina Gomez/0000-0003-3948-1473; Bermudez Brito, Miriam/0000-0003-4156-143X	Hero Spain S.A. [3143]; Fundacion General Universidad de Granada Empresa; CDTI, a public entity of the Ministry of Economy and Competitiveness of the Spanish Government; Plan Propio of University of Granada	Hero Spain S.A.; Fundacion General Universidad de Granada Empresa; CDTI, a public entity of the Ministry of Economy and Competitiveness of the Spanish Government; Plan Propio of University of Granada	This work was funded by Hero Spain S.A. through the contract no 3143 signed with the Fundacion General Universidad de Granada Empresa and co-sponsored by the CDTI, a public entity of the Ministry of Economy and Competitiveness of the Spanish Government. Carolina Gomez-Llorente received a postdoctoral fellowship from Plan Propio of University of Granada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bongaerts GPA, 2005, MED HYPOTHESES, V64, P1089, DOI 10.1016/j.mehy.2004.10.018; Borchers AT, 2009, J GASTROENTEROL, V44, P26, DOI 10.1007/s00535-008-2296-0; Castillo NA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-177; Clarke JO, 2008, NUTR CLIN PRACT, V23, P49, DOI 10.1177/011542650802300149; Collado MC, 2009, CURR DRUG METAB, V10, P68, DOI 10.2174/138920009787048437; Coombes JL, 2007, SEMIN IMMUNOL, V19, P116, DOI 10.1016/j.smim.2007.01.001; Corr SC, 2009, ADV FOOD NUTR RES, V56, P1, DOI 10.1016/S1043-4526(08)00601-3; Cosseau C, 2008, INFECT IMMUN, V76, P4163, DOI 10.1128/IAI.00188-08; Galdeano CM, 2006, CLIN VACCINE IMMUNOL, V13, P219, DOI 10.1128/CVI.13.2.219-226.2006; Gomez-Llorente C, 2010, P NUTR SOC, V69, P381, DOI 10.1017/S0029665110001527; Hotel ACP., 2001, PREVENTION, V5, P1; Huang JS, 2002, DIGEST DIS SCI, V47, P2625, DOI 10.1023/A:1020501202369; Huang Y, 2010, BRIT J NUTR, V103, P473, DOI 10.1017/S0007114509991991; Imaoka A, 2008, WORLD J GASTROENTERO, V14, P2511, DOI 10.3748/wjg.14.2511; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Kim YG, 2006, MICROBES INFECT, V8, P994, DOI 10.1016/j.micinf.2005.10.019; Kingma SDK, 2011, J NUTR, V141, P1023, DOI 10.3945/jn.110.135517; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Lavelle EC, 2010, MUCOSAL IMMUNOL, V3, P17, DOI 10.1038/mi.2009.124; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lomax AR, 2009, CURR PHARM DESIGN, V15, P1428, DOI 10.2174/138161209788168155; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; Medellin-Pena MJ, 2007, APPL ENVIRON MICROB, V73, P4259, DOI 10.1128/AEM.00159-07; Meijerink M, 2010, BENEF MICROBES, V1, P317, DOI 10.3920/BM2010.0029; Mesquita D, 2010, REV BRAS REUMATOL, V50, P566, DOI 10.1590/S0482-50042010000500008; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; Munoz-Quezada S, 2013, Br. J. Nutr., V109, pS51, Patent No. 090006; Niess JH, 2005, CURR OPIN GASTROEN, V21, P687, DOI 10.1097/01.mog.0000181710.96904.58; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Ouwehand AC, 2009, WORLD J GASTROENTERO, V15, P3261, DOI 10.3748/wjg.15.3261; Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Pinto MGV, 2009, INT J FOOD MICROBIOL, V133, P86, DOI 10.1016/j.ijfoodmicro.2009.05.013; Putaala H, 2008, RES MICROBIOL, V159, P692, DOI 10.1016/j.resmic.2008.08.002; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Rizzello V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/473097; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Villena J, 2012, CLIN VACCINE IMMUNOL; Voltan S, 2007, CLIN VACCINE IMMUNOL, V14, P1138, DOI 10.1128/CVI.00079-07; Weiss G, 2011, CYTOKINE, V56, P520, DOI 10.1016/j.cyto.2011.07.024; Weiss G, 2010, IMMUNOLOGY, V131, P268, DOI 10.1111/j.1365-2567.2010.03301.x; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Zhou C, 2008, WORLD J GASTROENTERO, V14, P5090, DOI 10.3748/wjg.14.5090	50	58	62	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43197	10.1371/journal.pone.0043197	http://dx.doi.org/10.1371/journal.pone.0043197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905233	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800060
J	Kitamura, K; Kishi-Itakura, C; Tsuboi, T; Sato, S; Kita, K; Ohta, N; Mizushima, N				Kitamura, Kei; Kishi-Itakura, Chieko; Tsuboi, Takafumi; Sato, Shigeharu; Kita, Kiyoshi; Ohta, Nobuo; Mizushima, Noboru			Autophagy-Related Atg8 Localizes to the Apicoplast of the Human Malaria Parasite Plasmodium falciparum	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; ERYTHROCYTIC STAGES; ALGAL ORIGIN; MEMBRANE; PROTEINS; MITOCHONDRIA; APICOMPLEXAN; HOMOLOG; COMPLEX; SYSTEM	Autophagy is a membrane-mediated degradation process, which is governed by sequential functions of Atg proteins. Although Atg proteins are highly conserved in eukaryotes, protozoa possess only a partial set of Atg proteins. Nonetheless, almost all protozoa have the complete factors belonging to the Atg8 conjugation system, namely, Atg3, Atg4, Atg7, and Atg8. Here, we report the biochemical properties and subcellular localization of the Atg8 protein of the human malaria parasite Plasmodium falciparum (PfAtg8). PfAtg8 is expressed during intra-erythrocytic development and associates with membranes likely as a lipid-conjugated form. Fluorescence microscopy and immunoelectron microscopy show that PfAtg8 localizes to the apicoplast, a four membrane-bound non-photosynthetic plastid. Autophagosome-like structures are not observed in the erythrocytic stages. These data suggest that, although Plasmodium parasites have lost most Atg proteins during evolution, they use the Atg8 conjugation system for the unique organelle, the apicoplast.	[Kitamura, Kei; Kishi-Itakura, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo, Japan; [Kitamura, Kei; Ohta, Nobuo] Tokyo Med & Dent Univ, Dept Environm Parasitol, Tokyo, Japan; [Tsuboi, Takafumi] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan; [Tsuboi, Takafumi] Ehime Univ, Venture Business Lab, Matsuyama, Ehime, Japan; [Sato, Shigeharu] MRC Natl Inst Med Res, Div Parasitol, London, England; [Kita, Kiyoshi] Univ Tokyo, Dept Biomed Chem, Grad Sch Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Ehime University; Ehime University; MRC National Institute for Medical Research; University of Tokyo	Kitamura, K (corresponding author), Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo, Japan.	matata.vip@tmd.ac.jp; nmizu.phy2@tmd.ac.jp	Tsuboi, Takafumi/AAK-6145-2021; Mizushima, Noboru/C-3635-2009; Sato, Shigeharu/K-9464-2013	Mizushima, Noboru/0000-0002-6258-6444; Sato, Shigeharu/0000-0003-2738-430X; Tsuboi, Takafumi/0000-0002-7415-1325; Sato, Shigeharu/0000-0001-9559-7580; Kita, Kiyoshi/0000-0002-0426-4308	Ministry of Education, Culture, Sports, Science and Technology [23117008]; British Medical Research Council [U117584270]; Creative Scientific Research Grant [18GS0314]; grant for Ministry of Health, Labor and Welfare [H23-Kokui-004]; Funding Program for Next Generation World-Leading Researchers; MRC [MC_U117532072] Funding Source: UKRI; Medical Research Council [MC_U117532072, U117584270] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Creative Scientific Research Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); grant for Ministry of Health, Labor and Welfare; Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (23117008) (to T.T.), the British Medical Research Council (U117584270) (to S. S.), Creative Scientific Research Grant 18GS0314 (to K. Kita), a grant for Ministry of Health, Labor and Welfare (H23-Kokui-004) (to N.O.) and the Funding Program for Next Generation World-Leading Researchers (to N.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VE, 2008, AUTOPHAGY, V4, P361, DOI 10.4161/auto.5592; Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Brennand A, 2011, MOL BIOCHEM PARASIT, V177, P83, DOI 10.1016/j.molbiopara.2011.02.003; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Cuervo AM, 2011, NAT REV MOL CELL BIO, V12, P535, DOI 10.1038/nrm3150; CULVENOR JG, 1991, INFECT IMMUN, V59, P1183, DOI 10.1128/IAI.59.3.1183-1187.1991; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Duszenko M, 2011, AUTOPHAGY, V7, P127, DOI 10.4161/auto.7.2.13310; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hayashi M, 2001, J BIOL CHEM, V276, P15249, DOI 10.1074/jbc.M011709200; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Ito D, 2011, PARASITOL INT, V60, P132, DOI 10.1016/j.parint.2011.01.001; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kageyama Shun, 2011, Mol Biol Cell, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Kalanon M, 2010, BIOCHEM SOC T, V38, P775, DOI 10.1042/BST0380775; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kobayashi T, 2007, MITOCHONDRION, V7, P125, DOI 10.1016/j.mito.2006.11.021; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Kovacs AL, 2007, AUTOPHAGY, V3, P655, DOI 10.4161/auto.4590; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lim L, 2009, TRENDS PARASITOL, V25, P197, DOI 10.1016/j.pt.2009.02.001; McFadden GI, 2011, PROTOPLASMA, V248, P641, DOI 10.1007/s00709-010-0250-5; McFadden GI, 1999, TRENDS MICROBIOL, V7, P328, DOI 10.1016/S0966-842X(99)01547-4; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Picazarri K, 2008, INFECT IMMUN, V76, P278, DOI 10.1128/IAI.00636-07; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Rigden DJ, 2009, AUTOPHAGY, V5, P784, DOI 10.4161/auto.8838; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sasaki N, 2009, FEBS LETT, V583, P1446, DOI 10.1016/j.febslet.2009.03.071; Sato S, 2003, MOL BIOCHEM PARASIT, V130, P155, DOI 10.1016/S0166-6851(03)00166-X; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Stanway RR, 2011, CELL MICROBIOL, V13, P1768, DOI 10.1111/j.1462-5822.2011.01657.x; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Tonkin CJ, 2008, TRAFFIC, V9, P166, DOI 10.1111/j.1600-0854.2007.00660.x; Tonkin CJ, 2006, MOL MICROBIOL, V61, P614, DOI 10.1111/j.1365-2958.2006.05244.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180	72	59	59	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42977	10.1371/journal.pone.0042977	http://dx.doi.org/10.1371/journal.pone.0042977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900071	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900089
J	Kugler, P				Kuegler, Philipp			Moment Fitting for Parameter Inference in Repeatedly and Partially Observed Stochastic Biological Models	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; SYSTEMS; IDENTIFIABILITY; REGULARIZATION; PROTEINS; CELLS	The inference of reaction rate parameters in biochemical network models from time series concentration data is a central task in computational systems biology. Under the assumption of well mixed conditions the network dynamics are typically described by the chemical master equation, the Fokker Planck equation, the linear noise approximation or the macroscopic rate equation. The inverse problem of estimating the parameters of the underlying network model can be approached in deterministic and stochastic ways, and available methods often compare individual or mean concentration traces obtained from experiments with theoretical model predictions when maximizing likelihoods, minimizing regularized least squares functionals, approximating posterior distributions or sequentially processing the data. In this article we assume that the biological reaction network can be observed at least partially and repeatedly over time such that sample moments of species molecule numbers for various time points can be calculated from the data. Based on the chemical master equation we furthermore derive closed systems of parameter dependent nonlinear ordinary differential equations that predict the time evolution of the statistical moments. For inferring the reaction rate parameters we suggest to not only compare the sample mean with the theoretical mean prediction but also to take the residual of higher order moments explicitly into account. Cost functions that involve residuals of higher order moments may form landscapes in the parameter space that have more pronounced curvatures at the minimizer and hence may weaken or even overcome parameter sloppiness and uncertainty. As a consequence both deterministic and stochastic parameter inference algorithms may be improved with respect to accuracy and efficiency. We demonstrate the potential of moment fitting for parameter inference by means of illustrative stochastic biological models from the literature and address topics for future research.	Johann Radon Inst Computat & Appl Math, Linz, Austria		Kugler, P (corresponding author), Johann Radon Inst Computat & Appl Math, Linz, Austria.	philipp.kuegler@oeaw.ac.at	Kügler, Philipp/B-4444-2015	Kügler, Philipp/0000-0002-1041-9265	Isaac Newton Institute for Mathematical Sciences, Cambridge, UK	Isaac Newton Institute for Mathematical Sciences, Cambridge, UK	I have developed the moment fitting concept presented in this paper during my visiting fellowship at the Isaac Newton Institute for Mathematical Sciences, Cambridge, UK and kindly acknowledge the opportunities granted.	Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Anguelova M, 2007, IET SYST BIOL, V1, P230, DOI 10.1049/iet-syb:20060081; [Anonymous], [No title captured], DOI [10.3182/20080706-5-KR-1001.3521, DOI 10.3182/20080706-5-KR-1001.3521]; Ashyraliyev M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-83; Audoly S, 2001, IEEE T BIO-MED ENG, V48, P55, DOI 10.1109/10.900248; Bandara S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000558; BARTHOLOMAY ANTHONY F., 1958, BULL MATH BIOPHYS, V20, P97, DOI 10.1007/BF02477571; Bishwal J.P., 2008, PARAMETER ESTIMATION; Brown KS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021904; Bruckstein AM, 2009, SIAM REV, V51, P34, DOI 10.1137/060657704; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; Engblom S, 2006, APPL MATH COMPUT, V180, P498, DOI 10.1016/j.amc.2005.12.032; Engl HW, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123014; Ferguson ML, 2012, P NATL ACAD SCI USA, V109, P155, DOI 10.1073/pnas.1110541108; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gillespie C, 2008, PARAMETER ESTIMATION; Gillespie CS, 2009, IET SYST BIOL, V3, P52, DOI 10.1049/iet-syb:20070031; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goutte C, 1997, NEURAL NETWORKS, V10, P1053, DOI 10.1016/S0893-6080(97)00027-0; Grima R, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3702848; Grima R, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3625958; Gutenkunst RN, 2007, PLOS COMPUTATIONAL B, V3; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; Isakov V., 2006, INVERSE PROBLEMS PAR, V127; Jaqaman K, 2006, NAT REV MOL CELL BIO, V7, P813, DOI 10.1038/nrm2030; Kaipio J., 2004, STAT COMPUTATIONAL I; Kaltenbacher B, 2008, RADON SER COMPUT APP, V6, P1, DOI 10.1515/9783110208276; KANG K, 1990, IIE TRANS, V22, P15, DOI 10.1080/07408179008964153; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Komorowski M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-343; Kugler P, 2009, J PHYS CHEM A, V113, P2775, DOI 10.1021/jp808792u; Kugler P, 2012, SIAM J APPL MATH; Lai M.J., 2010, J CONCR APPL MATH, V8, P296; Lecca P, 2009, UKSIM INT CONF COMP, P200, DOI 10.1109/UKSIM.2009.18; Lee CH, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3103264; Liese F, 2006, IEEE T INFORM THEORY, V52, P4394, DOI 10.1109/TIT.2006.881731; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Mathworks T, 2010, MATL VERS 7 10 0 499; Matis TI, 2010, MATH J, P12; Milner P, 2011, MATH BIOSCI, V231, P99, DOI 10.1016/j.mbs.2011.02.006; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Poovathingal SK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-414; Rodriguez-Fernandez M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-483; Ross S.M., 2010, INTRO PROBABILITY MO; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Seber G. A. F., 2003, NONLINEAR REGRESSION; Shen H, 2006, J R SOC INTERFACE, V3, P787, DOI 10.1098/rsif.2006.0137; Singh A, 2011, IEEE T AUTOMAT CONTR, V56, P414, DOI 10.1109/TAC.2010.2088631; Sun XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003758; Tabachnick B. G., 2006, USING MULTIVARIATE S; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Wackerly DD, 2008, MATH STAT APPL; Wilkinson JD, 2012, STOCHASTIC MODELLING; Wu JQ, 2008, METHOD CELL BIOL, V89, P253, DOI 10.1016/S0091-679X(08)00609-2; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230	63	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43001	10.1371/journal.pone.0043001	http://dx.doi.org/10.1371/journal.pone.0043001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900079	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900097
J	Shibata, K; Miura, M; Watanabe, Y; Saito, K; Nishimura, A; Furuta, K; Toyoshima, YY				Shibata, Keitaro; Miura, Michi; Watanabe, Yuta; Saito, Kei; Nishimura, Atsuko; Furuta, Ken'ya; Toyoshima, Yoko Y.			A Single Protofilament Is Sufficient to Support Unidirectional Walking of Dynein and Kinesin	PLOS ONE			English	Article							AAA PLUS RING; CYTOPLASMIC DYNEIN; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; MOTOR-PROTEIN; BETA-TUBULIN; DOMAIN; MICROTUBULES; MECHANISM; MOTILITY	Cytoplasmic dynein and kinesin are two-headed microtubule motor proteins that move in opposite directions on microtubules. It is known that kinesin steps by a 'hand-over-hand' mechanism, but it is unclear by which mechanism dynein steps. Because dynein has a completely different structure from that of kinesin and its head is massive, it is suspected that dynein uses multiple protofilaments of microtubules for walking. One way to test this is to ask whether dynein can step along a single protofilament. Here, we examined dynein and kinesin motility on zinc-induced tubulin sheets (zinc-sheets) which have only one protofilament available as a track for motor proteins. Single molecules of both dynein and kinesin moved at similar velocities on zinc-sheets compared to microtubules, clearly demonstrating that dynein and kinesin can walk on a single protofilament and multiple rows of parallel protofilaments are not essential for their motility. Considering the size and the motile properties of dynein, we suggest that dynein may step by an inchworm mechanism rather than a hand-over-hand mechanism.	[Shibata, Keitaro; Miura, Michi; Watanabe, Yuta; Saito, Kei; Nishimura, Atsuko; Furuta, Ken'ya; Toyoshima, Yoko Y.] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	University of Tokyo	Shibata, K (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	cyytoyo@mail.ecc.u-tokyo.ac.jp		Miura, Michi/0000-0002-6943-3782	MEXT [20370057]; JST; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [10J10101] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research (B) (20370057) from MEXT and by the Strategic International Science and Technology Cooperation Program (http://www.jst.go.jp/inter/index.html) from JST to YYT. K. Shibata was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TS, 1978, J MOL BIOL, V123, P89, DOI 10.1016/0022-2836(78)90378-9; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; CROSS RA, 1995, J MUSCLE RES CELL M, V16, P91, DOI 10.1007/BF00122526; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; DeWitt MA, 2012, SCIENCE, V335, P221, DOI 10.1126/science.1215804; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; Furuta K, 2008, J BIOL CHEM, V283, P36465, DOI 10.1074/jbc.M803730200; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; HIROSE K, 1995, NATURE, V376, P277, DOI 10.1038/376277a0; HOENGER A, 1995, NATURE, V376, P271, DOI 10.1038/376271a0; Inoue Y, 2001, BIOPHYS J, V81, P2838, DOI 10.1016/S0006-3495(01)75925-5; KAMIMURA S, 1992, J CELL BIOL, V118, P865, DOI 10.1083/jcb.118.4.865; KIKKAWA M, 1995, NATURE, V376, P274, DOI 10.1038/376274a0; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Miura M, 2010, FEBS LETT, V584, P2351, DOI 10.1016/j.febslet.2010.04.016; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; RAY S, 1995, CELL MOTIL CYTOSKEL, V30, P146, DOI 10.1002/cm.970300206; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; SONG YH, 1993, P NATL ACAD SCI USA, V90, P1671, DOI 10.1073/pnas.90.5.1671; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Toba S, 2004, CELL MOTIL CYTOSKEL, V58, P281, DOI 10.1002/cm.20018; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373; WOLF SG, 1993, J STRUCT BIOL, V111, P190, DOI 10.1006/jsbi.1993.1049	43	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42990	10.1371/journal.pone.0042990	http://dx.doi.org/10.1371/journal.pone.0042990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900078	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900096
J	Frank, S; Lee, S; Preissl, H; Schultes, B; Birbaumer, N; Veit, R				Frank, Sabine; Lee, Sangkyun; Preissl, Hubert; Schultes, Bernd; Birbaumer, Niels; Veit, Ralf			The Obese Brain Athlete: Self-Regulation of the Anterior Insula in Adiposity	PLOS ONE			English	Article							NEURAL MECHANISMS; FOOD; FMRI; SATIATION	The anterior insular cortex (AIC) is involved in emotional processes and gustatory functions which can be examined by imaging techniques. Such imaging studies showed increased activation in the insula in response to food stimuli as well as a differential activation in lean and obese people. Additionally, studies investigating lean subjects established the voluntary regulation of the insula by a real-time functional magnetic resonance imaging-brain computer interface (rtfMRI-BCI) approach. In this exploratory study, 11 lean and 10 obese healthy, male participants were investigated in a rtfMRI-BCI protocol. During the training sessions, all obese participants were able to regulate the activity of the AIC voluntarily, while four lean participants were not able to regulate at all. In successful regulators, functional connectivity during regulation vs. relaxation between the AIC and all other regions of the brain was determined by a seed voxel approach. Lean in comparison to obese regulators showed stronger connectivity in cingular and temporal cortices during regulation. We conclude, that obese people possess an improved capacity to self-regulate the anterior insula, a brain system tightly related to bodily awareness and gustatory functions.	[Frank, Sabine; Preissl, Hubert; Veit, Ralf] Univ Tubingen, MEG Ctr, Tubingen, Germany; [Frank, Sabine; Lee, Sangkyun; Birbaumer, Niels; Veit, Ralf] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Preissl, Hubert] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA; [Schultes, Bernd] Cantonal Hosp St Gallen, Interdisciplinary Obes Ctr, CH-9400 Rorschach, Switzerland; [Birbaumer, Niels] Osped San Camillo, Ist Ricovero & Cura Carattere Sci, Venice, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Kantonsspital St. Gallen	Frank, S (corresponding author), Univ Tubingen, MEG Ctr, Tubingen, Germany.	sabine.frank@med.uni-tuebingen.de	Frank-Podlech, Sabine/I-8986-2012; Veit, Ralf/F-8907-2012; Preißl, Hubert/E-9070-2012	Frank-Podlech, Sabine/0000-0002-9646-3987; Veit, Ralf/0000-0001-9860-642X; Preißl, Hubert/0000-0002-8859-4661; Birbaumer, Niels/0000-0002-6786-5127	Kompetenznetz Adipositas (Competence Network for Adiposity); German Federal Ministry of Education and Research (BMBF) [FKZ 01GI0837]; German Research Foundation (DFG) [PAK347]	Kompetenznetz Adipositas (Competence Network for Adiposity); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the "Kompetenznetz Adipositas (Competence Network for Adiposity)'' funded by the German Federal Ministry of Education and Research (BMBF FKZ 01GI0837) and by the German Research Foundation (DFG PAK347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Caria A, 2012, NEUROSCIENTIST, V18, P487, DOI 10.1177/1073858411407205; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Gautier JF, 2001, OBES RES, V9, P676, DOI 10.1038/oby.2001.92; Gautier JF, 2000, DIABETES, V49, P838, DOI 10.2337/diabetes.49.5.838; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; Hammer EM, 2012, BIOL PSYCHOL, V89, P80, DOI 10.1016/j.biopsycho.2011.09.006; Kullmann S, 2012, HUM BRAIN MAPP, V33, P1052, DOI 10.1002/hbm.21268; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Murdaugh DL, 2012, NEUROIMAGE, V59, P2709, DOI 10.1016/j.neuroimage.2011.10.071; Neumann N, 2003, J NEUROL NEUROSUR PS, V74, P1117, DOI 10.1136/jnnp.74.8.1117; Nijs IMT, 2007, APPETITE, V49, P38, DOI 10.1016/j.appet.2006.11.001; Porubska K, 2006, NEUROIMAGE, V32, P1273, DOI 10.1016/j.neuroimage.2006.04.216; Pudel D, 1989, FRAGEBOGEN ESSVERHAL; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Sitaram Ranganatha, 2007, Comput Intell Neurosci, P25487, DOI 10.1155/2007/25487; Veldhuizen MG, 2011, HUM BRAIN MAPP, V32, P2256, DOI 10.1002/hbm.21188; Weiskopf N, 2007, MAGN RESON IMAGING, V25, P989, DOI 10.1016/j.mri.2007.02.007; World Health Organization, 2016, OB OV; Yokum S, 2011, OBESITY, V19, P1775, DOI 10.1038/oby.2011.168	27	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42570	10.1371/journal.pone.0042570	http://dx.doi.org/10.1371/journal.pone.0042570			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905151	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100049
J	Leroy, V; Gregoire, J; Magen, E; Gross, JJ; Mikolajczak, M				Leroy, Veronique; Gregoire, Jacques; Magen, Eran; Gross, James J.; Mikolajczak, Moira			Lead Me Not into Temptation: Using Cognitive Reappraisal to Reduce Goal Inconsistent Behavior	PLOS ONE			English	Article							GRATIFICATION; DELAY	Temptations besiege us, and we must resist their appeal if we are to achieve our long-term goals. In two studies, we tested the hypothesis that cognitive reappraisal could be used to successfully maintain performance in a task embedded in temptation. In Study 1, 62 participants had to search for information on the Internet while resisting attractive task-irrelevant content on preselected sites. In Study 2, 58 participants had to count target words in a funny TV sequence. Compared to the no-reappraisal condition, participants who understood the situation as a test of willpower (the reappraisal condition) (1) performed better at the task (Studies 1 and 2), and (2) were less tempted by the attractive content of the TV sequence (Study 2). These findings suggest that, by making the temptation less attractive and the task more appealing, cognitive reappraisal can help us resist temptation.	[Leroy, Veronique; Gregoire, Jacques; Mikolajczak, Moira] Catholic Univ Louvain, Dept Psychol, B-3000 Louvain, Belgium; [Magen, Eran] Univ Penn, Counseling & Psychol Serv, Philadelphia, PA 19104 USA; [Gross, James J.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Universite Catholique Louvain; University of Pennsylvania; Stanford University	Leroy, V (corresponding author), Catholic Univ Louvain, Dept Psychol, Tiensestr 102, B-3000 Louvain, Belgium.	Veronique.leroy@uclouvain.be	Magen, Eli/N-7960-2014; Gross, James/AAM-4104-2020	Magen, Eli/0000-0002-7713-423X; Mikolajczak, Moira/0000-0002-7333-1578				Leroy V., 2007, EUR ASS RES LEARN IN; Magen E, 2007, EMOTION, V7, P415, DOI 10.1037/1528-3542.7.2.415; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Peake PK, 2002, DEV PSYCHOL, V38, P313, DOI 10.1037//0012-1649.38.2.313; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Schmeichel B.J., 2004, HDB SELF REGULATION, V1st, P84, DOI DOI 10.1016/J.CEDPSYCH.2015.01.001; Schmeichel BJ, 2003, J PERS SOC PSYCHOL, V85, P33, DOI 10.1037/0022-3514.85.1.33; Vohs K. D., 2004, HDB SELF REGULATION, P1; Zettle R. D., 2007, ACT DEPRESSION CLINI	10	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e39493	10.1371/journal.pone.0039493	http://dx.doi.org/10.1371/journal.pone.0039493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	978NX	22911686	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300005
J	Pacheco, A; Twiss, JL				Pacheco, Almudena; Twiss, Jeffery L.			Localized IRES-Dependent Translation of ER Chaperone Protein mRNA in Sensory Axons	PLOS ONE			English	Article							RIBOSOMAL ENTRY SITE; INTERNAL INITIATION; MEDIATED TRANSLATION; SYMPATHETIC NEURONS; PERIPHERAL-NERVE; GROWTH CONES; ACTIN; PHOSPHORYLATION; TRANSPORT; REPERTOIRE	Transport of neuronal mRNAs into distal nerve terminals and growth cones allows axonal processes to generate proteins autonomous from the cell body. While the mechanisms for targeting mRNAs for transport into axons has received much attention, how specificity is provided to the localized translational apparatus remains largely unknown. In other cellular systems, protein synthesis can be regulated by both cap-dependent and cap-independent mechanisms. The possibility that these mechanisms are used by axons has not been tested. Here, we have used expression constructs encoding axonally targeted bicistronic reporter mRNAs to determine if sensory axons can translate mRNAs through cap-independent mechanisms. Our data show that the well-defined IRES element of encephalomyocarditis virus (EMCV) can drive internal translational initiation of a bicistronic reporter mRNA in distal DRG axons. To test the potential for cap-independent translation of cellular mRNAs, we asked if calreticulin or grp78/BiP mRNA 59UTRs might have IRES activity in axons. Only grp78/BiP mRNA 5'UTR showed clear IRES activity in axons when placed between the open reading frames of diffusion limited fluorescent reporters. Indeed, calreticulin's 5'UTR provided an excellent control for potential read through by ribosomes, since there was no evidence of internal initiation when this UTR was placed between reporter ORFs in a bicistronic mRNA. This study shows that axons have the capacity to translate through internal ribosome entry sites, but a simple binary choice between cap-dependent and cap-independent translation cannot explain the specificity for translation of individual mRNAs in distal axons.	[Pacheco, Almudena; Twiss, Jeffery L.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA	Drexel University	Pacheco, A (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	jeff.twiss@drexel.edu			NIH [R01-NS041596]; Miriam and Sheldon F. Aldelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041596] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miriam and Sheldon F. Aldelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from NIH (R01-NS041596) and the Miriam and Sheldon F. Aldelson Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Aschrafi A, 2008, J NEUROSCI, V28, P12581, DOI 10.1523/JNEUROSCI.3338-08.2008; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; Borman AM, 1997, NUCLEIC ACIDS RES, V25, P925, DOI 10.1093/nar/25.5.925; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Dobson T, 2005, NUCLEIC ACIDS RES, V33, P2929, DOI 10.1093/nar/gki605; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; Donnelly CJ, 2010, TRAFFIC, V11, P1498, DOI 10.1111/j.1600-0854.2010.01118.x; Eng H, 1999, J NEUROSCI, V19, P1; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Gale E.F., 1981, MOL BASIS ANTIBIOTIC, Vsecond; GROLLMAN AP, 1967, J BIOL CHEM, V242, P3226; Gromeier M, 1999, J VIROL, V73, P958, DOI 10.1128/JVI.73.2.958-964.1999; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kim YK, 2002, BIOCHEM BIOPH RES CO, V297, P224, DOI 10.1016/S0006-291X(02)02154-X; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Le Quesne JPC, 2010, J PATHOL, V220, P140, DOI 10.1002/path.2627; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Licursi M, 2011, GENE THER, V18, P631, DOI 10.1038/gt.2011.11; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; Murashov AK, 2007, FASEB J, V21, P656, DOI 10.1096/fj.06-6155com; Natera-Naranjo O, 2010, RNA, V16, P1516, DOI 10.1261/rna.1833310; Pacheco A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/458927; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Pinkstaff JK, 2001, P NATL ACAD SCI USA, V98, P2770, DOI 10.1073/pnas.051623398; SARNOW P, 1989, P NATL ACAD SCI USA, V86, P5795, DOI 10.1073/pnas.86.15.5795; Sasaki Y, 2010, J NEUROSCI, V30, P9349, DOI 10.1523/JNEUROSCI.0499-10.2010; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Twiss JL, 2009, TRENDS CELL BIOL, V19, P236, DOI 10.1016/j.tcb.2009.02.007; Vuppalanchi D, 2012, MOL CELL NE IN PRESS; Vuppalanchi D, 2010, J BIOL CHEM, V285, P18025, DOI 10.1074/jbc.M109.061333; Walker BA, 2012, GENE THER; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	51	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40788	10.1371/journal.pone.0040788	http://dx.doi.org/10.1371/journal.pone.0040788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911708	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300014
J	Sabol, I; Matovina, M; Si-Mohamed, A; Grce, M				Sabol, Ivan; Matovina, Mihaela; Si-Mohamed, Ali; Grce, Magdalena			Characterization and Whole Genome Analysis of Human Papillomavirus Type 16 E1-1374(boolean AND)63nt Variants	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; 16 E6 VARIANTS; HUMAN-PAPILLOMAVIRUS-16 E6; GENE-EXPRESSION; E1 GENE; PROTEIN; CODON; SEQUENCE; CANCER; E7	Background: The variation of the most common Human papillomavirus (HPV) type found in cervical cancer, the HPV16, has been extensively investigated in almost all viral genes. The E1 gene variation, however, has been rarely studied. The main objective of the present investigation was to analyze the variability of the E6 and E1 genes, focusing on the recently identified E1-1374(boolean AND)63nt variant. Methodology/Principal Findings: Variation within the E6 of 786 HPV16 positive cervical samples was analyzed using high-resolution melting, while the E1-1374(boolean AND)63nt duplication was assayed by PCR. Both techniques were supplemented with sequencing. The E1-1374(boolean AND)63nt duplication was linked with the E-G350 and the E-C109/G350 variants. In comparison to the referent HPV16, the E1-1374(boolean AND)63nt E-G350 variant was significantly associated with lower grade cervical lesions (p = 0.029), while the E1-1374(boolean AND)63nt E-C109/G350 variant was equally distributed between high and low grade lesions. The E1-1374(boolean AND)63nt variants were phylogenetically closest to E-G350 variant lineage (A2 sub-lineage based on full genome classification). The major differences between E1-1374(boolean AND)63nt variants were within the LCR and the E6 region. On the other hand, changes within the E1 region were the major differences from the A2 sub-lineage, which has been historically but inconclusively associated with high grade cervical disease. Thus, the shared variations cannot explain the particular association of the E1-1374(boolean AND)63nt variant with lower grade cervical lesions. Conclusions/Significance: The E1 region has been thus far considered to be well conserved among all HPVs and therefore uninteresting for variability studies. However, this study shows that the variations within the E1 region could possibly affect cervical disease, since the E1-1374(boolean AND)63nt E-G350 variant is significantly associated with lower grade cervical lesions, in comparison to the A1 and A2 sub-lineage variants. Furthermore, it appears that the silent variation 109T>C of the E-C109/G350 variant might have a significant role in the viral life cycle and warrants further study.	[Sabol, Ivan; Grce, Magdalena] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Matovina, Mihaela] Univ Rijeka, Sch Med, Dept Microbiol & Parasitol, Rijeka, Croatia; [Si-Mohamed, Ali] Hop Europeen Georges Pompidou, Virol Lab, Paris, France	Rudjer Boskovic Institute; University of Rijeka; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Sabol, I (corresponding author), Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia.	grce@irb.hr	Matovina, Mihaela/J-3834-2012; Matovina, Mihaela/P-7426-2019; Sabol, Ivan/B-7455-2012; GRCE, MAGDALENA/ABD-2768-2020	Matovina, Mihaela/0000-0001-7647-3339; Sabol, Ivan/0000-0002-5753-8528; Grce, Magdalena/0000-0001-6178-8418	Croatian Ministry of Science, Education and Sports [098-0982464-2510]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	This work was supported by the Croatian Ministry of Science, Education and Sports grant no. 098-0982464-2510 (http://public.mzos.hr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; ANDROPHY EJ, 1987, EMBO J, V6, P989, DOI 10.1002/j.1460-2075.1987.tb04849.x; [Anonymous], 2007, MON EV CARC RISKS HU; Asadurian Y, 2007, J MED VIROL, V79, P1751, DOI 10.1002/jmv.20978; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Bernard HU, 2002, ANTIVIR THER, V7, P219; Bhattacharjee B, 2006, GYNECOL ONCOL, V100, P372, DOI 10.1016/j.ygyno.2005.09.016; Bhattacharjee B, 2008, VIROLOGY, V377, P143, DOI 10.1016/j.virol.2008.04.007; Bogovac Z, 2011, ACTA DERMATOVEN ALP, V20, P135; Bontkes HJ, 1998, INT J CANCER, V78, P166, DOI 10.1002/(SICI)1097-0215(19981005)78:2<166::AID-IJC8>3.0.CO;2-X; Brady CS, 1999, J GEN VIROL, V80, P3233, DOI 10.1099/0022-1317-80-12-3233; Burk RD, 2003, CANCER RES, V63, P7215; Burk Robert D, 2011, Acta Dermatovenerol Alp Pannonica Adriat, V20, P113; Chakrabarti O, 2004, J VIROL, V78, P5934, DOI 10.1128/JVI.78.11.5934-5945.2004; CHEN GFT, 1990, NUCLEIC ACIDS RES, V18, P1465, DOI 10.1093/nar/18.6.1465; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Cid-Arregui A, 2003, J VIROL, V77, P4928, DOI 10.1128/JVI.77.8.4928-4937.2003; de Boer MA, 2004, GYNECOL ONCOL, V94, P488, DOI 10.1016/j.ygyno.2004.05.037; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Enemark EJ, 2000, MOL CELL, V6, P149, DOI 10.1016/S1097-2765(00)00016-2; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; FU CW, 1994, MOL GEN GENET, V243, P434, DOI 10.1007/BF00280474; Giannoudis A, 2001, J PATHOL, V193, P295, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH809&gt;3.0.CO;2-C; Grodzki M, 2006, CANCER EPIDEM BIOMAR, V15, P820, DOI 10.1158/1055-9965.EPI-05-0864; GRUNERT S, 1994, EMBO J, V13, P3618, DOI 10.1002/j.1460-2075.1994.tb06669.x; Hu XR, 2001, J PATHOL, V195, P307, DOI 10.1002/path.944; Hu XR, 1999, INT J CANCER, V83, P34, DOI 10.1002/(SICI)1097-0215(19990924)83:1<34::AID-IJC7>3.0.CO;2-Q; Hubert WG, 2005, J VIROL, V79, P5914, DOI 10.1128/JVI.79.10.5914-5922.2005; Huertas-Salgado A, 2011, VIROLOGY, V410, P201, DOI 10.1016/j.virol.2010.10.039; Kammer C, 2002, BRIT J CANCER, V86, P269, DOI 10.1038/sj.bjc.6600024; Kanodia S, 2007, CURR CANCER DRUG TAR, V7, P79, DOI 10.2174/156800907780006869; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lee K, 2008, VIRUS RES, V131, P106, DOI 10.1016/j.virusres.2007.08.003; Lentz MR, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-13; LOOMAN AC, 1991, YEAST, V7, P157, DOI 10.1002/yea.320070209; Lurchachaiwong W, 2009, VIRUS GENES, V39, P30, DOI 10.1007/s11262-009-0363-0; Matovina M, 2009, GYNECOL ONCOL, V113, P120, DOI 10.1016/j.ygyno.2008.12.004; Milutin-Gagperov N, 2007, COLLEGIUM ANTROPOL, V31, P89; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nindl I, 1999, INT J CANCER, V82, P203, DOI 10.1002/(SICI)1097-0215(19990719)82:2<203::AID-IJC9>3.0.CO;2-9; O'Connor M, 1995, HUMAN PAPILLOMAVIRUS, pIII21; Ortiz M, 2006, J CLIN MICROBIOL, V44, P1428, DOI 10.1128/JCM.44.4.1428-1434.2006; OVANINRAKIC A, 2003, GYNAECOL PERINATOL, V12, P148; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sabol I, 2008, J MED VIROL, V80, P2134, DOI 10.1002/jmv.21304; Sabol I, 2009, J VIROL METHODS, V162, P142, DOI 10.1016/j.jviromet.2009.07.029; Sailaja G, 1999, J GEN VIROL, V80, P1715, DOI 10.1099/0022-1317-80-7-1715; Smith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021375; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Sreekumar E, 2005, INT J IMMUNOGENET, V32, P355, DOI 10.1111/j.1744-313X.2005.00538.x; Stacey SN, 2000, J VIROL, V74, P7284, DOI 10.1128/JVI.74.16.7284-7297.2000; SVERDRUP F, 1997, HUMAN PAPILLOMAVIRUS, P37; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Duin M, 2000, J GEN VIROL, V81, P317, DOI 10.1099/0022-1317-81-2-317; Volkova OA, 2010, J BIOMOL STRUCT DYN, V27, P611, DOI 10.1080/07391102.2010.10508575; Wheeler CM, 1997, J CLIN MICROBIOL, V35, P11, DOI 10.1128/JCM.35.1.11-19.1997; Wilson VG, 2002, VIRUS GENES, V24, P275, DOI 10.1023/A:1015336817836; Wisniewska MB, 2007, J MOL BIOL, V371, P569, DOI 10.1016/j.jmb.2007.05.079; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Yasugi T, 1997, J VIROL, V71, P891, DOI 10.1128/JVI.71.2.891-899.1997; Zehbe I, 1998, LANCET, V352, P1441, DOI 10.1016/S0140-6736(05)61263-9; Zehbe I, 2001, INT J CANCER, V94, P711, DOI 10.1002/ijc.1520; Zehbe I, 1998, CANCER RES, V58, P829; Zehbe I, 2009, VIROLOGY, V383, P69, DOI 10.1016/j.virol.2008.09.036; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao KN, 2003, VIRUS RES, V98, P95, DOI 10.1016/j.virusres.2003.08.019; Zhao KN, 2011, REV MED VIROL, V21, P397, DOI 10.1002/rmv.707; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; Zouridis H, 2008, BIOPHYS J, V95, P1018, DOI 10.1529/biophysj.107.126128; Zuna RE, 2009, INT J CANCER, V125, P2609, DOI 10.1002/ijc.24706	72	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41045	10.1371/journal.pone.0041045	http://dx.doi.org/10.1371/journal.pone.0041045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911739	gold, Green Published, Green Submitted			2022-12-27	WOS:000306751300022
J	Fenouille, N; Tichet, M; Dufies, M; Pottier, A; Mogha, A; Soo, JK; Rocchi, S; Mallavialle, A; Galibert, MD; Khammari, A; Lacour, JP; Ballotti, R; Deckert, M; Tartare-Deckert, S				Fenouille, Nina; Tichet, Melanie; Dufies, Maeva; Pottier, Anais; Mogha, Ariane; Soo, Julia K.; Rocchi, Stephane; Mallavialle, Aude; Galibert, Marie-Dominique; Khammari, Amir; Lacour, Jean-Philippe; Ballotti, Robert; Deckert, Marcel; Tartare-Deckert, Sophie			The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion	PLOS ONE			English	Article							REPRESSES E-CADHERIN; TRANSCRIPTION FACTOR SLUG; MALIGNANT-MELANOMA; SIGNALING PATHWAY; EXPRESSION; KINASE; PROTEIN; GROWTH; TUMOR; PROGRESSION	During progression of melanoma, malignant melanocytes can be reprogrammed into mesenchymal-like cells through a process similar to epithelial-mesenchymal transition (EMT), which is associated with downregulation of the junctional protein E-cadherin and acquisition of a migratory phenotype. Recent evidence supports a role for SLUG, a transcriptional repressor of E-cadherin, as a melanocyte lineage transcription factor that predisposes to melanoma metastasis. However, the signals responsible for SLUG expression in melanoma are unclear and its role in the invasive phenotype is not fully elucidated. Here, we report that SLUG expression and activation is driven by SPARC (also known as osteonectin), a secreted extracellular matrix-associated factor that promotes EMT-like changes. Ectopic expression or knockdown of SPARC resulted in increased or reduced expression of SLUG, respectively. SLUG increase occurred concomitantly with SPARC-mediated downregulation of E-cadherin and P-cadherin, and induction of mesenchymal traits in human melanocytes and melanoma cells. Pharmacological blockade of PI3 kinase/AKT signaling impeded SPARC-induced SLUG levels and cell migration, whereas adenoviral introduction of constitutively active AKT allowed rescue of SLUG and migratory capabilities of SPARC knockdown cells. We also observed that pharmacological inhibition of oncogenic BRAF(V600E) using PLX4720 did not influence SLUG expression in melanoma cells harboring BRAF(V600E). Furthermore, SLUG is a bona fide transcriptional repressor of E-cadherin as well as a regulator of P-cadherin in melanoma cells and its knockdown attenuated invasive behavior and blocked SPARC-enhanced cell migration. Notably, inhibition of cell migration in SPARC-depleted cells was rescued by expression of a SLUG transgene. In freshly isolated metastatic melanoma cells, a positive association between SPARC and SLUG mRNA levels was also found. These findings reveal that autocrine SPARC maintains heightened SLUG expression in melanoma cells and indicate that SPARC may promote EMT-associated tumor invasion by supporting AKT-dependent upregulation of SLUG.	[Fenouille, Nina; Tichet, Melanie; Dufies, Maeva; Pottier, Anais; Rocchi, Stephane; Ballotti, Robert; Tartare-Deckert, Sophie] Ctr Mediterraneen Med Mol Biol & Pathol Melanocyt, INSERM, U1065, Nice, France; [Fenouille, Nina; Tichet, Melanie; Pottier, Anais; Mallavialle, Aude; Deckert, Marcel; Tartare-Deckert, Sophie] C3M, INSERM, U1065, Nice, France; [Fenouille, Nina; Tichet, Melanie; Dufies, Maeva; Pottier, Anais; Rocchi, Stephane; Mallavialle, Aude; Ballotti, Robert; Deckert, Marcel; Tartare-Deckert, Sophie] Univ Nice Sophia Antipolis, Fac Med, Inst Signalisat & Pathol IFR50, Nice, France; [Mogha, Ariane; Galibert, Marie-Dominique] Univ Rennes 1, CHU, CNRS UMR6290, Rennes, France; [Soo, Julia K.] Univ London, Div Biomed Sci, London, England; [Khammari, Amir] CHU Nantes, INSERM, Dept OncoDermatol, U892, F-44035 Nantes 01, France; [Rocchi, Stephane; Lacour, Jean-Philippe; Ballotti, Robert; Tartare-Deckert, Sophie] CHU Nice, Hop Archet, Serv Dermatol, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Rennes; Universite de Rennes; University of London; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; CHU Nice	Fenouille, N (corresponding author), Ctr Mediterraneen Med Mol Biol & Pathol Melanocyt, INSERM, U1065, Nice, France.	tartare@unice.fr	Deckert, Marcel/M-4998-2016; Fenouille, Nina/AAI-1027-2021; Deckert, Marcel/T-3566-2019; BALLOTTI, Robert/F-8825-2013; TARTARE-DECKERT, Sophie/P-6057-2015; Rocchi, Stephane/O-4152-2016	Deckert, Marcel/0000-0003-2094-559X; TARTARE-DECKERT, Sophie/0000-0001-8680-5720; Rocchi, Stephane/0000-0002-0943-1304; Tichet, Melanie/0000-0001-7128-4061; BALLOTTI, Robert/0000-0002-7322-4908; mallavialle, aude/0000-0002-9380-6788; Dufies, Maeva/0000-0003-1732-0388	Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche sur le Cancer (ARC); ARC; Contrat d'Interface Clinique, Service de Dermatologie, CHU de Nice	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); ARC(Australian Research Council); Contrat d'Interface Clinique, Service de Dermatologie, CHU de Nice	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Association pour la Recherche sur le Cancer (ARC). NF is a recipient of a doctoral fellowship from ARC. STD is a recipient of a Contrat d'Interface Clinique, Service de Dermatologie, CHU de Nice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MJ, 2005, CANCER RES, V65, P5123, DOI 10.1158/0008-5472.CAN-04-1102; Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Bailet O, 2009, CANCER RES, V69, P2748, DOI 10.1158/0008-5472.CAN-08-2690; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bauer R, 2005, EXP CELL RES, V305, P418, DOI 10.1016/j.yexcr.2005.01.024; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Clark CJ, 2008, J CELL BIOCHEM, V104, P721, DOI 10.1002/jcb.21688; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fenouille N, 2011, ONCOGENE, V30, P4887, DOI 10.1038/onc.2011.198; Fenouille N, 2011, PIGM CELL MELANOMA R, V24, P219, DOI 10.1111/j.1755-148X.2010.00790.x; Fenouille N, 2010, CANCER RES, V70, P9659, DOI 10.1158/0008-5472.CAN-10-2034; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Gaggioli C, 2005, ONCOGENE, V24, P1423, DOI 10.1038/sj.onc.1208318; Grille SJ, 2003, CANCER RES, V63, P2172; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hajra KM, 2002, CANCER RES, V62, P1613; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hsu MY, 2000, AM J PATHOL, V156, P1515, DOI 10.1016/S0002-9440(10)65023-7; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Koefinger P, 2011, PIGM CELL MELANOMA R, V24, P382, DOI 10.1111/j.1755-148X.2010.00807.x; Kuphal S, 2009, PIGM CELL MELANOMA R, V22, P296, DOI 10.1111/j.1755-148X.2009.00568.x; Ledda MF, 1997, NAT MED, V3, P171, DOI 10.1038/nm0297-171; LEDOUARIN NM, 1994, CURR OPIN GENET DEV, V4, P685, DOI 10.1016/0959-437X(94)90135-P; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Murakami M, 2010, MOL BIOL REP, V37, P1279, DOI 10.1007/s11033-009-9502-x; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Losada J, 2003, ONCOGENE, V22, P4205, DOI 10.1038/sj.onc.1206467; Pla P, 2001, J CELL PHYSIOL, V189, P121, DOI 10.1002/jcp.10008; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Robertson GP, 2005, CANCER METAST REV, V24, P273, DOI 10.1007/s10555-005-1577-9; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Sanchez-Martin M, 2002, HUM MOL GENET, V11, P3231, DOI 10.1093/hmg/11.25.3231; Sanchez-Martin MS, 2003, AM J MED GENET A, V122A, P125, DOI 10.1002/ajmg.a.20345; Satyamoorthy K, 2003, CANCER RES, V63, P756; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Smit DJ, 2007, INT J CANCER, V121, P2653, DOI 10.1002/ijc.23039; Soo JK, 2011, PIGM CELL MELANOMA R, V24, P490, DOI 10.1111/j.1755-148X.2011.00850.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Turner FE, 2006, J BIOL CHEM, V281, P21321, DOI 10.1074/jbc.M509731200; Van Marck V, 2011, INT J CANCER, V128, P1031, DOI 10.1002/ijc.25427; Vannini I, 2007, CELL ONCOL, V29, P279; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029	54	145	150	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40378	10.1371/journal.pone.0040378	http://dx.doi.org/10.1371/journal.pone.0040378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911700	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600018
J	Murugan, R				Murugan, Rajamanickam			Theory on the Dynamics of Feedforward Loops in the Transcription Factor Networks	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; RESPONSE-TIMES; FLUCTUATIONS; CELL	Feedforward loops (FFLs) consist of three genes which code for three different transcription factors A, B and C where B regulates C and A regulates both B and C. We develop a detailed model to describe the dynamical behavior of various types of coherent and incoherent FFLs in the transcription factor networks. We consider the deterministic and stochastic dynamics of both promoter-states and synthesis and degradation of mRNAs of various genes associated with FFL motifs. Detailed analysis shows that the response times of FFLs strongly dependent on the ratios (w(h) = gamma(pc)/gamma(ph) where h = a, b, c corresponding to genes A, B and C) between the lifetimes of mRNAs (1/gamma(mh)) of genes A, B and C and the protein of C (1/gamma(pc)). Under strong binding conditions we can categorize all the possible types of FFLs into groups I, II and III based on the dependence of the response times of FFLs on w(h). Group I that includes C1 and I1 type FFLs seem to be less sensitive to the changes in w(h). The coherent C1 type seems to be more robust against changes in other system parameters. We argue that this could be one of the reasons for the abundant nature of C1 type coherent FFLs.	Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Murugan, R (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India.	rmurugan@gmail.com	Murugan, Rajamanickam/A-9700-2008	Murugan, Rajamanickam/0000-0002-5454-3540				Alberts B, 1994, MOL BIOL CELL, P331; Alon U., 2006, INTRO SYSTEMS BIOL D, P41; [Anonymous], 2004, HDB STOCHASTIC METHO; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Elkon R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-259; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Levin B, 2011, GENES X, P546; Lomholt MA, 2009, P NATL ACAD SCI USA, V106, P8204, DOI 10.1073/pnas.0903293106; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Murugan R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011901; Murugan R, 2010, BIOPHYS J, V99, P353, DOI 10.1016/j.bpj.2010.04.026; Murugan R, 2010, J PHYS A, V43; Murugan R, 2011, BIOPHYS J, V101, P1297, DOI 10.1016/j.bpj.2011.08.005; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ptashne M, 2001, GENES SIGNALS, P60; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Wall ME, 2005, J MOL BIOL, V349, P501, DOI 10.1016/j.jmb.2005.04.022	28	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41027	10.1371/journal.pone.0041027	http://dx.doi.org/10.1371/journal.pone.0041027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911735	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600039
J	Steere, N; Chae, V; Burke, M; Li, FQ; Takemaru, KI; Kuriyama, R				Steere, Nathan; Chae, Vanessa; Burke, Michael; Li, Feng-Qian; Takemaru, Ken-Ichi; Kuriyama, Ryoko			A Wnt/beta-Catenin Pathway Antagonist Chibby Binds Cenexin at the Distal End of Mother Centrioles and Functions in Primary Cilia Formation	PLOS ONE			English	Article							BETA-CATENIN; EPITHELIAL-CELLS; AXIN LOCALIZES; BASAL BODY; CENTROSOME; COMPLEX; CYCLE; CILIOGENESIS; TRANSITION; COMPONENT	The mother centriole of the centrosome is distinguished from immature daughter centrioles by the presence of accessory structures (distal and subdistal appendages), which play an important role in the organization of the primary cilium in quiescent cells. Primary cilia serve as sensory organelles, thus have been implicated in mediating intracellular signal transduction pathways. Here we report that Chibby (Cby), a highly conserved antagonist of the Wnt/beta-catenin pathway, is a centriolar component specifically located at the distal end of the mother centriole and essential for assembly of the primary cilium. Cby appeared as a discrete dot in the middle of a ring-like structure revealed by staining with a distal appendage component of Cep164. Cby interacted with one of the appendage components, Cenexin (Cnx), which thereby abrogated the inhibitory effect of Cby on beta-catenin-mediated transcriptional activation in a dose-dependent manner. Cby and Cnx did not precisely align, as Cby was detected at a more distal position than Cnx. Cnx emerged earlier than Cby during the cell cycle and was required for recruitment of Cby to the mother centriole. However, Cby was dispensable for Cnx localization to the centriole. During massive centriogenesis in in vitro cultured mouse tracheal epithelial cells, Cby and Cnx were expressed in a similar pattern, which was coincident with the expression of Foxj1. Our results suggest that Cby plays an important role in organization of both primary and motile cilia in collaboration with Cnx.	[Steere, Nathan; Chae, Vanessa; Kuriyama, Ryoko] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Burke, Michael; Takemaru, Ken-Ichi] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; [Burke, Michael; Takemaru, Ken-Ichi] SUNY Stony Brook, Med Scientist Training Program, Stony Brook, NY 11794 USA; [Li, Feng-Qian; Takemaru, Ken-Ichi] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Steere, N (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	kuriy001@umn.edu			National Institutes of Health [GM55735, HL107493]; National Science Foundation [MCB1140033]; Minnesota Medical Foundation; American Heart Association [09GRNT2261212]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107493, R56HL107493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055735, T32GM008444] Funding Source: NIH RePORTER; Direct For Biological Sciences [1140033] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Minnesota Medical Foundation; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health Grant Numbers GM55735 (Dr. Kuriyama) and HL107493 (Dr. Takemaru), National Science Foundation Grant Number MCB1140033 (Dr. Kuriyama), Minnesota Medical Foundation (Dr. Kuriyama), and American Heart Association Grant Number 09GRNT2261212 (Dr. Takemaru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova EM, 2010, DEV DYNAM, V239, P261, DOI 10.1002/dvdy.22125; Alieva IB, 2004, CELL BIOL INT, V28, P139, DOI 10.1016/j.cellbi.2003.11.013; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Gaillard CLB, 2011, MOL BIOL CELL, V22, P4549, DOI 10.1091/mbc.E11-05-0405; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Itoh K, 2009, J CELL SCI, V122, P3791, DOI 10.1242/jcs.057067; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Kim SM, 2009, EXP CELL RES, V315, P943, DOI 10.1016/j.yexcr.2009.01.013; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Li FQ, 2010, MOL BIOL CELL, V21, P311, DOI 10.1091/mbc.E09-05-0437; Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939; Love D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013600; Mogensen MM, 2000, J CELL SCI, V113, P3013; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Ocbina PJR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006839; Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Sillibourne JE, 2011, CYTOSKELETON, V68, P619, DOI 10.1002/cm.20536; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; SOROKIN SP, 1968, J CELL SCI, V3, P207; Soung NK, 2009, DEV CELL, V16, P539, DOI 10.1016/j.devcel.2009.02.004; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Voronina VA, 2009, J CELL BIOL, V181, P1141; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	47	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41077	10.1371/journal.pone.0041077	http://dx.doi.org/10.1371/journal.pone.0041077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911743	Green Submitted, gold, Green Published			2022-12-27	WOS:000306644600043
J	Switt, AIM; den Bakker, HC; Cummings, CA; Rodriguez-Rivera, LD; Govoni, G; Raneiri, ML; Degoricija, L; Brown, S; Hoelzer, K; Peters, JE; Bolchacova, E; Furtado, MR; Wiedmann, M				Switt, Andrea I. Moreno; den Bakker, Henk C.; Cummings, Craig A.; Rodriguez-Rivera, Lorraine D.; Govoni, Gregory; Raneiri, Matthew L.; Degoricija, Lovorka; Brown, Stephanie; Hoelzer, Karin; Peters, Joseph E.; Bolchacova, Elena; Furtado, Manohar R.; Wiedmann, Martin			Identification and Characterization of Novel Salmonella Mobile Elements Involved in the Dissemination of Genes Linked to Virulence and Transmission	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEMS; ENTERICA SEROVAR TYPHIMURIUM; COMPLETE GENOME SEQUENCE; TOXIN-ANTITOXIN SYSTEMS; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; PATHOGENICITY ISLAND; UNITED-STATES; ANTIBIOTIC-RESISTANCE; CONJUGATIVE ELEMENTS	The genetic diversity represented by >2,500 different Salmonella serovars provides a yet largely uncharacterized reservoir of mobile elements that can contribute to the frequent emergence of new pathogenic strains of this important zoonotic pathogen. Currently, our understanding of Salmonella mobile elements is skewed by the fact that most studies have focused on highly virulent or common serovars. To gain a more global picture of mobile elements in Salmonella, we used prediction algorithms to screen for mobile elements in 16 sequenced Salmonella genomes representing serovars for which no prior genome scale mobile element data were available. From these results, selected mobile elements underwent further analyses in the form of validation studies, comparative analyses, and PCR-based population screens. Through this analysis we identified a novel plasmid that has two cointegrated replicons (IncI1-IncFIB); this plasmid type was found in four genomes representing different Salmonella serovars and contained a virulence gene array that had not been previously identified. A Salmonella Montevideo isolate contained an IncHI and an IncN2 plasmid, which both encoded antimicrobial resistance genes. We also identified two novel genomic islands (SGI2 and SGI3), and 42 prophages with mosaic architecture, seven of them harboring known virulence genes. Finally, we identified a novel integrative conjugative element (ICE) encoding a type IVb pilus operon in three non-typhoidal Salmonella serovars. Our analyses not only identified a considerable number of mobile elements that have not been previously reported in Salmonella, but also found evidence that these elements facilitate transfer of genes that were previously thought to be limited in their distribution among Salmonella serovars. The abundance of mobile elements encoding pathogenic properties may facilitate the emergence of strains with novel combinations of pathogenic traits.	[Switt, Andrea I. Moreno; den Bakker, Henk C.; Rodriguez-Rivera, Lorraine D.; Raneiri, Matthew L.; Brown, Stephanie; Hoelzer, Karin; Wiedmann, Martin] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Cummings, Craig A.; Govoni, Gregory; Degoricija, Lovorka; Bolchacova, Elena; Furtado, Manohar R.] Life Technol Corp, Foster City, CA USA; [Peters, Joseph E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Cornell University; Thermo Fisher Scientific; Cornell University	Switt, AIM (corresponding author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.	mw16@cornell.edu	Peters, Joseph/P-7130-2019; Wiedmann, Martin/A-9683-2008; Bakker, Henk den/AAF-8282-2020; den Bakker, Hendrik/A-8136-2010; Switt, Andrea I Moreno/B-3285-2017; Rodriguez-Rivera, Lorraine D/E-6098-2013	Peters, Joseph/0000-0001-8309-3297; Wiedmann, Martin/0000-0002-4168-5662; den Bakker, Hendrik/0000-0002-4086-1580; Switt, Andrea I Moreno/0000-0001-8231-9397; Rodriguez-Rivera, Lorraine D/0000-0002-0890-2274; Govoni, Gregory/0000-0002-4664-0834; Furtado, Manohar/0000-0001-6016-1357	USDA [2006-34459-16952, 2009-34459-19750, 2010-34459-20756]; Life Technologies Corporation	USDA(United States Department of Agriculture (USDA)); Life Technologies Corporation	This work was supported by USDA (http://www.csrees.usda.gov/fo/agriculturalandfoodresearchinitiativeafri.cfm) Special Research Grants 2006-34459-16952; 2009-34459-19750, and 2010-34459-20756 (to MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, Life Technologies Corporation partially funded this study by providing sequencing reagents and instruments and by compensating its employees (GG, CAC, LD, EB and MRF), who participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bishop AL, 2005, J BACTERIOL, V187, P2469, DOI 10.1128/JB.187.7.2469-2482.2005; Boquet P, 2000, MICROBES INFECT, V2, P837, DOI 10.1016/S1286-4579(00)90369-1; Brown JM, 2003, J BACTERIOL, V185, P6600, DOI 10.1128/JB.185.22.6600-6608.2003; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Bukowski M, 2011, ACTA BIOCHIM POL, V58, P1; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; [CDC] Center for Disease Control and Prevention, 2009, SALM ANN SUMM; Centers for Disease Control and Prevention, 2011, NAT ENT DIS SURV SAL; Chu C, 2012, CLIN MICROBIOL INFEC, V18, P47, DOI 10.1111/j.1469-0691.2011.03464.x; Chu CS, 2006, MICROBES INFECT, V8, P1931, DOI 10.1016/j.micinf.2005.12.026; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Cogez V, 2002, EUR J BIOCHEM, V269, P2473, DOI 10.1046/j.1432-1033.2002.02907.x; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Douard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015302; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Doublet B, 2004, ANTIMICROB AGENTS CH, V48, P3806, DOI 10.1128/AAC.48.10.3806-3812.2004; Doublet B, 2009, J ANTIMICROB CHEMOTH, V63, P282, DOI 10.1093/jac/dkn500; Doumith M, 2012, J ANTIMICROB CHEMOTH, V67, P878, DOI 10.1093/jac/dkr553; Ehrbar K, 2003, J BACTERIOL, V185, P6950, DOI 10.1128/JB.185.23.6950-6967.2003; Ehrbar Kristin, 2005, Infection Genetics and Evolution, V5, P1; Fernandez-Alarcon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023415; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Folster JP, 2011, FOODBORNE PATHOG DIS, V8, P1289, DOI 10.1089/fpd.2011.0944; Fookes M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002191; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Fries M, 2007, EMBO J, V26, P3879, DOI 10.1038/sj.emboj.7601816; Furuta Y, 2010, NUCLEIC ACIDS RES, V38, P2428, DOI 10.1093/nar/gkp1226; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Gough NR, 2008, SCI SIGNAL, V1, pec129; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Hall RM, 2010, FUTURE MICROBIOL, V5, P1525, DOI 10.2217/FMB.10.122; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Herrero A, 2009, EUR J CLIN MICROBIOL, V28, P1087, DOI 10.1007/s10096-009-0753-1; Ho TD, 2002, J BACTERIOL, V184, P5234, DOI 10.1128/JB.184.19.5234-5239.2002; Holt KE, 2007, J BACTERIOL, V189, P4257, DOI 10.1128/JB.00232-07; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Johnson TJ, 2006, ANTIMICROB AGENTS CH, V50, P3929, DOI 10.1128/AAC.00569-06; Johnson TJ, 2011, PLASMID, V66, P144, DOI 10.1016/j.plasmid.2011.07.003; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; KOMANO T, 1994, J MOL BIOL, V243, P6, DOI 10.1006/jmbi.1994.1625; Lee S, 2009, BMB REP, V42, P769, DOI 10.5483/BMBRep.2009.42.12.769; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; McLaughlin LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000671; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mirold S, 2001, J MOL BIOL, V312, P7, DOI 10.1006/jmbi.2001.4950; Morris C, 2003, MICROB PATHOGENESIS, V35, P279, DOI 10.1016/j.micpath.2003.08.001; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parks AR, 2009, PLASMID, V61, P1, DOI 10.1016/j.plasmid.2008.09.008; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; Pimenta AL, 2005, J BACTERIOL, V187, P7471, DOI 10.1128/JB.187.21.7471-7480.2005; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Savard P, 2011, ANTIMICROB AGENTS CH, V55, P5957, DOI 10.1128/AAC.05719-11; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Seth-Smith HMB, 2012, J BACTERIOL, V194, P1494, DOI 10.1128/JB.06403-11; Seth-Smith HMB, 2008, J INFECT DEV COUNTR, V2, P267, DOI 10.3855/jidc.220; Sibley MH, 2004, NUCLEIC ACIDS RES, V32, P522, DOI 10.1093/nar/gkh194; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanley TL, 2000, J BACTERIOL, V182, P4406, DOI 10.1128/JB.182.16.4406-4413.2000; Sulakvelidze Andrew M. Kropinski Alexander, 2007, V394, P133, DOI 10.1007/978-1-59745-512-1_9; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Takahashi H, 2011, PLASMID, V66, P112, DOI 10.1016/j.plasmid.2011.06.004; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Tracz DM, 2006, J CLIN MICROBIOL, V44, P2007, DOI 10.1128/JCM.02630-05; Uchida I, 2009, MICROBIOL-SGM, V155, P3710, DOI 10.1099/mic.0.028399-0; van Asten AJAM, 2005, FEMS IMMUNOL MED MIC, V44, P251, DOI 10.1016/j.femsim.2005.02.002; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Zhang XL, 2000, INFECT IMMUN, V68, P3067, DOI 10.1128/IAI.68.6.3067-3073.2000; Zou QH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-729	88	39	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41247	10.1371/journal.pone.0041247	http://dx.doi.org/10.1371/journal.pone.0041247			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911766	Green Submitted, Green Published, gold			2022-12-27	WOS:000306644600060
J	Yang, J; Bachrati, CZ; Hickson, ID; Brown, GW				Yang, Jay; Bachrati, Csanad Z.; Hickson, Ian D.; Brown, Grant W.			BLM and RMI1 Alleviate RPA Inhibition of TopoIII alpha Decatenase Activity	PLOS ONE			English	Article							REPLICATION PROTEIN-A; TOPOISOMERASE-III-ALPHA; BLOOMS-SYNDROME PROTEIN; STRANDED-DNA-BINDING; SUBSTRATE; HELICASE; PURIFICATION; BLAP75; WERNER	RPA is a single-stranded DNA binding protein that physically associates with the BLM complex. RPA stimulates BLM helicase activity as well as the double Holliday junction dissolution activity of the BLM-topoisomerase III alpha complex. We investigated the effect of RPA on the ssDNA decatenase activity of topoisomerase III alpha. We found that RPA and other ssDNA binding proteins inhibit decatenation by topoisomerase III alpha. Complex formation between BLM, TopoIII alpha, and RMI1 ablates inhibition of decatenation by ssDNA binding proteins. Together, these data indicate that inhibition by RPA does not involve species-specific interactions between RPA and BLM-TopoIII alpha-RMI1, which contrasts with RPA modulation of double Holliday junction dissolution. We propose that topoisomerase III alpha and RPA compete to bind to single-stranded regions of catenanes. Interactions with BLM and RMI1 enhance toposiomerase III alpha activity, promoting decatenation in the presence of RPA.	[Yang, Jay; Brown, Grant W.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Yang, Jay; Brown, Grant W.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Bachrati, Csanad Z.; Hickson, Ian D.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Hickson, Ian D.] Univ Copenhagen, Ctr Healthy Aging, Dept Cellular & Mol Med, Copenhagen, Denmark	University of Toronto; University of Toronto; University of Oxford; University of Copenhagen	Yang, J (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	grant.brown@utoronto.ca	Bachrati, Csanad/ABF-2020-2021; Hickson, Ian/AAJ-7548-2020	Bachrati, Csanad/0000-0003-1703-5894; Brown, Grant/0000-0002-9002-5003; Hickson, Ian/0000-0002-0583-566X	Canadian Institutes of Health Research [MOP-79368]; Cancer Research UK; Bloom's Syndrome Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK); Bloom's Syndrome Foundation	This work was supported by Canadian Institutes of Health Research Grant MOP-79368 (to GWB), and by Cancer Research UK and the Bloom's Syndrome Foundation (to IDH and CZB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Desai NA, 2003, FEMS MICROBIOL REV, V26, P457, DOI 10.1016/S0168-6445(02)00129-8; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; Garcia PL, 2004, NUCLEIC ACIDS RES, V32, P3771, DOI 10.1093/nar/gkh709; Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; KIRKEGAARD K, 1985, J MOL BIOL, V185, P625, DOI 10.1016/0022-2836(85)90075-0; Liu Y, 2008, GENE DEV, V22, P2737, DOI 10.1101/gad.1732808; Machwe A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-1; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Plank JL, 2005, J BIOL CHEM, V280, P3564, DOI 10.1074/jbc.M411337200; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Raynard S, 2008, J BIOL CHEM, V283, P15701, DOI 10.1074/jbc.M802127200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Sharma S, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/724215; Sikder D, 2001, J MOL BIOL, V306, P669, DOI 10.1006/jmbi.2000.4384; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41208	10.1371/journal.pone.0041208	http://dx.doi.org/10.1371/journal.pone.0041208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911760	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000306644600056
J	Li, S; Roberts, S; Plebanski, M; Gouillou, M; Spelman, T; Latour, P; Jackson, D; Brown, L; Sparrow, RL; Prince, HM; Hart, D; Loveland, BE; Gowans, EJ				Li, Shuo; Roberts, Stuart; Plebanski, Magdalena; Gouillou, Maelenn; Spelman, Tim; Latour, Philippe; Jackson, David; Brown, Lorena; Sparrow, Rosemary L.; Prince, H. Miles; Hart, Derek; Loveland, Bruce E.; Gowans, Eric J.			Induction of Multi-Functional T Cells in a Phase I Clinical Trial of Dendritic Cell Immunotherapy in Hepatitis C Virus Infected Individuals	PLOS ONE			English	Article							TNF-ALPHA; QUALITY; MEMORY	We have previously reported a world-first phase I clinical trial to treat HCV patients using monocyte-derived dendritic cells (Mo-DC) loaded with HCV-specific lipopeptides. While the brief treatment proved to be safe, it failed to reduce the viral load and induced only transient cell-mediated immune responses, measured by IFN gamma ELIspot. Here we reanalysed the PBMC samples from this trial to further elucidate the immunological events associated with the Mo-DC therapy. We found that HCV-specific single-and multi-cytokine secreting T cells were induced by the Mo-DC immunotherapy in some patients, although at irregular intervals and not consistently directed to the same HCV antigen. Despite the vaccination, the responses were generally poor in quality and comprised of primarily single-cytokine secreting cells. The frequency of FOXP3(+) regulatory T cells (Treg) fluctuated following DC infusion and eventually dropped to below baseline by week 12, an interesting trend suggesting that the vaccination may have resulted in a more subtle outcome than was initially apparent. Our data suggested that Mo-DC therapy induced complex immune responses in vivo that may or may not lead to clinical benefit.	[Li, Shuo; Gouillou, Maelenn; Spelman, Tim; Latour, Philippe; Loveland, Bruce E.; Gowans, Eric J.] Burnet Inst, Melbourne, Vic, Australia; [Li, Shuo; Plebanski, Magdalena; Sparrow, Rosemary L.; Loveland, Bruce E.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Roberts, Stuart] Alfred Hosp, Melbourne, Vic, Australia; [Spelman, Tim] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Jackson, David; Brown, Lorena] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Sparrow, Rosemary L.] Australian Red Cross Blood Serv, Melbourne, Vic, Australia; [Prince, H. Miles] Peter MacCallum Canc Ctr, Ctr Blood Cell Therapies, Melbourne, Australia; [Prince, H. Miles] Univ Melbourne, Melbourne, Vic 3010, Australia; [Hart, Derek] Univ Sydney, Sydney, NSW 2006, Australia; [Gowans, Eric J.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Gowans, Eric J.] Univ Adelaide, Discipline Surg, Adelaide, SA, Australia	Burnet Institute; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; Australian Red Cross Blood Service; Peter Maccallum Cancer Center; University of Melbourne; University of Sydney; Monash University; University of Adelaide	Li, S (corresponding author), Burnet Inst, Melbourne, Vic, Australia.	shuo.li@burnet.edu.au; eric.gowans@adelaide.edu.au	gowans, eric J/M-3689-2017; Hart, Derek NJ/B-9505-2014; Li, Shuo/A-3994-2019; Plebanski, Magdalena/AAU-3144-2021	Li, Shuo/0000-0002-2763-8624; Brown, Lorena/0000-0001-9342-909X; Sparrow, Rosemary/0000-0002-6689-2983; , Magdalena/0000-0001-6889-3667; Jackson, David/0000-0001-7255-270X	National Health and Medical Research Council (NHMRC) of Australia [433908]; National Institutes of Health [RO1A1054459]; NHMRC	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The funding for this work was provided by grants from 1. National Health and Medical Research Council (NHMRC) of Australia, ID 433908; 2. National Institutes of Health RO1A1054459; and 3. Private donations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Calum de Burgh (University of Aberdeen, UK) for general technical assistance; Laurie Lamoreaux (Vaccine Research Centre, NIH) for critical advice on data interpretation; and Geza Paukovics (Burnet Institute) for assistance in flow cytometry. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. EJG is a recipient of a NHMRC Senior Research Fellow award. The following reagent was obtained through BEI Resources, NIAID, NIH: Peptide Arrays for Hepatitis C Virus H77.	Ahmed R, 2011, IMMUNOL CELL BIOL, V89, P340, DOI 10.1038/icb.2010.155; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Banerjee DK, 2006, BLOOD, V108, P2655, DOI 10.1182/blood-2006-03-011353; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Chen X, 2010, CURR DIR AUTOIMMUN, V11, P119, DOI 10.1159/000289201; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Gowans EJ, 2010, J HEPATOL, V53, P599, DOI 10.1016/j.jhep.2010.05.007; Housley WJ, 2011, J IMMUNOL, V186, P6779, DOI 10.4049/jimmunol.1003868; Jones KL, 2008, J VIRAL HEPATITIS, V15, P761, DOI 10.1111/j.1365-2893.2008.01003.x; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Li S, 2008, J VIROL, V82, P21, DOI 10.1128/JVI.01768-07; Li S, 2007, IMMUNOL CELL BIOL, V85, P197, DOI 10.1038/sj.icb.7100020; Li S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000707; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	18	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e39368	10.1371/journal.pone.0039368	http://dx.doi.org/10.1371/journal.pone.0039368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905088	Green Submitted, gold, Green Published			2022-12-27	WOS:000307500800001
J	Huang, CY; Shih, CM; Tsao, NW; Chen, YH; Li, CY; Chang, YJ; Chang, NC; Ou, KL; Lin, CY; Lin, YW; Nien, CH; Lin, FY				Huang, Chun-Yao; Shih, Chun-Ming; Tsao, Nai-Wen; Chen, Yung-Hsiang; Li, Chi-Yuan; Chang, Yu-Jia; Chang, Nen-Chung; Ou, Keng-Liang; Lin, Cheng-Yen; Lin, Yi-Wen; Nien, Chih-Hao; Lin, Feng-Yen			GroEL1, from Chlamydia pneumoniae, Induces Vascular Adhesion Molecule 1 Expression by p37(AUF1) in Endothelial Cells and Hypercholesterolemic Rabbit	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; AU-RICH ELEMENT; RANDOMIZED CONTROLLED-TRIALS; MESSENGER-RNA STABILITY; SMOOTH-MUSCLE-CELLS; HEAT-SHOCK PROTEINS; TNF-ALPHA; DIFFERENTIAL REGULATION; EARLY ATHEROSCLEROSIS; VCAM-1 EXPRESSION	The expression of vascular adhesion molecule-1 (VCAM-1) by endothelial cells may play a major role in atherogenesis. The actual mechanisms of chlamydia pneumoniae (C. pneumoniae) relate to atherogenesis are unclear. We investigate the influence of VCAM-1 expression in the GroEL1 from C. pneumoniae-administered human coronary artery endothelial cells (HCAECs) and hypercholesterolemic rabbits. In this study, we constructed the recombinant GroEL1 from C. pneumoniae. The HCAECs/THP-1 adhesion assay, tube formation assay, western blotting, enzyme-linked immunosorbent assay, actinomycin D chase experiment, luciferase reporter assay, and immunohistochemical stainings were performed. The results show that GroEL1 increased both VCAM-1expression and THP-1 cell adhesives, and impaired tube-formation capacity in the HCAECs. GroEL1 significantly increased the VCAM-1 mRNA stability and cytosolic AU-binding factor 1 (AUF1) level. Overexpression of the p37(AUF1) significantly increased VCAM-1 gene expression in GroEL1-induced bovine aortic endothelial cells (BAECs). GroEL1 prolonged the stability of VCAM-1 mRNA by increasing both p(37AUF1) and the regulation of the 5' untranslated region (UTR) of the VCAM-1 mRNA in BAECs. In hypercholesterolemic rabbits, GroEL1 administration enhanced fatty-streak and macrophage infiltration in atherosclerotic lesions, which may be mediated by elevated VCAM-1 expression. In conclusion, GroEL1 induces VCAM-1 expression by p37(AUF1) in endothelial cells and enhances atherogenesis in hypercholesterolemic rabbits.	[Huang, Chun-Yao; Shih, Chun-Ming; Chang, Nen-Chung; Lin, Feng-Yen] Taipei Med Univ, Dept Internal Med, Sch Med, Coll Med, Taipei, Taiwan; [Huang, Chun-Yao; Chang, Yu-Jia] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Huang, Chun-Yao; Ou, Keng-Liang] Taipei Med Univ, Res Ctr Biomed Implants & Microsurg Devices, Taipei, Taiwan; [Huang, Chun-Yao; Shih, Chun-Ming; Chang, Nen-Chung; Lin, Yi-Wen; Nien, Chih-Hao; Lin, Feng-Yen] Taipei Med Univ Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Tsao, Nai-Wen] Taipei Med Univ Hosp, Div Cardiovasc Surg, Dept Surg, Taipei, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Li, Chi-Yuan] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Li, Chi-Yuan] China Med Univ Hosp, Dept Anesthesiol, Taichung, Taiwan; [Chang, Nen-Chung; Lin, Yi-Wen; Nien, Chih-Hao; Lin, Feng-Yen] Taipei Med Univ Hosp, Cardiovasc Res Ctr, Taipei, Taiwan; [Lin, Cheng-Yen] Hung Kuang Univ, Dept Comp Sci & Informat Management, Taichung, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; Taipei Medical University Hospital; Hungkuang University	Huang, CY (corresponding author), Taipei Med Univ, Dept Internal Med, Sch Med, Coll Med, Taipei, Taiwan.	g870905@tmu.edu.tw	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113; Li, Chi-Yuan/0000-0003-3390-7568; Chang, Yu-Jia/0000-0003-3978-3244	National Science Council [NSC 99-2314-B-038-030-MY2]; Taiwan Department of Health Clinical Trial and Research Center of Excellence, Taiwan [DOH100-TD-B-111-004]	National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence, Taiwan	This work was funded partial by the National Science Council (NSC 99-2314-B-038-030-MY2) and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsuta J, 1999, AM J RESP CELL MOL, V20, P643, DOI 10.1165/ajrcmb.20.4.3265; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; BENNETT CF, 1994, J IMMUNOL, V152, P3530; Blessing E, 2001, ATHEROSCLEROSIS, V158, P13, DOI 10.1016/S0021-9150(00)00758-9; Borel N, 2008, ATHEROSCLEROSIS, V199, P154, DOI 10.1016/j.atherosclerosis.2007.09.026; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Croft D, 1999, AM J PATHOL, V154, P1149, DOI 10.1016/S0002-9440(10)65367-9; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hogdahl M, 2008, APMIS, V116, P1082, DOI 10.1111/j.1600-0463.2008.01145.x; Hortovanyi E, 2003, PATHOL ONCOL RES, V9, P42, DOI 10.1007/BF03033713; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Illoh KO, 2005, ATHEROSCLEROSIS, V179, P403, DOI 10.1016/j.atherosclerosis.2004.10.034; Kalayoglu MV, 1999, J INFECT DIS, V180, P780, DOI 10.1086/314931; KaukorantaTolvanen SSE, 1996, MICROB PATHOGENESIS, V21, P407, DOI 10.1006/mpat.1996.0071; Kohara K, 2002, STROKE, V33, P1474, DOI 10.1161/01.STR.0000018974.05768.FB; Kol A, 1998, CIRCULATION, V98, P300, DOI 10.1161/01.CIR.98.4.300; Kol A, 1999, J CLIN INVEST, V103, P571, DOI 10.1172/JCI5310; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Krull M, 1999, J IMMUNOL, V162, P4834; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lin FY, 2011, SHOCK, V36, P279, DOI 10.1097/SHK.0b013e3182236e7e; Lin FY, 2011, J IMMUNOL, V186, P4405, DOI 10.4049/jimmunol.1003116; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Pietersma A, 1997, BIOCHEM BIOPH RES CO, V230, P44, DOI 10.1006/bbrc.1996.5886; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Schumacher A, 2002, CLIN MICROBIOL INFEC, V8, P654, DOI 10.1046/j.1469-0691.2002.00439.x; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Tsai CS, 2009, SHOCK, V32, P40, DOI 10.1097/SHK.0b013e318199608d; Ueda R, 2009, P NATL ACAD SCI USA, V106, P10746, DOI 10.1073/pnas.0811817106; Volanen I, 2006, ARTERIOSCL THROM VAS, V26, P649, DOI 10.1161/01.ATV.0000202664.76816.bb; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Wells BJ, 2004, ARCH INTERN MED, V164, P2156, DOI 10.1001/archinte.164.19.2156; WERTHEIMER SJ, 1992, J BIOL CHEM, V267, P12030; Wuppermann FN, 2008, J BACTERIOL, V190, P3757, DOI 10.1128/JB.01638-07; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Xu QB, 2003, CURR OPIN CARDIOL, V18, P245, DOI 10.1097/00001573-200307000-00001; Yu H, 2011, CYTOKINE, V56, P245, DOI 10.1016/j.cyto.2011.06.006; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	45	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42808	10.1371/journal.pone.0042808	http://dx.doi.org/10.1371/journal.pone.0042808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900050	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900068
J	Wang, YF; Zhu, S; Weisman, GA; Gitlin, JD; Petris, MJ				Wang, Yanfang; Zhu, Sha; Weisman, Gary A.; Gitlin, Jonathan D.; Petris, Michael J.			Conditional Knockout of the Menkes Disease Copper Transporter Demonstrates Its Critical Role in Embryogenesis	PLOS ONE			English	Article							P-TYPE ATPASE; MOUSE; ATP7A; GENE; MICE; HOMEOSTASIS; PROTEIN; ACTIVATION; EXPRESSION; RESISTANCE	The transition metal, copper (Cu), is an enzymatic cofactor required for a wide range of biochemical processes. Its essentiality is demonstrated by Menkes disease, an X-linked copper deficiency disorder characterized by defects in nervous-, cardiovascular-and skeletal systems, and is caused by mutations in the ATP7A copper transporter. Certain ATP7A mutations also cause X-linked Spinal Muscular Atrophy type 3 (SMAX3), which is characterized by neuromuscular defects absent an underlying systemic copper deficiency. While an understanding of these ATP7A-related disorders would clearly benefit from an animal model that permits tissue-specific deletion of the ATP7A gene, no such model currently exists. In this study, we generated a floxed mouse model allowing the conditional deletion of the Atp7a gene using Cre recombinase. Global deletion of Atp7a resulted in morphological and vascular defects in hemizygous male embryos and death in utero. Heterozygous deletion in females resulted in a 50% reduction in live births and a high postnatal lethality. These studies demonstrate the essential role of the Atp7a gene in mouse embryonic development and establish a powerful model for understanding the tissue-specific roles of ATP7A in copper metabolism and disease.	[Wang, Yanfang; Zhu, Sha; Weisman, Gary A.; Petris, Michael J.] Univ Missouri, Dept Biochem, Columbia, MO USA; [Wang, Yanfang; Petris, Michael J.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Wang, Yanfang; Zhu, Sha; Weisman, Gary A.; Petris, Michael J.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA; [Gitlin, Jonathan D.] Marine Biol Lab, Woods Hole, MA 02543 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Marine Biological Laboratory - Woods Hole	Wang, YF (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO USA.	petrism@missouri.edu	Johnson, Michael D. L./B-4352-2012		National Institutes of Health [DK59893, DK093386, DK44464]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044464, R01DK059893, R01DK093386, R01DK044464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK59893 and DK093386 to M.J.P., and DK44464 to J.D.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashino T, 2010, CIRC RES, V107, P787, DOI 10.1161/CIRCRESAHA.110.225334; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Czyzyk TA, 2005, DEV BIOL, V287, P301, DOI 10.1016/j.ydbio.2005.09.001; Donsante A, 2011, MOL THERAPY J AM SOC; El Meskini R, 2007, MOL CELL NEUROSCI, V34, P409, DOI 10.1016/j.mcn.2006.11.018; GREEN MA, 1988, J NUCL MED, V29, P1549; HUNT DM, 1974, NATURE, V249, P852, DOI 10.1038/249852a0; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kennerson ML, 2010, AM J HUM GENET, V86, P343, DOI 10.1016/j.ajhg.2010.01.027; Levinson B, 1997, NAT GENET, V16, P224, DOI 10.1038/ng0797-224; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; MERCER JFB, 1994, NAT GENET, V6, P374, DOI 10.1038/ng0494-374; Mercer JFB, 1998, AM J CLIN NUTR, V67, p1022S, DOI 10.1093/ajcn/67.5.1022S; Mototani Y, 2006, GENOMICS, V87, P191, DOI 10.1016/j.ygeno.2005.09.011; Owatari S, 2007, CANCER RES, V67, P4860, DOI 10.1158/0008-5472.CAN-06-3096; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Prohaska JR, 2003, ARCH BIOCHEM BIOPHYS, V417, P227, DOI 10.1016/S0003-9861(03)00364-3; Qin ZY, 2010, J LIPID RES, V51, P1471, DOI 10.1194/jlr.M003426; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; VOLPINTESTA EJ, 1974, AM J DIS CHILD, V128, P244, DOI 10.1001/archpedi.1974.02110270118024; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030; Zheng ZQ, 2010, J NEUROCHEM, V114, P1630, DOI 10.1111/j.1471-4159.2010.06888.x	32	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43039	10.1371/journal.pone.0043039	http://dx.doi.org/10.1371/journal.pone.0043039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900086	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900104
J	Zhang, PD; Liu, SS; Ngan, HYS				Zhang, Pingde; Liu, Stephanie Si; Ngan, Hextan Yuen Sheung			TAp73-Mediated the Activation of C-Jun N-Terminal Kinase Enhances Cellular Chemosensitivity to Cisplatin in Ovarian Cancer Cells	PLOS ONE			English	Article							DNA-DAMAGE; SIGNAL-TRANSDUCTION; CARCINOMA-CELLS; P73; APOPTOSIS; STRESS; JNK; P53; GADD45A; PROTEIN	P73, one member of the tumor suppressor p53 family, shares highly structural and functional similarity to p53. Like p53, the transcriptionally active TAp73 can mediate cellular response to chemotherapeutic agents in human cancer cells by up-regulating the expressions of its pro-apoptotic target genes such as PUMA, Bax, NOXA. Here, we demonstrated a novel molecular mechanism for TAp73-mediated apoptosis in response to cisplatin in ovarian cancer cells, and that was irrespective of p53 status. We found that TAp73 acted as an activator of the c-Jun N-terminal kinase (JNK) signaling pathway by up-regulating the expression of its target growth arrest and DNA-damage-inducible protein GADD45 alpha (GADD45 alpha) and subsequently activating mitogen-activated protein kinase kinase-4 (MKK4). Inhibition of JNK activity by a specific inhibitor or small interfering RNA (siRNA) significantly abrogated TAp73-mediated apoptosis induced by cisplatin. Furthermore, inhibition of GADD45 alpha by siRNA inactivated MKK4/JNK activities and also blocked TAp73-mediated apoptosis induction by cisplatin. Our study has demonstrated that TAp73 activated the JNK apoptotic signaling pathway in response to cisplatin in ovarian cancer cells.	[Zhang, Pingde; Liu, Stephanie Si; Ngan, Hextan Yuen Sheung] Univ Hong Kong, Dept Obstet & Gynecol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Zhang, PD (corresponding author), Univ Hong Kong, Dept Obstet & Gynecol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	gyonc@hku.hk		Ngan, Hextan Y S/0000-0003-3945-159X	Wong Check She Charitable Foundation; Department of Obstetrics and Gynaecology, the University of Hong Kong	Wong Check She Charitable Foundation; Department of Obstetrics and Gynaecology, the University of Hong Kong(University of Hong Kong)	This research was jointly funded by the Wong Check She Charitable Foundation and the research fund from the Department of Obstetrics and Gynaecology, the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Das S, 2005, CANCER GENE THER, V12, P417, DOI 10.1038/sj.cgt.7700803; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Gong JG, 1999, NATURE, V399, P806; Hildesheim J, 2002, CANCER RES, V62, P7305; Ibrahim N, 2010, CANCER RES, V70, P7155, DOI 10.1158/0008-5472.CAN-10-0668; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jones EV, 2007, BIOCHEM J, V405, P617, DOI 10.1042/BJ20061778; Lee CW, 1999, ONCOGENE, V18, P4171, DOI 10.1038/sj.onc.1202793; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Ramadan S, 2005, BIOCHEM BIOPH RES CO, V331, P713, DOI 10.1016/j.bbrc.2005.03.156; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Shimodaira H, 2003, P NATL ACAD SCI USA, V100, P2420, DOI 10.1073/pnas.0438031100; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tront JS, 2006, CANCER RES, V66, P8448, DOI 10.1158/0008-5472.CAN-06-2013; Wei N, 2009, MOL CANCER, V8, P1408; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055; Zhang X, 2004, BRIT J CANCER, V91, P2042, DOI 10.1038/sj.bjc.6602254; Zhu JH, 2001, ONCOGENE, V20, P4050, DOI 10.1038/sj.onc.1204516; Zhu JH, 1998, CANCER RES, V58, P5061	30	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42985	10.1371/journal.pone.0042985	http://dx.doi.org/10.1371/journal.pone.0042985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900074	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900092
J	Conn, PB; Laake, JL; Johnson, DS				Conn, Paul B.; Laake, Jeffrey L.; Johnson, Devin S.			A Hierarchical Modeling Framework for Multiple Observer Transect Surveys	PLOS ONE			English	Article							SPATIAL MODELS; MARK-RECAPTURE; ABUNDANCE; CHOICE; SIZE; BIAS; SEA	Ecologists often use multiple observer transect surveys to census animal populations. In addition to animal counts, these surveys produce sequences of detections and non-detections for each observer. When combined with additional data (i.e. covariates such as distance from the transect line), these sequences provide the additional information to estimate absolute abundance when detectability on the transect line is less than one. Although existing analysis approaches for such data have proven extremely useful, they have some limitations. For instance, it is difficult to extrapolate from observed areas to unobserved areas unless a rigorous sampling design is adhered to; it is also difficult to share information across spatial and temporal domains or to accommodate habitat-abundance relationships. In this paper, we introduce a hierarchical modeling framework for multiple observer line transects that removes these limitations. In particular, abundance intensities can be modeled as a function of habitat covariates, making it easier to extrapolate to unsampled areas. Our approach relies on a complete data representation of the state space, where unobserved animals and their covariates are modeled using a reversible jump Markov chain Monte Carlo algorithm. Observer detections are modeled via a bivariate normal distribution on the probit scale, with dependence induced by a distance-dependent correlation parameter. We illustrate performance of our approach with simulated data and on a known population of golf tees. In both cases, we show that our hierarchical modeling approach yields accurate inference about abundance and related parameters. In addition, we obtain accurate inference about population-level covariates (e.g. group size). We recommend that ecologists consider using hierarchical models when analyzing multiple-observer transect data, especially when it is difficult to rigorously follow pre-specified sampling designs. We provide a new R package, hierarchicalDS, to facilitate the building and fitting of these models.	[Conn, Paul B.; Laake, Jeffrey L.; Johnson, Devin S.] NOAA, Natl Marine Fisheries Serv, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Conn, PB (corresponding author), NOAA, Natl Marine Fisheries Serv, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA.	paul.conn@noaa.gov			National Oceanic and Atmospheric Administration	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	Research was supported by the National Oceanic and Atmospheric Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; Becker EA, 2010, MAR ECOL PROG SER, V413, P163, DOI 10.3354/meps08696; Bengtson JL, 2005, POLAR BIOL, V28, P833, DOI 10.1007/s00300-005-0009-1; Borchers D.L., 2002, ESTIMATING ANIMAL AB; Borchers DL, 1998, BIOMETRICS, V54, P1207, DOI 10.2307/2533651; Borchers DL, 2006, BIOMETRICS, V62, P372, DOI 10.1111/j.1541-0420.2005.00493.x; Buckland S.T., 2001, pi; Buckland ST, 2006, AUK, V123, P345, DOI 10.1642/0004-8038(2006)123[345:PSFSRM]2.0.CO;2; Buckland ST, 2010, BIOMETRICS, V66, P169, DOI 10.1111/j.1541-0420.2009.01239.x; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122; Chelgren ND, 2011, HERPETOL CONSERV BIO, V6, P175; Cochran WG., 1963, SAMPLING TECHNIQUES; Collett D, 2003, C&H TEXT STAT SCI, P45; Diefenbach DR, 2007, AUK, V124, P96, DOI 10.1642/0004-8038(2007)124[96:IAFDIE]2.0.CO;2; DRUMMER TD, 1987, BIOMETRICS, V43, P13, DOI 10.2307/2531944; Durban JW, 2005, J AGR BIOL ENVIR ST, V10, P291, DOI 10.1198/108571105X58630; Forney KA, 2000, CONSERV BIOL, V14, P1271, DOI 10.1046/j.1523-1739.2000.99412.x; Gelfand AE, 1998, BIOMETRIKA, V85, P1, DOI 10.1093/biomet/85.1.1; Gelman A., 2004, BAYESIAN DATA ANAL; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; Hoef JMV, 2007, ENVIRONMETRICS, V18, P697, DOI 10.1002/env.873; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Laake JL, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P108; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; McClintock BT, 2009, BIOMETRICS, V65, P237, DOI 10.1111/j.1541-0420.2008.01047.x; McCullagh P, 1989, GEN LINEAR MODELS; McLAREN IAN A., 1961, ARCTIC, V14, P162; Moore JE, 2011, J APPL ECOL, V48, P1195, DOI 10.1111/j.1365-2664.2011.02018.x; Nichols JD, 2009, ENVIRON ECOL STAT SE, V3, P201, DOI 10.1007/978-0-387-78151-8_9; R Development Core Team, 2007, R LANG ENV STAT COMP; RAMSEY FL, 1987, BIOMETRICS, V43, P1, DOI 10.2307/2531943; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle J. A., 2008, J COMPUTATIONAL GRAP; Royle JA, 2008, J AGR BIOL ENVIR ST, V13, P23, DOI 10.1198/108571108X273188; Royle JA, 2007, ECOL MONOGR, V77, P465, DOI 10.1890/06-0912.1; Royle JA, 2012, J ORNITHOL, V152, pS521, DOI 10.1007/s10336-010-0619-4; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; Schmidt JH, 2012, J WILDLIFE MANAGE, V76, P317, DOI 10.1002/jwmg.216; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; TANNER MA, 1987, J AM STAT ASSOC, V82, P528, DOI 10.2307/2289457; Ver Hoef JM, STAT METHOD IN PRESS	48	20	20	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42294	10.1371/journal.pone.0042294	http://dx.doi.org/10.1371/journal.pone.0042294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905121	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100030
J	Jurman, G; Riccadonna, S; Furlanello, C				Jurman, Giuseppe; Riccadonna, Samantha; Furlanello, Cesare			A Comparison of MCC and CEN Error Measures in Multi-Class Prediction	PLOS ONE			English	Article							ROC CURVE; STATISTICAL COMPARISONS; AREA; PERFORMANCE; CLASSIFIERS; CLASSIFICATION; ACCURACY; AUC	We show that the Confusion Entropy, a measure of performance in multiclass problems has a strong (monotone) relation with the multiclass generalization of a classical metric, the Matthews Correlation Coefficient. Analytical results are provided for the limit cases of general no-information (n-face dice rolling) of the binary classification. Computational evidence supports the claim in the general case.	[Jurman, Giuseppe; Riccadonna, Samantha; Furlanello, Cesare] Fdn Bruno Kessler, Trento, Italy	Fondazione Bruno Kessler	Jurman, G (corresponding author), Fdn Bruno Kessler, Trento, Italy.	jurman@fbk.eu	Riccadonna, Samantha/H-7247-2019; Jurman, Giuseppe/GRS-8221-2022	Riccadonna, Samantha/0000-0002-9737-8274; Furlanello, Cesare/0000-0002-5384-3605; Jurman, Giuseppe/0000-0002-2705-5728	European Union FP7 Project HiperDART; PAT funded Project ENVIROCHANGE	European Union FP7 Project HiperDART; PAT funded Project ENVIROCHANGE	The authors acknowledge funding by the European Union FP7 Project HiperDART and by the PAT funded Project ENVIROCHANGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson N. M., 1963, INFORM THEORY CODING; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Demsar J, 2006, J MACH LEARN RES, V7, P1; Diri B, 2008, EXPERT SYST APPL, V34, P628, DOI 10.1016/j.eswa.2006.10.016; Everson RM, 2006, PATTERN RECOGN LETT, V27, P918, DOI 10.1016/j.patrec.2005.10.016; Felkin M., 2007, STUD COMPUT INTELL, V43, P277; Ferri C, 2003, LECT NOTES ARTIF INT, V2837, P108; Ferri C, 2009, PATTERN RECOGN LETT, V30, P27, DOI 10.1016/j.patrec.2008.08.010; Freitas C, 2007, P INT JOINT C NEUR N, P2729; Freitas COA, 2007, LECT NOTES COMPUT SC, V4756, P387; Garcia S, 2008, J MACH LEARN RES, V9, P2677; Gorodkin J, 2004, COMPUT BIOL CHEM, V28, P367, DOI 10.1016/j.compbiolchem.2004.09.006; Hand DJ, 2010, STAT MED, V29, P1502, DOI 10.1002/sim.3859; Hand DJ, 2009, MACH LEARN, V77, P103, DOI 10.1007/s10994-009-5119-5; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hastie T., 2003, ELEMENTS STAT LEARNI; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Landgrebe T., 2006, 17 ANN S PATT REC AS, P241; Landgrebe T, 2005, P 16 ANN S PATT REC, P165; Landgrebe TCW, 2008, IEEE T PATTERN ANAL, V30, P810, DOI 10.1109/TPAMI.2007.70740; Li Y, 2009, THESIS GEORGIA STATE; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Sindhwani V., 2001, SIAM, P1; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stokic D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-253; Supper J, 2007, LECT NOTES COMPUT SC, V4447, P270; Van Calster B, 2008, IEEE IJCNN, P1390, DOI 10.1109/IJCNN.2008.4633979; van Son R, 1994, IFA P; Wei JM, 2010, EXPERT SYST APPL, V37, P3799, DOI 10.1016/j.eswa.2009.11.040; Wei JM, 2010, INFORM PROCESS UNPUB	35	152	152	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41882	10.1371/journal.pone.0041882	http://dx.doi.org/10.1371/journal.pone.0041882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905111	Green Submitted, gold, Green Published			2022-12-27	WOS:000307331100021
J	Lipski, R; Lippincott, DJ; Durden, BC; Kaplan, AR; Keiser, HE; Park, JH; Levesque, AA				Lipski, Robert; Lippincott, Daniel J.; Durden, Brittany C.; Kaplan, Anne R.; Keiser, Hilary E.; Park, Jung-Ho; Levesque, Aime A.			p53 Dimers Associate with a Head-to-Tail Response Element to Repress Cyclin B Transcription	PLOS ONE			English	Article							MAMMALIAN-CELL CYCLE; DNA-DAMAGE; IONIZING-RADIATION; PREMATURE MITOSIS; DEPENDENT KINASES; TUMOR-SUPPRESSOR; BINDING-SITE; CHECKPOINT; ARREST; ACTIVATION	DNA damage induced by the topoisomerase I inhibitor SN38 activates cell cycle checkpoints which promote cell cycle arrest. This arrest can be abrogated in p53-defective cells by the Chk1 inhibitor 7-hydroxystaurosporine (UCN-01). Previously, we compared p53 wild-type MCF10A cells with derivatives whose p53 function was inhibited by over-expression of the tetramerization domain (MCF10A/OD) or expression of shRNA against p53 (MCF10A/Delta p53). Treatment of SN38-arrested MCF10A/OD cells with UCN-01 abrogated S, but not G2 arrest, while the MCF10A/Delta p53 cells abrogated both S and G2 arrest. The MCF10A/OD cells had reduced levels of cyclin B, suggesting that tetramerization of p53 is not required for repression of cyclin B gene expression. In the present study, we analyzed p53 oligomerization status using glutaraldehyde cross-linking. Following SN38 treatment, MCF10A cells contained oligomeric forms of p53 with molecular weights approximating monomers, dimers, trimers, and tetramers. However, MCF10A/OD cells possessed only monomers and dimers suggesting that these complexes may be involved in repression of cyclin B. While genes transcriptionally activated by p53 contain a consensus sequence with elements repeated in a head-to-head orientation, the cyclin B promoter contains similar elements oriented head-to-tail. Chromatin immunoprecipitation (ChIP) assays revealed that p53 associates with this head-to-tail element in both MCF10A and MCF10A/OD. Electrophoretic mobility shift assays ( EMSA) using a biotin-labeled probe containing the head-to-tail element showed a shift in mobility consistent with the molecular weight of tetramers and dimers in MCF10A nuclear extract, but only the dimer in MCF10A/OD nuclear extract. Taken together, these results suggest a novel mechanism whereby p53 dimers associate with the head-to-tail element to repress cyclin B transcription.	[Lipski, Robert; Lippincott, Daniel J.; Durden, Brittany C.; Kaplan, Anne R.; Keiser, Hilary E.; Park, Jung-Ho; Levesque, Aime A.] Univ Hartford, Dept Biol, Hartford, CT 06117 USA	University of Hartford	Lipski, R (corresponding author), Univ Hartford, Dept Biol, Hartford, CT 06117 USA.	alevesque@hartford.edu	Levesque, Aime/GNM-9708-2022	Levesque, Aime/0000-0002-2907-229X	Young Investigator's Grant from the Breast Cancer Alliance; Women's Education and Leadership Fund; Legacy of the Hartford College for Women at the University of Hartford; Dorothy Goodwin Summer Scholars Program from the Women's Education and Leadership Fund at the University of Hartford; Vincent B. Coffin grant from the College of Arts and Sciences Dean's Office at the University of Hartford; Greenberg grant from the College of Arts and Sciences Dean's Office at the University of Hartford; Faculty Research grants from the College of Arts and Sciences Dean's Office at the University of Hartford	Young Investigator's Grant from the Breast Cancer Alliance; Women's Education and Leadership Fund; Legacy of the Hartford College for Women at the University of Hartford; Dorothy Goodwin Summer Scholars Program from the Women's Education and Leadership Fund at the University of Hartford; Vincent B. Coffin grant from the College of Arts and Sciences Dean's Office at the University of Hartford; Greenberg grant from the College of Arts and Sciences Dean's Office at the University of Hartford; Faculty Research grants from the College of Arts and Sciences Dean's Office at the University of Hartford	This work was supported, in part, by the Young Investigator's Grant from the Breast Cancer Alliance (AAL) (breastcanceralliance.org), a grant from the Women's Education and Leadership Fund, a Legacy of the Hartford College for Women at the University of Hartford (AAL) (http://www.hartford.edu/welfund/), a grant from the Dorothy Goodwin Summer Scholars Program from the Women's Education and Leadership Fund at the University of Hartford (AAL, BCD) (http://www.hartford.edu/welfund/) as well as the Vincent B. Coffin grant, Greenberg grant, and Faculty Research grants from the College of Arts and Sciences Dean's Office at the University of Hartford (AAL)(http://hartford.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atz J, 2000, J CELL BIOCHEM, V76, P572, DOI 10.1002/(SICI)1097-4644(20000315)76:4<572::AID-JCB6>3.0.CO;2-6; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chin PL, 1997, ONCOGENE, V15, P87, DOI 10.1038/sj.onc.1201161; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Hanson S, 2005, ONCOGENE, V24, P1641, DOI 10.1038/sj.onc.1208351; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hengstschlager M, 1999, MUTAT RES-REV MUTAT, V436, P1, DOI 10.1016/S1383-5742(98)00022-2; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Hoffmann TK, 2011, ANTICANCER RES, V31, P3151; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; Johnson RA, 2001, J BIOL CHEM, V276, P27716, DOI 10.1074/jbc.C100121200; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kohn EA, 2002, J BIOL CHEM, V277, P26553, DOI 10.1074/jbc.M202040200; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laronga C, 2000, J BIOL CHEM, V275, P23106, DOI 10.1074/jbc.M905616199; Levesque AA, 2005, ONCOGENE, V24, P3786, DOI 10.1038/sj.onc.1208451; Levesque AA, 2008, MOL CANCER THER, V7, P252, DOI 10.1158/1535-7163.MCT-07-2066; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Menendez D, 2006, P NATL ACAD SCI USA, V103, P1406, DOI 10.1073/pnas.0508103103; Menendez D, 2007, MOL CELL BIOL, V27, P2590, DOI 10.1128/MCB.01742-06; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Shieh SY, 2000, GENE DEV, V14, P289; STENGER JE, 1992, MOL CARCINOGEN, V5, P102, DOI 10.1002/mc.2940050204; TAM SW, 1995, J CELL BIOCHEM, V59, P339, DOI 10.1002/jcb.240590306; Taylor WR, 1999, MOL BIOL CELL, V10, P3607, DOI 10.1091/mbc.10.11.3607; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yan J, 2009, J BIOL CHEM, V284, P19280, DOI 10.1074/jbc.M109.013102; Yin XY, 2001, CANCER RES, V61, P6487; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667	46	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42615	10.1371/journal.pone.0042615	http://dx.doi.org/10.1371/journal.pone.0042615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905155	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100052
J	Seth, AK; Geringer, MR; Hong, SJ; Leung, KP; Galiano, RD; Mustoe, TA				Seth, Akhil K.; Geringer, Matthew R.; Hong, Seok J.; Leung, Kai P.; Galiano, Robert D.; Mustoe, Thomas A.			Comparative Analysis of Single-Species and Polybacterial Wound Biofilms Using a Quantitative, In Vivo, Rabbit Ear Model	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS SLIME; PSEUDOMONAS-AERUGINOSA; BACTERIAL BIOFILMS; PRESSURE ULCERS; AUREUS BIOFILMS; VITRO MODEL; HEALTH; INFECTIONS; VIRULENCE; OUTCOMES	Introduction: The recent literature suggests that chronic wound biofilms often consist of multiple bacterial species. However, without appropriate in vivo, polybacterial biofilm models, our understanding of these complex infections remains limited. We evaluate and compare the effect of single- and mixed-species biofilm infections on host wound healing dynamics using a quantitative, in vivo, rabbit ear model. Methods: Six-mm dermal punch wounds in New Zealand rabbit ears were inoculated with Staphylococcus aureus strain UAMS-1, Pseudomonas aeruginosa strain PAO1, or both, totaling 10(boolean AND)6 colony-forming units/wound. Bacterial proliferation and maintenance in vivo were done using procedures from our previously published model. Wounds were harvested for histological measurement of wound healing, viable bacterial counts using selective media, or inflammatory cytokine (IL-1 beta, TNF-alpha) expression via quantitative reverse-transcription PCR. Biofilm structure was studied using scanning electron microscopy (SEM). For comparison, biofilm deficient mutant UAMS-929 replaced strain UAMS-1 in some mixed-species infections. Results: Bacterial counts verified the presence of both strains UAMS-1 and PAO1 in polybacterial wounds. Over time, strain PAO1 became predominant (p<0.001).SEM showed colocalization of both species within an extracellular matrix at multiple time-points. Compared to each monospecies infection, polybacterial biofilms impaired all wound healing parameters (p<0.01), and increased expression of IL-1 beta and TNF-alpha (p<0.05). In contrast, mixed-species infections using biofilm-deficient mutant UAMS-929 instead of wild-type strain UAMS-1 showed less wound impairment (p<0.01) with decreased host cytokine expression (p<0.01), despite a bacterial burden and distribution comparable to that of mixed-wild-type wounds. Conclusions: This study reveals that mixed-species biofilms have a greater impact on wound healing dynamics than their monospecies counterparts. The increased virulence of polybacterial biofilm appears dependent on the combined pathogenicity of each species, verified using a mutant strain. These data suggest that individual bacterial species can interact synergistically within a single biofilm structure.	[Seth, Akhil K.; Geringer, Matthew R.; Hong, Seok J.; Galiano, Robert D.; Mustoe, Thomas A.] Northwestern Univ, Div Plast Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Leung, Kai P.] US Army Dent & Trauma Res Detachment, Microbiol Branch, Inst Surg Res, San Antonio, TX USA	Northwestern University; Feinberg School of Medicine	Seth, AK (corresponding author), Northwestern Univ, Div Plast Surg, Feinberg Sch Med, Chicago, IL 60611 USA.	akhil-seth@fsm.northwestern.edu; tmustoe@nmh.org						Andersen A, 2007, J Wound Care, V16, P171; Beckrich K, 1999, NURS ECON, V17, P263; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; Davies CE, 2004, J CLIN MICROBIOL, V42, P3549, DOI 10.1128/JCM.42.8.3549-3557.2004; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Fleck Cynthia A, 2006, Adv Skin Wound Care, V19, P188, DOI 10.1097/00129334-200605000-00009; Fogerty MD, 2008, WOUND REPAIR REGEN, V16, P11, DOI 10.1111/j.1524-475X.2007.00327.x; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Gordois A, 2003, DIABETES CARE, V26, P1790, DOI 10.2337/diacare.26.6.1790; Gurjala AN, 2011, WOUND REPAIR REGEN, V19, P400, DOI 10.1111/j.1524-475X.2011.00690.x; Harrison-Balestra C, 2003, DERMATOL SURG, V29, P631, DOI 10.1046/j.1524-4725.2003.29146.x; Hendricks KJ, 2001, J BONE JOINT SURG AM, V83A, P855, DOI 10.2106/00004623-200106000-00006; Hill KE, 2010, J ANTIMICROB CHEMOTH, V65, P1195, DOI 10.1093/jac/dkq105; Hill KE, 2003, J MED MICROBIOL, V52, P365, DOI 10.1099/jmm.0.05030-0; Hirsch EM, 2012, PLAST RECONSTR SURG, V129, P354, DOI 10.1097/PRS.0b013e31823ae8b1; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; JOHNSON GM, 1986, INFECT IMMUN, V54, P13, DOI 10.1128/IAI.54.1.13-20.1986; Kirker KR, 2009, WOUND REPAIR REGEN, V17, P690, DOI 10.1111/j.1524-475X.2009.00523.x; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lindsay D, 2006, J HOSP INFECT, V64, P313, DOI 10.1016/j.jhin.2006.06.028; Loryman C, 2008, WOUND REPAIR REGEN, V16, P45, DOI 10.1111/j.1524-475X.2007.00290.x; Ma HY, 2010, J IND MICROBIOL BIOT, V37, P1081, DOI 10.1007/s10295-010-0756-z; Mastropaolo MD, 2005, INFECT IMMUN, V73, P6055, DOI 10.1128/IAI.73.9.6055-6063.2005; McGuckin Maryanne, 2003, Adv Skin Wound Care, V16, P12, DOI 10.1097/00129334-200301000-00011; Nakagami G, 2008, WOUND REPAIR REGEN, V16, P30, DOI 10.1111/j.1524-475X.2007.00329.x; Nakagami G, 2011, WOUND REPAIR REGEN, V19, P214, DOI 10.1111/j.1524-475X.2010.00653.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Percival SL, 2004, WOUNDS, V16, P234; Pihl M, 2010, FEMS IMMUNOL MED MIC, V59, P504, DOI 10.1111/j.1574-695X.2010.00707.x; Ramsey SD, 1999, PHARMACOECONOMICS, V16, P285, DOI 10.2165/00019053-199916030-00005; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Schierle CF, 2009, WOUND REPAIR REGEN, V17, P354, DOI 10.1111/j.1524-475X.2009.00489.x; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Seth AK, 2012, WOUND REPAIR REGEN, V20, P214, DOI 10.1111/j.1524-475X.2012.00764.x; Shiau AL, 1998, MICROBIOL IMMUNOL, V42, P33, DOI 10.1111/j.1348-0421.1998.tb01966.x; Shigeta M, 1997, CHEMOTHERAPY, V43, P340, DOI 10.1159/000239587; Sillankorva S, 2010, BIOFOULING, V26, P567, DOI 10.1080/08927014.2010.494251; Standar K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013135; Stubblefield BA, 2010, APPL MICROBIOL BIOT, V86, P1941, DOI 10.1007/s00253-010-2473-y; Sun Y, 2008, WOUND REPAIR REGEN, V16, P805, DOI 10.1111/j.1524-475X.2008.00434.x; Thomsen TR, 2010, WOUND REPAIR REGEN, V18, P38, DOI 10.1111/j.1524-475X.2009.00561.x; Thomson P D, 2000, Ostomy Wound Manage, V46, p77S; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P4096, DOI 10.1128/AAC.00484-09; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P2475, DOI 10.1128/AAC.01432-08; Woods J, 2012, J APPL MICROBIOL, V112, P998, DOI 10.1111/j.1365-2672.2012.05264.x; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004; Zhao G, 2010, WOUND REPAIR REGEN, V18, P467, DOI 10.1111/j.1524-475X.2010.00608.x	55	58	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42897	10.1371/journal.pone.0042897	http://dx.doi.org/10.1371/journal.pone.0042897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905182	Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100072
J	Wu, T; Wang, YJ; Guo, DJ				Wu, Ting; Wang, Yejun; Guo, Dianjing			Investigation of Glandular Trichome Proteins in Artemisia annua L. Using Comparative Proteomics	PLOS ONE			English	Article							2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE; ISOPRENOID BIOSYNTHESIS; MOLECULAR-CLONING; STRESS; ENZYME; PLANTS; IDENTIFICATION; EXPRESSION; TOLERANCE; REDUCTASE	Glandular secreting trichomes (GSTs) are called biofactories because they are active in synthesizing, storing and secreting various types of plant secondary metabolites. As the most effective drug against malaria, artemisinin, a sesquiterpene lactone is derived from GSTs of Artemisia annua. However, low artemisinin content (0.001%similar to 1.54% of dry weight) has hindered its wide application. We investigate the GST-expressed proteins in Artemisia annua using a comparative proteomics approach, aiming for a better understanding of the trichome proteome and arteminisin metabolism. 2D-electrophoresis was employed to compare the protein profiles of GSTs and leaves. More than 700 spots were resolved for GSTs, of which similar to 93 non-redundant proteins were confidently identified by searching NCBI and Artemisia EST databases. Over 70% of these proteins were highly expressed in GTSs. Functional classification of these GSTs enriched proteins revealed that many of them participate in major plant metabolic processes such as electron transport, transcription and translation.	[Wu, Ting] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, State Kay Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Wu, T (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	djguo@cuhk.edu.hk		Wu, Ting/0000-0003-4021-6298	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 4609647, CUHK 4610651]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project no. CUHK 4609647 and CUHK 4610651). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amme S, 2005, PROTEOMICS, V5, P2508, DOI 10.1002/pmic.200401274; Bae MS, 2003, PLANT J, V36, P652, DOI 10.1046/j.1365-313X.2003.01907.x; Balbuena TS, 2011, J PROTEOME RES, V10, P2330, DOI 10.1021/pr101137q; Bertea CM, 2006, ARCH BIOCHEM BIOPHYS, V448, P3, DOI 10.1016/j.abb.2006.02.026; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; Brown GD, 2004, TETRAHEDRON, V60, P1139, DOI 10.1016/j.tet.2003.11.070; Brown GD, 2007, TETRAHEDRON, V63, P9548, DOI 10.1016/j.tet.2007.06.062; Brown GD, 2010, MOLECULES, V15, P7603, DOI 10.3390/molecules15117603; Covello PS, 2007, PHYTOCHEMISTRY, V68, P1864, DOI 10.1016/j.phytochem.2007.02.016; Cui SX, 2005, PROTEOMICS, V5, P3162, DOI 10.1002/pmic.200401148; Cushman JC, 2001, AM ZOOL, V41, P758, DOI 10.1668/0003-1569(2001)041[0758:OIPIFA]2.0.CO;2; FERREIRA JFS, 1995, INT J PLANT SCI, V156, P807, DOI 10.1086/297304; Ferreira JFS, 1998, PROGR NEW CROPS, P579; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Goulas E, 2006, PLANT J, V47, P720, DOI 10.1111/j.1365-313X.2006.02821.x; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Kim SM, 2006, PLANT CELL REP, V25, P829, DOI 10.1007/s00299-006-0136-3; Kjellsen TD, 2010, J PROTEOMICS, V73, P965, DOI 10.1016/j.jprot.2009.12.010; Lan P, 2011, PLANT SIGNAL BEHAV, V6, P528, DOI 10.4161/psb.6.4.14747; Laughlin JC, 1995, ACTA HORTIC, P67, DOI 10.17660/ActaHortic.1995.390.8; Mahmoud SS, 2002, TRENDS PLANT SCI, V7, P366, DOI 10.1016/S1360-1385(02)02303-8; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Matsushita Y, 1996, GENE, V172, P207, DOI 10.1016/0378-1119(96)00054-6; Mercke P, 2000, ARCH BIOCHEM BIOPHYS, V381, P173, DOI 10.1006/abbi.2000.1962; Millar AH, 2001, PLANT PHYSIOL, V127, P1711, DOI 10.1104/pp.010387; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Motshwene P, 2003, BIOCHEM J, V369, P357, DOI 10.1042/BJ20021352; Musumeci MA, 2011, ADV PHOTOSYNTHESIS F, P540; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Pamela JW, 2006, IN VITRO CELL DEP PL, V42, P309; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Picaud S, ARCH BIOCH BIOPHYS, V448, P150; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Richard SB, 2002, J BIOL CHEM, V277, P8667, DOI 10.1074/jbc.C100739200; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rodriguez RE, 2007, PLANT PHYSIOL, V143, P639, DOI 10.1104/pp.106.090449; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Schilmiller AL, 2008, PLANT J, V54, P702, DOI 10.1111/j.1365-313X.2008.03432.x; Schramek N, 2010, PHYTOCHEMISTRY, V71, P179, DOI 10.1016/j.phytochem.2009.10.015; Sobhanian H, 2011, J PROTEOMICS, V74, P1323, DOI 10.1016/j.jprot.2011.03.018; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; WAGNER GJ, 1991, PLANT PHYSIOL, V96, P675, DOI 10.1104/pp.96.3.675; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wehrl W, 2000, J BACTERIOL, V182, P3870, DOI 10.1128/JB.182.13.3870-3873.2000; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; Zhang Y, 2008, J BIOL CHEM, V283, P21501, DOI 10.1074/jbc.M803090200	48	13	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41822	10.1371/journal.pone.0041822	http://dx.doi.org/10.1371/journal.pone.0041822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905110	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100020
J	Mihara, M; Hara, H; Hayashi, Y; Narushima, M; Yamamoto, T; Todokoro, T; Iida, T; Sawamoto, N; Araki, J; Kikuchi, K; Murai, N; Okitsu, T; Kisu, I; Koshima, I				Mihara, Makoto; Hara, Hisako; Hayashi, Yohei; Narushima, Mitsunaga; Yamamoto, Takumi; Todokoro, Takeshi; Iida, Takuya; Sawamoto, Naoya; Araki, Jun; Kikuchi, Kazuki; Murai, Noriyuki; Okitsu, Taro; Kisu, Iori; Koshima, Isao			Pathological Steps of Cancer-Related Lymphedema: Histological Changes in the Collecting Lymphatic Vessels after Lymphadenectomy	PLOS ONE			English	Article							SMOOTH-MUSCLE; FLUORESCENCE LYMPHOGRAPHY; CONSERVATIVE TREATMENT; INDOCYANINE GREEN; EXTREMITIES	Introduction: To date, an electron microscopy study of the collecting lymphatic vessels has not been conducted to examine the early stages of lymphedema. However, such histological studies could be useful for elucidating the mechanism of lymphedema onset. The aim of this study was to clarify the changes occurring in collecting lymphatic vessels after lymphadenectomy. Methods: The study was conducted on 114 specimens from 37 patients who developed lymphedema of the lower limbs after receiving surgical treatment for gynecologic cancers and who consulted the University of Tokyo Hospital and affiliated hospitals from April 2009 to March 2011. Lymphatic vessels that were not needed for lymphatico venous anastomosis surgery were trimmed and subsequently examined using electron microscopy and light microscopy. Results: Based on macroscopic findings, the histochemical changes in the collecting lymphatic vessels were defined as follows: normal, ectasis, contraction, and sclerosis type (NECST). In the ectasis type, an increase in endolymphatic pressure was accompanied by a flattening of the lymphatic vessel endothelial cells. In the contraction type, smooth muscle cells were transformed into synthetic cells and promoted the growth of collagen fibers. In the sclerosis type, fibrous elements accounted for the majority of the components, the lymphatic vessels lost their transport and concentrating abilities, and the lumen was either narrowed or completely obstructed. Concl usions: The increase in pressure inside the collecting lymphatic vessels after lymphadenectomy was accompanied by histological changes that began before the onset of lymphedema.	[Mihara, Makoto; Hara, Hisako; Hayashi, Yohei; Narushima, Mitsunaga; Yamamoto, Takumi; Todokoro, Takeshi; Iida, Takuya; Sawamoto, Naoya; Araki, Jun; Kikuchi, Kazuki; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Murai, Noriyuki] Saiseikai Kawaguchi Gen Hosp, Dept Vasc Surg, Saitama, Japan; [Okitsu, Taro] Keio Univ, Dept Rehabil Med, Tokyo, Japan; [Kisu, Iori] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan	University of Tokyo; Keio University; Keio University	Mihara, M (corresponding author), Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan.	mihara@keiseigeka.name	Yamamoto, Takumi/Y-7658-2019; Sawamoto, Mitsuo/AAH-3955-2020	Hayashi, Yohei/0000-0003-3914-9999	Japanese funding program for next generation world-leading researchers (NEXT program) [LS039]	Japanese funding program for next generation world-leading researchers (NEXT program)	The grant was provided by a Japanese funding program for next generation world-leading researchers (NEXT program, LS039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkill KP, 2010, J ANAT, V216, P547, DOI 10.1111/j.1469-7580.2010.01215.x; Becker C, 2006, ANN SURG, V243, P313, DOI 10.1097/01.sla.0000201258.10304.16; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Campisi C, 2010, MICROSURG, V30, P256, DOI 10.1002/micr.20737; Danz B, 2005, EUR J DERMATOL, V15, P474; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; FOLDI E, 1985, ANGIOLOGY, V36, P171, DOI 10.1177/000331978503600306; Foldi E, 1998, CANCER, V83, P2833, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2833::AID-CNCR35>3.0.CO;2-3; Jensen MR, 2010, CLIN PHYSIOL FUNCT I, V30, P389, DOI 10.1111/j.1475-097X.2010.00969.x; Koshima I, 1996, PLAST RECONSTR SURG, V97, P397, DOI 10.1097/00006534-199602000-00018; Koshima I, 2003, J RECONSTR MICROSURG, V19, P209; LEAK LV, 1968, J CELL BIOL, V36, P129, DOI 10.1083/jcb.36.1.129; Ogata F, 2010, JAPANESE J LYMPHOLOG, V33, P64; OHHASHI T, 1984, MICROVASC RES, V27, P71, DOI 10.1016/0026-2862(84)90042-6; OHTANI O, 1992, ARCH HISTOL CYTOL, V55, P429, DOI 10.1679/aohc.55.429; Quick CM, 2009, AM J PHYSIOL-HEART C, V296, pH662, DOI 10.1152/ajpheart.00322.2008; Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0; Roy P, 2004, EJSO-EUR J SURG ONC, V30, P982, DOI 10.1016/j.ejso.2004.07.027; Suami H, 2010, PLAST RECONSTR SURG, V126, P1853, DOI 10.1097/PRS.0b013e3181f44658; Szuba A, 2000, AM J MED, V109, P296, DOI 10.1016/S0002-9343(00)00503-9; Unno N, 2008, EUR J VASC ENDOVASC, V36, P230, DOI 10.1016/j.ejvs.2008.04.013; Unno N, 2007, J VASC SURG, V45, P1016, DOI 10.1016/j.jvs.2007.01.023; Unno N, 2010, J VASC SURG, V52, P946, DOI 10.1016/j.jvs.2010.04.067; von der Weid PY, 2004, INT J BIOCHEM CELL B, V36, P1147, DOI 10.1016/j.biocel.2003.12.008; Wagner S, 2011, VASA, V40, P271, DOI 10.1024/0301-1526/a000115	25	77	78	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41126	10.1371/journal.pone.0041126	http://dx.doi.org/10.1371/journal.pone.0041126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911751	Green Published, gold			2022-12-27	WOS:000306751300024
J	Kaufman, M; Corner, MA; Ziv, NE				Kaufman, Maya; Corner, Michael A.; Ziv, Noam E.			Long-term Relationships between Cholinergic Tone, Synchronous Bursting and Synaptic Remodeling	PLOS ONE			English	Article							SLEEP-WAKE CYCLE; CEREBRAL-CORTEX; NEOCORTICAL NEURONS; DEVELOPING NETWORKS; HZ OSCILLATION; SPINDLE BURSTS; IN-VITRO; PLASTICITY; DYNAMICS; RAT	Cholinergic neuromodulation plays key roles in the regulation of neuronal excitability, network activity, arousal, and behavior. On longer time scales, cholinergic systems play essential roles in cortical development, maturation, and plasticity. Presumably, these processes are associated with substantial synaptic remodeling, yet to date, long-term relationships between cholinergic tone and synaptic remodeling remain largely unknown. Here we used automated microscopy combined with multielectrode array recordings to study long-term relationships between cholinergic tone, excitatory synapse remodeling, and network activity characteristics in networks of cortical neurons grown on multielectrode array substrates. Experimental elevations of cholinergic tone led to the abrupt suppression of episodic synchronous bursting activity (but not of general activity), followed by a gradual growth of excitatory synapses over hours. Subsequent blockage of cholinergic receptors led to an immediate restoration of synchronous bursting and the gradual reversal of synaptic growth. Neither synaptic growth nor downsizing was governed by multiplicative scaling rules. Instead, these occurred in a subset of synapses, irrespective of initial synaptic size. Synaptic growth seemed to depend on intrinsic network activity, but not on the degree to which bursting was suppressed. Intriguingly, sustained elevations of cholinergic tone were associated with a gradual recovery of synchronous bursting but not with a reversal of synaptic growth. These findings show that cholinergic tone can strongly affect synaptic remodeling and synchronous bursting activity, but do not support a strict coupling between the two. Finally, the reemergence of synchronous bursting in the presence of elevated cholinergic tone indicates that the capacity of cholinergic neuromodulation to indefinitely suppress synchronous bursting might be inherently limited.	[Kaufman, Maya; Ziv, Noam E.] Lorry Lokey Ctr Life Sci & Engn, Dept Physiol & Biophys, Haifa, Israel; [Kaufman, Maya; Ziv, Noam E.] Lorry Lokey Ctr Life Sci & Engn, Rappaport Inst, Technion Fac Med, Haifa, Israel; [Kaufman, Maya; Ziv, Noam E.] Lorry Lokey Ctr Life Sci & Engn, Network Biol Res Labs, Haifa, Israel; [Corner, Michael A.] Netherlands Inst Brain Res, Amsterdam, Netherlands	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Kaufman, M (corresponding author), Lorry Lokey Ctr Life Sci & Engn, Dept Physiol & Biophys, Haifa, Israel.	noamz@netvision.net.il	Ziv, Noam/ABA-6551-2020	Ziv, Noam/0000-0001-9197-326X	Israel Science Foundation [1780/07, 1038/09]	Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the Israel Science Foundation (1780/07; 1038/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Baker RE, 2006, BRAIN RES, V1101, P29, DOI 10.1016/j.brainres.2006.05.028; BARNES CA, 1977, SCIENCE, V197, P91, DOI 10.1126/science.194313; Beggs JM, 2003, J NEUROSCI, V23, P11167; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Birtoli B, 2004, J NEUROSCI, V24, P4935, DOI 10.1523/JNEUROSCI.0795-04.2004; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Chiappalone M, 2010, P 7 INT M SUBSTR INT, P65; Chiappalone M, 2007, INT J NEURAL SYST, V17, P87, DOI 10.1142/S0129065707000968; Cohen D, 2009, J NEUROPHYSIOL, V101, P2077, DOI 10.1152/jn.91085.2008; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Corner MA, 2005, PROG BRAIN RES, V147, P231, DOI 10.1016/S0079-6123(04)47018-6; Corner MA, 2008, NEUROSCI BIOBEHAV R, V32, P1569, DOI 10.1016/j.neubiorev.2008.06.008; Corner MA, 2008, BRAIN RES REV, V59, P221, DOI 10.1016/j.brainresrev.2008.08.001; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Fisher-Lavie A, 2011, J NEUROSCI, V31, P16770, DOI 10.1523/JNEUROSCI.3384-11.2011; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Golshani P, 2009, J NEUROSCI, V29, P10890, DOI 10.1523/JNEUROSCI.2012-09.2009; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; Gu ZL, 2011, NEURON, V71, P155, DOI 10.1016/j.neuron.2011.04.026; Hanganu IL, 2007, J NEUROSCI, V27, P5694, DOI 10.1523/JNEUROSCI.5233-06.2007; Hanganu IL, 2009, CEREB CORTEX, V19, P89, DOI 10.1093/cercor/bhn061; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Hohmann CF, 1998, PERSPECT DEV NEUROBI, V5, P401; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; JASPER HH, 1971, SCIENCE, V172, P601, DOI 10.1126/science.172.3983.601; Johnson HA, 2007, J NEUROSCI, V27, P5915, DOI 10.1523/JNEUROSCI.0447-07.2007; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Lante F, 2011, J NEUROSCI, V31, P3953, DOI 10.1523/JNEUROSCI.3210-10.2011; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Loewenstein Y, 2011, J NEUROSCI, V31, P9481, DOI 10.1523/JNEUROSCI.6130-10.2011; MAEDA E, 1995, J NEUROSCI, V15, P6834; Maret S, 2011, NAT NEUROSCI, V14, P1418, DOI 10.1038/nn.2934; MARROSU F, 1995, BRAIN RES, V671, P329, DOI 10.1016/0006-8993(94)01399-3; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V392, P147, DOI 10.1113/jphysiol.1987.sp016774; METHERATE R, 1992, J NEUROSCI, V12, P4701; Minerbi A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000136; Moore AR, 2011, J NEUROSCI, V31, P2391, DOI 10.1523/JNEUROSCI.3886-10.2011; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Platt B, 2011, BEHAV BRAIN RES, V221, P499, DOI 10.1016/j.bbr.2011.01.017; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Ramanathan D, 2009, J NEUROSCI, V29, P5992, DOI 10.1523/JNEUROSCI.0230-09.2009; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schatzle P, 2011, J PHYSIOL-LONDON, V589, P4353, DOI 10.1113/jphysiol.2010.204446; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shaffery JP, 2009, CURRENT ADV SLEEP BI, P177; SIEGEL JM, 1988, BRAIN RES REV, V13, P213, DOI 10.1016/0165-0173(88)90007-0; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tateno T, 2005, NEUROSCIENCE, V134, P425, DOI 10.1016/j.neuroscience.2005.04.049; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Yang G, 2012, DEV NEUROBIOL, V72, P1391, DOI 10.1002/dneu.20996; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008	80	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40980	10.1371/journal.pone.0040980	http://dx.doi.org/10.1371/journal.pone.0040980			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911726	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700032
J	Douarre, C; Sourbier, C; Dalla Rosa, I; Das, BB; Redon, CE; Zhang, HL; Neckers, L; Pommier, Y				Douarre, Celine; Sourbier, Carole; Dalla Rosa, Ilaria; Das, Benu Brata; Redon, Christophe E.; Zhang, Hongliang; Neckers, Len; Pommier, Yves			Mitochondrial Topoisomerase I is Critical for Mitochondrial Integrity and Cellular Energy Metabolism	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; DNA; BIOGENESIS; AUTOPHAGY; CANCER; CELLS; NUCLEAR; DISEASE; ATM	Background: Mitochondria contain their own DNA genome (mtDNA), as well as specific DNA replication and protein synthesis machineries. Relaxation of the circular, double-stranded mtDNA relies on the presence of topoisomerase activity. Three different topoisomerases have been identified in mitochondria: Top1mt, Top3 alpha and a truncated form of Top2 beta. Methodology/Principal Findings: The present study shows the importance of Top1mt in mitochondrial homeostasis. Here we show that Top1mt(-/-) murine embryonic fibroblasts (MEF) exhibit dysfunctional mitochondrial respiration, which leads decreased ATP production and compensation by increased glycolysis and fatty acid oxidation. ROS production in Top1mt(-/-) MEF cells is involved in nuclear DNA damage and induction of autophagy. Lack of Top1mt also triggers oxidative stress and DNA damage associated with lipid peroxidation and mitophagy in Top1mt(-/-) mice. Conclusion/Significance: Together, our data implicate Top1mt for mitochondrial integrity and energy metabolism. The compensation mechanism described here contributes to the survival of Top1mt(-/-) cells and mice despite alterations of mitochondrial functions and metabolism. Therefore, this study supports a novel model for cellular adaptation to mitochondrial damage.	[Douarre, Celine; Dalla Rosa, Ilaria; Das, Benu Brata; Redon, Christophe E.; Zhang, Hongliang] NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; [Sourbier, Carole; Neckers, Len; Pommier, Yves] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Douarre, C (corresponding author), NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA.	celine.douarre@umontreal.ca	Das, Benu Brata/AAC-3452-2022; DAS, BENU BRATA BRATA/AAX-4347-2021	DAS, BENU BRATA BRATA/0000-0003-2519-7105; Dalla Rosa, Ilaria/0000-0003-4801-2396	Center for Cancer Research, Intramural Program of the U.S. National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010683, ZIABC006161] Funding Source: NIH RePORTER	Center for Cancer Research, Intramural Program of the U.S. National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Center for Cancer Research, Intramural Program of the U.S. National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CM, 2010, BBA-PROTEINS PROTEOM, V1804, P1213, DOI 10.1016/j.bbapap.2010.01.007; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Da Cruz S, 2008, BBA-MOL CELL RES, V1783, P904, DOI 10.1016/j.bbamcr.2008.02.006; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; Erol A, 2005, MED HYPOTHESES, V65, P525, DOI 10.1016/j.mehy.2005.03.022; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Feldser D, 1999, CANCER RES, V59, P3915; Fernandez-Checa JC, 1998, BIOFACTORS, V8, P7, DOI 10.1002/biof.5520080102; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gong BD, 1998, RADIAT RES, V150, P505, DOI 10.2307/3579866; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang DC, 2005, CURR MED CHEM, V12, P429, DOI 10.2174/0929867053363081; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kluza J, 2004, ONCOGENE, V23, P7018, DOI 10.1038/sj.onc.1207936; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Patel AJ, 1998, J NEUROSCI, V18, P3117; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rendina AR, 2005, BIOCHEM J, V388, P895, DOI 10.1042/BJ20041963; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Tanaka T, 2006, CELL CYCLE, V5, P2671, DOI 10.4161/cc.5.22.3472; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhang HL, 2004, NUCLEIC ACIDS RES, V32, P2087, DOI 10.1093/nar/gkh525; Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998; Zhang HL, 2008, BIOCHEMISTRY-US, V47, P11196, DOI 10.1021/bi800774b; Zoppoli G, 2011, NUCLEIC ACIDS RES, V39, P6620, DOI 10.1093/nar/gkr208	55	71	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41094	10.1371/journal.pone.0041094	http://dx.doi.org/10.1371/journal.pone.0041094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911747	gold, Green Submitted, Green Published			2022-12-27	WOS:000306644600046
J	Elliott, EC; Cornell, SJ				Elliott, Elizabeth C.; Cornell, Stephen J.			Dispersal Polymorphism and the Speed of Biological Invasions	PLOS ONE			English	Article							CLIMATE-CHANGE; TRADE-OFFS; EVOLUTION; RANGE; POPULATIONS; DYNAMICS; SPREAD; RATES	The speed at which biological range expansions occur has important consequences for the conservation management of species experiencing climate change and for invasion by exotic organisms. Rates of dispersal and population growth are known to affect the speed of invasion, but little is known about the effect of having a community of dispersal phenotypes on the rate of range expansion. We use reaction-diffusion equations to model the invasion of a species with two dispersal phenotypes into a previously unoccupied landscape. These phenotypes differ in both their dispersal rate and population growth rate. We find that the presence of both phenotypes can result in faster range expansions than if only a single phenotype were present in the landscape. For biologically realistic parameters, the invasion can occur up to twice as fast as a result of this polymorphism. This has implications for predicting the speed of biological invasions, suggesting that speeds cannot just be predicted from looking at a single phenotype and that the full community of phenotypes needs to be taken into consideration.	[Elliott, Elizabeth C.; Cornell, Stephen J.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England	University of Leeds	Elliott, EC (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	jhs5ece@leeds.ac.uk	Cornell, Stephen J/D-3955-2009		Natural Environment Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Elizabeth Elliott was supported by a Natural Environment Research Council studentship, funders website: www.nerc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton KA, 2012, P ROY SOC B-BIOL SCI, V279, P1194, DOI 10.1098/rspb.2011.1254; Bonte D, 2010, OIKOS, V119, P560, DOI 10.1111/j.1600-0706.2009.17943.x; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Duckworth RA, 2008, AM NAT, V172, pS4, DOI 10.1086/588289; Ellner SP, 2012, THEOR POPUL BIOL, V82, P283, DOI 10.1016/j.tpb.2012.03.005; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Garcia-Ramos G, 2002, EVOLUTION, V56, P661, DOI 10.1554/0014-3820(2002)056[0661:ESOSI]2.0.CO;2; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hanski I, 2006, J ANIM ECOL, V75, P91, DOI 10.1111/j.1365-2656.2005.01024.x; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2011, ANNU REV ENTOMOL, V56, P143, DOI 10.1146/annurev-ento-120709-144746; Hill JK, 1999, OECOLOGIA, V121, P165, DOI 10.1007/s004420050918; Hughes CL, 2003, P ROY SOC B-BIOL SCI, V270, pS147, DOI 10.1098/rsbl.2003.0049; Hughes CL, 2007, ECOL ENTOMOL, V32, P437, DOI 10.1111/j.1365-2311.2007.00890.x; Jansen VAA, 2007, EVOLUTION, V61, P2386, DOI 10.1111/j.1558-5646.2007.00201.x; Kubisch A, 2010, ECOLOGY, V91, P3094, DOI 10.1890/09-2022.1; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Mustin K, 2009, OIKOS, V118, P131, DOI 10.1111/j.1600-0706.2008.17025.x; Ovaskainen O, 2006, THEOR POPUL BIOL, V69, P13, DOI 10.1016/j.tpb.2005.05.005; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Phillips BL, 2009, BIOL LETTERS, V5, P802, DOI 10.1098/rsbl.2009.0367; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saastamoinen M, 2007, OECOLOGIA, V153, P569, DOI 10.1007/s00442-007-0772-5; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; SORENSEN AE, 1978, NATURE, V276, P174, DOI 10.1038/276174a0; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Travis JMJ, 2010, DIVERS DISTRIB, V16, P690, DOI 10.1111/j.1472-4642.2010.00674.x; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; van Saarloos W, 2003, PHYS REP, V386, P29, DOI 10.1016/j.physrep.2003.08.001; Weinberger HF, 2007, J MATH BIOL, V55, P207, DOI 10.1007/s00285-007-0078-6; Weinberger HF, 2002, J MATH BIOL, V45, P183, DOI 10.1007/s002850200145; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Ziska LH, 2011, CLIMATIC CHANGE, V105, P13, DOI 10.1007/s10584-010-9879-5	39	24	24	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40496	10.1371/journal.pone.0040496	http://dx.doi.org/10.1371/journal.pone.0040496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911701	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600019
J	Sahebzadeh, N; Mardan, M; Ali, AM; Tan, SG; Adam, NA; Lau, WH				Sahebzadeh, Najmeh; Mardan, Makhdzir; Ali, Abdul Manaf; Tan, Soon Guan; Adam, Nur Azura; Lau, Wei Hong			Genetic Relatedness of Low Solitary Nests of Apis dorsata from Marang, Terengganu, Malaysia	PLOS ONE			English	Article							MELLIFERA; POPULATION; AGGREGATIONS; HYMENOPTERA; DISTANCES	Knowledge on the population of genetic structure and ecological behaviour of Apis dorsata from Peninsular Malaysia is needed for effective management and conservation of this species since unsustainable whole solitary low nest cutting for product harvesting is the current common practice here. The analysis of 15 single locus DNA microsatellite markers on samples from 20 solitary nests of A. dorsata showed that while these markers were polymorphic, high intracolonial relatedness existed. Furthermore, in general, slightly negative values of intercolony relatedness (R) among the nests of A. dorsata were found. However, positive values of mean intercolony relatedness were observed between 54 pairs of nests out of 190 possible combinations. The R values among nest pairs 3-4 and 3-5 was higher than 0.50 showing that their queens were half siblings, whereas nest pair 19-20 showed relatedness of 0.95 indicating that the same queen was sampled. The results that we obtained could not conclusively support the hypothesis of this study that the honey hunters in Marang district of Malaysia repeatedly harvest the same nest located at a different site and at a different time during the same honey harvesting season. However, our finding of an appreciable level of intercolonial relatedness between several pairs of nests in this pioneer study indicated that a comprehensive study with a larger sample size of solitary nests found throughout the region would be necessary to provide concrete proof for this novel idea.	[Sahebzadeh, Najmeh; Adam, Nur Azura; Lau, Wei Hong] Univ Putra Malaysia, Dept Plant Protect, Fac Agr, Serdang, Selangor, Malaysia; [Mardan, Makhdzir] Univ Putra Malaysia, Dept Agr Technol, Fac Agr, Serdang, Selangor, Malaysia; [Ali, Abdul Manaf] Univ Sultan Zainal Abidin, Fac Agr & Biotechnol, Dept Biotechnol, Kuala Terengganu, Terengganu, Malaysia; [Tan, Soon Guan] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Sultan Zainal Abidin; Universiti Putra Malaysia	Sahebzadeh, N (corresponding author), Univ Putra Malaysia, Dept Plant Protect, Fac Agr, Serdang, Selangor, Malaysia.	najmeh.sahebzadeh@gmail.com	Sahebzadeh, Najmeh/ABA-3727-2021; Tan, S G/B-2448-2010; Tan, Soon Guan/V-1782-2019	Sahebzadeh, Najmeh/0000-0001-5736-1702; Tan, S G/0000-0001-9960-4493; Tan, Soon Guan/0000-0001-9960-4493	University Putra Malaysia via FRGS [07-04-10-819FR]	University Putra Malaysia via FRGS	University Putra Malaysia supported this research via FRGS grant (07-04-10-819FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cornuet JM, 1996, GENETICS, V144, P2001; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; ESTOUP A, 1995, GENETICS, V140, P679; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HAMID A H, 1997, P INT C TROP BEES EN, P60; Insuan S, 2007, BIOCHEM GENET, V45, P345, DOI 10.1007/s10528-007-9079-9; Kastberger G, 2000, APIDOLOGIE, V31, P727, DOI 10.1051/apido:2000157; Mardan M, 2007, BEES DEV, V83, P7; MARDAN MB, 1989, THESIS U GUELPH ONTA; Michalakis Y, 1996, GENETICS, V142, P1061; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Norris AT, 1999, AQUACULTURE, V180, P247, DOI 10.1016/S0044-8486(99)00212-4; OLDROYD B, 1995, APIDOLOGIE, V26, P119, DOI 10.1051/apido:19950205; Oldroyd BP, 1996, ANN ENTOMOL SOC AM, V89, P276, DOI 10.1093/aesa/89.2.276; Oldroyd BP, 2000, INSECT SOC, V47, P94, DOI 10.1007/s000400050015; Oldroyd BP, 2006, ASIAN HONEY BEES BIO; Ott J., 2001, ANAL HUMAN GENETIC L; Paar J, 2004, J HERED, V95, P119, DOI 10.1093/jhered/esh026; Park S., 2008, EXCEL MICROSATELLITE; Peakall R, 2010, GENALEX 6 41 GENETIC; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RINDERER TE, 1994, J APICULT RES, V33, P171, DOI 10.1080/00218839.1994.11100866; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Saberioon M. M., 2010, American Journal of Applied Sciences, V7, P252; Solignac M, 2003, MOL ECOL NOTES, V3, P307, DOI 10.1046/j.1471-8286.2003.00436.x; Takezaki N, 1996, GENETICS, V144, P389; Ting J, 2008, RES J ANIMAL SCI, V2, P178; WANG J, 2008, COLONY VERSION 2 0 1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS, 1990, GENETIC DATA ANAL ME, P222; Yong PL, 2007, EC VALUES HONEY BEES, P120	32	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41020	10.1371/journal.pone.0041020	http://dx.doi.org/10.1371/journal.pone.0041020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911733	gold, Green Submitted, Green Published			2022-12-27	WOS:000306644600037
J	Xiong, DP; Xiao, F; Liu, L; Hu, K; Tan, YP; He, SM; Gao, XP				Xiong, Dapeng; Xiao, Fen; Liu, Li; Hu, Kai; Tan, Yanping; He, Shunmin; Gao, Xieping			Towards a Better Detection of Horizontally Transferred Genes by Combining Unusual Properties Effectively	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; ESCHERICHIA-COLI; BACTERIAL; PREDICTION; ARCHAEAL	Background: Horizontal gene transfer (HGT) is one of the major mechanisms contributing to microbial genome diversification. A number of computational methods for finding horizontally transferred genes have been proposed in the past decades; however none of them has provided a reliable detector yet. In existing parametric approaches, only one single compositional property can participate in the detection process, or the results obtained through each single property are just simply combined. It's known that different properties may mean different information, so the single property can't sufficiently contain the information encoded by gene sequences. In addition, the class imbalance problem in the datasets, which also results in great errors for the gene detection, hasn't been considered by the published methods. Here we developed an effective classifier system (Hgtident) that used support vector machine (SVM) by combining unusual properties effectively for HGT detection. Results: Our approach Hgtident includes the introduction of more representative datasets, optimization of SVM model, feature selection, handling of imbalance problem in the datasets and extensive performance evaluation via systematic cross-validation methods. Through feature selection, we found that JS-DN and JS-CB have higher discriminating power for HGT detection, while GC1-GC3 and k-mer (k = 1, 2, ..., 7) make the least contribution. Extensive experiments indicated the new classifier could reduce Mean error dramatically, and also improve Recall by a certain level. For the testing genomes, compared with the existing popular multiple-threshold approach, on average, our Recall and Mean error was respectively improved by 2.81% and reduced by 26.32%, which means that numerous false positives were identified correctly. Conclusions: Hgtident introduced here is an effective approach for better detecting HGT. Combining multiple features of HGT is also essential for a wider range of HGT events detection.	[Xiong, Dapeng; Xiao, Fen; Hu, Kai; Tan, Yanping; Gao, Xieping] Xiangtan Univ, Minist Educ, Key Lab Intelligent Comp & Informat Proc, Xiangtan, Hunan, Peoples R China; [Liu, Li; He, Shunmin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China	Xiangtan University; Chinese Academy of Sciences; Institute of Zoology, CAS	Xiong, DP (corresponding author), Xiangtan Univ, Minist Educ, Key Lab Intelligent Comp & Informat Proc, Xiangtan, Hunan, Peoples R China.	heshunmin@gmail.com; xpgao@xtu.edu.cn	He, Shunmin/B-8037-2011; Gao, Xieping/G-1969-2016	He, Shunmin/0000-0002-7294-0865; 	National Natural Science Foundation of China [61172171]; Chinese Academy of Science Knowledge Innovation [KSCX2-EW-R-01-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science Knowledge Innovation	This work was supported by grants from the National Natural Science Foundation of China under Grant No. 61172171 and the Chinese Academy of Science Knowledge Innovation Project No. KSCX2-EW-R-01-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad RK, 2007, NUCLEIC ACIDS RES, V35, P4629, DOI 10.1093/nar/gkm204; Azad RK, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr059; Azad RK, 2005, PLOS COMPUT BIOL, V1, P461, DOI 10.1371/journal.pcbi.0010056; Bapteste E, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-33; Becq J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009989; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen Y, 2010, CHINESE J ELECTRON, V19, P86; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Faguy DM, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-13; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Hamady M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-476; Huang CL, 2006, EXPERT SYST APPL, V31, P231, DOI 10.1016/j.eswa.2005.09.024; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Podell S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r16; Ragan MA, 2001, FEMS MICROBIOL LETT, V201, P187, DOI 10.1111/j.1574-6968.2001.tb10755.x; Tsirigos A, 2005, NUCLEIC ACIDS RES, V33, P3699, DOI 10.1093/nar/gki660; Tsirigos A, 2005, NUCLEIC ACIDS RES, V33, P922, DOI 10.1093/nar/gki187; Weiss G. M., 2004, SIGKDD EXPLORATIONS, V6, P7, DOI DOI 10.1145/1007730.1007734; Zhou FF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-546	26	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43126	10.1371/journal.pone.0043126	http://dx.doi.org/10.1371/journal.pone.0043126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905214	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800048
J	Andersen, LG; Baker, JL; Sorensen, TIA				Andersen, Lise Geisler; Baker, Jennifer L.; Sorensen, Thorkild I. A.			Contributions of Incidence and Persistence to the Prevalence of Childhood Obesity during the Emerging Epidemic in Denmark	PLOS ONE			English	Article							BODY-MASS INDEX; YOUNG-CHILDREN; OVERWEIGHT; TRACKING; WEIGHT; COHORT; TRENDS; BIRTH; RISK; AGE	Background: Prevalence of obesity is the result of preceding incidence of newly developed obesity and persistence of obesity. We investigated whether increasing incidence and/or persistence during childhood drove the prevalence of childhood obesity during the emerging epidemic. Methods: Height and weight were measured at ages 7 and 13 years in 192,992 Danish school children born 1930-1969. Trends in the incidence (proportion obese at 13 years among those not obese at 7 years) and persistence (proportion obese at 13 years among those obese at 7 years) across birth cohort periods (1930-41 with low stable prevalence of obesity, 194-251 with increasing prevalence, 1952-69 with the higher, but stable prevalence) were investigated. Logistic regression was used to examine the associations between BMI at 7 years as a continuous trait, allowing interactions with the birth cohorts, and occurrence of obesity at 13 years. Results: The prevalence of obesity was similar at 7 and 13 years and increased across birth cohorts in boys from around 0.1% to 0.5% and in girls from around 0.3% to 0.7%. The incidence of obesity between ages 7 and 13 years increased from 0.15% to 0.35% in boys and from 0.20% to 0.44% in girls. The persistence increased from 28.6% to 41.4% in boys and from 16.4% to 31.0% in girls. Despite a decrease over time, the remission of obesity occurred in > 60% of obese children in the last birth cohort. However, the odds ratios of obesity at age 13 years in relation to the full range of BMI at 7 years remained unchanged across the birth cohort periods. Conclusions/Significance: The development of the obesity epidemic in children was due to an increase in both incidence and persistence of obesity. Contrary to prevailing expectations, a large, although declining, proportion of children obese at an early age underwent remission during childhood.	[Andersen, Lise Geisler; Baker, Jennifer L.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark	University of Copenhagen	Andersen, LG (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	lg@ipm.regionh.dk	Baker, Jennifer L./AAH-4693-2020; Bjerregaard, Lise Geisler/F-3818-2014; Baker, Jennifer/F-1917-2010	Baker, Jennifer L./0000-0002-9649-6615; Bjerregaard, Lise Geisler/0000-0001-8471-0832; Baker, Jennifer/0000-0002-9649-6615	Danish Heart Foundation; Rosalie Petersen's Foundation; Aase and Ejner Danielsen's Foundation; Danish PhD School of Molecular Metabolism; University of Copenhagen; Novo Nordisk Foundation; Capital region of Denmark; Danish Council for Strategic Research [2101-06-0005]	Danish Heart Foundation; Rosalie Petersen's Foundation; Aase and Ejner Danielsen's Foundation; Danish PhD School of Molecular Metabolism; University of Copenhagen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Capital region of Denmark; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Danish Heart Foundation; the Rosalie Petersen's Foundation; the Aase and Ejner Danielsen's Foundation; the Danish PhD School of Molecular Metabolism; University of Copenhagen; the Novo Nordisk Foundation; the Capital region of Denmark; and the Danish Council for Strategic Research (grant 2101-06-0005). The study is part of the activities in the Danish Obesity Research Centre (DanORC, see http://www.danorc.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008450; Armitage P, 2002, STAT METHODS MED RES, P503; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baker JL, 2009, INT J EPIDEMIOL, V38, P656, DOI 10.1093/ije/dyn164; Bua J, 2007, OBESITY, V15, P977, DOI 10.1038/oby.2007.603; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Eriksson M, 2005, ACTA PAEDIATR, V94, P1558, DOI 10.1080/08035250500274926; Evers S, 2007, J AM COLL NUTR, V26, P219, DOI 10.1080/07315724.2007.10719604; Fuentes RM, 2003, INT J OBESITY, V27, P716, DOI 10.1038/sj.ijo.0802271; Heitmann BL, 2004, PUBLIC HEALTH NUTR, V7, P453, DOI 10.1079/PHN2003542; Julia M, 2008, HORM RES, V69, P301, DOI 10.1159/000114862; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kim J, 2005, AM J PUBLIC HEALTH, V95, P1588, DOI 10.2105/AJPH.2004.054015; Kunesova M, 2011, OBES REV, V12, P483, DOI 10.1111/j.1467-789X.2011.00870.x; Lee JM, 2010, INT J OBESITY, V34, P614, DOI 10.1038/ijo.2009.235; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Olsen LW, 2006, EPIDEMIOLOGY, V17, P292, DOI 10.1097/01.ede.0000208349.16893.e0; Pearson Seija, 2005, Ugeskr Laeger, V167, P158; Pearson S, 2010, ACTA PAEDIATR, V99, P1675, DOI 10.1111/j.1651-2227.2010.01897.x; Robbins JM, 2007, ARCH PEDIAT ADOL MED, V161, P17, DOI 10.1001/archpedi.161.1.17; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027135; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P29; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; Sorensen T I, 1988, Acta Med Scand Suppl, V723, P11; Sorensen TIA, 2009, P NUTR SOC, V68, P43, DOI 10.1017/S0029665108008847; SORENSEN TIA, 1988, AM J EPIDEMIOL, V127, P104, DOI 10.1093/oxfordjournals.aje.a114770; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Summerbell CD, 2003, COCHRANE DATABASE SY; Taveras EM, 2005, OBES RES, V13, P900, DOI 10.1038/oby.2005.104; The Danish Data Protection agency, 2011, COMP VERS ACT PROC P; Thomsen BL, 1999, INT J OBESITY, V23, P693, DOI 10.1038/sj.ijo.0800907; Wang YF, 2003, PUBLIC HEALTH NUTR, V6, P549, DOI 10.1079/PHN2003470; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Williams PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027657; Williamson DA, 2011, OBESITY, V19, P667, DOI 10.1038/oby.2010.221; Zellner K, 2004, ECON HUM BIOL, V2, P281, DOI 10.1016/j.ehb.2004.04.006; Zimmerman MB, 2004, SWISS MED WKLY, V134, P523	42	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42521	10.1371/journal.pone.0042521	http://dx.doi.org/10.1371/journal.pone.0042521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900026	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900042
J	Le, DT; Nishiyama, R; Watanabe, Y; Vankova, R; Tanaka, M; Seki, M; Ham, LH; Yamaguchi-Shinozaki, K; Shinozaki, K; Tran, LSP				Dung Tien Le; Nishiyama, Rie; Watanabe, Yasuko; Vankova, Radomira; Tanaka, Maho; Seki, Motoaki; Le Huy Ham; Yamaguchi-Shinozaki, Kazuko; Shinozaki, Kazuo; Lam-Son Phan Tran			Identification and Expression Analysis of Cytokinin Metabolic Genes in Soybean under Normal and Drought Conditions in Relation to Cytokinin Levels	PLOS ONE			English	Article							ZEATIN-TYPE CYTOKININS; TRANSCRIPTIONAL REGULATORY NETWORKS; RESPONSIVE 2-COMPONENT SYSTEM; TRANSGENIC TOBACCO PLANTS; LIGAND-BINDING PROPERTIES; ABSCISIC-ACID; LEAF SENESCENCE; OXIDASE ACTIVITY; FACTOR FAMILY; CIS-ZEATIN	Cytokinins (CKs) mediate cellular responses to drought stress and targeted control of CK metabolism can be used to develop drought-tolerant plants. Aiming to manipulate CK levels to improve drought tolerance of soybean cultivars through genetic engineering of CK metabolic genes, we surveyed the soybean genome and identified 14 CK biosynthetic (isopentenyltransferase, GmIPT) and 17 CK degradative (CK dehydrogenase, GmCKX) genes. Comparative analyses of GmIPTs and GmCKXs with Arabidopsis counterparts revealed their similar architecture. The average numbers of abiotic stress-inducible cis-elements per promoter were 0.4 and 1.2 for GmIPT and GmCKX genes, respectively, suggesting that upregulation of GmCKXs, thereby reduction of CK levels, maybe the major events under abiotic stresses. Indeed, the expression of 12 GmCKX genes was upregulated by dehydration in R2 roots. Overall, the expressions of soybean CK metabolic genes in various tissues at various stages were highly responsive to drought. CK contents in various organs at the reproductive (R2) stage were also determined under well-watered and drought stress conditions. Although tRNA-type GmIPT genes were highly expressed in soybean, cis-zeatin and its derivatives were found at low concentrations. Moreover, reduction of total CK content in R2 leaves under drought was attributable to the decrease in dihydrozeatin levels, suggesting a role of this molecule in regulating soybean's responses to drought stress. Our systematic analysis of the GmIPT and GmCKX families has provided an insight into CK metabolism in soybean under drought stress and a solid foundation for in-depth characterization and future development of improved drought-tolerant soybean cultivars by manipulation of CK levels via biotechnological approach.	[Dung Tien Le; Nishiyama, Rie; Watanabe, Yasuko; Lam-Son Phan Tran] RIKEN Plant Sci Ctr, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan; [Dung Tien Le; Le Huy Ham] Vietnamese Acad Agr Sci, Natl Key Lab Plant Cell Biotechnol, Hanoi, Vietnam; [Vankova, Radomira] Acad Sci Czech Republ, Lab Hormonal Regulat Plants, Inst Expt Bot, Prague, Czech Republic; [Tanaka, Maho; Seki, Motoaki] RIKEN Plant Sci Ctr, Plant Genom Network Res Team, Yokohama, Kanagawa, Japan; [Yamaguchi-Shinozaki, Kazuko] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki, Japan; [Shinozaki, Kazuo] RIKEN Plant Sci Ctr, Gene Discovery Res Grp, Yokohama, Kanagawa, Japan; [Dung Tien Le; Le Huy Ham] Vietnamese Acad Agr Sci, Agr Genet Inst, Hanoi, Vietnam	RIKEN; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; RIKEN; Japan International Research Center for Agricultural Sciences; RIKEN	Le, DT (corresponding author), RIKEN Plant Sci Ctr, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan.	tran@psc.riken.jp	Vanková, Radomíra/G-6808-2014; Yamaguchi-Shinozaki, Kazuko/K-9004-2015; Seki, Motoaki/I-2854-2012; Shinozaki, Kazuo/G-4202-2013; Shinozaki, Kazuo/AAB-4945-2019; Tran, Lam-Son P/A-1346-2009; Le, Dung Tien/A-7276-2008	Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Seki, Motoaki/0000-0001-8288-0467; Shinozaki, Kazuo/0000-0002-6317-9867; Shinozaki, Kazuo/0000-0002-6317-9867; Tran, Lam-Son P/0000-0001-9883-9768; Le, Dung Tien/0000-0002-5117-3476	Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan) (RIKEN) Foreign Postdoctoral Fellowship (Japan); RIKEN Strategic Research Program for R D (Japan) [AP24-1-0076]	Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan) (RIKEN) Foreign Postdoctoral Fellowship (Japan); RIKEN Strategic Research Program for R D (Japan)	This work was supported by a Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan) (RIKEN) Foreign Postdoctoral Fellowship (Japan; http://www.riken.go.jp/engn/) to DTL and by a grant (No. AP24-1-0076) from the RIKEN Strategic Research Program for R & D (Japan; http://www.riken.go.jp/engn/) to L-SPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; Dobrev P, 2002, PLANT PHYSIOL BIOCH, V40, P333, DOI 10.1016/S0981-9428(02)01383-9; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Gajdosova S, 2011, J EXP BOT, V62, P2827, DOI 10.1093/jxb/erq457; Galuszka P, 2007, J PLANT GROWTH REGUL, V26, P255, DOI 10.1007/s00344-007-9008-5; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Havlova M, 2008, PLANT CELL ENVIRON, V31, P341, DOI 10.1111/j.1365-3040.2007.01766.x; HEWELT A, 1994, PLANT J, V6, P879, DOI 10.1046/j.1365-313X.1994.6060879.x; Jogaiah S, 2012, CRIT REV BIOTECHNOL, DOI [10.3109/07388551.2012.659174, DOI 10.3109/07388551.2012.659174]; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kudoyarova GR, 2007, J EXP BOT, V58, P161, DOI 10.1093/jxb/erl116; Tran LSP, 2010, PLANT SIGNAL BEHAV, V5, P148, DOI 10.4161/psb.5.2.10411; Le DT, 2011, DNA RES, V18, P17, DOI 10.1093/dnares/dsq032; LI Y, 1992, DEV BIOL, V153, P386, DOI 10.1016/0012-1606(92)90123-X; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Lomin SN, 2011, J EXP BOT, V62, P5149, DOI 10.1093/jxb/err220; Ma QH, 2008, CRIT REV BIOTECHNOL, V28, P213, DOI 10.1080/07388550802262205 ; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; MARTIN RC, 1989, PLANT PHYSIOL, V90, P1630, DOI 10.1104/pp.90.4.1630; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Mochida K, 2010, DNA RES, V17, P303, DOI 10.1093/dnares/dsq021; Mok DWS, 1990, PLANT GROWTH SUBSTAN, P267; Motyka V, 2003, PHYSIOL PLANTARUM, V117, P11, DOI 10.1034/j.1399-3054.2003.1170102.x; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Thao NP, 2012, CRIT REV BIOTECHNOL, V32, P349, DOI 10.3109/07388551.2011.643463; Nishiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032124; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Peleg Z, 2011, ADV BOT RES, V57, P405, DOI 10.1016/B978-0-12-387692-8.00012-6; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Qin H, 2011, PLANT CELL PHYSIOL, V52, P1904, DOI 10.1093/pcp/pcr125; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Rivero RM, 2009, PLANT PHYSIOL, V150, P1530, DOI 10.1104/pp.109.139378; Romanov GA, 2006, J EXP BOT, V57, P4051, DOI 10.1093/jxb/erl179; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Spichal L, 2004, PLANT CELL PHYSIOL, V45, P1299, DOI 10.1093/pcp/pch132; Synkova H, 1999, J PLANT PHYSIOL, V155, P173, DOI 10.1016/S0176-1617(99)80004-2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Tran LSP, 2009, MOL GENET GENOMICS, V281, P647, DOI 10.1007/s00438-009-0436-8; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Walther D, 2007, PLOS GENET, V3, P216, DOI 10.1371/journal.pgen.0030011; Wang J, 1997, AUST J PLANT PHYSIOL, V24, P661, DOI 10.1071/PP96101; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang SJ, 2010, MOL PLANT, V3, P469, DOI 10.1093/mp/ssq016; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang WX, 2005, BIOINFORMATICS, V21, P3074, DOI 10.1093/bioinformatics/bti490	63	87	91	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42411	10.1371/journal.pone.0042411	http://dx.doi.org/10.1371/journal.pone.0042411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900018	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900035
J	Mohibullah, M; Williams, M; Vandenbroucke, TRA; Sabbe, K; Zalasiewicz, JA				Mohibullah, Mohibullah; Williams, Mark; Vandenbroucke, Thijs R. A.; Sabbe, Koen; Zalasiewicz, Jan A.			Marine Ostracod Provinciality in the Late Ordovician of Palaeocontinental Laurentia and Its Environmental and Geographical Expression	PLOS ONE			English	Article							EASTERN UNITED-STATES; GIRVAN DISTRICT; SPECIATION; APARCHITIDAE; BIOGEOGRAPHY; LITHOFACIES; PATTERNS; ZONATION; BEARING	Background: We examine the environmental, climatic and geographical controls on tropical ostracod distribution in the marine Ordovician of North America. Methodology/Principal Findings: Analysis of the inter-regional distribution patterns of Ordovician Laurentian ostracods, focussing particularly on the diverse Late Ordovician Sandbian (ca 461 to 456 Ma) faunas, demonstrates strong endemicity at the species-level. Local endemism is very pronounced, ranging from 25% (e. g. Foxe basin) to 75% (e. g. Michigan basin) in each basin, a pattern that is also reflected in other benthic faunas such as brachiopods. Multivariate (ordination) analyses of the ostracod faunas allow demarcation of a Midcontinent Province and a southern Marginal Province in Laurentia. While these are most clearly differentiated at the stratigraphical level of the bicornis graptolite biozone, analyses of the entire dataset suggest that these provinces remain distinct throughout the Sandbian interval. Differences in species composition between the provinces appear to have been controlled by changes in physical parameters (e. g. temperature and salinity) related to water depth and latitude and a possible regional geographic barrier, and these differences persist into the Katian and possibly the Hirnantian. Local environmental parameters, perhaps operating at the microhabitat scale, may have been significant in driving local speciation events from ancestor species in each region. Conclusions/Significance: Our work establishes a refined methodology for assessing marine benthic arthropod micro-benthos provinciality for the Early Palaeozoic.	[Mohibullah, Mohibullah; Williams, Mark; Zalasiewicz, Jan A.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Mohibullah, Mohibullah] Univ Balochistan, Dept Geol, Quetta, Pakistan; [Vandenbroucke, Thijs R. A.] Univ Lille 1, Lille, France; [Sabbe, Koen] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium	University of Leicester; University of Balochistan; Universite de Lille - ISITE; Universite de Lille; Ghent University	Mohibullah, M (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.	mk241@le.ac.uk	Vandenbroucke, Thijs R. A./B-7974-2009; Williams, Mark/B-7590-2009	Vandenbroucke, Thijs R. A./0000-0002-8182-3708; Williams, Mark/0000-0002-7987-6069	University of Balochistan, Quetta, Pakistan	University of Balochistan, Quetta, Pakistan	This study was supported by the University of Balochistan, Quetta, Pakistan (http://www.uob.edu.pk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHAB A, 1989, J PALEONTOL, V63, P14, DOI 10.1017/S0022336000040907; Anstey RL, 2003, PALEOBIOLOGY, V29, P305, DOI 10.1666/0094-8373(2003)029<0305:POBETT>2.0.CO;2; Becker G, 1990, BRIT MICROPALAEONTOL, P422; Bennett Carys, 2008, Senckenbergiana Lethaea, V88, P37; Bennett CE, 2011, GEOLOGICAL IN PRESS; BERDAN JM, 1988, NEW MEXICO BUREAU MI, V44, P273; Bergstrom SM, 2009, LETHAIA, V42, P97, DOI 10.1111/j.1502-3931.2008.00136.x; Bergstrom S.M., 1986, Geological Society Special Publication, P61; Bergstrom SM, 2000, EPISODES, V23, P102; Bergstrom SM, 1973, ATLAS PALAEOBIGEOGRA, P45; BERGSTROM SM, 1998, P 6 INT GRAPT C GWG, V23, P148; Butlin RK, 2000, HYDROBIOLOGIA, V419, P1, DOI 10.1023/A:1003925705735; Cocks LRM, 2011, EARTH-SCI REV, V106, P1, DOI 10.1016/j.earscirev.2011.01.007; COCKS LRM, 1990, GEO SOC MEM, V12, P97, DOI 10.1144/GSL.MEM.1990.012.01.08; Cocks LRM, 2005, EARTH-SCI REV, V72, P39, DOI 10.1016/j.earscirev.2005.04.001; COOPER RA, 1991, LETHAIA, V24, P199, DOI 10.1111/j.1502-3931.1991.tb01468.x; Copeland M. J., 1965, Bulletin Geological Survey of Canada, V127, P1; Copeland M.J., 1977, Bulletin geol Surv Can, VNo. 269, P77; Copeland M.J., 1982, B GEOL SURV CAN, P1; Copeland MJ, 2000, B GEOLOGICAL SURVEY, V557, P217; Cronin T.M., 1988, Developments in Palaeontology and Stratigraphy, V11, P871; CRONIN TM, 1990, MAR MICROPALEONTOL, V16, P117, DOI 10.1016/0377-8398(90)90032-H; CRONIN TM, 1993, PALEOCEANOGRAPHY, V8, P161, DOI 10.1029/93PA00060; CRONIN TM, 1985, SCIENCE, V227, P60, DOI 10.1126/science.227.4682.60; Cronin TM, 1988, CAUSES EVOLUTION PAL, P210; Dowsett HJ, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P459; Dowsett H, 2010, STRATIGRAPHY, V7, P123; Dowsett HJ, 2009, PHILOS T R SOC A, V367, P109, DOI 10.1098/rsta.2008.0206; Floyd JD, 1999, SCOT J GEOL, V35, P15, DOI 10.1144/sjg35010015; Fortey RA, 2003, EARTH-SCI REV, V61, P245, DOI 10.1016/S0012-8252(02)00115-0; Hansen J, 2010, B GEOSCI, V85, P497, DOI 10.3140/bull.geosci.1178; Harper DAT, 2008, EARTH ENV SCI T R SO, V98, P281, DOI 10.1017/S1755691007078450; Harris R. W., 1957, Bulletin of the Oklahoma Geological Survey, V75, P1; Harris R.W., 1931, OKLAHOMA GEOLOGICAL; Hart MB, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P235; Harvey THP, 2012, P NATL ACAD SCI USA, V109, P1589, DOI 10.1073/pnas.1115244109; Horne DJ, 2002, GEOPH MONOG SERIES, V131, P5; Ingham JK, 2000, GEOL SOC SPEC REPORT, P43; Jones TR, 1858, ANN MAGAZINE NATUR 3, V1, P241; Jongman RHG, 1995, DATA ANAL COMMUNITY; Salas MJ, 2007, J PALEONTOL, V81, P1384, DOI 10.1666/05-134.1; KAY G. MARSHALL, 1934, JOUR PALEONTOL, V8, P328; KAY G. MARSHALL, 1940, JOUR PALEONTOL, V14, P234; KESLING ROBERT V., 1960, CONTR MUS PALEONTOL UNIV MICHIGAN, V15, P349; KESLING ROBERT V., 1960, CONTR MUS PALEONTOL UNIV MICHIGAN, V15, P365; Kraft JC, 1962, MEMOIR GEOLOGICAL SO, V86; Kucera M, 2007, DEV MARINE GEOL, V1, P213, DOI 10.1016/S1572-5480(07)01011-1; LEVINSON STUART A., 1961, MICROPALEONTOLOGY, V7, P359, DOI 10.2307/1484369; Liebau A, 2005, HYDROBIOLOGIA, V538, P115, DOI 10.1007/s10750-004-4943-7; Longman M.W., 1982, University of Kansas Paleontological Contributions Monograph, V1, P17; Loydell DK, 2012, GEOL MAG, V149, P124, DOI 10.1017/S0016756811000513; Meidla T, BIOGEOGRAPH IN PRESS; Meidla T, 1993, NEUES JB GEOLOGIE PA, V188, P289; Mohibullah M, 2010, GEOL MAG, V147, P919, DOI 10.1017/S0016756810000385; Mohibullah M, 2011, SCOT J GEOL, V47, P57, DOI 10.1144/0036-9276/01-428; Neckaja A.I, 1966, VSESOYUZNOGO NEFTYAN, V251, P1; Norford B. S, 1981, INT UNION GEOLOGICAL; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; POKORNY V., 1978, INTRO MARINE MICROPA, P109; POTTER AW, 1992, GLOBAL PERSPECTIVES ON ORDOVICIAN GEOLOGY, P307; Pour MG, 2011, ALCHERINGA, V35, P517, DOI 10.1080/03115518.2011.538909; Pruss SB, 2010, PALAIOS, V25, P73, DOI 10.2110/palo.2009.p09-101r; ROSS RJ, 1982, INT UNION GEOLOGICAL, V12; SCHALLREUTER REL, 1985, PALAEONTOLOGY, V28, P577; Schellenberg SA., 2007, ENCY QUATERNARY SCI, P2046, DOI [10.1016/B0-444-52747-8/00249-0, DOI 10.1016/B0-444-52747-8/00249-0]; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; Siveter DJ, 2009, MICROPALEAEONTOLOGIC, P15; Siveter DJ, 1991, J MICROPALAEONTOL, V10, P51; Steusloff A., 1895, Z DTSCH GEOLOGISCHEN, V46, P775; SWAIN FM, 1962, J PALEONTOL, V36, P719; Swain FM, 1996, GEOL SOC SPEC PUBL, V102, P97, DOI 10.1144/GSL.SP.1996.001.01.07; SWAIN FM, 1961, J PALEONTOL, V35, P345; SWAIN FM, 1957, J PALEONTOL, V31, P528; Teichert C, 1937, ORDOVICIAN SILURIAN; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Tinn O, 2004, PALAEONTOLOGY, V47, P199, DOI 10.1111/j.0031-0239.2004.00369.x; TUCKEY ME, 1990, PALAEOGEOGR PALAEOCL, V77, P91, DOI 10.1016/0031-0182(90)90128-T; uLRICH E.O., 1894, MINNESOTA GEOLOGICAL, V3, P629, DOI [DOI 10.5962/BHL.TITLE.57281, 10.5962/bhl.title.57281]; Ulrich EO, 1889, CONTRIBUTIONS MICR 2, P48; Vandenbroucke TRA, 2010, P NATL ACAD SCI USA, V107, P14983, DOI 10.1073/pnas.1003220107; Vandenbroucke TRA, 2010, PALAEOGEOGR PALAEOCL, V294, P202, DOI 10.1016/j.palaeo.2009.11.026; Vandenbroucke TRA, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/0008PA001720; VANNIER JMC, 1989, PALAEONTOLOGY, V32, P163; WARsHAuER s.M., 1982, GEOLOGICAL SURVEY PR, DOI [10.3133/pp1066H, DOI 10.3133/PP1066H]; Webby B.D., 2004, GREAT ORDOVICIAN BIO, DOI DOI 10.7312/WEBB12678; Whately R.C., 1988, Developments in Palaeontology and Stratigraphy, V11, P1021; Williams M, 2004, SCOT J GEOL, V40, P97, DOI 10.1144/sjg40020097; Williams M, 2003, PALAEOGEOGR PALAEOCL, V195, P193, DOI 10.1016/S0031-0182(03)00308-0; Williams M, 2001, T ROY SOC EDIN-EARTH, V91, P499; Williams M, 2000, SCOT J GEOL, V36, P51, DOI 10.1144/sjg36010051; Williams M, 1996, J MICROPALAEONTOL, V15, P69, DOI 10.1144/jm.15.1.69; Williams M, 2001, GEOL MAG, V138, P589, DOI 10.1017/S0016756801005726; Williams Mark, 2008, Senckenbergiana Lethaea, V88, P11; Wood A.M., 1994, Holocene, V4, P174, DOI 10.1177/095968369400400207; Zalasiewicz JA, 2009, GEOL MAG, V146, P785, DOI 10.1017/S0016756809990434; Zhen YY, 2003, LETHAIA, V36, P357, DOI 10.1080/00241160310006402	96	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41682	10.1371/journal.pone.0041682	http://dx.doi.org/10.1371/journal.pone.0041682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900000	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900015
J	Rybakin, V; Gascoigne, NRJ				Rybakin, Vasily; Gascoigne, Nicholas R. J.			Negative Selection Assay Based on Stimulation of T Cell Receptor Transgenic Thymocytes with Peptide-MHC Tetramers	PLOS ONE			English	Article							POSITIVE SELECTION; CD4(+)CD8(+) THYMOCYTES; FLOW-CYTOMETRY; APOPTOSIS; DEATH; THYMUS; REQUIREMENT; PATHWAYS; CULTURE; BINDING	Thymocyte negative selection is a requirement for the development of self tolerance. Although it is possible to assay the induction of cell death in thymocytes in vitro using antibody cross-linking, this stimulus is much stronger than the normal range of T cell receptor ligands that could be encountered during normal development. Signaling in thymocytes is finely balanced between positive and negative selection stimuli, where a negative selecting ligand can be only marginally higher affinity than a positive selecting ligand. We have therefore developed an assay for the induction of negative selection that can distinguish such cases, and that is amenable to high-throughput analysis. The assay is based on the induction of activated caspase 3 in thymocytes expressing a defined T cell receptor, after stimulation with MHC-peptide tetramers in vitro for 24 hours or less.	[Rybakin, Vasily; Gascoigne, Nicholas R. J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Rybakin, V (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	vrybakin@scripps.edu; ngascoigne@scripps.edu	Rybakin, Vasily/J-6310-2019	Rybakin, Vasily/0000-0002-5093-1757	National Institutes of Health [AI073870, AI074074, GM065230]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074074, R01AI073870, R56AI073870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants AI073870, AI074074 and GM065230. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 1997, J EXP MED, V186, P1503, DOI 10.1084/jem.186.9.1503; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Anderson G., 2007, CSH PROTOC; Anderson MS, 2011, CURR OPIN IMMUNOL, V23, P198, DOI 10.1016/j.coi.2010.11.007; Bogojevic D, 2012, LAB CHIP, V12, P627, DOI 10.1039/c2lc20893h; Brunelle JK, 2010, DRUG RESIST UPDATE, V13, P172, DOI 10.1016/j.drup.2010.09.001; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Einarsdottir T, 2009, INFECT IMMUN, V77, P4621, DOI 10.1128/IAI.00415-09; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fu G, 2009, J IMMUNOL METHODS, V350, P194, DOI 10.1016/j.jim.2009.07.009; Gamen S, 1996, FEBS LETT, V390, P233, DOI 10.1016/0014-5793(96)00666-7; Garza AS, 2009, LEUKEMIA RES, V33, P717, DOI 10.1016/j.leukres.2008.10.006; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jiang D, 1999, CELL DEATH DIFFER, V6, P402, DOI 10.1038/sj.cdd.4400513; Lawson BR, 2004, J EXP MED, V199, P547, DOI 10.1084/jem.20031685; Le Meur N, 2007, CYTOM PART A, V71A, P393, DOI 10.1002/cyto.a.20396; Mingueneau M, 2012, J EXP MED, V209, P623, DOI 10.1084/jem.20112593; Murakami K, 2010, EUR J IMMUNOL, V40, P3372, DOI 10.1002/eji.201040475; Ohta T, 1997, J BIOL CHEM, V272, P23111, DOI 10.1074/jbc.272.37.23111; PAGE DM, 1993, J IMMUNOL, V151, P1868; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Punt JA, 1997, J EXP MED, V186, P1911, DOI 10.1084/jem.186.11.1911; Schlegel J, 1996, J BIOL CHEM, V271, P1841, DOI 10.1074/jbc.271.4.1841; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Staton TL, 2011, NATURE, V472, P105, DOI 10.1038/nature09848; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M	33	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43191	10.1371/journal.pone.0043191	http://dx.doi.org/10.1371/journal.pone.0043191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900100	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900118
J	Kutay, H; Klepper, C; Wang, B; Hsu, SH; Datta, J; Yu, LB; Zhang, XL; Majumder, S; Motiwala, T; Khan, N; Belury, M; McClain, C; Jacob, S; Ghoshal, K				Kutay, Huban; Klepper, Corie; Wang, Bo; Hsu, Shu-hao; Datta, Jharna; Yu, Lianbo; Zhang, Xiaoli; Majumder, Sarmila; Motiwala, Tasneem; Khan, Nuzhat; Belury, Martha; McClain, Craig; Jacob, Samson; Ghoshal, Kalpana			Reduced Susceptibility of DNA Methyltransferase 1 Hypomorphic (Dnmt1(N/+)) Mice to Hepatic Steatosis upon Feeding Liquid Alcohol Diet	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; MOLECULAR-MECHANISMS; FATTY LIVER; METHYLATION; CANCER; HYPOMETHYLATION; DNMT3B; SUPPRESSION	Background: Methylation at C-5 (5-mdC) of CpG base pairs, the most abundant epigenetic modification of DNA, is catalyzed by 3 essential DNA methyltransferases (Dnmt1, Dnmt3a and Dnmt3b). Aberrations in DNA methylation and Dnmts are linked to different diseases including cancer. However, their role in alcoholic liver disease (ALD) has not been elucidated. Methodology/Principal Findings: Dnmt1 wild type (Dnmt1(+/+)) and hypomorphic (Dnmt1(N/+)) male mice that express reduced level of Dnmt1 were fed Lieber-DeCarli liquid diet containing ethanol for 6 weeks. Control mice were pair-fed calorie-matched alcohol-free liquid diet, and Dnmtase activity, 5-mdC content, gene expression profile and liver histopathology were evaluated. Ethanol feeding caused pronounced decrease in hepatic Dnmtase activity in Dnmt1(+/+) mice due to decrease in Dnmt1 and Dnmt3b protein levels and upregulation of miR-148 and miR-152 that target both Dnmt1 and Dnmt3b. Microarray and qPCR analysis showed that the genes involved in lipid, xenobiotic and glutathione metabolism, mitochondrial function and cell proliferation were dysregulated in the wild type mice fed alcohol. Surprisingly, Dnmt1(N/+) mice were less susceptible to alcoholic steatosis compared to Dnmt1(+/+) mice. Expression of several key genes involved in alcohol (Aldh3b1), lipid (Ppara, Lepr, Vldlr, Agpat9) and xenobiotic (Cyp39a1) metabolism, and oxidative stress (Mt-1, Fmo3) were significantly (P<0.05) altered in Dnmt1(N/+) mice relative to the wild type mice fed alcohol diet. However, CpG islands encompassing the promoter regions of Agpat9, Lepr, Mt1 and Ppara were methylation-free in both genotypes irrespective of the diet, suggesting that promoter methylation does not regulate their expression. Similarly, 5-mdC content of the liver genome, as measured by LC-MS/MS analysis, was not affected by alcohol diet in the wild type or hypomorphic mice. Conclusions/Significance: Although feeding alcohol diet reduced Dnmtase activity, the loss of one copy of Dnmt1 protected mice from alcoholic hepatosteatosis by dysregulating genes involved in lipid metabolism and oxidative stress.	[Kutay, Huban; Wang, Bo; Hsu, Shu-hao; Majumder, Sarmila; Motiwala, Tasneem; Jacob, Samson; Ghoshal, Kalpana] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Klepper, Corie; Wang, Bo; Hsu, Shu-hao; Datta, Jharna; Khan, Nuzhat; Jacob, Samson] Ohio State Univ, Coll Med, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Wang, Bo; Hsu, Shu-hao] Ohio State Univ, Coll Med, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Yu, Lianbo; Zhang, Xiaoli] Ohio State Univ, Coll Med, Ctr Biostat, Columbus, OH 43210 USA; [Belury, Martha] Ohio State Univ, Coll Med, Dept Nutr, Columbus, OH 43210 USA; [McClain, Craig] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [McClain, Craig] Robley Rex Louisville VAMC, Louisville, KY USA; [Jacob, Samson] Ohio State Univ, Coll Med, Expt Therapeut Program, Columbus, OH 43210 USA; [Ghoshal, Kalpana] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Louisville; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kutay, H (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	samson.jacob@osumc.edu; kalpana.ghoshal@osumc.edu	Motiwala, Tasneem/AAB-9067-2021; yu, lianbo/B-3472-2010	HSU, SHU-HAO/0000-0002-9444-4192; Wang, Bo/0000-0001-9234-035X	National Institutes of Health [AA016677, CA086978, DK088076]; Pelotonia predoctoral fellowship; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA086978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA016677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pelotonia predoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in part, by grants AA016677, CA086978 and DK088076 from the National Institutes of Health. Bo Wang was supported, in part, by a Pelotonia predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Datta J, 2009, CANCER RES, V69, P4277, DOI 10.1158/0008-5472.CAN-08-3669; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Eads CA, 2002, CANCER RES, V62, P1296; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Ghoshal K, 2002, MOL CELL BIOL, V22, P8302, DOI 10.1128/MCB.22.23.8302-8319.2002; Ghoshal K, 2001, MOL CELL BIOL, V21, P8301, DOI 10.1128/MCB.21.24.8301-8317.2001; Ghoshal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010338; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gordon D, 2007, GENET EPIDEMIOL, V31, P853, DOI 10.1002/gepi.20246; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Huang W, 2009, HEPATOLOGY, V49, P1525, DOI 10.1002/hep.22815; Irizarry MC, 2003, ANN NEUROL, V54, P7, DOI 10.1002/ana.10642; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; Kinney SRM, 2010, MOL CELL BIOL, V30, P4159, DOI 10.1128/MCB.00235-10; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Liu Z, 2009, ANAL BIOCHEM, V391, P106, DOI 10.1016/j.ab.2009.05.012; Majumder S, 2002, J BIOL CHEM, V277, P16048, DOI 10.1074/jbc.M111662200; Majumder S, 2006, J BIOL CHEM; McClain C, 2005, ALCOHOL CLIN EXP RES, V29, p180S, DOI 10.1097/01.alc.0000189276.34230.f5; Motiwala T, 2003, ONCOGENE, V22, P6319, DOI 10.1038/sj.onc.1206750; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; Okiyama W, 2009, J HEPATOL, V50, P1236, DOI 10.1016/j.jhep.2009.01.025; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Purohit V, 2007, AM J CLIN NUTR, V86, P14, DOI 10.1093/ajcn/86.1.14; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Shukla SD, 2008, ALCOHOL CLIN EXP RES, V32, P1525, DOI 10.1111/j.1530-0277.2008.00729.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Trinh BN, 2002, MOL CELL BIOL, V22, P2906, DOI 10.1128/MCB.22.9.2906-2917.2002; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang B, 2009, HEPATOLOGY IN PRESS; Yamada Y, 2005, P NATL ACAD SCI USA, V102, P13580, DOI 10.1073/pnas.0506612102; Yu HS, 2010, CHEM-BIOL INTERACT, V188, P367, DOI 10.1016/j.cbi.2010.08.005; Yu MC, 2008, J GASTROEN HEPATOL, V23, pS92, DOI 10.1111/j.1440-1746.2007.05293.x	46	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41949	10.1371/journal.pone.0041949	http://dx.doi.org/10.1371/journal.pone.0041949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905112	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100022
J	Chuang, CC; Hsiao, CH; Tan, HY; Ma, DHK; Lin, KK; Chang, CJ; Huang, YC				Chuang, Chih-Chun; Hsiao, Ching-Hsi; Tan, Hsin-Yuan; Ma, David Hui-Kang; Lin, Ken-Kuo; Chang, Chee-Jen; Huang, Yhu-Chering			Staphylococcus aureus Ocular Infection: Methicillin-Resistance, Clinical Features, and Antibiotic Susceptibilities	PLOS ONE			English	Article							UNITED-STATES; ANTIMICROBIAL SUSCEPTIBILITY; REFRACTIVE SURGERY; NORTHERN TAIWAN; KERATITIS; SURVEILLANCE; BACTEREMIA; VANCOMYCIN; EYE; CONJUNCTIVITIS	Background: Methicillin-resistant Staphylococcus aureus (MRSA) infection is an important public health issue. The study aimed to determine the prevalence of ocular infections caused by MRSA and to identify the clinical characteristics and antibiotic susceptibility of ocular MRSA infections by comparing those of ocular methicillin-sensitive S. aureus (MSSA) infections. Methodology/Principal Findings: The medical records of the patients (n = 519) with culture-proven S. aureus ocular infections seen between January 1, 1999 and December 31, 2008 in Chang Gung Memorial Hospital were retrospectively reviewed. Two hundred and seventy-four patients with MRSA and 245 with MSSA ocular infections were identified. The average rate of MRSA in S. aureus infections was 52.8% and the trend was stable over the ten years (P value for trend = 0.228). MRSA ocular infections were significantly more common among the patients with healthcare exposure (P = 0.024), but 66.1% (181/274) patients with MRSA ocular infections had no healthcare exposure. The most common clinical presentation for both MRSA and MSSA ocular infections was keratitis; MRSA and MSSA caused a similar disease spectrum except for lid infections. MRSA was significantly more resistant than MSSA to clindamycin, erythromycin and sulfamethoxazole/trimethoprim (all P < 0.001). Conclusions/significance: We demonstrated a paralleled trend of ocular MRSA infection in a highly prevalent MRSA country by hospital-based survey. Except for lid disorder, MRSA shared similar spectrum of ocular pathology with MSSA. Since S. aureus is a common ocular pathogen, our results raise clinician's attention to the existence of highly prevalent MRSA.	[Chuang, Chih-Chun; Hsiao, Ching-Hsi; Tan, Hsin-Yuan; Ma, David Hui-Kang; Lin, Ken-Kuo] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Chuang, Chih-Chun] Changhua Christian Hosp, Dept Ophthalmol, Changhua, Taiwan; [Chuang, Chih-Chun] Yuan Sheng Hosp, Dept Ophthalmol, Changhua, Taiwan; [Hsiao, Ching-Hsi; Tan, Hsin-Yuan; Ma, David Hui-Kang; Lin, Ken-Kuo; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Tao Yuan, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp, Div Pediat Infect Dis, Dept Pediat, Linkou, Taiwan	Chang Gung Memorial Hospital; Changhua Christian Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chuang, CC (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan.	ychuang@adm.cgmh.org.tw		Chang, Chee Jen/0000-0002-7725-7555	Chang Gung Memorial Hospital, Linkou, Taiwan [CMRPG381511]	Chang Gung Memorial Hospital, Linkou, Taiwan(Chang Gung Memorial Hospital)	This work was supported in part by Chang Gung Memorial Hospital, Linkou, Taiwan, grant number CMRPG381511. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo A, 2011, GRAEF ARCH CLIN EXP, V249, P111, DOI 10.1007/s00417-010-1426-6; Asbell PA, 2008, AM J OPHTHALMOL, V145, P951, DOI 10.1016/j.ajo.2008.01.025; Asbell PA, 2008, J CATARACT REFR SURG, V34, P814, DOI 10.1016/j.jcrs.2008.01.016; Blomquist Preston Howard, 2006, Trans Am Ophthalmol Soc, V104, P322; Broekema NM, 2009, J CLIN MICROBIOL, V47, P217, DOI 10.1128/JCM.01506-08; Cavuoto K, 2008, OPHTHALMOLOGY, V115, P51, DOI 10.1016/j.ophtha.2007.03.076; Center for Disease Control (CDC), 1995, AM J HEALTH-SYST PH, V52, P1272; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chen Chih-Jung, 2005, Journal of Microbiology Immunology and Infection, V38, P376; Chen FJ, 2009, DIAGN MICR INFEC DIS, V65, P351, DOI 10.1016/j.diagmicrobio.2009.07.024; Chen ML, 1999, J FORMOS MED ASSOC, V98, P426; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Deramo VA, 2008, AM J OPHTHALMOL, V145, P413, DOI 10.1016/j.ajo.2007.10.020; Deresinski S, 2005, CLIN INFECT DIS, V40, P562, DOI 10.1086/427701; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Donnenfeld ED, 2003, OPHTHALMOLOGY, V110, P743, DOI 10.1016/S0161-6420(02)01936-X; Force A-CT, 1999, QUAL CAR PUBL, V515; Freidlin J, 2007, AM J OPHTHALMOL, V144, P313, DOI 10.1016/j.ajo.2007.03.032; Fridkin SK, 2003, CLIN INFECT DIS, V36, P429, DOI 10.1086/346207; Fukuda M, 2002, CORNEA, V21, pS86, DOI 10.1097/01.ico.0000263125.99262.42; Gordon YJ, 2001, AM J OPHTHALMOL, V131, P371, DOI 10.1016/S0002-9394(00)00955-7; Haas W, 2011, AM J OPHTHALMOL, V152, P567, DOI 10.1016/j.ajo.2011.03.010; Hawser SP, 2011, INT J ANTIMICROB AG, V37, P219, DOI 10.1016/j.ijantimicag.2010.10.029; Hsiao CH, 2012, OPHTHALMOLOGY, V119, P522, DOI 10.1016/j.ophtha.2011.08.038; Hsueh PR, 2002, EMERG INFECT DIS, V8, P132; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Kotlus BS, 2006, AM J OPHTHALMOL, V142, P726, DOI 10.1016/j.ajo.2006.06.030; Kotlus BS, 2005, OPHTHAL PLAST RECONS, V21, P371, DOI 10.1097/01.iop.0000175035.22953.71; Major JC, 2010, AM J OPHTHALMOL, V149, P278, DOI 10.1016/j.ajo.2009.08.023; Marangon FB, 2004, AM J OPHTHALMOL, V137, P453, DOI 10.1016/j.ajo.2003.10.026; McDonald LC, 2004, INT J ANTIMICROB AG, V23, P362, DOI 10.1016/j.ijantimicag.2003.09.021; Melzer M, 2003, CLIN INFECT DIS, V37, P1453, DOI 10.1086/379321; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Rutar T, 2006, OPHTHALMOLOGY, V113, P1455, DOI 10.1016/j.ophtha.2006.03.031; Shanmuganathan VA, 2005, EYE, V19, P284, DOI 10.1038/sj.eye.6701465; Skiest DJ, 2007, J INFECTION, V54, P427, DOI 10.1016/j.jinf.2006.09.012; Solomon R, 2007, AM J OPHTHALMOL, V143, P629, DOI 10.1016/j.ajo.2006.12.029; Solomon R, 2011, J CATARACT REFR SURG, V37, P1343, DOI 10.1016/j.jcrs.2011.05.006; Sotozono C, 2002, CORNEA, V21, pS94, DOI 10.1097/01.ico.0000263127.84015.3f; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	43	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42437	10.1371/journal.pone.0042437	http://dx.doi.org/10.1371/journal.pone.0042437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880135	gold, Green Submitted, Green Published			2022-12-27	WOS:000307437900040
J	Sun, Z; Tian, WD				Sun, Zheng; Tian, Weidong			SAP-A Sequence Mapping and Analyzing Program for Long Sequence Reads Alignment and Accurate Variants Discovery	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; ULTRAFAST; TOOL; DNA	The third-generation of sequencing technologies produces sequence reads of 1000 bp or more that may contain high polymorphism information. However, most currently available sequence analysis tools are developed specifically for analyzing short sequence reads. While the traditional Smith-Waterman (SW) algorithm can be used to map long sequence reads, its naive implementation is computationally infeasible. We have developed a new Sequence mapping and Analyzing Program (SAP) that implements a modified version of SW to speed up the alignment process. In benchmarks with simulated and real exon sequencing data and a real E. coli genome sequence data generated by the third-generation sequencing technologies, SAP outperforms currently available tools for mapping short and long sequence reads in both speed and proportion of captured reads. In addition, it achieves high accuracy in detecting SNPs and InDels in the simulated data. SAP is available at https://github.com/davidsun/SAP.	[Sun, Zheng; Tian, Weidong] Fudan Univ, Sch Life Sci, Inst Biostat, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Fudan University	Sun, Z (corresponding author), Fudan Univ, Sch Life Sci, Inst Biostat, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	weidong.tian@fudan.edu.cn			National Basic Research Program of China [2012CB316505, 2010CB529505]; National Natural Science Foundation of China [30971643, 31071113]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Basic Research Program of China (Grant No. 2012CB316505, 2010CB529505), and the National Natural Science Foundation of China (Grant No. 30971643, 31071113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrows M., 1994, BLOCK SORTING LOSSLE; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Idury R M, 1995, J Comput Biol, V2, P291, DOI 10.1089/cmb.1995.2.291; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lam TW, 2008, BIOINFORMATICS, V24, P791, DOI 10.1093/bioinformatics/btn032; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin H, 2008, BIOINFORMATICS, V24, P2431, DOI 10.1093/bioinformatics/btn416; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248	16	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42887	10.1371/journal.pone.0042887	http://dx.doi.org/10.1371/journal.pone.0042887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880129	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900059
J	Ochi, N; Hotta, K; Takigawa, N; Oze, I; Fujiwara, Y; Ichihara, E; Hisamoto, A; Tabata, M; Tanimoto, M; Kiura, K				Ochi, Nobuaki; Hotta, Katsuyuki; Takigawa, Nagio; Oze, Isao; Fujiwara, Yoshiro; Ichihara, Eiki; Hisamoto, Akiko; Tabata, Masahiro; Tanimoto, Mitsune; Kiura, Katsuyuki			Treatment-Related Death in Patients with Small-Cell Lung Cancer in Phase III Trials over the Last Two Decades	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INDUCED FEBRILE NEUTROPENIA; THORACIC RADIOTHERAPY; CHEMOTHERAPY; SURVIVAL; METAANALYSIS; CYCLOPHOSPHAMIDE; DOXORUBICIN; CISPLATIN; ETOPOSIDE	Introduction: Treatment-related death (TRD) remains a serious problem in small-cell lung cancer (SCLC), despite recent improvements in supportive care. However, few studies have formally assessed time trends in the proportion of TRD over the past two decades. The aim of this study was to determine the frequency and pattern of TRD over time. Methods: We examined phase 3 trials conducted between 1990 and 2010 to address the role of systemic treatment for SCLC. The time trend was assessed using linear regression analysis. Results: In total, 97 trials including nearly 25,000 enrolled patients were analyzed. The overall TRD proportion was 2.95%. Regarding the time trend, while it was not statistically significant, it tended to decrease, with a 0.138% decrease per year and 2.76% decrease per two decades. The most common cause of death was febrile neutropenia without any significant time trend in its incidence over the years examined (p = 0.139). However, deaths due to febrile neutropenia as well as all causes in patients treated with non-platinum chemotherapy increased significantly (p = 0.033). Conclusions: The overall TRD rate has been low, but not negligible, in phase III trials for SCLC over the past two decades.	[Ochi, Nobuaki; Hotta, Katsuyuki; Takigawa, Nagio; Oze, Isao; Fujiwara, Yoshiro; Ichihara, Eiki; Hisamoto, Akiko; Tabata, Masahiro; Tanimoto, Mitsune; Kiura, Katsuyuki] Okayama Univ Hosp, Dept Resp Med, Okayama, Japan; [Ochi, Nobuaki; Takigawa, Nagio] Kawasaki Hosp, Kawasaki Med Sch, Dept Gen Internal Med 4, Okayama, Japan	Okayama University; Kawasaki Medical School	Ochi, N (corresponding author), Okayama Univ Hosp, Dept Resp Med, Okayama, Japan.	khotta@md.okayama-u.ac.jp	Oze, Isao/E-8288-2018; KIURA, Katsuyuki/B-1991-2011	Oze, Isao/0000-0002-0762-1147; Kiura, Katsuyuki/0000-0002-9172-9379				Auperin A, 1999, NEW ENGL J MED, V341, P476, DOI 10.1056/NEJM199908123410703; Clark OAC, 2005, J CLIN ONCOL, V23, P4198, DOI 10.1200/JCO.2005.05.645; CRAWFORD J, 1991, NEW ENGL J MED, V325, P164, DOI 10.1056/NEJM199107183250305; Fujiwara Y, 2011, ANN ONCOL, V22, P376, DOI 10.1093/annonc/mdq360; GOODMAN GE, 1990, J CLIN ONCOL, V8, P39, DOI 10.1200/JCO.1990.8.1.39; GREEN RA, 1969, AM J MED, V46, P516, DOI 10.1016/0002-9343(69)90071-0; Hanna N, 2006, J CLIN ONCOL, V24, P2038, DOI 10.1200/JCO.2005.04.8595; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; Hotta K, 2004, J CLIN ONCOL, V22, P3860, DOI 10.1200/JCO.2004.01.153; Hotta K, 2009, ANN ONCOL, V20, P829, DOI 10.1093/annonc/mdp020; Hotta K, 2004, ANN ONCOL, V15, P1782, DOI 10.1093/annonc/mdh476; Hotta K, 2007, J THORAC ONCOL, V2, P402, DOI 10.1097/01.JTO.0000268673.95119.c7; Hotta K, 2007, CANCER-AM CANCER SOC, V109, P939, DOI 10.1002/cncr.22478; Hotta K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026646; Hotta K, 2009, J THORAC ONCOL, V4, P311, DOI 10.1097/JTO.0b013e3181989bd2; Kuderer NM, 2007, J CLIN ONCOL, V25, P3158, DOI 10.1200/JCO.2006.08.8823; Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061; Lebeau B, 1999, CANCER-AM CANCER SOC, V86, P1480, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1480::AID-CNCR14>3.0.CO;2-O; Murray N, 1999, J CLIN ONCOL, V17, P2300, DOI 10.1200/JCO.1999.17.8.2300; Noda W, 2002, NEW ENGL J MED, V346, P85, DOI 10.1056/NEJMoa003034; Ohe Y, 2001, EUR J CANCER, V37, P54, DOI 10.1016/S0959-8049(00)00350-6; Oze I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007835; PIGNON JP, 1992, NEW ENGL J MED, V327, P1618, DOI 10.1056/NEJM199212033272302; ROTH BJ, 1992, J CLIN ONCOL, V10, P282, DOI 10.1200/JCO.1992.10.2.282; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Thatcher N, 2000, J CLIN ONCOL, V18, P395, DOI 10.1200/JCO.2000.18.2.395; Timmer-Bonte JN, 2005, J CLIN ONCOL, V23, P7974, DOI 10.1200/JCO.2004.00.7955; Urban T, 1999, CANCER-AM CANCER SOC, V86, P2238, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2238::AID-CNCR10>3.3.CO;2-7; Urban T, 1999, LUNG CANCER-J IASLC, V25, P105, DOI 10.1016/S0169-5002(99)00050-1	29	12	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42798	10.1371/journal.pone.0042798	http://dx.doi.org/10.1371/journal.pone.0042798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880112	Green Submitted, Green Published, gold			2022-12-27	WOS:000307810000072
J	Matsumoto, H; Shibasaki, K; Uchigashima, M; Koizumi, A; Kurachi, M; Moriwaki, Y; Misawa, H; Kawashima, K; Watanabe, M; Kishi, S; Ishizaki, Y				Matsumoto, Hidetaka; Shibasaki, Koji; Uchigashima, Motokazu; Koizumi, Amane; Kurachi, Masashi; Moriwaki, Yasuhiro; Misawa, Hidemi; Kawashima, Koichiro; Watanabe, Masahiko; Kishi, Shoji; Ishizaki, Yasuki			Localization of Acetylcholine-Related Molecules in the Retina: Implication of the Communication from Photoreceptor to Retinal Pigment Epithelium	PLOS ONE			English	Article							AFFINITY CHOLINE TRANSPORTER; CENTRAL-NERVOUS-SYSTEM; RABBIT RETINA; NONNEURONAL ACETYLCHOLINE; CLINICAL-ASPECTS; AMACRINE CELLS; OUTER SEGMENT; RECEPTORS; SLURP-1; IDENTIFICATION	It has been long speculated that specific signals are transmitted from photoreceptors to the retinal pigment epithelium (RPE). However, such signals have not been identified. In this study, we examined the retinal expression and localization of acetylcholine-related molecules as putative candidates for these signals. Previous reports revealed that alpha 7 nicotinic acetylcholine receptors (nAChRs) are present in the microvilli of RPE cells that envelope the tips of photoreceptor outer segments (OS). Secreted mammalian leukocyte antigen 6/urokinase-type plasminogen activator receptor-related protein-1 (SLURP-1) is a positive allosteric modulator of the alpha 7 nAChR. Therefore, we first focused on the expression of SLURP-1. SLURP-1 mRNA was expressed in the outer nuclear layer, which is comprised of photoreceptor cell bodies. SLURP-1 immunoreactivity co-localized with rhodopsin and S-opsin in photoreceptor OS, while choline acetyltransferase (ChAT) and high affinity choline transporter (CHT-1) were also expressed in photoreceptor OS. Immunoelectron microscopy identified that the majority of SLURP-1 was localized to the plasma membranes of photoreceptor OS. These results provide evidence that SLURP-1 is synthesized in photoreceptor cell bodies and transported to photoreceptor OS, where SLURP-1 may also be secreted. Our findings suggest that photoreceptor OS communicate via neurotransmitters such as ACh and SLURP-1, while RPE cells might receive these signals through alpha 7 nAChRs in their microvilli.	[Matsumoto, Hidetaka; Kishi, Shoji] Gunma Univ, Dept Ophthalmol, Grad Sch Med, Maebashi, Gunma 371, Japan; [Shibasaki, Koji; Kurachi, Masashi; Ishizaki, Yasuki] Gunma Univ, Dept Mol & Cellular Neurobiol, Grad Sch Med, Maebashi, Gunma 371, Japan; [Uchigashima, Motokazu; Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Koizumi, Amane] Natl Inst Physiol Sci, Sect Correlat Physiol, Okazaki, Aichi 444, Japan; [Moriwaki, Yasuhiro; Misawa, Hidemi] Keio Univ, Dept Pharmacol, Fac Pharm, Minato Ku, Tokyo, Japan; [Kawashima, Koichiro] Kitasato Univ, Dept Mol Pharmacol, Sch Pharm, Minato Ku, Tokyo, Japan	Gunma University; Gunma University; Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Keio University; Kitasato University	Matsumoto, H (corresponding author), Gunma Univ, Dept Ophthalmol, Grad Sch Med, Maebashi, Gunma 371, Japan.	hide-m@showa.gunma-u.ac.jp	Ishizaki, Yasuki/AAB-1209-2020; WATANABE, Masahiko/A-4055-2012; Shibasaki, Koji/U-8674-2018; Watanabe, Masahiko/S-3614-2019; Misawa, Hiroaki/A-4312-2012	WATANABE, Masahiko/0000-0001-5037-7138; Shibasaki, Koji/0000-0003-2330-1749; Watanabe, Masahiko/0000-0001-5037-7138; Misawa, Hiroaki/0000-0003-1070-387X; Moriwaki, Yasuhiro/0000-0001-9533-0421; Koizumi, Amane/0000-0003-1177-0185	Uehara Memorial Foundation, Tokyo, Japan; Takeda Science Foundation, Tokyo, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan [21200012, 20399554, 24111507, 23650159]; Sumitomo Foundation	Uehara Memorial Foundation, Tokyo, Japan(Uehara Memorial Foundation); Takeda Science Foundation, Tokyo, Japan(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation	This work was supported by the Uehara Memorial Foundation, Tokyo, Japan (to YI), by a grant from Takeda Science Foundation, Tokyo, Japan (to YI), by a grant from Grants-in-Aid for Scientific Research (Project. 21200012, 20399554, 24111507 to KS, 23650159 to YI) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a grant from the Sumitomo Foundation (to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Arvidsson U, 1997, J COMP NEUROL, V378, P454; Bchetnia Mbarka, 2010, J Med Case Rep, V4, P108, DOI 10.1186/1752-1947-4-108; BRANDON C, 1987, BRAIN RES, V401, P385, DOI 10.1016/0006-8993(87)91426-0; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Durmus M, 1999, RETINA-J RET VIT DIS, V19, P247, DOI 10.1097/00006982-199903000-00013; Fischer AJ, 1998, J COMP NEUROL, V392, P273; Fischer J, 2001, HUM MOL GENET, V10, P875, DOI 10.1093/hmg/10.8.875; FRIEDMAN Z, 1988, BRAIN RES, V446, P11, DOI 10.1016/0006-8993(88)91291-7; Fujii T, 2009, J NEUROSCI RES, V87, P3024, DOI 10.1002/jnr.22117; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Grando SA, 2008, J PHARMACOL SCI, V106, P174, DOI 10.1254/jphs.FM0070087; Hogan MJ, 1971, HISTOLOGY HUMAN EYE; Horiguchi K, 2009, J NEUROSCI RES, V87, P2740, DOI 10.1002/jnr.22102; Kawashima K, 2008, J PHARMACOL SCI, V106, P167, DOI 10.1254/jphs.FM0070073; Koizumi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000221; Maneu V, 2010, VISUAL NEUROSCI, V27, P139, DOI 10.1017/S0952523810000246; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P121, DOI 10.1098/rspb.1984.0086; MASLAND RH, 1979, J CELL BIOL, V83, P159, DOI 10.1083/jcb.83.1.159; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P79, DOI 10.1098/rspb.1984.0084; Mastrangeli R, 2003, EUR J DERMATOL, V13, P560; Matsumoto H, 2008, AM J OPHTHALMOL, V145, P162, DOI 10.1016/j.ajo.2007.08.024; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Misawa H, 2001, NEUROSCIENCE, V105, P87, DOI 10.1016/S0306-4522(01)00147-6; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Moritoh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012917; Moriwaki Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/j.neures.2009.04.014; Narumoto O, 2010, BIOCHEM BIOPH RES CO, V398, P713, DOI 10.1016/j.bbrc.2010.07.006; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; OSBORNE NN, 1991, VISION RES, V31, P1119, DOI 10.1016/0042-6989(91)90038-7; Phan TCA, 2010, J PERIODONTAL RES, V45, P331, DOI 10.1111/j.1600-0765.2009.01240.x; Pons M, 2011, INVEST OPHTH VIS SCI, V52, P3842, DOI 10.1167/iovs.10-6254; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Shibasaki K, 2007, GENE EXPR PATTERNS, V7, P57, DOI 10.1016/j.modgep.2006.05.008; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; USDIN TB, 1995, TRENDS NEUROSCI, V18, P218, DOI 10.1016/0166-2236(95)93906-E; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Westfall JE, 2010, J NEUROSCI, V30, P8759, DOI 10.1523/JNEUROSCI.5229-09.2010	42	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42841	10.1371/journal.pone.0042841	http://dx.doi.org/10.1371/journal.pone.0042841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880119	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100175
J	Jeffery, JAL; Clements, ACA; Nguyen, YT; Nguyen, LH; Tran, SH; Le, NT; Vu, NS; Ryan, PA; Kay, BH				Jeffery, Jason A. L.; Clements, Archie C. A.; Nguyen, Yen Thi; Nguyen, Le Hoang; Tran, Son Hai; Le, Nghia Trung; Vu, Nam Sinh; Ryan, Peter A.; Kay, Brian H.			Water Level Flux in Household Containers in Vietnam - A Key Determinant of Aedes aegypti Population Dynamics	PLOS ONE			English	Article							DENGUE VECTOR; WOLBACHIA INFECTION; MODEL DEVELOPMENT; DIPTERA; SURVEILLANCE; TRANSMISSION; OVIPOSITION; IQUITOS; DISEASE; PERU	We examined changes in the abundance of immature Aedes aegypti at the household and water storage container level during the dry-season (June-July, 2008) in Tri Nguyen village, central Vietnam. We conducted quantitative immature mosquito surveys of 171 containers in the same 41 households, with replacement of samples, every two days during a 29-day period. We developed multi-level mixed effects regression models to investigate container and household variability in pupal abundance. The percentage of houses that were positive for I/II instars, III/IV instars and pupae during any one survey ranged from 19.5-43.9%, 48.8-75.6% and 17.1-53.7%, respectively. The mean numbers of Ae. aegypti pupae per house ranged between 1.9-12.6 over the study period. Estimates of absolute pupal abundance were highly variable over the 29-day period despite relatively stable weather conditions. Most variability in pupal abundance occurred at the container rather than the household level. A key determinant of Ae. aegypti production was the frequent filling of the containers with water, which caused asynchronous hatching of Ae. aegypti eggs and development of cohorts of immatures. We calculated the probability of the water volume of a large container (>500L) increasing or decreasing by >= 20% to be 0.05 and 0.07 per day, respectively, and for small containers (<500L) to be 0.11 and 0.13 per day, respectively. These human water-management behaviors are important determinants of Ae. aegypti production during the dry season. This has implications for choosing a suitable Wolbachia strain for release as it appears that prolonged egg desiccation does not occur in this village.	[Jeffery, Jason A. L.; Clements, Archie C. A.; Ryan, Peter A.; Kay, Brian H.] PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld, Australia; [Clements, Archie C. A.] Univ Queensland, Infect Dis Epidemiol Unit, Sch Populat Hlth, Herston, Qld, Australia; [Nguyen, Yen Thi; Nguyen, Le Hoang; Tran, Son Hai] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Le, Nghia Trung] Inst Pasteur, Nha Trang, Vietnam; [Vu, Nam Sinh] Minist Hlth, Gen Dept Prevent Med & Environm Hlth, Hanoi, Vietnam	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; National Institute of Hygiene & Epidemiology (NIHE)	Jeffery, JAL (corresponding author), PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld, Australia.	brian.kay@qimr.edu.au	Clements, Archie/ABD-1615-2020; Clements, Archie/D-9619-2013	Ryan, Peter/0000-0003-0674-4441	Bill and Melinda Gates Foundation "Grand Challenges in Global Health" [55]	Bill and Melinda Gates Foundation "Grand Challenges in Global Health"(Bill & Melinda Gates Foundation)	This study was funded by a grant from the Bill and Melinda Gates Foundation "Grand Challenges in Global Health" #55, administered by FNIH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521; Chadee DD, 2004, B ENTOMOL RES, V94, P201, DOI 10.1079/BER2004297; Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x; Clements ACA, 2006, PARASITOLOGY, V133, P711, DOI 10.1017/S0031182006001181; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Gubler DJ, 1997, DENGUE DENGUE HEMORR; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; Knox TB, 2007, J MED ENTOMOL, V44, P192, DOI 10.1603/0022-2585(2007)44[192:CEOQSM]2.0.CO;2; Knox TB, 2010, J MED ENTOMOL, V47, P748, DOI 10.1603/ME09297; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Padmanabha H, 2010, ECOHEALTH, V7, P78, DOI 10.1007/s10393-010-0301-6; SOUTHWOOD T R E, 1972, Bulletin of the World Health Organization, V46, P211; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Tran HP, 2010, INT HEALTH, V2, P136, DOI 10.1016/j.inhe.2009.12.007; TunLin W, 1995, AM J TROP MED HYG, V53, P595, DOI 10.4269/ajtmh.1995.53.595; Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015; Wong J, 2011, J MED ENTOMOL, V48, P45, DOI 10.1603/ME10149	25	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e39067	10.1371/journal.pone.0039067	http://dx.doi.org/10.1371/journal.pone.0039067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911683	Green Published, gold			2022-12-27	WOS:000306751300003
J	Selvaraj, S; Liu, K; Robinson, AM; Epstein, VA; Conley, DB; Kern, RC; Richter, CP				Selvaraj, Senthil; Liu, Kevin; Robinson, Alan M.; Epstein, Victoria A.; Conley, David B.; Kern, Robert C.; Richter, Claus-Peter			In Vivo Determination of Mouse Olfactory Mucus Cation Concentrations in Normal and Inflammatory States	PLOS ONE			English	Article							AIRWAY SURFACE LIQUID; ODOR IDENTIFICATION; K+; DISCRIMINATION; TRANSDUCTION; PATHOGENESIS; CHANNEL; PROTEIN; ANOSMIA; CILIA	Objective: Olfaction is impaired in chronic rhinosinusitis (CRS). The study has two aims: (1) to determine whether changes in cation concentration occur in the olfactory mucus of mice with CRS, which may affect chemo-electrical transduction, (2) and to examine whether these alterations are physiologically significant in humans. Study Design: Animal study in mice and translational study in humans. Methods: Inflammation was induced by sensitization and chronic exposure of 16 C57BL/6 mice to Aspergillus fumigatus. The control group included 16 untreated mice. Ion-selective microelectrodes were used to measure free cation concentrations in the olfactory mucus of 8 mice from each treatment group, while the remaining mice were sacrificed for histology. To validate the findings in the animal model, olfactory threshold was measured in 11 healthy human participants using Sniffin' Sticks before and after nasal irrigation with solutions that were composed of either of the cation concentrations. Results: In 8 mice, olfactory mucus of chronically inflamed mice had lower [Na+] (84.8 +/- 4.45 mM versus 93.73 +/- 3.06 mM, p = 0.02), and higher [K+] (7.2 +/- 0.65 mM versus 5.7 +/- 0.20 mM, p = 0.04) than controls. No difference existed in [Ca2+] (0.50 +/- 0.12 mM versus 0.54 +/- 0.06 mM, p = 0.39). In humans, rinsing with solutions replicating ion concentrations of the mouse mucosa with chronic inflammation caused a significant elevation in the median olfactory threshold (9.0 to 4.8, p = 0.003) but not with the control solution (8.3 to 7.8, p = 0.75). Conclusion: Chronic inflammation elevates potassium and lowers sodium ion concentration in mice olfactory mucus. Nasal irrigation with a corresponding solution induced olfactory threshold shift in humans.	[Selvaraj, Senthil; Liu, Kevin; Robinson, Alan M.; Epstein, Victoria A.; Conley, David B.; Kern, Robert C.; Richter, Claus-Peter] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Commun Sci & Disorders, Hugh Knowles Ctr, Evanston, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Selvaraj, S (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA.	CRI529@northwestern.edu		Selvaraj, Senthil/0000-0001-8418-7623	Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University; American Academy of Otolaryngic Allergy	Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University; American Academy of Otolaryngic Allergy	This work was supported by the Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University and the American Academy of Otolaryngic Allergy (V.A.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2008, CHEM SENSES, V33, P461, DOI 10.1093/chemse/bjn013; Carr VM, 2012, CHEM SENSES; Dalton P, 2004, CURR ALLERGY ASTHM R, V4, P230, DOI 10.1007/s11882-004-0031-3; Dejima K, 2006, ARCH OTOLARYNGOL, V132, P1352, DOI 10.1001/archotol.132.12.1352; FRINGS S, 1991, J GEN PHYSIOL, V97, P725, DOI 10.1085/jgp.97.4.725; Gamel K, 2000, BIOPHYS J, V79, P2475, DOI 10.1016/S0006-3495(00)76490-3; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.me.44.020193.000505; Gold GH, 1999, ANNU REV PHYSIOL, V61, P857, DOI 10.1146/annurev.physiol.61.1.857; Grubb BR, 2002, AM J PHYSIOL-CELL PH, V282, pC1423, DOI 10.1152/ajpcell.00612.2001; HISAMATSU K, 1990, J ALLERGY CLIN IMMUN, V86, P52, DOI 10.1016/S0091-6749(05)80123-X; Holmgren M, 2003, J GEN PHYSIOL, V121, P61, DOI 10.1085/jgp.20028722; Hull J, 1998, AM J RESP CRIT CARE, V157, P10, DOI 10.1164/ajrccm.157.1.9703045; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hussain I, 2001, CLIN EXP ALLERGY, V31, P1048, DOI 10.1046/j.1365-2222.2001.01129.x; JOSHI H, 1987, NEUROSCI LETT, V82, P321, DOI 10.1016/0304-3940(87)90276-X; Kern RC, 2000, LARYNGOSCOPE, V110, P1071, DOI 10.1097/00005537-200007000-00001; KLEENE SJ, 1993, J MEMBRANE BIOL, V131, P237, DOI 10.1007/BF02260112; Knowles MR, 1997, J CLIN INVEST, V100, P2588, DOI 10.1172/JCI119802; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Kozlova I, 2006, UPSALA J MED SCI, V111, P137, DOI 10.3109/2000-1967-016; Kozlova I, 2005, AM J PHYSIOL-LUNG C, V288, pL874, DOI 10.1152/ajplung.00303.2004; Kramer MF, 2006, AM J OTOLARYNG, V27, P190, DOI 10.1016/j.amjoto.2005.09.013; Kushnir NM, 2011, IMMUNOL ALLERGY CLIN, V31, P601, DOI 10.1016/j.iac.2011.05.008; Liu GX, 1998, ACTA PHARMACOL SIN, V19, P238; MARGOLIS FL, 1972, P NATL ACAD SCI USA, V69, P1221, DOI 10.1073/pnas.69.5.1221; Meyerholz DK, 2009, TOXICOL PATHOL, V37, P249, DOI 10.1177/0192623308329342; Namkung W, 2009, J BIOL CHEM, V284, P15916, DOI 10.1074/jbc.M808021200; Panagiotopoulos G, 2005, RHINOLOGY, V43, P130; Ponikau JU, 2005, CURR ALLERGY ASTHM R, V5, P472, DOI 10.1007/s11882-005-0028-6; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Robinson AM, 2003, NEUROREPORT, V14, P1891, DOI 10.1097/00001756-200310270-00002; Sauer G, 1999, HEARING RES, V129, P1, DOI 10.1016/S0378-5955(98)00230-5; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; van de Rijn M, 1998, J ALLERGY CLIN IMMUN, V102, P65, DOI 10.1016/S0091-6749(98)70056-9; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39600	10.1371/journal.pone.0039600	http://dx.doi.org/10.1371/journal.pone.0039600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911687	Green Submitted, Green Published, gold			2022-12-27	WOS:000306644600006
J	Blair, ME; Melnick, DJ				Blair, Mary E.; Melnick, Don J.			Scale-Dependent Effects of a Heterogeneous Landscape on Genetic Differentiation in the Central American Squirrel Monkey (Saimiri oerstedii)	PLOS ONE			English	Article							POPULATION-STRUCTURE; HABITAT FRAGMENTATION; MICROSATELLITE VARIATION; DISPERSAL PATTERNS; RECENT MIGRATION; CIRCUIT-THEORY; COSTA-RICA; FLOW; CONNECTIVITY; INFERENCE	Landscape genetic studies offer a fine-scale understanding of how habitat heterogeneity influences population genetic structure. We examined population genetic structure and conducted a landscape genetic analysis for the endangered Central American Squirrel Monkey (Saimiri oerstedii) that lives in the fragmented, human-modified habitats of the Central Pacific region of Costa Rica. We analyzed non-invasively collected fecal samples from 244 individuals from 14 groups for 16 microsatellite markers. We found two geographically separate genetic clusters in the Central Pacific region with evidence of recent gene flow among them. We also found significant differentiation among groups of S. o. citrinellus using pairwise FST comparisons. These groups are in fragments of secondary forest separated by unsuitable "matrix" habitats such as cattle pasture, commercial African oil palm plantations, and human residential areas. We used an individual-based landscape genetic approach to measure spatial patterns of genetic variance while taking into account landscape heterogeneity. We found that large, commercial oil palm plantations represent moderate barriers to gene flow between populations, but cattle pastures, rivers, and residential areas do not. However, the influence of oil palm plantations on genetic variance was diminished when we restricted analyses to within population pairs, suggesting that their effect is scale-dependent and manifests during longer dispersal events among populations. We show that when landscape genetic methods are applied rigorously and at the right scale, they are sensitive enough to track population processes even in species with long, overlapping generations such as primates. Thus landscape genetic approaches are extremely valuable for the conservation management of a diverse array of endangered species in heterogeneous, human-modified habitats. Our results also stress the importance of explicitly considering the heterogeneity of matrix habitats in landscape genetic studies, instead of assuming that all matrix habitats have a uniform effect on population genetic processes.	[Blair, Mary E.; Melnick, Don J.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Blair, Mary E.; Melnick, Don J.] New York Consortium Evolutionary Primatol, New York, NY USA	Columbia University	Blair, ME (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	mblair1@amnh.org			National Science Foundation (NSF) [BCS-0847912]; American Association of University Women; Margot Marsh Biodiversity Foundation; Columbia University; International Primatological Society; American Society of Primatologists; Northwest Primate Conservation Society; NSF; New York Consortium in Evolutionary Primatology [DGE-0333415]	National Science Foundation (NSF)(National Science Foundation (NSF)); American Association of University Women; Margot Marsh Biodiversity Foundation; Columbia University; International Primatological Society; American Society of Primatologists; Northwest Primate Conservation Society; NSF(National Science Foundation (NSF)); New York Consortium in Evolutionary Primatology	This research was generously funded by National Science Foundation (NSF) Award No. BCS-0847912, the American Association of University Women, the Margot Marsh Biodiversity Foundation, Columbia University, the International Primatological Society, the American Society of Primatologists, and the Northwest Primate Conservation Society. MEB was supported during her graduate training by a NSF Integrative Graduate Education and Research Traineeship program, the New York Consortium in Evolutionary Primatology, Award No. DGE-0333415. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; Arauz J, 1993, ESTADO CONSERVACION; Balkenhol N, 2009, LANDSCAPE ECOL, V24, P455, DOI 10.1007/s10980-009-9334-z; Baum KA, 2004, ECOLOGY, V85, P2671, DOI 10.1890/04-0500; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Blair ME, 2012, AM J PRIMATOL, V74, P37, DOI 10.1002/ajp.21007; Blair ME, 2011, THESIS COLUMBIA U NE; Blumenthal JM, 2009, MOL ECOL, V18, P4841, DOI 10.1111/j.1365-294X.2009.04403.x; Bohle UR, 2002, MOL ECOL NOTES, V2, P1; Boinski S, 1999, EVOL ANTHROPOL, V8, P101, DOI 10.1002/(SICI)1520-6505(1999)8:3<101::AID-EVAN5>3.0.CO;2-O; Boinski S, 2005, BEHAVIOUR, V142, P633, DOI 10.1163/1568539054352860; Boinski S, 1997, FOLIA PRIMATOL, V68, P181, DOI 10.1159/000157245; Boinski S, 1998, ORYX, V32, P45, DOI 10.1017/S0030605300029756; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Bourgain C, 2004, GENETICS, V168, P2349, DOI 10.1534/genetics.104.031617; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Braunisch V, 2010, MOL ECOL, V19, P3664, DOI 10.1111/j.1365-294X.2010.04703.x; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Broquet T, 2007, CONSERV GENET, V8, P249, DOI 10.1007/s10592-006-9146-5; Broquet T, 2006, LANDSCAPE ECOL, V21, P877, DOI 10.1007/s10980-005-5956-y; Bull RAS, 2011, MOL ECOL, V20, P1092, DOI 10.1111/j.1365-294X.2010.04944.x; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Cornuet JM, 1999, GENETICS, V153, P1989; Cornuet JM, 1996, GENETICS, V144, P2001; Crooks K. R., 2006, CONNECTIVITY CONSERV; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Di Fiore A, 2004, MOL ECOL NOTES, V4, P246, DOI 10.1111/j.1471-8286.2004.00631.x; Dunford W, 2005, LANDSCAPE ECOL, V20, P497, DOI 10.1007/s10980-004-5650-5; EOSL CCT FONAFIFO, 2002, EST COB FOR COST RIC; Epperson BK, 2003, GEOGRAPHIC GENETICS; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fogelqvist J, 2010, MOL ECOL RESOUR, V10, P314, DOI 10.1111/j.1755-0998.2009.02756.x; Frantz AC, 2010, MOL ECOL, V19, P1663, DOI 10.1111/j.1365-294X.2010.04605.x; Gehring TM, 2003, BIOL CONSERV, V109, P283, DOI 10.1016/S0006-3207(02)00156-8; Goncalves da Silva A, 2007, CAUSES SPATIAL GENET; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grativol AD, 2001, CONSERV GENET, V2, P1, DOI 10.1023/A:1011543401239; Greenwald KR, 2009, BIOL CONSERV, V142, P2493, DOI 10.1016/j.biocon.2009.05.021; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Hokit DG, 2010, CONSERV GENET, V11, P149, DOI 10.1007/s10592-009-0014-y; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Jack K., 2007, PRIMATES PERSPECTIVE, P107; Jaquiery J, 2011, MOL ECOL, V20, P692, DOI 10.1111/j.1365-294X.2010.04966.x; Jules ES, 2003, J VEG SCI, V14, P459, DOI 10.1111/j.1654-1103.2003.tb02172.x; Keyghobadi N, 1999, MOL ECOL, V8, P1481, DOI 10.1046/j.1365-294x.1999.00726.x; Kindlmann P, 2005, ECOL COMPLEX, V2, P150, DOI 10.1016/j.ecocom.2004.11.007; Knowlton JL, 2010, BIOL CONSERV, V143, P1342, DOI 10.1016/j.biocon.2010.03.011; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; Lada H, 2008, J APPL ECOL, V45, P1732, DOI 10.1111/j.1365-2664.2008.01563.x; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Latch EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027794; Liu ZJ, 2009, MOL ECOL, V18, P3831, DOI 10.1111/j.1365-294X.2009.04330.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lukas D, 2004, MOL ECOL, V13, P3389, DOI 10.1111/j.1365-294X.2004.02353.x; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; MANTEL N, 1967, CANCER RES, V27, P209; Mattey J, 1992, COLONIZACION ESPONTA; McRae B., 2009, CIRCUITSCAPE USER GU; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Munshi-South J, 2012, MOL ECOL, V21, P1360, DOI 10.1111/j.1365-294X.2012.05476.x; Nabe-Nielsen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008932; Najera A, 2010, AGROFOREST SYST, V80, P203, DOI 10.1007/s10457-010-9278-y; Nievergelt CM, 1998, MOL ECOL, V7, P1432; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Perez-Espona S, 2008, MOL ECOL, V17, P981, DOI 10.1111/j.1365-294X.2007.03629.x; Perez-Sweeney BM, 2005, MOL ECOL NOTES, V5, P198, DOI 10.1111/j.1471-8286.2005.00875.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Quemere E, 2010, MOL ECOL, V19, P1606, DOI 10.1111/j.1365-294X.2010.04581.x; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; Roon DA, 2005, MOL ECOL, V14, P195, DOI 10.1111/j.1365-294X.2004.02385.x; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; Sierra Claudine, 2003, Primate Conservation, V19, P5; SIMBERLOFF D, 1988, ANNU REV ECOL SYST, V19, P473, DOI 10.1146/annurev.ecolsys.19.1.473; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sork VL, 2010, MOL ECOL, V19, P3489, DOI 10.1111/j.1365-294X.2010.04786.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Tracey JA, 2006, CONNECTIVITY CONSERV, P343; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vigilant L, 2002, EVOL ANTHROPOL, V11, P162, DOI 10.1002/evan.10082; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Watling JI, 2011, GLOBAL ECOL BIOGEOGR, V20, P209, DOI 10.1111/j.1466-8238.2010.00586.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Wong G, 1990, USO HABITAT ESTIMACI; WRIGHT S, 1978, P580; Zaldivar ME, 2004, REV BIOL TROP, V52, P679; [No title captured]	108	27	28	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43027	10.1371/journal.pone.0043027	http://dx.doi.org/10.1371/journal.pone.0043027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905197	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600040
J	Jaroszewicz, J; Reiberger, T; Meyer-Olson, D; Mauss, S; Vogel, M; Ingiliz, P; Payer, BA; Stoll, M; Manns, MP; Schmidt, RE; Flisiak, R; Wedemeyer, H; Peck-Radosavljevic, M; Rockstroh, J; Cornberg, M				Jaroszewicz, Jerzy; Reiberger, Thomas; Meyer-Olson, Dirk; Mauss, Stefan; Vogel, Martin; Ingiliz, Patrick; Payer, Berit Anna; Stoll, Matthias; Manns, Michael P.; Schmidt, Reinhold E.; Flisiak, Robert; Wedemeyer, Heiner; Peck-Radosavljevic, Markus; Rockstroh, Juergen; Cornberg, Markus			Hepatitis B Surface Antigen Concentrations in Patients with HIV/HBV Co-Infection	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; NATURAL-HISTORY; SERUM-LEVELS; VIRUS; EPIDEMIOLOGY; PREDICTION; TENOFOVIR; KINETICS; DECLINE	HBsAg clearance is associated with clinical cure of chronic hepatitis B virus (HBV) infection. Quantification of HBsAg may help to predict HBsAg clearance during the natural course of HBV infection and during antiviral therapy. Most studies investigating quantitative HBsAg were performed in HBV mono-infected patients. However, the immune status is considered to be important for HBsAg decline and subsequent HBsAg loss. HIV co-infection unfavorably influences the course of chronic hepatitis B. In this cross-sectional study we investigated quantitative HBsAg in 173 HBV/HIV co-infected patients from 6 centers and evaluated the importance of immunodeficiency and antiretroviral therapy. We also compared 46 untreated HIV/HBV infected patients with 46 well-matched HBV mono-infected patients. HBsAg levels correlated with CD4 T-cell count and were higher in patients with more advanced HIV CDC stage. Patients on combination antiretroviral therapy (cART) including nucleos(t)ide analogues active against HBV demonstrated significant lower HBsAg levels compared to untreated patients. Importantly, HBsAg levels were significantly lower in patients who had a stronger increase between nadir CD4 and current CD4 T-cell count during cART. Untreated HIV/HBV patients demonstrated higher HBsAg levels than HBV mono-infected patients despite similar HBV DNA levels. In conclusion, HBsAg decline is dependent on an effective immune status. Restoration of CD4 T-cells during treatment with cART including nucleos(t) ide analogues seems to be important for HBsAg decrease and subsequent HBsAg loss.	[Jaroszewicz, Jerzy; Manns, Michael P.; Wedemeyer, Heiner; Cornberg, Markus] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Reiberger, Thomas; Payer, Berit Anna; Peck-Radosavljevic, Markus] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Meyer-Olson, Dirk; Stoll, Matthias; Schmidt, Reinhold E.] Hannover Med Sch, Dept Clin Immunol & Rheumatol, D-3000 Hannover, Germany; [Mauss, Stefan] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany; [Vogel, Martin; Rockstroh, Juergen] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Ingiliz, Patrick] Med Ctr Infect Dis MIB, Berlin, Germany; [Jaroszewicz, Jerzy; Flisiak, Robert] Med Univ Bialystok, Dept Infect Dis & Hepatol, Bialystok, Poland	Hannover Medical School; Medical University of Vienna; Hannover Medical School; University of Bonn; Medical University of Bialystok	Jaroszewicz, J (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany.	Cornberg.Markus@mh-hannover.de	Cornberg, Markus/AAN-6939-2021; Reiberger, Thomas/H-7613-2019; Peck-Radosavljevic, Markus/J-6353-2013; Flisiak, Robert/S-5356-2018	Cornberg, Markus/0000-0002-9141-8001; Reiberger, Thomas/0000-0002-4590-3583; Peck-Radosavljevic, Markus/0000-0002-0597-2728; Flisiak, Robert/0000-0003-3394-1635; Jaroszewicz, Jerzy/0000-0003-0139-4753	BMBF; Roche; Gilead; Abbott; MSD; Bristol Myers-Squibb; Boehringer Ingelheim; Chugai; Pfizer; BMS; Janssen; Tibotec; Boehringer-Ingelheim; Glaxo-Smith-Kline; ViiV-Healthcare; Janssen-Cilag; Merck, Sharp Dohme; GSK; Novartis; Boehringer; Roche Tibotec; ViiV	BMBF(Federal Ministry of Education & Research (BMBF)); Roche(Roche Holding); Gilead(Gilead Sciences); Abbott(Abbott Laboratories); MSD; Bristol Myers-Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Chugai; Pfizer(Pfizer); BMS(Bristol-Myers Squibb); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Tibotec; Boehringer-Ingelheim(Boehringer Ingelheim); Glaxo-Smith-Kline(GlaxoSmithKline); ViiV-Healthcare; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck, Sharp Dohme(Merck & Company); GSK(GlaxoSmithKline); Novartis(Novartis); Boehringer(Boehringer Ingelheim); Roche Tibotec; ViiV	This study was supported by the BMBF funded German Center for Infectious Disease Research (DZIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following conflicts: Lamivudine, GlaxoSmithKline (GSK); Tenofovir and Emtricitabine Gilead; HBsAg test, Abbott, Roche, Siemens. Dr. Jaroszewicz received lecture fees or travel grants from Roche, Gilead and Abbott. Dr. Reiberger received support from Roche (travel grant, lecture fee, grant support), MSD (travel grant, lecture fee) and Gilead (travel grant, grant support). Dr. Meyer-Olson received lecture fees or travel grants from Abbott, Bristol Myers-Squibb, Boehringer Ingelheim, Chugai, Pfizer, Roche. Dr. Mauss received lecture fees Abbott, BMS, Gilead, Janssen, MSD, Roche, advisory board BMS, Gilead, Janssen, Roche. Dr. Vogel has been employed at Janssen-Cilag since June 2011. Dr. Ingiliz has received lecture fees/consultancy fees from Roche, MSD, Gilead, BMS, Abbott, Tibotec. Dr. Payer received support from Roche (grants, lecture fees), MSD (travel grants) and Janssen (travel grants). Dr. Stoll received lecture fees and/or consult fees by Abbott, BMS, Boehringer-Ingelheim, Glaxo-Smith-Kline, ViiV-Healthcare, Roche, Gilead, Janssen-Cilag, Tibotec, Pfizer, and Merck, Sharp & Dohme. Dr. Manns received grants, lectural fees and/or consult fees from GSK, Gilead, Novartis, BMS, and Abbott. Dr. Schmidt received grants lecture fees or consult fees from Gilead, Abbott and Roche. Dr. Flisiak received advisory Board fee from Gilead; Lecture fees from Gilead, Abbott and Roche. Dr. Wedemeyer received grants, lectural fees and/or consult fees from Gilead, Novartis, BMS, and Abbott. Dr. Wedemeyer is also Academic Editor of PLoS ONE. Dr. Peck-Radosavljevic received lecture fee/advisory board from Roche, BMS, Gilead, speaker fees/consulting fees from MSD and grant support from Roche and MSD. Dr. Rockstroh received lecture fees and consult fees from Abbott, BMS, Boehringer, Gilead, GSK, Janssen, Merck, Roche Tibotec, and ViiV. Dr. Cornberg received lecture fees and/or consult fees from GSK, Gilead, Novartis, BMS, Roche, MSD and grant support from Roche and MSD. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chen CJ, 2011, HEPATOLOGY, V54, p881A; Cornberg M, 2010, Minerva Gastroenterol Dietol, V56, P451; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Jaroszewicz J, 2011, ANTIVIR THER, V16, P915, DOI 10.3851/IMP1866; Jaroszewicz J, 2010, J HEPATOL, V52, P514, DOI 10.1016/j.jhep.2010.01.014; Martin-Carbonero L, 2011, AIDS, V25, P73, DOI 10.1097/QAD.0b013e328340fde2; Maylin S, 2012, AIDS, V26, P939, DOI 10.1097/QAD.0b013e328352224d; Nguyen T, 2010, J HEPATOL, V52, P508, DOI 10.1016/j.jhep.2010.01.007; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; Reijnders JGP, 2010, J HEPATOL, V52, P493, DOI 10.1016/j.jhep.2010.01.012; Thibault V, 2011, ANTIVIR THER, V16, P199, DOI 10.3851/IMP1723; Thio CL, 2003, SEMIN LIVER DIS, V23, P125; Thompson AJV, 2010, HEPATOLOGY, V51, P1933, DOI 10.1002/hep.23571; Tuma P, 2010, ANTIVIR THER, V15, P881, DOI 10.3851/IMP1630; van Bommel F, 2002, HEPATOLOGY, V36, P507, DOI 10.1053/jhep.2002.35328; Wursthorn K, 2010, HEPATOLOGY, V52, P1611, DOI 10.1002/hep.23905; Zoutendijk R, 2011, J INFECT DIS, V204, P415, DOI 10.1093/infdis/jir282	22	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43143	10.1371/journal.pone.0043143	http://dx.doi.org/10.1371/journal.pone.0043143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905219	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600051
J	Zgheib, C; Kurdi, M; Zouein, FA; Gunter, BW; Stanley, BA; Zgheib, J; Romero, DG; King, SB; Paolocci, N; Booz, GW				Zgheib, Carlos; Kurdi, Mazen; Zouein, Fouad A.; Gunter, Barak W.; Stanley, Brian A.; Zgheib, Joe; Romero, Damian G.; King, S. Bruce; Paolocci, Nazareno; Booz, George W.			Acyloxy Nitroso Compounds Inhibit LIF Signaling in Endothelial Cells and Cardiac Myocytes: Evidence That STAT3 Signaling Is Redox-Sensitive	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MYOCARDIAL-INFARCTION; S-GLUTATHIONYLATION; OXIDATIVE STRESS; TRANSGENIC MICE; SULFENIC ACID; JAK-STAT; ACTIVATION; OVEREXPRESSION; INFLAMMATION	We previously showed that oxidative stress inhibits leukemia inhibitory factor (LIF) signaling by targeting JAK1, and the catalytic domains of JAK 1 and 2 have a cysteine-based redox switch. Thus, we postulated that the NO sibling and thiophylic compound, nitroxyl (HNO), would inhibit LIF-induced JAK-STAT3 activation. Pretreatment of human microvascular endothelial cells (HMEC-1) or neonatal rat cardiomyocytes with the HNO donors Angeli's salt or nitrosocyclohexyl acetate (NCA) inhibited LIF-induced STAT3 activation. NCA pretreatment also blocked the induction of downstream inflammatory genes (e. g. intercellular adhesion molecule 1, CCAAT/enhancer binding protein delta). The related 1-nitrosocyclohexyl pivalate (NCP; not a nitroxyl donor) was equally effective in inhibiting STAT3 activation, suggesting that these compounds act as thiolate targeting electrophiles. The JAK1 redox switch is likely not a target of acyloxy nitroso compounds, as NCA had no effect on JAK1 catalytic activity and only modestly affected JAK1-induced phosphorylation of the LIF receptor. However, pretreatment of recombinant human STAT3 with NCA or NCP reduced labeling of free sulfhydryl residues. We show that NCP in the presence of diamide enhanced STAT3 glutathionylation and dimerization in adult mouse cardiac myocytes and altered STAT3 under non-reducing conditions. Finally, we show that monomeric STAT3 levels are decreased in the G alpha q model of heart failure in a redox-sensitive manner. Altogether, our evidence indicates that STAT3 has redox-sensitive cysteines that regulate its activation and are targeted by HNO donors and acyloxy nitroso compounds. These findings raise the possibility of new therapeutic strategies to target STAT3 signaling via a redox-dependent manner, particularly in the context of cardiac and non-cardiac diseases with prominent pro-inflammatory signaling.	[Zgheib, Carlos; Zouein, Fouad A.; Gunter, Barak W.; Booz, George W.] Univ Mississippi, Med Ctr, Dept Pharmacol, Jackson, MS 39216 USA; [Zgheib, Carlos; Zouein, Fouad A.; Gunter, Barak W.; Booz, George W.] Univ Mississippi, Med Ctr, Dept Toxicol, Sch Med, Jackson, MS 39216 USA; [Zgheib, Carlos; Zouein, Fouad A.; Gunter, Barak W.; Romero, Damian G.; Booz, George W.] Univ Mississippi, Med Ctr, Ctr Excellence Cardiovasc Renal Res, Jackson, MS 39216 USA; [Kurdi, Mazen] Lebanese Univ, Dept Chem & Biochem, Fac Sci, Hadath, Lebanon; [Stanley, Brian A.; Paolocci, Nazareno] Johns Hopkins Med Inst, Div Cardiol, Baltimore, MD 21205 USA; [Zgheib, Joe] Ctr Hosp Univ Nancy, Div Cardiol, Dept Med, Brabois, France; [Romero, Damian G.] Univ Mississippi, Med Ctr, Dept Biochem, Sch Med, Jackson, MS 39216 USA; [King, S. Bruce] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Paolocci, Nazareno] Univ Perugia, Dept Clin Med, Sect Gen Pathol, I-06100 Perugia, Italy	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Lebanese University; Johns Hopkins University; Johns Hopkins Medicine; CHU de Nancy; University of Mississippi; University of Mississippi Medical Center; Wake Forest University; University of Perugia	Zgheib, C (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol, Jackson, MS 39216 USA.	gbooz@umc.edu	paolocci, nazareno/A-7124-2009	Paolocci, Nazareno/0000-0001-7011-997X; Zouein, Fouad/0000-0003-4451-804X	Lebanese University [MK-02-2011]; Lebanese National Council for Scientific Research (CNRS) [05-10-09]; COMSTECH-TWAS [09-122 RG/PHA/AF/AC_C]; National Heart, Lung, and Blood Institute [R01HL088101-05, R01HL62198, R01HL091923-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062198, R01HL091923, R01HL088101] Funding Source: NIH RePORTER	Lebanese University; Lebanese National Council for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); COMSTECH-TWAS; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants to MK from The Lebanese University (MK-02-2011), The Lebanese National Council for Scientific Research (CNRS; 05-10-09), and The COMSTECH-TWAS (09-122 RG/PHA/AF/AC_C); and grants from the National Heart, Lung, and Blood Institute to GWB (R01HL088101-05), SBK (R01HL62198), and NP (R01HL091923-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alturkmani HJ, 2012, J INORG BIO IN PRESS; Arany I, 2012, AM J PHYSIOL-RENAL, V302, pF722, DOI 10.1152/ajprenal.00338.2011; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; Booz GW, 2003, BASIC RES CARDIOL, V98, P33, DOI 10.1007/s00395-003-0387-x; Brown DA, 2010, J MOL CELL CARDIOL, V48, P673, DOI 10.1016/j.yjmcc.2009.11.011; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; Fischer P, 2007, BASIC RES CARDIOL, V102, P393, DOI 10.1007/s00395-007-0674-z; Fritzenwanger M, 2006, CYTOKINE, V33, P46, DOI 10.1016/j.cyto.2005.11.016; Froehlich JP, 2008, BIOCHEMISTRY-US, V47, P13150, DOI 10.1021/bi801925p; Fujio Y, 2011, J PHARMACOL SCI, V117, P213, DOI 10.1254/jphs.11R05CR; Haghikia A, 2011, HEART FAIL REV, V16, P35, DOI 10.1007/s10741-010-9170-x; Hong HY, 2000, ELECTROPHORESIS, V21, P841, DOI 10.1002/(SICI)1522-2683(20000301)21:5<841::AID-ELPS841>3.3.CO;2-W; Kim YS, 2007, J CARDIOVASC PHARM, V50, P41, DOI 10.1097/FJC.0b013e31805559b9; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Kurdi M, 2007, J CARDIOVASC PHARM, V50, P126, DOI 10.1097/FJC.0b013e318068dd49; Kurdi M, 2007, J CELL PHYSIOL, V212, P424, DOI 10.1002/jcp.21033; Kurdi M, 2009, AM J PHYSIOL-HEART C, V297, pH1545, DOI 10.1152/ajpheart.00032.2009; Li L, 2004, BIOCHEM BIOPH RES CO, V322, P1005, DOI 10.1016/j.bbrc.2004.08.014; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Miranda KM, 2005, J AM CHEM SOC, V127, P722, DOI 10.1021/ja045480z; Morimoto H, 2006, CIRC RES, V99, P891, DOI 10.1161/01.RES.0000246113.82111.2d; Paolocci N, 2003, P NATL ACAD SCI USA, V100, P5537, DOI 10.1073/pnas.0937302100; Paolocci N, 2001, P NATL ACAD SCI USA, V98, P10463, DOI 10.1073/pnas.181191198; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Qin FZ, 2010, CIRC-HEART FAIL, V3, P306, DOI 10.1161/CIRCHEARTFAILURE.109.864785; Rajasingh J, 2006, EXP CELL RES, V312, P2538, DOI 10.1016/j.yexcr.2006.04.010; Rehder DS, 2010, BIOCHEMISTRY-US, V49, P7748, DOI 10.1021/bi1008694; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Shoman ME, 2011, J MED CHEM, V54, P1059, DOI 10.1021/jm101432z; Silver JS, 2010, J LEUKOCYTE BIOL, V88, P1145, DOI 10.1189/jlb.0410217; Smith JK, 2012, FREE RADIC BIOL MED; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Taflin C, 2011, P NATL ACAD SCI USA, V108, P2891, DOI 10.1073/pnas.1011811108; Tocchetti CG, 2011, ANTIOXID REDOX SIGN, V14, P1687, DOI 10.1089/ars.2010.3859; Wang MJ, 2007, AM J PHYSIOL-HEART C, V293, pH2101, DOI 10.1152/ajpheart.00125.2007; Wang M, 2007, AM J PHYSIOL-ENDOC M, V293, pE872, DOI 10.1152/ajpendo.00251.2007; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wung BS, 2006, LIFE SCI, V78, P3035, DOI 10.1016/j.lfs.2005.12.013; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Zgheib C, 2012, J INTERF CYTOK RES, V32, P87, DOI 10.1089/jir.2011.0059	44	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43313	10.1371/journal.pone.0043313	http://dx.doi.org/10.1371/journal.pone.0043313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905257	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600068
J	Elliott, MA; Salva, OR; Mulcahy, P; Regolin, L				Elliott, Mark A.; Salva, Orsola Rosa; Mulcahy, Paul; Regolin, Lucia			Structural Imbalance Promotes Behavior Analogous to Aesthetic Preference in Domestic Chicks	PLOS ONE			English	Article							MEMORY; DIRECTION; SYMMETRY; POSITION; BIOLOGY; MALES	Background: Visual images may be judged 'aesthetic' when their positioning appears imbalanced. An apparent imbalance may signify an as yet incomplete action or event requiring more detailed processing. As such it may refer to phylogenetically ancient stimulus-response mechanisms such as those mediating attentional deployment. Methodology/Principal Findings: We studied preferences for structural balance or imbalance in week-old domestic chicks (Gallus gallus), using a conditioning procedure to reinforce pecking at either "aligned" (balanced) or "misaligned" (imbalanced) training stimuli. A testing phase with novel balanced and imbalanced stimuli established whether chicks would retain their conditioned behavior or revert to chance responding. Whereas those trained on aligned stimuli were equally likely to choose aligned or misaligned stimuli, chicks trained on misaligned stimuli maintained the trained preference. Conclusions/Significance: Our results are consistent with the idea that the coding of structural imbalance is primary and even overrides classical conditioning. Generalized to the humans, these results suggest aesthetic judgments based upon structural imbalance may be based on evolutionarily ancient mechanisms, which are shared by different vertebrate species.	[Elliott, Mark A.; Mulcahy, Paul] Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland; [Elliott, Mark A.] Kyushu Univ, Ctr Appl Perceptual Res, Dept Human Sci, Fukuoka 812, Japan; [Salva, Orsola Rosa] Univ Trento, Ctr Mind Brain Sci, Trento, Italy; [Salva, Orsola Rosa; Regolin, Lucia] Univ Padua, Dept Gen Psychol, I-35100 Padua, Italy	Ollscoil na Gaillimhe-University of Galway; Kyushu University; University of Trento; University of Padua	Elliott, MA (corresponding author), Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland.	mark.elliott@nuigalway.ie	Rosa Salva, Orsola/B-7831-2010; Regolin, Lucia/N-9564-2019	Rosa Salva, Orsola/0000-0003-1662-6094; Regolin, Lucia/0000-0001-8960-0309; Mulcahy, Paul/0000-0002-4005-1588; Elliott, Mark/0000-0003-2560-8760	Irish Research Council for Humanities andf Social Sciences; European Commission ERASMUS MUNDUS	Irish Research Council for Humanities andf Social Sciences(Irish Research Council for Science, Engineering and Technology); European Commission ERASMUS MUNDUS	The study was supported by a student stipend form the Irish Research Council for Humanities andf Social Sciences and a European Commission ERASMUS MUNDUS mobility award, both to Dr. Mulcahy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado Luis, 2003, Span J Psychol, V6, P155; Arnheim R., 1954, ART VISUAL PERCEPTIO; Berlyne D.E., 1974, STUDIES NEW EXPT AES, P175; Clara E, 2007, J EXP PSYCHOL-ANIM B, V33, P12, DOI 10.1037/0097-7403.33.1.12; Clara E, 2006, PERCEPTION, V35, P983, DOI 10.1068/p5420; FELLOWS BJ, 1967, PSYCHOL BULL, V67, P87, DOI 10.1037/h0024098; FREYD JJ, 1987, PSYCHOL REV, V94, P427, DOI 10.1037/0033-295X.94.4.427; Ghirlanda S, 2002, HUM NATURE-INT BIOS, V13, P383, DOI 10.1007/s12110-002-1021-6; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kandel ER, 1999, PHILOS T R SOC B, V354, P2027, DOI 10.1098/rstb.1999.0542; Kandel ER., 1976, CELLULAR BASIS BEHAV; Koffka K, 1922, PSYCHOL BULL, V19, P531, DOI 10.1037/h0072422; Livingstone M., 2002, VISION ART BIOL SEEI; Mascalzoni E, 2010, P NATL ACAD SCI USA, V107, P4483, DOI 10.1073/pnas.0908792107; McManus IC, 2011, I-PERCEPTION, V2, P615, DOI 10.1068/i0445aap; Moller AP, 1997, ASYMMETRY DEV STABIL; NICKI RM, 1975, ANIM BEHAV, V23, P116, DOI 10.1016/0003-3472(75)90057-3; Nicol C, 2006, APPL ANIM BEHAV SCI, V100, P58, DOI 10.1016/j.applanim.2006.04.004; Nicol CJ, 2004, LEARN BEHAV, V32, P72; PALMER SE, 1991, PERCEPTION OF STRUCTURE, P23, DOI 10.1037/10101-001; Palmer SE, 2008, SPATIAL VISION, V21, P421, DOI 10.1163/156856808784532662; Ramachandran V.S., 1999, J CONSCIOUSNESS STUD, V6, P15, DOI [10.1179/174327908X392906, DOI 10.1179/174327908X392906]; Regolin L, 2005, ANIM BEHAV, V70, P855, DOI 10.1016/j.anbehav.2005.01.014; Regolin L, 2005, BEHAV BRAIN RES, V157, P1, DOI 10.1016/j.bbr.2004.06.012; Rosa-Salva O, 2010, DEVELOPMENTAL SCI, V13, P565, DOI 10.1111/j.1467-7687.2009.00914.x; Rugani R, 2009, P ROY SOC B-BIOL SCI, V276, P2451, DOI 10.1098/rspb.2009.0044; SWADDLE JP, 1994, NATURE, V367, P165, DOI 10.1038/367165a0; SWADDLE JP, 1994, P ROY SOC B-BIOL SCI, V258, P267, DOI 10.1098/rspb.1994.0172; SWADDLE JP, 1995, P ROY SOC B-BIOL SCI, V261, P111, DOI 10.1098/rspb.1995.0124; Vallortigara G, 2006, CURR BIOL, V16, pR279, DOI 10.1016/j.cub.2006.03.052; van Zoest W, 2010, CURR DIR PSYCHOL SCI, V19, P116, DOI 10.1177/0963721410363895; WITTER MS, 1994, P ROY SOC B-BIOL SCI, V256, P299, DOI 10.1098/rspb.1994.0084; Zeigarnik B, 1927, PSYCHOL FORSCH, V9, P1	35	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43029	10.1371/journal.pone.0043029	http://dx.doi.org/10.1371/journal.pone.0043029			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OQ	22905198	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800039
J	Kalisvaart, H; van Broeckhuysen, S; Buhring, M; Kool, MB; van Dulmen, S; Geenen, R				Kalisvaart, Hanneke; van Broeckhuysen, Saskia; Buhring, Martina; Kool, Marianne B.; van Dulmen, Sandra; Geenen, Rinie			Definition and Structure of Body-Relatedness from the Perspective of Patients with Severe Somatoform Disorder and Their Therapists	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; MANAGEMENT; AWARENESS; FIBROMYALGIA; ACCEPTANCE; ANXIETY; PEOPLE; PAIN	Background: How a patient is connected with one's body is core to rehabilitation of somatoform disorder but a common model to describe body-relatedness is missing. The aim of our study was to investigate the components and hierarchical structure of body-relatedness as perceived by patients with severe somatoform disorder and their therapists. Methods: Interviews with patients and therapists yielded statements about components of body-relatedness. Patients and therapists individually sorted these statements according to similarity. Hierarchical cluster analysis was applied to these sortings. Analysis of variance was used to compare the perceived importance of the statements between patients and therapists. Results: The hierarchical structure included 71 characteristics of body-relatedness. It consisted of three levels with eight clusters at the lowest level: 1) understanding, 2) acceptance, 3) adjustment, 4) respect for the body, 5) regulation, 6) confidence, 7) self-esteem, and 8) autonomy. The cluster 'understanding' was considered most important by patients and therapists. Patients valued 'regulating the body' more than therapists. Conclusion: According to patients with somatoform disorders and their therapists, body-relatedness includes awareness of the body and self by understanding, accepting and adjusting to bodily signals, by respecting and regulating the body, by confiding and esteeming oneself and by being autonomous. This definition and structure of body-relatedness may help professionals to improve interdisciplinary communication, assessment, and treatment, and it may help patients to better understand their symptoms and treatment. (German language abstract, Abstract S1; Spanish language abstract, Abstract S2).	[Kalisvaart, Hanneke; van Broeckhuysen, Saskia; Buhring, Martina] Altrecht Psychosomat Med, Zeist, Netherlands; [Kool, Marianne B.; Geenen, Rinie] Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands; [van Dulmen, Sandra] NIVEL Netherlands Inst Hlth Serv Res, Utrecht, Netherlands	Utrecht University; Netherlands Institute for Health Services Research	Kalisvaart, H (corresponding author), Altrecht Psychosomat Med, Zeist, Netherlands.	h.kalisvaart@altrecht.nl	van Dulmen, A.M./L-4287-2015	van Dulmen, A.M./0000-0002-1651-7544; Geenen, Rinie/0000-0002-6615-6708				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Clatworthy J, 2005, BRIT J HEALTH PSYCH, V10, P329, DOI 10.1348/135910705X25697; De Waal MWM, 2004, BRIT J PSYCHIAT, V184, P470, DOI 10.1192/bjp.184.6.470; Fink P, 2008, CURR OPIN PSYCHIATR, V21, P182, DOI 10.1097/YCO.0b013e3282f51254; Gallager S, 2005, BODY SHAPES MIND; Gard G, 2005, DISABIL REHABIL, V27, P725, DOI 10.1080/09638280400009071; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Lanes RD, 2008, PSYCHOSOM MED, V70, P214, DOI 10.1097/PSY.0b013e3181647e44; Looper KJ, 2002, J CONSULT CLIN PSYCH, V70, P810, DOI 10.1037//0022-006X.70.3.810; Mayou R, 2005, AM J PSYCHIAT, V162, P847, DOI 10.1176/appi.ajp.162.5.847; McCracken LM, 2009, J PAIN, V10, P408, DOI 10.1016/j.jpain.2008.09.015; Mehling Wolf E, 2011, Philos Ethics Humanit Med, V6, P6, DOI 10.1186/1747-5341-6-6; Mehling WE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005614; Nater UM, 2010, PSYCHOTHER PSYCHOSOM, V79, P312, DOI 10.1159/000319312; Nickel M, 2006, J PSYCHOSOM RES, V61, P507, DOI 10.1016/j.jpsychores.2006.01.004; Nijs J, 2008, J REHABIL MED, V40, P241, DOI 10.2340/16501977-0185; Probst M, 2008, INT J EAT DISORDER, V41, P657, DOI 10.1002/eat.20531; Rohricht F, 2004, PSYCHOTHER PSYCH MED, V54, P1; Silver J, 2010, INT J PSYCHIAT CLIN, V14, P190, DOI 10.3109/13651501003735492; Steen E, 2000, PATIENT EDUC COUNS, V41, P181, DOI 10.1016/S0738-3991(99)00077-4; Steen E, 2001, PATIENT EDUC COUNS, V42, P35, DOI 10.1016/S0738-3991(00)00088-4; Strassnig M, 2006, CURR OPIN PSYCHIATR, V19, P194, DOI 10.1097/01.yco.0000214348.38787.d3; Taleporos G, 2001, SEX DISABIL, V19, P293, DOI 10.1023/A:1017909526508; TROCHIM WMK, 1989, EVAL PROGRAM PLANN, V12, P1, DOI 10.1016/0149-7189(89)90016-5; Van Houdenhove B, 2006, PSYCHOTHER PSYCHOSOM, V75, P396, DOI 10.1159/000095448; Van Houdenhove B, 2008, PSYCHOSOMATICS, V49, P470, DOI 10.1176/appi.psy.49.6.470; Whitbourne SK, 2002, BODY IMAGE: A HANDBOOK OF THEORY, RESEARCH, AND CLINICAL PRACTICE, P83	28	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42534	10.1371/journal.pone.0042534	http://dx.doi.org/10.1371/journal.pone.0042534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OQ	22905144	gold, Green Submitted, Green Published			2022-12-27	WOS:000307500800014
J	Moffitt, KL; Malley, R; Lu, YJ				Moffitt, Kristin L.; Malley, Richard; Lu, Ying-Jie			Identification of Protective Pneumococcal T(H)17 Antigens from the Soluble Fraction of a Killed Whole Cell Vaccine	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; INTRANASAL IMMUNIZATION; COLONIZATION; PROTEIN; DISEASE; IMMUNITY; SURFACE	Mucosal or parenteral immunization with a killed unencapsulated pneumococcal whole cell antigen (WCA) with an adjuvant protects mice from colonization by a T(H)17 CD4+ cell-mediated mechanism. Using preparative SDS gels, we separated the soluble proteins that compose the WCA in order to identify fractions that were immunogenic and protective. We screened these fractions for their ability to stimulate IL-17A secretion from splenocytes obtained from mice immunized with WCA and adjuvant. We identified 12 proteins within the stimulatory fractions by mass spectrometry; these proteins were then cloned, recombinantly expressed and purified using an Escherichia coli expression system. The ability of these proteins to induce IL-17A secretion was then evaluated by stimulation of mouse splenocytes. Of the four most stimulatory proteins, three were protective in a mouse pneumococcal serotype 6B colonization model. This work thus describes a method for identifying immunogenic proteins from the soluble fraction of pneumococcus and shows that several of the proteins identified protect mice from colonization when used as mucosal vaccines. We propose that, by providing protection against pneumococcal colonization, one or more of these proteins may serve as components of a multivalent pneumococcal vaccine.	[Moffitt, Kristin L.; Malley, Richard; Lu, Ying-Jie] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Moffitt, KL (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA.	kristin.moffitt@childrens.harvard.edu		Moffitt, Kristin/0000-0003-4581-7199	Pediatric Infectious Diseases Society; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [1K08AI095352-01]; Bill & Melinda Gates Foundation through the Grand Challenge Explorations program; Children's Hospital Technology Development grant; Translational Research Program at Children's Hospital Boston; NIH [R01 AI067737]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI095352, R01AI067737] Funding Source: NIH RePORTER	Pediatric Infectious Diseases Society; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation through the Grand Challenge Explorations program; Children's Hospital Technology Development grant; Translational Research Program at Children's Hospital Boston; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KLM acknowledges support from a fellowship award from the Pediatric Infectious Diseases Society and from National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) grant 1K08AI095352-01. This work was supported by the Bill & Melinda Gates Foundation through the Grand Challenge Explorations program and Children's Hospital Technology Development grant (to YJL and RM). RM acknowledges support from the Translational Research Program at Children's Hospital Boston and NIH grant R01 AI067737. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1992, SCAND J IMMUNOL, V36, P823, DOI 10.1111/j.1365-3083.1992.tb03144.x; Basset A, 2007, INFECT IMMUN, V75, P5460, DOI 10.1128/IAI.00773-07; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Green BA, 2005, INFECT IMMUN, V73, P981, DOI 10.1128/IAI.73.2.981-989.2005; Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lu YJ, 2012, VACCINE, V30, P3405, DOI 10.1016/j.vaccine.2012.03.039; Lu YJ, 2010, VACCINE, V28, P7468, DOI 10.1016/j.vaccine.2010.09.031; Lu YJ, 2010, CLIN VACCINE IMMUNOL, V17, P1005, DOI 10.1128/CVI.00036-10; Lu YJ, 2009, INFECT IMMUN, V77, P2076, DOI 10.1128/IAI.01554-08; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Malley R, 2001, INFECT IMMUN, V69, P4870, DOI 10.1128/IAI.69.8.4870-4873.2001; Medina M, 2008, INFECT IMMUN, V76, P2696, DOI 10.1128/IAI.00119-08; Moffitt KL, VACCINE IN PRESS; Moffitt KL, 2011, CURR OPIN IMMUNOL, V23, P407, DOI 10.1016/j.coi.2011.04.002; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001	22	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43445	10.1371/journal.pone.0043445	http://dx.doi.org/10.1371/journal.pone.0043445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905267	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800083
J	Gaubert, P; Bloch, C; Benyacoub, S; Abdelhamid, A; Pagani, P; Djagoun, CAMS; Couloux, A; Dufour, S				Gaubert, Philippe; Bloch, Cecile; Benyacoub, Slim; Abdelhamid, Adnan; Pagani, Paolo; Djagoun, Chabi Adeyemi Marc Sylvestre; Couloux, Arnaud; Dufour, Sylvain			Reviving the African Wolf Canis lupus lupaster in North and West Africa: A Mitochondrial Lineage Ranging More than 6,000 km Wide	PLOS ONE			English	Article							POPULATION-SIZE; SEQUENCES; PHYLOGEOGRAPHY; HYBRIDIZATION; DISPERSAL; EVOLUTION; HISTORY; CLIMATE; MAMMALS; REGION	The recent discovery of a lineage of gray wolf in North-East Africa suggests the presence of a cryptic canid on the continent, the African wolf Canis lupus lupaster. We analyzed the mtDNA diversity (cytochrome b and control region) of a series of African Canis including wolf-like animals from North and West Africa. Our objectives were to assess the actual range of C. l. lupaster, to further estimate the genetic characteristics and demographic history of its lineage, and to question its taxonomic delineation from the golden jackal C. aureus, with which it has been considered synonymous. We confirmed the existence of four distinct lineages within the gray wolf, including C. lupus/familiaris (Holarctic wolves and dogs), C. l. pallipes, C. l. chanco and C. l. lupaster. Taxonomic assignment procedures identified wolf-like individuals from Algeria, Mali and Senegal, as belonging to C. l. lupaster, expanding its known distribution c. 6,000 km to the west. We estimated that the African wolf lineage (i) had the highest level of genetic diversity within C. lupus, (ii) coalesced during the Late Pleistocene, contemporaneously with Holarctic wolves and dogs, and (iii) had an effective population size of c. 80,000 females. Our results suggest that the African wolf is a relatively ancient gray wolf lineage with a fairly large, past effective population size, as also suggested by the Pleistocene fossil record. Unique field observations in Senegal allowed us to provide a morphological and behavioral diagnosis of the African wolf that clearly distinguished it from the sympatric golden jackal. However, the detection of C. l. lupaster mtDNA haplotypes in C. aureus from Senegal brings the delineation between the African wolf and the golden jackal into question. In terms of conservation, it appears urgent to further characterize the status of the African wolf with regard to the African golden jackal.	[Gaubert, Philippe] Museum Natl Hist Nat, UMR BOREA IRD 207, F-75231 Paris, France; [Bloch, Cecile; Dufour, Sylvain] SYLVATROP, Nantes, France; [Benyacoub, Slim] Univ Annaba, Lab Ecol Syst Terr & Aquat, Fac Sci, Annaba, Algeria; [Abdelhamid, Adnan] Egyptian Environm Affairs Agcy, Nat Conservat Sect, Cairo, Egypt; [Pagani, Paolo] Dutch Wildlife Hlth Ctr, Utrecht, Netherlands; [Djagoun, Chabi Adeyemi Marc Sylvestre] Univ Abomey Calavi, Lab Ecol Appl, Fac Sci Agron, Cotonou, Benin; [Couloux, Arnaud] Genoscope, Ctr Natl Sequencage, Evry, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universite Badji Mokhtar - Annaba; University of Abomey Calavi; CEA; UDICE-French Research Universities; Universite Paris Saclay	Gaubert, P (corresponding author), Museum Natl Hist Nat, UMR BOREA IRD 207, F-75231 Paris, France.	gaubert@mnhn.fr	Gaubert, Philippe/AGV-9979-2022	Couloux, Arnaud/0000-0003-2356-0062; Gaubert, Philippe/0000-0002-1375-9935	Action Transversale "Biodiversite actuelle et fossile"; Societe des Amis du Museum National d'Histoire Naturelle et du Jardin des Plantes (MNHN, Paris, France); Consortium National de Recherche en Genomique; Service de Systematique Moleculaire of the Museum National d'Histoire Naturelle [CNRS - UMS 2700]	Action Transversale "Biodiversite actuelle et fossile"; Societe des Amis du Museum National d'Histoire Naturelle et du Jardin des Plantes (MNHN, Paris, France); Consortium National de Recherche en Genomique; Service de Systematique Moleculaire of the Museum National d'Histoire Naturelle(Centre National de la Recherche Scientifique (CNRS))	PG received funding for lab work and field surveys from Action Transversale "Biodiversite actuelle et fossile" and Societe des Amis du Museum National d'Histoire Naturelle et du Jardin des Plantes (MNHN, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the following persons for contributing to the sampling effort: Severin Tchibozo (Centre de Recherche pour la Gestion de la Biodiversite, Cotonou, Benin), Geraldine Veron and Raphael Cornette (Museum National d'Histoire Naturelle, Paris, France), and Gauthier Dobigny (Institut de Recherche pour le Developpement, Montpellier, France). We are grateful to Baba Sarr (Direction des eaux et forets et de la chasse) for giving permission to carry out fieldwork in Senegal, and to Lamine Gueye (Parc de Hann, Dakar) and Rene Bancal (Ranch de Bango, Saint-Louis) for providing logistical support. Laboratory work was supported by the Consortium National de Recherche en Genomique, and the Service de Systematique Moleculaire of the Museum National d'Histoire Naturelle (CNRS - UMS 2700). It is part of agreement 2005/67 between Genoscope and the Museum National d'Histoire Naturelle on the project "Macrophylogeny of life" directed by Guillaume Lecointre. We thank Joseph Brennan, Mike Hoffmann and three anonymous reviewers for their useful comments on an earlier draft of the manuscript.	Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Anderson J., 1902, ZOOLOGY EGYPT MAMMAL; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; DAYAN T, 1991, PALEOBIOLOGY, V17, P189, DOI 10.1017/S0094837300010484; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; FERGUSON WW, 1981, MAMMALIA, V45, P459, DOI 10.1515/mamm.1981.45.4.459; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Gaubert P, 2011, J BIOGEOGR, V38, P341, DOI 10.1111/j.1365-2699.2010.02406.x; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Geraads D, 2011, PALAEONTOLOGY, V54, P429, DOI 10.1111/j.1475-4983.2011.01039.x; GOTTELLI D, 1994, MOL ECOL, V3, P301, DOI 10.1111/j.1365-294X.1994.tb00070.x; Gray A.P., 1971, MAMMALIAN HYBRIDS CH; Hailer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003333; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huxley T. H., 1880, Proceedings of the Zoological Society, P238; Jhala Y. V, 2008, CANIS AUREUS IUCN 20; JOLICOEUR P, 1959, EVOLUTION, V13, P283, DOI 10.1111/j.1558-5646.1959.tb03016.x; Kays R, 2010, BIOL LETTERS, V6, P89, DOI 10.1098/rsbl.2009.0575; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Krystufek B., 1990, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V91, P7; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li QF, 2008, J GENET GENOMICS, V35, P335, DOI 10.1016/S1673-8527(08)60049-1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MAHAN BR, 1978, AM MIDL NAT, V100, P408, DOI 10.2307/2424840; MECH L D, 1974, Mammalian Species, V37, P1; Mech LD, 2008, CANIS LUPUS IUCN 201; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Nassef M, 2003, THESIS U LEEDS LEEDS; Palomares F, 2002, MOL ECOL, V11, P2171, DOI 10.1046/j.1365-294X.2002.01608.x; Piganeau G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004396; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2008, TRACER VERSION 1 4 1; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Rueness EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016385; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; SIDIYENE EA, 1990, MAMMALIA, V54, P471, DOI 10.1515/mamm.1990.54.3.471; Sillero-Zubiri C., 2009, P352; Simeneh G., 2010, HABITAT USE DIET GOL; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiwari J, 2004, CANID NEWS, V7, P5; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; WAYNE RK, 1989, J HERED, V80, P447, DOI 10.1093/oxfordjournals.jhered.a110896; WAYNE RK, 1992, CONSERV BIOL, V6, P590, DOI 10.1046/j.1523-1739.1992.06040590.x; WAYNE RK, 1986, EVOLUTION, V40, P243, DOI 10.1111/j.1558-5646.1986.tb00467.x; Wayne RK, 1997, SYST BIOL, V46, P622, DOI 10.2307/2413498; Wozencraft WC, 2005, MAMMAL SPECIES WORLD, P532	53	63	68	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42740	10.1371/journal.pone.0042740	http://dx.doi.org/10.1371/journal.pone.0042740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900047	gold, Green Published			2022-12-27	WOS:000307380900064
J	Medici, D; Olsen, BR				Medici, Damian; Olsen, Bjorn R.			Rapamycin Inhibits Proliferation of Hemangioma Endothelial Cells by Reducing HIF-1-Dependent Expression of VEGF	PLOS ONE			English	Article							HYPOXIA; HIF-1; RESPONSES; THERAPY; PATHWAY; CANCER; MTOR	Hemangiomas are tumors formed by hyper-proliferation of vascular endothelial cells. This is caused by elevated vascular endothelial growth factor (VEGF) signaling through VEGF receptor 2 (VEGFR2). Here we show that elevated VEGF levels produced by hemangioma endothelial cells are reduced by the mTOR inhibitor rapamycin. mTOR activates p70S6K, which controls translation of mRNA to generate proteins such as hypoxia inducible factor-1 (HIF-1). VEGF is a known HIF-1 target gene, and our data show that VEGF levels in hemangioma endothelial cells are reduced by HIF-1 alpha siRNA. Over-expression of HIF-1 alpha increases VEGF levels and endothelial cell proliferation. Furthermore, both rapamycin and HIF-1 alpha siRNA reduce proliferation of hemangioma endothelial cells. These data suggest that mTOR and HIF-1 contribute to hemangioma endothelial cell proliferation by stimulating an autocrine loop of VEGF signaling. Furthermore, mTOR and HIF-1 may be therapeutic targets for the treatment of hemangiomas.	[Medici, Damian] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Matrix Biol, Dept Med,Med Sch, Boston, MA 02215 USA; [Medici, Damian; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Sch Med, Boston, MA 02115 USA; [Olsen, Bjorn R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard School of Dental Medicine; Harvard University; Harvard Medical School	Medici, D (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Matrix Biol, Dept Med,Med Sch, Boston, MA 02215 USA.	damian_medici@hms.harvard.edu			John Butler Mulliken Foundation; National Institutes of Health [P01-AR048564]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	John Butler Mulliken Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the John Butler Mulliken Foundation to DM and grant P01-AR048564 from the National Institutes of Health to BRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Bian CX, 2010, BIOCHEM BIOPH RES CO, V398, P395, DOI 10.1016/j.bbrc.2010.06.080; Boye E, 2001, J CLIN INVEST, V107, P745, DOI 10.1172/JCI11432; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Clauss M, 1998, TRENDS CARDIOVAS MED, V8, P241, DOI 10.1016/S1050-1738(98)00015-2; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; Hamilton HK, 2011, NEW ENGL J MED, V364, P1061, DOI 10.1056/NEJMicm1005598; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kleinman ME, 2007, ARTERIOSCL THROM VAS, V27, P2664, DOI 10.1161/ATVBAHA.107.150284; Koenig MK, 2009, TOPICAL RAPAMYCIN TH; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Oellerich M, 2004, CLIN BIOCHEM, V37, P424, DOI 10.1016/j.clinbiochem.2004.04.001; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Straatman LP, 2000, TRANSPLANTATION, V70, P541, DOI 10.1097/00007890-200008150-00025; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002	22	58	69	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42913	10.1371/journal.pone.0042913	http://dx.doi.org/10.1371/journal.pone.0042913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900063	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900081
J	Zhang, ZS; Li, G; Gao, HY; Zhang, LT; Yang, C; Liu, P; Meng, QW				Zhang, Zishan; Li, Geng; Gao, Huiyuan; Zhang, Litao; Yang, Cheng; Liu, Peng; Meng, Qingwei			Characterization of Photosynthetic Performance during Senescence in Stay-Green and Quick-Leaf-Senescence Zea mays L. Inbred Lines	PLOS ONE			English	Article							CHLOROPHYLL-A; ELECTRON-TRANSPORT; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; CO2 ASSIMILATION; PHOTOSYSTEM-I; BARLEY LEAVES; JIP-TEST; FLUORESCENCE; DEGRADATION; TEMPERATURE	The net photosynthetic rate, chlorophyll content, chlorophyll fluorescence and 820 nm transmission were investigated to explore the behavior of the photosynthetic apparatus, including light absorption, energy transformation and the photoactivities of photosystem II (PSII) and photosystem I (PSI) during senescence in the stay-green inbred line of maize (Zea mays) Q319 and the quick-leaf-senescence inbred line of maize HZ4. The relationship between the photosynthetic performance and the decrease in chlorophyll content in the two inbred lines was also studied. Both the field and laboratory data indicated that the chlorophyll content, net photosynthetic rate, and the photoactivities of PSII and PSI decreased later and slower in Q319 than in HZ4, indicating that Q319 is a functional stay-green inbred line. In order to avoid the influence of different development stages and environmental factors on senescence, age-matched detached leaf segments from the two inbred lines were treated with ethephon under controlled conditions to induce senescence. The net photosynthetic rate, light absorption, energy transformation, the activities of PSII acceptor side and donor side and the PSI activities decreased much slower in Q319 than in HZ4 during the ethephon-induced senescence. These results suggest that the retention of light absorption, energy transformation and activity of electron transfer contribute to the extended duration of active photosynthesis in Q319. Although the chlorophyll content decreased faster in HZ4, with decrease of chlorophyll content induced by ethephon, photosynthetic performance of Q319 deteriorated much more severely than that of HZ4, indicating that, compared with Q319, HZ4 has an advantage at maintaining higher photosynthetic activity with decrease of chlorophyll although HZ4 is a quick-leaf-senescence inbred line. We conclude that attention should be paid to two favorable characteristics in breeding long duration of active photosynthesis hybrids: 1) maintaining more chlorophyll content during senescence and 2) maintaining higher photosynthetic activity during the loss of chlorophyll.	[Zhang, Zishan; Li, Geng; Gao, Huiyuan; Zhang, Litao; Yang, Cheng; Liu, Peng; Meng, Qingwei] State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Zishan; Gao, Huiyuan; Zhang, Litao; Yang, Cheng; Meng, Qingwei] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Li, Geng; Liu, Peng] Shandong Agr Univ, Coll Agr, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Zhang, ZS (corresponding author), State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	gaohy@sdau.edu.cn	Zhang, zs/GXN-3521-2022; Meng, Q./GSI-6185-2022		State Key Basic Research and Development Plan of China [2009CB118500]; Specialized Research Fund for the Doctoral Program of Higher Education [20113702110008]; National Key Technologies R&D Program of China [2006BAD02A13-2-2, 2006CB101700]	State Key Basic Research and Development Plan of China(National Basic Research Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Key Technologies R&D Program of China(National Key Technology R&D Program)	State Key Basic Research and Development Plan of China (2009CB118500), the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20113702110008), the National Key Technologies R&D Program of China (2006BAD02A13-2-2, 2006CB101700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r24; [Anonymous], 1978, CHLOROPLAST DEV; BENDAVID H, 1983, PLANT PHYSIOL, V73, P507, DOI 10.1104/pp.73.2.507; Borrell AK, 2000, CROP SCI, V40, P1037, DOI 10.2135/cropsci2000.4041037x; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Cen YP, 2005, PLANT PHYSIOL, V139, P979, DOI 10.1104/pp.105.066233; Chiba A, 2003, PLANT CELL PHYSIOL, V44, P914, DOI 10.1093/pcp/pcg118; Choi SM, 2002, PLANTA, V216, P315, DOI 10.1007/s00425-002-0852-z; De Ronde JA, 2004, J PLANT PHYSIOL, V161, P1211, DOI 10.1016/j.jplph.2004.01.014; DUJARDYN M, 1989, PLANT PHYSIOL, V91, P1562, DOI 10.1104/pp.91.4.1562; El-Lithy ME, 2005, J EXP BOT, V56, P1625, DOI 10.1093/jxb/eri157; EVANS JR, 1988, AUST J PLANT PHYSIOL, V15, P93, DOI 10.1071/PP9880093; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; GRBIC V, 1995, PLANT J, V8, P595, DOI 10.1046/j.1365-313X.1995.8040595.x; Guiamet JJ, 1996, PHYSIOL PLANTARUM, V96, P655, DOI 10.1111/j.1399-3054.1996.tb00239.x; Haldimann P, 1999, PHOTOSYNTH RES, V62, P67, DOI 10.1023/A:1006321126009; Hortensteiner S, 2009, TRENDS PLANT SCI, V14, P155, DOI 10.1016/j.tplants.2009.01.002; HOLT JS, 1993, ANNU REV PLANT PHYS, V44, P203, DOI 10.1146/annurev.pp.44.060193.001223; Ivanov AG, 1998, FEBS LETT, V430, P288, DOI 10.1016/S0014-5793(98)00681-4; Ivanov AG, 2006, PLANT CELL PHYSIOL, V47, P1146, DOI 10.1093/pcp/pcj089; Jiang CD, 2006, PHOTOSYNTHETICA, V44, P454, DOI 10.1007/s11099-006-0050-5; Jiang HX, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-102; Jose A, 2010, J PHYSL, V167, P430; Li PM, 2007, PHOTOSYNTHETICA, V45, P496, DOI 10.1007/s11099-007-0086-1; Lin ZH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-43; Ma BL, 1998, PLANT SOIL, V199, P283, DOI 10.1023/A:1004397219723; Martinez DE, 2008, PLANT BIOLOGY, V10, P15, DOI 10.1111/j.1438-8677.2008.00089.x; Miersch I, 2000, PLANT BIOLOGY, V2, P618, DOI 10.1055/s-2000-16632; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; NELSON CJ, 1988, PLANT PHYSIOL BIOCH, V26, P543; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Schansker G, 2005, BBA-BIOENERGETICS, V1706, P250, DOI 10.1016/j.bbabio.2004.11.006; Schansker G, 2003, FUNCT PLANT BIOL, V30, P785, DOI 10.1071/FP03032; Schansker G, 2008, PHOTOSYNTHESIS ENERG, P951; Schrader SM, 2004, PLANT CELL ENVIRON, V27, P725, DOI 10.1111/j.1365-3040.2004.01172.x; Sharkey TD, 2005, PLANT CELL ENVIRON, V28, P269, DOI 10.1111/j.1365-3040.2005.01324.x; Spano G, 2003, J EXP BOT, V54, P1415, DOI 10.1093/jxb/erg150; Srivastava A, 1998, BBA-BIOENERGETICS, V1364, P326, DOI 10.1016/S0005-2728(98)00014-0; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; Strasser BJ, 1997, PHOTOSYNTH RES, V52, P147, DOI 10.1023/A:1005896029778; Strasser RJ, 2010, BBA-BIOENERGETICS, V1797, P1313, DOI 10.1016/j.bbabio.2010.03.008; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; Thomas H, 2000, J EXP BOT, V51, P329, DOI 10.1093/jexbot/51.suppl_1.329; TOLLENAAR M, 1978, CAN J PLANT SCI, V58, P869, DOI 10.4141/cjps78-126; Toth SZ, 2005, J PLANT PHYSIOL, V162, P181, DOI 10.1016/j.jplph.2004.06.010; Toth SZ, 2007, BBA-BIOENERGETICS, V1767, P295, DOI 10.1016/j.bbabio.2007.02.019; Tsimilli-Michael M., 2008, MYCORRHIZA, DOI [DOI 10.1007/978-3-540-78826-3_32, 10.1007/978-3-540-78826-3_32, DOI 10.1007/978]; Weaver LM, 2001, PLANT PHYSIOL, V127, P876, DOI 10.1104/pp.010312; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Wingler A, 1998, PLANT PHYSIOL, V116, P329, DOI 10.1104/pp.116.1.329; WOLFE DW, 1988, AGRON J, V80, P859, DOI 10.2134/agronj1988.00021962008000060004x; Yamori W, 2010, PLANT PHYSIOL, V152, P388, DOI 10.1104/pp.109.145862; Yordanov I, 2008, J PLANT PHYSIOL, V165, P1954, DOI 10.1016/j.jplph.2008.05.003; Zhang ZS, 2011, PLANTA, V234, P883, DOI 10.1007/s00425-011-1447-3	54	65	77	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42936	10.1371/journal.pone.0042936	http://dx.doi.org/10.1371/journal.pone.0042936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900069	gold, Green Published, Green Submitted			2022-12-27	WOS:000307380900087
J	Swami, V; Tovee, MJ				Swami, Viren; Tovee, Martin J.			The Impact of Psychological Stress on Men's Judgements of Female Body Size	PLOS ONE			English	Article							TO-HIP RATIO; PREFERENCES; ATTRACTIVENESS; PERCEPTIONS; VALIDITY; BEHAVIOR; BRITAIN; WEIGHT; HUNGER; POWER	Background: Previous work has suggested that the experience of psychological stress may influence physical attractiveness ideals, but most evidence in favour of this hypothesis remains archival. The objective of this study was to experimentally investigate the impact of stress on men's judgements of female body size. Methods: Men were randomly assigned to either an experimental group, in which they took part in a task that heightened stress (experimental group, n = 41) or in which they did not take part in such a task (control group, n = 40). Both groups rated the attractiveness of female bodies varying in size from emaciated to obese, completed a measure of appetite sensation, and had their body mass indices (BMIs) measured. Results: Between-groups analyses showed that the experimental group was matched with the control group in terms of mean age, BMI, and appetite sensation. Further analyses showed that men in the experimental group rated a significantly heavier female body size as maximally attractive than the control group. Men in the experimental group also rated heavier female bodies as more attractive and idealised a wider range of female figures than did the control group. Conclusion: This study found that the experience of stress was associated with a preference among men for heavier female body sizes. These results indicate that human attractiveness judgements are sensitive to variations in local ecologies and reflect adaptive strategies for dealing with changing environmental conditions.	[Swami, Viren] Univ Westminster, Dept Psychol, London W1R 8AL, England; [Swami, Viren] HELP Univ Coll, Dept Psychol, Kuala Lumpur, Malaysia; [Tovee, Martin J.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Westminster; Help University; Newcastle University - UK	Swami, V (corresponding author), Univ Westminster, Dept Psychol, London W1R 8AL, England.	v.swami@westminster.ac.uk		Tovee, Martin/0000-0001-9642-4462				ANDERSON JL, 1992, ETHOL SOCIOBIOL, V13, P197, DOI 10.1016/0162-3095(92)90033-Z; BROWN PJ, 1987, ANN NY ACAD SCI, V499, P29, DOI 10.1111/j.1749-6632.1987.tb36195.x; Clow A., 2004, J HOLISTIC HEALTHCAR, V1, P10; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; ELLISON PT, 1990, AM ANTHROPOL, V92, P933, DOI 10.1525/aa.1990.92.4.02a00050; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Kirschbaum C, 1993, NEUROPSYCHOBIOLOGY, V28, P81; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; MELAMED T, 1992, PERS INDIV DIFFER, V13, P1349, DOI 10.1016/0191-8869(92)90179-S; Merrill EP, 2002, APPETITE, V39, P181, DOI 10.1006/appe.2002.0496; Nelson LD, 2005, PSYCHOL SCI, V16, P167, DOI 10.1111/j.0956-7976.2005.00798.x; Nelson LD, 2007, BODY BEAUTIFUL EVOLU, P185; Ortigosa A, 2002, ANIM BEHAV, V64, P369, DOI 10.1006/anbe.2002.3065; Pettijohn II T. F., 2003, N AM J PSYCHOL, V5, P335; Pettijohn II T. F., 1999, MEDIA PSYCHOL, V1, P229, DOI [10.1207/s1532785xmep0103_3, DOI 10.1207/S1532785XMEP0103_3]; Pettijohn T. F., 2009, J SOC EVOL CULT PSYC, V3, P216, DOI [DOI 10.1037/H0099321, 10.1037/h0099321]; Pettijohn TE, 2005, J SOC PSYCHOL, V145, P547, DOI 10.3200/SOCP.145.5.547-570; Pettijohn TF, 2004, PERS SOC PSYCHOL B, V30, P1186, DOI 10.1177/0146167204264078; Sugiyama LS, 2004, EVOL HUM BEHAV, V25, P51, DOI 10.1016/S1090-5138(03)00083-7; Swami V, J PERS ASSE IN PRESS; Swami V, 2008, J SOCIO-ECON, V37, P1363, DOI DOI 10.1016/j.socec.2007.03.006; Swami V., 2011, WILEY BLACKWELL HDB, P747; Swami V., 2006, J ARTIC SUPPORT NULL, V4, P17; Swami V, 2008, PERS INDIV DIFFER, V44, P1752, DOI 10.1016/j.paid.2008.02.002; Swami V, 2007, BODY IMAGE, V4, P219, DOI 10.1016/j.bodyim.2007.01.002; Swami V, 2007, SCAND J PSYCHOL, V48, P43, DOI 10.1111/j.1467-9450.2006.00526.x; Swami Viren, 2005, Body Image, V2, P115, DOI 10.1016/j.bodyim.2005.02.002; Swami V, 2006, BRIT J PSYCHOL, V97, P353, DOI 10.1348/000712605X80713; Swami V, 2010, J SOC PSYCHOL, V150, P628, DOI 10.1080/00224540903365497; Swami Viren, 2005, Body Image, V2, P383, DOI 10.1016/j.bodyim.2005.08.001; Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702; Swami V, 2009, BRIT J PSYCHOL, V100, P313, DOI 10.1348/000712608X329525; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; Tovee MJ, 2007, BODY BEAUTIFUL EVOLU, P108, DOI DOI 10.1057/9780230596887_7; von Dawans B, 2011, PSYCHONEUROENDOCRINO, V36, P514, DOI 10.1016/j.psyneuen.2010.08.004; Webster G. D., 2008, J SOCIAL EVOLUTIONAR, V2, P23, DOI DOI 10.1037/H0099357	39	12	12	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42593	10.1371/journal.pone.0042593	http://dx.doi.org/10.1371/journal.pone.0042593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905153	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000307331100051
J	van den Brand, JMA; Stittelaar, KJ; van Amerongen, G; Reperant, L; de Waal, L; Osterhaus, ADME; Kuiken, T				van den Brand, Judith M. A.; Stittelaar, Koert J.; van Amerongen, Geert; Reperant, Leslie; de Waal, Leon; Osterhaus, Albert D. M. E.; Kuiken, Thijs			Comparison of Temporal and Spatial Dynamics of Seasonal H3N2, Pandemic H1N1 and Highly Pathogenic Avian Influenza H5N1 Virus Infections in Ferrets	PLOS ONE			English	Article							COMPARATIVE PATHOLOGY; LUNG INJURY; A VIRUSES; IN-VITRO; HUMANS; TRANSMISSION; VIRULENCE; RESPONSES; ROUTES; CELLS	Humans may be infected by different influenza A viruses-seasonal, pandemic, and zoonotic-which differ in presentation from mild upper respiratory tract disease to severe and sometimes fatal pneumonia with extra-respiratory spread. Differences in spatial and temporal dynamics of these infections are poorly understood. Therefore, we inoculated ferrets with seasonal H3N2, pandemic H1N1 (pH1N1), and highly pathogenic avian H5N1 influenza virus and performed detailed virological and pathological analyses at time points from 0.5 to 14 days post inoculation (dpi), as well as describing clinical signs and hematological parameters. H3N2 infection was restricted to the nose and peaked at 1 dpi. pH1N1 infection also peaked at 1 dpi, but occurred at similar levels throughout the respiratory tract. H5N1 infection occurred predominantly in the alveoli, where it peaked for a longer period, from 1 to 3 dpi. The associated lesions followed the same spatial distribution as virus infection, but their severity peaked between 1 and 6 days later. Neutrophil and monocyte counts in peripheral blood correlated with inflammatory cell influx in the alveoli. Of the different parameters used to measure lower respiratory tract disease, relative lung weight and affected lung tissue allowed the best quantitative distinction between the virus groups. There was extra-respiratory spread to more tissues-including the central nervous system-for H5N1 infection than for pH1N1 infection, and to none for H3N2 infection. This study shows that seasonal, pandemic, and zoonotic influenza viruses differ strongly in the spatial and temporal dynamics of infection in the respiratory tract and extra-respiratory tissues of ferrets.	[van den Brand, Judith M. A.; van Amerongen, Geert; Reperant, Leslie; Osterhaus, Albert D. M. E.; Kuiken, Thijs] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Stittelaar, Koert J.; Osterhaus, Albert D. M. E.] Viroclin Biosci BV, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van den Brand, JMA (corresponding author), Erasmus MC, Dept Virol, Rotterdam, Netherlands.	t.kuiken@erasmusmc.nl		Reperant, Leslie/0000-0002-7212-1595; Osterhaus, Albert/0000-0002-6074-1172; Kuiken, Thijs/0000-0001-5501-9049	TI Pharma [T4-214]; FP7 ADITEC [280873]	TI Pharma; FP7 ADITEC	This work was supported by TI Pharma (www.tipharma.com), grant T4-214, and by FP7 ADITEC, project # 280873. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Baras B, 2011, VACCINE, V29, P2120, DOI 10.1016/j.vaccine.2010.12.125; Belser JA, 2011, J VIROL, V85, P1563, DOI 10.1128/JVI.02231-10; BENNE CA, 1995, J INFECT DIS, V171, P335, DOI 10.1093/infdis/171.2.335; Berthiaume Y, 2007, RESP PHYSIOL NEUROBI, V159, P350, DOI 10.1016/j.resp.2007.05.010; Bodewes R, 2011, AM J PATHOL, V179, P30, DOI 10.1016/j.ajpath.2011.03.026; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dellmann HD, 1993, TXB VET HISTOLOGY, P56; Folkesson HG, 1998, AM J PHYSIOL-LUNG C, V275, pL478, DOI 10.1152/ajplung.1998.275.3.L478; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Guarner J, 2009, ARCH MED RES, V40, P655, DOI 10.1016/j.arcmed.2009.10.001; Haagmans BL, 2004, NAT MED, V10, P290, DOI 10.1038/nm1001; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Karpuzoglu E, 2006, NITRIC OXIDE-BIOL CH, V15, P177, DOI 10.1016/j.niox.2006.03.009; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Lin YP, 2010, J VIROL, V84, P6769, DOI 10.1128/JVI.00458-10; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2012, J INFECT DIS, V205, P474, DOI 10.1093/infdis/jir768; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; McBrayer A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-149; Meunier I, 2012, VIROLOGY, V422, P125, DOI 10.1016/j.virol.2011.10.018; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Schrauwen EJA, 2012, J VIROL, V86, P3975, DOI 10.1128/JVI.06828-11; Smith JH, 2011, J VIROL, V85, P7572, DOI 10.1128/JVI.00512-11; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; van den Brand JMA, 2012, VET PATHOL, V49, P562, DOI 10.1177/0300985811429812; van den Brand JMA, 2011, J VIROL, V85, P2851, DOI 10.1128/JVI.01939-10; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; WHO, 2012, NUMB HUM H5N1 CAS; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	41	75	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42343	10.1371/journal.pone.0042343	http://dx.doi.org/10.1371/journal.pone.0042343			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905124	Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100033
J	Chong, HS; Campbell, L; Padula, MP; Hill, C; Harry, E; Li, SS; Wilkins, MR; Herbert, B; Carter, D				Chong, Hin Siong; Campbell, Leona; Padula, Matthew P.; Hill, Cameron; Harry, Elizabeth; Li, Simone S.; Wilkins, Marc R.; Herbert, Ben; Carter, Dee			Time-Course Proteome Analysis Reveals the Dynamic Response of Cryptococcus gattii Cells to Fluconazole	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; CANDIDA-ALBICANS; IN-VITRO; SACCHAROMYCES-CEREVISIAE; BENZODIAZEPINE-RECEPTOR; MITOCHONDRIAL HSP70; KARYOPHERIN KAP95; STATISTICAL-MODEL; GENE-EXPRESSION; 14-3-3 PROTEINS	Cryptococcus gattii is an encapsulated fungus capable of causing fatal disease in immunocompetent humans and animals. As current antifungal therapies are few and limited in efficacy, and resistance is an emerging issue, the development of new treatment strategies is urgently required. The current study undertook a time-course analysis of the proteome of C. gattii during treatment with fluconazole (FLC), which is used widely in prophylactic and maintenance therapies. The aims were to analyze the overall cellular response to FLC, and to find fungal proteins involved in this response that might be useful targets in therapies that augment the antifungal activity of FLC. During FLC treatment, an increase in stress response, ATP synthesis and mitochondrial respiratory chain proteins, and a decrease in most ribosomal proteins was observed, suggesting that ATP-dependent efflux pumps had been initiated for survival and that the maintenance of ribosome synthesis was differentially expressed. Two proteins involved in fungal specific pathways were responsive to FLC. An integrative network analysis revealed co-ordinated processes involved in drug response, and highlighted hubs in the network representing essential proteins that are required for cell viability. This work demonstrates the dynamic cellular response of a typical susceptible isolate of C. gattii to FLC, and identified a number of proteins and pathways that could be targeted to augment the activity of FLC.	[Chong, Hin Siong; Campbell, Leona; Carter, Dee] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Padula, Matthew P.; Harry, Elizabeth] Univ Technol, Ithree Inst, Broadway, NSW, Australia; [Hill, Cameron; Herbert, Ben] Macquarie Univ, Sch Chem & Biomol Sci, N Ryde, NSW, Australia; [Li, Simone S.; Wilkins, Marc R.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Kensington, NSW 2033, Australia	University of Sydney; University of Technology Sydney; Macquarie University; University of New South Wales Sydney	Chong, HS (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	dee.carter@sydney.edu.au	Harry, Elizabeth/G-8123-2017; Carter, Dee/C-1331-2010; Harry, Liz/AAT-9396-2020; Padula, Matthew P/R-6150-2016	Carter, Dee/0000-0002-4638-0059; Padula, Matthew P/0000-0002-8283-0643; Harry, Elizabeth/0000-0003-0858-9473; Li, Simone S/0000-0002-0073-3656; herbert, ben/0000-0003-4697-8197	Australian National Health and Medical Research Council [971254]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The Australian National Health and Medical Research Council grant # 971254 (to DC). Australian Government EIF Super Science Scheme (to MW). NSW State Government Science Leveraging Fund (to MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2009, BBA-BIOMEMBRANES, V1788, P743, DOI 10.1016/j.bbamem.2008.12.002; Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Biggins S, 2001, GENETICS, V159, P453; Bledi Yaniv, 2003, Briefings in Functional Genomics & Proteomics, V2, P254, DOI 10.1093/bfgp/2.3.254; BOGERD AM, 1994, J CELL BIOL, V127, P319, DOI 10.1083/jcb.127.2.319; Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Brummer E, 1998, MED MYCOL, V36, P227, DOI 10.1080/02681219880000341; Bucci M, 1998, MOL BIOL CELL, V9, P2439, DOI 10.1091/mbc.9.9.2439; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Camasses A, 1998, MOL CELL BIOL, V18, P1956, DOI 10.1128/MCB.18.4.1956; Chong HS, 2010, J CLIN MICROBIOL, V48, P4115, DOI 10.1128/JCM.01271-10; Cognetti D, 2002, YEAST, V19, P55, DOI 10.1002/yea.804; Cohen-Gihon I, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035009; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; CRAIG EA, 1987, P NATL ACAD SCI USA, V84, P4156, DOI 10.1073/pnas.84.12.4156; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; Dieckhoff P, 2004, MOL MICROBIOL, V51, P1375, DOI 10.1046/j.1365-2958.2003.03910.x; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Fabre E, 1997, ANNU REV GENET, V31, P277, DOI 10.1146/annurev.genet.31.1.277; Florio AR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-97; Frank W, 2007, PLANT J, V51, P1004, DOI 10.1111/j.1365-313X.2007.03198.x; Gautam P, 2008, ANTIMICROB AGENTS CH, V52, P4220, DOI 10.1128/AAC.01431-07; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Harun A, 2010, MED MYCOL, V48, pS70, DOI 10.3109/13693786.2010.515254; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Ho E, 2008, J PROTEOME RES, V7, P104, DOI 10.1021/pr070274m; Hoehamer CF, 2010, ANTIMICROB AGENTS CH, V54, P1655, DOI 10.1128/AAC.00756-09; Horst M, 1997, EMBO J, V16, P1842, DOI 10.1093/emboj/16.8.1842; Hsing M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-80; Hwang YC, 2009, MOL BIOSYST, V5, P1672, DOI [10.1039/b900611g, 10.1039/B900611G]; Iqbal N, 2010, J CLIN MICROBIOL, V48, P539, DOI 10.1128/JCM.01505-09; Jobbins SE, 2010, J PROTEOME RES, V9, P3832, DOI 10.1021/pr100028t; Taberner FJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-47; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kawai A, 2001, J CELL SCI, V114, P3565; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kontoyiannis DP, 2002, LANCET, V359, P1135, DOI 10.1016/S0140-6736(02)08162-X; Lepak A, 2006, ANTIMICROB AGENTS CH, V50, P1311, DOI 10.1128/AAC.50.4.1311-1319.2006; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Mahmud SA, 2010, J BIOSCI BIOENG, V109, P262, DOI 10.1016/j.jbiosc.2009.08.500; Manavathu EK, 1998, ANTIMICROB AGENTS CH, V42, P3018, DOI 10.1128/AAC.42.11.3018; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2373, DOI 10.1128/AAC.44.9.2373-2381.2000; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mukhopadhyay K, 2004, ANTIMICROB AGENTS CH, V48, P1778, DOI 10.1128/AAC.48.5.1778-1787.2004; Nailis H, 2010, RES MICROBIOL, V161, P284, DOI 10.1016/j.resmic.2010.02.004; Nakamoto RK, 1999, ANNU REV BIOPH BIOM, V28, P205, DOI 10.1146/annurev.biophys.28.1.205; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; Palmer DA, 2006, J BIOL CHEM, V281, P32596, DOI 10.1074/jbc.M602768200; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PARKINSON T, 1995, ANTIMICROB AGENTS CH, V39, P1696, DOI 10.1128/AAC.39.8.1696; Pedersen SK, 2003, J PROTEOME RES, V2, P303, DOI 10.1021/pr025588i; Pfaller MA, 1998, DIAGN MICR INFEC DIS, V30, P251, DOI 10.1016/S0732-8893(97)00246-0; Roberts RL, 1997, CELL, V89, P1055, DOI 10.1016/S0092-8674(00)80293-7; Rogers PD, 2006, J ANTIMICROB CHEMOTH, V58, P434, DOI 10.1093/jac/dkl221; ROY J, 1995, MOL CELL BIOL, V15, P445, DOI 10.1128/MCB.15.1.445; Ryan KJ, 2007, MOL BIOL CELL, V18, P886, DOI 10.1091/mbc.E06-06-0525; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; SNYDER SH, 1987, FASEB J, V1, P282, DOI 10.1096/fasebj.1.4.2820823; Steen BR, 2003, EUKARYOT CELL, V2, P1336, DOI 10.1128/EC.2.6.1336-1349.2003; SYNETOS D, 1992, J BIOL CHEM, V267, P3008; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Veen M, 2005, BIOCHEM SOC T, V33, P1178, DOI 10.1042/BST0331178; Voit EO, 2003, J THEOR BIOL, V223, P55, DOI 10.1016/S0022-5193(03)00072-9; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zybailov BL, 2007, MOL BIOSYST, V3, P354, DOI 10.1039/b701483j; [No title captured]	76	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42835	10.1371/journal.pone.0042835	http://dx.doi.org/10.1371/journal.pone.0042835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880118	gold, Green Published, Green Submitted			2022-12-27	WOS:000307810000076
J	Gupta, S; Singh, R				Gupta, Saurabh; Singh, Raghvendra			Analysis of the Virus Dynamics Model Reveals That Early Treatment of HCV Infection May Lead to the Sustained Virological Response	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; INTERFERON-ALPHA THERAPY; VIRAL DYNAMICS; HEPATOCELLULAR-CARCINOMA; RIBAVIRIN THERAPY; INITIAL TREATMENT; PLUS RIBAVIRIN; DRUG EFFICACY; IN-VIVO; CLEARANCE	Considerable progress has been made towards understanding hepatitis C virus, its pathogenesis and the effect of the drug therapy on the viral load, yet around 50% of patients do not achieve the sustained virological response (SVR) by the standard treatment. Although several personalized factors such as patients' age and weight may be important, by mathematical modeling we show that the time of the start of the therapy is a significant factor in determining the outcome. Toward this end, we first performed sensitivity analysis on the standard virus dynamics model. The analysis revealed four phases when the sensitivity of the infection to drug treatment differs. Further, we added a perturbation term in the model to simulate the drug treatment period and predict the outcome when the therapy is carried out during each of the four phases. The study shows that while the infection may be difficult to treat in the late phases, the therapy is likely to result in SVR if it is carried out in the first or second phase. Thus, development of newer and more sensitive screening methods is needed for the early detection of the infection. Moreover, the analysis predicts that the drug that blocks new infections is more effective than the drug that blocks the virus production.	[Gupta, Saurabh; Singh, Raghvendra] Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Gupta, S (corresponding author), Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India.	raghvend@iitk.ac.in			Indian Institute of Technology Kanpur [IITK/CHE/20090282]	Indian Institute of Technology Kanpur	This work was supported by the Indian Institute of Technology Kanpur grant IITK/CHE/20090282 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 1997, HEPATOLOGY, V26, pS137, DOI 10.1002/hep.510260724; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; BALLARDINI G, 1995, J CLIN INVEST, V95, P2067, DOI 10.1172/JCI117893; Bekkering F C, 2001, BMC Gastroenterol, V1, P14, DOI 10.1186/1471-230X-1-14; Bekkering FC, 2001, HEPATOLOGY, V33, P419, DOI 10.1053/jhep.2001.21552; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P6971, DOI 10.1073/pnas.94.13.6971; Chang M, 2003, AM J PATHOL, V163, P433, DOI 10.1016/S0002-9440(10)63673-5; Dahari H, 2007, J THEOR BIOL, V247, P371, DOI 10.1016/j.jtbi.2007.03.006; Dahari H, 2007, HEPATOLOGY, V46, P16, DOI 10.1002/hep.21657; Delang L, 2011, ANTIMICROB AGENTS CH, V55, P4103, DOI 10.1128/AAC.00294-11; Di Bisceglie AM, 1998, LANCET, V351, P351, DOI 10.1016/S0140-6736(97)07361-3; Dixit NM, 2004, ANTIVIR THER, V9, P237; Dixit NM, 2004, NATURE, V432, P922, DOI 10.1038/nature03153; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Guedj J, 2010, J THEOR BIOL, V267, P330, DOI 10.1016/j.jtbi.2010.08.036; Herrmann E, 2003, HEPATOLOGY, V37, P1351, DOI 10.1053/jhep.2003.50218; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Kamal SM, 2006, GASTROENTEROLOGY, V130, P632, DOI 10.1053/j.gastro.2006.01.034; Lam NP, 1997, DIGEST DIS SCI, V42, P178, DOI 10.1023/A:1018865928308; Lam NP, 1997, HEPATOLOGY, V26, P226; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Licata A, 2003, J HEPATOL, V39, P1056, DOI 10.1016/S0168-8278(03)00461-6; Lopez-Labrador FX, 1999, HEPATOLOGY, V29, P897, DOI 10.1002/hep.510290306; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MARTINOTPEIGNOUX M, 1995, HEPATOLOGY, V22, P1050, DOI 10.1016/0270-9139(95)90608-8; Matthews GV, 2009, CLIN INFECT DIS, V48, P650, DOI 10.1086/596770; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Neumann AU, 2000, J INFECT DIS, V182, P28, DOI 10.1086/315661; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Poynard T, 2000, HEPATOLOGY, V32, P1131, DOI 10.1053/jhep.2000.19347; Reluga TC, 2009, SIAM J APPL MATH, V69, P999, DOI 10.1137/080714579; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Santantonio T, 2005, J HEPATOL, V42, P329, DOI 10.1016/j.jhep.2004.11.021; Sentjens RE, 2002, EUR J GASTROEN HEPAT, V14, P833, DOI 10.1097/00042737-200208000-00004; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1947; Shirakawa H, 2008, HEPATOLOGY, V48, P1753, DOI 10.1002/hep.22543; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	49	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41209	10.1371/journal.pone.0041209	http://dx.doi.org/10.1371/journal.pone.0041209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911761	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300027
J	Andersen, LL; Clausen, T; Burr, H; Holtermann, A				Andersen, Lars L.; Clausen, Thomas; Burr, Hermann; Holtermann, Andreas			Threshold of Musculoskeletal Pain Intensity for Increased Risk of Long-Term Sickness Absence among Female Healthcare Workers in Eldercare	PLOS ONE			English	Article							LOW-BACK-PAIN; PROSPECTIVE COHORT; NECK-SHOULDER; FOLLOW-UP; PROGNOSTIC-FACTORS; POPULATION; QUESTIONNAIRE; DISABILITY; DISORDERS; EMPLOYEES	Purpose: Musculoskeletal disorders increase the risk for absenteeism and work disability. However, the threshold when musculoskeletal pain intensity significantly increases the risk of sickness absence among different occupations is unknown. This study estimates the risk for long-term sickness absence (LTSA) from different pain intensities in the low back, neck/shoulder and knees among female healthcare workers in eldercare. Methods: Prospective cohort study among 8,732 Danish female healthcare workers responding to a questionnaire in 20042005, and subsequently followed for one year in a national register of social transfer payments (DREAM). Using Cox regression hazard ratio (HR) analysis we modeled risk estimates of pain intensities on a scale from 0-9 (reference 0, where 0 is no pain and 9 is worst imaginable pain) in the low back, neck/shoulders and knees during the last three months for onset of LTSA (receiving sickness absence compensation for at least eight consecutive weeks) during one-year follow-up. Results: During follow-up, the 12-month prevalence of LTSA was 6.3%. With adjustment for age, BMI, smoking and leisure physical activity, the thresholds of pain intensities significantly increasing risk of LTSA for the low back (HR 1.44 [95% CI 1.07-1.93]), neck/shoulders (HR 1.47 [95% CI 1.10-1.96]) and knees (HR 1.43 [95% CI 1.06-1.93]) were 5, 4 and 3 (scale 0-9), respectively, referencing pain intensity of 0. Conclusion: The threshold of pain intensity significantly increasing the risk for LTSA among female healthcare workers varies across body regions, with knee pain having the lowest threshold. This knowledge may be used in the prevention of LTSA among health care workers.	[Andersen, Lars L.; Clausen, Thomas; Holtermann, Andreas] Natl Res Ctr Working Environm, Copenhagen O, Denmark; [Burr, Hermann] Fed Inst Occupat Safety & Hlth BAuA, Berlin, Germany	National Research Centre for the Working Environment	Andersen, LL (corresponding author), Natl Res Ctr Working Environm, Copenhagen O, Denmark.	LLA@NRCWE.DK	Andersen, Lars Louis/AAQ-4802-2020	Burr, Hermann/0000-0002-3864-6347; Andersen, Lars L./0000-0003-2777-8085	Danish Parliament	Danish Parliament	The study was supported by a grant from the Danish Parliament (SATS 2004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LL, 2012, INT ARCH OCC ENV HEA, V85, P615, DOI 10.1007/s00420-011-0709-5; Andersen LL, 2011, OCCUP ENVIRON MED, V68, P590, DOI 10.1136/oem.2010.056259; [Anonymous], GUID NOT; Bergstrom G, 2007, OCCUP ENVIRON MED, V64, P279, DOI 10.1136/oem.2006.026583; Bevan S, 2009, FIT WORK MUSCULOSKEL, P1; Buchbinder R, 2001, BRIT MED J, V322, P1516, DOI 10.1136/bmj.322.7301.1516; Clausen T, 2012, J ADV NURS, V68, P127, DOI 10.1111/j.1365-2648.2011.05724.x; Eriksen W, 2004, OCCUP ENVIRON MED, V61, P398, DOI 10.1136/oem.2003.008482; Herin F, 2011, PAIN, V152, P2006, DOI 10.1016/j.pain.2011.04.018; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; Hogelund J, 2003, 0320 DAN NAT I SOC R; Hollmann S, 1999, SCAND J WORK ENV HEA, V25, P105, DOI 10.5271/sjweh.412; Holmberg SAC, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-66; Holtermann A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-120; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P34, DOI 10.5271/sjweh.2883; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; Kaergaard A, 2000, PAIN, V86, P305, DOI 10.1016/S0304-3959(00)00261-X; Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364; Kuiper JI, 1999, INT J IND ERGONOM, V24, P389, DOI 10.1016/S0169-8141(99)00006-2; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Lotters F, 2003, SCAND J WORK ENV HEA, V29, P431; Lund T, 2005, J OCCUP ENVIRON MED, V47, P1141, DOI 10.1097/01.jom.0000174301.80318.f2; Morken T, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-21; Natvig B, 2002, SCAND J PUBLIC HEALT, V30, P288, DOI 10.1080/14034940210133951; Nyman T, 2007, EUR SPINE J, V16, P631, DOI 10.1007/s00586-006-0152-6; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Pincus T, 2008, J RHEUMATOL, V35, P1550; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; The Danish Data Protection Agency, 2008, STAND TERMS RES PROJ; Tubach F, 2002, J OCCUP ENVIRON MED, V44, P451, DOI 10.1097/00043764-200205000-00013; van den Heuvel SG, 2004, SCAND J WORK ENV HEA, V30, P459, DOI 10.5271/sjweh.835; Veale D J, 2008, Ir Med J, V101, P208; Waddell G., 2006, IS WORK GOOD YOUR HL; Waters T, 2006, ORTHOP NURS, V25, P380	34	78	78	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41287	10.1371/journal.pone.0041287	http://dx.doi.org/10.1371/journal.pone.0041287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911772	Green Submitted, Green Published, gold			2022-12-27	WOS:000306644600066
J	Feng, L; Zhou, X; Su, LX; Feng, D; Jia, YH; Xie, LX				Feng, Lin; Zhou, Xin; Su, Long-Xiang; Feng, Dan; Jia, Yan-Hong; Xie, Li-Xin			Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study	PLOS ONE			English	Article							EPIDEMIOLOGY; DYSFUNCTION; EXPRESSION; COMMUNITY; SURVIVAL	Objective: We investigated serum soluble CD163 (sCD163) levels for use in the diagnosis, severity assessment, and prognosis of sepsis in the critical ill patients and compared sCD163 with other infection-related variables. Methods: During july 2010 and April 2011, serum was obtained from 102 sepsis patients (days 1, 3, 5, 7, and 10 after admission to an ICU) and 30 systemic inflammatory response syndrome (SIRS) patients with no sepsis diagnosed. Serum levels of sCD163, procalcitonon (PCT), and C reactive protein (CRP) were determined respectively. Sequential organ failure assessment (SOFA) scores for sepsis patients were also recorded. Then evaluated their roles in sepsis. Results: The sCD163 levels were 0.88(0.78-1.00) ug/mL for SIRS patients, 1.50(0.92-2.00) ug/mL for moderate sepsis patients, and 2.95(2.18-5.57) ug/mL for severe sepsis patients on day1. The areas under the ROC curves for sCD163, CRP, and PCT for the diagnosis of sepsis were, respectively, 0.856(95% CI: 0.791-0.921), 0.696(95% CI: 0.595-0.797), and 0.629(95% CI: 0.495-0.763), At the recommended cut-off 1.49 ug/mL for sCD163, the sensitivity is 74.0% with 93.3% specificity. Based on 28-day survivals, sCD163 levels in the surviving group stay constant, while they tended to gradually increase in the non-surviving group. The area under the ROC curve for sCD163 for sepsis prognosis was 0.706(95% CI 0.558-0.804). Levels of sCD163 with cut-off point >2.84 ug/mL have sensitivity of 55.8.0%, specificity 80.4%. Common risk factors for death and sCD163 were included in multivariate logistic regression analysis; the odds ratios (OR) for sCD163 and SOFA scores for sepsis prognosis were 1.173 and 1.396, respectively (P<0.05). Spearman rank correlation analysis showed that sCD163 was weakly, but positively correlated with CRP, PCT, and SOFA scores (0.2 < r < 0.4, P<0.0001), but not with leukocyte counts (r<0.2, P = 0.450). Conclusion: Serum sCD163 is superior to PCT and CRP for the diagnosis of sepsis and differentiate the severity of sepsis. sCD163 levels were more sensitive for dynamic evaluations of sepsis prognosis. Serum sCD163 and SOFA scores are prognostic factors for sepsis.	[Feng, Lin; Xie, Li-Xin] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Resp Med, Sanya, Hainan Province, Peoples R China; [Feng, Lin] Guangzhou Childrens Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Zhou, Xin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Zhou, Xin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Zhou, Xin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Su, Long-Xiang; Jia, Yan-Hong; Xie, Li-Xin] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Med, Beijing, Peoples R China; [Feng, Dan] Chinese Peoples Liberat Army Gen Hosp, Dept Med Stat, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Feng, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Resp Med, Sanya, Hainan Province, Peoples R China.	fenglinkuaile@mail.nankai.edu.cn	Su, Longxiang/I-6788-2019; Xie, li/HGE-6052-2022	Su, Longxiang/0000-0002-0942-2870; 	Chinese National Science and Technology Pillar Program [2009BAI86B03]	Chinese National Science and Technology Pillar Program	This Study was supported by the Chinese National Science and Technology Pillar Program (NO: 2009BAI86B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2006, CIRC RES, V99, P911, DOI 10.1161/01.RES.0000249616.10603.d6; Adrie C, 2005, J CRIT CARE, V20, P46, DOI 10.1016/j.jcrc.2004.10.005; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Cheng BL, 2007, CRIT CARE MED, V35, P2538, DOI 10.1097/01.CCM.0000284492.30800.00; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; Felbinger TW, 1999, NEW ENGL J MED, V341, P56; Gaini S, 2006, APMIS, V114, P103, DOI 10.1111/j.1600-0463.2006.apm_341.x; Kibe S, 2011, J ANTIMICROB CHEMOTH, V66, pII33, DOI 10.1093/jac/dkq523; Knudsen TB, 2005, CLIN MICROBIOL INFEC, V11, P730, DOI 10.1111/j.1469-0691.2005.01229.x; Larsen R, 2011, SCI TRANSL MED, V2, P51; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A	16	183	196	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e38400	10.1371/journal.pone.0038400	http://dx.doi.org/10.1371/journal.pone.0038400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911680	gold, Green Submitted, Green Published			2022-12-27	WOS:000306644600002
J	Lichtenfels, R; Mougiakakos, D; Johansson, CC; Dressler, SP; Recktenwald, CV; Kiessling, R; Seliger, B				Lichtenfels, Rudolf; Mougiakakos, Dimitrios; Johansson, C. Christian; Dressler, Sven P.; Recktenwald, Christian V.; Kiessling, Rolf; Seliger, Barbara			Comparative Expression Profiling of Distinct T Cell Subsets Undergoing Oxidative Stress	PLOS ONE			English	Article							PROTEIN S-GLUTATHIONYLATION; NF-KAPPA-B; REDOX REGULATION; EPITHELIAL-CELLS; APOPTOSIS; DEATH; IDENTIFICATION; THIOREDOXIN; ACTIVATION; CANCER	The clinical outcome of adoptive T cell transfer-based immunotherapies is often limited due to different escape mechanisms established by tumors in order to evade the hosts' immune system. The establishment of an immunosuppressive micromilieu by tumor cells along with distinct subsets of tumor-infiltrating lymphocytes is often associated with oxidative stress that can affect antigen-specific memory/effector cytotoxic T cells thereby substantially reducing their frequency and functional activation. Therefore, protection of tumor-reactive cytotoxic T lymphocytes from oxidative stress may enhance the anti-tumor-directed immune response. In order to better define the key pathways/proteins involved in the response to oxidative stress a comparative 2-DE-based proteome analysis of naive CD45RA(+) and their memory/effector CD45RO(+) T cell counterparts in the presence and absence of low dose hydrogen peroxide (H2O2) was performed in this pilot study. Based on the profiling data of these T cell subpopulations under the various conditions, a series of differentially expressed spots were defined, members thereof identified by mass spectrometry and subsequently classified according to their cellular function and localization. Representative targets responding to oxidative stress including proteins involved in signaling pathways, in regulating the cellular redox status as well as in shaping/maintaining the structural cell integrity were independently verified at the transcript and protein level under the same conditions in both T cell subsets. In conclusion the resulting profiling data describe complex, oxidative stress-induced, but not strictly concordant changes within the respective expression profiles of CD45RA(+) and CD45RO(+) T cells. Some of the differentially expressed genes/proteins might be further exploited as potential targets toward modulating the redox capacity of the distinct lymphocyte subsets thereby providing the basis for further studies aiming at rendering them more resistant to tumor micromilieu-induced oxidative stress.	[Lichtenfels, Rudolf; Dressler, Sven P.; Recktenwald, Christian V.; Seliger, Barbara] Univ Halle Wittenberg, Inst Med Immunol, Halle, Germany; [Mougiakakos, Dimitrios; Johansson, C. Christian; Kiessling, Rolf] Canc Ctr Karolinska, Dept Pathol & Oncol, Stockholm, Sweden; [Mougiakakos, Dimitrios] Univ Erlangen Nurnberg, Dept Internal Med 5, Erlangen, Germany	Martin Luther University Halle Wittenberg; Karolinska Institutet; University of Erlangen Nuremberg	Lichtenfels, R (corresponding author), Univ Halle Wittenberg, Inst Med Immunol, Halle, Germany.	Barbara.Seliger@uk-halle.de		Recktenwald, Christian Viktor/0000-0003-1710-1863; Seliger, Barbara/0000-0002-5544-4958	European Framework 7 Program (EUCAAD); Bundesministerium fur Forschung und Technologie [NGFN 031U101H]; Mildred Scheel Foundation [107967]; intramural Roux program [FKZ 23/18]	European Framework 7 Program (EUCAAD); Bundesministerium fur Forschung und Technologie; Mildred Scheel Foundation(Deutsche Krebshilfe); intramural Roux program	This work was supported by the European Framework 7 Program (EUCAAD, B.S.), the Bundesministerium fur Forschung und Technologie, NGFN 031U101H (B.S.), the Mildred Scheel Foundation 107967 (B.S.) and the intramural Roux program FKZ 23/18 (B. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2008, J IMMUNOL, V181, P8382, DOI 10.4049/jimmunol.181.12.8382; BELLOMO G, 1990, J CELL PHYSIOL, V143, P118, DOI 10.1002/jcp.1041430116; Bhattacharyya S, 2007, CANCER RES, V67, P362, DOI 10.1158/0008-5472.CAN-06-2583; Cemerski S, 2003, EUR J IMMUNOL, V33, P2178, DOI 10.1002/eji.200323898; Chang WK, 1999, CLIN EXP IMMUNOL, V117, P482, DOI 10.1046/j.1365-2249.1999.01009.x; Croci S, 2010, PROTEOMICS, V10, P3835, DOI 10.1002/pmic.200900643; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dautel F, 2011, J PROTEOME RES, V10, P379, DOI 10.1021/pr100723d; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Go YM, 2010, FREE RADICAL BIO MED, V48, P275, DOI 10.1016/j.freeradbiomed.2009.10.050; Harlin H, 2007, J IMMUNOL, V179, P4513, DOI 10.4049/jimmunol.179.7.4513; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; HWANG C, 1991, PRODUCTION OF BIOLOGICALS FROM ANIMAL CELLS IN CULTURE, P548; Jiang SN, 2005, INVEST OPHTH VIS SCI, V46, P1054, DOI 10.1167/iovs.04-0949; Jones DP, 2010, J INTERN MED, V268, P432, DOI 10.1111/j.1365-2796.2010.02268.x; KANG YJ, 1994, J CELL PHYSIOL, V161, P589, DOI 10.1002/jcp.1041610323; Klemke M, 2009, ADV ENZYME REGUL, V49, P107, DOI 10.1016/j.advenzreg.2008.12.006; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Kwon YW, 2003, BIOL CHEM, V384, P991, DOI 10.1515/BC.2003.111; Larbi A, 2007, EXP GERONTOL, V42, P852, DOI 10.1016/j.exger.2007.05.004; Li JY, 2010, AUTOPHAGY, V6, P711, DOI 10.4161/auto.6.6.12397; Li W, 2008, ATHEROSCLEROSIS, V199, P65, DOI 10.1016/j.atherosclerosis.2007.10.031; Lichtenfels R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032994; Malmberg KJ, 2001, J IMMUNOL, V167, P2595, DOI 10.4049/jimmunol.167.5.2595; Mehrotra S, 2009, ADV CANCER RES, V102, P197, DOI 10.1016/S0065-230X(09)02006-5; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Morbt N, 2011, J PROTEOME RES, V10, P363, DOI 10.1021/pr1005718; Mougiakakos D, 2011, BLOOD, V117, P857, DOI 10.1182/blood-2010-09-307041; Mougiakakos D, 2009, BLOOD, V113, P3542, DOI 10.1182/blood-2008-09-181040; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Oh J, 2009, ONCOGENE, V28, P3145, DOI 10.1038/onc.2009.169; Otto WR, 1996, EUR J BIOCHEM, V235, P64, DOI 10.1111/j.1432-1033.1996.00064.x; Peraldi MN, 2009, J IMMUNOL, V182, P1696, DOI 10.4049/jimmunol.182.3.1696; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Seliger B, 2005, PROTEOMICS, V5, P2631, DOI 10.1002/pmic.200401264; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; Takahashi A, 2005, J IMMUNOL, V174, P6080, DOI 10.4049/jimmunol.174.10.6080; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Wink DA, 2011, J LEUKOC BIOL	45	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41345	10.1371/journal.pone.0041345	http://dx.doi.org/10.1371/journal.pone.0041345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911781	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600072
J	Napoleon, C; Claquin, P				Napoleon, Camille; Claquin, Pascal			Multi-Parametric Relationships between PAM Measurements and Carbon Incorporation, an In Situ Approach	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; MARINE-PHYTOPLANKTON; QUANTUM YIELD; OXYGEN EVOLUTION; FLUORESCENCE; LIGHT; TEMPERATURE; ECOSYSTEM; PSII; CHLAMYDOMONAS	Primary production (PP) in the English Channel was measured using C-13 uptake and compared to the electron transport rate (ETR) measured using PAM (pulse amplitude modulated fluorometer). The relationship between carbon incorporation (P-obs) and ETR was not linear but logarithmic. This result can be explained by alternative electron sinks at high irradiance which protect the phytoplankton from photoinhibition. A multi-parametric model was developed to estimate PP by ETR. This approach highlighted the importance of taking physicochemical parameters like incident light and nutrient concentrations into account. The variation in the ETR/P-obs ratio as a function of the light revealed different trends which were characterized by three parameters (R-max, the maximum value of ETR/P-obs; E-Rmax, the light intensity at which R-max is measured; c the initial slope of the curve). Based on the values of these three parameters, data were divided into six groups which were highly dependent on the seasons and on the physicochemical conditions. Using the multi-parametric model which we defined by P-obs and ETR measurements at low frequencies, the high frequency measurements of ETR enabled us to estimate the primary production capacity between November 2009 and December 2010 at high temporal and spatial scales.	[Napoleon, Camille; Claquin, Pascal] Univ Caen Basse Normandie, BIOMEA CNRS FRE3484, Caen, France; [Napoleon, Camille; Claquin, Pascal] CNRS INEE, BIOMEA FRE3484, Caen, France; [Napoleon, Camille] IFREMER, Lab Environm Ressources Normandie, Port En Bessin, France	Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer	Napoleon, C (corresponding author), Univ Caen Basse Normandie, BIOMEA CNRS FRE3484, Caen, France.	pascal.claquin@unicaen.fr		Claquin, Pascal/0000-0002-5183-203X	European project Interreg 4a CHannel integrated Approach for marine Resource 3 (CHARM 3)	European project Interreg 4a CHannel integrated Approach for marine Resource 3 (CHARM 3)	This study was supported by the European project Interreg 4a CHannel integrated Approach for marine Resource 3 (CHARM 3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminot A., 2007, DOSAGE AUTOMATIQUE N; Aminot A., 1983, MANUEL ANAL CHIMIQUE; BABIN M, 1993, LIMNOL OCEANOGR, V38, P154, DOI 10.4319/lo.1993.38.1.0154; Babin M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000882; Babin M, 1996, DEEP-SEA RES PT I, V43, P1241, DOI 10.1016/0967-0637(96)00058-1; BABIN M, 1994, LIMNOL OCEANOGR, V39, P694, DOI 10.4319/lo.1994.39.3.0694; Barranguet C, 2000, MAR ECOL PROG SER, V204, P39, DOI 10.3354/meps204039; Behrenfeld MJ, 2004, J PHYCOL, V40, P4, DOI 10.1046/j.1529-8817.2004.03083.x; BIRMINGHAM BC, 1982, PLANT PHYSIOL, V69, P259, DOI 10.1104/pp.69.1.259; BURNS BD, 1987, J EXP MAR BIOL ECOL, V107, P75, DOI 10.1016/0022-0981(87)90125-0; Claquin P, 2004, EUR J PHYCOL, V39, P33, DOI 10.1080/0967026032000157165; Claquin P, 2010, ESTUAR COAST SHELF S, V86, P93, DOI 10.1016/j.ecss.2009.10.017; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Falkowski P.G., 1985, Internationale Vereinigung fuer Theoretische und Angewandte Limnologie Verhandlungen, V22, P2830; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Flameling IA, 1998, LIMNOL OCEANOGR, V43, P284, DOI 10.4319/lo.1998.43.2.0284; Gaxiola-Castro G, 1999, J PLANKTON RES, V21, P231, DOI 10.1093/plankt/21.2.231; Geel C, 1997, PHOTOSYNTH RES, V51, P61, DOI 10.1023/A:1005779112140; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Grangere K, 2009, ESTUAR COAST SHELF S, V81, P169, DOI 10.1016/j.ecss.2008.10.009; HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282; Hancke K, 2008, J PHYCOL, V44, P501, DOI 10.1111/j.1529-8817.2008.00487.x; Hartig P, 1998, MAR ECOL PROG SER, V166, P53, DOI 10.3354/meps166053; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Jouenne F, 2007, MAR BIOL, V151, P805, DOI 10.1007/s00227-006-0440-z; Juneau P, 2005, PHOTOCHEM PHOTOBIOL, V81, P649, DOI 10.1562/2005-01-13-RA-414.1; KOLBER Z, 1988, PLANT PHYSIOL, V88, P923, DOI 10.1104/pp.88.3.923; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; Kromkamp JC, 2003, EUR J PHYCOL, V38, P103, DOI 10.1080/0967026031000094094; Lefebvre S, 2007, J PHOTOCH PHOTOBIO B, V86, P131, DOI 10.1016/j.jphotobiol.2006.08.012; Lippemeier S, 1999, J PLANKTON RES, V21, P269, DOI 10.1093/plankt/21.2.269; Lomas MW, 1999, LIMNOL OCEANOGR, V44, P556, DOI 10.4319/lo.1999.44.3.0556; Marchetti A, 2006, DEEP-SEA RES PT II, V53, P2131, DOI 10.1016/j.dsr2.2006.05.032; Masojidek J, 2001, J PLANKTON RES, V23, P57, DOI 10.1093/plankt/23.1.57; Morris EP, 2003, EUR J PHYCOL, V38, P133, DOI 10.1080/0967026031000085832; Napoleon C, 2012, J SEA RES, V69, P43, DOI 10.1016/j.seares.2012.01.005; NELSON NB, 1993, MAR ECOL PROG SER, V94, P217, DOI 10.3354/meps094217; Pannard A, 2008, ESTUAR COAST SHELF S, V80, P212, DOI 10.1016/j.ecss.2008.08.008; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; PELTIER G, 1985, PLANT PHYSIOL, V79, P225, DOI 10.1104/pp.79.1.225; Platt T, 2008, REMOTE SENS ENVIRON, V112, P3437, DOI 10.1016/j.rse.2007.11.018; PREZELIN BB, 1986, MAR BIOL, V93, P1, DOI 10.1007/BF00428648; Raven JA, 2000, J MAR BIOL ASSOC UK, V80, P1, DOI 10.1017/S0025315499001526; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; SAVIDGE G, 1995, DEEP-SEA RES PT I, V42, P599, DOI 10.1016/0967-0637(95)00016-Y; Schaeffer BA, 2007, J PHYCOL, V43, P702, DOI 10.1111/j.1529-8817.2007.00377.x; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Tan SC, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000854; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wilhelm C, 2006, PROTIST, V157, P91, DOI 10.1016/j.protis.2006.02.003; Xue XP, 1996, PLANT PHYSIOL, V112, P1005, DOI 10.1104/pp.112.3.1005	53	28	29	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40284	10.1371/journal.pone.0040284	http://dx.doi.org/10.1371/journal.pone.0040284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911698	Green Published, gold			2022-12-27	WOS:000306644600016
J	Savin, C; Leclercq, A; Carniel, E				Savin, Cyril; Leclercq, Alexandre; Carniel, Elisabeth			Evaluation of a Single Procedure Allowing the Isolation of Enteropathogenic Yersinia along with Other Bacterial Enteropathogens from Human Stools	PLOS ONE			English	Article							SELECTIVE AGAR MEDIUM; ENTEROCOLITICA INFECTION; PSEUDOTUBERCULOSIS; ENRICHMENT; SEROTYPE-O3; RECOVERY; OUTBREAK; MEDIA; BROTH	Enteropathogenic Yersinia are among the most frequent agents of human diarrhea in temperate and cold countries. However, the incidence of yersiniosis is largely underestimated because of the peculiar growth characteristics of pathogenic Yersinia, which make their isolation from poly-contaminated samples difficult. The use of specific procedures for Yersinia isolation is required, but is expensive and time consuming, and therefore is not systematically performed in clinical pathology laboratories. A means to circumvent this problem would be to use a single procedure for the isolation of all bacterial enteropathogens. Since the Statens Serum Institut enteric medium (SSI) has been reported to allow the growth at 37 degrees C of most Gram-negative bacteria, including Yersinia, our study aimed at evaluating its performances for Yersinia isolation, as compared to the commonly used Yersinia-specific semi-selective Cefsulodin-Irgasan-Novobiocin medium (CIN) incubated at 28 degrees C. Our results show that Yersinia pseudotuberculosis growth was strongly inhibited on SSI at 37 degrees C, and therefore that this medium is not suitable for the isolation of this species. All Yersinia enterocolitica strains tested grew on SSI, while some non-pathogenic Yersinia species were inhibited. The morphology of Y. enterocolitica colonies on SSI allowed their differentiation from various other Gram-negative bacteria commonly isolated from stool samples. However, in artificially contaminated human stools, the recovery of Y. enterocolitica colonies on SSI at 37 degrees C was difficult and was 3 logs less sensitive than on CIN at 28 degrees C. Therefore, despite its limitations, the use of a specific procedure (CIN incubated at 28 degrees C) is still required for an efficient isolation of enteropathogenic Yersinia from stools.	[Savin, Cyril] Inst Pasteur, Yersinia Res Unit, Paris, France; Inst Pasteur, Natl Reference Lab, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Savin, C (corresponding author), Inst Pasteur, Yersinia Res Unit, Paris, France.	cyril.savin@pasteur.fr	Alexandre, Leclercq Jean-Louis/H-2140-2018; Savin, Cyril/ABG-3807-2020	Alexandre, Leclercq Jean-Louis/0000-0003-3778-7313; Savin, Cyril/0000-0003-2659-3433	'Institut de Veille Sanitaire' (InVS), France	'Institut de Veille Sanitaire' (InVS), France	This work was funded in part by the 'Institut de Veille Sanitaire' (InVS), France. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers ML, 2000, J INFECT DIS, V181, P1834, DOI 10.1086/315436; BERCOVIER H, 1984, CURR MICROBIOL, V10, P121, DOI 10.1007/BF01576770; BLACK RE, 1978, NEW ENGL J MED, V298, P76, DOI 10.1056/NEJM197801122980204; Blom M, 1999, J CLIN MICROBIOL, V37, P2312, DOI 10.1128/JCM.37.7.2312-2316.1999; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; Carniel E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P270, DOI 10.1007/0-387-30746-x_13; Denis M, 2011, J PATHOG, V2011, DOI 10.4061/2011/296275; DEZUTTER L, 1994, INT J FOOD MICROBIOL, V23, P231, DOI 10.1016/0168-1605(94)90057-4; European Food Safety Authority, 2011, EFSA Journal, V9, P2090; Fredriksson-Ahomaa M, 2003, CLIN MICROBIOL REV, V16, P220, DOI 10.1128/CMR.16.2.220-229.2003; FUKUSHIMA H, 1986, J CLIN MICROBIOL, V24, P116, DOI 10.1128/JCM.24.1.116-120.1986; FUKUSHIMA H, 1987, J CLIN MICROBIOL, V25, P1068, DOI 10.1128/JCM.25.6.1068-1073.1987; Gilliss Debra, 2011, Morbidity and Mortality Weekly Report, V60, P749; Hallanvuo S, 2006, J CLIN MICROBIOL, V44, P1077, DOI 10.1128/JCM.44.3.1077-1080.2006; HEAD CB, 1982, J CLIN MICROBIOL, V16, P615, DOI 10.1128/JCM.16.4.615-621.1982; HOOGKAMPKORSTANJE JAA, 1986, J INFECT DIS, V153, P138, DOI 10.1093/infdis/153.1.138; Jalava K, 2004, J CLIN MICROBIOL, V42, P2789, DOI 10.1128/JCM.42.6.2789-2791.2004; Jalava K, 2006, J INFECT DIS, V194, P1209, DOI 10.1086/508191; Jiang GC, 2000, J FOOD PROTECT, V63, P1483, DOI 10.4315/0362-028X-63.11.1483; LJUNGBERG P, 1995, EUR J CLIN MICROBIOL, V14, P804, DOI 10.1007/BF01690998; Long C, 2010, EMERG INFECT DIS, V16, P566, DOI 10.3201/eid1603.091106; MARKS MI, 1980, J PEDIATR-US, V96, P26, DOI 10.1016/S0022-3476(80)80318-0; Okwori AEJ, 2009, FOOD MICROBIOL, V26, P872, DOI 10.1016/j.fm.2009.06.001; SATO K, 1983, PEDIATR INFECT DIS J, V2, P123, DOI 10.1097/00006454-198303000-00011; Savin C, 2010, B EPID HEBD, V29, P307; Savin C, 2008, REV FRANCOPH LAB, V400, P49; SCHIEMANN DA, 1979, CAN J MICROBIOL, V25, P1298, DOI 10.1139/m79-205; Smirnova YY, 2004, EPIDEMIOLOGICAL FEAT; SOMOV GP, 1973, CONTRIB MICROBIOL IM, V2, P214; TSUBOKURA M, 1989, J CLIN MICROBIOL, V27, P790, DOI 10.1128/JCM.27.4.790-791.1989; VANNOYEN R, 1980, J CLIN MICROBIOL, V11, P127, DOI 10.1128/JCM.11.2.127-131.1980; VERHAEGEN J, 1991, CONTRIB TO MICROBIOL, V12, P11; WAUTERS G, 1988, APPL ENVIRON MICROB, V54, P851, DOI 10.1128/AEM.54.4.851-854.1988; WEAGANT SD, 1983, APPL ENVIRON MICROB, V45, P468, DOI 10.1128/AEM.45.2.468-471.1983; Weagant SD, 2008, J MICROBIOL METH, V72, P185, DOI 10.1016/j.mimet.2007.11.019; Weber P, 2003, B EPID HEBD, V8, P45; Zheng H, 2008, EUR J CLIN MICROBIOL, V27, P741, DOI 10.1007/s10096-008-0562-y	38	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41176	10.1371/journal.pone.0041176	http://dx.doi.org/10.1371/journal.pone.0041176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911756	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600052
J	Singh, JP; Volavka, J; Czobor, P; Van Dorn, RA				Singh, Jay P.; Volavka, Jan; Czobor, Pal; Van Dorn, Richard A.			A Meta-Analysis of the Val158Met COMT Polymorphism and Violent Behavior in Schizophrenia	PLOS ONE			English	Article							METHYLTRANSFERASE GENE POLYMORPHISM; AGGRESSIVE-BEHAVIOR; SUICIDAL-BEHAVIOR; SUBSTANCE-ABUSE; ASSOCIATION; RISK; HETEROGENEITY; NEUROBIOLOGY; ADHERENCE; PATHWAYS	We conducted a meta-analysis of studies examining the association between the Val158Met COMT polymorphism and violence against others in schizophrenia. A systematic search current to November 1, 2011 was conducted using MEDLINE, EMBASE, CINAHL, PsycINFO, ProQuest, and the National Criminal Justice Reference Service and identified 15 studies comprising 2,370 individuals with schizophrenia for inclusion. Bivariate analyses of study sensitivities and specificities were conducted. This methodology allowed for the calculation of pooled diagnostic odds ratios (DOR). Evidence of a significant association between the presence of a Met allele and violence was found such that men's violence risk increased by approximately 50% for those with at least one Met allele compared with homozygous Val individuals (DOR = 1.45; 95% CI = 1.05-2.00; z = 2.37, p = 0.02). No significant association between the presence of a Met allele and violence was found for women or when outcome was restricted to homicide. We conclude that male schizophrenia patients who carry the low activity Met allele in the COMT gene are at a modestly elevated risk of violence. This finding has potential implications for the pharmacogenetics of violent behavior in schizophrenia.	[Singh, Jay P.; Van Dorn, Richard A.] Univ S Florida, Dept Mental Hlth Law & Policy, Tampa, FL 33620 USA; [Volavka, Jan] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Czobor, Pal] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Czobor, Pal] Semmelweis Univ, Dept Psychiat & Psychotherapy, H-1085 Budapest, Hungary; [Van Dorn, Richard A.] Res Triangle Inst Int, Durham, NC USA	State University System of Florida; University of South Florida; New York University; Nathan Kline Institute for Psychiatric Research; Semmelweis University; Research Triangle Institute	Singh, JP (corresponding author), Univ S Florida, Dept Mental Hlth Law & Policy, Tampa, FL 33620 USA.	jaysingh@usf.edu	Volavka, Jan/E-9529-2019	Volavka, Jan/0000-0002-4178-8207				Alia-Klein N, 2007, AGGRESSIVE BEHAV, V33, P86, DOI 10.1002/ab.20170; Allan ER, 1996, J CLIN PSYCHIAT, V57, P455, DOI 10.4088/JCP.v57n1003; Ascher-Svanum H, 2006, J CLIN PSYCHIAT, V67, P453, DOI 10.4088/JCP.v67n0317; Barnett JH, 2007, MOL PSYCHIATR, V12, P502, DOI 10.1038/sj.mp.4001973; Collip D, 2011, CNS NEUROSCI THER, V17, P612, DOI 10.1111/j.1755-5949.2010.00213.x; Comai S, 2012, J CLIN PSYCHOPHARM, V32, P83, DOI 10.1097/JCP.0b013e31823f8770; Costas J, 2011, J PSYCHIATR RES, V45, P7, DOI 10.1016/j.jpsychires.2010.04.021; Fazel S, 2009, J CLIN PSYCHIAT, V70, P362, DOI 10.4088/JCP.08m04274; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Fernandes C, 2004, EUR J NEUROSCI, V19, P2576, DOI 10.1111/j.0953-816X.2004.03358.x; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Graves PM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000974.pub2; Gu Y, 2009, MED SCI MONITOR, V15, pCR484; Han DH, 2006, NEUROREPORT, V17, P95, DOI 10.1097/01.wnr.0000192740.38653.91; Han DH, 2004, PSYCHIAT RES, V129, P29, DOI 10.1016/j.psychres.2004.06.013; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hodgins S, 2005, SCHIZOPHR RES, V78, P323, DOI 10.1016/j.schres.2005.05.021; Hong JP, 2008, AM J MED GENET B, V147B, P658, DOI 10.1002/ajmg.b.30649; Iancu I, 2010, PSYCHOPATHOLOGY, V43, P223, DOI 10.1159/000313520; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jones G, 2001, BRIT J PSYCHIAT, V179, P351, DOI 10.1192/bjp.179.4.351; KAY SR, 1988, J NERV MENT DIS, V176, P539, DOI 10.1097/00005053-198809000-00007; Kim YR, 2008, EUR NEUROPSYCHOPHARM, V18, P820, DOI 10.1016/j.euroneuro.2008.07.009; Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851; Koen L, 2004, AUST NZ J PSYCHIAT, V38, P254, DOI 10.1111/j.1440-1614.2004.01338.x; Koh KB, 2012, J CLIN PSYCHIAT, V73, P159, DOI 10.4088/JCP.10m06443; Kotler M, 1999, AM J MED GENET, V88, P628, DOI 10.1002/(SICI)1096-8628(19991215)88:6<628::AID-AJMG10>3.0.CO;2-E; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liou YJ, 2001, NEUROPSYCHOBIOLOGY, V43, P11, DOI 10.1159/000054858; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Munafo MR, 2007, MOL PSYCHIATR, V12, P454, DOI 10.1038/sj.mp.4001938; Nedic G, 2011, INT J NEUROPSYCHOPH, V14, P377, DOI 10.1017/S1461145710001057; Nolan KA, 2003, PSYCHIAT SERV, V54, P1012, DOI 10.1176/appi.ps.54.7.1012; Nolan KA, 2000, PSYCHIAT GENET, V10, P117, DOI 10.1097/00041444-200010030-00003; Park TW, 2002, EUR NEUROPSYCHOPHARM, V12, P299, DOI 10.1016/S0924-977X(02)00030-5; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Silver JM, 1999, J NEUROPSYCH CLIN N, V11, P328, DOI 10.1176/jnp.11.3.328; Soyka M, 2011, SCHIZOPHRENIA BULL, V37, P913, DOI 10.1093/schbul/sbr103; Strous RD, 2003, AM J MED GENET B, V120B, P29, DOI 10.1002/ajmg.b.20021; Strous RD, 1997, BIOL PSYCHIAT, V41, P493, DOI 10.1016/S0006-3223(96)00474-X; Strous RD, 1997, PSYCHIAT RES, V69, P71, DOI 10.1016/S0165-1781(96)03111-3; Swanson JW, 2008, LAW HUMAN BEHAV, V32, P228, DOI 10.1007/s10979-007-9095-7; Swartz MS, 1998, SOC PSYCH PSYCH EPID, V33, pS75, DOI 10.1007/s001270050213; Thompson JMD, 2012, DEV MED CHILD NEUROL, V54, P148, DOI 10.1111/j.1469-8749.2011.04129.x; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tosato S, 2011, NEUROSCI LETT, V495, P17, DOI 10.1016/j.neulet.2011.03.018; Tovilla-Zarate C, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-151; Velligan DI, 2009, J CLIN PSYCHIAT, V70, P6; Volavka J., 2002, NEUROBIOLOGY VIOLENC; Volavka J, 2012, COMPREHENSIVE CARE S, P262; Volavka J, 2012, INT J NEUROPSYCHOPH, V15, P1201, DOI 10.1017/S1461145712000284; Volavka J, 2011, SCHIZOPHRENIA BULL, V37, P921, DOI 10.1093/schbul/sbr041; Xiong H, 2010, GUANGDONG MED J, V31, P82; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; Zammit S, 2004, AM J MED GENET B, V128B, P19, DOI 10.1002/ajmg.b.30021	64	35	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43423	10.1371/journal.pone.0043423	http://dx.doi.org/10.1371/journal.pone.0043423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OQ	22905266	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800082
J	Karimian, G; Buist-Homan, M; Faber, KN; Moshage, H				Karimian, Golnar; Buist-Homan, Manon; Faber, Klaas Nico; Moshage, Han			Pertussis Toxin, an Inhibitor of G(alpha i) PCR, Inhibits Bile Acid- and Cytokine-Induced Apoptosis in Primary Rat Hepatocytes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ISLET-ACTIVATING PROTEIN; FARNESOID-X-RECEPTOR; SUBUNIT STRUCTURE; MEMBRANE-PROTEIN; ADP-RIBOSYLATION; DRUG DISCOVERY; GI-PROTEIN; CELL-DEATH; LIVER	Excessive hepatocyte apoptosis is a common event in acute and chronic liver diseases leading to loss of functional liver tissue. Approaches to prevent apoptosis have therefore high potential for the treatment of liver disease. G-protein coupled receptors (GPCR) play crucial roles in cell fate (proliferation, cell death) and act through heterotrimeric G-proteins. G(alpha i)PCRs have been shown to regulate lipoapoptosis in hepatocytes, but their role in inflammation- or bile acid-induced apoptosis is unknown. Here, we analyzed the effect of inhibiting G(alpha i)PCR function, using pertussis toxin (PT), on bile acid-and cytokine-induced apoptosis in hepatocytes. Primary rat hepatocytes, HepG2-rNtcp cells (human hepatocellular carcinoma cells) or H-4-II-E cells (rat hepatoma cells) were exposed to glycochenodeoxycholic acid (GCDCA) or tumor necrosis factor-alpha (TNF alpha)/actinomycin D (ActD). PT (50-200 nmol/L) was added 30 minutes prior to the apoptotic stimulus. Apoptosis (caspase-3 activity, acridine orange staining) and necrosis (sytox green staining) were assessed. PT significantly reduced GCDCA-and TNF alpha/ActD-induced apoptosis in rat hepatocytes (260%, p, 0.05) in a dose-dependent manner (with no shift to necrosis), but not in HepG2-rNtcp cells or rat H-4-II-E cells. The protective effect of pertussis toxin was independent of the activation of selected cell survival signal transduction pathways, including ERK, p38 MAPK, PI3K and PKC pathways, as specific protein kinase inhibitors did not reverse the protective effects of pertussis toxin in GCDCA-exposed hepatocytes. Conclusion: Pertussis toxin, an inhibitor of G(alpha i)PCRs, protects hepatocytes, but not hepatocellular carcinoma cells, against bile acid-and cytokine-induced apoptosis and has therapeutic potential as primary hepatoprotective drug, as well as adjuvant in anticancer therapy.	[Karimian, Golnar; Buist-Homan, Manon; Faber, Klaas Nico; Moshage, Han] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands	University of Groningen	Karimian, G (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.	g.karimian01@umcg.nl		Moshage, Han/0000-0002-4764-0246				Almendro V, 2010, CURR DRUG TARGETS, V11, P1169, DOI 10.2174/138945010792006807; BURNS DL, 1988, MICROBIOL SCI, V5, P285; Cao RS, 2010, J LIPID RES, V51, P2234, DOI 10.1194/jlr.M004929; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dent P, 2005, HEPATOLOGY, V42, P1291, DOI 10.1002/hep.20942; Gonzalez B, 2000, MOL CELL BIOCHEM, V207, P19, DOI 10.1023/A:1007021710825; Gonzalez-Maeso J, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-20; Guicciardi ME, 2010, SEMIN LIVER DIS, V30, P402, DOI 10.1055/s-0030-1267540; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Han MS, 2008, J LIPID RES, V49, P84, DOI 10.1194/jlr.M700184-JLR200; James ND, 2010, BJU INT, V106, P966, DOI 10.1111/j.1464-410X.2010.09638.x; KATADA T, 1982, J BIOL CHEM, V257, P7210; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kramer L, 2004, WIEN KLIN WOCHENSCHR, V116, P67, DOI 10.1007/BF03040699; Kukkonen JP, 2011, CELL CALCIUM, V50, P9, DOI 10.1016/j.ceca.2011.04.005; Kullak-Ublick GA, 2000, CYTOTECHNOLOGY, V34, pB1, DOI 10.1023/A:1008152729133; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lemasters JJ, 1999, AM J PHYSIOL-GASTR L, V276, pG1, DOI 10.1152/ajpgi.1999.276.1.G1; Maiga A, 2011, TOXICON; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; MOSHAGE H, 1990, HEPATOLOGY, V12, P511, DOI 10.1002/hep.1840120311; Muntane J, 2011, ANTI-CANCER AGENT ME, V11, P576, DOI 10.2174/187152011796011082; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Olsavsky KM, 2007, TOXICOL APPL PHARM, V222, P42, DOI 10.1016/j.taap.2007.03.032; Plass JRM, 2002, HEPATOLOGY, V35, P589, DOI 10.1053/jhep.2002.31724; Reinehr R, 2009, BIOL CHEM, V390, P1033, DOI 10.1515/BC.2009.106; Ros JE, 2001, HEPATOLOGY, V33, P1425, DOI 10.1053/jhep.2001.24667; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Schoemaker MH, 2004, CLIN SCI, V107, P13, DOI 10.1042/CS20040090; Schoemaker MH, 2003, J HEPATOL, V39, P153, DOI 10.1016/S0168-8278(03)00214-9; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Sola S, 2007, CURR ISSUES MOL BIOL, V9, P123; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; TAMURA M, 1982, BIOCHEMISTRY-US, V21, P5516, DOI 10.1021/bi00265a021; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Wang Kun, 2002, J Toxicol Sci, V27, P229, DOI 10.2131/jts.27.229; Waters C, 2004, SEMIN CELL DEV BIOL, V15, P309, DOI 10.1016/j.semcdb.2003.12.020; Woudenberg-Vrenken TE, 2010, LIVER INT, V30, P1511, DOI 10.1111/j.1478-3231.2010.02325.x; YANG LJ, 1991, J BIOL CHEM, V266, P22451; YANG LJ, 1993, J BIOL CHEM, V268, P3739	44	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43156	10.1371/journal.pone.0043156	http://dx.doi.org/10.1371/journal.pone.0043156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900098	gold, Green Published, Green Submitted			2022-12-27	WOS:000307380900116
J	Wiens, JJ; Tiu, J				Wiens, John J.; Tiu, Jonathan			Highly Incomplete Taxa Can Rescue Phylogenetic Analyses from the Negative Impacts of Limited Taxon Sampling	PLOS ONE			English	Article							MISSING DATA; MAXIMUM-LIKELIHOOD; DATA SETS; ACCURACY; FOSSILS; PHYLOGENOMICS; IMPROVE; TREE; PERFORMANCE; CHARACTERS	Background: Phylogenies are essential to many areas of biology, but phylogenetic methods may give incorrect estimates under some conditions. A potentially common scenario of this type is when few taxa are sampled and terminal branches for the sampled taxa are relatively long. However, the best solution in such cases (i.e., sampling more taxa versus more characters) has been highly controversial. A widespread assumption in this debate is that added taxa must be complete (no missing data) in order to save analyses from the negative impacts of limited taxon sampling. Here, we evaluate whether incomplete taxa can also rescue analyses under these conditions (empirically testing predictions from an earlier simulation study). Methodology/Principal Findings: We utilize DNA sequence data from 16 vertebrate species with well-established phylogenetic relationships. In each replicate, we randomly sample 4 species, estimate their phylogeny (using Bayesian, likelihood, and parsimony methods), and then evaluate whether adding in the remaining 12 species (which have 50, 75, or 90% of their data replaced with missing data cells) can improve phylogenetic accuracy relative to analyzing the 4 complete taxa alone. We find that in those cases where sampling few taxa yields an incorrect estimate, adding taxa with 50% or 75% missing data can frequently (>75% of relevant replicates) rescue Bayesian and likelihood analyses, recovering accurate phylogenies for the original 4 taxa. Even taxa with 90% missing data can sometimes be beneficial. Conclusions: We show that adding taxa that are highly incomplete can improve phylogenetic accuracy in cases where analyses are misled by limited taxon sampling. These surprising empirical results confirm those from simulations, and show that the benefits of adding taxa may be obtained with unexpectedly small amounts of data. These findings have important implications for the debate on sampling taxa versus characters, and for studies attempting to resolve difficult phylogenetic problems.	[Wiens, John J.; Tiu, Jonathan] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wiens, JJ (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	wiensj@life.bio.sunysb.edu		Wiens, John/0000-0003-4243-1127				Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; Cobbett A, 2007, SYST BIOL, V56, P753, DOI 10.1080/10635150701627296; DeBry RW, 2005, SYST BIOL, V54, P432, DOI 10.1080/10635150590946745; DONOGHUE MJ, 1989, ANNU REV ECOL SYST, V20, P431, DOI 10.1146/annurev.es.20.110189.002243; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J., 2004, INFERRING PHYLOGENIE; Gouveia-Oliveira R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-312; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; HILLIS DM, 1995, SYST BIOL, V44, P3, DOI 10.2307/2413480; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; HUELSENBECK JP, 1991, SYST ZOOL, V40, P458, DOI 10.2307/2992240; HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Kim J, 1998, SYST BIOL, V47, P43, DOI 10.1080/106351598261021; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Manos PS, 2007, SYST BIOL, V56, P412, DOI 10.1080/10635150701408523; Meyer A, 2003, ANNU REV ECOL EVOL S, V34, P311, DOI 10.1146/annurev.ecolsys.34.011802.132351; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Poe S, 1999, NATURE, V398, P299, DOI 10.1038/18592; Poe S, 2003, SYST BIOL, V52, P423, DOI 10.1080/10635150390197046; Rannala B, 1998, SYST BIOL, V47, P702, DOI 10.1080/106351598260680; Rosenberg MS, 2001, P NATL ACAD SCI USA, V98, P10751, DOI 10.1073/pnas.191248498; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Russo CAM, 1996, MOL BIOL EVOL, V13, P525, DOI 10.1093/oxfordjournals.molbev.a025613; Sanderson MJ, 2011, SCIENCE, V333, P448, DOI 10.1126/science.1206357; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Santos JC, 2009, PLOS BIOL, V7, P448, DOI 10.1371/journal.pbio.1000056; Soltis DE, 1998, SYST BIOL, V47, P32, DOI 10.1080/106351598261012; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Wiens JJ, 1998, SYST BIOL, V47, P427, DOI 10.1080/106351598260806; Wiens JJ, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234625; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wiens JJ, 1998, SYST BIOL, V47, P625, DOI 10.1080/106351598260635; Wiens JJ, 2008, J SYST EVOL, V46, P307, DOI 10.3724/SP.J.1002.2008.08040; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; Wiens JJ, 2009, SYST BIOL, V58, P87, DOI 10.1093/sysbio/syp012; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	47	120	120	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42925	10.1371/journal.pone.0042925	http://dx.doi.org/10.1371/journal.pone.0042925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900065	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900083
J	Alhyas, L; McKay, A; Majeed, A				Alhyas, Layla; McKay, Ailsa; Majeed, Azeem			Prevalence of Type 2 Diabetes in the States of The Co-Operation Council for the Arab States of the Gulf: A Systematic Review	PLOS ONE			English	Review							IMPAIRED GLUCOSE-TOLERANCE; RISK-FACTORS; AL-AIN; MELLITUS; POPULATION; OBESITY; CHILDREN; URBANIZATION; INTOLERANCE; MALES	Aims: The recent and ongoing worldwide expansion in prevalence of Type 2 Diabetes (T2DM) is a considerable risk to individuals, health systems and economies. The increase in prevalence has been particularly marked in the states of the Co-operation Council for the Arab States of the Gulf (GCC), and these trends are set to continue. We aimed to systematically review the current prevalence of T2DM within these states, and also within particular sub-populations. Methods: We identified 27 published studies for review. Studies were identified by systematic database searches. Medline and Embase were searched using terms such as diabetes mellitus, non-insulin-dependent, hyperglycemia, prevalence, epidemiology and Gulf States. Our search also included scanning reference lists, contacting experts and hand-searching key journals. Studies were judged against pre-determined inclusion and exclusion criteria, and where suitable for inclusion, data extraction and quality assessment was achieved using a specifically-designed tool. All studies where prevalence of diabetes was investigated were eligible for inclusion. The inclusion criteria required that the study population be of a GCC country, but otherwise all ages, sexes and ethnicities were included, resident and migrant populations, urban and rural, of all socioeconomic and educational backgrounds. No limitations on publication type, publication status, study design or language of publication were imposed. However, we did not include secondary reports of data, such as review articles without novel data synthesis. Conclusions: The prevalence ofT2DM is an increasing problem for all GCC states. They may therefore benefit to a relatively high degree from co-ordinated implementation of broadly consistent management strategies. Further study of prevalence in children and in national versus expatriate populations would also be useful.	[Alhyas, Layla; McKay, Ailsa; Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England	Imperial College London	Alhyas, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	l.alhyas08@imperial.ac.uk		Majeed, Azeem/0000-0002-2357-9858	UAE Ministry of research and higher education; NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) Scheme; NIHR Biomedical Research Centre scheme; Imperial Centre for Patient Safety and Service Quality	UAE Ministry of research and higher education; NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) Scheme; NIHR Biomedical Research Centre scheme(National Institute for Health Research (NIHR)); Imperial Centre for Patient Safety and Service Quality	Fundign provided by UAE Ministry of research and higher education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for contributions of Igor Wei who assisted with the electronic search strategy. The Department of Primary Care & Public Health at Imperial College is grateful for support from the NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) Scheme, the NIHR Biomedical Research Centre scheme, and the Imperial Centre for Patient Safety and Service Quality.	Abdella N, 1996, ACTA DIABETOL, V33, P145; ABUZEID HAH, 1992, DIABETES CARE, V15, P484, DOI 10.2337/diacare.15.4.484; Al-Asi T, 2003, OCCUP MED-OXFORD, V53, P431, DOI 10.1093/occmed/kqg110; Al-Lawati JA, 2000, ANN SAUDI MED, V20, P12, DOI 10.5144/0256-4947.2000.12; Al-Lawati JA, 2004, SAUDI MED J, V25, P346; Al-Lawati JA, 2002, DIABETIC MED, V19, P954, DOI 10.1046/j.1464-5491.2002.00818.x; Al-Mahroos F, 2001, ANN SAUDI MED, V21, P183, DOI 10.5144/0256-4947.2001.183; Al-Mahroos F, 1998, DIABETES CARE, V21, P936, DOI 10.2337/diacare.21.6.936; Al-Moosa Siba, 2006, Popul Health Metr, V4, P5, DOI 10.1186/1478-7954-4-5; Al-Nozha MM, 2004, SAUDI MED J, V25, P1603; Alhyas Layla, 2011, JRSM Short Rep, V2, P55, DOI 10.1258/shorts.2011.011019; AlNuaim AR, 1997, DIABETIC MED, V14, P595; AlShammari SA, 1996, ANN SAUDI MED, V16, P269, DOI 10.5144/0256-4947.1996.269; Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I; ANOKUTE CC, 1990, J ROY SOC HEALTH, V110, P201, DOI 10.1177/146642409011000604; [Anonymous], 2009, SYSTEMATIC REV CRDS; Asfour MG, 1995, DIABETIC MED, V12, P1122, DOI 10.1111/j.1464-5491.1995.tb00431.x; BACCHUS RA, 1982, DIABETOLOGIA, V23, P330, DOI 10.1007/BF00253739; Balasy E S, 1990, J Egypt Public Health Assoc, V65, P633; Baynouna LM, 2008, SAUDI MED J, V29, P1173; Bener A, 2009, DIABETES RES CLIN PR, V84, P99, DOI 10.1016/j.diabres.2009.02.003; Diabetes Prevention Program Research Group, 2009, NEW ENGL J MED, V346, P393; El-Hazmi M. A. F., 1998, Eastern Mediterranean Health Journal, V4, P58; ElHazmi MAF, 1996, ANN SAUDI MED, V16, P381, DOI 10.5144/0256-4947.1996.381; ElHazmi MAF, 1996, SAUDI MED J, V17, P591; Fagot-Campagna A, 2000, J PEDIATR ENDOCR MET, V13, P1395; FATANI HH, 1987, DIABETES CARE, V10, P180, DOI 10.2337/diacare.10.2.180; Glasgow NJ, 1997, INTJDIABETES METABOL, V5, P221; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; *INT DIAB FED, 2009, DIAB FACTS FIG; International Diabetes Federation, 2009, IDF DIAB ATL; Joint Statement for the Ministers' of Health for the Cooperation Council States on Diabetes, 2007, 63 C HLTH MIN COUNC; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Mahfouz A, 1993, HLTH SERVICES J EMRO, V7, P15; Malik M, 2005, DIABETES RES CLIN PR, V69, P188, DOI 10.1016/j.diabres.2004.12.005; Moussa MAA, 2008, MED PRIN PRACT, V17, P270, DOI 10.1159/000129604; Ramachandran A, 1999, DIABETES RES CLIN PR, V44, P207, DOI 10.1016/S0168-8227(99)00024-8; Saadi H, 2007, DIABETES RES CLIN PR, V78, P369, DOI 10.1016/j.diabres.2007.04.008; TAYLOR R, 1991, MED J AUSTRALIA, V155, P86, DOI 10.5694/j.1326-5377.1991.tb142133.x; Townsend T, 1997, INT J DIABETES, V4, P129; Vivian EM, 2006, CURR MED RES OPIN, V22, P297, DOI 10.1185/030079906X80495; *WHO, 2009, FACT SHEET 312 DIAB; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Economic Forum, 2010, GLOB RISKS 2010 GLOB; World Health Organisation, 2007, FACT SHEET 310 TOP 1	45	81	83	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e40948	10.1371/journal.pone.0040948	http://dx.doi.org/10.1371/journal.pone.0040948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905094	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100006
J	Lee, JH; Kim, DG; Bae, TJ; Rho, K; Kim, JT; Lee, JJ; Jang, Y; Kim, BC; Park, KM; Kim, S				Lee, Ji-Hyun; Kim, Dae Gyu; Bae, Tae Jeong; Rho, Kyoohyoung; Kim, Ji-Tae; Lee, Jong-Jun; Jang, Yeongjun; Kim, Byung Cheol; Park, Kyoung Mii; Kim, Sunghoon			CDA: Combinatorial Drug Discovery Using Transcriptional Response Modules	PLOS ONE			English	Article							BREAST-CANCER CELLS; ANTICANCER DRUGS; KINASE INHIBITOR; ZD1839 IRESSA; DATABASE; EXPRESSION; RECEPTOR; APOPTOSIS; ESTROGEN; DISEASE	Background: Anticancer therapies that target single signal transduction pathways often fail to prevent proliferation of cancer cells because of overlapping functions and cross-talk between different signaling pathways. Recent research has identified that balanced multi-component therapies might be more efficacious than highly specific single component therapies in certain cases. Ideally, synergistic combinations can provide 1) increased efficacy of the therapeutic effect 2) reduced toxicity as a result of decreased dosage providing equivalent or increased efficacy 3) the avoidance or delayed onset of drug resistance. Therefore, the interest in combinatorial drug discovery based on systems-oriented approaches has been increasing steadily in recent years. Methodology: Here we describe the development of Combinatorial Drug Assembler (CDA), a genomics and bioinformatics system, whereby using gene expression profiling, multiple signaling pathways are targeted for combinatorial drug discovery. CDA performs expression pattern matching of signaling pathway components to compare genes expressed in an input cell line (or patient sample data), with expression patterns in cell lines treated with different small molecules. Then it detects best pattern matching combinatorial drug pairs across the input gene set-related signaling pathways to detect where gene expression patterns overlap and those predicted drug pairs could likely be applied as combination therapy. We carried out in vitro validations on non-small cell lung cancer cells and triple-negative breast cancer (TNBC) cells. We found two combinatorial drug pairs that showed synergistic effect on lung cancer cells. Furthermore, we also observed that halofantrine and vinblastine were synergistic on TNBC cells. Conclusions: CDA provides a new way for rational drug combination. Together with phExplorer, CDA also provides functional insights into combinatorial drugs. CDA is freely available at http://cda.i-pharm.org.	[Lee, Ji-Hyun; Kim, Dae Gyu; Bae, Tae Jeong; Rho, Kyoohyoung; Kim, Ji-Tae; Lee, Jong-Jun; Kim, Byung Cheol; Park, Kyoung Mii; Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul, South Korea; [Lee, Ji-Hyun; Bae, Tae Jeong; Rho, Kyoohyoung; Kim, Ji-Tae; Kim, Byung Cheol] Seoul Natl Univ, Informat Ctr Biopharmacol Network, Suwon, South Korea; [Jang, Yeongjun] KRIBB, Korean BioInformat Ctr KOBIC, Taejon, South Korea; [Kim, Sunghoon] Seoul Natl Univ, WCU Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU)	Lee, JH (corresponding author), Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul, South Korea.	sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020; Bae, Taejeong/AAW-6003-2021	Bae, Taejeong/0000-0002-4626-3725; kim, sunghoon/0000-0002-1570-3230; Jang, Yeongjun/0000-0002-7816-3278	Global Frontier [NRF-M1AXA002-2010-0029785]; Research Information Center Supporting Program [370C-20090004]; WCU project of the Ministry of Education, Science, and Technology and Korea Healthcare Technology [R31-2008-000-10103-0, A092255-0911-1110100]; Ministry of Health and Welfare Affairs; Gyonggi-do; EU project of the 7th framework programme (METOXIA); Korean Ministry of Education, Science and Technology (MEST) [20110002321]	Global Frontier; Research Information Center Supporting Program; WCU project of the Ministry of Education, Science, and Technology and Korea Healthcare Technology; Ministry of Health and Welfare Affairs; Gyonggi-do; EU project of the 7th framework programme (METOXIA); Korean Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the grants of the Global Frontier (NRF-M1AXA002-2010-0029785) and the Research Information Center Supporting Program (370C-20090004) and the WCU project (R31-2008-000-10103-0) of the Ministry of Education, Science, and Technology and Korea Healthcare Technology (A092255-0911-1110100), the Ministry of Health and Welfare Affairs, and Gyonggi-do to Dr. Sunghoon Kim, an EU project of the 7th framework programme (METOXIA), and by the Korean Ministry of Education, Science and Technology (MEST) under grant number 20110002321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bange J, 2001, NAT MED, V7, P548, DOI 10.1038/87872; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Bouchaud O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-289; Brazelle W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014335; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chatterjee MS, 2010, NAT BIOTECHNOL, V28, P727, DOI 10.1038/nbt.1642; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Croxtall JD, 2011, DRUGS, V71, P363, DOI 10.2165/11204810-000000000-00000; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gonzalez-Arenas A, 2008, BBA-MOL CELL RES, V1783, P253, DOI 10.1016/j.bbamcr.2007.11.014; Guo Y, 2008, ORAL ONCOL, V44, P23, DOI 10.1016/j.oraloncology.2006.11.020; Gupta Eric K, 2002, Heart Dis, V4, P124; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Hama K, 2006, LIFE SCI, V79, P1736, DOI 10.1016/j.lfs.2006.06.002; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Kubinyi H, 2003, NAT REV DRUG DISCOV, V2, P665, DOI 10.1038/nrd1156; Lahusen T, 2003, MOL CARCINOGEN, V36, P183, DOI 10.1002/mc.10114; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; Lee EJ, 2008, INT J ONCOL, V33, P767, DOI 10.3892/ijo_00000063; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Marsh S, 2010, PHARMACOGENOMICS, V11, P1003, DOI [10.2217/pgs.10.95, 10.2217/PGS.10.95]; Miller WR, 2007, PHARMACOGENET GENOM, V17, P813, DOI 10.1097/FPC.0b013e32820b853a; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Moulder SL, 2001, CANCER RES, V61, P8887; Nelander S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.53; Nelson HS, 2001, J ALLERGY CLIN IMMUN, V107, P397, DOI 10.1067/mai.2001.112939; Normanno N, 2002, ANN ONCOL, V13, P65, DOI 10.1093/annonc/mdf020; Oesterreich S, 2003, CANCER RES, V63, P5203; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Stein T, 2010, AM J PATHOL, V177, P2323, DOI 10.2353/ajpath.2010.100209; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tamm I, 1998, CANCER RES, V58, P5315; Thorn CF, 2010, PHARMACOGENOMICS, V11, P501, DOI 10.2217/PGS.10.15; Valabrega G, 2011, BREAST CANCER RES TR, V130, P29, DOI 10.1007/s10549-010-1281-5; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wu ZK, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S7; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zhao XM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002323; Zhao ZY, 2011, BRAIN RES BULL, V86, P189, DOI 10.1016/j.brainresbull.2011.07.010; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014	57	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42573	10.1371/journal.pone.0042573	http://dx.doi.org/10.1371/journal.pone.0042573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905152	Green Published, gold			2022-12-27	WOS:000307331100050
J	Temunovic, M; Franjic, J; Satovic, Z; Grgurev, M; Frascaria-Lacoste, N; Fernandez-Manjarre, JF				Temunovic, Martina; Franjic, Jozo; Satovic, Zlatko; Grgurev, Marin; Frascaria-Lacoste, Nathalie; Fernandez-Manjarre, Juan F.			Environmental Heterogeneity Explains the Genetic Structure of Continental and Mediterranean Populations of Fraxinus angustifolia Vahl	PLOS ONE			English	Article							EXCELSIOR L.; CHLOROPLAST DNA; SPECIES DISTRIBUTIONS; NICHE CONSERVATISM; MOLECULAR ECOLOGY; GLACIAL REFUGIA; PHYLOGEOGRAPHY; LANDSCAPE; HISTORY; ASSOCIATION	Tree species with wide distributions often exhibit different levels of genetic structuring correlated to their environment. However, understanding how environmental heterogeneity influences genetic variation is difficult because the effects of gene flow, drift and selection are confounded. We investigated the genetic variation and its ecological correlates in a wind-pollinated Mediterranean tree species, Fraxinus angustifolia Vahl, within a recognised glacial refugium in Croatia. We sampled 11 populations from environmentally divergent habitats within the Continental and Mediterranean biogeographical regions. We combined genetic data analyses based on nuclear microsatellite loci, multivariate statistics on environmental data and ecological niche modelling (ENM). We identified a geographic structure with a high genetic diversity and low differentiation in the Continental region, which contrasted with the significantly lower genetic diversity and higher population divergence in the Mediterranean region. The positive and significant correlation between environmental and genetic distances after controlling for geographic distance suggests an important influence of ecological divergence of the sites in shaping genetic variation. The ENM provided support for niche differentiation between the populations from the Continental and Mediterranean regions, suggesting that contemporary populations may represent two divergent ecotypes. Ecotype differentiation was also supported by multivariate environmental and genetic distance analyses. Our results suggest that despite extensive gene flow in continental areas, long-term stability of heterogeneous environments have likely promoted genetic divergence of ashes in this region and can explain the present-day genetic variation patterns of these ancient populations.	[Temunovic, Martina; Franjic, Jozo] Univ Zagreb, Dept Forest Genet Dendrol & Bot, Fac Forestry, Zagreb 41000, Croatia; [Satovic, Zlatko] Univ Zagreb, Fac Agr, Dept Seed Sci & Technol, Zagreb 41000, Croatia; [Grgurev, Marin] State Inst Nat Protect, Zagreb, Croatia; [Frascaria-Lacoste, Nathalie; Fernandez-Manjarre, Juan F.] AgroParisTech, Lab Ecol Systemat & Evolut, UMR 8079, Orsay, France; [Frascaria-Lacoste, Nathalie; Fernandez-Manjarre, Juan F.] Univ Paris 11, UMR 8079, Orsay, France; [Frascaria-Lacoste, Nathalie; Fernandez-Manjarre, Juan F.] CNRS, UMR 8079, F-91405 Orsay, France	University of Zagreb; University of Zagreb; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Temunovic, M (corresponding author), Univ Zagreb, Dept Forest Genet Dendrol & Bot, Fac Forestry, Zagreb 41000, Croatia.	martina.temunovic@gmail.com	Šatović, Zlatko/AAA-9626-2020	Šatović, Zlatko/0000-0002-9848-1601; Frascaria-Lacoste, Nathalie/0000-0002-3425-7838	EU Network of Excellence EVOLTREE; bilateral project between Croatia and France within Cogito Programme of Hubert Curien Partnership (PHC) [25031UM]; Croatian Science Foundation doctoral fellowship [03.01/69]	EU Network of Excellence EVOLTREE; bilateral project between Croatia and France within Cogito Programme of Hubert Curien Partnership (PHC); Croatian Science Foundation doctoral fellowship	This study was supported by the EU Network of Excellence EVOLTREE (http://www.evoltree.eu) and by a bilateral project between Croatia and France (no. 25031UM) within Cogito Programme of Hubert Curien Partnership (PHC). M.T. was supported by a Croatian Science Foundation doctoral fellowship (03.01/69). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2011, MOL ECOL RESOUR, V11, P219, DOI 10.1111/j.1755-0998.2010.02944.x; Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; Bockelmann AC, 2003, MOL ECOL, V12, P505, DOI 10.1046/j.1365-294X.2003.01706.x; Bogdan S, 2007, PERIOD BIOL, V109, P1; Brachet S, 1999, MOL ECOL, V8, P160; Cavlovic J, 2010, PRVA NACIONALMA INVE; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fernandez-Manjarres JF, 2006, MOL ECOL, V15, P3245, DOI 10.1111/j.1365-294X.2006.02975.x; Ferrazzini D, 2007, ANN FOREST SCI, V64, P159, DOI 10.1051/forest:2006100; FRAXIGEN, 2005, ASH SPECIES IN EUROP, P128; Freedman AH, 2010, MOL ECOL, V19, P3773, DOI 10.1111/j.1365-294X.2010.04684.x; Fukarek P., 1983, SUMARSKA ENCIKLOPEDI; Gerard PR, 2006, MOL ECOL, V15, P3655, DOI 10.1111/j.1365-294X.2006.03032.x; Gonzalez-Martinez SC, 2010, MOL PHYLOGENET EVOL, V55, P805, DOI 10.1016/j.ympev.2010.03.001; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gram WK, 2001, ECOLOGY, V82, P2012, DOI 10.1890/0012-9658(2001)082[2012:ABEAGH]2.0.CO;2; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hampe A, 2003, MOL ECOL, V12, P3415, DOI 10.1046/j.1365-294X.2003.02006.x; Heuertz M, 2004, MOL ECOL, V13, P3437, DOI 10.1111/j.1365-294X.2004.02333.x; Heuertz M, 2006, MOL ECOL, V15, P2131, DOI 10.1111/j.1365-294X.2006.02897.x; Heuertz M, 2001, MOL ECOL, V10, P1615, DOI 10.1046/j.1365-294X.2001.01300.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jakob SS, 2007, MOL ECOL, V16, P1713, DOI 10.1111/j.1365-294X.2007.03228.x; Klimo E., 2008, FLOODPLAIN FORESTS T; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Lee CR, 2011, MOL ECOL, V20, P4631, DOI 10.1111/j.1365-294X.2011.05310.x; Lefort F, 1999, MOL ECOL, V8, P1088, DOI 10.1046/j.1365-294X.1999.00655_8.x; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Minch E, 1997, MICROSAT COMPUTER PR; Morand ME, 2002, MOL ECOL, V11, P377, DOI 10.1046/j.1365-294X.2002.01461.x; Murphy HT, 2007, OIKOS, V116, P99, DOI 10.1111/j.2006.0030-1299.15050.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Petit RJ, 2005, TAXON, V54, P877, DOI 10.2307/25065474; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rohlf FJ, 1997, NTSYS PC VERSION 2 0; Sork VL, 2010, MOL ECOL, V19, P3806, DOI 10.1111/j.1365-294X.2010.04726.x; Stoffberg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031946; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Surina B, 2011, J BIOGEOGR, V38, P1381, DOI 10.1111/j.1365-2699.2011.02493.x; Sutherland BG, 2010, MOL ECOL, V19, P2196, DOI 10.1111/j.1365-294X.2009.04376.x; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Tutin TG, 1972, FLORA EUROPAEA; Tzedakis PC, 2004, BALKAN BIODIVERSITY: PATTERN AND PROCESS IN THE EUROPEAN HOTSPOT, P49; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; WILLIS KJ, 1994, QUATERNARY SCI REV, V13, P769, DOI 10.1016/0277-3791(94)90104-X; Wright S, 1943, GENETICS, V28, P114; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	69	53	53	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42764	10.1371/journal.pone.0042764	http://dx.doi.org/10.1371/journal.pone.0042764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905171	Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100064
J	Gaddi, PJ; Crane, MJ; Kamanaka, M; Flavell, RA; Yap, GS; Salazar-Mather, TP				Gaddi, Pamela J.; Crane, Meredith J.; Kamanaka, Masahito; Flavell, Richard A.; Yap, George S.; Salazar-Mather, Thais P.			IL-10 Mediated Regulation of Liver Inflammation during Acute Murine Cytomegalovirus Infection	PLOS ONE			English	Article							T-CELL RESPONSES; NATURAL-KILLER-CELLS; ANTIVIRAL DEFENSE; VIRUS-INFECTION; CYTOKINE PRODUCTION; VIRAL PERSISTENCE; IFN-GAMMA; IN-VIVO; EXPRESSION; HEPATITIS	Various cell types in both lymphoid and non-lymphoid tissues produce the anti-inflammatory cytokine interleukin (IL)-10 during murine cytomegalovirus (MCMV) infection. The functions of IL-10 in the liver during acute infection and the cells that generate this cytokine at this site have not been extensively investigated. In this study, we demonstrate that the production of IL-10 in the liver is elevated in C57BL/6 mice during late acute MCMV infection. Using IL-10 green fluorescence protein (GFP) reporter knock-in mice, designated IL-10-internal ribosomal entry site (IRES)-GFP-enhanced reporter (tiger), NK cells are identified as major IL-10 expressing cells in the liver after infection, along with T cells and other leukocytes. In the absence of IL-10, mice exhibit marked elevations in proinflammatory cytokines and in the numbers of mononuclear cells and lymphocytes infiltrating the liver during this infection. IL-10-deficiency also enhances liver injury without improving viral clearance from this site. Collectively, the results indicate that IL-10-producing cells in the liver provide protection from collateral injury by modulating the inflammatory response associated with MCMV infection.	[Gaddi, Pamela J.; Crane, Meredith J.; Salazar-Mather, Thais P.] Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Gaddi, Pamela J.; Crane, Meredith J.; Salazar-Mather, Thais P.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Kamanaka, Masahito; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Yap, George S.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Yap, George S.] Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA	Brown University; Brown University; Yale University; Howard Hughes Medical Institute; Yale University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gaddi, PJ (corresponding author), Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	Thais_Mather@brown.edu			Ruth L. Kirschstein National Research Service Award Individual Pre-doctoral Fellowship [1F31AI075614-01]; National Institutes of Health [AI083405, AA018772]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083405, R01AI083405, F31AI075614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018772] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award Individual Pre-doctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Ruth L. Kirschstein National Research Service Award Individual Pre-doctoral Fellowship, 1F31AI075614-01 (to PJG), and in part by National Institutes of Health Grants AI083405 (to GSY) and AA018772 (to TSM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Arens R, 2008, J IMMUNOL, V180, P6472, DOI 10.4049/jimmunol.180.10.6472; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Cai GF, 1999, EUR J IMMUNOL, V29, P2658, DOI 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.3.CO;2-7; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Crane MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039161; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Diehl L, 2008, HEPATOLOGY, V47, P296, DOI 10.1002/hep.21965; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Endharti AT, 2011, J IMMUNOL, V186, P41, DOI 10.4049/jimmunol.1000800; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Filippi CM, 2008, J PATHOL, V214, P224, DOI 10.1002/path.2272; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Gold MC, 2002, J IMMUNOL, V169, P359, DOI 10.4049/jimmunol.169.1.359; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Hokeness KL, 2007, J VIROL, V81, P1241, DOI 10.1128/JVI.01937-06; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Hokeness-Antonelli KL, 2007, J IMMUNOL, V179, P6176, DOI 10.4049/jimmunol.179.9.6176; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Karrer U, 2004, J VIROL, V78, P2255, DOI 10.1128/JVI.78.5.2255-2264.2004; Kassel R, 2009, HEPATOLOGY, V50, P1625, DOI 10.1002/hep.23173; KOSZINOWSKI UH, 1990, CURR TOP MICROBIOL, V154, P189; KOSZINOWSKI UH, 1991, CURR OPIN IMMUNOL, V3, P471, DOI 10.1016/0952-7915(91)90005-L; Krmpotic A, 2003, MICROBES INFECT, V5, P1263, DOI 10.1016/j.micinf.2003.09.007; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Lin MT, 1998, VIROLOGY, V245, P270, DOI 10.1006/viro.1998.9170; Loebbermann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032371; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Maroof A, 2008, IMMUNITY, V29, P295, DOI 10.1016/j.immuni.2008.06.012; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Mutnal MB, 2010, J NEUROIMMUNOL, V227, P101, DOI 10.1016/j.jneuroim.2010.06.020; Oakley OR, 2008, CLIN EXP IMMUNOL, V151, P155, DOI 10.1111/j.1365-2249.2007.03533.x; OLVER SD, 1994, CLIN EXP IMMUNOL, V98, P375; Orange JS, 1997, J VIROL, V71, P9248, DOI 10.1128/JVI.71.12.9248-9258.1997; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Redpath S, 1999, J IMMUNOL, V162, P6701; Robbins SH, 2004, J IMMUNOL, V173, P259, DOI 10.4049/jimmunol.173.1.259; Salazar-Mather TP, 2000, J CLIN INVEST, V105, P985, DOI 10.1172/JCI9232; Salazar-Mather TP, 2002, J CLIN INVEST, V110, P321, DOI 10.1172/JCI200215376; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sarangi PP, 2008, J IMMUNOL, V180, P6297, DOI 10.4049/jimmunol.180.9.6297; Schlub TE, 2011, J IMMUNOL, V187, P1385, DOI 10.4049/jimmunol.1100416; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Sehrawat S, 2009, J IMMUNOL, V182, P3191, DOI 10.4049/jimmunol.0803673; Sharma S, 2011, P NATL ACAD SCI USA, V108, P19001, DOI 10.1073/pnas.1107087108; Sumaria N, 2009, IMMUNOL CELL BIOL, V87, P559, DOI 10.1038/icb.2009.41; Sun J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002173; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Tang-Feldman YJ, 2011, INFLAMM RES, V60, P233, DOI 10.1007/s00011-010-0259-4; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Trgovcich J, 2000, ARCH VIROL, V145, P2601, DOI 10.1007/s007050070010; van Dommelen SLH, 2006, IMMUNITY, V25, P835, DOI 10.1016/j.immuni.2006.09.010; Walton SM, 2008, J IMMUNOL, V181, P1128, DOI 10.4049/jimmunol.181.2.1128; Yu MC, 2004, HEPATOLOGY, V40, P1312, DOI 10.1002/hep.20488; Zhang Z, 2008, GASTROENTEROLOGY, V134, P1938, DOI 10.1053/j.gastro.2008.03.037	66	24	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42850	10.1371/journal.pone.0042850	http://dx.doi.org/10.1371/journal.pone.0042850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880122	Green Submitted, gold, Green Published			2022-12-27	WOS:000307284100176
J	Daley, SME; Kappell, AD; Carrick, MJ; Burnap, RL				Daley, Shawn M. E.; Kappell, Anthony D.; Carrick, Marla J.; Burnap, Robert L.			Regulation of the Cyanobacterial CO2-Concentrating Mechanism Involves Internal Sensing of NADP(+) and alpha-Ketogutarate Levels by Transcription Factor CcmR	PLOS ONE			English	Article							INORGANIC CARBON LIMITATION; CO2 CONCENTRATING MECHANISMS; SYNECHOCYSTIS SP PCC-6803; SURFACE-PLASMON RESONANCE; MOBILITY SHIFT ASSAY; NDH-1 COMPLEXES; BICARBONATE TRANSPORTER; SYNECHOCOCCUS PCC7942; GENE-PRODUCTS; ACTIVATION	Inorganic carbon is the major macronutrient required by organisms utilizing oxygenic photosynthesis for autotrophic growth. Aquatic photoautotrophic organisms are dependent upon a CO2 concentrating mechanism (CCM) to overcome the poor CO2-affinity of the major carbon-fixing enzyme, ribulose-bisphosphate carboxylase/oxygenase (Rubisco). The CCM involves the active transport of inorganic forms of carbon (C-i) into the cell to increase the CO2 concentration around the active site of Rubisco. It employs both bicarbonate transporters and redox-powered CO2-hydration enzymes coupled to membranous NDH-type electron transport complexes that collectively produce C-i concentrations up to a 1000-fold greater in the cytoplasm compared to the external environment. The CCM is regulated: a high affinity CCM comprised of multiple components is induced under limiting external C-i concentrations. The LysR-type transcriptional regulator CcmR has been shown to repress its own expression along with structural genes encoding high affinity C-i transporters distributed throughout the genome of Synechocystis sp. PCC 6803. While much has been learned about the structural genes of the CCM and the identity of the transcriptional regulators controlling their expression, little is known about the physiological signals that elicit the induction of the high affinity CCM. Here CcmR is studied to identify metabolites that modulate its transcriptional repressor activity. Using surface plasmon resonance (SPR) alpha-ketoglutarate (alpha-KG) and the oxidized form of nicotinamide adenine dinucleotide phosphate (NADP(+)) have been identified as the co-repressors of CcmR. Additionally, ribulose-1,5-bisphosphate (RuBP) and 2-phosphoglycolate (2-PG) have been confirmed as co-activators of CmpR which controls the expression of the ABC-type bicarbonate transporter.	[Daley, Shawn M. E.; Carrick, Marla J.; Burnap, Robert L.] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Daley, SME (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	rob.burnap@okstate.edu			United States Department of Energy, Office of Basic Energy Sciences [DE-FG02-08ER15968]; Oklahoma State University Foundation	United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Oklahoma State University Foundation	This work was supported by the United States Department of Energy, Office of Basic Energy Sciences, DE-FG02-08ER15968. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank: Dr. Hong Jin Hwang for his assistance with data analysis, editing, and experimental design; Prof. Aaron Kaplan for his suggestion of SPR for ligand molecule identification; Prof. Archie Portis for his kind gift of 2-PG (originally from Sigma); Steven Holland for assisting in the spectroscopic assays, Prof. Uday DeSilva for his kind gift of the Taq enzyme construct; and Dr. Drew Dangel and Prof. Robert Tabita for their assistance with EMSA buffers and protocols are gratefully acknowledged. MJC was gratefully supported by Wentz and Niblack undergraduate research scholarships through the Oklahoma State University Foundation.	Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Bundy BM, 2002, P NATL ACAD SCI USA, V99, P7693, DOI 10.1073/pnas.102605799; CHANCE B, 1964, P NATL ACAD SCI USA, V51, P1244, DOI 10.1073/pnas.51.6.1244; Eisenhut M, 2008, PLANT PHYSIOL, V148, P2109, DOI 10.1104/pp.108.129403; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Ezezika OC, 2007, J MOL BIOL, V367, P616, DOI 10.1016/j.jmb.2006.09.090; Figge RM, 2001, MOL MICROBIOL, V39, P455, DOI 10.1046/j.1365-2958.2001.02239.x; Galmozzi CV, 2007, MOL MICROBIOL, V65, P166, DOI 10.1111/j.1365-2958.2007.05773.x; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Hackenberg C, 2009, PLANTA, V230, P625, DOI 10.1007/s00425-009-0972-9; Hanson TE, 2011, FUNCTIONAL GENOMICS, P225; Hisbergues M, 1999, FEBS LETT, V463, P216, DOI 10.1016/S0014-5793(99)01624-5; Jing D, 2004, ELECTROPHORESIS, V25, P2439, DOI 10.1002/elps.200405994; Jing D, 2003, PROTEOMICS, V3, P1172, DOI 10.1002/pmic.200300438; KAPLAN A, 1991, PLANT PHYSIOL, V97, P851, DOI 10.1104/pp.97.3.851; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Klughammer B, 1999, MOL MICROBIOL, V32, P1305, DOI 10.1046/j.1365-2958.1999.01457.x; Lee HM, 1999, J BACTERIOL, V181, P2697, DOI 10.1128/JB.181.9.2697-2702.1999; Lieman-Hurwitz J, 2009, ENVIRON MICROBIOL, V11, P927, DOI 10.1111/j.1462-2920.2008.01818.x; Maeda S, 2002, MOL MICROBIOL, V43, P425, DOI 10.1046/j.1365-2958.2002.02753.x; MARCUS Y, 1983, PLANT PHYSIOL, V71, P208, DOI 10.1104/pp.71.1.208; McGinn PJ, 2004, PLANT CELL ENVIRON, V27, P615, DOI 10.1111/j.1365-3040.2004.01175.x; McGinn PJ, 2003, PLANT PHYSIOL, V132, P218, DOI 10.1104/pp.102.019349; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Momany C, 2012, MOL MICROBIOL, V83, P453, DOI 10.1111/j.1365-2958.2011.07960.x; Muro-Pastor MI, 2001, J BIOL CHEM, V276, P38320; Muro-Pastor MI, 2005, PHOTOSYNTH RES, V83, P135, DOI 10.1007/s11120-004-2082-7; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nishimura T, 2008, MOL MICROBIOL; Omata T, 1999, P NATL ACAD SCI USA, V96, P13571, DOI 10.1073/pnas.96.23.13571; Omata T, 2001, J BACTERIOL, V183, P1891, DOI 10.1128/JB.183.6.1891-1898.2001; Pattnaik P, 2005, APPL BIOCHEM BIOTECH, V126, P79, DOI 10.1385/ABAB:126:2:079; PLUTHERO FG, 1993, NUCLEIC ACIDS RES, V21, P4850, DOI 10.1093/nar/21.20.4850; Poulsen AK, 2008, BIOCHEMISTRY-US, V47, P7477, DOI 10.1021/bi800396e; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Price GD, 2004, P NATL ACAD SCI USA, V101, P18228, DOI 10.1073/pnas.0405211101; PRICE GD, 1989, PLANT PHYSIOL, V89, P37, DOI 10.1104/pp.89.1.37; Prommeenate P, 2004, J BIOL CHEM, V279, P28165, DOI 10.1074/jbc.M401107200; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schwarz D, 2011, PLANT PHYSIOL, V155, P1640, DOI 10.1104/pp.110.170225; Shibata M, 2002, J BIOL CHEM, V277, P18658, DOI 10.1074/jbc.M112468200; Shibata M, 2001, P NATL ACAD SCI USA, V98, P11789, DOI 10.1073/pnas.191258298; STANIER RY, 1977, ANNU REV MICROBIOL, V31, P225, DOI 10.1146/annurev.mi.31.100177.001301; Stockley PG, 1998, BIOSENS BIOELECTRON, V13, P637, DOI 10.1016/S0956-5663(98)00019-0; Takahashi H, 2008, J EXP BOT, V59, P3009, DOI 10.1093/jxb/ern157; Takahashi Y, 2004, MOL MICROBIOL, V52, P837, DOI 10.1111/j.1365-2958.2004.04021.x; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Tyrrell PN, 1996, PLANT PHYSIOL, V112, P79, DOI 10.1104/pp.112.1.79; van Keulen G, 2003, J BACTERIOL, V185, P1245, DOI 10.1128/JB.185.4.1245-1252.2003; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Woodger FJ, 2007, J BACTERIOL, V189, P3335, DOI 10.1128/JB.01745-06; Woodger FJ, 2005, PLANT PHYSIOL, V139, P1959, DOI 10.1104/pp.105.069146; Woodger FJ, 2003, PLANT PHYSIOL, V133, P2069, DOI 10.1104/pp.103.029728; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526; Zhou XH, 2010, J MOL BIOL, V396, P1012, DOI 10.1016/j.jmb.2009.12.033	57	54	56	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41286	10.1371/journal.pone.0041286	http://dx.doi.org/10.1371/journal.pone.0041286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911771	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600065
J	Dombrowski, SU; Sniehotta, FF; Mackintosh, J; White, M; Rodgers, H; Thomson, RG; Murtagh, MJ; Ford, GA; Eccles, MP; Araujo-Soares, V				Dombrowski, Stephan U.; Sniehotta, Falko F.; Mackintosh, Joan; White, Martin; Rodgers, Helen; Thomson, Richard G.; Murtagh, Madeleine J.; Ford, Gary A.; Eccles, Martin P.; Araujo-Soares, Vera			Witness Response at Acute Onset of Stroke: A Qualitative Theory-Guided Study	PLOS ONE			English	Article							DELAY; SEEKING; HEALTH; CARE; INTERVENTIONS; ASSOCIATION; STATEMENT; SYMPTOMS; DECISION; BEHAVIOR	Background: Delay in calling emergency medical services following stroke limits access to early treatment that can reduce disability. Emergency medical services contact is mostly initiated by stroke witnesses (often relatives), rather than stroke patients. This study explored appraisal and behavioural factors that are potentially important in influencing witness behaviour in response to stroke. Methods and Findings: Semi-structured interviews with 26 stroke witnesses were transcribed and theory-guided content analysed was undertaken based on the Common Sense Self-Regulation Model (appraisal processes) and Theory Domains Framework (behavioural determinants). Response behaviours were often influenced by heuristics-guided appraisal (i.e. mental rules of thumb). Some witnesses described their responses to the situation as 'automatic' and 'instinctive', rather than products of deliberation. Potential behavioural influences included: environmental context and resources (e. g. time of day), social influence (e. g. prompts from patients) and beliefs about consequences (e. g. 999 accesses rapid help). Findings are based on retrospective accounts and need further verification in prospective studies. Conclusions: Witnesses play a key role in patient access to emergency medical services. Factors that potentially influence witnesses' responses to stroke were identified and could inform behavioural interventions and future research. Interventions might benefit from linking automatic/instinctive threat perceptions with deliberate appraisal of stroke symptoms, prompting action to call emergency medical services.	[Dombrowski, Stephan U.; Sniehotta, Falko F.; Mackintosh, Joan; White, Martin; Thomson, Richard G.; Murtagh, Madeleine J.; Eccles, Martin P.; Araujo-Soares, Vera] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rodgers, Helen; Ford, Gary A.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Murtagh, Madeleine J.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Ford, Gary A.] Newcastle Upon Tyne Hosp Natl Hlth Serv Fdn Trust, Royal Victoria Infirm, Acute Stroke Serv, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; University of Leicester; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Dombrowski, SU (corresponding author), Newcastle Univ, Inst Hlth & Soc, Baddiley Clark Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	stephan.dombrowski@ncl.ac.uk	Eccles, Martin P/AAD-4029-2020; Araujo-Soares, Vera/ABF-8144-2021; Sniehotta, Falko/ABF-7131-2021; Ford, Gary/AAY-6405-2020; Rodgers, Helen/K-4358-2012; Araujo-Soares, Vera/F-1806-2015; Sniehotta, Falko F/C-5481-2008; Dombrowski, Stephan/I-2350-2013	Araujo-Soares, Vera/0000-0003-4044-2527; Sniehotta, Falko/0000-0003-1738-4269; Ford, Gary/0000-0001-8719-4968; Araujo-Soares, Vera/0000-0003-4044-2527; Sniehotta, Falko F/0000-0003-1738-4269; White, Martin/0000-0002-1861-6757; Dombrowski, Stephan U/0000-0001-9832-2777	National Institute of Health Research [RP-PG-0606-1241]; Medical Research Council [G0900686] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1241, NF-SI-0507-10249] Funding Source: researchfish; MRC [G0900686] Funding Source: UKRI	National Institute of Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research formed part of a research programme to Develop And evaluate Services for Hyperacute stroke, funded by the National Institute of Health Research (grant number: RP-PG-0606-1241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BL, 1995, BRIT J SOCIAL PSYC 1, V34; Department of Health, 2009, STROK ACT FAST; Evenson KR, 2009, INT J STROKE, V4, P187, DOI 10.1111/j.1747-4949.2009.00276.x; Flynn D, 2011, CEREBROVASC DIS, V31, P77; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Handschu R, 2003, STROKE, V34, P1005, DOI 10.1161/01.STR.0000063366.98459.1F; Jones SP, INT J STROK IN PRESS; Jones SP, 2010, AGE AGEING, V39, P11, DOI 10.1093/ageing/afp196; Kleindorfer D, 2010, AM J EMERG MED, V28, P607, DOI 10.1016/j.ajem.2009.02.016; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; Leventhal H, 2007, HDB HLTH PSYCHOL AGI; Lowe R, 2011, BRIT J HEALTH PSYCH, V16, P862, DOI 10.1111/j.2044-8287.2011.02023.x; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2004, PSYCHOL HEALTH, V19, P29, DOI 10.1080/0887044031000141199; Moser DK, 2006, CIRCULATION, V114, P168, DOI 10.1161/CIRCULATIONAHA.106.176040; Mosley I, 2007, STROKE, V38, P361, DOI 10.1161/01.STR.0000254528.17405.cc; Porteous G H, 1999, Prehosp Emerg Care, V3, P211; Prestwich A, 2005, PSYCHOL HEALTH, V20, P743, DOI 10.1080/14768320500183335; Redfern J, 2006, STROKE, V37, P2410, DOI 10.1161/01.STR.0000237097.00342.a9; Rosamond Wayne D, 2005, Prehosp Emerg Care, V9, P19, DOI 10.1080/10903120590891985; SAFER MA, 1979, MED CARE, V17, P11, DOI 10.1097/00005650-197901000-00002; Scott S, 2010, SOC PERSONAL PSYCHOL, V4, P531, DOI 10.1111/j.1751-9004.2010.00287.x; Sniehotta FF, 2009, BRIT J HEALTH PSYCH, V14, P261, DOI 10.1348/135910708X389042; Teuschl Y, 2010, INT J STROKE, V5, P187, DOI 10.1111/j.1747-4949.2010.00428.x; The Stroke Collaborative, 2008, GIV ME 5 STROK; Walter F, 2011, HLTH SERVICES RES PO; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68	28	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39852	10.1371/journal.pone.0039852	http://dx.doi.org/10.1371/journal.pone.0039852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977GL	22911691	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600010
J	Kim, DS; Lee, DR; Kim, HS; Yoo, JE; Jung, SJ; Lim, BY; Jang, J; Kang, HC; You, S; Hwang, DY; Leem, JW; Nam, TS; Cho, SR; Kim, DW				Kim, Dae-Sung; Lee, Dongjin R.; Kim, Han-Soo; Yoo, Jeong-Eun; Jung, Sung Jun; Lim, Bo Young; Jang, Jiho; Kang, Hoon-Chul; You, Seungkwon; Hwang, Dong-Youn; Leem, Joong Woo; Nam, Taick Sang; Cho, Sung-Rae; Kim, Dong-Wook			Highly Pure and Expandable PSA-NCAM-Positive Neural Precursors from Human ESC and iPSC-Derived Neural Rosettes	PLOS ONE			English	Article							LONG-TERM PROLIFERATION; EMBRYONIC STEM-CELLS; DOPAMINE NEURONS; LINEAGE SELECTION; POLYSIALIC ACID; DIFFERENTIATION; PLASTICITY; EXPRESSION	Homogeneous culture of neural precursor cells (NPCs) derived from human pluripotent stem cells (hPSCs) would provide a powerful tool for biomedical applications. However, previous efforts to expand mechanically dissected neural rosettes for cultivation of NPCs remain concerns regarding non-neural cell contamination. In addition, several attempts to purify NPCs using cell surface markers have not demonstrated the expansion capability of the sorted cells. In the present study, we show that polysialic acid-neural cell adhesion molecule (PSA-NCAM) is detected in neural rosette cells derived from hPSCs, and employ PSA-NCAM as a marker for purifying expandable primitive NPCs from the neural rosettes. PSA-NCAM-positive NPCs (termed hNPC(PSA-NCAM+)) were isolated from the heterogeneous cell population of mechanically harvested neural rosettes using magnetic-based cell sorting. The hNPC(PSA-NCAM+) extensively expressed neural markers such as Sox1, Sox2, Nestin, and Musashi-1 (80 similar to 98% of the total cells) and were propagated for multiple passages while retaining their primitive characteristics in our culture condition. Interestingly, PSA-NCAM-negative cells largely exhibited characteristics of neural crest cells. The hNPC(PSA-NCAM+) showed multipotency and responsiveness to instructive cues towards region-specific neuronal subtypes in vitro. When transplanted into the rat striatum, hNPC(PSA-NCAM+) differentiated into neurons, astrocytes, and oligodendrocytes without particular signs of tumorigenesis. Furthermore, Ki67-positive proliferating cells and non-neural lineage cells were rarely detected in the grafts of hNPC(PSA-NCAM+) compared to those of neural rosette cells. Our results suggest that PSA-NCAM-mediated cell isolation provides a highly expandable population of pure primitive NPCs from hPSCs that will lend themselves as a promising strategy for drug screening and cell therapy for neurodegenerative disorders.	[Kim, Dae-Sung; Lee, Dongjin R.; Yoo, Jeong-Eun; Lim, Bo Young; Jang, Jiho; Leem, Joong Woo; Nam, Taick Sang; Kim, Dong-Wook] Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Lee, Dongjin R.; Yoo, Jeong-Eun; Lim, Bo Young; Kim, Dong-Wook] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Kim, Han-Soo] Yonsei Univ, Coll Med, Ctr Cell Therapy, Seoul, South Korea; [Kim, Han-Soo] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Jung, Sung Jun] Hanyang Univ, Coll Med, Dept Physiol, Seoul 133791, South Korea; [Kang, Hoon-Chul] Yonsei Univ, Coll Med, Severance Childrens Hosp, Dept Pediat,Div Pediat Neurol, Seoul, South Korea; [You, Seungkwon] Korea Univ, Coll Life Sci & Biotechnol, Seoul, South Korea; [Hwang, Dong-Youn] CHA Univ, Coll Med, CHA Stem Cell Inst, Seoul, South Korea; [Cho, Sung-Rae] Yonsei Univ, Coll Med, Dept & Res Inst Rehabil Med, Seoul, South Korea; [Kim, Dong-Wook] Yonsei Univ, Coll Med, Severance Biomed Res Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hanyang University; Yonsei University; Yonsei University Health System; Korea University; Pochon Cha University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, DS (corresponding author), Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea.	dwkim2@yuhs.ac	Kim, Dae-Sung/H-1116-2015; Kang, Phil Jun/F-4716-2013; You, Seungkwon/H-3067-2015	Kim, Dae-Sung/0000-0002-3835-4803; Dong-Wook, Kim/0000-0002-5025-1532; Kang, Hoon-Chul/0000-0002-3659-8847; Cho, Sung-Rae/0000-0003-1429-2684; Leem, Joong/0000-0002-1605-2230	Stem Cell Research Center of the 21st Century Frontier Research Program [SC1110]; National Research Foundation [NRF 2010-0020408, 2010-0020353]; Ministry of Education, Science and Technology, Korea	Stem Cell Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Stem Cell Research Center of the 21st Century Frontier Research Program (SC1110), National Research Foundation (NRF 2010-0020408 and 2010-0020353) funded by the Ministry of Education, Science and Technology, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Colleoni S, 2010, EXP CELL RES, V316, P1148, DOI 10.1016/j.yexcr.2010.02.013; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; Daadi MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001644; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Hedlund E, 2007, STEM CELLS, V25, P1126, DOI 10.1634/stemcells.2006-0540; Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Jong J, 2012, EXP MOL MED, V44, P202, DOI 10.3858/emm.2012.44.3.015; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Ladewig J, 2008, STEM CELLS, V26, P1705, DOI 10.1634/stemcells.2008-0007; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Oh SK, 2005, STEM CELLS, V23, P605, DOI 10.1634/stemcells.2004-0297; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Schmandt T, 2005, STEM CELLS DEV, V14, P55, DOI 10.1089/scd.2005.14.55; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang S, 2010, J NEUROSCI, V30, P14635, DOI 10.1523/JNEUROSCI.1729-10.2010; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zola H, 2006, MOL MED, V12, P312, DOI 10.2119/2006-00081.Zola	36	48	54	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39715	10.1371/journal.pone.0039715	http://dx.doi.org/10.1371/journal.pone.0039715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911689	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600008
J	Mocroft, A; Neuhaus, J; Peters, L; Ryom, L; Bickel, M; Grint, D; Koirala, J; Szymczak, A; Lundgren, J; Ross, MJ; Wyatt, CM				Mocroft, Amanda; Neuhaus, Jacqueline; Peters, Lars; Ryom, Lene; Bickel, Markus; Grint, Daniel; Koirala, Janak; Szymczak, Aleksandra; Lundgren, Jens; Ross, Michael J.; Wyatt, Christina M.		INSIGHT SMART Study Grp; ESPRIT Study Grp	Hepatitis B and C Co-Infection Are Independent Predictors of Progressive Kidney Disease in HIV-Positive, Antiretroviral-Treated Adults	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; INFECTED PATIENTS; MEMBRANOUS NEPHROPATHY; VIRUS COINFECTION; RISK-FACTORS; CIRRHOSIS; FIBROSIS; THERAPY; GLOMERULONEPHRITIS; ALBUMINURIA	Chronic kidney disease (CKD) is an important cause of morbidity and mortality in HIV-positive individuals. Hepatitis C (HCV) co-infection has been associated with increased risk of CKD, but prior studies lack information on potential mechanisms. We evaluated the association between HCV or hepatitis B (HBV) co-infection and progressive CKD among 3,441 antiretroviral-treated clinical trial participants. Progressive CKD was defined as the composite of end-stage renal disease, renal death, or significant glomerular filtration rate (eGFR) decline (25% decline to eGFR <60 mL/min/1.73 m(2) or 25% decline with a baseline <60). Generalized Estimating Equations were used to model the odds of progressive CKD. At baseline, 13.8% and 3.3% of participants were co-infected with HCV and HBV, respectively. Median eGFR was 111, and 3.7% developed progressive CKD. After adjustment, the odds of progressive CKD were increased in participants with HCV (OR 1.72, 95% CI 1.07-2.76) or HBV (OR 2.26, 95% CI 1.15-4.44). Participants with undetectable or low HCV-RNA had similar odds of progressive CKD as HCV seronegative participants, while participants with HCV-RNA >800,000 IU/ml had increased odds (OR 3.07; 95% CI 1.60-5.90). Interleukin-6, hyaluronic acid, and the FIB-4 hepatic fibrosis index were higher among participants who developed progressive CKD, but were no longer associated with progressive CKD after adjustment. Future studies should validate the relationship between HCV viremia and CKD.	[Mocroft, Amanda; Grint, Daniel] UCL, Sch Med, Res Dept Infect & Populat Hlth, London W1N 8AA, England; [Neuhaus, Jacqueline] Univ Minnesota, Sch Publ Hlth, Dept Biostat, Minneapolis, MN USA; [Peters, Lars; Ryom, Lene; Lundgren, Jens] Univ Copenhagen, Fac Hlth Sci, Copenhagen HIV Programme, Copenhagen, Denmark; [Bickel, Markus] JW Goethe Univ Clin, Dept Infect Dis, Frankfurt, Germany; [Koirala, Janak] So Illinois Univ, Sch Med, Dept Med, Div Infect Dis, Springfield, IL 62708 USA; [Szymczak, Aleksandra] Wroclaw Med Univ, Dept Infect Dis Liver Dis & Acquired Immunodefici, Wroclaw, Poland; [Lundgren, Jens] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Ross, Michael J.; Wyatt, Christina M.] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY USA	University of London; University College London; UCL Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of Copenhagen; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Southern Illinois University System; Southern Illinois University; Wroclaw Medical University; Rigshospitalet; University of Copenhagen; Icahn School of Medicine at Mount Sinai	Mocroft, A (corresponding author), UCL, Sch Med, Res Dept Infect & Populat Hlth, Mortimer St, London W1N 8AA, England.	Christina.wyatt@mssm.edu	Lundgren, Jens/AAE-6876-2019; Szymczak, Aleksandra/ABD-3498-2021	Szymczak, Aleksandra/0000-0001-6695-2942; Lundgren, Jens/0000-0001-8901-7850; Grint, Daniel/0000-0001-8001-6544; Koirala, Janak/0000-0002-3608-474X	National Institutes of Health, National Institute of Allergy and Infectious Disease [U01AI042170, U01A1068641, U01AI46362, U01AI046957]; National Institute of Diabetes and Digestive and Kidney Diseases [K23DK077568]; Medical Research Council [MC_U122886352] Funding Source: researchfish; MRC [MC_U122886352] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046957, U01AI042170, U01AI046362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK077568, R01DK078510] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Disease, grants U01AI042170, U01A1068641, and U01AI46362 (SMART) and grant U01AI046957 (ESPRIT). The current analysis was also supported by the National Institute of Diabetes and Digestive and Kidney Diseases, grant K23DK077568 (CMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Butt AA, 2011, AM J KIDNEY DIS, V57, P396, DOI 10.1053/j.ajkd.2010.09.023; Cheng JT, 1999, J AM SOC NEPHROL, V10, P1566; Choi AI, 2010, CIRCULATION, V121, P651, DOI 10.1161/CIRCULATIONAHA.109.898585; CONJEEVARAM HS, 1995, GASTROENTEROLOGY, V109, P540, DOI 10.1016/0016-5085(95)90343-7; Di Biagio A, 2011, CLIN NEPHROL, V75, P518, DOI 10.5414/CNP75518; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; George E, 2011, MEDICINE, V90, P289, DOI 10.1097/MD.0b013e31822f5915; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Huang JF, 2006, J INTERN MED, V260, P255, DOI 10.1111/j.1365-2796.2006.01686.x; Jotwani V, 2011, AM J KIDNEY DIS; LAI KN, 1991, NEW ENGL J MED, V324, P1457, DOI 10.1056/NEJM199105233242103; Lee JJ, 2010, AM J KIDNEY DIS, V56, P23, DOI 10.1053/j.ajkd.2010.01.015; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Martin-Carbonero L, 2011, AIDS, V25, P73, DOI 10.1097/QAD.0b013e328340fde2; McGuire BM, 2006, ANN INTERN MED, V144, P735, DOI 10.7326/0003-4819-144-10-200605160-00007; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Oberti F, 1997, GASTROENTEROLOGY, V113, P1609, DOI 10.1053/gast.1997.v113.pm9352863; Peters L, 2012, AIDS IN PRESS; Sorli ML, 2008, JAIDS-J ACQ IMM DEF, V48, P506, DOI 10.1097/QAI.0b013e31817bbecb; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; System USRD, 2011, USRDS 2011 ANN DAT R; Szczech LA, 2004, KIDNEY INT, V66, P1145, DOI 10.1111/j.1523-1755.2004.00865.x; Tang S, 2005, KIDNEY INT, V68, P1750, DOI 10.1111/j.1523-1755.2005.00591.x; Tsui JI, 2006, J AM SOC NEPHROL, V17, P1168, DOI 10.1681/ASN.2005091006; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wyatt CA, 2008, AIDS, V22, P1799, DOI 10.1097/QAD.0b013e32830e0152; Wyatt CM, 2011, ANTIVIR THER, V16, P591, DOI 10.3851/IMP1766	30	57	62	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40245	10.1371/journal.pone.0040245	http://dx.doi.org/10.1371/journal.pone.0040245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911697	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600015
J	Girault, EM; Alkemade, A; Foppen, E; Ackermans, MT; Fliers, E; Kalsbeek, A				Girault, Elodie M.; Alkemade, Anneke; Foppen, Ewout; Ackermans, Mariette T.; Fliers, Eric; Kalsbeek, Andries			Acute Peripheral but Not Central Administration of Olanzapine Induces Hyperglycemia Associated with Hepatic and Extra-Hepatic Insulin Resistance	PLOS ONE			English	Article							INDUCED WEIGHT-GAIN; LIVER PLASMA-MEMBRANE; ATYPICAL ANTIPSYCHOTICS; IN-VIVO; RECEPTOR; RAT; SCHIZOPHRENIA; PHOSPHORYLATION; PREDOMINANCE; OCCUPANCY	Atypical antipsychotic drugs such as Olanzapine induce weight gain and metabolic changes associated with the development of type 2 diabetes. The mechanisms underlying the metabolic side-effects of these centrally acting drugs are still unknown to a large extent. We compared the effects of peripheral (intragastric; 3 mg/kg/h) versus central (intracerebroventricular; 30 mg/kg/h) administration of Olanzapine on glucose metabolism using the stable isotope dilution technique (Experiment 1) in combination with low and high hyperinsulinemic-euglycemic clamps (Experiments 2 and 3), in order to evaluate hepatic and extra-hepatic insulin sensitivity, in adult male Wistar rats. Blood glucose, plasma corticosterone and insulin levels were measured alongside endogenous glucose production and glucose disappearance. Livers were harvested to determine glycogen content. Under basal conditions peripheral administration of Olanzapine induced pronounced hyperglycemia without a significant increase in hepatic glucose production (Experiment 1). The clamp experiments revealed a clear insulin resistance both at hepatic (Experiment 2) and extra-hepatic levels (Experiment 3). The induction of insulin resistance in Experiments 2 and 3 was supported by decreased hepatic glycogen stores in Olanzapine-treated rats. Central administration of Olanzapine, however, did not result in any significant changes in blood glucose, plasma insulin or corticosterone concentrations nor in glucose production. In conclusion, acute intragastric administration of Olanzapine leads to hyperglycemia and insulin resistance in male rats. The metabolic side-effects of Olanzapine appear to be mediated primarily via a peripheral mechanism, and not to have a central origin.	[Girault, Elodie M.; Foppen, Ewout; Kalsbeek, Andries] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Alkemade, Anneke; Foppen, Ewout; Fliers, Eric; Kalsbeek, Andries] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [Ackermans, Mariette T.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Endocrinol, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Girault, EM (corresponding author), Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands.	e.girault@nin.knaw.nl	Kalsbeek, Andries/H-3076-2019	Kalsbeek, Andries/0000-0001-9606-8453; Fliers, Eric/0000-0001-8048-9050	Top Institute Pharma [T2-105]	Top Institute Pharma	This work was supported in part by a grant from Top Institute Pharma (project T2-105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Belanoff JK, 2011, EUR J PHARMACOL, V655, P117, DOI 10.1016/j.ejphar.2011.01.019; Bymaster FP, 1996, NEUROPSYCHOPHARMACOL, V14, P87, DOI 10.1016/0893-133X(94)00129-N; Chintoh AF, 2008, J CLIN PSYCHOPHARM, V28, P494, DOI 10.1097/JCP.0b013e318184b4c5; Citrome L, 2004, POSTGRAD MED, V116, P49, DOI 10.3810/pgm.2004.10.1601; Davoodi N, 2008, BEHAV PHARMACOL, V19, P121, DOI 10.1097/FBP.0b013e3282f62c66; Deng C, 2010, PROG NEURO-PSYCHOPH, V34, P1, DOI 10.1016/j.pnpbp.2009.11.009; Ferno J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020571; GIORGINO F, 1993, J CLIN INVEST, V91, P2020, DOI 10.1172/JCI116424; Hoiberg MP, 2006, NORD J PSYCHIAT, V60, P207, DOI 10.1080/08039480600636296; Houseknecht KL, 2007, NEUROPSYCHOPHARMACOL, V32, P289, DOI 10.1038/sj.npp.1301209; Huang XF, 2006, BEHAV BRAIN RES, V171, P355, DOI 10.1016/j.bbr.2006.03.040; IMOTO M, 1985, BIOCHEM BIOPH RES CO, V127, P885, DOI 10.1016/S0006-291X(85)80026-7; Kapur S, 2003, J PHARMACOL EXP THER, V305, P625, DOI 10.1124/jpet.102.046987; KAWAI Y, 1986, J CLIN ENDOCR METAB, V62, P827, DOI 10.1210/jcem-62-5-827; Kirk SL, 2009, PSYCHOPHARMACOLOGY, V207, P119, DOI 10.1007/s00213-009-1639-8; Lee CT, 2002, J CLIN PSYCHIAT, V63, P569, DOI 10.4088/JCP.v63n0706; Lublin H, 2005, INT CLIN PSYCHOPHARM, V20, P183, DOI 10.1097/00004850-200507000-00001; Martins PJF, 2010, DIABETES, V59, P2418, DOI 10.2337/db10-0449; McIntyre RS, 2001, CAN J PSYCHIAT, V46, P273, DOI 10.1177/070674370104600308; Morgan SA, 2009, DIABETES, V58, P2506, DOI 10.2337/db09-0525; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; NASSAR CF, 1986, GEN PHARMACOL, V17, P367, DOI 10.1016/0306-3623(86)90057-1; NORDSTROM AL, 1993, BIOL PSYCHIAT, V33, P227, DOI 10.1016/0006-3223(93)90288-O; Ruddell RG, 2008, J HEPATOL, V48, P666, DOI 10.1016/j.jhep.2008.01.006; Sirota P, 2006, HUM PSYCHOPHARM CLIN, V21, P227, DOI 10.1002/hup.763; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; van Bruggen J, 2003, INT CLIN PSYCHOPHARM, V18, P341, DOI 10.1097/00004850-200311000-00005; VANDERVIES J, 1954, BIOCHEM J, V57, P410, DOI 10.1042/bj0570410; Vatamaniuk MZ, 2003, LIFE SCI, V72, P1871, DOI 10.1016/S0024-3205(02)02506-7; Wetterling T, 2001, DRUG SAFETY, V24, P59, DOI 10.2165/00002018-200124010-00005	33	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43244	10.1371/journal.pone.0043244	http://dx.doi.org/10.1371/journal.pone.0043244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905238	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500800063
J	M'Kada, H; Perazzo, H; Munteanu, M; Ngo, Y; Ramanujam, N; Fautrel, B; Imbert-Bismut, F; Ratziu, V; Schuppe-Koistinen, I; Leblond, V; Delattre, JY; Samson, Y; Caen, OL; Bricaire, F; Khayat, D; Pierrot-Deseilligny, C; Herson, S; Amoura, Z; Tilleul, P; Deckmyn, O; Coriat, P; Delpech, VN; Boulogne, P; Bonnefont-Rousselot, D; Poynard, T				M'Kada, Helmi; Perazzo, Hugo; Munteanu, Mona; Ngo, Yen; Ramanujam, Nittia; Fautrel, Bruno; Imbert-Bismut, Francoise; Ratziu, Vlad; Schuppe-Koistinen, Ina; Leblond, Veronique; Delattre, Jean Yves; Samson, Yves; Caen, Olivier Lyon; Bricaire, Francois; Khayat, David; Pierrot-Deseilligny, Charles; Herson, Serge; Amoura, Zahir; Tilleul, Patrick; Deckmyn, Olivier; Coriat, Pierre; Delpech, Vincent Nicolas; Boulogne, Philippe; Bonnefont-Rousselot, Dominique; Poynard, Thierry		DILI-GHPS Grp; SAFE-T Consortium	Real Time Identification of Drug-Induced Liver Injury (DILI) through Daily Screening of ALT Results: A Prospective Pilot Cohort Study	PLOS ONE			English	Article							ALANINE TRANSAMINASE-ACTIVITY; PREVALENCE; ADMISSIONS; BIOMARKER; EVENTS; VALUES	Objective: Identification of drug-induced liver disease (DILI) is difficult, even among hospitalized patients. The aim of this pilot study was to assess the impact of a specific strategy for DILI screening. Design: We prospectively compared the number of acute DILI cases identified in one week of a proactive strategy based on centralized elevated ALT values to those identified with a standard of care strategy for 24-week period based on referral cases to the hepatology unit. In the centralized strategy, a designated study biochemist identified patients with ALT greater than 3 times the upper limit of normal values (ULN) and notified the designated hepatologists, who then went to the patients' wards, analyzed the charts, and if necessary, interviewed the identified patients. During these two periods, patients with possible DILI were included after signing an informed consent in an ongoing European diagnostic study (SAFE-T consortium). Results: During the 24-week period of the standard strategy, 12 (0.04%) patients out of a total of 28,145 were identified as having possible DILI, and 11 of these accepted to be included in the protocol. During the one-week proactive period, 7 patients out of a total of 1407 inpatients (0.498%) [odds ratio vs. standard = 12.1 (95% CI, 3.9-32.3); P < 0.0001] were identified with possible DILI, and 5 were included in the protocol. Conclusion: A simple strategy based on the daily analysis of cases with ALT > 3 ULN by designated biochemists and hepatologists identified 12 times more acute cases of drug-induced liver disease than the standard strategy. This pilot cohort is registered on the number AP-HP P110201/1/08-03-2011 and AFSSAPS B110346-70.	[M'Kada, Helmi; Ramanujam, Nittia; Imbert-Bismut, Francoise; Ratziu, Vlad; Bonnefont-Rousselot, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Biochim Metab, F-75634 Paris, France; [M'Kada, Helmi; Perazzo, Hugo; Ramanujam, Nittia; Poynard, Thierry] Univ Paris 06, AP HP, Ctr Liver, Paris, France; [Munteanu, Mona; Ngo, Yen; Deckmyn, Olivier] Biopredictive, Paris, France; [Fautrel, Bruno] GHPS, Rheumatol Unit, Paris, France; [Schuppe-Koistinen, Ina] Astra Zeneca, Sodertalje, Sweden; [Leblond, Veronique] GHPS, Hematol Unit, Paris, France; [Delattre, Jean Yves] GHPS, Neurol Unit 2, Paris, France; [Samson, Yves] GHPS, Cerebral Vasc Emergency Unit, Paris, France; [Bricaire, Francois] GHPS, Infect Dis Unit, Paris, France; [Caen, Olivier Lyon] Neurol 4 GHPS, Paris, France; [Khayat, David] GHPS, Oncol Unit, Paris, France; [Pierrot-Deseilligny, Charles] Neurol 1 GHPS, Paris, France; [Herson, Serge] Internal Med 2 GHPS, Paris, France; [Amoura, Zahir] Internal Med 1 GHPS, Paris, France; [Tilleul, Patrick] GHPS, Pharmacol Unit, Paris, France; [Coriat, Pierre] Intens Care Anesthesiol GHPS, Paris, France; [Delpech, Vincent Nicolas] Adm Direct GHPS, Paris, France; [Boulogne, Philippe] GHPS, Informat Technol Unit, Paris, France; [Bonnefont-Rousselot, Dominique] Univ Paris 05, Fac Sci Pharmaceut & Biol, EA 4466, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; AstraZeneca; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	M'Kada, H (corresponding author), Grp Hosp Pitie Salpetriere, AP HP, Serv Biochim Metab, F-75634 Paris, France.	tpoynard@teaser.fr	Rousselot, Bonnefont/U-7434-2019; samson, yves/C-5647-2013; Poynard, Thierry/C-1355-2010; AMOURA, Zahir/P-5324-2017; BACHET, Jean-Baptiste/N-6943-2017; Amoura, Zahir/P-5325-2017	Poynard, Thierry/0000-0002-3726-7230; AMOURA, Zahir/0000-0003-0292-9043; BACHET, Jean-Baptiste/0000-0003-4337-286X; Munteanu, Mona/0000-0003-4517-2757; Bonnefont-Rousselot, Dominique/0000-0003-4689-9202; delpech, valerie/0000-0002-9952-8109; Poynard, Thierry/0000-0002-2050-640X; Deckmyn, Olivier/0000-0002-1589-9368; samson, yves/0000-0002-8080-1427; Perazzo, Hugo/0000-0003-0931-6418; Schuppe-Koistinen, Ina/0000-0002-1423-3089	Innovative Medicines Initiative Safer and Faster Evidence-based Translation (IMI-SAFE-T) consortium	Innovative Medicines Initiative Safer and Faster Evidence-based Translation (IMI-SAFE-T) consortium	This study was supported by the Innovative Medicines Initiative Safer and Faster Evidence-based Translation (IMI-SAFE-T) consortium (FP-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader T, 2012, J HEPATOL, V56, P305, DOI 10.1016/j.jhep.2011.08.016; Bagheri H, 2000, BRIT J CLIN PHARMACO, V50, P479, DOI 10.1046/j.1365-2125.2000.00282.x; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; BENICHOU C, 1993, J CLIN EPIDEMIOL, V46, P1331, DOI 10.1016/0895-4356(93)90102-7; Carey EJ, 2008, DIGEST DIS SCI, V53, P1977, DOI 10.1007/s10620-008-0250-x; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; Devarbhavi H, 2010, AM J GASTROENTEROL, V105, P2396, DOI 10.1038/ajg.2010.287; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEWIS JH, 1989, HEPATOLOGY, V9, P679, DOI 10.1002/hep.1840090504; M'Kada H, 2011, REGUL TOXICOL PHARM, V60, P290, DOI 10.1016/j.yrtph.2011.04.002; Matheis K, 2011, DRUG DISCOV TODAY, V16, P600, DOI 10.1016/j.drudis.2011.04.011; Meier Y, 2005, EUR J CLIN PHARMACOL, V61, P135, DOI 10.1007/s00228-004-0888-z; Moore N, 1998, BRIT J CLIN PHARMACO, V45, P301, DOI 10.1046/j.1365-2125.1998.00667.x; Nebeker JR, 2007, MED CARE, V45, pS81, DOI 10.1097/MLR.0b013e3180616c2c; Ozer JS, 2010, BIOMARK MED, V4, P475, DOI 10.2217/BMM.10.9; Ozer JS, 2010, REGUL TOXICOL PHARM, V56, P237, DOI 10.1016/j.yrtph.2009.11.001; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Piton A, 1998, HEPATOLOGY, V27, P1213, DOI 10.1002/hep.510270505; Stausberg J, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-134; Verma S, 2009, GUT, V58, P1555, DOI 10.1136/gut.2008.163675; Watkins PB, 2008, HEPATOLOGY, V48, P1680, DOI 10.1002/hep.22633	21	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42418	10.1371/journal.pone.0042418	http://dx.doi.org/10.1371/journal.pone.0042418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905129	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800010
J	Pardee, TS				Pardee, Timothy S.			Overexpression of MN1 Confers Resistance to Chemotherapy, Accelerates Leukemia Onset, and Suppresses p53 and Bim Induction	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; DNA-DAMAGE RESPONSE; GROUP-B; MEDIATED TRANSCRIPTION; PROGNOSTIC-FACTORS; AML; CANCER; CYTOGENETICS; CONTRIBUTES; EXPRESSION	Background: The transcriptional co-activator MN1 confers a worse prognosis for patients with acute myeloid leukemia (AML) when highly expressed; however, the mechanisms involved are unknown. We sought to model the effects of high MN1 expression in AML models to explore the underlying mechanisms. Methodology/Principal Findings: We used cell lines and a genetically defined mouse model of AML to examine the effects of MN1 overexpression on prognosis and response to cytarabine and doxorubicin in vitro and in vivo. Murine AML that was engineered to overexpress MN1 became more aggressive in vivo, leading to shortened survival in both treated and control groups. In vitro murine AML cells that overexpressed MN1 became resistant to treatment with cytarabine and highly resistant to doxorubicin. This resistant phenotype was also seen in vivo, where treatment with the combination of cytarabine and doxorubicin selected for cells expressing MN1. When therapy-induced DNA damage levels were assessed by gamma H2AX foci, no reduction was seen in MN1 expressing cells arguing against a drug efflux mechanism. Despite no reduction in DNA damage, MN1-expressing cells showed less apoptosis as assessed by annexin V and propidium iodide staining. Following treatment, p53 and BIM induction were markedly reduced in cells expressing MN1. Pharmacologic inhibition of the p53 E3 ligase MDM2 resulted in increased p53 levels and improved response to doxorubicin in vitro. Conclusions/Significance: MN1 overexpression accelerates an already aggressive leukemia, confers resistance to chemotherapy, and suppresses p53 and BIM induction, resulting in decreased apoptosis. This provides a mechanistic explanation of the poor prognosis observed with high MN1 expression and suggests that therapies directed at increasing p53 function may be useful for these patients.	[Pardee, Timothy S.] Wake Forest Univ Hlth Sci, Dept Internal Med, Sect Hematol & Oncol, Winston Salem, NC 27157 USA; [Pardee, Timothy S.] Wake Forest Sch Med, Dept Canc Biol, Ctr Comprehens Canc, Winston Salem, NC USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University	Pardee, TS (corresponding author), Wake Forest Univ Hlth Sci, Dept Internal Med, Sect Hematol & Oncol, Winston Salem, NC 27157 USA.	tspardee@wakehealth.edu		Pardee, Timothy/0000-0002-1186-6948	National Cancer Institute [P30CA012197]; Doug Coley Leukemia Research Foundation; MacKay Foundation for Cancer Research; Leight Endowed Research Fund; Frances P. Tutwiler Fund; NATIONAL CANCER INSTITUTE [P30CA012197, K08CA169809] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Doug Coley Leukemia Research Foundation; MacKay Foundation for Cancer Research; Leight Endowed Research Fund; Frances P. Tutwiler Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for the studies contained in the manuscript was obtained from: The Doug Coley Leukemia Research Foundation (http://dougcoleyfoundation.org/), The MacKay Foundation for Cancer Research (http://www.mackayfoundation.org/), The Leight Endowed Research Fund and the Frances P. Tutwiler Fund. Additional support provided by P30CA012197 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON JLA, 1995, MOL CELL BIOL, V15, P6953; Boehrer S, 2009, ONCOGENE, V28, P2205, DOI 10.1038/onc.2009.69; BUIJS A, 1995, ONCOGENE, V10, P1511; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Carella C, 2007, LEUKEMIA, V21, P1679, DOI 10.1038/sj.leu.2404778; CHEN W, 1989, LEUKEMIA, V3, P264; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Farag SS, 2006, BLOOD, V108, P63, DOI 10.1182/blood-2005-11-4354; Frohling S, 2006, BLOOD, V108, P3280, DOI 10.1182/blood-2006-04-014324; Gocek E, 2011, CANCER RES, V71, P6230, DOI 10.1158/0008-5472.CAN-11-1717; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Haferlach C, 2011, GENES CHROMOSOMES CA; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Heuser M, 2007, BLOOD, V110, P1639, DOI 10.1182/blood-2007-03-080523; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Ju JF, 1998, CLIN CANCER RES, V4, P1315; Kawagoe H, 2005, BLOOD, V106, P4269, DOI 10.1182/blood-2005-04-1679; Kornblau SM, 2010, CLIN CANCER RES, V16, P1865, DOI 10.1158/1078-0432.CCR-09-2551; Langer C, 2009, J CLIN ONCOL, V27, P3198, DOI 10.1200/JCO.2008.20.6110; Lee BD, 2007, LEUKEMIA RES, V31, P1131, DOI 10.1016/j.leukres.2006.11.012; Lin Yunping, 1997, Leukemia (Basingstoke), V11, P324; Liu T, 2010, LEUKEMIA, V24, P601, DOI 10.1038/leu.2009.272; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Meester-Smoor MA, 2007, J MOL ENDOCRINOL, V38, P113, DOI 10.1677/jme.1.02110; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Pardee TS, 2012, BLOOD, V119, P3561, DOI 10.1182/blood-2011-06-362442; Pardee TS, 2011, EXP HEMATOL; Rahmani M, 2009, BLOOD, V114, P4507, DOI 10.1182/blood-2008-09-177881; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012405; Santamaria CM, 2009, LEUKEMIA RES, V33, P1706, DOI 10.1016/j.leukres.2009.04.024; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schwind S, 2011, BLOOD, V118, P4188, DOI 10.1182/blood-2011-06-357764; Seedhouse CH, 2006, LEUKEMIA, V20, P2130, DOI 10.1038/sj.leu.2404439; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Sutton ALM, 2005, MOL ENDOCRINOL, V19, P2234, DOI 10.1210/me.2005-0081; Thepot S, 2011, CELL CYCLE, V10, P2323, DOI 10.4161/cc.10.14.16399; van Wely KHM, 2003, ONCOGENE, V22, P699, DOI 10.1038/sj.onc.1206124; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Walker A, 2011, HAEMATOL-HEMATOL J, V96, P640, DOI 10.3324/haematol.2011.042739; Yin B, 2006, EXP HEMATOL, V34, P631, DOI 10.1016/j.exphem.2006.01.015; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	44	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43185	10.1371/journal.pone.0043185	http://dx.doi.org/10.1371/journal.pone.0043185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905229	gold, Green Submitted, Green Published			2022-12-27	WOS:000307500800058
J	Wagenaar, BH; Christiansen-Lindquist, L; Khosropour, C; Salazar, LF; Benbow, N; Prachand, N; Sineath, RC; Stephenson, R; Sullivan, PS				Wagenaar, Bradley H.; Christiansen-Lindquist, Lauren; Khosropour, Christine; Salazar, Laura F.; Benbow, Nanette; Prachand, Nik; Sineath, R. Craig; Stephenson, Rob; Sullivan, Patrick S.			Willingness of US Men Who Have Sex with Men (MSM) to Participate in Couples HIV Voluntary Counseling and Testing (CVCT)	PLOS ONE			English	Article							DISCORDANT COUPLES; SEROCONVERSION; PARTNERS; EPIDEMIC; BEHAVIOR; RISK	Background: We evaluated willingness to participate in CVCT and associated factors among MSM in the United States. Methods: 5,980 MSM in the US, recruited through MySpace.com, completed an online survey March-April, 2009. A multivariable logistic regression model was built using being "willing'' or "unwilling'' to participate in CVCT in the next 12 months as the outcome. Results: Overall, 81.5% of respondents expressed willingness to participate in CVCT in the next year. Factors positively associated with willingness were: being of non-Hispanic Black (adjusted odds ratio [aOR]: 1.5, 95% confidence interval [Cl]: 1.2-1.8), Hispanic (aOR: 1.3, Cl: 1.1-1.6), or other (aOR: 1.4, Cl: 1.1-1.8) race/ethnicity compared to non-Hispanic White; being aged 18-24 (aOR: 2.5, Cl: 1.7-3.8), 25-29 (aOR: 2.3, Cl: 1.5-3.6), 30-34 (aOR: 1.9, Cl: 1.2-3.1), and 35-45 (aOR: 2.3, Cl: 1.4-3.7) years, all compared to those over 45 years of age; and having had a main male sex partner in the last 12 months (aOR: 1.9, Cl: 1.6-2.2). Factors negatively associated with willingness were: not knowing most recent male sex partner's HIV status (aOR: 0.81, Cl: 0.69-0.95) compared to knowing that the partner was HIV-negative; having had 4-7 (aOR: 0.75, Cl: 0.61-0.92) or > 7 male sex partners in the last 12 months (aOR: 0.62, Cl: 0.50-0.78) compared to 1 partner; and never testing for HIV (aOR: 0.38, Cl: 0.31-0.46), having been tested over 12 months ago (aOR: 0.63, Cl: 0.50-0.79), or not knowing when last HIV tested (aOR: 0.67, Cl: 0.51-0.89), all compared to having tested 0-6 months previously. Conclusions: Young MSM, men of color, and those with main sex partners expressed a high level of willingness to participate in couples HIV counseling and testing with a male partner in the next year. Given this willingness, it is likely feasible to scale up and evaluate CVCT interventions for US MSM.	[Wagenaar, Bradley H.; Christiansen-Lindquist, Lauren; Khosropour, Christine; Sineath, R. Craig; Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Salazar, Laura F.] Georgia State Univ, Inst Publ Hlth, Dept Hlth Promot & Behav, Atlanta, GA 30303 USA; [Benbow, Nanette; Prachand, Nik] Chicago Dept Publ Hlth, Chicago, IL USA; [Stephenson, Rob] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; University System of Georgia; Georgia State University; Chicago Department of Public Health; Emory University; Rollins School Public Health	Wagenaar, BH (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.	pssulli@emory.edu	Stephenson, Rob/J-9876-2012; Khosropour, Christine M/J-5036-2013	Khosropour, Christine M/0000-0002-9743-0829; Sineath, Robert/0000-0002-7302-8640; Sullivan, Patrick Sean/0000-0002-7728-0587	National Institute of Mental Health [R34-MH086331]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [T32HD052460]; MAC AIDS Fund; Emory Center for AIDS Research [P30 AI050409]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH086331] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MAC AIDS Fund; Emory Center for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from National Institute of Mental Health (R34-MH086331) the Eunice Kennedy Shriver National Institute of Child Health & Human Development (T32HD052460), the MAC AIDS Fund, and by the Emory Center for AIDS Research (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2010, BEST EV INT; Centers for Disease Control and Prevention, 2005, HITS SURV REP 2002; Centers for Disease Control and Prevention, 2007, COUPL HIV COUNS TEST; Colfax GN, 2002, AIDS CARE, V14, P675, DOI 10.1080/0954012021000005533a; Davidovich U, 2001, AIDS, V15, P1303, DOI 10.1097/00002030-200107060-00013; Department of Health and Human Services, 2011, TECHN GUID COMB HIV; Ellingson JE, 1999, J APPL PSYCHOL, V84, P155, DOI 10.1037/0021-9010.84.2.155; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Kellerman SE, 2002, JAIDS-J ACQ IMM DEF, V31, P202, DOI 10.1097/00126334-200210010-00011; Painter TM, 2001, SOC SCI MED, V53, P1397, DOI 10.1016/S0277-9536(00)00427-5; Pew Internet & American Life Project, 2011, 65 ONL AD US SOC NET; Pew Internet & American Life Project, 2012, DIG DIFF; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Stephenson R, 2011, AIDS BEHAV, V15, pS80, DOI 10.1007/s10461-011-9893-2; Sullivan PS, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1797; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Zack M, 2010, COLLINEARITY DIAGNOS	23	38	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42953	10.1371/journal.pone.0042953	http://dx.doi.org/10.1371/journal.pone.0042953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OQ	22905191	gold, Green Submitted, Green Published			2022-12-27	WOS:000307500800033
J	Del Coso, J; Gonzalez-Millan, C; Salinero, JJ; Abian-Vicen, J; Soriano, L; Garde, S; Perez-Gonzalez, B				Del Coso, Juan; Gonzalez-Millan, Cristina; Jose Salinero, Juan; Abian-Vicen, Javier; Soriano, Lidon; Garde, Sergio; Perez-Gonzalez, Benito			Muscle Damage and Its Relationship with Muscle Fatigue During a Half-Iron Triathlon	PLOS ONE			English	Article							PROLONGED STRENUOUS EXERCISE; FLUID BALANCE; CARBOHYDRATE; HEMATURIA; DEHYDRATION; PERFORMANCE; INTENSITY; INGESTION; HYDRATION; FEEDINGS	Background: To investigate the cause/s of muscle fatigue experienced during a half-iron distance triathlon. Methodology/Principal Findings: We recruited 25 trained triathletes (36 +/- 7 yr; 75.1 +/- 9.8 kg) for the study. Before and just after the race, jump height and leg muscle power output were measured during a countermovement jump on a force platform to determine leg muscle fatigue. Body weight, handgrip maximal force and blood and urine samples were also obtained before and after the race. Blood myoglobin and creatine kinase concentrations were determined as markers of muscle damage. Results: Jump height (from 30.3 +/- 5.0 to 23.4 +/- 6.4 cm; P<0.05) and leg power output (from 25.6 +/- 2.9 to 20.7 +/- 4.6 W.kg (-1); P<0.05) were significantly reduced after the race. However, handgrip maximal force was unaffected by the race (430 +/- 59 to 430 +/- 62 N). Mean dehydration after the race was 2.3 +/- 1.2% with high inter-individual variability in the responses. Blood myoglobin and creatine kinase concentration increased to 516 +/- 248 mu g.L-1 and 442 +/- 204 U.L-1, respectively (P<0.05) after the race. Pre-to post-race jump change did not correlate with dehydration (r = 0.16; P>0.05) but significantly correlated with myoglobin concentration (r = 0.65; P<0.001) and creatine kinase concentration (r = 0.54; P<0.001). Conclusions/significance: During a half-iron distance triathlon, the capacity of leg muscles to produce force was notably diminished while arm muscle force output remained unaffected. Leg muscle fatigue was correlated with blood markers of muscle damage suggesting that muscle breakdown is one of the most relevant sources of muscle fatigue during a triathlon.	[Del Coso, Juan; Gonzalez-Millan, Cristina; Jose Salinero, Juan; Abian-Vicen, Javier; Soriano, Lidon; Garde, Sergio; Perez-Gonzalez, Benito] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain	Camilo Jose Cela University	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain.	jdelcoso@ucjc.edu	Abián-Vicén, Javier/I-8509-2012; Salinero, Juan J./GLT-1243-2022; Pérez-González, Benito/AAF-7128-2021; Del Coso, Juan/AAC-7117-2020; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012	Abián-Vicén, Javier/0000-0001-9635-3289; Salinero, Juan J./0000-0003-4153-5100; Pérez-González, Benito/0000-0002-6191-2885; Del Coso, Juan/0000-0002-5785-984X; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Gonzalez-Millan, Cristina/0000-0002-3371-9420				ABARBANEL J, 1990, J UROLOGY, V143, P887, DOI 10.1016/S0022-5347(17)40125-X; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; COGGAN AR, 1987, J APPL PHYSIOL, V63, P2388, DOI 10.1152/jappl.1987.63.6.2388; Coso JD, 2011, EUR J SPORT SCI, V11; Coso JD, 2012, ANN C SPAN IN PRESS; COYLE EF, 1986, J APPL PHYSIOL, V61, P165, DOI 10.1152/jappl.1986.61.1.165; Del Coso J, 2008, APPL PHYSIOL NUTR ME, V33, P290, DOI 10.1139/H07-188; Del Coso J, 2008, MED SCI SPORT EXER, V40, P744, DOI 10.1249/MSS.0b013e3181621336; Del Coso J, 2011, EUR J APPL PHYSIOL, V111, P2173, DOI 10.1007/s00421-011-1847-x; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; FRIDEN J, 1983, INT J SPORTS MED, V4, P170, DOI 10.1055/s-2008-1026030; GUR H, 1994, BRIT J SPORT MED, V28, P61, DOI 10.1136/bjsm.28.1.61; Jeukendrup A, 1997, INT J SPORTS MED, V18, P125, DOI 10.1055/s-2007-972607; Jeukendrup AE, 2000, SPORTS MED, V29, P407, DOI 10.2165/00007256-200029060-00004; Jeukendrup AE, 2005, SPORTS MED, V35, P163, DOI 10.2165/00007256-200535020-00005; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Kimber NE, 2002, INT J SPORT NUTR EXE, V12, P47, DOI 10.1123/ijsnem.12.1.47; Knechtle B, 2010, RES Q EXERCISE SPORT, V81, P319; Knechtle Beat, 2008, Res Sports Med, V16, P97, DOI 10.1080/15438620701878881; Laursen PB, 2006, BRIT J SPORT MED, V40, P320, DOI 10.1136/bjsm.2005.022426; Margaritis I, 1999, J SPORT MED PHYS FIT, V39, P133; McInnis MD, 1998, EUR J APPL PHYSIOL O, V79, P99; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Nybo L, 2003, MED SCI SPORT EXER, V35, P589, DOI 10.1249/01.MSS.0000058433.85789.66; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; REID RI, 1987, BRIT J UROL, V59, P133, DOI 10.1111/j.1464-410X.1987.tb04803.x; Saboisky J, 2003, EXP PHYSIOL, V88, P783, DOI 10.1113/eph8802611; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; SCHIFF HB, 1978, Q J MED, V47, P463; Smith JE, 2004, BRIT J SPORT MED, V38, P292, DOI 10.1136/bjsm.2002.002873; Speedy DB, 2001, CLIN J SPORT MED, V11, P44, DOI 10.1097/00042752-200101000-00008; Speedy DB, 2000, CLIN J SPORT MED, V10, P272, DOI 10.1097/00042752-200010000-00009; Suzuki K, 2006, EUR J APPL PHYSIOL, V98, P525, DOI 10.1007/s00421-006-0296-4; Vrijens DMJ, 1999, J APPL PHYSIOL, V86, P1847, DOI 10.1152/jappl.1999.86.6.1847	34	43	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43280	10.1371/journal.pone.0043280	http://dx.doi.org/10.1371/journal.pone.0043280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900101	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900119
J	Avizienis, AV; Sillin, HO; Martin-Olmos, C; Shieh, HH; Aono, M; Stieg, AZ; Gimzewski, JK				Avizienis, Audrius V.; Sillin, Henry O.; Martin-Olmos, Cristina; Shieh, Hsien Hang; Aono, Masakazu; Stieg, Adam Z.; Gimzewski, James K.			Neuromorphic Atomic Switch Networks	PLOS ONE			English	Article							OBJECT RECOGNITION; DYNAMICAL-SYSTEMS; NEURAL-NETWORKS; BRAIN NETWORKS; 1/F NOISE; CIRCUITS; SILVER; DIFFUSION; MEMRISTOR; NANOSTRUCTURES	Efforts to emulate the formidable information processing capabilities of the brain through neuromorphic engineering have been bolstered by recent progress in the fabrication of nonlinear, nanoscale circuit elements that exhibit synapse-like operational characteristics. However, conventional fabrication techniques are unable to efficiently generate structures with the highly complex interconnectivity found in biological neuronal networks. Here we demonstrate the physical realization of a self-assembled neuromorphic device which implements basic concepts of systems neuroscience through a hardware-based platform comprised of over a billion interconnected atomic-switch inorganic synapses embedded in a complex network of silver nanowires. Observations of network activation and passive harmonic generation demonstrate a collective response to input stimulus in agreement with recent theoretical predictions. Further, emergent behaviors unique to the complex network of atomic switches and akin to brain function are observed, namely spatially distributed memory, recurrent dynamics and the activation of feedforward subnetworks. These devices display the functional characteristics required for implementing unconventional, biologically and neurally inspired computational methodologies in a synthetic experimental system.	[Avizienis, Audrius V.; Sillin, Henry O.; Martin-Olmos, Cristina; Gimzewski, James K.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Shieh, Hsien Hang; Stieg, Adam Z.; Gimzewski, James K.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90024 USA; [Aono, Masakazu; Stieg, Adam Z.; Gimzewski, James K.] Natl Inst Mat Sci, World Premier Int Ctr Mat Nanoarchitectond, Tsukuba, Ibaraki, Japan	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institute for Materials Science	Avizienis, AV (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	stieg@cnsi.ucla.edu	Martin-Olmos, Cristina/A-6489-2011; Stieg, Adam/C-5816-2009; Stieg, Adam/AAI-8505-2021	Martin-Olmos, Cristina/0000-0003-0688-484X; Stieg, Adam/0000-0001-7312-9364; Stieg, Adam/0000-0001-7312-9364; gimzewski, james/0000-0003-4333-6957	Defense Advanced Research Projects Agency (DARPA) [HR0011-10-1-0008]; WPI International Center for Materials Nanoarchitectonics (MANA)	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); WPI International Center for Materials Nanoarchitectonics (MANA)	This research was partially supported by the Defense Advanced Research Projects Agency (DARPA) "Physical Intelligence" program (contract number: HR0011-10-1-0008), and by the WPI International Center for Materials Nanoarchitectonics (MANA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abeles M., 1991, CORTICONICS; ALLEN RL, 1959, J PHYS CHEM-US, V63, P223, DOI 10.1021/j150572a021; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Chua L, 2011, APPL PHYS A-MATER, V102, P765, DOI 10.1007/s00339-011-6264-9; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Chung A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/41/412001; Cohen GZ, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3698153; Coombes S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021915; DOUGLAS R, 1995, ANNU REV NEUROSCI, V18, P255, DOI 10.1146/annurev.ne.18.030195.001351; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; GRIER BH, 1984, PHYS REV B, V29, P3810, DOI 10.1103/PhysRevB.29.3810; Hasegawa T, 2010, ADV MATER, V22, P1831, DOI 10.1002/adma.200903680; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Ho R, 2001, P IEEE, V89, P490, DOI 10.1109/5.920580; Ielmini D, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3304167; Indiveri G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00073; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; KUHN A, 1995, J ELECTROANAL CHEM, V397, P93, DOI 10.1016/0022-0728(95)04157-X; Kumar A, 2010, NAT REV NEUROSCI, V11, P615, DOI 10.1038/nrn2886; Kundu M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2199067; Likharev K, 2003, ANN NY ACAD SCI, V1006, P146, DOI 10.1196/annals.1292.010; Lukosevicius M, 2009, COMPUT SCI REV, V3, P127, DOI 10.1016/j.cosrev.2009.03.005; Lv S, 2009, SOLID STATE COMMUN, V149, P227, DOI 10.1016/j.ssc.2008.11.021; Martin-Olmos C, 2012, ADV FUNCT MATER, V22, P1482, DOI 10.1002/adfm.201102789; MEAD C, 1990, P IEEE, V78, P1629, DOI 10.1109/5.58356; MEAD CA, 1988, NEURAL NETWORKS, V1, P91, DOI 10.1016/0893-6080(88)90024-X; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Ohno T, 2011, NAT MATER, V10, P591, DOI [10.1038/NMAT3054, 10.1038/nmat3054]; Oskoee EN, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031105; RALLS KS, 1991, PHYS REV B, V44, P5800, DOI 10.1103/PhysRevB.44.5800; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rowland NC, 2008, J NEUROPHYSIOL, V99, P704, DOI 10.1152/jn.01100.2007; Roychowdhury VP, 1996, IEEE T ELECTRON DEV, V43, P1688, DOI 10.1109/16.536815; SEARLE JR, 1980, BEHAV BRAIN SCI, V3, P417, DOI 10.1017/S0140525X00006038; Segev R, 1998, PHYS LETT A, V237, P307, DOI 10.1016/S0375-9601(97)00870-0; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Stieg AZ, 2012, ADV MATER, V24, P286, DOI 10.1002/adma.201103053; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190; Teuscher C, 2008, IEEE INT SYMP CIRC S, P2785, DOI 10.1109/ISCAS.2008.4542035; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Tour JM, 2002, IEEE T NANOTECHNOL, V1, P100, DOI 10.1109/TNANO.2002.804744; Ullman S, 2007, TRENDS COGN SCI, V11, P58, DOI 10.1016/j.tics.2006.11.009; Wang Z, 2007, NANO LETT, V7, P2688, DOI 10.1021/nl0711054; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023; Wen XG, 2006, LANGMUIR, V22, P4836, DOI 10.1021/la060267x; Xia QF, 2009, NANO LETT, V9, P3640, DOI 10.1021/nl901874j; Xu Z, 2010, ACS NANO, V4, P2515, DOI 10.1021/nn100483a	59	106	106	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42772	10.1371/journal.pone.0042772	http://dx.doi.org/10.1371/journal.pone.0042772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880101	Green Submitted, gold, Green Published			2022-12-27	WOS:000307810000068
J	Cherrington, BD; Zhang, XS; McElwee, JL; Morency, E; Anguish, LJ; Coonrod, SA				Cherrington, Brian D.; Zhang, Xuesen; McElwee, John L.; Morency, Eric; Anguish, Lynne J.; Coonrod, Scott A.			Potential Role for PAD2 in Gene Regulation in Breast Cancer Cells	PLOS ONE			English	Article							PEPTIDYLARGININE DEIMINASE; ARGININE METHYLATION; HISTONE DEIMINATION; TRANSGENIC MICE; EXPRESSION; LOCALIZATION; DISEASE; ANGIOGENESIS; PLEIOTROPHIN; INVOLVEMENT	The peptidylarginine deiminase (PAD) family of enzymes post-translationally convert positively charged arginine residues in substrate proteins to the neutral, non-standard residue citrulline. PAD family members 1, 2, 3, and 6 have previously been localized to the cell cytoplasm and, thus, their potential to regulate gene activity has not been described. We recently demonstrated that PAD2 is expressed in the canine mammary gland epithelium and that levels of histone citrullination in this tissue correlate with PAD2 expression. Given these observations, we decided to test whether PAD2 might localize to the nuclear compartment of the human mammary epithelium and regulate gene activity in these cells. Here we show, for the first time, that PAD2 is specifically expressed in human mammary gland epithelial cells and that a portion of PAD2 associates with chromatin in MCF-7 breast cancer cells. We investigated a potential nuclear function for PAD2 by microarray, qPCR, and chromatin immunoprecipitation analysis. Results show that the expression of a unique subset of genes is disregulated following depletion of PAD2 from MCF-7 cells. Further, ChIP analysis of two of the most highly up-and down-regulated genes (PTN and MAGEA12, respectively) found that PAD2 binds directly to these gene promoters and that the likely mechanism by which PAD2 regulates expression of these genes is via citrullination of arginine residues 2-8-17 on histone H3 tails. Thus, our findings define a novel role for PAD2 in gene expression in human mammary epithelial cells.	[Cherrington, Brian D.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Zhang, Xuesen; McElwee, John L.; Morency, Eric; Anguish, Lynne J.; Coonrod, Scott A.] Cornell Univ, Coll Vet Med, James A Baker Inst Anim Hlth, Ithaca, NY 14853 USA	University of Wyoming; Cornell University	Cherrington, BD (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	sac269@cornell.edu		McElwee, John/0000-0003-1538-533X; Cherrington, Brian/0000-0001-5847-2295	DOD Era of Hope Scholar Award [W871XWH-07-1-0372]; Post Doctoral Fellowship from Susan G. Komen for the Cure [KG101303]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER	DOD Era of Hope Scholar Award; Post Doctoral Fellowship from Susan G. Komen for the Cure; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a DOD Era of Hope Scholar Award (grant W871XWH-07-1-0372) to SAC. XZ was supported by a Post Doctoral Fellowship from Susan G. Komen for the Cure, KG101303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita K, 2006, P NATL ACAD SCI USA, V103, P5291, DOI 10.1073/pnas.0509639103; Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Chang XT, 2006, MOL CARCINOGEN, V45, P183, DOI 10.1002/mc.20169; Cherrington BD, 2010, PLOS ONE, V5, DOI [10.1371/journal/pone.0011768, 10.1371/journal.pone.0011768]; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dardik R, 2006, EXP CELL RES, V312, P2973, DOI 10.1016/j.yexcr.2006.05.019; Denis H, 2009, MOL CELL BIOL, V29, P4982, DOI 10.1128/MCB.00285-09; Feng Y, 2011, PROTEIN CELL, V2, P7, DOI 10.1007/s13238-011-1002-9; Ishigami A, 2005, J NEUROSCI RES, V80, P120, DOI 10.1002/jnr.20431; Jang B, 2010, ACTA NEUROPATHOL, V119, P199, DOI 10.1007/s00401-009-0625-x; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Lee HJ, 2010, J BIOL CHEM; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Liu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021314; Luo Y, 2006, J AM CHEM SOC, V128, P1092, DOI 10.1021/ja0576233; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mastronardi FG, 1996, J CLIN INVEST, V97, P349, DOI 10.1172/JCI118422; Miranda EI, 2010, LEUKEMIA RES, V34, P1121, DOI 10.1016/j.leukres.2010.03.045; Musse AA, 2008, DIS MODEL MECH, V1, P229, DOI 10.1242/dmm.000729; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; Perez-Pinera P, 2007, CELL CYCLE, V6, P2877, DOI 10.4161/cc.6.23.5090; SENSHU T, 1989, ENDOCRINOLOGY, V124, P2666, DOI 10.1210/endo-124-6-2666; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; TAKAHARA H, 1989, J BIOL CHEM, V264, P13361; TAKAHARA H, 1992, J BIOL CHEM, V267, P520; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wood DD, 2008, LAB INVEST, V88, P354, DOI 10.1038/labinvest.3700748; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yao HJ, 2008, J BIOL CHEM, V283, P20060, DOI 10.1074/jbc.M802940200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang XS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002112	35	61	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41242	10.1371/journal.pone.0041242	http://dx.doi.org/10.1371/journal.pone.0041242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911765	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300028
J	Shi, YY; Bai, YJ; Zou, YG; Cai, B; Liu, F; Fu, P; Wang, LL				Shi, Yunying; Bai, Yangjuan; Zou, Yuangao; Cai, Bei; Liu, Fei; Fu, Ping; Wang, Lanlan			The Value of Plasma Paraquat Concentration in Predicting Therapeutic Effects of Haemoperfusion in Patients with Acute Paraquat Poisoning	PLOS ONE			English	Article							TOXICITY	Objective: This study was aimed to analyze the scavenging effect of haemoperfusion on plasma paraquat (PQ) and to evaluate the clinical significance of PQ examination in the treatment of patients with acute paraquat poisoning. Methods: 85 patients with acute paraquat intoxication by oral ingestion were admitted in West China Hospital from Jun, 2010 to Mar, 2011. A standardized therapeutic regimen including emergency haemoperfusion was given on all subjects. A total of 91 whole blood samples were taken before (0h), underway (1h after haemoperfusion beginning) and at the end (2h) of the haemoperfusion therapy. The clearance rate was calculated and related factors were analyzed. Results: As heamoperfusion was going on, the plasma paraquat concentration of the patients kept falling down. After 1 hour of haemoperfusion, the average clearance rate (R-1) was 37.06 +/- 21.81%. After 2 hours of haemoperfusion, the average clearance rate (R-2) was 45.99 +/- 23.13%. The average of R-1/R-2 ratio was 76.61 +/- 22.80%. In the high paraquat concentration group (plasma paraquat concentration (C-0)>300 ng/mL), both the averages of R-1 and R-2 were significantly higher than those of the low paraquat concentration group (C-0 <= 200 ng/mL) (p<0.05), and there was no significant difference of R-1/R-2 between these two groups (p>0.05). Conclusions: The dynamic monitoring of plasma PQ concentration was not only critical in the clinical evaluation but also helpful in guiding the treatment of patients with acute PQ intoxication. Haemoperfusion can effectively eliminate paraquat from the plasma in patients with high initial plasma PQ concentration, while in patients with low initial plasma PQ concentration (<200 ng/ml), the clearance effect of harmoperfusion was very limited. Increasing HP time might improve the overall clearance rate of HP on plasma PQ yet decrease the elimination efficiency of HP, while repeated HP treatment was helpful against the rebound phenomena.	[Shi, Yunying; Liu, Fei; Fu, Ping] Sichuan Univ, W China Hosp, Dept Nephrol, Chengdu 610064, Peoples R China; [Bai, Yangjuan; Zou, Yuangao; Cai, Bei; Wang, Lanlan] Sichuan Univ, W China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Shi, YY (corresponding author), Sichuan Univ, W China Hosp, Dept Nephrol, Chengdu 610064, Peoples R China.	wangll87@126.com	Shi, Yun Ying/GWZ-9476-2022	Shi, Yun Ying/0000-0002-4544-5439	National Natural Science Foundation of China [81072443, 81100536, 30772051, 30950010, 81001325]; Foundation of Education Ministry of China [20090181120099, 20090181110026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Education Ministry of China(Ministry of Education, China)	This research was sponsored by National Natural Science Foundation of China (Nos. 81072443, 81100536, 30772051, 30950010, 81001325) and Foundation of Education Ministry of China (20090181120099, 20090181110026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro Rui, 2005, Acta Med Port, V18, P423; Chen Yan-jun, 2010, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V28, P358; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; HAMPSON ECGM, 1988, MED TOXICOL ADV DRUG, V3, P64, DOI 10.1007/BF03259932; Hong SY, 2003, TOXICOL IND HEALTH, V19, P17, DOI 10.1191/0748233703th171oa; Jones AL, 1999, QJM-MON J ASSOC PHYS, V92, P573, DOI 10.1093/qjmed/92.10.573; Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926; Kang MS, 2009, J KOREAN MED SCI, V24, pS156, DOI 10.3346/jkms.2009.24.S1.S156; Lee EY, 2002, TOXICOL IND HEALTH, V18, P201, DOI 10.1191/0748233702th141oa; Lopez Lago A M, 2002, An Med Interna, V19, P310; Sabzghabaee AM, 2010, SINGAP MED J, V51, P496; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Smith L L, 1978, Ciba Found Symp, P321; SMITH LL, 1985, PHILOS T R SOC B, V311, P647, DOI 10.1098/rstb.1985.0170; SMITH LL, 1987, HUM TOXICOL, V6, P31, DOI 10.1177/096032718700600105; SUZUKI K, 1993, HUM EXP TOXICOL, V12, P323, DOI 10.1177/096032719301200411; Yoon SCTW, 2002, KOREAN J NEPHROL, V21, P914; Yoon Sung-Chul, 2009, Korean J Intern Med, V24, P93, DOI 10.3904/kjim.2009.24.2.93; Zou YG, 2011, J CHROMATOGR B, V879, P1809, DOI 10.1016/j.jchromb.2011.05.004	19	28	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40911	10.1371/journal.pone.0040911	http://dx.doi.org/10.1371/journal.pone.0040911			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911716	gold, Green Submitted, Green Published			2022-12-27	WOS:000306644600027
J	Wang, ZX; Wang, Y; Farhangfar, F; Zimmer, M; Zhang, YX				Wang, Zhenxiang; Wang, Ying; Farhangfar, Farhang; Zimmer, Monica; Zhang, Yongxin			Enhanced Keratinocyte Proliferation and Migration in Co-culture with Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR EGF; IFN-GAMMA PRODUCTION; FACTOR HB-EGF; IN-VITRO; DERMAL FIBROBLASTS; CONNECTIVE-TISSUE; CELL-MIGRATION; SCRATCH ASSAY; FACTOR-ALPHA; EPIDERMAL-KERATINOCYTES	Wound healing is primarily controlled by the proliferation and migration of keratinocytes and fibroblasts as well as the complex interactions between these two cell types. To investigate the interactions between keratinocytes and fibroblasts and the effects of direct cell-to-cell contact on the proliferation and migration of keratinocytes, keratinocytes and fibroblasts were stained with different fluorescence dyes and co-cultured with or without transwells. During the early stage (first 5 days) of the culture, the keratinocytes in contact with fibroblasts proliferated significantly faster than those not in contact with fibroblasts, but in the late stage (11th to 15th day), keratinocyte growth slowed down in all cultures unless EGF was added. In addition, keratinocyte migration was enhanced in co-cultures with fibroblasts in direct contact, but not in the transwells. Furthermore, the effects of the fibroblasts on keratinocyte migration and growth at early culture stage correlated with heparin-binding EGF-like growth factor (HB-EGF), IL-1 alpha and TGF-beta 1 levels in the cultures where the cells were grown in direct contact. These effects were inhibited by anti-HB-EGF, anti-IL-1 alpha and anti-TGF-beta 1 antibodies and anti-HB-EGF showed the greatest inhibition. Co-culture of keratinocytes and IL-1 alpha and TGF-beta 1 siRNA-transfected fibroblasts exhibited a significant reduction in HB-EGF production and keratinocyte proliferation. These results suggest that contact with fibroblasts stimulates the migration and proliferation of keratinocytes during wound healing, and that HB-EGF plays a central role in this process and can be up-regulated by IL-1 alpha and TGF-beta 1, which also regulate keratinocyte proliferation differently during the early and late stage.	[Wang, Zhenxiang; Zimmer, Monica] Third Mil Med Univ, Southwest Hosp, Dept Plast & Aesthet Surg, Chongqing, Peoples R China; [Wang, Ying; Zhang, Yongxin] ZYX Biotech Co, Dept R&D, Carrollton, TX USA; [Farhangfar, Farhang] Regenetech Inc, Houston, TX USA	Army Medical University	Wang, ZX (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Plast & Aesthet Surg, Chongqing, Peoples R China.	zyx@zyxbiotech.com	Zhang, Yongxin/AAI-5646-2020		Zyxell Inc.; National Natural Science Foundation of China [81071563]	Zyxell Inc.; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Zyxell Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Some experiments done for the manuscript revisions were supported by National Natural Science Foundation of China (81071563). No additional external funding was received for this study.	Abdullah KM, 1999, ENDOCRINE, V10, P35, DOI 10.1385/ENDO:10:1:35; ANFINOGENOV VA, 1992, TSITOLOGIYA+, V34, P60; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; CHEN JD, 1995, J INVEST DERMATOL, V104, P729, DOI 10.1111/1523-1747.ep12606970; Cribbs RK, 1998, J BURN CARE REHABIL, V19, P95, DOI 10.1097/00004630-199803000-00002; Decline F, 2003, CELL MOTIL CYTOSKEL, V54, P64, DOI 10.1002/cm.10086; DELAPORTE E, 1989, PATHOL BIOL, V37, P875; Ding Y, 2010, J BIOL CHEM, V285, P37909, DOI 10.1074/jbc.M109.093724; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Fagot D, 2002, ARCH DERMATOL RES, V293, P576, DOI 10.1007/s00403-001-0271-1; [富建华 Fu Jianhua], 2011, [中国当代儿科杂志, Chinese Journal of Contemporary Pediatrics], V13, P36; Funayama Emi, 2002, Hokkaido Journal of Medical Science, V77, P533; Fusenig N E, 1994, J Dermatol Sci, V7 Suppl, pS142, DOI 10.1016/0923-1811(94)90045-0; GAIL MH, 1973, EXP CELL RES, V79, P386, DOI 10.1016/0014-4827(73)90458-8; GAIL MH, 1971, EXP CELL RES, V65, P221, DOI 10.1016/S0014-4827(71)80070-8; Garner WL, 1998, PLAST RECONSTR SURG, V102, P135, DOI 10.1097/00006534-199807000-00021; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Goetsch KP, 2011, ANAL BIOCHEM, V411, P158, DOI 10.1016/j.ab.2010.12.012; GONUL B, 1992, EXP EYE RES, V54, P519, DOI 10.1016/0014-4835(92)90130-K; Goretsky MJ, 1996, J TRAUMA, V40, P894, DOI 10.1097/00005373-199606000-00006; Haber M, 2003, VET OPHTHALMOL, V6, P211, DOI 10.1046/j.1463-5224.2003.00296.x; Harrison CA, 2005, WOUND REPAIR REGEN, V13, P543, DOI 10.1111/j.1524-475X.2005.00076.x; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; Hashimoto K, 2000, J DERMATOL SCI, V24, pS46, DOI 10.1016/S0923-1811(00)00141-9; Haverstock B D, 2001, Clin Podiatr Med Surg, V18, P147; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HODARA ML, 1991, ARCH BIOCHEM BIOPHYS, V286, P85, DOI 10.1016/0003-9861(91)90011-7; Huang S, 2010, BIOMATERIALS, V31, P5520, DOI 10.1016/j.biomaterials.2010.03.060; Jeong HW, 2004, J CELL BIOCHEM, V92, P770, DOI 10.1002/jcb.20110; Kitano Y, 1976, Med J Osaka Univ, V26, P147; KIYOHARA Y, 1991, J PHARMACOBIO-DYNAM, V14, P47, DOI 10.1248/bpb1978.14.47; Koivisto L, 2006, EXP CELL RES, V312, P2791, DOI 10.1016/j.yexcr.2006.05.009; Konstantinova N V, 1996, Biull Eksp Biol Med, V121, P181; Laato M, 1990, Duodecim, V106, P860; Laco F, 2009, J DERMATOL SCI, V55, P150, DOI 10.1016/j.jdermsci.2009.05.009; LACROIX M, 1995, ARCH DERMATOL RES, V287, P659, DOI 10.1007/BF00371739; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Maas-Szabowski N, 2000, J INVEST DERMATOL, V114, P1075, DOI 10.1046/j.1523-1747.2000.00987.x; Marikovsky M, 1996, J INVEST DERMATOL, V106, P616, DOI 10.1111/1523-1747.ep12345413; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; McCawley LJ, 1997, ENDOCRINOLOGY, V138, P121, DOI 10.1210/en.138.1.121; Moon H, 2012, ARCH PHARM RES, V35, P383, DOI 10.1007/s12272-012-0220-x; Newby CS, 2000, J INVEST DERMATOL, V115, P292, DOI 10.1046/j.1523-1747.2000.00056.x; Nolte SV, 2008, CELLS TISSUES ORGANS, V187, P165, DOI 10.1159/000111805; Nowinski D, 2002, J INVEST DERMATOL, V119, P449, DOI 10.1046/j.1523-1747.2002.01841.x; O'Toole EA, 1997, J CLIN INVEST, V100, P2881, DOI 10.1172/JCI119837; OKUMURA K, 1990, PHARMACEUT RES, V7, P1289, DOI 10.1023/A:1015946123697; Parnigotto Pier Paolo, 1993, Italian Journal of Anatomy and Embryology, V98, P31; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Rasanen K, 2010, EXP CELL RES, V316, P1739, DOI 10.1016/j.yexcr.2010.01.020; Rose MT, 2012, VET J; Sawicki G, 2005, MOL CELL BIOCHEM, V269, P209, DOI 10.1007/s11010-005-3178-x; SCHULTZ G, 1991, J CELL BIOCHEM, V45, P346, DOI 10.1002/jcb.240450407; Seomun Y, 2008, J CELL BIOCHEM, V104, P934, DOI 10.1002/jcb.21675; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; Snyder R J, 2001, Ostomy Wound Manage, V47, P20; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; Sugai J, 1998, J DERMATOL SCI, V17, P190, DOI 10.1016/S0923-1811(98)00006-1; Sun T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002129; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tsuboi Ryoji, 1992, Journal of Dermatology (Tokyo), V19, P652; TUAN TL, 1994, J CELL SCI, V107, P2285; Uchino T, 2009, TOXICOL IN VITRO, V23, P333, DOI 10.1016/j.tiv.2008.12.003; Watanabe Takashi, 2006, Tanpakushitsu Kakusan Koso, V51, P715; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; WOODLEY DT, 1993, DERMATOL CLIN, V11, P641, DOI 10.1016/S0733-8635(18)30217-1; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Ye H, 2011, WOUND REPAIR REGEN, V19, P392, DOI 10.1111/j.1524-475X.2011.00680.x; Yoshioka R, 2010, INVEST OPHTH VIS SCI, V51, P5630, DOI 10.1167/iovs.10-5158; Zhang Y, 2002, CELL DEATH DIFFER, V9, P651, DOI 10.1038/sj.cdd.4401011; Zhang YX, 2000, J INTERF CYTOK RES, V20, P235, DOI 10.1089/107999000312658; Zhang YX, 2002, IMMUNOLOGY, V105, P286, DOI 10.1046/j.0019-2805.2001.01368.x; Zhang YX, 2002, EXP BIOL MED, V227, P133, DOI 10.1177/153537020222700208; Zhang YX, 2001, J INTERF CYTOK RES, V21, P843, DOI 10.1089/107999001753238097; Zhu Yao-Feng, 2008, Zhonghua Yi Xue Za Zhi, V88, P697	75	71	73	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40951	10.1371/journal.pone.0040951	http://dx.doi.org/10.1371/journal.pone.0040951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911722	Green Published, Green Submitted, gold			2022-12-27	WOS:000306644600031
J	Zielinski, R; Hassan, M; Lyakhov, I; Needle, D; Chernomordik, V; Garcia-Glaessner, A; Ardeshirpour, Y; Capala, J; Gandjbakhche, A				Zielinski, Rafal; Hassan, Moinuddin; Lyakhov, Ilya; Needle, Danielle; Chernomordik, Victor; Garcia-Glaessner, Alejandra; Ardeshirpour, Yasaman; Capala, Jacek; Gandjbakhche, Amir			Affibody-DyLight Conjugates for In Vivo Assessment of HER2 Expression by Near-Infrared Optical Imaging	PLOS ONE			English	Article							MALIGNANT-TUMORS; BREAST-CANCER; HER2-POSITIVE TUMORS; FLUORESCENT PROTEINS; BINDING-PROTEINS; MOLECULES; THERAPY; RECOMBINANT; TRACER; AGENT	Purpose: Amplification of the HER2/neu gene and/or overexpression of the corresponding protein have been identified in approximately 20% of invasive breast carcinomas. Assessment of HER2 expression in vivo would advance development of new HER2-targeted therapeutic agents and, potentially, facilitate choice of the proper treatment strategy offered to the individual patient. We present novel HER2-specific probes for in vivo evaluation of the receptor status by near-infrared (NIR) optical imaging. Experimental Design: Affibody molecules were expressed, purified, and labeled with NIR-fluorescent dyes. The binding affinity and specificity of the obtained probe were tested in vitro. For in vivo validation, the relationship of the measured NIR signal and HER2 expression was characterized in four breast cancer xenograft models, expressing different levels of HER2. Accumulation of Affibody molecules in tumor tissue was further confirmed by ex vivo analysis. Results: Affibody-DyLight conjugates showed high affinity to HER2 (K-D = 3.66 +/- 0.26). No acute toxicity resulted from injection of the probes (up to 0.5 mg/kg) into mice. Pharmacokinetic studies revealed a relatively short (37.53 +/- 2.8 min) half-life of the tracer in blood. Fluorescence accumulation in HER2-positive BT-474 xenografts was evident as soon as a few minutes post injection and reached its maximum at 90 minutes. On the other hand, no signal retention was observed in HER2-negative MDA-MB-468 xenografts. Immunostaining of extracted tumor tissue confirmed penetration of the tracer into tumor tissue. Conclusions: The results of our studies suggest that Affibody-DyLight-750 conjugate is a powerful tool to monitor HER2 status in a preclinical setting. Following clinical validation, it might provide complementary means for assessment of HER2 expression in breast cancer patients (assuming availability of proper NIR scanners) and/or be used to facilitate detection of HER2-positive metastatic lesions during NIR-assisted surgery.	[Zielinski, Rafal; Garcia-Glaessner, Alejandra; Capala, Jacek] NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zielinski, Rafal] John Paul II Catholic Univ Lublin, Dept Mol Biol, Lublin, Poland; [Hassan, Moinuddin; Chernomordik, Victor; Ardeshirpour, Yasaman; Gandjbakhche, Amir] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Analyt & Funct Biophoton, Program Pediat Imaging & Tissue Sci, NIH, Bethesda, MD USA; [Lyakhov, Ilya] NCI, Prot Chem Lab, SAIC Frederick Inc, Frederick, MD 21701 USA; [Lyakhov, Ilya] VARNISS LLC, Frederick, MD USA; [Needle, Danielle] NCI, Ctr Canc Res, Nanobiol Program, Frederick, MD 21701 USA; [Needle, Danielle] NCI, Prot Engn Sect, Macromol Crystallog Lab, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Catholic University of Lublin; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zielinski, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	rjzielinski@mdanderson.org	Capala, Jacek/S-3553-2019	Garcia Glaessner, Alejandra/0000-0002-0766-9917	National Cancer Institute, NIH; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000261] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research is supported by the Intramural Research Program of National Cancer Institute, NIH, and Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison M, 2010, NAT BIOTECHNOL, V28, P117, DOI 10.1038/nbt0210-117; Ardeshirpour Y, 2011, TECHNOL CANCER RES T, V10, P549, DOI 10.1177/153303461101000605; Chernomordik V, 2010, MOL IMAGING, V9, P192, DOI 10.2310/7290.2010.00018; Crawley MJ, 2005, STAT INTRO USING R, P327, DOI DOI 10.1002/9781119941750; Eigenbrot C, 2010, P NATL ACAD SCI USA, V107, P15039, DOI 10.1073/pnas.1005025107; Ekblad T, 2008, EUR J NUCL MED MOL I, V35, P2245, DOI 10.1007/s00259-008-0845-7; Hassan M, 2007, MOL IMAGING, V6, P229, DOI 10.2310/7290.2007.00019; Hassan M, 2012, MOL IMAGING, V11, P177, DOI 10.2310/7290.2011.00038; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hofmann M, 2006, NEOPLASIA, V8, P89, DOI 10.1593/neo.05469; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kramer-Marek G, EUR J NUCL MED MOL I; Kramer-Marek G, 2008, EUR J NUCL MED MOL I, V35, P1008, DOI 10.1007/s00259-007-0658-0; Lee SB, 2008, CLIN CANCER RES, V14, P3840, DOI 10.1158/1078-0432.CCR-07-4076; Lundberg E, 2007, J IMMUNOL METHODS, V319, P53, DOI 10.1016/j.jim.2006.10.013; Lyakhov I, 2010, CHEMBIOCHEM, V11, P345, DOI 10.1002/cbic.200900532; Menard S, 2003, ONCOGENE, V22, P6570, DOI 10.1038/sj.onc.1206779; Meric-Bernstam F, 2006, CLIN CANCER RES, V12, P6326, DOI 10.1158/1078-0432.CCR-06-1732; Nord K, 1997, NAT BIOTECHNOL, V15, P772, DOI 10.1038/nbt0897-772; Nordberg E, 2008, ONCOL REP, V19, P853; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; Orlova A, 2007, CANCER RES, V67, P2178, DOI 10.1158/0008-5472.CAN-06-2887; Puri A, 2008, J LIPOSOME RES, V18, P293, DOI [10.1080/08982100802457377, 10.1080/08982100802457377 ]; Schuetz F, 2011, BREAST CARE, V6, P179, DOI 10.1159/000329336; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smith B, J CONTROL RELEASE, V153, P187; Tolmachev V, 2006, J NUCL MED, V47, P846; Tolmachev V, 2009, J NUCL MED, V50, P274, DOI 10.2967/jnumed.108.055525; Tran T, 2007, BIOCONJUGATE CHEM, V18, P1956, DOI 10.1021/bc7002617; Tran TA, 2009, EUR J NUCL MED MOL I, V36, P1864, DOI 10.1007/s00259-009-1176-z; Urica N, 2008, EGFR HER2 TARGETING, P50; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Zielinski R, 2011, CLIN CANCER RES, V17, P5071, DOI 10.1158/1078-0432.CCR-10-2887; Zielinski R, 2009, J IMMUNOTHER, V32, P817, DOI 10.1097/CJI.0b013e3181ad4d5d	35	17	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41016	10.1371/journal.pone.0041016	http://dx.doi.org/10.1371/journal.pone.0041016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911732	Green Published, Green Submitted, gold			2022-12-27	WOS:000306644600036
J	Fayolle, A; Engelbrecht, B; Freycon, V; Mortier, F; Swaine, M; Rejou-Mechain, M; Doucet, JL; Fauvet, N; Cornu, G; Gourlet-Fleury, S				Fayolle, Adeline; Engelbrecht, Bettina; Freycon, Vincent; Mortier, Frederic; Swaine, Michael; Rejou-Mechain, Maxime; Doucet, Jean-Louis; Fauvet, Nicolas; Cornu, Guillaume; Gourlet-Fleury, Sylvie			Geological Substrates Shape Tree Species and Trait Distributions in African Moist Forests	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; HABITAT ASSOCIATIONS; FUNCTIONAL TRAITS; PATTERNS; SPECIALIZATION; CONVERGENCE; PERFORMANCE; ENVIRONMENT; DIVERSITY; SEEDLINGS	Background: Understanding the factors that shape the distribution of tropical tree species at large scales is a central issue in ecology, conservation and forest management. The aims of this study were to (i) assess the importance of environmental factors relative to historical factors for tree species distributions in the semi-evergreen forests of the northern Congo basin; and to (ii) identify potential mechanisms explaining distribution patterns through a trait-based approach. Methodology/Principal Findings: We analyzed the distribution patterns of 31 common tree species in an area of more than 700,000 km(2) spanning the borders of Cameroon, the Central African Republic, and the Republic of Congo using forest inventory data from 56,445 0.5-ha plots. Spatial variation of environmental (climate, topography and geology) and historical factors (human disturbance) were quantified from maps and satellite records. Four key functional traits (leaf phenology, shade tolerance, wood density, and maximum growth rate) were extracted from the literature. The geological substrate was of major importance for the distribution of the focal species, while climate and past human disturbances had a significant but lesser impact. Species distribution patterns were significantly related to functional traits. Species associated with sandy soils typical of sandstone and alluvium were characterized by slow growth rates, shade tolerance, evergreen leaves, and high wood density, traits allowing persistence on resource-poor soils. In contrast, fast-growing pioneer species rarely occurred on sandy soils, except for Lophira alata. Conclusions/Significance: The results indicate strong environmental filtering due to differential soil resource availability across geological substrates. Additionally, long-term human disturbances in resource-rich areas may have accentuated the observed patterns of species and trait distributions. Trait differences across geological substrates imply pronounced differences in population and ecosystem processes, and call for different conservation and management strategies.	[Fayolle, Adeline; Freycon, Vincent; Mortier, Frederic; Fauvet, Nicolas; Cornu, Guillaume; Gourlet-Fleury, Sylvie] Ctr Cooperat Int Rech Agron Dev CIRAD, UPR Biens & Serv Ecosyst Forestiers Tropicaux BSE, Montpellier, France; [Fayolle, Adeline; Doucet, Jean-Louis] Univ Liege ULg, Gembloux Agrobio Tech GxABT, Unite Gest Ressources Forestieres & Milieux Nat G, Lab Foresterie Reg Trop & Subtrop FORTHOP, Gembloux, Belgium; [Engelbrecht, Bettina] Univ Bayreuth, Dept Plant Ecol, Bayreuth Ctr Ecol & Environm Res BayCEER, Bayreuth, Germany; [Engelbrecht, Bettina] Smithsonian Trop Res Inst STRI, Balboa, Ancon, Panama; [Swaine, Michael] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Rejou-Mechain, Maxime] Univ Toulouse 3, CNRS, Lab Evolut & Divers Biol, F-31062 Toulouse, France	CIRAD; University of Bayreuth; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Aberdeen; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Fayolle, A (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, UPR Biens & Serv Ecosyst Forestiers Tropicaux BSE, Montpellier, France.	adeline.fayolle@ulg.ac.be	Cornu, Guillaume/C-1607-2014	Cornu, Guillaume/0000-0002-7523-5176; FAYOLLE, Adeline/0000-0002-6770-0031; Mortier, Frederic/0000-0001-5473-709X; Rejou-Mechain, Maxime/0000-0003-2824-267X	National Research Agency (ANR); Natural Environment Research Council (NERC)	National Research Agency (ANR)(French National Research Agency (ANR)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study is part of the ErA Net BiodivERsA CoForChange project, funded by the National Research Agency (ANR) and the Natural Environment Research Council (NERC), involving 16 European, African and international partners and a number of timber companies (see list on the website, http://www.coforchange.eu). AF was supported by ANR funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; Anderson D. R., 2008, MODEL BASED INFERENC; Arbelaez MV, 2004, J VEG SCI, V15, P181, DOI 10.1111/j.1654-1103.2004.tb02253.x; Aubreville A., 1959, FLORE FORESTIERE COT; Bivand R., 2020, SPDEP SPATIAL DEPEND; Bongers F, 1999, J VEG SCI, V10, P371, DOI 10.2307/3237066; Brncic TM, 2007, PHILOS T R SOC B, V362, P229, DOI 10.1098/rstb.2006.1982; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; CLARK DA, 1995, ECOLOGY, V76, P2581, DOI 10.2307/2265829; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Couteron P, 2003, FOREST ECOL MANAG, V172, P89, DOI 10.1016/S0378-1127(02)00310-9; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DUIVENVOORDEN JF, 1995, VEGETATIO, V120, P91, DOI 10.1007/BF00034341; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Furrer R., 2012, FIELDS TOOLS SPATIAL; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; Gourlet-Fleury S, 2011, J ECOL, V99, P981, DOI 10.1111/j.1365-2745.2011.01829.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Hall JS, 2004, ECOLOGY, V85, P2171, DOI 10.1890/03-0043; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hawthorne W.D., 1995, ECOLOGICAL PROFILES; HILL MO, 1974, ROY STAT SOC C-APP, V23, P340; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Lebrun J., 1954, CLASSIFICATION ECOLO; Lebrun J.-P, 1991, ENUMERATION PLANTES; Maharjan SK, 2011, BIOTROPICA, V43, P552, DOI 10.1111/j.1744-7429.2010.00747.x; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; Palmiotto PA, 2004, J ECOL, V92, P609, DOI 10.1111/j.0022-0477.2004.00894.x; PHILLIPS OL, 1994, P NATL ACAD SCI USA, V91, P2805, DOI 10.1073/pnas.91.7.2805; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Pyke CR, 2001, J VEG SCI, V12, P553, DOI 10.2307/3237007; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Rejou-Mechain M, 2008, J TROP ECOL, V24, P663, DOI 10.1017/S0266467408005506; Rejou-Mechain M, 2011, FOREST ECOL MANAG, V261, P187, DOI 10.1016/j.foreco.2010.10.003; Russo SE, 2008, J ECOL, V96, P192, DOI 10.1111/j.1365-2745.2007.01330.x; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Swaine MD, 1996, J ECOL, V84, P419, DOI 10.2307/2261203; Ter Steege H, 2001, ECOLOGY, V82, P3197, DOI 10.1890/0012-9658(2001)082[3197:CCDADI]2.0.CO;2; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Tuomisto H, 2003, ECOL APPL, V13, P352, DOI 10.1890/1051-0761(2003)013[0352:LFPWSH]2.0.CO;2; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Veenendaal EM, 1996, FUNCT ECOL, V10, P501, DOI 10.2307/2389943; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Walters MB, 1996, ECOLOGY, V77, P841, DOI 10.2307/2265505; Webb CO, 2000, J ECOL, V88, P464, DOI 10.1046/j.1365-2745.2000.00462.x; Willis KJ, 2004, SCIENCE, V304, P402, DOI 10.1126/science.1093991; Wright IJ, 2001, OECOLOGIA, V127, P21, DOI 10.1007/s004420000554; Wright S Joseph, 2010, Ecology, V91, P3664, DOI 10.1890/09-2335.1	65	66	67	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42381	10.1371/journal.pone.0042381	http://dx.doi.org/10.1371/journal.pone.0042381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905127	Green Published, gold			2022-12-27	WOS:000307823600012
J	Gu, LL; Musiienko, V; Bai, ZJ; Qin, AJ; Schneller, SW; Li, QJ				Gu, Linlin; Musiienko, Volodymyr; Bai, Zhijun; Qin, Aijian; Schneller, Stewart W.; Li, Qianjun			Novel Virostatic Agents against Bluetongue Virus	PLOS ONE			English	Article							SEROTYPE 8; INFECTIOUS-DISEASES; MEDITERRANEAN BASIN; MAMMALIAN-CELLS; AUTOPHAGY; REPLICATION; APOPTOSIS; MACHINERY; PROTEINS; EUROPE	Bluetongue virus (BTV), a member in the family Reoviridae, is a re-emerging animal disease infecting cattle and sheep. With its recent outbreaks in Europe, there is a pressing need for efficacious antivirals. We presented here the identification and characterization of a novel virostatic molecule against BTV, an aminothiophenecarboxylic acid derivative named compound 003 (C003). The virostatic efficacy of C003 could be improved via chemical modification, leading to a de novo synthesized compound 052 (C052). The 50% effective concentrations (EC50) of C003 and C052 were determined at 1.76 +/- 0.73 mu M and 0.27 +/- 0.12 mu M, respectively. The 50% cytotoxicity concentration (CC50) of C003 was over 100 mu M and the CC50 of C052 was at 82.69 mu M. Accordingly, the 50% selective index (SI50) of C003 and C052 against BTV was over 57 and 306, respectively. The inhibitory effect of C003/C052 on BTV-induced apoptosis was also confirmed via the inhibition of caspase-3/-7 activation post BTV infection. C003/C052 could inhibit BTV induced CPE even when added as late as 24 h.p.i., indicating that they might act at late stage of viral life-cycle. C003/C052 could reduce over two-logs of both the progeny virus production and the number of genomic viral RNA copies. Interestingly, both the activation of host autophagy and viral protein expression were inhibited post BTV infection when cells were treated with C003 and C052, suggesting that C003/C052 might act as virostatic agents via inhibiting host autophagy activation. Although further investigations might be needed to pin down the exact mechanism of C003/C052, our finding suggested that these compounds might be potent lead compounds with potential novel mechanism of action against BTV.	[Gu, Linlin; Qin, Aijian] Yangzhou Univ, Jiangsu Key Lab Prevent Vet Med, Yangzhou, Peoples R China; [Gu, Linlin; Bai, Zhijun; Li, Qianjun] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Musiienko, Volodymyr; Schneller, Stewart W.] Auburn Univ, Dept Chem & Biochem, Molette Lab Drug Discovery, Auburn, AL 36849 USA; [Bai, Zhijun] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China	Yangzhou University; University of Alabama System; University of Alabama Birmingham; Auburn University System; Auburn University	Gu, LL (corresponding author), Yangzhou Univ, Jiangsu Key Lab Prevent Vet Med, Yangzhou, Peoples R China.	liq@uab.edu			NIH [1R03MH08127-01, 7R03MH08127-02]; IMPACT funds from Department of Medicine at University of Alabama	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IMPACT funds from Department of Medicine at University of Alabama	This project was supported by grant 1R03MH08127-01 and 7R03MH08127-02 from NIH to Q. Li, and by the IMPACT funds from Department of Medicine at University of Alabama to Q. Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartram DJ, 2011, VET J; Berkova Z, 2006, J VIROL, V80, P6061, DOI 10.1128/JVI.02167-05; Bhanuprakash V, 2009, EXPERT REV VACCINES, V8, P191, DOI 10.1586/14760584.8.2.191; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Boyce M, 2007, J VIROL, V81, P2179, DOI 10.1128/JVI.01819-06; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Celma CCP, 2009, J VIROL, V83, P6806, DOI 10.1128/JVI.00263-09; Cherra SJ, 2010, NEUROPATH APPL NEURO, V36, P125, DOI [10.1111/j.1365-2990.2009.01062.x, 10.1111/j.1365-2990.2010.01062.x]; Clarke TE, 2003, INT REV IMMUNOL, V22, P401, DOI 10.1080/08830180305215; De A, 2009, VET ITAL, V45, P339; Dreux M, CELL CYCLE, V9, P1295; Dreux M, 2009, AUTOPHAGY, V5, P1224, DOI 10.4161/auto.5.8.10219; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Dungu B, 2004, DEV BIOLOGICALS, V119, P463; El-Batta A, 2007, J ORG CHEM, V72, P5244, DOI 10.1021/jo070665k; Enserink M, 2006, SCIENCE, V313, P1218; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Fimia GM, 2009, CELL DEATH DIFFER, V16, P933, DOI 10.1038/cdd.2009.47; Forzan M, 2007, J VIROL, V81, P4819, DOI 10.1128/JVI.02284-06; Gougeon ML, 2009, APOPTOSIS, V14, P501, DOI 10.1007/s10495-009-0314-1; Hamers C, 2009, VET REC, V165, P369, DOI 10.1136/vr.165.13.369; Harty RN, 2009, ANTIVIR RES, V81, P189, DOI 10.1016/j.antiviral.2008.12.003; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Hyser JM, J VIROL, V86, P4921; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jonsson CB, 2007, EUROPEAN PHARM REV, P4; Kar AK, 2003, J VIROL, V77, P11347, DOI 10.1128/JVI.77.21.11347-11356.2003; Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0; Koyama A. Hajime, 1998, Journal of Medical Investigation, V45, P37; Landry ML, 2000, ANTIMICROB AGENTS CH, V44, P688, DOI 10.1128/AAC.44.3.688-692.2000; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Law AHY, 2010, CELL MOL IMMUNOL, V7, P263, DOI 10.1038/cmi.2010.25; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Li Q, 2007, INSECT MOL BIOL, V16, P93, DOI 10.1111/j.1365-2583.2007.00705.x; Li QJ, 2009, ANTIVIR RES, V83, P267, DOI 10.1016/j.antiviral.2009.06.004; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; MacLachlan NJ, 2000, ANIM REPROD SCI, V60, P643, DOI 10.1016/S0378-4320(00)00105-6; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; Mehlhorn H, 2008, PARASITOL RES, V103, pS79, DOI 10.1007/s00436-008-1100-7; Mehlhorn H, 2009, PARASITOL RES, V105, P313, DOI 10.1007/s00436-009-1416-y; Meiswinkel R, 2008, PREV VET MED, V87, P182, DOI 10.1016/j.prevetmed.2008.06.008; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Meroc E, 2009, TRANSBOUND EMERG DIS, V56, P39, DOI 10.1111/j.1865-1682.2008.01063.x; Mertens P P C, 2004, Vet Ital, V40, P426; MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7; Mortola E, 2004, J VIROL, V78, P2875, DOI 10.1128/JVI.78.6.2875-2883.2004; Mortola E, 2009, REV ARGENT MICROBIOL, V41, P134; Nagaleekar VK, 2007, ARCH VIROL, V152, P1751, DOI 10.1007/s00705-007-0988-z; Noah JW, 2007, ANTIVIR RES, V73, P50, DOI 10.1016/j.antiviral.2006.07.006; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; Paweska JT, 2002, MED VET ENTOMOL, V16, P10, DOI 10.1046/j.1365-2915.2002.00334.x; Phillips T, 2011, J VIROL METHODS, V173, P182, DOI 10.1016/j.jviromet.2011.02.002; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Rossman JS, 2009, CELL HOST MICROBE, V6, P299, DOI 10.1016/j.chom.2009.09.009; Roy P, 2006, CURR TOP MICROBIOL, V309, P87; Roy P, 2005, ADV VIRUS RES, V64, P69, DOI 10.1016/S0065-3527(05)64004-3; Roy P, 2008, J GEN VIROL, V89, P1789, DOI 10.1099/vir.0.2008/002089-0; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; Sabnis RW, 1999, J HETEROCYCLIC CHEM, V36, P333, DOI 10.1002/jhet.5570360203; Saegerman C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009405; Santman-Berends IMGA, 2010, THERIOGENOLOGY, V74, P1377, DOI 10.1016/j.theriogenology.2010.06.008; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Singletary K, 2008, CANCER EPIDEM BIOMAR, V17, P1596, DOI 10.1158/1055-9965.EPI-07-2917; Stauber N, 1997, J VIROL, V71, P7220; Stewart ME, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-362; Szmaragd C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009353; Touchard FP, 2004, TETRAHEDRON LETT, V45, P5519, DOI 10.1016/j.tetlet.2004.05.026; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Vandenbussche F, 2009, TRANSBOUND EMERG DIS, V56, P346, DOI 10.1111/j.1865-1682.2009.01093.x; Wackerlin R, 2010, VACCINE; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Worwa G, 2008, SCHWEIZ ARCH TIERH, V150, P491, DOI 10.1024/0036-7281.150.10.491; Worwa G, 2010, VET MICROBIOL; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	79	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43341	10.1371/journal.pone.0043341	http://dx.doi.org/10.1371/journal.pone.0043341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905259	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600070
J	Wang, LL; Wang, LL; Zhang, H; Zhou, Z; Siva, VS; Song, LS				Wang, Leilei; Wang, Lingling; Zhang, Huan; Zhou, Zhi; Siva, Vinu S.; Song, Linsheng			A C1q Domain Containing Protein from Scallop Chlamys farreri Serving as Pattern Recognition Receptor with Heat-Aggregated IgG Binding Activity	PLOS ONE			English	Article							C-TYPE LECTIN; CLASSICAL COMPLEMENT PATHWAY; OYSTER CRASSOSTREA-GIGAS; IMMUNE GENE REPERTOIRE; GLOBULAR HEAD; B-CHAIN; C1Q-DOMAIN-CONTAINING PROTEIN; INNATE IMMUNITY; HUMAN-MONOCYTES; A-CHAINS	Background: The C1q domain containing (C1qDC) proteins refer to a family of all proteins that contain the globular C1q (gC1q) domain, and participate in a series of immune responses depending on their gC1q domains to bind a variety of self and non-self binding ligands. Methodology: In the present study, the mRNA expression patterns, localization, and activities of a C1qDC protein from scallop Chlamys farreri (CfC1qDC) were investigated to understand its possible functions in innate immunity. The relative expression levels of CfC1qDC mRNA in hemocytes were all significantly up-regulated after four typical PAMPs (LPS, PGN, beta-glucan and polyl:C) stimulation. During the embryonic development of scallop, the mRNA transcripts of CfC1qDC were detected in all the stages, and the expression level was up-regulated from D-hinged larva and reached the highest at eyespot larva. The endogenous CfC1qDC was dominantly located in the hepatopancreas, gill, kidney and gonad of adult scallop through immunofluorescence. The recombinant protein of CfC1qDC (rCfC1qDC) could not only bind various PAMPs, such as LPS, PGN, beta-glucan as well as polyl: C, but also enhance the phagocytic activity of scallop hemocytes towards Escherichia coli. Meanwhile, rCfC1qDC could interact with human heat-aggregated IgG, and this interaction could be inhibited by LPS. Conclusions: All these results indicated that CfC1qDC in C. farreri not only served as a PRR involved in the PAMPs recognition, but also an opsonin participating in the clearance of invaders in innate immunity. Moreover, the ability of CfC1qDC to interact with immunoglobulins provided a clue to understand the evolution of classical pathway in complement system.	[Wang, Leilei; Wang, Lingling; Zhang, Huan; Zhou, Zhi; Siva, Vinu S.; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wang, Leilei; Siva, Vinu S.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, LL (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@qdio.ac.cn; wanglingling@qdio.ac.cn; lshsong@ms.qdio.ac.cn	zhi, zhouzhi/J-8063-2013		National Natural Science Foundation of China (NSFC) [30925028, 40806064]; 973 program [2010CB126404]; Shandong Provincial Natural Science Foundation [JQ201110]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-QN206]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This research was supported by grants (Nos. 30925028 and 40806064) from the National Natural Science Foundation of China (NSFC) (http://www.nsfc.gov.cn/), the 973 program (No. 2010CB126404) (http://www.973.gov.cn/), the Shandong Provincial Natural Science Foundation (No. JQ201110) (http://www.sdnsf. gov.cn/), and the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KZCX2-YW-QN206) (http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema CM, 2010, MOL IMMUNOL, V47, P849, DOI 10.1016/j.molimm.2009.10.019; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BOBAK DA, 1987, J IMMUNOL, V138, P1150; BOBAK DA, 1988, J IMMUNOL, V141, P592; Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014; Cheng SF, 2006, J VIROL METHODS, V135, P173, DOI 10.1016/j.jviromet.2006.03.016; Dodds AW, 2007, IMMUNOBIOLOGY, V212, P233, DOI 10.1016/j.imbio.2006.11.009; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Gerdol M, 2011, DEV COMP IMMUNOLOGY; Gestal C, 2010, DEV COMP IMMUNOL, V34, P926, DOI 10.1016/j.dci.2010.02.012; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kishore U, 2003, J IMMUNOL, V171, P812, DOI 10.4049/jimmunol.171.2.812; Kishore U, 2001, J IMMUNOL, V166, P559, DOI 10.4049/jimmunol.166.1.559; Kishore U, 1998, BIOCHEM J, V333, P27, DOI 10.1042/bj3330027; Kishore W, 2004, IMMUNOL LETT, V95, P113, DOI 10.1016/j.imlet.2004.06.015; Kojouharova MS, 2004, J IMMUNOL, V172, P4351, DOI 10.4049/jimmunol.172.7.4351; Kojouharova MS, 2003, BBA-PROTEINS PROTEOM, V1652, P64, DOI 10.1016/j.bbapap.2003.08.003; Kong PF, 2010, DEV COMP IMMUNOL, V34, P837, DOI 10.1016/j.dci.2010.03.006; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; Matsushita M, 2004, P NATL ACAD SCI USA, V101, P10127, DOI 10.1073/pnas.0402180101; Nepomuceno RR, 1997, IMMUNITY, V6, P119, DOI 10.1016/S1074-7613(00)80419-7; OSTREIKO KK, 1987, IMMUNOL LETT, V15, P311, DOI 10.1016/0165-2478(87)90134-9; Perrigault M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-377; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P72, DOI 10.1016/j.fsi.2008.03.002; SELLAR GC, 1991, BIOCHEM J, V274, P481, DOI 10.1042/bj2740481; Sjowall C, 2007, BIOCHEM BIOPH RES CO, V352, P251, DOI 10.1016/j.bbrc.2006.11.013; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Tahtouh M, 2009, MOL IMMUNOL, V46, P523, DOI 10.1016/j.molimm.2008.07.026; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; Taris N, 2009, ANIM GENET, V40, P663, DOI 10.1111/j.1365-2052.2009.01894.x; Tirape A, 2007, DEV COMP IMMUNOL, V31, P859, DOI 10.1016/j.dci.2007.01.005; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Wang L, 2011, DEV COMP IMMUNOLOGY; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P195, DOI 10.1016/S1050-4648(02)00161-4; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Yang JL, 2010, DEV COMP IMMUNOL, V34, P1274, DOI 10.1016/j.dci.2010.07.004; Yu YH, 2008, J IMMUNOL, V181, P7024, DOI 10.4049/jimmunol.181.10.7024; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zhang H, 2008, FISH SHELLFISH IMMUN, V25, P281, DOI 10.1016/j.fsi.2008.06.003; Zhang HA, 2011, FISH SHELLFISH IMMUN, V30, P17, DOI 10.1016/j.fsi.2009.12.019; Zhang H, 2009, DEV COMP IMMUNOL, V33, P780, DOI 10.1016/j.dci.2009.01.003; Zhou Z, 2012, FISH SHELLFISH IMMUN, V33, P67, DOI 10.1016/j.fsi.2012.04.002	50	14	19	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43289	10.1371/journal.pone.0043289	http://dx.doi.org/10.1371/journal.pone.0043289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905248	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600064
J	Baldan, R; Testa, F; Lore, NI; Bragonzi, A; Cichero, P; Ossi, C; Biancardi, A; Nizzero, P; Moro, M; Cirillo, DM				Baldan, Rossella; Testa, Francesca; Lore, Nicola I.; Bragonzi, Alessandra; Cichero, Paola; Ossi, Cristina; Biancardi, Anna; Nizzero, Paola; Moro, Matteo; Cirillo, Daniela M.			Factors Contributing to Epidemic MRSA Clones Replacement in a Hospital Setting	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SURVEILLANCE; INFECTION; VIRULENCE; CELLS; EVOLUTION; BIOFILM; FITNESS; PERIOD; TOXIN	The mechanisms governing the epidemiology dynamics and success determinants of a specific healthcare-associated methicillin-resistant S. aureus (HA-MRSA) clone in hospital settings are still unclear. Important epidemiological changes have occurred in Europe since 2000 that have been related to the appearance of the ST22-IV clone. Between 2006 and 2010, we observed the establishment of the ST22-IV clone displacing the predominant Italian clone, ST228-I, in a large Italian university hospital. To investigate the factors associated with a successful spread of epidemic MRSA clones we studied the biofilm production, the competitive behavior in co-culture, the capacity of invasion of the A549 cells, and the susceptibility to infection in a murine model of acute pneumonia of the two major HA-MRSA clones, ST22-IV and ST228-I. We showed that persistence of ST22-IV is associated with its increased biofilm production and capacity to inhibit the growth of ST228-I in co-culture. Compared to ST228-I, ST22-IV had a significantly higher capacity to invade the A549 cells and a higher virulence in a murine model of acute lung infection causing severe inflammation and determining death in all the mice within 60 hours. On the contrary, ST228-I was associated with mice survival and clearance of the infection. ST22-IV, compared with ST228-I, caused a higher number of persistent, long lasting bacteremia. These data suggest that ST22-IV could have exploited its capacity to i) increase its biofilm production over time, ii) maintain its growth kinetics in the presence of a competitor and iii) be particularly invasive and virulent both in vitro and in vivo, to replace other well-established MRSA clones, becoming the predominant European clone.	[Baldan, Rossella; Testa, Francesca; Cirillo, Daniela M.] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Lore, Nicola I.; Bragonzi, Alessandra] Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy; [Cichero, Paola; Ossi, Cristina] Laboraf Diagnost & Res San Raffaele, Milan, Italy; [Biancardi, Anna; Nizzero, Paola; Moro, Matteo] Ist Sci San Raffaele, Chief Med Off, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Baldan, R (corresponding author), Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy.	cirillo.daniela@hsr.it	Cirillo, Daniela Maria/AAB-3646-2019; Lorè, Nicola Ivan/K-9285-2016; Bragonzi, Alessandra/AAC-6751-2022	Cirillo, Daniela Maria/0000-0001-6415-1535; Lorè, Nicola Ivan/0000-0001-9159-1632; moro, matteo/0000-0001-5398-6000; Bragonzi, Alessandra/0000-0002-5808-7669; Baldan, Rossella/0000-0002-4674-4326	Fondazione per la ricerca sulla Fibrosi Cistica [FFC 9/2010]	Fondazione per la ricerca sulla Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This study was supported to DMC and A. Bragonzi by Fondazione per la ricerca sulla Fibrosi Cistica (project FFC#9/2010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Amaral MM, 2005, J INFECT DIS, V192, P801, DOI 10.1086/432515; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; CAMPANILE F, 2009, ANN CLIN MICROB ANTI, V24, P8; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; DEMARIA TF, 1978, INFECT IMMUN, V21, P114, DOI 10.1128/IAI.21.1.114-123.1978; Denis O, 2004, ANTIMICROB AGENTS CH, V48, P3625, DOI 10.1128/AAC.48.9.3625-3629.2004; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Giese B, 2011, CELL MICROBIOL, V13, P316, DOI 10.1111/j.1462-5822.2010.01538.x; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Laurent F, 2001, J ANTIMICROB CHEMOTH, V47, P277, DOI 10.1093/jac/47.3.277; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Matthews TD, 2010, J BACTERIOL, V192, P6086, DOI 10.1128/JB.00649-10; Melter O, 2006, EUROSURVEILLANCE, V11; Moore CL, 2009, INT J ANTIMICROB AG, V34, P148, DOI 10.1016/j.ijantimicag.2009.03.004; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Perez-Roth E, 2004, J CLIN MICROBIOL, V42, P4649, DOI 10.1128/JCM.42.10.4649-4656.2004; Rubinstein E, 2008, CLIN INFECT DIS, V46, pS378, DOI 10.1086/533594; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000; Skov RL, 2009, J HOSP INFECT, V73, P364, DOI 10.1016/j.jhin.2009.07.004; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Strommenger B, 2004, EUR J CLIN MICROBIOL, V23, P15, DOI 10.1007/s10096-003-1046-8; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672	36	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43153	10.1371/journal.pone.0043153	http://dx.doi.org/10.1371/journal.pone.0043153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905220	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800052
J	Canale, GR; Peres, CA; Guidorizzi, CE; Gatto, CAF; Kierulff, MCM				Canale, Gustavo R.; Peres, Carlos A.; Guidorizzi, Carlos E.; Ferreira Gatto, Cassiano A.; Kierulff, Maria Cecilia M.			Pervasive Defaunation of Forest Remnants in a Tropical Biodiversity Hotspot	PLOS ONE			English	Article							BRAZILIAN ATLANTIC FOREST; AREA RELATIONSHIPS; PATCH SIZE; CONSERVATION; LANDSCAPE; FRAGMENTATION; EXTINCTIONS; ABUNDANCE; PROSPECTS	Tropical deforestation and forest fragmentation are among the most important biodiversity conservation issues worldwide, yet local extinctions of millions of animal and plant populations stranded in unprotected forest remnants remain poorly explained. Here, we report unprecedented rates of local extinctions of medium to large-bodied mammals in one of the world's most important tropical biodiversity hotspots. We scrutinized 8,846 person-years of local knowledge to derive patch occupancy data for 18 mammal species within 196 forest patches across a 252,669-km(2) study region of the Brazilian Atlantic Forest. We uncovered a staggering rate of local extinctions in the mammal fauna, with only 767 from a possible 3,528 populations still persisting. On average, forest patches retained 3.9 out of 18 potential species occupancies, and geographic ranges had contracted to 0-14.4% of their former distributions, including five large-bodied species that had been extirpated at a regional scale. Forest fragments were highly accessible to hunters and exposed to edge effects and fires, thereby severely diminishing the predictive power of species-area relationships, with the power model explaining only similar to 9% of the variation in species richness per patch. Hence, conventional species-area curves provided over-optimistic estimates of species persistence in that most forest fragments had lost species at a much faster rate than predicted by habitat loss alone.	[Canale, Gustavo R.] Univ Cambridge, Sch Anat, Wildlife Res Grp, Cambridge, England; [Canale, Gustavo R.] Univ Estado Mato Grosso UNEMAT, Dept Biol, Tangara Da Serra, Mato Grosso, Brazil; [Peres, Carlos A.] Univ E Anglia, Sch Environm Sci, Ctr Biodivers Res, Norwich NR4 7TJ, Norfolk, England; [Guidorizzi, Carlos E.] Brazilian Minist Environm ICMBIO, Inst Chico Mendes, Brasilia, DF, Brazil; [Ferreira Gatto, Cassiano A.] Inst Nacl Pesquisa Amazonia INPA, Manaus, Amazonas, Brazil; [Kierulff, Maria Cecilia M.] Inst Primatas Conservacao Biodiversidade, Belo Horizonte, MG, Brazil	University of Cambridge; Universidade do Estado de Mato Grosso; University of East Anglia; Institute Nacional de Pesquisas da Amazonia	Canale, GR (corresponding author), Univ Cambridge, Sch Anat, Wildlife Res Grp, Cambridge, England.	g.canale@cantab.net	Guidorizzi, Carlos Eduardo/AAG-2086-2020; Gatto, Cassiano/AAH-3409-2021; Peres, Carlos A./ABE-8361-2020; Peres, Carlos Augusto/N-8275-2019; Peres, Carlos A./B-1276-2013	Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765; Canale, Gustavo/0000-0002-3932-282X	Brazilian Ministry of Education/CAPES; Brazilian Ministry of Environment (PROBIO); Brazilian Ministry of Education (CAPES)	Brazilian Ministry of Education/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Ministry of Environment (PROBIO); Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank Brazilian Ministry of Environment/Probio for supporting fieldwork and Brazilian Ministry of Education/CAPES for PhD studentship of G. Canale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Brazilian Ministry of Environment (PROBIO) for funding the fieldwork, the Instituto de Estudos Socioambientais do Sul da Bahia (especially Gabriel Santos, Paulo Vila Nova and Alexandre Coelho) for logistical support; Leticia Castro for helping with data entry; and the Brazilian Ministry of Education (CAPES) for funding GRC's PhD studentship.	Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Brooks T, 1999, ANIM CONSERV, V2, P211, DOI 10.1111/j.1469-1795.1999.tb00067.x; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Cassano CR, 2009, BIODIVERS CONSERV, V18, P577, DOI 10.1007/s10531-008-9526-x; da Silva AP, 2008, BIODIVERS CONSERV, V17, P1455, DOI 10.1007/s10531-008-9353-0; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; Dean Warren, 1995, BROADAX FIREBRAND DE; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Galetti M, 2009, BIOL CONSERV, V142, P1229, DOI 10.1016/j.biocon.2009.01.023; Galindo-Leal C, 2003, STATE HOTS, P3; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gonzalez A, 2000, ECOL LETT, V3, P441, DOI 10.1046/j.1461-0248.2000.00171.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Laurance WF, 2001, CONSERV BIOL, V15, P1488, DOI 10.1046/j.1523-1739.2001.01088.x; MA, 2005, ECOSYSTEMS HUMAN WEL; Mendonca JR, 1993, HIST LAND CLEARING S; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; Michalski F, 2007, CONSERV BIOL, V21, P1626, DOI 10.1111/j.1523-1739.2007.00797.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Norris D, 2008, MAMMALIA, V72, P15, DOI 10.1515/MAMM.2008.002; Norris D, 2010, J MAMMAL, V91, P551, DOI 10.1644/09-MAMM-A-199.1; Paglia AP, 2004, C BRAS UN CONS FUND, P39; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; Peres Carlos A., 2006, P105; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; STRIER KB, 1989, FOLIA PRIMATOL, V52, P70, DOI 10.1159/000156383; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z	33	159	166	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e41671	10.1371/journal.pone.0041671	http://dx.doi.org/10.1371/journal.pone.0041671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905103	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800006
J	Liu, JX; Ding, DP; Wang, XX; Chen, YZ; Li, R; Zhang, Y; Luo, RC				Liu, Jinxin; Ding, Dapeng; Wang, Xiaoxue; Chen, Yizhi; Li, Rong; Zhang, Ying; Luo, Rongcheng			N-Acetyltransferase Polymorphism and Risk of Colorectal Adenoma and Cancer: A Pooled Analysis of Variations from 59 Studies	PLOS ONE			English	Article							CARCINOGEN-METABOLIZING ENZYMES; RED MEAT INTAKE; GENETIC SUSCEPTIBILITY; HETEROCYCLIC AMINES; NAT2 POLYMORPHISMS; CIGARETTE-SMOKING; POLYADENYLATION POLYMORPHISM; ACETYLATOR STATUS; TOBACCO-SMOKE; COLON-CANCER	Background: There have been an increasing number of studies with evidence suggesting that the N-acetyltransferase 1 (NAT1) and N-acetyltransferase 2 (NAT2) genotypes may be implicated in the development of colorectal cancer (CRC) and colorectal adenoma (CRA). So far the published data on this association has remained controversial, however. We performed a meta-analysis of case-cohort and case-control studies using a subset of the published data, with an aim to derive a better understanding of the underlying relationship. Methods/Principal Findings: A literature search was performed using Medline database for relevant studies published through October 31, 2011. A total of 39 publications were selected for this meta-analysis, including 11,724 cases and 16,215 controls for CRC, and 3,701 cases and 5,149 controls for CRA. In our pooled analysis of all these studies, the results of our meta-analysis suggested that the NAT1 genotype was not significantly associated with an elevated CRC risk (OR 0.99, 95% CI 0.91-1.07). We also found that individuals with the rapid NAT2 genotype did have an elevated risk of CRC (OR 1.07, 95% CI 1.01-1.13). There was no evidence for an association between the NAT1 and 2 rapid genotype and an elevated CRA risk (NAT1: OR 1.14, 95% CI 0.99-1.29; NAT2: OR 0.94, 95% CI 0.86-1.03). Conclusion: This meta-analysis suggests that individuals with NAT2 genotype had an elevated risk of CRC. There was no evidence for the association between NAT1 and 2 rapid genotype and CRA risk.	[Liu, Jinxin; Li, Rong; Luo, Rongcheng] So Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Liu, Jinxin] Longgang Dist Cent Hosp ShenZhen, Dept Oncol, Shenzhen, Peoples R China; [Ding, Dapeng] So Med Univ, Inst Genet Engn, Guangzhou, Guangdong, Peoples R China; [Wang, Xiaoxue] Sun Yat Sen Univ, Dept Proctol, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yizhi] Longgang Dist Cent Hosp ShenZhen, Dept Hlth Records, Shenzhen, Peoples R China; [Zhang, Ying] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Sun Yat Sen University; Jinan University	Liu, JX (corresponding author), So Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China.	ebmmedicine@gmail.com; luorc01@163.com			Guangdong Natural Science Foundation [S2011040003028]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by Guangdong Natural Science Foundation (Grant No. S2011040003028). The funder conceived and designed the experiments, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2000, SCAND J GASTROENTERO, V35, P1087; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Barrett JH, 2003, CARCINOGENESIS, V24, P275, DOI 10.1093/carcin/24.2.275; BELL DA, 1995, CANCER RES, V55, P3537; Borlak J, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-58; Brockton N, 2000, AM J EPIDEMIOL, V151, P846; Butler LM, 2008, MUTAT RES-FUND MOL M, V638, P162, DOI 10.1016/j.mrfmmm.2007.10.002; Chan AT, 2005, INT J CANCER, V115, P648, DOI 10.1002/ijc.20890; Chen J, 1998, CANCER RES, V58, P3307; Chen Kun, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P659; Cleary SP, 2010, AM J EPIDEMIOL, V172, P1000, DOI 10.1093/aje/kwq245; Cotterchio M, 2008, CANCER EPIDEM BIOMAR, V17, P3098, DOI 10.1158/1055-9965.EPI-08-0341; da Silva TD, 2011, WORLD J GASTROENTERO, V17, P760, DOI 10.3748/wjg.v17.i6.760; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Gil JP, 1998, CARCINOGENESIS, V19, P37, DOI 10.1093/carcin/19.1.37; He LJ, 2005, WORLD J GASTROENTERO, V11, P4268; Hirvonen A, 1999, IARC Sci Publ, P251; Huang CC, 2007, DIS COLON RECTUM, V50, P981, DOI 10.1007/s10350-007-0230-9; Hubbard AL, 1998, BRIT J CANCER, V77, P913, DOI 10.1038/bjc.1998.151; Ishibe N, 2002, PHARMACOGENETICS, V12, P145, DOI 10.1097/00008571-200203000-00008; Kampman E, 1999, CANCER EPIDEM BIOMAR, V8, P15; Katoh T, 2000, INT J CANCER, V85, P46, DOI 10.1002/(SICI)1097-0215(20000101)85:1<46::AID-IJC8>3.0.CO;2-0; Kiss I, 2004, ANTICANCER RES, V24, P3965; Lamberti C, 2002, PHARMACOGENETICS, V12, P49, DOI 10.1097/00008571-200201000-00007; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Lee EJD, 1998, PHARMACOGENETICS, V8, P513, DOI 10.1097/00008571-199812000-00008; LeMarchand L, 1996, CANCER EPIDEM BIOMAR, V5, P449; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lilla C, 2006, CANCER EPIDEM BIOMAR, V15, P99, DOI 10.1158/1055-9965.EPI-05-0618; Mahid SS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-28; Moslehi R, 2006, PHARMACOGENOMICS, V7, P819, DOI 10.2217/14622416.7.6.819; Nothlings U, 2009, CANCER EPIDEM BIOMAR, V18, P2098, DOI 10.1158/1055-9965.EPI-08-1218; Osian Gelu, 2006, J Gastrointestin Liver Dis, V15, P347; Pistorius S, 2007, INT J COLORECTAL DIS, V22, P137, DOI 10.1007/s00384-006-0171-0; Potter JD, 1999, CANCER EPIDEM BIOMAR, V8, P69; PROBSTHENSCH NM, 1995, CANCER RES, V55, P2017; ProbstHensch NM, 1996, CARCINOGENESIS, V17, P2125, DOI 10.1093/carcin/17.10.2125; Roemer HC, 2008, J TOXICOL ENV HEAL A, V71, P902, DOI 10.1080/15287390801988582; Shin A, 2008, CANCER EPIDEM BIOMAR, V17, P320, DOI 10.1158/1055-9965.EPI-07-0615; Sorensen M, 2008, CANCER LETT, V266, P186, DOI 10.1016/j.canlet.2008.02.046; Tiemersma EW, 2004, CANCER CAUSE CONTROL, V15, P225, DOI 10.1023/B:CACO.0000024263.44973.92; Tiemersma EW, 2002, CANCER CAUSE CONTROL, V13, P383, DOI 10.1023/A:1015236701054; Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623; van der Hel OL, 2003, CANCER CAUSE CONTROL, V14, P293, DOI 10.1023/A:1023601922106; van der Hel OL, 2003, CANCER EPIDEM BIOMAR, V12, P681; Voskuil DW, 1997, CANCER LETT, V114, P309, DOI 10.1016/S0304-3835(97)04689-2; Wang HS, 2011, CARCINOGENESIS, V32, P203, DOI 10.1093/carcin/bgq237; Welfare MR, 1997, CARCINOGENESIS, V18, P1351, DOI 10.1093/carcin/18.7.1351; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; YE Z, 2002, MED SCI MONITOR, V8, P558; Yeh CC, 2009, DIS COLON RECTUM, V52, P104, DOI 10.1007/DCR.0b013e31819734d7; Yoshida K, 2007, ASIAN PAC J CANCER P, V8, P438; Zupa A, 2009, ANTICANCER RES, V29, P1709	54	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42797	10.1371/journal.pone.0042797	http://dx.doi.org/10.1371/journal.pone.0042797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905173	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800023
J	Klepac, P; Bjornstad, ON; Metcalf, CJE; Grenfell, BT				Klepac, Petra; Bjornstad, Ottar N.; Metcalf, C. Jessica E.; Grenfell, Bryan T.			Optimizing Reactive Responses to Outbreaks of Immunizing Infections: Balancing Case Management and Vaccination	PLOS ONE			English	Article							PATHOGEN TRANSMISSION; SPATIAL HIERARCHIES; ADAPTIVE MANAGEMENT; MEASLES EPIDEMICS; DYNAMICS; TIME; PERSISTENCE; STRATEGIES; DISEASES; DENSITY	For vaccine-preventable infections, immunization generally needs to be supplemented by palliative care of individuals missed by the vaccination. Costs and availability of vaccine doses and palliative care vary by disease and by region. In many situations, resources for delivery of palliative care are independent of resources required for vaccination; however we also need to consider the conservative scenario where there is some trade-off between efforts, which is of potential relevance for resource-poor settings. We formulate an SEIR model that includes those two control strategies - vaccination and palliative care. We consider their relative merit and optimal allocation in the context of a highly efficacious vaccine, and under the assumption that palliative care may reduce transmission. We investigate the utility of a range of mixed or pure strategies that can be implemented after an epidemic has started, and look for rule-of-thumb principles of how best to reduce the burden of disease during an acute outbreak over a spectrum of vaccine-preventable infections. Intuitively, we expect the best strategy to initially focus on vaccination, and enhanced palliative care after the infection has peaked, but a number of plausible realistic constraints for control result in important qualifications on the intervention strategy. The time in the epidemic when one should switch strategy depends sensitively on the relative cost of vaccine to palliative care, the available budget, and R-0. Crucially, outbreak response vaccination may be more effective in managing low-R-0 diseases, while high R-0 scenarios enhance the importance of routine vaccination and case management.	[Klepac, Petra; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Bjornstad, Ottar N.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Bjornstad, Ottar N.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Metcalf, C. Jessica E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Grenfell, Bryan T.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA	Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Oxford; Princeton University	Klepac, P (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	pklepac@alum.mit.edu	Bjornstad, Ottar N/I-4518-2012		Bill and Melinda Gates Foundation; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Bill and Melinda Gates Foundation, the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Anderson RM, 1997, LANCET, V350, P1466, DOI 10.1016/S0140-6736(97)03255-8; Arinaminpathy N, 2009, J BIOETHIC INQ, V6, P171, DOI 10.1007/s11673-009-9164-3; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; BOLKER B, 1995, PHILOS T R SOC B, V348, P309, DOI 10.1098/rstb.1995.0070; Bolker BM, 1996, P NATL ACAD SCI USA, V93, P12648, DOI 10.1073/pnas.93.22.12648; CUTTS FT, 1991, B WORLD HEALTH ORGAN, V69, P1; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Finkenstadt B, 1998, P ROY SOC B-BIOL SCI, V265, P753, DOI 10.1098/rspb.1998.0357; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Forster GA, 2007, P NATL ACAD SCI USA, V104, P4984, DOI 10.1073/pnas.0607900104; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; Grais RF, 2008, J R SOC INTERFACE, V5, P67, DOI 10.1098/rsif.2007.1038; Grais RF, 2006, EPIDEMIOL INFECT, V134, P845, DOI 10.1017/S0950268805005716; Grais RF, 2006, T ROY SOC TROP MED H, V100, P867, DOI 10.1016/j.trstmh.2005.10.014; Grenfell B T, 1995, Stat Methods Med Res, V4, P160, DOI 10.1177/096228029500400205; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; GRENFELL BT, 1992, J ROY STAT SOC B MET, V54, P383; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Gudelj I, 2004, THEOR POPUL BIOL, V66, P139, DOI 10.1016/j.tpb.2004.04.003; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Kleczkowski A, 2012, J R SOC INTERFACE, V9, P158, DOI 10.1098/rsif.2011.0216; Klein E, 2007, ENVIRON DEV ECON, V12, P707, DOI 10.1017/S1355770X0700383X; Klepac P, 2011, P NATL ACAD SCI USA, V108, P14366, DOI 10.1073/pnas.1101694108; Klepac P, 2011, THEOR ECOL-NETH, V4, P301, DOI 10.1007/s12080-010-0079-8; Klepac P, 2009, P ROY SOC B-BIOL SCI, V276, P2469, DOI 10.1098/rspb.2009.0175; Laxminarayan R, 2004, AM J TROP MED HYG, V71, P187, DOI 10.4269/ajtmh.2004.71.187; Laxminarayan R, 2009, HEALTH AFFAIR, V28, pW730, DOI 10.1377/hlthaff.28.4.w730; Lloyd-Smith JO, 2004, P ROY SOC B-BIOL SCI, V271, P625, DOI 10.1098/rspb.2003.2632; Mbah MLN, 2010, J R SOC INTERFACE, V7, P1421, DOI 10.1098/rsif.2010.0056; Mbah MLN, 2010, J THEOR BIOL, V262, P757, DOI 10.1016/j.jtbi.2009.11.001; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Merl D, 2010, J STAT SOFTW, V36, P1; Merl D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005807; NOKES DJ, 1995, VET MICROBIOL, V44, P333, DOI 10.1016/0378-1135(95)00027-8; Perisic A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000280; Rowthorn RE, 2009, J R SOC INTERFACE, V6, P1135, DOI 10.1098/rsif.2008.0402; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Smith DL, 2005, P NATL ACAD SCI USA, V102, P3153, DOI 10.1073/pnas.0409523102; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Turner J, 2003, P ROY SOC B-BIOL SCI, V270, P105, DOI 10.1098/rspb.2002.2213; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; WHO website, 20041068 USGS; World Health Organization, 1999, WHOCDSCSRISR991	53	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41428	10.1371/journal.pone.0041428	http://dx.doi.org/10.1371/journal.pone.0041428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899996	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900011
J	Napoli, E; Ross-Inta, C; Wong, S; Hung, C; Fujisawa, Y; Sakaguchi, D; Angelastro, J; Omanska-Klusek, A; Schoenfeld, R; Giulivi, C				Napoli, Eleonora; Ross-Inta, Catherine; Wong, Sarah; Hung, Connie; Fujisawa, Yasuko; Sakaguchi, Danielle; Angelastro, James; Omanska-Klusek, Alicja; Schoenfeld, Robert; Giulivi, Cecilia			Mitochondrial Dysfunction in Pten Haplo-Insufficient Mice with Social Deficits and Repetitive Behavior: Interplay between Pten and p53	PLOS ONE			English	Article							C-OXIDASE DEFICIENCY; AUTISM SPECTRUM DISORDERS; LHERMITTE-DUCLOS-DISEASE; RILEY-RUVALCABA-SYNDROME; TUMOR-SUPPRESSOR GENE; FRAGILE-X-SYNDROME; COPY NUMBER; TRANSCRIPTION FACTOR; DNA-DAMAGE; ALZHEIMERS-DISEASE	Etiology of aberrant social behavior consistently points to a strong polygenetic component involved in fundamental developmental pathways, with the potential of being enhanced by defects in bioenergetics. To this end, the occurrence of social deficits and mitochondrial outcomes were evaluated in conditional Pten (Phosphatase and tensin homolog) haplo-insufficient mice, in which only one allele was selectively knocked-out in neural tissues. Pten mutations have been linked to Alzheimer's disease and syndromic autism spectrum disorders, among others. By 4-6 weeks of age, Pten insufficiency resulted in the increase of several mitochondrial Complex activities (II-III, IV and V) not accompanied by increases in mitochondrial mass, consistent with an activation of the PI3K/Akt pathway, of which Pten is a negative modulator. At 8-13 weeks of age, Pten haplo-insufficient mice did not show significant behavioral abnormalities or changes in mitochondrial outcomes, but by 20-29 weeks, they displayed aberrant social behavior (social avoidance, failure to recognize familiar mouse, and repetitive self-grooming), macrocephaly, increased oxidative stress, decreased cytochrome c oxidase (CCO) activity (50%) and increased mtDNA deletions in cerebellum and hippocampus. Mitochondrial dysfunction was the result of a downregulation of p53-signaling pathway evaluated by lower protein expression of p21 (65% of controls) and the CCO chaperone SCO2 (47% of controls), two p53-downstream targets. This mechanism was confirmed in Pten-deficient striatal neurons and, HCT 116 cells with different p53 gene dosage. These results suggest a unique pathogenic mechanism of the Pten-p53 axis in mice with aberrant social behavior: loss of Pten (via p53) impairs mitochondrial function elicited by an early defective assembly of CCO and later enhanced by the accumulation of mtDNA deletions. Consistent with our results, (i) SCO2 deficiency and/or CCO activity defects have been reported in patients with learning disabilities including autism and (ii) mutated proteins in ASD have been found associated with p53-signaling pathways.	[Napoli, Eleonora; Ross-Inta, Catherine; Wong, Sarah; Hung, Connie; Fujisawa, Yasuko; Sakaguchi, Danielle; Angelastro, James; Omanska-Klusek, Alicja; Schoenfeld, Robert; Giulivi, Cecilia] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Giulivi, Cecilia] Univ Calif Davis, Med Invest Neurodev Disorders Inst, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Napoli, E (corresponding author), Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA.	cgiulivi@ucdavis.edu	Giulivi, Cecilia/AAV-6774-2021; Napoli, Eleonora/AAQ-6079-2021; Giulivi, Cecilia/ABB-7809-2020	Napoli, Eleonora/0000-0001-8808-4242; Giulivi, Cecilia/0000-0003-1033-7435	Autism Speaks Foundation [58739]; MIND Institute; Elsa U. Pardee Foundation; National Institute of Environmental Health Sciences [NIEHS R01-ES012691, NIEHS R01-ES020392]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012691, R01ES020392] Funding Source: NIH RePORTER	Autism Speaks Foundation; MIND Institute; Elsa U. Pardee Foundation; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by funds provided by Autism Speaks Foundation (#58739); and, partially, by the MIND Institute, Elsa U. Pardee Foundation and National Institute of Environmental Health Sciences (NIEHS R01-ES012691 & NIEHS R01-ES020392). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carper RA, 2000, BRAIN, V123, P836, DOI 10.1093/brain/123.4.836; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chauhan A, 2011, J NEUROCHEM, V117, P209, DOI 10.1111/j.1471-4159.2011.07189.x; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chiu S, 2007, J DEV BEHAV PEDIATR, V28, P31, DOI 10.1097/01.DBP.0000257518.60083.2d; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Cinato E, 2001, GENESIS, V31, P118, DOI 10.1002/gene.10014; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Cusco I, 2009, HUM MOL GENET, V18, P1795, DOI 10.1093/hmg/ddp092; Delatycki MB, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e92; Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602; Drage MG, 2002, J NEUROCYTOL, V31, P681, DOI 10.1023/A:1025747813463; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Elder LM, 2008, J AUTISM DEV DISORD, V38, P1104, DOI 10.1007/s10803-007-0495-9; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Ezugha H, 2010, J CHILD NEUROL, V25, P1232, DOI 10.1177/0883073809361165; Fombonne E, 1999, J AUTISM DEV DISORD, V29, P113, DOI 10.1023/A:1023036509476; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Gaveriaux-Ruff C, 2007, PHARMACOL THERAPEUT, V113, P619, DOI 10.1016/j.pharmthera.2006.12.003; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Goghari VM, 2007, CEREB CORTEX, V17, P415, DOI 10.1093/cercor/bhj158; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; HALTIA M, 1992, BRAIN PATHOL, V2, P133, DOI 10.1111/j.1750-3639.1992.tb00681.x; Hardan AY, 2006, AM J PSYCHIAT, V163, P1290, DOI 10.1176/appi.ajp.163.7.1290; Hassel B, 1998, J NEUROCHEM, V71, P1511; Haukvik UK, 2009, J PSYCHIATR RES, V43, P1287, DOI 10.1016/j.jpsychires.2009.05.001; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Haynes V, 2010, AM J PHYSIOL-ENDOC M, V298, pE978, DOI 10.1152/ajpendo.00739.2009; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Herman GE, 2007, AM J MED GENET A, V143A, P589, DOI 10.1002/ajmg.a.31619; Hertz-Picciotto I, 2006, ENVIRON HEALTH PERSP, V114, P1119, DOI 10.1289/ehp.8483; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; Hirasawa M, 2001, NEUROSCI RES, V40, P125, DOI 10.1016/S0168-0102(01)00216-4; Howard R, 2000, AM J PSYCHIAT, V157, P172, DOI 10.1176/appi.ajp.157.2.172; Isaacs JS, 1997, CANCER RES, V57, P2986; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; Joost K, 2010, PEDIATR NEUROL, V42, P227, DOI 10.1016/j.pediatrneurol.2009.10.004; Kakiuchi C, 2005, INT J NEUROPSYCHOPH, V8, P515, DOI 10.1017/S1461145705005213; Kalkman HO, 2006, PHARMACOL THERAPEUT, V110, P117, DOI 10.1016/j.pharmthera.2005.10.014; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; KEMPER TL, 1993, NEUROL CLIN, V11, P175, DOI 10.1016/S0733-8619(18)30176-2; Kerr F, 2006, FEBS LETT, V580, P3121, DOI 10.1016/j.febslet.2006.04.064; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lawrence YA, 2010, ACTA NEUROL SCAND, V121, P99, DOI 10.1111/j.1600-0404.2009.01234.x; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li YT, 2011, BLOOD, V117, P6702, DOI 10.1182/blood-2010-09-309864; Mao JH, 2003, ONCOGENE, V22, P8379, DOI 10.1038/sj.onc.1207083; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; McKenzie PP, 1999, CLIN CANCER RES, V5, P4199; Meesters PD, 2012, AM J GERIAT PSYCHIAT, V20, P18, DOI 10.1097/JGP.0b013e3182011b7f; Merks JHM, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e111; Moretti A, 2003, MOL PSYCHIATR, V8, P773, DOI 10.1038/sj.mp.4001353; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Napoli E, 2011, HUM MOL GENET, V20, P3079, DOI 10.1093/hmg/ddr211; Noack H, 2006, BBA-GEN SUBJECTS, V1760, P141, DOI 10.1016/j.bbagen.2005.12.007; O'Roak B.J., 2012, NATURE; O'Roak BJ, 2012, NAT GENET, V44, P471, DOI 10.1038/ng0412-471; Ozonoff S, 2008, AUTISM RES, V1, P320, DOI 10.1002/aur.53; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Pessah IN, 2008, NEUROTOXICOLOGY, V29, P532, DOI 10.1016/j.neuro.2008.02.006; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Rickle A, 2006, J NEUROSCI RES, V84, P596, DOI 10.1002/jnr.20970; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Santoro L, 2000, NEUROMUSCULAR DISORD, V10, P450, DOI 10.1016/S0960-8966(99)00122-4; Sayan BS, 2006, J BIOL CHEM, V281, P13566, DOI 10.1074/jbc.M512467200; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Sung HJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1003; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918; Tang YY, 2000, MOL BIOL CELL, V11, P2349, DOI 10.1091/mbc.11.7.2349; TAYLOR RW, 1993, BIOCHIM BIOPHYS ACTA, V1181, P261, DOI 10.1016/0925-4439(93)90030-5; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Torres M, 2004, INT J RADIAT ONCOL, V58, P479, DOI 10.1016/j.ijrobp.2003.09.062; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tulinius M, 2003, NEUROPEDIATRICS, V34, P87; Varga EA, 2009, GENET MED, V11, P111, DOI 10.1097/GIM.0b013e31818fd762; Wanka C, 2011, ONCOGENE; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; Wolfe A, 2008, J NEUROENDOCRINOL, V20, P909, DOI 10.1111/j.1365-2826.2008.01746.x; Yang H, 2010, HUM MOL GENET, V19, P170, DOI 10.1093/hmg/ddp477; Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164; Zhang XD, 2010, ACTA PHARMACOL SIN, V31, P1208, DOI 10.1038/aps.2010.151; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; Zori RT, 1998, AM J MED GENET, V80, P399, DOI 10.1002/(SICI)1096-8628(19981204)80:4<399::AID-AJMG18>3.3.CO;2-F	119	81	83	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42504	10.1371/journal.pone.0042504	http://dx.doi.org/10.1371/journal.pone.0042504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900024	gold, Green Published, Green Submitted			2022-12-27	WOS:000307380900040
J	Strijk, JS; Noyes, RD; Strasberg, D; Cruaud, C; Gavory, F; Chase, MW; Abbott, RJ; Thebaud, C				Strijk, Joeri S.; Noyes, Richard D.; Strasberg, Dominique; Cruaud, Corinne; Gavory, Frederic; Chase, Mark W.; Abbott, Richard J.; Thebaud, Christophe			In and out of Madagascar: Dispersal to Peripheral Islands, Insular Speciation and Diversification of Indian Ocean Daisy Trees (Psiadia, Asteraceae)	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; LONG-DISTANCE DISPERSAL; DES-NEIGES VOLCANO; PHYLOGENETIC ANALYSIS; COLONIZATION HISTORY; MOLECULAR EVIDENCE; REUNION-ISLAND; BIODIVERSITY HOTSPOTS; ENDEMIC CLADES; EAST GONDWANA	Madagascar is surrounded by archipelagos varying widely in origin, age and structure. Although small and geologically young, these archipelagos have accumulated disproportionate numbers of unique lineages in comparison to Madagascar, highlighting the role of waif-dispersal and rapid in situ diversification processes in generating endemic biodiversity. We reconstruct the evolutionary and biogeographical history of the genus Psiadia (Asteraceae), a plant genus with near equal numbers of species in Madagascar and surrounding islands. Analyzing patterns and processes of diversification, we explain species accumulation on peripheral islands and aim to offer new insights on the origin and potential causes for diversification in the Madagascar and Indian Ocean Islands biodiversity hotspot. Our results provide support for an African origin of the group, with strong support for non-monophyly. Colonization of the Mascarenes took place by two evolutionary distinct lineages from Madagascar, via two independent dispersal events, each unique for their spatial and temporal properties. Significant shifts in diversification rate followed regional expansion, resulting in co-occurring and phenotypically convergent species on high-elevation volcanic slopes. Like other endemic island lineages, Psiadia have been highly successful in dispersing to and radiating on isolated oceanic islands, typified by high habitat diversity and dynamic ecosystems fuelled by continued geological activity. Results stress the important biogeographical role for Rodrigues in serving as an outlying stepping stone from which regional colonization took place. We discuss how isolated volcanic islands contribute to regional diversity by generating substantial numbers of endemic species on short temporal scales. Factors pertaining to the mode and tempo of archipelago formation and its geographical isolation strongly govern evolutionary pathways available for species diversification, and the potential for successful diversification of dispersed lineages, therefore, appears highly dependent on the timing of arrival, as habitat and resource properties change dramatically over the course of oceanic island evolution.	[Strijk, Joeri S.] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Strijk, Joeri S.; Thebaud, Christophe] Univ Toulouse 3, Lab Evolut & Diversite Biol, UMR CNRS 5174, ENFA, F-31062 Toulouse, France; [Noyes, Richard D.] Univ Cent Arkansas, Dept Biol, Conway, AR USA; [Strasberg, Dominique] Univ La Reunion, UMR PVBMT, Fac Sci & Technol, St Denis, La Reunion, France; [Cruaud, Corinne; Gavory, Frederic] Ctr Natl Sequencage, CEA, Inst Genom, Genoscope, Evry, France; [Chase, Mark W.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Abbott, Richard J.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); University of Central Arkansas; University of La Reunion; CEA; Royal Botanic Gardens, Kew; University of St Andrews	Strijk, JS (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	joeristrijk@xtbg.org.cn	Thébaud, Christophe/N-3916-2016; Chase, Mark W/A-6642-2011; Strijk, Joeri S./F-8220-2019	Thébaud, Christophe/0000-0002-8586-1234; Strijk, Joeri S./0000-0003-1109-7015; Cruaud, Corinne/0000-0002-4752-7278; Strasberg, Dominique/0000-0003-3012-252X; Gavory, Frederick/0000-0003-1534-5725	European Union's HOTSPOTS Training Network [MEST-2005-020561]; French National Research Agency [ANR-06-BDIV-002]; "Laboratoire d'Excellence" TULIP [ANR-10-LABX-41]	European Union's HOTSPOTS Training Network; French National Research Agency(French National Research Agency (ANR)); "Laboratoire d'Excellence" TULIP	This study was supported by the European Union's HOTSPOTS Training Network (MEST-2005-020561), the French National Research Agency's Biodiversity program (ANR-06-BDIV-002) and the "Laboratoire d'Excellence'' TULIP (ANR-10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2012, CURRENT TOPICS IN PHYLOGENETICS AND PHYLOGEOGRAPHY OF TERRESTRIAL AND AQUATIC SYSTEMS, P33; Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Antoine R, 1993, COMPOSEES, P80; Audru JC, 2006, CR GEOSCI, V338, P1240, DOI 10.1016/j.crte.2006.07.010; Austin JJ, 2004, MOL PHYLOGENET EVOL, V31, P109, DOI 10.1016/j.ympev.2003.07.011; Austin JJ, 2001, P ROY SOC B-BIOL SCI, V268, P2515, DOI 10.1098/rspb.2001.1825; BALDWIN BG, 1990, ANN MO BOT GARD, V77, P96, DOI 10.2307/2399629; Barreda V, 2012, REV PALAEOBOT PALYNO, V160, P102; Barreda VD, 2010, SCIENCE, V329, P1621, DOI 10.1126/science.1193108; Barreda VD, 2010, ANN BOT, V109, P127; Becker HF., 1969, PALAEONTOGR ABT B, V127, P1; Beentje H, 2002, COMPOSITAE, P514; Bergh NG, 2009, MOL PHYLOGENET EVOL, V51, P5, DOI 10.1016/j.ympev.2008.09.001; Bone RE, 2012, BOT J LINN SOC, V169, P284, DOI 10.1111/j.1095-8339.2012.01221.x; Bremer K, 1997, P NATL ACAD SCI USA, V94, P9188, DOI 10.1073/pnas.94.17.9188; BREMER K, 1992, NORD J BOT, V12, P141, DOI 10.1111/j.1756-1051.1992.tb01281.x; Bremer K., 1994, ASTERACEAE CLADISTIC; Bremer K, 1994, P INT COMP C, P1; Cadet LJT, 1977, VEG IL REUN; Carr GD, 2003, TARWEEDS SILVERSWORD, P229; CBOL-Kew, 2007, DNA BARC PHAS 2 PROT; Chan KMA, 2005, BIOINFORMATICS, V21, P1709, DOI 10.1093/bioinformatics/bti175; Chan KMA, 2002, SYST BIOL, V51, P855, DOI 10.1080/10635150290155836; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Collier JS, 2008, EARTH PLANET SC LETT, V272, P264, DOI 10.1016/j.epsl.2008.04.045; Couvreur TLP, 2008, BEAST PARTITIONING M; Cross EW, 2002, PLANT SYST EVOL, V235, P99, DOI 10.1007/s00606-002-0198-9; Cuenca A, 2008, MOL PHYLOGENET EVOL, V46, P760, DOI 10.1016/j.ympev.2007.10.010; DENIEL C, 1992, J VOLCANOL GEOTH RES, V51, P253, DOI 10.1016/0377-0273(92)90126-X; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dyment J, 2003, INTERRIDGE S WORKSH; Eastwood A, 2004, BOT J LINN SOC, V144, P69, DOI 10.1111/j.0024-4074.2004.00238.x; Elsik William C., 2000, Palynology, V24, P177, DOI 10.2113/0240177; Francisco-Ortega J, 2008, BOT REV, V74, P112, DOI 10.1007/s12229-008-9008-6; Francisco-Ortega Javier, 1997, P407; FranciscoOrtega J, 1996, P NATL ACAD SCI USA, V93, P4085, DOI 10.1073/pnas.93.9.4085; Fretzdorff S, 2000, B VOLCANOL, V62, P266, DOI 10.1007/s004450000095; Fuchs J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-197; Funk VA., 2005, BIOL SKRIFTER, V55, P343; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman SM, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3538[1:ANSOEC]2.0.CO;2; Gradstein F.M., 2004, A; Graham, 1994, P INT COMPOSITAE C, P123; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harmon LJ, 2008, SYST BIOL, V57, P562, DOI 10.1080/10635150802304779; Heads M, 2011, SYST BIOL, V60, P204, DOI 10.1093/sysbio/syq075; HEARD SB, 1992, EVOLUTION, V46, P1818, DOI 10.1111/j.1558-5646.1992.tb01171.x; Hedges SB, 2004, TRENDS GENET, V20, P242, DOI 10.1016/j.tig.2004.03.004; Hobohm C, 2000, FLORA, V195, P9; Humbert H, 1960, COMPOSEES, P267; Hume J., 2008, LOST LAND DODO; JANSEN RK, 1990, EVOLUTION, V44, P2089, DOI 10.1111/j.1558-5646.1990.tb04314.x; JANSEN RK, 1996, COMPOSITAE SYSTEMATI, V1, P317; Janssen T, 2008, EVOLUTION, V62, P1876, DOI 10.1111/j.1558-5646.2008.00408.x; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KARIS PO, 1992, ANN MO BOT GARD, V79, P416, DOI 10.2307/2399778; KIEFFER G, 1993, CR ACAD SCI II, V317, P835; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; KIM KJ, 1995, P NATL ACAD SCI USA, V92, P10379, DOI 10.1073/pnas.92.22.10379; KIM KJ, 1992, ANN MO BOT GARD, V79, P428, DOI 10.2307/2399779; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kuntner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-119; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Le Pechon T, 2009, TAXON, V58, P519; Lewis P. O, 2010, PHYCAS V1 2 0; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Malcomber ST, 2002, EVOLUTION, V56, P42, DOI 10.1111/j.0014-3820.2002.tb00848.x; MBG, 2011, MAD CAT CAT VASC PLA; MCDOUGAL.I, 1969, GEOL SOC AM BULL, V80, P1419, DOI 10.1130/0016-7606(1969)80[1419:IDAGPS]2.0.CO;2; MCDOUGALL I, 1965, NATURE, V206, P26, DOI 10.1038/206026a0; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; McMullen C.K., 1999, FLOWERING PLANTS GAL; MOORE BR, 2004, COMPU BIOL, V4, P487; Morley RJ, 2003, PERSPECT PLANT ECOL, V6, P5, DOI 10.1078/1433-8319-00039; Mourer-Chauvire C, 1999, SM C PALEOB, P1; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; Myers N, 2003, BIOSCIENCE, V53, P916; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; Nougier J., 1986, Journal of African Earth Sciences, V5, P135, DOI 10.1016/0899-5362(86)90003-5; Oehler JF, 2004, B VOLCANOL, V66, P585, DOI 10.1007/s00445-004-0341-2; Ott M, 2007, LARGE SCALE MAXIMUM, P1; Panero JL, 1999, P NATL ACAD SCI USA, V96, P13886, DOI 10.1073/pnas.96.24.13886; Perroud B., 1982, ETUDE VOLCANO STRUCT; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Pybus OG, 2002, BIOINFORMATICS, V18, P1404, DOI 10.1093/bioinformatics/18.10.1404; RABINOWITZ PD, 1983, SCIENCE, V220, P67, DOI 10.1126/science.220.4592.67; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A, 2007, LOGCOMBINER MCMC SAM; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Rambaut A., 2002, PHYLOGEN PHYLOGENETI, V1.1; Rambaut A., 2007, TREEANNOTATOR V1 4 8; Rambaut A., 2002, TREEEDIT PHYLOGENETI; Rambaut A., 2007, TRACE 1 4; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Renner S, 2004, INT J PLANT SCI, V165, pS23, DOI 10.1086/383334; Renner SS, 2010, J BIOGEOGR, V37, P1227, DOI 10.1111/j.1365-2699.2010.02319.x; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Saddul P, 1995, MAURITIUS GEOMORPHOL; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, TRENDS PLANT SCI, V8, P374, DOI 10.1016/S1360-1385(03)00165-1; SANG T, 1994, AM J BOT, V81, P1494, DOI 10.2307/2445322; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schluter T, 2006, COMOROS GEOLOGICAL A; SCOTT A J, 1991, Kew Bulletin, V46, P339, DOI 10.2307/4110609; Scott L, 2006, REV PALAEOBOT PALYNO, V142, P47, DOI 10.1016/j.revpalbo.2006.07.010; SHAO KT, 1990, SYST ZOOL, V39, P266, DOI 10.2307/2992186; Shapiro B, 2002, SCIENCE, V295, P1683, DOI 10.1126/science.295.5560.1683; Sheldon FH, 2009, J BIOGEOGR, V36, P1070, DOI 10.1111/j.1365-2699.2009.02087.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; SLOWINSKI JB, 1989, SYST ZOOL, V38, P189, DOI 10.2307/2992389; SLOWINSKI JB, 1989, AM NAT, V134, P907, DOI 10.1086/285021; Song ZC, 1999, FOSSIL SPORES POLLEN, P749; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; Sun XJ, 1981, TERTIARY PALACONTOLO; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thebaud C, 2009, ENCY ISLANDS, P612; Trenel P, 2007, MOL PHYLOGENET EVOL, V45, P272, DOI 10.1016/j.ympev.2007.03.018; Vences M, 2001, J BIOGEOGR, V28, P1091, DOI 10.1046/j.1365-2699.2001.00624.x; Walter KS, 1998, 1997 IUCN RED LIST T; Wang WM, 2004, BOT J LINN SOC, V145, P331, DOI 10.1111/j.1095-8339.2004.00287.x; Warren BH, 2006, MOL ECOL, V15, P3769, DOI 10.1111/j.1365-294X.2006.03058.x; Warren BH, 2010, CLADISTICS, V26, P526, DOI 10.1111/j.1096-0031.2009.00300.x; Warren BH, 2005, BIOL J LINN SOC, V85, P271, DOI 10.1111/j.1095-8312.2005.00492.x; Warren BH, 2003, MOL PHYLOGENET EVOL, V29, P67, DOI 10.1016/S1055-7903(03)00063-0; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6; Yu Y., 2011, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Yuan YM, 2005, SYST BIOL, V54, P21, DOI 10.1080/10635150590905867; ZHANG XP, 1993, PLANT SYST EVOL, V184, P259; [No title captured]	149	41	42	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42932	10.1371/journal.pone.0042932	http://dx.doi.org/10.1371/journal.pone.0042932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900068	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900086
J	Liu, SH; Rao, DD; Nemunaitis, J; Senzer, N; Zhou, GS; Dawson, D; Gingras, MC; Wang, ZH; Gibbs, R; Norman, M; Templeton, NS; DeMayo, FJ; O'Malley, B; Sanchez, R; Fisher, WE; Brunicardi, FC				Liu, Shi-He; Rao, Donald D.; Nemunaitis, John; Senzer, Neil; Zhou, Guisheng; Dawson, David; Gingras, Marie-Claude; Wang, Zhaohui; Gibbs, Richard; Norman, Michael; Templeton, Nancy S.; DeMayo, Francesco J.; O'Malley, Bert; Sanchez, Robbi; Fisher, William E.; Brunicardi, F. Charles			PDX-1 Is a Therapeutic Target for Pancreatic Cancer, Insulinoma and Islet Neoplasia Using a Novel RNA Interference Platform	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PDX-1; DUODENAL HOMEOBOX-1; IN-VIVO; GENE-EXPRESSION; CELLS; POLYPEPTIDE; DELIVERY; DIFFERENTIATION; INVOLVEMENT; ACTIVATION	Pancreatic and duodenal homeobox-1 (PDX-1) is a transcription factor that regulates insulin expression and islet maintenance in the adult pancreas. Our recent studies demonstrate that PDX-1 is an oncogene for pancreatic cancer and is overexpressed in pancreatic cancer. The purpose of this study was to demonstrate that PDX-1 is a therapeutic target for both hormonal symptoms and tumor volume in mouse models of pancreatic cancer, insulinoma and islet neoplasia. Immunohistochemistry of human pancreatic and islet neoplasia specimens revealed marked PDX-1 overexpression, suggesting PDX-1 as a "drugable" target within these diseases. To do so, a novel RNA interference effector platform, bifunctional shRNA(PDX-1), was developed and studied in mouse and human cell lines as well as in mouse models of pancreatic cancer, insulinoma and islet neoplasia. Systemic delivery of bi-shRNA(humanPDX-1) lipoplexes resulted in marked reduction of tumor volume and improved survival in a human pancreatic cancer xenograft mouse model. bi-shRNA(mousePDX-1) lipoplexes prevented death from hyperinsulinemia and hypoglycemia in an insulinoma mouse model. shRNA(mousePDX-1) lipoplexes reversed hyperinsulinemia and hypoglycemia in an immune-competent mouse model of islet neoplasia. PDX-1 was overexpressed in pancreatic neuroendocrine tumors and nesidioblastosis. These data demonstrate that PDX-1 RNAi therapy controls hormonal symptoms and tumor volume in mouse models of pancreatic cancer, insulinoma and islet neoplasia, therefore, PDX-1 is a potential therapeutic target for these pancreatic diseases.	[Liu, Shi-He; Zhou, Guisheng; Sanchez, Robbi; Brunicardi, F. Charles] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Dawson, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Liu, Shi-He; Zhou, Guisheng; Norman, Michael; Fisher, William E.; Brunicardi, F. Charles] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Fisher, William E.; Brunicardi, F. Charles] Baylor Coll Med, Elkins Pancreas Ctr, Houston, TX 77030 USA; [DeMayo, Francesco J.; O'Malley, Bert] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Gingras, Marie-Claude; Gibbs, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Rao, Donald D.; Nemunaitis, John; Senzer, Neil; Wang, Zhaohui] Gradalis Inc, Dallas, TX USA; [Nemunaitis, John; Senzer, Neil] Mary Crowley Canc Res Ctr, Dallas, TX USA; [Nemunaitis, John; Senzer, Neil] Texas Oncol PA, Dallas, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Mary Crowley Cancer Research; Texas Oncology	Liu, SH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA.	cbrunicardi@mednet.ucla.edu	Dawson, David/I-5917-2014; DeMayo, Francesco/C-6255-2019; Templeton, Nancy S/C-9565-2011	DeMayo, Francesco/0000-0002-9480-7336; 	National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK46441]; National Cancer Institute [R01-CA095731]; Alkek Foundation; Vivian L. Smith Foundation; MD Anderson Foundation; Bill and Olivia Heintz family; NATIONAL CANCER INSTITUTE [R01CA095731] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046441] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alkek Foundation; Vivian L. Smith Foundation; MD Anderson Foundation; Bill and Olivia Heintz family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant R01-DK46441 from the National Institute of Diabetes and Digestive and Kidney Diseases; grant R01-CA095731 from the National Cancer Institute; the Alkek Foundation; the Vivian L. Smith Foundation; the MD Anderson Foundation; and the generosity of the Bill and Olivia Heintz family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa S, 2004, PANCREAS, V28, P109, DOI 10.1097/00006676-200403000-00001; Aviv V, 2009, J BIOL CHEM, V284, P33509, DOI 10.1074/jbc.M109.017608; Bischof LJ, 2001, DIABETES, V50, P502, DOI 10.2337/diabetes.50.3.502; Carty MD, 1997, J BIOL CHEM, V272, P11986, DOI 10.1074/jbc.272.18.11986; Elbein SC, 2002, J CLIN ENDOCR METAB, V87, P650, DOI 10.1210/jc.87.2.650; Feanny MA, 2008, J SURG RES, V144, P8, DOI 10.1016/j.jss.2007.04.018; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Hui HX, 2002, EUR J ENDOCRINOL, V146, P129, DOI 10.1530/eje.0.1460129; Ito I, 2004, CANCER GENE THER, V11, P733, DOI 10.1038/sj.cgt.7700756; Jepeal LI, 2005, ENDOCRINOLOGY, V146, P383, DOI 10.1210/en.2004-0223; Kaltsas GA, 2004, ENDOCR REV, V25, P458, DOI 10.1210/er.2003-0014; Koizumi M, 2005, SURGERY, V138, P125, DOI 10.1016/j.surg.2005.06.008; Koizumi M, 2003, SURGERY, V134, P260, DOI 10.1067/msy.2003.231; Li YH, 2007, J CELL PHYSIOL, V211, P36, DOI 10.1002/jcp.20897; Liu SH, CANCER, V117, P723; Liu SH, 2008, PANCREAS, V37, P210, DOI 10.1097/MPA.0b013e31816a4a33; Liu SH, 2007, J SURG RES, V137, P1, DOI 10.1016/j.jss.2006.04.039; Liu T, 2007, WORLD J GASTROENTERO, V13, P2615, DOI 10.3748/wjg.v13.i18.2615; Liu Tao, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P464; Lu C, 2010, J CLIN ONCOL S, V28, p15s; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Nemunaitis G, 2010, J GENE MED, V12, P403, DOI 10.1002/jgm.1450; Offield MF, 1996, DEVELOPMENT, V122, P983; Ramesh R, 2001, MOL THER, V3, P337, DOI 10.1006/mthe.2001.0266; Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53; Rao DD, CANC GENE THER, V17, P780; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Serup P, 1996, P NATL ACAD SCI USA, V93, P9015, DOI 10.1073/pnas.93.17.9015; Shih David Q, 2002, Curr Diab Rep, V2, P125, DOI 10.1007/s11892-002-0071-9; Simberg D, 2005, HUM GENE THER, V16, P1087, DOI 10.1089/hum.2005.16.1087; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Taguchi M, 2002, J PATHOL, V197, P638, DOI 10.1002/path.1134; Templeton NS, 2002, BIOSCIENCE REP, V22, P283; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang XL, 2001, ENDOCRINOLOGY, V142, P1820, DOI 10.1210/en.142.5.1820; Wang XP, 2005, WORLD J SURG, V29, P334, DOI 10.1007/s00268-004-7823-4; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Watada H, 1996, DIABETES, V45, P1826, DOI 10.2337/diabetes.45.12.1826; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568; Zhou J, 2002, J CELL PHYSIOL, V192, P304, DOI 10.1002/jcp.10143	41	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e40452	10.1371/journal.pone.0040452	http://dx.doi.org/10.1371/journal.pone.0040452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905092	gold, Green Published			2022-12-27	WOS:000307331100004
J	Wang, HM; Wu, JM; Liu, X; He, HB; Ding, FR; Yang, HJ; Cheng, L; Liu, WH; Zhong, JF; Dai, YP; Li, GP; He, CQ; Yu, L; Li, JB				Wang, Hongmei; Wu, Jianming; Liu, Xiao; He, Hongbin; Ding, Fangrong; Yang, Hongjun; Cheng, Lei; Liu, Wenhao; Zhong, Jifeng; Dai, Yunping; Li, Guangpeng; He, Chengqiang; Yu, Li; Li, Jianbin			Identification of Short Hairpin RNA Targeting Foot-And-Mouth Disease Virus with Transgenic Bovine Fetal Epithelium Cells	PLOS ONE			English	Article							CONSERVED REGIONS; INTERFERING RNA; SUCKLING MICE; GUINEA-PIGS; IN-VITRO; REPLICATION; INHIBITION; INFECTION; GENOME; GENE	Background: Although it is known that RNA interference (RNAi) targeting viral genes protects experimental animals, such as mice, from the challenge of Foot-and-mouth disease virus (FMDV), it has not been previously investigated whether shRNAs targeting FMDV in transgenic dairy cattle or primary transgenic bovine epithelium cells will confer resistance against FMDV challenge. Principal Finding: Here we constructed three recombinant lentiviral vectors containing shRNA against VP2 (RNAi-VP2), VP3 (RNAi-VP3), or VP4 (RNAi-VP4) of FMDV, and found that all of them strongly suppressed the transient expression of a FLAG-tagged viral gene fusion protein in 293T cells. In BHK-21 cells, RNAi-VP4 was found to be more potent in inhibition of viral replication than the others with over 98% inhibition of viral replication. Therefore, recombinant lentiviral vector RNAi-VP4 was transfected into bovine fetal fibroblast cells to generate transgenic nuclear donor cells. With subsequent somatic cell cloning, we generated forty transgenic blastocysts, and then transferred them to 20 synchronized recipient cows. Three transgenic bovine fetuses were obtained after pregnant period of 4 months, and integration into chromosome in cloned fetuses was confirmed by Southern hybridization. The primary tongue epithelium cells of transgenic fetuses were isolated and inoculated with 100 TCID50 of FMDV, and it was observed that shRNA significantly suppressed viral RNA synthesis and inhibited over 91% of viral replication after inoculation of FMDV for 48 h. Conclusion: RNAi-VP4 targeting viral VP4 gene appears to prevent primary epithelium cells of transgenic bovine fetus from FMDV infection, and it could be a candidate shRNA used for cultivation of transgenic cattle against FMDV.	[Wang, Hongmei; Wu, Jianming; Liu, Xiao; He, Hongbin; Yang, Hongjun; Liu, Wenhao; Zhong, Jifeng; Li, Jianbin] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan, Peoples R China; [Ding, Fangrong; Dai, Yunping] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Cheng, Lei; Li, Guangpeng] Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China; [He, Chengqiang] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China; [Yu, Li] Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Livestock Infect Dis, Harbin, Peoples R China	Shandong Academy of Agricultural Sciences; China Agricultural University; Inner Mongolia University; Shandong Normal University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, HM (corresponding author), Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan, Peoples R China.	hongbinhe@yahoo.com; guangpengli@yahoo.com		Li, Jianbin/0000-0002-9587-2666	Taishan Scholar and Distinguished Experts from overseas; earmarked fund for China Agriculture Research System; State Major Project of Transgenic [2009ZX08007-006B, 2011ZX08007-002]; National Natural Science Fund of China [31072160]; Science and Technology Research Fund of Shandong Province [2009GG20002032]; University and Institute Independent Innovation Program of Jinan [201004027]; Opening Fund of State Key Laboratory of Veterinary Biotechnology [SKLVBF200806]	Taishan Scholar and Distinguished Experts from overseas; earmarked fund for China Agriculture Research System; State Major Project of Transgenic; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Fund of Shandong Province; University and Institute Independent Innovation Program of Jinan; Opening Fund of State Key Laboratory of Veterinary Biotechnology	This work was partially supported by grants from Taishan Scholar and Distinguished Experts from overseas (HH), the earmarked fund for China Agriculture Research System (HH), State Major Project of Transgenic (2009ZX08007-006B to JZ; 2011ZX08007-002 to GL), National Natural Science Fund of China (31072160 to HH), Science and Technology Research Fund of Shandong Province (2009GG20002032 to HH), University and Institute Independent Innovation Program of Jinan (201004027 to HH), and Opening Fund of State Key Laboratory of Veterinary Biotechnology (SKLVBF200806 to HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalil A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-188; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; BROOKSBY JB, 1982, INTERVIROLOGY, V18, P1, DOI 10.1159/000149299; Chen FY, 2011, J GEN VIROL, V92, P945, DOI 10.1099/vir.0.027680-0; Chen WZ, 2006, J VIROL, V80, P3559, DOI 10.1128/JVI.80.7.3559-3566.2006; Chen WZ, 2004, J VIROL, V78, P6900, DOI 10.1128/JVI.78.13.6900-6907.2004; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cong W, 2010, VET RES COMMUN, V34, P335, DOI 10.1007/s11259-010-9360-y; Cong W, 2010, VET RES, V41, DOI 10.1051/vetres/2010002; Domingo E, 2003, VIRUS RES, V91, P47, DOI 10.1016/S0168-1702(02)00259-9; Donovan DM, 2005, TRANSGENIC RES, V14, P563, DOI 10.1007/s11248-005-0670-8; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Haydon DT, 2001, PREV VET MED, V51, P111, DOI 10.1016/S0167-5877(01)00210-0; He H, 2007, ONCOGENE, V26, P2707, DOI 10.1038/sj.onc.1210073; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Joyappa DH, 2009, VET RES COMMUN, V33, P263, DOI 10.1007/s11259-008-9174-3; Kahana R, 2004, J GEN VIROL, V85, P3213, DOI 10.1099/vir.0.80133-0; Kerr DE, 2003, J ANIM SCI, V81, P38; Kim SM, 2008, ANTIVIR RES, V80, P178, DOI 10.1016/j.antiviral.2008.06.001; Leforban Y, 1999, VACCINE, V17, P1755, DOI 10.1016/S0264-410X(98)00445-9; Leonard JN, 2006, GENE THER, V13, P532, DOI 10.1038/sj.gt.3302645; Li MJ, 2005, MOL THER, V12, P900, DOI 10.1016/j.ymthe.2005.07.524; Liu MQ, 2005, VIROLOGY, V336, P51, DOI 10.1016/j.virol.2005.01.051; Lv K, 2009, RES VET SCI, V86, P443, DOI 10.1016/j.rvsc.2008.10.011; Perrimon N, 2010, CSH PERSPECT BIOL, V2, P10; Santos TDL, 2005, VIROLOGY, V335, P222, DOI 10.1016/j.virol.2005.03.001; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Summerfield A, 2009, VET IMMUNOL IMMUNOP, V128, P205, DOI 10.1016/j.vetimm.2008.10.296; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wang PY, 2010, ANTIVIR RES, V87, P265, DOI 10.1016/j.antiviral.2010.02.319; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Wu XJ, 2012, TRANSGENIC RES, V21, P1359, DOI 10.1007/s11248-012-9612-4	34	15	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42356	10.1371/journal.pone.0042356	http://dx.doi.org/10.1371/journal.pone.0042356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905125	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100034
J	Wu, GS; Jiang, MS; Liu, YH; Nagaoka, Y; Rao, NA				Wu, Guey Shuang; Jiang, Meisheng; Liu, Yi-Hsin; Nagaoka, Yoshiko; Rao, Narsing A.			Phenotype of Transgenic Mice Overexpressed with Inducible Nitric Oxide Synthase in the Retina	PLOS ONE			English	Article							PHOTORECEPTOR CELL-DEATH; ALPHA-A-CRYSTALLIN; CYTOCHROME-C; NITROSATIVE STRESS; ZYGOSITY DETERMINATION; UP-REGULATION; MITOCHONDRIA; EXPRESSION; APOPTOSIS; OPSIN	Background: Unlike its constitutive isoforms, including neuronal and endothelial nitric oxide synthase, inducible nitric oxide synthase (iNOS) along with a series of cytokines are generated in inflammatory pathologic conditions in retinal photoreceptors. In this study, we constructed transgenic mice overexpressing iNOS in the retina to evaluate the effect of sustained, intense iNOS generation in the photoreceptor damage. Methods: For construction of opsin/iNOS transgene in the CMVSport 6 expression vector, the 4.4 kb Acc65I/Xhol mouse rod opsin promoter was ligated upstream to a 4.1 kb fragment encoding the complete mouse cDNA of iNOS. From the four founders identified, two heterozygote lines and one homozygote line were established. The presence of iNOS in the retina was confirmed and the pathologic role of iNOS was assessed by detecting nitrotyrosine products and apoptosis. Commercial TUNEL kit was used to detect DNA strand breaks, a later step in a sequence of morphologic changes of apoptosis process. Results: The insertion and translation of iNOS gene were demonstrated by an intense single 130 kDa band in Western blot and specific immunolocalization at the photoreceptors of the retina. Cellular toxicity in the retinas of transgenic animals was detected by a post-translational modification product, tyrosine-nitrated protein, the most significant one of which was nitrated cytochrome c. Following the accumulation of nitrated mitochondrial proteins and cytochrome c release, marked apoptosis was detected in the photoreceptor cell nuclei of the retina. Conclusions: We have generated a pathologic phenotype with sustained iNOS overexpression and, therefore, high output of nitric oxide. Under basal conditions, such overexpression of iNOS causes marked mitochondrial cytochrome c nitration and release and subsequent photoreceptor apoptosis in the retina. Therefore, the modulation of pathways leading to iNOS generation or its effective neutralization can be of significant therapeutic benefit in the oxidative stress-mediated retinal degeneration, a leading cause of blindness.	[Wu, Guey Shuang; Liu, Yi-Hsin; Rao, Narsing A.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Doheny Eye Inst, Los Angeles, CA 90033 USA; [Jiang, Meisheng; Nagaoka, Yoshiko] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Doheny Eye Institute; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wu, GS (corresponding author), Univ So Calif, Keck Sch Med, Dept Ophthalmol, Doheny Eye Inst, Los Angeles, CA 90033 USA.	nrao@usc.edu			National Institute of Health [EY017347]; NATIONAL EYE INSTITUTE [R01EY017347] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants EY017347 from National Institute of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Berg RMG, 2011, J CEREBR BLOOD F MET, V31, P1532, DOI 10.1038/jcbfm.2011.48; CAPALDI RA, 1982, FEBS LETT, V138, P1, DOI 10.1016/0014-5793(82)80382-7; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; CHANG CJ, 1995, ARCH OPHTHALMOL-CHIC, V113, P880, DOI 10.1001/archopht.1995.01100070054025; Conner DA, 2005, CURR PROTOC MOL BIOL; Doran E, 2000, BIOCHEM J, V348, P343, DOI 10.1042/0264-6021:3480343; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Godecke A, 2003, J BIOL CHEM, V278, P21761, DOI 10.1074/jbc.M302573200; Haurogne K, 2007, TRANSGENIC RES, V16, P127, DOI 10.1007/s11248-006-9024-4; HEVEL JM, 1991, J BIOL CHEM, V266, P22789; Hickey MJ, 2001, ACTA PHYSIOL SCAND, V173, P119, DOI 10.1046/j.1365-201X.2001.00892.x; Hirst DG, 2010, CURR PHARM DESIGN, V16, P45, DOI 10.2174/138161210789941838; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; KIEDROWSKI L, 1991, NEUROPHARMACOLOGY, V30, P1241, DOI 10.1016/0028-3908(91)90171-7; Kubes P, 2000, GUT, V47, P6, DOI 10.1136/gut.47.1.6; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Mizuno K, 2001, INVEST OPHTH VIS SCI, V42, P688; Moon KH, 2008, GASTROENTEROLOGY, V135, P1344, DOI 10.1053/j.gastro.2008.06.048; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pang JJ, 2010, J COMP NEUROL, V518, P2456, DOI 10.1002/cne.22347; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Quiambao AB, 1997, VISUAL NEUROSCI, V14, P617, DOI 10.1017/S095252380001258X; Rao NA, 2008, INVEST OPHTH VIS SCI, V49, P1161, DOI 10.1167/iovs.07-1259; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; Reinartz M, 2008, J BIOL CHEM, V283, P17440, DOI 10.1074/jbc.M800126200; Roebroek Anton J M, 2003, Methods Mol Biol, V209, P187; Sakurai T, 2008, TRANSGENIC RES, V17, P149, DOI 10.1007/s11248-007-9134-7; Saraswathy S, 2010, INVEST OPHTH VIS SCI, V51, P3680, DOI 10.1167/iovs.09-4575; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Stone J, 2008, BRAIN RES, V1189, P58, DOI 10.1016/j.brainres.2007.10.083; Sugiura H, 2011, NITRIC OXIDE-BIOL CH, V25, P138, DOI 10.1016/j.niox.2011.03.079; Tsutsui M, 2010, PHARMACOL THERAPEUT, V128, P499, DOI 10.1016/j.pharmthera.2010.08.010; Vorwerk CK, 1997, INVEST OPHTH VIS SCI, V38, P2038; Wang XD, 2001, GENE DEV, V15, P2922; Wu GS, 2005, INVEST OPHTH VIS SCI, V46, P2271, DOI 10.1167/iovs.04-1525; Wu GS, 2008, EXPERT REV OPHTHALMO, V3, P299, DOI 10.1586/17469899.3.3.299; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zhu YL, 2006, EXP EYE RES, V82, P153, DOI 10.1016/j.exer.2005.06.005	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e43089	10.1371/journal.pone.0043089	http://dx.doi.org/10.1371/journal.pone.0043089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905206	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100083
J	Takaku, M; Tomita, S; Kurobe, H; Kihira, Y; Morimoto, A; Higashida, M; Ikeda, Y; Ushiyama, A; Hashimoto, I; Nakanishi, H; Tamaki, T				Takaku, Mitsuru; Tomita, Shuhei; Kurobe, Hirotsugu; Kihira, Yoshitaka; Morimoto, Atsushi; Higashida, Mayuko; Ikeda, Yasumasa; Ushiyama, Akira; Hashimoto, Ichiro; Nakanishi, Hideki; Tamaki, Toshiaki			Systemic Preconditioning by a Prolyl Hydroxylase Inhibitor Promotes Prevention of Skin Flap Necrosis via HIF-1-Induced Bone Marrow-Derived Cells	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; HIF-1-ALPHA GENE; ANGIOGENIC CELLS; RECRUITMENT; NEOVASCULARIZATION; MICE; REVASCULARIZATION; STABILIZATION; MOBILIZATION; CONTRIBUTES	Background: Local skin flaps often present with flap necrosis caused by critical disruption of the blood supply. Although animal studies demonstrate enhanced angiogenesis in ischemic tissue, no strategy for clinical application of this phenomenon has yet been defined. Hypoxia-inducible factor 1 (HIF-1) plays a pivotal role in ischemic vascular responses, and its expression is induced by the prolyl hydroxylase inhibitor dimethyloxalylglycine (DMOG). We assessed whether preoperative stabilization of HIF-1 by systemic introduction of DMOG improves skin flap survival. Methods and Results: Mice with ischemic skin flaps on the dorsum were treated intraperitoneally with DMOG 48 hr prior to surgery. The surviving area with neovascularization of the ischemic flaps was significantly greater in the DMOG-treated mice. Significantly fewer apoptotic cells were present in the ischemic flaps of DMOG-treated mice. Interestingly, marked increases in circulating endothelial progenitor cells (EPCs) and bone marrow proliferative progenitor cells were observed within 48 hr after DMOG treatment. Furthermore, heterozygous HIF-1 alpha-deficient mice exhibited smaller surviving flap areas, fewer circulating EPCs, and larger numbers of apoptotic cells than did wild-type mice, while DMOG pretreatment of the mutant mice completely restored these parameters. Finally, reconstitution of wild-type mice with the heterozygous deficient bone marrow cells significantly decreased skin flap survival. Conclusion: We demonstrated that transient activation of the HIF signaling pathway by a single systemic DMOG treatment upregulates not only anti-apoptotic pathways but also enhances neovascularization with concomitant increase in the numbers of bone marrow-derived progenitor cells.	[Takaku, Mitsuru; Morimoto, Atsushi; Hashimoto, Ichiro; Nakanishi, Hideki] Univ Tokushima, Grad Sch, Dept Plast & Reconstruct Surg, Tokushima 770, Japan; [Tomita, Shuhei; Kihira, Yoshitaka; Ikeda, Yasumasa; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Dept Pharmacol, Tokushima 770, Japan; [Kurobe, Hirotsugu] Univ Tokushima, Grad Sch, Dept Cardiovasc Surg, Tokushima 770, Japan; [Higashida, Mayuko] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 770, Japan; [Ushiyama, Akira] Natl Inst Publ Hlth, Dept Environm Hlth, Saitama, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; National Institute of Public Health - Japan	Takaku, M (corresponding author), Univ Tokushima, Grad Sch, Dept Plast & Reconstruct Surg, Tokushima 770, Japan.	tomita@basic.med.tokushima-u.ac.jp	Ushiyama, Akira/AAT-5226-2020; KUROBE, Hirotsugu/ABC-8384-2021	KUROBE, Hirotsugu/0000-0002-5789-5402; Ikeda, Yasumasa/0000-0003-4318-7349	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21590335]; Grants for the Regional Innovation Cluster Program in Japan; Grants-in-Aid for Scientific Research [23790089, 24590381] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants for the Regional Innovation Cluster Program in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants-in-Aid for Scientific Research (C) (to ST, #21590335) and Grants for the Regional Innovation Cluster Program in Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita T, 2003, LAB INVEST, V83, P65, DOI 10.1097/01.LAB.0000050761.67879.E4; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chang EI, 2007, CIRCULATION, V116, P2818, DOI 10.1161/CIRCULATIONAHA.107.715847; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Fadini GP, 2010, CARDIOVASC RES, V87, P12, DOI 10.1093/cvr/cvq119; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Horrevoets AJG, 2009, AM J PATHOL, V174, P1594, DOI 10.2353/ajpath.2009.090198; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Jiang M, 2008, INT J BIOCHEM CELL B, V40, P2284, DOI 10.1016/j.biocel.2008.03.012; Jiang M, 2008, J CELL BIOCHEM, V103, P321, DOI 10.1002/jcb.21416; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Jones CP, 2009, STEM CELLS, V27, P3074, DOI 10.1002/stem.222; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Loinard C, 2009, CIRCULATION, V120, P50, DOI 10.1161/CIRCULATIONAHA.108.813303; Minet E, 2001, FREE RADICAL BIO MED, V31, P847, DOI 10.1016/S0891-5849(01)00657-8; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rey S, 2011, BLOOD, V117, P4988, DOI 10.1182/blood-2010-11-321190; Rey S, 2009, P NATL ACAD SCI USA, V106, P20399, DOI 10.1073/pnas.0911921106; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sendoel A, 2010, NATURE, V465, P577, DOI 10.1038/nature09141; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Ushiyama A, 2004, MICROVASC RES, V68, P147, DOI 10.1016/j.mvr.2004.05.004; Wu RX, 2011, CIRC RES, V108, P60, DOI 10.1161/CIRCRESAHA.110.223115; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang XJ, 2010, WOUND REPAIR REGEN, V18, P193, DOI 10.1111/j.1524-475X.2010.00570.x	33	29	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42964	10.1371/journal.pone.0042964	http://dx.doi.org/10.1371/journal.pone.0042964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880134	Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900064
J	Anthony, KC; Kaur, J; Kak, I; Assi, J; MacMillan, C; Ralhan, R; Walfish, PG				Anthony, K. -C.; Kaur, Jatinder; Kak, Ipshita; Assi, Jasmeet; MacMillan, Christina; Ralhan, Ranju; Walfish, Paul G.			Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; ENDOTHELIAL GROWTH-FACTOR; BRAF V600E MUTATION; CARCINOMAS; RECURRENCE; EXPRESSION; KINASE	Biotinidase was identified in secretome analysis of thyroid cancer cell lines using proteomics. The goal of the current study was to analyze the expression of biotinidase in thyroid cancer tissues and fine needle aspiration (FNA) samples to evaluate its diagnostic and prognostic potential in thyroid cancer. Immunohistochemical analysis of biotinidase was carried out in 129 papillary thyroid cancer (PTC, 34 benign thyroid tissues and 43 FNA samples and correlated with patients' prognosis. Overall biotinidase expression was decreased in PTC compared to benign nodules (p = 0.001). Comparison of aggressive and non-aggressive PTC showed decrease in overall biotinidase expression in the former (p = 0.001). Loss of overall biotinidase expression was associated with poor disease free survival (p = 0.019, Hazards ratio (HR) = 3.1). We examined the effect of subcellular compartmentalization of nuclear and cytoplasmic biotinidase on patient survival. Decreased nuclear expression of biotinidase was observed in PTC as compared to benign tissues (p, 0.001). Upon stratification within PTC, nuclear expression was reduced in aggressive as compared to non-aggressive tumors (p, 0.001). Kaplan-Meier survival analysis showed significant association of loss of nuclear biotinidase expression with reduced disease free survival (p = 0.014, HR = 5.4). Cytoplasmic biotinidase expression was reduced in aggressive thyroid cancers in comparison with non-aggressive tumors (p = 0.002, Odds ratio (OR) = 0.29) which was evident by its significant association with advanced T stage (p = 0.003, OR = 0.28), nodal metastasis (p<0.001, OR = 0.16), advanced TNM stage (p, 0.001, OR = 0.21) and extrathyroidal extension (p = 0.001, OR = 0.23). However, in multivariate analysis extrathyroidal extension emerged as the most significant prognostic marker for aggressive thyroid carcinomas (p = 0.015, HR = 12.8). In conclusion, loss of overall biotinidase expression is a novel marker for thyroid cancer aggressiveness.	[Anthony, K. -C.; Kaur, Jatinder; Kak, Ipshita; Assi, Jasmeet; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Alex & Simona Shnaider Lab Mol Oncol, Dept Pathol & Lab Med, Joseph & Wolf Lebov Hlth Complex, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Anthony, KC (corresponding author), Mt Sinai Hosp, Alex & Simona Shnaider Lab Mol Oncol, Dept Pathol & Lab Med, Joseph & Wolf Lebov Hlth Complex, Toronto, ON M5G 1X5, Canada.	rralhan@mtsinai.on.ca; pwalfish@mtsinai.on.ca	Bhurji, Jatinder K/B-6767-2013; Kak, Ipshita/AAK-8658-2021	Kaur, Jatinder/0000-0003-1650-0707	Mount Sinai Foundation of Toronto; Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Temmy Latner/Dynacare Foundation; Mount Sinai Hospital Department of Medicine Research Fund	Mount Sinai Foundation of Toronto; Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Temmy Latner/Dynacare Foundation; Mount Sinai Hospital Department of Medicine Research Fund	The financial support of this work from Mount Sinai Foundation of Toronto, Da Vinci Gala Fundraiser, Alex and Simona Shnaider Chair in Thyroid Cancer, The Temmy Latner/Dynacare Foundation, and the Mount Sinai Hospital Department of Medicine Research Fund is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carpi A, 2008, CANCER LETT, V264, P163, DOI 10.1016/j.canlet.2008.02.056; Catalano MG, 2012, FRONTIERS IN ENDOCRI, P3; Ciampi R, 2005, ENDOCR PATHOL, V16, P163, DOI 10.1385/EP:16:3:163; Coorough N, 2011, J SURG RES, V170, P48, DOI 10.1016/j.jss.2011.02.048; Durante C, 2007, J CLIN ENDOCR METAB, V92, P2840, DOI 10.1210/jc.2006-2707; Fagin JA, 2004, J ENDOCRINOL, V183, P249, DOI 10.1677/joe.1.05895; Ghossein R, 2009, ARCH PATHOL LAB MED, V133, P683, DOI 10.1043/1543-2165-133.5.683; Guerra A, 2012, J CLIN ENDOCRINOL ME; Huang L, 2011, CANCER-AM CANCER SOC, V117, P3363, DOI 10.1002/cncr.25870; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jo YS, 2006, J CLIN ENDOCR METAB, V91, P3667, DOI 10.1210/jc.2005-2836; Kang UB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-114; Kashat L, 2010, J PROTEOME RES, V9, P5757, DOI 10.1021/pr100529t; Kazaure HS, 2011, ANN SURG ONCOL; Knauf JA, 2011, ONCOGENE, V30, P3153, DOI 10.1038/onc.2011.44; Lee JI, 2012, HEAD NECK; Lee ST, 2012, J CLIN ENDOCRINOL ME; Lennard CM, 2001, SURGERY, V129, P552, DOI 10.1067/msy.2001.112592; Lin JD, 2005, THYROID, V15, P708, DOI 10.1089/thy.2005.15.708; Nagaiah G, 2011, J ONCOL, V2011, DOI 10.1155/2011/542358; Nikiforov YE, 2009, J CLIN ENDOCR METAB, V94, P2092, DOI 10.1210/jc.2009-0247; Pelttari H, 2012, APMIS, V120, P380, DOI 10.1111/j.1600-0463.2011.02844.x; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Ricarte-Filho J, 2012, THYROID; Smallridge RC, 2009, ENDOCR-RELAT CANCER, V16, P17, DOI 10.1677/ERC-08-0154; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Zempleni Janos, 2008, Expert Rev Endocrinol Metab, V3, P715, DOI 10.1586/17446651.3.6.715	27	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40956	10.1371/journal.pone.0040956	http://dx.doi.org/10.1371/journal.pone.0040956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911723	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700027
J	de Waal, CG; Weisglas-Kuperus, N; van Goudoever, JB; Walther, FJ				de Waal, Cornelia G.; Weisglas-Kuperus, Nynke; van Goudoever, Johannes B.; Walther, Frans J.		Neoned Study Grp; LNF Study Grp	Mortality, Neonatal Morbidity and Two Year Follow-Up of Extremely Preterm Infants Born in the Netherlands in 2007	PLOS ONE			English	Article							ANTENATAL CORTICOSTEROIDS; DEVELOPMENTAL-DISABILITY; INTENSIVE-CARE; AGE; OUTCOMES; MANAGEMENT; GESTATION; DISCHARGE; SURVIVAL; CHILDREN	Background: Extremely preterm infants are at high risk of neonatal mortality and adverse outcome. Survival rates are slowly improving, but increased survival may come at the expense of more handicaps. Methodology/Principal Findings: Prospective population-based cohort study of all infants born at 23 to 27 weeks of gestation in the Netherlands in 2007. 276 of 345 (80%) infants were born alive. Early neonatal death occurred in 96 (34.8%) live born infants, including 61 cases of delivery room death. 29 (10.5%) infants died during the late neonatal period. Survival rates for live born infants at 23, 24, 25 and 26 weeks of gestation were 0%, 6.7%, 57.9% and 71% respectively. 43.1% of 144 surviving infants developed severe neonatal morbidity (retinopathy of prematurity grade >= 3, bronchopulmonary dysplasia and/or severe brain injury). At two years of age 70.6% of the children had no disability, 17.6% was mild disabled and 11.8% had a moderate-to-severe disability. Severe brain injury (p = 0.028), retinopathy of prematurity grade >= 3 (p = 0.024), low gestational age (p = 0.019) and non-Dutch nationality of the mother (p = 0.004) increased the risk of disability. Conclusions/Significance: 52% of extremely preterm infants born in the Netherlands in 2007 survived. Surviving infants had less severe neonatal morbidity compared to previous studies. At two years of age less than 30% of the infants were disabled. Disability was associated with gestational age and neonatal morbidity.	[de Waal, Cornelia G.; Walther, Frans J.] Leiden Univ, Med Ctr, Willem Alexander Childrens Hosp, Div Neonatol, Leiden, Netherlands; [Weisglas-Kuperus, Nynke; van Goudoever, Johannes B.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	de Waal, CG (corresponding author), Leiden Univ, Med Ctr, Willem Alexander Childrens Hosp, Div Neonatol, Leiden, Netherlands.	F.J.Walther@lumc.nl	van der Hoeven, Markus/M-8558-2015; van Goudoever, Johannes Bernard/Y-4520-2018; Liem, K.D./L-4489-2015	van der Hoeven, Markus/0000-0002-3978-256X; van Goudoever, Johannes (Hans)/0000-0003-3960-1703; Walther, Frans/0000-0003-1931-159X				AGUILAR T, 1995, PUBLIC HEALTH REP, V110, P327; [Anonymous], 2005, BAYLEY SCALES INFANT; [Anonymous], 2009, GROSS MOT FUNCT CLAS; Austeng D, 2010, ACTA PAEDIATR, V99, P978, DOI 10.1111/j.1651-2227.2010.01846.x; Bader D, 2010, PEDIATRICS, V125, P696, DOI 10.1542/peds.2009-1607; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Chan K, 2001, AM J OBSTET GYNECOL, V185, P220, DOI 10.1067/mob.2001.115280; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; De Groote I, 2007, OBSTET GYNECOL, V110, P855, DOI 10.1097/01.AOG.0000284447.43442.55; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; GARITE TJ, 1992, AM J OBSTET GYNECOL, V166, P646, DOI 10.1016/0002-9378(92)91691-3; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2009, PEDIATRICS, V124, pE249, DOI 10.1542/peds.2008-3743; Larroque B, 2004, ARCH DIS CHILD-FETAL, V89, P139, DOI 10.1136/adc.2002.020396; Leversen KT, 2011, PEDIATRICS, V127, pE630, DOI 10.1542/peds.2010-1001; Leversen KT, 2010, EARLY HUM DEV, V86, P581, DOI 10.1016/j.earlhumdev.2010.07.009; Leviton A, 1999, AM J OBSTET GYNECOL, V181, P1007, DOI 10.1016/S0002-9378(99)70344-3; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Onland W, 2011, AM J PERINAT, V28, P33, DOI 10.1055/s-0030-1262509; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Serenius F, 2004, ACTA PAEDIATR, V93, P1090, DOI [10.1111/j.1651-2227.2004.tb02722.x, 10.1080/08035250410027760]; Sheldon T, 2001, BRIT MED J, V322, P1383, DOI 10.1136/bmj.322.7299.1383; Silver RK, 1996, OBSTET GYNECOL, V87, P683, DOI 10.1016/0029-7844(96)00033-6; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Vanhaesebrouck P, 2004, PEDIATRICS, V114, P663, DOI 10.1542/peds.2003-0903-L; Verloove-Vanhorick SP, 2006, BJOG-INT J OBSTET GY, V113, P13, DOI 10.1111/j.1471-0528.2006.01119.x; Weiner J, 2011, ARCH PEDIAT ADOL MED, V165, P630, DOI 10.1001/archpediatrics.2011.102; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601; World Health Organization, 2011, HLTH STAT HLTH INF S	35	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41302	10.1371/journal.pone.0041302	http://dx.doi.org/10.1371/journal.pone.0041302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911776	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700066
J	Chen, T; Huang, Q; Li, ZL; Zhang, W; Lu, CP; Yao, HC				Chen, Tao; Huang, Qin; Li, Zhaolong; Zhang, Wei; Lu, Chengping; Yao, Huochun			Construction and Characterization of a Streptococcus suis Serotype 2 Recombinant Expressing Enhanced Green Fluorescent Protein	PLOS ONE			English	Article							FLOW-CYTOMETRY; VIRULENCE; BACTERIA; GFP; IDENTIFICATION; PHAGOCYTOSIS; PATHOGEN; TYPE-2; HEMOLYSIN; SUILYSIN	Streptococcus suis serotype 2 (S. suis 2) is an important pathogen, responsible for diverse diseases in swine and humans. To obtain a S. suis 2 strain that can be tracked in vitro and in vivo, we constructed the Egfp-HA9801 recombinant S. suis 2 strain with egfp and spc(r) genes inserted via homologous recombination. To assess the effects of the egfp and spc(r) genes in HA9801, the biochemical characteristics, growth features and virulence in Balb/C mice were compared between the recombinant and the parent HA9801 strain. We detected the EGFP expression from Egfp-HA9801 by epifluorescence microscopy. The results showed that the biochemical characterization and growth features of the Egfp-HA9801 recombinant were highly similar to that of the parent HA9801. We did not find significant differences in lethality (50% lethal dose), morbidity and mortality between the two strains. Furthermore, the bacterial counts in each various tissues of Egfp-HA9801-infected mice displayed similar dynamic compared with the HA9801-infected mice. Our results also showed that the Egfp-HA9801 cells grown at 37 degrees C for 36 h displayed greater green fluorescence signals than the cells grown at 28 degrees C for 36 h and 37 degrees C for 24 h. The fluorescence in the tissue cryosections of Egfp-HA9801-injected mice was also stronger than that of the HA9801 group. Together, these results indicate that the egfp and spc(r) insertions into the Egfp-HA9801 recombinant did not significantly change the virulence when compared with HA980, and this EGFP labeled strain can be used for future S. suis 2 pathogenesis research.	[Chen, Tao; Huang, Qin; Li, Zhaolong; Zhang, Wei; Lu, Chengping; Yao, Huochun] Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Chen, T (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China.	yaohch@njau.edu.cn			Foundation of National Natural Science Foundation of China [30671558]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Foundation of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by The Foundation of National Natural Science Foundation of China (No. 30671558), and The Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthelot-Herault F, 2000, VET RES, V31, P473, DOI 10.1051/vetres:2000133; CHANTER N, 1993, VET MICROBIOL, V36, P39, DOI 10.1016/0378-1135(93)90127-S; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; GOTTSCHALK MG, 1995, MICROBIOL-SGM, V141, P189, DOI 10.1099/00221287-141-1-189; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Heinzelmann M, 1999, MICROBIOL IMMUNOL, V43, P505, DOI 10.1111/j.1348-0421.1999.tb02435.x; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Jean PC, 1995, GENE, V164, P123; Jin Z, 2005, J BIOTECHNOL, V119, P368; Li L, 2008, MICROB PATHOGENESIS, V45, P192, DOI 10.1016/j.micpath.2008.05.008; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Nicholas B, 2001, ANAL BIOCHEM, V291, P175; Normile D, 2005, SCIENCE, V309, P1308; Rodriguez ME, 2001, J IMMUNOL METHODS, V252, P33, DOI 10.1016/S0022-1759(01)00329-5; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Scott KP, 1998, FEMS MICROBIOL ECOL, V26, P219, DOI 10.1111/j.1574-6941.1998.tb00507.x; Shichun L, 2004, J MICROBIOLOGICAL ME, V56, P401; Smith HE, 1999, INFECT IMMUN, V67, P1750; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Stretton S, 1998, APPL ENVIRON MICROB, V64, P2554; Suarez A, 1997, GENE, V196, P69, DOI 10.1016/S0378-1119(97)00197-2; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Tombolini R, 1997, FEMS MICROBIOL ECOL, V22, P17, DOI 10.1111/j.1574-6941.1997.tb00352.x; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Vanier G, 2009, MICROB PATHOGENESIS, V46, P13, DOI 10.1016/j.micpath.2008.10.003; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; WILLIAMS AE, 1990, MICROB PATHOGENESIS, V8, P189, DOI 10.1016/0882-4010(90)90046-S; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	32	2	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39697	10.1371/journal.pone.0039697	http://dx.doi.org/10.1371/journal.pone.0039697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911688	Green Submitted, gold, Green Published			2022-12-27	WOS:000306644600007
J	Decker, LM; Cignetti, F; Potter, JF; Studenski, SA; Stergiou, N				Decker, Leslie M.; Cignetti, Fabien; Potter, Jane F.; Studenski, Stephanie A.; Stergiou, Nicholas			Use of Motor Abundance in Young and Older Adults during Dual-Task Treadmill Walking	PLOS ONE			English	Article							AGE-RELATED-CHANGES; MINI-MENTAL-STATE; PARKINSONS-DISEASE; GAIT VARIABILITY; UNIT DISCHARGE; SPEED; COORDINATION; DISORDERS; ATTENTION; BRAIN	Motor abundance allows individuals to perform any task reliably while being variable in movement's particulars. The study investigated age-related differences in this feature when young adults (YA) and older adults (OA) performed challenging tasks, namely treadmill walking alone and while performing a cognitive task. A goal function for treadmill walking was first defined, i.e., maintain constant speed at each step, which led to a goal equivalent manifold (GEM) containing all combinations of step time and step length that equally satisfied the function. Given the GEM, amounts of goal-equivalent and non-goal-equivalent variability were afterwards determined and used to define an index providing information about the set of effective motor solutions relative to the GEM. The set was limited in OA compared to YA in treadmill walking alone, indicating that OA made less flexible use of motor abundance than YA. However, this differentiation between YA and OA disappeared when concurrently performing the cognitive task. It is proposed that OA might have benefited from cognitive compensation.	[Decker, Leslie M.; Cignetti, Fabien; Stergiou, Nicholas] Univ Nebraska, Nebraska Biomech Core Facil, Omaha, NE 68182 USA; [Cignetti, Fabien] CNRS, Lab Neurosci Cognit, UMR 7291, Marseille, France; [Cignetti, Fabien] Aix Marseille Univ, Marseille, France; [Potter, Jane F.] Univ Nebraska, Div Geriatr, Med Ctr, Omaha, NE 68182 USA; [Studenski, Stephanie A.] Univ Pittsburgh, Div Geriatr Med, Pittsburgh, PA USA; [Stergiou, Nicholas] Univ Nebraska, Coll Publ Hlth Dept, Med Ctr, Omaha, NE 68182 USA	University of Nebraska System; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Nebraska System; University of Nebraska Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Nebraska System; University of Nebraska Medical Center	Decker, LM (corresponding author), Univ Nebraska, Nebraska Biomech Core Facil, Omaha, NE 68182 USA.	leslie.decker@univ-amu.fr	Cignetti, Fabien/P-4551-2015; Decker, Leslie Marion/N-8923-2015	Decker, Leslie Marion/0000-0003-2929-0761; Potter, Jane/0000-0002-4170-4106; Cignetti, Fabien/0000-0002-9050-8056	United States National Institutes of Health [1K99AG033684]; NATIONAL INSTITUTE ON AGING [K99AG033684] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by United States National Institutes of Health grant 1K99AG033684. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2003, HUM BRAIN MAPP, V20, P29, DOI 10.1002/hbm.10126; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Beauchet O, 2003, J AM GERIATR SOC, V51, P1187, DOI 10.1046/j.1532-5415.2003.51385.x; Beauchet O, 2008, J AM GERIATR SOC, V56, P1265, DOI 10.1111/j.1532-5415.2008.01766.x; Beauchet Olivier, 2005, J Neuroeng Rehabil, V2, P26, DOI 10.1186/1743-0003-2-26; Beauchet O, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-32; Bernard JA, 2012, NEUROBIOL AGING, V33, P1890, DOI 10.1016/j.neurobiolaging.2011.06.021; Bernstein N, 1967, COORDINATION REGULAT; Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; Camicioli R, 1997, NEUROLOGY, V48, P955, DOI 10.1212/WNL.48.4.955; Carp J, 2010, FRONT HUM NEUROSCI, V22, P4; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Cusumano JP, 2006, BIOL CYBERN, V94, P367, DOI 10.1007/s00422-006-0052-1; Damouras S, 2010, GAIT POSTURE, V31, P336, DOI 10.1016/j.gaitpost.2009.12.002; Dietz V, 2003, CLIN NEUROPHYSIOL, V114, P1379, DOI 10.1016/S1388-2457(03)00120-2; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2010, GAIT POSTURE, V32, P348, DOI 10.1016/j.gaitpost.2010.06.004; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Domkin D, 2002, EXP BRAIN RES, V143, P11, DOI 10.1007/s00221-001-0944-1; ESCOBAR JI, 1986, J NERV MENT DIS, V174, P607, DOI 10.1097/00005053-198610000-00005; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goodglass H., 1983, BOSTON NAMING TEST; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hausdorff JM, 1997, ARCH PHYS MED REHAB, V78, P278, DOI 10.1016/S0003-9993(97)90034-4; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; HAWKINS KA, 1993, ARCH CLIN NEUROPSYCH, V8, P525, DOI 10.1016/0887-6177(93)90053-4; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Hill KD, 1996, ARCH PHYS MED REHAB, V77, P1025, DOI 10.1016/S0003-9993(96)90063-5; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hodges JR, 2005, COGNITIVE ASSESSMENT; Hollman JH, 2007, GAIT POSTURE, V26, P113, DOI 10.1016/j.gaitpost.2006.08.005; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kahneman D., 1973, ATTENTION EFFORT; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Killgore WDS, 1999, PERCEPT MOTOR SKILL, V89, P327, DOI 10.2466/PMS.89.5.327-337; Latash M, 2000, MOTOR CONTROL, V4, P259, DOI 10.1123/mcj.4.3.259; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Latash ML, 2008, SYNERGY; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Lindenberger U, 2000, PSYCHOL AGING, V15, P417, DOI 10.1037//0882-7974.15.3.417; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Lovden M, 2008, J GERONTOL B-PSYCHOL, V63, pP121; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; Morris ME, 2001, ADV NEUROL, V87, P347; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Nielsen JB, 2003, NEUROSCIENTIST, V9, P195, DOI 10.1177/1073858403009003012; NIGG BM, 1993, J BIOMECH, V26, P909, DOI 10.1016/0021-9290(93)90053-H; Olafsdottir H, 2007, J APPL PHYSIOL, V102, P1490, DOI 10.1152/japplphysiol.00966.2006; Pahapill PA, 2000, BRAIN, V123, P1767, DOI 10.1093/brain/123.9.1767; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Randolph C, 1999, ARCH CLIN NEUROPSYCH, V14, P489, DOI 10.1016/S0887-6177(98)00023-7; Reisman DS, 2003, BRAIN, V126, P2510, DOI 10.1093/brain/awg246; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Shim JK, 2004, J APPL PHYSIOL, V97, P213, DOI 10.1152/japplphysiol.00045.2004; Shinohara M, 2004, EXP BRAIN RES, V156, P282, DOI 10.1007/s00221-003-1786-9; Snijders AH, 2007, LANCET NEUROL, V6, P63, DOI 10.1016/S1474-4422(06)70678-0; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Strauss E, 2006, COMPENDIUM NEUROPSYC; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tracy BL, 2005, MUSCLE NERVE, V32, P533, DOI 10.1002/mus.20392; Trebuchon-Da Fonseca A, 2009, BRAIN, V132, P2772, DOI 10.1093/brain/awp083; Vaillancourt DE, 2003, NEUROBIOL AGING, V24, P25, DOI 10.1016/S0197-4580(02)00014-3; Vaughan C., 1999, DYNAMICS HUMAN GAIT; Verrel J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.006; Verrel J, 2009, PSYCHOL AGING, V24, P75, DOI 10.1037/a0014272; Weschler D, 1981, WECHSLER ADULT INTEL; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Yordanova J, 2004, BRAIN, V127, P351, DOI 10.1093/brain/awh042	79	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41306	10.1371/journal.pone.0041306	http://dx.doi.org/10.1371/journal.pone.0041306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911777	gold, Green Published			2022-12-27	WOS:000306644600069
J	Jonsson, CB; Camp, JV; Wu, A; Zheng, HY; Kraenzle, JL; Biller, AE; Vanover, CD; Chu, YK; Ng, CK; Proctor, M; Sherwood, L; Steffen, MC; Mollura, DJ				Jonsson, Colleen B.; Camp, Jeremy V.; Wu, Albert; Zheng, Huaiyu; Kraenzle, Jennifer L.; Biller, Ashley E.; Vanover, Carol D.; Chu, Yong-Kyu; Ng, Chin K.; Proctor, Mary; Sherwood, Leslie; Steffen, Marlene C.; Mollura, Daniel J.			Molecular Imaging Reveals a Progressive Pulmonary Inflammation in Lower Airways in Ferrets Infected with 2009 H1N1 Pandemic Influenza Virus	PLOS ONE			English	Article							A H1N1; RECEPTOR SPECIFICITY; CELL TROPISM; HEMAGGLUTININ; D222G; SUBSTITUTION; PROFILES	Molecular imaging has gained attention as a possible approach for the study of the progression of inflammation and disease dynamics. Herein we used [F-18]-2-deoxy-2-fluoro-D-glucose ([F-18]-FDG) as a radiotracer for PET imaging coupled with CT (FDG-PET/CT) to gain insight into the spatiotemporal progression of the inflammatory response of ferrets infected with a clinical isolate of a pandemic influenza virus, H1N1 (H1N1pdm). The thoracic regions of mock-and H1N1pdm-infected ferrets were imaged prior to infection and at 1, 2, 3 and 6 days post-infection (DPI). On 1 DPI, FDG-PET/CT imaging revealed areas of consolidation in the right caudal lobe which corresponded with elevated [F-18]-FDG uptake (maximum standardized uptake values (SUVMax), 4.7-7.0). By days 2 and 3, consolidation (CT) and inflammation ([F-18]-FDG) appeared in the left caudal lobe. By 6 DPI, CT images showed extensive areas of patchy ground-glass opacities (GGO) and consolidations with the largest lesions having high SUVMax (6.0-7.6). Viral shedding and replication were detected in most nasal, throat and rectal swabs and nasal turbinates and lungs on 1, 2 and 3 DPI, but not on day 7, respectively. In conclusion, molecular imaging of infected ferrets revealed a progressive consolidation on CT with corresponding [F-18]-FDG uptake. Strong positive correlations were measured between SUVMax and bronchiolitis-related pathologic scoring (Spearman's rho = 0.75). Importantly, the extensive areas of patchy GGO and consolidation seen on CT in the ferret model at 6 DPI are similar to that reported for human H1N1pdm infections. In summary, these first molecular imaging studies of lower respiratory infection with H1N1pdm show that FDG-PET can give insight into the spatiotemporal progression of the inflammation in real-time.	[Jonsson, Colleen B.; Camp, Jeremy V.; Kraenzle, Jennifer L.; Biller, Ashley E.; Vanover, Carol D.; Chu, Yong-Kyu; Steffen, Marlene C.] Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA; [Jonsson, Colleen B.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Wu, Albert; Mollura, Daniel J.] NIH, Ctr Infect Dis Imaging, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Zheng, Huaiyu; Ng, Chin K.] Univ Louisville, Dept Radiol, Louisville, KY 40292 USA; [Proctor, Mary; Sherwood, Leslie] Univ Louisville, Dept Res Resources Facil, Louisville, KY 40292 USA	University of Louisville; University of Louisville; National Institutes of Health (NIH) - USA; University of Louisville; University of Louisville	Jonsson, CB (corresponding author), Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA.	cbjons01@louisville.edu	Jonsson, Colleen/X-2360-2019; Camp, Jeremy V./AAS-6184-2020; Jonsson, Colleen/GPC-4424-2022	Camp, Jeremy V./0000-0002-9040-5786; Jonsson, Colleen/0000-0002-2640-7672	Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville; Clinical Research Training Program; United States National Institutes of Health (NIH); Pfizer Inc.; Center for Infectious Disease Imaging in the Intramural Research Program of the NIH	Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville; Clinical Research Training Program; United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Inc.(Pfizer); Center for Infectious Disease Imaging in the Intramural Research Program of the NIH	Financial support was provided in part by the Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville to C.B.J., the Clinical Research Training Program (a public-private partnership supported jointly by the United States National Institutes of Health (NIH) and Pfizer Inc. via a grant to the Foundation for NIH from Pfizer Inc.), and the Center for Infectious Disease Imaging in the Intramural Research Program of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PP, 2009, AM J ROENTGENOL, V193, P1488, DOI 10.2214/AJR.09.3599; Anton A, 2010, DIAGN MICR INFEC DIS, V67, P207, DOI 10.1016/j.diagmicrobio.2010.02.002; Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; Bellani G, 2010, INTENS CARE MED, V36, P717, DOI 10.1007/s00134-010-1756-1; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Bray M, 2011, J INFECT DIS, V203, P1348, DOI 10.1093/infdis/jir038; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Chen DL, 2006, J APPL PHYSIOL, V100, P1602, DOI 10.1152/japplphysiol.01429.2005; Chen DL, 2004, AM J PHYSIOL-LUNG C, V286, pL834, DOI 10.1152/ajplung.00339.2003; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Davis SL, 2009, ANTIMICROB AGENTS CH, V53, P4879, DOI 10.1128/AAC.00789-09; Davis SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006297; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jones HA, 1997, EUR RESPIR J, V10, P795; Jones HA, 1998, AM J RESP CRIT CARE, V158, P620, DOI 10.1164/ajrccm.158.2.9711075; Kilander A, 2010, EURO SURVEILL, V15; Kroeze EJBV, 2011, J GEN VIROL, V92, P1854, DOI 10.1099/vir.0.032805-0; Kuster SP, 2010, EUR J CLIN MICROBIOL, V29, P835, DOI 10.1007/s10096-010-0935-x; LEE EJ, 1982, LAB ANIM, V16, P133, DOI 10.1258/002367782781110241; Lee NLS, 2009, HONG KONG MED J, V15, P38; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Louie JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018221; Lucker LM, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13177; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Mollura DJ, 2010, J AM COLL RADIOL, V7, P690, DOI 10.1016/j.jacr.2010.01.007; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; O'Donnell CD, 2011, MICROBES INFECT, V13, P502, DOI 10.1016/j.micinf.2011.01.014; Patel M, 2010, BRIT J ANAESTH, V104, P128, DOI 10.1093/bja/aep375; Qureshi NR, 2006, J THORAC IMAG, V21, P259, DOI 10.1097/01.rti.0000213573.94032.53; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Salem N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000827; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Shim SS, 2011, CLIN RADIOL, V66, P118, DOI 10.1016/j.crad.2010.07.011; Shope RE, 1934, J EXP MED, V60, P49, DOI 10.1084/jem.60.1.49; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785	47	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40094	10.1371/journal.pone.0040094	http://dx.doi.org/10.1371/journal.pone.0040094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911695	gold, Green Submitted, Green Published			2022-12-27	WOS:000306644600014
J	Pan, H; Cui, BL; Zhang, DG; Farrar, J; Law, F; Ba-Thein, W				Pan, Hui; Cui, Binglin; Zhang, Dangui; Farrar, Jeremy; Law, Frieda; Ba-Thein, William			Prior Knowledge, Older Age, and Higher Allowance Are Risk Factors for Self-Medication with Antibiotics among University Students in Southern China	PLOS ONE			English	Article							ANTIMICROBIAL DRUGS; RESISTANCE; CHILDREN; COMMUNITY; ANTIMALARIALS; POPULATION; NIGERIA; EUROPE	Background: Self-medication with antibiotics (SMA) has been reported among university students in many countries, but little research has been done on this issue in China. The objective of this study was to evaluate knowledge and behaviors of university students and risk factors concerning SMA. Methodology/Principal Findings: Using a novel questionnaire-based data collection instrument, an anonymous online survey was conducted with the students of Shantou University (STU), a university comprising 8 schools/colleges in eastern Guangdong, China. Of 1,300 respondents (13.8% of total eligible participants), 47.8% had self-treated with antibiotics. Logistic regression analysis identified prior knowledge of antibiotics (PKA), older age, and higher monthly allowance as independent risk factors for SMA. PKA significantly influenced students' knowledge about antibiotics, their uses, and common adverse reactions (all p, 0.05). Among self-medicated students, 61.7% used antibiotics at least twice in the previous year. Community pharmacies were the major source of self-prescribed antibiotics. Reported common indications for SMA were sore throat (59.7%), fever (38.2%), cough (37.4%), runny nose (29.3%), and nasal congestion (28.7%). While 74.1% of self-medication episodes were based on students' own experiences, only 31.1% of students claimed to understand the package insert. Alteration of antibiotics and dosage during the course of self-treatment was made by 63.8% and 55.6% of students, respectively. At least two kinds of antibiotics were simultaneously taken by 82.6% of students. The majority of self-medicated students failed to complete the course of antibiotics. Adverse reactions were reported by 16.3% of students. Amoxicillin was the most common antibiotic used for self-medication. Conclusions: High prevalence of SMA was noted among STU students. Presence of risk factors and risk-associated behaviors/attitudes in the study population calls for focused educational intervention and stricter governmental legislation and regulation of antibiotic use and sale in pharmacies.	[Pan, Hui; Cui, Binglin; Zhang, Dangui; Farrar, Jeremy; Ba-Thein, William] Shantou Univ, Shantou Oxford Clin Res Unit, Coll Med, Shantou, Guangdong, Peoples R China; [Farrar, Jeremy] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Law, Frieda] Shantou Univ, Consultant Off, Coll Med, Shantou, Guangdong, Peoples R China; [Ba-Thein, William] Shantou Univ, Dept Microbiol & Immunol, Coll Med, Shantou, Guangdong, Peoples R China	Shantou University; University of Oxford; Shantou University; Shantou University	Pan, H (corresponding author), Shantou Univ, Shantou Oxford Clin Res Unit, Coll Med, Shantou, Guangdong, Peoples R China.	wbathein@stu.edu.cn	Farrar, Jeremy J./HGA-7610-2022; Zhang, Dangui/CAE-9930-2022	Farrar, Jeremy/0000-0002-2700-623X; Pan, Hui/0000-0001-6873-5749	Li Ka Shing Foundation; Shantou University Medical College; Li Ka Shing Foundation-University of Oxford Global Health Programme [B9RSRT0-14]	Li Ka Shing Foundation; Shantou University Medical College; Li Ka Shing Foundation-University of Oxford Global Health Programme	This study was supported by the Li Ka Shing Foundation, Shantou University Medical College, and the Li Ka Shing Foundation-University of Oxford Global Health Programme (grant no. B9RSRT0-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Azzam Sayer I., 2007, International Journal of Occupational Medicine and Environmental Health, V20, P373, DOI 10.2478/v10001-007-0038-9; Awad A, 2005, J PHARM PHARM SCI, V8, P326; Awad AI, 2007, ANN PHARMACOTHER, V41, P1249, DOI 10.1345/aph.1K068; Bi P, 2000, SOC SCI MED, V50, P1445, DOI 10.1016/S0277-9536(99)00304-4; Buke AC, 2003, INT J ANTIMICROB AG, V21, P63, DOI 10.1016/S0924-8579(02)00272-8; Buke C, 2005, J INFECTION, V51, P135, DOI 10.1016/j.jinf.2004.12.001; Chen Q, 2008, J NW U NATL NATURAL, V29, P90; Chen Y, 2003, CHINESE RURAL HLTH S, V23, P52; Duong DV, 1997, TROP MED INT HEALTH, V2, P1133, DOI 10.1046/j.1365-3156.1997.d01-213.x; Esimone CO, 2007, PHARM WORLD SCI, V29, P655, DOI 10.1007/s11096-007-9124-0; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Hadi U, 2008, INT J INFECT DIS, V12, P622, DOI 10.1016/j.ijid.2008.01.002; Han F, 2011, J LIAONING U TCM, V13, P139; Harbarth S, 2005, EMERG INFECT DIS, V11, P794, DOI 10.3201/eid1106.050167; Kristiansson C, 2008, TROP MED INT HEALTH, V13, P434, DOI 10.1111/j.1365-3156.2008.02019.x; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Larsson M, 2000, TROP MED INT HEALTH, V5, P711, DOI 10.1046/j.1365-3156.2000.00630.x; Lewis K, 2009, CAN MED ASSOC J, V181, pE237, DOI 10.1503/cmaj.109-3070; Li J, 2008, CHINESE MED ETHICS, V21, P94; Li M, 2011, SOCIAL SCI J U SHANX, V23, P17; Liu M, 2009, J PEDIAT PHARM, V15, P34; McNulty CAM, 2006, EMERG INFECT DIS, V12, P1523, DOI 10.3201/eid1210.051471; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Mu S, 2001, CLIN FOCUS, V16, P540; Sapkota AR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-610; SCHORLING JB, 1991, INT J EPIDEMIOL, V20, P293, DOI 10.1093/ije/20.1.293; Skliros E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-58; Togoobaatar G, 2010, B WORLD HEALTH ORGAN, V88, P930, DOI 10.2471/BLT.10.079004; Xing Y, 2007, CHINESE J SCH DOCTOR, V21, P287; [徐京杭 XU Jinghang], 2007, [中国实用内科杂志, Chinese Journal of Practical Internal Medicine], V27, P1692; Ye L, 2005, CHINESE NURSING RES, V19, P2373; 杨永弘, 2002, [中国实用儿科杂志, Chinese Journal of Practical Pediatrics], V17, P148	33	83	85	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41314	10.1371/journal.pone.0041314	http://dx.doi.org/10.1371/journal.pone.0041314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911779	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600070
J	Sharifmoghadam, MR; Curto, MA; Hoya, M; de Leon, N; Martin-Garcia, R; Doncel, C; Valdivieso, MH				Sharifmoghadam, Mohammad Reza; Curto, M-Angeles; Hoya, Marta; de Leon, Nagore; Martin-Garcia, Rebeca; Doncel, Cristina; Valdivieso, M-Henar			The Integrity of the Cytokinesis Machinery under Stress Conditions Requires the Glucan Synthase Bgs1p and Its Regulator Cfh3p	PLOS ONE			English	Article							FISSION-YEAST; CELL-DIVISION; CONTRACTILE RING; OSMOTIC-STRESS; PRIMARY SEPTUM; ACTOMYOSIN RING; KINASE PATHWAYS; PROTEIN-KINASE; POLO KINASE; TIP GROWTH	In yeast, cytokinesis requires coordination between nuclear division, acto-myosin ring contraction, and septum synthesis. We studied the role of the Schizosaccharomyces pombe Bgs1p and Cfh3p proteins during cytokinesis under stress conditions. Cfh3p formed a ring in the septal area that contracted during mitosis; Cfh3p colocalized and co-immunoprecipitated with Cdc15p, showing that Cfh3p interacted with the contractile acto-myosin ring. In a wild-type strain, a significant number of contractile rings collapsed under stress conditions and this number increased dramatically in the cfh3 Delta, bgs1cps1-191, and cfh3 Delta bgs1/cps1-191. Our results show that after osmotic shock Cfh3p is essential for the stability of the (1,3) glucan synthase Bgs1p in the septal area, but not at the cell poles. Finally, cells adapted to stress; they repaired their contractile rings and re-localized Bgs1p to the cell surface some time after osmotic shock. A detailed analysis of the cytokinesis machinery in the presence of KCl revealed that the actomyosin ring collapsed before Bgs1p was internalized, and that it was repaired before Bgs1p re-localized to the cell surface. In the cfh3 Delta, bgs1/cps1-191, and cfh3 Delta bgs1/cps1-191 mutants, which have reduced glucan synthesis, the damage produced to the ring had stronger consequences, suggesting that an intact primary septum contributes to ring stability. The results show that the contractile actomyosin ring is very sensitive to stress, and that cells have efficient mechanisms to remedy the damage produced in this structure.	[Sharifmoghadam, Mohammad Reza; Curto, M-Angeles; Hoya, Marta; de Leon, Nagore; Martin-Garcia, Rebeca; Doncel, Cristina; Valdivieso, M-Henar] Univ Salamanca, Dept Microbiol & Genet, Inst Biol Func & Genom, Consejo Super Invest Cient, E-37008 Salamanca, Spain; [Sharifmoghadam, Mohammad Reza] Univ Zabol, Fac Vet Med, Zabol, Iran	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Sharifmoghadam, MR (corresponding author), Univ Salamanca, Dept Microbiol & Genet, Inst Biol Func & Genom, Consejo Super Invest Cient, E-37008 Salamanca, Spain.	henar@usal.es	Angeles, Maria/HCH-1574-2022; Sharifmoghadam, Mohammad Reza/AAI-8210-2021; Valdivieso, M.-Henar/B-5199-2017; Martín-García, Rebeca/H-5547-2015	Sharifmoghadam, Mohammad Reza/0000-0002-3638-0653; Valdivieso, M.-Henar/0000-0002-6857-7493; Martín-García, Rebeca/0000-0001-8318-2898; Curto, Maria Angeles/0000-0002-0306-382X; Hoya, Marta/0000-0002-3186-2514; Doncel, Cristina/0000-0002-1592-3583	Fundacion Ramon Areces; Comision Interministerial de Ciencia y Tecnologia (CICYT) (Spain)/European Union FEDER (Fondo Europeo de Desarrollo Regional) program [BFU2007-61866]; Junta de Castilla y Leon; Formacion de Personal Investigador (FPU) fellowship; FPU fellowship from the Ministry of Science; Junta de Ampliacion de Estudios fellowship Ministry of Science; Consejo Superior de Investigaciones Cientificas (CSIC), Spain	Fundacion Ramon Areces; Comision Interministerial de Ciencia y Tecnologia (CICYT) (Spain)/European Union FEDER (Fondo Europeo de Desarrollo Regional) program; Junta de Castilla y Leon(Junta de Castilla y Leon); Formacion de Personal Investigador (FPU) fellowship(Spanish Government); FPU fellowship from the Ministry of Science; Junta de Ampliacion de Estudios fellowship Ministry of Science; Consejo Superior de Investigaciones Cientificas (CSIC), Spain	Financial support to the Instituto de Biologia Funcional y Genomica (IBFG) from the Fundacion Ramon Areces and to our group from the Comision Interministerial de Ciencia y Tecnologia (CICYT) (Spain)/European Union FEDER (Fondo Europeo de Desarrollo Regional) program (grant BFU2007-61866) made this work possible. Dr. Curto was supported by a contract for training in research and technological innovation by Junta de Castilla y Leon and by Formacion de Personal Investigador (FPU) fellowship. Dr. de Leon and Dr. Hoya were supported by FPU and Junta de Ampliacion de Estudios (JAE)-PREDOC fellowships from the Ministry of Science and Consejo Superior de Investigaciones Cientificas (CSIC), Spain, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Balasubramanian MK, 2000, J CELL SCI, V113, P1503; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Burgess DR, 2005, TRENDS CELL BIOL, V15, P156, DOI 10.1016/j.tcb.2005.01.006; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; Daga RR, 2005, P NATL ACAD SCI USA, V102, P8228, DOI 10.1073/pnas.0409021102; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Di Ciano C, 2002, AM J PHYSIOL-CELL PH, V283, pC850, DOI 10.1152/ajpcell.00018.2002; Duran A, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P269; FANKHAUSER C, 1995, CELL, V82, P435, DOI 10.1016/0092-8674(95)90432-8; Feierbach B, 2001, CURR OPIN MICROBIOL, V4, P713, DOI 10.1016/S1369-5274(01)00273-9; Garcia I, 2005, BIOL CELL, V97, P569; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goya A, 2011, CYTOSKELETON, V68, P69, DOI 10.1002/cm.20500; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Hales KG, 1999, CURR OPIN CELL BIOL, V11, P717, DOI 10.1016/S0955-0674(99)00042-3; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Kinnunen PKJ, 2000, CELL PHYSIOL BIOCHEM, V10, P243, DOI 10.1159/000016360; Krapp A, 2004, CURR BIOL, V14, pR722, DOI 10.1016/j.cub.2004.08.049; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; Martin-Garcia R, 2003, FEBS LETT, V549, P176, DOI 10.1016/S0014-5793(03)00812-3; Martin-Garcia R, 2006, J CELL SCI, V119, P2768, DOI 10.1242/jcs.02998; Matsuo Y, 2004, YEAST, V21, P1005, DOI 10.1002/yea.1145; Mishra M, 2008, CURR BIOL, V18, pR247, DOI 10.1016/j.cub.2008.01.029; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; Roberts-Galbraith RH, 2010, MOL CELL, V39, P86, DOI 10.1016/j.molcel.2010.06.012; Robertson AM, 2008, J CELL SCI, V121, P4055, DOI 10.1242/jcs.034488; Rupes I, 1999, MOL BIOL CELL, V10, P1495, DOI 10.1091/mbc.10.5.1495; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmidt M, 2002, J CELL SCI, V115, P293; Sharifmoghadam MR, 2009, J BIOL CHEM, V284, P11070, DOI 10.1074/jbc.M808353200; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Soto T, 2007, MICROBIOL-SGM, V153, P1519, DOI 10.1099/mic.0.2006/004283-0; Tatebe H, 2005, CURR BIOL, V15, P1006, DOI 10.1016/j.cub.2005.04.061; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; VerPlank L, 2005, MOL BIOL CELL, V16, P2529, DOI 10.1091/mbc.E04-12-1090; Wolfe BA, 2005, TRENDS CELL BIOL, V15, P10, DOI 10.1016/j.tcb.2004.11.006; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230	52	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42726	10.1371/journal.pone.0042726	http://dx.doi.org/10.1371/journal.pone.0042726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905165	gold, Green Submitted, Green Published			2022-12-27	WOS:000307823600025
J	Zupancic, ML; Cantarel, BL; Liu, ZQ; Drabek, EF; Ryan, KA; Cirimotich, S; Jones, C; Knight, R; Walters, WA; Knights, D; Mongodin, EF; Horenstein, RB; Mitchell, BD; Steinle, N; Snitker, S; Shuldiner, AR; Fraser, CM				Zupancic, Margaret L.; Cantarel, Brandi L.; Liu, Zhenqiu; Drabek, Elliott F.; Ryan, Kathleen A.; Cirimotich, Shana; Jones, Cheron; Knight, Rob; Walters, William A.; Knights, Daniel; Mongodin, Emmanuel F.; Horenstein, Richard B.; Mitchell, Braxton D.; Steinle, Nanette; Snitker, Soren; Shuldiner, Alan R.; Fraser, Claire M.			Analysis of the Gut Microbiota in the Old Order Amish and Its Relation to the Metabolic Syndrome	PLOS ONE			English	Article							OBESITY; PREVOTELLA	Obesity has been linked to the human gut microbiota; however, the contribution of gut bacterial species to the obese phenotype remains controversial because of conflicting results from studies in different populations. To explore the possible dysbiosis of gut microbiota in obesity and its metabolic complications, we studied men and women over a range of body mass indices from the Old Order Amish sect, a culturally homogeneous Caucasian population of Central European ancestry. We characterized the gut microbiota in 310 subjects by deep pyrosequencing of bar-coded PCR amplicons from the V1-V3 region of the 16S rRNA gene. Three communities of interacting bacteria were identified in the gut microbiota, analogous to previously identified gut enterotypes. Neither BMI nor any metabolic syndrome trait was associated with a particular gut community. Network analysis identified twenty-two bacterial species and four OTUs that were either positively or inversely correlated with metabolic syndrome traits, suggesting that certain members of the gut microbiota may play a role in these metabolic derangements.	[Zupancic, Margaret L.; Cantarel, Brandi L.; Drabek, Elliott F.; Cirimotich, Shana; Jones, Cheron; Mongodin, Emmanuel F.; Fraser, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Ryan, Kathleen A.; Horenstein, Richard B.; Mitchell, Braxton D.; Steinle, Nanette; Snitker, Soren; Shuldiner, Alan R.] Univ Maryland, Sch Med, Program Personalized & Genom Med, Div Endocrinol Diabet & Nutr,Dept Med, Baltimore, MD 21201 USA; [Cantarel, Brandi L.; Mongodin, Emmanuel F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Liu, Zhenqiu] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Knight, Rob; Knights, Daniel] Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Walters, William A.; Steinle, Nanette] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Zupancic, ML (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	cmfraser@som.umaryland.edu	Mitchell, Braxton/CAF-0876-2022; Mongodin, Emmanuel/AAF-1850-2020; Knight, Rob/D-1299-2010; Cantarel, Brandi/ABF-5756-2020	Mongodin, Emmanuel/0000-0003-3833-7437; Cantarel, Brandi/0000-0003-4126-4478; Fraser, Claire/0000-0003-1462-2428; Knight, Rob/0000-0002-0975-9019; Shuldiner, Alan/0000-0001-9921-4305; Mitchell, Braxton/0000-0003-4920-4744	National Institutes of Health [DK83982];  [U01 GM074518];  [P30 DK072488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488, UH2DK083982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work in this study was supported by UH2/UH3 award DK83982 from the National Institutes of Health to CMF-L and ARS, and U01 GM074518 and P30 DK072488 (Mid-Atlantic Nutrition and Obesity Research Center) to ARS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CROSS HE, 1976, NATURE, V262, P17, DOI 10.1038/262017a0; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Desper R, 2006, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi0603s15, DOI 10.1002/0471250953.BI0603S15]; Felsenstein J, PHYLIP PHYLOGENY INF; Ford PJ, 2006, ORAL MICROBIOL IMMUN, V21, P206, DOI 10.1111/j.1399-302X.2006.00276.x; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P238; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Pollin TI, 2008, HUM HERED, V65, P91, DOI 10.1159/000108941; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uyeno Y, 2007, J APPL MICROBIOL, V103, P1995, DOI 10.1111/j.1365-2672.2007.03443.x; Zhou JZ, 2010, MBIO, V1, DOI 10.1128/mBio.00169-10	37	158	165	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43052	10.1371/journal.pone.0043052	http://dx.doi.org/10.1371/journal.pone.0043052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905200	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600044
J	Faircloth, BC; Glenn, TC				Faircloth, Brant C.; Glenn, Travis C.			Not All Sequence Tags Are Created Equal: Designing and Validating Sequence Identification Tags Robust to Indels	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; ERROR-CORRECTING CODES; DNA-POLYMERASE; SHORT-READ; LIBRARIES; FIDELITY; PRIMERS; OLIGONUCLEOTIDES; PERFORMANCE; LIGATION	Ligating adapters with unique synthetic oligonucleotide sequences (sequence tags) onto individual DNA samples before massively parallel sequencing is a popular and efficient way to obtain sequence data from many individual samples. Tag sequences should be numerous and sufficiently different to ensure sequencing, replication, and oligonucleotide synthesis errors do not cause tags to be unrecoverable or confused. However, many design approaches only protect against substitution errors during sequencing and extant tag sets contain too few tag sequences. We developed an open-source software package to validate sequence tags for conformance to two distance metrics and design sequence tags robust to indel and substitution errors. We use this software package to evaluate several commercial and non-commercial sequence tag sets, design several large sets (max(count) = 7,198) of edit metric sequence tags having different lengths and degrees of error correction, and integrate a subset of these edit metric tags to polymerase chain reaction (PCR) primers and sequencing adapters. We validate a subset of these edit metric tagged PCR primers and sequencing adapters by sequencing on several platforms and subsequent comparison to commercially available alternatives. We find that several commonly used sets of sequence tags or design methodologies used to produce sequence tags do not meet the minimum expectations of their underlying distance metric, and we find that PCR primers and sequencing adapters incorporating edit metric sequence tags designed by our software package perform as well as their commercial counterparts. We suggest that researchers evaluate sequence tags prior to use or evaluate tags that they have been using. The sequence tag sets we design improve on extant sets because they are large, valid across the set, and robust to the suite of substitution, insertion, and deletion errors affecting massively parallel sequencing workflows on all currently used platforms.	[Faircloth, Brant C.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA	University of California System; University of California Los Angeles; University System of Georgia; University of Georgia	Faircloth, BC (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	brant@faircloth-lab.org	Glenn, Travis C/A-2390-2008; Faircloth, Brant C/Y-3978-2019	Glenn, Travis C/0000-0001-7725-3637; Faircloth, Brant/0000-0002-1943-0217	Smithsonian Scholarly Studies Grant; National Science Foundation (NSF) [DEB-1136626]; NSF [DEB-0614208]; Amazon Web Services Educational grant; Division Of Environmental Biology [1136626] Funding Source: National Science Foundation	Smithsonian Scholarly Studies Grant; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Amazon Web Services Educational grant; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a Smithsonian Scholarly Studies Grant to Stephen P. Hubbell and BCF, National Science Foundation (NSF) grant DEB-1136626 to BCF and TCG, NSF grant DEB-0614208 to TCG, an Amazon Web Services Educational grant to BCF and TCG, and material (TruSeq-style adapters) and sequencing contributions (HiSeq lanes) from Integrated DNA Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Ashlock D, 2002, IEEE C EVOL COMPUTAT, P1296, DOI 10.1109/CEC.2002.1004430; Ashlock D, 2009, CIBCB: 2009 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P38; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Blumenstiel Brendan, 2010, Curr Protoc Hum Genet, VChapter 18, DOI 10.1002/0471142905.hg1804s66; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Bystrykh LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036852; Chen DH, 1999, NUCLEIC ACIDS RES, V27, P389, DOI 10.1093/nar/27.2.389; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Cole R, 2004, P 36 ANN ACM S THEOR, V91; CONWAY JH, 1986, IEEE T INFORM THEORY, V32, P337, DOI 10.1109/TIT.1986.1057187; Cummings N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-641; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Doyle J. J., 1987, PHYTOCHEM B, P11; DUNNING AM, 1988, NUCLEIC ACIDS RES, V16, P10393, DOI 10.1093/nar/16.21.10393; Eckert K A, 1991, PCR Methods Appl, V1, P17; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gilar M, 2001, ANAL BIOCHEM, V298, P196, DOI 10.1006/abio.2001.5386; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gusfield D., 1997, ALGORITHMS STRINGS T; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Housby JN, 1998, NUCLEIC ACIDS RES, V26, P4259, DOI 10.1093/nar/26.18.4259; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Pon RT, 1996, BIOTECHNIQUES, V21, P680; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Qiu F, 2003, PLANT PHYSIOL, V133, P475, DOI 10.1104/pp.103.025015; Quail MA, 2012, NAT METHODS, V9, P10, DOI 10.1038/nmeth.1814; Roche, 2009, ROCHE TECHNICAL B; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stephen G, 1994, STRING SEARCHING ALG; TEMSAMANI J, 1995, NUCLEIC ACIDS RES, V23, P1841, DOI 10.1093/nar/23.11.1841; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596	56	189	202	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42543	10.1371/journal.pone.0042543	http://dx.doi.org/10.1371/journal.pone.0042543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900027	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900043
J	Kapoor, R; Kakkar, P				Kapoor, Radhika; Kakkar, Poonam			Protective Role of Morin, a Flavonoid, against High Glucose Induced Oxidative Stress Mediated Apoptosis in Primary Rat Hepatocytes	PLOS ONE			English	Article							HYPERGLYCEMIC CONDITIONS; MITOCHONDRIAL; CELLS; PATHWAYS; ACID; INVOLVEMENT; EXTRACT; INJURY	Apoptosis is an early event of liver damage in diabetes and oxidative stress has been linked to accelerate the apoptosis in hepatocytes. Therefore, the compounds that can scavenge ROS may confer regulatory effects on high-glucose induced apoptosis. In the present study, primary rat hepatocytes were exposed to high concentration (40 mM) of glucose. At this concentration decreased cell viability and enhanced ROS generation was observed. Depleted antioxidant status of hepatocytes under high glucose stress was also observed as evident from transcriptional level and activities of antioxidant enzymes. Further, mitochondrial depolarisation was accompanied by the loss of mitochondrial integrity and altered expression of Bax and Bcl-2. Increased translocation of apoptotic proteins like AIF (Apoptosis inducing factor) & Endo-G (endonuclease-G) from its resident place mitochondria to nucleus was also observed. Cyt-c residing in the inter-membrane space of mitochondria also translocated to cytoplasm. These apoptotic proteins initiated caspase activation, DNA fragmentation, chromatin condensation, increased apoptotic DNA content in glucose treated hepatocytes, suggesting mitochondria mediated apoptotic mode of cell death. Morin, a dietary flavonoid from Psidium guajava was effective in increasing the cell viability and decreasing the ROS level. It maintained mitochondrial integrity, inhibited release of apoptotic proteins from mitochondria, prevented DNA fragmentation, chromatin condensation and hypodiploid DNA upon exposure to high glucose. This study confirms the capacity of dietary flavonoid Morin in regulating apoptosis induced by high glucose via mitochondrial mediated pathway through intervention of oxidative stress.	[Kapoor, Radhika; Kakkar, Poonam] Indian Inst Toxicol Res, CSIR, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Kapoor, R (corresponding author), Indian Inst Toxicol Res, CSIR, Lucknow, Uttar Pradesh, India.	poonam_kakkar@yahoo.com			Indian Council of Medical Research, New Delhi; Supra-Institutional Project-08 of Council of Scientific & Industrial Research (CSIR)	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Supra-Institutional Project-08 of Council of Scientific & Industrial Research (CSIR)	This work was supported by Indian Council of Medical Research, New Delhi and Supra-Institutional Project-08 of Council of Scientific & Industrial Research (CSIR). The funding agencies approved the broad study design. They had no role in data collection and analysis, preparation of the manuscript or decision to publish.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; BarathManiKanth Selvaraj, 2010, Journal of Nanobiotechnology, V8, P16, DOI 10.1186/1477-3155-8-16; Bell David S H, 2007, Endocr Pract, V13, P300; Chandrasekaran K, 2010, TOXICOL IN VITRO, V24, P387, DOI 10.1016/j.tiv.2009.10.020; Chen Y, 2010, P NATL ACAD SCI USA, V107, P9035, DOI 10.1073/pnas.0914013107; Chu HL, 2011, FOOD CHEM, V129, P871, DOI 10.1016/j.foodchem.2011.05.037; Cloherty JP, 2012, MANUAL NEONATAL CARE, P22; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; Das J, 2012, AMINO ACIDS, V43, P1509, DOI 10.1007/s00726-012-1225-y; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Han ZM, 2008, AM J PHYSIOL-ENDOC M, V295, pE798, DOI 10.1152/ajpendo.00683.2007; Hornick T, 2008, CLEV CLIN J MED, V75, P153, DOI 10.3949/ccjm.75.2.153; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kamboj SS, 2011, MITOCHONDRION, V11, P214, DOI 10.1016/j.mito.2010.09.014; Kandhare AD, 2012, FITOTERAPIA, V83, P650, DOI 10.1016/j.fitote.2012.01.010; Kapoor R, 2009, ENVIRON TOXICOL PHAR, V27, P62, DOI 10.1016/j.etap.2008.08.007; Kassab A, 2012, BIOCHIMIE; Leal EC, 2009, EXP EYE RES, V88, P983, DOI 10.1016/j.exer.2008.12.010; Leinninger GM, 2004, CELL DEATH DIFFER, V11, P885, DOI 10.1038/sj.cdd.4401429; Li AF, 2009, INVEST OPHTH VIS SCI, V50, P1400, DOI 10.1167/iovs.07-1519; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malfitano C, 2010, EUR J HEART FAIL, V12, P659, DOI 10.1093/eurjhf/hfq053; Meng LD, 2008, ARCH PHARM RES, V31, P357, DOI [10.1007/s12272-001-1164-y, 10.1007/s00000-001-1164-y]; Mokini Z, 2010, DIABETES RES CLIN PR, V87, P313, DOI 10.1016/j.diabres.2009.11.018; Mustapha NM, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/746978; Nigam N, 2010, CANCER CHEMOTH PHARM, V65, P687, DOI 10.1007/s00280-009-1074-x; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Rattanachaikunsopon P, 2010, J MED PLANTS RES, V4, P393; Ricardo KFS, 2001, BRAZ ARCH BIOL TECHN, V44, P263, DOI 10.1590/S1516-89132001000300007; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Samadder A, 2011, EUR J PHARM SCI, V44, P207, DOI 10.1016/j.ejps.2011.07.012; Seglen PO, 1976, METHOD CELL BIOL, V19, P187; Singh BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034200; Sreedharan V, 2009, INVEST NEW DRUG, V27, P21, DOI 10.1007/s10637-008-9136-1; Sun LQ, 2012, NEUROCHEM RES, V37, P996, DOI 10.1007/s11064-011-0695-8; Taneda S, 2010, AM J PHYSIOL-RENAL, V299, pF1451, DOI 10.1152/ajprenal.00637.2009; Thurau M, 2009, J VIROL, V83, P598, DOI 10.1128/JVI.00629-08; Tripathi M, 2010, TOXICOL IN VITRO, V24, P495, DOI 10.1016/j.tiv.2009.09.011; Varma S, 2005, AM J PHYSIOL-HEART C, V289, pH1744, DOI 10.1152/ajpheart.01088.2004; Velagapudi C, 2011, J AM SOC NEPHROL, V22, P262, DOI 10.1681/ASN.2010040352; Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zand RSR, 2000, BREAST CANCER RES TR, V62, P35, DOI 10.1023/A:1006422302173; Zhang Jie, 2009, Shengli Xuebao, V61, P379; Zhang R, 2011, BASIC CLIN PHARMACOL, V108, P63, DOI 10.1111/j.1742-7843.2010.00629.x; Zhang YL, 2011, EUR J PHARMACOL, V670, P325, DOI 10.1016/j.ejphar.2011.08.011	48	117	118	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41663	10.1371/journal.pone.0041663	http://dx.doi.org/10.1371/journal.pone.0041663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899998	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900013
J	Nawaz-Ul-Rehman, MS; Briddon, RW; Fauquet, CM				Nawaz-ul-Rehman, Muhammad Shah; Briddon, Rob W.; Fauquet, Claude M.			A Melting Pot of Old World Begomoviruses and Their Satellites Infecting a Collection of Gossypium Species in Pakistan	PLOS ONE			English	Article							LEAF CURL DISEASE; CASSAVA MOSAIC-VIRUS; YELLOW VEIN DISEASE; MOVEMENT PROTEIN NSP; STRANDED-DNA VIRUSES; MONOPARTITE BEGOMOVIRUSES; PHYLOGENETIC EVIDENCE; FAMILY GEMINIVIRIDAE; NUCLEOTIDE-SEQUENCES; NORTHWESTERN INDIA	CLCuD in southern Asia is caused by a complex of multiple begomoviruses (whitefly transmitted, single-stranded [ ss] DNA viruses) in association with a specific ssDNA satellite; Cotton leaf curl Multan betasatellite (CLCuMuB). A further single ssDNA molecule, for which the collective name alphasatellites has been proposed, is also frequently associated with begomovirus-betasatellite complexes. Multan is in the center of the cotton growing area of Pakistan and has seen some of the worst problems caused by CLCuD. An exhaustive analysis of the diversity of begomoviruses and their satellites occurring in 15 Gossypium species (including G. hirsutum, the mainstay of Pakistan's cotton production) that are maintained in an orchard in the vicinity of Multan has been conducted using phi 29 DNA polymerase-mediated rolling-circle amplification, cloning and sequence analysis. The non-cultivated Gossypium species, including non-symptomatic plants, were found to harbor a much greater diversity of begomoviruses and satellites than found in the cultivated G. hirsutum. Furthermore an African cassava mosaic virus (a virus previously only identified in Africa) DNA-A component and a Jatropha curcas mosaic virus (a virus occurring only in southern India) DNA-B component were identified. Consistent with earlier studies of cotton in southern Asia, only a single species of betasatellite, CLCuMuB, was identified. The diversity of alphasatellites was much greater, with many previously unknown species, in the non-cultivated cotton species than in G. hirsutum. Inoculation of newly identified components showed them to be competent for symptomatic infection of Nicotiana benthamiana plants. The significance of the findings with respect to our understanding of the role of host selection in virus diversity in crops and the geographical spread of viruses by human activity are discussed.	[Nawaz-ul-Rehman, Muhammad Shah; Fauquet, Claude M.] Danforth Plant Sci Ctr, St Louis, MO USA; [Briddon, Rob W.] Natl Inst Biotechnol & Genet Engn, Agr Biotechnol Div, Faisalabad, Pakistan	Donald Danforth Plant Science Center; Pakistan Institute of Engineering & Applied Science	Nawaz-Ul-Rehman, MS (corresponding author), Univ Agr Faisalabad, CABB, Mol Virol Lab, Faisalabad, Pakistan.	iltab@danforthcenter.org	Briddon, Rob W./I-5921-2012; Directorate of CABB, Muhammad Shah Nawaz-ul-Rehman - Associate Professor/AAF-3137-2021	Briddon, Rob W./0000-0001-8738-0365; 	Pak-US linkage program (Pakistan-US Science and Technology Cooperation Program) [PGA-7251-05-007]; Higher Education Commission (Pakistan) under the Foreign Faculty Hiring Program	Pak-US linkage program (Pakistan-US Science and Technology Cooperation Program); Higher Education Commission (Pakistan) under the Foreign Faculty Hiring Program	This project was supported by the Pak-US linkage program (Pakistan-US Science and Technology Cooperation Program) under the contract PGA-7251-05-007. Dr. Briddon is supported by the Higher Education Commission (Pakistan) under the Foreign Faculty Hiring Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar KP, 2010, ANN APPL BIOL, V157, P135, DOI 10.1111/j.1744-7348.2010.00416.x; Alabi OJ, 2008, ARCH VIROL, V153, P1743, DOI 10.1007/s00705-008-0169-8; Amin I, 2006, ARCH VIROL, V151, P2055, DOI 10.1007/s00705-006-0773-4; Amrao L, 2010, VIRUS RES, V153, P161, DOI 10.1016/j.virusres.2010.07.003; Amrao L, 2010, VIRUS RES, V152, P153, DOI 10.1016/j.virusres.2010.06.019; Arguello-Astorga GR, 2001, ARCH VIROL, V146, P1465, DOI 10.1007/s007050170072; Ariyo OA, 2006, J VIROL METHODS, V137, P43, DOI 10.1016/j.jviromet.2006.05.031; Bataille A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002094; Briddon RW, 2008, ARCH VIROL, V153, P763, DOI 10.1007/s00705-007-0013-6; Briddon RW, 2006, VIROLOGY, V344, P198, DOI 10.1016/j.virol.2005.09.042; Briddon RW, 2004, VIROLOGY, V324, P462, DOI 10.1016/j.virol.2004.03.041; Briddon RW, 2003, VIROLOGY, V312, P106, DOI 10.1016/S0042-6822(03)00200-9; Briddon RW, 2000, VIRUS GENES, V20, P19, DOI 10.1023/A:1008151921937; Briddon RW, 2001, VIROLOGY, V285, P234, DOI 10.1006/viro.2001.0949; Brown JK, 2011, VIRUS TAXONOMY, P351; CAMI B, 1978, NUCLEIC ACIDS RES, V5, P2381, DOI 10.1093/nar/5.7.2381; Carvalho MF, 2006, PLANT PHYSIOL, V140, P1317, DOI 10.1104/pp.105.075556; Carvalho MF, 2004, J VIROL, V78, P11161, DOI 10.1128/JVI.78.20.11161-11171.2004; Chatterjee A, 2007, VIRUS GENES, V35, P835, DOI 10.1007/s11262-007-0160-6; Chatterji A, 2000, VIROLOGY, V273, P341, DOI 10.1006/viro.2000.0434; Cui XF, 2005, J VIROL, V79, P10764, DOI 10.1128/JVI.79.16.10764-10775.2005; Das S, 2008, VIRUS GENES, V37, P414, DOI 10.1007/s11262-008-0287-0; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; Duffy S, 2009, J GEN VIROL, V90, P1539, DOI 10.1099/vir.0.009266-0; FAUQUET C, 1990, PLANT DIS, V74, P404, DOI 10.1094/PD-74-0404; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Fauquet CM, 2003, ARCH VIROL, V148, P405, DOI 10.1007/s00705-002-0957-5; Gao SQ, 2010, ARCH VIROL, V155, P607, DOI 10.1007/s00705-010-0625-0; Gilbertson RL, 2003, PLANT CELL, V15, P2578, DOI 10.1105/tpc.015057; Homs M, 2008, VIRUS RES, V136, P124, DOI 10.1016/j.virusres.2008.04.027; Hussain T., 1991, Pakistan Journal of Phytopathology, V3, P57; Idris AM, 2011, J GEN VIROL, V92, P706, DOI 10.1099/vir.0.025288-0; Idris AM, 2004, PHYTOPATHOLOGY, V94, P1068, DOI 10.1094/PHYTO.2004.94.10.1068; Ilyas M, 2010, J GEN VIROL, V91, P2091, DOI 10.1099/vir.0.020404-0; Kirthi N, 2004, ARCH VIROL, V149, P2047, DOI 10.1007/s00705-004-0352-5; Lefeuvre P, 2007, J GEN VIROL, V88, P3458, DOI 10.1099/vir.0.83252-0; Lefeuvre P, 2009, J VIROL, V83, P2697, DOI 10.1128/JVI.02152-08; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Lewis JD, 2010, P NATL ACAD SCI USA, V107, P2491, DOI 10.1073/pnas.0909080107; Li ZH, 2005, PHYTOPATHOLOGY, V95, P902, DOI 10.1094/PHYTO-95-0902; Mansoor S, 2003, PLANT PATHOL, V52, P784, DOI 10.1111/j.1365-3059.2003.00893.x; Mansoor S, 2003, ARCH VIROL, V148, P1969, DOI 10.1007/s00705-003-0149-y; Mansoor S, 1999, VIROLOGY, V259, P190, DOI 10.1006/viro.1999.9766; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; McGarry RC, 2003, PLANT CELL, V15, P1605, DOI 10.1105/tpc.012120; Moffat AS, 1999, SCIENCE, V286, P1835, DOI 10.1126/science.286.5446.1835; Monde G, 2010, ARCH VIROL, V155, P1865, DOI 10.1007/s00705-010-0772-3; Moulherat Christophe, 2002, Journal of Archaeological Science, V29, P1393, DOI 10.1006/jasc.2001.0779; Nahid N, 2008, ARCH VIROL, V153, P1441, DOI 10.1007/s00705-008-0133-7; Nawaz-ul-Rehman MS, 2010, VIROLOGY, V405, P300, DOI 10.1016/j.virol.2010.06.024; Nawaz-Ul-Rehman MS, 2009, J VIROL, V83, P9347, DOI 10.1128/JVI.00795-09; PADIDAM M, 1995, J GEN VIROL, V76, P25, DOI 10.1099/0022-1317-76-1-25; Paprotka T, 2010, VIROLOGY, V404, P148, DOI 10.1016/j.virol.2010.05.003; Patil BL, 2009, MOL PLANT PATHOL, V10, P685, DOI [10.1111/j.1364-3703.2009.00559.x, 10.1111/J.1364-3703.2009.00559.X]; Paul S, 2006, AUSTRALAS PLANT DIS, V1, P29, DOI 10.1071/DN06013; Qazi J, 2007, VIRUS RES, V128, P135, DOI 10.1016/j.virusres.2007.04.002; Rahman M, 2005, PLANT PATHOL, V54, P764, DOI 10.1111/j.1365-3059.2005.01280.x; Rajagopalan PA, 2012, ARCH VIROL, V157, P855, DOI 10.1007/s00705-012-1225-y; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Rojas MR, 1998, CELL, V95, P105, DOI 10.1016/S0092-8674(00)81786-9; Saeed M, 2007, J GEN VIROL, V88, P2881, DOI 10.1099/vir.0.83049-0; Saunders K, 2004, VIROLOGY, V324, P37, DOI 10.1016/j.virol.2004.03.018; Saunders K, 2002, J GEN VIROL, V83, P907, DOI 10.1099/0022-1317-83-4-907; Saunders K, 2002, VIROLOGY, V293, P63, DOI 10.1006/viro.2001.1251; Saunders K, 2001, VIROLOGY, V282, P38, DOI 10.1006/viro.2000.0832; Saunders K, 2008, J GEN VIROL, V89, P3165, DOI 10.1099/vir.0.2008/003848-0; Shahid MS, 2007, ARCH VIROL, V152, P2131, DOI 10.1007/s00705-007-1043-9; STANLEY J, 1983, NATURE, V305, P643, DOI 10.1038/305643a0; STANLEY J, 1983, NATURE, V301, P260, DOI 10.1038/301260a0; Tahir M, 2010, AUSTRALAS PLANT DIS, V5, P21, DOI 10.1071/DN10009; Tahir MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020366; TAMURA K., 2011, MOL BIO EVOL; Tao XR, 2008, J GEN VIROL, V89, P306, DOI 10.1099/vir.0.83388-0; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Wendel JF, 2009, EVOLUTION NATURAL HI, P1; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zaffalon V, 2012, ARCH VIROL, V157, P483, DOI 10.1007/s00705-011-1201-y; Zhou XP, 1998, J GEN VIROL, V79, P915, DOI 10.1099/0022-1317-79-4-915	80	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e40050	10.1371/journal.pone.0040050	http://dx.doi.org/10.1371/journal.pone.0040050			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899988	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900003
J	Yang, GR; Jia, ZJ; Aoyagi, T; McClain, D; Mortensen, RM; Yang, TX				Yang, Guangrui; Jia, Zhanjun; Aoyagi, Toshinori; McClain, Donald; Mortensen, Richard M.; Yang, Tianxin			Systemic PPAR gamma Deletion Impairs Circadian Rhythms of Behavior and Metabolism	PLOS ONE			English	Article							REV-ERB-ALPHA; ACTIVATED RECEPTOR-GAMMA; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); SUPRACHIASMATIC NUCLEUS; ADIPOCYTE DETERMINATION; ESSENTIAL COMPONENTS; INSULIN-RESISTANCE; GENE-EXPRESSION; CLOCK; TRANSCRIPTION	Compelling evidence from both human and animal studies suggests a physiological link between the circadian rhythm and metabolism but the underlying mechanism is still incompletely understood. We examined the role of PPAR gamma, a key regulator of energy metabolism, in the control of physiological and behavioral rhythms by analyzing two strains of whole-body PPAR gamma null mouse models. Systemic inactivation of PPAR gamma was generated constitutively by using Mox2-Cre mice (MoxCre/flox) or inducibly by using the tamoxifen system (EsrCre/flox/TM). Circadian variations in oxygen consumption, CO2 production, food and water intake, locomotor activity, and cardiovascular parameters were all remarkably suppressed in MoxCre/flox mice. A similar phenotype was observed in EsrCre/flox/TM mice, accompanied by impaired rhythmicity of the canonical clock genes in adipose tissues and liver but not skeletal muscles or the kidney. PPAR gamma inactivation in isolated preadipocytes following exposure to tamoxifen led to a similar blockade of the rhythmicity of the clock gene expression. Together, these results support an essential role of PPAR gamma in the coordinated control of circadian clocks and metabolic pathways.	[Yang, Guangrui; Jia, Zhanjun; Aoyagi, Toshinori; McClain, Donald; Yang, Tianxin] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Yang, Guangrui; Jia, Zhanjun; Aoyagi, Toshinori; McClain, Donald; Yang, Tianxin] Salt Lake Vet Affairs Med Ctr, Salt Lake City, UT USA; [Mortensen, Richard M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Yang, Tianxin] Sun Yat Sen Univ, Sch Med, Inst Hypertens, Guangzhou 510275, Guangdong, Peoples R China	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; University of Michigan System; University of Michigan; Sun Yat Sen University	Yang, GR (corresponding author), Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA.	tianxin.yang@hsc.utah.edu	YANG, GUANGRUI/F-9693-2013	YANG, GUANGRUI/0000-0002-8310-8257; McClain, Don/0000-0002-3310-2359	VA Merit Review; National Basic Research Program of China 973 Program [2012CB517600, 2012CB517602]; National Institute of Diabetes and Digestive and Kidney Diseases [DK079162]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079162, P30DK020572] Funding Source: NIH RePORTER	VA Merit Review(US Department of Veterans Affairs); National Basic Research Program of China 973 Program(National Basic Research Program of China); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the VA Merit Review, the National Basic Research Program of China 973 Program 2012CB517600 (No. 2012CB517602), and the National Institute of Diabetes and Digestive and Kidney Diseases DK079162. TY is an Established Investigator from the American Heart Association and Research Career Scientist in Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; CHAWLA A, 1993, J BIOL CHEM, V268, P16265; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gayarre J, 2005, FEBS LETT, V579, P5803, DOI 10.1016/j.febslet.2005.09.069; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Jia ZJ, 2006, CIRC RES, V99, P1243, DOI 10.1161/01.RES.0000251306.40546.08; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Kawada N, 2005, HYPERTENSION; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Koutnikova H, 2003, P NATL ACAD SCI USA, V100, P14457, DOI 10.1073/pnas.2336090100; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lantinga-van Leeuwen IS, 2006, GENESIS, V44, P225, DOI 10.1002/dvg.20207; Lumeng JC, 2007, PEDIATRICS, V120, P1020, DOI 10.1542/peds.2006-3295; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Nakahata Y, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-5; Pande V, 2005, BIOORG MED CHEM LETT, V15, P4057, DOI 10.1016/j.bmcl.2005.06.025; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosen ED, 2000, GENE DEV, V14, P1293; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sanchez-Gomez FJ, 2007, ARCH BIOCHEM BIOPHYS, V457, P150, DOI 10.1016/j.abb.2006.10.032; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shiraki T, 2006, BIOCHEM J, V393, P749, DOI 10.1042/BJ20050930; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Teboul M, 2009, J APPL PHYSIOL, V107, P1965, DOI 10.1152/japplphysiol.00515.2009; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2007, COLD SPRING HARB SYM, V72, P365, DOI 10.1101/sqb.2007.72.047; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	52	64	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e38117	10.1371/journal.pone.0038117	http://dx.doi.org/10.1371/journal.pone.0038117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899986	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900001
J	Zomer, A; Burghout, P; Bootsma, HJ; Hermans, PWM; van Hijum, SAFT				Zomer, Aldert; Burghout, Peter; Bootsma, Hester J.; Hermans, Peter W. M.; van Hijum, Sacha A. F. T.			ESSENTIALS: Software for Rapid Analysis of High Throughput Transposon Insertion Sequencing Data	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CONDITIONALLY ESSENTIAL GENES; IDENTIFICATION; GENOME	High-throughput analysis of genome-wide random transposon mutant libraries is a powerful tool for (conditional) essential gene discovery. Recently, several next-generation sequencing approaches, e.g. Tn-seq/INseq, HITS and TraDIS, have been developed that accurately map the site of transposon insertions by mutant-specific amplification and sequence readout of DNA flanking the transposon insertions site, assigning a measure of essentiality based on the number of reads per insertion site flanking sequence or per gene. However, analysis of these large and complex datasets is hampered by the lack of an easy to use and automated tool for transposon insertion sequencing data. To fill this gap, we developed ESSENTIALS, an open source, web-based software tool for researchers in the genomics field utilizing transposon insertion sequencing analysis. It accurately predicts (conditionally) essential genes and offers the flexibility of using different sample normalization methods, genomic location bias correction, data preprocessing steps, appropriate statistical tests and various visualizations to examine the results, while requiring only a minimum of input and hands-on work from the researcher. We successfully applied ESSENTIALS to in-house and published Tn-seq, TraDIS and HITS datasets and we show that the various pre- and post-processing steps on the sequence reads and count data with ESSENTIALS considerably improve the sensitivity and specificity of predicted gene essentiality.	[Zomer, Aldert; Burghout, Peter; Bootsma, Hester J.; Hermans, Peter W. M.] Radboud Univ Nijmegen, Lab Pediat Infect Dis, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Zomer, Aldert; van Hijum, Sacha A. F. T.] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Hijum, Sacha A. F. T.] Kluyver Ctr Genom Ind Fermentat, NIZO Food Res, Ede, Netherlands; [van Hijum, Sacha A. F. T.] TI Food & Nutr, Wageningen, Netherlands; [van Hijum, Sacha A. F. T.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; NIZO Food Research; Top Institute Food & Nutrition	Zomer, A (corresponding author), Radboud Univ Nijmegen, Lab Pediat Infect Dis, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	a.zomer@cukz.umcn.nl	van Hijum, Sacha/F-6445-2014; Fu, Lixia/B-7429-2009; Hermans, Peter W.M./H-8042-2014	van Hijum, Sacha/0000-0003-0741-2991; Zomer, Aldert/0000-0002-0758-5190	European Commission [274586]; Netherlands Genomics Initiative Horizon Breakthrough [93518023]	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Genomics Initiative Horizon Breakthrough	This work was supported by the European Commission FP7 Marie Curie IEF Action [274586 to AZ] and by the Netherlands Genomics Initiative Horizon Breakthrough [93518023 to PB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brouwer RWW, 2009, BIOINFORMATICS, V25, P139, DOI 10.1093/bioinformatics/btn588; Burghout P, 2007, J BACTERIOL, V189, P6540, DOI 10.1128/JB.00573-07; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; Gallagher LA, 2011, MBIO, V2, DOI 10.1128/mBio.00315-10; Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lee S, 2009, P NATL ACAD SCI USA, V106, P14570, DOI 10.1073/pnas.0903619106; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Mobegi FM, IDENTIFICATION UNPUB; Oh J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001140; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]	26	92	92	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43012	10.1371/journal.pone.0043012	http://dx.doi.org/10.1371/journal.pone.0043012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900082	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900100
J	He, Q; Chen, HL; Huang, L; Dong, JJ; Guo, DG; Mao, MM; Kong, L; Li, Y; Wu, ZX; Lei, W				He, Qiang; Chen, Huiling; Huang, Li; Dong, Jingjing; Guo, Dagang; Mao, Mengmeng; Kong, Liang; Li, Yang; Wu, Zixiang; Lei, Wei			Porous Surface Modified Bioactive Bone Cement for Enhanced Bone Bonding	PLOS ONE			English	Article							HYDROXYAPATITE; POLYMETHYLMETHACRYLATE; PHOSPHATE; CHITOSAN; INGROWTH; CELLS; GLASS; DIFFERENTIATION; PARTICLES; ADHESION	Background: Polymethylmethacrylate bone cement cannot provide an adhesive chemical bonding to form a stable cement-bone interface. Bioactive bone cements show bone bonding ability, but their clinical application is limited because bone resorption is observed after implantation. Porous polymethylmethacrylate can be achieved with the addition of carboxymethylcellulose, alginate and gelatin microparticles to promote bone ingrowth, but the mechanical properties are too low to be used in orthopedic applications. Bone ingrowth into cement could decrease the possibility of bone resorption and promote the formation of a stable interface. However, scarce literature is reported on bioactive bone cements that allow bone ingrowth. In this paper, we reported a porous surface modified bioactive bone cement with desired mechanical properties, which could allow for bone ingrowth. Materials and Methods: The porous surface modified bioactive bone cement was evaluated to determine its handling characteristics, mechanical properties and behavior in a simulated body fluid. The in vitro cellular responses of the samples were also investigated in terms of cell attachment, proliferation, and osteoblastic differentiation. Furthermore, bone ingrowth was examined in a rabbit femoral condyle defect model by using micro-CT imaging and histological analysis. The strength of the implant-bone interface was also investigated by push-out tests. Results: The modified bone cement with a low content of bioactive fillers resulted in proper handling characteristics and adequate mechanical properties, but slightly affected its bioactivity. Moreover, the degree of attachment, proliferation and osteogenic differentiation of preosteoblast cells was also increased. The results of the push-out test revealed that higher interfacial bonding strength was achieved with the modified bone cement because of the formation of the apatite layer and the osseointegration after implantation in the bony defect. Conclusions: Our findings suggested a new bioactive bone cement for prosthetic fixation in total joint replacement.	[He, Qiang; Dong, Jingjing; Li, Yang; Wu, Zixiang; Lei, Wei] Fourth Mil Med Univ, Inst Orthopaed, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Chen, Huiling] Fourth Mil Med Univ, Dept Hlth Serv, Sch Publ Hlth & Mil Prevent, Xian 710032, Shaanxi, Peoples R China; [Huang, Li] Fourth Mil Med Univ, Dept Gen Dent, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China; [Guo, Dagang; Mao, Mengmeng] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Sch Mat Sci & Engn, Xian 710049, Shaanxi, Peoples R China; [Kong, Liang] Fourth Mil Med Univ, Dept Oral & Maxillofacial Surg, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University; Air Force Military Medical University	He, Q (corresponding author), Fourth Mil Med Univ, Inst Orthopaed, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.	wuzixiang@fmmu.edu.cn; fmmuleiwei@gmail.com	chen, hui/HDO-2955-2022	Lei, Wei/0000-0002-7346-6915; Guo, Dagang/0000-0001-8802-5453	Research Fund for the National Natural Science Foundation of China [31170913/C1002]	Research Fund for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Research Fund for the National Natural Science Foundation of China (No.31170913/C1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Samad H, 2011, BIO-MED MATER ENG, V21, P247, DOI 10.3233/BME-2011-0673; Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552; Bernards MT, 2008, J BIOMED MATER RES A, V86A, P779, DOI 10.1002/jbm.a.31650; Fini M, 2002, BIOMATERIALS, V23, P4523, DOI 10.1016/S0142-9612(02)00196-5; FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489, DOI 10.1302/0301-620X.64B4.7096429; FRIEDMAN RJ, 1993, J BONE JOINT SURG AM, V75A, P1086, DOI 10.2106/00004623-199307000-00017; Fujita H, 2000, J BIOMED MATER RES, V49, P273, DOI 10.1002/(SICI)1097-4636(200002)49:2<273::AID-JBM17>3.0.CO;2-Y; GETTLEMAN L, 1980, J DENT RES, V59, P139, DOI 10.1177/00220345800590021001; Ginebra M. P., 1994, Clinical Materials, V17, P99, DOI 10.1016/0267-6605(94)90018-3; Guldberg RE, 2008, BIOMATERIALS, V29, P3757, DOI 10.1016/j.biomaterials.2008.06.018; Guo DG, 2005, BIOMATERIALS, V26, P4073, DOI 10.1016/j.biomaterials.2004.10.032; Heikkila JT, 1996, BIOMATERIALS, V17, P1755, DOI 10.1016/0142-9612(95)00326-6; Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014; HENNIG W, 1979, J BIOMED MATER RES, V13, P89, DOI 10.1002/jbm.820130110; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; *ISO, 1992, 5833 ISO; Ito Y, 2004, J BIOMED MATER RES A, V69A, P454, DOI 10.1002/jbm.a.30014; Itoh S, 2006, BIOMATERIALS, V27, P5572, DOI 10.1016/j.biomaterials.2006.07.007; JASTY M, 1990, J BONE JOINT SURG AM, V72A, P1220, DOI 10.2106/00004623-199072080-00015; Jeong JC, 2004, TOXICOL IN VITRO, V18, P829, DOI 10.1016/j.tiv.2004.05.002; Kawashita M, 2010, ACTA BIOMATER, V6, P3187, DOI 10.1016/j.actbio.2010.02.047; Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022; Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C; Lye KW, 2011, CLIN ORAL IMPLAN RES, V8, P1; Markus DS, 2011, PLOS ONE, V6; MARTENS M, 1980, ARCH ORTHOP TRAUM SU, V97, P111, DOI 10.1007/BF00450933; Moursi AM, 2002, BIOMATERIALS, V23, P133, DOI 10.1016/S0142-9612(01)00088-6; Ohashi KL, 2000, J BIOMED MATER RES, V51, P172, DOI 10.1002/(SICI)1097-4636(200008)51:2<172::AID-JBM5>3.0.CO;2-Y; Qi XP, 2009, J BIOMED MATER RES A, V89A, P980, DOI 10.1002/jbm.a.32054; Ralf S, 1999, BIOMATERIALS, V21, P2137; RAMAKRISHNAN N, 1990, B MATER SCI, V13, P217, DOI 10.1007/BF02744949; Shi M, 2011, J CONTROL RELEASE, V152, P196, DOI 10.1016/j.jconrel.2011.01.029; Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036; Shinzato S, 2001, J BIOMED MATER RES, V54, P491, DOI 10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.3.CO;2-F; Tsukeoka T, 2006, BIOMATERIALS, V27, P3897, DOI 10.1016/j.biomaterials.2006.03.002; Tunney MM, 2008, J MATER SCI-MATER M, V19, P1609, DOI 10.1007/s10856-008-3394-5; Wang W, 2009, ACTA BIOMATER, V5, P3132, DOI 10.1016/j.actbio.2009.04.036; Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6	40	28	31	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42525	10.1371/journal.pone.0042525	http://dx.doi.org/10.1371/journal.pone.0042525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905143	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100046
J	Khan, SU; Gurley, ES; Hossain, MJ; Nahar, N; Sharker, MAY; Luby, SP				Khan, Salah Uddin; Gurley, Emily S.; Hossain, M. Jahangir; Nahar, Nazmun; Sharker, M. A. Yushuf; Luby, Stephen P.			A Randomized Controlled Trial of Interventions to Impede Date Palm Sap Contamination by Bats to Prevent Nipah Virus Transmission in Bangladesh	PLOS ONE			English	Article								Background: Drinking raw date palm sap is a risk factor for human Nipah virus (NiV) infection. Fruit bats, the natural reservoir of NiV, commonly contaminate raw sap with saliva by licking date palm's sap producing surface. We evaluated four types of physical barriers that may prevent bats from contacting sap. Methods: During 2009, we used a crossover design and randomly selected 20 date palm sap producing trees and observed each tree for 2 nights: one night with a bamboo skirt intervention applied and one night without the intervention. During 2010, we selected 120 trees and randomly assigned four types of interventions to 15 trees each: bamboo, dhoincha (local plant), jute stick and polythene skirts covering the shaved part, sap stream, tap and collection pot. We enrolled the remaining 60 trees as controls. We used motion sensor activated infrared cameras to examine bat contact with sap. Results: During 2009 bats contacted date palm sap in 85% of observation nights when no intervention was used compared with 35% of nights when the intervention was used [p<0.001]. Bats were able to contact the sap when the skirt did not entirely cover the sap producing surface. Therefore, in 2010 we requested the sap harvesters to use larger skirts. During 2010 bats contacted date palm sap [2% vs. 83%, p<0.001] less frequently in trees protected with skirts compared to control trees. No bats contacted sap in trees with bamboo (p<0.001 compared to control), dhoincha skirt (p<0.001) or polythene covering (p<0.001), but bats did contact sap during one night (7%) with the jute stick skirt (p<0.001). Conclusion: Bamboo, dhoincha, jute stick and polythene skirts covering the sap producing areas of a tree effectively prevented bat-sap contact. Community interventions should promote applying these skirts to prevent occasional Nipah spillovers to human.	[Khan, Salah Uddin; Gurley, Emily S.; Hossain, M. Jahangir; Nahar, Nazmun; Sharker, M. A. Yushuf; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Luby, Stephen P.] Ctr Dis Control & Prevent CDC, Atlanta, GA USA	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA	Khan, SU (corresponding author), Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.	khansu@icddrb.org	Khan, Salah Uddin/I-4015-2019; Gurley, Emily S/B-7903-2010	Khan, Salah Uddin/0000-0001-5928-9257; Gurley, Emily S/0000-0002-8648-9403; Nahar, Nazmun/0000-0002-4530-6009	United States Centers for Disease Control and Prevention (CDC) [5U01CI00298-05, 3U01CI00628-01]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000298] Funding Source: NIH RePORTER; National Center for Preparedness, Detection, and Control of Infectious Diseases [U01CI000628] Funding Source: NIH RePORTER	United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Preparedness, Detection, and Control of Infectious Diseases(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research study was funded by the United States Centers for Disease Control and Prevention (CDC) grant numbers 5U01CI00298-05 and 3U01CI00628-01. ICDDR,B acknowledges with gratitude the commitment of the CDC to it's research efforts. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or the ICDDR, B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo KE, 2006, FEMS YEAST RES, V6, P30, DOI 10.1111/j.1567-1364.2005.00015.x; Antonova GF, 1997, TREES-STRUCT FUNCT, V11, P462, DOI 10.1007/PL00009687; Glass G.V., 1995, STAT METHODS ED PSYC, V3rd; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Homaira N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013570; ICDDR B, 2010, HLTH SCI B; ICDDRB, 2010, HLTH SCI B; International Centre for Diarrhoeal Disease Research Bangladesh/Government of The People's Republic of Bangladesh, 2011, HSB (Health Science Bulletin), V9, P13; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Khan MSU, 2010, ECOHEALTH, V7, P517, DOI 10.1007/s10393-010-0366-2; Khan Mohammad Ali Reza, 2001, Zoos' Print Journal, V16, P479; KUNDU B. C., 1960, BOT GAZ, V121, P257, DOI 10.1086/336080; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237; Mitra SK, 2010, ACTA HORTIC, V863, P29; Nahar N, 2012, HEALTH PROMOT INT; Nahar N, 2010, ECOHEALTH, V7, P196, DOI 10.1007/s10393-010-0320-3; Olson JG, 2002, EMERG INFECT DIS, V8, P987, DOI 10.3201/eid0809.010515; Rahman Muhammad Aziz, 2011, VECTOR BORNE Z UNPUB; Sun Huizhen, 2006, FRONTIERS FORESTRY C, V1, P387; WACHARAPLUESADE.S, 2009, VECTOR BORNE ZOONOTI; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	24	62	63	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42689	10.1371/journal.pone.0042689	http://dx.doi.org/10.1371/journal.pone.0042689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905160	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100056
J	Park, TS; Huo, JS; Peters, A; Talbot, CC; Verma, K; Zimmerlin, L; Kaplan, IM; Zambidis, ET				Park, Tea Soon; Huo, Jeffrey S.; Peters, Ann; Talbot, C. Conover, Jr.; Verma, Karan; Zimmerlin, Ludovic; Kaplan, Ian M.; Zambidis, Elias T.			Growth Factor-Activated Stem Cell Circuits and Stromal Signals Cooperatively Accelerate Non-Integrated iPSC Reprogramming of Human Myeloid Progenitors	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORK; EMBRYONIC STEM; HEMATOPOIETIC STEM; TRANSCRIPTIONAL NETWORK; DIFFERENTIATED CELLS; SELF-RENEWAL; PLURIPOTENT; EXPRESSION; CHROMATIN; EFFICIENT	Nonviral conversion of skin or blood cells into clinically useful human induced pluripotent stem cells (hiPSC) occurs in only rare fractions (similar to 0.001%-0.5%) of donor cells transfected with non-integrating reprogramming factors. Pluripotency induction of developmentally immature stem-progenitors is generally more efficient than differentiated somatic cell targets. However, the nature of augmented progenitor reprogramming remains obscure, and its potential has not been fully explored for improving the extremely slow pace of non-integrated reprogramming. Here, we report highly optimized four-factor reprogramming of lineage-committed cord blood (CB) myeloid progenitors with bulk efficiencies of similar to 50% in purified episome-expressing cells. Lineage-committed CD33(+)CD45(+)CD34(-) myeloid cells and not primitive hematopoietic stem-progenitors were the main targets of a rapid and nearly complete non-integrated reprogramming. The efficient conversion of mature myeloid populations into NANOG(+)TRA-1-81(+) hiPSC was mediated by synergies between hematopoietic growth factor (GF), stromal activation signals, and episomal Yamanaka factor expression. Using a modular bioinformatics approach, we demonstrated that efficient myeloid reprogramming correlated not to increased proliferation or endogenous Core factor expressions, but to poised expression of GF-activated transcriptional circuits that commonly regulate plasticity in both hematopoietic progenitors and embryonic stem cells (ESC). Factor-driven conversion of myeloid progenitors to a high-fidelity pluripotent state was further accelerated by soluble and contact-dependent stromal signals that included an implied and unexpected role for Toll receptor-NF kappa B signaling. These data provide a paradigm for understanding the augmented reprogramming capacity of somatic progenitors, and reveal that efficient induced pluripotency in other cell types may also require extrinsic activation of a molecular framework that commonly regulates self-renewal and differentiation in both hematopoietic progenitors and ESC.	[Park, Tea Soon; Huo, Jeffrey S.; Peters, Ann; Verma, Karan; Zimmerlin, Ludovic; Kaplan, Ian M.; Zambidis, Elias T.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Park, Tea Soon; Huo, Jeffrey S.; Peters, Ann; Verma, Karan; Zimmerlin, Ludovic; Kaplan, Ian M.; Zambidis, Elias T.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Div Pediat Oncol, Baltimore, MD USA; [Talbot, C. Conover, Jr.] Inst Basic Biomed Sci Johns Hopkins, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Park, TS (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.	ezambid1@jhmi.edu		Huo, Jeffrey/0000-0002-0057-9118	National Institutes of Health (NIH) [1U01HL099775, U01HL100397]; National Cancer Institute (NCI) [CA60441]; Maryland Stem Cell Research Fund [2011-MS CRF II-0008-00, 2007-MSCRF II-0379-00]; NATIONAL CANCER INSTITUTE [T32CA060441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL096220, U01HL100397, K08HL077595, U01HL099775] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Maryland Stem Cell Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from National Institutes of Health (NIH) 1U01HL099775 and U01HL100397 (Dr. Zambidis), the National Cancer Institute (NCI) CA60441 (Dr. Huo), and grants from the Maryland Stem Cell Research Fund (2011-MS CRF II-0008-00 and 2007-MSCRF II-0379-00: Dr. Zambidis; MSCRF Postdoctoral Fellowship: Dr. Park). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Chung YS, 2009, BLOOD, V114, P4968, DOI 10.1182/blood-2009-01-197780; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hasegawa Y, 2011, STEM CELLS, V29, P1196, DOI 10.1002/stem.673; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hu KJ, 2011, BLOOD, V117, pE109, DOI 10.1182/blood-2010-07-298331; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Koh SH, 2005, BIOCHEM BIOPH RES CO, V329, P1039, DOI 10.1016/j.bbrc.2005.02.077; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee J, 2012, ACTIVATION IN PRESS; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Murray LJ, 1999, EXP HEMATOL, V27, P1019, DOI 10.1016/S0301-472X(99)00031-4; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Peters A, 2012, SPRINGER PROTOCOLS H, DOI [10.1007/978-1-61779-267-0, DOI 10.1007/978-1-61779-267-0]; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Taylor T, 2010, STEM CELLS DEV, V19, P1333, DOI 10.1089/scd.2009.0484; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weishaupt H, 2010, BLOOD, V115, P247, DOI 10.1182/blood-2009-07-235176; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yamaguchi M, 2001, EXP HEMATOL, V29, P174, DOI 10.1016/S0301-472X(00)00653-6; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zambidis ET, 2008, BLOOD, V112, P3601, DOI 10.1182/blood-2008-03-144766; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522	56	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42838	10.1371/journal.pone.0042838	http://dx.doi.org/10.1371/journal.pone.0042838			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905176	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100068
J	Vaca, RA; Golicher, DJ; Cayuela, L; Hewson, J; Steininger, M				Vaca, Raul Abel; Golicher, Duncan John; Cayuela, Luis; Hewson, Jenny; Steininger, Marc			Evidence of Incipient Forest Transition in Southern Mexico	PLOS ONE			English	Article							LAND-COVER CHANGE; TROPICAL FOREST; SELVA-LACANDONA; CENTRAL-AMERICA; OUT-MIGRATION; DEFORESTATION; CONSERVATION; DYNAMICS; CHIAPAS; CLASSIFICATION	Case studies of land use change have suggested that deforestation across Southern Mexico is accelerating. However, forest transition theory predicts that trajectories of change can be modified by economic factors, leading to spatial and temporal heterogeneity in rates of change that may take the form of the Environmental Kuznets Curve (EKC). This study aimed to assess the evidence regarding potential forest transition in Southern Mexico by classifying regional forest cover change using Landsat imagery from 1990 through to 2006. Patterns of forest cover change were found to be complex and nonlinear. When rates of forest loss were averaged over 342 municipalities using mixed-effects modelling the results showed a significant (p< 0.001) overall reduction of the mean rate of forest loss from 0.85% per year in the 1990-2000 period to 0.67% in the 2000-2006 period. The overall regional annual rate of deforestation has fallen from 0.33% to 0.28% from the 1990s to 2000s. A high proportion of the spatial variability in forest cover change cannot be explained statistically. However analysis using spline based general additive models detected underlying relationships between forest cover and income or population density of a form consistent with the EKC. The incipient forest transition has not, as yet, resulted in widespread reforestation. Forest recovery remains below 0.20% per year. Reforestation is mostly the result of passive processes associated with reductions in the intensity of land use. Deforestation continues to occur at high rates in some focal areas. A transition could be accelerated if there were a broader recognition among policy makers that the regional rate of forest loss has now begun to fall. The changing trajectory provides an opportunity to actively restore forest cover through stimulating afforestation and stimulating more sustainable land use practices. The results have clear implications for policy aimed at carbon sequestration through reducing deforestation and enhancing forest growth.	[Vaca, Raul Abel; Golicher, Duncan John] El Colegio Frontera Sur, Dept Ecol & Sistemat Terrestre, Div Conservac Biodiversidad, San Cristobal De La Casa, Chiapas, Mexico; [Golicher, Duncan John] Bournemouth Univ, Sch Conservat Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England; [Cayuela, Luis] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Madrid, Spain; [Hewson, Jenny; Steininger, Marc] Conservat Int, Arlington, VA USA	El Colegio de la Frontera Sur (ECOSUR); Bournemouth University; Universidad Rey Juan Carlos; Conservation International	Vaca, RA (corresponding author), El Colegio Frontera Sur, Dept Ecol & Sistemat Terrestre, Div Conservac Biodiversidad, San Cristobal De La Casa, Chiapas, Mexico.	rgenuit@ecosur.mx	Cayuela, Luis/K-7255-2015; Golicher, Duncan/B-4240-2009; Vaca, Raúl/AAF-9324-2020	Cayuela, Luis/0000-0003-3562-2662; Vaca, Raúl/0000-0003-0500-1291	Critical Ecosystem Partnership Fund; Project ReForLan (Restoration of Forest Landscapes for Biodiversity Conservation and Rural Development in the Drylands of Latin America	Critical Ecosystem Partnership Fund; Project ReForLan (Restoration of Forest Landscapes for Biodiversity Conservation and Rural Development in the Drylands of Latin America	This work was financed by: (1) The Critical Ecosystem Partnership Fund (http://www.cepf.net/Pages/default.aspx); and (2) Project ReForLan (Restoration of Forest Landscapes for Biodiversity Conservation and Rural Development in the Drylands of Latin America (http://reforlan.bournemouth.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro-Montiel C., 2010, Tropical and Subtropical Agroecosystems, V12, P605; Alix-Garcia J, 2005, ASSESSMENT MEXICOS P; Angelsen A, 1999, WORLD BANK RES OBSER, V14, P73, DOI 10.1093/wbro/14.1.73; [Anonymous], 2 CONT POBL VIV; [Anonymous], 2002, SELLING FOREST ENV S; [Anonymous], 2011, STAT WORLDS FOR; Aranda Marcelo, 1996, Acta Zoologica Mexicana Nueva Serie, V68, P45; BOUMAN CA, 1994, IEEE T IMAGE PROCESS, V3, P162, DOI 10.1109/83.277898; Bray D. B., 2005, Environment and History, V11, P195, DOI 10.3197/096734005774434584; Bray DB, 2010, LANDSC SER, V10, P85, DOI 10.1007/978-1-4020-9656-3_5; Browder J.O., 1997, RAINFOREST CITIES UR; Castro-Soto G, 2009, WRM B, V144, P21; Castro-Soto G, 2009, PALMA AFRICANA MEXIC; Cayuela L, 2006, INT J REMOTE SENS, V27, P1951, DOI 10.1080/01431160500181788; Cayuela L, 2006, FOREST ECOL MANAG, V226, P208, DOI 10.1016/j.foreco.2006.01.047; Challenger A, 1998, ZONA ECOLOGICA TROPI, P375; Challenger A, 1998, AMBIENTE FISICO ZONA, P269; Chowdhury RR, 2006, APPL GEOGR, V26, P129, DOI 10.1016/j.apgeog.2005.11.004; Christie T, 2007, ORYX, V41, P539, DOI 10.1017/S0030605307000609; Cochrane MA, 2001, CONSERV BIOL, V15, P1515, DOI 10.1046/j.1523-1739.2001.01091.x; Comision Nacional de A reas Naturales Protegidas ( CONANP) & Fondo Mundial Para la Conservacion de la Naturaleza A.C. (FMCN), 2008, SIST MON EV FOND AR; Corbera E, 2009, ECOL ECON, V68, P743, DOI 10.1016/j.ecolecon.2008.06.008; Cortina Sergio, 2006, DEFORESTACION ALTOS; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; De Jong BHJ, 2000, AMBIO, V29, P504, DOI 10.1639/0044-7447(2000)029[0504:CFAPOL]2.0.CO;2; DIRZO R, 1992, CONSERV BIOL, V6, P84, DOI 10.1046/j.1523-1739.1992.610084.x; Elbers C, 2002, ECONOMETRICA, V57, P1027; FAO-Food and Agriculture Organization of the United Nations, 1995, FOR RES ASS 1990 GLO; Flamenco-Sandoval A, 2007, BIOL CONSERV, V138, P131, DOI 10.1016/j.biocon.2007.04.022; GABRIELMORALES J, 2006, GACETA ECOLOGICA, V79, P53; Garcia-Barrios L, 2009, BIOSCIENCE, V59, P863, DOI 10.1525/bio.2009.59.10.8; Gobierno del estado de Tabasco, 2007, MUN HUIM; Grau HR, 2003, BIOSCIENCE, V53, P1159, DOI 10.1641/0006-3568(2003)053[1159:TECOSA]2.0.CO;2; Guevara Sada S, 1999, DOCUMENTOS TRABAJO; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hecht SB, 2006, WORLD DEV, V34, P308, DOI 10.1016/j.worlddev.2005.09.005; Helmer EH, 2000, INT J REMOTE SENS, V21, P2163, DOI 10.1080/01431160050029495; Hernandez Tovilla, 2005, ECOFRONTERAS, V25, P5; INEGI (Instituto Nacional de Estadistica y Geografia), 2000, 12 CENS GEN POBL VIV; Instituto Nacional de Estadistica y Geografia (INEGI), 1990, 11 CENS GEN POBL VIV; Kaimowitz D, 2008, INT FOREST REV, V10, P485, DOI 10.1505/ifor.10.3.485; Kleinn C, 2002, ENVIRON MONIT ASSESS, V73, P17, DOI 10.1023/A:1012659129083; Klepeis P, 2003, ECON GEOGR, V79, P221; Klooster D, 2003, PROF GEOGR, V55, P227; Klooster D, 2000, GLOBAL ENVIRON CHANG, V10, P259, DOI 10.1016/S0959-3780(00)00033-9; Klooster D, 2010, FOREST TRANSITION MO; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; Lambin EF, 2010, LAND USE POLICY, V27, P108, DOI 10.1016/j.landusepol.2009.09.003; Landell-Mills N, 2002, SILVER BULLET FOOLS; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2007, CURR SCI INDIA, V93, P1544; Leimgruber P, 2005, ENVIRON CONSERV, V32, P356, DOI 10.1017/S0376892905002493; Mas J. F., 2004, International Journal of Applied Earth Observation and Geoinformation, V5, P249, DOI 10.1016/j.jag.2004.06.002; MASERA O, 1992, CIENCIA, V43, P151; Masera OR, 1997, CLIMATIC CHANGE, V35, P265, DOI 10.1023/A:1005309908420; Mather AS, 2007, INT FOREST REV, V9, P491, DOI 10.1505/ifor.9.1.491; MATHER AS, 1992, AREA, V24, P367; Mather AS, 2000, GEOGR J, V166, P2, DOI 10.1111/j.1475-4959.2000.tb00002.x; MEDELLIN RA, 1994, CONSERV BIOL, V8, P780, DOI 10.1046/j.1523-1739.1994.08030780.x; Meyfroidt P, 2008, GLOBAL CHANGE BIOL, V14, P1319, DOI 10.1111/j.1365-2486.2008.01575.x; MYERS N, 1980, ENVIRON CONSERV, V7, P101, DOI 10.1017/S0376892900007098; MYERS N, 1991, CLIMATIC CHANGE, V19, P3, DOI 10.1007/BF00142209; NICHOLSON CF, 1995, J DAIRY SCI, V78, P719, DOI 10.3168/jds.S0022-0302(95)76684-X; Ochoa-Gaona S, 2000, APPL GEOGR, V20, P17, DOI 10.1016/S0143-6228(99)00017-X; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pasch R., 2006, TROPICAL CYCLONE REP; Pedroni L, 2003, INT J REMOTE SENS, V24, P91, DOI 10.1080/01431160304998; Perez Sanchez JM, 2011, DESARROLLO LOCAL TRO; Perz SG, 2007, PROF GEOGR, V59, P105, DOI 10.1111/j.1467-9272.2007.00594.x; Pinheiro J, 2009, R PACKAGE NLME LINEA; Puebla-Olivares Fernando, 2002, Ornitologia Neotropical, V13, P381; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Richter M, 2000, MT RES DEV, V20, P332, DOI 10.1659/0276-4741(2000)020[0332:TECICA]2.0.CO;2; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; ROSENFIELD GH, 1986, PHOTOGRAMM ENG REM S, V52, P223; Rudel T., 2005, TROPICAL FORESTS REG; Rudel TK, 2010, LAND USE POLICY, V27, P95, DOI 10.1016/j.landusepol.2009.09.021; Rudel TK, 2002, ANN ASSOC AM GEOGR, V92, P87, DOI 10.1111/1467-8306.00281; Rudel TK, 1998, RURAL SOCIOL, V63, P533, DOI 10.1111/j.1549-0831.1998.tb00691.x; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Rzedowski J., 1978, VEGETACION MEXICO; SAYER JA, 1991, BIOL CONSERV, V55, P199, DOI 10.1016/0006-3207(91)90056-F; Secretaria de Agricultura y Recursos Hidraulicos (SARH), 1994, INV NAC FOR PER MEX; Sohn YS, 1999, PHOTOGRAMM ENG REM S, V65, P947; Stasinopoulos D.M., 2007, J STAT SOFTW, V23, P1, DOI [10.18637/jss.v023.i07, DOI 10.18637/JSS.V023.I07]; Steininger MK, 2001, ENVIRON CONSERV, V28, P127, DOI 10.1017/S0376892901000133; Toledo V. M., 1988, CIENCIA DESARROLLO, V81, P17; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Tucker CJ, 2004, PHOTOGRAMM ENG REM S, V70, P313, DOI 10.14358/PERS.70.3.313; Tucker CJ, 2000, INT J REMOTE SENS, V21, P1461, DOI 10.1080/014311600210263; Turner BL, 2010, LAND USE POLICY, V27, P170, DOI 10.1016/j.landusepol.2009.03.006; Vaca RA, 2011, APPL VEG SCI, V14, P388, DOI 10.1111/j.1654-109X.2011.01132.x; Vargas JD, 2006, ORNITOL NEOTROP, V17, P39; VELAZQUEZ A, 2002, UNASYLVA, P7; Vos Jan de, 2002, TIERRA SEMBRAR SUENO; World Wildlife Found & Conservation International, 2004, INT MAN CHIM WAT; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Wright SJ, 2008, ECOL SOC, V13; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x; Xu Jianchu, 2007, Tropical Ecology, V48, P137; Zuur Alain F., 2009, P1	102	41	44	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42309	10.1371/journal.pone.0042309	http://dx.doi.org/10.1371/journal.pone.0042309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905123	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100032
J	Wu, YA; Wang, XT; Wu, FB; Huang, RL; Xue, FQ; Liang, GT; Tao, M; Cai, PW; Huang, Y				Wu, Yan'an; Wang, Xuetao; Wu, Fangbo; Huang, Ruolei; Xue, Fangqin; Liang, Guantao; Tao, Min; Cai, Pengwei; Huang, Yi			Transcriptome Profiling of the Cancer, Adjacent Non-Tumor and Distant Normal Tissues from a Colorectal Cancer Patient by Deep Sequencing	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; GENE-EXPRESSION; COLON-CANCER; INTEGRATIVE ANALYSIS; RNA-SEQ; TUMOR; EXON; MUTATIONS; FUSIONS; MATRIX	Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in the world. A genome-wide screening of transcriptome dysregulation between cancer and normal tissue would provide insight into the molecular basis of CRC initiation and progression. Compared with microarray technology, which is commonly used to identify transcriptional changes, the recently developed RNA-seq technique has the ability to detect other abnormal regulations in the cancer transcriptome, such as alternative splicing, novel transcripts or gene fusion. In this study, we performed high-throughput transcriptome sequencing at similar to 50x coverage on CRC, adjacent non-tumor and distant normal tissue. The results revealed cancer-specific, differentially expressed genes and differential alternative splicing, suggesting that the extracellular matrix and metabolic pathways are activated and the genes related to cell homeostasis are suppressed in CRC. In addition, one tumor-restricted gene fusion, PRTEN-NOTCH2, was also detected and experimentally confirmed. This study reveals some common features in tumor invasion and provides a comprehensive survey of the CRC transcriptome, which provides better insight into the complexity of regulatory changes during tumorigenesis.	[Wu, Yan'an; Wang, Xuetao; Wu, Fangbo; Liang, Guantao; Tao, Min; Cai, Pengwei; Huang, Yi] Fujian Med Univ, Fujian Prov Clin Med Coll, Fujian Prov Hosp, Dept Clin Lab, Fuzhou, Peoples R China; [Huang, Ruolei; Xue, Fangqin] Fujian Med Univ, Fujian Prov Clin Med Coll, Fujian Prov Hosp, Dept Tumor Surg, Fuzhou, Peoples R China	Fujian Medical University; Fujian Provincial Hospital; Fujian Medical University; Fujian Provincial Hospital	Wu, YA (corresponding author), Fujian Med Univ, Fujian Prov Clin Med Coll, Fujian Prov Hosp, Dept Clin Lab, Fuzhou, Peoples R China.	wya_sl@yahoo.com.cn			Medical Innovation Project of Fujian Province [2012-CXB-6]	Medical Innovation Project of Fujian Province	This work was supported by the Medical Innovation Project of Fujian Province (2012-CXB-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Chu D, 2011, ANN ONCOL, V22, P2440, DOI 10.1093/annonc/mdq776; Chu D, 2009, ANN SURG ONCOL, V16, P3259, DOI 10.1245/s10434-009-0655-6; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Davies RJ, 2005, NAT REV CANCER, V5, P199, DOI 10.1038/nrc1569; Dukes CE, 1932, J PATHOL BACTERIOL, V35, P323, DOI 10.1002/path.1700350303; Dutertre M, 2010, CANCER RES, V70, P896, DOI 10.1158/0008-5472.CAN-09-2703; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; Gout S, 2008, CANCER MICROENVIRON, V1, P69, DOI 10.1007/s12307-008-0007-2; Grade M, 2007, CANCER RES, V67, P1877; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim D, 2011, CSHL BIOL GEN C; Kleivi K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-2; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Markowitz SD, 2002, CANCER CELL, V1, P233, DOI 10.1016/S1535-6108(02)00053-3; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Mook ORF, 2004, BBA-REV CANCER, V1705, P69, DOI 10.1016/j.bbcan.2004.09.006; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Ogino S, 2009, J CLIN ONCOL, V27, P4591, DOI 10.1200/JCO.2009.22.8858; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Salomonis N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000553; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Skovbjerg H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-136; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Yi JM, 2011, CLIN CANCER RES, V17, P1535, DOI 10.1158/1078-0432.CCR-10-2509	71	55	61	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41001	10.1371/journal.pone.0041001	http://dx.doi.org/10.1371/journal.pone.0041001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905095	Green Submitted, gold, Green Published			2022-12-27	WOS:000307331100007
J	Li, SW; Yang, X; Shao, J; Shen, YQ				Li, Siwei; Yang, Xue; Shao, Juan; Shen, Yuequan			Structural Insights into the Assembly of CARMA1 and BCL10	PLOS ONE			English	Article							NF-KAPPA-B; ONCOGENIC CARD11 MUTATIONS; ANTIGEN RECEPTOR; CHROMOSOMAL TRANSLOCATION; LYMPHOCYTE DEVELOPMENT; SIGNAL-TRANSDUCTION; ACTIVATION; PHOSPHORYLATION; PROTEIN; KINASE	The CBM complex (CARMA1, BCL10 and MALT1) plays a crucial role in B and T lymphocyte activation. CARMA1 serves as a scaffold for BCL10, MALT1 and other effector proteins and regulates various signaling pathways related to the immune response. The assembly of CARMA1 and BCL10 is mediated through a CARD-CARD interaction. Here, we report the crystal structure of the CARD domain of CARMA1 at a resolution of 1.75 angstrom. The structure consists of six helices, as previously determined for CARD domains. Structural and computational analysis identified the binding interface between CARMA1-CARD and BCL10-CARD, which consists of a basic patch in CARMA1 and an acidic patch in BCL10. Site-directed mutagenesis, co-immunoprecipitation and an NF-kappa B activation assay confirmed that the interface is necessary for association and downstream signaling. Our studies provide molecular insight into the assembly of CARMA1 and BCL10.	[Li, Siwei; Yang, Xue; Shao, Juan; Shen, Yuequan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Li, Siwei; Yang, Xue; Shao, Juan; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Li, SW (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	yuequan74@yahoo.com	Shen, Yuequan/C-8950-2013	Shen, Yuequan/0000-0002-3775-0900	973 Program [2012CB917201, 2009CB825504]; NSFC [31170684]; Fundamental Research Funds for the Central Universities [65020241]	973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the 973 Program (grants 2012CB917201 and 2009CB825504), NSFC (grant 31170684) and the Fundamental Research Funds for the Central Universities (grant 65020241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hara H, 2009, TRENDS IMMUNOL, V30, P234, DOI 10.1016/j.it.2009.03.002; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Koseki T, 1999, J BIOL CHEM, V274, P9955, DOI 10.1074/jbc.274.15.9955; Lamason RL, 2010, BIOCHEMISTRY-US, V49, P8240, DOI 10.1021/bi101052d; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shen LJ, 2003, BLOOD, V102, P1553, DOI 10.1182/blood-2003-04-1286; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Tanner MJ, 2007, J BIOL CHEM, V282, P17141, DOI 10.1074/jbc.M700169200; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yang X, 2009, J STRUCT BIOL, V168, P437, DOI 10.1016/j.jsb.2009.09.001	42	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42775	10.1371/journal.pone.0042775	http://dx.doi.org/10.1371/journal.pone.0042775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880103	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100168
J	Zheng, L; Zhang, DM; Chen, XC; Yang, L; Wei, YQ; Zhao, X				Zheng, Lan; Zhang, Dongmei; Chen, Xiancheng; Yang, Li; Wei, Yuquan; Zhao, Xia			Antitumor Activities of Human Placenta-Derived Mesenchymal Stem Cells Expressing Endostatin on Ovarian Cancer	PLOS ONE			English	Article							CELLULAR VEHICLES; PROGENITOR CELLS; GENE-THERAPY; GROWTH; TRAFFICKING; INDUCTION; MIGRATION; CHEMOKINE; DELIVERY; FOCUS	Endostatin is an important endogenous inhibitor of neovascularization that has been widely used in anti-angiogenesis therapy for the treatment of cancer. However, its clinical application is largely hampered by its low efficacy. Human placenta-derived mesenchymal stem cells (hpMSCs) are particularly attractive cells for clinical use in cell-based therapies. In the present study, hpMSCs were isolated and characterized. We then evaluated the tumor targeting properties and antitumor effects of hpMSCs as gene delivery vehicles for ovarian cancer therapy. We efficiently engineered hpMSCs to deliver endostatin via adenoviral transduction mediated by Lipofectamine 2000. The tropism capacity of the engineered hpMSCs toward tumor cells was then confirmed by in vitro migration assays and in vivo by intraperitoneal injection of hpMSCs into nude mice. The hpMSCs expressing the human endostatin gene demonstrated preferential homing to the tumor site and significantly decreased the tumor volume without apparent systemic toxic effects. These observations were associated with significantly decreased blood sprouts and tumor cell proliferation as well as a dramatically increased tumor apoptosis index. These results suggested that hpMSCs are potentially an effective delivery vehicle for therapeutic genes for the treatment of ovarian cancer.	[Zheng, Lan; Zhao, Xia] Sichuan Univ, Dept Gynecol & Obstet, W China Hosp 2, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Dongmei; Chen, Xiancheng; Yang, Li; Wei, Yuquan] W China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Zhang, Dongmei; Chen, Xiancheng; Yang, Li; Wei, Yuquan] W China Hosp, Ctr Canc, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Zheng, L (corresponding author), Sichuan Univ, Dept Gynecol & Obstet, W China Hosp 2, Chengdu 610064, Sichuan, Peoples R China.	xia-zhao@126.com			National 973 Program of China [2011CB910703]	National 973 Program of China(National Basic Research Program of China)	This work was supported by National 973 Program of China grants (2011CB910703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Dkhissi F, 2003, HUM GENE THER, V14, P997, DOI 10.1089/104303403766682250; Eichna DM, 2008, CLIN J ONCOL NURS, V12, P108, DOI 10.1188/08.CJON.108-112; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Gasparini G, 1999, DRUGS, V58, P17, DOI 10.2165/00003495-199958010-00003; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Indraccolo S, 2002, GENE THER, V9, P867, DOI 10.1038/sj.gt.3301703; Kassem M, 2004, BASIC CLIN PHARMACOL, V95, P209, DOI 10.1111/j.1742-7843.2004.pto950502.x; Kleinman ME, 2007, ARTERIOSCL THROM VAS, V27, P2664, DOI 10.1161/ATVBAHA.107.150284; Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334; Li L, 2004, WORLD J GASTROENTERO, V10, P1867; Liang ZH, 2004, CHINESE MED J-PEKING, V117, P1809; Liu JY, 2003, BLOOD, V102, P1815, DOI 10.1182/blood-2002-12-3772; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Luo X, 2005, TECHNOL CANCER RES T, V4, P193, DOI 10.1177/153303460500400208; Malecki M, 2005, GENE THER, V12, pS159, DOI 10.1038/sj.gt.3302621; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Pereboeva L, 2004, BIODRUGS, V18, P361, DOI 10.2165/00063030-200418060-00003; Pereboeva L, 2003, STEM CELLS, V21, P389, DOI 10.1634/stemcells.21-4-389; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rosu-Myles M, 2005, J CELL SCI, V118, P4343, DOI 10.1242/jcs.02555; Semenov OV, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.869; Shan WW, 2009, CELL CYCLE, V8, P731, DOI 10.4161/cc.8.5.7848; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Studeny M, 2002, CANCER RES, V62, P3603; Wang Lei, 2002, Hematology, V7, P113; Wang Li, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P190; Yamanaka R, 2001, CANCER GENE THER, V8, P796, DOI 10.1038/sj.cgt.7700367; Yang L, 2010, CANCER GENE THER, V17, P49, DOI 10.1038/cgt.2009.47	34	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e39119	10.1371/journal.pone.0039119	http://dx.doi.org/10.1371/journal.pone.0039119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911684	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300004
J	Gartner, S; Liu, YL; Natesan, S				Gartner, Suzanne; Liu, Yiling; Natesan, Senthilkumar			De novo Generation of Cells within Human Nurse Macrophages and Consequences following HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CIRCULATING CD14(+) MONOCYTES; RECENT THYMIC EMIGRANTS; CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; CHRONIC LYMPHOCYTIC-LEUKEMIA; RECEPTOR EXCISION CIRCLES; STEM-CELLS; GASTROINTESTINAL-TRACT; HTLV-III/LAV	Nurse cells are defined as those that provide for the development of other cells. We report here, that in vitro, human monocyte-derived macrophages can behave as nurse cells with functional capabilities that include de novo generation of CD4+ T-lymphocytes and a previously unknown small cell with monocytoid characteristics. We named these novel cells "self-renewing monocytoid cells" (SRMC), because they could develop into nurse macrophages that produced another generation of SRMC. SRMC were not detectable in blood. Their transition to nurse behavior was characterized by expression of CD10, a marker of thymic epithelium and bone marrow stroma, typically absent on macrophages. Bromodeoxyuridine labeling and immunostaining for cdc6 expression confirmed DNA synthesis within nurse macrophages. T-cell excision circles were detected in macrophages, along with expression of pre-T-cell receptor alpha and recombination activating gene 1, suggesting that genetic recombination events associated with generation of the T-cell receptor were occurring in these cells. SRMC expressed CCR5, the coreceptor for R5 HIV-1 isolates, and were highly susceptible to HIV-1 entry leading to productive infection. While expressing HIV-1, SRMC could differentiate into nurse macrophages that produced another generation of HIV-1-expressing SRMC. The infected nurse macrophage/SRMC cycle could continue in vitro for multiple generations, suggesting it might represent a mechanism whereby HIV-1 can maintain persistence in vivo. HIV-1 infection of nurse macrophages led to a decline in CD4+ T-cell production. There was severe, preferential loss of the CCR5+ CD4+ T-cell subpopulation. Confocal microscopy revealed individual HIV-1-expressing nurse macrophages simultaneously producing both HIV-1-expressing SRMC and non-expressing CD3+ cells, suggesting that nurse macrophages might be a source of latently infected CD4+ T-cells. Real-time PCR experiments confirmed this by demonstrating 10-fold more HIV-1-genome-harboring T-cells, than virus-expressing ones. These phenomena have far-reaching implications, and elicit new perspectives regarding HIV pathogenesis and T-cell and hematopoietic cell development.	[Gartner, Suzanne; Liu, Yiling; Natesan, Senthilkumar] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University	Gartner, S (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	sgartner@ihv.umaryland.edu			NIH/NIMH [R01 MH63039, R01 MH067831]; NIH/NIAID [R01 AI057007]; Dept. of Neurology at Johns Hopkins University School of Medicine; Johns Hopkins National Institute of Mental Health (NIMH) Center for Novel Therapeutics of HIV-associated Cognitive Disorders; NIMH [P30MH075673]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067831, R01MH063039, P30MH075673] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dept. of Neurology at Johns Hopkins University School of Medicine; Johns Hopkins National Institute of Mental Health (NIMH) Center for Novel Therapeutics of HIV-associated Cognitive Disorders; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by research grants from NIH/NIMH R01 MH63039 and R01 MH067831 and from NIH/NIAID R01 AI057007 (all to S. G.). Additional financial support came from the Dept. of Neurology at Johns Hopkins University School of Medicine and the Johns Hopkins National Institute of Mental Health (NIMH) Center for Novel Therapeutics of HIV-associated Cognitive Disorders, funded by NIMH Grant P30MH075673. Generous support was also provided by the Institute of Human Virology, University of Maryland School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTERBERRY CF, 1984, P NATL ACAD SCI-BIOL, V81, P7383, DOI 10.1073/pnas.81.23.7383; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brown A, 2005, J LEUKOCYTE BIOL, V78, P675, DOI 10.1189/jlb.0505237; Burger JA, 2000, BLOOD, V96, P2655; Chou CS, 1997, P NATL ACAD SCI USA, V94, P1361, DOI 10.1073/pnas.94.4.1361; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; GARTNER S, 1990, AIDS RES HUM RETROV, V6, P1017, DOI 10.1089/aid.1990.6.1017; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Guerin S, 1997, FASEB J, V11, P376, DOI 10.1096/fasebj.11.5.9141505; Guerin S, 1997, FASEB J, V11, P1003, DOI 10.1096/fasebj.11.12.9337153; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; HOXIE JA, 1986, SCIENCE, V234, P1123, DOI 10.1126/science.3095925; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Kodama H, 2006, IMMUNOL CELL BIOL, V84, P209, DOI 10.1111/j.1440-1711.2006.01424.x; Kodama H, 2005, STEM CELLS DEV, V14, P676, DOI 10.1089/scd.2005.14.676; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Kucia M, 2007, LEUKEMIA, V21, P297, DOI 10.1038/sj.leu.2404470; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170; Kuwana M, 2006, STEM CELLS, V24, P2733, DOI 10.1634/stemcells.2006-0026; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; LI SL, 1991, RES VIROLOGY, V142, P173, DOI 10.1016/0923-2516(91)90054-7; Ling B, 2007, AIDS, V21, P2377, DOI 10.1097/QAD.0b013e3282f08b32; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Manwani D, 2008, CURR TOP DEV BIOL, V82, P23, DOI 10.1016/S0070-2153(07)00002-6; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338; Mochizuki K, 2010, WIRES RNA, V1, P376, DOI 10.1002/wrna.34; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; NICHOLSON JKA, 1986, J IMMUNOL, V137, P323; Nottet HSLM, 2009, JAIDS-J ACQ IMM DEF, V50, P345, DOI 10.1097/QAI.0b013e318197eb04; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Persaud D, 2004, J VIROL, V78, P968, DOI 10.1128/JVI.78.2.968-979.2004; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; Pujol BF, 2000, DIFFERENTIATION, V65, P287, DOI 10.1046/j.1432-0436.2000.6550287.x; RITTER MA, 1981, IMMUNOLOGY, V44, P439; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SANDOR M, 1994, P NATL ACAD SCI USA, V91, P12857, DOI 10.1073/pnas.91.26.12857; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Shieh JTC, 2000, J VIROL, V74, P693, DOI 10.1128/JVI.74.2.693-701.2000; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; SOLARI F, 1995, J CELL SCI, V108, P3233; Spradling Allan C., 1993, P1; Touloumi G, 2004, AIDS RES HUM RETROV, V20, P47, DOI 10.1089/088922204322749495; Tsukada N, 2002, BLOOD, V99, P1030, DOI 10.1182/blood.V99.3.1030; TURK JL, 1982, IMMUNOBIOLOGY, V161, P274, DOI 10.1016/S0171-2985(82)80083-1; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; WEKERLE H, 1980, J EXP MED, V151, P925, DOI 10.1084/jem.151.4.925; WEKERLE H, 1980, NATURE, V283, P402, DOI 10.1038/283402a0; Wojakowski W, 2009, J AM COLL CARDIOL, V53, P1, DOI 10.1016/j.jacc.2008.09.029; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; Yamanaka K, 2005, CLIN CANCER RES, V11, P5748, DOI 10.1158/1078-0432.CCR-04-2514; YAO M, 1974, CHROMOSOMA, V48, P1; YAO MC, 1984, CELL, V36, P433, DOI 10.1016/0092-8674(84)90236-8; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100	82	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40139	10.1371/journal.pone.0040139	http://dx.doi.org/10.1371/journal.pone.0040139			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22911696	gold, Green Submitted, Green Published			2022-12-27	WOS:000306548900017
J	Kimbrough, EO; Reiss, JP				Kimbrough, Erik O.; Reiss, J. Philipp			Measuring the Distribution of Spitefulness	PLOS ONE			English	Article							ANTISOCIAL-BEHAVIOR; SPITE; RULES	Spiteful, antisocial behavior may undermine the moral and institutional fabric of society, producing disorder, fear, and mistrust. Previous research demonstrates the willingness of individuals to harm others, but little is understood about how far people are willing to go in being spiteful ( relative to how far they could have gone) or their consistency in spitefulness across repeated trials. Our experiment is the first to provide individuals with repeated opportunities to spitefully harm anonymous others when the decision entails zero cost to the spiter and cannot be observed as such by the object of spite. This method reveals that the majority of individuals exhibit consistent (non-)spitefulness over time and that the distribution of spitefulness is bipolar: when choosing whether to be spiteful, most individuals either avoid spite altogether or impose the maximum possible harm on their unwitting victims.	[Kimbrough, Erik O.] Simon Fraser Univ, Dept Econ, Burnaby, BC V5A 1S6, Canada; [Reiss, J. Philipp] Maastricht Univ, Dept Econ AE1, Maastricht, Limburg, Netherlands	Simon Fraser University; Maastricht University	Kimbrough, EO (corresponding author), Simon Fraser Univ, Dept Econ, Burnaby, BC V5A 1S6, Canada.	ekimbrou@sfu.ca			Maastricht University's METEOR research program in Economic Behavior, Theory and Computing	Maastricht University's METEOR research program in Economic Behavior, Theory and Computing	This research was funded by grants from Maastricht University's METEOR research program in Economic Behavior, Theory and Computing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bjorn Bartling, Dan Friedman, workshop participants at Simon Fraser University, two anonymous referees, and an associate editor for helpful comments. This research was funded by grants from Maastricht University's METEOR research program in Economic Behavior, Theory and Computing.	Abbink K, 2009, ECON LETT, V105, P306, DOI 10.1016/j.econlet.2009.08.024; [Anonymous], 2011, GAMES, DOI DOI 10.3390/g2030365; Ariely D, 2005, RAND J ECON, V36, P890; Cason TN, 2002, EXP ECON, V5, P133, DOI 10.1023/A:1020317321607; Cooper DJ, 2008, ECON J, V118, P1572, DOI 10.1111/j.1468-0297.2008.02181.x; Fehr E, 2008, AM ECON REV, V98, P494, DOI 10.1257/aer.98.2.494; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Foster KR, 2000, TRENDS ECOL EVOL, V15, P469, DOI 10.1016/S0169-5347(00)01978-9; Gill D, 2012, AM ECON REV, V102, P469, DOI 10.1257/aer.102.1.469; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HANEY C, 1973, NAV RES REV, V26, P1; Haney C. B., 1973, INT J CRIMINOLOGY PE, V1, P69, DOI DOI 10.1037/H0076835; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Houser D, 2010, ECON LETT, V109, P20, DOI 10.1016/j.econlet.2010.07.008; HURST LD, 1991, J THEOR BIOL, V148, P269, DOI 10.1016/S0022-5193(05)80344-3; HYDE JS, 1984, DEV PSYCHOL, V20, P722, DOI 10.1037/0012-1649.20.4.722; KNOWLTON N, 1979, NATURE, V279, P419, DOI 10.1038/279419a0; Levine DK, 1998, REV ECON DYNAM, V1, P593; Merton RK, 1938, AM SOCIOL REV, V3, P672, DOI 10.2307/2084686; Miller JD, 2001, CRIMINOLOGY, V39, P765, DOI 10.1111/j.1745-9125.2001.tb00940.x; Morgan J., 2003, CONTRIBUTIONS EC ANA, V2, P1102; PATTERSON GR, 1989, AM PSYCHOL, V44, P329, DOI 10.1037/0003-066X.44.2.329; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; R Core Team, 2016, R FDN STAT COMP; Rand DG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1442; Rhee SH, 2002, PSYCHOL BULL, V128, P490, DOI 10.1037//0033-2909.128.3.490; ROBINS LN, 1978, PSYCHOL MED, V8, P611, DOI 10.1017/S0033291700018821; Roth AE, 2002, AM ECON REV, V92, P1093, DOI 10.1257/00028280260344632; Tilly Charles, 2003, POLITICS COLLECTIVE	31	24	24	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e41812	10.1371/journal.pone.0041812	http://dx.doi.org/10.1371/journal.pone.0041812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AG	22905108	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600006
J	Lee, TMC; Leung, MK; Hou, WK; Tang, JCY; Yin, J; So, KF; Lee, CF; Chan, CCH				Lee, Tatia M. C.; Leung, Mei-Kei; Hou, Wai-Kai; Tang, Joey C. Y.; Yin, Jing; So, Kwok-Fai; Lee, Chack-Fan; Chan, Chetwyn C. H.			Distinct Neural Activity Associated with Focused-Attention Meditation and Loving-Kindness Meditation	PLOS ONE			English	Article							COMPASSION MEDITATION; EMOTION REGULATION; MINDFULNESS SCALE; NEGATIVE AFFECT; FMRI; RECOGNITION; PERFORMANCE; VALIDATION; ACTIVATION; AROUSAL	This study examined the dissociable neural effects of anapanasati (focused-attention meditation, FAM) and metta (loving-kindness meditation, LKM) on BOLD signals during cognitive (continuous performance test, CPT) and affective (emotion-processing task, EPT, in which participants viewed affective pictures) processing. Twenty-two male Chinese expert meditators (11 FAM experts, 11 LKM experts) and 22 male Chinese novice meditators (11 FAM novices, 11 LKM novices) had their brain activity monitored by a 3T MRI scanner while performing the cognitive and affective tasks in both meditation and baseline states. We examined the interaction between state (meditation vs. baseline) and expertise (expert vs. novice) separately during LKM and FAM, using a conjunction approach to reveal common regions sensitive to the expert meditative state. Additionally, exclusive masking techniques revealed distinct interactions between state and group during LKM and FAM. Specifically, we demonstrated that the practice of FAM was associated with expertise-related behavioral improvements and neural activation differences in attention task performance. However, the effect of state LKM meditation did not carry over to attention task performance. On the other hand, both FAM and LKM practice appeared to affect the neural responses to affective pictures. For viewing sad faces, the regions activated for FAM practitioners were consistent with attention-related processing; whereas responses of LKM experts to sad pictures were more in line with differentiating emotional contagion from compassion/emotional regulation processes. Our findings provide the first report of distinct neural activity associated with forms of meditation during sustained attention and emotion processing.	[Lee, Tatia M. C.; Leung, Mei-Kei; Hou, Wai-Kai; Tang, Joey C. Y.] Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.; Leung, Mei-Kei; Hou, Wai-Kai] Univ Hong Kong, Lab Cognit Affect Neurosci, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.; So, Kwok-Fai] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.; Hou, Wai-Kai; Yin, Jing; So, Kwok-Fai; Lee, Chack-Fan; Chan, Chetwyn C. H.] Univ Hong Kong, Social Neurosci Res Network, Hong Kong, Hong Kong, Peoples R China; [Tang, Joey C. Y.] Univ Hong Kong, Number Lab, Hong Kong, Hong Kong, Peoples R China; [Yin, Jing; Lee, Chack-Fan] Univ Hong Kong, Ctr Buddhist Studies, Hong Kong, Hong Kong, Peoples R China; [So, Kwok-Fai] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Chan, Chetwyn C. H.] Hong Kong Polytech Univ, Dept Rehabil Sci, Appl Cognit Neurosci Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Hong Kong Polytechnic University	Lee, TMC (corresponding author), Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China.	tmclee@hku.hk; Chetwyn.Chan@inet.polyu.edu.hk	Hou, Wai Kai/AFK-6179-2022	Hou, Wai Kai/0000-0003-1402-2318; So, Kwok-Fai/0000-0003-4039-4246; Chan, Chetwyn C. H./0000-0003-0307-6337	Centre of Buddhist Studies of The University of Hong Kong; Research Grant Council General Research Fund [HKU747612H]	Centre of Buddhist Studies of The University of Hong Kong; Research Grant Council General Research Fund	This study was supported by research funding from the Centre of Buddhist Studies of The University of Hong Kong and the Research Grant Council General Research Fund (Ref: HKU747612H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Anders S, 2004, HUM BRAIN MAPP, V23, P200, DOI 10.1002/hbm.20048; Bradley M. M., 2007, HDB EMOTION ELICITAT, P29; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Britton JC, 2006, NEUROIMAGE, V31, P906, DOI 10.1016/j.neuroimage.2005.12.050; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Carretie L, 2009, NEUROSCIENCE, V164, P1615, DOI 10.1016/j.neuroscience.2009.09.031; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chiesa A, 2010, PSYCHOL MED, V40, P1239, DOI 10.1017/S0033291709991747; Colibazzi T, 2010, EMOTION, V10, P377, DOI 10.1037/a0018484; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Feldman G, 2007, J PSYCHOPATHOL BEHAV, V29, P177, DOI 10.1007/s10862-006-9035-8; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goldstein RZ, 2007, NEUROIMAGE, V35, P194, DOI 10.1016/j.neuroimage.2006.12.004; Hager F, 1998, EUR ARCH PSY CLIN N, V248, P161; Hamid PN, 1996, EDUC PSYCHOL MEAS, V56, P995, DOI 10.1177/0013164496056006006; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Holzel BK, 2007, NEUROSCI LETT, V421, P16, DOI 10.1016/j.neulet.2007.04.074; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Lau MA, 2006, J CLIN PSYCHOL, V62, P1445, DOI 10.1002/jclp.20326; Lee BT, 2011, NEUROPSYCHOBIOLOGY, V63, P119, DOI 10.1159/000318086; Lee TMC, 2005, MOL PSYCHIATR, V10, P450, DOI 10.1038/sj.mp.4001595; Lee TMC, 2002, NEUROSCI LETT, V333, P13, DOI 10.1016/S0304-3940(02)00965-5; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Lutz A, 2007, CAMB HANDB PSYCHOL, P499; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; Lutz A, 2009, NEUROIMAGE, V47, P1038, DOI 10.1016/j.neuroimage.2009.04.081; Mak AKY, 2009, NEUROSCI LETT, V457, P101, DOI 10.1016/j.neulet.2009.03.094; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Mitterschiffthaler MT, 2003, NEUROREPORT, V14, P177, DOI 10.1097/00001756-200302100-00003; Nielen MMA, 2009, BRAIN COGNITION, V71, P387, DOI 10.1016/j.bandc.2009.05.007; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Ogg RJ, 2008, MAGN RESON IMAGING, V26, P504, DOI 10.1016/j.mri.2007.09.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; Pagnoni G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003083; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Portas CM, 1998, J NEUROSCI, V18, P8979; Quirin M, 2011, SOC COGN AFFECT NEUR; Roiser JP, 2008, NEUROPSYCHOPHARMACOL, V33, P1992, DOI 10.1038/sj.npp.1301581; Rubia K, 2009, BIOL PSYCHOL, V82, P1, DOI 10.1016/j.biopsycho.2009.04.003; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; Salgado-Pineda P, 2004, NEUROIMAGE, V21, P840, DOI 10.1016/j.neuroimage.2003.10.027; Salzberg S., 1995, LOVING KINDNESS REVO; Srinivasan N, 2007, NEUROREPORT, V18, P1709, DOI 10.1097/WNR.0b013e3282f0d2d8; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	58	62	62	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e40054	10.1371/journal.pone.0040054	http://dx.doi.org/10.1371/journal.pone.0040054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AG	22905090	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600003
J	Xiao, L; Wang, BL; Li, Y; Wang, QQ; Liu, SH; Wang, Y; Liu, GY; Lu, J; Ye, XT; Zhang, LM				Xiao Liang; Wang Beilei; Li Ying; Wang Qianqian; Liu Sihua; Wang Yang; Liu Guoyan; Lu Jia; Ye Xuting; Zhang Liming			Cardiovascular Effect Is Independent of Hemolytic Toxicity of Tentacle-Only Extract from the Jellyfish Cyanea capillata	PLOS ONE			English	Article							NEMOPILEMA-NOMURAI SCYPHOZOA; PHYSALIA-PHYSALIS VENOM; CHIRONEX-FLECKERI VENOM; BOX-JELLYFISH; NEMATOCYST VENOM; CHIROPSALMUS-QUADRIGATUS; HABU-KURAGE; SEA WASP; NOZAKII KISHINOUYE; PROTEIN TOXIN	Our previous studies have confirmed that the crude tentacle-only extract (cTOE) from the jellyfish Cyanea capillata (Cyaneidae) exhibits hemolytic and cardiovascular toxicities simultaneously. So, it is quite difficult to discern the underlying active component responsible for heart injury caused by cTOE. The inactivation of the hemolytic toxicity from cTOE accompanied with a removal of plenty of precipitates would facilitate the separation of cardiovascular component and the investigation of its cardiovascular injury mechanism. In our research, after the treatment of one-step alkaline denaturation followed by twice dialysis, the protein concentration of the treated tentacle-only extract (tTOE) was about 1/3 of cTOE, and SDS-PAGE showed smaller numbers and lower density of protein bands in tTOE. The hemolytic toxicity of tTOE was completely lost while its cardiovascular toxicity was well retained. The observations of cardiac function, histopathology and ultrastructural pathology all support tTOE with significant cardiovascular toxicity. Blood gas indexes and electrolytes changed far less by tTOE than those by cTOE, though still with significant difference from normal. In summary, the cardiovascular toxicity of cTOE can exist independently of the hemolytic toxicity and tTOE can be employed as a better venom sample for further purification and mechanism research on the jellyfish cardiovascular toxic proteins.	[Xiao Liang; Wang Beilei; Wang Qianqian; Liu Sihua; Liu Guoyan; Lu Jia; Zhang Liming] Second Mil Med Univ, Fac Naval Med, Dept Chem Def Med, Shanghai, Peoples R China; [Li Ying] Second Mil Med Univ, Sch Nursing, Shanghai, Peoples R China; [Wang Yang] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China; [Ye Xuting] Second Mil Med Univ, Dept Biophys, Sch Basic Med Sci, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University	Xiao, L (corresponding author), Second Mil Med Univ, Fac Naval Med, Dept Chem Def Med, Shanghai, Peoples R China.	lilly_wang@126.com; lmzhang1969@yahoo.com.cn			National Natural Science Foundation Young Scientists Fund [81000098]; Natural Science Foundation of Shanghai Municipal Government [10ZR1437900]; Foundation of the Key Discipline and Specialties of Nautical Medicine [2010ZL03]	National Natural Science Foundation Young Scientists Fund; Natural Science Foundation of Shanghai Municipal Government; Foundation of the Key Discipline and Specialties of Nautical Medicine	This research was funded by the National Natural Science Foundation Young Scientists Fund (81000098), the Natural Science Foundation of Shanghai Municipal Government (10ZR1437900) and the Foundation of the Key Discipline and Specialties of Nautical Medicine (2010ZL03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey PM, 2005, TOXICON, V45, P233, DOI 10.1016/j.toxicon.2004.10.013; Beilei W, 2011, J CARDIOVASC PHARM; Bloom DA, 1998, TOXICON, V36, P1075, DOI 10.1016/S0041-0101(98)00096-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkman D, 2007, TOXICON, V50, P850, DOI 10.1016/j.toxicon.2007.06.016; Brinkman DL, 2009, TOXICON, V54, P1162, DOI 10.1016/j.toxicon.2009.02.006; CURRIE B, 1994, TOXICON, V32, P1305, DOI 10.1016/0041-0101(94)90403-0; Edwards L, 2000, TOXICON, V38, P323, DOI 10.1016/S0041-0101(99)00156-7; Edwards LP, 2002, TOXICON, V40, P1299, DOI 10.1016/S0041-0101(02)00138-1; Feng JH, 2010, TOXICOL IN VITRO, V24, P1750, DOI 10.1016/j.tiv.2010.02.010; Feng JH, 2010, TOXICON, V55, P118, DOI 10.1016/j.toxicon.2009.07.008; Fenner PJ, 2010, J TRAVEL MED, V17, P133, DOI 10.1111/j.1708-8305.2009.00390.x; Helmholz H, 2008, J CHROMATOGR B, V871, P60, DOI 10.1016/j.jchromb.2008.06.040; Howarth FC, 2002, PFLUG ARCH EUR J PHY, V444, P446, DOI 10.1007/s00424-002-0830-0; Kang C, 2009, COMP BIOCHEM PHYS C, V150, P85, DOI 10.1016/j.cbpc.2009.03.003; Kim E, 2006, TOXICOL LETT, V167, P205, DOI 10.1016/j.toxlet.2006.09.009; Li R, 2011, TOXICOL LETT, V201, P221, DOI 10.1016/j.toxlet.2011.01.003; Nagai H, 2002, BIOSCI BIOTECH BIOCH, V66, P97, DOI 10.1271/bbb.66.97; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P589, DOI 10.1006/bbrc.2000.3352; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P582, DOI 10.1006/bbrc.2000.3353; [聂菲 NIE Fei], 2008, [第二军医大学学报, Academic Journal of Second Military Medical University], V29, P83; Noguchi K, 2005, TOXICON, V45, P519, DOI 10.1016/j.toxicon.2004.12.015; Ramasamy S, 2005, TOXICOL LETT, V155, P219, DOI 10.1016/j.toxlet.2004.09.018; Ramasamy S, 2005, TOXICOL LETT, V155, P135, DOI 10.1016/j.toxlet.2004.09.004; Ramasamy S, 2004, TOXICON, V43, P685, DOI 10.1016/j.toxicon.2004.02.024; Sakanashi M, 2002, ANAESTH INTENS CARE, V30, P570, DOI 10.1177/0310057X0203000504; Sando JJ, 2010, J CLIN NURS, V19, P109, DOI 10.1111/j.1365-2702.2009.03034.x; Suput D, 2009, TOXICON, V54, P1190, DOI 10.1016/j.toxicon.2009.03.001; Tibballs J, 1998, ANAESTH INTENS CARE, V26, P40, DOI 10.1177/0310057X9802600105; Tibballs J, 2006, TOXICON, V48, P830, DOI 10.1016/j.toxicon.2006.07.020; Wang Q, 2011, EXP TOXICOL PATHOL; Winter KL, 2007, TOXICON, V49, P804, DOI 10.1016/j.toxicon.2006.11.031; Winter KL, 2007, TOXICOL LETT, V168, P13, DOI 10.1016/j.toxlet.2006.10.011; Xiao L, 2011, MAR DRUGS, V9, P526, DOI 10.3390/md9040526; Xiao LA, 2010, TOXICOL IN VITRO, V24, P1203, DOI 10.1016/j.tiv.2010.02.009; Xiao L, 2010, TOXICON, V55, P838, DOI 10.1016/j.toxicon.2009.11.022; Xiao L, 2009, TOXICON, V53, P146, DOI 10.1016/j.toxicon.2008.10.023	37	6	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43096	10.1371/journal.pone.0043096	http://dx.doi.org/10.1371/journal.pone.0043096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905209	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600047
J	Simons, MJP; Cohen, AA; Verhulst, S				Simons, Mirre J. P.; Cohen, Alan A.; Verhulst, Simon			What Does Carotenoid-Dependent Coloration Tell? Plasma Carotenoid Level Signals Immunocompetence and Oxidative Stress State in Birds-A Meta-Analysis	PLOS ONE			English	Article							NESTLING BLUE TITS; MEDIATED IMMUNE-RESPONSE; HISTORY TRADE-OFFS; PLUMAGE COLORATION; PARUS-MAJOR; BILL COLOR; LIFE-HISTORY; GREAT TITS; SEXUAL ATTRACTIVENESS; REPRODUCTIVE SUCCESS	Mechanisms maintaining honesty of sexual signals are far from resolved, limiting our understanding of sexual selection and potential important parts of physiology. Carotenoid pigmented visual signals are among the most extensively studied sexual displays, but evidence regarding hypotheses on how carotenoids ensure signal honesty is mixed. Using a phylogenetically controlled meta-analysis of 357 effect sizes across 88 different species of birds, we tested two prominent hypotheses in the field: that carotenoid-dependent coloration signals i) immunocompetence and/or ii) oxidative stress state. Separate meta-analyses were performed for the relationships of trait coloration and circulating carotenoid level with different measures of immunocompetence and oxidative stress state. For immunocompetence we find that carotenoid levels (r = 0.20) and trait color intensity (r = 0.17) are significantly positively related to PHA response. Additionally we find that carotenoids are significantly positively related to antioxidant capacity (r = 0.10), but not significantly related to oxidative damage (r = -0.02). Thus our analyses provide support for both hypotheses, in that at least for some aspects of immunity and oxidative stress state the predicted correlations were found. Furthermore, we tested for differences in effect size between experimental and observational studies; a larger effect in observational studies would indicate that co-variation might not be causal. However, we detected no significant difference, suggesting that the relationships we found are causal. The overall effect sizes we report are modest and we discuss potential factors contributing to this, including differences between species. We suggest complementary mechanisms maintaining honesty rather than the involvement of carotenoids in immune function and oxidative stress and suggest experiments on how to test these.	[Simons, Mirre J. P.; Verhulst, Simon] Univ Groningen, Groningen, Netherlands; [Cohen, Alan A.] Univ Sherbrooke, Dept Family Med, Sherbrooke, PQ J1K 2R1, Canada	University of Groningen; University of Sherbrooke	Simons, MJP (corresponding author), Univ Groningen, Groningen, Netherlands.	mirresimons@gmail.com	Verhulst, Simon/B-1613-2009; Verhulst, Simon/S-3404-2019	Verhulst, Simon/0000-0002-1143-6868; Verhulst, Simon/0000-0002-1143-6868; Cohen, Alan/0000-0003-4113-3988; Simons, Mirre/0000-0001-7406-7708	Netherlands Organization of Scientific Research (NWO); Centre de recherche clinique Etienne-Le Bel; Centre de recherche sur le vieillissement; NSERC [402079-2011]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Centre de recherche clinique Etienne-Le Bel; Centre de recherche sur le vieillissement; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	MJPS was funded by a Toptalent grant from the Netherlands Organization of Scientific Research (NWO). AAC is member of the FRSQ-funded Centre de recherche clinique Etienne-Le Bel and the Centre de recherche sur le vieillissement, and is supported by NSERC Discovery Grant 402079-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aguilera E, 2007, NATURWISSENSCHAFTEN, V94, P895, DOI 10.1007/s00114-007-0268-5; Alonso-Alvarez C, 2008, J EVOLUTION BIOL, V21, P1789, DOI 10.1111/j.1420-9101.2008.01591.x; Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Alonso-Alvarez C, 2009, P ROY SOC B-BIOL SCI, V276, P2093, DOI 10.1098/rspb.2008.1891; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Alonso-Alvarez C, 2006, EVOLUTION, V60, P1913, DOI 10.1111/j.0014-3820.2006.tb00534.x; Alonso-Alvarez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019403; Alonso-Alvarez C, 2010, PHYSIOL BIOCHEM ZOOL, V83, P110, DOI 10.1086/605395; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Arnold KE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1857, DOI 10.1007/s00265-010-0997-x; Arriero E, 2006, NATURWISSENSCHAFTEN, V93, P173, DOI 10.1007/s00114-006-0090-5; Baeta R, 2008, P ROY SOC B-BIOL SCI, V275, P427, DOI 10.1098/rspb.2007.1383; Bedecarrats GY, 2006, J APPL POULTRY RES, V15, P183, DOI 10.1093/japr/15.2.183; BEGG CB, 1988, J ROY STAT SOC A STA, V151, P419, DOI 10.2307/2982993; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; BENDICH A, 1989, J NUTR, V119, P112, DOI 10.1093/jn/119.1.112; Benito MM, 2011, J COMP PHYSIOL B, V181, P539, DOI 10.1007/s00360-010-0537-z; Bertrand S, 2006, OECOLOGIA, V147, P576, DOI 10.1007/s00442-005-0317-8; Bertrand S, 2006, J EXP BIOL, V209, P4414, DOI 10.1242/jeb.02540; Biard C, 2009, J EXP BIOL, V212, P1336, DOI 10.1242/jeb.028449; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; Biard C, 2007, J EVOLUTION BIOL, V20, P326, DOI 10.1111/j.1420-9101.2006.01194.x; Biard C, 2010, NATURWISSENSCHAFTEN, V97, P987, DOI 10.1007/s00114-010-0716-5; Birkhead TR, 1998, BEHAV ECOL SOCIOBIOL, V44, P179, DOI 10.1007/s002650050530; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Blount JD, 2002, P ROY SOC B-BIOL SCI, V269, P29, DOI 10.1098/rspb.2001.1840; Blount JD, 2012, FUNCT ECOL, V26, P37, DOI 10.1111/j.1365-2435.2011.01926.x; Blount Jonathan D., 2008, V4, P213, DOI 10.1007/978-3-7643-7499-0_11; Bonisoli-Alquati A, 2011, BEHAV ECOL SOCIOBIOL, V65, P1779, DOI 10.1007/s00265-011-1186-2; Bortolotti GR, 2003, FUNCT ECOL, V17, P651, DOI 10.1046/j.1365-2435.2003.00778.x; Bortolotti GR, 1996, P ROY SOC B-BIOL SCI, V263, P1171, DOI 10.1098/rspb.1996.0171; Bortolotti GR, 2000, P ROY SOC B-BIOL SCI, V267, P1433, DOI 10.1098/rspb.2000.1160; Bright A, 2004, BEHAV PROCESS, V65, P123, DOI 10.1016/j.beproc.2003.08.003; BURLEY N, 1987, ETHOLOGY, V76, P133; Burley N., 1991, Oxford Ornithology Series, P359; Butler MW, 2011, J COMP PHYSIOL B, V181, P551, DOI 10.1007/s00360-010-0529-z; Butler MW, 2011, BEHAV ECOL SOCIOBIOL, V65, P401, DOI 10.1007/s00265-010-1074-1; Butler MW, 2010, ARCH BIOCHEM BIOPHYS, V504, P154, DOI 10.1016/j.abb.2010.07.003; Camplani A, 1999, P ROY SOC B-BIOL SCI, V266, P1111, DOI 10.1098/rspb.1999.0751; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Casagrande S, 2006, J AVIAN BIOL, V37, P190, DOI 10.1111/j.0908-8857.2006.03515.x; Casagrande S, 2011, COMP BIOCHEM PHYS A, V160, P16, DOI 10.1016/j.cbpa.2011.04.011; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Chui CKS, 2011, J AVIAN BIOL, V42, P309, DOI 10.1111/j.1600-048X.2011.05240.x; Cohen A, 2007, COMP BIOCHEM PHYS B, V147, P110, DOI 10.1016/j.cbpb.2006.12.015; Cohen AA, 2009, FUNCT ECOL, V23, P310, DOI 10.1111/j.1365-2435.2009.01540.x; Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x; Costantini D, 2006, J COMP PHYSIOL B, V176, P329, DOI 10.1007/s00360-005-0055-6; Costantini D, 2008, J COMP PHYSIOL B, V178, P829, DOI 10.1007/s00360-008-0270-z; Costantini D, 2007, J COMP PHYSIOL B, V177, P723, DOI 10.1007/s00360-007-0169-0; Costantini D, 2007, J EXP BIOL, V210, P1238, DOI 10.1242/jeb.002741; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Costantini D, 2011, METHODS ECOL EVOL, V2, P321, DOI 10.1111/j.2041-210X.2010.00080.x; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; Cote J, 2010, J EXP BIOL, V213, P271, DOI 10.1242/jeb.035188; Cucco M, 2006, BEHAV PROCESS, V73, P325, DOI 10.1016/j.beproc.2006.08.002; Cucco M, 2007, COMP BIOCHEM PHYS A, V147, P1038, DOI 10.1016/j.cbpa.2007.03.014; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Davis KE, 2008, THESIS U GLASGOW; Dawson RD, 2006, NATURWISSENSCHAFTEN, V93, P597, DOI 10.1007/s00114-006-0146-6; de Ayala RM, 2007, BEHAV ECOL, V18, P526, DOI 10.1093/beheco/arm006; De la Fuente M, 2000, IMMUNOL CELL BIOL, V78, P49, DOI 10.1046/j.1440-1711.2000.00884.x; De la Fuente M, 2002, EUR J CLIN NUTR, V56, pS5, DOI 10.1038/sj.ejcn.1601476; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1021, DOI 10.1098/rspb.1997.0141; del Cerro S, 2010, OECOLOGIA, V162, P825, DOI 10.1007/s00442-009-1510-y; DUFVA R, 1995, FUNCT ECOL, V9, P785, DOI 10.2307/2390253; Dugas MB, 2011, CONDOR, V113, P691, DOI 10.1525/cond.2011.100204; Dunn PO, 2010, FUNCT ECOL, V24, P149, DOI 10.1111/j.1365-2435.2009.01606.x; Edler AU, 2010, BIOL J LINN SOC, V99, P384, DOI 10.1111/j.1095-8312.2009.01354.x; Eeva T, 2009, J AVIAN BIOL, V40, P491, DOI 10.1111/j.1600-048X.2008.04535.x; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Eraud C, 2007, J EXP BIOL, V210, P3571, DOI 10.1242/jeb.005496; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Faivre B, 2003, ANIM BEHAV, V65, P1125, DOI 10.1006/anbe.2003.2142; Fenoglio S, 2004, ETHOL ECOL EVOL, V16, P171; Fenoglio S, 2002, BIRD STUDY, V49, P89, DOI 10.1080/00063650209461249; Fenoglio S, 2002, ETHOL ECOL EVOL, V14, P149; Figuerola J, 1999, FUNCT ECOL, V13, P594, DOI 10.1046/j.1365-2435.1999.00354.x; Figuerola J, 2005, CAN J ZOOL, V83, P389, DOI 10.1139/Z05-022; Figuerola J, 2003, ANIM BEHAV, V65, P551, DOI 10.1006/anbe.2003.2072; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fisher, 1958, GENETICAL THEORY NAT; Fitze PS, 2007, AM NAT, V169, pS137, DOI 10.1086/510094; Freeman-Gallant CR, 2011, BIOL LETTERS, V7, P429, DOI 10.1098/rsbl.2010.1186; Galvan I, 2009, ACTA ORNITHOL, V44, P139, DOI 10.3161/000164509X482722; Galvan I, 2009, P ROY SOC B-BIOL SCI, V276, P3089, DOI 10.1098/rspb.2009.0774; GARBE A, 1992, J EXP MED, V176, P109, DOI 10.1084/jem.176.1.109; Garvin JC, 2008, BEHAV ECOL, V19, P54, DOI 10.1093/beheco/arm099; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gladbach A, 2010, BEHAV ECOL SOCIOBIOL, V64, P1779, DOI 10.1007/s00265-010-0990-4; Gladbach A, 2010, COMP BIOCHEM PHYS A, V156, P269, DOI 10.1016/j.cbpa.2010.02.012; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Gray DA, 1996, AM NAT, V148, P453, DOI 10.1086/285935; GROSS WG, 1980, POULTRY SCI, V59, P205, DOI 10.3382/ps.0590205; Hadfield JD, 2006, J EVOLUTION BIOL, V19, P1104, DOI 10.1111/j.1420-9101.2006.01095.x; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hartley RC, 2004, TRENDS ECOL EVOL, V19, P353, DOI 10.1016/j.tree.2004.04.002; Hasa L, 2006, THESIS J JYVASKYLA; HILL GE, 1994, FUNCT ECOL, V8, P343, DOI 10.2307/2389827; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Hill Geoffrey E., 2006, P137; Hill GE, 2009, J EXP BIOL, V212, P1225, DOI 10.1242/jeb.026963; Horak P, 2004, J ANIM ECOL, V73, P935, DOI 10.1111/j.0021-8790.2004.00870.x; Horak P, 2004, J AVIAN BIOL, V35, P63, DOI 10.1111/j.0908-8857.2004.03167.x; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Horak P, 2006, J EXP BIOL, V209, P4329, DOI 10.1242/jeb.02502; Horak P, 2010, FUNCT ECOL, V24, P960, DOI 10.1111/j.1365-2435.2010.01755.x; Horak P, 2010, J EXP BIOL, V213, P2225, DOI 10.1242/jeb.042085; Horvathova T, 2012, P R SOC B IN PRESS; Hughes DA, 1999, P NUTR SOC, V58, P713, DOI 10.1017/S0029665199000932; Isaksson C, 2008, P ROY SOC B-BIOL SCI, V275, P309, DOI 10.1098/rspb.2007.1474; Isaksson C, 2007, FUNCT ECOL, V21, P1123, DOI 10.1111/j.1365-2435.2007.01317.x; Jawor JM, 2003, BEHAV ECOL, V14, P515, DOI 10.1093/beheco/arg041; Jouventin P, 2007, WATERBIRDS, V30, P573, DOI 10.1675/1524-4695(2007)030[0573:DCSAOB]2.0.CO;2; Karu U, 2008, ECOL RES, V23, P931, DOI 10.1007/s11284-007-0457-x; Karu U, 2007, PHYSIOL BIOCHEM ZOOL, V80, P663, DOI 10.1086/521084; Kemp DJ, 2012, BEHAV ECOL, V23, P233, DOI 10.1093/beheco/arr153; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Kunzler R, 2001, BEHAV ECOL, V12, P681, DOI 10.1093/beheco/12.6.681; Larcombe SD, 2008, J EXP BIOL, V211, P2859, DOI 10.1242/jeb.017970; Larcombe SD, 2010, NATURWISSENSCHAFTEN, V97, P903, DOI 10.1007/s00114-010-0708-5; Leclaire S, 2011, NATURWISSENSCHAFTEN, V98, P773, DOI 10.1007/s00114-011-0827-7; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lopez G, 2011, J ORNITHOL, V152, P965, DOI 10.1007/s10336-011-0679-0; Losdat S, 2011, BEHAV ECOL, V22, P1218, DOI 10.1093/beheco/arr116; Losdat S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022221; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Maan ME, 2011, ECOL LETT, V14, P591, DOI 10.1111/j.1461-0248.2011.01606.x; Maney DL, 2008, ETHOLOGY, V114, P369, DOI 10.1111/j.1439-0310.2008.01476.x; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Martinez-Haro M, 2011, ENVIRON RES, V111, P530, DOI 10.1016/j.envres.2011.02.012; Martinez-Padilla J, 2007, BIOL LETTERS, V3, P161, DOI 10.1098/rsbl.2006.0593; McGraw KJ, 2006, FUNCT ECOL, V20, P678, DOI 10.1111/j.1365-2435.2006.01121.x; McGraw KJ, 2006, ETHOLOGY, V112, P1209, DOI 10.1111/j.1439-0310.2006.01280.x; McGraw Kevin J., 2006, P177; McGraw KJ, 2006, AUK, V123, P1161, DOI 10.1642/0004-8038(2006)123[1161:CIAICI]2.0.CO;2; McGraw KJ, 2011, BIOL J LINN SOC, V102, P560, DOI 10.1111/j.1095-8312.2010.01594.x; McGraw KJ, 2003, AUK, V120, P400, DOI 10.1642/0004-8038(2003)120[0400:DPCASC]2.0.CO;2; McGraw KJ, 2006, PHYSIOL BEHAV, V87, P103, DOI 10.1016/j.physbeh.2005.09.001; McGraw KJ, 2004, J AVIAN BIOL, V35, P471, DOI 10.1111/j.0908-8857.2004.03405.x; McGraw KJ, 2004, CONDOR, V106, P390, DOI 10.1650/7384; McGraw KJ, 2005, EVOL ECOL RES, V7, P251; McGraw KJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P843, DOI 10.1086/323797; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Merila J, 1999, ECOSCIENCE, V6, P12, DOI 10.1080/11956860.1999.11952203; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Morales J, 2009, BEHAV ECOL, V20, P117, DOI 10.1093/beheco/arn122; Mougeot F, 2007, FUNCT ECOL, V21, P886, DOI 10.1111/j.1365-2435.2007.01302.x; Mougeot F, 2010, J EXP BIOL, V213, P400, DOI 10.1242/jeb.037101; Mougeot F, 2009, J AVIAN BIOL, V40, P67, DOI 10.1111/j.1600-048X.2008.04439.x; Nakagawa S, 2012, EVOLUTIONAR IN PRESS; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Navara KJ, 2003, BEHAV ECOL, V14, P909, DOI 10.1093/beheco/arg085; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; O'Brien EL, 2009, OIKOS, V118, P1743, DOI 10.1111/j.1600-0706.2009.17692.x; Ohlsson T, 2002, P ROY SOC B-BIOL SCI, V269, P21, DOI 10.1098/rspb.2001.1848; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Olson VA, 2005, J EVOLUTION BIOL, V18, P1534, DOI 10.1111/j.1420-9101.2005.00940.x; Orledge JM, 2012, FUNCT ECOL, V26, P254, DOI 10.1111/j.1365-2435.2011.01932.x; Pap PL, 2011, AUK, V128, P330, DOI 10.1525/auk.2011.10142; Pap PL, 2002, CAN J ZOOL, V80, P2090, DOI 10.1139/Z02-200; Peluc SI, 2012, J COMP PH B IN PRESS; Perez C, 2008, BEHAV ECOL, V19, P967, DOI 10.1093/beheco/arn053; Perez C, 2010, OECOLOGIA, V163, P875, DOI 10.1007/s00442-010-1677-2; Perez-Rodriguez L, 2008, NATURWISSENSCHAFTEN, V95, P821, DOI 10.1007/s00114-008-0389-5; Perez-Rodriguez L, 2008, J EXP BIOL, V211, P2155, DOI 10.1242/jeb.017178; Perez-Rodriguez L, 2008, BEHAV ECOL SOCIOBIOL, V62, P995, DOI 10.1007/s00265-007-0527-7; Perez-Rodriguez L, 2010, J EXP BIOL, V213, P1685, DOI 10.1242/jeb.039982; Perez-Rodriguez L, 2009, BIOESSAYS, V31, P1116, DOI 10.1002/bies.200900070; Peters A, 2004, J EVOLUTION BIOL, V17, P1111, DOI 10.1111/j.1420-9101.2004.00743.x; Peters A, 2008, FUNCT ECOL, V22, P831, DOI 10.1111/j.1365-2435.2008.01437.x; Peters A, 2007, AM NAT, V169, pS122, DOI 10.1086/510139; Peters A, 2007, BIOESSAYS, V29, P427, DOI 10.1002/bies.20563; Peters A, 2011, OECOLOGIA, V166, P35, DOI 10.1007/s00442-011-1921-4; Pike TW, 2007, BIOL LETTERS, V3, P353, DOI 10.1098/rsbl.2007.0072; Pike TW, 2007, P ROY SOC B-BIOL SCI, V274, P1591, DOI 10.1098/rspb.2007.0317; Pike TW, 2011, BEHAV ECOL SOCIOBIOL, V65, P849, DOI 10.1007/s00265-010-1097-7; Quillfeldt P, 2004, POLAR BIOL, V27, P168, DOI 10.1007/s00300-003-0572-2; R Core Team, 2021, R LANGUAGE ENV STAT; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Safran RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009420; Saino N, 2003, BEHAV ECOL, V14, P16, DOI 10.1093/beheco/14.1.16; Saino N, 1999, AM NAT, V154, P441, DOI 10.1086/303246; Saino N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019593; Saks L, 2003, OECOLOGIA, V134, P301, DOI 10.1007/s00442-002-1125-z; Semba RD, 1998, NUTR REV, V56, pS38, DOI 10.1111/j.1753-4887.1998.tb01643.x; Sepp T, 2011, EXP PARASITOL, V127, P651, DOI 10.1016/j.exppara.2010.12.004; SEUTIN G, 1994, OIKOS, V70, P280, DOI 10.2307/3545639; Shanmugasundaram R, 2011, POULTRY SCI, V90, P971, DOI 10.3382/ps.2010-01150; Shykoff JA, 1996, NATURWISSENSCHAFTEN, V83, P113, DOI 10.1007/BF01142175; Sild E, 2011, J EXP BIOL, V214, P3467, DOI 10.1242/jeb.062182; Simons MJP, 2011, BEHAV ECOL, V22, P755, DOI 10.1093/beheco/arr043; Smith CL, 2011, ZOOLOGY, V114, P171, DOI 10.1016/j.zool.2010.12.001; Smith HG, 2007, J EVOLUTION BIOL, V20, P310, DOI 10.1111/j.1420-9101.2006.01203.x; Sternalski A, 2012, BIOL J LINN SOC, V105, P13, DOI 10.1111/j.1095-8312.2011.01773.x; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stirnemann I, 2009, EMU, V109, P344, DOI 10.1071/MU08069; Stradi R, 2001, COMP BIOCHEM PHYS B, V128, P529, DOI 10.1016/S1096-4959(00)00353-5; Sundberg J, 1995, OIKOS, V74, P331, DOI 10.2307/3545664; SUNDBERG J, 1995, BEHAV ECOL SOCIOBIOL, V37, P275, DOI 10.1007/s002650050191; Svensson PA, 2011, BEHAVIOUR, V148, P131, DOI 10.1163/000579510X548673; Szamado S, 2011, ANIM BEHAV, V81, P3, DOI 10.1016/j.anbehav.2010.08.022; Tella JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003295; TENGERDY RP, 1990, AVIAN DIS, V34, P848, DOI 10.2307/1591372; Thompson CW, 1997, AM NAT, V149, P270, DOI 10.1086/285990; Thorogood R, 2008, FUNCT ECOL, V22, P1044, DOI 10.1111/j.1365-2435.2008.01455.x; Toomey MB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-3; Toomey MB, 2010, J EXP BIOL, V213, P1709, DOI 10.1242/jeb.041004; Torres R, 2007, J ANIM ECOL, V76, P1161, DOI 10.1111/j.1365-2656.2007.01282.x; Travers M, 2009, THESIS BISHOPS U; Tschirren B, 2003, J EVOLUTION BIOL, V16, P91, DOI 10.1046/j.1420-9101.2003.00483.x; Tummeleht L, 2006, COMP BIOCHEM PHYS C, V144, P166, DOI 10.1016/j.cbpc.2006.08.004; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; Velando A, 2006, OECOLOGIA, V149, P535, DOI 10.1007/s00442-006-0457-5; Verhulst S, 2005, J AVIAN BIOL, V36, P22, DOI 10.1111/j.0908-8857.2005.03342.x; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vinkler M, 2012, ANIM BEHAV, V83, P17, DOI 10.1016/j.anbehav.2011.10.001; Vinkler M, 2010, FUNCT ECOL, V24, P1081, DOI 10.1111/j.1365-2435.2010.01711.x; Vinkler M, 2010, NATURWISSENSCHAFTEN, V97, P19, DOI 10.1007/s00114-009-0595-9; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; WEATHERHEAD PJ, 1993, BEHAV ECOL SOCIOBIOL, V33, P13, DOI 10.1007/BF00164342; Wiehn J, 1997, ETHOLOGY, V103, P304, DOI 10.1111/j.1439-0310.1997.tb00020.x; Woodall AA, 1996, BRIT J NUTR, V76, P307, DOI 10.1079/BJN19960034; Yeum KJ, 2009, CAROTENOIDS SER, V5, P235, DOI 10.1007/978-3-7643-7501-0_12; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zhang W, 2011, POULTRY SCI, V90, P1516, DOI 10.3382/ps.2010-01126	234	122	124	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43088	10.1371/journal.pone.0043088	http://dx.doi.org/10.1371/journal.pone.0043088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OQ	22905205	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500800044
J	Denison, FC; Semple, SI; Stock, SJ; Walker, J; Marshall, I; Norman, JE				Denison, Fiona C.; Semple, Scott I.; Stock, Sarah J.; Walker, Jane; Marshall, Ian; Norman, Jane E.			Novel Use of Proton Magnetic Resonance Spectroscopy (1HMRS) to Non-Invasively Assess Placental Metabolism	PLOS ONE			English	Article							IN-UTERO; FOOTPRINT; APOPTOSIS; FETUSES; BIRTH	Background: Placental insufficiency is a major cause of antepartum stillbirth and fetal growth restriction (FGR). In affected pregnancies, delivery is expedited when the risks of ongoing pregnancy outweigh those of prematurity. Current tests are unable to assess placental function and determine optimal timing for delivery. An accurate, non-invasive test that clearly defines the failing placenta would address a major unmet clinical need. Proton magnetic resonance spectroscopy (H-1 MRS) can be used to assess the metabolic profile of tissue in-vivo. In FGR pregnancies, a reduction in N-acetylaspartate (NAA)/choline ratio and detection of lactate methyl are emerging as biomarkers of impaired neuronal metabolism and fetal hypoxia, respectively. However, fetal brain hypoxia is a late and sometimes fatal event in placental compromise, limiting clinical utility of brain H-1 MRS to prevent stillbirth. We hypothesised that abnormal placental H-1 MRS may be an earlier biomarker of intrauterine hypoxia, affording the opportunity to optimise timing of delivery in at-risk fetuses. Methods and Findings: We recruited three women with severe placental insufficiency/FGR and three matched controls. Using a 3T MR system and a combination of phased-array coils, a 20x20x40 mm H-1 MRS voxel was selected along the 'long-axis' of the placenta with saturation bands placed around the voxel to prevent contaminant signals. A significant choline peak (choline/lipid ratio 1.35-1.79) was detected in all healthy placentae. In contrast, in pregnancies complicated by FGR, the choline/lipid ratio was <= 0.02 in all placentae, despite preservation of the lipid peak (p<0.001). Conclusions: This novel proof-of-concept study suggests that in severe placental insufficiency/FGR, the observed 60-fold reduction in the choline/lipid ratio by H-1 MRS may represent an early biomarker of critical placental insufficiency. Further studies will determine performance of this test and the potential role of 1H-MRS in the in-vivo assessment of placental function to inform timing of delivery.	[Denison, Fiona C.; Stock, Sarah J.; Norman, Jane E.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Lothian, Scotland; [Semple, Scott I.] Univ Edinburgh, Clin Res Imaging Ctr, Queens Med Res Inst, Edinburgh, Lothian, Scotland; [Walker, Jane] Royal Edinburgh Infirm, Simpson Ctr Reprod Hlth, Edinburgh, Lothian, Scotland; [Marshall, Ian] Univ Edinburgh, Sch Clin Sci, Edinburgh, Lothian, Scotland	University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Denison, FC (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Lothian, Scotland.	Fiona.Denison@ed.ac.uk		Norman, Jane/0000-0001-6031-6953; Denison, Fiona/0000-0003-0371-2014	Tommy's; Baby Charity; Action Medical Research; Albert McKern Trust; Medical Research Council [G0701127, G1002033] Funding Source: researchfish; Action Medical Research [1811] Funding Source: researchfish; MRC [G1002033, G0701127] Funding Source: UKRI	Tommy's; Baby Charity; Action Medical Research; Albert McKern Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank Tommy's, the Baby Charity, Action Medical Research and the Albert McKern Trust for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonel HM, 2010, RADIOLOGY, V257, P810, DOI 10.1148/radiol.10092283; Bonellie Sandra, 2008, BMC Pregnancy Childbirth, V8, P5, DOI 10.1186/1471-2393-8-5; Brighina E, 2009, PEDIATR NEUROL, V40, P327, DOI 10.1016/j.pediatrneurol.2008.11.001; Brunelli R, 2010, PLACENTA, V31, P1051, DOI 10.1016/j.placenta.2010.09.004; Cetin I, 2009, PLACENTA, V30, pS77, DOI 10.1016/j.placenta.2008.12.006; Cetin I, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.020; Chalubinski KM, 2011, ULTRASOUND OBSTET GY; Damodaram M, 2010, PLACENTA, V31, P491, DOI 10.1016/j.placenta.2010.03.001; Derwig IE, 2011, J MAGN RESON IMAGING, V34, P1125, DOI 10.1002/jmri.22794; Dunn WB, 2009, PLACENTA, V30, P974, DOI 10.1016/j.placenta.2009.08.008; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Hasegawa J, 2010, J PERINAT MED, V38, P29, DOI [10.1515/JPM.2010.003, 10.1515/jpm.2010.003]; Heazell AEP, 2008, PLACENTA, V29, P691, DOI 10.1016/j.placenta.2008.05.002; Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3; Horgan RP, 2010, PLACENTA, V31, P893, DOI 10.1016/j.placenta.2010.07.002; Kakogawa J, 2010, AM J PERINAT, V27, P463, DOI 10.1055/s-0030-1247600; Kakogawa J, 2010, AM J PERINAT, V27, P25, DOI 10.1055/s-0029-1234038; KAZZI GM, 1983, AM J OBSTET GYNECOL, V145, P733, DOI 10.1016/0002-9378(83)90582-3; Lindskog M, 2005, CANCER LETT, V228, P247, DOI 10.1016/j.canlet.2004.12.055; Loughna P, 2009, ULTRASOUND, V17, P160, DOI 10.1179/174313409X448543; Macara L, 1996, PLACENTA, V17, P37, DOI 10.1016/S0143-4004(05)80642-3; Madazli R, 2003, PLACENTA, V24, P510, DOI 10.1053/plac.2002.0945; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; Moore RJ, 2000, PLACENTA, V21, P726, DOI 10.1053/plac.2000.0567; Sankaran S, 2009, BEST PRACT RES CL OB, V23, P765, DOI 10.1016/j.bpobgyn.2009.05.003; Schott J, J FAM HLTH CARE, V20, P116; Sebire NJ, 2008, J CLIN PATHOL, V61, P1276, DOI 10.1136/jcp.2008.055251; Semple SIK, 2001, MAGN RESON IMAGING, V19, P921, DOI 10.1016/S0730-725X(01)00421-0; Sibley CP, 2005, PEDIATR RES, V58, P827, DOI 10.1203/01.PDR.0000181381.82856.23; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Story L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.032; Story L, 2011, EUR J OBSTET GYN R B, V158, P3, DOI 10.1016/j.ejogrb.2010.03.003; Teo TH, 2009, CLIN RADIOL, V64, P511, DOI 10.1016/j.crad.2009.02.003; Wright C, 2011, PLACENTA, V32, P1010, DOI 10.1016/j.placenta.2011.07.008; Yin TT, 2009, PLACENTA, V30, P726, DOI 10.1016/j.placenta.2009.05.002	35	23	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42926	10.1371/journal.pone.0042926	http://dx.doi.org/10.1371/journal.pone.0042926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900066	gold, Green Published, Green Submitted			2022-12-27	WOS:000307380900084
J	Hjouj, M; Last, D; Guez, D; Daniels, D; Sharabi, S; Lavee, J; Rubinsky, B; Mardor, Y				Hjouj, Mohammad; Last, David; Guez, David; Daniels, Dianne; Sharabi, Shirley; Lavee, Jacob; Rubinsky, Boris; Mardor, Yael			MRI Study on Reversible and Irreversible Electroporation Induced Blood Brain Barrier Disruption	PLOS ONE			English	Article							MAGNETIC-RESONANCE; TISSUE ABLATION; DRUG-DELIVERY; ELECTROTRANSFER; CONTRAST; CELLS	Electroporation, is known to induce cell membrane permeabilization in the reversible (RE) mode and cell death in the irreversible (IRE) mode. Using an experimental system designed to produce a continuum of IRE followed by RE around a single electrode we used MRI to study the effects of electroporation on the brain. Fifty-four rats were injected with Gd-DOTA and treated with a G25 electrode implanted 5.5 mm deep into the striata. MRI was acquired immediately after treatment, 10 min, 20 min, 30 min, and up to three weeks following the treatment using: T1W, T2W, Gradient echo (GE), serial SPGR (DCE-MRI) with flip angles ranging over 5-25 degrees, and diffusion-weighted MRI (DWMRI). Blood brain barrier (BBB) disruption was depicted as clear enhancement on T1W images. The average signal intensity in the regions of T1-enhancement, representing BBB disruption, increased from 1887 +/- 83 (arbitrary units) immediately post treatment to 2246 +/- 94 20 min post treatment, then reached a plateau towards the 30 min scan where it reached 2289 +/- 87. DWMRI at 30 min showed no significant effects. Early treatment effects and late irreversible damage were clearly depicted on T2W. The enhancing volume on T2W has increased by an average of 2.27 +/- 0.27 in the first 24-48 hours post treatment, suggesting an inflammatory tissue response. The permanent tissue damage, depicted as an enhancing region on T2W, 3 weeks post treatment, decreased to an average of 50 +/- 10% of the T2W enhancing volumes on the day of the treatment which was 33 +/- 5% of the BBB disruption volume. Permanent tissue damage was significantly smaller than the volume of BBB disruption, suggesting, that BBB disruption is associated with RE while tissue damage with IRE. These results demonstrate the feasibility of applying reversible and irreversible electroporation for transient BBB disruption or permanent damage, respectively, and applying MRI for planning/monitoring disruption volume/ shape by optimizing electrode positions and treatment parameters.	[Hjouj, Mohammad] Hebrew Univ Jerusalem, Ctr Bioengn Serv Human & Soc, Sch Comp Sci & Engn, Jerusalem, Israel; [Last, David; Guez, David; Daniels, Dianne; Sharabi, Shirley; Mardor, Yael] Chaim Sheba Med Ctr, Adv Technol Ctr, Ramat Gan, Israel; [Mardor, Yael] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Lavee, Jacob] Chaim Sheba Med Ctr, Cardiol Inst, Ramat Gan, Israel; [Rubinsky, Boris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	Hebrew University of Jerusalem; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; University of California System; University of California Berkeley	Hjouj, M (corresponding author), Hebrew Univ Jerusalem, Ctr Bioengn Serv Human & Soc, Sch Comp Sci & Engn, Jerusalem, Israel.	yael.mardor@sheba.health.gov.il		guez, david/0000-0002-9143-2575; sharabi, shirley/0000-0002-1561-7965; Daniels, Dianne/0000-0002-0912-8719; Hjouj, Mohammad/0000-0001-8002-3488; Lavee, Jacob/0000-0002-3641-1114				Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Aung W, 2009, GENE THER, V16, P830, DOI 10.1038/gt.2009.55; Bagla S, 2012, J VASC INTERV RADIOL, V23, P142, DOI 10.1016/j.jvir.2011.10.002; Ball C, 2010, ANESTH ANALG, V110, P1305, DOI 10.1213/ANE.0b013e3181d27b30; Brigger I, 2002, J PHARMACOL EXP THER, V303, P928, DOI 10.1124/jpet.102.039669; Bureau MF, 2010, BBA-GEN SUBJECTS, V1800, P537, DOI 10.1016/j.bbagen.2010.02.003; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Dev SB, 2002, MAGN RESON IMAGING, V20, P389, DOI 10.1016/S0730-725X(02)00517-9; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Ellis TL, 2011, J NEUROSURG, V114, P681, DOI 10.3171/2010.5.JNS091448; Filippi M, 1998, J NEUROL NEUROSUR PS, V64, pS88; Garcia PA, 2010, J MEMBRANE BIOL, V236, P127, DOI 10.1007/s00232-010-9284-z; Ghosh N, 2011, J MAGN RESON IMAGING, V33, P772, DOI 10.1002/jmri.22488; Hannig J, 1999, P 1 JOINT BMES EMBS; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Heller LC, 2006, HUM GENE THER, V17, P890, DOI 10.1089/hum.2006.17.890; Hjouj M, 2011, NEUROONCOL S3, V13; Hjouj M, 2010, J MEMBRANE BIOL, V236, P137, DOI 10.1007/s00232-010-9281-2; Ivorra A, 2007, BIOELECTROCHEMISTRY, V70, P287, DOI 10.1016/j.bioelechem.2006.10.005; Leroy-Willig A, 2005, GENE THER, V12, P1434, DOI 10.1038/sj.gt.3302541; Lopez-Quintero SV, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016005; Mahmood F, 2011, J MEMBRANE BIOL, V240, P131, DOI 10.1007/s00232-011-9351-0; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Maor E, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001035; Mardor Y, 2005, CANCER RES, V65, P6858, DOI 10.1158/0008-5472.CAN-05-0161; Mardor Y, 2001, CANCER RES, V61, P4971; McDannold N, 2008, ULTRASOUND MED BIOL, V34, P834, DOI 10.1016/j.ultrasmedbio.2007.10.016; Mikulis DJ, 2007, J MAGN RESON IMAGING, V26, P838, DOI 10.1002/jmri.21041; Mir LM, 2006, EJC SUPPL, V4, P38, DOI 10.1016/j.ejcsup.2006.08.005; Neal RE, 2011, J CLIN ONCOL, V29, pE372, DOI 10.1200/JCO.2010.33.0902; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Pakhomov AG, 2010, ADV ELECTROPORATION; Phillips MA, 2012, BRIT J CANCER, V106, P490, DOI 10.1038/bjc.2011.582; Phillips M, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001882; Rosman Y, 2012, J APPL TOXICOL, V32, P409, DOI 10.1002/jat.1715; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; RUNGE VM, 1995, TOP MAGN RESON IMAG, V7, P158; Runge VM, 1898, RADIOGRAPHICS, V9, P929; Sersa G, 1998, ELECTRO MAGNETOBIOL, V17, P299; Silva GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S4; Simon JH, 2006, AM J NEURORADIOL, V27, P455; Sinnecker T, 2012, ARCH NEUROL; Thomson K, 2010, HUMAN EXPERIENCE IRR; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820; Zhang Y, 2010, RADIOLOGY, V256, P424, DOI 10.1148/radiol.10091955	48	54	85	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42817	10.1371/journal.pone.0042817	http://dx.doi.org/10.1371/journal.pone.0042817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900052	Green Published, gold			2022-12-27	WOS:000307380900070
J	Yi, ZJ; Fu, YR; Ji, R; Li, RF; Guan, ZY				Yi, Zhengjun; Fu, Yurong; Ji, Rui; Li, Ruifang; Guan, Zhiyu			Altered microRNA Signatures in Sputum of Patients with Active Pulmonary Tuberculosis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; PROTEIN EXPRESSION; IMMUNE-RESPONSES; CYSTIC-FIBROSIS; INFECTION; DISEASE; INNATE; INDUCTION; CHILDREN; SMOKERS	Role of microRNA (miRNA) has been highlighted in pathogen-host interactions recently. At present, their role in active pulmonary tuberculosis is unknown. The aim of the study was to delineate miRNA expression in sputum supernatant of patients with active pulmonary tuberculosis. Expression of miRNAs was evaluated by microarray analysis and differentially expressed miRNAs were validated by RT-qPCR. Secreted cytokines TNF-alpha and IL-6 were measured by ELISA. We found that 95 miRNAs were differentially expressed between tuberculosis group and controls. More miRNAs (52 out of 95 miRNAs) were underexpressed than overexpressed during tuberculosis infection. Overexpression of miR-3179, miR-147 and underexpression of miR-19b-2* in TB group compared with controls were confirmed in the validation cohort. TNF-alpha and IL-6 levels were not significantly altered between TB group and controls. For the first time, differential expression of miRNAs in sputum was found in active pulmonary tuberculosis. The study provides rationale for identifying the role of miRNAs in the pathogenesis of pulmonary tuberculosis and indicates potential for miRNA-based therapeutic strategies.	[Yi, Zhengjun] Weifang Med Univ, Key Lab Clin Lab Diagnost Univ Shandong, Affiliated Hosp, Dept Lab Med,Clin Fac, Weifang, Peoples R China; [Fu, Yurong; Ji, Rui; Li, Ruifang; Guan, Zhiyu] Weifang Med Univ, Dept Med Microbiol, Weifang, Peoples R China	Weifang Medical University; Weifang Medical University	Yi, ZJ (corresponding author), Weifang Med Univ, Key Lab Clin Lab Diagnost Univ Shandong, Affiliated Hosp, Dept Lab Med,Clin Fac, Weifang, Peoples R China.	yifuyurong@163.com			National Science Foundation of China [30972639]; Project of Shandong Province Higher Educational Science and Technology Program of China [J09LF20]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Shandong Province Higher Educational Science and Technology Program of China	This work was supported by the grants of National Science Foundation of China (No. 30972639) and the Project of Shandong Province Higher Educational Science and Technology Program of China (No. J09LF20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casado B, 2007, J PROTEOME RES, V6, P4615, DOI 10.1021/pr070440q; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Gershman NH, 1999, J ALLERGY CLIN IMMUN, V104, P322, DOI 10.1016/S0091-6749(99)70374-X; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Ma RM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-38; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Oglesby IK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-148; Sagel SD, 2001, AM J RESP CRIT CARE, V164, P1425, DOI 10.1164/ajrccm.164.8.2104075; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Sloane AJ, 2005, AM J RESP CRIT CARE, V172, P1416, DOI 10.1164/rccm.200409-1215OC; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thunnissen FBJM, 2003, J CLIN PATHOL, V56, P805, DOI 10.1136/jcp.56.11.805; Van Pottelberge GR, 2011, AM J RESP CRIT CARE, V183, P898, DOI 10.1164/rccm.201002-0304OC; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie Y, 2010, LUNG CANCER, V67, P170, DOI 10.1016/j.lungcan.2009.04.004; Yu L, 2010, INT J CANCER, V127, P2870, DOI 10.1002/ijc.25289; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	31	80	96	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43184	10.1371/journal.pone.0043184	http://dx.doi.org/10.1371/journal.pone.0043184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900099	Green Published, gold			2022-12-27	WOS:000307380900117
J	Deng, BC; Zhang, SJ; Geng, YZ; Zhang, YZ; Wang, YC; Yao, WQ; Wen, Y; Cui, W; Zhou, Y; Gu, QH; Wang, W; Wang, Y; Shao, Z; Wang, YL; Li, CB; Wang, DL; Zhao, YT; Liu, P				Deng, Baocheng; Zhang, Shujun; Geng, Yingzhi; Zhang, Yuzhong; Wang, Yuncheng; Yao, Wenqing; Wen, Ying; Cui, Wei; Zhou, Ying; Gu, Qiuhong; Wang, Wen; Wang, Yu; Shao, Zhen; Wang, Yanli; Li, Chengbo; Wang, Donglei; Zhao, Yitong; Liu, Pei			Cytokine and Chemokine Levels in Patients with Severe Fever with Thrombocytopenia Syndrome Virus	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; IFN-GAMMA; HEMORRHAGIC-FEVER; INTERFERON-GAMMA; T-CELL; EXPRESSION; DENGUE; BUNYAVIRUS; INFECTION; CHINA	Background: Severe fever with thrombocytopenia syndrome virus (SFTSV), which can cause hemorrhagic fever-like illness, is a newly discovered bunyavirus in China. The pathogenesis of SFTSV infection is poorly understood. However, it has been suggested that immune mechanisms, including cytokines and chemokines, play an important role in disease pathogenesis. In the present study, we investigated host cytokine and chemokine profiles in serum samples of patients with SFTSV infection from Northeast China and explored a possible correlation between cytokine levels and disease severity. Methods and Principal Findings: Acute phase serum samples from 40 patients, diagnosed with SFTSV infection were included. Patients were divided into two groups - severe or non-severe - based on disease severity. Levels of tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta, interleukin-6, interferon (IFN)-gamma, IFN-gamma-induced protein (IP)-10 and RANTES were measured in the serum samples with commercial ELISAs. Statistical analysis showed that increases in TNF-alpha, IP-10 and IFN-gamma were associated with disease severity. Conclusions: We suggest that a cytokine-mediated inflammatory response, characterized by cytokine and chemokine production imbalance, might be in part responsible for the disease progression of patients with SFTSV infection.	[Deng, Baocheng; Wen, Ying; Cui, Wei; Zhou, Ying; Gu, Qiuhong; Wang, Wen; Wang, Yu; Shao, Zhen; Wang, Yanli; Li, Chengbo; Wang, Donglei; Zhao, Yitong; Liu, Pei] China Med Univ, Affiliated Hosp 1, Dept Infect Dis, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Shujun; Zhang, Yuzhong; Wang, Yuncheng] Kuandian Country Hosp, Dept Infect Dis, Dandong, Liaoning Provin, Peoples R China; [Geng, Yingzhi; Yao, Wenqing] Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Liu, P (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Infect Dis, Shenyang, Liaoning Provin, Peoples R China.	syliupei2003@yahoo.com.cn						Azeredo EL, 2006, MEM I OSWALDO CRUZ, V101, P437, DOI 10.1590/S0074-02762006000400016; Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Chakravarti A, 2006, INDIAN J MED RES, V123, P25; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; Liu Y, 2011, VECTOR BORNE ZOONOTI; Marta RF, 1999, AM J TROP MED HYG, V60, P85, DOI 10.4269/ajtmh.1999.60.85; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Papa A, 2006, J CLIN VIROL, V36, P272, DOI 10.1016/j.jcv.2006.04.007; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Proost P, 2003, EUR J IMMUNOL, V33, P3146, DOI 10.1002/eji.200324136; Rostami MN, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000845; Sadeghi M, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-65; Saksida A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-142; Schnittler HJ, 2003, THROMB HAEMOSTASIS, V89, P967; Sobek V, 2002, EUR J IMMUNOL, V32, P2490, DOI 10.1002/1521-4141(200209)32:9<2490::AID-IMMU2490>3.0.CO;2-G; Sundstrom JB, 2001, J VIROL, V75, P6070, DOI 10.1128/JVI.75.13.6070-6085.2001; Villinger F, 1999, J INFECT DIS, V179, pS188, DOI 10.1086/514283; Vollmer-Conna U, 2008, CLIN INFECT DIS, V47, P1418, DOI 10.1086/592967; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Yu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020575, 10.1371/journal.pone.0028680]; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zeng RH, 2011, CYTOKINE, V53, P1, DOI 10.1016/j.cyto.2010.09.011; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhang YZ, 2011, CLIN INFECT DIS	29	87	98	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41365	10.1371/journal.pone.0041365	http://dx.doi.org/10.1371/journal.pone.0041365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911786	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300034
J	Mughal, SK; Myazin, AE; Zhavoronkov, LP; Rubanovich, AV; Dubrova, YE				Mughal, Safeer K.; Myazin, Andrey E.; Zhavoronkov, Leonid P.; Rubanovich, Alexander V.; Dubrova, Yuri E.			The Dose and Dose-Rate Effects of Paternal Irradiation on Transgenerational Instability in Mice: A Radiotherapy Connection	PLOS ONE			English	Article							REPEAT DNA LOCI; GENOMIC INSTABILITY; MUTATION-INDUCTION; GERM-LINE; ANTICANCER DRUGS; MOUSE GERMLINE; BONE-MARROW; NO EVIDENCE; RADIATION; EXPOSURE	The non-targeted effects of human exposure to ionising radiation, including transgenerational instability manifesting in the children of irradiated parents, remains poorly understood. Employing a mouse model, we have analysed whether low-dose acute or low-dose-rate chronic paternal c-irradiation can destabilise the genomes of their first-generation offspring. Using single-molecule PCR, the frequency of mutation at the mouse expanded simple tandem repeat (ESTR) locus Ms6-hm was established in DNA samples extracted from sperm of directly exposed BALB/c male mice, as well as from sperm and the brain of their first-generation offspring. For acute c-irradiation from 10-100 cGy a linear dose-response for ESTR mutation induction was found in the germ line of directly exposed mice, with a doubling dose of 57 cGy. The mutagenicity of acute exposure to 100 cGy was more pronounced than that for chronic low-dose-rate irradiation. The analysis of transgenerational effects of paternal irradiation revealed that ESTR mutation frequencies were equally elevated in the germ line (sperm) and brain of the offspring of fathers exposed to 50 and 100 cGy of acute c-rays. In contrast, neither paternal acute irradiation at lower doses (10-25 cGy), nor low-dose-rate exposure to 100 cGy affected stability of their offspring. Our data imply that the manifestation of transgenerational instability is triggered by a threshold dose of acute paternal irradiation. The results of our study also suggest that most doses of human exposure to ionising radiation, including radiotherapy regimens, may be unlikely to result in transgenerational instability in the offspring children of irradiated fathers.	[Mughal, Safeer K.; Dubrova, Yuri E.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Myazin, Andrey E.; Rubanovich, Alexander V.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Zhavoronkov, Leonid P.] Russian Minist Hlth & Social Dev, Med Radiol Res Ctr, Obninsk, Russia	University of Leicester; Russian Academy of Sciences; Vavilov Institute of General Genetics; Ministry of Health of the Russian Federation	Mughal, SK (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	yed2@le.ac.uk	Zhavoronkov, Leonid Petrovich/AAG-9214-2019; Dubrova, Yuri/ABA-7148-2020; Zhavoronkov, Leonid/W-4116-2017; Rubanovich, Alexander/B-4992-2017	Zhavoronkov, Leonid Petrovich/0000-0001-5100-9118; Zhavoronkov, Leonid/0000-0001-5100-9118; Dubrova, Yuri/0000-0001-5281-7539	European Commission [036465]; Cancer Research UK [C23612/A9483, C23912/A12262]; Wellcome Trust [091106/Z/10/Z]; Electromagnetic Field (EMF) Biological Research Trust [BRT 11/42]	European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Electromagnetic Field (EMF) Biological Research Trust	This work was supported by a research grant from the European Commission (http://www.wellcome.ac.uk/; NOTE, contract number 036465; http://ec.europa.eu/research/fp6/). Y.E.D. work is also supported by research grants from Cancer Research UK (http://www.cancerresearchuk.org/; contract number C23612/A9483 and C23912/A12262), the Wellcome Trust (http://www.wellcome.ac.uk/; contract number 091106/Z/10/Z), and the Electromagnetic Field (EMF) Biological Research Trust (http://www.emfbrt.org/; contract number BRT 11/42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanyan A, 2011, ENVIRON MOL MUTAGEN, V52, P538, DOI 10.1002/em.20655; Ali HEA, 2012, MUTAT RES-FUND MOL M, V732, P21, DOI 10.1016/j.mrfmmm.2012.01.003; Barber R, 2002, P NATL ACAD SCI USA, V99, P6877, DOI 10.1073/pnas.102015399; Barber RC, 2006, ONCOGENE, V25, P7336, DOI 10.1038/sj.onc.1209723; Barber RC, 2009, MUTAT RES-FUND MOL M, V664, P6, DOI 10.1016/j.mrfmmm.2009.01.011; Ding LH, 2005, RADIAT RES, V164, P17, DOI 10.1667/RR3354; Dubrova YE, 2000, MUTAT RES-FUND MOL M, V453, P17, DOI 10.1016/S0027-5107(00)00068-3; Dubrova YE, 2005, RADIAT RES, V163, P200, DOI 10.1667/RR3296; Dubrova YE, 1998, P NATL ACAD SCI USA, V95, P6251, DOI 10.1073/pnas.95.11.6251; Dubrova YE, 2000, NATURE, V405, P37, DOI 10.1038/35011135; Dubrova YE, 2008, ENVIRON MOL MUTAGEN, V49, P308, DOI 10.1002/em.20385; FRANKENBERGSCHWAGER M, 1990, RADIAT ENVIRON BIOPH, V29, P273, DOI 10.1007/BF01210408; Glen CD, 2008, CANCER RES, V68, P3630, DOI 10.1158/0008-5472.CAN-08-0484; Glen CD, 2012, P NATL ACAD SCI USA, V109, P2984, DOI 10.1073/pnas.1119396109; Hatch T, 2007, ONCOGENE, V26, P4720, DOI 10.1038/sj.onc.1210253; LYON MF, 1972, MUTAT RES, V15, P185, DOI 10.1016/0027-5107(72)90031-0; Rithidech KN, 2012, DOSE-RESPONSE, V10, P11, DOI 10.2203/dose-response.11-002.Rithidech; RUSSELL WL, 1982, P NATL ACAD SCI-BIOL, V79, P542, DOI 10.1073/pnas.79.2.542; RUSSELL WL, 1982, P NATL ACAD SCI-BIOL, V79, P539, DOI 10.1073/pnas.79.2.539; SEARLE AG, 1974, ADV RADIAT BIOL, V4, P131; Shiraishi K, 2002, RADIAT RES, V157, P661, DOI 10.1667/0033-7587(2002)157[0661:PIOSRO]2.0.CO;2; Tawn EJ, 2005, MUTAT RES-GEN TOX EN, V583, P198, DOI 10.1016/j.mrgentox.2005.03.007; Tucker JD, 1998, MUTAT RES, V400, P231; UNSCEAR, 2000, SOURC EFF ION RAD UN, VI; UNSCEAR, 2001, UN SCI COMM EFF AT R; Vilarino-Guell C, 2003, MUTAT RES-FUND MOL M, V526, P63, DOI 10.1016/S0027-5107(03)00016-2; Zheng NJ, 2000, ENVIRON MOL MUTAGEN, V36, P134, DOI 10.1002/1098-2280(2000)36:2<134::AID-EM8>3.0.CO;2-D; Zyuzikov NA, 2011, RADIAT RES, V175, P322, DOI 10.1667/RR2386.1	28	26	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41300	10.1371/journal.pone.0041300	http://dx.doi.org/10.1371/journal.pone.0041300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911775	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300029
J	Heskes, AM; Goodger, JQD; Tsegay, S; Quach, T; Williams, SJ; Woodrow, IE				Heskes, Allison M.; Goodger, Jason Q. D.; Tsegay, Sammi; Quach, Tim; Williams, Spencer J.; Woodrow, Ian E.			Localization of Oleuropeyl Glucose Esters and a Flavanone to Secretory Cavities of Myrtaceae	PLOS ONE			English	Article							EUCALYPTUS-GLOBULUS; FLAVONOL GLYCOSIDES; GLANDULAR TRICHOMES; PHENOLIC-COMPOUNDS; MASS-SPECTROMETRY; LEAVES; CHEMISTRY; ACID; CYPELLOCARPA; POLYBRACTEA	We report the widespread occurrence of structurally diverse oleuropeyl glucose esters, including the new diester eucaglobulin B, localized specifically to the essential oil secretory cavities of myrtaceous species. Clear taxonomic patterns in the composition of cavity extracts within the genus Eucalyptus are shown with species from subgenus Symphyomyrtus dominated by oleuropeyl glucose esters and species from subgenus Eucalyptus dominated instead by the flavanone, pinocembrin. We also examined the intra-species occurrence of oleuropeyl glucose esters by quantifying the abundant constituents cuniloside B and froggattiside A in trees from two populations of Eucalyptus polybractea R. T. Baker. All trees contained both compounds, which were positively correlated with total essential oil concentration. This apparent ubiquity of oleuropeyl glucose esters at both intra-and inter-specific levels in Eucalyptus is indicative of important physiological or ecological functions. The significance of their prevalence and the sequestration of these esters and also pinocembrin to the extracellular domain of secretory cavities is discussed in light of their potential biological activities and our findings that they are spatially segregated to the exterior of cavity lumina. The localization of oleuropeyl glucose esters to a specific and isolatable tissue type has the potential to aid in future elucidation of function and biosynthesis.	[Heskes, Allison M.; Goodger, Jason Q. D.; Woodrow, Ian E.] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Tsegay, Sammi; Quach, Tim; Williams, Spencer J.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Tsegay, Sammi; Quach, Tim; Williams, Spencer J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Heskes, AM (corresponding author), Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia.	a.heskes@student.unimelb.edu.au	Williams, Spencer/C-3545-2009; Goodger, Jason/B-2779-2013	Williams, Spencer/0000-0001-6341-4364; Goodger, Jason/0000-0001-7392-3891; Heskes, Allison/0000-0002-2732-5185	Holsworth Wildlife Research Endowment; Australian Research Council [DP1094530, LP110100138];  [DP1093356]	Holsworth Wildlife Research Endowment; Australian Research Council(Australian Research Council); 	Allison M. Heskes was supported by the Holsworth Wildlife Research Endowment (managed by ANZ Trustees). Jason Q. D. Goodger and Ian E. Woodrow were supported by the Australian Research Council (Project DP1094530 and LP110100138), and Spencer J. Williams, Sammi Tsegay and Tim Quach (Project DP1093356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeras E, 2003, PLANT J, V34, P202, DOI 10.1046/j.1365-313X.2003.01718.x; BICK IRC, 1972, AUST J CHEM, V25, P449, DOI 10.1071/CH9720449; Boulekbache-Makhlouf L, 2010, J AGR FOOD CHEM, V58, P12615, DOI 10.1021/jf1029509; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; Cadahia E, 1997, PHYTOCHEM ANALYSIS, V8, P78; Close DC, 2001, AUST J PLANT PHYSIOL, V28, P269, DOI 10.1071/PP00112; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; Napal GND, 2009, BIORESOURCE TECHNOL, V100, P3669, DOI 10.1016/j.biortech.2009.02.050; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; EDWARDS PB, 1993, OECOLOGIA, V95, P551, DOI 10.1007/BF00317440; Eyles A, 2004, TREES-STRUCT FUNCT, V18, P204, DOI 10.1007/s00468-003-0297-4; Eyles A, 2003, FOREST PATHOL, V33, P317, DOI 10.1046/j.1439-0329.2003.00332.x; FAHN A, 1988, NEW PHYTOL, V108, P229, DOI 10.1111/j.1469-8137.1988.tb04159.x; Ghisalberti EL, 1996, PHYTOCHEMISTRY, V41, P7, DOI 10.1016/0031-9422(95)00484-X; Gilles M, 2010, FOOD CHEM, V119, P731, DOI 10.1016/j.foodchem.2009.07.021; Gobbo-Neto L, 2008, RAPID COMMUN MASS SP, V22, P3802, DOI 10.1002/rcm.3802; Goodger JQD, 2007, FOREST ECOL MANAG, V250, P196, DOI 10.1016/j.foreco.2007.05.015; Goodger JQD, 2011, PHYTOCHEMISTRY, V72, P2259, DOI 10.1016/j.phytochem.2011.08.026; Goodger JQD, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-20; Goodger JQD, 2009, PHYTOCHEMISTRY, V70, P1187, DOI 10.1016/j.phytochem.2009.06.004; Hakki Z, 2010, CARBOHYD RES, V345, P2079, DOI 10.1016/j.carres.2010.07.029; Hanawa F, 2001, PHYTOCHEMISTRY, V57, P223, DOI 10.1016/S0031-9422(00)00514-8; Hasegawa T, 2008, PHYTOCHEMISTRY, V69, P747, DOI 10.1016/j.phytochem.2007.08.030; Henery ML, 2007, NEW PHYTOL, V176, P82, DOI 10.1111/j.1469-8137.2007.02159.x; Heskes AM, 2012, J MICROSC-OXFORD, V247, P33, DOI 10.1111/j.1365-2818.2011.03593.x; Hou AJ, 2000, J ASIAN NAT PROD RES, V2, P205, DOI 10.1080/10286020008039912; HYODO S, 1992, BIOSCI BIOTECH BIOCH, V56, P138, DOI 10.1271/bbb.56.138; Ito H, 2000, J NAT PROD, V63, P1253, DOI 10.1021/np0001981; JUNG JH, 1990, PHYTOCHEMISTRY, V29, P1667, DOI 10.1016/0031-9422(90)80142-4; Kasajima N, 2005, CHEM PHARM BULL, V53, P1345, DOI 10.1248/cpb.53.1345; King DJ, 2004, FUNCT PLANT BIOL, V31, P451, DOI 10.1071/FP03217; Lawler IR, 1999, J CHEM ECOL, V25, P401, DOI 10.1023/A:1020863216892; MANNS D, 1994, PLANTA MED, V60, P467, DOI 10.1055/s-2006-959534; Matsuki M, 2011, J CHEM ECOL, V37, P286, DOI 10.1007/s10886-011-9916-5; Moore BD, 2004, J CHEM ECOL, V30, P1743, DOI 10.1023/B:JOEC.0000042399.06553.c6; Nakanishi T, 2005, CHEM PHARM BULL, V53, P783, DOI 10.1248/cpb.53.783; PROKSCH M, 1985, PHYTOCHEMISTRY, V24, P2889, DOI 10.1016/0031-9422(85)80021-2; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; SCARPATI ML, 1966, TETRAHEDRON LETT, P5673; SHAIN L, 1982, PHYTOPATHOLOGY, V72, P877, DOI 10.1094/Phyto-72-877; Tian LW, 2009, J NAT PROD, V72, P1608, DOI 10.1021/np900290s; Turner GW, 2000, PLANT PHYSIOL, V124, P665, DOI 10.1104/pp.124.2.665; WOLLENWEBER E, 1982, PHYTOCHEMISTRY, V21, P1063, DOI 10.1016/S0031-9422(00)82416-4; Yao LH, 2004, J AGR FOOD CHEM, V52, P210, DOI 10.1021/jf034990u; Yuan Y, 2008, J ASIAN NAT PROD RES, V10, P999, DOI 10.1080/10286020802240418	45	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40856	10.1371/journal.pone.0040856	http://dx.doi.org/10.1371/journal.pone.0040856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911712	Green Submitted, Green Published, gold			2022-12-27	WOS:000306644600023
J	Hsu, PH; Miaw, SC; Chuang, CC; Chang, PY; Fu, SJ; Jow, GM; Chiu, MM; Jeng, CJ				Hsu, Po-Hao; Miaw, Shi-Chuen; Chuang, Chau-Ching; Chang, Pei-Yu; Fu, Ssu-Ju; Jow, Guey-Mei; Chiu, Mei-Miao; Jeng, Chung-Jiuan			14-3-3 theta is a Binding Partner of Rat Eag1 Potassium Channels	PLOS ONE			English	Article							PHOSPHORYLATION-INDEPENDENT INTERACTION; DIFFERENTIAL LOCALIZATION; FUNCTIONAL EXPRESSION; PAS DOMAINS; K+ CHANNELS; HUMAN ETHER; PROTEINS; FAMILY; DROSOPHILA; CAMKII	The ether-a-go-go (Eag) potassium (K+) channel belongs to the superfamily of voltage-gated K+ channel. In mammals, the expression of Eag channels is neuron-specific but their neurophysiological role remains obscure. We have applied the yeast two-hybrid screening system to identify rat Eag1 (rEag1)-interacting proteins from a rat brain cDNA library. One of the clones we identified was 14-3-3 theta, which belongs to a family of small acidic protein abundantly expressed in the brain. Data from in vitro yeast two-hybrid and GST pull-down assays suggested that the direct association with 14-3-3 theta was mediated by both the N- and the C-termini of rEag1. Co-precipitation of the two proteins was confirmed in both heterologous HEK293T cells and native hippocampal neurons. Electrophysiological studies showed that over-expression of 14-3-3 theta led to a sizable suppression of rEag1 K+ currents with no apparent alteration of the steady-state voltage dependence and gating kinetics. Furthermore, co-expression with 14-3-3 theta failed to affect the total protein level, membrane trafficking, and single channel conductance of rEag1, implying that 14-3-3 theta binding may render a fraction of the channel locked in a nonconducting state. Together these data suggest that 14-3-3 theta is a binding partner of rEag1 and may modulate the functional expression of the K+ channel in neurons.	[Hsu, Po-Hao; Chuang, Chau-Ching; Chang, Pei-Yu; Fu, Ssu-Ju; Chiu, Mei-Miao; Jeng, Chung-Jiuan] Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei 112, Taiwan; [Jeng, Chung-Jiuan] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Miaw, Shi-Chuen] Natl Taiwan Univ, Grad Inst Immunol, Coll Med, Taipei 10764, Taiwan; [Jow, Guey-Mei] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; Fu Jen Catholic University	Hsu, PH (corresponding author), Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei 112, Taiwan.	cjjeng@ym.edu.tw		MIAW, SHI-CHUEN/0000-0003-1347-9367	National Science Council, Taiwan [NSC97-2320-B-010-020-MY3]; Aim for the Top University Plan, Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Aim for the Top University Plan, Ministry of Education, Taiwan	This work was supported by research grants from National Science Council, Taiwan (NSC97-2320-B-010-020-MY3) and from the Aim for the Top University Plan, Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Chen IH, 2011, J BIOL CHEM, V286, P27183, DOI 10.1074/jbc.M111.233825; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Frings S, 1998, J GEN PHYSIOL, V111, P583, DOI 10.1085/jgp.111.4.583; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fuglsang AT, 2003, J BIOL CHEM, V278, P42266, DOI 10.1074/jbc.M306707200; Heusser K, 2006, J CELL SCI, V119, P4353, DOI 10.1242/jcs.03196; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jagemann LR, 2008, J BIOL CHEM, V283, P17450, DOI 10.1074/jbc.M709185200; Jeng CJ, 2005, NEUROREPORT, V16, P229, DOI 10.1097/00001756-200502280-00005; Jow GM, 2008, NEUROSCI LETT, V431, P12, DOI 10.1016/j.neulet.2007.11.017; Kagan A, 2002, EMBO J, V21, P1889, DOI 10.1093/emboj/21.8.1889; Li Y, 2006, NEURON, V51, P755, DOI 10.1016/j.neuron.2006.08.014; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; Ludwig J, 2000, MOL CELL NEUROSCI, V16, P59, DOI 10.1006/mcne.2000.0851; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Marble DD, 2005, J NEUROSCI, V25, P4898, DOI 10.1523/JNEUROSCI.4566-04.2005; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Partch CL, 2010, J CELL PHYSIOL, V223, P553, DOI 10.1002/jcp.22067; Philip N, 2001, J NEUROSCI, V21, P8417, DOI 10.1523/JNEUROSCI.21-21-08417.2001; Piros ET, 1999, J BIOL CHEM, V274, P33677, DOI 10.1074/jbc.274.47.33677; Pulina MV, 2006, J BIOL CHEM, V281, P19645, DOI 10.1074/jbc.M602033200; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Saganich MJ, 1999, J NEUROSCI, V19, P10789, DOI 10.1523/JNEUROSCI.19-24-10789.1999; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Stevens L, 2009, EUR BIOPHYS J BIOPHY, V38, P523, DOI 10.1007/s00249-009-0402-8; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Wang Z, 2002, J BIOL CHEM, V277, P24022, DOI 10.1074/jbc.M201949200; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	50	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41203	10.1371/journal.pone.0041203	http://dx.doi.org/10.1371/journal.pone.0041203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911758	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600054
J	Joseph, MS; Ying, Z; Zhuang, YM; Zhong, H; Wu, AG; Bhatia, HS; Cruz, R; Tillakaratne, NJK; Roy, RR; Edgerton, VR; Gomez-Pinilla, F				Joseph, M. Selvan; Ying, Zhe; Zhuang, Yumei; Zhong, Hui; Wu, Aiguo; Bhatia, Harsharan S.; Cruz, Rusvelda; Tillakaratne, Niranjala J. K.; Roy, Roland R.; Edgerton, V. Reggie; Gomez-Pinilla, Fernando			Effects of Diet and/or Exercise in Enhancing Spinal Cord Sensorimotor Learning	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SATURATED-FAT DIET; DOCOSAHEXAENOIC ACID; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; MEMBRANE HOMEOSTASIS; BDNF; RECOVERY; RATS	Given that the spinal cord is capable of learning sensorimotor tasks and that dietary interventions can influence learning involving supraspinal centers, we asked whether the presence of omega-3 fatty acid docosahexaenoic acid (DHA) and the curry spice curcumin (Cur) by themselves or in combination with voluntary exercise could affect spinal cord learning in adult spinal mice. Using an instrumental learning paradigm to assess spinal learning we observed that mice fed a diet containing DHA/Cur performed better in the spinal learning paradigm than mice fed a diet deficient in DHA/Cur. The enhanced performance was accompanied by increases in the mRNA levels of molecular markers of learning, i.e., BDNF, CREB, CaMKII, and syntaxin 3. Concurrent exposure to exercise was complementary to the dietary treatment effects on spinal learning. The diet containing DHA/Cur resulted in higher levels of DHA and lower levels of omega-6 fatty acid arachidonic acid (AA) in the spinal cord than the diet deficient in DHA/Cur. The level of spinal learning was inversely related to the ratio of AA: DHA. These results emphasize the capacity of select dietary factors and exercise to foster spinal cord learning. Given the non-invasiveness and safety of the modulation of diet and exercise, these interventions should be considered in light of their potential to enhance relearning of sensorimotor tasks during rehabilitative training paradigms after a spinal cord injury.	[Joseph, M. Selvan; Ying, Zhe; Wu, Aiguo; Bhatia, Harsharan S.; Cruz, Rusvelda; Tillakaratne, Niranjala J. K.; Roy, Roland R.; Edgerton, V. Reggie; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Zhuang, Yumei; Edgerton, V. Reggie; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, UCLA Brain Injury Res Ctr, Los Angeles, CA USA; [Zhong, Hui; Tillakaratne, Niranjala J. K.; Roy, Roland R.; Edgerton, V. Reggie; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Joseph, MS (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	Bhatia, Harsharan singh/AAR-4628-2021	Bhatia, Harsharan Singh/0000-0001-9912-8263; Joseph, Michael Selvan/0000-0002-0620-9249	National Institutes of Health [R01 NS056413, NS056413, R01 NS050465]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050465, R01NS056413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health R01 NS056413, Diversity Supplement NS056413, and R01 NS050465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Alberini CM, 1999, J EXP BIOL, V202, P2887; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; ARAUJO DM, 1989, BRAIN RES, V484, P130, DOI 10.1016/0006-8993(89)90355-7; Baumbauer KM, 2009, J NEUROSCI, V29, P14383, DOI 10.1523/JNEUROSCI.3583-09.2009; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Blanquet PR, 2003, NEUROSCIENCE, V118, P477, DOI 10.1016/S0306-4522(02)00963-6; Chung WL, 2008, J NUTR, V138, P1165, DOI 10.1093/jn/138.6.1165; Chytrova G, 2010, BRAIN RES, V1341, P32, DOI 10.1016/j.brainres.2009.05.018; Cole Greg M., 2006, Nutrition and Health (Bicester), V18, P249; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Curtis LB, 2008, J COMP NEUROL, V510, P550, DOI 10.1002/cne.21806; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329, DOI 10.1152/jn.1998.79.3.1329; de Leon RD, 1998, J NEUROPHYSIOL, V80, P83; DELEON R, 1994, BRAIN RES, V654, P241, DOI 10.1016/0006-8993(94)90485-5; Edgerton VE, 2009, ENCY NEUROSCIENCE, P629; Edgerton VR, 2001, J PHYSIOL-LONDON, V533, P15, DOI 10.1111/j.1469-7793.2001.0015b.x; Engesser-Cesar C, 2005, J NEUROTRAUM, V22, P157, DOI 10.1089/neu.2005.22.157; Engesser-Cesar C, 2007, EUR J NEUROSCI, V25, P1931, DOI 10.1111/j.1460-9568.2007.05469.x; Figueroa JD, 2012, J NEUROTRAUM, V29, P551, DOI 10.1089/neu.2011.2141; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P283, DOI 10.1111/j.1748-1716.1980.tb06534.x; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P269, DOI 10.1111/j.1748-1716.1980.tb06533.x; Fujita S, 2001, BRIT J PHARMACOL, V132, P1417, DOI 10.1038/sj.bjp.0703970; Gomez-Pinilla F, 2007, NEUROSCIENCE, V148, P893, DOI 10.1016/j.neuroscience.2007.05.051; Gomez-Pinilla F, 2010, NEUROSCIENCE, V168, P130, DOI 10.1016/j.neuroscience.2010.02.070; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Gomez-Pinilla F, 2011, PREV MED, V52, pS75, DOI 10.1016/j.ypmed.2011.01.023; Grau James W, 2006, Behav Cogn Neurosci Rev, V5, P191, DOI 10.1177/1534582306289738; Grau JW, 1998, BEHAV NEUROSCI, V112, P1366, DOI 10.1037/0735-7044.112.6.1366; Greiner RS, 1999, LIPIDS, V34, pS239, DOI 10.1007/BF02562305; Harkema S. J., 2011, ARCH PHYS MED REHABI; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Hashimoto M, 2006, CLIN EXP PHARMACOL P, V33, P934, DOI 10.1111/j.1440-1681.2006.04467.x; HORRIDGE G. A., 1962, NATURE, V193, P697, DOI 10.1038/193697a0; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Huie JR, 2012, NEUROSCIENCE, V200, P74, DOI 10.1016/j.neuroscience.2011.10.028; Igarashi M, 2011, J NEUROCHEM; Igarashi M., 2011, BIOCH BIOPHYS ACTA; Jindrich DL, 2009, J NEUROSCI METH, V182, P250, DOI 10.1016/j.jneumeth.2009.06.001; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; Keeler BE, 2012, BRAIN RES, V1438, P8, DOI 10.1016/j.brainres.2011.12.015; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Lim SY, 2001, J NUTR, V131, P319, DOI 10.1093/jn/131.2.319; Liu YB, 2008, J NEUROCHEM, V105, P1336, DOI 10.1111/j.1471-4159.2008.05236.x; Ma D, 2008, HIPPOCAMPUS, V18, P326, DOI 10.1002/hipo.20393; Ma DX, 2010, BRAIN RES, V1330, P1, DOI 10.1016/j.brainres.2010.03.002; Maher P, 2010, NEUROBIOL AGING, V31, P706, DOI 10.1016/j.neurobiolaging.2008.05.020; Marini AM, 2008, CNS NEUROL DISORD-DR, V7, P382, DOI 10.2174/187152708786441849; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; Mendell LM, 2001, J PHYSIOL-LONDON, V533, P91, DOI 10.1111/j.1469-7793.2001.0091b.x; Mizuno M, 2002, BEHAV BRAIN RES, V133, P135, DOI 10.1016/S0166-4328(01)00470-3; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Rao JS, 2007, MOL PSYCHIATR, V12, P36, DOI 10.1038/sj.mp.4001888; Rodger J, 1998, J NEUROCHEM, V71, P666; Rongo C, 2002, BIOESSAYS, V24, P223, DOI 10.1002/bies.10057; ROY RR, 1992, LAB ANIM SCI, V42, P335; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Shah Prithvi K, 2012, Eur J Neurosci, V36, P2054, DOI 10.1111/j.1460-9568.2012.08106.x; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Skup M, 2002, EXP NEUROL, V176, P289, DOI 10.1006/exnr.2002.7943; Suganuma H, 2010, NEUROPATHOLOGY, V30, P597, DOI 10.1111/j.1440-1789.2010.01114.x; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Teague WE, 2002, CELL MOL BIOL LETT, V7, P262; Tillakaratne NJK, 2010, NEUROSCIENCE, V166, P23, DOI 10.1016/j.neuroscience.2009.12.010; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Yamashima T, 2008, PROG NEUROBIOL, V84, P105, DOI 10.1016/j.pneurobio.2007.11.002; Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057; Ying Z, 2003, BRAIN RES, V987, P93, DOI 10.1016/S0006-8993(03)03258-X; Zhong H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00112	87	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41288	10.1371/journal.pone.0041288	http://dx.doi.org/10.1371/journal.pone.0041288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911773	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600067
J	Aonuma, H; Watanabe, T				Aonuma, Hitoshi; Watanabe, Takayuki			Changes in the Content of Brain Biogenic Amine Associated with Early Colony Establishment in the Queen of the Ant, Formica japonica	PLOS ONE			English	Article							DIVISION-OF-LABOR; HONEY-BEE COLONIES; AGE-RELATED-CHANGES; JUVENILE-HORMONE; PHEIDOLE-DENTATA; APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; NESTMATE RECOGNITION; TEMPORAL POLYETHISM; GRYLLUS-BIMACULATUS	We examined changes in the content of biogenic amines in the brains of ant queen associated with early colony establishment. In ants, including Formica japonica, winged virgin queens lose their wings following copulation, and then start establishing a colony. Significant changes in brain biogenic amine content in the queen are associated with transition from winged virgin queen to wingless mated queen. The levels of serotonin (5HT), octopamine (OA) and dopamine (DA) decreased significantly in the brain of the queen after starting a colony. On the other hand, tyramine (TA) increased significantly in the brain following colony establishment. Catabolized substances of the biogenic amines in the brain were also measured. The levels of N-acetyloctopamine (Nac-OA) and N-acetyltyramine (Nac-TA) in the brain did not show a significant change after the queen established a colony. However, the levels of N-acetylserotonin (Nac-5HT) in the brain were significantly higher in wingless mated queens than in winged virgin queens, whereas levels of N-acetyldopamine (Nac-DA) in the brain were significantly lower in wingless mated queens than winged virgin queens. These results suggest that serotonergic and octopaminergic systems in the brain of the queen change when the mated queen starts to establish a new colony.	[Aonuma, Hitoshi; Watanabe, Takayuki] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan	Hokkaido University	Aonuma, H (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan.	aon@es.hokudai.ac.jp	Aonuma, Hitoshi/D-6540-2012	Aonuma, Hitoshi/0000-0001-8380-1820; Watanabe, Takayuki/0000-0003-4211-0032	MEXT, Scientific Research on Priority Areas [454, 17075001]; JSPS [23300113]	MEXT, Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was partly supported by grants-in-aid for Scientific Research (KAKENHI) from the MEXT, Scientific Research on Priority Areas (Area No. 454) to H. Aonuma (No. 17075001) and from the JSPS to H. Aonuma (No. 23300113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Aonuma H, 2012, ACTA BIOL HUNG, V63, P63, DOI 10.1556/ABiol.63.2012.Suppl.2.6; Barron AB, 2002, J COMP PHYSIOL A, V188, P603, DOI 10.1007/s00359-002-0335-5; Baumann A., 2003, ENCY INSECTS, P91; Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; Beggs KT, 2009, CURR BIOL, V19, P1206, DOI 10.1016/j.cub.2009.05.051; Boulay R, 2001, BEHAV PROCESS, V55, P67, DOI 10.1016/S0376-6357(01)00163-2; Boulay R, 2000, J EXP BIOL, V203, P513; Boulay R, 2000, ANIM BEHAV, V59, P1127, DOI 10.1006/anbe.2000.1408; Buschinger A, 1974, SOZIALPOLYMORPHISMUS; Chen YL, 2008, ARCH INSECT BIOCHEM, V68, P241, DOI 10.1002/arch.20259; Dolezal AG, 2012, J EXP BIOL, V215, P454, DOI 10.1242/jeb.060822; Evans P.D., 1980, Advances in Insect Physiology, V15, P317, DOI 10.1016/S0065-2806(08)60143-5; FRANKS NR, 1994, ANIM BEHAV, V48, P470, DOI 10.1006/anbe.1994.1261; Gatellier L, 2004, J EXP BIOL, V207, P2487, DOI 10.1242/jeb.01035; Giray T, 2005, P NATL ACAD SCI USA, V102, P3330, DOI 10.1073/pnas.0409560102; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Gruntenko N, 2004, ARCH INSECT BIOCHEM, V55, P55, DOI 10.1002/arch.10123; HARRIS JW, 1992, J INSECT PHYSIOL, V38, P29, DOI 10.1016/0022-1910(92)90019-A; Hoyer SC, 2005, ARTHROPOD STRUCT DEV, V34, P429, DOI 10.1016/j.asd.2005.03.003; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; KAATZ H, 1994, J INSECT PHYSIOL, V40, P865, DOI 10.1016/0022-1910(94)90020-5; KONDOH M, 1968, Japanese Journal of Ecology, V18, P124; KOSTOWSKI W, 1975, PHARMACOL BIOCHEM BE, V3, P717, DOI 10.1016/0091-3057(75)90200-2; Lehman HK, 2006, J EXP BIOL, V209, P2774, DOI 10.1242/jeb.02296; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; LENT CM, 1985, BRAIN RES BULL, V14, P643, DOI 10.1016/0361-9230(85)90114-5; LONG TF, 1983, P NATL ACAD SCI-BIOL, V80, P4159, DOI 10.1073/pnas.80.13.4159; Masuko K, 1998, ZOOL SCI, V15, P409, DOI 10.2108/zsj.15.409; Meer RKV, 2008, NATURWISSENSCHAFTEN, V95, P1155, DOI 10.1007/s00114-008-0432-6; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Mizunami M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-46; Muscedere ML, 2012, J COMP PHYSIOL A, V198, P219, DOI 10.1007/s00359-011-0701-2; NAGAO T, 1991, J COMP PHYSIOL A, V168, P159, DOI 10.1007/BF00218408; Neckameyer WS, 1998, J NEUROGENET, V12, P101, DOI 10.3109/01677069809167259; Neckameyer WS, 2005, STRESS, V8, P117, DOI 10.1080/10253890500147381; Obara Y, 2011, NATURWISSENSCHAFTEN, V98, P989, DOI 10.1007/s00114-011-0847-3; Pophof B, 2000, J COMP PHYSIOL A, V186, P307, DOI 10.1007/s003590050431; Pophof B, 2002, J COMP PHYSIOL A, V188, P659, DOI 10.1007/s00359-002-0343-5; PUNZO F, 1994, COMP BIOCHEM PHYS C, V107, P387, DOI 10.1016/1367-8280(94)90066-3; RAUSCHENBACH IY, 1993, J INSECT PHYSIOL, V39, P761, DOI 10.1016/0022-1910(93)90051-R; Rillich J, 2011, P ROY SOC B-BIOL SCI, V278, P1873, DOI 10.1098/rspb.2010.2099; ROBINSON GE, 1994, ANIM BEHAV, V48, P467, DOI 10.1006/anbe.1994.1260; Robinson GE, 1999, NATURE, V399, P534, DOI 10.1038/21095; ROBINSON GE, 1987, BEHAV ECOL SOCIOBIOL, V20, P329, DOI 10.1007/BF00300679; Roeder T, 2003, ARCH INSECT BIOCHEM, V54, P1, DOI 10.1002/arch.10102; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Sasaki K, 2001, J INSECT PHYSIOL, V47, P1205, DOI 10.1016/S0022-1910(01)00105-6; Sasaki K, 2007, J INSECT PHYSIOL, V53, P940, DOI 10.1016/j.jinsphys.2007.03.006; Saveer AM, 2012, P ROY SOC B-BIOL SCI, V279, P2314, DOI 10.1098/rspb.2011.2710; Scheiner R, 2006, CURR NEUROPHARMACOL, V4, P259, DOI 10.2174/157015906778520791; Schrempf A, 2005, CURR BIOL, V15, P267, DOI 10.1016/S0960-9822(05)00071-0; Schulz DJ, 1999, J COMP PHYSIOL A, V184, P481, DOI 10.1007/s003590050348; Schulz DJ, 2001, J COMP PHYSIOL A, V187, P53, DOI 10.1007/s003590000177; Seid MA, 2005, NATURWISSENSCHAFTEN, V92, P198, DOI 10.1007/s00114-005-0610-8; Seid MA, 2008, DEV NEUROBIOL, V68, P1325, DOI 10.1002/dneu.20663; Seid MA, 2006, BEHAV ECOL SOCIOBIOL, V60, P631, DOI 10.1007/s00265-006-0207-z; Sitaraman D, 2005, PNAS, V105, P5579; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Wada-Katsumata A, 2011, J EXP BIOL, V214, P1707, DOI 10.1242/jeb.051565; Wagener-Hulme C, 1999, J COMP PHYSIOL A, V184, P471, DOI 10.1007/s003590050347; WILSON EO, 1983, BEHAV ECOL SOCIOBIOL, V14, P47, DOI 10.1007/BF00366655; WOODRING J, 1994, J INSECT PHYSIOL, V40, P797, DOI 10.1016/0022-1910(94)90009-4; WOODRING JP, 1988, J INSECT PHYSIOL, V34, P759, DOI 10.1016/0022-1910(88)90149-7	66	19	21	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43377	10.1371/journal.pone.0043377	http://dx.doi.org/10.1371/journal.pone.0043377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905265	Green Published, gold			2022-12-27	WOS:000307823600075
J	Wu, DD; Li, GM; Jin, W; Li, Y; Zhang, YP				Wu, Dong-Dong; Li, Gui-Mei; Jin, Wei; Li, Yan; Zhang, Ya-Ping			Positive Selection on the Osteoarthritis-Risk and Decreased-Height Associated Variants at the GDF5 Gene in East Asians	PLOS ONE			English	Article							HUMAN GENOME; POPULATION DIFFERENTIATION; HAPLOTYPE RECONSTRUCTION; STATISTICAL-METHOD; NATURAL-SELECTION; BODY-SIZE; MUTATION; SUSCEPTIBILITY; SNP; POLYMORPHISM	GDF5 is a member of the bone morphogenetic protein (BMP) gene family, and plays an important role in the development of the skeletal system. Variants of the gene are associated with osteoarthritis and height in some human populations. Here, we resequenced the gene in individuals from four geographically separated human populations, and found that the evolution of the promoter region deviated from neutral expectations, with the sequence evolution driven by positive selection in the East Asian population, especially the haplotypes carrying the derived alleles of 5' UTR SNPs rs143384 and rs143383. The derived alleles of rs143384 and rs143383, which are associated with a risk of osteoarthritis and decreased height, have high frequencies in non-Africans and show strong extended haplotype homozygosity and high population differentiation in East Asian. It is concluded that positive selection has driven the rapid evolution of the two osteoarthritis osteoarthritis-risk and decreased height associated variants of the human GDF5 gene, and supports the suggestion that the reduction in body size during the terminal Pleistocene and Holocene period might have been an adaptive process influenced by genetic factors.	[Wu, Dong-Dong; Li, Yan; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Li, Gui-Mei; Jin, Wei; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University	Wu, DD (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn	Wu, Dong-Dong/AAR-5615-2020		National Natural Science Foundation of China [31061160189]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31061160189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Cann HM, 2002, SCIENCE, V296, P261; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Chapman K, 2008, HUM MOL GENET, V17, P1497, DOI 10.1093/hmg/ddn038; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Egli RJ, 2009, ARTHRITIS RHEUM-US, V60, P2055, DOI 10.1002/art.24616; Faiyaz-Ul-Haque M, 2002, CLIN GENET, V61, P454, DOI 10.1034/j.1399-0004.2002.610610.x; Fay JC, 2000, GENETICS, V155, P1405; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FRISANCH.AR, 1973, AM J PHYS ANTHROPOL, V39, P255, DOI 10.1002/ajpa.1330390216; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Harpending H, 2002, P NATL ACAD SCI USA, V99, P10, DOI 10.1073/pnas.012612799; Hawks J, 2011, ARXIV11025604V1; He F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002948; KIMURA M, 1973, GENETICS, V75, P199; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; LEPPALUOTO J, 1991, ARCTIC, V44, P139; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; NEI M, 1995, P NATL ACAD SCI USA, V92, P6720, DOI 10.1073/pnas.92.15.6720; Ruff C, 2002, ANNU REV ANTHROPOL, V31, P211, DOI 10.1146/annurev.anthro.31.040402.085407; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P361; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stini WA, 1975, PHYSL MORPHOLOGICAL, P387; TAJIMA F, 1989, GENETICS, V123, P585; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wu DD, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-16; Wu DD, 2010, HUM MOL GENET, V19, P2341, DOI 10.1093/hmg/ddq107; Wu DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010959; Wu DD, 2008, CHINESE SCI BULL, V53, P1457, DOI 10.1007/s11434-008-0202-z; Yang W, 2008, J HUM GENET, V53, P368, DOI 10.1007/s10038-008-0253-7	46	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42553	10.1371/journal.pone.0042553	http://dx.doi.org/10.1371/journal.pone.0042553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905146	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500800015
J	Zou, MX; Tang, LH; Zhao, SS; Zhao, ZJ; Chen, LY; Chen, P; Huang, ZB; Li, J; Chen, LZ; Fan, XG				Zou, Mingxiang; Tang, Lanhua; Zhao, Shushan; Zhao, Zijin; Chen, Luyao; Chen, Peng; Huang, Zebing; Li, Jun; Chen, Lizhang; Fan, Xuegong			Systematic Review and Meta-Analysis of Detecting Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosing Invasive Aspergillosis	PLOS ONE			English	Review							REAL-TIME PCR; LUNG-TRANSPLANT RECIPIENTS; LINKED-IMMUNOSORBENT-ASSAY; POLYMERASE-CHAIN-REACTION; PULMONARY ASPERGILLOSIS; ENZYME-IMMUNOASSAY; HEMATOLOGIC MALIGNANCIES; ANTIGEN-DETECTION; IMMUNOCOMPROMISED PATIENTS; BIVARIATE METAANALYSIS	Background: Bronchoalveolar lavage (BAL) galactomannan (GM) assay has been used for diagnosing invasive aspergillosis (IA). We aimed to derive a definitive estimate of the overall accuracy of BAL-GM for diagnosing IA. Methods and Results: We undertook a systematic review of thirty diagnostic studies that evaluated the BAL-GM assay for diagnosing IA. PubMed and CBM (China Biological Medicine Database) databasees were searched for relevant studies published in all languages up until Feb 2012. The pooled diagnostic odds ratio (DOR) and summary receiver operating characteristic (SROC) were constructed for each cutoff value. Additionally, pooled sensitivity (SEN), specificity (SPE), and positive and negative likelihood ratios (PLR and NLR, respectively) were calculated for summarizing overall test performance. Thirty studies were included in this meta-analysis. The summary estimates of pooled DOR, SEN, SPE, PLR, and NLR of the BAL-GM assay (cutoff value 0.5) for proven or probable IA were 52.7 (95% confidence interval (CI) 31.8-87.3), 0.87 (95% CI 0.79-0.92), 0.89 (95% CI 0.85-0.92), 8.0 (95% CI 5.7-11.1) and 0.15 (95% CI 0.10-0.23) respectively. The SROC was 0.94 (95% CI 0.92-0.96). Compared with cutoff value of 0.5, it has higher DOR, SPE and PLR, and similar SEN and NLR with cutoff value of 1.0, which indicated the optimal cutoff value might be 1.0. Compared with BAL-GM, serum GM has a lower SEN and higher SPE, while PCR displays a lower SEN and a similar SPE. Conclusion: With the optimal cutoff value of 1.0, the BAL-GM assay has higher SEN compared to PCR and serum GM test. It is a useful adjunct in the diagnosis of proven and probable IA.	[Zou, Mingxiang; Li, Jun] Cent S Univ, Xiangya Hosp, Dept Clin Lab, Changsha, Hunan, Peoples R China; [Tang, Lanhua; Zhao, Shushan; Zhao, Zijin; Chen, Luyao] Cent S Univ, Xiangya Hosp, Year Program 8, Changsha, Hunan, Peoples R China; [Chen, Peng] Cent S Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Huang, Zebing; Fan, Xuegong] Cent S Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Chen, Lizhang] Cent S Univ, Sch Publ Hlth, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University	Zou, MX (corresponding author), Cent S Univ, Xiangya Hosp, Dept Clin Lab, Changsha, Hunan, Peoples R China.	zhaoshuiquan@126.com	赵, 树山/F-1536-2011	zhao, shu shan/0000-0001-9852-6219				Acosta J, 2011, CLIN MICROBIOL INFEC, V17, P1053, DOI 10.1111/j.1469-0691.2010.03357.x; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Baddley JW, 2011, MED MYCOL, V49, pS7, DOI 10.3109/13693786.2010.505204; Becker MJ, 2003, BRIT J HAEMATOL, V121, P448, DOI 10.1046/j.1365-2141.2003.04308.x; Bergeron A, 2012, J CLIN MICROBIOL, V50, P823, DOI 10.1128/JCM.00750-11; Bergeron A, 2010, CHEST, V137, P410, DOI 10.1378/chest.09-0701; Boonsarngsuk V, 2010, SCAND J INFECT DIS, V42, P461, DOI 10.3109/00365541003602064; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Burgos A, 2008, PEDIATRICS, V121, pE1286, DOI 10.1542/peds.2007-2117; Chamilos G, 2005, DRUG RESIST UPDATE, V8, P344, DOI 10.1016/j.drup.2006.01.001; Clancy CJ, 2007, J CLIN MICROBIOL, V45, P1759, DOI 10.1128/JCM.00077-07; D'Haese J, 2012, J CLIN MICROBIOL; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Dalle F, 2005, J CLIN MICROBIOL, V43, P2929, DOI 10.1128/JCM.43.6.2929-2931.2005; Danpornprasert Praniti, 2010, J Med Assoc Thai, V93 Suppl 1, pS86; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Del Bono V, 2008, CURR OPIN HEMATOL, V15, P586, DOI 10.1097/MOH.0b013e328311890c; Desai R, 2009, PEDIATR INFECT DIS J, V28, P283, DOI 10.1097/INF.0b013e31818f0934; Drummond MF, 1997, JAMA-J AM MED ASSOC, V277, P1552, DOI 10.1001/jama.277.19.1552; Foy PC, 2007, BIOL BLOOD MARROW TR, V13, P440, DOI 10.1016/j.bbmt.2006.11.014; Francesconi A, 2006, J CLIN MICROBIOL, V44, P2475, DOI 10.1128/JCM.02693-05; Frealle E, 2009, EUR J CLIN MICROBIOL, V28, P223, DOI 10.1007/s10096-008-0616-1; Gerlinger MP, 2012, MED MALADIES INFECT, V42, P10, DOI 10.1016/j.medmal.2011.10.018; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Guo YL, 2010, CHEST, V138, P817, DOI 10.1378/chest.10-0488; Hadrich I, 2011, PATHOL BIOL PARIS; Hadrich I, 2011, MED MYCOL, V49, P489, DOI 10.3109/13693786.2010.540724; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hope WW, 2007, J INFECT DIS, V195, P455, DOI 10.1086/510535; Hope WW, 2005, LANCET INFECT DIS, V5, P609, DOI 10.1016/S1473-3099(05)70238-3; Hsu LY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-44; Husain S, 2008, CLIN VACCINE IMMUNOL, V15, P1760, DOI 10.1128/CVI.00226-08; Husain S, 2007, TRANSPLANTATION, V83, P1330, DOI 10.1097/01.tp.0000263992.41003.33; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Jin X, 2010, CHINESE J HLTH LAB T, V20, P2900; Kimura S, 2009, INT J HEMATOL, V90, P463, DOI 10.1007/s12185-009-0429-8; Kradin RL, 2008, ARCH PATHOL LAB MED, V132, P606, DOI 10.1043/1543-2165(2008)132[606:TPOPDD]2.0.CO;2; Leng Yun, 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P551; [林其昌 LIN Qi-chang], 2011, [中华老年医学杂志, Chinese Journal of Geriatrics], V30, P732; Lu Y, 2011, INTERNAL MED, V50, P2783, DOI 10.2169/internalmedicine.50.6175; Luong ML, 2011, CLIN INFECT DIS, V52, P1218, DOI 10.1093/cid/cir185; Luong ML, 2010, DIAGN MICR INFEC DIS, V68, P132, DOI 10.1016/j.diagmicrobio.2010.03.017; Maertens J, 2007, MYCOSES, V50, P2, DOI 10.1111/j.1439-0507.2007.01375.x; Maertens J, 2009, CLIN INFECT DIS, V49, P1688, DOI 10.1086/647935; Maschmeyer G, 2007, DRUGS, V67, P1567, DOI 10.2165/00003495-200767110-00004; Meersseman W, 2008, AM J RESP CRIT CARE, V177, P27, DOI 10.1164/rccm.200704-606OC; Mengoli C, 2009, LANCET INFECT DIS, V9, P89, DOI 10.1016/S1473-3099(09)70019-2; Mennink-Kersten MASH, 2004, LANCET INFECT DIS, V4, P349, DOI 10.1016/S1473-3099(04)01045-X; Musher B, 2004, J CLIN MICROBIOL, V42, P5517, DOI 10.1128/JCM.42.12.5517-5522.2004; Nguyen MH, 2007, J CLIN MICROBIOL, V45, P2787, DOI 10.1128/JCM.00716-07; Nguyen MH, 2011, BIOL BLOOD MARROW TR, V17, P1043, DOI 10.1016/j.bbmt.2010.11.013; Park SY, 2011, CLIN INFECT DIS, V52, pE149, DOI 10.1093/cid/cir027; Park SY, 2010, J INFECTION, V61, P492, DOI 10.1016/j.jinf.2010.08.014; Pasqualotto AC, 2010, TRANSPLANTATION, V90, P306, DOI 10.1097/TP.0b013e3181e49bc1; Paugam A, 2010, PATHOL BIOL, V58, P100, DOI 10.1016/j.patbio.2009.07.011; Pfeiffer CD, 2006, CLIN INFECT DIS, V42, P1417, DOI 10.1086/503427; Racil Z, 2011, INT J INFECT DIS, V15, pE874, DOI 10.1016/j.ijid.2011.09.011; Reichenberger F, 2002, EUR RESPIR J, V19, P743, DOI 10.1183/09031936.02.00256102; Rodloff AC, 2011, EUR J MED RES, V16, P187, DOI 10.1186/2047-783X-16-4-187; Saghrouni F, 2011, MED MALADIES INFECT, V41, P657, DOI 10.1016/j.medmal.2011.09.011; Sanguinetti M, 2003, J CLIN MICROBIOL, V41, P3922, DOI 10.1128/JCM.41.8.3922-3925.2003; Shahid M, 2008, CANCER-AM CANCER SOC, V113, P547, DOI 10.1002/cncr.23570; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; Torelli R, 2011, J CLIN MICROBIOL, V49, P4273, DOI 10.1128/JCM.05026-11; VERWEIJ PE, 1995, J CLIN MICROBIOL, V33, P3150, DOI 10.1128/JCM.33.12.3150-3153.1995; VONEIFF M, 1995, RESPIRATION, V62, P341, DOI 10.1159/000196477; Wang J, 2007, STUDY EARLY DIAGNOSI; Wheat LJ, 2008, EUR J CLIN MICROBIOL, V27, P245, DOI 10.1007/s10096-007-0437-7; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Zedek DC, 2006, J CLIN MICROBIOL, V44, P1601, DOI 10.1128/JCM.44.4.1601.2006	71	134	144	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43347	10.1371/journal.pone.0043347	http://dx.doi.org/10.1371/journal.pone.0043347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905261	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500800080
J	Ott, IM; Alter, ML; von Websky, K; Kretschmer, A; Tsuprykov, O; Sharkovska, Y; Krause-Relle, K; Raila, J; Henze, A; Stasch, JP; Hocher, B				Ott, Ina M.; Alter, Markus L.; von Websky, Karoline; Kretschmer, Axel; Tsuprykov, Oleg; Sharkovska, Yuliya; Krause-Relle, Katharina; Raila, Jens; Henze, Andrea; Stasch, Johannes-Peter; Hocher, Berthold			Effects of Stimulation of Soluble Guanylate Cyclase on Diabetic Nephropathy in Diabetic eNOS Knockout Mice on Top of Angiotensin II Receptor Blockade	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; ANTI-THY1 GLOMERULONEPHRITIS; CARDIOVASCULAR-DISEASE; GLOMERULAR-LESIONS; GENE POLYMORPHISM; HYPERTENSIVE-RATS; TELMISARTAN; FIBROSIS; RISK	The prevalence of diabetes mellitus and its complications, such as diabetic nephropathy (DN), is rising worldwide and prevention and treatment are therefore becoming increasingly important. Therapy of DN is particularly important for patients who do not adequately respond to angiotensin receptor blocker (ARB) treatment. Novel approaches include the stimulation of soluble guanylate cyclase (sGC) as it is reported to have beneficial effects on cardiac and renal damage. We aimed to investigate the effects of the sGC stimulator riociguat and ARB telmisartan on kidney function and structure in a hypertensive model of diabetic nephropathy. Seventy-six diabetic male eNOS knockout C57BL/6J mice were randomly divided after having received streptozotocin: telmisartan (1 mg/kg/d), riociguat (3 mg/kg/d), riociguat+telmisartan (3+1 mg/kg/d), and vehicle. Fourteen mice were used as non-diabetic controls. Treatment duration was 11 weeks. Glucose concentrations were increased and similar in all diabetic groups. Telmisartan insignificantly reduced blood pressure by 5.9 mmHg compared with diabetic controls (111.2 +/- 2.3 mmHg vs. 117.1 +/- 2.2 mmHg; p = 0.071). Treatment with riociguat both alone and in combination with telmisartan led to a significant reduction of blood pressure towards diabetic vehicle (105.2 +/- 2.5 mmHg and 105.0 +/- 3.2 mmHg, respectively, vs. 117.1 +/- 2.2 mmHg). Combined treatment also significantly decreased albuminuria compared with diabetic controls (47.3 +/- 9.6 mu g/24 h vs. 170.8 +/- 34.2 mu g/24 h; p = 0.002) reaching levels similar to those of non-diabetic controls (34.4 +/- 10.6 mu g/24 h), whereas the reduction by single treatment with either telmisartan (97.8 +/- 26.4 mu g/24 h) or riociguat (97.1 +/- 15.7 mu g/24 h) was not statistically significant. The combination treatment led to a significant (p < 0.01) decrease of tissue immunoreactivity of malondialdehyde, as consequence of reduced oxidative stress. In conclusion, stimulation of sGC significantly reduced urinary albumin excretion in diabetic eNOS knockout mice treated already with ARB. Thus, this new drug class on top of standard ARBs administration may offer a new therapeutic approach for patients resistant to ARB treatment.	[Ott, Ina M.; von Websky, Karoline; Tsuprykov, Oleg; Krause-Relle, Katharina; Raila, Jens; Henze, Andrea; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Ott, Ina M.; Alter, Markus L.; von Websky, Karoline; Tsuprykov, Oleg; Sharkovska, Yuliya; Krause-Relle, Katharina; Hocher, Berthold] Charite Campus Mitte, Cardiovasc Res Ctr, Berlin, Germany; [Alter, Markus L.] Charite Campus Benjamin Franklin, Dept Nephrol, Berlin, Germany; [Stasch, Johannes-Peter] Univ Halle Wittenberg, Inst Pharm, Halle, Saale, Germany; [Kretschmer, Axel; Stasch, Johannes-Peter] Bayer HealthCare, Wuppertal, Germany	University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Martin Luther University Halle Wittenberg; Bayer AG; Bayer Healthcare Pharmaceuticals	Hocher, B (corresponding author), Univ Potsdam, Inst Nutr Sci, Potsdam, Germany.	hocher@uni-potsdam.de	Henze, Andrea/A-9176-2019; Henze, Andrea/G-7214-2016; Hocher, Berthold/AAC-3510-2020	Henze, Andrea/0000-0002-5708-2989; Henze, Andrea/0000-0002-5708-2989; Hocher, Berthold/0000-0001-8143-0579	Bayer HealthCare AG, Wuppertal, Germany; Dr. Werner Jackstadt- Stiftung	Bayer HealthCare AG, Wuppertal, Germany(Bayer AGBayer Healthcare Pharmaceuticals); Dr. Werner Jackstadt- Stiftung	This study was supported by Bayer HealthCare AG, Wuppertal, Germany (http://www.wuppertal.bayer.de/). The work of Dr. Alter was supported by a grant from the Dr. Werner Jackstadt- Stiftung (http://www.jackstaedt-stiftung.de/). No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Bayer HealthCare AG, Wuppertal, Germany, who played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. Dr. Stasch and Dr. Kretschmer are employees of Bayer HealthCare AG, Wuppertal, Germany (http://www.wuppertal.bayer.de/). Bayer HealthCare AG holds the patent of riociguat (patent number: PIXXD2 WO 2003/095451). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. No further conflicts of interest.	Alexopoulos E, 2000, NEPHROL DIAL TRANSPL, V15, P1348, DOI 10.1093/ndt/15.9.1348; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Benz K, 2007, KIDNEY BLOOD PRESS R, V30, P224, DOI 10.1159/000104091; Brosius FC, 2008, REV ENDOCR METAB DIS, V9, P245, DOI 10.1007/s11154-008-9100-6; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chen S, 2001, RENAL FAILURE, V23, P471, DOI 10.1081/JDI-100104730; Clausell N, 1999, CARDIOVASC PATHOL, V8, P145, DOI 10.1016/S1054-8807(98)00033-7; Conlon PJ, 1996, CLIN NEPHROL, V46, P170; Van Wijngaarden RAFD, 2006, J AM SOC NEPHROL, V17, P2264, DOI 10.1681/ASN.2005080870; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Ezzidi I, 2008, J DIABETES COMPLICAT, V22, P331, DOI 10.1016/j.jdiacomp.2007.11.011; Futrakul N, 2006, CLIN HEMORHEOL MICRO, V34, P373; Geschka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021853; Gray SP, 2011, NAT REV NEPHROL, V7, P71, DOI 10.1038/nrneph.2010.176; Haffner D, 2005, J HYPERTENS, V23, P1067, DOI 10.1097/01.hjh.0000166849.72721.1c; Higashi Y, 2000, J AM COLL CARDIOL, V35, P284, DOI 10.1016/S0735-1097(99)00561-6; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hocher B, 2000, J HYPERTENS, V18, P1807, DOI 10.1097/00004872-200018120-00015; Hohenstein B, 2005, AM J PHYSIOL-RENAL, V288, pF685, DOI 10.1152/ajprenal.00280.2004; Horie K, 1997, J CLIN INVEST, V100, P2995, DOI 10.1172/JCI119853; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Jandeleit-Dahm KAM, 2005, J HYPERTENS, V23, P463, DOI 10.1097/01.hjh.0000160198.05416.72; Jones ES, 2009, BMC PHARM S1, pP29; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kosugi T, 2010, AM J PATHOL, V176, P619, DOI 10.2353/ajpath.2010.090578; Ladeia AM, 2005, DIABETES CARE, V28, P2048, DOI 10.2337/diacare.28.8.2048; Makino H, 2007, DIABETES CARE, V30, P1577, DOI 10.2337/dc06-1998; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Masuyama H, 2006, HYPERTENSION, V48, P972, DOI 10.1161/01.HYP.0000241087.12492.47; Masuyama H, 2009, HYPERTENS RES, V32, P597, DOI 10.1038/hr.2009.64; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Mittendorf J, 2009, CHEMMEDCHEM, V4, P853, DOI 10.1002/cmdc.200900014; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; Onozato ML, 2002, KIDNEY INT, V61, P186, DOI 10.1046/j.1523-1755.2002.00123.x; Peters H, 2004, KIDNEY INT, V66, P2224, DOI 10.1111/j.1523-1755.2004.66012.x; Peters H, 2003, KIDNEY INT, V64, P509, DOI 10.1046/j.1523-1755.2003.00112.x; Ritz E, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-60; Schermuly RT, 2008, EUR RESPIR J, V32, P881, DOI 10.1183/09031936.00114407; Schmieder RE, 2007, DIABETES CARE, V30, P1351, DOI 10.2337/dc06-1551; Sharkovska Y, 2010, J HYPERTENS, V28, P1666, DOI 10.1097/HJH.0b013e32833b558c; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Stasch JP, 2002, BRIT J PHARMACOL, V135, P344, DOI 10.1038/sj.bjp.0704483; Suzuki D, 1999, J AM SOC NEPHROL, V10, P822; Tomson C, 2007, NEPHROL DIAL TRANSPL, V22, P58, DOI 10.1093/ndt/gfm330; Tsukada T, 1998, BIOCHEM BIOPH RES CO, V245, P190, DOI 10.1006/bbrc.1998.8267; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Veldman BA, 2002, J HYPERTENS, V20, P2023, DOI 10.1097/00004872-200210000-00022; Wang YR, 2005, KIDNEY INT, V68, P47, DOI 10.1111/j.1523-1755.2005.00380.x; Wang YR, 2006, AM J PHYSIOL-RENAL, V290, pF167, DOI 10.1152/ajprenal.00197.2005; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zanchi A, 2000, KIDNEY INT, V57, P405, DOI 10.1046/j.1523-1755.2000.00860.x; Zanfolin M, 2006, J CARDIOVASC PHARM, V47, P391; ZATZ R, 1986, J CLIN INVEST, V77, P1925, DOI 10.1172/JCI112521; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	57	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42623	10.1371/journal.pone.0042623	http://dx.doi.org/10.1371/journal.pone.0042623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900035	Green Published, gold			2022-12-27	WOS:000307380900051
J	Cattaneo, ER; Pellon-Maison, M; Rabassa, ME; Lacunza, E; Coleman, RA; Gonzalez-Baro, MR				Cattaneo, Elizabeth R.; Pellon-Maison, Magali; Rabassa, Martin E.; Lacunza, Ezequiel; Coleman, Rosalind A.; Gonzalez-Baro, Maria R.			Glycerol-3-Phosphate Acyltransferase-2 Is Expressed in Spermatic Germ Cells and Incorporates Arachidonic Acid into Triacylglycerols	PLOS ONE			English	Article							SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; HORMONAL-REGULATION; FATTY-ACIDS; IDENTIFICATION; APOPTOSIS; CLONING; ENZYME; PHOSPHOLIPIDS; BIOSYNTHESIS	Background: De novo glycerolipid synthesis begins with the acylation of glycerol-3 phosphate catalyzed by glycerol-3-phosphate acyltransferase (GPAT). In mammals, at least four GPAT isoforms have been described, differing in their cell and tissue locations and sensitivity to sulfhydryl reagents. In this work we show that mitochondrial GPAT2 overexpression in CHO-K1 cells increased TAG content and both GPAT and AGPAT activities 2-fold with arachidonoyl-CoA as a substrate, indicating specificity for this fatty acid. Methods and Results: Incubation of GPAT2-transfected CHO-K1 cells with [1-C-14] arachidonate for 3 h increased incorporation of [C-14] arachidonate into TAG by 40%. Consistently, arachidonic acid was present in the TAG fraction of cells that overexpressed GPAT2, but not in control cells, corroborating GPAT2's role in synthesizing TAG that is rich in arachidonic acid. In rat and mouse testis, Gpat2 mRNA was expressed only in primary spermatocytes; the protein was also detected in late stages of spermatogenesis. During rat sexual maturation, both the testicular TAG content and the arachidonic acid content in the TAG fraction peaked at 30 d, matching the highest expression of Gpat2 mRNA and protein. Conclusions: These results strongly suggest that GPAT2 expression is linked to arachidonoyl-CoA incorporation into TAG in spermatogenic germ cells.	[Cattaneo, Elizabeth R.; Pellon-Maison, Magali; Gonzalez-Baro, Maria R.] Univ Nacl La Plata, Inst Invest Bioquim La Plata, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Med, La Plata, Buenos Aires, Argentina; [Rabassa, Martin E.; Lacunza, Ezequiel] Univ Nacl La Plata, Ctr Invest Inmunol Basicas & Aplicadas, Fac Ciencias Med, La Plata, Buenos Aires, Argentina; [Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; University of North Carolina; University of North Carolina Chapel Hill	Cattaneo, ER (corresponding author), Univ Nacl La Plata, Inst Invest Bioquim La Plata, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Med, La Plata, Buenos Aires, Argentina.	mgbaro@med.unlp.edu.ar	Rabassa, Martín/AAI-3447-2020	Rabassa, Martin Enrique/0000-0001-7195-2891; Pellon-Maison, Magali/0000-0002-7981-5258	National Institutes of Health [TW8698, DK56598]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina; CONICET, Argentina [PIP0527]; ANPCyT, Argentina [PICT2246]; UNLP, Argentina [M137]; FOGARTY INTERNATIONAL CENTER [R03TW008698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT, Argentina(ANPCyT); UNLP, Argentina(National University of La Plata); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health grants TW8698 and DK56598, Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET PIP0527, ANPCyT PICT2246 and UNLP M137, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astudillo AM, 2011, BBA-MOL CELL BIOL L, V1811, P97, DOI 10.1016/j.bbalip.2010.11.009; Bhat BG, 1999, BBA-MOL CELL BIOL L, V1439, P415, DOI 10.1016/S1388-1981(99)00103-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Chilton FH, 1996, BBA-LIPID LIPID MET, V1299, P1, DOI 10.1016/0005-2760(95)00169-7; Fonteh AN, 2001, J BIOL CHEM, V276, P1439, DOI 10.1074/jbc.M006551200; Gonzalez-Baro MR, 2007, AM J PHYSIOL-GASTR L, V292, pG1195, DOI 10.1152/ajpgi.00553.2006; Igal RA, 2001, J BIOL CHEM, V276, P42205, DOI 10.1074/jbc.M103386200; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Lenzi A, 2000, MOL HUM REPROD, V6, P226, DOI 10.1093/molehr/6.3.226; Lewin TM, 2004, J BIOL CHEM, V279, P13488, DOI 10.1074/jbc.M314032200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marty MS, 2003, BIRTH DEFECTS RES B, V68, P125, DOI 10.1002/bdrb.10015; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; Pellon-Maison M, 2009, LIPIDS, V44, P337, DOI 10.1007/s11745-008-3275-1; Pellon-Maison M, 2006, ARCH BIOCHEM BIOPHYS, V450, P157, DOI 10.1016/j.abb.2006.03.009; Pellon-Malson M, 2007, BBA-MOL CELL BIOL L, V1771, P830, DOI 10.1016/j.bbalip.2007.04.001; Perez R, 2006, J LIPID RES, V47, P484, DOI 10.1194/jlr.M500397-JLR200; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Qiu QM, 2009, ACTA BIOCH BIOPH SIN, V41, P668, DOI 10.1093/abbs/gmp055; Sambrook J., 2001, MOL CLONING LAB MANU; SCHLOSSMAN DM, 1977, ARCH BIOCHEM BIOPHYS, V182, P732, DOI 10.1016/0003-9861(77)90555-0; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Sukumaran S, 2009, J MOL ENDOCRINOL, V42, P469, DOI 10.1677/JME-09-0010; Sul HS, 1998, ANNU REV NUTR, V18, P331, DOI 10.1146/annurev.nutr.18.1.331; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Wang S, 2007, ARCH BIOCHEM BIOPHYS, V465, P347, DOI 10.1016/j.abb.2007.06.033; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wolf Leslie A., 1999, Cell Biochemistry and Biophysics, V30, P353, DOI 10.1007/BF02738119; Zalata AA, 1998, MOL HUM REPROD, V4, P111, DOI 10.1093/molehr/4.2.111	34	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42986	10.1371/journal.pone.0042986	http://dx.doi.org/10.1371/journal.pone.0042986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905194	Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100079
J	Li, JC; Foighil, DO; Middelfart, P				Li, Jingchun; Foighil, Diarmaid O.; Middelfart, Peter			The Evolutionary Ecology of Biotic Association in a Megadiverse Bivalve Superfamily: Sponsorship Required for Permanent Residency in Sediment	PLOS ONE			English	Article							MYSELLA-CHARCOTI LAMY; CLAM MYA-ARENARIA; RED QUEEN; MACOMA-BALTHICA; BURYING DEPTH; SPECIES-DIVERSITY; PANOPEA-ABRUPTA; CHESAPEAKE BAY; FOSSIL RECORD; COURT JESTER	Background: Marine lineage diversification is shaped by the interaction of biotic and abiotic factors but our understanding of their relative roles is underdeveloped. The megadiverse bivalve superfamily Galeommatoidea represents a promising study system to address this issue. It is composed of small-bodied clams that are either free-living or have commensal associations with invertebrate hosts. To test if the evolution of this lifestyle dichotomy is correlated with specific ecologies, we have performed a statistical analysis on the lifestyle and habitat preference of 121 species based on 90 source documents. Methodology/Principal Findings: Galeommatoidea has significant diversity in the two primary benthic habitats: hard- and soft-bottoms. Hard-bottom dwellers are overwhelmingly free-living, typically hidden within crevices of rocks/coral heads/encrusting epifauna. In contrast, species in soft-bottom habitats are almost exclusively infaunal commensals. These infaunal biotic associations may involve direct attachment to a host, or clustering around its tube/burrow, but all commensals locate within the oxygenated sediment envelope produced by the host's bioturbation. Conclusions/Significance: The formation of commensal associations by galeommatoidean clams is robustly correlated with an abiotic environmental setting: living in sediments (P<0.001). Sediment-dwelling bivalves are exposed to intense predation pressure that drops markedly with depth of burial. Commensal galeommatoideans routinely attain depth refuges many times their body lengths, independent of siphonal investment, by virtue of their host's burrowing and bioturbation. In effect, they use their much larger hosts as giant auto-irrigating siphon substitutes. The evolution of biotic associations with infaunal bioturbating hosts may have been a prerequisite for the diversification of Galeommatoidea in sediments and has likely been a key factor in the success of this exceptionally diverse bivalve superfamily.	[Li, Jingchun; Foighil, Diarmaid O.] Univ Michigan, Museum Zool, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Middelfart, Peter] Australian Museum, Sydney, NSW 2000, Australia	University of Michigan System; University of Michigan; Australian Museum	Li, JC (corresponding author), Univ Michigan, Museum Zool, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	jingchun@umich.edu		Li, Jingchun/0000-0001-7947-0950	Malacological Society of Australasia Molluscan Research Grant; National Science Foundation OCE award [0850625]	Malacological Society of Australasia Molluscan Research Grant; National Science Foundation OCE award	This study is supported by the Malacological Society of Australasia Molluscan Research Grant to JL and National Science Foundation OCE award 0850625 to DOF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aberhan M, 2006, PALEOBIOLOGY, V32, P259, DOI 10.1666/05028.1; Alejandrino A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-164; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Anker A, 2005, ZOOL STUD, V44, P157; Barber PH, 2009, J BIOGEOGR, V36, P1845, DOI 10.1111/j.1365-2699.2009.02198.x; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Bertics VJ, 2010, MAR ECOL PROG SER, V409, P1, DOI 10.3354/meps08639; BLUNDON JA, 1982, J EXP MAR BIOL ECOL, V65, P67, DOI 10.1016/0022-0981(82)90176-9; Bottjer D.J., 2000, GSA TODAY, V10, P1; Bouchet P, 2002, BIOL J LINN SOC, V75, P421, DOI 10.1046/j.1095-8312.2002.00052.x; Bourne G, 1906, CEYLON PEARL OYSTER, P212; Bronstein JL, 2009, J ECOL, V97, P1160, DOI 10.1111/j.1365-2745.2009.01566.x; Buschbaum C, 2009, HELGOLAND MAR RES, V63, P47, DOI 10.1007/s10152-008-0139-2; Campbell A, 2004, J SHELLFISH RES, V23, P661; Carpenter SM, 2005, NAUTILUS, V119, P105; Cledon M, 2010, MAR BIOL, V157, P737, DOI 10.1007/s00227-009-1357-0; Coan E. V., 2000, BIVALVE SEASHELLS W; Coma R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022017; Cotton BC, 1938, VICTORIAN NAT, V55, P58; Cowles A, 2009, MAR ECOL PROG SER, V384, P175, DOI 10.3354/meps08038; Danovaro R, 2002, MAR ECOL PROG SER, V230, P159, DOI 10.3354/meps230159; de Goeij P, 2001, OECOLOGIA, V126, P500, DOI 10.1007/s004420000526; Domaneschi O, 2002, POLAR BIOL, V25, P538, DOI 10.1007/s00300-002-0379-6; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; GAGE J, 1968, CAN J ZOOLOG, V46, P877, DOI 10.1139/z68-124; GAGE J, 1966, J MAR BIOL ASSOC UK, V46, P71, DOI 10.1017/S0025315400017550; GAGE JD, 1979, J MAR BIOL ASSOC UK, V59, P635, DOI 10.1017/S0025315400045653; GALLAGHER ED, 1983, ECOLOGY, V64, P1200, DOI 10.2307/1937829; Huber M., 2010, COMPENDIUM BIVALVES; Hultgren KM, 2010, MAR ECOL PROG SER, V407, P1, DOI 10.3354/meps08609; Jablonski D, 2008, EVOLUTION, V62, P715, DOI 10.1111/j.1558-5646.2008.00317.x; Jespersen A, 2004, ZOOL ANZ, V243, P3, DOI 10.1016/j.jcz.2004.04.001; Jespersen A, 2006, ZOOMORPHOLOGY, V125, P157, DOI 10.1007/s00435-006-0020-2; Jespersen A, 2009, ACTA ZOOL-STOCKHOLM, V90, P51, DOI 10.1111/j.1463-6395.2008.00332.x; JONES NS, 1950, BIOL REV, V25, P283, DOI 10.1111/j.1469-185X.1950.tb01587.x; Judd W, 1971, J MOLLUS STUD, V39, P343; KAMERMANS P, 1994, J EXP MAR BIOL ECOL, V175, P59, DOI 10.1016/0022-0981(94)90176-7; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kelsey FW, 1902, NAUTILUS, V15, P144; Kerr G, 1998, MAR FRESHWATER RES, V49, P801, DOI 10.1071/MF97093; Kosnik MA, 2011, PALEOBIOLOGY, V37, P303, DOI 10.1666/10022.1; KRANTZBERG G, 1985, ENVIRON POLLUT A, V39, P99, DOI 10.1016/0143-1471(85)90009-1; Lanterbecq D, 2010, MOL PHYLOGENET EVOL, V54, P357, DOI 10.1016/j.ympev.2009.08.011; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Lutzen J, 2005, ZOOL J LINN SOC-LOND, V144, P261, DOI 10.1111/j.1096-3642.2005.00168.x; Lutzen J, 2001, J ZOOL, V254, P429, DOI 10.1017/S0952836901000929; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; McInnes L, 2011, BIOL LETT; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; MIKKELSEN PM, 1992, MALACOLOGIA, V34, P1; MORTON B, 1989, Asian Marine Biology, V6, P129; MORTON B, 1973, J ZOOL, V170, P463; MORTON JE, 1960, J MAR BIOL ASSOC UK, V39, P5, DOI 10.1017/S0025315400013060; Nicell L, 1995, J NAT HIST, V29, P871; O'Foighil D, 1985, VELIGER, V27, P72; O'Foighil D, 1988, VELIGER, V31, P205; OCKELMANN KW, 1978, OPHELIA, V17, P1; Oliver PG, 2006, ZOOL J LINN SOC-LOND, V148, P237, DOI 10.1111/j.1096-3642.2006.00256.x; Oliver PG, 2011, J CONCHOL, V40, P365; Oliver PG, 1993, P 5 INT MAR BIOL WOR, P634; Osman RW, 2004, J EXP MAR BIOL ECOL, V311, P117, DOI 10.1016/j.jembe.2004.05.001; Passos FD, 2006, POLAR BIOL, V29, P389, DOI 10.1007/s00300-005-0068-3; Passos FD, 2005, POLAR BIOL, V28, P372, DOI 10.1007/s00300-004-0702-5; Paulay Gustav, 2003, Micronesica, V35-36, P218; Pillay D, 2011, OCEANOGR MAR BIOL, V49, P137; Pillay D, 2010, MAR ECOL PROG SER, V409, P301, DOI 10.3354/meps08628; Ponder W.F., 1998, FAUNA AUSTR MOLLUSCA, P316; PONDER WF, 1965, T ROY SOC NZ ZOOL, V6, P75; Prevedelli D, 2001, J MAR BIOL ASSOC UK, V81, P897, DOI 10.1017/S0025315401004817; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; RUSS GR, 1980, J EXP MAR BIOL ECOL, V42, P55, DOI 10.1016/0022-0981(80)90166-5; SEILACHER A, 1984, PALAEONTOLOGY, V27, P207; Seitz RD, 2001, ECOLOGY, V82, P2435, DOI 10.1890/0012-9658(2001)082[2435:DDPHVA]2.0.CO;2; SENDALL KA, 1995, CAN J ZOOL, V73, P509, DOI 10.1139/z95-058; Smith TE, 1999, J EXP MAR BIOL ECOL, V238, P185, DOI 10.1016/S0022-0981(98)00157-9; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; Vadopalas B, 2010, MALACOLOGIA, V52, P169, DOI 10.4002/040.052.0111; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630; Vermeij GJ, 2008, PALAEOGEOGR PALAEOCL, V263, P3, DOI 10.1016/j.palaeo.2008.01.023; VIRNSTEIN RW, 1977, ECOLOGY, V58, P1199, DOI 10.2307/1935076; WEAR RG, 1966, BIOL BULL, V130, P141, DOI 10.2307/1539960; Whitlow WL, 2003, BIOL INVASIONS, V5, P23, DOI 10.1023/A:1024059025890; Zaklan SD, 1997, J EXP MAR BIOL ECOL, V215, P1, DOI 10.1016/S0022-0981(97)00021-X; ZWARTS L, 1989, MAR BIOL, V100, P227, DOI 10.1007/BF00391963; ZWARTS L, 1994, J EXP MAR BIOL ECOL, V183, P193, DOI 10.1016/0022-0981(94)90087-6	91	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42121	10.1371/journal.pone.0042121	http://dx.doi.org/10.1371/journal.pone.0042121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905116	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100026
J	Schlecht, U; St Onge, RP; Walther, T; Francois, JM; Davis, RW				Schlecht, Ulrich; St Onge, Robert P.; Walther, Thomas; Francois, Jean-Marie; Davis, Ronald W.			Cationic Amphiphilic Drugs Are Potent Inhibitors of Yeast Sporulation	PLOS ONE			English	Article							VACUOLE TARGETING PATHWAY; SACCHAROMYCES-CEREVISIAE; AMINOPHOSPHOLIPID TRANSLOCASES; TRANSCRIPTIONAL REGULATION; DELETION STRAINS; BUDDING YEAST; MEIOSIS; AUTOPHAGY; GENES; RECOMBINATION	Meiosis is a highly regulated developmental process that occurs in all eukaryotes that engage in sexual reproduction. Previous epidemiological work shows that male and female infertility is rising and environmental factors, including pollutants such as organic solvents, are thought to play a role in this phenomenon. To better understand how organic compounds interfere with meiotic development, the model organism Saccharomyces cerevisiae was exposed to 446 bioactive molecules while undergoing meiotic development, and sporulation efficiency was quantified employing two different high-throughput assays. 12 chemicals were identified that strongly inhibited spore formation but did not interfere with vegetative growth. Many of these chemicals are known to bind to monoamine-receptors in higher eukaryotes and are cationic amphiphilic drugs. A detailed analysis of one of these drugs, tripelennamine, revealed that it induces sporulation-specific cytotoxicity and a strong inhibition of meiotic M phase. The drug, however, only mildly interfered with pre-meiotic DNA synthesis and the early meiotic transcriptional program. Chemical-genomic screening identified genes involved in autophagy as hypersensitive to tripelennamine. In addition, we found that growing and sporulating yeast cells heterozygous for the aminophospholipid translocase, NEO1, are haploinsufficient in the presence of the drug.	[Schlecht, Ulrich; St Onge, Robert P.; Davis, Ronald W.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Walther, Thomas; Francois, Jean-Marie] Univ Toulouse, Lab Ingn Syst Biol & Proc, Toulouse, France	Stanford University; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Schlecht, U (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	ulrich.schlecht@stanford.edu		Francois, Jean marie/0000-0001-9884-5535	Swiss National Foundation grant [PBBSA-118661]	Swiss National Foundation grant(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation grant no. PBBSA-118661 to US. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson N, 2006, FEBS LETT, V580, P5533, DOI 10.1016/j.febslet.2006.08.061; Barth H, 2001, FEBS LETT, V508, P23, DOI 10.1016/S0014-5793(01)03016-2; BETZ H, 1976, EUR J BIOCHEM, V70, P385, DOI 10.1111/j.1432-1033.1976.tb11028.x; Brachmann CB, 1998, YEAST, V14, P115; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Briza P, 2002, YEAST, V19, P403, DOI 10.1002/yea.843; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Christodoulidou A, 1996, J BIOL CHEM, V271, P31420, DOI 10.1074/jbc.271.49.31420; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; ENGEBRECHT J, 1991, CELL, V66, P1257, DOI 10.1016/0092-8674(91)90047-3; Enyenihi AH, 2003, GENETICS, V163, P47; ESPOSITO MS, 1969, J BACTERIOL, V100, P180, DOI 10.1128/JB.100.1.180-186.1969; ESPOSITO RE, 1974, P NATL ACAD SCI USA, V71, P3172, DOI 10.1073/pnas.71.8.3172; Esposito RE, 2006, MEIOSIS SPORE DEV, P157; FAN QQ, 1995, MOL CELL BIOL, V15, P1679; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GLAUMANN H, 1987, EXP MOL PATHOL, V47, P346, DOI 10.1016/0014-4800(87)90018-9; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Groussac E, 2000, ENZYME MICROB TECH, V26, P715, DOI 10.1016/S0141-0229(00)00163-0; Guttmann-Raviv N, 2002, MOL CELL BIOL, V22, P2047, DOI 10.1128/MCB.22.7.2047-2056.2002; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Loret MO, 2007, YEAST, V24, P47, DOI 10.1002/yea.1435; Mallory MJ, 2007, MOL CELL, V27, P951, DOI 10.1016/j.molcel.2007.08.019; Mendola Pauline, 2008, Fertil Steril, V89, pe81, DOI 10.1016/j.fertnstert.2007.12.036; MILLER JJ, 1963, CAN J MICROBIOL, V9, P259, DOI 10.1139/m63-032; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Paulusma CC, 2005, BBA-MOL BASIS DIS, V1741, P11, DOI 10.1016/j.bbadis.2005.04.006; Piekarska I, 2010, EUR J CELL BIOL, V89, P780, DOI 10.1016/j.ejcb.2010.06.009; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Rose MD., 1990, METHODS YEAST GENETI; Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762; Schlecht U, 2003, REPRODUCTION, V125, P447, DOI 10.1530/reprod/125.4.447; Schlecht U, 2008, MOL BIOL CELL, V19, P2193, DOI 10.1091/mbc.E07-12-1242; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; SORA S, 1983, MUTAT RES, V107, P249, DOI 10.1016/0027-5107(83)90167-7; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SUROSKY RT, 1992, MOL CELL BIOL, V12, P3948, DOI 10.1128/MCB.12.9.3948; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tenreiro S, 2000, YEAST, V16, P1469, DOI 10.1002/1097-0061(200012)16:16&lt;1469::AID-YEA640&gt;3.0.CO;2-A; Thonneau P, 1998, HUM REPROD, V13, P2122, DOI 10.1093/humrep/13.8.2122; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vershon AK, 2000, CURR OPIN CELL BIOL, V12, P334, DOI 10.1016/S0955-0674(00)00104-6; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004	60	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42853	10.1371/journal.pone.0042853	http://dx.doi.org/10.1371/journal.pone.0042853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905177	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100069
J	Arnan, X; Molowny-Horas, R; Rodrigo, A; Retana, J				Arnan, Xavier; Molowny-Horas, Roberto; Rodrigo, Anselm; Retana, Javier			Uncoupling the Effects of Seed Predation and Seed Dispersal by Granivorous Ants on Plant Population Dynamics	PLOS ONE			English	Article							HARVESTING ANTS; FORAGING BEHAVIOR; RECRUITMENT; SELECTION; PATTERNS; FRUIT; PROTECTION; RESOURCES; EVOLUTION; COMMUNITY	Secondary seed dispersal is an important plant-animal interaction, which is central to understanding plant population and community dynamics. Very little information is still available on the effects of dispersal on plant demography and, particularly, for ant-seed dispersal interactions. As many other interactions, seed dispersal by animals involves costs (seed predation) and benefits (seed dispersal), the balance of which determines the outcome of the interaction. Separate quantification of each of them is essential in order to understand the effects of this interaction. To address this issue, we have successfully separated and analyzed the costs and benefits of seed dispersal by seed-harvesting ants on the plant population dynamics of three shrub species with different traits. To that aim a stochastic, spatially-explicit individually-based simulation model has been implemented based on actual data sets. The results from our simulation model agree with theoretical models of plant response dependent on seed dispersal, for one plant species, and ant-mediated seed predation, for another one. In these cases, model predictions were close to the observed values at field. Nonetheless, these ecological processes did not affect in anyway a third species, for which the model predictions were far from the observed values. This indicates that the balance between costs and benefits associated to secondary seed dispersal is clearly related to specific traits. This study is one of the first works that analyze tradeoffs of secondary seed dispersal on plant population dynamics, by disentangling the effects of related costs and benefits. We suggest analyzing the effects of interactions on population dynamics as opposed to merely analyzing the partners and their interaction strength.	[Arnan, Xavier; Molowny-Horas, Roberto; Rodrigo, Anselm; Retana, Javier] Univ Autonoma Barcelona, Fac Biociencies, CREAF, Bellaterra, Catalonia, Spain; [Rodrigo, Anselm; Retana, Javier] Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Anim Biol Vegetal & Ecol, Unitat Ecol, Bellaterra, Catalonia, Spain	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona	Arnan, X (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, CREAF, Bellaterra, Catalonia, Spain.	x.arnan@creaf.uab.es	Rodrigo, Anselm/AAH-1553-2022; Arnan, Xavier/N-7829-2013; Molowny-Horas, Roberto/D-1171-2014; Rodrigo, Anselm/AFL-9450-2022; Retana, Javier/L-1214-2014	Arnan, Xavier/0000-0002-9904-274X; Molowny-Horas, Roberto/0000-0003-2626-6379; Retana, Javier/0000-0002-7505-9467; Rodrigo, Anselm/0000-0001-6341-0363	CICYT project [REN2001-2500/GLO]; CONSOLIDER INGENIO project [CSD 2008-0040]	CICYT project(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); CONSOLIDER INGENIO project(Spanish Government)	This research was partly funded by CICYT project REN2001-2500/GLO and by the CONSOLIDER INGENIO project CSD 2008-0040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSEN AN, 1989, OECOLOGIA, V81, P310, DOI 10.1007/BF00377076; Arnan X, 2010, INSECT SOC, V57, P421, DOI 10.1007/s00040-010-0100-7; Arnan X, 2010, PLANT BIOLOGY, V12, P842, DOI 10.1111/j.1438-8677.2009.00294.x; Arnan X, 2007, ECOGRAPHY, V30, P161, DOI [10.1111/j.2006.0906-7590.04796.x, 10.1111/j.0906-7590.2007.04796.x]; Arnan X, 2011, OECOLOGIA, V167, P1027, DOI 10.1007/s00442-011-2034-9; Azcarate FM, 2005, FUNCT ECOL, V19, P273, DOI 10.1111/j.0269-8463.2005.00956.x; BEATTIE AJ, 1981, ECOLOGY, V62, P107, DOI 10.2307/1936674; Bernard F., 1968, FOURMIS HYMENOPTERA; Bernard F., 1983, FOURMIS LEUR MILIEU; Boulay R, 2007, P ROY SOC B-BIOL SCI, V274, P2515, DOI 10.1098/rspb.2007.0594; Brodie JF, 2009, ECOLOGY, V90, P688, DOI 10.1890/08-0111.1; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Bronstein JL, 2001, AM ZOOL, V41, P825, DOI 10.1668/0003-1569(2001)041[0825:TCOM]2.0.CO;2; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Brown MJF, 1997, OECOLOGIA, V112, P237, DOI 10.1007/s004420050306; CERDA X, 1994, J APPL ENTOMOL, V117, P268, DOI 10.1111/j.1439-0418.1994.tb00735.x; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; CRIST TO, 1992, ECOLOGY, V73, P1768, DOI 10.2307/1940028; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; de Bolos O., 1993, FLORA MANUAL PAISOS; Dixon PM, 2002, ENCY ENVIRONMETRICS; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; Fehmi JS, 2001, J VEG SCI, V12, P467, DOI 10.2307/3236998; Giladi I, 2006, OIKOS, V112, P481, DOI 10.1111/j.0030-1299.2006.14258.x; Godinez-Alvarez H., 2007, Seed dispersal: theory and its application in a changing world, P391, DOI 10.1079/9781845931650.0391; Holland J.N., 2008, ENCY ECOLOGY 5 VOLUM, P2485, DOI DOI 10.1016/B978-008045405-4.00673-X; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Howe HF, 2004, BIOSCIENCE, V54, P651, DOI 10.1641/0006-3568(2004)054[0651:WSDM]2.0.CO;2; JORDANO P, 1995, ECOLOGY, V76, P2627, DOI 10.2307/2265833; Jordano Pedro, 2002, P305, DOI 10.1079/9780851995250.0305; Kersch MF, 2005, ECOLOGY, V86, P2117, DOI 10.1890/04-1916; LEVEY DJ, 1993, ECOLOGY, V74, P1802, DOI 10.2307/1939938; Liu JG, 1998, ECOL MODEL, V106, P177, DOI 10.1016/S0304-3800(97)00191-9; MacMahon JA, 2000, ANNU REV ECOL SYST, V31, P265, DOI 10.1146/annurev.ecolsys.31.1.265; Manzaneda AJ, 2009, J EVOLUTION BIOL, V22, P1407, DOI 10.1111/j.1420-9101.2009.01752.x; Manzaneda AJ, 2007, BIOL J LINN SOC, V92, P135, DOI 10.1111/j.1095-8312.2007.00831.x; Mladenoff D. J., 1999, Spatial modeling of forest landscape change: approaches and applications. Papers presented at a symposium in Albuquerque, New Mexico, USA, 1977., P1; Ness JH, 2004, ECOLOGY, V85, P1244, DOI 10.1890/03-0364; Ordonez JL, 2006, ECOL MODEL, V197, P405, DOI 10.1016/j.ecolmodel.2006.03.027; PONS X., 2000, MIRAMON SISTEMA INFO; Retana J, 2000, OECOLOGIA, V123, P436, DOI 10.1007/s004420051031; Retana J, 2004, OIKOS, V105, P377, DOI 10.1111/j.0030-1299.2004.12854.x; Rey PJ, 2007, J ECOL, V95, P1381, DOI 10.1111/j.1365-2745.2007.01293.x; Rodriguez-Perez J, 2011, OECOLOGIA, V167, P97, DOI 10.1007/s00442-011-1964-6; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; SCHUPP EW, 1993, VEGETATIO, V108, P15; Stoyan D, 2000, STAT SCI, V15, P61; Vander Wall SB, 2005, ECOLOGY, V86, P801, DOI 10.1890/04-0847; Veech JA, 2001, BEHAV ECOL, V12, P467, DOI 10.1093/beheco/12.4.467; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zwolak R, 2012, OIKOS, V121, P20, DOI 10.1111/j.1600-0706.2011.19849.x	52	21	21	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42869	10.1371/journal.pone.0042869	http://dx.doi.org/10.1371/journal.pone.0042869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880125	gold, Green Published, Green Submitted			2022-12-27	WOS:000307437900056
J	Phillips, L; Litcofsky, KA; Pelster, M; Gelfand, M; Ullman, MT; Charles, PD				Phillips, Lara; Litcofsky, Kaitlyn A.; Pelster, Michael; Gelfand, Matthew; Ullman, Michael T.; Charles, P. David			Subthalamic Nucleus Deep Brain Stimulation Impacts Language in Early Parkinson's Disease	PLOS ONE			English	Article							DECLARATIVE/PROCEDURAL MODEL; VERBAL FLUENCY; BASAL GANGLIA; PAST-TENSE; KNOWLEDGE; MEMORY; REPRESENTATION; COMPREHENSION; METAANALYSIS; FREQUENCY	Although deep brain stimulation (DBS) of the basal ganglia improves motor outcomes in Parkinson's disease (PD), its effects on cognition, including language, remain unclear. This study examined the impact of subthalamic nucleus (STN) DBS on two fundamental capacities of language, grammatical and lexical functions. These functions were tested with the production of regular and irregular past-tenses, which contrast aspects of grammatical (regulars) and lexical (irregulars) processing while controlling for multiple potentially confounding factors. Aspects of the motor system were tested by contrasting the naming of manipulated (motor) and non-manipulated (non-motor) objects. Performance was compared between healthy controls and early-stage PD patients treated with either DBS/medications or medications alone. Patients were assessed on and off treatment, with controls following a parallel testing schedule. STN-DBS improved naming of manipulated (motor) but not non-manipulated (non-motor) objects, as compared to both controls and patients with just medications, who did not differ from each other across assessment sessions. In contrast, STN-DBS led to worse performance at regulars (grammar) but not irregulars (lexicon), as compared to the other two subject groups, who again did not differ. The results suggest that STN-DBS negatively impacts language in early PD, but may be specific in depressing aspects of grammatical and not lexical processing. The finding that STN-DBS affects both motor and grammar (but not lexical) functions strengthens the view that both depend on basal ganglia circuitry, although the mechanisms for its differential impact on the two (improved motor, impaired grammar) remain to be elucidated.	[Phillips, Lara; Pelster, Michael; Charles, P. David] Vanderbilt Univ, Dept Neurol, Nashville, TN 37212 USA; [Litcofsky, Kaitlyn A.; Gelfand, Matthew; Ullman, Michael T.] Georgetown Univ, Dept Neurosci, Brain & Language Lab, Washington, DC USA; [Litcofsky, Kaitlyn A.] Penn State Univ, Dept Psychol, Ctr Language Sci, University Pk, PA 16802 USA	Vanderbilt University; Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Phillips, L (corresponding author), Vanderbilt Univ, Dept Neurol, Nashville, TN 37212 USA.	lara.phillips@vanderbilt.edu; michael@georgetown.edu; david.charles@vanderbilt.edu			NIH-NCRR [IUL1RR024975]; NIH [RO1 HD049347]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049347] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, KL2RR024977, TL1RR024978] Funding Source: NIH RePORTER	NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by NIH-NCRR IUL1RR024975 (to PDC) and NIH RO1 HD049347 (to MU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegret M, 2004, MOVEMENT DISORD, V19, P1463, DOI 10.1002/mds.20237; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Boulenger V, 2008, NEUROPSYCHOLOGIA, V46, P743, DOI 10.1016/j.neuropsychologia.2007.10.007; Buxbaum LJ, 2002, BRAIN LANG, V82, P179, DOI 10.1016/S0093-934X(02)00014-7; Cameli L, 2005, ISB4 P 4 INT S BIL, P452; Campanella F, 2010, NEUROPSYCHOLOGIA, V48, P1583, DOI 10.1016/j.neuropsychologia.2010.02.002; Castner JE, 2007, BRAIN, V130, P1395, DOI 10.1093/brain/awm059; Church K.W., 1988, STOCHASTIC PARTS PRO, P136; Clahsen H, 1999, BEHAV BRAIN SCI, V22, P991, DOI 10.1017/S0140525X99002228; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; FRANCIS Nelson, 1982, FREQUENCY ANAL ENGLI; Grossman M, 1999, BRAIN COGNITION, V40, P387, DOI 10.1006/brcg.1999.1087; GROSSMAN M, 1992, BRAIN LANG, V42, P347, DOI 10.1016/0093-934X(92)90074-O; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Heo JH, 2008, J NEUROL SCI, V273, P19, DOI 10.1016/j.jns.2008.06.010; ILLES J, 1988, BRAIN LANG, V33, P146, DOI 10.1016/0093-934X(88)90059-4; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Kellenbach ML, 2003, J COGNITIVE NEUROSCI, V15, P30, DOI 10.1162/089892903321107800; Kulisevsky J, 1996, BRAIN, V119, P2121, DOI 10.1093/brain/119.6.2121; LIEBERMAN P, 1990, J NERV MENT DIS, V178, P360, DOI 10.1097/00005053-199006000-00003; Longworth CE, 2005, BRAIN, V128, P584, DOI 10.1093/brain/awh387; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; McIntyre CC, 2004, J CLIN NEUROPHYSIOL, V21, P40, DOI 10.1097/00004691-200401000-00006; Moretti R, 2003, PARKINSONISM RELAT D, V10, P73, DOI 10.1016/S1353-8020(03)00073-7; Naskar S, 2010, BRAIN RES REV, V65, P1, DOI 10.1016/j.brainresrev.2010.04.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Pinker S., 1999, WORDS RULES INGREDIE; Portin R, 2000, ARCH NEUROL-CHICAGO, V57, P1338, DOI 10.1001/archneur.57.9.1338; Prado EL, 2009, J EXP PSYCHOL LEARN, V35, P849, DOI 10.1037/a0015286; Randolph C., 1993, NEUROPSYCHOLOGY, V7, P82, DOI [10.1037/0894-4105.7.1.82, DOI 10.1037/0894-4105.7.1.82]; Schroeder U, 2002, BRAIN, V125, P1995, DOI 10.1093/brain/awf199; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Ullman M.T., 2008, SEX DIFFERENCES BRAI, P291; Ullman MT, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P189, DOI 10.1016/B978-0-08-045352-1.00018-5; Ullman MT, 1999, LANG COGNITIVE PROC, V14, P47, DOI 10.1080/016909699386374; Ullman MT, 2001, J PSYCHOLINGUIST RES, V30, P37, DOI 10.1023/A:1005204207369; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Ullman MT, 1997, J COGNITIVE NEUROSCI, V9, P266, DOI 10.1162/jocn.1997.9.2.266; Walenski M, 2007, NEUROPSYCHOLOGIA, V45, P2447, DOI 10.1016/j.neuropsychologia.2007.04.001; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Whelan BM, 2003, J NEUROL NEUROSUR PS, V74, P1543, DOI 10.1136/jnnp.74.11.1543; Wojtecki L, 2006, ARCH NEUROL-CHICAGO, V63, P1273, DOI 10.1001/archneur.63.9.1273; Zanini S, 2003, NEUROREPORT, V14, P511, DOI 10.1097/01.wnr.0000058775.36017.86; Zgaljardic Dennis J, 2003, Cogn Behav Neurol, V16, P193, DOI 10.1097/00146965-200312000-00001	50	17	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42829	10.1371/journal.pone.0042829	http://dx.doi.org/10.1371/journal.pone.0042829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880117	Green Published, gold			2022-12-27	WOS:000307437900054
J	van Cleef, BAGL; Kluytmans, JAJW; van Benthem, BHB; Haenen, A; Monen, J; Daniels-Haardt, I; Jurke, A; Friedrich, AW				van Cleef, Brigitte A. G. L.; Kluytmans, Jan A. J. W.; van Benthem, Birgit H. B.; Haenen, Anja; Monen, Jos; Daniels-Haardt, Inka; Jurke, Annette; Friedrich, Alexander W.			Cross Border Comparison of MRSA Bacteraemia between The Netherlands and North Rhine-Westphalia (Germany): A Cross-Sectional Study	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PREVALENCE; HOSPITALS; ADMISSION; CARRIAGE; CARE	Background: We describe the impact of methicillin-resistant Staphylococcus aureus (MRSA) in two neighbouring regions in Europe with a comparable population size, North Rhine-Westphalia (NRW) in Germany and the Netherlands. Methodology/Principal Findings: We compared the occurrence of MRSA in blood cultures from surveillance systems. In the Netherlands in 2009, 14 of 1,510 (0.9%) Staphylococcus aureus bacteraemia episodes under surveillance were MRSA. Extrapolation using the number of clinical admissions results in a total of 29 MRSA bacteraemia episodes in the Netherlands or 1.8 episodes per 1,000,000 inhabitants. In 2010 in NRW, 1,029 MRSA bacteraemias were reported, resulting in 57.6 episodes of MRSA bacteraemia per 1,000,000 inhabitants: a 32-fold higher incidence than in the Netherlands. Conclusion/Significance: Based on an estimated attributable mortality of 15%, the Dutch approach would save approximately 150 lives per year by the prevention of bacteraemia only.	[van Cleef, Brigitte A. G. L.; van Benthem, Birgit H. B.; Haenen, Anja; Monen, Jos] RIVM Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands; [Kluytmans, Jan A. J. W.; van Benthem, Birgit H. B.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Prevent, Amsterdam, Netherlands; [Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Friedrich, Alexander W.] Univ Groningen, Dept Med Microbiol, Univ Med Ctr Groningen, Groningen, Netherlands; [Daniels-Haardt, Inka; Jurke, Annette] N Rhine Westphalian Ctr Hlth, Munster, Germany	Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Amphia Hospital; University of Groningen	van Cleef, BAGL (corresponding author), RIVM Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands.	Brigitte.van.Cleef@rivm.nl	Friedrich, Alex/ABG-9823-2020; Haenen, Anja/E-1621-2016		Dutch Ministry of Health, Welfare and Sport; Euregio Dutch-German cross-border EurSafety Health-net [InterregIVa III-1-01 = 073]	Dutch Ministry of Health, Welfare and Sport; Euregio Dutch-German cross-border EurSafety Health-net	For this study no funding was present for the study design, data analysis and interpretation, writing of the manuscript or the decision to submit it for publication. Routine data collection in the Netherlands as part of the national surveillance program (ISIS-AR) was funded by the Dutch Ministry of Health, Welfare and Sport, Interpretation of data from NRW as part of the regional surveillance program (LZG.NRW) was partly funded by the Euregio Dutch-German cross-border EurSafety Health-net (InterregIVa III-1-01 = 073) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerlaan H, 2010, CLIN IMPACT METHICIL, P117; Ammerlaan HSM, 2011, J ANTIMICROB CHEMOTH, V66, P2409, DOI 10.1093/jac/dkr243; Blot SI, 2002, ARCH INTERN MED, V162, P2229, DOI 10.1001/archinte.162.19.2229; Clements A, 2008, LANCET INFECT DIS, V8, P427, DOI 10.1016/S1473-3099(08)70151-8; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harbarth S, 2001, Lancet Infect Dis, V1, P251, DOI 10.1016/S1473-3099(01)00120-7; Kaiser AM, 2010, INFECT CONT HOSP EP, V31, P1188, DOI 10.1086/656744; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Kock R, 2009, J HOSP INFECT, V71, P320, DOI 10.1016/j.jhin.2008.12.001; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Sande-Bruinsma van de N, 2011, CLIN MICROBIOL INFEC, V17, pS108; Schweickert B, 2012, EUR J CLIN MICROBIOL, V31, P1855, DOI 10.1007/s10096-011-1511-8; SWAB, 2011, NETHMAP 2011 CONS AN; Tacconelli E, 2011, J ANTIMICROB CHEMOTH, V66, P2195, DOI 10.1093/jac/dkr309; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; Verhoeven F, 2007, TECHNOLOGY HLTH CARE, V15, P366; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wassenberg MWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011562; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; Woltering R, 2008, DEUT MED WOCHENSCHR, V133, P999, DOI 10.1055/s-2008-1075683	21	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42787	10.1371/journal.pone.0042787	http://dx.doi.org/10.1371/journal.pone.0042787			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880109	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100172
J	Abdalla, H; Srinivasan, L; Shah, S; Mayer-Barber, KD; Sher, A; Sutterwala, FS; Briken, V				Abdalla, Hana; Srinivasan, Lalitha; Shah, Swati; Mayer-Barber, Katrin D.; Sher, Alan; Sutterwala, Fayyaz S.; Briken, Volker			Mycobacterium tuberculosis Infection of Dendritic Cells Leads to Partially Caspase-1/11-Independent IL-1 beta and IL-18 Secretion but Not to Pyroptosis	PLOS ONE			English	Article							INFLAMMASOME ACTIVATION; IN-VIVO; MACROPHAGE APOPTOSIS; ADAPTIVE IMMUNITY; INNATE IMMUNITY; CASPASE-1; DEATH; MICE; RECEPTOR; BINDING	Background: Interleukin-1 beta (IL-1 beta) is important for host resistance against Mycobacterium tuberculosis (Mtb) infections. The response of the dendritic cell inflammasome during Mtb infections has not been investigated in detail. Methodology/Principal Findings: Here we show that Mtb infection of bone marrow-derived dendritic cells (BMDCs) induces IL-1 beta secretion and that this induction is dependent upon the presence of functional ASC and NLRP3 but not NLRC4 or NOD2. The analysis of cell death induction in BMDCs derived from these knock-out mice revealed the important induction of host cell apoptosis but not necrosis, pyroptosis or pyronecrosis. Furthermore, NLRP3 inflammasome activation and apoptosis induction were both reduced in BMDCs infected with the esxA deletion mutant of Mtb demonstrating the importance of a functional ESX-1 secretion system. Surprisingly, caspase-1/11-deficient BMDCs still secreted residual levels of IL-1 beta and IL-18 upon Mtb infection which was abolished in cells infected with the esxA Mtb mutant. Conclusion: Altogether we demonstrate the partially caspase-1/11-independent, but NLRP3- and ASC-dependent IL-1 beta secretion in Mtb-infected BMDCs. These findings point towards a potential role of DCs in the host innate immune response to mycobacterial infections via their capacity to induce IL-1 beta and IL-18 secretion.	[Abdalla, Hana; Srinivasan, Lalitha; Shah, Swati; Briken, Volker] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Abdalla, Hana; Srinivasan, Lalitha; Shah, Swati; Briken, Volker] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Mayer-Barber, Katrin D.; Sher, Alan] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Sutterwala, Fayyaz S.] Univ Iowa, Dept Internal Med, Inflammat Program, Iowa City, IA 52242 USA; [Sutterwala, Fayyaz S.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Abdalla, H (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	vbriken@umd.edu	Sutterwala, Fayyaz/AAH-5859-2021; Cassel, Suzanne/AAI-3947-2021	Cassel, Suzanne/0000-0003-2492-1923; Briken, Volker/0000-0001-5830-6107	National Institutes of Health [NIAID RO1 AI072584]; Heiser Program for Research in Leprosy and Tuberculosis postdoctoral fellowship of the New York Community Trust; Scholar Rescue Fund; NIAID, NIH; Veterans Administration [IBX000167A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072584] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heiser Program for Research in Leprosy and Tuberculosis postdoctoral fellowship of the New York Community Trust; Scholar Rescue Fund; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported by the National Institutes of Health grant NIAID RO1 AI072584 (H. A., L. S., V. B.), the Heiser Program for Research in Leprosy and Tuberculosis postdoctoral fellowship of the New York Community Trust (to H. A.), the Scholar Rescue Fund (H. A.), the Intramural Research Program of the NIAID, NIH (K.D.M.-B. and A. S.) and a Veterans Administration Merit Review Grant IBX000167A (F. S. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Beausejour A, 1998, INFECT IMMUN, V66, P676; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Blomgran R, 2012, CELL HOST MICROBE, V11, P81, DOI 10.1016/j.chom.2011.11.012; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Dorhoi A, 2011, EUR J IMMUNOL; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gandotra S, 2007, INFECT IMMUN, V75, P5127, DOI 10.1128/IAI.00458-07; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kleinnijenhuis J, 2009, EUR J IMMUNOL, V39, P1914, DOI 10.1002/eji.200839115; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Kuranaga E, 2012, GENES CELLS; Kurenuma T, 2009, INFECT IMMUN, V77, P3992, DOI 10.1128/IAI.00015-09; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miller J, 2010, NY TIMES BK REV, P6; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Schneider BE, 2010, EUR J IMMUNOL, V40, P396, DOI 10.1002/eji.200939583; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Sugawara I, 1999, INFECT IMMUN, V67, P2585, DOI 10.1128/IAI.67.5.2585-2589.1999; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Urdahl KB, 2011, MUCOSAL IMMUNOL, V4, P288, DOI 10.1038/mi.2011.10; Walter K, 2010, IMMUNOBIOLOGY, V215, P804, DOI 10.1016/j.imbio.2010.05.015; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	62	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40722	10.1371/journal.pone.0040722	http://dx.doi.org/10.1371/journal.pone.0040722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911706	Green Submitted, gold, Green Published			2022-12-27	WOS:000306751300011
J	Borobia, AM; Lubomirov, R; Ramirez, E; Lorenzo, A; Campos, A; Munoz-Romo, R; Fernandez-Capitan, C; Frias, J; Carcas, AJ				Borobia, Alberto M.; Lubomirov, Rubin; Ramirez, Elena; Lorenzo, Alicia; Campos, Armando; Munoz-Romo, Raul; Fernandez-Capitan, Carmen; Frias, Jesus; Carcas, Antonio J.			An Acenocoumarol Dosing Algorithm Using Clinical and Pharmacogenetic Data in Spanish Patients with Thromboembolic Disease	PLOS ONE			English	Article							ORAL ANTICOAGULANT-THERAPY; BLEEDING COMPLICATIONS; DOSE REQUIREMENTS; WARFARIN; CYP2C9; VKORC1; GENOTYPE; POLYMORPHISM; ASSOCIATION; TRIAL	Appropriate dosing of coumarins is difficult to establish, due to significant inter-individual variability in the dose required to obtain stable anticoagulation. Several genetic and other clinical factors have been associated with the coumarins dose, and some pharmacogenetic-guided dosing algorithms for warfarin and acenocoumarol have been developed for mixed populations. We recruited 147 patients with thromboembolic disease who were on stable doses and with an international normalized ratio (INR) between 2 and 3. We ascertained the influence of clinical and genetic variables on the stable acenocoumarol dose by multiple linear regression analysis in a derivation cohort (DC; n = 117) and developed an algorithm for dosing that included clinical factors (age, body mass index and concomitant drugs) and genetic variations of VKORC1, CYP2C9, CYP4F2 and APOE. For purposes of comparison, a model including only clinical data was created. The clinical factors explained 22% of the dose variability, which increased to 60.6% when pharmacogenetic information was included (p<0.001); CYP4F2 and APOE variants explained 4.9% of this variability. The mean absolute error of the predicted acenocoumarol dose (mg/week) obtained with the pharmacogenetic algorithm was 3.63 vs. 5.08 mg/week with the clinical algorithm (95% CI: 0.88 to 2.04). In the testing cohort (n = 30), clinical factors explained a mere 7% of the dose variability, compared to 39% explained by the pharmacogenetic algorithm. Considering a more clinically relevant parameter, the pharmacogenetic algorithm correctly predicted the real stable dose in 59.8% of the cases (DC) vs. only 37.6% predicted by the clinical algorithm (95% CI: 10 to 35). Therefore the number of patients needed to genotype to avoid one over-or underdosing was estimated to be 5.	[Borobia, Alberto M.; Ramirez, Elena; Frias, Jesus; Carcas, Antonio J.] Univ Autonoma Madrid, Clin Pharmacol Serv, La Paz Univ Hosp, Dept Pharmacol,Sch Med,IdiPAZ, Madrid, Spain; [Fernandez-Capitan, Carmen] Univ Autonoma Madrid, Dept Internal Med, La Paz Univ Hosp, Sch Med, Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz	Borobia, AM (corresponding author), Univ Autonoma Madrid, Clin Pharmacol Serv, La Paz Univ Hosp, Dept Pharmacol,Sch Med,IdiPAZ, Madrid, Spain.	a.borobia@gmail.com; antonio.carcas@uam.es	Ramírez, Elena/AGX-8858-2022; Carcas, Antonio J/E-1149-2012; Ramírez, Elena/S-5600-2018; Iniesta, Jesus A Frias/L-2692-2013; Borobia, Alberto M./H-6887-2013	Ramírez, Elena/0000-0002-4052-8876; Carcas, Antonio J/0000-0003-1823-4174; Ramírez, Elena/0000-0002-4052-8876; Borobia, Alberto M./0000-0002-8584-3263	Instituto de Salud Carlos III [FIS PI070710]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was supported by a research grant from Instituto de Salud Carlos III (FIS PI070710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Ansell J, 2001, CHEST, V119, p22S, DOI 10.1378/chest.119.1_suppl.22S; Cadamuro J, 2010, EUR J CLIN PHARMACOL, V66, P253, DOI 10.1007/s00228-009-0768-7; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Caldwell MD, 2007, CLIN MED RES, V5, P8, DOI 10.3121/cmr.2007.724; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; Cavallari LH, 2011, PHARMACOTHERAPY, V31, P785, DOI 10.1592/phco.31.8.785; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Gadisseur APA, 2002, BRIT J HAEMATOL, V117, P940, DOI 10.1046/j.1365-2141.2002.03493.x; Guijarro R, 2008, EUR J INTERN MED, V19, P443, DOI 10.1016/j.ejim.2007.06.026; Hirsh J, 2003, CIRCULATION, V107, P1692, DOI 10.1161/01.CIR.0000063575.17904.4E; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; LANDEFELD CS, 1989, AM J MED, V87, P144; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Meijer K, 2011, THROMB HAEMOSTASIS, V105, P232, DOI 10.1160/TH10-05-0324; Millican EA, 2007, BLOOD, V110, P1511, DOI 10.1182/blood-2007-01-069609; Moreau C, 2011, J THROMB HAEMOST, V9, P711, DOI 10.1111/j.1538-7836.2011.04213.x; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Perez-Andreu V, 2010, J THROMB HAEMOST, V8, P1012, DOI 10.1111/j.1538-7836.2010.03800.x; Perez-Andreu V, 2009, BLOOD, V113, P4977, DOI 10.1182/blood-2008-09-176222; Rathore SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037844; Sagrieya H, 2010, PHARMACOGENET GENOM, V20, P407, DOI 10.1097/FPC.0b013e328338bac2; Schalekamp T, 2006, CLIN PHARMACOL THER, V80, P13, DOI 10.1016/j.clpt.2006.04.006; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; SHEINER LB, 1981, J PHARMACOKINET BIOP, V9, P503, DOI 10.1007/BF01060893; Spreafico M, 2008, PHARMACOGENOMICS, V9, P1237, DOI 10.2217/14622416.9.9.1237; Stehle S, 2008, CLIN PHARMACOKINET, V47, P565, DOI 10.2165/00003088-200847090-00002; Takahashi H, 2004, CLIN PHARMACOL THER, V75, P376, DOI 10.1016/j.clpt.2004.01.007; Teichert M, 2009, CLIN PHARMACOL THER, V85, P379, DOI 10.1038/clpt.2008.294; Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309; van Schie RMF, 2011, EUR HEART J, V32, P1909, DOI 10.1093/eurheartj/ehr116; van Schie RMF, 2009, PHARMACOGENOMICS, V10, P1687, DOI [10.2217/pgs.09.125, 10.2217/PGS.09.125]; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; Verde Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011210; Visser LE, 2005, PHARMACOGENET GENOM, V15, P69, DOI 10.1097/01213011-200502000-00002; Wu AHB, 2007, PHARMACOGENOMICS, V8, P851, DOI 10.2217/14622416.8.7.851; Zambon CF, 2011, PHARMACOGENOMICS, V12, P15, DOI [10.2217/pgs.10.162, 10.2217/PGS.10.162]	38	44	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41360	10.1371/journal.pone.0041360	http://dx.doi.org/10.1371/journal.pone.0041360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911785	Green Published, Green Submitted, gold			2022-12-27	WOS:000306644600075
J	Choo, YY; Hagen, T				Choo, Yin Yin; Hagen, Thilo			Mechanism of Cullin3 E3 Ubiquitin Ligase Dimerization	PLOS ONE			English	Article							RECOGNITION MODEL; MAMMALIAN-CELLS; DLG MOTIFS; C-ELEGANS; COMPLEX; PROTEIN; KEAP1; NRF2; DEGRADATION; ACTIVATION	Cullin E3 ligases are the largest family of ubiquitin ligases with diverse cellular functions. One of seven cullin proteins serves as a scaffold protein for the assembly of the multisubunit ubiquitin ligase complex. Cullin binds the RING domain protein Rbx1/Rbx2 via its C-terminus and a cullin-specific substrate adaptor protein via its N-terminus. In the Cul3 ubiquitin ligase complex, Cul3 substrate receptors contain a BTB/POZ domain. Several studies have established that Cul3-based E3 ubiquitin ligases exist in a dimeric state which is required for binding of a number of substrates and has been suggested to promote ubiquitin transfer. In two different models, Cul3 has been proposed to dimerize either via BTB/POZ domain dependent substrate receptor homodimerization or via direct interaction between two Cul3 proteins that is mediated by Nedd8 modification of one of the dimerization partners. In this study, we show that the majority of the Cul3 proteins in cells exist as dimers or multimers and that Cul3 self-association is mediated via the Cul3 N-terminus while the Cul3 C-terminus is not required. Furthermore, we show that Cul3 self-association is independent of its modification with Nedd8. Our results provide evidence for BTB substrate receptor dependent Cul3 dimerization which is likely to play an important role in promoting substrate ubiquitination.	[Choo, Yin Yin; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	National University of Singapore	Choo, YY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchth@nus.edu.sg			Singapore National Medical Research Council [EDG09May050]	Singapore National Medical Research Council(National Medical Research Council, Singapore)	This study was supported by a grant from the Singapore National Medical Research Council (grant number EDG09May050). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Choo YY, 2011, MOL BIOL CELL, V22, P4706, DOI 10.1091/mbc.E11-03-0251; Correale S, 2011, BIOCHIMIE, V93, P715, DOI 10.1016/j.biochi.2010.12.014; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Liu J, 2009, SCIENCE, V323, P1218, DOI 10.1126/science.1157669; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Luke-Glaser S, 2007, J CELL SCI, V120, P3179, DOI 10.1242/jcs.015883; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Moreau D, 2011, DEV CELL, V21, P231, DOI 10.1016/j.devcel.2011.06.014; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Small E, 2010, BIOCHEM BIOPH RES CO, V400, P471, DOI 10.1016/j.bbrc.2010.08.062; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	41	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41350	10.1371/journal.pone.0041350	http://dx.doi.org/10.1371/journal.pone.0041350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911784	Green Published, Green Submitted, gold			2022-12-27	WOS:000306644600074
J	Gassling, V; Holterhus, PM; Herbers, D; Kulle, A; Niederberger, U; Hedderich, J; Wiltfang, J; Gerber, WD				Gassling, Volker; Holterhus, Paul-Martin; Herbers, Dorothee; Kulle, Alexandra; Niederberger, Uwe; Hedderich, Juergen; Wiltfang, Joerg; Gerber, Wolf-Dieter			Stress-Coping and Cortisol Analysis in Patients with Non-Syndromic Cleft Lip and Palate: An Explorative Study	PLOS ONE			English	Article							SALIVARY CORTISOL; PSYCHOSOCIAL ADJUSTMENT; SOCIAL STRESS; CHILDREN; ADOLESCENTS; RESPONSES; HEALTH; SATISFACTION; RESILIENCE; PARENTS	Background: Non-syndromic clefts of the orofacial region occur in approximately 1 per 500 to 2,500 live births, depending on geographical area and ethnicity. It can be supposed that the disruption of the normal facial structure and the long-standing pressure of treatment from birth to adulthood bring about a range of life stressors which may lead to a long-lasting impact on affected subjects throughout their lives. Therefore, the present study aimed to assess different aspects of psychosocial stress in affected individuals. Methods: The study was divided into two parts: first, the Trier Social Stress Test which involves uncontrollability and high levels of social-evaluative stress under real conditions and second, the query of various aspects of coping with psychosocial stress. The test group consisted of 30 affected adult subjects, and an equally sized control group of unaffected volunteers. Cortisol dysregulation was determined by saliva samples before and after stress induction. Meanwhile, participants were asked to complete the SVF 120 stress-coping questionnaire. Results: The analysis of saliva samples showed a similar baseline concentration as well as a similar increase in cortisol levels after stress induction for both groups. Subsequently, the decline in cortisol concentrations was significantly faster in the CLP group (course: p<0.001; groups: p = 0.102; interaction: p = 0.167). The evaluation of the stress-coping questionnaire revealed a significantly shorter rumination about a stressful event in individuals with CLP-related malformations (p = 0.03). Conclusion: We conclude that adults with CLP have significantly better stress-coping strategies than their healthy peers.	[Gassling, Volker; Herbers, Dorothee; Wiltfang, Joerg] Univ Hosp Schleswig Holstein, Dept Oral & Maxillofacial Surg, Kiel, Germany; [Holterhus, Paul-Martin; Kulle, Alexandra] Univ Hosp Schleswig Holstein, Dept Pediat, Div Pediat Endocrinol & Diabet, Kiel, Germany; [Niederberger, Uwe; Gerber, Wolf-Dieter] Univ Hosp Schleswig Holstein, Inst Med Psychol & Med Sociol, Kiel, Germany; [Hedderich, Juergen] Univ Hosp Schleswig Holstein, Inst Med Informat & Stat, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Gassling, V (corresponding author), Univ Hosp Schleswig Holstein, Dept Oral & Maxillofacial Surg, Kiel, Germany.	gassling@mkg.uni-kiel.de	Niederberger, Uwe/A-8256-2010; Wiltfang, Jörg/B-1767-2010; Gassling, Volker/E-4671-2016; Cruz e Silva, Odete/AAH-5595-2020	Niederberger, Uwe/0000-0003-3099-0183; Gassling, Volker/0000-0002-0096-6142; 				Baid SK, 2007, J CLIN ENDOCR METAB, V92, P3102, DOI 10.1210/jc.2006-2861; Baker SR, 2009, CLEFT PALATE-CRAN J, V46, P229, DOI 10.1597/08-075.1; Berger ZE, 2011, CLEFT PALATE-CRAN J, V48, P82, DOI 10.1597/08-094; Berger ZE, 2009, CLEFT PALATE-CRAN J, V46, P435, DOI 10.1597/08-093.1; Briegel J, 2009, INTENS CARE MED, V35, P2151, DOI 10.1007/s00134-009-1627-9; Brosschot JF, 2006, J PSYCHOSOM RES, V60, P113, DOI 10.1016/j.jpsychores.2005.06.074; Christensen K, 2004, BRIT MED J, V328, P1405, DOI 10.1136/bmj.38106.559120.7C; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Feragen KB, 2009, CLEFT PALATE-CRAN J, V46, P65, DOI 10.1597/07-124.1; Fisher M, 2010, AUST NZ J PSYCHIAT, V44, P1057, DOI 10.3109/00048674.2010.509311; Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3; Gaab J, 2003, PSYCHONEUROENDOCRINO, V28, P767, DOI 10.1016/S0306-4530(02)00069-0; GARMEZY N, 1991, PEDIATR ANN, V20, P459, DOI 10.3928/0090-4481-19910901-05; Gee GC, 2004, ENVIRON HEALTH PERSP, V112, P1645, DOI 10.1289/ehp.7074; Harkness KL, 2011, PSYCHONEUROENDOCRINO, V36, P173, DOI 10.1016/j.psyneuen.2010.07.006; Hellhammer J, 2012, PSYCHONEUROENDOCRINO, V37, P119, DOI 10.1016/j.psyneuen.2011.05.012; Hoek Ineke H C, 2009, Ned Tijdschr Geneeskd, V153, pB352; Hunt O, 2007, CLEFT PALATE-CRAN J, V44, P304, DOI 10.1597/05-205; Hunt O, 2006, CLEFT PALATE-CRAN J, V43, P598, DOI 10.1597/05-080; JANKE W, 2002, STRESSVERARBEITUNGSF; Jonsson BAG, 2003, J CHROMATOGR B, V784, P63, DOI 10.1016/S1570-0232(02)00753-5; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kulle AE, 2010, J CLIN ENDOCR METAB, V95, P2399, DOI 10.1210/jc.2009-1670; LAZARUS RS, 1964, J ABNORM SOC PSYCH, V69, P195, DOI 10.1037/h0044635; Lindley SE, 2004, BIOL PSYCHIAT, V55, P940, DOI 10.1016/j.biopsych.2003.12.021; Maes S., 1996, HDB COPING THEORY RE, P221; Meyer-Marcotty P, 2010, J DENT RES, V89, P400, DOI 10.1177/0022034509359488; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Noor SNFM, 2007, CLEFT PALATE-CRAN J, V44, P292, DOI 10.1597/05-151; Oosterkamp BCM, 2007, INT J ORAL MAX SURG, V36, P890, DOI 10.1016/j.ijom.2007.07.008; Perogamvros I, 2009, J CHROMATOGR B, V877, P3771, DOI 10.1016/j.jchromb.2009.09.014; Pinquart M, 2011, J PEDIATR PSYCHOL, V36, P375, DOI 10.1093/jpepsy/jsq104; Sapienza JK, 2011, CURR OPIN PSYCHIATR, V24, P267, DOI 10.1097/YCO.0b013e32834776a8; Schuster M, 2003, HNO, V51, P507, DOI 10.1007/s00106-003-0843-9; Sjogren E, 2006, INT J BEHAV MED, V13, P193, DOI 10.1207/s15327558ijbm1303_2; Tlili C, 2011, BIOSENS BIOELECTRON, V26, P4382, DOI 10.1016/j.bios.2011.04.045; TOBIASEN JM, 1993, CLIN PLAST SURG, V20, P623; TSIGOS C, 1994, ENDOCRIN METAB CLIN, V23, P451, DOI 10.1016/S0889-8529(18)30078-1; Turpeinen U, 2009, SCAND J CLIN LAB INV, V69, P592, DOI 10.1080/00365510902890331; VINING RF, 1983, ANN CLIN BIOCHEM, V20, P329, DOI 10.1177/000456328302000601; Wilhelm I, 2007, PSYCHONEUROENDOCRINO, V32, P358, DOI 10.1016/j.psyneuen.2007.01.008; Wood P, 2009, ANN CLIN BIOCHEM, V46, P183, DOI 10.1258/acb.2008.008208; Wust S, 2000, PSYCHONEUROENDOCRINO, V25, P707, DOI 10.1016/s0306-4530(00)00021-4; Yehuda R, 2004, PSYCHONEUROENDOCRINO, V29, P389, DOI 10.1016/S0306-4530(03)00052-0; Zoccola PM, 2010, STRESS, V13, P435, DOI 10.3109/10253891003713765	48	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41015	10.1371/journal.pone.0041015	http://dx.doi.org/10.1371/journal.pone.0041015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911731	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600035
J	Guasch-Ferre, M; Bullo, M; Martinez-Gonzalez, MA; Corella, D; Estruch, R; Covas, MI; Aros, F; Warnberg, J; Fiol, M; Lapetra, J; Munoz, MA; Serra-Majem, L; Pinto, X; Babio, N; Diaz-Lopez, A; Salas-Salvado, J				Guasch-Ferre, Marta; Bullo, Monica; Martinez-Gonzalez, Miguel Angel; Corella, Dolores; Estruch, Ramon; Covas, Maria-Isabel; Aros, Fernando; Waernberg, Julia; Fiol, Miquel; Lapetra, Jose; Munoz, Miguel Angel; Serra-Majem, Lluis; Pinto, Xavier; Babio, Nancy; Diaz-Lopez, Andres; Salas-Salvado, Jordi			Waist-to-Height Ratio and Cardiovascular Risk Factors in Elderly Individuals at High Cardiovascular Risk	PLOS ONE			English	Article							METABOLIC SYNDROME; ANTHROPOMETRIC INDICATORS; ABDOMINAL OBESITY; DISEASE; QUESTIONNAIRE; ASSOCIATION; OVERWEIGHT; CRITERIA; INDEXES; COULD	Introduction: Several anthropometric measurements have been associated with cardiovascular disease, type-2 diabetes mellitus and other cardiovascular risk conditions, such as hypertension or metabolic syndrome. Waist-to-height-ratio has been proposed as a useful tool for assessing abdominal obesity, correcting other measurements for the height of the individual. We compared the ability of several anthropometric measurements to predict the presence of type-2 diabetes, hyperglycemia, hypertension, atherogenic dyslipidemia or metabolic syndrome. Materials and Methods: In our cross-sectional analyses we included 7447 Spanish individuals at high cardiovascular risk, men aged 55-80 years and women aged 60-80 years, from the PREDIMED study. Logistic regression models were fitted to evaluate the odds ratio of presenting each cardiovascular risk factor according to various anthropometric measures. The areas under the receiver-operating characteristic curve (AUC) were used to compare the predictive ability of these measurements. Results: In this relatively homogeneous cohort with 48.6% of type-2 diabetic individuals, the great majority of the studied anthropometric parameters were significantly and positively associated with the cardiovascular risk factors. No association was found between BMI and body weight and diabetes mellitus. The AUCs for the waist-to-height ratio and waist circumference were significantly higher than the AUCs for BMI or weight for type-2 diabetes, hyperglycemia, atherogenic dyslipidemia and metabolic syndrome. Conversely, BMI was the strongest predictor of hypertension. Conclusions: We concluded that measures of abdominal obesity showed higher discriminative ability for diabetes mellitus, high fasting plasma glucose, atherogenic dyslipidemia and metabolic syndrome than BMI or weight in a large cohort of elderly Mediterranean individuals at high cardiovascular risk. No significant differences were found between the predictive abilities of waist-to-height ratio and waist circumference on the metabolic disease.	[Guasch-Ferre, Marta; Bullo, Monica; Babio, Nancy; Diaz-Lopez, Andres; Salas-Salvado, Jordi] Univ Rovira & Virgili, IISPV, Fac Med & Hlth Sci, Human Nutr Unit, E-43201 Reus, Spain; [Guasch-Ferre, Marta; Bullo, Monica; Estruch, Ramon; Babio, Nancy; Diaz-Lopez, Andres; Salas-Salvado, Jordi] Inst Hlth Carlos III, CIBERobn Ctr Invest Biomed Red Fisiopatol Obesida, Madrid, Spain; [Martinez-Gonzalez, Miguel Angel; Aros, Fernando; Serra-Majem, Lluis; Pinto, Xavier] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Corella, Dolores] Univ Valencia, Dept Prevent Med, Valencia, Spain; [Estruch, Ramon] Univ Barcelona, Hosp Clin Barcelona, Dept Internal Med, Barcelona, Spain; [Covas, Maria-Isabel] Inst Municipal Invest Med, Cardiovasc Risk & Nutr Res Grp, E-08003 Barcelona, Spain; [Aros, Fernando] Univ Hosp Txagorritxu, Dept Cardiol, Vitoria, Spain; [Waernberg, Julia] Univ Malaga, Dept Prevent Med, E-29071 Malaga, Spain; [Fiol, Miquel] Univ Balearic Isl, Inst Hlth Sci, Palma de Mallorca, Spain; [Fiol, Miquel] Hosp Son Espases, Palma de Mallorca, Spain; [Lapetra, Jose] San Pablo Hlth Ctr, Primary Care Div Sevilla, Dept Family Med, Seville, Spain; [Munoz, Miguel Angel] Catalan Inst Hlth, Primary Care Div, Barcelona, Spain; [Serra-Majem, Lluis] Univ La Palmas Gran Canaria, Dept Clin Sci, La Palmas, Spain; [Pinto, Xavier] Hospitalet Llobregat, Hosp Univ Bellvitge, Lipids & Vasc Risk Unit, Barcelona, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Navarra; University of Valencia; University of Barcelona; Hospital Clinic de Barcelona; University Hospital of Araba; Universidad de Malaga; Universitat de les Illes Balears; Hospital Universitari Son Espases; Universidad de Las Palmas de Gran Canaria; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital	Guasch-Ferre, M (corresponding author), Univ Rovira & Virgili, IISPV, Fac Med & Hlth Sci, Human Nutr Unit, C St Llorenc 21, E-43201 Reus, Spain.	jordi.salas@urv.cat	Serra-Majem, Lluis/I-6708-2019; Estruch, Ramon/AAZ-3723-2020; perez, miguel/GXF-5077-2022; Warnberg, Julia/G-1390-2011; Bulló, Mònica/F-2925-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Pintó, Xavier/AGI-4297-2022; Lapetra, Jose/F-2552-2015; Guasch-Ferre, Marta/H-6680-2019; Fiol, Miguel/F-6793-2016; Salas-Salvado, Jordi/C-7229-2017; Babio, Nancy/AAN-2715-2020; Muñoz, Miguel Angel/X-3511-2019; IBIS, ATENCION PRIMARIA/I-3524-2016	Serra-Majem, Lluis/0000-0002-9658-9061; Warnberg, Julia/0000-0002-8408-316X; Bulló, Mònica/0000-0002-0218-7046; Pintó, Xavier/0000-0002-2216-2444; Guasch-Ferre, Marta/0000-0001-8525-1404; Fiol, Miguel/0000-0002-5370-1391; Salas-Salvado, Jordi/0000-0003-2700-7459; Babio, Nancy/0000-0003-3527-5277; Muñoz, Miguel Angel/0000-0002-4083-3248; Diaz-Lopez, Andres/0000-0002-7500-5629; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Spanish Ministry of Health (ISCIII) [PI1001407]; Thematic Network [G03/140, RD06/0045]; FEDER (Fondo Europeo de Desarrollo Regional); Centre Catala de la Nutricio de l'Institut d'Estudis Catalans	Spanish Ministry of Health (ISCIII)(Instituto de Salud Carlos IIISpanish Government); Thematic Network; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission); Centre Catala de la Nutricio de l'Institut d'Estudis Catalans	This study was funded, in part, by the Spanish Ministry of Health (ISCIII), PI1001407, Thematic Network G03/140, RD06/0045, FEDER (Fondo Europeo de Desarrollo Regional), and the Centre Catala de la Nutricio de l'Institut d'Estudis Catalans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CIBERobn is an initiative of ISCIII, Spain.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Bertsias G, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-3; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Carr MC, 2004, J CLIN ENDOCR METAB, V89, P2601, DOI 10.1210/jc.2004-0432; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dong XL, 2011, POSTGRAD MED J, V87, P251, DOI 10.1136/pgmj.2010.100453; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Esmaillzadeh A, 2006, PUBLIC HEALTH NUTR, V9, P61, DOI 10.1079/PHN2005833; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Gonzalez AS, 2007, NUTRITION, V23, P36, DOI 10.1016/j.nut.2006.08.019; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hadaegh F, 2006, EXP CLIN ENDOCR DIAB, V114, P310, DOI 10.1055/s-2006-924123; Hsieh SD, 2006, PREV MED, V42, P135, DOI 10.1016/j.ypmed.2005.08.007; Klein S, 2004, AM J CLIN NUTR, V80, P257, DOI 10.1093/ajcn/80.2.257; Langenberg C, 2005, AM J PUBLIC HEALTH, V95, P628, DOI 10.2105/2004.046219; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Li M, 2010, DIABETES RES CLIN PR, V87, P401, DOI 10.1016/j.diabres.2009.12.004; Mombelli G, 2009, METAB SYNDR RELAT D, V7, P477, DOI 10.1089/met.2008.0101; Pi-Sunyer FX, 2000, P NUTR SOC, V59, P505, DOI 10.1017/S0029665100000732; Perez MDR, 2010, MED CLIN-BARCELONA, V134, P386, DOI 10.1016/j.medcli.2009.09.047; Schneider HJ, 2007, J CLIN ENDOCR METAB, V92, P589, DOI 10.1210/jc.2006-0254; Schneider Harald J, 2011, Diabetes Care, V34, pe7, DOI 10.2337/dc10-1794; Schulze MB, 2006, DIABETES CARE, V29, P1921, DOI 10.2337/dc06-0895; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6	29	57	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43275	10.1371/journal.pone.0043275	http://dx.doi.org/10.1371/journal.pone.0043275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905246	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800070
J	Shang, XW; Li, YP; Liu, AL; Zhang, Q; Hu, XQ; Du, SM; Ma, J; Xu, GF; Li, Y; Guo, HW; Du, L; Ma, GS				Shang, Xianwen; Li, Yanping; Liu, Ailing; Zhang, Qian; Hu, Xiaoqi; Du, Songming; Ma, Jun; Xu, Guifa; Li, Ying; Guo, Hongwei; Du, Lin; Ma, Guansheng			Dietary Pattern and Its Association with the Prevalence of Obesity and Related Cardiometabolic Risk Factors among Chinese Children	PLOS ONE			English	Article							MEDITERRANEAN-STYLE DIET; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; NUTRITION TRANSITION; EATING PATTERNS; BLOOD-PRESSURE; DAIRY FOODS; LIFE-STYLE; OVERWEIGHT; CHILDHOOD	Background: The association of dietary pattern with chronic diseases has been investigated widely in western countries. However, information is quite limited among children in China. Our study is aimed to identify the dietary patterns of Chinese children and examine their association with obesity and related cardiometabolic risk factors. Methods: A total of 5267 children were selected using multistage random sampling from 30 primary schools of 5 provincial capital cities in China. Dietary intake was derived from 24 hour dietary recall for three consecutive days. Anthropometric measurements, glucose and lipid profiles were obtained. Factor analysis combined with cluster analysis was used for identifying major dietary patterns. The associations of dietary patterns with obesity and related cardiometabolic risk factors were examined by logistic regression analysis. Results: Three mutually exclusive dietary patterns were identified, which were labeled as the healthy dietary pattern, the transitive dietary pattern, and the Western dietary pattern. Compared with children of the healthy dietary pattern, the multiple-adjusted odds ratios (95% confidence interval (CI)) of obesity were 1.11 (0.89-1.38) for children with the transitive dietary pattern and 1.80 (1.15-2.81) for children with the Western dietary pattern, which was 1.31 (95% CI 1.09-1.56) and 1.71 (95% CI: 1.13-2.56), respectively, for abdominal obesity. The Western dietary pattern was associated with significantly higher concentrations of low-density lipoprotein cholesterol (P<. 001), triglycerides (P<.001), systolic blood pressure (P = 0.0435) and fasting glucose (P = 0.0082) and a lower concentration of high-density lipoprotein cholesterol (P = 0.0023), as compared with the healthy dietary pattern. Conclusions: The Western dietary pattern characterized by red meat, eggs, refined grain and products, was positively associated with odds of obesity, the levels of plasma glucose, low-density lipoprotein cholesterol and triglycerides, and was inversely associated with the level of high-density lipoprotein cholesterol.	[Shang, Xianwen; Li, Yanping; Liu, Ailing; Zhang, Qian; Hu, Xiaoqi; Du, Songming; Ma, Guansheng] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Beijing, Peoples R China; [Shang, Xianwen] Chinese Acad Med Sci, China Oxford Ctr Int Hlth Res, Cardiovasc Inst, Beijing 100730, Peoples R China; [Shang, Xianwen] Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100730, Peoples R China; [Shang, Xianwen] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Jun] Beijing Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Xu, Guifa] Shandong Univ, Jinan 250100, Shandong, Peoples R China; [Li, Ying] Haerbin Med Univ, Coll Publ Hlth, Haerbin, Heilongjiang, Peoples R China; [Guo, Hongwei] Fudan Univ, Shanghai 200433, Peoples R China; [Du, Lin] Guangzhou Ctr Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University; Shandong University; Harbin Medical University; Fudan University	Shang, XW (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Beijing, Peoples R China.	mags@chinacdc.cn	Ma, Guansheng/AAD-6767-2020; Li, Yanping/H-6437-2011	Shang, Xianwen/0000-0001-6143-9349; Shang, Xianwen/0000-0002-2362-3222; Li, Yanping/0000-0002-0412-2748	China Ministry of Science Technology [2008BAI58B05]	China Ministry of Science Technology(Ministry of Science and Technology, China)	This project has been funded by China Ministry of Science & Technology as "Key Projects in the National Science & Technology Pillar Program during the Eleventh Five-Year Plan Period." Grant number: 2008BAI58B05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014126; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Balthazar Emilia A, 2011, BMC Res Notes, V4, P567, DOI 10.1186/1756-0500-4-567; Berg CM, 2008, AM J CLIN NUTR, V88, P289; Botton J, 2007, METABOLISM, V56, P614, DOI 10.1016/j.metabol.2006.12.006; Buckland G, 2008, OBES REV, V9, P582, DOI 10.1111/j.1467-789X.2008.00503.x; Cary NC, 1999, SAS STAT US GUID VER, P1122; Cary NC, 1999, SAS STAT US GUID VER, P1194; Chen Chun-ming, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P95; Chinese Medical Association Professional Committee of Children's Health, 2007, CHIN J EVID BASED PE, V22, P69; Chivers P, 2010, INT J OBESITY, V34, P1169, DOI 10.1038/ijo.2010.61; Crawford D, 2010, INT J OBESITY, V34, P1177, DOI 10.1038/ijo.2010.57; de Lorgeril M, 2006, PUBLIC HEALTH NUTR, V9, P118, DOI 10.1079/PHN2005933; Denova-Gutierrez E, 2011, J NUTR, V141, P921, DOI 10.3945/jn.110.132332; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Esfahani A, 2011, J AM COLL NUTR, V30, P285, DOI 10.1080/07315724.2011.10719971; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; German JB, 2009, EUR J NUTR, V48, P191, DOI 10.1007/s00394-009-0002-5; Gibson RA, 2009, BRIT J NUTR, V102, P1267, DOI 10.1017/S0007114509371664; He YN, 2009, DIABETES CARE, V32, P1972, DOI 10.2337/dc09-0714; Hoffmann K, 2000, PUBLIC HEALTH NUTR, V5, P89; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Jason A, 2010, J AM DIET ASSOC, V110, P434; Jenkins DJA, 2003, JAMA-J AM MED ASSOC, V290, P502, DOI 10.1001/jama.290.4.502; Ji CY, 2010, BIOMED ENVIRON SCI, V23, P12, DOI 10.1016/S0895-3988(10)60026-8; Kant AK, 2005, INT J OBESITY, V29, P950, DOI 10.1038/sj.ijo.0802980; Kral TVE, 2010, PHYSIOL BEHAV, V100, P567, DOI 10.1016/j.physbeh.2010.04.031; Lebars MA, 2010, ARCH PEDIATRIE, V17, P1126, DOI 10.1016/j.arcped.2010.04.014; Lee SA, 2010, BRIT J NUTR, V104, P265, DOI 10.1017/S0007114510000383; Li YP, 2008, ASIA PAC J CLIN NUTR, V17, P131; Lim JH, 2011, J KOREAN MED SCI, V26, P1201, DOI 10.3346/jkms.2011.26.9.1201; Liu Ai-Ling, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P901; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Melnik BC, 2009, MED HYPOTHESES, V72, P631, DOI 10.1016/j.mehy.2009.01.008; Menik BC, 2011, MED HYPOTHESES, V76, P553, DOI 10.1016/j.mehy.2010.12.017; Mercedes DO, 2007, DEV WHO GROWTH REFER; [米杰 MI Jie], 2010, [中国循证儿科杂志, Chinese JOurnal of Evidence Based Pediatrics], V5, P4; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Olinto MT, 2010, PUBLIC HEALTH NUTR, V25, P1; Osler M, 2001, BRIT J NUTR, V85, P219, DOI 10.1079/BJN2000240; Paletas K, 2010, J AM COLL NUTR, V29, P41, DOI 10.1080/07315724.2010.10719815; Patro B, 2010, CURR OPIN CLIN NUTR, V13, P300, DOI 10.1097/MCO.0b013e32833681a2; Paul Z, 2007, LANCET, V369, P2059; Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S; Power ML, 1999, AM J OBSTET GYNECOL, V181, P1560, DOI 10.1016/S0002-9378(99)70404-7; RAITAKARI OT, 1994, ACTA PAEDIATR, V83, P935, DOI 10.1111/j.1651-2227.1994.tb13176.x; Resnick L, 1999, PROG CARDIOVASC DIS, V42, P1, DOI 10.1016/S0033-0620(99)70006-X; Rezazadeh A, 2010, J NUTR SCI VITAMINOL, V56, P132, DOI 10.3177/jnsv.56.132; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Sabate J, 2010, AM J CLIN NUTR, V91, p1525S, DOI 10.3945/ajcn.2010.28701F; Samuelson G, 2000, EUR J CLIN NUTR, V54, pS21, DOI 10.1038/sj.ejcn.1600980; Schiel R, 2006, EUR J MED RES, V11, P97; SCHWERIN HS, 1982, AM J CLIN NUTR, V35, P1319, DOI 10.1093/ajcn/35.5.1319; Shi H, 2001, FASEB J, V15, P2751, DOI 10.1096/fj.01-0584fje; Steemburgo T, 2007, ARQ BRAS ENDOCRINOL, V51, P1425, DOI 10.1590/S0004-27302007000900004; Tan F, 2000, J Epidemiol, V10, P255; Thompson DR, 2007, J PEDIATR-US, V150, P18, DOI 10.1016/j.jpeds.2006.09.039; Tseng, 2000, Ann Epidemiol, V10, P481, DOI 10.1016/S1047-2797(00)00088-0; Twisk JWR, 1999, J CARDIOVASC RISK, V6, P355; Vergnaud AC, 2012, AM J CLIN NUTR, V95, P184, DOI 10.3945/ajcn.111.019968; Vergnaud AC, 2010, AM J CLIN NUTR, V92, P398, DOI 10.3945/ajcn.2009.28713; Villegas R, 2010, INT J EPIDEMIOL, V39, P889, DOI 10.1093/ije/dyq008; Wang GJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e81; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6; Williams DEM, 2000, BRIT J NUTR, V83, P257, DOI 10.1017/S0007114500000337; Wosje KS, 2010, AM J CLIN NUTR, V92, P294, DOI 10.3945/ajcn.2009.28925; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x	74	86	89	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43183	10.1371/journal.pone.0043183	http://dx.doi.org/10.1371/journal.pone.0043183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905228	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500800057
J	Morlan, JD; Qu, KB; Sinicropi, DV				Morlan, John D.; Qu, Kunbin; Sinicropi, Dominick V.			Selective Depletion of rRNA Enables Whole Transcriptome Profiling of Archival Fixed Tissue	PLOS ONE			English	Article							COPY-NUMBER; CELL; DNA	We report a method for Selective Depletion of abundant RNA (SDRNA) species from Human total RNA isolated from formalin-fixed, paraffin-embedded (FFPE) tissue, here demonstrating removal of ribosomal and mitochondrial transcripts from clinical FFPE tissue RNA archived up to 20 years. Importantly, SDRNA removes 98% of targeted RNAs while preserving relative abundance profiles of non-targeted RNAs, enabling routine whole transcriptome analysis of clinically valuable archival tissue specimens by Next-Generation Sequencing.	[Morlan, John D.; Qu, Kunbin; Sinicropi, Dominick V.] Genom Hlth Inc, Redwood City, CA USA	Genomic Health	Morlan, JD (corresponding author), Genom Hlth Inc, Redwood City, CA USA.	jmorlan@genomichealth.com						Armour CD, 2009, NAT METHODS, V6, P647, DOI [10.1038/NMETH.1360, 10.1038/nmeth.1360]; Beck AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008768; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Kapranov P, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-149; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; MADEN BEH, 1987, BIOCHEM J, V246, P519, DOI 10.1042/bj2460519; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Wood HM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq510; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	13	103	112	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42882	10.1371/journal.pone.0042882	http://dx.doi.org/10.1371/journal.pone.0042882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900061	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900079
J	Rana, VS; Singh, ST; Priya, NG; Kumar, J; Rajagopal, R				Rana, Vipin Singh; Singh, Shalini Thakur; Priya, Natarajan Gayatri; Kumar, Jitendra; Rajagopal, Raman			Arsenophonus GroEL Interacts with CLCuV and Is Localized in Midgut and Salivary Gland of Whitefly B. tabaci	PLOS ONE			English	Article							LEAF CURL VIRUS; BEMISIA-TABACI; CIRCULATIVE TRANSMISSION; ENDOSYMBIOTIC BACTERIA; COAT PROTEIN; SARDINIA-VIRUS; SPECIES LEVEL; VECTOR; APHIDS; ALEYRODIDAE	Cotton leaf curl virus (CLCuV) (Gemininiviridae: Begomovirus) is the causative agent of leaf curl disease in cotton plants (Gossypium hirsutum). CLCuV is exclusively transmitted by the whitefly species B. tabaci (Gennadius) (Hemiptera: Alerodidae). B. tabaci contains several biotypes which harbor dissimilar bacterial endo-symbiotic community. It is reported that these bacterial endosymbionts produce a 63 kDa chaperon GroEL protein which binds to geminivirus particles and protects them from rapid degradation in gut and haemolymph. In biotype B, GroEL protein of Hamiltonella has been shown to interact with Tomato yellow leaf curl virus (TYLCV). The present study was initiated to find out whether endosymbionts of B. tabaci are similarly involved in CLCuV transmission in Sriganganagar (Rajasthan), an area endemic with cotton leaf curl disease. Biotype and endosymbiont diversity of B. tabaci were identified using MtCO1 and 16S rDNA genes respectively. Analysis of our results indicated that the collected B. tabaci population belong to AsiaII genetic group and harbor the primary endosymbiont Portiera and the secondary endosymbiont Arsenophonus. The GroEL proteins of Portiera and Arsenophonus were purified and in-vitro interaction studies were carried out using pull down and co-immunoprecipitation assays. In-vivo interaction was confirmed using yeast two hybrid system. In both in-vitro and in-vivo studies, the GroEL protein of Arsenophonus was found to be interacting with the CLCuV coat protein. Further, we also localized the presence of Arsenophonus in the salivary glands and the midgut of B. tabaci besides the already reported bacteriocytes. These results suggest the involvement of Arsenophonus in the transmission of CLCuV in AsiaII genetic group of B. tabaci.	[Rana, Vipin Singh; Singh, Shalini Thakur; Priya, Natarajan Gayatri; Kumar, Jitendra; Rajagopal, Raman] Univ Delhi, Dept Zool, Delhi 110007, India	University of Delhi	Rana, VS (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	zoorajagopal@gmail.com	Rana, Vipin/ABB-5594-2021; Rana, Vipin Singh/AAE-6615-2021; KUMAR, JITENDRA/AFJ-9849-2022	Rana, Vipin/0000-0003-2673-7871; KUMAR, JITENDRA/0000-0003-4222-446X	University of Delhi Faculty Research Grant; National Agricultural Innovation Project (NAIP) grant of the Indian Council for Agricultural Research	University of Delhi Faculty Research Grant; National Agricultural Innovation Project (NAIP) grant of the Indian Council for Agricultural Research	This work has been funded by 1. University of Delhi Faculty Research Grant and 2. National Agricultural Innovation Project (NAIP) grant of the Indian Council for Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmera B. D, 1994, NAT SEM COTT PROD CH; Baumann L, 2004, CURR MICROBIOL, V48, P77, DOI 10.1007/s00284-003-4132-3; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BAUMANN P, 1993, ASM NEWS, V59, P21; Bouvaine S, 2011, J GEN VIROL, V92, P1467, DOI 10.1099/vir.0.029355-0; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BRIDDON RW, 1990, VIROLOGY, V177, P85, DOI 10.1016/0042-6822(90)90462-Z; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Caciagli P, 2009, J VIROL, V83, P5784, DOI 10.1128/JVI.02267-08; Choudhury NR, 2006, NUCLEIC ACIDS RES, V34, P6362, DOI 10.1093/nar/gkl903; Cicero JM, 2011, ANN ENTOMOL SOC AM, V104, P261, DOI 10.1603/AN10075; Czosnek H, 2002, ANN APPL BIOL, V140, P215, DOI 10.1111/j.1744-7348.2002.tb00175.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Fauquet CM, 2005, ARCH VIROL, V150, P2151, DOI 10.1007/s00705-005-0583-0; Filichkin SA, 1997, J VIROL, V71, P569, DOI 10.1128/JVI.71.1.569-577.1997; Ghanim M, 1998, VIROLOGY, V240, P295, DOI 10.1006/viro.1997.8937; Ghanim M, 2007, TOMATO YELLOW LEAF C, P175; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hofer P, 1997, VIROLOGY, V236, P288, DOI 10.1006/viro.1997.8751; Hogenhout SA, 1998, J VIROL, V72, P358, DOI 10.1128/JVI.72.1.358-365.1998; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Jiang Y. X., 2004, Spanish Journal of Agricultural Research, V2, P115; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Kumar A, 2010, VIRUS GENES, V40, P282, DOI 10.1007/s11262-009-0439-x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Liu SJ, 2009, ARCH VIROL, V154, P469, DOI 10.1007/s00705-009-0327-7; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Mansoor S, 2003, TRENDS PLANT SCI, V8, P128, DOI 10.1016/S1360-1385(03)00007-4; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Medina V, 2006, J PLANT PATHOL, V88, P299; Monga D, 2011, 5 M AS COTT RES DEV; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Morin S, 1999, VIROLOGY, V256, P75, DOI 10.1006/viro.1999.9631; NARULA AM, 1999, J COTTON RES DEV, V0013, P00129; Noris E, 1998, J VIROL, V72, P10050, DOI 10.1128/JVI.72.12.10050-10057.1998; Ohnesorge S, 2009, INSECT MOL BIOL, V18, P693, DOI 10.1111/j.1365-2583.2009.00906.x; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Seal SE, 2006, CRIT REV PLANT SCI, V25, P23, DOI 10.1080/07352680500365257; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Singh ST, 2012, INFECT GENET EVOL, V12, P411, DOI 10.1016/j.meegid.2012.01.015; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; VANDENHEUVEL JFJM, 1994, J GEN VIROL, V75, P2559, DOI 10.1099/0022-1317-75-10-2559; VandenHeuvel JFJM, 1997, J VIROL, V71, P7258, DOI 10.1128/JVI.71.10.7258-7265.1997; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2	58	76	78	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42168	10.1371/journal.pone.0042168	http://dx.doi.org/10.1371/journal.pone.0042168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900008	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900023
J	Li, Q; Qi, Y; Liu, XY; Luo, J				Li, Qi; Qi, Yue; Liu, Xianyun; Luo, Jing			Can Contrast Effects Regulate Emotions? A Follow-Up Study of Vital Loss Decisions	PLOS ONE			English	Article							CINGULATE CORTEX; REGRET; CHOICE; PAIN; CONFLICT; MONEY; DISAPPOINTMENT; OUTCOMES; REWARD; CONSEQUENCES	Although many studies focus on the how contrast effects can impact cognitive evaluations, the question of whether emotions are regulated by such contrast effects is still the subject of considerable debate, especially in the study of loss-related decisions. To address this gap in the literature, we designed three decision making loss conditions: (i) both losses are trivial (TT), (ii) one loss is trivial and the other loss is vital (TV), or (iii) one loss is trivial and the other loss is routine (TR). In study 1, which compared the difference between the negative emotion ratings in TT and TV, we found that negative emotions were affected by the contrast effects. In study 2, which compared the difference between the importance of trivial options in TT and TV, we found that the contrast effects differentially changed the importance of trivial options in the two conditions, which in turn down-regulated negative emotions. In study 3, the impact of decision difficulty was controlled by predetermining the items to be lost. In this study, we found that, when comparing the differences between the negative emotions of losing trivial options in TV and TR, the contrast effects still modulated the loss-related emotions. We concluded that the contrast effects could down-regulate emotions. To our knowledge, this is the first demonstration that contrast effects can alleviate negative affect in loss-related decision making. This study will enrich and extend the literature on emotion regulation theory, and it will provide a new cost-effective mitigation strategy for regulating negative emotions.	[Li, Qi] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Qi, Yue] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Qi, Yue] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Liu, Xianyun] Tianjin Normal Univ, Acad Psychol & Behav, Tianjin, Peoples R China; [Luo, Jing] Capital Normal Univ, Beijing Key Lab Learning & Cognit, Dept Psychol, Beijing, Peoples R China; [Luo, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tianjin Normal University; Capital Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS	Li, Q (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	luoj@psych.ac.cn		Qi, Yue/0000-0002-7546-0613	Young Scientists Fund of the Institute of Psychology [Y1CX242005]; Talented Faculty Start-up funding, Tianjin Normal University [5RW092]; National Basic Research Program of China [2010CB833904]; National Natural Science Foundation of China [30970890, 30770708]; National Hi-Tech Research and Development Program of China [2008AA022604, 2009BAI77B06]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-8]	Young Scientists Fund of the Institute of Psychology; Talented Faculty Start-up funding, Tianjin Normal University; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This research was supported by the Young Scientists Fund of the Institute of Psychology (Grant Y1CX242005), the Talented Faculty Start-up funding, Tianjin Normal University (Grant No. 5RW092), the National Basic Research Program of China (Grant 2010CB833904), the National Natural Science Foundation of China (Grants 30970890 and 30770708), the National Hi-Tech Research and Development Program of China (Grants 2008AA022604 and 2009BAI77B06), and the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant KSCX2-EW-J-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; [Anonymous], EMOTIONAL DECISIONS; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; BETTMAN JR, 1993, J EXP PSYCHOL LEARN, V19, P931; Bjork JM, 2008, NEUROIMAGE, V42, P1609, DOI 10.1016/j.neuroimage.2008.06.035; CABANAC M, 1986, J EXP ANAL BEHAV, V46, P37, DOI 10.1901/jeab.1986.46-37; Cacioppo J, 1981, ATTITUDES PERSUASION; CAMPBELL DT, 1958, J EXP PSYCHOL, V55, P220, DOI 10.1037/h0045310; Chandrasekhar PVS, 2008, NEUROIMAGE, V39, P1472, DOI 10.1016/j.neuroimage.2007.10.027; Chua HF, 2009, NEUROIMAGE, V47, P2031, DOI 10.1016/j.neuroimage.2009.06.006; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Derbyshire SWG, 2004, NEUROIMAGE, V23, P392, DOI 10.1016/j.neuroimage.2004.04.033; Drolet A, 2004, J CONSUM RES, V31, P63, DOI 10.1086/383424; Druckman JN, 2001, J ECON PSYCHOL, V22, P91, DOI 10.1016/S0167-4870(00)00032-5; Eiser J.R., 1990, SOCIAL JUDGMENT; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FOLKMAN S, 1988, J PERS SOC PSYCHOL, V54, P466, DOI 10.1037/0022-3514.54.3.466; Fujiwara J, 2009, J NEUROPHYSIOL, V101, P3284, DOI 10.1152/jn.90909.2008; Fujiwara J, 2009, NEUROIMAGE, V44, P1163, DOI 10.1016/j.neuroimage.2008.09.050; Ginges J, 2007, P NATL ACAD SCI USA, V104, P7357, DOI 10.1073/pnas.0701768104; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Gu XS, 2007, BEHAV BRAIN RES, V181, P218, DOI 10.1016/j.bbr.2007.04.008; Guttentag R, 2004, DEV PSYCHOL, V40, P764, DOI 10.1037/0012-1649.40.5.764; Haffenden AM, 1998, J COGNITIVE NEUROSCI, V10, P122, DOI 10.1162/089892998563824; Hanselmann M, 2008, JUDGM DECIS MAK, V3, P51; HERR PM, 1983, J EXP SOC PSYCHOL, V19, P323, DOI 10.1016/0022-1031(83)90026-4; HOVLAND CI, 1957, J ABNORM SOC PSYCH, V55, P244, DOI 10.1037/h0048480; Janis I.L., 1977, DECISION MAKING PSYC; KAHNEMAN D., 1979, ECONOMETRICA, P263; Kasser Tim., 2003, HIGH PRICE MAT; KOSSLYN SM, 1975, COGNITIVE PSYCHOL, V7, P341, DOI 10.1016/0010-0285(75)90015-8; LAZARUS RS, 1991, AM PSYCHOL, V46, P819, DOI 10.1037/0003-066X.46.8.819; Li Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017544; Li S, 2006, THINK REASONING, V12, P129, DOI 10.1080/13546780500145652; Lichtenstein S, 2007, JUDGM DECIS MAK, V2, P169; Lin CH, 2006, J ECON PSYCHOL, V27, P781, DOI 10.1016/j.joep.2006.03.004; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; Luce MF, 1999, J MARKETING RES, V36, P143, DOI 10.2307/3152089; Luce MF, 1998, J CONSUM RES, V24, P409, DOI 10.1086/209518; MANIS M, 1971, J EXP SOC PSYCHOL, V7, P381, DOI 10.1016/0022-1031(71)90072-2; MEDVEC VH, 1995, J PERS SOC PSYCHOL, V69, P603, DOI 10.1037/0022-3514.69.4.603; Mellers BA, 2001, CURR DIR PSYCHOL SCI, V10, P210, DOI 10.1111/1467-8721.00151; Osaka N, 2004, BEHAV BRAIN RES, V153, P123, DOI 10.1016/j.bbr.2003.11.013; PEPITONE A, 1976, J PERS SOC PSYCHOL, V33, P448, DOI 10.1037/0022-3514.33.4.448; Priya R, 2006, J BUS RES, V59, P1053; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; SHERMAN SJ, 1978, J EXP SOC PSYCHOL, V14, P340, DOI 10.1016/0022-1031(78)90030-6; Simon HA, 1987, MAKING MANAGEMENT DE, P57; SIMPSON DD, 1976, J PERS SOC PSYCHOL, V34, P625, DOI 10.1037/0022-3514.34.4.625; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Su S, 2009, MOTIV EMOTION, V33, P219, DOI 10.1007/s11031-009-9127-3; Thornton B, 1999, SEX ROLES, V40, P379, DOI 10.1023/A:1018867409265; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Tykocinski OE, 2001, PERS SOC PSYCHOL B, V27, P376, DOI 10.1177/0146167201273011; van Dijk WW, 2002, MOTIV EMOTION, V26, P321, DOI 10.1023/A:1022823221146; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wedell DH, 2007, ASSIMILATION AND CONTRAST IN SOCIAL PSYCHOLOGY, P45; Yuan L., 1990, DICT USAGE FREQUENCY; Zeelenberg M, 1998, ORGAN BEHAV HUM DEC, V75, P117, DOI 10.1006/obhd.1998.2784; Zeelenberg M, 2007, J CONSUM PSYCHOL, V17, P3, DOI 10.1207/s15327663jcp1701_3; Zhou XY, 2009, PSYCHOL SCI, V20, P700, DOI 10.1111/j.1467-9280.2009.02353.x; Zhou XY, 2008, PSYCHOL INQ, V19, P208, DOI 10.1080/10478400802644496	65	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42763	10.1371/journal.pone.0042763	http://dx.doi.org/10.1371/journal.pone.0042763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905170	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100063
J	Tian, TH; Song, JN				Tian, Tianhai; Song, Jiangning			Mathematical Modelling of the MAP Kinase Pathway Using Proteomic Datasets	PLOS ONE			English	Article							SPECTROMETRY-BASED PROTEOMICS; MASS-SPECTROMETRY; SIGNAL-TRANSDUCTION; SYSTEMS BIOLOGY; PHOSPHORYLATION NETWORKS; ROBUSTNESS ANALYSIS; GENE-EXPRESSION; IN-VIVO; CASCADE; PHOSPHATASES	The advances in proteomics technologies offer an unprecedented opportunity and valuable resources to understand how living organisms execute necessary functions at systems levels. However, little work has been done up to date to utilize the highly accurate spatio-temporal dynamic proteome data generated by phosphoprotemics for mathematical modeling of complex cell signaling pathways. This work proposed a novel computational framework to develop mathematical models based on proteomic datasets. Using the MAP kinase pathway as the test system, we developed a mathematical model including the cytosolic and nuclear subsystems; and applied the genetic algorithm to infer unknown model parameters. Robustness property of the mathematical model was used as a criterion to select the appropriate rate constants from the estimated candidates. Quantitative information regarding the absolute protein concentrations was used to refine the mathematical model. We have demonstrated that the incorporation of more experimental data could significantly enhance both the simulation accuracy and robustness property of the proposed model. In addition, we used the MAP kinase pathway inhibited by phosphatases with different concentrations to predict the signal output influenced by different cellular conditions. Our predictions are in good agreement with the experimental observations when the MAP kinase pathway was inhibited by phosphatase PP2A and MKP3. The successful application of the proposed modeling framework to the MAP kinase pathway suggests that our method is very promising for developing accurate mathematical models and yielding insights into the regulatory mechanisms of complex cell signaling pathways.	[Tian, Tianhai] Monash Univ, Fac Sci, Sch Math Sci, Clayton, Vic, Australia; [Song, Jiangning] Monash Univ, Fac Med, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University; Monash University	Tian, TH (corresponding author), Monash Univ, Fac Sci, Sch Math Sci, Clayton, Vic, Australia.	tianhai.tian@monash.edu	Tian, Tianhai/AAU-2335-2021; Song, Jiangning/F-9787-2010	Song, Jiangning/0000-0001-8031-9086; Tian, Tianhai/0000-0001-6191-0209	Australian Research Council (ARC) [FT100100748]; National Health and Medical Research Council of Australia (NHMRC)	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (ARC) (project number FT100100748) and the National Health and Medical Research Council of Australia (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Ahrens CH, 2010, NAT REV MOL CELL BIO, V11, P789, DOI 10.1038/nrm2973; Apri M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009865; Barr AJ, 2006, TRENDS PHARMACOL SCI, V27, P525, DOI 10.1016/j.tips.2006.08.005; Bates DG, 2011, IET SYST BIOL, V5, P229, DOI 10.1049/iet-syb.2010.0072; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Bourret RB, 2008, MOL MICROBIOL, V69, P1336, DOI 10.1111/j.1365-2958.2008.06379.x; Chaudhri VK, 2010, J BIOL CHEM, V285, P1296, DOI 10.1074/jbc.M109.055863; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Chipperfield A.J., 1994, P AD COMP ENG DES CO, P128; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Collins MO, 2007, PROTEOMICS, V7, P2751, DOI 10.1002/pmic.200700145; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Slezak DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013283; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Grethe S, 2006, CELL SIGNAL, V18, P531, DOI 10.1016/j.cellsig.2005.05.023; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Iadevaia S, 2010, CANCER RES, V70, P6704, DOI 10.1158/0008-5472.CAN-10-0460; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Kall L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002277; Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083; Kersten B, 2009, PROTEOMICS, V9, P964, DOI 10.1002/pmic.200800548; Kilili GK, 2010, J BIOL CHEM, V285, P15076, DOI 10.1074/jbc.M109.078915; Kitano H, 2003, NATURE, V426, P125, DOI 10.1038/426125a; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Le Bihan T, 2011, J PROTEOMICS, V74, P2060, DOI 10.1016/j.jprot.2011.05.028; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Martin SF, 2011, J PROTEOME RES; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Mayya V, 2009, EXPERT REV PROTEOMIC, V6, P605, DOI 10.1586/EPR.09.84; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Raabe T, 2003, CURR BIOL, V13, pR635, DOI 10.1016/S0960-9822(03)00568-2; Rizk A, 2009, BIOINFORMATICS, V25, pI169, DOI 10.1093/bioinformatics/btp200; Schilling M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.91; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schwacke JH, 2007, PROTEOMICS, V7, P890, DOI 10.1002/pmic.200600927; Sieburth DS, 1999, GENE DEV, V13, P2562, DOI 10.1101/gad.13.19.2562; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Stasyk T, 2011, TRENDS MOL MED; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P2473, DOI 10.1073/pnas.0906885107; Tasaki S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013926; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tian TH, 2007, BIOINFORMATICS, V23, P84, DOI 10.1093/bioinformatics/btl552; Tian TH, 2011, INTEGR BIOL-UK, V3, P17, DOI 10.1039/c0ib00046a; Tian TH, 2010, BIOSYSTEMS, V99, P192, DOI 10.1016/j.biosystems.2009.11.002; Toni T, 2010, BIOINFORMATICS, V26, P104, DOI 10.1093/bioinformatics/btp619; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Wang JB, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-36; Wilkins MR, 1996, BIO-TECHNOL, V14, P61, DOI 10.1038/nbt0196-61; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100	67	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42230	10.1371/journal.pone.0042230	http://dx.doi.org/10.1371/journal.pone.0042230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905119	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100028
J	van der Heide, T; Eklof, JS; van Nes, EH; van der Zee, EM; Donadi, S; Weerman, EJ; Olff, H; Eriksson, BK				van der Heide, Tjisse; Eklof, Johan S.; van Nes, Egbert H.; van der Zee, Els M.; Donadi, Serena; Weerman, Ellen J.; Olff, Han; Eriksson, Britas Klemens			Ecosystem Engineering by Seagrasses Interacts with Grazing to Shape an Intertidal Landscape	PLOS ONE			English	Article							SPATIAL VEGETATION PATTERNS; GEESE BRANTA-BERNICLA; BRENT GEESE; ARID ECOSYSTEMS; ZOSTERA-NOLTII; WADDEN SEA; DYNAMICS; ORGANISMS; DESERTIFICATION; EXPLOITATION	Self-facilitation through ecosystem engineering (i.e., organism modification of the abiotic environment) and consumer-resource interactions are both major determinants of spatial patchiness in ecosystems. However, interactive effects of these two mechanisms on spatial complexity have not been extensively studied. We investigated the mechanisms underlying a spatial mosaic of low-tide exposed hummocks and waterlogged hollows on an intertidal mudflat in the Wadden Sea dominated by the seagrass Zostera noltii. A combination of field measurements, an experiment and a spatially explicit model indicated that the mosaic resulted from localized sediment accretion by seagrass followed by selective waterfowl grazing. Hollows were bare in winter, but were rapidly colonized by seagrass during the growth season. Colonized hollows were heavily grazed by brent geese and widgeon in autumn, converting these patches to a bare state again and disrupting sediment accretion by seagrass. In contrast, hummocks were covered by seagrass throughout the year and were rarely grazed, most likely because the waterfowl were not able to employ their preferred but water requiring feeding strategy ('dabbling') here. Our study exemplifies that interactions between ecosystem engineering by a foundation species (seagrass) and consumption (waterfowl grazing) can increase spatial complexity at the landscape level.	[van der Heide, Tjisse; Weerman, Ellen J.; Olff, Han] Univ Groningen, Community & Conservat Ecol Grp, CEES, Groningen, Netherlands; [van Nes, Egbert H.] Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands; [van der Zee, Els M.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Texel, Netherlands; [van der Zee, Els M.] Univ Groningen, Anim Ecol Grp, CEES, Groningen, Netherlands; [Eklof, Johan S.] Univ Gothenburg, Dept Biol & Environm Sci Kristineberg, Fiskebackskil, Sweden; [Eklof, Johan S.] Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden	University of Groningen; Wageningen University & Research; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Groningen; University of Gothenburg; Stockholm University	van der Heide, T (corresponding author), Univ Groningen, Community & Conservat Ecol Grp, CEES, Groningen, Netherlands.	T.van.der.Heide@rug.nl	Eklöf, Johan S/C-7722-2017; Donadi, Serena/I-5092-2019; Eriksson, Britas Klemens/D-8601-2015; van der Heide, Tjisse/M-3000-2013; van Nes, Egbert H/F-2681-2011; Olff, Han/A-8516-2008	Eklöf, Johan S/0000-0001-6936-0926; Donadi, Serena/0000-0002-8920-9630; Eriksson, Britas Klemens/0000-0003-4752-922X; Olff, Han/0000-0003-2154-3576; van Nes, Egbert/0000-0002-6345-104X	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [2008-839]; ZKO program from the Netherlands Organization of Scientific Research (NWO) [839.08.310]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); ZKO program from the Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was financially supported by a post-doctoral grant from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) to JSE (grant no. 2008-839), and by a grant from the ZKO program from the Netherlands Organization of Scientific Research (NWO) to BKE, TVDH, EW, SD and EVDZ (grant no. 839.08.310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SS, 1999, ECOSYSTEMS, V2, P493, DOI 10.1007/s100219900097; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Cromsigt JPGM, 2008, OIKOS, V117, P1444, DOI 10.1111/j.0030-1299.2008.16651.x; Eklof JS, 2012, ECOL LETT, V15, P864, DOI 10.1111/j.1461-0248.2012.01810.x; Eklof JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023229; Eklof JS, 2009, MAR FRESHWATER RES, V60, P1317, DOI 10.1071/MF09008; Eriksson BK, 2010, ECOSYSTEMS, V13, P752, DOI 10.1007/s10021-010-9352-3; Fonseca M, 2002, ECOL APPL, V12, P218, DOI 10.1890/1051-0761(2002)012[0218:MSLPAA]2.0.CO;2; Fox AD, 1996, BIRD STUDY, V43, P257, DOI 10.1080/00063659609461018; Ganter B, 2000, HELGOLAND MAR RES, V54, P63, DOI 10.1007/s101520050003; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones CG, 2010, OIKOS, V119, P1862, DOI 10.1111/j.1600-0706.2010.18782.x; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kefi S, 2007, THEOR POPUL BIOL, V71, P367, DOI 10.1016/j.tpb.2006.09.003; Lin Y, 2010, LANDSCAPE ECOL, V25, P1519, DOI 10.1007/s10980-010-9520-z; MARBA N, 1995, J ECOL, V83, P381, DOI 10.2307/2261592; Maron JL, 1997, SCIENCE, V278, P1619, DOI 10.1126/science.278.5343.1619; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; Moore KA, 2004, J COASTAL RES, P162, DOI 10.2112/SI45-162.1; Nacken N, 2000, HELGOLAND MAR RES, V54, P87, DOI 10.1007/s101520050006; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; PATRIQUIN D G, 1975, Aquatic Botany, V1, P163, DOI 10.1016/0304-3770(75)90021-2; Percival SM, 1997, IBIS, V139, P121, DOI 10.1111/j.1474-919X.1997.tb04511.x; Person BT, 2003, OECOLOGIA, V135, P583, DOI 10.1007/s00442-003-1197-4; Pringle RM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000377; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; ROBBINS BD, 1994, TRENDS ECOL EVOL, V9, P301, DOI 10.1016/0169-5347(94)90041-8; van der Heide T, 2008, OECOLOGIA, V158, P411, DOI 10.1007/s00442-008-1155-2; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; van der Heide T, 2012, SCIENCE, V336, P1432, DOI 10.1126/science.1219973; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; van der Heide T, 2010, ECOLOGY, V91, P362, DOI 10.1890/08-1567.1; van Wesenbeeck BK, 2007, OIKOS, V116, P742, DOI [10.1111/j.2007.0030-1299.15485.x, 10.1111/j.0030-1299.2007.15485.x]; VERMAAT JE, 1987, AQUAT BOT, V28, P287, DOI 10.1016/0304-3770(87)90006-4; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Weerman EJ, 2012, ECOLOGY, V93, P608, DOI 10.1890/11-0625.1; Weerman EJ, 2011, ECOLOGY, V92, P487, DOI 10.1890/10-0270.1; Zipperle AM, 2010, AQUAT BOT, V93, P202, DOI 10.1016/j.aquabot.2010.05.002	42	40	40	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42060	10.1371/journal.pone.0042060	http://dx.doi.org/10.1371/journal.pone.0042060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905115	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100025
J	Sun, W; Peng, CS; Zhao, YY; Li, ZY				Sun, Wei; Peng, Chongsheng; Zhao, Yunyu; Li, Zhiyong			Functional Gene-Guided Discovery of Type II Polyketides from Culturable Actinomycetes Associated with Soft Coral Scleronephthya sp	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; MARINE MICROMONOSPORA; ACROPORA-DIGITIFERA; JADOMYCIN-B; SP-NOV.; BACTERIA; ACTINOBACTERIA; MUCUS; DEPSIPEPTIDE; THIOCORALINE	Compared with the actinomycetes in stone corals, the phylogenetic diversity of soft coral-associated culturable actinomycetes is essentially unexplored. Meanwhile, the knowledge of the natural products from coral-associated actinomycetes is very limited. In this study, thirty-two strains were isolated from the tissue of the soft coral Scleronephthya sp. in the East China Sea, which were grouped into eight genera by 16S rDNA phylogenetic analysis: Micromonospora, Gordonia, Mycobacterium, Nocardioides, Streptomyces, Cellulomonas, Dietzia and Rhodococcus. 6 Micromonospora strains and 4 Streptomyces strains were found to be with the potential for producing aromatic polyketides based on the analysis of KS alpha (ketoacyl-synthase) gene in the PKS II (type II polyketides synthase) gene cluster. Among the 6 Micromonospora strains, angucycline cyclase gene was amplified in 2 strains (A5-1 and A6-2), suggesting their potential in synthesizing angucyclines e. g. jadomycin. Under the guidance of functional gene prediction, one jadomycin B analogue (7b, 13-dihydro-7-O-methyl jadomycin B) was detected in the fermentation broth of Micromonospora sp. strain A5-1. This study highlights the phylogenetically diverse culturable actinomycetes associated with the tissue of soft coral Scleronephthya sp. and the potential of coral-derived actinomycetes especially Micromonospora in producing aromatic polyketides.	[Sun, Wei; Li, Zhiyong] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Marine Biotechnol Lab, Shanghai 200030, Peoples R China; [Sun, Wei; Li, Zhiyong] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Peng, Chongsheng; Zhao, Yunyu] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, W (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Marine Biotechnol Lab, Shanghai 200030, Peoples R China.	zyli@sjtu.edu.cn			National Natural Science Foundation of China [81102417]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81102417) http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen UR, 2010, MAR DRUGS, V8, P399, DOI 10.3390/md8030399; Anzai K, 2008, J BIOSCI BIOENG, V106, P215, DOI 10.1263/jbb.106.215; Baz JP, 1997, J ANTIBIOT, V50, P738, DOI 10.7164/antibiotics.50.738; Blunt JW, 2009, NAT PROD REP, V26, P170, DOI 10.1039/b805113p; Bredholdt H, 2007, ENVIRON MICROBIOL, V9, P2756, DOI 10.1111/j.1462-2920.2007.01387.x; Bull AT, 2007, TRENDS MICROBIOL, V15, P491, DOI 10.1016/j.tim.2007.10.004; Charan RD, 2004, J NAT PROD, V67, P1431, DOI 10.1021/np040042r; DOULL JL, 1994, J IND MICROBIOL, V13, P120, DOI 10.1007/BF01584109; Fiedler HP, 2008, J ANTIBIOT, V61, P158, DOI 10.1038/ja.2008.125; Gontang EA, 2010, APPL ENVIRON MICROB, V76, P2487, DOI 10.1128/AEM.02852-09; Han L, 2010, BIOCHEM SYST ECOL, V38, P243, DOI 10.1016/j.bse.2009.12.030; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Hirsch AM, 2010, SOIL BIOL BIOCHEM, V42, P536, DOI 10.1016/j.soilbio.2009.11.023; Izumi H, 2010, FEMS MICROBIOL LETT, V313, P33, DOI 10.1111/j.1574-6968.2010.02118.x; Jakeman DL, 2005, BIOORG MED CHEM LETT, V15, P1447, DOI 10.1016/j.bmcl.2004.12.082; Jiang SM, 2007, ANTON LEEUW INT J G, V92, P405, DOI 10.1007/s10482-007-9169-z; Khan ST, 2011, ENVIRON MICROBIOL, V13, P391, DOI 10.1111/j.1462-2920.2010.02337.x; Lampert Y, 2008, FEMS MICROBIOL ECOL, V64, P187, DOI 10.1111/j.1574-6941.2008.00458.x; Lampert Y, 2006, FEMS MICROBIOL ECOL, V58, P99, DOI 10.1111/j.1574-6941.2006.00136.x; Li K, 2011, MAR DRUGS, V9, P690, DOI 10.3390/md9050690; Li L, 2011, J NAT PROD, V74, P2089, DOI 10.1021/np2003325; LI XA, 1995, PHYTOPATHOLOGY, V85, P837, DOI 10.1094/Phyto-85-837; Macherla VR, 2007, J NAT PROD, V70, P1454, DOI 10.1021/np0702032; Martin GDA, 2007, J NAT PROD, V70, P1406, DOI 10.1021/np060621r; Metsa-Ketela M, 1999, FEMS MICROBIOL LETT, V180, P1; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; Nithyanand P, 2011, FEMS MICROBIOL LETT, V314, P112, DOI 10.1111/j.1574-6968.2010.02149.x; Nithyanand P, 2010, CURR MICROBIOL, V60, P454, DOI 10.1007/s00284-009-9564-y; Nithyanand P, 2009, FEMS MICROBIOL ECOL, V69, P384, DOI 10.1111/j.1574-6941.2009.00723.x; Olson JB, 2007, INT J SYST EVOL MICR, V57, P1478, DOI 10.1099/ijs.0.64837-0; Ouyang YC, 2011, ANTON LEEUW INT J G, V99, P807, DOI 10.1007/s10482-011-9554-5; PADGITT PJ, 1987, INT J SYST BACTERIOL, V37, P186, DOI 10.1099/00207713-37-3-186; Radjasa OK, 2011, BIOORGAN MED CHEM, V19, P6658, DOI 10.1016/j.bmc.2011.07.017; Rix U, 2004, J AM CHEM SOC, V126, P4496, DOI 10.1021/ja031724o; Romero F, 1997, J ANTIBIOT, V50, P734, DOI 10.7164/antibiotics.50.734; Schneemann I, 2010, APPL ENVIRON MICROB, V76, P3702, DOI 10.1128/AEM.00780-10; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ward AC, 2006, CURR OPIN MICROBIOL, V9, P279, DOI 10.1016/j.mib.2006.04.004; Webster NS, 2001, APPL ENVIRON MICROB, V67, P434, DOI 10.1128/AEM.67.1.434-444.2001; Williams PG, 2005, J ORG CHEM, V70, P6196, DOI 10.1021/jo050511+; WOESE CR, 1983, MICROBIOL REV, V47, P621, DOI 10.1128/MMBR.47.4.621-669.1983; Xiao J, 2011, INT J SYST EVOL MICR, V61, P16, DOI 10.1099/ijs.0.019976-0; Yan XH, 2007, TETRAHEDRON LETT, V48, P5313, DOI 10.1016/j.tetlet.2007.05.096; Yan XH, 2011, J NAT PROD, V74, P175, DOI 10.1021/np100562n; Zhang HT, 2008, ANTON LEEUW INT J G, V93, P241, DOI 10.1007/s10482-007-9196-9; Zhang HT, 2006, INT J SYST EVOL MICR, V56, P2309, DOI 10.1099/ijs.0.64217-0; Zhang HT, 2006, ANTON LEEUW INT J G, V90, P159, DOI 10.1007/s10482-006-9070-1	47	33	38	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42847	10.1371/journal.pone.0042847	http://dx.doi.org/10.1371/journal.pone.0042847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880121	Green Published, Green Submitted, gold			2022-12-27	WOS:000307437900055
J	Ahmad, R; Wolber, W; Eckardt, S; Koch, P; Schmitt, J; Semechkin, R; Geis, C; Heckmann, M; Brustle, O; McLaughlin, JK; Siren, AL; Muller, AM				Ahmad, Ruhel; Wolber, Wanja; Eckardt, Sigrid; Koch, Philipp; Schmitt, Jessica; Semechkin, Ruslan; Geis, Christian; Heckmann, Manfred; Bruestle, Oliver; McLaughlin, John K.; Siren, Anna-Leena; Mueller, Albrecht M.			Functional Neuronal Cells Generated by Human Parthenogenetic Stem Cells	PLOS ONE			English	Article							IN-VITRO; BRAIN-DEVELOPMENT; LINES; DIFFERENTIATION; PLURIPOTENT; BLASTOCYSTS; DERIVATION; MICE; SPECIFICATION; METHYLATION	Parent of origin imprints on the genome have been implicated in the regulation of neural cell type differentiation. The ability of human parthenogenetic (PG) embryonic stem cells (hpESCs) to undergo neural lineage and cell type-specific differentiation is undefined. We determined the potential of hpESCs to differentiate into various neural subtypes. Concurrently, we examined DNA methylation and expression status of imprinted genes. Under culture conditions promoting neural differentiation, hpESC-derived neural stem cells (hpNSCs) gave rise to glia and neuron-like cells that expressed subtype-specific markers and generated action potentials. Analysis of imprinting in hpESCs and in hpNSCs revealed that maternal-specific gene expression patterns and imprinting marks were generally maintained in PG cells upon differentiation. Our results demonstrate that despite the lack of a paternal genome, hpESCs generate proliferating NSCs that are capable of differentiation into physiologically functional neuron-like cells and maintain allele-specific expression of imprinted genes. Thus, hpESCs can serve as a model to study the role of maternal and paternal genomes in neural development and to better understand imprinting-associated brain diseases.	[Ahmad, Ruhel; Schmitt, Jessica; Mueller, Albrecht M.] Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, Ctr Expt Mol Med ZEMM, Wurzburg, Germany; [Wolber, Wanja; Siren, Anna-Leena] Univ Wurzburg, Dept Neurosurg, Wurzburg, Germany; [Eckardt, Sigrid; McLaughlin, John K.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH USA; [Koch, Philipp; Bruestle, Oliver] Univ Bonn, Inst Reconstruct Neurobiol, Life & Brain Ctr, Bonn, Germany; [Koch, Philipp; Bruestle, Oliver] Hertie Fdn, Bonn, Germany; [Geis, Christian] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Heckmann, Manfred] Univ Wurzburg, Dept Physiol, D-8700 Wurzburg, Germany; [Semechkin, Ruslan] Int Stem Cell Corp, Oceanside, CA USA	University of Wurzburg; University of Wurzburg; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Bonn; University of Wurzburg; University of Wurzburg	Ahmad, R (corresponding author), Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, Ctr Expt Mol Med ZEMM, Wurzburg, Germany.	albrecht.mueller@uni-wuerzburg.de	Koch, Philipp/M-1186-2016; Sirén, Anna-Leena/AAE-1374-2019; McLaughlin, Kenneth/E-3648-2011; Koch, Philipp/AAZ-3751-2020	Sirén, Anna-Leena/0000-0002-2217-0081; Koch, Philipp/0000-0003-3713-8786; Heckmann, Manfred/0000-0002-4874-1735	BMBF [01GN0825, 01GN1009B]; IZKF Wurzburg [D-103]; DFG [SFB-TR3 D2]; EU [222943]; Hertie Foundation; German Excellence Initiative to the Graduate School of Life Sciences (GSLS), University of Wurzburg	BMBF(Federal Ministry of Education & Research (BMBF)); IZKF Wurzburg; DFG(German Research Foundation (DFG)); EU(European Commission); Hertie Foundation; German Excellence Initiative to the Graduate School of Life Sciences (GSLS), University of Wurzburg	This work was supported by the BMBF-funded project 01GN0825 and 01GN1009B, the IZKF Wurzburg project D-103, the DFG (SFB-TR3 D2), the EU 7FP project Neurostemcell (#222943) and the Hertie Foundation. RA was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences (GSLS), University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Brevini TA, 2012, STEM CELL REV; Brevini TAL, 2009, STEM CELL REV REP, V5, P340, DOI 10.1007/s12015-009-9086-9; Chen Y, 2012, STEM CELLS DEV, V21, P143, DOI 10.1089/scd.2010.0585; Choi SW, 2010, INT J DEV BIOL, V54, P1755, DOI 10.1387/ijdb.103188sc; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dinger TC, 2008, STEM CELLS, V26, P1474, DOI 10.1634/stemcells.2007-0877; Eckardt S, 2007, GENE DEV, V21, P409, DOI 10.1101/gad.1524207; Eckardt S, 2011, J CLIN INVEST, V121, P623, DOI 10.1172/JCI45377; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Harness JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014499; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Isaev DA, 2012, REGEN MED, V7, P37, DOI [10.2217/RME.11.110, 10.2217/rme.11.110]; Jinno Y, 1996, HUM MOL GENET, V5, P1155, DOI 10.1093/hmg/5.8.1155; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Keverne EB, 1996, DEV BRAIN RES, V92, P91, DOI 10.1016/0165-3806(95)00209-X; Khoureiry R, 2008, J MED GENET, V45, P583, DOI 10.1136/jmg.2008.057943; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lengerke C, 2007, ANN NY ACAD SCI, V1106, P209, DOI 10.1196/annals.1392.011; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lin G, 2007, CELL RES, V17, P999, DOI 10.1038/cr.2007.97; Mai QY, 2007, CELL RES, V17, P1008, DOI 10.1038/cr.2007.102; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Teramura T, 2009, J REPROD DEVELOP, V55, P283, DOI 10.1262/jrd.20146; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turovets N, 2012, CELL TRANSPLANT, V21, P217, DOI 10.3727/096368911X582723; Wilkins JF, 2011, PROG MOL BIOL TRANSL, V101, P401, DOI 10.1016/B978-0-12-387685-0.00013-5; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x	45	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42800	10.1371/journal.pone.0042800	http://dx.doi.org/10.1371/journal.pone.0042800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880113	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000073
J	Muthu, M; Richardson, KA; Sutherland-Smith, AJ				Muthu, Muralidharan; Richardson, Kylie A.; Sutherland-Smith, Andrew J.			The Crystal Structures of Dystrophin and Utrophin Spectrin Repeats: Implications for Domain Boundaries	PLOS ONE			English	Article							ALPHA-ACTININ ROD; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; PLAKIN DOMAIN; MDX MICE; GLYCOPROTEIN COMPLEX; MOLECULAR-GRAPHICS; PROTEIN-STRUCTURE; NUCLEIC-ACIDS; F-ACTIN	Dystrophin and utrophin link the F-actin cytoskeleton to the cell membrane via an associated glycoprotein complex. This functionality results from their domain organization having an N-terminal actin-binding domain followed by multiple spectrin-repeat domains and then C-terminal protein-binding motifs. Therapeutic strategies to replace defective dystrophin with utrophin in patients with Duchenne muscular dystrophy require full-characterization of both these proteins to assess their degree of structural and functional equivalence. Here the high resolution structures of the first spectrin repeats (N-terminal repeat 1) from both dystrophin and utrophin have been determined by x-ray crystallography. The repeat structures both display a three-helix bundle fold very similar to one another and to homologous domains from spectrin, a-actinin and plectin. The utrophin and dystrophin repeat structures reveal the relationship between the structural domain and the canonical spectrin repeat domain sequence motif, showing the compact structural domain of spectrin repeat one to be extended at the C-terminus relative to its previously defined sequence repeat. These structures explain previous in vitro biochemical studies in which extending dystrophin spectrin repeat domain length leads to increased protein stability. Furthermore we show that the first dystrophin and utrophin spectrin repeats have no affinity for F-actin in the absence of other domains.	[Muthu, Muralidharan; Richardson, Kylie A.; Sutherland-Smith, Andrew J.] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand	Massey University	Muthu, M (corresponding author), Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand.	A.J.Sutherland-Smith@massey.ac.nz	Sutherland-Smith, Andrew/F-1813-2011	Sutherland-Smith, Andrew/0000-0001-9485-1428	Massey University; Neurological Foundation of New Zealand; Palmerston North Medical Research Foundation	Massey University; Neurological Foundation of New Zealand; Palmerston North Medical Research Foundation	The authors acknowledge funding of a Massey University Doctoral Scholarship to MM and Neurological Foundation of New Zealand, Palmerston North Medical Research Foundation and Massey University Research Fund grants to AJSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altmann SM, 2002, STRUCTURE, V10, P1085, DOI 10.1016/S0969-2126(02)00808-0; Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; Amann KJ, 1999, J BIOL CHEM, V274, P35375, DOI 10.1074/jbc.274.50.35375; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Banatao DR, 2006, P NATL ACAD SCI USA, V103, P16230, DOI 10.1073/pnas.0607674103; Bhasin N, 2005, J MOL BIOL, V352, P795, DOI 10.1016/j.jmb.2005.07.064; Bhosle RC, 2006, BIOCHEM BIOPH RES CO, V346, P768, DOI 10.1016/j.bbrc.2006.05.192; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BLOCH R J, 1992, Trends in Cell Biology, V2, P186, DOI 10.1016/0962-8924(92)90231-B; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Calvert R, 1996, BIOPHYS J, V71, P1605, DOI 10.1016/S0006-3495(96)79363-3; Choi HJ, 2011, J MOL BIOL, V409, P800, DOI 10.1016/j.jmb.2011.04.046; Clark AR, 2009, HUM MOL GENET, V18, P4791, DOI 10.1093/hmg/ddp442; CLERK A, 1993, HISTOCHEM J, V25, P554; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Certo MG, 2010, HUM MOL GENET, V19, P752, DOI 10.1093/hmg/ddp539; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Henderson DM, 2011, HUM MOL GENET, V20, P2955, DOI 10.1093/hmg/ddr199; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jefferson JJ, 2007, J MOL BIOL, V366, P244, DOI 10.1016/j.jmb.2006.11.036; KAHANA E, 1994, J MOL BIOL, V235, P1271, DOI 10.1006/jmbi.1994.1080; KAHANA E, 1995, BIOCHEMISTRY-US, V34, P8110, DOI 10.1021/bi00025a017; KOENIG M, 1990, J BIOL CHEM, V265, P4560; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Rumeur E, 2003, J BIOL CHEM, V278, P5993, DOI 10.1074/jbc.M207321200; Legardinier S, 2009, J BIOL CHEM, V284, P8822, DOI 10.1074/jbc.M805846200; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menhart N, 2006, BBA-PROTEINS PROTEOM, V1764, P993, DOI 10.1016/j.bbapap.2006.03.017; Mirza A, 2010, BBA-PROTEINS PROTEOM, V1804, P1796, DOI 10.1016/j.bbapap.2010.03.009; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen T M, 1991, J Cell Biol, V115, P1695, DOI 10.1083/jcb.115.6.1695; Pantazatos DP, 1997, J BIOL CHEM, V272, P21052, DOI 10.1074/jbc.272.34.21052; PARRY DAD, 1992, BIOPHYS J, V61, P858, DOI 10.1016/S0006-3495(92)81893-3; Pascual J, 1997, J MOL BIOL, V273, P740, DOI 10.1006/jmbi.1997.1344; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prochniewicz E, 2009, P NATL ACAD SCI USA, V106, P7822, DOI 10.1073/pnas.0812007106; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Rybakova IN, 2005, J BIOL CHEM, V280, P23018, DOI 10.1074/jbc.M502530200; Rybakova IN, 1997, J BIOL CHEM, V272, P28771, DOI 10.1074/jbc.272.45.28771; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Saadat L, 2006, BBA-PROTEINS PROTEOM, V1764, P943, DOI 10.1016/j.bbapap.2006.02.012; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Sonnenberg A, 2007, J MOL BIOL, V368, P1379, DOI 10.1016/j.jmb.2007.02.090; Stone MR, 2005, MOL BIOL CELL, V16, P4280, DOI 10.1091/mbc.E05-02-0112; Sutherland-Smith AJ, 2003, J MOL BIOL, V329, P15, DOI 10.1016/S0022-2836(03)00422-4; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; WINDER SJ, 1995, FEBS LETT, V369, P27, DOI 10.1016/0014-5793(95)00398-S; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamashita K, 2010, BIOCHEM BIOPH RES CO, V391, P812, DOI 10.1016/j.bbrc.2009.11.144; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Zuellig RA, 2000, J CELL BIOCHEM, V77, P418, DOI 10.1002/(SICI)1097-4644(20000601)77:3<418::AID-JCB7>3.0.CO;2-Z	70	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40066	10.1371/journal.pone.0040066	http://dx.doi.org/10.1371/journal.pone.0040066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911693	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600012
J	Tekedereli, I; Alpay, SN; Tavares, CDJ; Cobanoglu, ZE; Kaoud, TS; Sahin, I; Sood, AK; Lopez-Berestein, G; Dalby, KN; Ozpolat, B				Tekedereli, Ibrahim; Alpay, S. Neslihan; Tavares, Clint D. J.; Cobanoglu, Zehra E.; Kaoud, Tamer S.; Sahin, Ibrahim; Sood, Anil K.; Lopez-Berestein, Gabriel; Dalby, Kevin N.; Ozpolat, Bulent			Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer	PLOS ONE			English	Article							MR 100,000 SUBSTRATE; HUMAN GLIOMA-CELLS; PROTEIN-SYNTHESIS; C-MYC; EUKARYOTIC ELONGATION-FACTOR-2; CYCLIN D1; SIGNAL-TRANSDUCTION; IN-SITU; CALMODULIN; SRC	Eukaryotic elongation factor 2 kinase (eEF-2K), through its phosphorylation of elongation factor 2 (eEF2), provides a mechanism by which cells can control the rate of the elongation phase of protein synthesis. The activity of eEF-2K is increased in rapidly proliferating malignant cells, is inhibited during mitosis, and may contribute to the promotion of autophagy in response to anti-cancer therapies. The purpose of this study was to examine the therapeutic potential of targeting eEF-2K in breast cancer tumors. Through the systemic administration of liposomal eEF-2K siRNA (twice a week, i.v. 150 mu g/kg), the expression of eEF-2K was down-regulated in vivo in an orthotopic xenograft mouse model of a highly aggressive triple negative MDA-MB-231 tumor. This targeting resulted in a substantial decrease in eEF2 phosphorylation in the tumors, and led to the inhibition of tumor growth, the induction of apoptosis and the sensitization of tumors to the chemotherapy agent doxorubicin. eEF-2K down-modulation in vitro resulted in a decrease in the expression of c-Myc and cyclin D1 with a concomitant increase in the expression of p27(Kip1). A decrease in the basal activity of c-Src (phospho-Tyr-416), focal adhesion kinase (phospho-Tyr-397), and Akt (phospho-Ser-473) was also detected following eEF-2K down-regulation in MDA-MB-231 cells, as determined by Western blotting. Where tested, similar results were seen in ER-positive MCF-7 cells. These effects were also accompanied by a decrease in the observed invasive phenotype of the MDA-MB-231 cells. These data support the notion that the disruption of eEF-2K expression in breast cancer cells results in the down-regulation of signaling pathways affecting growth, survival and resistance and has potential as a therapeutic approach for the treatment of breast cancer.	[Tekedereli, Ibrahim; Alpay, S. Neslihan; Cobanoglu, Zehra E.; Sahin, Ibrahim; Lopez-Berestein, Gabriel; Ozpolat, Bulent] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Tavares, Clint D. J.; Dalby, Kevin N.] Univ Texas Austin, Grad Program Cell & Mol Biol, Austin, TX 78712 USA; [Kaoud, Tamer S.; Dalby, Kevin N.] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Sood, Anil K.; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Sood, Anil K.; Lopez-Berestein, Gabriel; Ozpolat, Bulent] Univ Texas MD Anderson Canc Ctr, Ctr RNAi & Noncoding RNA, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Tekedereli, I (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	kinases@me.com; bozpolat@mdanderson.org	Dalby, Kevin N/A-1905-2013; Kaoud, Tamer S/C-3618-2019; Sahin, Ibrahim/AAO-1035-2020; Şahin, İbrahim/HHY-8303-2022	Dalby, Kevin N/0000-0001-9272-5129; Kaoud, Tamer S/0000-0003-1298-8725; 	Norman Hackerman Advanced Technology Research Program [003658-0069-2009]; Cancer Prevention and Research Institute of Texas [RP120406]; Welch Foundation [F-1390]; National Institutes of Health [GM59802]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059802] Funding Source: NIH RePORTER	Norman Hackerman Advanced Technology Research Program; Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by grants from The Norman Hackerman Advanced Technology Research Program (003658-0069-2009), The Cancer Prevention and Research Institute of Texas (RP120406) to BO and KND, the Welch Foundation (F-1390) and the National Institutes of Health to KND (GM59802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 1998, LANCET, V352, P930; Abramczyk O, 2011, PROTEIN EXPRES PURIF, V79, P237, DOI 10.1016/j.pep.2011.05.005; Akar U, 2008, AUTOPHAGY, V4, P669, DOI 10.4161/auto.6083; Akar U, 2010, MOL CANCER THER, V9, P1180, DOI 10.1158/1535-7163.MCT-09-1025; Alkarain A, 2004, J MAMMARY GLAND BIOL, V9, P67, DOI 10.1023/B:JOMG.0000023589.00994.5e; Arora S, 2005, CANCER RES, V65, P3806, DOI 10.1158/0008-5472.CAN-04-4036; BAGAGLIO DM, 1994, CELL GROWTH DIFFER, V5, P1403; Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Boyce M, 2008, CELL DEATH DIFFER, V15, P589, DOI 10.1038/sj.cdd.4402296; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; CARLBERG U, 1991, BIOCHEM BIOPH RES CO, V180, P1372, DOI 10.1016/S0006-291X(05)81347-6; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; CHAFOULEAS JG, 1981, P NATL ACAD SCI-BIOL, V78, P996, DOI 10.1073/pnas.78.2.996; Chen CY, 2011, CANCER SCI, V102, P1582, DOI 10.1111/j.1349-7006.2011.01975.x; Chen Z, 2011, J BIOL CHEM; Cheng Y, 2011, CANCER RES, V71, P2654, DOI 10.1158/0008-5472.CAN-10-2889; Cheng Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009715; Cobleigh MA, 2011, SEMIN ONCOL, V38, pS11, DOI 10.1053/j.seminoncol.2011.04.005; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; DAKSIS JI, 1994, ONCOGENE, V9, P3635; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Devkota AK, 2012, BIOCHEMISTRY; Devkota AK, 2012, BIOCHEMISTRY-US, V51, P2100, DOI 10.1021/bi201787p; ENGEL LW, 1978, CANCER RES, V38, P4327; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gildish I, 2012, LEARN MEMORY, V19, P116, DOI 10.1101/lm.023937.111; GILLETT C, 1994, CANCER RES, V54, P1812; Hait WN, 2006, AUTOPHAGY, V2, P294, DOI 10.4161/auto.2857; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Liao D. Joshua, 2007, Critical Reviews in Oncogenesis, V13, P93; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moon DO, 2009, ARCH PHARM RES, V32, P1351, DOI 10.1007/s12272-009-2002-7; NAIRN AC, 1985, P NATL ACAD SCI USA, V82, P7939, DOI 10.1073/pnas.82.23.7939; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Nakamura J, 2009, INT J ONCOL, V34, P1181, DOI 10.3892/ijo_00000246; NILSSON A, 1995, BBA-MOL CELL RES, V1268, P263, DOI 10.1016/0167-4889(95)00084-6; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ozpolat B, 2010, J INTERN MED, V267, P44, DOI 10.1111/j.1365-2796.2009.02191.x; Ozpolat B, 2010, P AM ASS CANC RES AA; Ozpolat B, 2007, MOL CANCER RES, V5, P95, DOI 10.1158/1541-7786.MCR-06-0125; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; PARKIN N, 1988, MOL CELL BIOL, V8, P2875, DOI 10.1128/MCB.8.7.2875; Parmer TG, 1999, BRIT J CANCER, V79, P59, DOI 10.1038/sj.bjc.6690012; Parmer TG, 1997, CELL GROWTH DIFFER, V8, P327; Plumb JA, 1999, METH MOLEC MED, V28, P17, DOI 10.1385/1-59259-687-8:17; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Rosenwald IB, 1995, CELL PROLIFERAT, V28, P631, DOI 10.1111/j.1365-2184.1995.tb00050.x; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Shahid R, 2010, BIOCHEMISTRY-US, V49, P8300, DOI 10.1021/bi100957h; Shaw Leslie M., 2004, V294, P97; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Spagnou S, 2004, BIOCHEMISTRY-US, V43, P13348, DOI 10.1021/bi048950a; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Tavares CDJ, 2012, BIOCHEMISTRY-US, V51, P2232, DOI 10.1021/bi201788e; Weatherill DB, 2011, J NEUROCHEM, V117, P841, DOI 10.1111/j.1471-4159.2011.07251.x; Wilson GR, 2006, BRIT J CANCER, V95, P1410, DOI 10.1038/sj.bjc.6603444; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Yang J, 2001, CANCER RES, V61, P4010; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Zhang L, 2011, ACTA PHARMACOL SIN, V32, P361, DOI 10.1038/aps.2010.213; Zhang Y, 2011, BIOCHEM BIOPH RES CO, V414, P129, DOI 10.1016/j.bbrc.2011.09.038	72	86	90	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41171	10.1371/journal.pone.0041171	http://dx.doi.org/10.1371/journal.pone.0041171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911754	Green Submitted, gold, Green Published			2022-12-27	WOS:000306644600050
J	Thio, M; Kormelink, TG; Fischer, MJ; Blokhuis, BR; Nijkamp, FP; Redegeld, FA				Thio, Marco; Kormelink, Tom Groot; Fischer, Marcel J.; Blokhuis, Bart R.; Nijkamp, Frans P.; Redegeld, Frank A.			Antigen Binding Characteristics of Immunoglobulin Free Light Chains: Crosslinking by Antigen is Essential to Induce Allergic Inflammation	PLOS ONE			English	Article							STEM-CELL FACTOR; ANTIBODY-ACTIVITY; MAST-CELLS; RECEPTOR; HEAVY; DIMER; RECOGNITION	Beside the production of complete immunoglobulins IgG, IgE, IgA, IgM and IgD, consisting of tetrameric heterodimers of immunoglobulin heavy and light chains, B cells also secrete immunoglobulin free light chains (Ig-fLC). Previous studies showed that Ig-fLCs are able to induce immediate hypersensitivity reactions. It is apparent that recognition and binding of antigen are crucial steps in the onset of these inflammatory responses. In this study, the binding characteristics of Ig-fLC to antigen were further investigated using various biochemical approaches. In addition, we investigated whether antigen-mediated crosslinking of Ig-fLC is required to initiate allergic skin inflammation in vivo. Our study shows that binding of Ig-fLCs to antigen can be measured with different experimental setups. Surface plasmon resonance analysis showed real-time antigen binding characteristics. Specific antigen binding by Ig-fLCs was further detected using immunoblotting and ELISA. Using the ELISA-based assay, a binding affinity of 76.9 +/- 3.8 nM was determined for TNP-specific Ig-fLC. Antigen-induced ear swelling in mice passively sensitized with trinitrophenol-specific Ig-fLC was inhibited when multivalent antigen was combined with excess of monovalent antigen during challenge. We conclude that Ig-fLCs are able to interact with antigen, a prerequisite for antigen-specific cellular activation. In analogy to antigen-specific Fc receptor-induced mast cell activation, crosslinking of Ig-fLCs is necessary to initiate a local allergic response.	[Thio, Marco; Kormelink, Tom Groot; Blokhuis, Bart R.; Nijkamp, Frans P.; Redegeld, Frank A.] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands; [Fischer, Marcel J.] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Div Med Chem, Utrecht, Netherlands	Utrecht University; Utrecht University	Thio, M (corresponding author), Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands.	f.a.m.redegeld@uu.nl	Redegeld, Frank A/O-6534-2016	Redegeld, Frank A/0000-0001-8830-7960	Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University	Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University	This study has been financially supported by the Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Contini C, 2000, J NEUROIMMUNOL, V108, P221, DOI 10.1016/S0165-5728(00)00280-0; Holowka D, 2007, IMMUNOL REV, V217, P269, DOI 10.1111/j.1600-065X.2007.00517.x; Jokiranta TS, 1999, J IMMUNOL, V163, P4590; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Karimi K, 2000, EXP HEMATOL, V28, P626, DOI 10.1016/S0301-472X(00)00161-2; Karimi K, 1999, EXP HEMATOL, V27, P654, DOI 10.1016/S0301-472X(98)00083-6; Kraneveld AD, 2005, P NATL ACAD SCI USA, V102, P1578, DOI 10.1073/pnas.0406808102; LEDBETTER JA, 1987, MOL IMMUNOL, V24, P1255, DOI 10.1016/0161-5890(87)90119-2; Lu JH, 2011, P NATL ACAD SCI USA, V108, P4974, DOI 10.1073/pnas.1018369108; MAHANA W, 1994, SCAND J IMMUNOL, V39, P107, DOI 10.1111/j.1365-3083.1994.tb03347.x; MASAT L, 1994, P NATL ACAD SCI USA, V91, P893, DOI 10.1073/pnas.91.3.893; Matsumori A, 2010, CIRC RES, V106, P1533, DOI 10.1161/CIRCRESAHA.110.218438; METZGER H, 1994, ADV EXP MED BIOL, V365, P175; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Mortaz E, 2005, BIOCHEM PHARMACOL, V69, P1049, DOI 10.1016/j.bcp.2004.12.018; Nakano T, 2006, CLIN BIOCHEM, V39, P955, DOI 10.1016/j.clinbiochem.2006.05.008; Nakano T, 2011, CLIN CHIM ACTA, V412, P843, DOI 10.1016/j.cca.2011.03.007; Nishimura Eisaku, 1999, Human Antibodies, V9, P111; Noel D, 1996, J IMMUNOL METHODS, V193, P177, DOI 10.1016/0022-1759(96)00043-9; PAINTER RG, 1972, BIOCHEMISTRY-US, V11, P1338, DOI 10.1021/bi00758a002; PAINTER RG, 1972, BIOCHEMISTRY-US, V11, P1327, DOI 10.1021/bi00758a001; Pomes A, 2002, EUR J BIOCHEM, V269, P3086, DOI 10.1046/j.1432-1033.2002.02990.x; Redegeld FA, 2002, NAT MED, V8, P694, DOI 10.1038/nm722; Rijnierse A, 2010, J IMMUNOL, V185, P653, DOI 10.4049/jimmunol.0901129; SCHECHTER I, 1976, BIOCHEMISTRY-US, V15, P2785, DOI 10.1021/bi00658a013; Schouten B, 2010, J ALLERGY CLIN IMMUN, V125, P1308, DOI 10.1016/j.jaci.2010.02.039; Song MK, 2000, BIOCHEM BIOPH RES CO, V268, P390, DOI 10.1006/bbrc.2000.2134; SUN M, 1994, J BIOL CHEM, V269, P734; Thio M, 2008, TRENDS PHARMACOL SCI, V29, P170, DOI 10.1016/j.tips.2008.01.004; VALENTA R, 1991, J ALLERGY CLIN IMMUN, V88, P889, DOI 10.1016/0091-6749(91)90245-J; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P11251, DOI 10.1073/pnas.91.23.11251; YOO TJ, 1967, SCIENCE, V157, P707, DOI 10.1126/science.157.3789.707	32	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40986	10.1371/journal.pone.0040986	http://dx.doi.org/10.1371/journal.pone.0040986			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911727	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600032
J	Kang, WH; Seo, JK; Chung, BN; Kim, KH; Kang, BC				Kang, Won-Hee; Seo, Jang-Kyun; Chung, Bong Nam; Kim, Kook-Hyung; Kang, Byoung-Cheorl			Helicase Domain Encoded by Cucumber mosaic virus RNA1 Determines Systemic Infection of Cmr1 in Pepper	PLOS ONE			English	Article							TO-CELL MOVEMENT; LONG-DISTANCE MOVEMENT; SATELLITE RNA; COAT PROTEIN; 1A PROTEIN; METHYLTRANSFERASE DOMAIN; HYPERSENSITIVE RESPONSE; ZUCCHINI SQUASH; VIRAL SPREAD; 3A PROTEIN	The Cmr1 gene in peppers confers resistance to Cucumber mosaic virus isolate-P0 (CMV-P0). Cmr1 restricts the systemic spread of CMV strain-Fny (CMV-Fny), whereas this gene cannot block the spread of CMV isolate-P1 (CMV-P1) to the upper leaves, resulting in systemic infection. To identify the virulence determinant of CMV-P1, six reassortant viruses and six chimeric viruses derived from CMV-Fny and CMV-P1 cDNA clones were used. Our results demonstrate that the C-terminus of the helicase domain encoded by CMV-P1 RNA1 determines susceptibility to systemic infection, and that the helicase domain contains six different amino acid substitutions between CMV-Fny and CMV-P1. To identify the key amino acids of the helicase domain determining systemic infection with CMV-P1, we then constructed amino acid substitution mutants. Of the mutants tested, amino acid residues at positions 865, 896, 957, and 980 in the 1a protein sequence of CMV-P1 affected the systemic infection. Virus localization studies with GFP-tagged CMV clones and in situ localization of virus RNA revealed that these four amino acid residues together form the movement determinant for CMV-P1 movement from the epidermal cell layer to mesophyll cell layers. Quantitative real-time PCR revealed that CMV-P1 and a chimeric virus with four amino acid residues of CMV-P1 accumulated more genomic RNA in inoculated leaves than did CMV-Fny, indicating that those four amino acids are also involved in virus replication. These results demonstrate that the C-terminal region of the helicase domain is responsible for systemic infection by controlling virus replication and cell-to-cell movement. Whereas four amino acids are responsible for acquiring virulence in CMV-Fny, six amino acid (positions at 865, 896, 901, 957, 980 and 993) substitutions in CMV-P1 were required for complete loss of virulence in 'Bukang'.	[Kang, Won-Hee; Kang, Byoung-Cheorl] Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea; [Kang, Won-Hee; Kang, Byoung-Cheorl] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Seo, Jang-Kyun; Kim, Kook-Hyung] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Chung, Bong Nam] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Suwon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Kang, WH (corresponding author), Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea.	bk54@snu.ac.kr	Kang, Byoung-Cheorl/Q-6174-2019		Vegetable Breeding Research Center through Agriculture Research Center (ARC) from Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [0636-20110005]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0005310]	Vegetable Breeding Research Center through Agriculture Research Center (ARC) from Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant (code: 0636-20110005) from the Vegetable Breeding Research Center through Agriculture Research Center (ARC) program from Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea and by Basic Science Research Program though the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0005310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Chaim A, 2001, THEOR APPL GENET, V102, P1213, DOI 10.1007/s001220100581; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Canto T, 1997, VIROLOGY, V237, P237, DOI 10.1006/viro.1997.8804; Canto T, 2001, J VIROL, V75, P9114, DOI 10.1128/JVI.75.19.9114-9120.2001; Canto T, 1999, VIROLOGY, V265, P74, DOI 10.1006/viro.1999.0028; Caranta C, 1997, THEOR APPL GENET, V94, P431, DOI 10.1007/s001220050433; Caranta C, 2002, THEOR APPL GENET, V104, P586, DOI 10.1007/s001220100753; Chu MH, 1997, MOL PLANT MICROBE IN, V10, P472, DOI 10.1094/MPMI.1997.10.4.472; Ding SW, 1996, P NATL ACAD SCI USA, V93, P7470, DOI 10.1073/pnas.93.15.7470; DING SW, 1995, EMBO J, V14, P5762, DOI 10.1002/j.1460-2075.1995.tb00265.x; DING SW, 1994, VIROLOGY, V198, P593, DOI 10.1006/viro.1994.1071; DIVEKI Z, 2004, MOL PLANT MICROBE IN, V17, P837; DUFOUR O, 1989, CAN J BOT, V67, P655, DOI 10.1139/b89-088; Eggenberger AL, 2008, MOL PLANT MICROBE IN, V21, P931, DOI 10.1094/MPMI-21-7-0931; Feng JL, 2006, ACTA BIOCH BIOPH SIN, V38, P669, DOI [10.1111/j.1745-7270.2006.00216.x, 10.1111/J.1745-7270.2006.00216.x]; GALON A, 1994, VIROLOGY, V205, P280, DOI 10.1006/viro.1994.1644; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Grube RC, 2000, PLANT DIS, V84, P885, DOI 10.1094/PDIS.2000.84.8.885; Guo HS, 2002, EMBO J, V21, P398, DOI 10.1093/emboj/21.3.398; Havelda Z, 2000, PLANT CELL, V12, P1975, DOI 10.1105/tpc.12.10.1975; HAYES RJ, 1990, CELL, V63, P363, DOI 10.1016/0092-8674(90)90169-F; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; 이미연, 2006, The Plant Pathology Journal, V22, P265; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kang WH, 2010, THEOR APPL GENET, V120, P1587, DOI 10.1007/s00122-010-1278-9; Kaplan IB, 1997, VIROLOGY, V230, P343, DOI 10.1006/viro.1997.8468; Karasawa A, 1999, PHYTOPATHOLOGY, V89, P1186, DOI 10.1094/PHYTO.1999.89.12.1186; Kim CH, 1997, EMBO J, V16, P4060, DOI 10.1093/emboj/16.13.4060; Kim MJ, 2008, J VIROL, V82, P4823, DOI 10.1128/JVI.02518-07; Kim MJ, 2006, J GEN VIROL, V87, P3425, DOI 10.1099/vir.0.82252-0; Kim MJ, 2006, BIOCHEM BIOPH RES CO, V340, P228, DOI 10.1016/j.bbrc.2005.11.178; Kim MJ, 2005, PLANT MOL BIOL, V59, P981, DOI 10.1007/s11103-005-2619-y; LAKSHMAN DK, 1985, PHYTOPATHOLOGY, V75, P758, DOI 10.1094/Phyto-75-758; Lapidot M, 1997, PLANT DIS, V81, P185, DOI 10.1094/PDIS.1997.81.2.185; Leach JE, 2001, ANNU REV PHYTOPATHOL, V39, P187, DOI 10.1146/annurev.phyto.39.1.187; Li QB, 2001, MOL PLANT MICROBE IN, V14, P378, DOI 10.1094/MPMI.2001.14.3.378; MCGARVEY P, 1995, J GEN VIROL, V76, P2257, DOI 10.1099/0022-1317-76-9-2257; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; Roossinck MJ, 1997, J VIROL, V71, P608, DOI 10.1128/JVI.71.1.608-612.1997; ROOSSINCK MJ, 1990, MOL PLANT MICROBE IN, V3, P188, DOI 10.1094/MPMI-3-188; ROZANOV MN, 1992, J GEN VIROL, V73, P2129, DOI 10.1099/0022-1317-73-8-2129; Ryu KH, 1998, MOL PLANT MICROBE IN, V11, P351, DOI 10.1094/MPMI.1998.11.5.351; Salanki K, 2007, VIROLOGY, V358, P109, DOI 10.1016/j.virol.2006.08.014; Seo JK, 2009, VIROLOGY, V383, P248, DOI 10.1016/j.virol.2008.10.033; Shi BJ, 2002, MOL PLANT MICROBE IN, V15, P947, DOI 10.1094/MPMI.2002.15.9.947; Soards AJ, 2002, MOL PLANT MICROBE IN, V15, P647, DOI 10.1094/MPMI.2002.15.7.647; Stamova BS, 2000, THEOR APPL GENET, V101, P527, DOI 10.1007/s001220051512; Takahashi Hideki, 2000, Journal of General Plant Pathology, V66, P335, DOI 10.1007/PL00012975; Takeshita M, 2004, VIROLOGY, V328, P45, DOI 10.1016/j.virol.2004.06.046; Takeshita M, 2001, ARCH VIROL, V146, P697, DOI 10.1007/s007050170140; Takeshita M, 2012, MOL PLANT MICROBE IN, V25, P18, DOI 10.1094/MPMI-06-11-0170; Takeshita M, 2009, VIROLOGY, V389, P59, DOI 10.1016/j.virol.2009.04.010; Valkonen JPT, 1999, THEOR APPL GENET, V99, P996, DOI 10.1007/s001220051407; Wong SM, 1999, MOL PLANT MICROBE IN, V12, P628, DOI 10.1094/MPMI.1999.12.7.628; Xu P, 2000, PLANT CELL, V12, P1079, DOI 10.1105/tpc.12.7.1079; Yamaguchi N, 2005, J GEN VIROL, V86, P2359, DOI 10.1099/vir.0.81059-0; Yeom SI, 2011, MOL PLANT MICROBE IN, V24, P671, DOI 10.1094/MPMI-08-10-0183; Ziebell H, 2007, J GEN VIROL, V88, P2862, DOI 10.1099/vir.0.83138-0	59	32	33	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43136	10.1371/journal.pone.0043136	http://dx.doi.org/10.1371/journal.pone.0043136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905216	gold, Green Submitted, Green Published			2022-12-27	WOS:000307823600050
J	Blijdorp, K; van den Heuvel-Eibrink, MM; Pieters, R; Boot, AM; Delhanty, PJD; van der Lely, AJ; Neggers, SJCMM				Blijdorp, Karin; van den Heuvel-Eibrink, Marry M.; Pieters, Rob; Boot, Annemieke M.; Delhanty, Patric J. D.; van der Lely, Aart-Jan; Neggers, Sebastian J. C. M. M.			Obesity Is Underestimated Using Body Mass Index and Waist-Hip Ratio in Long-Term Adult Survivors of Childhood Cancer	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MINERAL DENSITY; X-RAY ABSORPTIOMETRY; INSULIN-RESISTANCE; METABOLIC SYNDROME; FAT; GROWTH; FATNESS; RISK	Objective: Obesity, represented by high body mass index (BMI), is a major complication after treatment for childhood cancer. However, it has been shown that high total fat percentage and low lean body mass are more reliable predictors of cardiovascular morbidity. In this study longitudinal changes of BMI and body composition, as well as the value of BMI and waist-hip ratio representing obesity, were evaluated in adult childhood cancer survivors. Methods: Data from 410 survivors who had visited the late effects clinic twice were analyzed. Median follow-up time was 16 years (interquartile range 11-21) and time between visits was 3.2 years (2.9-3.6). BMI was measured and body composition was assessed by dual X-ray absorptiometry (DXA, Lunar Prodigy; available twice in 182 survivors). Data were compared with healthy Dutch references and calculated as standard deviation scores (SDS). BMI, waist-hip ratio and total fat percentage were evaluated cross-sectionally in 422 survivors, in who at least one DXA scan was assessed. Results: BMI was significantly higher in women, without significant change over time. In men BMI changed significantly with time (Delta SDS = 0.19, P<0.001). Percentage fat was significantly higher than references in all survivors, with the highest SDS after cranial radiotherapy (CRT) (mean SDS 1.73 in men, 1.48 in women, P<0.001). Only in men, increase in total fat percentage was significantly higher than references (Delta SDS = 0.22, P<0.001). Using total fat percentage as the gold standard, 65% of female and 42% of male survivors were misclassified as non-obese using BMI. Misclassification of obesity using waist-hip ratio was 40% in women and 24% in men. Conclusions: Sixteen years after treatment for childhood cancer, the increase in BMI and total fat percentage was significantly greater than expected, especially after CRT. This is important as we could show that obesity was grossly underestimated using BMI and waist-hip ratio.	[Blijdorp, Karin; van den Heuvel-Eibrink, Marry M.; Pieters, Rob; Neggers, Sebastian J. C. M. M.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Blijdorp, Karin; van der Lely, Aart-Jan; Neggers, Sebastian J. C. M. M.] Erasmus Univ, Dept Med, Endocrinol Sect, Med Ctr, Rotterdam, Netherlands; [Boot, Annemieke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Endocrinol, NL-9713 AV Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Blijdorp, K (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands.	k.blijdorp@erasmusmc.nl						Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Bjorntorp P, 1997, NUTRITION, V13, P795, DOI 10.1016/S0899-9007(97)00191-3; Boot AM, 2010, BONE, V46, P336, DOI 10.1016/j.bone.2009.10.003; Brouwer CAJ, 2007, CRIT REV ONCOL HEMAT, V63, P32, DOI 10.1016/j.critrevonc.2007.01.007; Brouwer CA, 2011, SUPPORT CARE CANC; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Garmey EG, 2008, J CLIN ONCOL, V26, P4639, DOI 10.1200/JCO.2008.16.3527; Hazem A, 2012, EUR J ENDOCRINOL, V166, P13, DOI 10.1530/EJE-11-0558; Health BNIo, 2000, NIH PUBLICATION; Janiszewski PM, 2007, J CLIN ENDOCR METAB, V92, P3816, DOI 10.1210/jc.2006-2178; Jarfelt M, 2005, EUR J ENDOCRINOL, V153, P81, DOI 10.1530/eje.1.01931; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; Marinovic D, 2005, PEDIATRICS, V116, pE102, DOI 10.1542/peds.2004-1838; Nysom K, 2003, MED PEDIATR ONCOL, V40, P239, DOI 10.1002/mpo.10260; Oeffinger KC, 2003, J CLIN ONCOL, V21, P1359, DOI 10.1200/JCO.2003.06.131; PAGANO L, 1994, INT J CLIN LAB RES, V24, P117, DOI 10.1007/BF02593912; Paradisi G, 1999, DIABETES CARE, V22, P1310, DOI 10.2337/diacare.22.8.1310; Ries L., 2005, SEER CANC STAT REV 1; Sardinha LB, 2000, METABOLISM, V49, P1379, DOI [10.1053/meta.2000.17716, 10.1053/meta.2000.7716]; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Simone J.V., 2003, CHILDHOOD CANC SURVI; van Beek RD, 2006, PEDIATR BLOOD CANCER, V46, P88, DOI 10.1002/pbc.20437; van der Sluis IM, 2000, MED PEDIATR ONCOL, V35, P415, DOI 10.1002/1096-911X(20001001)35:4<415::AID-MPO4>3.3.CO;2-0; van der Sluis IM, 2002, ARCH DIS CHILD, V87, P341, DOI 10.1136/adc.87.4.341; van Waas M, 2010, ANN ONCOL, V21, P1121, DOI 10.1093/annonc/mdp414; van Waas M, 2010, J PEDIAT HEMATOL ONC, V32, P171, DOI 10.1097/MPH.0b013e3181d419c3; VANDONGENMELMAN JEWM, 1995, PEDIATR RES, V38, P86, DOI 10.1203/00006450-199507000-00015; Warner JT, 1997, ARCH DIS CHILD, V76, P298, DOI 10.1136/adc.76.4.298	29	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43269	10.1371/journal.pone.0043269	http://dx.doi.org/10.1371/journal.pone.0043269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905245	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800069
J	Carbonara, S; Bruno, G; Di Ciaula, G; Pantaleo, AD; Angarano, G; Monno, L				Carbonara, Sergio; Bruno, Giuseppe; Di Ciaula, Giuseppe; Pantaleo, Anna Donata; Angarano, Gioacchino; Monno, Laura			Limiting Severe Outcomes and Impact on Intensive Care Units of Moderate-Intermediate 2009 Pandemic Influenza: Role of Infectious Diseases Units	PLOS ONE			English	Article							H1N1 INFLUENZA; RISK-FACTORS; BACTERIAL PNEUMONIA; A(H1N1) INFECTION; HOSPITALIZATION; VIRUS; CLARITHROMYCIN; MACROLIDES; DEATH	Purpose: The rate of severe outcomes of patients with 2009 pandemic (A/H1N1) influenza (2009pI) hospitalized in non-intensive care units (ICUs) has not been defined thus far. This study aims to assess the efficacy of the management of patients with influenza-like illness (ILI) of moderate intermediate severity in an infectious diseases unit (IDU) during the first wave of 2009pI and its influence on the burden of ICUs. Methods: All patients hospitalized from October 27, 2009, to February 5, 2010, with ILI were included in this prospective observational study. The IDU was organized and the staff was trained to provide intermediate care; patients were transferred to the ICU only if they required invasive ventilation, extracorporeal membrane oxygenation, or advanced cardiovascular support. Demographic data, clinical presentation, coexisting medical conditions, and laboratory and radiological findings were recorded and analyzed, as well as treatment and outcome data. Results: Overall, 108 patients (median age 36 years [IQR 27-54], 57.4% males) including 66.7% with >= 1 risk factor for severe influenza, 47.2% with confirmed 2009pI by RT-PCR and 63.9% with pneumonia, were enrolled in the study. All subjects received intravenous fluids and 83.3% were administered oseltamivir, 96.3% antibacterials, 19.4% oxygen therapy without ventilatory support, and 10.2% non-invasive ventilation. A total of 106 (98.1%) subjects were discharged after a 6-day median hospital stay [IQR 4-9]. Two patients (1.9%) were transferred to the ICU. There were no deaths. Conclusions: These results suggest that the aggressive treatment of patients with moderate intermediate severity 2009 pandemic ILI in non-ICU wards may result in a low rate of severe outcomes and brief hospitalization. IDUs, if properly organized for intermediate care, may efficiently provide correct disease management, in addition to complying with infection control requirements, thus reducing the burden of the pandemic on ICUs. Further studies are warranted to evaluate the outcome of patients with moderate intermediate 2009pI in different non-ICU settings.	[Carbonara, Sergio; Bruno, Giuseppe; Di Ciaula, Giuseppe; Pantaleo, Anna Donata; Angarano, Gioacchino; Monno, Laura] Univ Bari, Clin Infect Dis, Sch Med & Surg, Bari, Italy	Universita degli Studi di Bari Aldo Moro	Carbonara, S (corresponding author), Univ Bari, Clin Infect Dis, Sch Med & Surg, Bari, Italy.	s_carbonara@yahoo.it	Carbonara, Sergio/AAE-7283-2022	Carbonara, Sergio/0000-0001-6757-2458; ANGARANO, Gioacchino/0000-0003-3207-7523; MONNO, Laura/0000-0002-2713-4258				Agenzia Italiana del Farmaco, 2008, GAZZETTA UFFICI 0331, V76, P68; Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Bassetti M, 2011, CLIN MICROBIOL INFEC, V17, P247, DOI 10.1111/j.1469-0691.2010.03275.x; Baudouin S, 2002, THORAX, V57, P192; Bermejo-Martin JF, 2009, J INFECT DEV COUNTR, V3, P159, DOI 10.3855/jidc.18; British Thoracic Society Royal College of Physicians London Intensive Care Society, 2008, US NON VENT MAN PAT; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Centers for Disease Control and Prevention (CDC), 2009, UPD CDC EST 2009 H1N; Charles PGP, 2009, MED J AUSTRALIA, V191, P517, DOI 10.5694/j.1326-5377.2009.tb02922.x; ECDC, 2010, 2009 H1N1 PAND EUR R; European Centre for Disease Prevention and Control (ECDC), 2010, INFL SURV EUR 2008 0; Gilca R, 2011, INFLUENZA OTHER RESP, V5, P247, DOI 10.1111/j.1750-2659.2011.00204.x; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Leelarasamee Amorn, 2008, Journal of the Medical Association of Thailand, V91, P924; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Louie J., 2009, Morbidity and Mortality Weekly Report, V58, P1071; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mereckiene J, 2008, Euro Surveill, V13; Ministero del Lavoro della Salute e delle Politiche Sociali Dipartimento della prevenzione e della comunicazione Direzione generale della prevenzione sanitaria Ufficio V-Malattie Infettive e Profilassi Internazionale Roma, 2009, 0034102 MIN LAV SAL; Ministero della Salute, 2010, CIRC INFL 2010 2011; Miyamoto D, 2008, BIOL PHARM BULL, V31, P217, DOI 10.1248/bpb.31.217; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; National Center for Immunization and Respiratory Diseases CDC, 2009, MMWR Recomm Rep, V58, P1; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Ninomiya Keiko, 2003, Jpn J Antibiot, V56 Suppl A, P84; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; de la Tabla VO, 2010, J CLIN MICROBIOL, V48, P3492, DOI 10.1128/JCM.01105-10; Parnham Michael J, 2005, Curr Opin Infect Dis, V18, P125, DOI 10.1097/01.qco.0000160901.71813.fe; Poeppl W, 2011, INFECTION, V39, P341, DOI 10.1007/s15010-011-0121-9; Santa-Olalla Peralta P, 2010, EUROSURVEILLANCE, V15; Sato K, 1998, AM J RESP CRIT CARE, V157, P853, DOI 10.1164/ajrccm.157.3.9703098; SCHWARZMANN SW, 1971, ARCH INTERN MED, V127, P1037, DOI 10.1001/archinte.127.6.1037; STAUDINGER T, 2010, WIEN KLIN WOCHENSCHR, V122, P3, DOI DOI 10.1007/S00508-010-1304-6; Tsigrelis C, 2010, INFECTION, V38, P237, DOI 10.1007/s15010-010-0009-0; Tsurita M, 2001, J PHARMACOL EXP THER, V298, P362; U. K. Department of Health (DH), 2009, PAND H1N1 2009 INFL; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; White DB, 2009, JAMA-J AM MED ASSOC, V302, P1905, DOI 10.1001/jama.2009.1539; World Health Organization, 2009, HUM INF PAND H1N1 20; World Health Organization, 2009, CLIN MAN HUM INF PAN; World Health Organization (2010), 2009, EV PAND H1N1 2009 AP; World Health Organization (WHO), GUID PHARM MAN PAN 1; Yang SG, 2012, PLOS ONE, V71; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	53	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42940	10.1371/journal.pone.0042940	http://dx.doi.org/10.1371/journal.pone.0042940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905188	Green Published, gold			2022-12-27	WOS:000307500800031
J	Francois, S; D'Orlando, C; Fatone, T; Touvier, T; Pessina, P; Meneveri, R; Brunelli, S				Francois, Stephanie; D'Orlando, Cristina; Fatone, Tiziana; Touvier, Thierry; Pessina, Patrizia; Meneveri, Raffaella; Brunelli, Silvia			Necdin Enhances Myoblasts Survival by Facilitating the Degradation of the Mediator of Apoptosis CCAR1/CARP1	PLOS ONE			English	Article							GROWTH SUPPRESSOR NECDIN; CELL-CYCLE; REGULATORY PROTEIN-1; SKELETAL-MUSCLE; NITRIC-OXIDE; TRANSCRIPTION; RING; INTERACTS; PAX7; MAGE	Regeneration of muscle fibers, lost during pathological muscle degeneration or after injuries, is sustained by the production of new myofibers by means of the satellite cells. Survival of the satellite cells is a critical requirement for efficient muscle reconstitution. Necdin, a member of the MAGE proteins family, is expressed in satellite cell-derived myogenic precursors during perinatal growth and in the adult upon activation during muscle regeneration, where it plays an important role both in myoblast differentiation and survival. We show here that necdin exerts its pro-survival activity by counteracting the action of the pro-apoptotic protein Cell Cycle Apoptosis Regulatory Protein (CCAR1/CARP1) that we have identified as a new molecular interactor of necdin by two-hybrid screening. Necdin is responsible for the maintenance of CCAR1 protein levels, by implementing its ubiquitination and degradation through the proteasome. Taken together, these data shed new light on the molecular mechanism of necdin anti-apoptotic activity in myogenesis.	[Francois, Stephanie; D'Orlando, Cristina; Fatone, Tiziana; Pessina, Patrizia; Meneveri, Raffaella; Brunelli, Silvia] Univ Milano Bicocca, Dept Expt Med, Monza, Italy; [Touvier, Thierry] E Medea Sci Inst, Lecce, Italy; [Brunelli, Silvia] Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy	University of Milano-Bicocca; IRCCS Eugenio Medea; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Francois, S (corresponding author), Univ Milano Bicocca, Dept Expt Med, Monza, Italy.	silvia.brunelli@unimib.it	Touvier, Thierry/K-6194-2016; Brunelli, Silvia/P-3853-2019; Pessina, Patrizia/I-2093-2015; Brunelli, Silvia/J-3248-2014	Touvier, Thierry/0000-0002-9700-9911; Brunelli, Silvia/0000-0003-1753-5346; Pessina, Patrizia/0000-0002-4227-411X; Brunelli, Silvia/0000-0003-1753-5346	Italian Ministry of University and Research; European Community's Seventh Framework Programme in the project ENDOSTEM [241440]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Community's Seventh Framework Programme in the project ENDOSTEM	This work has benefited from research funding from the Italian Ministry of University and Research (PRIN 2009, S.B.) and the European Community's Seventh Framework Programme in the project ENDOSTEM (Grant agreement number 241440, S.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Brunelli S, 2008, PHARMACOL RES, V58, P117, DOI 10.1016/j.phrs.2008.06.008; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Deponti D, 2007, J CELL BIOL, V179, P305, DOI 10.1083/jcb.200701027; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Espantman KC, 2010, MOL CELL, V39, P835, DOI 10.1016/j.molcel.2010.09.006; Feng Y, 2011, PROTEIN CELL, V2, P7, DOI 10.1007/s13238-011-1002-9; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Jiang Yan, 2010, J Mol Signal, V5, P7, DOI 10.1186/1750-2187-5-7; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Lee MH, 2006, SEMIN CANCER BIOL, V16, P225, DOI 10.1016/j.semcancer.2006.03.009; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Moon HE, 2005, FEBS LETT, V579, P3797, DOI 10.1016/j.febslet.2005.05.072; Ou C-Y, 2009, J BIOL CHEM, P1; Pani L, 2002, GENE DEV, V16, P676, DOI 10.1101/gad.969302; Pessina P, 2011, CELL DEATH DIFFER; Pisconti A, 2006, J CELL BIOL, V172, P233, DOI 10.1083/jcb.200507083; Puliyappadamba Vineshkumar Thidil, 2011, J Biol Chem, V286, P38000, DOI 10.1074/jbc.M111.222398; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Sciorati C, 2006, J CELL SCI, V119, P5114, DOI 10.1242/jcs.03300; Sciorati C, 2009, J CELL SCI, V122, P1119, DOI 10.1242/jcs.041665; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Taniguchi N, 2000, J BIOL CHEM, V275, P31674, DOI 10.1074/jbc.M005103200; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Taniura H, 2002, J CELL BIOCHEM, V84, P545, DOI 10.1002/jcb.10047.abs; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	40	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43335	10.1371/journal.pone.0043335	http://dx.doi.org/10.1371/journal.pone.0043335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905258	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500800078
J	Weinstein, S; Emmanuel, R; Jacobi, AM; Abraham, A; Behlke, MA; Sprague, AG; Novobrantseva, TI; Nagler, A; Peer, D				Weinstein, Shiri; Emmanuel, Rafi; Jacobi, Ashley M.; Abraham, Avigdor; Behlke, Mark A.; Sprague, Andrew G.; Novobrantseva, Tatiana I.; Nagler, Arnon; Peer, Dan			RNA Inhibition Highlights Cyclin D1 as a Potential Therapeutic Target for Mantle Cell Lymphoma	PLOS ONE			English	Article							IN-VITRO; CANCER; PATHOGENESIS; PATHWAYS; D2	Mantle cell lymphoma is characterized by a genetic translocation results in aberrant overexpression of the CCND1 gene, which encodes cyclin D1. This protein functions as a regulator of the cell cycle progression, hence is considered to play an important role in the pathogenesis of the disease. In this study, we used RNA interference strategies to examine whether cyclin D1 might serve as a therapeutic target for mantle cell lymphoma. Knocking down cyclin D1 resulted in significant growth retardation, cell cycle arrest, and most importantly, induction of apoptosis. These results mark cyclin D1 as a target for mantle cell lymphoma and emphasize the therapeutic potential hidden in its silencing.	[Weinstein, Shiri; Emmanuel, Rafi; Peer, Dan] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Lab NanoMed, IL-69978 Tel Aviv, Israel; [Weinstein, Shiri; Emmanuel, Rafi; Peer, Dan] Tel Aviv Univ, Ctr Nanosci & Nanotechnol, IL-69978 Tel Aviv, Israel; [Jacobi, Ashley M.; Behlke, Mark A.] Integrated DNA Technol Inc, Corvallis, IA USA; [Abraham, Avigdor; Nagler, Arnon] Chaim Sheba Med Ctr, Div Hematol, IL-52621 Tel Hashomer, Israel; [Sprague, Andrew G.; Novobrantseva, Tatiana I.] Alnylam Pharmaceut, Cambridge, MA USA	Tel Aviv University; Tel Aviv University; Chaim Sheba Medical Center	Weinstein, S (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Lab NanoMed, IL-69978 Tel Aviv, Israel.	peer@tauex.tau.ac.il	Peer, Dan/A-1785-2011	Peer, Dan/0000-0001-8238-0673; Behlke, Mark/0000-0002-4218-857X	Lewis Family Trust; Israel Science Foundation [181/10]	Lewis Family Trust; Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the Lewis Family Trust and Israel Science Foundation (www.isf.org.il) (Award #181/10) to DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 2006, NAT PROTOC, V1, P508, DOI 10.1038/nprot.2006.72; Beltran E, 2011, P NATL ACAD SCI USA, V108, P12461, DOI 10.1073/pnas.1018941108; Chen R, 2010, CANCER RES, V70, P6587, DOI 10.1158/0008-5472.CAN-09-3578; Fernadez V, 2005, J CLIN ONCOL, V23, P6364, DOI 10.1200/JCO.2005.05.019; Gershoni JM, 1988, METHODS BIOCH ANAL, V33, P1; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Klier M, 2008, LEUKEMIA, V22, P2097, DOI 10.1038/leu.2008.213; Liu Q, 2010, CLIN CANCER RES, V16, P3182, DOI 10.1158/1078-0432.CCR-09-2484; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Tchakarska G, 2009, HAEMATOL-HEMATOL J, V94, P1781, DOI 10.3324/haematol.2009.011460; Tiemann K, 2011, LEUKEMIA LYMPHOMA, V52, P2148, DOI 10.3109/10428194.2011.593272; Venkataraman G, 2006, LEUKEMIA RES, V30, P1377, DOI 10.1016/j.leukres.2006.03.004	16	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43343	10.1371/journal.pone.0043343	http://dx.doi.org/10.1371/journal.pone.0043343			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905260	Green Published, gold			2022-12-27	WOS:000307500800079
J	Dufresne, SF; Datta, K; Li, XM; Dadachova, E; Staab, JF; Patterson, TF; Feldmesser, M; Marr, KA				Dufresne, Simon F.; Datta, Kausik; Li, Xinming; Dadachova, Ekaterina; Staab, Janet F.; Patterson, Thomas F.; Feldmesser, Marta; Marr, Kieren A.			Detection of Urinary Excreted Fungal Galactomannan-like Antigens for Diagnosis of Invasive Aspergillosis	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; LATEX AGGLUTINATION-TEST; ENZYME-IMMUNOASSAY; PULMONARY ASPERGILLOSIS; NEUTROPENIC PATIENTS; INFECTED-RABBITS; FUMIGATUS; SERUM; PCR; SAMPLES	Mortality associated with invasive aspergillosis (IA) remains high, partly because of delayed diagnosis. Detection of microbial exoantigens, released in serum and other body fluids during infection, may help timely diagnosis. In course of IA, Aspergillus galactomannan (GM), a well established polysaccharide biomarker, is released in body fluids including urine. Urine is an abundant, safely collected specimen, well-suited for point-of-care (POC) testing, which could play an increasing role in screening for early disease. Our main objective was to demonstrate GM antigenuria as a clinically relevant biological phenomenon in IA and establish proof-of-concept that it could be translated to POC diagnosis. Utilizing a novel IgM monoclonal antibody (MAb476) that recognizes GM-like antigens from Aspergillus and other molds, we demonstrated antigenuria in an experimental animal IA model (guinea pig), as well as in human patients. In addition, we investigated the chemical nature of the urinary excreted antigen in human samples, characterized antigen detection in urine by immunoassays, described a putative assay inhibitor in urine, and indicated means of alleviation of the inhibition. We also designed and used a lateral flow immunochromatographic assay to detect urinary excreted antigen in a limited number of IA patient urine samples. In this study, we establish that POC diagnosis of IA based on urinary GM detection is feasible. Prospective studies will be necessary to establish the performance characteristics of an optimized device and define its optimal clinical use.	[Dufresne, Simon F.; Datta, Kausik; Staab, Janet F.; Marr, Kieren A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Marr, Kieren A.] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Li, Xinming; Dadachova, Ekaterina; Feldmesser, Marta] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Patterson, Thomas F.] S Texas Vet Healthcare Syst, San Antonio, TX USA; [Patterson, Thomas F.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Dufresne, Simon F.] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Li, Xinming] China Med Univ, Shenyang, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Yeshiva University; Albert Einstein College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; Universite de Montreal; China Medical University	Dufresne, SF (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	kmarr4@jhmi.edu	Datta, Kausik/A-2879-2016; Dadachova, Ekaterina/I-7838-2013	Datta, Kausik/0000-0001-8666-143X; 	Johns Hopkins Accelerated Translational Incubator Pilot (ATIP) program; National Institutes of Health [AI065745, AI060507]; National Institute of Allergy and Infectious Disease [AI30041]; Hopital Maisonneuve-Rosemont and Universite de Montreal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065745, R56AI060507, R01AI060507] Funding Source: NIH RePORTER	Johns Hopkins Accelerated Translational Incubator Pilot (ATIP) program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Hopital Maisonneuve-Rosemont and Universite de Montreal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Johns Hopkins Accelerated Translational Incubator Pilot (ATIP) program grant to JFS; National Institutes of Health [R21 grant AI065745 to MF, grant AI060507 to ED and National Institute of Allergy and Infectious Disease N01 Contract AI30041 to TFP]; and Hopital Maisonneuve-Rosemont and Universite de Montreal [fellowship grant to SFD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSORG R, 1994, EUR J CLIN MICROBIOL, V13, P582, DOI 10.1007/BF01971310; Antinori S, 2010, TRANSPL INFECT DIS, V12, P64, DOI 10.1111/j.1399-3062.2009.00460.x; Asgeirsson D, 2007, ACTA PHYSIOL, V191, P237, DOI 10.1111/j.1748-1716.2007.01733.x; Baddley JW, 2010, CLIN INFECT DIS, V50, P1559, DOI 10.1086/652768; BENNETT JE, 1987, J INFECT DIS, V155, P1005, DOI 10.1093/infdis/155.5.1005; CAPEDING MRZ, 1991, J CLIN MICROBIOL, V29, P1818, DOI 10.1128/JCM.29.9.1818-1821.1991; Dadachova E, 2003, P NATL ACAD SCI USA, V100, P10942, DOI 10.1073/pnas.1731272100; De Jesus M, 2010, EUKARYOT CELL, V9, P1018, DOI 10.1128/EC.00268-09; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dominguez J, 1999, EUR J CLIN MICROBIOL, V18, P896, DOI 10.1007/s100960050427; Dowell SF, 2001, CLIN INFECT DIS, V32, P824, DOI 10.1086/319205; DUPONT B, 1987, J INFECT DIS, V155, P1, DOI 10.1093/infdis/155.1.1; Gohda T, 2012, AM J PHYSL RENAL PHY; Hawk PB, 1918, URINE PHYSL CONSTITU, P369; HAYNES KA, 1990, J CLIN MICROBIOL, V28, P2040, DOI 10.1128/JCM.28.9.2040-2044.1990; Howard CP, 1926, J CLIN INVEST, V2, P587, DOI 10.1172/JCI100066; Ikuta K, 1997, BIOCHEM J, V323, P297, DOI 10.1042/bj3230297; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Kawazu M, 2004, J CLIN MICROBIOL, V42, P2733, DOI 10.1128/JCM.42.6.2733-2741.2004; KOHLER RB, 1981, ANN INTERN MED, V94, P601, DOI 10.7326/0003-4819-94-5-601; Labbe AC, 2007, BIOL BLOOD MARROW TR, V13, P1192, DOI 10.1016/j.bbmt.2007.06.013; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lay LDAR, 2003, CLIN DIAGN LAB IMMUN, V10, P492, DOI 10.1128/CDLI.10.3.492-494.2003; Leeflang MM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007394; LEHMANN PF, 1978, INFECT IMMUN, V20, P570, DOI 10.1128/IAI.20.2.570-572.1978; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; Lindsley MD, 2007, CLIN VACCINE IMMUNOL, V14, P700, DOI 10.1128/CVI.00083-07; Maertens J, 2005, CLIN INFECT DIS, V41, P1242, DOI 10.1086/496927; Marr KA, 2004, J INFECT DIS, V190, P641, DOI 10.1086/422009; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Mengoli C, 2009, LANCET INFECT DIS, V9, P89, DOI 10.1016/S1473-3099(09)70019-2; Mennink-Kersten MASH, 2004, LANCET INFECT DIS, V4, P349, DOI 10.1016/S1473-3099(04)01045-X; Mokaddas E, 2010, J MED MICROBIOL, V59, P1519, DOI 10.1099/jmm.0.023630-0; Peltier P, 2008, CARBOHYD RES, V343, P1897, DOI 10.1016/j.carres.2008.02.010; Salas V, 2011, ANTIMICROB AGENTS CH, V55, P676, DOI 10.1128/AAC.00736-10; Salonen J, 2000, SCAND J INFECT DIS, V32, P485, DOI 10.1080/003655400458749; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Shimizu K, 2001, GENETICS, V157, P591; Simenel C, 2008, GLYCOBIOLOGY, V18, P84, DOI 10.1093/glycob/cwm122; Staab JF, 2009, J CLIN MICROBIOL, V47, P2079, DOI 10.1128/JCM.00551-09; Stephens-Romero SD, 2005, INFECT IMMUN, V73, P114, DOI 10.1128/IAI.73.1.114-125.2005; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; STYNEN D, 1992, INFECT IMMUN, V60, P2237, DOI 10.1128/IAI.60.6.2237-2245.1992; TEMSTET A, 1992, J CLIN MICROBIOL, V30, P2544, DOI 10.1128/JCM.30.10.2544-2550.1992; Vallor AC, 2008, ANTIMICROB AGENTS CH, V52, P2593, DOI 10.1128/AAC.00276-08; Varga J, 2005, ANTON LEEUW INT J G, V88, P141, DOI 10.1007/s10482-005-3870-6; VERWEIJ PE, 1995, J CLIN MICROBIOL, V33, P1912, DOI 10.1128/JCM.33.7.1912-1914.1995; VERWEIJ PE, 1995, J CLIN PATHOL, V48, P474, DOI 10.1136/jcp.48.5.474; Weber CJ, 1928, J BIOL CHEM, V78, P465; Wheat LJ, 2007, CLIN VACCINE IMMUNOL, V14, P638, DOI 10.1128/CVI.00479-06	52	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42736	10.1371/journal.pone.0042736	http://dx.doi.org/10.1371/journal.pone.0042736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900046	gold, Green Submitted, Green Published			2022-12-27	WOS:000307380900063
J	Gu, SH; Wang, SY; Zhang, XY; Ji, P; Liu, JT; Wang, GR; Wu, KM; Guo, YY; Zhou, JJ; Zhang, YJ				Gu, Shao-Hua; Wang, Song-Ying; Zhang, Xue-Ying; Ji, Ping; Liu, Jing-Tao; Wang, Gui-Rong; Wu, Kong-Ming; Guo, Yu-Yuan; Zhou, Jing-Jiang; Zhang, Yong-Jun			Functional Characterizations of Chemosensory Proteins of the Alfalfa Plant Bug Adelphocoris lineolatus Indicate Their Involvement in Host Recognition	PLOS ONE			English	Article							ODORANT-BINDING-PROTEIN; MOLECULAR-CLONING; EXPRESSION PATTERN; REGENERATING LEGS; SILKWORM MOTH; VOLATILES; LOCALIZATION; IMMUNOLOCALIZATION; PURIFICATION; ATTRACTION	Insect chemosensory proteins (CSPs) have been proposed to capture and transport hydrophobic chemicals from air to olfactory receptors in the lymph of antennal chemosensilla. They may represent a new class of soluble carrier protein involved in insect chemoreception. However, their specific functional roles in insect chemoreception have not been fully elucidated. In this study, we report for the first time three novel CSP genes (AlinCSP1-3) of the alfalfa plant bug Adelphocoris lineolatus (Goeze) by screening the antennal cDNA library. The qRT-PCR examinations of the transcript levels revealed that all three genes (AlinCSP1-3) are mainly expressed in the antennae. Interestingly, these CSP genes AlinCSP1-3 are also highly expressed in the 5th instar nymphs, suggesting a proposed function of these CSP proteins (AlinCSP1-3) in the olfactory reception and in maintaining particular life activities into the adult stage. Using bacterial expression system, the three CSP proteins were expressed and purified. For the first time we characterized the types of sensilla in the antennae of the plant bug using scanning electron microscopy (SEM). Immunocytochemistry analysis indicated that the CSP proteins were expressed in the pheromone-sensitive sensilla trichodea and general odorant-sensitive sensilla basiconica, providing further evidence of their involvement in chemoreception. The antennal activity of 55 host-related semiochemicals and sex pheromone compounds in the host location and mate selection behavior of A. lineolatus was investigated using electroantennogram (EAG), and the binding affinities of these chemicals to the three CSPs (AlinCSP1-3) were measured using fluorescent binding assays. The results showed several host-related semiochemicals, (Z)-3-hexen-1-ol, (E)-2-hexen-1-al and valeraldehyde, have a high binding affinity with AlinCSP1-3 and can elicit significant high EAG responses of A. lineolatus antennae. Our studies indicate the three antennae-biased CSPs may mediate host recognition in the alfalfa plant bug A. lineolatus.	[Gu, Shao-Hua; Wang, Song-Ying; Zhang, Xue-Ying; Ji, Ping; Liu, Jing-Tao; Wang, Gui-Rong; Wu, Kong-Ming; Guo, Yu-Yuan; Zhang, Yong-Jun] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Zhou, Jing-Jiang] Rothamsted Res, Dept Biol Chem, Harpenden, Herts, England	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Gu, SH (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	jing-jiang.zhou@rothamsted.ac.uk; yjzhang@ippcaas.cn			China National "973" Basic Research Program [2012CB114104]; National Natural Science Foundation of China [31071694, 31171858]; Royal Society, United Kingdom [31111130203]	China National "973" Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society, United Kingdom(Royal Society of London)	This work was supported by the China National "973" Basic Research Program (2012CB114104), and the National Natural Science Foundation of China (31071694 and 31171858). JJ Zhou and YJ Zhang acknowledge financial support from the Royal Society, United Kingdom, for the international joint project between China and the United Kingdom (31111130203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH JR, 1988, ANNU REV ENTOMOL, V33, P211, DOI 10.1146/annurev.en.33.010188.001235; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Bai SX, 2001, THESIS CHINESE ACAD, P20; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blackmer JL, 2004, J CHEM ECOL, V30, P1547, DOI 10.1023/B:JOEC.0000042067.27698.30; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Campanacci V, 2003, P NATL ACAD SCI USA, V100, P5069, DOI 10.1073/pnas.0836654100; Chinta S, 1997, INT J INSECT MORPHOL, V26, P21, DOI 10.1016/S0020-7322(96)00022-0; CRAIG C. H., 1963, CANADIAN ENTOMOL, V95, P6; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P81, DOI 10.1007/BF00592572; de Santis F, 2006, J CHEM ECOL, V32, P1703, DOI 10.1007/s10886-006-9103-2; Drukker B, 2000, PHYSIOL ENTOMOL, V25, P260, DOI 10.1046/j.1365-3032.2000.00190.x; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Gu SH, 2011, ARCH INSECT BIOCHEM, V77, P81, DOI 10.1002/arch.20427; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; GUELDNER RC, 1978, INSECT BIOCHEM, V8, P389, DOI 10.1016/0020-1790(78)90026-4; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; James DG, 2005, J CHEM ECOL, V31, P481, DOI 10.1007/s10886-005-2020-y; Jiang QY, 2009, INSECT BIOCHEM MOLEC, V39, P440, DOI 10.1016/j.ibmb.2009.04.004; Jin X, 2005, CELL MOL LIFE SCI, V62, P1156, DOI 10.1007/s00018-005-5014-6; Kaissling K.-E., 1971, Handbook of sensory physiology, Vol. IV, P351; Kendra PE, 2005, ENVIRON ENTOMOL, V34, P584, DOI 10.1603/0046-225X-34.3.584; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu XL, 2010, J BIOCHEM, V148, P189, DOI 10.1093/jb/mvq050; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2009, CROP PROT, V28, P77, DOI 10.1016/j.cropro.2008.08.018; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Millar JG, 2005, TOP CURR CHEM, V240, P37, DOI 10.1007/b98315; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Mosbah A, 2003, BIOCHEM J, V369, P39, DOI 10.1042/BJ20021217; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; Ngumbi E, 2009, J CHEM ECOL, V35, P1009, DOI 10.1007/s10886-009-9700-y; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Plettner E, 2002, CURR MED CHEM, V9, P1075, DOI 10.2174/0929867024606669; PRESTWICH GD, 1993, PROTEIN SCI, V2, P420; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robert D, 2002, CURR OPIN NEUROBIOL, V12, P715, DOI 10.1016/S0959-4388(02)00378-1; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; SCHNEIDER D, 1957, Z VERGL PHYSIOL, V40, P8, DOI 10.1007/BF00298148; SCHNEIDER D, 1969, SCIENCE, V163, P1031, DOI 10.1126/science.163.3871.1031; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomaselli S, 2006, BIOCHEMISTRY-US, V45, P10606, DOI 10.1021/bi060998w; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; VISSER JH, 1979, ENTOMOL EXP APPL, V25, P86, DOI 10.1007/BF00421821; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Wardle AR, 2003, J CHEM ECOL, V29, P931, DOI 10.1023/A:1022987901330; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852; Whitbey RM, 1999, ENVIRON ENTOMOL, V28, P201, DOI 10.1093/ee/28.2.201; Yu Hui-lin, 2007, Yingyong Shengtai Xuebao, V18, P859; Zhao N, 2010, PLANT PHYSIOL BIOCH, V48, P279, DOI 10.1016/j.plaphy.2010.01.023; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015; Zhou JingJiang, 2010, Outlooks on Pest Management, V21, P31, DOI 10.1564/21feb08; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x	72	96	113	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42871	10.1371/journal.pone.0042871	http://dx.doi.org/10.1371/journal.pone.0042871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900060	Green Submitted, gold, Green Published			2022-12-27	WOS:000307380900078
J	Hoover, WC; Zhang, WW; Xue, ZD; Gao, HL; Chernoff, J; Clapp, DW; Gunst, SJ; Tepper, RS				Hoover, Wyn C.; Zhang, Wenwu; Xue, Zhidong; Gao, Huanling; Chernoff, Jonathan; Clapp, D. Wade; Gunst, Susan J.; Tepper, Robert S.			Inhibition of p21 Activated Kinase (PAK) Reduces Airway Responsiveness In Vivo and In Vitro in Murine and Human Airways	PLOS ONE			English	Article							P21-ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE; CONTRACTION; MECHANISMS; PHOSPHORYLATION; TARGETS; CELLS; MAPK	The p21-activated protein kinases (Paks) have been implicated in the regulation of smooth muscle contractility, but the physiologic effects of Pak activation on airway reactivity in vivo are unknown. A mouse model with a genetic deletion of Pak1 (Pak1(-/-)) was used to determine the role of Pak in the response of the airways in vivo to challenge with inhaled or intravenous acetylcholine (ACh). Pulmonary resistance was measured in anesthetized mechanically ventilated Pak1(-/-) and wild type mice. Pak1(-/-) mice exhibited lower airway reactivity to ACh compared with wild type mice. Tracheal segments dissected from Pak1(-/-) mice and studied in vitro also exhibited reduced responsiveness to ACh compared with tracheas from wild type mice. Morphometric assessment and pulmonary function analysis revealed no differences in the structure of the airways or lung parenchyma, suggesting that that the reduced airway responsiveness did not result from structural abnormalities in the lungs or airways due to Pak1 deletion. Inhalation of the small molecule synthetic Pak1 inhibitor, IPA3, also significantly reduced in vivo airway responsiveness to ACh and 5-hydroxytryptamine (5-Ht) in wild type mice. IPA3 inhibited the contractility of isolated human bronchial tissues to ACh, confirming that this inhibitor is also effective in human airway smooth muscle tissue. The results demonstrate that Pak is a critical component of the contractile activation process in airway smooth muscle, and suggest that Pak inhibition could provide a novel strategy for reducing airway hyperresponsiveness.	[Hoover, Wyn C.; Xue, Zhidong; Gao, Huanling; Clapp, D. Wade; Tepper, Robert S.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46204 USA; [Hoover, Wyn C.; Xue, Zhidong; Gao, Huanling; Clapp, D. Wade; Tepper, Robert S.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA; [Zhang, Wenwu; Gunst, Susan J.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA; [Chernoff, Jonathan] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Clapp, D. Wade] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Fox Chase Cancer Center; Indiana University System; Indiana University Bloomington	Hoover, WC (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46204 USA.	rtepper@iupui.edu	Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836; Gunst, Susan/0000-0001-9836-4782	American Asthma Foundation [08-0049];  [NIH-HL29289];  [HL074099]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074099, R01HL109629, R01HL029289, R23HL029289] Funding Source: NIH RePORTER	American Asthma Foundation; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH-HL29289, HL074099, and American Asthma Foundation 08-0049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2009, BLOOD, V113, P2695, DOI 10.1182/blood-2008-06-160861; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dechert MA, 2001, AM J PHYSIOL-CELL PH, V281, pC123, DOI 10.1152/ajpcell.2001.281.1.C123; Foster DB, 2000, J BIOL CHEM, V275, P1959, DOI 10.1074/jbc.275.3.1959; Gatti A, 1999, J BIOL CHEM, V274, P8022, DOI 10.1074/jbc.274.12.8022; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; McDaniel AS, 2008, BLOOD, V112, P4646, DOI 10.1182/blood-2008-04-155085; McFawn PK, 2003, AM J PHYSIOL-LUNG C, V284, pL863, DOI 10.1152/ajplung.00068.2002; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Murthy KS, 2003, BIOCHEM J, V374, P1; Pacheco A, 2010, INT J BIOCHEM CELL B, V42, P13, DOI 10.1016/j.biocel.2009.09.006; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; THURLBEC.WM, 1967, THORAX, V22, P483, DOI 10.1136/thx.22.6.483; Van Eyk JE, 1998, J BIOL CHEM, V273, P23433, DOI 10.1074/jbc.273.36.23433; Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006; Wang ZX, 2011, J BIOL CHEM, V286, P41359, DOI 10.1074/jbc.M111.291500; Wirth A, 2003, J PHYSL, V549, P2; Xue Z, 2008, J APPL PHYSIOL, V104, P610, DOI 10.1152/japplphysiol.00241.2007; Xue Z, 2005, J APPL PHYSIOL, V99, P677, DOI 10.1152/japplphysiol.00165.2005; Yi CL, 2010, BIOCHEM PHARMACOL, V80, P683, DOI 10.1016/j.bcp.2010.03.012; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	23	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42601	10.1371/journal.pone.0042601	http://dx.doi.org/10.1371/journal.pone.0042601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900031	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900047
J	Faustman, DL; Wang, LM; Okubo, Y; Burger, D; Ban, LQ; Man, GT; Zheng, H; Schoenfeld, D; Pompei, R; Avruch, J; Nathan, DM				Faustman, Denise L.; Wang, Limei; Okubo, Yoshiaki; Burger, Douglas; Ban, Liqin; Man, Guotong; Zheng, Hui; Schoenfeld, David; Pompei, Richard; Avruch, Joseph; Nathan, David M.			Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BETA-CELL FUNCTION; NOD MICE; MULTIPLE-SCLEROSIS; TNF-ALPHA; T-CELLS; AUTOIMMUNE-DISEASES; FREUND ADJUVANT	Background: No targeted immunotherapies reverse type 1 diabetes in humans. However, in a rodent model of type 1 diabetes, Bacillus Calmette-Guerin (BCG) reverses disease by restoring insulin secretion. Specifically, it stimulates innate immunity by inducing the host to produce tumor necrosis factor (TNF), which, in turn, kills disease-causing autoimmune cells and restores pancreatic beta-cell function through regeneration. Methodology/Principal Findings: Translating these findings to humans, we administered BCG, a generic vaccine, in a proof-of-principle, double-blind, placebo-controlled trial of adults with long-term type 1 diabetes (mean: 15.3 years) at one clinical center in North America. Six subjects were randomly assigned to BCG or placebo and compared to self, healthy paired controls (n = 6) or reference subjects with (n = 57) or without (n = 16) type 1 diabetes, depending upon the outcome measure. We monitored weekly blood samples for 20 weeks for insulin-autoreactive T cells, regulatory T cells (Tregs), glutamic acid decarboxylase (GAD) and other autoantibodies, and C-peptide, a marker of insulin secretion. BCG-treated patients and one placebo-treated patient who, after enrollment, unexpectedly developed acute Epstein-Barr virus infection, a known TNF inducer, exclusively showed increases in dead insulin-autoreactive T cells and induction of Tregs. C-peptide levels (pmol/L) significantly rose transiently in two BCG-treated subjects (means: 3.49 pmol/L [95% CI 2.95-3.8], 2.57 [95% CI 1.65-3.49]) and the EBV-infected subject (3.16 [95% CI 2.54-3.69]) vs. 1.65 [95% CI 1.55-3.2] in reference diabetic subjects. BCG-treated subjects each had more than 50% of their C-peptide values above the 95th percentile of the reference subjects. The EBV-infected subject had 18% of C-peptide values above this level. Conclusions/Significance: We conclude that BCG treatment or EBV infection transiently modified the autoimmunity that underlies type 1 diabetes by stimulating the host innate immune response. This suggests that BCG or other stimulators of host innate immunity may have value in the treatment of long-term diabetes.	[Faustman, Denise L.; Wang, Limei; Okubo, Yoshiaki; Burger, Douglas; Ban, Liqin; Man, Guotong] Massachusetts Gen Hosp, Immunobiol Lab, Boston, MA 02114 USA; [Faustman, Denise L.; Wang, Limei; Okubo, Yoshiaki; Burger, Douglas; Ban, Liqin; Man, Guotong] Harvard Univ, Sch Med, Boston, MA USA; [Zheng, Hui; Schoenfeld, David] Massachusetts Gen Hosp, Dept Biostat, Boston, MA 02114 USA; [Pompei, Richard; Avruch, Joseph; Nathan, David M.] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Faustman, DL (corresponding author), Massachusetts Gen Hosp, Immunobiol Lab, Boston, MA 02114 USA.	faustman@helix.mgh.harvard.edu			Iacocca Foundation; Charlton Fund for Innovative Diabetes Research; NIH [P30DK057521]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER	Iacocca Foundation; Charlton Fund for Innovative Diabetes Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Iacocca Foundation and philanthropic dollars supported this study. The authors also reserve gratitude to the James B Pendleton Charitable Trust. Finally, the authors extend their appreciation to the Friends United for Juvenile Diabetes Research and Partnership for Cures. DMN was supported in part by the Charlton Fund for Innovative Diabetes Research. NIH support included #P30DK057521 to DLF. No drug company or for-profit resources supported this trial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was funded by philanthropic grants only.	Achenbach P, 2009, DIABETOLOGIA, V52, P1881, DOI 10.1007/s00125-009-1438-0; Allcock RJN, 1999, IMMUNOGENETICS, V49, P660, DOI 10.1007/s002510050662; Allcock RJN, 1999, HUM IMMUNOL, V60, P1266, DOI 10.1016/S0198-8859(99)00127-5; Allen HF, 1999, DIABETES CARE, V22, P1703, DOI 10.2337/diacare.22.10.1703; [Anonymous], 2001, SMALL CLIN TRIALS IS; Ban LQ, 2008, P NATL ACAD SCI USA, V105, P13644, DOI 10.1073/pnas.0803429105; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Bosi E, 2001, DIABETES, V50, P2464, DOI 10.2337/diabetes.50.11.2464; Boulton JG, 2007, RHEUMATOLOGY, V46, P178, DOI 10.1093/rheumatology/kel322; Braghi S, 2000, DIABETES, V49, P218, DOI 10.2337/diabetes.49.2.218; Burger DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022430; Castiblanco J, 2008, HUM IMMUNOL, V69, P45, DOI 10.1016/j.humimm.2007.11.008; Christen U, 2002, ANN NY ACAD SCI, V958, P166; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Elliott JF, 1998, DIABETES CARE, V21, P1691, DOI 10.2337/diacare.21.10.1691; Enayati PJ, 2005, J CLIN GASTROENTEROL, V39, P303, DOI 10.1097/01.mcg.0000155126.82171.32; Fu YN, 1998, ANN NY ACAD SCI, V842, P138, DOI 10.1111/j.1749-6632.1998.tb09642.x; Grewal IS, 1996, J EXP MED, V184, P1963, DOI 10.1084/jem.184.5.1963; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; HARADA M, 1990, DIABETES RES CLIN PR, V8, P85, DOI 10.1016/0168-8227(90)90017-N; Hayashi T, 1999, MOL CELL BIOL, V19, P8646; Hayashi T, 2000, NAT MED, V6, P1065, DOI 10.1038/80353; Hayashi T, 2001, J APPL PHYSIOL, V91, P2804, DOI 10.1152/jappl.2001.91.6.2804; Kessel A, 2004, J CLIN IMMUNOL, V24, P30, DOI 10.1023/B:JOCI.0000018060.36183.bb; Khan M, 2012, CONT J MED, V2, P1; Ko JM, 2009, J DERMATOL TREAT, V20, P100, DOI 10.1080/09546630802441234; Kodama S, 2005, CELL MOL LIFE SCI, V62, P1850, DOI 10.1007/s00018-005-5022-6; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; MCINERNEY MF, 1991, DIABETES, V40, P715, DOI 10.2337/diabetes.40.6.715; Miterski B, 2002, GENES IMMUN, V3, P211, DOI 10.1038/sj.gene.6363846; Okubo Y, 2006, DIABETES A, V281, P1193; Paolillo A, 2003, J NEUROL, V250, P247, DOI 10.1007/s00415-003-0967-6; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Pozzilli P, 1997, LANCET, V349, P1520, DOI 10.1016/S0140-6736(05)62100-9; Qin HY, 2004, INT IMMUNOL, V16, P1723, DOI 10.1093/intimm/dxh173; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Ramos-Casals M, 2008, BEST PRACT RES CL RH, V22, P847, DOI 10.1016/j.berh.2008.09.008; Ristori G, 1999, NEUROLOGY, V53, P1588, DOI 10.1212/WNL.53.7.1588; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; SADELAIN MWJ, 1990, J AUTOIMMUN, V3, P671, DOI 10.1016/S0896-8411(05)80034-4; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Sanjeevi CB, 2002, ANN NY ACAD SCI, V958, P293; SATOH J, 1989, J CLIN INVEST, V84, P1345, DOI 10.1172/JCI114304; SHEHADEH N, 1994, LANCET, V343, P706, DOI 10.1016/S0140-6736(94)91583-0; Sicotte NL, 2001, NEUROLOGY, V57, P1885, DOI 10.1212/WNL.57.10.1885; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Thomas CW, 2004, INFLAMM BOWEL DIS, V10, P28, DOI 10.1097/00054725-200401000-00004; Till A, 2005, J BIOL CHEM, V280, P5994, DOI 10.1074/jbc.M411541200; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Valero R, 2002, J IMMUNOL, V169, P185, DOI 10.4049/jimmunol.169.1.185; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wandinger KP, 2001, ANN NEUROL, V50, P349, DOI 10.1002/ana.1096; Wong HK, 1999, J IMMUNOL, V163, P1682; Zaiss DMW, 2011, J IMMUNOL, V187, P2302, DOI 10.4049/jimmunol.1101003; Zhang GL, 2011, INFLAMM RES, V60, P11, DOI 10.1007/s00011-010-0216-2	56	92	96	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41756	10.1371/journal.pone.0041756	http://dx.doi.org/10.1371/journal.pone.0041756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905105	Green Published, gold			2022-12-27	WOS:000307331100016
J	Kumar, P; Lindberg, L; Thirkill, TL; Ji, JW; Martsching, L; Douglas, GC				Kumar, Priyadarsina; Lindberg, Louise; Thirkill, Twanda L.; Ji, Jennifer W.; Martsching, Lindsay; Douglas, Gordon C.			The MUC1 Extracellular Domain Subunit Is Found in Nuclear Speckles and Associates with Spliceosomes	PLOS ONE			English	Article							POLYMORPHIC EPITHELIAL MUCIN; CARCINOMA-ASSOCIATED PROTEIN; CELL-SURFACE RECEPTORS; GROWTH-FACTOR RECEPTOR; CYTOPLASMIC TAIL; BREAST-CARCINOMA; CANCER-CELLS; BETA-CATENIN; IN-SITU; SUBNUCLEAR LOCALIZATION	MUC1 is a large transmembrane glycoprotein and oncogene expressed by epithelial cells and overexpressed and underglycosylated in cancer cells. The MUC1 cytoplasmic subunit (MUC1-C) can translocate to the nucleus and regulate gene expression. It is frequently assumed that the MUC1 extracellular subunit (MUC1-N) does not enter the nucleus. Based on an unexpected observation that MUC1 extracellular domain antibody produced an apparently nucleus-associated staining pattern in trophoblasts, we have tested the hypothesis that MUC1-N is expressed inside the nucleus. Three different antibodies were used to identify MUC1-N in normal epithelial cells and tissues as well as in several cancer cell lines. The results of immunofluorescence and confocal microscopy analyses as well as subcellular fractionation, Western blotting, and siRNA/shRNA studies, confirm that MUC1-N is found within nuclei of all cell types examined. More detailed examination of its intranuclear distribution using a proximity ligation assay, subcellular fractionation, and immunoprecipitation suggests that MUC1-N is located in nuclear speckles (interchromatin granule clusters) and closely associates with the spliceosome protein U2AF65. Nuclear localization of MUC1-N was abolished when cells were treated with RNase A and nuclear localization was altered when cells were incubated with the transcription inhibitor 5,6-dichloro-1-b-d-ribofuranosylbenzimidazole (DRB). While MUC1-N predominantly associated with speckles, MUC1-C was present in the nuclear matrix, nucleoli, and the nuclear periphery. In some nuclei, confocal microscopic analysis suggest that MUC1-C staining is located close to, but only partially overlaps, MUC1-N in speckles. However, only MUC1-N was found in isolated speckles by Western blotting. Also, MUC1-C and MUC1-N distributed differently during mitosis. These results suggest that MUC1-N translocates to the nucleus where it is expressed in nuclear speckles and that MUC1-N and MUC1-C have dissimilar intranuclear distribution patterns.	[Kumar, Priyadarsina; Lindberg, Louise; Thirkill, Twanda L.; Ji, Jennifer W.; Martsching, Lindsay; Douglas, Gordon C.] Univ Calif Davis, Dept Cell Biol & Human Anat, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis	Kumar, P (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, Sch Med, Davis, CA 95616 USA.	gcdouglas@ucdavis.edu			National Institutes of Health Grant [5R01HL068035]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068035] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant 5R01HL068035 (GCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1989, CANCER RES, V49, P2834; Agrawal B, 2005, INT IMMUNOL, V17, P391, DOI 10.1093/intimm/dxh219; Akporiaye ET, 2007, VACCINE, V25, P6965, DOI 10.1016/j.vaccine.2007.06.063; Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Aplin JD, 2009, PLACENTA, V30, P293, DOI 10.1016/j.placenta.2008.12.001; Arcasoy SM, 1997, AM J RESP CELL MOL, V17, P422, DOI 10.1165/ajrcmb.17.4.2714; Baruch A, 1999, CANCER RES, V59, P1552; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Bitler BG, 2010, J CELL SCI, V123, P1716, DOI 10.1242/jcs.062661; BOSHELL M, 1992, BIOCHEM BIOPH RES CO, V185, P1, DOI 10.1016/S0006-291X(05)80946-5; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Cao Y, 1998, TUMOR BIOL, V19, P88, DOI 10.1159/000056509; Cascio S, 2011, J BIOL CHEM, V286, P42248, DOI 10.1074/jbc.M111.297630; CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; Chusainow J, 2005, RNA, V11, P1201, DOI 10.1261/rna.7277705; Croce MV, 2003, J HISTOCHEM CYTOCHEM, V51, P781, DOI 10.1177/002215540305100609; David A, 2011, J BIOL CHEM, V286, P20688, DOI 10.1074/jbc.M110.209452; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; DOUGLAS GC, 1990, IN VITRO CELL DEV B, V26, P754; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Fakan Stanislav, 1994, Trends in Cell Biology, V4, P86, DOI 10.1016/0962-8924(94)90180-5; Francis LW, 2009, BIOL CELL, V101, P481, DOI 10.1042/BC20080189; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; GENDLER S, 1988, J BIOL CHEM, V263, P12820; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; GENDLER SJ, 1987, P NATL ACAD SCI USA, V84, P6060, DOI 10.1073/pnas.84.17.6060; Gilles F, 2000, BLOOD, V95, P2930, DOI 10.1182/blood.V95.9.2930.009k39_2930_2936; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; HERLYN M, 1987, ADV CANCER RES, V49, P189, DOI 10.1016/S0065-230X(08)60798-8; Hiesberger T, 2006, J BIOL CHEM, V281, P34357, DOI 10.1074/jbc.M606740200; Hikita ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003312; Hinojosa-Kurtzberg AM, 2003, AM J PHYSIOL-GASTR L, V284, pG853, DOI 10.1152/ajpgi.00326.2002; Hirasawa Y, 1997, AM J RESP CELL MOL, V17, P501, DOI 10.1165/ajrcmb.17.4.2253; Jonckheere Nicolas, 2008, Critical Reviews in Oncogenesis, V14, P177; Julian J, 2002, BIOCHEM BIOPH RES CO, V293, P1183, DOI 10.1016/S0006-291X(02)00352-2; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lallena MJ, 1997, J CELL SCI, V110, P239; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; Li YQ, 2003, MOL CANCER RES, V1, P765; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; LIU XH, 1995, GLYCOCONJUGATE J, V12, P607, DOI 10.1007/BF00731254; Liu XL, 2008, BIOCHEM BIOPH RES CO, V376, P688, DOI 10.1016/j.bbrc.2008.09.065; Mahanta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002054; Marcos NT, 2003, J HISTOCHEM CYTOCHEM, V51, P761, DOI 10.1177/002215540305100607; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Massinen S, 2009, HUM MOL GENET, V18, P2802, DOI 10.1093/hmg/ddp215; Mattila PE, 2009, BIOL CHEM, V390, P551, DOI 10.1515/BC.2009.088; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Oppizzi ML, 2008, TRAFFIC, V9, P2063, DOI 10.1111/j.1600-0854.2008.00822.x; PATTILLO RA, 1972, J CLIN ENDOCR METAB, V34, P59, DOI 10.1210/jcem-34-1-59; Planque Nathalie, 2006, Cell Commun Signal, V4, P7, DOI 10.1186/1478-811X-4-7; Rahn JJ, 2001, CANCER, V91, P1973, DOI 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A; Reddish MA, 1992, J TUMOR MARKER ONCOL, V7, P19; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Rino J, 2007, PLOS COMPUT BIOL, V3, P2019, DOI 10.1371/journal.pcbi.0030201; Rockel TD, 2002, J STRUCT BIOL, V140, P189; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Schut IC, 2003, BJU INT, V91, P278, DOI 10.1046/j.1464-410X.2003.03062.x; Shalom-Barak T, 2004, MOL CELL BIOL, V24, P10661, DOI 10.1128/MCB.24.24.10661-10669.2004; Shyu M-K, 2008, BIOL REPROD BIOLREPR, V108; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Soghomonians A, 2002, BBA-MOL CELL RES, V1589, P233, DOI 10.1016/S0167-4889(02)00179-9; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Spector DL, 2011, COLD SPRING HARBOR P, P3; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; Thirkill TL, 2007, BBA-MOL CELL RES, V1773, P1007, DOI 10.1016/j.bbamcr.2007.04.006; Thompson EJ, 2006, MOL CANCER RES, V4, P489, DOI 10.1158/1541-7786.MCR-06-0038; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Wang P, 2008, BIOL REPROD, V78, P290, DOI 10.1095/biolreprod.107.064584; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wells A, 2002, NAT REV MOL CELL BIO, V3, P697, DOI 10.1038/nrm905; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; WRESCHNER DH, 1990, EUR J BIOCHEM, V189, P463, DOI 10.1111/j.1432-1033.1990.tb15511.x; Yamada N, 2008, CANCER RES, V68, P2708, DOI 10.1158/0008-5472.CAN-07-6844; Yang Y, 2010, J NEUROCHEM, V112, P134, DOI 10.1111/j.1471-4159.2009.06433.x	90	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42712	10.1371/journal.pone.0042712	http://dx.doi.org/10.1371/journal.pone.0042712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905162	Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100058
J	Li, S; Kang, J; Yu, WD; Zhou, Y; Zhang, WL; Xin, Y; Ma, YF				Li, Shuang; Kang, Jian; Yu, Wendan; Zhou, Yan; Zhang, Wenli; Xin, Yi; Ma, Yufang			Identification of M-tuberculosis Rv3441c and M-smegmatis MSMEG_1556 and Essentiality of M-smegmatis MSMEG_1556	PLOS ONE			English	Article							ENCODING PHOSPHOGLUCOSAMINE MUTASE; DRUG-RESISTANT TUBERCULOSIS; ESCHERICHIA-COLI; N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE; GLUCOSAMINE-1-PHOSPHATE ACETYLTRANSFERASE; GLMM GENE; ENVELOPE; SEQUENCE; ARABINAN; GROWTH	The normal growth of mycobacteria attributes to the integrity of cell wall core which consists of peptidoglycan (PG), arabinogalactan (AG) and mycolic acids. N-acetyl glucosamine (GlcNAc) is an essential component in both PG and AG of mycobacterial cell wall. The biosynthetic pathway for UDP-N-acetylglucosamine (UDP-GlcNAc), as a sugar donor of GlcNAc, is different in prokaryotes and eukaryotes. The conversion of glucosamine-6-phosphate to glucosamine-1-phosphate, which is catalyzed by phosphoglucosamine mutase (GlmM), is unique to prokaryotes. Bioinformatic analysis showed that Msm MSMEG_1556 and Mtb Rv3441c are homologous to Ec GlmM. In this study, soluble Msm MSMEG_1556 protein and Mtb Rv3441c protein were expressed in E. coli BL21(DE3) and their phosphoglucosamine mutase activity were detected. In order to further investigate the essentiality of MSMEG_1556 for the growth of M. smegmatis, we generated a conditional MSMEG_1556 knockout mutant, which harbored thermo-sensitive rescue plasmid carrying Mtb Rv3441c. As the rescue plasmid was unable to complement MSMEG_1556 deficiency at 42 degrees C, MSMEG_1556 knockout mutant did not grow. The dramatic morphological changes of MSMEG_1556 knockout mutant after temperature shift from 30 degrees C to 42 degrees C have been observed by scanning electron microscope. These results demonstrated that MSMEG_1556 is essential for growth of M. smegmatis. This study provided evidence that GlmM enzyme could be as a potential target for developing anti-tuberculosis drugs.	[Li, Shuang; Kang, Jian; Yu, Wendan; Zhou, Yan; Zhang, Wenli; Ma, Yufang] Dalian Med Univ, Dept Biochem & Mol Biol, Dalian, Liaoning, Peoples R China; [Xin, Yi] Dalian Med Univ, Dept Biotechnol, Dalian, Liaoning, Peoples R China; [Xin, Yi; Ma, Yufang] Liaoning Prov Core Lab Glycobiol & Glycoengn, Dalian, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University	Li, S (corresponding author), Dalian Med Univ, Dept Biochem & Mol Biol, Dalian, Liaoning, Peoples R China.	yufang_ma@hotmail.com			National Basic Research Program of China [2012CB518803]; National Natural Science Foundation of China [30970067]; National Science and Technology Major Project [2012ZX10003003-006]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project	This work was supported by the National Basic Research Program of China (2012CB518803; http://www.973.gov.cn/English/Index.aspx), the National Natural Science Foundation of China (30970067; http://www.nsfc.gov.cn/Portal0/default166.htm), and the National Science and Technology Major Project (2012ZX10003003-006; http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DeReuse H, 1997, J BACTERIOL, V179, P3488, DOI 10.1128/jb.179.11.3488-3493.1997; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; GUILHOT C, 1994, J BACTERIOL, V176, P535, DOI 10.1128/JB.176.2.535-539.1994; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Jolly L, 1999, EUR J BIOCHEM, V262, P202, DOI 10.1046/j.1432-1327.1999.00373.x; Jolly L, 1997, J BACTERIOL, V179, P5321, DOI 10.1128/jb.179.17.5321-5325.1997; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Li W, 2006, BIOCHEM BIOPH RES CO, V342, P170, DOI 10.1016/j.bbrc.2006.01.130; Liu XD, 2009, ORAL MICROBIOL IMMUN, V24, P272, DOI 10.1111/j.1399-302X.2009.00503.x; MCNEIL MR, 1991, RES MICROBIOL, V142, P451, DOI 10.1016/0923-2508(91)90120-Y; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; MenginLecreulx D, 1996, J BIOL CHEM, V271, P32, DOI 10.1074/jbc.271.1.32; MENGINLECREULX D, 1993, J BACTERIOL, V175, P6150, DOI 10.1128/JB.175.19.6150-6157.1993; Meniche X, 2008, MICROBIOL-SGM, V154, P2315, DOI 10.1099/mic.0.2008/016378-0; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; Pelicic V, 1996, MOL MICROBIOL, V20, P919, DOI 10.1111/j.1365-2958.1996.tb02533.x; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; Riccardi G, 2009, FUTURE MICROBIOL, V4, P597, DOI [10.2217/fmb.09.20, 10.2217/FMB.09.20]; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shimazu K, 2008, FEMS IMMUNOL MED MIC, V53, P166, DOI 10.1111/j.1574-695X.2008.00410.x; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Tavares IM, 2000, J BACTERIOL, V182, P4453, DOI 10.1128/JB.182.16.4453-4457.2000; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Zhang WL, 2008, INT J BIOCHEM CELL B, V40, P2560, DOI 10.1016/j.biocel.2008.05.003; Zhou Y, 2011, ARCH MICROBIOL, V193, P751, DOI 10.1007/s00203-011-0715-8	32	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42769	10.1371/journal.pone.0042769	http://dx.doi.org/10.1371/journal.pone.0042769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905172	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100065
J	Murray, AM; Nobre, AC; Astle, DE; Stokes, MG				Murray, Alexandra M.; Nobre, Anna C.; Astle, Duncan E.; Stokes, Mark G.			Lacking Control over the Trade-Off between Quality and Quantity in Visual Short-Term Memory	PLOS ONE			English	Article							TOP-DOWN CONTROL; WORKING-MEMORY; PREFRONTAL CORTEX; NEURAL MECHANISMS; ATTENTION; REPRESENTATIONS; CAPACITY; ALLOCATION; RESOURCE	Visual short-term memory (VSTM) is limited in the quantity and quality of items that can be retained over time. Importantly, these two mnemonic parameters interact: increasing the number of items in VSTM reduces the quality with which they are represented. Here, we ask whether this trade-off is under top-down control. Specifically, we test whether participants can strategically optimise the trade-off between quality and quantity for VSTM according to task demands. We manipulated strategic trade-off by varying expectations about the number of to be-remembered items (Experiments 1-2) or the precision required for the memory-based judgement (Experiment 3). In a final experiment, we manipulated both variables in a complementary way to maximise the motivation to strategically control the balance between number and the quality of items encoded into VSTM. In different blocks, performance would benefit most either by encoding a large number of items with low precision or by encoding a small number of items with high precision (Experiment 4). In all experiments, we compared VSTM performance on trials matched for mnemonic demand, but within contexts emphasising the quality or quantity of VSTM representations. Across all four experiments, we found no evidence to suggest that participants use this contextual information to bias the balance between the number and precision of items in VSTM. Rather, our data suggest that the trade-off may be determined primarily by stimulus-driven factors at encoding.	[Murray, Alexandra M.; Nobre, Anna C.; Astle, Duncan E.; Stokes, Mark G.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Nobre, Anna C.; Stokes, Mark G.] Univ Oxford, Oxford Ctr Human Brain Act, Oxford, England; [Astle, Duncan E.] MRC, Cognit & Brain Sci Unit, Cambridge, England	University of Oxford; University of Oxford	Murray, AM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	mark.stokes@ohba.ox.ac.uk		Murray, Alexandra/0000-0001-7143-287X; Astle, Duncan/0000-0002-7042-5392; Nobre, Anna Christina/0000-0001-5762-2802	Wellcome Trust [WT082791MA]; Commonwealth Scholarship; St John's College, Oxford; British Academy; Royal Society; Medical Research Council [MR/J009024/1, MC_UP_A060_1103] Funding Source: researchfish; MRC [MC_UP_A060_1103, MR/J009024/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Commonwealth Scholarship; St John's College, Oxford; British Academy; Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust [to ACN; WT082791MA]. In addition, AMM was supported by a Commonwealth Scholarship, MGS was supported by St John's College, Oxford, and DEA was supported by a Postdoctoral Fellowship from the British Academy and by a project grant from the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle DE, 2012, ATTEN PERCEPT PSYCHO, V74, P146, DOI 10.3758/s13414-011-0218-3; Barton B, 2009, J EXP PSYCHOL HUMAN, V35, P1359, DOI 10.1037/a0015792; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; Fukuda K, 2010, CURR OPIN NEUROBIOL, V20, P177, DOI 10.1016/j.conb.2010.03.005; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kingdom F, 2009, PALAMEDES MATLAB ROU; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murray AM, 2011, NEUROPSYCHOLOGIA, V49, P1458, DOI 10.1016/j.neuropsychologia.2011.02.016; Neurobehavioral Systems, 2009, PRES V 13 0; Nobre AC, 2000, NEUROPSYCHOLOGIA, V38, P964, DOI 10.1016/S0028-3932(00)00015-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; Rouder JN, 2008, P NATL ACAD SCI USA, V105, P5975, DOI 10.1073/pnas.0711295105; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Stokes M, 2011, ATTENTION VSTM; Stokes M, 2009, P NATL ACAD SCI USA, V106, P19569, DOI 10.1073/pnas.0905306106; Wilken P, 2004, J VISION, V4, P1120, DOI 10.1167/4.12.11; Wyble B, 2011, J EXP PSYCHOL GEN, V140, P488, DOI 10.1037/a0023612; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860; Zhang WW, 2011, PSYCHOL SCI, V22, P1434, DOI 10.1177/0956797611417006; Zhang WW, 2009, PSYCHOL SCI, V20, P423, DOI 10.1111/j.1467-9280.2009.02322.x	26	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41223	10.1371/journal.pone.0041223	http://dx.doi.org/10.1371/journal.pone.0041223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905099	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100012
J	Prasad, R; Vaid, M; Katiyar, SK				Prasad, Ram; Vaid, Mudit; Katiyar, Santosh K.			Grape Proanthocyanidin Inhibit Pancreatic Cancer Cell Growth In Vitro and In Vivo through Induction of Apoptosis and by Targeting the PI3K/Akt Pathway	PLOS ONE			English	Article							ACTIVATED AKT; CARCINOMA-CELLS; CYCLE CONTROL; BCL-2 FAMILY; EXPRESSION; PROTEIN; PHOSPHORYLATION; KINASES; MICE; SKIN	Pancreatic cancer is an aggressive malignancy that is frequently diagnosed at an advanced stage with poor prognosis. Here, we report the chemotherapeutic effects of bioactive proanthocyanidins from grape seeds (GSPs) as assessed using In Vitro and In Vivo models. Treatment of human pancreatic cancer cells (Miapaca-2, PANC-1 and AsPC-1) with GSPs In Vitro reduced cell viability and increased G2/M phase arrest of the cell cycle leading to induction of apoptosis in a dose- and time-dependent manner. The GSPs-induced apoptosis of pancreatic cancer cells was associated with a decrease in the levels of Bcl-2 and Bcl-xl and an increase in the levels of Bax and activated caspase-3. Treatment of Miapaca-2 and PANC-1 cells with GSPs also decreased the levels of phosphatidylinositol-3-kinase (PI3K) and phosphorylation of Akt at ser(473). siRNA knockdown of PI3K from pancreatic cancer cells also reduced the phosphorylation of Akt. Further, dietary administration of GSPs (0.5%, w/w) as a supplemented AIN76A control diet significantly inhibited the growth of Miapaca-2 pancreatic tumor xenografts grown subcutaneously in athymic nude mice, which was associated with: (i) inhibition of cell proliferation, (ii) induction of apoptosis of tumor cells, (iii) increased expression of Bax, reduced expression of anti-apoptotic proteins and activation of caspase-3-positive cells, and (iv) decreased expression of PI3K and p-Akt in tumor xenograft tissues. Together, these results suggest that GSPs may have a potential chemotherapeutic effect on pancreatic cancer cell growth.	[Prasad, Ram; Vaid, Mudit; Katiyar, Santosh K.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Prasad, R (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	skatiyar@uab.edu			Veterans Administration Merit Review Award	Veterans Administration Merit Review Award(US Department of Veterans Affairs)	This work was supported by funds from the Veterans Administration Merit Review Award (SKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Bondar VM, 2002, MOL CANCER THER, V1, P989; Chadha KS, 2006, ANN SURG ONCOL, V13, P933, DOI 10.1245/ASO.2006.07.011; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; DEMESQUITA HBB, 1991, INT J CANCER, V48, P540, DOI 10.1002/ijc.2910480411; Fahy BN, 2003, BRIT J CANCER, V89, P391, DOI 10.1038/sj.bjc.6601037; GRANA X, 1995, ONCOGENE, V11, P211; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; KASTAN MB, 1995, CANCER METAST REV, V14, P3, DOI 10.1007/BF00690207; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Magee CJ, 2002, BEST PRACT RES CL GA, V16, P435, DOI 10.1053/bega.2002.0317; Mantena SK, 2005, J NUTR, V135, P2871, DOI 10.1093/jn/135.12.2871; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Meeran SM, 2009, CARCINOGENESIS, V30, P520, DOI 10.1093/carcin/bgp019; Mittal A, 2003, CARCINOGENESIS, V24, P1379, DOI 10.1093/carcin/bgg095; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; Nandakumar V, 2008, CANC LETT, V375, P162; Ng SSW, 2001, CLIN CANCER RES, V7, P3269; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Sharma SD, 2007, MOL CANCER THER, V6, P995, DOI 10.1158/1535-7163.MCT-06-0661; Sharma SD, 2010, MOL CANCER THER, V9, P569, DOI 10.1158/1535-7163.MCT-09-0638; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027444; Sun Q, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-134; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021539; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	36	62	72	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e43064	10.1371/journal.pone.0043064	http://dx.doi.org/10.1371/journal.pone.0043064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905202	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100082
J	Spanos, A; Theocharis, G; Karageorgopoulos, DE; Peppas, G; Fouskakis, D; Falagas, ME				Spanos, Alex; Theocharis, George; Karageorgopoulos, Drosos E.; Peppas, George; Fouskakis, Dimitris; Falagas, Matthew E.			Surveillance of Community Outbreaks of Respiratory Tract Infections Based on House-Call Visits in the Metropolitan Area of Athens, Greece	PLOS ONE			English	Article							METEOROLOGICAL VARIABLES; INFLUENZA; ETIOLOGY	Background: The traditional Serfling-type approach for influenza-like illness surveillance requires long historical time-series. We retrospectively evaluated the use of recent, short, historical time-series for recognizing the onset of community outbreaks of respiratory tract infections (RTIs). Methods: The data used referred to the proportion of diagnoses for upper or lower RTIs to total diagnoses for house-call visits, performed by a private network of medical specialists (SOS Doctors) in the metropolitan area of Athens, Greece, between January 01, 2000 and October 12, 2008. The reference standard classification of the observations was obtained by generating epidemic thresholds after analyzing the full 9-year period. We evaluated two different alert generating methods [simple regression and cumulative sum (CUSUM), respectively], under a range of input parameters, using data for the previous running 4-6 week period. These methods were applied if the previous weeks contained non-aberrant observations. Results: We found that the CUSUM model with a specific set of parameters performed marginally better than simple regression for both groups. The best results (sensitivity, specificity) for simple regression and CUSUM models for upper RTIs were (1.00, 0.82) and (0.94, 0.93) respectively. Corresponding results for lower RTIs were (1.00, 0.80) and (0.93, 0.91) respectively. Conclusions: Short-term data for house-call visits can be used rather reliably to identify respiratory tract outbreaks in the community using simple regression and CUSUM methods. Such surveillance models could be particularly useful when a large historical database is either unavailable or inaccurate and, thus, traditional methods are not optimal.	[Spanos, Alex; Karageorgopoulos, Drosos E.; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Theocharis, George; Peppas, George] SOS Doctors, Athens, Greece; [Fouskakis, Dimitris] Natl Tech Univ Athens, Dept Math, GR-15773 Athens, Greece; [Falagas, Matthew E.] Henry Dunant Hosp, Dept Med, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; National Technical University of Athens; Henry Dunant Hospital; Tufts University	Spanos, A (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	Karageorgopoulos, Drosos/K-9241-2018; Fouskakis, Dimitris/AAG-3101-2021	Karageorgopoulos, Drosos/0000-0002-9959-9978; Fouskakis, Dimitris/0000-0001-8514-6911				Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Falagas ME, 2011, EPIDEMIOL INFECT, V139, P27, DOI 10.1017/S0950268810002037; Falagas ME, 2009, EUR J CLIN MICROBIOL, V28, P709, DOI 10.1007/s10096-008-0679-z; Falagas ME, 2008, RESP MED, V102, P733, DOI 10.1016/j.rmed.2007.12.010; Falagas ME, 2009, CAN MED ASSOC J, V181, P484, DOI 10.1503/cmaj.090694; Foldy Seth L, 2004, MMWR Suppl, V53, P12; GARIBALDI RA, 1985, AM J MED, V78, P32, DOI 10.1016/0002-9343(85)90361-4; Gault G, 2009, J PUBLIC HEALTH-UK, V31, P286, DOI 10.1093/pubmed/fdp020; Han SW, 2010, QUAL RELIAB ENG INT, V26, P279, DOI 10.1002/qre.1056; Hawkins DM., 1998, STAT ENGN PHYS SCI, DOI 10.2307/2670188; Heisterkamp SH, 2006, STAT MED, V25, P4179, DOI 10.1002/sim.2674; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Hutwagner L, 2005, EMERG INFECT DIS, V11, P314, DOI 10.3201/eid1102.040587; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; Karageorgopoulos D. E., 2011, PLoS ONE, pe21690, DOI 10.1371/journal.pone.0021690; Lazarus R, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-9; Lenz HJ, 2001, FRONTIERS STAT QUALI, V9; Lu HM, 2010, IEEE T KNOWL DATA EN, V22, P565, DOI 10.1109/TKDE.2009.115; Martinez-Beneito MA, 2008, STAT MED, V27, P4455, DOI 10.1002/sim.3320; Montgomery D.C., 2011, INTRO STAT QUALITY C, V6th; Oakland JS, 2007, STAT PROCESS CONTROL, DOI 10.4324/9780080551739; Pelat C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-29; Peppas G, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-112; Pham H., 2006, SPRINGER HDB ENG STA; R Development Core Team, R LANG ENV STAT COMP; Rath TM, 2003, AUTOMATED DETECTION; Ryan TP., 2007, MODERN ENG STAT; Sebastiani P., 2006, STAT MED, V25, P1817; Sebastiani P, 2006, STAT MED, V25, P1803, DOI 10.1002/sim.2566; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Unkel S, 2010, STAT METHODS PROSPEC; Wagner M M, 2001, J Public Health Manag Pract, V7, P51; Wagner MM., 2006, HDB BIOSURVEILLANCE; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	38	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e40310	10.1371/journal.pone.0040310	http://dx.doi.org/10.1371/journal.pone.0040310			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905091	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100003
J	Hsu, WL; Tse, KP; Liang, SR; Chien, YC; Su, WH; Yu, KJ; Cheng, YJ; Tsang, NM; Hsu, MM; Chang, KP; Chen, IH; Chen, TI; Yang, CS; Goldstein, AM; Chen, CJ; Chang, YS; Hildesheim, A				Hsu, Wan-Lun; Tse, Ka-Po; Liang, Sharon; Chien, Yin-Chu; Su, Wen-Hui; Yu, Kelly J.; Cheng, Yu-Juen; Tsang, Ngan-Ming; Hsu, Mow-Ming; Chang, Kai-Ping; Chen, I-How; Chen, Tzu-I; Yang, Czau-Siung; Goldstein, Alisa M.; Chen, Chien-Jen; Chang, Yu-Sun; Hildesheim, Allan			Evaluation of Human Leukocyte Antigen-A (HLA-A), Other Non-HLA Markers on Chromosome 6p21 and Risk of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CLASS-I; SUSCEPTIBILITY; TAIWAN; ASSOCIATION; HAPLOTYPES; ALLELES	Background: The association between human leukocyte antigen (HLA) genes (located in the Major Histocompatibility Complex [MHC] region of chromosome 6p21) and NPC has been known for some time. Recently, two genome-wide association studies (GWAS) conducted in Taiwan and China confirmed that the strongest evidence for NPC association was mapped to the MHC region. It is still unclear, however, whether these findings reflect direct associations with Human Leukocyte Antigen (HLA) genes and/or to other genes in this gene-rich region. Methods: To better understand genetic associations for NPC within the MHC region of chromosome 6, we conducted an evaluation that pooled two previously conducted NPC case-control studies in Taiwan (N = 591 cases and N = 521 controls). PCR-based genotyping was performed for 12 significant SNPs identified within 6p21 in the Taiwan NPC GWAS and for the HLA-A gene (exons 2 and 3). Findings: After confirming homogeneity between the two studies, pooled odds ratios (OR) and 95% confidence intervals (CI) were estimated by logistic regression. We found that HLA-A (p-trend = 0.0006) and rs29232 (within the GABBR1 gene; p-trend = 0.005) were independent risk factors for NPC after adjustment for age, gender, study and each other. NPC risk was highest among individuals who were homozygous for the HLA-A*0207 risk allele and carriers of the rs29232 risk allele (A). Conclusion: Our study suggests that most of the SNPs significantly associated with NPC from GWAS reflect previously identified HLA-A associations. An independent effect of rs29232 (GABBR1), however, remained, suggesting that additional genes within this region might be associated with NPC risk.	[Hsu, Wan-Lun; Chen, Tzu-I; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Tse, Ka-Po; Chang, Yu-Sun] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Genome Med Core, Tao Yuan, Taiwan; [Liang, Sharon; Yu, Kelly J.; Goldstein, Alisa M.] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Liang, Sharon] US FDA, Rockville, MD 20857 USA; [Chien, Yin-Chu] China Med Univ Hosp, Mol & Genom Epidemiol Res Ctr, Taichung, Taiwan; [Su, Wen-Hui] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Mol Epidemiol Core, Tao Yuan, Taiwan; [Su, Wen-Hui] Chang Gung Univ, Grad Inst Biomed Sci, Dept Biomed Sci, Tao Yuan, Taiwan; [Yu, Kelly J.] NCI, Canc Prevent Div, Rockville, MD USA; [Cheng, Yu-Juen; Chen, Chien-Jen] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Tsang, Ngan-Ming] Chang Gung Mem Hosp Lin Kou, Dept Radiat Oncol, Tao Yuan, Taiwan; [Hsu, Mow-Ming] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Chang, Kai-Ping; Chen, I-How] Chang Gung Mem Hosp Lin Kou, Dept Otolaryngol, Tao Yuan, Taiwan; [Yang, Czau-Siung] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA); China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Taiwan University; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; National Taiwan University	Hsu, WL (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	ysc@mail.cgu.edu.tw	Hildesheim, Allan/B-9760-2015; Chen, Chien-Jen/C-6976-2008; Chen, Chien-Jen/N-4723-2019	Hildesheim, Allan/0000-0003-0257-2363; Chang, Yu-Sun/0000-0002-6457-3890; Su, Wen-Hui/0000-0003-1037-4615	National Institutes of Health, USA; Ministry of Education, Taiwan; NATIONAL CANCER INSTITUTE [ZIACP010210] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Taiwan(Ministry of Education, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by the intramural funds from the National Institutes of Health, USA and The Top University Project of Ministry of Education, Taiwan (to Chang Gung University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, IARC MONOGRAPHS EVAL, V70, P47; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Chen LC, 2011, MODERN PATHOL, V24, P175, DOI 10.1038/modpathol.2010.193; Cheng YJ, 1999, CANCER CAUSE CONTROL, V10, P201, DOI 10.1023/A:1008893109257; Chien Y., 2003, CANC REV ASIA PAC, V01, P1, DOI [10.1142/s0219836303000074, DOI 10.1142/S0219836303000074]; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; GAVIOLI R, 1993, J VIROL, V67, P1572, DOI 10.1128/JVI.67.3.1572-1578.1993; Helmberg W, 2004, NUCLEIC ACIDS RES, V32, pW173, DOI 10.1093/nar/gkh424; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; HILDESHEIM A, 1993, EPIDEMIOL REV, V15, P466, DOI 10.1093/oxfordjournals.epirev.a036130; Hildesheim A, 1997, J NATL CANCER I, V89, P1207, DOI 10.1093/jnci/89.16.1207; Lai MJ, 2010, HUM IMMUNOL, V71, P777, DOI 10.1016/j.humimm.2010.05.013; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014562; SANTAMARIA P, 1993, HUM IMMUNOL, V37, P39, DOI 10.1016/0198-8859(93)90141-M; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; Tang M, 2010, GENES IMMUN, V11, P334, DOI 10.1038/gene.2009.109; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Xiong W, 2004, CANCER RES, V64, P1972, DOI 10.1158/0008-5472.CAN-03-3253; Yu KJ, 2009, HUM IMMUNOL, V70, P910, DOI 10.1016/j.humimm.2009.08.005	20	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42767	10.1371/journal.pone.0042767	http://dx.doi.org/10.1371/journal.pone.0042767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880099	Green Published, Green Submitted, gold			2022-12-27	WOS:000307437900053
J	Sato, Y; Nagata, S; Takiguchi, M				Sato, Yoshinori; Nagata, Sayaka; Takiguchi, Masafumi			Effective Elicitation of Human Effector CD8(+) T Cells in HLA-B*51:01 Transgenic Humanized Mice after Infection with HIV-1	PLOS ONE			English	Article							SCID IL2R-GAMMA(NULL) MICE; MHC CLASS-I; RESTRICTED IMMUNE-RESPONSES; HEMATOPOIETIC STEM-CELLS; BLOOD CD34(+) CELLS; ALPHA-3 DOMAIN; MOUSE MODEL; PHENOTYPIC CLASSIFICATION; HOMEOSTATIC PROLIFERATION; SPECIES-SPECIFICITY	Humanized mice are expected to be useful as small animal models for in vivo studies on the pathogenesis of infectious diseases. However, it is well known that human CD8(+) T cells cannot differentiate into effector cells in immunodeficient mice transplanted with only human CD34(+) hematopoietic stem cells (HSCs), because human T cells are not educated by HLA in the mouse thymus. We here established HLA-B*51:01 transgenic humanized mice by transplanting human CD34(+) HSCs into HLA-B*51:01 transgenic NOD/SCID/Jak3(-/-) mice (hNOK/B51Tg mice) and investigated whether human effector CD8(+) T cells would be elicited in the mice or in those infected with HIV-1 NL4-3. There were no differences in the frequency of late effector memory and effector subsets (CD27(low)CD28(-)CD45RA(+/-)CCR7(-) and CD27(-)CD28(-)CD45RA(+/-)CCR7(-), respectively) among human CD8(+) T cells and in that of human CD8(+) T cells expressing CX3CR1 and/or CXCR1 between hNOK/B51Tg and hNOK mice. In contrast, the frequency of late effector memory and effector CD8(+) T cell subsets and of those expressing CX3CR1 and/or CXCR1 was significantly higher in HIV-1-infected hNOK/B51Tg mice than in uninfected ones, whereas there was no difference in that of these subsets between HIV-1-infected and uninfected hNOK mice. These results suggest that hNOK/B51Tg mice had CD8(+) T cells that were capable of differentiating into effector T cells after viral antigen stimulation and had a greater ability to elicit effector CD8(+) T cells than hNOK ones.	[Sato, Yoshinori; Nagata, Sayaka; Takiguchi, Masafumi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	Kumamoto University	Sato, Y (corresponding author), Kumamoto Univ, Ctr AIDS Res, 2-2-1 Honjo, Kumamoto, Japan.	masafumi@kumamoto-u.ac.jp	Sato, Yoshinori/J-2497-2015; Takiguchi, Masafumi/E-7468-2013	Sato, Yoshinori/0000-0001-8250-6598; 	Global COE program "Global Education and Research Center Aiming at the Control of AIDS" [F-13]; Ministry of Education, Science, Sports, Culture and Technology, Japan [23700513]	Global COE program "Global Education and Research Center Aiming at the Control of AIDS"; Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Global COE program "Global Education and Research Center Aiming at the Control of AIDS," (No. F-13) launched as a project commissioned by the Ministry of Education, Science, Sports, and Culture and Technology, Japan; and by a grant-in-aid (No. 23700513) for scientific research from the Ministry of Education, Science, Sports, Culture and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir AL, 2010, BLOOD, V115, P3146, DOI 10.1182/blood-2009-07-234906; Appay V, 2002, J IMMUNOL, V168, P3660, DOI 10.4049/jimmunol.168.7.3660; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Berges BK, 2010, VIROLOGY, V397, P100, DOI 10.1016/j.virol.2009.10.034; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brehm MA, 2012, BLOOD, V119, P2778, DOI 10.1182/blood-2011-05-353243; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; COMBADIERE B, 2003, 17 INT AIDS C MEX CI, V17, P1279, DOI DOI 10.1097/01.AIDS.0000060413.18106.9D; Denton PW, 2011, AIDS REV, V13, P135; Eisenman J, 2002, CYTOKINE, V20, P121, DOI 10.1006/cyto.2002.1989; Garcia S, 2012, IMMUNOL LETT; Gasser O, 2005, BLOOD, V106, P3718, DOI 10.1182/blood-2005-04-1366; Gorantla S, 2010, J IMMUNOL, V184, P7082, DOI 10.4049/jimmunol.1000438; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Pham HP, 2012, EUR J IMMUNOL, V42, P760, DOI 10.1002/eji.201141798; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Hess C, 2004, BLOOD, V104, P3463, DOI 10.1182/blood-2004-03-1067; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Jaiswal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007251; Jiang Q, 2008, BLOOD, V112, P2858, DOI 10.1182/blood-2008-03-145946; KAMEYAMA Y, 1994, NEUROTOXICOLOGY, V15, P75; KARAKI S, 1993, IMMUNOGENETICS, V37, P139; LAFACE DM, 1995, J EXP MED, V182, P1315, DOI 10.1084/jem.182.5.1315; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; Marodon G, 2009, EUR J IMMUNOL, V39, P2136, DOI 10.1002/eji.200939480; Matsumura B, 2003, EXP HEMATOL, V31, P789, DOI 10.1016/S0301-472X(03)00193-0; Melenhorst JJ, 2010, BLOOD, V116, P4700, DOI 10.1182/blood-2010-06-289991; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Nauta AJ, 2005, EXP HEMATOL, V33, P1249, DOI 10.1016/j.exphem.2005.06.019; Nesic D, 1998, J IMMUNOL, V160, P3705; NEWBERG MH, 1992, J IMMUNOL, V149, P136; Nie CY, 2009, VIROLOGY, V394, P64, DOI 10.1016/j.virol.2009.08.011; Nishimura M, 2002, J IMMUNOL, V168, P6173, DOI 10.4049/jimmunol.168.12.6173; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; Okada R, 2008, INT IMMUNOL, V20, P1189, DOI 10.1093/intimm/dxn075; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; Sato K, 2010, J VIROL, V84, P9546, DOI 10.1128/JVI.00823-10; Sato Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013109; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Singh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038491; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Takata H, 2004, J IMMUNOL, V173, P2231, DOI 10.4049/jimmunol.173.4.2231; Takata H, 2006, J IMMUNOL, V177, P4330, DOI 10.4049/jimmunol.177.7.4330; TEITELL M, 1993, J EXP MED, V178, P2139, DOI 10.1084/jem.178.6.2139; Tomiyama H, 2005, J IMMUNOL, V174, P36, DOI 10.4049/jimmunol.174.1.36; Tomiyama H, 2002, J VIROL, V76, P7535, DOI 10.1128/JVI.76.15.7535-7543.2002; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Watanabe S, 2007, J VIROL, V81, P13259, DOI 10.1128/JVI.01353-07; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Wils EJ, 2011, J IMMUNOL, V187, P2974, DOI 10.4049/jimmunol.1004209; Yahata T, 2002, J IMMUNOL, V169, P204, DOI 10.4049/jimmunol.169.1.204; Yajima M, 2008, J INFECT DIS, V198, P673, DOI 10.1086/590502	66	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42776	10.1371/journal.pone.0042776	http://dx.doi.org/10.1371/journal.pone.0042776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880104	gold, Green Published, Green Submitted			2022-12-27	WOS:000307810000069
J	Zou, L; Xu, HG; Ren, W; Jin, R; Wang, Y; Zhou, GP				Zou, Li; Xu, Hua-Guo; Ren, Wei; Jin, Rui; Wang, Yi; Zhou, Guo-Ping			Transcriptional Activation of the Human CD2AP Promoter by E2F1	PLOS ONE			English	Article							CD2-ASSOCIATED PROTEIN; NEPHROTIC SYNDROME; INDUCED APOPTOSIS; COMPLEX; FAMILY; PROLIFERATION; ENDOCYTOSIS; EXPRESSION; REPRESSION; MUTATION	CD2-associated protein (CD2AP) is an adaptor molecule involved in T cell receptor signaling and podocyte homeostasis. CD2AP-deficient mice develop nephritic syndrome and renal failure caused by glomerulosclerosis. Transcription factor E2F1 is a key regulator of cell proliferation and apoptosis. Here we report that E2F1 up-regulates the human CD2AP promoter and further increases the mRNA and protein levels of the human CD2AP in human embryonic kidney (HEK) 293 cells. By semi-quantitative RT-PCR and Western blot analysis we demonstrate that ectopic expression of E2F1 elevates the mRNA and protein levels of CD2AP. Consistently, transient transfection assays prove that overexpression of E2F1 transactivates the CD2AP promoter while knocking-down of endogenous E2F1 by a shRNA strategy results in reduction of the CD2AP promoter activity. Toward understanding the underlying mechanism of this regulation, we performed chromatin immunoprecipitation and mutations of the putative Sp1 binding sites, demonstrating that E2F1 can bind to Sp1 binding site and overexpression of E2F1 is capable of increasing the binding of E2F1 and decreasing the binding of Sp1 to Sp1 binding sites.	[Zou, Li; Xu, Hua-Guo; Ren, Wei; Jin, Rui; Wang, Yi; Zhou, Guo-Ping] Nanjing Med Univ, Dept Pediat, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Xu, Hua-Guo] Nanjing Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zou, L (corresponding author), Nanjing Med Univ, Dept Pediat, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	gpzhou2003@126.com			National Natural Science Foundation of China [30570863, 30872804, 81170661]; Natural Science Foundation of Jiangsu Province of China [BK2007244]; Specialized Research Fund for the Doctoral Program of Higher Education [20113234110010]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Medical Academic Key Talent Program of Jiangsu Province in China [RC2007050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Medical Academic Key Talent Program of Jiangsu Province in China	This work was supported by the National Natural Science Foundation of China (30570863, 30872804, 81170661), Natural Science Foundation of Jiangsu Province of China (BK2007244), Specialized Research Fund for the Doctoral Program of Higher Education (20113234110010), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and Medical Academic Key Talent Program of Jiangsu Province in China (RC2007050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bukur J, 2010, J BIOL CHEM, V285, P30419, DOI 10.1074/jbc.M109.094284; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; DeGregori J, 2006, CURR MOL MED, V6, P739; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Gubler MC, 2003, J AM SOC NEPHROL, V14, pS22, DOI 10.1097/01.ASN.0000067648.75923.68; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Kobayashi S, 2004, FASEB J, V18, P929, DOI 10.1096/fj.03-0767fje; Lowik MM, 2007, KIDNEY INT, V72, P1198, DOI 10.1038/sj.ki.5002469; Lu CT, 2008, INT J ARTIF INTELL T, V17, P1; Lu C, 2009, GENE, V433, P56, DOI 10.1016/j.gene.2008.11.015; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Ma YH, 2003, MOL CANCER THER, V2, P73; Racek T, 2008, J BIOL CHEM, V283, P34305, DOI 10.1074/jbc.M803925200; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Smoyer WE, 1998, J MOL MED, V76, P172, DOI 10.1007/s001090050206; Su XM, 2009, AM J NEPHROL, V29, P203, DOI 10.1159/000155658; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Weber S, 2004, KIDNEY INT, V66, P571, DOI 10.1111/j.1523-1755.2004.00776.x; Xavier S, 2009, J AM SOC NEPHROL, V20, P2127, DOI 10.1681/ASN.2008070806; Xu HG, 2012, MOL BIOL REP, V39, P1479, DOI 10.1007/s11033-011-0885-0; Xu HG, 2011, IMMUNOGENETICS, V63, P189, DOI 10.1007/s00251-010-0505-5; Xu HG, 2010, MOL BIOL REP, V37, P3073, DOI 10.1007/s11033-009-9880-0; Zhang HJ, 2009, J CELL BIOCHEM, V106, P464, DOI 10.1002/jcb.22033; Zhou DJ, 2005, GENE, V361, P89, DOI 10.1016/j.gene.2005.07.012	31	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42774	10.1371/journal.pone.0042774	http://dx.doi.org/10.1371/journal.pone.0042774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880102	Green Submitted, Green Published, gold			2022-12-27	WOS:000307284100167
J	Makino, K; Kawamura, K; Sato, W; Kawamura, N; Fujimoto, T; Terada, Y				Makino, Kenichi; Kawamura, Kazuhiro; Sato, Wataru; Kawamura, Nanami; Fujimoto, Toshio; Terada, Yukihiro			Inhibition of Uterine Sarcoma Cell Growth through Suppression of Endogenous Tyrosine Kinase B Signaling	PLOS ONE			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; PHASE-II TRIAL; PHOSPHATIDYLINOSITOL 3'-KINASE PATHWAY; PROTECTS NEUROBLASTOMA-CELLS; NEUROTROPHIC FACTOR; PREIMPLANTATION EMBRYOS; ADVANCED LEIOMYOSARCOMA; PROGNOSTIC-FACTORS; RECEPTOR TRKB; IN-VITRO	Uterine leiomyosarcoma is an aggressive tumor typically found at advanced stages due to difficulties with early diagnosis. Because uterine leiomyosarcoma is resistant to conventional radiation and chemotherapy, the development of more potent medical therapeutics is anticipated. Using quantitative real-time RT-PCR and immunostaining, we found the expression of brain-derived neurotrophic factor (BDNF) and neurotropin-4/5, together with their receptor, tyrosine kinase B (TrkB), in different uterine sarcoma cell lines and primary tumor samples from uterine leiomyosarcoma patients. We noted that levels of BDNF were more abundant than those of neurotropin-4/5. Moreover, the expression of TrkB and its ligands was elevated in a multidrug-resistant cell line and samples obtained from patients with leiomyosarcoma. In cultured uterine sarcoma cells, inhibition of endogenous TrkB signaling by treatment with either the soluble TrkB ectodomain or the Trk receptor inhibitor, K252a, suppressed cell proliferation and increased apoptosis based on cell viability and proliferation, in situ terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate nick end-labeling and caspase-3/7 assays, whereas an inactive plasma membrane nonpermeable K252b was ineffective. Correspondingly, treatment with exogenous BDNF increased cell proliferation. In in vivo studies in athymic nude mice bearing multidrug-resistant uterine sarcoma cell tumors, we demonstrate suppression of tumor growth by treatment with K252a, but not K252b, as reflected by decreased cell proliferation and increased levels of apoptosis and caspase-3/7 activities without obvious side effects. Our findings indicated that endogenous signaling of the TrkB pathway contributed to uterine sarcoma cell growth, and inhibition of TrkB signaling in these tumors could provide a novel medical therapy for patients with uterine sarcomas.	[Makino, Kenichi; Kawamura, Kazuhiro; Sato, Wataru; Kawamura, Nanami; Fujimoto, Toshio; Terada, Yukihiro] Akita Univ, Sch Med, Dept Obstet & Gynecol, Akita 010, Japan	Akita University	Makino, K (corresponding author), Akita Univ, Sch Med, Dept Obstet & Gynecol, Akita 010, Japan.	kawamura@yf7.so-net.ne.jp		Fujimoto, Toshio/0000-0001-5678-0438	Terumo Life Science Foundation [21791539, 23013004]; Kanae Foundation for the Promotion of Medical Science; Naito Foundation; Novartis Foundation for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation;  [21390447]	Terumo Life Science Foundation(Terumo Life Science Foundation); Kanae Foundation for the Promotion of Medical Science; Naito Foundation(Naito Memorial Foundation); Novartis Foundation for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation); 	This work was supported by grants from a Grant-In-Aid for Scientific Research (K. K.; Grant-In-Aid for Young Scientists B (grant numbers 21791539), Grant-In-Aid for Scientific Research on Priority Areas, THE GERMLINE: Its Developmental Cycle and Epigenome Network (grant numbers 23013004)) and research funds from the Terumo Life Science Foundation (K. K., http://www.terumozaidan.or.jp), the Kanae Foundation for the Promotion of Medical Science (K. K., http://www.kanae-zaidan.com/), the Naito Foundation (K. K., http://www.naito-f.or.jp), the Novartis Foundation for the Promotion of Science (K. K., http://novartisfound.or.jp/eng/index-e.html), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (K. K., http://www.mochida.co.jp/zaidan/), the Uehara Memorial Foundation (Y.T., http://www.ueharazaidan.com/), and Grant-In-Aid for Scientific Research B (Y.T., grant numbers 21390447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahira J, 2006, ONCOLOGY-BASEL, V71, P333, DOI 10.1159/000107107; Aoyama M, 2001, CANCER LETT, V164, P51, DOI 10.1016/S0304-3835(00)00715-1; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; Chen G, 1997, J BIOL CHEM, V272, P5974, DOI 10.1074/jbc.272.9.5974; Cimmino F, 2009, ONCOGENE, V28, P2015, DOI 10.1038/onc.2009.70; D'Adamo DR, 2005, J CLIN ONCOL, V23, P7135, DOI 10.1200/JCO.2005.16.139; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Dinh TA, 2004, GYNECOL ONCOL, V92, P648, DOI 10.1016/j.ygyno.2003.10.044; Dusenbery KE, 2004, GYNECOL ONCOL, V94, P191, DOI 10.1016/j.ygyno.2004.04.001; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; HARKER WG, 1985, CANCER RES, V45, P4091; Hensley ML, 2009, GYNECOL ONCOL, V115, P460, DOI 10.1016/j.ygyno.2009.09.011; Hensley ML, 2002, J CLIN ONCOL, V20, P2824, DOI 10.1200/JCO.2002.11.050; Ho R, 2002, CANCER RES, V62, P6462; ISHIWATA I, 1977, CANCER RES, V37, P658; Jaboin J, 2002, CANCER RES, V62, P6756; Kapp DS, 2008, CANCER-AM CANCER SOC, V112, P820, DOI 10.1002/cncr.23245; Kawamura K, 2005, BIOL REPROD, V73, P1094, DOI 10.1095/biolreprod.105.042754; Kawamura K, 2005, P NATL ACAD SCI USA, V102, P9206, DOI 10.1073/pnas.0502442102; Kawamura K, 2003, ENDOCRINOLOGY, V144, P2623, DOI 10.1210/en.2003-0033; Kawamura K, 2007, DEV BIOL, V311, P147, DOI 10.1016/j.ydbio.2007.08.026; Kawamura K, 2011, ENDOCRINOLOGY, V152, P1090, DOI 10.1210/en.2010-1124; Kawamura K, 2009, ENDOCRINOLOGY, V150, P3774, DOI 10.1210/en.2009-0213; Kawamura N, 2010, ENDOCRINOLOGY, V151, P3006, DOI 10.1210/en.2009-1378; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; LEIBSOHN S, 1990, AM J OBSTET GYNECOL, V162, P968, DOI 10.1016/0002-9378(90)91298-Q; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MATSUMOTO K, 1995, CANCER RES, V55, P1798; McMeekin DS, 2007, GYNECOL ONCOL, V106, P596, DOI 10.1016/j.ygyno.2007.05.013; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nakaigawa N, 2006, CANCER RES, V66, P3699, DOI 10.1158/0008-5472.CAN-05-0617; OMURA GA, 1983, CANCER, V52, P626, DOI 10.1002/1097-0142(19830815)52:4<626::AID-CNCR2820520409>3.0.CO;2-E; Reed NS, 2008, EUR J CANCER, V44, P808, DOI 10.1016/j.ejca.2008.01.019; Remmelink M, 1999, J CANCER RES CLIN, V125, P275, DOI 10.1007/s004320050274; Ren WH, 2008, CLIN CANCER RES, V14, P5466, DOI 10.1158/1078-0432.CCR-08-0562; Rose PG, 1998, GYNECOL ONCOL, V70, P267, DOI 10.1006/gyno.1998.5080; ROSS AH, 1995, J NEUROCHEM, V65, P2748; Sagae S, 2004, ONCOLOGY-BASEL, V67, P33, DOI 10.1159/000080283; Scala S, 1996, CANCER RES, V56, P3737; Sclabas GM, 2005, CLIN CANCER RES, V11, P440; Seddon BM, 2011, EUR J RADIOL, V78, P30, DOI 10.1016/j.ejrad.2010.12.057; Smith HO, 2002, GYNECOL ONCOL, V84, P140, DOI 10.1006/gyno.2001.6482; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Sutton G, 1996, GYNECOL ONCOL, V62, P226, DOI 10.1006/gyno.1996.0220; SUTTON GP, 1992, AM J OBSTET GYNECOL, V166, P556, DOI 10.1016/0002-9378(92)91671-V; TAPLEY P, 1992, ONCOGENE, V7, P371; THIGPEN JT, 1991, J CLIN ONCOL, V9, P1962, DOI 10.1200/JCO.1991.9.11.1962; Vanhecke E, 2011, CLIN CANCER RES, V17, P1741, DOI 10.1158/1078-0432.CCR-10-1890; Weissenbacher T, 2011, ANTICANCER RES, V31, P451; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765	53	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41049	10.1371/journal.pone.0041049	http://dx.doi.org/10.1371/journal.pone.0041049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911740	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700037
J	Chevalier, SA; Durand, S; Dasgupta, A; Radonovich, M; Cimarelli, A; Brady, JN; Mahieux, R; Pise-Masison, CA				Chevalier, Sebastien A.; Durand, Stephanie; Dasgupta, Arindam; Radonovich, Michael; Cimarelli, Andrea; Brady, John N.; Mahieux, Renaud; Pise-Masison, Cynthia A.			The Transcription Profile of Tax-3 Is More Similar to Tax-1 than Tax-2: Insights into HTLV-3 Potential Leukemogenic Properties	PLOS ONE			English	Article							T-LYMPHOTROPIC-VIRUS; NF-KAPPA-B; I-ASSOCIATED MYELOPATHY; NUCLEAR EXPORT SIGNAL; DOMAIN-BINDING MOTIF; GENE-EXPRESSION; TYPE-1 HTLV-1; PDZ DOMAIN; TRANSFORMING ACTIVITY; INTERACTION NETWORKS	Human T-cell Lymphotropic Viruses type 1 (HTLV-1) is the etiological agent of Adult T-cell Leukemia/Lymphoma. Although associated with lymphocytosis, HTLV-2 infection is not associated with any malignant hematological disease. Similarly, no infection-related symptom has been detected in HTLV-3-infected individuals studied so far. Differences in individual Tax transcriptional activity might account for these distinct physiopathological outcomes. Tax-1 and Tax-3 possess a PDZ binding motif in their sequence. Interestingly, this motif, which is critical for Tax-1 transforming activity, is absent from Tax-2. We used the DNA microarray technology to analyze and compare the global gene expression profiles of different T- and non T-cell types expressing Tax-1, Tax-2 or Tax-3 viral transactivators. In a T-cell line, this analysis allowed us to identify 48 genes whose expression is commonly affected by all Tax proteins and are hence characteristic of the HTLV infection, independently of the virus type. Importantly, we also identified a subset of genes (n = 70) which are specifically up-regulated by Tax-1 and Tax-3, while Tax-1 and Tax-2 shared only 1 gene and Tax-2 and Tax-3 shared 8 genes. These results demonstrate that Tax-3 and Tax-1 are closely related in terms of cellular gene deregulation. Analysis of the molecular interactions existing between those Tax-1/Tax-3 deregulated genes then allowed us to highlight biological networks of genes characteristic of HTLV-1 and HTLV-3 infection. The majority of those up-regulated genes are functionally linked in biological processes characteristic of HTLV-1-infected T-cells expressing Tax such as regulation of transcription and apoptosis, activation of the NF-kappa B cascade, T-cell mediated immunity and induction of cell proliferation and differentiation. In conclusion, our results demonstrate for the first time that, in T-and non T-cells types, Tax-3 is a functional analogue of Tax-1 in terms of transcriptional activation and suggest that HTLV-3 might share pathogenic features with HTLV-1 in vivo.	[Chevalier, Sebastien A.; Dasgupta, Arindam; Radonovich, Michael; Brady, John N.; Pise-Masison, Cynthia A.] NCI, Virus Tumor Biol Sect, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA; [Chevalier, Sebastien A.; Mahieux, Renaud] Ecole Normale Super, INSERM, U758, Retroviral Oncogenesis Lab, Lyon, France; [Durand, Stephanie; Cimarelli, Andrea] Ecole Normale Super, INSERM, U758, Lab Primate Lentiviruses, Lyon, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Chevalier, SA (corresponding author), NCI, Virus Tumor Biol Sect, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA.	sebastien.chevalier@ens-lyon.fr		mahieux, renaud/0000-0002-5129-6804; CIMARELLI, Andrea/0000-0003-0892-0488; DURAND, Stephanie/0000-0003-2434-9429	United States National Institutes of Health, National Cancer Institute; Center for Cancer Research; Fogerty fellowship; FRM (Fondation pour la Recherche Medicale); INCa (Institut National du Cancer); ANRS (Agence Nationale de Recherche sur le SIDA); SIDACTION; INSERM (Institut National de la Sante Et de la Recherche Medicale); ENS Lyon (Ecole Normale Superieure de Lyon)	United States National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fogerty fellowship; FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); ANRS (Agence Nationale de Recherche sur le SIDA)(ANRSFrench National Research Agency (ANR)); SIDACTION; INSERM (Institut National de la Sante Et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); ENS Lyon (Ecole Normale Superieure de Lyon)	This work was supported by the United States National Institutes of Health, National Cancer Institute, and the Center for Cancer Research. SAC was supported by Fogerty fellowship and is now supported by FRM (Fondation pour la Recherche Medicale) and by INCa (Institut National du Cancer). SD and AC are supported by ANRS (Agence Nationale de Recherche sur le SIDA) and SIDACTION. RM is supported by INSERM (Institut National de la Sante Et de la Recherche Medicale) and ENS Lyon (Ecole Normale Superieure de Lyon).	Afonso PV, 2010, BLOOD, V116, P3802, DOI 10.1182/blood-2010-02-270751; Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; [Anonymous], 1988, Int J Cancer, V41, P505, DOI 10.1002/ijc.2910410406; Araujo A, 2004, ANN NEUROL, V56, P10, DOI 10.1002/ana.20126; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bartman MT, 2008, BLOOD, V112, P3995, DOI 10.1182/blood-2008-05-155960; Baydoun HH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-302; Bellon M, 2010, BLOOD, V115, P2441, DOI 10.1182/blood-2009-08-241117; Bertazzoni U, 2011, VIRUSES-BASEL, V3, P541, DOI 10.3390/v3050541; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Calattini S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-30; Calattini S, 2006, J VIROL, V80, P9876, DOI 10.1128/JVI.00799-06; Calattini S, 2009, J INFECT DIS, V199, P561, DOI 10.1086/596206; Chevalier SA, 2006, ONCOGENE, V25, P4470, DOI 10.1038/sj.onc.1209472; Chevalier SA, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-70; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; De la Fuente C, 2000, AIDS RES HUM RETROV, V16, P1695, DOI 10.1089/08892220050193164; Douceron E, 2012, J INFECT DIS, V205, P82, DOI 10.1093/infdis/jir708; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Endo K, 2002, J VIROL, V76, P2648, DOI 10.1128/JVI.76.6.2648-2653.2002; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; GESSAIN A, 1985, LANCET, V2, P407; Halin M, 2009, BLOOD, V114, P2427, DOI 10.1182/blood-2008-09-179879; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Harhaj EW, 1999, ONCOGENE, V18, P1341, DOI 10.1038/sj.onc.1202405; Harhaj NS, 2007, J BIOL CHEM, V282, P4185, DOI 10.1074/jbc.M611031200; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; Hirata A, 2004, VIROLOGY, V318, P327, DOI 10.1016/j.virol.2003.10.006; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; JACOBSON S, 1993, ANN NEUROL, V33, P392, DOI 10.1002/ana.410330411; Journo C, 2009, FUTURE MICROBIOL, V4, P425, DOI 10.2217/FMB.09.13; Kadiu I, 2011, J PROTEOME RES, V10, P3225, DOI 10.1021/pr200262q; Kannian P, 2010, VIRUSES-BASEL, V2, P2037, DOI 10.3390/v2092037; Kfoury Y, 2008, ONCOGENE, V27, P1665, DOI 10.1038/sj.onc.1210804; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Larocque E, 2011, J VIROL, V85, P12673, DOI 10.1128/JVI.05296-11; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahieux R, 2000, J VIROL, V74, P6866, DOI 10.1128/JVI.74.15.6866-6874.2000; Mahieux R, 2011, VIRUSES-BASEL, V3, P1074, DOI 10.3390/v3071074; Matsuoka M, 2011, ONCOGENE, V30, P1379, DOI 10.1038/onc.2010.537; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Mauclere P, 2011, J INFECT DIS, V203, P1316, DOI 10.1093/infdis/jir031; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; Nejmeddine M, 2005, J BIOL CHEM, V280, P29653, DOI 10.1074/jbc.M502639200; Ng PWP, 2001, ONCOGENE, V20, P4484, DOI 10.1038/sj.onc.1204513; Nicot C, 2000, ONCOGENE, V19, P2155, DOI 10.1038/sj.onc.1203536; Oliere S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001177; OSAME M, 1986, LANCET, V1, P1031; Pise-Masison CA, 2002, CANCER RES, V62, P3562; Pise-Masison CA, 2009, BLOOD, V113, P4016, DOI 10.1182/blood-2008-08-175901; Ross TM, 1997, J VIROL, V71, P8912, DOI 10.1128/JVI.71.11.8912-8917.1997; Ross TM, 2000, J VIROL, V74, P2655, DOI 10.1128/JVI.74.6.2655-2662.2000; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Ruckes T, 2001, BLOOD, V98, P1150, DOI 10.1182/blood.V98.4.1150; Sasaki H, 2005, BLOOD, V105, P1204, DOI 10.1182/blood-2004-03-1222; Satou Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001274; Semmes OJ, 1996, VIROLOGY, V217, P373, DOI 10.1006/viro.1996.0126; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shoji T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-83; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takatsuki T., 1977, 16 INT C HEM AMST, P73; Tanaka Y, 1996, J VIROL, V70, P8508, DOI 10.1128/JVI.70.12.8508-8517.1996; Tattermusch S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002480; Tripp A, 2003, J VIROL, V77, P12152, DOI 10.1128/JVI.77.22.12152-12164.2003; Turci M, 2006, GENE, V365, P119, DOI 10.1016/J.gene.2005.09.043; Turci M, 2009, VIROLOGY; Van Prooyen N, 2010, MOL ASPECTS MED, V31, P333, DOI 10.1016/j.mam.2010.07.001; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; Wu XF, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-27; Wycuff DR, 2005, FRONT BIOSCI-LANDMRK, V10, P620, DOI 10.2741/1558; Xie L, 2006, BLOOD, V107, P1980, DOI 10.1182/blood-2005-03-1333; YAMAOKA S, 1992, ONCOGENE, V7, P433; Yan PR, 2009, BLOOD, V113, P4370, DOI 10.1182/blood-2008-10-185660; Zane L, 2010, VIROLOGY, V407, P341, DOI 10.1016/j.virol.2010.07.023; Zheng HQ, 2010, VIROLOGY, V401, P137, DOI 10.1016/j.virol.2010.03.010	87	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41003	10.1371/journal.pone.0041003	http://dx.doi.org/10.1371/journal.pone.0041003			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911729	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600033
J	Kotze, DJ; O'Hara, RB; Lehvavirta, S				Kotze, D. Johan; O'Hara, Robert B.; Lehvavirta, Susanna			Dealing with Varying Detection Probability, Unequal Sample Sizes and Clumped Distributions in Count Data	PLOS ONE			English	Article							CARABID BEETLE; ACTIVITY-DENSITY; COLEOPTERA; ASSEMBLAGES; DISPERSION; DYNAMICS; PATTERNS	Temporal variation in the detectability of a species can bias estimates of relative abundance if not handled correctly. For example, when effort varies in space and/or time it becomes necessary to take variation in detectability into account when data are analyzed. We demonstrate the importance of incorporating seasonality into the analysis of data with unequal sample sizes due to lost traps at a particular density of a species. A case study of count data was simulated using a spring-active carabid beetle. Traps were 'lost' randomly during high beetle activity in high abundance sites and during low beetle activity in low abundance sites. Five different models were fitted to datasets with different levels of loss. If sample sizes were unequal and a seasonality variable was not included in models that assumed the number of individuals was log-normally distributed, the models severely under-or overestimated the true effect size. Results did not improve when seasonality and number of trapping days were included in these models as offset terms, but only performed well when the response variable was specified as following a negative binomial distribution. Finally, if seasonal variation of a species is unknown, which is often the case, seasonality can be added as a free factor, resulting in well-performing negative binomial models. Based on these results we recommend (a) add sampling effort (number of trapping days in our example) to the models as an offset term, (b) if precise information is available on seasonal variation in detectability of a study object, add seasonality to the models as an offset term; (c) if information on seasonal variation in detectability is inadequate, add seasonality as a free factor; and (d) specify the response variable of count data as following a negative binomial or over-dispersed Poisson distribution.	[Kotze, D. Johan; Lehvavirta, Susanna] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [O'Hara, Robert B.] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [O'Hara, Robert B.] Biodivers & Climate Res Ctr, Frankfurt, Germany; [Lehvavirta, Susanna] Univ Helsinki, Finnish Museum Nat Hist, Bot Garden, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Kotze, DJ (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.	johan.kotze@helsinki.fi	O'Hara, Bob/A-7499-2008; Kotze, David J/A-2834-2008; Lehvävirta, Susanna/L-3948-2014	O'Hara, Bob/0000-0001-9737-3724; Kotze, David J/0000-0003-4211-4420; Lehvävirta, Susanna/0000-0002-8148-9981	Academy of Finland [126915]; Helsinki University Centre for Environment (HENVI); Biodiversity and Climate Research Centre (BiK-F) of Hesse's Ministry of Higher Education, Research and the Arts	Academy of Finland(Academy of Finland); Helsinki University Centre for Environment (HENVI); Biodiversity and Climate Research Centre (BiK-F) of Hesse's Ministry of Higher Education, Research and the Arts	Funding for D.J. Kotze and S. Lehvavirta was provided by the Academy of Finland (http://www.aka.fi/en-GB/A/, project number: 126915) and Helsinki University Centre for Environment (HENVI, http://www.helsinki.fi/henvi/english/). Funding for R. B. O'Hara was provided by the Biodiversity and Climate Research Centre (BiK-F), which is part of the LOEWE programme "Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaruikka D, 2002, J INSECT CONSERV, V6, P195, DOI 10.1023/A:1024432830064; [Anonymous], 1982, ESTIMATION ANIMAL AB; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Buckland S.T., 2001, pi; Carmona DM, 1999, ENVIRON ENTOMOL, V28, P1145, DOI 10.1093/ee/28.6.1145; Cornelissen T, 2008, BASIC APPL ECOL, V9, P67, DOI 10.1016/j.baae.2006.08.007; Crawley MJ, 2003, STAT COMPUTING INTRO; Cuesta D, 2008, ENVIRON POLLUT, V152, P394, DOI 10.1016/j.envpol.2007.06.073; Dennis P, 1997, J APPL ECOL, V34, P433, DOI 10.2307/2404888; Firle S, 1998, ECOLOGY, V79, P2113, DOI 10.1890/0012-9658(1998)079[2113:TIOMAR]2.0.CO;2; Giles J, 2006, NATURE, V443, P379, DOI 10.1038/443379b; Grandchamp A.C., 2000, URBAN ECOSYST, V4, P321; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Koivula M, 2004, J INSECT CONSERV, V8, P297, DOI 10.1007/s10841-004-0296-9; Koivula MJ, 2005, ANN ZOOL FENN, V42, P615; Kotze DJ, 2002, J BIOGEOGR, V29, P375, DOI 10.1046/j.1365-2699.2002.00681.x; Lehvavirta Susanna, 2006, Urban Ecosystems, V9, P13, DOI 10.1007/s11252-006-5526-3; Lindroth C.H., 1985, CARABIDAE COLEOPTE 1; Lindroth C.H., 1986, CARABIDAE COLEOPTE 2; Liu ZM, 2008, AUST J ENTOMOL, V47, P243, DOI 10.1111/j.1440-6055.2008.00651.x; Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; McCullagh P, 1989, GEN LINEAR MODELS; Niemela J, 2002, LANDSCAPE ECOL, V17, P387, DOI 10.1023/A:1021270121630; NIEMELA J, 1989, ANN ZOOL FENN, V26, P35; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; O'Hara RB, 2009, ANN ZOOL FENN, V46, P124, DOI 10.5735/086.046.0205; Onzo A, 2005, ENVIRON ENTOMOL, V34, P866, DOI 10.1603/0046-225X-34.4.866; Pawson SM, 2009, FOREST ECOL MANAG, V258, pS108, DOI 10.1016/j.foreco.2009.08.012; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2018, R LANG ENV STAT COMP; SEBER GAF, 1986, BIOMETRICS, V42, P267, DOI 10.2307/2531049; Thomas CFG, 1998, OECOLOGIA, V116, P103, DOI 10.1007/s004420050568; Underwood AJ, 1997, EXPT ECOLOGY; Venables WN., 2002, MODERN APPL STAT S 4; Venn SJ, 2003, EUR J ENTOMOL, V100, P73, DOI 10.14411/eje.2003.015; WARD D, 1992, J ARACHNOL, V20, P73; Whelan CJ, 2005, FUNCT ECOL, V19, P529, DOI 10.1111/j.1365-2435.2005.00996.x; White GC, 1996, ECOLOGY, V77, P2549, DOI 10.2307/2265753; WOLDA H, 1978, AM NAT, V112, P1017, DOI 10.1086/283344; Woltmann S, 2005, ORNITOL NEOTROP, V16, P337; Yin ZY, 2005, PLANT ECOL, V178, P189, DOI 10.1007/s11258-004-3285-x	43	31	31	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40923	10.1371/journal.pone.0040923	http://dx.doi.org/10.1371/journal.pone.0040923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911719	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600029
J	Pasotti, L; Politi, N; Zucca, S; De Angelis, MGC; Magni, P				Pasotti, Lorenzo; Politi, Nicolo; Zucca, Susanna; De Angelis, Maria Gabriella Cusella; Magni, Paolo			Bottom-Up Engineering of Biological Systems through Standard Bricks: A Modularity Study on Basic Parts and Devices	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; CONSTRUCTION; DESIGN; CELLS	Background: Modularity is a crucial issue in the engineering world, as it enables engineers to achieve predictable outcomes when different components are interconnected. Synthetic Biology aims to apply key concepts of engineering to design and construct new biological systems that exhibit a predictable behaviour. Even if physical and measurement standards have been recently proposed to facilitate the assembly and characterization of biological components, real modularity is still a major research issue. The success of the bottom-up approach strictly depends on the clear definition of the limits in which biological functions can be predictable. Results: The modularity of transcription-based biological components has been investigated in several conditions. First, the activity of a set of promoters was quantified in Escherichia coli via different measurement systems (i.e., different plasmids, reporter genes, ribosome binding sites) relative to an in vivo reference promoter. Second, promoter activity variation was measured when two independent gene expression cassettes were assembled in the same system. Third, the interchangeability of input modules (a set of constitutive promoters and two regulated promoters) connected to a fixed output device (a logic inverter) expressing GFP was evaluated. The three input modules provide tunable transcriptional signals that drive the output device. If modularity persists, identical transcriptional signals trigger identical GFP outputs. To verify this, all the input devices were individually characterized and then the input-output characteristic of the logic inverter was derived in the different configurations. Conclusions: Promoters activities (referred to a standard promoter) can vary when they are measured via different reporter devices (up to 22%), when they are used within a two-expression-cassette system (up to 35%) and when they drive another device in a functionally interconnected circuit (up to 44%). This paper provides a significant contribution to the study of modularity limitations in building biological systems by providing useful data on context-dependent variability of biological components.	[Pasotti, Lorenzo; Politi, Nicolo; Zucca, Susanna; Magni, Paolo] Univ Pavia, Dipartimento Ingn Ind & Informaz, I-27100 Pavia, Italy; [Pasotti, Lorenzo; Politi, Nicolo; Zucca, Susanna; De Angelis, Maria Gabriella Cusella; Magni, Paolo] Univ Pavia, Ctr Ingn Tissutale, I-27100 Pavia, Italy	University of Pavia; University of Pavia	Pasotti, L (corresponding author), Univ Pavia, Dipartimento Ingn Ind & Informaz, Via Palestro 3, I-27100 Pavia, Italy.	paolo.magni@unipv.it	Pasotti, Lorenzo/AAA-5215-2022; Zucca, Susanna/G-7087-2018	Pasotti, Lorenzo/0000-0002-5431-3083; Zucca, Susanna/0000-0001-8465-632X; Magni, Paolo/0000-0002-8931-4676; Cusella De Angelis, Maria Gabriella/0000-0003-2642-3346	Italian Ministero dell'Universita' e della Ricerca through the FIRB ITALBIONET project	Italian Ministero dell'Universita' e della Ricerca through the FIRB ITALBIONET project	This project was partially funded by the Italian Ministero dell'Universita' e della Ricerca through the FIRB ITALBIONET project. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Anderson JC, 2010, J BIOL ENG, V4; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cox IIIRS, 2010, J BIOL ENG, V4; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Foundation TB, BIOBRICKS STAND BIOL; French CE, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0527.focus; Hajimorad M, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-3; Heinemann M, 2006, BIOINFORMATICS, V22, P2790, DOI 10.1093/bioinformatics/btl469; Kelly JR, 2008, THESIS MIT; Kim K.H., 2010, J BIOL ENG, V4; Knight TF, 2003, INERT1989 ROC; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Martin L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007569; MIT, REG STAND BIOL PARTS; Pasotti L, 2011, BIOTECHNOL J, V6, P784, DOI 10.1002/biot.201100080; Pasotti L, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-8; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rubin AJ, 2009, J BIOL ENG, V3; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sauro HM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.3; Savage DF, 2008, ACS CHEM BIOL, V3, P13, DOI 10.1021/cb700259j; Serrano L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100202; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999; Zucca S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S11	35	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39407	10.1371/journal.pone.0039407	http://dx.doi.org/10.1371/journal.pone.0039407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911685	Green Published, gold			2022-12-27	WOS:000306644600005
J	Perney, NM; Braddick, L; Jurna, M; Garbacik, ET; Offerhaus, HL; Serpell, LC; Blanch, E; Holden-Dye, L; Brocklesby, WS; Melvin, T				Perney, Nicolas M.; Braddick, Lucy; Jurna, Martin; Garbacik, Erik T.; Offerhaus, Herman L.; Serpell, Louise C.; Blanch, Ewan; Holden-Dye, Lindy; Brocklesby, William S.; Melvin, Tracy			Polyglutamine Aggregate Structure In Vitro and In Vivo; New Avenues for Coherent Anti-Stokes Raman Scattering Microscopy	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; HUNTINGTONS-DISEASE; OPTICAL-ACTIVITY; PROTEIN; SPECTROSCOPY; CELLS; CARS; CONFORMATION; PATHOGENESIS; THRESHOLD	Coherent anti-Stokes Raman scattering (CARS) microscopy is applied for the first time for the evaluation of the protein secondary structure of polyglutamine (polyQ) aggregates in vivo. Our approach demonstrates the potential for translating information about protein structure that has been obtained in vitro by X-ray diffraction into a microscopy technique that allows the same protein structure to be detected in vivo. For these studies, fibres of polyQ containing peptides (D(2)Q(15)K(2)) were assembled in vitro and examined by electron microscopy and X-ray diffraction methods; the fibril structure was shown to be cross beta-sheet. The same polyQ fibres were evaluated by Raman spectroscopy and this further confirmed the beta-sheet structure, but indicated that the structure is highly rigid, as indicated by the strong Amide I signal at 1659 cm(-1). CARS spectra were simulated using the Raman spectrum taking into account potential non-resonant contributions, providing evidence that the Amide I signal remains strong, but slightly shifted to lower wavenumbers. Combined CARS (1657 cm(-1)) and multi-photon fluorescence microscopy of chimeric fusions of yellow fluorescent protein (YFP) with polyQ (Q40) expressed in the body wall muscle cells of Caenorhabditis elegans nematodes (1 day old adult hermaphrodites) revealed diffuse and foci patterns of Q40-YFP that were both fluorescent and exhibited stronger CARS (1657 cm(-1)) signals than in surrounding tissues at the resonance for the cross beta-sheet polyQ in vitro.	[Perney, Nicolas M.; Braddick, Lucy; Brocklesby, William S.; Melvin, Tracy] Univ Southampton, Optoelect Res Ctr, Highfield, Hants, England; [Jurna, Martin; Garbacik, Erik T.; Offerhaus, Herman L.] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Serpell, Louise C.] Univ Sussex, Sch Life Sci, Falmer, Sussex, England; [Blanch, Ewan] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Blanch, Ewan] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Holden-Dye, Lindy] Univ Southampton, Sch Biol Sci, Highfield, Hants, England	University of Southampton; University of Twente; University of Sussex; University of Manchester; University of Manchester; University of Southampton	Perney, NM (corresponding author), Univ Southampton, Optoelect Res Ctr, Highfield, Hants, England.	tm@orc.soton.ac.uk	Brocklesby, William S/D-4872-2011; Offerhaus, Herman/AAD-8742-2021; Offerhaus, Herman/D-4848-2014	Brocklesby, William S/0000-0002-2123-6712; Offerhaus, Herman/0000-0003-3697-5750; Offerhaus, Herman/0000-0003-3697-5750; Holden-Dye, Lindy/0000-0002-9704-1217; Serpell, Louise/0000-0001-9335-7751; Blanch, Ewan/0000-0002-0781-4926	EPSRC [EP/J019623/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J019623/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bell AF, 2000, BIOCHEMISTRY-US, V39, P4423, DOI 10.1021/bi992675o; Blanch EW, 2000, J MOL BIOL, V301, P553, DOI 10.1006/jmbi.2000.3981; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Cheng JX, 2002, BIOPHYS J, V83, P502, DOI 10.1016/S0006-3495(02)75186-2; Cheng JX, 2002, J OPT SOC AM B, V19, P1363, DOI 10.1364/JOSAB.19.001363; Cheng JX, 2001, OPT LETT, V26, P1341, DOI 10.1364/OL.26.001341; CHIKISHEV AY, 1992, BIOPHYS J, V63, P976, DOI 10.1016/S0006-3495(92)81691-0; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Fujita K, 2008, MOL CELLS, V26, P530; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Heiser V, 2002, P NATL ACAD SCI USA, V99, P16400, DOI 10.1073/pnas.182426599; Hellerer T, 2004, APPL PHYS LETT, V85, P25, DOI 10.1063/1.1768312; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Jurna M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.043905; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kirstein-Miles J, 2010, DEV DYNAM, V239, P1529, DOI 10.1002/dvdy.22292; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Konorov SO, 2007, ANAL CHEM, V79, P7221, DOI 10.1021/ac070544k; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kruglik SG, 2002, J AM CHEM SOC, V124, P10992, DOI 10.1021/ja0260824; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730; Le TT, 2010, J LIPID RES, V51, P672, DOI 10.1194/jlr.D000638; Makin OS, 2007, J APPL CRYSTALLOGR, V40, P966, DOI 10.1107/S0021889807034681; McColl IH, 2004, J AM CHEM SOC, V126, P5076, DOI 10.1021/ja049271q; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Petry R, 2003, CHEMPHYSCHEM, V4, P14, DOI 10.1002/cphc.200390004; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Sharma D, 1999, FEBS LETT, V456, P181, DOI 10.1016/S0014-5793(99)00933-3; Sikorski P, 2005, BIOMACROMOLECULES, V6, P425, DOI 10.1021/bm0494388; Vartiainen EM, 2006, OPT EXPRESS, V14, P3622, DOI 10.1364/OE.14.003622; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wyttenbach A, 2004, J MOL NEUROSCI, V23, P69, DOI 10.1385/JMN:23:1-2:069; Xie XS, 2006, SCIENCE, V312, P228, DOI 10.1126/science.1127566	42	9	10	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40536	10.1371/journal.pone.0040536	http://dx.doi.org/10.1371/journal.pone.0040536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911702	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000306644600020
J	Dehnert, M; Fingerle, V; Klier, C; Talaska, T; Schlaud, M; Krause, G; Wilking, H; Poggensee, G				Dehnert, Manuel; Fingerle, Volker; Klier, Christiane; Talaska, Thomas; Schlaud, Martin; Krause, Gerard; Wilking, Hendrik; Poggensee, Gabriele			Seropositivity of Lyme Borreliosis and Associated Risk Factors: A Population-Based Study in Children and Adolescents in Germany (KiGGS)	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; BURGDORFERI INFECTION; FORESTRY WORKERS; DISEASE; SEROPREVALENCE; URBAN; PREVALENCE; ANTIBODIES; BITES; SURVEILLANCE	Background: Lyme borreliosis (LB) caused by spirochetes of the Borrelia burgdorferi sensu lato complex is the most common tick-borne disease in the northern hemisphere. Data on the distribution and on risk factors in Germany are sketchy. Methodology/Principal Findings: Blood samples of a nationwide population-based cross-sectional study from 2003-2006 in children and adolescents aged 1 to 17 years in Germany (KiGGS) were analysed (n = 12,614) to assess the seroprevalence of anti-Borrelia antibodies. Data from standardized interviews were used to assess potential risk factors. First, sera were screened for anti-Borrelia antibodies by ELISA. The overall prevalence was 4.8% (95% confidence interval (CI) 4.3-5.4%). Positive and borderline ELISA test results were confirmed by a line blot revealing a combined prevalence of 4.0% (95% CI 3.6-4.5%). Seroprevalence of ELISA was significantly higher in males (odds ratio (OR) = 1.37; CI 1.15-1.63) and in the southern part of Germany (OR = 1.41; CI 1.09-1.83), but significantly lower in children and adolescents with migration background (OR = 0.33; CI 0.24-0.44). Study participants from households with cats had a higher chance of seropositivity (OR = 6.7; CI 5.6-8.0). In a multivariable model the odds of seropositivity increases by 11% for every year of age for boys and 6% for girls. Conclusions/Significance: This survey is the first nationwide, representative seroprevalence survey of LB in children and young adolescents. The study shows that infections with Borrelia burgdorferi are endemic in all parts of Germany despite regional differences. Even at a young age children are exposed to tick bites including seropositivity. Encouraging a thorough check for ticks and promptly removal of ticks are the key public health strategies to reduce the risk of LB and other tick-borne diseases in children and adolescents. Further epidemiological studies are warranted to better understand the burden of disease related to LB.	[Dehnert, Manuel; Krause, Gerard; Wilking, Hendrik; Poggensee, Gabriele] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Fingerle, Volker; Klier, Christiane] Bavarian Food & Hlth Safety Author, Natl Reference Ctr Borrelia, Oberschleissheim, Germany; [Talaska, Thomas] Inst Tickborne Dis, Brieskow Finkenheerd, Germany; [Schlaud, Martin] Robert Koch Inst, Dept Epidemiol & Hlth Reporting, Berlin, Germany	Robert Koch Institute; Bavarian Health & Food Safety Authority; Robert Koch Institute	Dehnert, M (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.	WilkingH@rki.de		Wilking, Hendrik/0000-0002-8574-5831; Krause, Gerard/0000-0003-3328-8808; Fingerle, Volker/0000-0002-3835-5646	German Federal Ministry of Health	German Federal Ministry of Health	The study was funded by a grant from the German Federal Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2011, EUR J CLIN MICROBIOL, V30, P1027, DOI 10.1007/s10096-011-1157-6; Barker TL, 2001, AM J TROP MED HYG, V65, P804, DOI 10.4269/ajtmh.2001.65.804; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; BOHME M, 1992, BEITR INFUS, V30, P96; Carlsson SA, 1998, SCAND J INFECT DIS, V30, P501, DOI 10.1080/00365549850161520; Castiglia P, 2004, Ann Ig, V16, P103; CHRISTEN HJ, 1993, ACTA PAEDIATR, V82, P1, DOI 10.1111/j.1651-2227.1993.tb18082.x; Cinco M., 1993, Alpe Adria Microbiology Journal, V2, P91; Franz JK, 2003, BEST PRACT RES CL RH, V17, P241, DOI 10.1016/S1521-6942(02)00129-8; Fulop B, 2008, PARASITOL RES, V103, pS117, DOI 10.1007/s00436-008-1060-y; GLASS GE, 1995, AM J PUBLIC HEALTH, V85, P944, DOI 10.2105/AJPH.85.7.944; GUY EC, 1991, LANCET, V338, P253, DOI 10.1016/0140-6736(91)90392-3; HASSLER D, 1992, DEUT MED WOCHENSCHR, V117, P767, DOI 10.1055/s-2008-1062374; HEININGER U, 1993, MONATSSCHR KINDERH, V141, P874; Hristea A, 2001, EUR J EPIDEMIOL, V17, P891, DOI 10.1023/A:1015600729900; Huppertz HI, 1999, EUR J CLIN MICROBIOL, V18, P697, DOI 10.1007/s100960050381; Junttila T, 1999, J CLIN MICROBIOL, V37, P1361, DOI 10.1128/JCM.37.5.1361-1365.1999; Kaya AD, 2008, NEW MICROBIOL, V31, P203; KORENBERG EI, 1993, EUR J EPIDEMIOL, V9, P86, DOI 10.1007/BF00463095; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lange R, 1993, VEKTORBIOLOGISCHE IN, P31; Letrilliart L, 2005, EPIDEMIOL INFECT, V133, P935, DOI 10.1017/S0950268805004413; Linard C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-15; Maetzel D, 2005, PARASITOL RES, V95, P5, DOI 10.1007/s00436-004-1240-3; MAGNARELLI LA, 1995, J CLIN MICROBIOL, V33, P541, DOI 10.1128/JCM.33.3.541-544.1995; Marangoni A, 2008, EUR J CLIN MICROBIOL, V27, P349, DOI 10.1007/s10096-007-0445-7; Matuschka FR, 1996, J INFECT DIS, V174, P1108, DOI 10.1093/infdis/174.5.1108; Muller I, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/595427; Oehme R, 2002, INT J MED MICROBIOL, V291, P22, DOI 10.1016/S1438-4221(02)80005-4; PAUL H, 1986, Zentralblatt fuer Bakteriologie Mikrobiologie und Hygiene Series A, V263, P473; POKORNY P, 1990, Ceskoslovenska Epidemiologie Mikrobiologie Imunologie, V39, P32; Reimer B, 1999, S GENT WILDB KREUTH; RKI, 2001, EPID B, V21, P147; RKI, 2007, EPID B, V38, P351; Robert Koch-Institut, 2010, EPID B, V12, P101; Schenk L, 2007, BUNDESGESUNDHEITSBLA, V50, P590, DOI 10.1007/s00103-007-0220-z; Skogman BH, 2010, ARCH DIS CHILD, V95, P1013, DOI 10.1136/adc.2010.183624; Smith R, 2000, EMERG INFECT DIS, V6, P404, DOI 10.3201/eid0604.000416; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; Thorin C, 2008, MED MALADIES INFECT, V38, P533, DOI 10.1016/j.medmal.2008.06.008; Tomao P, 2005, EUR J CLIN MICROBIOL, V24, P457, DOI 10.1007/s10096-005-1348-0; WEILAND T, 1992, BEITR INFUS, V30, P92; Weisshaar E, 2006, J INVEST DERMATOL, V126, P584, DOI 10.1038/sj.jid.5700160; Zhioua E, 1997, EUR J EPIDEMIOL, V13, P959, DOI 10.1023/A:1007465305193	45	56	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e41321	10.1371/journal.pone.0041321	http://dx.doi.org/10.1371/journal.pone.0041321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905101	Green Published, gold			2022-12-27	WOS:000307823600005
J	Fekete, N; Rojewski, MT; Furst, D; Kreja, L; Ignatius, A; Dausend, J; Schrezenmeier, H				Fekete, Natalie; Rojewski, Markus T.; Fuerst, Daniel; Kreja, Ludwika; Ignatius, Anita; Dausend, Julia; Schrezenmeier, Hubert			GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; STROMAL CELLS; PHENOTYPIC CHARACTERIZATION; DONOR VARIATION; HUMAN PLACENTA; DIFFERENTIATION; BLOOD	Background: Mesenchymal stromal cells (MSC) have gained importance in tissue repair, tissue engineering and in immunosupressive therapy during the last years. Due to the limited availability of MSC in the bone marrow, ex vivo amplification prior to clinical application is requisite to obtain therapeutic applicable cell doses. Translation of preclinical into clinical-grade large-scale MSC expansion necessitates precise definition and standardization of all procedural parameters including cell seeding density, culture medium and cultivation devices. While xenogeneic additives such as fetal calf serum are still widely used for cell culture, its use in the clinical context is associated with many risks, such as prion and viral transmission or adverse immunological reactions against xenogeneic components. Methods and Findings: We established animal-free expansion protocols using platelet lysate as medium supplement and thereby could confirm its safety and feasibility for large-scale MSC isolation and expansion. Five different GMP-compliant standardized protocols designed for the safe, reliable, efficient and economical isolation and expansion of MSC was performed and MSC obtained were analyzed for differentiation capacity by qPCR and histochemistry. Expression of standard MSC markers as defined by the International Society for Cellular Therapy as well as expression of additional MSC markers and of various chemokine and cytokine receptors was analysed by flow cytometry. Changes of metabolic markers and cytokines in the medium were addressed using the LUMINEX platform. Conclusions: The five different systems for isolation and expansion of MSC described in this study are all suitable to produce at least 100 millions of MSC, which is commonly regarded as a single clinical dose. Final products are equal according to the minimal criteria for MSC defined by the ISCT. We showed that chemokine and integrin receptors analyzed had the same expression pattern, suggesting that MSC from either of the systems show equal characteristics of homing and adhesion.	[Fekete, Natalie; Rojewski, Markus T.; Dausend, Julia; Schrezenmeier, Hubert] Univ Ulm Klinikum, Inst Transfus Med, Ulm, Germany; [Fekete, Natalie; Rojewski, Markus T.; Fuerst, Daniel; Dausend, Julia; Schrezenmeier, Hubert] Inst Klin Transfus Med & Immungenet, Ulm, Germany; [Kreja, Ludwika; Ignatius, Anita] Inst Unfallchirurg Forsch & Biomech, Ulm, Germany	Ulm University	Fekete, N (corresponding author), Univ Ulm Klinikum, Inst Transfus Med, Ulm, Germany.	markus.rojewski@uni-ulm.de	Fekete, Natalie/W-9220-2019; Ignatius, Anita/M-6012-2013	Ignatius, Anita/0000-0002-4782-1979; Rojewski, Markus/0000-0003-4265-0442; Fekete, Natalie/0000-0003-4856-9338	European Commission: CASCADE (Cultivated Adult Stem Cells as Alternative for Damaged Tissue) [223236, HEALTH-F5-2009-223236]; European Commission: REBORNE (Regenerating BOne defects using New biomedical Engineering approaches) [HEALTH- 2009-1.4.2-241879]; University Centre of Musculoskelettal Research, Ulm, Germany)	European Commission: CASCADE (Cultivated Adult Stem Cells as Alternative for Damaged Tissue); European Commission: REBORNE (Regenerating BOne defects using New biomedical Engineering approaches); University Centre of Musculoskelettal Research, Ulm, Germany)	This work was supported by grants from the 7th Framework Program of the European Commission: CASCADE (Cultivated Adult Stem Cells as Alternative for Damaged Tissue) (number 223236; HEALTH-F5-2009-223236) and REBORNE (Regenerating BOne defects using New biomedical Engineering approaches) (number HEALTH- 2009-1.4.2-241879), and the University Centre of Musculoskelettal Research, Ulm, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Antunes M., 2007, J EUR UNION, V324, P121; Arpornmaeklong P, 2004, INT J ORAL MAX SURG, V33, P60, DOI 10.1054/ijom.2003.0492; Battula VL, 2008, DIFFERENTIATION, V76, P326, DOI 10.1111/j.1432-0436.2007.00225.x; Bernardo ME, 2011, BEST PRACT RES CL HA, V24, P73, DOI 10.1016/j.beha.2010.11.002; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Buhring HJ, 2009, ANN NY ACAD SCI, V1176, P124, DOI 10.1111/j.1749-6632.2009.04564.x; Bundes_aerztekammer, 2010, RICHTL GEW BLUT BLUT; CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; European Commission, 2003, OJ L, V262, P1422; EuropeanCommission, 2002, OFFICIAL J EUROPEA L, V45, P30; FDA, 2011, GUID IND CURR GOOD T; Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420; Henschler R, 2008, TRANSFUS MED HEMOTH, V35, P306, DOI 10.1159/000143110; Horwitz EM, 2008, CYTOTHERAPY, V10, P771, DOI 10.1080/14653240802618085; Hwang JH, 2009, J KOREAN MED SCI, V24, P547, DOI 10.3346/jkms.2009.24.4.547; Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8; Rojewski MT, 2008, TRANSFUS MED HEMOTH, V35, P168, DOI 10.1159/000129013; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Subbanna PKT, 2007, MED HYPOTHESES, V69, P469, DOI 10.1016/j.mehy.2006.12.016; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Tautzenberger A, 2010, BIOMATERIALS, V31, P2064, DOI 10.1016/j.biomaterials.2009.11.099; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Vogel JP, 2006, PLATELETS, V17, P462, DOI 10.1080/09537100600758867; Wagner W, 2008, TRANSFUS MED HEMOTH, V35, P185, DOI 10.1159/000128956; Xia WJ, 2011, CELL BIOL INT, V35, P639, DOI 10.1042/CBI20100361; Zhukareva V, 2010, CYTOKINE, V50, P317, DOI 10.1016/j.cyto.2010.01.004	30	131	135	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43255	10.1371/journal.pone.0043255	http://dx.doi.org/10.1371/journal.pone.0043255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905242	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800067
J	Cauda, F; Torta, DME; Sacco, K; Geda, E; D'Agata, F; Costa, T; Duca, S; Geminiani, G; Amanzio, M				Cauda, Franco; Torta, Diana M-E.; Sacco, Katiuscia; Geda, Elisabetta; D'Agata, Federico; Costa, Tommaso; Duca, Sergio; Geminiani, Giuliano; Amanzio, Martina			Shared "Core" Areas between the Pain and Other Task-Related Networks	PLOS ONE			English	Article							EVOKED CUTANEOUS PAIN; HUMAN BRAIN; CINGULATE CORTEX; ANTERIOR INSULA; FUNCTIONAL CONNECTIVITY; COGNITIVE CONTROL; NEUROIMAGING DATA; ATTENTION; SYSTEM; DORSAL	The idea of a 'pain matrix' specifically devoted to the processing of nociceptive inputs has been challenged. Alternative views now propose that the activity of the primary and secondary somatosensory cortices (SI, SII), the insula and cingulate cortex may be related to a basic defensive system through which significant potentially dangerous events for the body's integrity are detected. By reviewing the role of the SI, SII, the cingulate and the insular cortices in the perception of nociceptive and tactile stimuli, in attentional, emotional and reward tasks, and in interoception and memory, we found that all these task-related networks overlap in the dorsal anterior cingulate cortex, the anterior insula and the dorsal medial thalamus. A thorough analysis revealed that the 'pain-related' network shares important functional similarities with both somatomotor-somatosensory networks and emotional-interoceptive ones. We suggest that these shared areas constitute the central part of an adaptive control system involved in the processing and integration of salient information coming both from external and internal sources. These areas are activated in almost all fMRI tasks and have been indicated to play a pivotal role in switching between externally directed and internally directed brain networks.	[Cauda, Franco; Sacco, Katiuscia; Geda, Elisabetta; D'Agata, Federico; Duca, Sergio; Geminiani, Giuliano] Koelliker Hosp, CCS FMRI, Turin, Italy; [Cauda, Franco; Torta, Diana M-E.; Sacco, Katiuscia; D'Agata, Federico; Costa, Tommaso; Geminiani, Giuliano; Amanzio, Martina] Univ Turin, Dept Psychol, Turin, Italy; [D'Agata, Federico] AOU San Giovanni Battista, Dept Neurosci, Turin, Italy; [Amanzio, Martina] Univ Turin, NIT, I-10124 Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Cauda, F (corresponding author), Koelliker Hosp, CCS FMRI, Turin, Italy.	franco.cauda@unito.it	Amanzio, Martina/A-9085-2010; D'Agata, Federico/ABG-8839-2021; Cauda, Franco/G-5021-2010; Sacco, Katiuscia/J-2133-2012	Amanzio, Martina/0000-0002-2504-032X; D'Agata, Federico/0000-0001-9432-0248; Cauda, Franco/0000-0003-1526-8475; Sacco, Katiuscia/0000-0002-9660-5236; Torta, Diana/0000-0002-3499-3982; BRISCHETTO COSTA, Tommaso/0000-0002-0822-862X	Regione Piemonte, bando ScienzeUmane e Sociali [4/2006]	Regione Piemonte, bando ScienzeUmane e Sociali(Regione Piemonte)	This work supported by Regione Piemonte, bando ScienzeUmane e Sociali 2008, L.R. n. 4/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian, 1999, Curr Rev Pain, V3, P308, DOI 10.1007/s11916-999-0047-4; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Bilder Robert M, 2009, Cogn Neuropsychiatry, V14, P419, DOI 10.1080/13546800902787180; Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27; Borsook D, 2009, NEURON, V61, P153, DOI 10.1016/j.neuron.2009.01.003; Buchsbaum MS, 2006, NEUROSCI LETT, V404, P282, DOI 10.1016/j.neulet.2006.05.063; Cauda F, 2012, NEUROIMAGE; Cauda F, 2011, J COGNITIVE NEUROSCI, V23, P2864, DOI 10.1162/jocn.2011.21624; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; Colloca L, 2008, PAIN, V139, P306, DOI 10.1016/j.pain.2008.04.021; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duerden EG, 2011, HUMAN BRAIN MAPPING; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; EDELMAN S, 1995, NEURAL COMPUT, V7, P408, DOI 10.1162/neco.1995.7.2.408; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Farmer M. A., 2012, NEUROSCI LETT; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox PT, 2005, HUM BRAIN MAPP, V25, P1, DOI 10.1002/hbm.20139; Friebel U, 2011, NEUROIMAGE, V58, P1070, DOI 10.1016/j.neuroimage.2011.07.022; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GREENSPAN JD, 1992, PAIN, V50, P29, DOI 10.1016/0304-3959(92)90109-O; GREENSPAN JD, 1994, SOMATOSENS MOT RES, V11, P311, DOI 10.3109/08990229409028875; Greenspan JD, 1997, SOMATOSENS MOT RES, V14, P107, DOI 10.1080/08990229771105; Grieve KL, 2000, TRENDS NEUROSCI, V23, P35, DOI 10.1016/S0166-2236(99)01482-4; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; Isnard J, 2011, PAIN, V152, P946, DOI 10.1016/j.pain.2010.12.025; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Kriegeskorte N, 2011, NEUROIMAGE, V56, P411, DOI 10.1016/j.neuroimage.2011.01.061; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Laird Angela R, 2009, Front Neuroinform, V3, P23, DOI 10.3389/neuro.11.023.2009; Laird AR, 2005, NEUROINFORMATICS, V3, P65, DOI 10.1385/NI:3:1:065; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Legrain V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020926; Legrain V, 2011, PAIN, V152, P453, DOI 10.1016/j.pain.2010.11.024; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Mazzola L, 2006, CEREB CORTEX, V16, P960, DOI 10.1093/cercor/bhj038; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Melzack R, 1999, PAIN, pS121, DOI 10.1016/S0304-3959(99)00145-1; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Parker D S, 2009, Summit Transl Bioinform, V2009, P90; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Robinson JL, 2010, HUM BRAIN MAPP, V31, P173, DOI 10.1002/hbm.20854; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]	68	48	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41929	10.1371/journal.pone.0041929	http://dx.doi.org/10.1371/journal.pone.0041929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900003	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900018
J	Khan, MR; Hu, JY; Ali, GM				Khan, Muhammad Ramzan; Hu, Jinyong; Ali, Ghulam Muhammad			Reciprocal Loss of CArG-Boxes and Auxin Response Elements Drives Expression Divergence of MPF2-Like MADS-Box Genes Controlling Calyx Inflation	PLOS ONE			English	Article							MORPHOLOGICAL NOVELTY; ARABIDOPSIS-THALIANA; FLORAL ORGAN; DNA-BINDING; EVOLUTION; CIS; TRANSCRIPTION; AUX/IAA; MEMBERS	Expression divergence is thought to be a hallmark of functional diversification between homologs post duplication. Modification in regulatory elements has been invoked to explain expression divergence after duplication for several MADS-box genes, however, verification of reciprocal loss of cis-regulatory elements is lacking in plants. Here, we report that the evolution of MPF2-like genes has entailed degenerative mutations in a core promoter CArG-box and an auxin response factor (ARF) binding element in the large 1st intron in the coding region. Previously, MPF2-like genes were duplicated into MPF2-like-A and -B through genome duplication in Withania and Tubocapsicum (Withaninae). The calyx of Withania grows exorbitantly after pollination unlike Tubocapsicum, where it degenerates. Besides inflated calyx syndrome formation, MPF2-like transcription factors are implicated in functions both during the vegetative and reproductive development as well as in phase transition. MPF2-like-A of Withania (WSA206) is strongly expressed in sepals, while MPF2-like-B (WSB206) is not. Interestingly, their combined expression patterns seem to replicate the pattern of their closely related hypothetical progenitors from Vassobia and Physalis. Using phylogenetic shadowing, site-directed mutagenesis and motif swapping, we could show that the loss of a conserved CArG-box in MPF2-like-B of Withania is responsible for impeding its expression in sepals. Conversely, loss of an ARE in MPF2-like-A relaxed the constraint on expression in sepals. Thus, the ARE is an active suppressor of MPF2-like gene expression in sepals, which in contrast is activated via the CArG-box. The observed expression divergence in MPF2-like genes due to reciprocal loss of cis-regulatory elements has added to genetic and phenotypic variations in the Withaninae and enhanced the potential of natural selection for the adaptive evolution of ICS. Moreover, these results provide insight into the interplay of floral developmental and hormonal pathways during ICS development and add to the understanding of the importance of polyploidy in plants.	[Khan, Muhammad Ramzan; Ali, Ghulam Muhammad] Natl Agr Res Ctr, Natl Inst Genom & Adv Biotechnol, Islamabad, Pakistan; [Hu, Jinyong] Max Planck Inst Plant Breeding Res, Dept Mol Plant Genet, Cologne, Germany	National Agricultural Research Council - Pakistan; Max Planck Society	Khan, MR (corresponding author), Natl Agr Res Ctr, Natl Inst Genom & Adv Biotechnol, Islamabad, Pakistan.	khan@mpiz-koeln.mpg.de	Khan, Muhammad Ramzan/AAD-9958-2022		MPG (Max Planck Society); DAAD (German Academic Exchange Service); HEC (Higher Education Commission of Pakistan); NIGAB (National Institute for Genomics and Advanced Biotechnology)	MPG (Max Planck Society)(Max Planck Society); DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); HEC (Higher Education Commission of Pakistan)(Higher Education Commission of Pakistan); NIGAB (National Institute for Genomics and Advanced Biotechnology)	Funding was provided by MPG (Max Planck Society), DAAD (German Academic Exchange Service), HEC (Higher Education Commission of Pakistan), and NIGAB (National Institute for Genomics and Advanced Biotechnology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000366; Aloni R, 2006, PLANTA, V223, P315, DOI 10.1007/s00425-005-0088-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chuck G, 2005, CURR OPIN PLANT BIOL, V8, P67, DOI 10.1016/j.pbi.2004.11.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Davies B, 1999, EMBO J, V18, P4023, DOI 10.1093/emboj/18.14.4023; de Folter S, 2006, PLANT J, V47, P934, DOI 10.1111/j.1365-313X.2006.02846.x; de Folter S, 2006, TRENDS PLANT SCI, V11, P224, DOI 10.1016/j.tplants.2006.03.008; de Folter S, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-47; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Fang SC, 2002, PLANT PHYSIOL, V130, P78, DOI 10.1104/pp.004721; Force A, 1999, GENETICS, V151, P1531; Force AG, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P315; Goode DK, 2011, DEVELOPMENT, V138, P879, DOI 10.1242/dev.055996; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hagen G, 2002, PLANT MOL BIOL, V15, P533; He CY, 2007, PLANT J, V49, P935, DOI 10.1111/j.1365-313X.2006.03008.x; He CY, 2010, PLANTA, V231, P767, DOI 10.1007/s00425-009-1087-z; He CY, 2005, P NATL ACAD SCI USA, V102, P5779, DOI 10.1073/pnas.0501877102; He CY, 2004, FEBS LETT, V567, P147, DOI 10.1016/j.febslet.2004.02.090; Hu JY, 2007, MOL BIOL EVOL, V24, P2443, DOI 10.1093/molbev/msm177; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Irish VF, 2006, ADV BOT RES, V44, P129, DOI 10.1016/S0065-2296(06)44003-9; Jarinova O, 2008, DEVELOPMENT, V135, P3543, DOI 10.1242/dev.025817; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Khan MR, 2009, MOL BIOL EVOL, V26, P2463, DOI 10.1093/molbev/msp159; Khan MR, 2012, J PLANT PHYSIOL, V169, P940, DOI 10.1016/j.jplph.2012.02.015; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Riechmann JL, 1996, NUCLEIC ACIDS RES, V24, P3134, DOI 10.1093/nar/24.16.3134; Rijpkema AS, 2007, CURR OPIN PLANT BIOL, V10, P32, DOI 10.1016/j.pbi.2006.11.010; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schauer SE, 2009, PLANT J, V59, P987, DOI 10.1111/j.1365-313X.2009.03928.x; Sethupathy P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003137; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tang WN, 2003, J BIOL CHEM, V278, P28154, DOI 10.1074/jbc.M212976200; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Tichopad A, 2006, COMPUT METH PROG BIO, V82, P44, DOI 10.1016/j.cmpb.2005.12.002; Tirosh Itay, 2009, J Biol, V8, P95, DOI 10.1186/jbiol204; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, P NATL ACAD SCI USA, V96, P5844; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; West AG, 1998, NUCLEIC ACIDS RES, V26, P5277, DOI 10.1093/nar/26.23.5277; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	57	18	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42781	10.1371/journal.pone.0042781	http://dx.doi.org/10.1371/journal.pone.0042781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900049	gold, Green Published			2022-12-27	WOS:000307380900067
J	Kim, DW; Kilgore, PE; Kim, EJ; Kim, SA; Anh, DD; Dong, BQ; Kim, JS; Seki, M				Kim, Dong Wook; Kilgore, Paul E.; Kim, Eun Jin; Kim, Soon Ae; Anh, Dang Duc; Dong, Bai Qing; Kim, Jung Soo; Seki, Mitsuko			The Enhanced Pneumococcal LAMP Assay: A Clinical Tool for the Diagnosis of Meningitis Due to Streptococcus pneumoniae	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; BACTERIAL-MENINGITIS; LYTA GENE; DNA; INFECTIONS; PATHOGENS; CHILDREN; PRIMERS; CULTURE	Background: Streptococcus pneumoniae is a leading cause of invasive bacterial disease in developed and developing countries. We studied the loop-mediated isothermal amplification (LAMP) technique to assess its suitability for detecting S. pneumoniae nucleic acid in cerebrospinal fluid (CSF). Methodology/Principal Findings: We established an improved LAMP assay targeting the lytA gene (Streptococcus pneumoniae [Sp] LAMP). The analytical specificity of the primers was validated by using 32 reference strains (10 Streptococcus and seven non-Streptococcus species) plus 25 clinical alpha-hemolytic streptococcal strains, including four S. pneumoniae strains and 21 other strains (3 S. oralis, 17 S. mitis, and one Streptococcus species) harboring virulence factor-encoding genes (lytA or ply). Within 30 minutes, the assay could detect as few as 10 copies of both purified DNA and spiked CSF specimens with greater sensitivity than conventional polymerase chain reaction (PCR). The linear determination range for this assay is 10 to 1,000,000 microorganisms per reaction mixture using real-time turbidimetry. We evaluated the clinical sensitivity and specificity of the Sp LAMP assay using 106 randomly selected CSF specimens from children with suspected meningitis in Korea, China and Vietnam. For comparison, CSF specimens were also tested against conventional PCR and culture tests. The detection rate of the LAMP method was substantially higher than the rates of PCR and culture tests. In this small sample, relative to the LAMP assay, the clinical sensitivity of PCR and culture tests was 54.5% and 33.3%, respectively, while clinical specificity of the two tests was 100%. Conclusions/Significance: Compared to PCR, Sp LAMP detected S. pneumoniae with higher analytical and clinical sensitivity. This specific and sensitive LAMP method offers significant advantages for screening patients on a population basis and for diagnosis in clinical settings.	[Kim, Dong Wook; Kim, Eun Jin] Hanyang Univ, Dept Pharm, Coll Pharm, Ansan, South Korea; [Kim, Dong Wook; Kim, Eun Jin] Int Vaccine Inst, Mol Bacteriol Lab, Seoul, South Korea; [Kilgore, Paul E.; Kim, Soon Ae] Int Vaccine Inst, Translat Res Div, Seoul, South Korea; [Kilgore, Paul E.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharm Practice, Detroit, MI USA; [Anh, Dang Duc] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Dong, Bai Qing] Ctr Dis Prevent & Control, Nanning, Guangxi, Peoples R China; [Kim, Jung Soo] Chonbuk Natl Univ, Sch Med, Jeonju, South Korea; [Seki, Mitsuko] Nihon Univ, Sch Dent, Dept Oral Hlth Sci, Tokyo 101, Japan; [Seki, Mitsuko] Nihon Univ, Sch Dent, Dent Res Ctr, Tokyo 101, Japan	Hanyang University; International Vaccine Institute; International Vaccine Institute; Wayne State University; National Institute of Hygiene & Epidemiology (NIHE); Jeonbuk National University; Nihon University; Nihon University	Kim, DW (corresponding author), Hanyang Univ, Dept Pharm, Coll Pharm, Ansan, South Korea.	seki-m@dent.nihon-u.ac.jp	Kilgore, Paul/AAD-2869-2019; Kilgore, Paul E/L-1462-2013; Kim, Dong Wook/H-8253-2015	Kilgore, Paul/0000-0003-3214-4482; Kilgore, Paul E/0000-0003-3214-4482; Kim, Dong Wook/0000-0001-5351-7597; Kim, Soon Ae/0000-0002-5945-2832	Ministry of Education, Culture, Sports, Science and Technology of Japan [10201004]; Regional Technology Innovation Program of the Ministry of Knowledge and Economy (MKE) [RTI05-01-01]; Hanyang University [HY-2011-N]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Regional Technology Innovation Program of the Ministry of Knowledge and Economy (MKE); Hanyang University	This investigation was supported by the Grant-in-Aid for Scientific Research (C) (No. 10201004) and a grant to promote multi-disciplinary research projects from the Ministry of Education, Culture, Sports, Science and Technology of Japan. DWK was supported by the grant RTI05-01-01 from the Regional Technology Innovation Program of the Ministry of Knowledge and Economy (MKE) and the research fund of Hanyang University (HY-2011-N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaschke AJ, 2011, CLIN INFECT DIS, V52, pS331, DOI 10.1093/cid/cir048; Brown PD, 1998, LANCET, V352, P1295, DOI 10.1016/S0140-6736(98)02239-9; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Isenberg HD, 1998, ESSENTIAL PROCEDURES, P67; Jacoby GA, 1996, ANNU REV MED, V47, P169; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Kennedy WA, 2007, EPIDEMIOL INFECT, V135, P1217, DOI 10.1017/S0950268806007734; Kim DW, 2011, J CLIN MICROBIOL, V49, P3621, DOI 10.1128/JCM.00515-11; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Nagai K, 2001, J ANTIMICROB CHEMOTH, V48, P915, DOI 10.1093/jac/48.6.915; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Nandakumar R, 2008, ORAL SURG ORAL MED O, V106, P145, DOI 10.1016/j.tripleo.2008.01.036; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; SALO P, 1995, J INFECT DIS, V171, P479, DOI 10.1093/infdis/171.2.479; Seki M, 2005, J CLIN MICROBIOL, V43, P1581, DOI 10.1128/JCM.43.4.1581-1586.2005; Sheppard CL, 2004, J MED MICROBIOL, V53, P189, DOI 10.1099/jmm.0.05460-0; Vernet G, 2011, CLIN MICROBIOL INFEC, V17, P1, DOI 10.1111/j.1469-0691.2011.03496.x; Wester CW, 2002, DIAGN MICR INFEC DIS, V42, P263, DOI 10.1016/S0732-8893(01)00358-3; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000	23	36	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42954	10.1371/journal.pone.0042954	http://dx.doi.org/10.1371/journal.pone.0042954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900070	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900088
J	Popova, S; Lange, S; Burd, L; Rehm, J				Popova, Svetlana; Lange, Shannon; Burd, Larry; Rehm, Juergen			Health Care Burden and Cost Associated with Fetal Alcohol Syndrome: Based on Official Canadian Data	PLOS ONE			English	Article							ECONOMIC-IMPACT; SPECTRUM DISORDER; MORTALITY; FAS	Background: Fetal Alcohol Spectrum Disorder (FASD) is a group of disorders caused by prenatal alcohol exposure. From this group, Fetal Alcohol Syndrome (FAS) is the only disorder coded in the International Classification of Diseases, version 10 (ICD-10). This coding was used to gain an understanding on the health care utilization and the mortality rate for individuals diagnosed with FAS, as well as to estimate the associated health care costs in Canada for the most recent available fiscal year (2008-2009). Methods: Health care utilization data associated with a diagnosis of FAS were directly obtained from the Canadian Institute for Health Information (CIHI). Mortality data associated with a diagnosis of FAS were obtained from Statistics Canada. Results: The total direct health care cost of acute care, psychiatric care, day surgery, and emergency department services associated with FAS in Canada in 2008-2009, based on the official CIHI data, was about $6.7 million. The vast majority of the most responsible diagnoses, which account for the majority of a patient's length of stay in hospital, fall within the ICD-10 category Mental and Behavioural Disorders (F00-F99). It was evident that the burden and cost of acute care hospitalizations due to FAS is increasing -1.6 times greater in 2008-2009, compared to 2002-2003. The mortality data due to FAS, obtained from Statistics Canada (2000-2008), may be underreported, and are likely invalid. Discussion: The official data on the utilization of health care services by individuals diagnosed with FAS are likely to be underreported and therefore, the reported cost figures are most likely underestimated. The quantification of the health care costs associated with FAS is crucial for policy developers and decision makers alike, of the impact of prenatal alcohol exposure, with the ultimate goal of initiating preventive interventions to address FASD.	[Popova, Svetlana; Lange, Shannon; Rehm, Juergen] Ctr Addict & Mental Hlth, Social & Epidemiol Res Dept, Toronto, ON, Canada; [Popova, Svetlana; Lange, Shannon; Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Popova, Svetlana] Univ Toronto, Factor Inwentash Fac Social Work, W Toronto, ON, Canada; [Burd, Larry] Univ N Dakota, Sch Med, Dept Pediat, Grand Forks, ND 58202 USA; [Rehm, Juergen] Tech Univ Dresden, Epidemiol Res Unit, D-01062 Dresden, Germany	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of North Dakota Grand Forks; Technische Universitat Dresden	Popova, S (corresponding author), Ctr Addict & Mental Hlth, Social & Epidemiol Res Dept, Toronto, ON, Canada.	Lana.Popova@camh.ca			Public Health Agency of Canada [4500278412]; Ontario Ministry of Health and Long-Term Care	Public Health Agency of Canada; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This work was supported by the Public Health Agency of Canada [contract #4500278412]. In addition, support to the Centre for Addiction and Mental Health for the salaries of scientists and infrastructure has been provided by the Ontario Ministry of Health and Long-Term Care. The views expressed in this manuscript do not necessarily reflect those of the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel E L, 1991, Recent Dev Alcohol, V9, P117; ABEL EL, 1991, ALCOHOL CLIN EXP RES, V15, P514, DOI 10.1111/j.1530-0277.1991.tb00553.x; ABEL EL, 1987, DRUG ALCOHOL DEPEN, V19, P51, DOI 10.1016/0376-8716(87)90087-1; Amendah DD, 2011, NEUROTOXICOL TERATOL, V33, P322, DOI 10.1016/j.ntt.2010.10.008; Astley SJ, 1995, DIAGNOSTIC GUIDE FET; Burd L, 2004, ADDICT BIOL, V9, P179, DOI 10.1080/13556210410001717088; Burd L, 2008, BIRTH DEFECTS RES A, V82, P217, DOI 10.1002/bdra.20445; Canadian Institute for Health Information (CIHI), 2010, HOSP RAT CAN CONT DE; Chudley AE, 2008, ARCH DIS CHILD, V93, P721, DOI 10.1136/adc.2008.137109; Crede S, 2011, DRUG ALCOHOL DEPEN, V115, P175, DOI 10.1016/j.drugalcdep.2010.10.019; Habbick BF, 1997, CAN J PUBLIC HEALTH, V88, P181, DOI 10.1007/BF03403884; Harwood H, 2003, EC COSTS FETAL ALCOH; Harwood H., 2000, NIH PUBLICATION; Harwood H. F., 1985, ALCOHOL HEALTH RES W, V10, P38; Harwood H.J., 1998, EC COSTS ALCOHOL DRU; Harwood H. J., 1984, EC COSTS SOC ALCOHOL; Iyasu S, 2002, JAMA-J AM MED ASSOC, V288, P2717, DOI 10.1001/jama.288.21.2717; Johansson P., 2006, SOCIAL COSTS ALCOHOL; Kloehn D, 1997, Minn Med, V80, P26; Klug MG, 2003, NEUROTOXICOL TERATOL, V25, P763, DOI 10.1016/j.ntt.2003.07.012; Lemoine P., 1968, OUEST MED, V25, P476; McDowell Group, 2005, EC COSTS ALC OTH DRU; Miller TR, 2006, J STUD ALCOHOL, V67, P519, DOI 10.15288/jsa.2006.67.519; Popova S., 2012, EC IMPACT FETAL ALCO; Popova S, 2012, J POPUL THER CLIN PH, V19, pE51; Popova S, 2011, ALCOHOL ALCOHOLISM, V46, P490, DOI 10.1093/alcalc/agr029; Popovici I, 2009, EC COSTS UNDERAGE DR; Public Health Agency of Canada (PHAC), 2003, FET ALC SPECTR DIS F; Public Health Agency of Canada (PHAC), 2003, FAS FAE INF TOOL KIT; Rice D, 1990, DHHS PUBLICATION, V(ADM) 90-1694; RICE DP, 1991, PUBLIC HEALTH REP, V106, P280; Rice RD, 1993, ALCOHOL HEALTH RES W, V17, P10; Roberts G, 2000, BEST PRACTICES FETAL; Rosen SM, 2008, ALCOHOL CLIN EXP RES, V32, P1925, DOI 10.1111/j.1530-0277.2008.00777.x; RUSSELL M, 1980, NEUROTOXICOL TERATOL, V2, P277; Stade B., 2006, J FETAL ALCOHOL SYND, V4, P1, DOI DOI 10.1093/PCH/9.SUPPL_A.41AA; Stade B, 2009, J POPUL THER CLIN PH, V16, pE91; Statistics Canada, 2011, TABL 051 0001 POP YE; Statistics Canada, 2011, TABL 102 0537 DEATHS; Stratton K., 1996, FETAL ALCOHOL SYNDRO; Thanh NX, 2009, J POPUL THER CLIN PH, V16, pE80; Weeks M, 1989, COMMUNICATION   0217	42	40	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43024	10.1371/journal.pone.0043024	http://dx.doi.org/10.1371/journal.pone.0043024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986XO	22900084	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900102
J	Rudick, CN; Jiang, MC; Yaggie, RE; Pavlov, VI; Done, J; Heckman, CJ; Whitfield, C; Schaeffer, AJ; Klumpp, DJ				Rudick, Charles N.; Jiang, Mingchen; Yaggie, Ryan E.; Pavlov, Vladimir I.; Done, Joseph; Heckman, Charles J.; Whitfield, Christopher; Schaeffer, Anthony J.; Klumpp, David J.			O-Antigen Modulates Infection-Induced Pain States	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; URINARY-TRACT-INFECTION; TOXOPLASMA; LIPOPOLYSACCHARIDE; RECOGNITION; VIRULENCE; MENINGITIS; MECHANISMS; RECEPTORS; INDUCTION	The molecular initiators of infection-associated pain are not understood. We recently found that uropathogenic E. coli (UPEC) elicited acute pelvic pain in murine urinary tract infection (UTI). UTI pain was due to E. coli lipopolysaccharide (LPS) and its receptor, TLR4, but pain was not correlated with inflammation. LPS is known to drive inflammation by interactions between the acylated lipid A component and TLR4, but the function of the O-antigen polysaccharide in host responses is unknown. Here, we examined the role of O-antigen in pain using cutaneous hypersensitivity (allodynia) to quantify pelvic pain behavior and using sacral spinal cord excitability to quantify central nervous system manifestations in murine UTI. A UPEC mutant defective for O-antigen biosynthesis induced chronic allodynia that persisted long after clearance of transient infections, but wild type UPEC evoked only acute pain. E. coli strains lacking O-antigen gene clusters had a chronic pain phenotype, and expressing cloned O-antigen gene clusters altered the pain phenotype in a predictable manner. Chronic allodynia was abrogated in TLR4-deficient mice, but inflammatory responses in wild type mice were similar among E. coli strains spanning a wide range of pain phenotypes, suggesting that O-antigen modulates pain independent of inflammation. Spinal cords of mice with chronic allodynia exhibited increased spontaneous firing and compromised short-term depression, consistent with centralized pain. Taken together, these findings suggest that O-antigen functions as a rheostat to modulate LPS-associated pain. These observations have implications for an infectious etiology of chronic pain and evolutionary modification of pathogens to alter host behaviors.	[Rudick, Charles N.; Yaggie, Ryan E.; Pavlov, Vladimir I.; Done, Joseph; Schaeffer, Anthony J.; Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Jiang, Mingchen; Heckman, Charles J.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Heckman, Charles J.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Immunol Microbiol, Chicago, IL 60611 USA; [Whitfield, Christopher] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Guelph	Rudick, CN (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	d-klumpp@northwestern.edu		Heckman, CJ/0000-0002-1324-7278	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [DK066112, DK082342, DK042648, T32DK062716-05]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042648, T32DK062716, R37DK042648, R01DK066112, U01DK082342] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases awards DK066112 (DJK), DK082342 (DJK and AJS), and DK042648 (AJS and DJK) and T32DK062716-05 (CNR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amor K, 2000, INFECT IMMUN, V68, P1116, DOI 10.1128/IAI.68.3.1116-1124.2000; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BATCHELOR RA, 1991, J BACTERIOL, V173, P5699, DOI 10.1128/jb.173.18.5699-5704.1991; Billips BK, 2008, INFECT IMMUN, V76, P3891, DOI 10.1128/IAI.00069-08; Bjorling DE, 2008, J UROLOGY, V179, P759, DOI 10.1016/j.juro.2007.09.024; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Clermont O, 2007, DIAGN MICR INFEC DIS, V57, P129, DOI 10.1016/j.diagmicrobio.2006.08.007; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeBerry J, 2010, J PAIN, V11, P247, DOI 10.1016/j.jpain.2009.07.010; Eder K, 2009, BIOCHEM BIOPH RES CO, V389, P46, DOI 10.1016/j.bbrc.2009.08.082; Farmer MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002613; Fischer H, 2006, EUR J IMMUNOL, V36, P267, DOI 10.1002/eji.200535149; Flegr J, 2007, SCHIZOPHRENIA BULL, V33, P757, DOI 10.1093/schbul/sbl074; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Foureau DM, 2010, J IMMUNOL, V184, P7022, DOI 10.4049/jimmunol.0901642; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; GIBB AP, 1992, J INFECT DIS, V166, P1051, DOI 10.1093/infdis/166.5.1051; HOPKINS WJ, 1995, J INFECT DIS, V171, P462, DOI 10.1093/infdis/171.2.462; Jiang MC, 2006, J NEUROSCI METH, V156, P31, DOI 10.1016/j.jneumeth.2006.02.002; Jiang MC, 2009, J NEUROSCI, V29, P15031, DOI 10.1523/JNEUROSCI.0574-09.2009; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Johnson JR, 2003, INFECT DIS CLIN N AM, V17, P261, DOI 10.1016/S0891-5520(03)00027-8; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; Laird JMA, 2001, PAIN, V92, P335, DOI 10.1016/S0304-3959(01)00275-5; Larue K, 2009, J BIOL CHEM, V284, P7395, DOI 10.1074/jbc.M809068200; Minns LA, 2006, J IMMUNOL, V176, P7589, DOI 10.4049/jimmunol.176.12.7589; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nelson C, 1999, VITAL HLTH STAT, V13; NEUHARD J, 1976, J BACTERIOL, V126, P999, DOI 10.1128/JB.126.2.999-1001.1976; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Peigne C, 2009, INFECT IMMUN, V77, P2272, DOI 10.1128/IAI.01333-08; Plainvert C, 2007, J BACTERIOL, V189, P8528, DOI 10.1128/JB.01013-07; Randich A, 2009, J UROLOGY, V182, P337, DOI 10.1016/j.juro.2009.02.107; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Rudick CN, 2010, J INFECT DIS, V201, P1240, DOI 10.1086/651275; Schaeffer EM, 2007, CAMPBELL WALSH UROLO, P223; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Svanborg C, 1996, ANN NY ACAD SCI, V797, P177, DOI 10.1111/j.1749-6632.1996.tb52959.x; Svanborg C, 1997, INFECT DIS CLIN N AM, V11, P513, DOI 10.1016/S0891-5520(05)70371-8; Vejborg RM, 2010, MOL GENET GENOMICS, V283, P469, DOI 10.1007/s00438-010-0532-9; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Vyas A, 2010, FOLIA PARASIT, V57, P88, DOI 10.14411/fp.2010.011; Warren JW, 2008, UROLOGY, V71, P1085, DOI 10.1016/j.urology.2007.12.091; White FA, 2007, P NATL ACAD SCI USA, V104, P20151, DOI 10.1073/pnas.0709250104; Whitfield C, 2008, NAT STRUCT MOL BIOL, V15, P121, DOI 10.1038/nsmb0208-121; Witkin SS, 2002, AM J OBSTET GYNECOL, V187, P589, DOI 10.1067/mob.2002.125889; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	52	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41273	10.1371/journal.pone.0041273	http://dx.doi.org/10.1371/journal.pone.0041273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899994	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900009
J	Wang, YM; Zhou, P; Wang, LY; Li, ZH; Zhang, YN; Zhang, YX				Wang, Ya-Mei; Zhou, Ping; Wang, Li-Yong; Li, Zhen-Hua; Zhang, Yao-Nan; Zhang, Yu-Xiang			Correlation Between DNase I Hypersensitive Site Distribution and Gene Expression in HeLa S3 Cells	PLOS ONE			English	Article							REGULATORY ELEMENTS; ANTISENSE TRANSCRIPTION; NUCLEAR ARCHITECTURE; OPEN CHROMATIN; BINDING-SITES; HUMAN GENOME; CHIP; IDENTIFICATION; VIVO; PCR	Mapping DNase I hypersensitive sites (DHSs) within nuclear chromatin is a traditional and powerful method of identifying genetic regulatory elements. DHSs have been mapped by capturing the ends of long DNase I-cut fragments (> 100,000 bp), or 100-1200 bp DNase I-double cleavage fragments (also called double-hit fragments). But next generation sequencing requires a DNA library containing DNA fragments of 100-500 bp. Therefore, we used short DNA fragments released by DNase I digestion to generate DNA libraries for next generation sequencing. The short segments are 100-300 bp and can be directly cloned and used for high-throughput sequencing. We identified 83,897 DHSs in 2,343,479 tags across the human genome. Our results indicate that the DHSs identified by this DHS assay are consistent with those identified by longer fragments in previous studies. We also found: (1) the distribution of DHSs in promoter and other gene regions of similarly expressed genes differs among different chromosomes; (2) silenced genes had a more open chromatin structure than previously thought; (3) DHSs in 3'untranslated regions (3'UTRs) are negatively correlated with level of gene expression.	[Wang, Ya-Mei; Li, Zhen-Hua; Zhang, Yao-Nan; Zhang, Yu-Xiang] Capital Med Univ, Inst Canc, Dept Biochem & Mol Biol, Beijing, Peoples R China; [Zhou, Ping] Capital Med Univ, Sch Biomed Engn, Dept Bioinformat & Comp Sci, Beijing, Peoples R China; [Wang, Li-Yong] Capital Med Univ, Microarray Core Facil, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Wang, YM (corresponding author), Capital Med Univ, Inst Canc, Dept Biochem & Mol Biol, Beijing, Peoples R China.	yxzhang@ccmu.edu.cn			National Natural Science Foundation of China [30873033]; Major State Basic Research Development Programs of China [2009CB521800, 2010CB529400]; Beijing Municipal Natural Science Foundation [5122004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Programs of China(National Basic Research Program of China); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by research grants from National Natural Science Foundation of China (30873033) and Major State Basic Research Development Programs of China (2009CB521800 and 2010CB529400;www.973.gov.cn), and a grant from Beijing Municipal Natural Science Foundation (5122004;www.bjnfc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Bar-Joseph Z, 2008, P NATL ACAD SCI USA, V105, P955, DOI 10.1073/pnas.0704723105; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; Dey D, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/619583; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Follows GA, 2006, GENOME RES, V16, P1310, DOI 10.1101/gr.5373606; Fox JL, 2011, NAT BIOTECHNOL, V29, P375, DOI 10.1038/nbt0511-375a; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Heddi B, 2010, J MOL BIOL, V395, P123, DOI 10.1016/j.jmb.2009.10.023; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khitrinskaya IY, 2003, MOL BIOL+, V37, P325, DOI 10.1023/A:1024218806634; Kim TM, 2011, WIRES SYST BIOL MED, V3, P21, DOI 10.1002/wsbm.105; Klevebring D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009762; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Richardson P, 2010, GENES-BASEL, V1, P385, DOI 10.3390/genes1030385; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shi BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-92; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136	52	24	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42414	10.1371/journal.pone.0042414	http://dx.doi.org/10.1371/journal.pone.0042414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900019	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900036
J	Golebiewska, U; Guo, YJ; Khalikaprasad, N; Zurawsky, C; Yerramilli, VS; Scarlata, S				Golebiewska, Urszula; Guo, Yuanjian; Khalikaprasad, Narindra; Zurawsky, Cassandra; Yerramilli, V. Siddhartha; Scarlata, Suzanne			gamma-Synuclein Interacts with Phospholipase C beta 2 to Modulate G Protein Activation	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; BREAST-CANCER CELLS; G-BETA-GAMMA; C-BETA; ALPHA-SYNUCLEIN; MEMBRANE INTERACTIONS; SUBUNITS; BINDING; FLUORESCENCE; STIMULATION	Phospholipase C beta 2 (PLC beta 2) is activated by G proteins and generates calcium signals in cells. PLC beta 2 is absent in normal breast tissue, but is highly expressed in breast tumors where its expression is correlated with the progression and migration of the tumor. This pattern of expression parallels the expression of the breast cancer specific gene protein 1 which is also known as gamma-synuclein. The cellular function of gamma-synuclein and the role it plays in proliferation are unknown. Here, we determined whether gamma-synuclein can interact with PLC beta 2 and affect its activity. Using co-immunprecitation and co-immunofluorescence, we find that in both benign and aggressive breast cancer cell lines gamma-synuclein and PLC beta 2 are associated. In solution, purified gamma-synuclein binds to PLC beta 2 with high affinity as measured by fluorescence methods. Protease digestion and mass spectrometry studies show that gamma-synuclein binds to a site on the C-terminus of PLC beta 2 that overlaps with the G alpha q binding site. Additionally, gamma-synuclein competes for Gaq association, but not for activators that bind to the N-terminus (i.e. Rac1 and G beta gamma). Binding of gamma-synuclein reduces the catalytic activity of PLC beta 2 by mechanism that involves inhibition of product release without affecting membrane interactions. Since activated G alpha q binds more strongly to PLC beta 2 than gamma-synuclein, addition of G alpha q(GTP gamma S) to the gamma-synuclein -PLC beta 2 complex allows for relief of enzyme inhibition along with concomitant activation. We also find that G beta gamma can reverse gamma-synuclein inhibition without dissociating the gamma-synuclein- PLC beta 2-complex. These studies point to a role of gamma-synuclein in promoting a more robust G protein activation of PLC beta 2.	[Golebiewska, Urszula; Guo, Yuanjian; Khalikaprasad, Narindra; Zurawsky, Cassandra; Yerramilli, V. Siddhartha; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Golebiewska, Urszula] CUNY Queensborough Community Coll, Dept Biol Sci & Geol, Bayside, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System	Golebiewska, U (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	Suzanne.Scarlata@sunysb.edu			National Institutes of Health [GM053132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM053132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bertagnolo V, 2006, INT J ONCOL, V28, P863; Bertagnolo V, 2007, CARCINOGENESIS; BLANK JL, 1992, J BIOL CHEM, V267, P23069; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Drin G, 2006, BIOCHEMISTRY-US, V45, P5712, DOI 10.1021/bi052317n; Feng JW, 2005, BIOCHEMISTRY-US, V44, P2577, DOI 10.1021/bi0482607; George JM, 2002, GENOME BIOL, V3; Guo YJ, 2012, CELL SIGNAL, V24, P1109, DOI 10.1016/j.cellsig.2012.01.007; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Inaba S, 2005, BREAST CANCER RES TR, V94, P25, DOI 10.1007/s10549-005-6938-0; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Ji HJ, 1997, CANCER RES, V57, P759; Jia TL, 1999, CANCER RES, V59, P742; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; LEE SB, 1993, J BIOL CHEM, V268, P25952; Narayanan V, 2001, BIOCHEMISTRY-US, V40, P9927, DOI 10.1021/bi002952n; Narayanan V, 2005, BIOCHEMISTRY-US, V44, P462, DOI 10.1021/bi0487140; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Phillips F, 2006, SOCIAL CULTURE AND HIGH-TECH ECONOMIC DEVELOPMENT, P15; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; Scarlata SF, 2004, REV FLUORESCENCE, V1, P75; Singh VK, 2007, CANCER RES, V67, P626, DOI 10.1158/0008-5472.CAN-06-1820; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Weinstein H, 2011, BBA-BIOMEMBRANES, V1808, P2940, DOI 10.1016/j.bbamem.2011.08.028	36	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41067	10.1371/journal.pone.0041067	http://dx.doi.org/10.1371/journal.pone.0041067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905097	Green Published, gold			2022-12-27	WOS:000307331100009
J	Longo, C; Pontassuglia, C; Corriero, G; Gaino, E				Longo, Caterina; Pontassuglia, Carmen; Corriero, Giuseppe; Gaino, Elda			Life-Cycle Traits of Paraleucilla magna, a Calcareous Sponge Invasive in a Coastal Mediterranean Basin	PLOS ONE			English	Article							SAN-FRANCISCO BAY; ATLANTIC-OCEAN; 2004 PORIFERA; POECILOSCLERIDA; REPRODUCTION; DEMOSPONGIAE; COMMUNITIES; CALIFORNIA; DISPERSAL; INCREASES	The calcareous sponge Paraleucilla magna, originally observed along the Brazilian coast (Atlantic Ocean), is the only allochthonous invasive species of Porifera reported in the Mediterranean Sea. A 1-year investigation of the population dynamics and life-cycle of this exotic species in the Mar Piccolo di Taranto (southern Italy, central Mediterranean Sea) has provided a good opportunity to test how environmental variations can influence its life-cycle and to ascertain what strategy can be adopted to successfully colonize a new environment. In the Mar Piccolo di Taranto, P. magna exhibits marked temporal changes in biomass. The studied specimens reproduce almost all year round, showing a seasonal pattern that peaks during warm months. This prolonged sexual activity allows P. magna to continuously produce young specimens, with repeated recruitment events taking place throughout the year, thus offsetting the seasonal mortality of adult specimens. This r-strategy enables the non-indigenous sponge to achieve a high degree of maintenance over relatively long periods (ten years at least).	[Longo, Caterina; Pontassuglia, Carmen; Corriero, Giuseppe] Univ Bari Aldo Moro, Dipartimento Biol, Bari, Italy; [Gaino, Elda] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy	Universita degli Studi di Bari Aldo Moro; University of Perugia	Longo, C (corresponding author), Univ Bari Aldo Moro, Dipartimento Biol, Bari, Italy.	caterina.longo@uniba.it	longo, caterina/J-4886-2013	LONGO, CATERINA/0000-0003-3123-1568; Corriero, Giuseppe/0000-0002-4076-5804	Dipartimento di Biologia, Universita degli Studi di Bari "Aldo Moro'' (Italy)	Dipartimento di Biologia, Universita degli Studi di Bari "Aldo Moro'' (Italy)	Funding for this work was provided by the Dipartimento di Biologia, Universita degli Studi di Bari "Aldo Moro'' (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Altman S, 2007, J EXP MAR BIOL ECOL, V342, P15, DOI 10.1016/j.jembe.2006.10.011; Amano S, 2001, BIOL BULL, V200, P20, DOI 10.2307/1543082; Avila E, 2009, BIOL INVASIONS, V11, P257, DOI 10.1007/s10530-008-9230-5; Azevedo F, 2007, ZOOTAXA, P1; Calcinai B, 2004, J MAR BIOL ASSOC UK, V84, P937, DOI 10.1017/S0025315404010227h; CARLTON JT, 1990, MAR ECOL PROG SER, V66, P81, DOI 10.3354/meps066081; Caroppo C., 1994, BIOL MARINA MEDITERR, V1, P201; Castilla JC, 2005, BIOL INVASIONS, V7, P213, DOI 10.1007/s10530-004-0198-5; COHEN AN, 1995, MAR BIOL, V122, P225; Coles SL, 2007, CORAL REEFS, V26, P911, DOI 10.1007/s00338-007-0295-x; Coles SL, 2002, 4 BIOL SURV BISH MUS; Corriero G, 2007, ITAL J ZOOL, V74, P21, DOI 10.1080/11250000601084100; Corriero Giuseppe, 2011, Fauna d'Italia, V46, P55; Crooks JA, 2011, BIOL INVASIONS, V13, P165, DOI 10.1007/s10530-010-9799-3; Duboscq O., 1944, ARCH ZOOL EXP ET GEN, V83, P445; Duran S, 2004, MOL ECOL, V13, P109, DOI 10.1046/j.1365-294X.2003.02022.x; ELVIN DW, 1976, BIOL BULL-US, V151, P108, DOI 10.2307/1540709; Ereskovsky AV, 2000, BIOL BULL, V198, P77, DOI 10.2307/1542805; Fell Paul E., 1993, P1; Floerl O, 2005, BIOL INVASIONS, V7, P459, DOI 10.1007/s10530-004-4863-5; Gaino E, 1996, ITAL J ZOOL, V63, P41, DOI 10.1080/11250009609356105; Gaino E, 2003, HYDROBIOLOGIA, V495, P127, DOI 10.1023/A:1025454506643; GAINO E, 1986, INT J INVER REP DEV, V10, P297, DOI 10.1080/01688170.1986.10510253; Gilis M, 2011, INVERTEBR BIOL, V130, P193, DOI 10.1111/j.1744-7410.2011.00239.x; Gravili C, 2010, CHEM ECOL, V26, P121, DOI 10.1080/02757541003627654; Guardiola M, 2012, HYDROBIOLOGIA, V687, P71, DOI 10.1007/s10750-011-0948-1; Henkel D, 2011, J MAR BIOL ASSOC UK, V91, P347, DOI 10.1017/S0025315410001487; ILAN M, 1993, OPHELIA, V38, P107, DOI 10.1080/00785326.1993.10429892; JOHNSON MF, 1978, MAR BIOL, V50, P73, DOI 10.1007/BF00390543; Klautau M, 2004, ZOOTAXA, P1; Lambert CC, 1998, MAR BIOL, V130, P675, DOI 10.1007/s002270050289; Lanna E, 2010, ZOOMORPHOLOGY, V129, P249, DOI 10.1007/s00435-010-0117-5; Lanna Emilio, 2007, V28, P413; Levin PS, 2002, ECOLOGY, V83, P3182, DOI 10.2307/3071852; Leys SP, 2005, INTEGR COMP BIOL, V45, P171; Longo C, 2007, J MAR BIOL ASSOC UK, V87, P1749, DOI 10.1017/S0025315407057748; Luppi TA, 2002, CIENC MAR, V28, P319, DOI 10.7773/cm.v28i4.242; Maldonado M, 2008, MAR ECOL-EVOL PERSP, V29, P298, DOI 10.1111/j.1439-0485.2008.00244.x; Mastrototaro Francesco, 2004, Biogeographia, V25, P47; Meurer Bruno C., 2010, Marine Biodiversity Records, V3, pe62; Occhipinti-Ambrogi A, 2011, BIOL INVASIONS, V13, P215, DOI 10.1007/s10530-010-9803-y; Padua A, 2013, MAR ECOL-EVOL PERSP, V34, P56, DOI 10.1111/j.1439-0485.2012.00524.x; Pierri C, 2010, J MAR BIOL ASSOC UK, V90, P159, DOI 10.1017/S0025315409990798; Piola RF, 2008, DIVERS DISTRIB, V14, P329, DOI 10.1111/j.1472-4642.2007.00430.x; PLUCERROSARIO G, 1987, CORAL REEFS, V5, P197, DOI 10.1007/BF00300963; Smith, 2001, 21 BISH MUS; Strusi A, 1975, OEBALIA, V1, P5; Zammit PP, 2009, MEDITERR MAR SCI, V10, P135, DOI 10.12681/mms.114; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87	50	26	26	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42392	10.1371/journal.pone.0042392	http://dx.doi.org/10.1371/journal.pone.0042392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905128	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100036
J	Marin, MB; Ghenea, S; Spiridon, LN; Chiritoiu, GN; Petrescu, AJ; Petrescu, SM				Marin, Marioara B.; Ghenea, Simona; Spiridon, Laurentiu N.; Chiritoiu, Gabriela N.; Petrescu, Andrei-Jose; Petrescu, Stefana-Maria			Tyrosinase Degradation Is Prevented when EDEM1 Lacks the Intrinsically Disordered Region	PLOS ONE			English	Article							ER-ASSOCIATED DEGRADATION; PROTEIN-STRUCTURE PREDICTION; STRONGLY-DENATURED PROTEIN; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MISFOLDED GLYCOPROTEINS; MOLECULAR-DYNAMICS; N-GLYCOSYLATION; CALNEXIN; SERVER	EDEM1 is a mannosidase-like protein that recruits misfolded glycoproteins from the calnexin/calreticulin folding cycle to downstream endoplasmic reticulum associated degradation (ERAD) pathway. Here, we investigate the role of EDEM1 in the processing of tyrosinase, a tumour antigen overexpressed in melanoma cells. First, we analyzed and modeled EDEM1 major domains. The homology model raised on the crystal structures of human and Saccharomyces cerevisiae ER class I alpha 1,2-mannosidases reveals that the major mannosidase domain located between aminoacids 121-598 fits with high accuracy. We have further identified an N-terminal region located between aminoacids 40-119, predicted to be intrinsically disordered (ID) and susceptible to adopt multiple conformations, hence facilitating protein-protein interactions. To investigate these two domains we have constructed an EDEM1 deletion mutant lacking the ID region and a triple mutant disrupting the glycan-binding domain and analyzed their association with tyrosinase. Tyrosinase is a glycoprotein partly degraded endogenously by ERAD and the ubiquitin proteasomal system. We found that the degradation of wild type and misfolded tyrosinase was enhanced when EDEM1 was overexpressed. Glycosylated and non-glycosylated mutants co-immunoprecipitated with EDEM1 even in the absence of its intact mannosidase-like domain, but not when the ID region was deleted. In contrast, calnexin and SEL 1L associated with the deletion mutant. Our data suggest that the ID region identified in the N-terminal end of EDEM1 is involved in the binding of glycosylated and non-glycosylated misfolded proteins. Accelerating tyrosinase degradation by EDEM1 overexpression may lead to an efficient antigen presentation and enhanced elimination of melanoma cells.	[Marin, Marioara B.; Ghenea, Simona; Chiritoiu, Gabriela N.; Petrescu, Stefana-Maria] Romanian Acad, Inst Biochem, Dept Mol Cell Biol, Bucharest, Romania; [Spiridon, Laurentiu N.; Petrescu, Andrei-Jose] Romanian Acad, Inst Biochem, Dept Bioinformat & Struct Biochem, Bucharest, Romania	Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Nicolae Simionescu Institute of Cellular Biology & Pathology; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest	Marin, MB (corresponding author), Romanian Acad, Inst Biochem, Dept Mol Cell Biol, Bucharest, Romania.	ap@biochim.ro; stefana.petrescu@biochim.ro	Chiritoiu, Mari/Q-3983-2017; Petrescu, Andrei-Jose J/G-4576-2016; Spiridon, Laurentiu N/A-3352-2017; Chiritoiu, Gabriela N/C-8860-2017; Chiritoiu, Gabriela/ABC-9002-2020; Petrescu, Stefana M/I-9240-2012; Petrescu, Stefana/AAJ-9505-2021	Chiritoiu, Mari/0000-0003-2064-2003; Petrescu, Andrei-Jose J/0000-0002-4478-3946; Spiridon, Laurentiu N/0000-0003-3080-1610; Chiritoiu, Gabriela/0000-0002-6321-6373; Petrescu, Stefana M/0000-0002-4047-0811; Petrescu, Stefana/0000-0002-4047-0811; Ghenea, Simona/0000-0002-5566-0335	Romanian Academy projects 1 and 3 of the Institute of Biochemistry; CNCSIS [1171 - 1018/2008, 3-0342 - 181/2011]; European Social Fund [POSDRU/89/1.5/S/60746]	Romanian Academy projects 1 and 3 of the Institute of Biochemistry; CNCSIS(Consiliul National al Cercetarii Stiintifice (CNCS)); European Social Fund(European Social Fund (ESF))	This work was supported by the Romanian Academy projects 1 and 3 of the Institute of Biochemistry(http://www.acad.ro) and CNCSIS Grants ID 1171 - 1018/2008 and ID 3-0342 - 181/2011 (http://www.uefiscdi.gov.ro). SG & LNS also acknowledges the postdoctoral program POSDRU/89/1.5/S/60746, from European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Branza-Nichita N, 2000, CHEM REV, V100, P4697, DOI 10.1021/cr990291y; Cali T, 2008, BIOCHEM BIOPH RES CO, V371, P405, DOI 10.1016/j.bbrc.2008.04.098; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cioaca D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019979; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Halaban R, 2000, P NATL ACAD SCI USA, V97, P5889, DOI 10.1073/pnas.97.11.5889; Halaban R, 2002, J BIOL CHEM, V277, P14821, DOI 10.1074/jbc.M111497200; Hanganu Andrei, 2009, Romanian Journal of Biochemistry, V46, P123; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lobsanov YD, 2002, J BIOL CHEM, V277, P5620, DOI 10.1074/jbc.M110243200; Michaeli Y, 2009, J IMMUNOL, V182, P6328, DOI 10.4049/jimmunol.0801898; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Ostankovitch M, 2005, J IMMUNOL, V174, P2544, DOI 10.4049/jimmunol.174.5.2544; Paduraru C, 2006, J BIOL CHEM, V281, P40369, DOI 10.1074/jbc.M608518200; Parodi AJ, 1999, BBA-GEN SUBJECTS, V1426, P287, DOI 10.1016/S0304-4165(98)00130-5; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Petrescu AJ, 1998, PROTEIN SCI, V7, P1396; Petrescu AJ, 1997, BIOPHYS J, V72, P335, DOI 10.1016/S0006-3495(97)78672-7; Petrescu AJ, 2006, CURR OPIN STRUC BIOL, V16, P600, DOI 10.1016/j.sbi.2006.08.007; Petrescu SM, 1997, J BIOL CHEM, V272, P15796, DOI 10.1074/jbc.272.25.15796; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Popescu CI, 2005, J BIOL CHEM, V280, P13833, DOI 10.1074/jbc.M413087200; Popescu CI, 2006, J BIOL CHEM, V281, P21682, DOI 10.1074/jbc.M603841200; Ron E, 2011, MOL BIOL CELL; Svedine S, 2004, J CELL SCI, V117, P2937, DOI 10.1242/jcs.01154; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3	51	30	33	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42998	10.1371/journal.pone.0042998	http://dx.doi.org/10.1371/journal.pone.0042998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905195	Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100080
J	Wong, MHT; Holst, C; Astrup, A; Handjieva-Darlenska, T; Jebb, SA; Kafatos, A; Kunesova, M; Larsen, TM; Martinez, JA; Pfeiffer, AFH; van Baak, MA; Saris, WHM; McNicholas, PD; Mutch, DM				Wong, Monica H. T.; Holst, Claus; Astrup, Arne; Handjieva-Darlenska, Teodora; Jebb, Susan A.; Kafatos, Anthony; Kunesova, Marie; Larsen, Thomas M.; Alfredo Martinez, J.; Pfeiffer, Andreas F. H.; van Baak, Marleen A.; Saris, Wim H. M.; McNicholas, Paul D.; Mutch, David M.		DiOGenes	Caloric Restriction Induces Changes in Insulin and Body Weight Measurements That Are Inversely Associated with Subsequent Weight Regain	PLOS ONE			English	Article							LOSS MAINTENANCE; GLYCEMIC INDEX; LOW-PROTEIN; LONG-TERM; ENERGY; WOMEN; DIETS; PREDICTORS; RESISTANCE; MEN	Background: Successful weight maintenance following weight loss is challenging for many people. Identifying predictors of longer-term success will help target clinical resources more effectively. To date, focus has been predominantly on the identification of predictors of weight loss. The goal of the current study was to determine if changes in anthropometric and clinical parameters during acute weight loss are associated with subsequent weight regain. Methodology: The study consisted of an 8-week low calorie diet (LCD) followed by a 6-month weight maintenance phase. Anthropometric and clinical parameters were analyzed before and after the LCD in the 285 participants (112 men, 173 women) who regained weight during the weight maintenance phase. Mixed model ANOVA, Spearman correlation, and linear regression were used to study the relationships between clinical measurements and weight regain. Principal Findings: Gender differences were observed for body weight and several clinical parameters at both baseline and during the LCD-induced weight loss phase. LCD-induced changes in BMI (Spearman's rho = 0.22, p = 0.0002) were inversely associated with weight regain in both men and women. LCD-induced changes in fasting insulin (rho = 0.18, p = 0.0043) and HOMA-IR (rho = 0.19, p = 0.0023) were also associated independently with weight regain in both genders. The aforementioned associations remained statistically significant in regression models taking account of variables known to independently influence body weight. Conclusions/Significance: LCD-induced changes in BMI, fasting insulin, and HOMA-IR are inversely associated with weight regain in the 6-month period following weight loss.	[Wong, Monica H. T.; McNicholas, Paul D.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Holst, Claus] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Astrup, Arne; Larsen, Thomas M.] Univ Copenhagen, Dept Human Nutr, Copenhagen, Denmark; [Handjieva-Darlenska, Teodora] Natl Multiprofile Transport Hosp, Sofia, Bulgaria; [Jebb, Susan A.] Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Kafatos, Anthony] Univ Crete, Sch Med, Dept Social Med, Prevent Med & Nutr Clin, Iraklion, Crete, Greece; [Kunesova, Marie] Inst Endocrinol, Obes Management Ctr, Prague, Czech Republic; [Alfredo Martinez, J.] Univ Navarra, Dept Physiol & Nutr, E-31080 Pamplona, Spain; [Pfeiffer, Andreas F. H.] German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, Nuthetal, Germany; [van Baak, Marleen A.; Saris, Wim H. M.] Univ Maastricht, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht, Maastricht, Netherlands; [Mutch, David M.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Copenhagen; University of Copenhagen; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; University of Crete; Institute of Endocrinology - Prague; University of Navarra; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Maastricht University; Maastricht University Medical Centre (MUMC); University of Guelph	Wong, MHT (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada.	dmutch@uoguelph.ca	Pfeiffer, Andreas F.H./AAJ-2311-2020; Martinez Hernandez, J Alfredo/K-8709-2014; Meinert Larsen, Thomas/D-4818-2015; Astrup, Arne/B-1407-2015	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Mutch, David/0000-0002-0908-7259; van Baak, Marleen/0000-0003-2592-6363; Martinez Hernandez, J Alfredo/0000-0001-5218-6941; McNicholas, Paul/0000-0002-2482-523X; Meinert Larsen, Thomas/0000-0001-7621-3131; Astrup, Arne/0000-0001-8968-8996; Jebb, Susan/0000-0001-9190-2920	European Community [FOOD-CT-2005-513946]; Medical Research Council [MC_U105960389] Funding Source: researchfish; MRC [MC_U105960389] Funding Source: UKRI	European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DIOGENES is the acronym of the project "Diet, Obesity and Genes" supported by the European Community (Contract no. FOOD-CT-2005-513946). The parties of the project are listed on the website of the project (http://www.diogenes-eu.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2007, INT J OBESITY, V31, P488, DOI 10.1038/sj.ijo.0803423; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Astrup A, 2000, Obes Rev, V1, P17, DOI 10.1046/j.1467-789x.2000.00004.x; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Boule NG, 2008, DIABETES-METAB RES, V24, P123, DOI 10.1002/dmrr.768; Butryn ML, 2009, OBESITY, V17, P1101, DOI 10.1038/oby.2008.646; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; Crujeiras AB, 2010, J CLIN ENDOCR METAB, V95, P5037, DOI 10.1210/jc.2009-2566; Dye L, 1997, HUM REPROD, V12, P1142; Eckel R. H, 2003, OBESITY MECH CLIN MA; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Erez G, 2011, INT J OBESITY, V35, P785, DOI 10.1038/ijo.2010.217; Forrestal SG, 2011, MATERN CHILD NUTR, V7, P112, DOI 10.1111/j.1740-8709.2010.00270.x; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Gripeteg L, 2010, OBESITY FACTS, V3, P159, DOI 10.1159/000314655; Handjieva-Darlenska T, 2011, CLIN OBES, V1, P62, DOI 10.1111/j.1758-8111.2011.00010.x; Handjieva-Darlenska T, 2010, EUR J CLIN NUTR, V64, P994, DOI 10.1038/ejcn.2010.110; Jeffery RW, 1998, J CONSULT CLIN PSYCH, V66, P641, DOI 10.1037/0022-006X.66.4.641; Larsen TM, 2010, OBES REV, V11, P76, DOI 10.1111/j.1467-789X.2009.00603.x; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Marquez-Quinones A, 2010, AM J CLIN NUTR, V92, P975, DOI 10.3945/ajcn.2010.29808; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Moore CS, 2010, OBES REV, V11, P67, DOI 10.1111/j.1467-789X.2009.00602.x; Mutch DM, 2011, AM J CLIN NUTR, V94, P1399, DOI 10.3945/ajcn.110.006858; Pannacciulli N, 2007, OBESITY, V15, P632, DOI 10.1038/oby.2007.572; Poslusna K, 2009, BRIT J NUTR, V101, pS73, DOI 10.1017/S0007114509990602; Raatz SK, 2005, J NUTR, V135, P2387, DOI 10.1093/jn/135.10.2387; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Rubio-Aliaga I, 2011, MOL NUTR FOOD RES, V55, P1603, DOI 10.1002/mnfr.201100081; Saris WHM, 2001, OBES RES, V9, p295S, DOI 10.1038/oby.2001.134; Saris WHM, 1998, INT J OBESITY, V22, pS15; Sartorio A, 2005, J ENDOCRINOL INVEST, V28, P494, DOI 10.1007/BF03347236; Schulz M, 2002, J NUTR, V132, P1335, DOI 10.1093/jn/132.6.1335; Svetkey LP, 2011, OBESITY; Turk MW, 2009, J CARDIOVASC NURS, V24, P58, DOI 10.1097/01.JCN.0000317471.58048.32; Vogels N, 2005, AM J CLIN NUTR, V82, P740, DOI 10.1093/ajcn/82.4.740; Wang P, 2012, INT J OBESITY LONDON; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016773; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Yost T J, 1995, Obes Res, V3, P583	40	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42858	10.1371/journal.pone.0042858	http://dx.doi.org/10.1371/journal.pone.0042858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905179	Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100071
J	Haege, S; Einer, C; Thiele, S; Mueller, W; Nietzsche, S; Lupp, A; Mackay, F; Schulz, S; Stumm, R				Haege, Sammy; Einer, Claudia; Thiele, Stefanie; Mueller, Wiebke; Nietzsche, Sandor; Lupp, Amelie; Mackay, Fabienne; Schulz, Stefan; Stumm, Ralf			CXC Chemokine Receptor 7 (CXCR7) Regulates CXCR4 Protein Expression and Capillary Tuft Development in Mouse Kidney	PLOS ONE			English	Article							INTERNEURON MIGRATION; NEURONAL MIGRATION; ADULT BRAIN; CELLS; HEMATOPOIESIS; ACTIVATION; MICE; MORPHOGENESIS; CXCL12/SDF-1; PLASTICITY	Background: The CXCL12/CXCR4 axis is involved in kidney development by regulating formation of the glomerular tuft. Recently, a second CXCL12 receptor was identified and designated CXCR7. Although it is established that CXCR7 regulates heart and brain development in conjunction with CXCL12 and CXCR4, little is known about the influence of CXCR7 on CXCL12 dependent kidney development. Methodology/Principal Findings: We provided analysis of CXCR7 expression and function in the developing mouse kidney. Using in situ hybridization, we identified CXCR7 mRNA in epithelial cells including podocytes at all nephron stages up to the mature glomerulus. CXCL12 mRNA showed a striking overlap with CXCR7 mRNA in epithelial structures. In addition, CXCL12 was detected in stromal cells and the glomerular tuft. Expression of CXCR4 was complementary to that of CXCR7 as it occurred in mesenchymal cells, outgrowing ureteric buds and glomerular endothelial cells but not in podocytes. Kidney examination in CXCR7 null mice revealed ballooning of glomerular capillaries as described earlier for CXCR4 null mice. Moreover, we detected a severe reduction of CXCR4 protein but not CXCR4 mRNA within the glomerular tuft and in the condensed mesenchyme. Malformation of the glomerular tuft in CXCR7 null mice was associated with mesangial cell clumping. Conclusions/Significance: We established that there is a similar glomerular pathology in CXCR7 and CXCR4 null embryos. Based on the phenotype and the anatomical organization of the CXCL12/CXCR4/CXCR7 system in the forming glomerulus, we propose that CXCR7 fine-tunes CXCL12/CXCR4 mediated signalling between podocytes and glomerular capillaries.	[Haege, Sammy; Einer, Claudia; Thiele, Stefanie; Mueller, Wiebke; Lupp, Amelie; Schulz, Stefan; Stumm, Ralf] Univ Jena, Inst Pharmacol & Toxicol, Univ Hosp Jena, D-6900 Jena, Germany; [Nietzsche, Sandor] Univ Jena, Electron Microscopy Ctr, Univ Hosp Jena, D-6900 Jena, Germany; [Mackay, Fabienne] Monash Univ, Dept Immunol, Cent Clin Sch, Alfred Med Res & Educ Precinct AMREP, Melbourne, Vic 3004, Australia	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Monash University	Haege, S (corresponding author), Univ Jena, Inst Pharmacol & Toxicol, Univ Hosp Jena, Lobderstr 1, D-6900 Jena, Germany.	sammy.haege@mti.uni-jena.de	Schulz, Stefan/A-6928-2017; Mackay, Fabienne/B-7440-2008	Schulz, Stefan/0000-0002-5997-8885; Mackay, Fabienne/0000-0002-6074-2693	Jena University; DFG [STUw295-5/1]	Jena University; DFG(German Research Foundation (DFG))	The study was supported by the Jena University grant program for young academics (to SH) and DFG grant STUw295-5/1 (to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; D'Alterio C, 2010, CELL CYCLE, V9, P4492, DOI 10.4161/cc.9.22.13680; Ding M, 2006, NAT MED, V12, P1081, DOI 10.1038/nm1460; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Fischer T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004069; Georgas K, 2008, HISTOCHEM CELL BIOL, V130, P927, DOI 10.1007/s00418-008-0454-3; Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Morishita Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023267; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Stumm R, 2007, J MOL ENDOCRINOL, V38, P377, DOI 10.1677/JME-06-0032; Stumm R, 2007, J COMP NEUROL, V502, P382, DOI 10.1002/cne.21336; Stumm RK, 2001, J NEUROSCI, V21, P798, DOI 10.1523/JNEUROSCI.21-03-00798.2001; Stumm RK, 2003, J NEUROSCI, V23, P5123; Stumm RK, 2002, J NEUROSCI, V22, P5865; Takabatake Y, 2009, J AM SOC NEPHROL, V20, P1714, DOI 10.1681/ASN.2008060640; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Ueland J, 2009, DEV DYNAM, V238, P1083, DOI 10.1002/dvdy.21943; Vaughan MR, 2008, J AM SOC NEPHROL, V19, P24, DOI 10.1681/ASN.2007040471; Veith AM, 2006, GENOMICS, V88, P185, DOI 10.1016/j.ygeno.2006.01.003; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Wehler TC, 2008, J ONCOL, V2008, DOI 10.1155/2008/626340; Yu SH, 2011, DEV DYNAM, V240, P384, DOI 10.1002/dvdy.22549; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	37	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42814	10.1371/journal.pone.0042814	http://dx.doi.org/10.1371/journal.pone.0042814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880115	Green Published, gold			2022-12-27	WOS:000307810000074
J	Bohmann, F; Mirceska, A; Pfeilschifter, J; Lindhoff-Last, E; Steinmetz, H; Foerch, C; Pfeilschifter, W				Bohmann, Ferdinand; Mirceska, Ana; Pfeilschifter, Josef; Lindhoff-Last, Edelgard; Steinmetz, Helmuth; Foerch, Christian; Pfeilschifter, Waltraud			No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke	PLOS ONE			English	Article							DIRECT THROMBIN INHIBITOR; NONVALVULAR ATRIAL-FIBRILLATION; RE-LY TRIAL; TISSUE-PLASMINOGEN ACTIVATOR; INTRACEREBRAL HEMORRHAGE; ETEXILATE; WARFARIN; THERAPY; PHARMACOKINETICS; PHARMACODYNAMICS	Background: Dabigatran etexilate (DE) is a new oral direct thrombin inhibitor. Clinical trials point towards a favourable risk-to-benefit profile of DE compared to warfarin. In this study, we evaluated whether hemorrhagic transformation (HT) occurs after experimental stroke under DE treatment as we have shown for warfarin. Methods: 44 male C57BL/6 mice were pretreated orally with 37.5 mg/kg DE, 75 mg/kg DE or saline and diluted thrombin time (dTT) and DE plasma concentrations were monitored. Ischemic stroke was induced by transient middle cerebral artery occlusion (tMCAO) for 1 h or 3 h. We assessed functional outcome and HT blood volume 24 h and 72 h after tMCAO. Results: After 1 h tMCAO, HT blood volume did not differ significantly between mice pretreated with DE 37.5 mg/kg and controls (1.5 +/- 0.5 mu l vs. 1.8 +/- 0.5 mu l, p > 0.05). After 3 h tMCAO, DE-anticoagulated mice did also not show an increase in HT, neither at the dose of 37.5 mg/kg equivalent to anticoagulant treatment in the therapeutic range (1.3 +/- 0.9 mu l vs. control 2.3 +/- 0.5 mu l, p > 0.05) nor at 75 mg/kg, clearly representing supratherapeutic anticoagulation (1.8 +/- 0.8 mu l, p>0.05). Furthermore, no significant increase in HT under continued anticoagulation with DE 75 mg/kg could be found at 72 h after tMCAO for 1 h (1.7 +/- 0.9 mu l vs. control 1.6 +/- 0.4 mu l, p>0.05). Conclusion: Our experimental data suggest that DE does not significantly increase hemorrhagic transformation after transient focal cerebral ischemia in mice. From a translational viewpoint, this indicates that a continuation of DE anticoagulation in case of an ischemic stroke might be safe, but clearly, clinical data on this question are warranted.	[Bohmann, Ferdinand; Steinmetz, Helmuth; Foerch, Christian; Pfeilschifter, Waltraud] Goethe Univ Frankfurt, Dept Neurol, Univ Hosp, Frankfurt, Germany; [Mirceska, Ana; Pfeilschifter, Josef] Goethe Univ Frankfurt, Dept Gen Pharmacol & Toxicol, Univ Hosp, Frankfurt, Germany; [Lindhoff-Last, Edelgard] Goethe Univ Frankfurt, Dept Internal Med, Div Vasc Med, Univ Hosp, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Bohmann, F (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Univ Hosp, Frankfurt, Germany.	w.pfeilschifter@med.uni-frankfurt.de	Pfeilschifter, Waltraud/K-6134-2012	Pfeilschifter, Waltraud/0000-0001-6935-8842				Britz, 2007, RQUBE VERSION 1 00 8; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Demchuk AM, 1999, STROKE, V30, P34, DOI 10.1161/01.STR.30.1.34; Di Nisio M, 2005, NEW ENGL J MED, V353, P1028, DOI 10.1056/NEJMra044440; Dirnagl Ulrich Group Members of the MCAO-SOP, 2009, STANDARD OPERATING P; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Ezekowitz MD, 2007, AM J CARDIOL, V100, P1419, DOI 10.1016/j.amjcard.2007.06.034; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Lauer A, 2011, CIRCULATION, V124, P1654, DOI 10.1161/CIRCULATIONAHA.111.035972; Lee CJ, 2011, BRIT J CLIN PHARMACO, V72, P581, DOI 10.1111/j.1365-2125.2011.03916.x; Liesenfeld KH, 2011, J THROMB HAEMOST, V9, P2168, DOI 10.1111/j.1538-7836.2011.04498.x; Mosesson MW, 2004, BIOPHYS CHEM, V110, P93, DOI 10.1016/j.bpc.2004.01.007; Nielsen VG, 2005, ACTA ANAESTH SCAND, V49, P222, DOI 10.1111/j.1399-6576.2005.00602.x; Oldgren J, 2011, ANN INTERN MED, V155, P660, DOI 10.7326/0003-4819-155-10-201111150-00004; Pfeilschifter W, 2011, STROKE, V42, P1116, DOI 10.1161/STROKEAHA.110.604652; Selim M, 2002, STROKE, V33, P2047, DOI 10.1161/01.STR.0000023577.65990.4E; Stangier J, 2008, CLIN PHARMACOKINET, V47, P285, DOI 10.2165/00003088-200847050-00001; Stangier J, 2007, BRIT J CLIN PHARMACO, V64, P292, DOI 10.1111/j.1365-2125.2007.02899.x; Tsakiris DA, 1999, THROMB HAEMOSTASIS, V81, P177, DOI 10.1055/s-0037-1614439; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758; Wienen W, 2007, THROMB HAEMOSTASIS, V98, P333, DOI 10.1160/TH07-02-0113; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	26	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40804	10.1371/journal.pone.0040804	http://dx.doi.org/10.1371/journal.pone.0040804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911709	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300015
J	Tran, BX				Bach Xuan Tran			Quality of Life Outcomes of Antiretroviral Treatment for HIV/AIDS Patients in Vietnam	PLOS ONE			English	Article							WHOQOL-HIV; THERAPY; VERSION; MORTALITY; SERVICES; SUPPORT; COHORT	Objective: This study assessed health-related quality of life (HRQOL) and its related factors in HIV/AIDS patients taking antiretroviral treatment (ART) in Vietnam. Methods: A cross-sectional study was conducted with 1016 patients (36.2% women, mean age = 35.4) in three epicenters of Vietnam, including Hanoi, Hai Phong, and Ho Chi Minh City. HRQOL was assessed using the Vietnamese version of the WHOQOL-HIV BREF. Factor analysis classified measure items into six HRQOL dimensions, namely Physical, Morbidity, Social, Spirituality, Performance, and Environment. Tobit censored regression models were applied to determine associations of patient's characteristics and HRQOL domain scores. Results: Internal consistency reliability of the six domains ranged from 0.69 to 0.89. The WHOQOL-HIV BREF had a good discriminative validity with patient's disease stages, CD4 cell counts, and duration of ART. In a band score of (4, 20), six domains were moderate; "Environment" had the highest score (13.8 +/- 2.8), and "Social" had the lowest score (11.2 +/- 3.3). Worse HRQOL were observed in patients at provincial and district clinics. Those patients who were male, had higher educational attainment, and are employed, reported better HRQOL. In reduced regression models, poorer HRQOL was found in patients who had advanced HIV infection and had CD4 cell count <200 cells/mL. Patients reported significantly poorer Physical and Social in the 1st year ART, but moderately better Performance, Morbidity, Spirituality, and Environment from the 2nd year ART, compared to those not-yet-on ART. Conclusion: Strengthening the quality of ART services at the provincial and district levels, gender-specific impact mitigation, and early treatment supports are recommended for further expansion of ART services in Vietnam. Regular assessments of HRQOL may provide important indicators for monitoring and evaluating HIV/AIDS services.	[Bach Xuan Tran] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Bach Xuan Tran] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam	University of Alberta; Hanoi Medical University	Tran, BX (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	bach@hmu.edu.vn						Tran BX, 2012, QUAL LIFE RES, V21, P613, DOI 10.1007/s11136-011-9963-y; Tran BX, 2011, AIDS CARE, V23, P1236, DOI 10.1080/09540121.2011.555749; Bajunirwe F, 2009, AIDS CARE, V21, P271, DOI 10.1080/09540120802241863; Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; Braithwaite RS, 2008, VALUE HEALTH, V11, P975, DOI 10.1111/j.1524-4733.2007.00315.x; Call SA, 2000, QUAL LIFE RES, V9, P977, DOI 10.1023/A:1016668802328; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; Dennison CR, 2002, AM J MANAG CARE, V8, pS580; Do TN, 2012, CLIN INFECT DIS, V54, pS306, DOI 10.1093/cid/cir1045; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jain MK, 2009, CLIN INFECT DIS, V48, P1772, DOI 10.1086/599111; Jayaweera D, 2009, HIV CLIN TRIALS, V10, P375, DOI 10.1310/hct1006-375; Kowal J, 2008, J PAIN SYMPTOM MANAG, V36, P247, DOI 10.1016/j.jpainsymman.2007.10.012; Liu CL, 2006, QUAL LIFE RES, V15, P941, DOI 10.1007/s11136-005-5913-x; Ministry of Health, 2008, NAT STRAT HIV AIDS P; Ministry of Health, 2009, ANN REV HIV AIDS CON; Ministry of Health, 2009, NAT GUID HIV AIDS DI; Ministry of Health, 2012, ANN REP HIV AIDS 201; National Committee for Aids Drugs Control and Prostitution Prevention UNAIDS, 2012, VIET NAM AIDS RESP P; O'Connell K, 2003, SOC SCI MED, V57, P1259, DOI 10.1016/S0277-9536(02)00506-3; O'Connell KA, 2004, AIDS CARE, V16, P882, DOI 10.1080/09540120412331290194; O'Connell KA, 2012, AIDS BEHAV, V16, P452, DOI 10.1007/s10461-010-9863-0; Oosterhoff P, 2008, WOMENS HLTH URBAN LI; Oosterhoff P, 2008, REPROD HEALTH MATTER, V16, P162, DOI 10.1016/S0968-8080(08)32408-2; Oosterhoff P, 2008, CULT HEALTH SEX, V10, P403, DOI 10.1080/13691050801915192; Perez IR, 2005, QUAL LIFE RES, V14, P1301, DOI 10.1007/s11136-004-4715-x; Saddki N, 2009, AIDS CARE, V21, P1271, DOI 10.1080/09540120902803216; Thu AN, 2009, J ASSOC NURSE AIDS C, V20, P141, DOI 10.1016/j.jana.2008.10.006; Tran BX, 2012, AIDS CARE; Twisk J, 2009, J CLIN EPIDEMIOL, V62, P953, DOI 10.1016/j.jclinepi.2008.10.003; *UNAIDS, 2008, UNAIDS0825EJC1510E; Vietnam Administration of HIV/AIDS Control, 2012, ANN REP HIV AIDS 201; Vietnam Administration of HIV/AIDS Control, 2010, REP CURR SIT HIV INF; Vu VT, 2011, AIDS CARE, V23, P139, DOI 10.1080/09540121.2010.507741; WHO, 2002, WHOMSDMER021; World Health Organization, 2002, WHO TRADITIONAL MED, P1; World Health Organization, 2011, TREATM 2 0 CAT NEXT; Zimpel RR, 2007, AIDS CARE, V19, P923, DOI 10.1080/09540120701213765; Zwahlen M, 2009, INT J EPIDEMIOL	40	62	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41062	10.1371/journal.pone.0041062	http://dx.doi.org/10.1371/journal.pone.0041062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977GL	22911742	Green Published, Green Submitted, gold			2022-12-27	WOS:000306644600042
J	De Conto, F; Di Lonardo, E; Arcangeletti, MC; Chezzi, C; Medici, MC; Calderaro, A				De Conto, Flora; Di Lonardo, Enrica; Arcangeletti, Maria Cristina; Chezzi, Carlo; Medici, Maria Cristina; Calderaro, Adriana			Highly Dynamic Microtubules Improve the Effectiveness of Early Stages of Human Influenza A/NWS/33 Virus Infection in LLC-MK2 Cells	PLOS ONE			English	Article							SWINE-FEVER VIRUS; VIRAL INTERACTIONS; EPITHELIAL-CELLS; TUBULIN; CYTOSKELETON; PROTEIN; TRANSPORT; ACTIN; ACETYLATION; AUTOPHAGY	Background: This study aims to investigate the role of microtubule dynamics in the initiation of NWS/33 human influenza A (NWS) virus infection in MDCK and LLC-MK2 mammalian kidney cells. We previously demonstrated a host-dependent role of the actin cytoskeleton in inducing restriction during the early phases of NWS infection. Furthermore, we showed the differential infectious entry of NWS virus in the above mentioned cell models. Methodology/Principal Findings: By first employing a panel of microtubule-modulators, we evidenced that microtubule-stabilization negatively interferes with NWS replication in LLC-MK2 but not in MDCK cells. Conversely, microtubule-depolymerization improves NWS growth in LLC-MK2 but not in the MDCK model. By using immunofluorescence labelling and Western blotting analyses upon NWS infection in mammalian kidney cells, it was observed that the occurrence of alpha-tubulin hyperacetylation - a post-translational modified form suggestive of stable microtubules - was significantly delayed in LLC-MK2 when compared to MDCK cells. Furthermore, mock-infected LLC-MK2 cells were shown to have higher levels of both acetylated alpha-tubulin and microtubule-associated protein 4 (MAP4), the latter being essential for the maintenance of normal microtubule polymer levels in interphase epithelial cells. Finally, to obtain highly dynamic microtubules in LLC-MK2 cells, we knocked down the expression of MAP4 by using a RNA-mediated RNA interference approach. The results evidenced that MAP4 silencing improves NWS growth in LLC-MK2 cells. Conclusion: By evidencing the cell type-dependent regulatory role of microtubule dynamics on NWS replication in mammalian kidney cells, we demonstrated that microtubule-stabilization represents a restriction factor for the initiation of NWS infection in LLC-MK2 but not in MDCK cells.	[De Conto, Flora; Di Lonardo, Enrica; Arcangeletti, Maria Cristina; Chezzi, Carlo; Medici, Maria Cristina; Calderaro, Adriana] Univ Parma, Microbiol Sect, Dept Pathol & Lab Med, I-43100 Parma, Italy	University of Parma; University Hospital of Parma	De Conto, F (corresponding author), Univ Parma, Microbiol Sect, Dept Pathol & Lab Med, I-43100 Parma, Italy.	flora.deconto@unipr.it	De Conto, Flora/H-9760-2019	De Conto, Flora/0000-0002-0493-2353	Ministry of University and Scientific Research FIL (Parma); Italian Scientific Research Fund PRIN	Ministry of University and Scientific Research FIL (Parma); Italian Scientific Research Fund PRIN	This work was supported by grants from Ministry of University and Scientific Research FIL 2009 (Parma) and the Italian Scientific Research Fund PRIN 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2001, J VIROL, V75, P9819, DOI 10.1128/JVI.75.20.9819-9827.2001; Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Arcangeletti MC, 2008, ARCH VIROL, V153, P1209, DOI 10.1007/s00705-008-0103-0; Balasubramani M, 2011, MUTAT RES-GEN TOX EN, V722, P154, DOI 10.1016/j.mrgentox.2010.08.019; Bulinski JC, 1997, J CELL SCI, V110, P3055; BULINSKI JC, 1980, J CELL BIOL, V87, P802, DOI 10.1083/jcb.87.3.802; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Cantin R, 2005, J VIROL, V79, P6577, DOI 10.1128/JVI.79.11.6577-6587.2005; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; De Conto F, 2011, VIRUS RES, V155, P221, DOI 10.1016/j.virusres.2010.10.008; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Frampton AR, 2010, VET MICROBIOL, V141, P12, DOI 10.1016/j.vetmic.2009.07.035; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Gilbert JM, 2003, J VIROL, V77, P2615, DOI 10.1128/JVI.77.4.2615-2622.2003; Glotzer JB, 2001, J VIROL, V75, P2421, DOI 10.1128/JVI.75.5.2421-2434.2001; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Hait William N, 2006, Trans Am Clin Climatol Assoc, V117, P85; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Holmfeldt P, 2002, CURR BIOL, V12, P1034, DOI 10.1016/S0960-9822(02)00897-7; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; HUNZIKER W, 1990, EMBO J, V9, P3515, DOI 10.1002/j.1460-2075.1990.tb07560.x; Husain M, 2011, FEBS LETT, V585, P128, DOI 10.1016/j.febslet.2010.11.023; JOACHIMS M, 1995, VIROLOGY, V211, P451, DOI 10.1006/viro.1995.1427; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Joseph RA, 2008, HEPATOLOGY, V47, P1745, DOI 10.1002/hep.22014; Jouvenet N, 2004, J VIROL, V78, P7990, DOI 10.1128/JVI.78.15.7990-8001.2004; Kannan H, 2009, J VIROL, V83, P6375, DOI 10.1128/JVI.02571-08; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; MANDELKOW E, 1995, CURR OPIN CELL BIOL, V7, P72, DOI 10.1016/0955-0674(95)80047-6; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Momose F, 2007, MICROBES INFECT, V9, P1422, DOI 10.1016/j.micinf.2007.07.007; Momose F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021123; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; PARYSEK LM, 1984, J CELL BIOL, V99, P2287, DOI 10.1083/jcb.99.6.2287; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Quinones GB, 2011, MOL BIOL CELL, V22, P1045, DOI 10.1091/mbc.E10-06-0519; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Suikkanen S, 2003, J VIROL, V77, P10270, DOI 10.1128/JVI.77.19.10270-10279.2003; VANZEIJL MJAH, 1990, CELL REGUL, V1, P921, DOI 10.1091/mbc.1.12.921; Vaughan JC, 2009, BIOPHYS J, V97, P1647, DOI 10.1016/j.bpj.2009.07.011; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang XM, 1996, J CELL BIOL, V132, P345, DOI 10.1083/jcb.132.3.345; Warren JC, 2007, CELL MOTIL CYTOSKEL, V64, P675, DOI 10.1002/cm.20215; Welte MA, 2010, CURR BIOL, V20, pR410, DOI 10.1016/j.cub.2010.03.018; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Yamauchi Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002316; Yedowitz JC, 2005, J VIROL, V79, P4730, DOI 10.1128/JVI.79.8.4730-4743.2005; Yoder A, 2011, J VIROL, V85, P3020, DOI 10.1128/JVI.02462-10; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	65	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41207	10.1371/journal.pone.0041207	http://dx.doi.org/10.1371/journal.pone.0041207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911759	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600055
J	Idring, S; Rai, D; Dal, H; Dalman, C; Sturm, H; Zander, E; Lee, BK; Serlachius, E; Magnusson, C				Idring, Selma; Rai, Dheeraj; Dal, Henrik; Dalman, Christina; Sturm, Harald; Zander, Eric; Lee, Brian K.; Serlachius, Eva; Magnusson, Cecilia			Autism Spectrum Disorders in the Stockholm Youth Cohort: Design, Prevalence and Validity	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; TELEPHONE INTERVIEW; CHILDHOOD AUTISM; A-TAC; CHILDREN; EPIDEMIOLOGY; ASSOCIATION; DIAGNOSIS; REGISTER; TICS	Objective: Reports of rising prevalence of autism spectrum disorders (ASD), along with their profound personal and societal burden, emphasize the need of methodologically sound studies to explore their causes and consequences. We here present the design of a large intergenerational resource for ASD research, along with population-based prevalence estimates of ASD and their diagnostic validity. Method: The Stockholm Youth Cohort is a record-linkage study comprising all individuals aged 0-17 years, ever resident in Stockholm County in 2001-2007 (N = 589,114). ASD cases (N = 5,100) were identified using a multisource approach, involving registers covering all pathways to ASD diagnosis and care, and categorized according to co-morbid intellectual disability. Prospectively recorded information on potential determinants and consequences of ASD were retrieved from national and regional health and administrative registers. Case ascertainment was validated through case-note review, and cross validation with co-existing cases in a national twin study. Results: The 2007 year prevalence of ASD in all children and young people was 11.5 per 1,000 (95% confidence interval 11.2-11.8), with a co-morbid intellectual disability recorded in 42.6% (41.0-44.2) of cases. We found 96.0% (92.0-98.4) of reviewed case-notes being consistent with a diagnosis of ASD, and confirmed ASD in 85.2% (66.2-95.8) of affected twins. Conclusions: Findings from this contemporary study accords with recently reported prevalence estimates from Western countries at around 1%, based on valid case ascertainment. The Stockholm Youth Cohort, in light of the availability of extensive information from Sweden's registers, constitutes an important resource for ASD research. On-going work, including collection of biological samples, will enrich the study further.	[Idring, Selma; Rai, Dheeraj; Dal, Henrik; Dalman, Christina; Magnusson, Cecilia] Karolinska Inst, Div Publ Hlth Epidemiol, Dept Publ Hlth Sci, Stockholm, Sweden; [Idring, Selma; Sturm, Harald; Zander, Eric] Stockholm Cty Council, Neuropsychiat Resource Team SE Stockholm, Stockholm, Sweden; [Rai, Dheeraj] Univ Bristol, Acad Unit Psychiat, Sch Social & Community Med, Bristol, Avon, England; [Rai, Dheeraj] Avon & Wiltshire Partnership NHS Mental Hlth Trus, Bristol, Avon, England; [Zander, Eric] Karolinska Inst, Ctr Neurodev Disorders, Karolinska Inst KIND, Stockholm, Sweden; [Zander, Eric] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Lee, Brian K.] Drexel Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Serlachius, Eva] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Stockholm County Council; University of Bristol; Karolinska Institutet; Karolinska Institutet; Drexel University; Karolinska Institutet	Idring, S (corresponding author), Karolinska Inst, Div Publ Hlth Epidemiol, Dept Publ Hlth Sci, Stockholm, Sweden.	Selma.idrizbegovic@ki.se	Zander, Eric/G-1064-2013; Serlachius, Eva/E-8956-2013; Zander, Eric/AAV-8436-2020; Romanova, Raisa/O-5724-2018	Zander, Eric/0000-0002-2267-5813; Serlachius, Eva/0000-0001-7115-6422; Lee, Brian/0000-0002-3635-8034; Dalman, Christina/0000-0002-3579-2357; Rai, Dheeraj/0000-0002-7239-3523; Magnusson, Cecilia/0000-0002-8567-6725	Stockholm County Council, Centre for Psychiatric Research	Stockholm County Council, Centre for Psychiatric Research	The source of funding is Stockholm County Council, Centre for Psychiatric Research, http://www.webbhotell.sll.se/Psykiatriforskning/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Association AP Proposed revision: Autism Spectrum Disorder, ASS AP PROP REV AUT; Atladottir HO, 2010, ARCH PEDIAT ADOL MED, V164, P470, DOI 10.1001/archpediatrics.2010.9; Axen M, 2010, REGIONALT VARDPROGRA; Baio J., 2012, MORBIDITY MORTALITY, V61; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Barbaresi WJ, 2009, J AUTISM DEV DISORD, V39, P464, DOI 10.1007/s10803-008-0645-8; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; BLOTH B, 1976, ACTA MED SCAND, V200, P281; Brottsforebyggande Radet, 2011, KRIM 2010; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; D'Onofrio BM, 2010, ARCH GEN PSYCHIAT, V67, P529, DOI 10.1001/archgenpsychiatry.2010.33; Fernell E, 2010, RES DEV DISABIL, V31, P680, DOI 10.1016/j.ridd.2010.01.007; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Giarelli E, 2010, DISABIL HEALTH J, V3, P107, DOI 10.1016/j.dhjo.2009.07.001; Gillberg C, 2006, J AUTISM DEV DISORD, V36, P429, DOI 10.1007/s10803-006-0081-6; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hansson SL, 2005, BRIT J PSYCHIAT, V187, P262, DOI 10.1192/bjp.187.3.262; Hertz-Picciotto I, 2006, ENVIRON HEALTH PERSP, V114, P1119, DOI 10.1289/ehp.8483; Honda H, 2005, DEV MED CHILD NEUROL, V47, P10, DOI 10.1017/S0012162205000034; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; Johansson LA, 2000, INT J EPIDEMIOL, V29, P495, DOI 10.1093/ije/29.3.495; Kadesjo B, 1999, J AUTISM DEV DISORD, V29, P327, DOI 10.1023/A:1022115520317; Kawamura Y, 2008, PSYCHIAT CLIN NEUROS, V62, P152, DOI 10.1111/j.1440-1819.2008.01748.x; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; King MD, 2011, AM SOCIOL REV, V76, P320, DOI 10.1177/0003122411399389; Lampi KM, 2010, ACTA PAEDIATR, V99, P1425, DOI 10.1111/j.1651-2227.2010.01835.x; Lampi KM, 2011, J AUTISM DEV DISORD, V41, P1090, DOI 10.1007/s10803-010-1132-6; Landrigan PJ, 2006, PEDIATRICS, V118, P2173, DOI 10.1542/peds.2006-0360; Landrigan PJ, 2010, CURR OPIN PEDIATR, V22, P219, DOI 10.1097/MOP.0b013e328336eb9a; Larson T, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-1; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mandell DS, 2005, PEDIATRICS, V116, P1480, DOI 10.1542/peds.2005-0185; Mattila ML, 2011, J AM ACAD CHILD PSY, V50, P583, DOI 10.1016/j.jaac.2011.04.001; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Parner ET, 2011, J AUTISM DEV DISORD, V41, P1601, DOI 10.1007/s10803-011-1186-0; Posserud M, 2009, SOC PSYCH PSYCH EPID, V45, P319; Schendel DE, 2012, J AUTISM DEV DISORD; Shattuck PT, 2009, J AM ACAD CHILD PSY, V48, P474, DOI 10.1097/CHI.0b013e31819b3848; Socialstyrelsen. Epidemiologiskt centrum Sverige. Socialstyrelsen. Epidemiologiskt centrum, 2007, IN PAT DIS SWED 1987; Statistics Sweden, 2009, INT DAT LAB MARK RES; Statistics Sweden, CENS SWED FOLK BOST; Statistiska centralbyran, 2008, TABL POP SWED 2007; Statistiska centralbyran, 2004, STAT MEDD SER UF; Stockholm Lans Landsting, 2011, MET BARNH; Stockholm Lans Landsting, 2004, 222004RK20040998 STO; Stockholm Lans Landsting, 2011, BARNH ARSR 2010; Stoltenberg C, 2010, MOL PSYCHIATR, V15, P676, DOI 10.1038/mp.2009.143; Sverige. Statistiska centralbyran, 2008, MULT REG 2007 DESCR; Szatmari P, 2007, INT REV PSYCHIATR, V19, P483, DOI 10.1080/09540260701563619; The National Bureau of Health and Welfare, 2003, SWED MED BIRTH REG S; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; *WHO, 1978, INT CLASS DIS; WHO, 2010, INT STAT CLASS DIS R; Williams E, 2008, DEV MED CHILD NEUROL, V50, P672, DOI 10.1111/j.1469-8749.2008.03042.x; Williams JG, 2006, ARCH DIS CHILD, V91, P8, DOI 10.1136/adc.2004.062083; Windham GC, 2006, ENVIRON HEALTH PERSP, V114, P1438, DOI 10.1289/ehp.9120	64	182	185	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41280	10.1371/journal.pone.0041280	http://dx.doi.org/10.1371/journal.pone.0041280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977GL	22911770	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600064
J	Liu, XY; Yue, CX; Xu, Z; Shu, H; Pu, MJ; Yu, H; Shi, YM; Zhuang, LY; Xu, XH; Zhang, ZJ				Liu, Xiaoyan; Yue, Chunxian; Xu, Zhi; Shu, Hao; Pu, Mengjia; Yu, Hui; Shi, Yongmei; Zhuang, Liying; Xu, Xiaohui; Zhang, Zhijun			Association Study of Candidate Gene Polymorphisms with Amnestic Mild Cognitive Impairment in a Chinese Population	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; SYNDROME CRITICAL REGION; LINKAGE DISEQUILIBRIUM; PLASMINOGEN-ACTIVATOR; PRECURSOR PROTEIN; TAU; BACE2; HOMOLOG; PLAU; MAPS	To investigate the relationship between amnestic mild cognitive impairment (aMCI) and candidate gene polymorphisms in a Chinese population, 116 aMCI patients and 93 normal controls were recruited. Multi-dimensional neuropsychological tests were used to extensively assess the cognitive functions of the subjects. MassARRAY and iPLEX systems were used to measure candidate single nucleotide polymorohisms (SNPs) and analyse allelic, genotypic or haplotypic distributions. The scores of the neuropsychological tests were significantly lower for the aMCI patients than for the normal controls. The distributions of SNPs relating to the amyloid cascade hypothesis (TOMM40 rs157581 G and TOMM40 rs2075650 G), to the cholesterol metabolism hypothesis (ApoE rs429358 C, LDLR rs11668477 G and CH25H rs7091822 T and PLAU rs2227564 CT) and to the tau hypothesis (MAPT/STH rs242562 GG) in aMCI were significantly different than those in normal controls. Interactions were also found in aMCI amongst SNPs in LDLR rs11668477, PLAU rs2227564, and TOMM40 rs157581, between SNPs in TOMM40 rs157580 and BACE2 rs9975138. The study suggests that aMCI is characterised by memory impairment and associated with SNPs in three systems relating to the pathogenesis of AD-those of the amyloid cascade, tau and cholesterol metabolism pathways. Interactions were also observed between genes in the amyloid pathway and between the amyloid and cholesterol pathways.	[Liu, Xiaoyan; Yue, Chunxian; Shu, Hao; Pu, Mengjia; Yu, Hui; Shi, Yongmei; Zhuang, Liying; Xu, Xiaohui; Zhang, Zhijun] Southeast Univ, Sch Clin Med, Nanjing, Peoples R China; [Liu, Xiaoyan; Yue, Chunxian; Xu, Zhi; Shu, Hao; Pu, Mengjia; Shi, Yongmei; Zhuang, Liying; Xu, Xiaohui; Zhang, Zhijun] Southeast Univ, Dept Neurol, Affiliated ZhongDa Hosp, Nanjing, Peoples R China	Southeast University - China; Southeast University - China	Liu, XY (corresponding author), Southeast Univ, Sch Clin Med, Nanjing, Peoples R China.	zhijunzhang@seu.edu.cn			National Nature Science Foundation of China for the Excellent Young Scientist [30825014]; National Natural Science Foundation of China [81171021]	National Nature Science Foundation of China for the Excellent Young Scientist(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Nature Science Foundation of China for the Excellent Young Scientist (No. 30825014 Zhijun Zhang) and National Natural Science Foundation of China (No. 81171021 Yongmei Shi). The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquati F, 2000, FEBS LETT, V468, P59, DOI 10.1016/S0014-5793(00)01192-3; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Benarroch EE, 2008, NEUROLOGY, V71, P1368, DOI 10.1212/01.wnl.0000333215.93440.36; Cheon MS, 2008, AMINO ACIDS, V35, P339, DOI 10.1007/s00726-007-0618-9; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Finckh U, 2003, NEUROGENETICS, V4, P213, DOI 10.1007/s10048-003-0157-9; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Han MR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-90; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Kivipelto M, 2002, ANN INTERN MED, V137, P149, DOI 10.7326/0003-4819-137-3-200208060-00006; Lamsa R, 2008, NEUROBIOL AGING, V29, P848, DOI 10.1016/j.neurobiolaging.2006.12.009; Lehmann DJ, 1997, HUM MOL GENET, V6, P1933, DOI 10.1093/hmg/6.11.1933; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; PERRY EK, 1986, BRIT MED BULL, V42, P63, DOI 10.1093/oxfordjournals.bmb.a072100; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Riemenschneider M, 2006, HUM MOL GENET, V15, P2446, DOI 10.1093/hmg/ddl167; Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69; Skipper L, 2004, AM J HUM GENET, V75, P669, DOI 10.1086/424492; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; Yu CE, 2007, GENOMICS, V89, P655, DOI 10.1016/j.ygeno.2007.02.002	26	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41198	10.1371/journal.pone.0041198	http://dx.doi.org/10.1371/journal.pone.0041198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911757	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600053
J	Malmstrom, S; Larsson, SB; Hannoun, C; Lindh, M				Malmstrom, Sebastian; Larsson, Simon B.; Hannoun, Charles; Lindh, Magnus			Hepatitis B Viral DNA Decline at Loss of HBeAg Is Mainly Explained by Reduced cccDNA Load - Down-Regulated Transcription of PgRNA Has Limited Impact	PLOS ONE			English	Article							BASAL CORE PROMOTER; VIRUS-REPLICATION; PRECORE MUTATIONS; SURFACE-ANTIGEN; INHIBITION; INFECTION	Background: Quantification of hepatitis B virus (HBV) DNA and surface antigen (HBsAg) serum levels have become increasingly important for the assessment of clinical stage and response to treatment for chronic hepatitis B. Effective immune clearance results in reduction of viremia by 4-5 log units and HBsAg levels by 2 log, but these processes are not well understood. Thus, it is uncertain to what extent mechanisms that inhibit transcription of the pregenomic RNA (pgRNA), an RNA intermediate, contribute to suppression of viremia. Likewise, it is unclear if transcriptional regulation is important for the excessive production of surface antigen (HBsAg) that is a hallmark of HBV infection. Methods: HBV RNA and cccDNA were quantified in 19 liver biopsies from patients with chronic HBV infection, as well as in transfected Huh7.5 cells and in PLC/PRF/5 cells carrying integrated HBV genome. Results: Patients negative for HBeAg had 2.15 log lower levels of cccDNA in liver tissue, 4.84 log lower serum levels of HBV DNA and 1.45 log lower serum levels of HBsAg, than HBeAg-positive patients. The pgRNA in liver tissue correlated strongly with cccDNA (R-2 = 0.87, p<0.0001) and HBV DNA levels in serum (R-2 = 0.81, p<0.0001), whereas S-RNA correlated strongly with cccDNA (R-2 = 0.65, p<0.0001) and HBsAg levels (R-2 = 0.57, p = 0.0003). The S-RNA/pgRNA ratio was higher in HBeAg-negative patients (ratio 40 vs. 3, p = 0.01) and in PLC/PRF/5 cells, and was in transfected Huh7.5 cells not influenced by mutations in the HBV core promoter. Conclusion: The reduction of viremia that is observed after loss of HBeAg was mainly explained by reduced cccDNA load in the liver, whereas the contribution of down-regulation of pgRNA transcription was relatively small. Enhanced transcription of S-RNA does not explain excessive production of HBsAg.	[Malmstrom, Sebastian; Larsson, Simon B.; Hannoun, Charles; Lindh, Magnus] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden	University of Gothenburg	Malmstrom, S (corresponding author), Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden.	magnus.lindh@microbio.gu.se	Larsson, Simon/AAA-8822-2020	Larsson, Simon/0000-0002-0964-6137	ALF-LUA [ALFGBG-146611]; Swedish Research Council [B0060901]	ALF-LUA; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The project was funded by grants from ALF-LUA (grant ALFGBG-146611) and the Swedish Research Council (grant B0060901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUSS V, 1991, P NATL ACAD SCI USA, V88, P1059, DOI 10.1073/pnas.88.3.1059; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chou YC, 2007, HEPATOLOGY, V46, P672, DOI 10.1002/hep.21726; Dandri M, 2008, HEPATOLOGY, V48, P1079, DOI 10.1002/hep.22469; Gordien E, 2001, J VIROL, V75, P2684, DOI 10.1128/JVI.75.6.2684-2691.2001; GUIDOTTI LG, 1994, P NATL ACAD SCI USA, V91, P3764, DOI 10.1073/pnas.91.9.3764; GUNTHER S, 1995, J VIROL, V69, P5437; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Laras A, 2002, VIROLOGY, V295, P86, DOI 10.1006/viro.2001.1352; Laras A, 2006, HEPATOLOGY, V44, P694, DOI 10.1002/hep.21299; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Lindh M, 2000, J VIRAL HEPATITIS, V7, P258; MACNAB GM, 1976, BRIT J CANCER, V34, P509, DOI 10.1038/bjc.1976.205; Nguyen T, 2010, J HEPATOL, V52, P508, DOI 10.1016/j.jhep.2010.01.007; Pollicino T, 2006, GASTROENTEROLOGY, V130, P823, DOI 10.1053/j.gastro.2006.01.001; Qin YL, 2011, J VIROL, V85, P10167, DOI 10.1128/JVI.00819-11; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Suri D, 2001, J HEPATOL, V35, P790, DOI 10.1016/S0168-8278(01)00215-X; Tacke F, 2004, J VIROL, V78, P8524, DOI 10.1128/JVI.78.16.8524-8535.2004; Thompson AJV, 2010, HEPATOLOGY, V51, P1933, DOI 10.1002/hep.23571; Tong Shuping, 2005, Int J Med Sci, V2, P2; Volz T, 2007, GASTROENTEROLOGY, V133, P843, DOI 10.1053/j.gastro.2007.06.057; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wursthorn K, 2006, HEPATOLOGY, V44, P675, DOI 10.1002/hep.21282	26	34	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e36349	10.1371/journal.pone.0036349	http://dx.doi.org/10.1371/journal.pone.0036349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911677	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600001
J	Panneerdoss, S; Chang, YF; Buddavarapu, KC; Chen, HIH; Shetty, G; Wang, HZ; Chen, YD; Kumar, TR; Rao, MK				Panneerdoss, Subbarayalu; Chang, Yao-Fu; Buddavarapu, Kalyan C.; Chen, Hung-I Harry; Shetty, Gunapala; Wang, Huizhen; Chen, Yidong; Kumar, T. Rajendra; Rao, Manjeet K.			Androgen-Responsive MicroRNAs in Mouse Sertoli Cells	PLOS ONE			English	Article							TESTIS BARRIER DYNAMICS; PROTEIN-KINASE; GENE-EXPRESSION; HOMEOBOX GENE; SPERMATOGENESIS; RECEPTOR; BIOGENESIS; TRANSCRIPTION; KNOCKOUT; SUBUNIT	Although decades of research have established that androgen is essential for spermatogenesis, androgen's mechanism of action remains elusive. This is in part because only a few androgen-responsive genes have been definitively identified in the testis. Here, we propose that microRNAs - small, non-coding RNAs - are one class of androgen-regulated trans-acting factors in the testis. Specifically, by using androgen suppression and androgen replacement in mice, we show that androgen regulates the expression of several microRNAs in Sertoli cells. Our results reveal that several of these microRNAs are preferentially expressed in the testis and regulate genes that are highly expressed in Sertoli cells. Because androgen receptor-mediated signaling is essential for the pre- and post-meiotic germ cell development, we propose that androgen controls these events by regulating Sertoli/germ cell-specific gene expression in a microRNA-dependent manner.	[Panneerdoss, Subbarayalu; Chang, Yao-Fu; Buddavarapu, Kalyan C.; Chen, Hung-I Harry; Chen, Yidong; Rao, Manjeet K.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Shetty, Gunapala] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Wang, Huizhen; Kumar, T. Rajendra] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Rao, Manjeet K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; UTMD Anderson Cancer Center; University of Kansas; University of Kansas Medical Center; University of Texas System; University of Texas Health San Antonio	Panneerdoss, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.	raom@uthscsa.edu		Shetty, Gunapala/0000-0001-5786-0667	National Institutes of Health (NIH) [R01, HD057118, P20 RR016475, R03 HD043945]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD043945, R01HD057118] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	MKR was supported by National Institutes of Health (NIH) R01 grant HD057118, and work in the TRK laboratory is supported in part by NIH grants P20 RR016475 and R03 HD043945. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir AL, 2003, J BIOL CHEM, V278, P30828, DOI 10.1074/jbc.M301208200; Anway MD, 2003, BIOL REPROD, V68, P996, DOI 10.1095/biolreprod.102.008045; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Chang YF, 2012, P NATL ACAD SCI USA, V109, P5750, DOI 10.1073/pnas.1117837109; Chang YF, 2011, BIOTECHNIQUES, V51, P341, DOI 10.2144/000113764; Chung SSW, 2004, DEV DYNAM, V230, P754, DOI 10.1002/dvdy.20083; Dahle MK, 2002, J BIOL CHEM, V277, P22902, DOI 10.1074/jbc.M200131200; Dean DM, 1996, MOL ENDOCRINOL, V10, P1489, DOI 10.1210/me.10.12.1489; Denolet E, 2006, MOL ENDOCRINOL, V20, P321, DOI 10.1210/me.2005-0113; Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101; Gregory CW, 2001, J ANDROL, V22, P537; Gye MC, 2003, ARCH ANDROLOGY, V49, P271, DOI [10.1080/713828170, 10.1080/01485010390204913]; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Imam JS, 2010, ONCOGENE IN PRESS, P223; King IA, 1996, J INVEST DERMATOL, V107, P531, DOI 10.1111/1523-1747.ep12582790; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lie PPY, 2010, INT J BIOCHEM CELL B, V42, P975, DOI 10.1016/j.biocel.2010.02.010; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Nicholls PK, 2011, ENDOCRINOLOGY, V152, P1670, DOI 10.1210/en.2010-1341; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Rao MK, 2003, MOL ENDOCRINOL, V17, P223, DOI 10.1210/me.2002-0232; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Scobey MJ, 2001, ENDOCRINOLOGY, V142, P948, DOI 10.1210/en.142.2.948; Shetty G, 2000, ENDOCRINOLOGY, V141, P1735, DOI 10.1210/en.141.5.1735; Wang RS, 2006, ENDOCRINOLOGY, V147, P5624, DOI 10.1210/en.2006-0138; Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025; Wong CH, 2005, ENDOCRINOLOGY, V146, P1893, DOI 10.1210/en.2004-1464; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998; Zhou Q, 2005, BIOL REPROD, V72, P1010, DOI 10.1095/biolreprod.104.035915	35	40	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41146	10.1371/journal.pone.0041146	http://dx.doi.org/10.1371/journal.pone.0041146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911753	Green Published, Green Submitted, gold			2022-12-27	WOS:000306644600049
J	Dorman, SE; Chihota, VN; Lewis, JJ; Shah, M; Clark, D; Grant, AD; Churchyard, GJ; Fielding, KL				Dorman, Susan E.; Chihota, Violet N.; Lewis, James J.; Shah, Maunank; Clark, David; Grant, Alison D.; Churchyard, Gavin J.; Fielding, Katherine L.			Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RIFAMPIN RESISTANCE; RANDOMIZED-TRIAL; DIAGNOSIS; HIV; ASSAY; ERA	Background: Xpert MTB/RIF ("Xpert'') is a molecular test for detection of Mycobacterium tuberculosis (MTB) in sputum. Performance characteristics have been established for its use during passive tuberculosis (TB) case detection in symptomatic TB suspects, but Xpert performance has not been assessed in other settings. Objectives were to determine Xpert performance and costs in the context of a TB prevalence survey. Methodology/Principal Findings: This was a diagnostic sub-study of a TB prevalence survey conducted in gold mining companies in South Africa. Sputa (one per participant) were tested using smear microscopy, liquid culture (reference comparator), and Xpert. Costs were collected using an ingredients approach and analyzed using a public health program perspective. 6893 participants provided a sputum specimen. 187/6893 (2.7%) were positive for MTB in culture, 144/6893 (2.1%) were positive for MTB by Xpert, and 91/6893 (1.3%) were positive for acid fast bacilli by microsocopy. Sensitivity, specificity, positive predictive value, and negative predictive value for detection of MTB by Xpert were 62.6% (95% confidence interval [CI] 55.2, 69.5), 99.6% (99.4, 99.7), 81.3% (73.9, 87.3), and 98.9 (98.6, 98.8); agreement between Xpert and culture was 98.5% (98.2, 98.8). Sensitivity of microscopy was 17.6% (12.5, 23.9). When individuals with a history of TB treatment were excluded from the analysis, Xpert specificity was 99.8 (99.7, 99.9) and PPV was 90.6 (83.3, 95.4) for detection of MTB. For the testing scenario of 7000 specimens with 2.7% of specimens culture positive for MTB, costs were $165,690 for Xpert and $115,360 for the package of microscopy plus culture. Conclusion: In the context of a TB prevalence survey, the Xpert diagnostic yield was substantially higher than that of microscopy yet lower than that of liquid culture. Xpert may be useful as a sole test for TB case detection in prevalence surveys, particularly in settings lacking capacity for liquid culture.	[Dorman, Susan E.; Shah, Maunank] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Chihota, Violet N.; Lewis, James J.; Clark, David; Churchyard, Gavin J.] Aurum Inst Hlth Res, Johannesburg, South Africa; [Lewis, James J.; Grant, Alison D.; Churchyard, Gavin J.; Fielding, Katherine L.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Churchyard, Gavin J.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	Johns Hopkins University; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand	Dorman, SE (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	dsusan1@jhmi.edu	Lewis, James/F-6333-2013; Chihota, Violet/DWH-9372-2022	Chihota, Violet/0000-0003-1444-9266; Lewis, James/0000-0002-8603-2761; Churchyard, Gavin/0000-0002-4269-3699	U.S. National Institutes of Health [RO1 AI51528, 5U2RTW007370, 5U2RTW007373]; Bill and Melinda Gates Foundation; Biostatistics core of the Consortium to Respond Effectively to the AIDS and TB Epidemics (CREATE); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089259, K23AI051528] Funding Source: NIH RePORTER; Medical Research Council [G0700837, MR/K007467/1] Funding Source: researchfish; National Institute for Health Research [PHCS/03/01] Funding Source: researchfish; MRC [G0700837, MR/K007467/1] Funding Source: UKRI	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Biostatistics core of the Consortium to Respond Effectively to the AIDS and TB Epidemics (CREATE); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the U.S. National Institutes of Health (RO1 AI51528, 5U2RTW007370, and 5U2RTW007373) and the Bill and Melinda Gates Foundation. Katherine Fielding was partially funded and James Lewis fully funded by the Biostatistics core of the Consortium to Respond Effectively to the AIDS and TB Epidemics (CREATE) with a grant from the Bill and Melinda Gates Foundation. The Foundation for Innovative New Diagnostics provided Xpert MTB/RIF cartridges at a reduced concessionary price. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Banada PP, 2010, J CLIN MICROBIOL, V48, P3551, DOI 10.1128/JCM.01053-10; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Burman WJ, 2000, CLIN INFECT DIS, V31, P1390, DOI 10.1086/317504; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8; Fielding KL, 2011, CONTEMP CLIN TRIALS, V32, P382, DOI 10.1016/j.cct.2010.12.008; Glaziou P, 2008, INT J TUBERC LUNG D, V12, P1003; Global TB Programme World Health Organization, WHOTB98258; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Kent PT, 1985, GUIDE LEVEL 3 LAB; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; van der Werf MJ, 2008, INT J TUBERC LUNG D, V12, P1255; Van Rie A, 2012, INT J TUBERC LUNG D, V16, P206, DOI 10.5588/ijtld.11.0395; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; World Health Organization, 2011, WHOHTMTB20112; World Health Organization, 2010, WHOHTMTB201017	25	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43307	10.1371/journal.pone.0043307	http://dx.doi.org/10.1371/journal.pone.0043307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905254	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600067
J	Liu, NS; Du, XL; Lu, J; He, BP				Liu, Nicole Suyun; Du, Xiaoli; Lu, Jia; He, Bei Ping			Diva Reduces Cell Death in Response to Oxidative Stress and Cytotoxicity	PLOS ONE			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; BCL-2 FAMILY-MEMBERS; BONE-MARROW-CELLS; BAX OLIGOMERIZATION; NEGATIVE REGULATOR; ISCHEMIC-INJURY; CYTOCHROME-C; BH3 DOMAINS; APOPTOSIS; EXPRESSION	Diva is a member of the Bcl2 family but its function in apoptosis remains largely unclear because of its specific expression found within limited adult tissues. Previous overexpression studies done on various cell lines yielded conflicting conclusions pertaining to its apoptotic function. Here, we discovered the expression of endogenous Diva in PC12 neuronal-like cell line and rat bone marrow mesenchymal stem cells (BMSCs), leading to their utilisation for the functional study of Diva. Through usage of recombinant Fas ligand, hydrogen peroxide, overexpression and knock down experiments, we discovered that Diva plays a crucial pro-survival role via the mitochondrial death pathway. In addition, immunoprecipitation studies also noted a decrease in Diva's interaction with Bcl2 and Bax following apoptosis induced by oxidative stress. By overexpressing Diva in BMSCs, we had observed an increase in the cells' capacity to survive under oxidative stress and microglial toxicity. The result obtained from our study gives us reason to believe that Diva plays an important role in controlling the survival of BMSCs. Through overexpression of Diva, the viability of these BMSCs may be boosted under adverse conditions.	[Liu, Nicole Suyun; Lu, Jia; He, Bei Ping] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Du, Xiaoli] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Lu, Jia] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore	National University of Singapore; National University of Singapore	Liu, NS (corresponding author), Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117548, Singapore.	anthebp@nus.edu.sg			Singapore National Research Foundation [NRF-CRP 002-082]	Singapore National Research Foundation(National Research Foundation, Singapore)	This work is supported by the Singapore National Research Foundation (NRF-CRP 002-082) under its Competitive Research Programme Funding Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anai S, 2007, MOL CANCER THER, V6, P101, DOI 10.1158/1535-7163.MCT-06-0367; Aouacheria A, 2001, ONCOGENE, V20, P5846, DOI 10.1038/sj.onc.1204740; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Carrio R, 1996, AM J PATHOL, V149, P2133; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; He BP, 2002, J NEUROIMMUNOL, V128, P31, DOI 10.1016/S0165-5728(02)00141-8; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Inohara N, 1998, J BIOL CHEM, V273, P32479, DOI 10.1074/jbc.273.49.32479; Ke N, 2001, J BIOL CHEM, V276, P12481, DOI 10.1074/jbc.C000871200; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee JC, 2005, GLIA, V50, P168, DOI 10.1002/glia.20164; Lee RM, 2001, BBA-GENE STRUCT EXPR, V1520, P187, DOI 10.1016/S0167-4781(01)00268-8; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Mandal D, 2005, J BIOL CHEM, V280, P39460, DOI 10.1074/jbc.M506928200; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; MERRITT AJ, 1995, J CELL SCI, V108, P2261; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Moriishi K, 1999, P NATL ACAD SCI USA, V96, P9683, DOI 10.1073/pnas.96.17.9683; Naumann U, 2001, FEBS LETT, V505, P23, DOI 10.1016/S0014-5793(01)02768-5; Ocker M, 2005, GUT, V54, P1298, DOI 10.1136/gut.2004.056192; Potten CS, 2004, APOPTOSIS LIFE DEATH, P165; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Ray SK, 2000, BRAIN RES, V852, P326, DOI 10.1016/S0006-8993(99)02148-4; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Russell HR, 2002, MOL CELL BIOL, V22, P6866, DOI 10.1128/MCB.22.19.6866-6870.2002; Sborgi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015575; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1299, DOI 10.1038/sj.cdd.4401974; Song QZ, 1999, EMBO J, V18, P167, DOI 10.1093/emboj/18.1.167; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Vander Heiden MG, 1999, MOL CELL, V3, P159; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wei MC, 2000, GENE DEV, V14, P2060; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Zamzami N, 1998, ONCOGENE, V16, P2265, DOI 10.1038/sj.onc.1201989; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	43	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43180	10.1371/journal.pone.0043180	http://dx.doi.org/10.1371/journal.pone.0043180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905226	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600053
J	Munoz, C; Saxena, A; Pakladok, T; Bogatikov, E; Wilmes, J; Seebohm, G; Foller, M; Lang, F				Munoz, Carlos; Saxena, Ambrish; Pakladok, Tatsiana; Bogatikov, Evgenii; Wilmes, Jan; Seebohm, Guiscard; Foeller, Michael; Lang, Florian			Stimulation of HERG Channel Activity by beta-catenin	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; THERAPEUTIC TARGET; SIGNALING PATHWAYS; POTASSIUM CHANNELS; UP-REGULATION; WNT; EXPRESSION; APOPTOSIS; CADHERIN; ALPHA	The multifunctional protein beta-catenin governs as transcription factor the expression of a wide variety of genes relevant for cell proliferation and cell survival. In addition, beta-catenin is localized at the cell membrane and may influence the function of channels. The present study explored the possibility that beta-catenin participates in the regulation of the HERG K+ channel. To this end, HERG was expressed in Xenopus oocytes with or without beta-catenin and the voltage-gated current determined utilizing the dual electrode voltage clamp. As a result, expression of beta-catenin markedly upregulated HERG channel activity, an effect not sensitive to inhibition of transcription with actinomycin D (10 mu M). According to chemiluminescence, beta-catenin may increase HERG channel abundance within the oocyte cell membrane. Following inhibition of channel insertion into the cell membrane by brefeldin A (5 mu M) the decay of current was similar in oocytes expressing HERG together with beta-catenin to oocytes expressing HERG alone. The experiments uncover a novel function of APC/beta-catenin, i.e. the regulation of HERG channels.	[Munoz, Carlos; Saxena, Ambrish; Pakladok, Tatsiana; Bogatikov, Evgenii; Wilmes, Jan; Foeller, Michael; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Seebohm, Guiscard] Ruhr Univ Bochum, Bochum, Germany; [Foeller, Michael] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada	Eberhard Karls University of Tubingen; Ruhr University Bochum; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Munoz, C (corresponding author), Univ Tubingen, Dept Physiol, Tubingen, Germany.	florian.lang@uni-tuebingen.de	Saxena, Ambrish/AAQ-5984-2020		Deutsche Forschungsgemeinschaft [GRK 1302/1, SE 1077/3, SFB 773]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (GRK 1302/1, SE 1077/3 and SFB 773). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Alesutan IS, 2010, CELL PHYSIOL BIOCHEM, V25, P187, DOI 10.1159/000276569; Arcangeli Annarosa, 2005, V266, P225; Asher V, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-113; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Blankesteijn WM, 2008, TRENDS PHARMACOL SCI, V29, P175, DOI 10.1016/j.tips.2008.01.003; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Covey TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013545; Croce Jenifer C., 2008, V469, P3, DOI 10.1007/978-1-60327-469-2_1; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Dermaku-Sopjani M, 2011, CELL PHYSIOL BIOCHEM, V28, P251, DOI 10.1159/000331737; Es-Salah-Lamoureux Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010876; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hirotani S, 2007, CIRC RES, V101, P1164, DOI 10.1161/CIRCRESAHA.107.160614; Hirschy A, 2010, BASIC RES CARDIOL, V105, P597, DOI 10.1007/s00395-010-0101-8; Hosseinzadeh Z, 2011, CELL PHYSIOL BIOCHEM, V28, P693, DOI 10.1159/000335763; Hu CJ, 2011, AM J MED SCI, V341, P119, DOI 10.1097/MAJ.0b013e3181f73f81; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Koutsouki E, 2007, BIOCHEM BIOPH RES CO, V363, P18, DOI 10.1016/j.bbrc.2007.07.181; Kuwabara M, 2007, FEBS LETT, V581, P4821, DOI 10.1016/j.febslet.2007.09.007; Lesage F, 2004, P NATL ACAD SCI USA, V101, P671, DOI 10.1073/pnas.0307681100; Maier G, 2006, CELL PHYSIOL BIOCHEM, V18, P177, DOI 10.1159/000097666; Masuelli L, 2003, CARDIOVASC RES, V60, P376, DOI 10.1016/j.cardiores.2003.08.005; Munoz C, 2012, BIOCHEM BIOPH RES CO, V417, P692, DOI 10.1016/j.bbrc.2011.11.156; Naishiro Y, 2005, ONCOGENE, V24, P3141, DOI 10.1038/sj.onc.1208517; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Sanguinetti MC, 1999, ANN NY ACAD SCI, V868, P406, DOI 10.1111/j.1749-6632.1999.tb11302.x; Schroen B, 2007, J EXP MED, V204, P1227, DOI 10.1084/jem.20070145; Schumann H, 2000, CARDIOVASC RES, V45, P720, DOI 10.1016/S0008-6363(99)00376-4; Sopjani M, 2010, BIOCHEM BIOPH RES CO, V402, P467, DOI 10.1016/j.bbrc.2010.10.049; Strutz-Seebohm N, 2011, CELL PHYSIOL BIOCHEM, V27, P443, DOI 10.1159/000329965; ter Horst P, 2012, ACTA PHYSIOL, V204, P110, DOI 10.1111/j.1748-1716.2011.02309.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vallon V, 2006, J MOL MED, V84, P396, DOI 10.1007/s00109-005-0027-z; Vallorosi CJ, 2000, J BIOL CHEM, V275, P3328, DOI 10.1074/jbc.275.5.3328; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vincent GM, 1998, ANNU REV MED, V49, P263; Wang JX, 2004, J BIOL CHEM, V279, P13289, DOI 10.1074/jbc.C400025200; Wang YH, 2008, BRIT J PHARMACOL, V154, P429, DOI 10.1038/bjp.2008.95; Wilmes J, 2012, MOL MEMBR BIOL, V29, P87, DOI 10.3109/09687688.2012.678017; Yao H, 2011, EXPERT OPIN THER TAR, V15, P873, DOI 10.1517/14728222.2011.577418	48	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43353	10.1371/journal.pone.0043353	http://dx.doi.org/10.1371/journal.pone.0043353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905262	Green Submitted, gold, Green Published			2022-12-27	WOS:000307823600071
J	Sharma, R; Ghasparian, A; Robinson, JA; McCullough, KC				Sharma, Rajni; Ghasparian, Arin; Robinson, John A.; McCullough, Kenneth C.			Synthetic Virus-Like Particles Target Dendritic Cell Lipid Rafts for Rapid Endocytosis Primarily but Not Exclusively by Macropinocytosis	PLOS ONE			English	Article							VACCINE DELIVERY; ANTIGEN; NANOPARTICLES; SYSTEM; LYMPHOCYTES; MATURATION	DC employ several endocytic routes for processing antigens, driving forward adaptive immunity. Recent advances in synthetic biology have created small (20-30 nm) virus-like particles based on lipopeptides containing a virus-derived coiled coil sequence coupled to synthetic B- and T-cell epitope mimetics. These self-assembling SVLP efficiently induce adaptive immunity without requirement for adjuvant. We hypothesized that the characteristics of DC interaction with SVLP would elaborate on the roles of cell membrane and intracellular compartments in the handling of a virus-like entity known for its efficacy as a vaccine. DC rapidly bind SVLP within min, co-localised with CTB and CD9, but not caveolin-1. In contrast, internalisation is a relatively slow process, delivering SVLP into the cell periphery where they are maintained for a number of hrs in association with microtubules. Although there is early association with clathrin, this is no longer seen after 10 min. Association with EEA-1(+) early endosomes is also early, but proteolytic processing appears slow, the SVLP-vesicles remaining peripheral. Association with transferrin occurs rarely, and only in the periphery, possibly signifying translocation of some SVLP for delivery to B-lymphocytes. Most SVLP co-localise with high molecular weight dextran. Uptake of both is impaired with mature DC, but there remains a residual uptake of SVLP. These results imply that DC use multiple endocytic routes for SVLP uptake, dominated by caveolin-independent, lipid raft-mediated macropinocytosis. With most SVLP-containing vesicles being retained in the periphery, not always interacting with early endosomes, this relates to slow proteolytic degradation and antigen retention by DC. The present characterization allows for a definition of how DC handle virus-like particles showing efficacious immunogenicity, elements valuable for novel vaccine design in the future.	[Sharma, Rajni; McCullough, Kenneth C.] Inst Virol & Immunoprophylaxis, Mittelhausern, Switzerland; [Ghasparian, Arin; Robinson, John A.] Univ Zurich, Dept Chem, Zurich, Switzerland	University of Zurich	Sharma, R (corresponding author), Inst Virol & Immunoprophylaxis, Mittelhausern, Switzerland.	kmc.projects1@gmail.com		Sharma, Rajni/0000-0003-0051-2308	Swiss National Science Foundation, project NANOVACC [310000-1198828]	Swiss National Science Foundation, project NANOVACC	The work was funded by the Swiss National Science Foundation, project NANOVACC, project number 310000-1198828 (http://www.snf.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boato F, 2007, ANGEW CHEM INT EDIT, V46, P9015, DOI 10.1002/anie.200702805; Borges O, 2005, INT J PHARMACEUT, V299, P155, DOI 10.1016/j.ijpharm.2005.04.037; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Ceppi M, 2005, J GENE MED, V7, P452, DOI 10.1002/jgm.685; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ghasparian A, 2011, CHEMBIOCHEM, V12, P100, DOI 10.1002/cbic.201000536; Guzylack-Piriou L, 2006, IMMUNOLOGY, V118, P78, DOI 10.1111/j.1365-2567.2006.02343.x; Halfon S, 1998, J BIOL CHEM, V273, P16400, DOI 10.1074/jbc.273.26.16400; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Johannes L, 2011, TRAFFIC, V12, P956, DOI 10.1111/j.1600-0854.2011.01200.x; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kiss AL, 2009, J CELL MOL MED, V13, P1228, DOI 10.1111/j.1582-4934.2009.00754.x; Kreuter J, 1996, J ANAT, V189, P503; Le Roux D, 2012, BLOOD, V119, P95, DOI 10.1182/blood-2011-02-336123; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; McCullough KC, 2008, DEV COMP IMMUNOL; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Ni J, 1998, J BIOL CHEM, V273, P24797, DOI 10.1074/jbc.273.38.24797; Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Perriman AW, 2010, SMALL, V6, P1191, DOI 10.1002/smll.200901186; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Riedel T, 2011, CHEMBIOCHEM, V12, P2829, DOI 10.1002/cbic.201100586; SIXMA TK, 1993, J MOL BIOL, V230, P890, DOI 10.1006/jmbi.1993.1209; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; van Niel G, 2008, CURR OPIN CELL BIOL, V20, P437, DOI 10.1016/j.ceb.2008.05.011; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Wykes M, 1998, J IMMUNOL, V161, P1313; Zilber MT, 2005, BLOOD, V106, P3074, DOI 10.1182/blood-2004-10-4094	32	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43248	10.1371/journal.pone.0043248	http://dx.doi.org/10.1371/journal.pone.0043248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905240	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000307500800065
J	Xu, Y; Cheng, WH; Nie, PY; Zhou, FF				Xu, Yun; Cheng, Wenhua; Nie, Pengyu; Zhou, Fengfeng			WinHAP: An Efficient Haplotype Phasing Algorithm Based on Scalable Sliding Windows	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; POPULATION GENOTYPE DATA; HUMAN GENOME; LINKAGE DISEQUILIBRIUM; PURE PARSIMONY; INFERENCE; RESOLUTION; RECONSTRUCTION; ASSOCIATION; IDENTIFICATION	Haplotype phasing represents an essential step in studying the association of genomic polymorphisms with complex genetic diseases, and in determining targets for drug designing. In recent years, huge amounts of genotype data are produced from the rapidly evolving high-throughput sequencing technologies, and the data volume challenges the community with more efficient haplotype phasing algorithms, in the senses of both running time and overall accuracy. 2SNP is one of the fastest haplotype phasing algorithms with comparable low error rates with the other algorithms. The most time-consuming step of 2SNP is the construction of a maximum spanning tree (MST) among all the heterozygous SNP pairs. We simplified this step by replacing the MST with the initial haplotypes of adjacent heterozygous SNP pairs. The multi-SNP haplotypes were estimated within a sliding window along the chromosomes. The comparative studies on four different-scale genotype datasets suggest that our algorithm WinHAP outperforms 2SNP and most of the other haplotype phasing algorithms in terms of both running speeds and overall accuracies. To facilitate the WinHAP's application in more practical biological datasets, we released the software for free at: http://staff.ustc.edu.cn/similar to xuyun/winhap/index.htm.	[Xu, Yun; Cheng, Wenhua; Nie, Pengyu] Univ Sci & Technol China, Dept Comp Sci & Technol, Hefei 230026, Anhui, Peoples R China; [Xu, Yun; Cheng, Wenhua; Nie, Pengyu] Univ Sci & Technol China, Anhui Prov MOST Co Key Lab High Performance Comp, Hefei 230026, Anhui, Peoples R China; [Zhou, Fengfeng] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China; [Zhou, Fengfeng] Chinese Acad Sci, Key Lab Hlth Informat, Shenzhen, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences	Xu, Y (corresponding author), Univ Sci & Technol China, Dept Comp Sci & Technol, Hefei 230026, Anhui, Peoples R China.	xuyun@ustc.edu.cn; ff.zhou@siat.ac.cn	Zhou, Fengfeng/A-8932-2008	Zhou, Fengfeng/0000-0002-8108-6007	National Natural Science Foundation of China [60970085, 31000447]; Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS); National Basic Research Program of China (973 Program) [2010CB732606-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work is supported by the National Natural Science Foundation of China (No. 60970085). FZ appreciates the startup fund from the Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS). FZ is also supported in part by the National Natural Science Foundation of China (31000447) and the National Basic Research Program of China (973 Program, 2010CB732606-6). Computing resources were partly provided by the Dawning supercomputing clusters at SIAT CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Bonizzoni P, 2003, J COMPUT SCI TECH-CH, V18, P675, DOI 10.1007/BF02945456; Brinza D, 2006, BIOINFORMATICS, V22, P371, DOI 10.1093/bioinformatics/bti785; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chung RH, 2003, BIOINFORMATICS, V19, P780, DOI 10.1093/bioinformatics/btg078; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Delaneau O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-205; Eronen L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-542; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein DB, 2001, CURR BIOL, V11, pR576, DOI 10.1016/S0960-9822(01)00348-7; Gusfield D, 2003, LECT NOTES COMPUT SC, V2676, P144; Gusfield D., 2002, P 6 ANN INT C COMP B, P166; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Jajamovich GH, 2012, IEEE T SIGNAL PROCES, V60; Keane MG, 2008, CIRCULATION, V117, P2802, DOI 10.1161/CIRCULATIONAHA.107.693523; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kimmel G, 2005, P NATL ACAD SCI USA, V102, P158, DOI 10.1073/pnas.0404730102; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lancia G, 2004, INFORMS J COMPUT, V16, P348, DOI 10.1287/ijoc.1040.0085; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Li ZP, 2005, BIOINFORMATICS, V21, P3475, DOI 10.1093/bioinformatics/bti572; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Nakano M, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-42; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stadler ZK, 2010, ONCOLOGY-NY, V24, P629; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tininini L, 2010, IEEE ACM T COMPUT BI, V7, P511, DOI 10.1109/TCBB.2008.130; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wang LS, 2003, BIOINFORMATICS, V19, P1773, DOI 10.1093/bioinformatics/btg239; Zhao YZ, 2008, BIOINFORMATICS, V24, P2720, DOI 10.1093/bioinformatics/btn519	39	2	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43163	10.1371/journal.pone.0043163	http://dx.doi.org/10.1371/journal.pone.0043163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905221	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800053
J	Jayaprakash, TP; Schellenberg, JJ; Hill, JE				Jayaprakash, Teenus Paramel; Schellenberg, John J.; Hill, Janet E.			Resolution and Characterization of Distinct cpn60-Based Subgroups of Gardnerella vaginalis in the Vaginal Microbiota	PLOS ONE			English	Article							ASYMPTOMATIC BACTERIAL VAGINOSIS; CHAPERONIN-60 UNIVERSAL TARGET; SEQUENCE-BASED METHODS; HSP60 GENE-SEQUENCES; PREDICTING RELATEDNESS; SPECIES IDENTIFICATION; NONSPECIFIC VAGINITIS; PHYLOGENETIC ANALYSIS; COMMUNITY COMPOSITION; QUANTITATIVE PCR	Bacterial vaginosis (BV), characterized by a shift of the vaginal microbiota from a Lactobacillus-dominated community to a dense biofilm containing a complex mixture of organisms, is an important risk factor in poor reproductive health outcomes. The Nugent score, based on Gram stain, is used to diagnose BV and Gardnerella vaginalis abundance in the sample is one factor determining Nugent score. A high Nugent score is indicative of BV but does not always correspond to the presence of clinical symptoms. G. vaginalis is recognized as a heterogeneous group of organisms, which can also be part of the normal, healthy vaginal microbiome. In addition, asymptomatic BV and non-Gardnerella types of BV are being recognized. In an attempt to resolve the heterogeneous group of G. vaginalis, a phylogenetic tree of cpn60 universal target sequences from G. vaginalis isolates was constructed that indicates the existence of four subgroups of G. vaginalis. This subdivision, supported by whole genome similarity calculation of representative strains using JSpecies, demonstrates that these subgroups may represent different species. The cpn60 subgroupings did not correspond with the Piot biotyping scheme, but did show consistency with ARDRA genotyping and sialidase gene presence. Isolates from all four subgroups produced biofilm in vitro. We also investigated the distribution of G. vaginalis subgroups in vaginal samples from Kenyan women with Nugent scores consistent with BV, Intermediate and Normal microbiota (n = 44). All subgroups of G. vaginalis were detected in these women, with a significant difference (z = -3.372, n = 39, p = 0.001) in frequency of G. vaginalis subgroup B between BV and Normal groups. Establishment of a quantifiable relationship between G. vaginalis subgroup distribution and clinical status could have significant diagnostic implications.	[Jayaprakash, Teenus Paramel; Hill, Janet E.] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Schellenberg, John J.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Saskatchewan; University of Manitoba	Jayaprakash, TP (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada.	janet.hill@usask.ca	Hill, Janet E./B-5001-2011	Hill, Janet E./0000-0002-2187-6277; Schellenberg, John/0000-0003-3970-1608	March of Dimes; Canadian Institutes for Health Research; University of Saskatchewan	March of Dimes(March of Dimes); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan	This research was supported by the March of Dimes (www.marchofdimes.com) and the Canadian Institutes for Health Research (www.cihr.ca). TJP is supported by a scholarship from the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; [Anonymous], 1988, J APPL BACTERIOL, V64, P283; Aroutcheva AA, 2001, CLIN INFECT DIS, V33, P1022, DOI 10.1086/323030; BENITO R, 1986, J MED MICROBIOL, V21, P357, DOI 10.1099/00222615-21-4-357; Blaiotta G, 2008, APPL ENVIRON MICROB, V74, P208, DOI 10.1128/AEM.01711-07; Brousseau R, 2001, APPL ENVIRON MICROB, V67, P4828, DOI 10.1128/AEM.67.10.4828-4833.2001; Chaban B, 2012, MICROB ECOL, V63, P348, DOI 10.1007/s00248-011-9931-7; Chaban B, 2009, APPL ENVIRON MICROB, V75, P3055, DOI 10.1128/AEM.00101-09; Cho JC, 2001, APPL ENVIRON MICROB, V67, P3677, DOI 10.1128/AEM.67.8.3677-3682.2001; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Demba E, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-12; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Desai AR, 2009, VET MICROBIOL, V137, P120, DOI 10.1016/j.vetmic.2008.12.019; Dumonceaux TJ, 2006, CAN J MICROBIOL, V52, P494, DOI 10.1139/W05-160; Dumonceaux Tim J, 2009, J Clin Microbiol, V47, P4067, DOI 10.1128/JCM.00112-09; Dumonceaux TJ, 2006, APPL ENVIRON MICROB, V72, P2815, DOI 10.1128/AEM.72.4.2815-2823.2006; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fernando WMU, 2010, BENEF MICROBES, V1, P197, DOI 10.3920/BM2009.0027; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Gibbs RS, 2007, AM J OBSTET GYNECOL, V196, P495, DOI 10.1016/j.ajog.2007.04.001; Goh SH, 1996, J CLIN MICROBIOL, V34, P818, DOI 10.1128/JCM.34.4.818-823.1996; Goh SH, 2000, J CLIN MICROBIOL, V38, P3953, DOI 10.1128/JCM.38.11.3953-3959.2000; Graham S, 2009, J MED MICROBIOL, V58, P1382, DOI 10.1099/jmm.0.007781-0; GREENWOOD JR, 1980, INT J SYST BACTERIOL, V30, P170, DOI 10.1099/00207713-30-1-170; Hill JE, 2006, J MED MICROBIOL, V55, P393, DOI 10.1099/jmm.0.46282-0; Hill JE, 2006, ENVIRON MICROBIOL, V8, P741, DOI 10.1111/j.1462-2920.2005.00944.x; Hill JE, 2005, AM J OBSTET GYNECOL, V193, P682, DOI 10.1016/j.ajog.2005.02.094; Hill JE, 2005, APPL ENVIRON MICROB, V71, P867, DOI 10.1128/AEM.71.2.867-875.2005; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Hill JE, 2002, APPL ENVIRON MICROB, V68, P3055, DOI 10.1128/AEM.68.6.3055-3066.2002; HILLIER SL, 1991, GENITOURIN MED, V67, P26; Holt J., 1994, BERGEYS MANUAL DETER; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Hung WC, 2010, J CLIN MICROBIOL, V48, P3532, DOI 10.1128/JCM.00787-10; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ingianni A, 1997, FEMS IMMUNOL MED MIC, V18, P61, DOI 10.1111/j.1574-695X.1997.tb01028.x; Jian WY, 2001, INT J SYST EVOL MICR, V51, P1633, DOI 10.1099/00207713-51-5-1633; JOHNSON AP, 1987, EPIDEMIOL INFECT, V98, P131, DOI 10.1017/S0950268800061835; Kampan NC, 2011, SEX REPROD HEALTHC, V2, P1, DOI 10.1016/j.srhc.2010.11.002; Leitich H, 2007, BEST PRACT RES CL OB, V21, P375, DOI 10.1016/j.bpobgyn.2006.12.005; LEOPOLD SIDNEY, 1953, U S ARMED FORCES MED JOUR, V4, P263; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Mastrobattista JM, 2000, OBSTET GYNECOL, V96, P504, DOI 10.1016/S0029-7844(00)00994-7; Menard JP, 2010, OBSTET GYNECOL, V115, P134, DOI 10.1097/AOG.0b013e3181c391d7; Mikamo H., 1999, J Infect Chemother, V5, P82, DOI 10.1007/s101560050013; Minana-Galbis D, 2009, INT J SYST EVOL MICR, V59, P1976, DOI 10.1099/ijs.0.005413-0; Ness RB, 2004, OBSTET GYNECOL, V104, P761, DOI 10.1097/01.AOG.0000139512.37582.17; Numanovic F, 2008, BOSNIAN J BASIC MED, V8, P270, DOI 10.17305/bjbms.2008.2932; PIOT P, 1984, J CLIN MICROBIOL, V20, P677, DOI 10.1128/JCM.20.4.677-679.1984; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Sakamoto M, 2010, INT J SYST EVOL MICR, V60, P2984, DOI 10.1099/ijs.0.021154-0; Sakamoto M, 2010, J MED MICROBIOL, V59, P1293, DOI 10.1099/jmm.0.020420-0; Schellenberg J, 2011, METHODS MOL BIOL, V733, P143, DOI 10.1007/978-1-61779-089-8_10; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Swidsinski A, 2010, GYNECOL OBSTET INVES, V70, P256, DOI 10.1159/000314015; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tosun I, 2007, MIKROBIYOL BUL, V41, P21; Verbeke TJ, 2011, SYST APPL MICROBIOL, V34, P171, DOI 10.1016/j.syapm.2010.11.019; Vermette CJ, 2010, MICROB ECOL, V59, P14, DOI 10.1007/s00248-009-9601-1; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0; ZINNEMANN K, 1963, J PATHOL BACTERIOL, V85, P213, DOI 10.1002/path.1700850120	67	55	56	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43009	10.1371/journal.pone.0043009	http://dx.doi.org/10.1371/journal.pone.0043009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900080	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900098
J	Le Sage, V; Banfield, BW				Le Sage, Valerie; Banfield, Bruce W.			Dysregulation of Autophagy in Murine Fibroblasts Resistant to HSV-1 Infection	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HEPARAN-SULFATE PROTEOGLYCANS; CELL-SURFACE; GLYCOPROTEIN-B; PROTEIN-KINASE; GAMMA(1)34.5 PROTEIN; PSEUDORABIES VIRUS; GRO2C CELLS; IN-VIVO; TYPE-1	The mouse L cell mutant, gro29, was selected for its ability to survive infection by herpes simplex virus type 1 (HSV-1). gro29 cells are fully susceptible to HSV-1 infection, however, they produce 2000-fold less infectious virus than parental L cells despite their capacity to synthesize late viral gene products and assemble virions. Because productive HSV-1 infection is presumed to result in the death of the host cell, we questioned how gro29 cells might survive infection. Using time-lapse video microscopy, we demonstrated that a fraction of infected gro29 cells survived infection and divided. Electron microscopy of infected gro29 cells, revealed large membranous vesicles that contained virions as well as cytoplasmic constituents. These structures were reminiscent of autophagosomes. Autophagy is an ancient cellular process that, under nutrient deprivation conditions, results in the degradation and catabolism of cytoplasmic components and organelles. We hypothesized that enhanced autophagy, and resultant degradation of virions, might explain the ability of gro29 to survive HSV-1 infection. Here we demonstrate that gro29 cells have enhanced basal autophagy as compared to parental L cells. Moreover, treatment of gro29 cells with 3-methyladenine, an inhibitor of autophagy, failed to prevent the formation of autophagosome-like organelles in gro29 cells indicating that autophagy was dysregulated in these cells. Additionally, we observed robust co-localization of the virion structural component, VP26, with the autophagosomal marker, GFP-LC3, in infected gro29 cells that was not seen in infected parental L cells. Collectively, these data support a model whereby gro29 cells prevent the release of infectious virus by directing intracellular virions to an autophagosome-like compartment. Importantly, induction of autophagy in parental L cells did not prevent HSV-1 production, indicating that the relationship between autophagy, virus replication, and survival of HSV-1 infection by gro29 cells is complex.	[Le Sage, Valerie; Banfield, Bruce W.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Le Sage, V (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	bruce.banfield@queensu.ca			Canadian Institutes of Health Research [93804]; Canada Foundation for Innovation award [16389]; Violet E. Powell Research Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation award; Violet E. Powell Research Fund	This work was supported by the Canadian Institutes of Health Research operating grant 93804, Canada Foundation for Innovation award 16389, and an award from the Violet E. Powell Research Fund to BWB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DE, 2008, AUTOPHAGY, V4, P101, DOI 10.4161/auto.5222; Altenburg JD, 2010, J VIROL, V84, P2563, DOI 10.1128/JVI.00342-09; Antinone SE, 2010, J VIROL, V84, P13019, DOI 10.1128/JVI.01296-10; BANFIELD BW, 1990, J VIROL, V64, P5716, DOI 10.1128/JVI.64.12.5716-5729.1990; BANFIELD BW, 1995, VIROLOGY, V208, P531, DOI 10.1006/viro.1995.1184; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Ben-Porat T., 1985, HERPESVIRUSES, P105; Bender FC, 2005, J VIROL, V79, P11588, DOI 10.1128/JVI.79.18.11588-11597.2005; Bengali Z, 2009, VIROLOGY, V389, P132, DOI 10.1016/j.virol.2009.04.012; Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; Calistri A, 2007, J VIROL, V81, P11468, DOI 10.1128/JVI.01364-07; Cassady KA, 2002, J VIROL, V76, P2029, DOI 10.1128/jvi.76.5.2029-2035.2002; Chaumorcel M, 2008, AUTOPHAGY, V4, P46, DOI 10.4161/auto.5184; Chiu WL, 2007, J VIROL, V81, P2149, DOI 10.1128/JVI.02302-06; CHOU J, 1992, P NATL ACAD SCI USA, V89, P3266, DOI 10.1073/pnas.89.8.3266; Crump CA, 2007, J VIROL, V81, P7380, DOI 10.1128/JVI.00222-07; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dyer AP, 1997, J VIROL, V71, P191, DOI 10.1128/JVI.71.1.191-198.1997; Finnen RL, 2010, VIROLOGY, V397, P23, DOI 10.1016/j.virol.2009.11.012; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; GARCIN D, 1990, VIROLOGY, V179, P208, DOI 10.1016/0042-6822(90)90290-8; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; HONESS RW, 1973, J VIROL, V12, P1347, DOI 10.1128/JVI.12.6.1347-1365.1973; Hung JJ, 2004, J VIROL, V78, P378, DOI 10.1128/JVI.78.1.378-388.2004; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jacquet A, 1998, VIRUS RES, V53, P197, DOI 10.1016/S0168-1702(97)00149-4; JOHNSON DC, 1982, J VIROL, V43, P1102, DOI 10.1128/JVI.43.3.1102-1112.1982; JONES F, 1988, J VIROL, V62, P2701, DOI 10.1128/JVI.62.8.2701-2711.1988; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; KARGER A, 1995, J VIROL, V69, P3482, DOI 10.1128/JVI.69.6.3482-3489.1995; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Laquerre S, 1998, J VIROL, V72, P6119, DOI 10.1128/JVI.72.7.6119-6130.1998; LIPPE R, 1993, J IMMUNOL, V150, P3170; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Mardberg K, 2002, J GEN VIROL, V83, P291, DOI 10.1099/0022-1317-83-2-291; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10; Mettenleiter TC, 2006, VET MICROBIOL, V113, P163, DOI 10.1016/j.vetmic.2005.11.040; MICHAELIS C, 1992, BIOCHEM CELL BIOL, V70, P1209, DOI 10.1139/o92-167; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pawliczek T, 2009, J VIROL, V83, P11254, DOI 10.1128/JVI.00574-09; Roizman B, 2001, FIELDS VIROLOGY, P2399; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; SANDVIG K, 1992, EXP CELL RES, V200, P253, DOI 10.1016/0014-4827(92)90171-4; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Suarez AL, 2011, J VIROL, V85, P6293, DOI 10.1128/JVI.00001-11; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; TALSINGER R, 1995, J VIROL, V69, P4471, DOI 10.1128/JVI.69.7.4471-4483.1995; Tanaka M, 2003, J VIROL, V77, P1382, DOI 10.1128/JVI.77.2.1382-1391.2003; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Taylor MP, 2007, J VIROL, V81, P12543, DOI 10.1128/JVI.00755-07; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; TUFARO F, 1987, J CELL BIOL, V105, P647, DOI 10.1083/jcb.105.2.647; Turcotte S, 2005, J VIROL, V79, P8847, DOI 10.1128/JVI.79.14.8847-8860.2005; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; WHEALY ME, 1992, J VIROL, V66, P3803, DOI 10.1128/JVI.66.6.3803-3810.1992; WHEALY ME, 1991, J VIROL, V65, P1066, DOI 10.1128/JVI.65.3.1066-1081.1991; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Zhang QJ, 2000, J IMMUNOL, V164, P4513, DOI 10.4049/jimmunol.164.9.4513	79	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42636	10.1371/journal.pone.0042636	http://dx.doi.org/10.1371/journal.pone.0042636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900036	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900052
J	Oh, Y; Franck, WL; Han, SO; Shows, A; Gokce, E; Muddiman, DC; Dean, RA				Oh, Yeonyee; Franck, William L.; Han, Sang-Oh; Shows, Angela; Gokce, Emine; Muddiman, David C.; Dean, Ralph A.			Polyubiquitin Is Required for Growth, Development and Pathogenicity in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							INFECTION STRUCTURE FORMATION; UBIQUITIN LIGASE RSP5; APPRESSORIUM FORMATION; FUNCTIONAL-ANALYSIS; ANALYSIS REVEALS; GENE-EXPRESSION; HEAT-SHOCK; RESISTANCE; GRISEA; GENOME	Protein ubiquitination, which is highly selective, regulates many important biological processes including cellular differentiation and pathogenesis in eukaryotic cells. Here, we integrated pharmacological, molecular and proteomic approaches to explore the role of ubiquitination in Magnaporthe oryzae, the leading fungal disease of rice world-wide. Inhibition of ubiquitin-mediated proteolysis using the 26S proteasome inhibitor, Bortezomib, significantly attenuated conidia germination, appressorium formation and pathogenicity in M. oryzae. Gene expression analysis revealed that many genes associated with protein ubiquitination were developmentally regulated during conidia germination. Only a few, including a polyubiquitin encoding gene, MGG_01282, were more abundantly expressed during appressorium formation and under nitrogen starvation. Targeted gene deletion of MGG_01282, in addition to a significant reduction in protein ubiquitination as determined by immuno blot assays, resulted in pleiotropic effects on M. oryzae including reduced growth and sporulation, abnormal conidia morphology, reduced germination and appressorium formation, and the inability to cause disease. Mutants were also defective in sexual development and were female sterile. Using mass spectrometry, we identified 63 candidate polyubiquitinated proteins under nitrogen starvation, which included overrepresentation of proteins involved in translation, transport and protein modification. Our study suggests that ubiquitination of target proteins plays an important role in nutrient assimilation, development and pathogenicity of M. oryzae.	[Oh, Yeonyee; Franck, William L.; Shows, Angela; Dean, Ralph A.] N Carolina State Univ, Dept Plant Pathol, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA; [Han, Sang-Oh] Duke Univ, Dept Med, Durham, NC USA; [Gokce, Emine; Muddiman, David C.] N Carolina State Univ, Dept Chem, WM Keck FT ICR Mass Spectrometry Lab, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; Duke University; University of North Carolina; North Carolina State University	Oh, Y (corresponding author), N Carolina State Univ, Dept Plant Pathol, Ctr Integrated Fungal Res, Box 7616, Raleigh, NC 27695 USA.	radean2@ncsu.edu		Muddiman, David/0000-0003-2216-499X; Oh, Yeonyee/0000-0002-5571-3687	National Science Foundation [0918611, 0605017]	National Science Foundation(National Science Foundation (NSF))	This work was supported through National Science Foundation Award #0918611 and #0605017. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Boase NA, 2004, MOL MICROBIOL, V53, P929, DOI 10.1111/j.1365-2958.2004.04172.x; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Donofrio NM, 2006, FUNGAL GENET BIOL, V43, P605, DOI 10.1016/j.fgb.2006.03.005; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; FRASER J, 1991, CURR GENET, V20, P17, DOI 10.1007/BF00312760; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gokce E, 2011, J AM SOC MASS SPECTR, V22, P2199, DOI 10.1007/s13361-011-0237-2; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Leach MD, 2011, MOL MICROBIOL, V79, P1574, DOI 10.1111/j.1365-2958.2011.07542.x; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; Liu XH, 2008, METHOD ENZYMOL, V451, P271, DOI 10.1016/S0076-6879(08)03219-9; Loser K, 1998, CURR GENET, V34, P404, DOI 10.1007/s002940050414; McCafferty HRK, 1998, CURR GENET, V33, P352, DOI 10.1007/s002940050347; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; OU SH, 1980, ANNU REV PHYTOPATHOL, V18, P167, DOI 10.1146/annurev.py.18.090180.001123; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PIETERSE CMJ, 1991, PLANT MOL BIOL, V17, P799, DOI 10.1007/BF00037062; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Saunders DGO, 2010, PLANT CELL, V22, P497, DOI 10.1105/tpc.109.072447; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Shcherbik N, 2011, RNA, V17, P1422, DOI 10.1261/rna.2615311; SWEIGARD JA, 1992, MOL GEN GENET, V232, P183, DOI 10.1007/BF00279995; Takada K, 1996, BBA-GEN SUBJECTS, V1290, P282, DOI 10.1016/0304-4165(96)00032-3; TANAKA K, 1988, EMBO J, V7, P495, DOI 10.1002/j.1460-2075.1988.tb02837.x; VALENT B, 1991, GENETICS, V127, P87; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Wang Y, 2011, PLANT PATHOLOGY J, V27, P225, DOI 10.5423/PPJ.2011.27.3.225; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696	43	31	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42868	10.1371/journal.pone.0042868	http://dx.doi.org/10.1371/journal.pone.0042868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900059	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900077
J	Song, SM; Ji, BA; Ramachandran, V; Wang, HM; Hafley, M; Logsdon, C; Bresalier, RS				Song, Shumei; Ji, Baoan; Ramachandran, Vijaya; Wang, Huamin; Hafley, Margarete; Logsdon, Craig; Bresalier, Robert S.			Overexpressed Galectin-3 in Pancreatic Cancer Induces Cell Proliferation and Invasion by Binding Ras and Activating Ras Signaling	PLOS ONE			English	Article							K-RAS; INTRAEPITHELIAL NEOPLASIA; EXPRESSION; ADENOCARCINOMA; CARCINOMAS; INCREASES; TUMORS	Pancreatic cancer (PDAC) is a lethal disease with a five-year survival of 3-5%. Mutations in K-Ras are found in nearly all cases, but K-Ras mutations alone are not sufficient for the development of PDAC. Additional factors contribute to activation of Ras signaling and lead to tumor formation. Galectin-3 (Gal-3), a multifunctional beta-galactoside-binding protein, is highly expressed in PDAC. We therefore investigated the functional role of Gal-3 in pancreatic cancer progression and its relationship to Ras signaling. Expression of Gal-3 was determined by immunohistochemistry, Q-PCR and immunoblot. Functional studies were performed using pancreatic cell lines genetically engineered to express high or low levels of Gal-3. Ras activity was examined by Raf pull-down assays. Co-immunoprecipitation and immunofluorescence were used to assess protein-protein interactions. In this study, we demonstrate that Gal-3 was highly up-regulated in human tumors and in a mutant K-Ras mouse model of PDAC. Down-regulation of Gal-3 by lentivirus shRNA decreased PDAC cell proliferation and invasion in vitro and reduced tumor volume and size in an orthotopic mouse model. Gal-3 bound Ras and maintained Ras activity; down-regulation of Gal-3 decreased Ras activity as well as Ras down-stream signaling including phosphorylation of ERK and AKT and Ral A activity. Transfection of Gal-3 cDNA into PDAC cells with low-level Gal-3 augmented Ras activity and its down-stream signaling. These results suggest that Gal-3 contributes to pancreatic cancer progression, in part, by binding Ras and activating Ras signaling. Gal-3 may therefore be a potential novel target for this deadly disease.	[Song, Shumei; Hafley, Margarete; Bresalier, Robert S.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Ji, Baoan; Ramachandran, Vijaya; Logsdon, Craig] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Song, SM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA.	ssong@mdanderson.org		Bresalier, Robert/0000-0002-9740-281X	National Institutes of Health/National Cancer Institute [R01CA69480]; American Gastroenterological Association; Public Health Service [DF56338]; NATIONAL CANCER INSTITUTE [R01CA069480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052067] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Gastroenterological Association; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by National Institutes of Health/National Cancer Institute grant R01CA69480 (R.S.B), American Gastroenterological Association Research Scholar Award (S. Song), and Public Health Service Grant DF56338, which supports the Texas Medical Center Digestive Diseases Center (S. Song). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andea A, 2003, MODERN PATHOL, V16, P996, DOI 10.1097/01.MP.0000087422.24733.62; Ashery U, 2006, CELL MOL NEUROBIOL, V26, P471, DOI 10.1007/s10571-006-9059-3; Berberat PO, 2001, J HISTOCHEM CYTOCHEM, V49, P539, DOI 10.1177/002215540104900414; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020859; Hebert E, 1996, CR ACAD SCI III-VIE, V319, P871; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Khayyata S, 2005, MODERN PATHOL, V18, P1504, DOI 10.1038/modpathol.3800460; Kim SJ, 2010, GASTROENTEROLOGY, V138, P1035, DOI 10.1053/j.gastro.2009.09.061; Kobayashi T, 2011, INT J CANCER, V129, P2775, DOI 10.1002/ijc.25946; Lavra L, 2009, J PATHOL, V218, P66, DOI 10.1002/path.2510; Levy R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027490; Levy R, 2010, MOL CANCER THER, V9, P2208, DOI 10.1158/1535-7163.MCT-10-0262; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Logsdon CD, 2009, CLIN GASTROENTEROL H, V7, pS40, DOI 10.1016/j.cgh.2009.07.040; Ottenhof NA, 2009, ARCH PATHOL LAB MED, V133, P375, DOI 10.1043/1543-2165-133.3.375; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Shalom-Feuerstein R, 2005, CANCER RES, V65, P7292, DOI 10.1158/0008-5472.CAN-05-0775; Shimamura T, 2002, CLIN CANCER RES, V8, P2570; Song SM, 2009, CLIN CANCER RES, V15, P622, DOI 10.1158/1078-0432.CCR-08-0772; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Song SM, 2005, GASTROENTEROLOGY, V129, P1581, DOI 10.1053/j.gastro.2005.09.002; Takaori K, 2004, PANCREAS, V28, P257, DOI 10.1097/00006676-200404000-00008; Terris B, 2002, AM J PATHOL, V160, P1745, DOI 10.1016/S0002-9440(10)61121-2; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; van den Brule F, 2002, GLYCOCONJUGATE J, V19, P537, DOI 10.1023/B:GLYC.0000014083.48508.6a; Wang L, 2000, LAB INVEST, V80, P1233, DOI 10.1038/labinvest.3780131; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719	32	65	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42699	10.1371/journal.pone.0042699	http://dx.doi.org/10.1371/journal.pone.0042699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900040	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900057
J	Hoppitt, W; Samson, J; Laland, KN; Thornton, A				Hoppitt, Will; Samson, Jamie; Laland, Kevin N.; Thornton, Alex			Identification of Learning Mechanisms in a Wild Meerkat Population	PLOS ONE			English	Article							ANIMALS; TRADITIONS; IMITATION; ARBITRARY	Vigorous debates as to the evolutionary origins of culture remain unresolved due to an absence of methods for identifying learning mechanisms in natural populations. While laboratory experiments on captive animals have revealed evidence for a number of mechanisms, these may not necessarily reflect the processes typically operating in nature. We developed a novel method that allows social and asocial learning mechanisms to be determined in animal groups from the patterns of interaction with, and solving of, a task. We deployed it to analyse learning in groups of wild meerkats (Suricata suricatta) presented with a novel foraging apparatus. We identify nine separate learning processes underlying the meerkats' foraging behaviour, in each case precisely quantifying their strength and duration, including local enhancement, emulation, and a hitherto unrecognized form of social learning, which we term `observational perseverance'. Our analysis suggests a key factor underlying the stability of behavioural traditions is a high ratio of specific to generalized social learning effects. The approach has widespread potential as an ecologically valid tool to investigate learning mechanisms in natural groups of animals, including humans.	[Hoppitt, Will; Laland, Kevin N.] Univ St Andrews, Sch Biol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland; [Samson, Jamie] Kuruman River Reserve, Kalahari Meerkat Project, Van Zylsrus, Northern Cape, South Africa; [Thornton, Alex] Univ Cambridge, Dept Zool, Cambridge, England; [Thornton, Alex] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of St Andrews; University of Cambridge; University of Cambridge	Hoppitt, W (corresponding author), Univ St Andrews, Sch Biol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.	wjeh1@st-andrews.ac.uk	Hoppitt, William/A-8216-2008	Hoppitt, William/0000-0003-0815-5720; Thornton, Alex/0000-0002-1607-2047; Laland, Kevin/0000-0002-2457-0900	Biotechnology and Biological Sciences Research Council (BBSRC) grant [BB/D015812/1]; Drapers' Company Fellowship from Pembroke College, Cambridge; David Phillips BBSRC Fellowship; BBSRC [BB/D015812/1, BB/C005430/1]; European Research Council (ERC) Advanced Grant [232823]; Biotechnology and Biological Sciences Research Council [BB/C005430/1, BB/D015812/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Drapers' Company Fellowship from Pembroke College, Cambridge; David Phillips BBSRC Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council (ERC) Advanced Grant(European Research Council (ERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	W.H. was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) grant (BB/D015812/1), A.T. was funded by a Drapers' Company Fellowship from Pembroke College, Cambridge and a David Phillips BBSRC Fellowship and K.N.L. by grants from the BBSRC (BB/C005430/1 and BB/D015812/1) and a European Research Council (ERC) Advanced Grant (EVOCULTURE, Ref. 232823) (http://www.bbsrc.ac.uk/, http://erc.europa.eu/, http://www.pem.cam.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1956, LEARNING INSTINCT AN; Bates D., 2008, LME4 LINEAR MIXED EF; Boyd R., 1985, CULTURE EVOLUTIONARY; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; Caldwell CA, 2009, PSYCHOL SCI, V20, P1478, DOI 10.1111/j.1467-9280.2009.02469.x; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P2291, DOI 10.1098/rspb.1998.0573; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Franz M, 2010, P ROY SOC B-BIOL SCI, V277, P3363, DOI 10.1098/rspb.2010.0705; Gajdon GK, 2004, LEARN BEHAV, V32, P62; Galef B G, 1992, Hum Nat, V3, P157, DOI 10.1007/BF02692251; Galef BG, 2004, LEARN BEHAV, V32, P53; GALEF BG, 1995, ANIM BEHAV, V50, P705, DOI 10.1016/0003-3472(95)80131-6; Haccou P., 1992, STAT ANAL BEHAV DATA; Harcourt JL, 2010, CURR BIOL, V20, P156, DOI 10.1016/j.cub.2009.11.045; Heyes CM, 2000, ADV STUD BEHAV, V29, P215, DOI 10.1016/S0065-3454(08)60106-0; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hodge SJ, 2009, BEHAV ECOL, V20, P930, DOI 10.1093/beheco/arp071; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Huber L, 2001, ANIM BEHAV, V62, P945, DOI 10.1006/anbe.2001.1822; Hunt GR, 2003, P ROY SOC B-BIOL SCI, V270, P867, DOI 10.1098/rspb.2002.2302; InoueNakamura N, 1997, J COMP PSYCHOL, V111, P159, DOI 10.1037/0735-7036.111.2.159; Kendal RL, 2010, LEARN BEHAV, V38, P187, DOI 10.3758/LB.38.3.187; Kendal RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006541; Kendal RL, 2007, INT J PSYCHOL PSYCHO, V7, P123; Lalalnd KN, 2009, QUESTION ANIMAL CULT; Laland K. N., 2009, QUESTION ANIMAL CULT; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; LALAND KN, 1991, ANIM BEHAV, V41, P997, DOI 10.1016/S0003-3472(05)80638-4; Laland KN, 1997, ANIM BEHAV, V53, P1161, DOI 10.1006/anbe.1996.0318; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; MCQUOID LM, 1992, J COMP PSYCHOL, V106, P137, DOI 10.1037/0735-7036.106.2.137; Muller CA, 2010, CURR BIOL, V20, P1171, DOI 10.1016/j.cub.2010.04.037; Plummer M., 2015, PACKAGE CODA; Reader SM, 2010, LEARN BEHAV, V38, P265, DOI 10.3758/LB.38.3.265; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Sargent BL, 2009, QUESTION ANIMAL CULT, P152; Schoning C, 2008, J HUM EVOL, V55, P48, DOI 10.1016/j.jhevol.2007.12.002; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Shipley B., 2000, CAUSE CORRELATIONS B; Spence KW, 1937, PSYCHOL REV, V44, P430, DOI 10.1037/h0062885; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Team RDC, 2019, R LANG ENV STAT COMP; Tebbich S, 2012, ETHOLOGY, V118, P135, DOI 10.1111/j.1439-0310.2011.02001.x; Therneau T., 2009, COXME MIXED EFFECTS; Therneau T.M., 2000, MODELING SURVIVAL DA; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Thornton A, 2009, ANIM BEHAV, V78, P255, DOI 10.1016/j.anbehav.2009.04.021; Thornton A, 2009, P ROY SOC B-BIOL SCI, V276, P1269, DOI 10.1098/rspb.2008.1794; Tomasello M., 1990, P274, DOI 10.1017/CBO9780511665486.012; Tomasello M, 1994, QUESTION CHIMPANZEE, P301; Van der Post DJ, 2008, ANIM BEHAV, V75, P133, DOI 10.1016/j.anbehav.2007.04.021; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134	54	34	35	3	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42044	10.1371/journal.pone.0042044	http://dx.doi.org/10.1371/journal.pone.0042044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905113	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100023
J	Nocito, L; Zafra, D; Calbo, J; Dominguez, J; Guinovart, JJ				Nocito, Laura; Zafra, Delia; Calbo, Joaquim; Dominguez, Jorge; Guinovart, Joan J.			Tungstate Reduces the Expression of Gluconeogenic Enzymes in STZ Rats	PLOS ONE			English	Article							STREPTOZOTOCIN-DIABETIC RATS; GLYCOGEN-SYNTHASE KINASE-3; RABBIT SKELETAL-MUSCLE; SODIUM TUNGSTATE; SIGNAL-TRANSDUCTION; ANTIDIABETIC AGENT; PROTEIN-KINASE; ISOLATED HEPATOCYTES; METABOLIC PATHWAYS; S6 KINASE	Aims: Oral administration of sodium tungstate has shown hyperglycemia-reducing activity in several animal models diabetes. We present new insights into the mechanism of action of tungstate. Methods: We studied protein expression and phosphorylation in the liver of STZ rats, a type I diabetes model, treated with sodium tungstate in the drinking water (2 mg/ml) and in primary cultured-hepatocytes, through Western blot and Real Time PCR analysis. Results: Tungstate treatment reduces the expression of gluconeogenic enzymes (PEPCK, G6Pase, and FBPase) and also regulates transcription factors accountable for the control of hepatic metabolism (c-jun, c-fos and PGC1 alpha). Moreover, ERK, p90rsk and GSK3, upstream kinases regulating the expression of c-jun and c-fos, are phosphorylated in response to tungstate. Interestingly, PKB/Akt phosphorylation is not altered by the treatment. Several of these observations were reproduced in isolated rat hepatocytes cultured in the absence of insulin, thereby indicating that those effects of tungstate are insulin-independent. Conclusions: Here we show that treatment with tungstate restores the phosphorylation state of various signaling proteins and changes the expression pattern of metabolic enzymes.	[Nocito, Laura; Zafra, Delia; Calbo, Joaquim; Dominguez, Jorge; Guinovart, Joan J.] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Nocito, Laura; Zafra, Delia; Calbo, Joaquim; Dominguez, Jorge; Guinovart, Joan J.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Nocito, Laura; Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona	Nocito, L (corresponding author), Inst Res Biomed IRB Barcelona, Barcelona, Spain.	guinovart@irbbarcelona.org		Zafra, Delia/0000-0003-4143-0659	Ministerio de Educacion y Ciencia (Spain); Intra-European Fellowship from the Marie Curie Actions [FP7-PEOPLE-2009-IEF]; Ministry of Science and Innovation, Spain [BFU2008-00769, SAF2007-64722]; Autonomous Government of Catalonia [2009SGR-1176]; Fundacion Marcelino Botin; CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministry of Science and Innovation, Spain)	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Intra-European Fellowship from the Marie Curie Actions; Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Autonomous Government of Catalonia(Generalitat de Catalunya); Fundacion Marcelino Botin; CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministry of Science and Innovation, Spain)	L.N. was a recipient of a predoctoral fellowship from the Ministerio de Educacion y Ciencia (www.micinn.es, Spain). J.C. is a recipient of an Intra-European Fellowship from the Marie Curie Actions (FP7-PEOPLE-2009-IEF; http://ec.europa.eu/research/mariecurieactions/). This study was supported by grants BFU2008-00769 and SAF2007-64722 (Ministry of Science and Innovation, Spain), 2009SGR-1176 (Autonomous Government of Catalonia), a grant from the Fundacion Marcelino Botin to J.J.G. and by CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministry of Science and Innovation, Spain; www.ciberdem.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS L, 1986, BIOCHEM J, V239, P593, DOI 10.1042/bj2390593; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Amigo-Correig M, 2011, DIABETES OBES METAB, V13, P235, DOI 10.1111/j.1463-1326.2010.01339.x; Ballester J, 2005, J ANDROL, V26, P706, DOI 10.2164/jandrol.04156; BARBERA A, 1994, J BIOL CHEM, V269, P20047; Barbera A, 2001, DIABETOLOGIA, V44, P507, DOI 10.1007/s001250100479; Barbera A, 1998, DIABETOLOGIA, V41, pA236; BJORBAEK C, 1995, J BIOL CHEM, V270, P18848, DOI 10.1074/jbc.270.32.18848; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Claret M, 2005, ENDOCRINOLOGY, V146, P4362, DOI 10.1210/en.2005-0385; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dominguez JE, 2003, J BIOL CHEM, V278, P42785, DOI 10.1074/jbc.M308334200; Ekladous D, 2008, CLIN EXP PHARMACOL P, V35, P971, DOI 10.1111/j.1440-1681.2008.04944.x; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Fernandez-Alvarez J, 2004, DIABETOLOGIA, V47, P470, DOI 10.1007/s00125-004-1332-8; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Garcia CA, 2009, J IMMUNOL, V183, P4475, DOI 10.4049/jimmunol.0901283; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Giron MD, 2008, DIABETOLOGIA, V51, P1285, DOI 10.1007/s00125-008-1003-2; Giron MD, 2003, FEBS LETT, V542, P84, DOI 10.1016/S0014-5793(03)00352-1; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; GURNEY AL, 1992, J BIOL CHEM, V267, P18133; He Q, 2010, AM J PHYSIOL-HEART C, V298, pH136, DOI 10.1152/ajpheart.00251.2009; JONES CG, 1993, BIOCHEM J, V289, P821, DOI 10.1042/bj2890821; Mage M, 2002, CAN J PHYSIOL PHARM, V80, P328, DOI 10.1139/Y02-024; MASSAGUE J, 1977, FEBS LETT, V82, P317, DOI 10.1016/0014-5793(77)80610-8; Miro-Queralt M, 2008, AM J PHYSIOL-GASTR L, V295, pG479, DOI 10.1152/ajpgi.00566.2007; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Munoz MC, 2001, DIABETES, V50, P131, DOI 10.2337/diabetes.50.1.131; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Naito Z, 2003, EXP MOL PATHOL, V74, P23, DOI 10.1016/S0014-4800(03)80005-9; Oyadomari S, 2000, FEBS LETT, V478, P141, DOI 10.1016/S0014-5793(00)01840-8; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Thirone ACP, 2002, DIABETES, V51, P2270, DOI 10.2337/diabetes.51.7.2270; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Yan SQ, 2001, CANCER RES, V61, P5016; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	45	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42305	10.1371/journal.pone.0042305	http://dx.doi.org/10.1371/journal.pone.0042305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905122	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100031
J	Wang, S; Fukuchi, M; Koch, C; Tsuchiya, N				Wang, Shuo; Fukuchi, Masaki; Koch, Christof; Tsuchiya, Naotsugu			Spatial Attention Is Attracted in a Sustained Fashion toward Singular Points in the Optic Flow	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; SUPERIOR TEMPORAL AREA; PURSUIT EYE-MOVEMENTS; MOTION-IN-DEPTH; MST NEURONS; COLLISION-AVOIDANCE; VISUAL CONTROL; IMPENDING COLLISION; SENSITIVE NEURONS; NUCLEUS ROTUNDUS	While a single approaching object is known to attract spatial attention, it is unknown how attention is directed when the background looms towards the observer as s/he moves forward in a quasi-stationary environment. In Experiment 1, we used a cued speeded discrimination task to quantify where and how spatial attention is directed towards the target superimposed onto a cloud of moving dots. We found that when the motion was expansive, attention was attracted towards the singular point of the optic flow (the focus of expansion, FOE) in a sustained fashion. The effects were less pronounced when the motion was contractive. The more ecologically valid the motion features became (e.g., temporal expansion of each dot, spatial depth structure implied by distribution of the size of the dots), the stronger the attentional effects. Further, the attentional effects were sustained over 1000 ms. Experiment 2 quantified these attentional effects using a change detection paradigm by zooming into or out of photographs of natural scenes. Spatial attention was attracted in a sustained manner such that change detection was facilitated or delayed depending on the location of the FOE only when the motion was expansive. Our results suggest that focal attention is strongly attracted towards singular points that signal the direction of forward ego-motion.	[Wang, Shuo; Fukuchi, Masaki; Koch, Christof; Tsuchiya, Naotsugu] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Fukuchi, Masaki] Sony Corp, Syst & Software Platform, Shinagawa Ku, Tokyo, Japan; [Koch, Christof] Allen Inst Brain Sci, Seattle, WA USA; [Tsuchiya, Naotsugu] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan; [Tsuchiya, Naotsugu] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Tsuchiya, Naotsugu] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia	California Institute of Technology; Sony Corporation; Allen Institute for Brain Science; Japan Science & Technology Agency (JST); RIKEN; Monash University	Wang, S (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	naotsugu.tsuchiya@monash.edu	Tsuchiya, Naotsugu/N-8153-2014	Tsuchiya, Naotsugu/0000-0003-4216-8701; Koch, Christof/0000-0001-6482-8067	Japan Society for the Promotion of Science; PRESTO award from Japan Science and Technology Agency; Office of Naval Research (via an award made through Johns Hopkins University); NeoVision program at DARPA; WCU program of the National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-10008]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); PRESTO award from Japan Science and Technology Agency; Office of Naval Research (via an award made through Johns Hopkins University); NeoVision program at DARPA; WCU program of the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	NT was funded by the Japan Society for the Promotion of Science and PRESTO award from Japan Science and Technology Agency. The research reported here is supported by the Office of Naval Research (via an award made through Johns Hopkins University), by the NeoVision program at DARPA and by the WCU program of the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-10008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL W, 1971, SCIENCE, V171, P818, DOI 10.1126/science.171.3973.818; BOWER TGR, 1971, PERCEPT PSYCHOPHYS, V9, P193, DOI 10.3758/BF03212627; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Britten KH, 2008, ANNU REV NEUROSCI, V31, P389, DOI 10.1146/annurev.neuro.29.051605.112953; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Brosseau-Lachaine O, 2008, J VISION, V8, DOI 10.1167/8.4.5; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; de Vries SEJ, 2012, CURR BIOL, V22, P353, DOI 10.1016/j.cub.2012.01.007; DILL LM, 1974, ANIM BEHAV, V22, P711, DOI 10.1016/S0003-3472(74)80022-9; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Efron B., 1994, CHAPMAN HALL CRC MON; Field DT, 2005, CURR BIOL, V15, P453, DOI 10.1016/j.cub.2004.12.081; Fotowat H, 2011, ANNU REV NEUROSCI, V34, P1, DOI 10.1146/annurev-neuro-061010-113632; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; Gray R, 1998, VISION RES, V38, P499, DOI 10.1016/S0042-6989(97)00230-7; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; HAYES WN, 1967, ANIM BEHAV, V15, P102, DOI 10.1016/S0003-3472(67)80018-6; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hemmi JM, 2012, CURR OPIN NEUROBIOL, V22, P194, DOI 10.1016/j.conb.2011.11.012; Ingle DJ, 1985, BRAIN MECH SPATIAL V, P229; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Lappe M, 1998, J NEUROPHYSIOL, V79, P1461, DOI 10.1152/jn.1998.79.3.1461; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; Laurent G, 1998, NAT NEUROSCI, V1, P261, DOI 10.1038/1071; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; LEE DN, 1993, J EXP BIOL, V180, P85; Lin JY, 2008, PSYCHOL SCI, V19, P686, DOI 10.1111/j.1467-9280.2008.02143.x; Lin JY, 2009, CURR BIOL, V19, P1118, DOI 10.1016/j.cub.2009.05.021; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Morrone MC, 1999, CURR BIOL, V9, P763, DOI 10.1016/S0960-9822(99)80338-8; Nakagawa H, 2010, J NEUROPHYSIOL, V104, P2487, DOI 10.1152/jn.01055.2009; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Niemann T, 1999, VISION RES, V39, P1359, DOI 10.1016/S0042-6989(98)00236-3; ORBAN GA, 1992, P NATL ACAD SCI USA, V89, P2595, DOI 10.1073/pnas.89.7.2595; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REGAN D, 1979, VISION RES, V19, P1331, DOI 10.1016/0042-6989(79)90205-0; Regan D, 2000, TRENDS COGN SCI, V4, P99, DOI 10.1016/S1364-6613(99)01442-4; REGAN D, 1978, VISION RES, V18, P209, DOI 10.1016/0042-6989(78)90188-8; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; SAITO H, 1986, J NEUROSCI, V6, P145; Schaafsma SJ, 1996, J NEUROPHYSIOL, V76, P4056; SCHIFF W, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093887; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; Schrater PR, 2001, NATURE, V410, P816, DOI 10.1038/35071075; Sidaway B, 1989, ECOL PSYCHOL, V1, P253, DOI DOI 10.1207/S15326969EC00103_2; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Takeuchi T, 1997, VISION RES, V37, P2083, DOI 10.1016/S0042-6989(96)00225-8; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TRONICK E, 1967, J COMP PHYSIOL PSYCH, V64, P529, DOI 10.1037/h0025206; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; von Muhlenen A, 2007, J EXP PSYCHOL HUMAN, V33, P1297, DOI 10.1037/0096-1523.33.6.1297; WAGNER H, 1982, NATURE, V297, P147, DOI 10.1038/297147a0; Wall MB, 2008, CURR BIOL, V18, P191, DOI 10.1016/j.cub.2007.12.053; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0; Yamamoto K, 2003, BRAIN BEHAV EVOLUT, V62, P201, DOI 10.1159/000073272; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; YILMAZ EH, 1995, J EXP PSYCHOL HUMAN, V21, P996, DOI 10.1037/0096-1523.21.5.996; Zhang T, 2004, NEURON, V42, P993, DOI 10.1016/j.neuron.2004.06.008	73	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41040	10.1371/journal.pone.0041040	http://dx.doi.org/10.1371/journal.pone.0041040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905096	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000307331100008
J	Yang, HL; Liu, YJ; Wang, CL; Zeng, QY				Yang, Hai-Ling; Liu, Yan-Jing; Wang, Cai-Ling; Zeng, Qing-Yin			Molecular Evolution of Trehalose-6-Phosphate Synthase (TPS) Gene Family in Populus, Arabidopsis and Rice	PLOS ONE			English	Article							TREHALOSE METABOLISM; VEGETATIVE GROWTH; PROTEINS; ACCUMULATION; EXPRESSION; TOLERANCE; INSIGHTS; SEEDS	Trehalose-6-phosphate synthase (TPS) plays important roles in trehalose metabolism and signaling. Plant TPS proteins contain both a TPS and a trehalose-6-phosphate phosphatase (TPP) domain, which are coded by a multi-gene family. The plant TPS gene family has been divided into class I and class II. A previous study showed that the Populus, Arabidopsis, and rice genomes have seven class I and 27 class II TPS genes. In this study, we found that all class I TPS genes had 16 introns within the protein-coding region, whereas class II TPS genes had two introns. A significant sequence difference between the two classes of TPS proteins was observed by pairwise sequence comparisons of the 34 TPS proteins. A phylogenetic analysis revealed that at least seven TPS genes were present in the monocot-dicot common ancestor. Segmental duplications contributed significantly to the expansion of this gene family. At least five and three TPS genes were created by segmental duplication events in the Populus and rice genomes, respectively. Both the TPS and TPP domains of 34 TPS genes have evolved under purifying selection, but the selective constraint on the TPP domain was more relaxed than that on the TPS domain. Among 34 TPS genes from Populus, Arabidopsis, and rice, four class I TPS genes (AtTPS1, OsTPS1, PtTPS1, and PtTPS2) were under stronger purifying selection, whereas three Arabidopsis class I TPS genes (AtTPS2, 3, and 4) apparently evolved under relaxed selective constraint. Additionally, a reverse transcription polymerase chain reaction analysis showed the expression divergence of the TPS gene family in Populus, Arabidopsis, and rice under normal growth conditions and in response to stressors. Our findings provide new insights into the mechanisms of gene family expansion and functional evolution.	[Yang, Hai-Ling; Wang, Cai-Ling] Beijing Forestry Univ, Coll Life Sci & Biotechnol, Beijing, Peoples R China; [Liu, Yan-Jing; Zeng, Qing-Yin] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS	Yang, HL (corresponding author), Beijing Forestry Univ, Coll Life Sci & Biotechnol, Beijing, Peoples R China.	yhailing@yahoo.com.cn; qingyin.zeng@ibcas.ac.cn	刘, 妍婧/HCI-6701-2022	Zeng, Qing-Yin/0000-0002-5730-3016	National Basic Research Program of China [2009CB119104]; Natural Science Foundation of China [NSFC 30800873]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-1]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This study was supported by grants from the National Basic Research Program of China (2009CB119104), the Natural Science Foundation of China (NSFC 30800873), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Chary SN, 2008, PLANT PHYSIOL, V146, P97, DOI 10.1104/pp.107.107441; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Force A, 1999, GENETICS, V151, P1531; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Glinski M, 2005, MOL CELL PROTEOMICS, V4, P1614, DOI 10.1074/mcp.M500134-MCP200; Goddijn OJM, 1999, TRENDS PLANT SCI, V4, P315, DOI 10.1016/S1360-1385(99)01446-6; Gomez LD, 2006, PLANT J, V46, P69, DOI 10.1111/j.1365-313X.2006.02662.x; Gomez LD, 2010, PLANT J, V64, P1, DOI 10.1111/j.1365-313X.2010.04312.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Jang IC, 2003, PLANT PHYSIOL, V131, P516, DOI 10.1104/pp.007237; Leyman B, 2001, TRENDS PLANT SCI, V6, P510, DOI 10.1016/S1360-1385(01)02125-2; Lunn JE, 2007, FUNCT PLANT BIOL, V34, P550, DOI 10.1071/FP06315; Ohno S., 1970, EVOLUTION GENE DUPLI; Ramon M, 2009, PLANT CELL ENVIRON, V32, P1015, DOI 10.1111/j.1365-3040.2009.01985.x; Shima S, 2007, FEBS J, V274, P1192, DOI 10.1111/j.1742-4658.2007.05658.x; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Vandesteene L, 2010, MOL PLANT, V3, P406, DOI 10.1093/mp/ssp114; White JA, 2000, PLANT PHYSIOL, V124, P1582, DOI 10.1104/pp.124.4.1582; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zang BS, 2011, PLANT MOL BIOL, V76, P507, DOI 10.1007/s11103-011-9781-1	28	45	46	14	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42438	10.1371/journal.pone.0042438	http://dx.doi.org/10.1371/journal.pone.0042438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905132	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100038
J	Fu, MS; De Sordi, L; Muhlschlegel, FA				Fu, Man-Shun; De Sordi, Luisa; Muehlschlegel, Fritz A.			Functional Characterization of the Small Heat Shock Protein Hsp12p from Candida albicans	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; TRANSCRIPTIONAL RESPONSE; ADENYLYL-CYCLASE; STRESS-RESPONSE; YEAST-CELLS; KINASE; GROWTH; MORPHOGENESIS; RESISTANCE	Hsp12p is considered to be a small heat shock protein and conserved among fungal species. To investigate the expression of this heat shock protein in the fungal pathogen Candida albicans we developed an anti-CaHsp12p antibody. We show that this protein is induced during stationary phase growth and under stress conditions including heat shock, osmotic, oxidative and heavy metal stress. Furthermore, we find that CaHsp12p expression is influenced by the quorum sensing molecule farnesol, the change of CO2 concentration and pH. Notably we show that the key transcription factor Efg1p acts as a positive regulator of CaHsp12p in response to heat shock and oxidative stress and demonstrate that CaHsp12p expression is additionally modulated by Hog1p and the cAMP-PKA signaling pathway. To study the function of Hsp12p in C. albicans we generated a null mutant, in which all four CaHSP12 genes have been deleted. Phenotypic analysis of the strain shows that CaHSP12 is not essential for stress resistance, morphogenesis or virulence when tested in a Drosophila model of infection. However, when overexpressed, CaHSP12 significantly enhanced cell-cell adhesion, germ tube formation and susceptibility to azole antifungal agents whilst desensitizing C. albicans to the quorum sensing molecule farnesol.	[Fu, Man-Shun; De Sordi, Luisa; Muehlschlegel, Fritz A.] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Muehlschlegel, Fritz A.] E Kent Hosp Univ NHS Fdn Trust, Clin Microbiol Serv, Ashford, Kent, England	University of Kent	Fu, MS (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	F.A.Muhlschlegel@kent.ac.uk	De Sordi, Luisa/ABC-2581-2021	De Sordi, Luisa/0000-0002-3785-550X	Medical Research Council (MRC); Biotechnology and Biological Sciences Research Council (BBSRC); University of Kent; MRC [G0601049] Funding Source: UKRI; Medical Research Council [G0601049] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Kent; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council (MRC)(http://www.mrc.ac.uk/index.htm); Biotechnology and Biological Sciences Research Council (BBSRC)(http://www.bbsrc.ac.uk/home/home.aspx); the University of Kent (http://www.kent.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLEY NJ, 1992, YEAST, V8, P95, DOI 10.1002/yea.320080204; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Brachmann CB, 1998, YEAST, V14, P115; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Burnie JR, 2006, FEMS MICROBIOL REV, V30, P53, DOI 10.1111/j.1574-6976.2005.00001.x; Carmelo V, 1997, FEMS MICROBIOL LETT, V149, P85, DOI 10.1016/S0378-1097(97)00059-1; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Cottier F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002485; Cowen LE, 2002, P NATL ACAD SCI USA, V99, P9284, DOI 10.1073/pnas.102291099; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Davis-Hanna A, 2008, MOL MICROBIOL, V67, P47, DOI 10.1111/j.1365-2958.2007.06013.x; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Eboigbodin KE, 2008, BIOMACROMOLECULES, V9, P686, DOI 10.1021/bm701043c; Eckert SE, 2007, FUNGAL GENET BIOL, V44, P368, DOI 10.1016/j.fgb.2006.12.006; El Barkani A, 2000, MOL CELL BIOL, V20, P4635, DOI 10.1128/MCB.20.13.4635-4647.2000; ELLIOTT B, 1993, YEAST, V9, P33, DOI 10.1002/yea.320090105; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; FONZI WA, 1993, GENETICS, V134, P717; Garstel M., 1997, GUIDEBOOK MOL CHAPER, P269; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hall RA, 2011, EUKARYOT CELL, V10, P1034, DOI 10.1128/EC.05060-11; Hall RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001193; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hiller E, 2007, EUKARYOT CELL, V6, P2056, DOI 10.1128/EC.00285-07; Hogan DA, 2011, CURR OPIN MICROBIOL, V14, P682, DOI 10.1016/j.mib.2011.09.014; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Hosking S, 1999, MOL FUNGAL BIOL, P322; JAMIESON DJ, 1994, MICROBIOL-UK, V140, P3277, DOI 10.1099/13500872-140-12-3277; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Karababa M, 2004, ANTIMICROB AGENTS CH, V48, P3064, DOI 10.1128/AAC.48.8.3064-3079.2004; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Krishnamurthy SS, 1999, FEMS MICROBIOL LETT, V173, P475, DOI 10.1111/j.1574-6968.1999.tb13541.x; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Liu TT, 2005, ANTIMICROB AGENTS CH, V49, P2226, DOI 10.1128/AAC.49.6.2226-2236.2005; Maeng S, 2010, EUKARYOT CELL, V9, P360, DOI 10.1128/EC.00309-09; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Motshwene P, 2004, BIOCHEM J, V377, P769, DOI 10.1042/bj20031301; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nicholls S, 2009, MOL MICROBIOL, V74, P844, DOI 10.1111/j.1365-2958.2009.06883.x; Nickerson KW, 2006, APPL ENVIRON MICROB, V72, P3805, DOI 10.1128/AEM.02765-05; PANARETOU B, 1992, EUR J BIOCHEM, V206, P635, DOI 10.1111/j.1432-1033.1992.tb16968.x; PETKO L, 1986, CELL, V45, P885, DOI 10.1016/0092-8674(86)90563-5; PRAEKELT UM, 1990, MOL GEN GENET, V223, P97, DOI 10.1007/BF00315801; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Setiadi ER, 2006, J MOL BIOL, V361, P399, DOI 10.1016/j.jmb.2006.06.040; Sheth CC, 2008, FUNGAL GENET BIOL, V45, P1075, DOI 10.1016/j.fgb.2008.04.004; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Thewes S, 2007, MOL MICROBIOL, V63, P1606, DOI 10.1111/j.1365-2958.2007.05614.x; VARELA JCS, 1995, MOL CELL BIOL, V15, P6232; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Weig M, 2001, MICROBIOL-SGM, V147, P2007, DOI 10.1099/00221287-147-8-2007; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Wendland J, 2003, CURR GENET, V44, P115, DOI 10.1007/s00294-003-0436-x; Westwater C, 2005, EUKARYOT CELL, V4, P1654, DOI 10.1128/EC.4.10.1654-1661.2005; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999	63	18	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42894	10.1371/journal.pone.0042894	http://dx.doi.org/10.1371/journal.pone.0042894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880130	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000307437900060
J	Liu, D; Shi, M; Zhang, H; Qian, L; Yu, M; Hu, MR; Zhang, RH; Wang, TY; Han, CL; Duan, HJ; Guo, N				Liu, Dan; Shi, Ming; Zhang, Hao; Qian, Lu; Yu, Ming; Hu, Meiru; Zhang, Ruihong; Wang, Tianyou; Han, Caili; Duan, Huijun; Guo, Ning			c-Myb Regulates Cell Cycle-Dependent Expression of Erbin: An Implication for a Novel Function of Erbin	PLOS ONE			English	Article							BASOLATERAL PDZ PROTEIN; HEMATOPOIETIC-CELLS; ACTIVATION; DOMAIN; DETERMINANTS; LOCALIZATION; COACTIVATOR; TRANSITION; INTERACTS; JUNCTIONS	In the present study, we demonstrated the cell cycle periodicity of Erbin expression with the maximal expression of Erbin in G2/M phase. A significant increase in Erbin promoter activity was observed in G2/M phase-synchronized cells. Sequence analysis revealed a c-Myb site in the core promoter region of Erbin. Mutagenesis of c-Myb consensus sequences abrogated the increased Erbin promoter activity in G2/M phase. ChIP and oligonucleotide pull-down assays validated that the recruitment of c-Myb to the consensus sequences was specific. The interaction of c-Myb with c-Myb site in the Erbin promoter was significantly enhanced in G2/M phase. Ectopic overexpression of c-Myb led to the up-regulation of Erbin promoter activity and c-Myb silencing by small interfering RNA significantly decreased Erbin protein level. Transfection of c-Myb rescued Erbin expression that was impaired by c-Myb knockdown. It proves that c-Myb and the c-Myb response element mediate the cell cycle-dependent expression of Erbin. Inactivation of Erbin causes an acceleration of the G1/S transition, the formation of multipolar spindles and abnormal chromosome congression. These results unravel a critical role of c-Myb in promoting Erbin transcription in G2/M phase and also predict an unappreciated function of Erbin in cell cycle progression.	[Liu, Dan; Zhang, Ruihong; Han, Caili; Duan, Huijun] Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China; [Shi, Ming; Zhang, Hao; Qian, Lu; Yu, Ming; Hu, Meiru; Guo, Ning] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathophysiol, Beijing 100730, Peoples R China; [Wang, Tianyou] Capital Inst Pediat, Beijing, Peoples R China	Hebei Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Capital Institute of Pediatrics (CIP)	Liu, D (corresponding author), Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China.	duanhj999@163.com; ningguo@nic.bmi.ac.cn	Zhang, Rui/GXN-3801-2022		National Basic Research Program of China (973 Program) [2010CB911904]; National Natural Science Foundation of China [30800582, 30972690]; Beijing National Natural Science Foundation [7122124]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing National Natural Science Foundation(Beijing Natural Science Foundation)	This work is supported by National Basic Research Program of China (973 Program, No. 2010CB911904), National Natural Science Foundation of China (No. 30800582 and 30972690) and Beijing National Natural Science Foundation (No. 7122124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Bilder D, 2000, NAT CELL BIOL, V2, pE114, DOI 10.1038/35017119; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038; CALABRETTA B, 1991, P NATL ACAD SCI USA, V88, P2351, DOI 10.1073/pnas.88.6.2351; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; Dai FY, 2007, MOL CELL BIOL, V27, P6183, DOI 10.1128/MCB.00132-07; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; Dai PG, 2006, J BIOL CHEM, V281, P927, DOI 10.1074/jbc.M507360200; DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267; DUDEK H, 1992, P NATL ACAD SCI USA, V89, P1291, DOI 10.1073/pnas.89.4.1291; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; FURUKAWA Y, 1990, SCIENCE, V250, P805, DOI 10.1126/science.2237430; GOLAY J, 1991, BLOOD, V77, P149; HERNANDEZMUNAIN C, 1995, MOL CELL BIOL, V15, P3090; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; Huang YZ, 2003, J BIOL CHEM, V278, P1108, DOI 10.1074/jbc.M205413200; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; Izawa I, 2002, GENES CELLS, V7, P475, DOI 10.1046/j.1365-2443.2002.00533.x; Jaulin-Bastard F, 2002, J BIOL CHEM, V277, P2869, DOI 10.1074/jbc.M109652200; Kolch Walter, 2003, Sci STKE, V2003, ppe37; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lebeau S, 2005, BRIT J DERMATOL, V152, P1248, DOI 10.1111/j.1365-2133.2005.06687.x; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; Legouis R, 2003, EMBO REP, V4, P1096, DOI 10.1038/sj.embor.7400006; Lei WL, 2005, BLOOD, V105, P3855, DOI 10.1182/blood-2004-08-3342; Mink S, 1996, MOL CELL BIOL, V16, P1316; Nakata Y, 2007, MOL CELL BIOL, V27, P2048, DOI 10.1128/MCB.01100-06; Ness SA, 1999, ONCOGENE, V18, P3039, DOI 10.1038/sj.onc.1202726; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Ohno H, 2002, ONCOGENE, V21, P7042, DOI 10.1038/sj.onc.1205852; Quintana AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017362; Rangwala R, 2005, J BIOL CHEM, V280, P11790, DOI 10.1074/jbc.M414154200; Ress A, 2006, PROTEIN PEPTIDE LETT, V13, P877, DOI 10.2174/092986606778256126; Shi M, 2013, INT J CARDIOL, V167, P1570, DOI 10.1016/j.ijcard.2012.04.093; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Wilkes MC, 2009, DEV CELL, V16, P433, DOI 10.1016/j.devcel.2009.01.009; Zhang H, 2008, PREP BIOCHEM BIOTECH, V38, P282, DOI 10.1080/10826060802165105	41	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42903	10.1371/journal.pone.0042903	http://dx.doi.org/10.1371/journal.pone.0042903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880131	Green Submitted, gold, Green Published			2022-12-27	WOS:000307437900061
J	Zhou, JB; Liu, C; Niu, WY; Xin, Z; Yu, M; Feng, JP; Yang, JK				Zhou, Jian-Bo; Liu, Chang; Niu, Wen-Yan; Xin, Zhong; Yu, Mei; Feng, Jian-Ping; Yang, Jin-Kui			Contributions of Renin-Angiotensin System-Related Gene Interactions to Obesity in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INDUCED WEIGHT-GAIN; BODY-MASS INDEX; ADULT OBESITY; FTO GENE; EPISTASIS; VARIANTS; RISK; ADIPOSITY; LOCI	Background: Gene-gene interactions may be partly responsible for complex traits such as obesity. Increasing evidence suggests that the renin-angiotensin system (RAS) contributes to the etiology of obesity. How the epistasis of genes in the RAS contributes to obesity is still under research. We aim to evaluate the contribution of RAS-related gene interactions to a predisposition of obesity in a Chinese population. Methodology and Principal Findings: We selected six single nucleotide polymorphisms (SNPs) located in angiotensin (AGT), angiotensin converting enzyme (ACE), angiotensin type 1 receptor (AGTR1), MAS1, nitric oxide synthase 3 (NOS3) and the bradykinin B2 receptor gene (BDKRB2), and genotyped them in 324 unrelated individuals with obesity (BMI >= 28 kg/m(2)) and 373 non-obese controls (BMI 18.5 to <24 kg/m(2)) from a large scale population-based cohort. We analyzed gene-gene interactions among 6 polymorphic loci using the Generalized Multifactor Dimensionality Reduction (GMDR) method, which has been shown to be effective for detecting gene-gene interactions in case-control studies with relatively small samples. Then we used logistic regression models to confirm the best combination of loci identified in the GMDR. It showed a significant gene-gene interaction between the rs220721 polymorphism in the MAS1 gene and the rs1799722 polymorphism in the gene BDKB2R. The best two-locus combination scored 9 for cross-validation consistency and 9 for sign test (p = 0.0107). This interaction showed the maximum consistency and minimum prediction error among all gene-gene interaction models evaluated. Moreover, the combination of the MAS1 rs220721 and the BDKRB2 rs1799722 was associated with a significantly increased risk of obesity (OR 1.82, CI 95%: 1.15-2.88, p = 0.0103). Conclusions and Significance: These results suggest that the SNPs from the RAS-related genes may contribute to the risk of obesity in an interactive manner in a Chinese population. The gene-gene interaction may serve as a novel area for obesity research.	[Zhou, Jian-Bo; Liu, Chang; Xin, Zhong; Yu, Mei; Feng, Jian-Ping; Yang, Jin-Kui] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China; [Niu, Wen-Yan] Tianjin Med Univ, Dept Immunol, Key Lab Immuno Microenvironm & Dis, Educ Minist China, Tianjin, Peoples R China	Capital Medical University; Tianjin Medical University	Zhou, JB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China.	jinkui.yang@gmail.com		Yang, Jin-Kui/0000-0002-5430-2149	Capital Medical Development Foundation [2009-Z-SQ03]; Expert Promotion Program of Beijing Health Systems [2009-3-34]; Tianjin Municipal Science and Technology Commission [09ZCZDSF04500]	Capital Medical Development Foundation; Expert Promotion Program of Beijing Health Systems; Tianjin Municipal Science and Technology Commission	This work was supported by the Capital Medical Development Foundation (No. 2009-Z-SQ03) and Expert Promotion Program of Beijing Health Systems (No. 2009-3-34) to Professor Jin-Kui Yang and by a grant to Wen-Yan Niu from the Tianjin Municipal Science and Technology Commission (No. 09ZCZDSF04500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin F, 2010, DNA CELL BIOL, V29, P207, DOI 10.1089/dna.2009.0934; Babu M, 2009, MOL BIOSYST, V5, P1439, DOI [10.1039/b907407d, 10.1039/B907407d]; Boustany CM, 2004, AM J PHYSIOL-REG I, V287, pR943, DOI 10.1152/ajpregu.00265.2004; Braun A, 1996, IMMUNOPHARMACOLOGY, V33, P32, DOI 10.1016/0162-3109(96)00079-3; Cong ND, 1999, P SOC EXP BIOL MED, V220, P46; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; de Kloet AD, 2009, ENDOCRINOLOGY, V150, P4114, DOI 10.1210/en.2009-0065; Dong CH, 2003, AM J HUM GENET, V72, P115, DOI 10.1086/345648; Feitosa MF, 2009, OBESITY, V17, P2190, DOI 10.1038/oby.2009.181; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Jayasooriya AP, 2005, P NATL ACAD SCI USA, V102, P7133, DOI 10.1073/pnas.0502594102; Jiang X, 2010, GENET EPIDEMIOL, V34, P575, DOI 10.1002/gepi.20514; Jones BH, 1997, ENDOCRINOLOGY, V138, P1512, DOI 10.1210/en.138.4.1512; Kouyama R, 2005, ENDOCRINOLOGY, V146, P3481, DOI 10.1210/en.2005-0003; Lei HP, 2012, J RENIN ANGIOTENSIN; Li WD, 2005, J LIPID RES, V46, P432, DOI 10.1194/jlr.M400391-JLR200; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Maier LM, 2005, AM J HUM GENET, V76, P517, DOI 10.1086/428387; Massiera F, 2001, ENDOCRINOLOGY, V142, P5220, DOI 10.1210/en.142.12.5220; Mehri S, 2012, MOL BIOL REP, V39, P4059, DOI 10.1007/s11033-011-1187-2; Mei Ling, 2007, BMC Proc, V1 Suppl 1, pS17; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Procopciuc LM, 2010, EUR J INTERN MED, V21, P414, DOI 10.1016/j.ejim.2010.06.001; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; Slager SL, 2001, HUM HERED, V52, P149, DOI 10.1159/000053370; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Thekkumkara TJ, 2003, BIOCHEM J, V370, P631, DOI 10.1042/BJ20020960; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tsai CT, 2007, ATHEROSCLEROSIS, V195, P172, DOI 10.1016/j.atherosclerosis.2006.09.014; Warden CH, 2004, NUTRITION, V20, P74, DOI 10.1016/j.nut.2003.09.013; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhou JB, 2010, MED SCI MONITOR, V16, pBR179; Zhou JB, 2010, MOL BIOL REP, V37, P67, DOI 10.1007/s11033-009-9648-6	41	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42881	10.1371/journal.pone.0042881	http://dx.doi.org/10.1371/journal.pone.0042881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880127	gold, Green Submitted, Green Published			2022-12-27	WOS:000307810000080
J	Tari, L; Vo, N; Liang, SS; Patel, J; Baral, C; Cai, J				Tari, Luis; Nguyen Vo; Liang, Shanshan; Patel, Jagruti; Baral, Chitta; Cai, James			Identifying Novel Drug Indications through Automated Reasoning	PLOS ONE			English	Article							DATABASE; DISCOVERY; DISEASE	Background: With the large amount of pharmacological and biological knowledge available in literature, finding novel drug indications for existing drugs using in silico approaches has become increasingly feasible. Typical literature-based approaches generate new hypotheses in the form of protein-protein interactions networks by means of linking concepts based on their cooccurrences within abstracts. However, this kind of approaches tends to generate too many hypotheses, and identifying new drug indications from large networks can be a time-consuming process. Methodology: In this work, we developed a method that acquires the necessary facts from literature and knowledge bases, and identifies new drug indications through automated reasoning. This is achieved by encoding the molecular effects caused by drug-target interactions and links to various diseases and drug mechanism as domain knowledge in AnsProlog, a declarative language that is useful for automated reasoning, including reasoning with incomplete information. Unlike other literature-based approaches, our approach is more fine-grained, especially in identifying indirect relationships for drug indications. Conclusion/Significance: To evaluate the capability of our approach in inferring novel drug indications, we applied our method to 943 drugs from DrugBank and asked if any of these drugs have potential anti-cancer activities based on information on their targets and molecular interaction types alone. A total of 507 drugs were found to have the potential to be used for cancer treatments. Among the potential anti-cancer drugs, 67 out of 81 drugs (a recall of 82.7%) are indeed known cancer drugs. In addition, 144 out of 289 drugs (a recall of 49.8%) are non-cancer drugs that are currently tested in clinical trials for cancer treatments. These results suggest that our method is able to infer drug indications (original or alternative) based on their molecular targets and interactions alone and has the potential to discover novel drug indications for existing drugs.	[Tari, Luis; Cai, James] Hoffmann La Roche, Pharma Res & Early Dev Informat, Dis & Translat Informat, Nutley, NJ USA; [Nguyen Vo; Liang, Shanshan; Baral, Chitta] Arizona State Univ, Dept Comp Sci & Engn, Tempe, AZ 85287 USA; [Patel, Jagruti] Hoffmann La Roche, Pharma Res & Early Dev Informat, Sci Informat Management, Nutley, NJ USA	Roche Holding; Arizona State University; Arizona State University-Tempe; Roche Holding	Tari, L (corresponding author), Knowledge Discovery Lab, Gen Elect Global Res Ctr, Niskayuna, NY USA.	luis.tari@asu.edu		Baral, Chitta/0000-0002-7549-723X				Andronis C, 2011, BRIEF BIOINFORM, V12, P357, DOI 10.1093/bib/bbr005; [Anonymous], 2008, PHASE I STUDY DISULF; [Anonymous], 2008, TOPICAL TAZAROTENE T; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Arighi CN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S1; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; BARAL C., 2003, KNOWLEDGE REPRESENTA; Bundschus M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-207; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Deftereos SN, 2011, WIRES SYST BIOL MED, V3, P323, DOI 10.1002/wsbm.147; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Dubus E, 2009, FUTURE MED CHEM, V1, P1723, DOI 10.4155/FMC.09.123; Gebser M, 2009, LECT NOTES COMPUT SC, V5649, P235, DOI 10.1007/978-3-642-02846-5_22; Gelfond M., 1991, New Generation Computing, V9, P365, DOI 10.1007/BF03037169; Gelfound M., 1988, Logic Programming: Proceedings of the Fifth International Conference and Symposium, P1070; Ghofrani HA, 2006, NAT REV DRUG DISCOV, V5, P689, DOI 10.1038/nrd2030; Ha S, 2008, BIOINFORMATICS, V24, P1413, DOI 10.1093/bioinformatics/btn138; Hakenberg J, 2008, BIOINFORMATICS, V24, pI126, DOI 10.1093/bioinformatics/btn299; Klein D, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P423, DOI 10.3115/1075096.1075150; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Leaman Robert, 2008, Pac Symp Biocomput, P652; LeWitt PA, 2008, NEW ENGL J MED, V359, P2468, DOI 10.1056/NEJMct0800326; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Pyysalo S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-50; Swanson D. R., 1991, SIGIR Forum, P280; Taboureau O, 2011, NUCLEIC ACIDS RES, V39, pD367, DOI 10.1093/nar/gkq906; Tari L, 2012, IEEE T KNOWL DATA EN, V24, P86, DOI 10.1109/TKDE.2010.214; Tari L, 2010, BIOINFORMATICS, V26, pi547, DOI 10.1093/bioinformatics/btq382; Tari L, 2010, BIOCOMPUT-PAC SYM, P465; Weeber M, 2003, J AM MED INFORM ASSN, V10, P252, DOI 10.1197/jamia.M1158; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yetisgen-Yildiz M, 2006, J BIOMED INFORM, V39, P600, DOI 10.1016/j.jbi.2005.11.010	33	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40946	10.1371/journal.pone.0040946	http://dx.doi.org/10.1371/journal.pone.0040946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911721	Green Published, gold			2022-12-27	WOS:000306687700025
J	Cote, GJ; Zhu, W; Thomas, A; Martin, E; Murad, F; Sharina, IG				Cote, Gilbert J.; Zhu, Wen; Thomas, Anthony; Martin, Emil; Murad, Ferid; Sharina, Iraida G.			Hydrogen Peroxide Alters Splicing of Soluble Guanylyl Cyclase and Selectively Modulates Expression of Splicing Regulators in Human Cancer Cells	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; IRES-MEDIATED TRANSLATION; MESSENGER-RNA BINDING; OXIDATIVE STRESS; NITRIC-OXIDE; CYSTEINE OXIDATION; EXON INCLUSION; MECHANISMS; ATHEROSCLEROSIS; PROLIFERATION	Background: Soluble guanylyl cyclase (sGC) plays a central role in nitric oxide (NO)-mediated signal transduction in the cardiovascular, nervous and gastrointestinal systems. Alternative RNA splicing has emerged as a potential mechanism to modulate sGC expression and activity. C-alpha 1 sGC is an alternative splice form that is resistant to oxidation-induced protein degradation and demonstrates preferential subcellular distribution to the oxidized environment of endoplasmic reticulum (ER). Methodology/Principal Findings: Here we report that splicing of C-alpha 1 sGC can be modulated by H2O2 treatment in BE2 neuroblastoma and MDA-MD-468 adenocarcinoma human cells. In addition, we show that the H2O2 treatment of MDA-MD-468 cells selectively decreases protein levels of PTBP1 and hnRNP A2/B1 splice factors identified as potential alpha 1 gene splicing regulators by in silico analysis. We further demonstrate that down-regulation of PTBP1 by H2O2 occurs at the protein level with variable regulation observed in different breast cancer cells. Conclusions/Significance: Our data demonstrate that H2O2 regulates RNA splicing to induce expression of the oxidation-resistant C-alpha 1 sGC subunit. We also report that H2O2 treatment selectively alters the expression of key splicing regulators. This process might play an important role in regulation of cellular adaptation to conditions of oxidative stress.	[Cote, Gilbert J.; Zhu, Wen] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA; [Thomas, Anthony; Martin, Emil; Sharina, Iraida G.] Univ Texas Med Sch, UTHealth, Dept Internal Med Cardiol, Houston, TX USA; [Murad, Ferid] George Washington Univ, Dept Biochem & Mol Biol, Washington, DC USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; George Washington University	Cote, GJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA.	Iraida.G.Sharina@uth.tmc.edu	Sharina, Iraida/C-9888-2014	Martin, Emil/0000-0002-9094-4165	NIH [RO1 HL088128, 3R01HL088128]; AHA South Central Affiliate [09GRNT2060182]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088128] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA South Central Affiliate; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants RO1 HL088128 and 3R01HL088128 and AHA South Central Affiliate Grant-in-Aid 09GRNT2060182 to E. M. and departmental start-up funds to I. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardanaz N, 2006, EXP BIOL MED, V231, P237; Ashibe B, 2007, J BIOL CHEM, V282, P20763, DOI 10.1074/jbc.M611853200; Back SH, 2002, J BIOL CHEM, V277, P27200, DOI 10.1074/jbc.M203887200; Baralle D, 2009, EMBO REP, V10, P810, DOI 10.1038/embor.2009.170; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Cheung HC, 2009, BRAIN, V132, P2277, DOI 10.1093/brain/awp153; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Grover R, 2008, CELL CYCLE, V7, P2189, DOI 10.4161/cc.7.14.6271; Gulden M, 2010, FREE RADICAL BIO MED, V49, P1298, DOI 10.1016/j.freeradbiomed.2010.07.015; Hang XY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-126; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Hirschfeld M, 2009, CANCER RES, V69, P2082, DOI 10.1158/0008-5472.CAN-08-1997; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jin W, 2000, CANCER RES, V60, P1221; Jin W, 2003, CANCER RES, V63, P6154; Kattapuram T, 2005, J BIOL CHEM, V280, P15340, DOI 10.1074/jbc.M500214200; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; Kraehling JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025772; Marengo B, 2008, FREE RADICAL BIO MED, V44, P474, DOI 10.1016/j.freeradbiomed.2007.10.031; MATSUO N, 1995, J BIOL CHEM, V270, P28216, DOI 10.1074/jbc.270.47.28216; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Monie TP, 2005, RNA, V11, P1803, DOI 10.1261/rna.2214405; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Nienhuis HLA, 2009, AUTOIMMUNITY, V42, P302, DOI 10.1080/08916930902831746; Panchenko MP, 2009, CARDIOVASC PATHOL, V18, P167, DOI 10.1016/j.carpath.2008.03.008; PIERCE GB, 1991, DIFFERENTIATION, V46, P181, DOI 10.1111/j.1432-0436.1991.tb00880.x; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Schepens B, 2005, NUCLEIC ACIDS RES, V33, P6884, DOI 10.1093/nar/gki1000; Sharin VG, 2010, STEM CELLS DEV; SHARINA IG, 2011, NITRIC OXIDE; Sharina IG, 2008, J BIOL CHEM, V283, P15104, DOI 10.1074/jbc.M710269200; Shi Y, 2007, MOL CELL, V28, P79, DOI 10.1016/j.molcel.2007.08.028; Shibayama M, 2009, FEBS J, V276, P6658, DOI 10.1111/j.1742-4658.2009.07380.x; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Takeo K, 2009, AM J PHYSIOL-CELL PH, V297, pC330, DOI 10.1152/ajpcell.00009.2009; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wang C, 2008, J BIOL CHEM, V283, P20277, DOI 10.1074/jbc.M803682200; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zhang J, 2009, CELL DEATH DIFFER, V16, P1460, DOI 10.1038/cdd.2009.87	51	18	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41099	10.1371/journal.pone.0041099	http://dx.doi.org/10.1371/journal.pone.0041099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911749	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600048
J	Stark, RJ; Aghakasiri, N; Rumbaut, RE				Stark, Ryan J.; Aghakasiri, Niloufar; Rumbaut, Rolando E.			Platelet-Derived Toll-Like Receptor 4 (Tlr-4) Is Sufficient to Promote Microvascular Thrombosis in Endotoxemia	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; MOUSE CREMASTER VENULES; P-SELECTIN; TISSUE FACTOR; IN-VIVO; LIPOPOLYSACCHARIDE; ACTIVATION; MICE; MICROPARTICLES; AGGREGATION	Endotoxin (lipopolysaccharide, LPS) produced by gram-negative bacteria initiates a host of pro-inflammatory effects through Toll-like receptor 4 (TLR-4). We reported previously that LPS enhances microvascular thrombosis in cremaster venules of wild-type mice, but had no effect in mice deficient in TLR-4. Since TLR-4 is expressed on various cell types, the cellular origin of TLR-4 responsible for the LPS-enhanced thrombosis remains undetermined. Platelets are known to express functional TLR-4. Platelet-derived TLR-4 has been suggested to mediate various inflammatory responses in endotoxemia, including production of tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta), two cytokines reported to enhance microvascular thrombosis. We determined whether platelet-derived TLR-4 was sufficient to mediate the enhanced thrombosis induced by endotoxin and whether these responses were accompanied by systemic increases in TNF-alpha and IL-1 beta. We isolated platelets from wild-type mice and transfused them into either of two strains of TLR-4-deficient mice (C57BL/10ScN and B6.B10ScN-TLR-4(lps-del)/Jth). The mice were then injected with LPS or saline, and the kinetics of thrombosis were studied 4 hours later. Transfusion of wild-type platelets restored responsiveness to LPS in TLR-4-deficient mice with regards to microvascular thrombosis but not to plasma levels of TNF-alpha or IL-1 beta. The accelerated rates of microvascular thrombosis induced by platelet transfusions were specific to TLR-4, since isolation and transfusion of platelets derived from TLR-4-deficient donors did not restore responsiveness to LPS. These studies demonstrate that platelet-derived TLR-4 is sufficient to promote microvascular thrombosis in endotoxemia, independent of systemic increases in TNF-alpha or IL-1 beta.	[Stark, Ryan J.; Rumbaut, Rolando E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Aghakasiri, Niloufar; Rumbaut, Rolando E.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Rumbaut, Rolando E.] Michael E DeBakey VA Med Ctr, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Stark, RJ (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	rrumbaut@bcm.edu	Stark, Ryan/O-1862-2019; Stark, Ryan/GZL-7445-2022	Stark, Ryan/0000-0001-6142-5502; Stark, Ryan/0000-0001-6142-5502; Rumbaut, Rolando/0000-0002-8486-1013	National Institutes of Health [HL-079368]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; NIH [T32-HL007939]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079368, T32HL007939] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported in part by National Institutes of Health grant HL-079368, and by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the United States Government. R.J. Stark was supported by NIH Grant T32-HL007939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Brown GT, 2011, J IMMUNOL, V186, P5489, DOI 10.4049/jimmunol.1001623; Cerwinka WH, 2003, AM J PHYSIOL-HEART C, V284, pH535, DOI 10.1152/ajpheart.00311.2002; Chou J, 2004, BLOOD, V104, P3190, DOI 10.1182/blood-2004-03-0935; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cribbs SK, 2007, CRIT CARE MED, V35, P2646, DOI 10.1097/01.CCM.0000288082.99980.90; Dasgupta SK, 2009, BLOOD, V113, P1332, DOI 10.1182/blood-2008-07-167148; DAVIS MJ, 1987, MICROVASC RES, V34, P223, DOI 10.1016/0026-2862(87)90055-0; Falati S, 2003, J EXP MED, V197, P1585, DOI 10.1084/jem.20021868; Gando S, 1996, THROMB HAEMOSTASIS, V75, P224; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Hashimoto K, 2009, J CARDIOVASC PHARM, V54, P57, DOI 10.1097/FJC.0b013e3181ab373d; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hrachovinova I, 2003, NAT MED, V9, P1020, DOI 10.1038/nm899; Jayachandran M, 2007, J APPL PHYSIOL, V102, P429, DOI 10.1152/japplphysiol.01576.2005; Kornerup KN, 2010, J APPL PHYSIOL, V109, P758, DOI 10.1152/japplphysiol.01086.2009; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P4794, DOI 10.1167/iovs.06-0381; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McCuskey RS, 1996, CARDIOVASC RES, V32, P752, DOI 10.1016/S0008-6363(96)00113-7; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rumbaut RE, 2006, AM J PHYSIOL-HEART C, V290, pH1671, DOI 10.1152/ajpheart.00305.2005; Rumbaut RE, 2004, MICROCIRCULATION, V11, P239, DOI 10.1080/10739680490425949; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Shashkin PN, 2008, J IMMUNOL, V181, P3495, DOI 10.4049/jimmunol.181.5.3495; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Yoshida H, 2011, INFLAMM BOWEL DIS, V17, P2217, DOI 10.1002/ibd.21593; Yoshida H, 2010, AM J PATHOL, V177, P2774, DOI 10.2353/ajpath.2010.100205; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884	36	59	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41254	10.1371/journal.pone.0041254	http://dx.doi.org/10.1371/journal.pone.0041254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911769	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600063
J	Ruan, XS; Crupper, SS; Schultz, BD; Robertson, DC; Zhang, WP				Ruan, Xiaosai; Crupper, Scott S.; Schultz, Bruce D.; Robertson, Donald C.; Zhang, Weiping			Escherichia coli Expressing EAST1 Toxin Did Not Cause an Increase of cAMP or cGMP Levels in Cells, and No Diarrhea in 5-Day Old Gnotobiotic Pigs	PLOS ONE			English	Article							HEAT-STABLE ENTEROTOXIN; VIRULENCE GENES; POSTWEANING DIARRHEA; LABILE ENTEROTOXIN; EDEMA DISEASE; BRUSH-BORDERS; WEANED PIGS; YOUNG-PIGS; OSAKA CITY; PREVALENCE	Background: Enterotoxigenic Escherichia coli (ETEC) strains are the leading bacterial cause of diarrhea to humans and farm animals. These ETEC strains produce heat-labile toxin (LT) and/or heat-stable toxins that include type I (STa), type II (STb), and enteroaggregative heat-stable toxin 1 (EAST1). LT, STa, and STb (in pigs) are proven the virulence determinants in ETEC diarrhea. However, significance of EAST1 in ETEC-associated diarrheal has not been determined, even though EAST1 is highly prevalent among ETEC strains. Methodology/Principal Findings: In this study, we constructed E. coli strains to express EAST1 toxin as the only toxin and studied them in cell lines and five-day old gnotobiotic piglets to determine significance of EAST1 toxin. Data from in vitro studies indicated that EAST1 did not stimulate an increase of intracellular cyclic AMP or GMP levels in T-84 cells or porcine cell line IPEC-J2, nor did it enhance LT or STa toxin of ETEC strains in stimulation of cAMP or cGMP in T-84 cells. In addition, 5-day old gnotobiotic pigs challenged with E. coli strains expressing EAST1 as the only toxin did not developed diarrhea or signs of clinical disease during 72 h post-inoculation. Conclusion/Significance: Results from this study indicated that EAST1 alone is not sufficient to cause diarrhea in five-day old gnotobiotic pigs, and suggest that EAST1 likely is not a virulence determinant in ETEC-associated diarrhea.	[Ruan, Xiaosai; Zhang, Weiping] S Dakota State Univ, Vet & Biomed Sci Dept, Ctr Infect Dis Res & Vaccinol, Brookings, SD 57007 USA; [Crupper, Scott S.] Emporia State Univ, Dept Biol Sci, Emporia, KS 66801 USA; [Schultz, Bruce D.; Robertson, Donald C.] Kansas State Univ, Sch Vet Med, Manhattan, KS 66506 USA	South Dakota State University; Kansas State University	Ruan, XS (corresponding author), S Dakota State Univ, Vet & Biomed Sci Dept, Ctr Infect Dis Res & Vaccinol, Brookings, SD 57007 USA.	weiping.zhang@sdstate.edu	Schultz, Bruce/F-8854-2013		National Institutes of Health [AI076871-01]; South Dakota Agricultural Experiment Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI076871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Dakota Agricultural Experiment Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this study was provided by National Institutes of Health AI076871-01 (WZ) and the South Dakota Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berberov EM, 2004, INFECT IMMUN, V72, P3914, DOI 10.1128/IAI.72.7.3914-3924.2004; BHAN MK, 1989, J INFECT DIS, V159, P1061, DOI 10.1093/infdis/159.6.1061; BIJLSMA IGW, 1982, INFECT IMMUN, V37, P891, DOI 10.1128/IAI.37.3.891-894.1982; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Choi C, 2001, J VET DIAGN INVEST, V13, P26, DOI 10.1177/104063870101300106; Choi C, 2001, VET MICROBIOL, V81, P65, DOI 10.1016/S0378-1135(01)00332-7; de Sousa CP, 2001, INT J MED MICROBIOL, V291, P15, DOI 10.1078/1438-4221-00097; DOUGAN G, 1986, INFECT IMMUN, V52, P344, DOI 10.1128/IAI.52.1.344-347.1986; ERICKSON AK, 1992, INFECT IMMUN, V60, P983, DOI 10.1128/IAI.60.3.983-988.1992; Erume J, 2008, INFECT IMMUN, V76, P3141, DOI 10.1128/IAI.01743-07; FRANCIS DH, 1991, AM J VET RES, V52, P1051; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; Fujihara S, 2009, JPN J INFECT DIS, V62, P318; Gascon J, 1998, J INFECT DIS, V177, P1409, DOI 10.1086/517826; Gascon J, 2000, J CLIN MICROBIOL, V38, P4459; Greenberg DE, 2002, J INFECT DIS, V185, P944, DOI 10.1086/339617; Harrington SM, 2006, FEMS MICROBIOL LETT, V254, P12, DOI 10.1111/j.1574-6968.2005.00005.x; HOWELL A, 1987, CANCER RES, V47, P296; Itoh Y, 1997, J CLIN MICROBIOL, V35, P2546, DOI 10.1128/JCM.35.10.2546-2550.1997; KUNG M, 1980, CLIN RES PROC, V16, P429; McVeigh A, 2000, INFECT IMMUN, V68, P5710, DOI 10.1128/IAI.68.10.5710-5715.2000; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; Ngeleka M, 2003, J VET DIAGN INVEST, V15, P242, DOI 10.1177/104063870301500305; Nishikawa Y, 1999, EMERG INFECT DIS, V5, P300, DOI 10.3201/eid0502.990220; Nishikawa Y, 2000, J CLIN MICROBIOL, V38, P2440; Noamani BN, 2003, VET MICROBIOL, V97, P87, DOI 10.1016/j.vetmic.2003.08.006; Osek J, 2003, VET MICROBIOL, V91, P65, DOI 10.1016/S0378-1135(02)00262-6; Piva IC, 2003, J CLIN MICROBIOL, V41, P1827, DOI 10.1128/JCM.41.5.1827-1832.2003; SACKETT DL, 1980, CAN J PUBLIC HEALTH, V71, P225; Savarino SJ, 1996, J INFECT DIS, V173, P1019, DOI 10.1093/infdis/173.4.1019; SAVARINO SJ, 1993, P NATL ACAD SCI USA, V90, P3093, DOI 10.1073/pnas.90.7.3093; SELLWOOD R, 1975, J MED MICROBIOL, V8, P405, DOI 10.1099/00222615-8-3-405; SOM P, 1980, J NUCL MED, V21, P670; Steiner TS, 1998, J INFECT DIS, V177, P88, DOI 10.1086/513809; TZIPORI S, 1983, AM J TROP MED HYG, V32, P931, DOI 10.4269/ajtmh.1983.32.931; TZIPORI S, 1992, INFECT IMMUN, V60, P5302, DOI 10.1128/IAI.60.12.5302-5306.1992; USDA, 2002, USDA APHIS VS CEAH 2; Veilleux S, 2006, VET RES, V37, P3, DOI 10.1051/vetres:2005045; Veilleux S, 2008, COMP IMMUNOL MICROB, V31, P567, DOI 10.1016/j.cimid.2007.10.003; VIAL PA, 1988, J INFECT DIS, V158, P70, DOI 10.1093/infdis/158.1.70; [WHO] World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P97; Yamamoto T, 1997, FEMS MICROBIOL LETT, V147, P89, DOI 10.1016/S0378-1097(96)00509-5; Yamamoto T, 1997, J CLIN MICROBIOL, V35, P223, DOI 10.1128/JCM.35.1.223-227.1997; Yamamoto T, 1996, INFECT IMMUN, V64, P1441, DOI 10.1128/IAI.64.4.1441-1445.1996; Yamamoto T, 2000, FEBS LETT, V472, P22, DOI 10.1016/S0014-5793(00)01414-9; Zhang CX, 2010, CLIN VACCINE IMMUNOL, V17, P1859, DOI 10.1128/CVI.00251-10; Zhang WP, 2008, APPL ENVIRON MICROB, V74, P5832, DOI 10.1128/AEM.00893-08; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05; Zhang WP, 2010, INFECT IMMUN, V78, P316, DOI 10.1128/IAI.00497-09	53	16	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43203	10.1371/journal.pone.0043203	http://dx.doi.org/10.1371/journal.pone.0043203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905235	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600059
J	Fernandez-Sanchez, L; Lax, P; Esquiva, G; Martin-Nieto, J; Pinilla, I; Cuenca, N				Fernandez-Sanchez, Laura; Lax, Pedro; Esquiva, Gema; Martin-Nieto, Jose; Pinilla, Isabel; Cuenca, Nicolas			Safranal, a Saffron Constituent, Attenuates Retinal Degeneration in P23H Rats	PLOS ONE			English	Article							CROCUS-SATIVUS L.; DOMINANT RETINITIS-PIGMENTOSA; PHOTORECEPTOR CELL-DEATH; INDUCED OXIDATIVE DAMAGE; ISCHEMIA-REPERFUSION; ACTIVE CONSTITUENTS; TRANSGENIC RAT; RHODOPSIN GENE; ANIMAL-MODEL; DNA-DAMAGE	Saffron, an extract from Crocus sativus, has been largely used in traditional medicine for its antiapoptotic and anticarcinogenic properties. In this work, we investigate the effects of safranal, a component of saffron stigmas, in attenuating retinal degeneration in the P23H rat model of autosomal dominant retinitis pigmentosa. We demonstrate that administration of safranal to homozygous P23H line-3 rats preserves both photoreceptor morphology and number. Electroretinographic recordings showed higher a- and b-wave amplitudes under both photopic and scotopic conditions in safranal-treated versus non-treated animals. Furthermore, the capillary network in safranal-treated animals was preserved, unlike that found in untreated animals. Our findings indicate that dietary supplementation with safranal slows photoreceptor cell degeneration and ameliorates the loss of retinal function and vascular network disruption in P23H rats. This work also suggests that safranal could be potentially useful to retard retinal degeneration in patients with retinitis pigmentosa.	[Fernandez-Sanchez, Laura; Lax, Pedro; Esquiva, Gema; Martin-Nieto, Jose; Cuenca, Nicolas] Univ Alicante, Dept Physiol Genet & Microbiol, E-03080 Alicante, Spain; [Pinilla, Isabel] Univ Hosp Lozano Blesa, Dept Ophthalmol, Zaragoza, Spain	Universitat d'Alacant; Lozano Blesa University Clinical Hospital	Fernandez-Sanchez, L (corresponding author), Univ Alicante, Dept Physiol Genet & Microbiol, E-03080 Alicante, Spain.	cuenca@ua.es	MARTÍN-NIETO, JOSÉ/R-5428-2018; Esquiva, Gema/ABA-6317-2020; Cuenca, Nicolas/I-2007-2015; Fernandez-Sanchez, Laura/AAB-5663-2019; Lax, Pedro/M-9074-2014; Esquiva, Gema/AAE-5642-2020	MARTÍN-NIETO, JOSÉ/0000-0002-7815-6887; Cuenca, Nicolas/0000-0002-6767-5710; Fernandez-Sanchez, Laura/0000-0002-3629-0156; Lax, Pedro/0000-0001-6931-1008; Esquiva, Gema/0000-0002-3951-6464; Pinilla, Isabel/0000-0003-0349-9997	Spanish Government [BFU2009-07793/BFI, RETICS RD07/0062/0012]; Organizacion Nacional de Ciegos de Espana (ONCE); Fundacion Lucha contra la Ceguera (FUNDALUCE); Fundacion Medica Mutua Madrilena	Spanish Government(Spanish GovernmentEuropean Commission); Organizacion Nacional de Ciegos de Espana (ONCE); Fundacion Lucha contra la Ceguera (FUNDALUCE); Fundacion Medica Mutua Madrilena(Instituto de Salud Carlos III)	This research was supported by grants from the Spanish Government (BFU2009-07793/BFI and RETICS RD07/0062/0012), Organizacion Nacional de Ciegos de Espana (ONCE), Fundacion Lucha contra la Ceguera (FUNDALUCE) and Fundacion Medica Mutua Madrilena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev FI, 2004, CANCER DETECT PREV, V28, P426, DOI 10.1016/j.cdp.2004.09.002; Abdullaev FI, 2002, EXP BIOL MED, V227, P20, DOI 10.1177/153537020222700104; Assimopoulou AN, 2005, PHYTOTHER RES, V19, P997, DOI 10.1002/ptr.1749; Basti AA, 2007, PROG NEURO-PSYCHOPH, V31, P439, DOI 10.1016/j.pnpbp.2006.11.010; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; Beutelspacher SC, 2011, GRAEF ARCH CLIN EXP, V249, P1855, DOI 10.1007/s00417-011-1757-y; Bharti S, 2011, EUR J NUTR; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Escribano J, 2000, PLANTA MED, V66, P157, DOI 10.1055/s-2000-11127; Escribano J, 1996, CANCER LETT, V100, P23, DOI 10.1016/0304-3835(95)04067-6; Falsini B, 2010, INVEST OPHTH VIS SCI, V51, P6118, DOI 10.1167/iovs.09-4995; Fatehi M, 2003, J ETHNOPHARMACOL, V84, P199, DOI 10.1016/S0378-8741(02)00299-4; Fernandez-Sanchez L, 2011, INVEST OPHTH VIS SCI, V52, P4998, DOI 10.1167/iovs.11-7496; Garcia-Ayuso D, 2010, EXP EYE RES; Hariri AT, 2011, PHYTOMEDICINE, V18, P499, DOI 10.1016/j.phymed.2010.10.001; Haverkamp S, 2000, CELL TISSUE RES, V302, P11, DOI 10.1007/s004410000267; Hosseinzadeh H, 2005, J PHARM PHARM SCI, V8, P394; Hosseinzadeh H, 2005, J PHARM PHARM SCI, V8, P387; Hosseinzadeh H, 2005, FITOTERAPIA, V76, P722, DOI 10.1016/j.fitote.2005.07.008; Hosseinzadeh H, 2011, PHYTOTHER RES; Hosseinzadeh H, 2008, DNA CELL BIOL, V27, P657, DOI 10.1089/dna.2008.0767; Hosseinzadeh H, 2007, DNA CELL BIOL, V26, P841, DOI 10.1089/dna.2007.0631; Hosseinzadeh Hossein, 2002, BMC Pharmacol, V2, P7; Hosseinzadeh H, 2009, EVID-BASED COMPL ALT, V6, P343, DOI 10.1093/ecam/nem125; Hosseinzadeh H, 2009, PHYTOTHER RES, V23, P768, DOI 10.1002/ptr.2597; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Imenshahidi M, 2010, PHYTOTHER RES, V24, P990, DOI 10.1002/ptr.3044; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Kanakis CD, 2009, J PHOTOCH PHOTOBIO B, V95, P204, DOI 10.1016/j.jphotobiol.2009.03.006; Kanakis CD, 2007, DNA CELL BIOL, V26, P63, DOI 10.1089/dna.2006.0529; Kanakis CD, 2007, J AGR FOOD CHEM, V55, P970, DOI 10.1021/jf062638l; Karimi E, 2010, MOLECULES, V15, P6244, DOI 10.3390/molecules15096244; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kolomiets B, 2010, NEUROBIOL DIS, V38, P47, DOI 10.1016/j.nbd.2009.12.025; Komeima K, 2007, J CELL PHYSIOL, V213, P809, DOI 10.1002/jcp.21152; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Laabich A, 2006, INVEST OPHTH VIS SCI, V47, P3156, DOI 10.1167/iovs.05-1621; Lax P, 2011, J PINEAL RES, V50, P183, DOI 10.1111/j.1600-079X.2010.00827.x; Maccarone R, 2008, INVEST OPHTH VIS SCI, V49, P1254, DOI 10.1167/iovs.07-0438; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Mehri S, 2012, CELL MOL NEUROBIOL, V32, P227, DOI 10.1007/s10571-011-9752-8; Miranda M, 2010, FREE RADICAL BIO MED, V48, P216, DOI 10.1016/j.freeradbiomed.2009.10.042; Moghaddasi MS, 2010, J MED PLANTS RES, V4, P427; Ochiai T, 2007, BBA-GEN SUBJECTS, V1770, P578, DOI 10.1016/j.bbagen.2006.11.012; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Penn JS, 2000, INVEST OPHTH VIS SCI, V41, P4007; Pinilla I, 2005, NEUROSCI LETT, V382, P16, DOI 10.1016/j.neulet.2005.02.055; Pinilla I, 2009, VISION RES, V49, P2067, DOI 10.1016/j.visres.2009.05.014; Pinilla I, 2007, EXP EYE RES, V85, P381, DOI 10.1016/j.exer.2007.06.002; Pitsikas N, 2008, PHYTOMEDICINE, V15, P1135, DOI 10.1016/j.phymed.2008.06.005; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Soeda S, 2001, LIFE SCI, V69, P2887, DOI 10.1016/S0024-3205(01)01357-1	57	67	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43074	10.1371/journal.pone.0043074	http://dx.doi.org/10.1371/journal.pone.0043074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900092	Green Published, gold			2022-12-27	WOS:000307380900110
J	McMullan, M; van Oosterhout, C				McMullan, Mark; van Oosterhout, Cock			Inference of Selection Based on Temporal Genetic Differentiation in the Study of Highly Polymorphic Multigene Families	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MHC CLASS-IIB; FREQUENCY-DEPENDENT SELECTION; BALANCING SELECTION; ALLELE FREQUENCIES; WILD POPULATIONS; WATER VOLE; DIVERSITY; PATHOGENS; GUPPIES	The co-evolutionary arms race between host immune genes and parasite virulence genes is known as Red Queen dynamics. Temporal fluctuations in allele frequencies, or the 'turnover' of alleles at immune genes, are concordant with predictions of the Red Queen hypothesis. Such observations are often taken as evidence of host-parasite co-evolution. Here, we use computer simulations of the Major Histocompatibility Complex (MHC) of guppies (Poecilia reticulata) to study the turnover rate of alleles (temporal genetic differentiation, G'(ST)). Temporal fluctuations in MHC allele frequencies can be >=<= order of magnitude larger than changes observed at neutral loci. Although such large fluctuations in the MHC are consistent with Red Queen dynamics, simulations show that other demographic and population genetic processes can account for this observation, these include: (1) overdominant selection, (2) fluctuating population size within a metapopulation, and (3) the number of novel MHC alleles introduced by immigrants when there are multiple duplicated genes. Synergy between these forces combined with migration rate and the effective population size can drive the rapid turnover in MHC alleles. We posit that rapid allelic turnover is an inherent property of highly polymorphic multigene families and that it cannot be taken as evidence of Red Queen dynamics. Furthermore, combining temporal samples in spatial F-ST outlier analysis may obscure the signal of selection.	[McMullan, Mark; van Oosterhout, Cock] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	McMullan, M (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	M.Mcmullan@uea.ac.uk		McMullan, Mark/0000-0002-0711-5666; van Oosterhout, Cock/0000-0002-5653-738X	Natural Environment Research Council [NE/E529241/1]; Earth and Life Systems Alliance (ELSA)	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Earth and Life Systems Alliance (ELSA)	Financial support was provided by a Natural Environment Research Council (http://www.nerc.ac.uk/) studentship to MM (NE/E529241/1) and the Earth and Life Systems Alliance (ELSA, http://www.elsa.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2010, MOL ECOL, V19, P691, DOI 10.1111/j.1365-294X.2009.04507.x; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Arkush KD, 2002, CAN J FISH AQUAT SCI, V59, P966, DOI 10.1139/F02-066; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bell G, 1982, MASTERPIECE NATURE E; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; Bryja J, 2007, MOL ECOL, V16, P5084, DOI 10.1111/j.1365-294X.2007.03584.x; Campos JL, 2010, MAMM BIOL, V76, P251; Charbonnel N, 2005, HEREDITY, V95, P377, DOI 10.1038/sj.hdy.6800735; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Dionne M, 2007, EVOLUTION, V61, P2154, DOI 10.1111/j.1558-5646.2007.00178.x; DOHERTY PC, 1975, LANCET, V1, P1406, DOI 10.1016/S0140-6736(75)92610-0; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Eimes JA, 2011, J EVOLUTION BIOL, V24, P1847, DOI 10.1111/j.1420-9101.2011.02311.x; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; Ejsmond MJ, 2011, CONSERV GENET, V12, P129, DOI 10.1007/s10592-009-9998-6; Ford MJ, 2002, MOL ECOL, V11, P1245, DOI 10.1046/j.1365-294X.2002.01536.x; Fraser BA, 2009, J FISH BIOL, V75, P2299, DOI 10.1111/j.1095-8649.2009.02449.x; Fraser BA, 2010, EVOLUTION, V64, P2086, DOI 10.1111/j.1558-5646.2010.00965.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jensen LF, 2008, HEREDITY, V100, P79, DOI 10.1038/sj.hdy.6801067; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; KOJIMA KI, 1971, EVOLUTION, V25, P281, DOI [10.2307/2406919, 10.1111/j.1558-5646.1971.tb01881.x]; Llaurens V, 2012, MOL BIOL EVOL, V29, P1631, DOI 10.1093/molbev/mss012; Llaurens V, 2008, EVOLUTION, V62, P2545, DOI 10.1111/j.1558-5646.2008.00469.x; McMullan M, 2011, THESIS U HULL; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Muirhead CA, 2001, EVOLUTION, V55, P1532; Nei M, 2005, MOL BIOL EVOL, V22, P2318, DOI 10.1093/molbev/msi242; Oliver MK, 2009, MOL ECOL, V18, P80, DOI 10.1111/j.1365-294X.2008.04015.x; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; Schierup MH, 1998, GENETICS, V149, P1153; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Stoeckel S, 2012, EVOLUTION, V66, P486, DOI 10.1111/j.1558-5646.2011.01457.x; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Tollenaere C, 2008, J EVOLUTION BIOL, V21, P1307, DOI 10.1111/j.1420-9101.2008.01563.x; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; van Oers K, 2010, J ORNITHOL, V151, P69, DOI 10.1007/s10336-009-0427-x; van Oosterhout C, 2007, INT J PARASITOL, V37, P805, DOI 10.1016/j.ijpara.2006.12.016; van Oosterhout C, 2006, HEREDITY, V97, P111, DOI 10.1038/sj.hdy.6800843; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; van Oosterhout C, 2009, P ROY SOC B-BIOL SCI, V276, P657, DOI 10.1098/rspb.2008.1299; Westerdahl H, 2004, J EVOLUTION BIOL, V17, P485, DOI 10.1111/j.1420-9101.2004.00711.x; Westerdahl H, 2011, P ROYAL SOC B; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569	54	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42119	10.1371/journal.pone.0042119	http://dx.doi.org/10.1371/journal.pone.0042119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900006	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000307380900021
J	Moffatt, S; Noble, E; White, M				Moffatt, Suzanne; Noble, Emma; White, Martin			Addressing the Financial Consequences of Cancer: Qualitative Evaluation of a Welfare Rights Advice Service	PLOS ONE			English	Article							OLDER; CARE; PERCEPTIONS; DISABILITY; BENEFITS; HEALTH; BREAST; LUNG	Background: The onset, treatment and trajectory of cancer is associated with financial stress among patients across a range of health and welfare systems and has been identified as a significant unmet need. Welfare rights advice can be delivered effectively in healthcare settings, has the potential to alleviate financial stress, but has not yet been evaluated. We present an evaluation of a welfare rights advice intervention designed to address the financial consequences of cancer. Methods: Descriptive study of welfare outcomes among 533 male and 641 female cancer patients and carers aged 4-95 (mean 62) years, who accessed the welfare rights advice service in North East England between April 2009 and March 2010; and qualitative interview study of a maximum variation sample of 35 patients and 9 carers. Results: Over two thirds of cancer patients and carers came from areas of high socio-economic deprivation. Welfare benefit claims were successful for 96% of claims made and resulted in a median increase in weekly income of 70.30 pound ($109.74, (sic)84.44). Thirty-four different types of benefits or grants were awarded. Additional resources were perceived to lessen the impact of lost earnings, help offset costs associated with cancer, reduce stress and anxiety and increase ability to maintain independence and capacity to engage in daily activities, all of which were perceived to impact positively on well-being and quality of life. Key barriers to accessing benefit entitlements were knowledge, system complexity, eligibility concerns and assumptions that health professionals would alert patients to entitlements. Conclusions: The intervention proved feasible, effectively increased income for cancer patients and was highly valued. Addressing the financial sequelae of cancer can have positive social and psychological consequences that could significantly enhance effective clinical management and suitable services should be routinely available. Further research is needed to evaluate health outcomes definitely and assess cost-effectiveness.	[Moffatt, Suzanne; Noble, Emma; White, Martin] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Moffatt, S (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	suzanne.moffatt@ncl.ac.uk		Moffatt, Suzanne/0000-0002-8553-249X; White, Martin/0000-0002-1861-6757	Macmillan Cancer Support; MRC [G0900686] Funding Source: UKRI; Medical Research Council [G0900686] Funding Source: researchfish	Macmillan Cancer Support; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Macmillan Cancer Support funded this study. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acheson D., 1998, INDEPENDENT INQUIRY; Adams J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-81; [Anonymous], 2010, MARMOT REV; [Anonymous], 2007, INDICES DEPRIVATION; [Anonymous], 2009, STAT PACKAGE SOCIAL; Arber S., 1995, CONNECTING GENDER AG; Argyle E, 2001, DISABIL SOC, V16, P585, DOI 10.1080/09687590120059559; Association of Public Health Observatories and Department of Health, 2009, HLTH SUMM COUNT DURH; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Brennan Shannon, 2011, JURISTATE B, P1; Chapple A, 2004, BRIT J GEN PRACT, V54, P589; Clayman SE, 1995, SITUATED ORDER STUDI, P1; Cook K, 2010, HEALTH SERV RES, V45, P418, DOI 10.1111/j.1475-6773.2009.01049.x; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; de Boer AGEM, 2009, JAMA-J AM MED ASSOC, V301, P753, DOI 10.1001/jama.2009.187; Denzin N., 1978, RES ACT, V2nd; Eikemo TA, 2008, J EPIDEMIOL COMMUN H, V62, P3, DOI 10.1136/jech.2007.066787; Francoeur RB, 2001, J PSYCHOSOC ONCOL, V19, P1, DOI 10.1300/J077v19n01_01; Francoeur RB, 2007, PATIENT EDUC COUNS, V69, P84, DOI 10.1016/j.pec.2007.07.005; Fraser of Allander Institute, 2003, IMP WELF SPEND GLASG; Glaser B.G., 1968, DISCOV GROUNDED THEO; Green J, 2009, QUALITATIVE METHODS; Hanratty B, 2007, PALLIATIVE MED, V21, P595, DOI 10.1177/0269216307082476; Himmelstein D.U., 2005, HLTH AFF, V24, pW5, DOI 10.1377/hlthaff.W5.63; Kogevinas M, 1997, IARC Sci Publ, P177; Lauzier S, 2008, J NATL CANCER I, V100, P321, DOI 10.1093/jnci/djn028; Macmillan Cancer Relief, 2004, UNCL MILL; Mayer DK, 2009, CLIN J ONCOL NURS, V13, P255, DOI 10.1188/09.CJON.255-256; McKee M, 2011, BMJ, P343; Men's Health Forum, 2009, CHALL CHOIC IMPR HLT; Moffatt S, 2008, AGEING SOC, V28, P875, DOI 10.1017/S0144686X08007253; Moffatt S, 2009, ETHNIC HEALTH, V14, P5, DOI 10.1080/13557850802056455; National Audit Office, 2005, DEP WORK PENS DEAL C; National Cancer Action Team, 2007, HOL COMM ASS SUPP PA; National Institute for Health and Clinical Excellence, 2004, IMPR SUPP PALL CAR P; National League Against Cancer, 2021, PAT RESS CANC EXP PA; Northern and Yorkshire Cancer Registry and Information Service, 2008, COUNT DURH PCT FACTS; Nosowska G, 2004, HEALTH SOC CARE COMM, V12, P283, DOI 10.1111/j.1365-2524.2004.00496.x; PARIS JAG, 1993, BRIT MED J, V306, P1518, DOI 10.1136/bmj.306.6891.1518; Pearce S, 1999, J ADV NURS, V33, P317; QSR International, 2007, NVIVO 7 COMP ASS SOF; Quinn MJ, 2001, STUDIES MED POPULATI; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rosengren A, 2004, EUR J EPIDEMIOL, V19, P533, DOI 10.1023/B:EJEP.0000032370.56821.71; Shack L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-271; Silverman D., 2017, DOING QUALITATIVE RE, V5th; Singh GK, 2003, 035417 NAT CANC I; Smith AE, 2004, AGEING SOC, V24, P793, DOI 10.1017/S0144686X04002569; Soothill K, 2001, SUPPORT CARE CANCER, V9, P597, DOI 10.1007/s005200100278; Syse Astri, 2008, J Cancer Surviv, V2, P149, DOI 10.1007/s11764-008-0053-2; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Welch LC, 2005, J AM GERIATR SOC, V53, P1145, DOI 10.1111/j.1532-5415.2005.53357.x; Wilson K, 2008, PSYCHO-ONCOLOGY, V17, P421, DOI 10.1002/pon.1265; Wintour P, 2011, GUARDIAN, P1; Wright EP, 2002, BRIT J CANCER, V87, P1099, DOI 10.1038/sj.bjc.6600642	55	31	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42979	10.1371/journal.pone.0042979	http://dx.doi.org/10.1371/journal.pone.0042979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986XO	22900073	gold, Green Published, Green Submitted			2022-12-27	WOS:000307380900091
J	Schumacher, A; Wafula, PO; Teles, A; El-Mousleh, T; Linzke, N; Zenclussen, ML; Langwisch, S; Heinze, K; Wollenberg, I; Casalis, PA; Volk, HD; Fest, S; Zenclussen, AC				Schumacher, Anne; Wafula, Paul Ojiambo; Teles, Ana; El-Mousleh, Tarek; Linzke, Nadja; Zenclussen, Maria Laura; Langwisch, Stefanie; Heinze, Kristina; Wollenberg, Ivonne; Casalis, Pablo Ariel; Volk, Hans-Dieter; Fest, Stefan; Zenclussen, Ana Claudia			Blockage of Heme Oxygenase-1 Abrogates the Protective Effect of Regulatory T Cells on Murine Pregnancy and Promotes the Maturation of Dendritic Cells	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; ALLOGENEIC PREGNANCY; SPONTANEOUS-ABORTION; ZINC-PROTOPORPHYRIN; PATERNAL ANTIGENS; FETAL REJECTION; CARBON-MONOXIDE; EXPRESSION; TOLERANCE; SUPPRESSION	Regulatory T cells (Treg) play an important role in fetal protection. They expand during normal pregnancy and protect fetal antigens from maternal effector cells. Their effect is associated with the up-regulation of tolerance-associated molecules at the fetal-maternal interface. Among these, Heme Oxygenase-1 (HO-1, coded by Hmox1) is of special importance as its blockage correlates with increased abortion rates and its up-regulation positively affects pregnancy outcome. Here, we aimed to investigate whether the protective effect of Treg is mediated by HO-1 in a mouse model. HO-1 blockage by Zinc Protoporhyrin (ZnPPIX) abrogated the protective effect of Treg transfer. We found that HO-1 is important in maintaining maternal dendritic cells (DCs) in an immature state, which contributes to the expansion of the peripheral Treg population. This brings to light one essential pathway through which Treg mediates the semi-allogeneic fetus tolerance.	[Schumacher, Anne; Teles, Ana; El-Mousleh, Tarek; Linzke, Nadja; Zenclussen, Maria Laura; Langwisch, Stefanie; Heinze, Kristina; Zenclussen, Ana Claudia] Univ Magdeburg, Dept Expt Obstet & Gynaecol, Fac Med, D-39106 Magdeburg, Germany; [Wafula, Paul Ojiambo; Wollenberg, Ivonne; Casalis, Pablo Ariel; Volk, Hans-Dieter; Zenclussen, Ana Claudia] Med Univ Berlin, Inst Med Immunol, Charite, Berlin, Germany; [Fest, Stefan] Univ Klinikum Leipzig, Leipzig, Germany	Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University	Schumacher, A (corresponding author), Univ Magdeburg, Dept Expt Obstet & Gynaecol, Fac Med, D-39106 Magdeburg, Germany.	ana.zenclussen@med.ovgu.de	Schumacher, Anne/AAG-6028-2021; Zenclussen, Ana/AAE-8760-2020; volk, hans-dieter/AAV-8053-2021; Zenclussen, Ana C/G-2186-2013	Zenclussen, Ana/0000-0003-3544-4552; volk, hans-dieter/0000-0002-7743-6668; Zenclussen, Ana C/0000-0003-3544-4552; Zenclussen, Maria Laura/0000-0003-2728-080X	German Research Association [DFG ZE-526/4-1, 526/5-1, DFG FE 914/2-1]; German Academic Exchange Program (DAAD); FCT foundation, Portugal	German Research Association(German Research Foundation (DFG)); German Academic Exchange Program (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); FCT foundation, Portugal	The present study was supported by grants from the German Research Association to ACZ (DFG ZE-526/4-1 and 526/5-1) and to SF (DFG FE 914/2-1). POW was funded by a PhD grant from the German Academic Exchange Program (DAAD) and Ana Teles is a grantee from the FCT foundation, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Bach FH, 1997, NAT MED, V3, P196, DOI 10.1038/nm0297-196; Biburger M, 2010, J LEUKOCYTE BIOL, V87, P192, DOI 10.1189/jlb.0508280; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Braudeau C, 2004, GENE THER, V11, P701, DOI 10.1038/sj.gt.3302208; Brusko TM, 2005, J IMMUNOL, V174, P5181, DOI 10.4049/jimmunol.174.9.5181; Chaouat G, 2001, AM J REPROD IMMUNOL, V45, P108, DOI 10.1111/j.8755-8920.2001.450208.x; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Choi BM, 2005, BIOCHEM BIOPH RES CO, V327, P1066, DOI 10.1016/j.bbrc.2004.12.106; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; CLARK DA, 1980, CELL IMMUNOL, V52, P106, DOI 10.1016/0008-8749(80)90404-9; COULAM CB, 1991, AM J REPROD IMMUNOL, V26, P23, DOI 10.1111/j.1600-0897.1991.tb00697.x; Critchley WR, 2012, IMMUNOLOGY, V136, P123, DOI 10.1111/j.1365-2567.2012.03560.x; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Denschlag D, 2004, MOL HUM REPROD, V10, P211, DOI 10.1093/molehr/gah024; Drechsler Y, 2006, J IMMUNOL, V177, P2592, DOI 10.4049/jimmunol.177.4.2592; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; George JF, 2008, AM J PATHOL, V173, P154, DOI 10.2353/ajpath.2008.070963; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hu CM, 2007, DIABETES, V56, P1240, DOI 10.2337/db06-0495; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Inoue S, 2001, HUM GENE THER, V12, P967, DOI 10.1089/104303401750195926; Josien R, 1998, J CLIN INVEST, V102, P1920, DOI 10.1172/JCI4221; Katori M, 2002, TRANSPLANTATION, V73, P287, DOI 10.1097/00007890-200201270-00023; Kotsch K, 2007, ANTIOXID REDOX SIGN, V9, P2049, DOI 10.1089/ars.2007.1801; Labbe RF, 1999, CLIN CHEM, V45, P2060; Leber A, 2011, METHODS MOL BIOL, V677, P397, DOI 10.1007/978-1-60761-869-0_25; LIN H, 1993, J IMMUNOL, V151, P4562; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lyall F, 2000, FASEB J, V14, P208, DOI 10.1096/fasebj.14.1.208; Mahnke K, 2007, J DERMATOL SCI, V46, P159, DOI 10.1016/j.jdermsci.2007.03.002; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1981, BIOCHIM BIOPHYS ACTA, V673, P339, DOI 10.1016/0304-4165(81)90465-7; Makrigiannakis A, 2003, BIOCHEM PHARMACOL, V65, P917, DOI 10.1016/S0006-2952(02)01547-2; Martins PNA, 2005, TRANSPL P, V37, P384, DOI 10.1016/j.transproceed.2005.01.004; McDaid J, 2005, FASEB J, V19, P458, DOI 10.1096/fj.04-2217fje; Moreau A, 2009, FASEB J, V23, P3070, DOI 10.1096/fj.08-128173; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Robillard PY, 2002, J REPROD IMMUNOL, V53, P279, DOI 10.1016/S0165-0378(01)00081-X; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; SAINTEMARIE G, 1962, J HISTOCHEM CYTOCHEM, V10, P250, DOI 10.1177/10.3.250; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Schumacher A, 2007, OBSTET GYNECOL, V110, P1137, DOI 10.1097/01.AOG.0000284625.10175.31; Shima T, 2010, J REPROD IMMUNOL, V85, P121, DOI 10.1016/j.jri.2010.02.006; Shojaeian J, 2007, J REPROD IMMUNOL, V75, P23, DOI 10.1016/j.jri.2007.02.006; Soares MP, 1999, IMMUNOL TODAY, V20, P434, DOI 10.1016/S0167-5699(99)01530-3; Soares MP, 2009, CURR OPIN PHARMACOL, V9, P1; Sollwedel A, 2005, J IMMUNOL, V175, P4875, DOI 10.4049/jimmunol.175.8.4875; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Svensson L, 2001, J REPROD IMMUNOL, V51, P3, DOI 10.1016/S0165-0378(01)00065-1; Thuere C, 2007, AM J REPROD IMMUNOL, V58, P514, DOI 10.1111/j.1600-0897.2007.00538.x; Yamashita K, 2006, FASEB J, V20, P776, DOI 10.1096/fj.05-4791fje; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Zelenay S, 2007, INT IMMUNOL, V19, P11, DOI 10.1093/intimm/dxl116; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4; Zenclussen AC, 2006, EUR J IMMUNOL, V36, P82, DOI 10.1002/eji.200535428; Zenclussen AC, 2005, INT IMMUNOPHARMACOL, V5, P41, DOI 10.1016/j.intimp.2004.09.011; Zenclussen ML, 2012, AM J REPROD IMMUNOL, V67, P376, DOI 10.1111/j.1600-0897.2011.01096.x; Zenclussen ML, 2011, J PATHOL, V225, P293, DOI 10.1002/path.2946; Zenclussen ML, 2006, J REPROD IMMUNOL, V69, P35, DOI 10.1016/j.jri.2005.10.001; Zhao H, 2009, PLACENTA, V30, P861, DOI 10.1016/j.placenta.2009.07.012	66	71	74	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42301	10.1371/journal.pone.0042301	http://dx.doi.org/10.1371/journal.pone.0042301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900010	gold, Green Submitted, Green Published			2022-12-27	WOS:000307380900027
J	Takenaka, M; Tiriveedhi, V; Subramanian, V; Hoshinaga, K; Patterson, AG; Mohanakumar, T				Takenaka, Masashi; Tiriveedhi, Venkataswarup; Subramanian, Vijay; Hoshinaga, Kiyotaka; Patterson, Alexander G.; Mohanakumar, Thalachallour			Antibodies to MHC Class II Molecules Induce Autoimmunity: Critical Role for Macrophages in the Immunopathogenesis of Obliterative Airway Disease	PLOS ONE			English	Article							LUNG ALLOGRAFT-REJECTION; REGULATORY T-CELLS; BRONCHIOLITIS OBLITERANS; TRANSPLANT RECIPIENTS; DENDRITIC CELLS; SELF-ANTIGEN; HLA; ACTIVATION; ALLORECOGNITION; PATHOGENESIS	Previous studies have shown that intrabronchial administration of antibodies (Abs) to MHC class I resulted in development of obliterative airway disease (OAD), a correlate of chronic human lung allograft rejection. Since development of Abs specific to mismatched donor HLA class II have also been associated with chronic human lung allograft rejection, we analyzed the role of Abs to MHC class II in inducing OAD. Administration of MHC class II Abs (M5/114) to C57BL/6 mice induced the classical features of OAD even though MHC class II expression is absent de novo on murine lung epithelial and endothelial cells. The induction of OAD was accompanied by enhanced cellular and humoral immune responses to self-antigens (Collagen V and K- alpha 1Tubulin). Further, lung-infiltrating macrophages demonstrated a switch in their phenotype predominance from M Phi 1 (F4/80(+)CD11c(+)) to M Phi 2 (F4/80(+)CD206(+)) following administration of Abs and prior to development of OAD. Passive administration of macrophages harvested from animals with OAD but not from naive animals induced OAD lesions. We conclude that MHC class II Abs induces a phenotype switch of lung infiltrating macrophages from M Phi 1 (F4/80(+)CD11c(+)) to M Phi 2 (F4/80(+)CD206(+)) resulting in the breakdown of self-tolerance along with an increase in autoimmune Th17 response leading to OAD.	[Takenaka, Masashi; Tiriveedhi, Venkataswarup; Subramanian, Vijay; Patterson, Alexander G.; Mohanakumar, Thalachallour] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Mohanakumar, Thalachallour] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Hoshinaga, Kiyotaka] Fujita Hlth Univ, Sch Med, Dept Urol, Toyoake, Aichi 47011, Japan	Washington University (WUSTL); Washington University (WUSTL); Fujita Health University	Takenaka, M (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.	kumart@wustl.edu			NIH/NHLBI (National Heart, Lung, and Blood Institute)/NIAID (National Institute of Allergy and Infectious Diseases) [HL092514-01A2]; Barnes-Jewish Children's Hospital Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092514] Funding Source: NIH RePORTER	NIH/NHLBI (National Heart, Lung, and Blood Institute)/NIAID (National Institute of Allergy and Infectious Diseases); Barnes-Jewish Children's Hospital Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH/NHLBI (National Heart, Lung, and Blood Institute)/NIAID (National Institute of Allergy and Infectious Diseases) HL092514-01A2 and the Barnes-Jewish Children's Hospital Foundation (TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWELL JD, 1986, J IMMUNOL, V136, P389; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Benichou G, 1996, Int Rev Immunol, V13, P231, DOI 10.3109/08830189609061750; Bharat A, 2006, AM J TRANSPLANT, V6, P1799, DOI 10.1111/j.1600-6143.2006.01383.x; Bharat A, 2008, ANN THORAC SURG, V86, P189, DOI 10.1016/j.athoracsur.2008.03.073; Bharat A, 2006, J IMMUNOL, V177, P5631, DOI 10.4049/jimmunol.177.8.5631; Boehler A, 2003, EUR RESPIR J, V22, P1007, DOI 10.1183/09031936.03.00039103; Boisgerault F, 2001, J IMMUNOL, V167, P1891, DOI 10.4049/jimmunol.167.4.1891; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Cihakova D, 2008, AM J PATHOL, V172, P1195, DOI 10.2353/ajpath.2008.070207; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Fall N, 2007, ARTHRITIS RHEUM-US, V56, P3793, DOI 10.1002/art.22981; Fan L, 2011, AM J TRANSPLANT, V11, P911, DOI 10.1111/j.1600-6143.2011.03482.x; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Fukami N, 2009, J IMMUNOL, V182, P309, DOI 10.4049/jimmunol.182.1.309; Girnita AL, 2006, PEDIATR TRANSPLANT, V10, P146, DOI 10.1111/j.1399-3046.2005.00425.x; Hachem RR, 2009, CURR OPIN ORGAN TRAN, V14, P477, DOI 10.1097/MOT.0b013e32832fb981; Hachem Ramsey R, 2004, Semin Thorac Cardiovasc Surg, V16, P350, DOI 10.1053/j.semtcvs.2004.09.011; HALLORAN PF, 1992, TRANSPLANTATION, V53, P550, DOI 10.1097/00007890-199203000-00011; Haque MA, 2002, J IMMUNOL, V169, P1542, DOI 10.4049/jimmunol.169.3.1542; Heeger PS, 2003, AM J TRANSPLANT, V3, P525, DOI 10.1034/j.1600-6143.2003.00123.x; Hele DJ, 2001, RESPIR RES, V2, P169, DOI 10.1186/rr55; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Irmler I, 2007, Z RHEUMATOL, V66, P17; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Jaramillo A, 1999, TRANSPLANT P, V31, P185, DOI 10.1016/S0041-1345(98)01495-X; Jaramillo A, 2003, HUM IMMUNOL, V64, P521, DOI 10.1016/S0198-8859(03)00038-7; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kreisel D, 2011, AM J TRANSPLANT, V11, P882, DOI 10.1111/j.1600-6143.2011.03483.x; Kreisel D, 2010, J IMMUNOL, V185, P3809, DOI 10.4049/jimmunol.1000971; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; Lu KC, 2003, J HEART LUNG TRANSPL, V22, P35, DOI 10.1016/S1053-2498(02)00478-3; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Nath DS, 2011, TRANSPLANTATION, V91, P1036, DOI 10.1097/TP.0b013e318211d2f4; Nath DS, 2010, CURR OPIN ORGAN TRAN, V15, P16, DOI 10.1097/MOT.0b013e3283342780; Okazaki M, 2007, AM J TRANSPLANT, V7, P1672, DOI 10.1111/j.1600-6143.2007.01819.x; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Reznik SI, 2001, AM J TRANSPLANT, V1, P228, DOI 10.1034/j.1600-6143.2001.001003228.x; Saadi S, 2002, XENOTRANSPLANTATION, V9, P239, DOI 10.1034/j.1399-3089.2002.02042.x; Saini D, 2011, J HEART LUNG TRANSPL, V30, P624, DOI 10.1016/j.healun.2011.01.708; Saini D, 2010, J HEART LUNG TRANSPL, V29, P1330, DOI 10.1016/j.healun.2010.05.036; Sayegh MH, 1998, NEW ENGL J MED, V338, P1813, DOI 10.1056/NEJM199806183382506; Seetharam A, 2010, CURR OPIN ORGAN TRAN, V15, P531, DOI 10.1097/MOT.0b013e32833b31f4; Siebert H, 2000, J NEUROIMMUNOL, V110, P177, DOI 10.1016/S0165-5728(00)00343-X; Smith MA, 1998, J THORAC CARDIOV SUR, V116, P812, DOI 10.1016/S0022-5223(98)00444-9; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Sundaresan S, 1998, TRANSPLANTATION, V65, P648, DOI 10.1097/00007890-199803150-00008; Tang JL, 2001, TRANSPLANTATION, V72, P348, DOI 10.1097/00007890-200107270-00035; Tiriveedhi V, 2012, CLIN EXP IMMUNOL, V167, P158, DOI 10.1111/j.1365-2249.2011.04486.x; Tiriveedhi V, 2010, DISCOV MED, V9, P229; Vos I H C, 2002, Transpl Infect Dis, V4, P152, DOI 10.1034/j.1399-3062.2002.t01-1-02002.x; Vos R, 2011, EUR RESPIR J, V37, P164, DOI 10.1183/09031936.00068310; Weber J., 2012, J HEART LUNG TRANSPL, V31, P419; Zamilpa R, 2011, AM J PHYSIOL-HEART C, V300, pH1418, DOI 10.1152/ajpheart.01002.2010; Zarkhin V, 2008, TRANSPLANTATION, V85, P1705, DOI 10.1097/TP.0b013e318177793e; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	56	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42370	10.1371/journal.pone.0042370	http://dx.doi.org/10.1371/journal.pone.0042370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900015	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900032
J	Wang, Y; Wang, Y; Zhu, L; Zhou, B; Tang, XX				Wang, Ying; Wang, You; Zhu, Lin; Zhou, Bin; Tang, Xuexi			Comparative Studies on the Ecophysiological Differences of Two Green Tide Macroalgae under Controlled Laboratory Conditions	PLOS ONE			English	Article							SALINITY STRESS; PHOTOSYNTHETIC RESPONSES; ALGAL BLOOMS; YELLOW SEA; ULVA; GROWTH; IRRADIANCE; LIGHT; CHLOROPHYTA; TEMPERATURE	Yellow Sea green tides have occurred in coastal China almost every year from 2007 to 2011. Ulva prolifera (Muller) J. Agardh has been identified as the causative macroalgal species. U. intestinalis, however, has been observed in the bloom areas, co-occurring with U. prolifera, but it has not been found to be causative. The Yellow Sea green tide has shown consistent phases of development that match corresponding environmental changes. U. prolifera, not U. intestinalis, is dominant. Our experimental design was based on these observed phenomena, and the results of our field investigation indicated a close relationship between changes in principal environmental factors (irradiance, temperature, and salinity) and the development of each phase of the bloom. These main environmental factors were simulated to allow estimation and comparison of the physiological responses of U. prolifera and U. intestinalis. Ecophysiological differences were found between these two species. (1) More photosynthetic activity and plasticity were detected in U. prolifera. (2) U. prolifera was found to be more sensitive to dynamic environments, especially harsh and changing environmental conditions. U. intestinalis was found to be more stable, probably due to the higher stress tolerance given by its antioxidant system. (3) Markedly higher nutrient absorption activity was observed in U. prolifera. Comparisons of the ecophysiological traits of these two species in this present study may foster understanding of their natural ecological processes. Specifically, U. prolifera seemed to be more engaged with the ephemeral blooms, while U. intestinalis seemed to be directed toward persistence. This also suggests that the ecological success of U. prolifera may be inextricably linked to its higher capacity for photosynthesis, nutrient absorption, and nutrient assimilation.	[Wang, Ying; Wang, You; Zhu, Lin; Zhou, Bin; Tang, Xuexi] Ocean Univ China, Coll Marine Life Sci, Dept Marine Ecol, Qingdao, Peoples R China	Ocean University of China	Wang, Y (corresponding author), Ocean Univ China, Coll Marine Life Sci, Dept Marine Ecol, Qingdao, Peoples R China.	tangxx@ouc.edu.cn	Wang, Ying/L-6963-2018	Wang, Ying/0000-0002-9940-7606	National Natural Science Foundation of China [3170458]; Research Award Fund for Excellent Young and Middle-aged Scientists of Shandong Province [BS2010HZ024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Award Fund for Excellent Young and Middle-aged Scientists of Shandong Province	This study was supported by the National Natural Science Foundation of China (No. 3170458) and the Research Award Fund for Excellent Young and Middle-aged Scientists of Shandong Province (No. BS2010HZ024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back S, 2000, ANN BOT FENN, V37, P155; Bischof K, 2006, MAR ECOL PROG SER, V306, P165, DOI 10.3354/meps306165; Blomster J, 2002, AM J BOT, V89, P1756, DOI 10.3732/ajb.89.11.1756; Bolam SG, 2000, J EXP MAR BIOL ECOL, V249, P123, DOI 10.1016/S0022-0981(00)00185-4; Choi Tae Seob, 2010, Algae, V25, P17, DOI 10.4490/algae.2010.25.1.017; Choo KS, 2004, J EXP MAR BIOL ECOL, V298, P111, DOI 10.1016/j.jembe.2003.08.007; Cohen RA, 2004, ESTUARIES, V27, P209, DOI 10.1007/BF02803378; Constantin AR, 2010, ADV PHOTOSYNTHESIS R, V31, P379; Eggert A, 2007, PHYCOLOGIA, V46, P22, DOI 10.2216/06-12.1; Figueroa FL, 2003, J PHOTOCH PHOTOBIO B, V72, P35, DOI 10.1016/j.jphotobiol.2003.09.002; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hiraoka M, 2004, HYDROBIOLOGIA, V512, P239, DOI 10.1023/B:HYDR.0000020332.12641.a2; Johansson G, 2002, MAR ECOL PROG SER, V244, P63, DOI 10.3354/meps244063; Kim JH, 2011, J APPL PHYCOL, V23, P421, DOI 10.1007/s10811-010-9590-y; Lambers H, 2008, PLANT PHYSL ECOLOGY, P26; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Leliaert F, 2009, PHYCOL RES, V57, P147, DOI 10.1111/j.1440-1835.2009.00532.x; Liu DY, 2010, MAR POLLUT BULL, V60, P1423, DOI 10.1016/j.marpolbul.2010.05.015; Liu DY, 2009, MAR POLLUT BULL, V58, P888, DOI 10.1016/j.marpolbul.2009.01.013; Liu F, 2010, PHYCOL RES, V58, P270, DOI 10.1111/j.1440-1835.2010.00586.x; Liu F, 2010, J APPL PHYCOL, V22, P531, DOI 10.1007/s10811-009-9489-7; Liu F, 2010, J EXP MAR BIOL ECOL, V382, P82, DOI 10.1016/j.jembe.2009.11.005; Lotze HK, 2000, OIKOS, V89, P46, DOI 10.1034/j.1600-0706.2000.890106.x; Lu IF, 2006, MAR BIOL, V150, P1, DOI 10.1007/s00227-006-0323-3; Luo M, 2011, J EXPT MARINE BIOL E, DOI [10.1016/j.jembe.2011.1008.1023, DOI 10.1016/J.JEMBE.2011.1008.1023]; Mackerness SAH, 1999, J PHOTOCH PHOTOBIO B, V48, P180; Merceron M, 2007, SCI TOTAL ENVIRON, V384, P293, DOI 10.1016/j.scitotenv.2007.05.007; MISHRA NP, 1993, PLANT PHYSIOL, V102, P903, DOI 10.1104/pp.102.3.903; Nelson TA, 2003, BOT MAR, V46, P263, DOI 10.1515/BOT.2003.024; Nelson TA, 2008, ECOLOGY, V89, P1287, DOI 10.1890/07-0494.1; Pardal MA, 2004, MAR ECOL PROG SER, V267, P1, DOI 10.3354/meps267001; PLATT T, 1980, J MAR RES, V38, P687; Poole L.J., 1997, PROGR PHYCOLOGICAL R, V12, P8; Rautenberger R, 2009, REV CHIL HIST NAT, V82, P43, DOI 10.4067/S0716-078X2009000100003; Ross C, 2007, J PHYCOL, V43, P466, DOI 10.1111/j.1529-8817.2007.00346.x; Sun S, 2008, NATURE P; Taylor R, 2001, BOT MAR, V44, P327, DOI 10.1515/BOT.2001.042; THIMIJAN RW, 1983, HORTSCIENCE, V18, P818; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Wang JF, 2010, AQUAT BOT, V93, P25, DOI 10.1016/j.aquabot.2010.03.001; [夏斌 XIA Bin], 2009, [渔业科学进展, Progress in Fishery Sciences], V30, P94; Xia JR, 2004, AQUAT BOT, V80, P129, DOI 10.1016/j.aquabot.2004.07.006; Yabe T, 2009, LIMNOLOGY, V10, P239, DOI 10.1007/s10201-009-0278-4; Ye N, 2008, NATURE P; Yi L, 2010, PERIODICAL OCEAN U C, V40, P15; Young EB, 2005, MAR ECOL PROG SER, V288, P103, DOI 10.3354/meps288103	46	38	47	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e38245	10.1371/journal.pone.0038245	http://dx.doi.org/10.1371/journal.pone.0038245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905087	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100001
J	Savas, S; Hyde, A; Stuckless, SN; Parfrey, P; Younghusband, HB; Green, R				Savas, Sevtap; Hyde, Angela; Stuckless, Susan N.; Parfrey, Patrick; Younghusband, H. Banfield; Green, Roger			Serotonin Transporter Gene (SLC6A4) Variations Are Associated with Poor Survival in Colorectal Cancer Patients	PLOS ONE			English	Article							DUAL ROLES; DEPRESSION; VASOPRESSIN; ANXIETY; LIFE; NEWFOUNDLAND; INFLAMMATION; RECEPTOR; WOMEN; BDNF	Prognosis in colorectal cancer patients is quite variable, even after adjustment for clinical parameters such as disease stage and microsatellite instability status. It is possible that the psychological distress experienced by patients, including anxiety and depression, may be correlated with poor prognosis. In the present study, we hypothesize that genetic variations within three genes biologically linked to the stress response, namely serotonin transporter (SLC6A4), brain-derived neurotrophic factor (BDNF), and arginine vasopressin receptor (AVPR1B) genes are associated with prognosis in colorectal cancer patients. We used a population-based cohort of 280 patients who were followed for up to 12.5 years after diagnosis. Our multivariate analysis showed that a tagSNP in the SLC6A4 gene (rs12150214) was a predictor of shorter overall survival (HR: 1.572, 95% CI: 1.142-2.164, p = 0.005) independent of stage, age, grade and MSI status. Additionally, a multivariate analysis using the combined genotypes of three polymorphisms in this gene demonstrated that the presence of any of the minor alleles at these polymorphic loci was an independent predictor of both shorter overall survival (HR: 1.631, 95% CI: 1.190-2.236, p = 0.002) and shorter disease specific survival (HR: 1.691, 95% CI: 1.138-2.512, p = 0.009). The 5-HTT protein coded by the SLC6A4 gene has also been implicated in inflammation. While our results remain to be replicated in other patient cohorts, we suggest that the genetic variations in the SLC6A4 gene contribute to poor survival in colorectal cancer patients.	[Savas, Sevtap; Hyde, Angela; Younghusband, H. Banfield; Green, Roger] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Savas, Sevtap] Mem Univ Newfoundland, Fac Med, Discipline Oncol, St John, NF, Canada; [Stuckless, Susan N.; Parfrey, Patrick] Mem Univ Newfoundland, Clin Epidemiol Unit, Fac Med, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland	Savas, S (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada.	savas@mun.ca		Savas, Sevtap/0000-0002-7324-938X	Canadian Institute of Health Research Institute of Genetics; Canadian Gene Cure Foundation; Memorial University of Newfoundland; Research and Development Corporation (RDC) of Newfoundland; CIHR; Atlantic Innovation Fund	Canadian Institute of Health Research Institute of Genetics(Canadian Institutes of Health Research (CIHR)); Canadian Gene Cure Foundation; Memorial University of Newfoundland; Research and Development Corporation (RDC) of Newfoundland; CIHR(Canadian Institutes of Health Research (CIHR)); Atlantic Innovation Fund	This work was supported by the Canadian Institute of Health Research Institute of Genetics and the Canadian Gene Cure Foundation, Memorial University of Newfoundland, Research and Development Corporation (RDC) of Newfoundland, Interdisciplinary Team in Colorectal Cancer funded by CIHR, and Interdisciplinary Team in Human Genetics funded by the Atlantic Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Anisman H, 2009, J PSYCHIATR NEUROSCI, V34, P4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker C, 2005, CELL CYCLE, V4, P217; *CAN CANC SOC STEE, 2010, CAN CANC STAT 2010; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chourbaji S, 2011, NEUROSCI BIOBEHAV R, V35, P599, DOI 10.1016/j.neubiorev.2010.07.003; Dempster EL, 2007, ARCH GEN PSYCHIAT, V64, P1189, DOI 10.1001/archpsyc.64.10.1189; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Ferrone C, 2010, J CLIN ONCOL, V28, P4045, DOI 10.1200/JCO.2010.27.9992; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; Griebel G, 2003, CNS NEUROL DISORD-DR, V2, P191, DOI 10.2174/1568007033482850; Gripp S, 2007, J CLIN ONCOL, V25, P3313, DOI 10.1200/JCO.2006.10.5411; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002; Haub S, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01479.x; Haub S, 2010, NEUROGASTROENT MOTIL, V22, pe229; Johansson M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-283; Kirstein M, 2002, CELL MOL LIFE SCI, V59, P1787, DOI 10.1007/PL00012506; Kuechler T, 2007, J CLIN ONCOL, V25, P2702, DOI 10.1200/JCO.2006.08.2883; Landgraf Rainer, 2006, CNS & Neurological Disorders-Drug Targets, V5, P167, DOI 10.2174/187152706776359664; Lazary J, 2008, BIOL PSYCHIAT, V64, P498, DOI 10.1016/j.biopsych.2008.03.030; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Murphy DL, 2011, CURR OPIN PHARMACOL, V11, P3, DOI 10.1016/j.coph.2011.02.008; Okayama A, 2007, ASIAN PAC J CANCER P, V8, P191; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Phillips KA, 2008, J CLIN ONCOL, V26, P4666, DOI 10.1200/JCO.2007.14.8718; Pucci S, 2009, CELL CYCLE, V8, P473, DOI 10.4161/cc.8.3.7652; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Savas S, 2009, HUM MUTAT, V30, P1369, DOI 10.1002/humu.21078; Sharma A, 2007, ANN SURG ONCOL, V14, P3435, DOI 10.1245/s10434-007-9554-x; Sharp T, 2011, CURR OPIN PHARMACOL, V11, P45, DOI 10.1016/j.coph.2011.02.003; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Spiller R, 2008, NEUROPHARMACOLOGY, V55, P1072, DOI 10.1016/j.neuropharm.2008.07.016; Su SY, 2009, CIRC-CARDIOVASC GENE, V2, P614, DOI 10.1161/CIRCGENETICS.109.870386; Surget A, 2008, EUR J PHARMACOL, V583, P340, DOI 10.1016/j.ejphar.2007.11.065; Ugnat AM, 2005, EUR J CANCER PREV, V14, P91, DOI 10.1097/00008469-200504000-00004; Wein S, 2010, CANCER J, V16, P493, DOI 10.1097/PPO.0b013e3181f28b64; Weinberger T, 2010, PSYCHIAT CLIN N AM, V33, P409, DOI 10.1016/j.psc.2010.01.005; Woods MO, 2005, CLIN CANCER RES, V11, P6853, DOI 10.1158/1078-0432.CCR-05-0726; Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651	42	20	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e38953	10.1371/journal.pone.0038953	http://dx.doi.org/10.1371/journal.pone.0038953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911682	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300002
J	Kumar, M; Liu, HB; Rice, AP				Kumar, Manish; Liu, Hongbing; Rice, Andrew P.			Regulation of Interferon-beta by MAGI-1 and Its Interaction with Influenza A Virus NS1 Protein with ESEV PBM	PLOS ONE			English	Article							ANTIVIRAL SIGNALING PROTEIN; PRE-MESSENGER-RNAS; PDZ-BINDING MOTIF; X-RAY-STRUCTURE; NF-KAPPA-B; RIG-I; INNATE IMMUNITY; UBIQUITIN LIGASE; EFFECTOR DOMAIN; ADAPTER PROTEIN	The NS1 protein from avian influenza A viruses contains a PDZ binding motif (PBM) at its carboxyl terminus with the consensus sequence ESEV. The ESEV PBM confers binding to several cellular PDZ proteins, including Dlg1, MAGI-1 and Scribble. The interaction between NS1 and Scribble protects infected cells from apoptosis, while the interaction between NS1 and both Dlg1 and Scribble disrupts tight junctions. In this study, we examined the MAGI-1 protein. We made the unexpected observation that siRNA depletion of MAGI-1 activates IRF3 and induces the IFN-beta promoter. We found that the ESEV NS1 protein sequesters MAGI-1 away from the plasma membrane in infected cells. Using plasmid vectors to express NS1 proteins, we observed that the ESEV PBM elicits an IFN-beta induction signal as indicated by activation of IRF3 and a relative deficiency in NS1 inhibition of induction of the IFN-beta promoter by dsRNA or RIG-I. Taken together, our data suggest that disruption of MAGI-1 by the ESEV PBM activates an IFN-beta induction signal. During viral infection, however, induction of the IFN-beta gene does not occur presumably because other anti-IFN functions dominate over the IFN-activation activity of the ESEV PBM. We postulate that the ESEV PBM's broad binding activity for PDZ proteins may allow NS1 to bind to some PDZ proteins such as MAGI-1 that confer no benefit or may even be detrimental to viral replication. However, the advantage of binding to key PDZ proteins such as Dlg1 and Scribble may dominate and therefore provide an overall benefit for the virus to encode the ESEV PBM.	[Kumar, Manish; Liu, Hongbing; Rice, Andrew P.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine	Kumar, M (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	arice@bcm.edu	Kumar, Manish/F-2497-2012	Kumar, Manish/0000-0003-2209-7547; Rice, Andrew/0000-0002-1237-4769	National Institutes of Health [R21AI083396]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a grant from National Institutes of Health (R21AI083396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Chastre E, 2009, FASEB J, V23, P916, DOI 10.1096/fj.08-106344; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gardiol D, 1998, J GEN VIROL, V79, P1963, DOI 10.1099/0022-1317-79-8-1963; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2008, VIROLOGY, V378, P1, DOI 10.1016/j.virol.2008.05.026; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kranjec C, 2011, J VIROL, V85, P1757, DOI 10.1128/JVI.01756-10; Kuo RL, 2010, VIROLOGY, V408, P146, DOI 10.1016/j.virol.2010.09.012; Laura RP, 2002, EXP CELL RES, V275, P155, DOI 10.1006/excr.2002.5475; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Liu JS, 1997, NAT STRUCT BIOL, V4, P896, DOI 10.1038/nsb1197-896; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ridgway LD, 2009, AM J PHYSIOL-CELL PH, V297, pC55, DOI 10.1152/ajpcell.00073.2009; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Thomas M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-25; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019511; Zaric J, 2011, ONCOGENE; Zhang H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-298; Zielecki F, 2010, J VIROL, V84, P10708, DOI 10.1128/JVI.00610-10	48	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41251	10.1371/journal.pone.0041251	http://dx.doi.org/10.1371/journal.pone.0041251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911767	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600061
J	Seixas, E; Ramalho, JS; Mota, LJ; Barral, DC; Seabra, MC				Seixas, Elsa; Ramalho, Jose S.; Mota, Luis J.; Barral, Duarte C.; Seabra, Miguel C.			Bacteria and Protozoa Differentially Modulate the Expression of Rab Proteins	PLOS ONE			English	Article							PHAGOSOME MATURATION; GTPASES; TRANSLOCATION; TRAFFICKING; FUSION; KISS; GUT	Phagocytic cells represent an important line of innate defense against microorganisms. Uptake of microorganisms by these cells involves the formation of a phagosome that matures by fusing with endocytic compartments, resulting in killing of the enclosed microbe. Small GTPases of the Rab family are key regulators of vesicular trafficking in the endocytic pathway. Intracellular pathogens can interfere with the function of these proteins in order to subvert host immune responses. However, it is unknown if this subversion can be achieved through the modulation of Rab gene expression. We compared the expression level of 23 distinct Rab GTPases in mouse macrophages after infection with the protozoan Plasmodium berghei, and the bacteria Escherichia coli and Salmonella enterica. We found that P. berghei induces an increase in the expression of a different set of Rab genes than E. coli and S. enterica, which behaved similarly. Strikingly, when one of the Rab proteins whose expression was increased by P. berghei, namely Rab14, was silenced, we observed a significant increase in the phagocytosis of P. berghei, whereas Rab14 overexpression led to a decrease in phagocytosis. This suggests that the parasite might induce the increase of Rab14 expression for its own advantage. Similarly, when Rab9a, whose expression was increased by E. coli and S. enterica, was silenced, we observed an increase in the phagocytosis of both bacterial species, whereas Rab9a overexpression caused a reduction in phagocytosis. This further suggests that the modulation of Rab gene expression could represent a mechanism of immune evasion. Thus, our study analyzes the modulation of Rab gene expression induced by bacteria and protozoa and suggests that this modulation could be necessary for the success of microbial infection.	[Seixas, Elsa; Ramalho, Jose S.; Barral, Duarte C.; Seabra, Miguel C.] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1200 Lisbon, Portugal; [Seixas, Elsa; Seabra, Miguel C.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Mota, Luis J.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa	Seixas, E (corresponding author), Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1200 Lisbon, Portugal.	duarte.barral@fcm.unl.pt; miguel.seabra@fcm.unl.pt	Seabra, Miguel C/M-3280-2013; Seabra, Miguel/AAC-3099-2019; Ramalho, Jose/M-6415-2015; Mota, Luis/B-9497-2008; Barral, Duarte/E-7548-2013	Seabra, Miguel C/0000-0002-6404-4892; Ramalho, Jose/0000-0002-1927-164X; Mota, Luis/0000-0002-5592-8397; Barral, Duarte/0000-0001-8867-2407; Seixas, Elsa/0000-0003-2819-2051	Fundacao para a Ciencia e a Tecnologia, Portugal [PEst-OE/EQB/LA0004/2011, PTDC/SAU-MII/104622/2008, SFRH/BPD/34094/2006]; Marie Curie International Reintegration Grant [PIRGOS-GA-2009-247726]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Marie Curie International Reintegration Grant(European Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal through Grants PEst-OE/EQB/LA0004/2011 (to L.J.M.); PTDC/SAU-MII/104622/2008 (to M. C. S.); SFRH/BPD/34094/2006 (to E. S.); and Marie Curie International Reintegration Grant, PIRGOS-GA-2009-247726 (to D. C. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERON W, 1995, TRENDS CELL BIOL, V5, P100, DOI 10.1016/S0962-8924(00)88958-8; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Capmany A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014084; DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8; Diekmann Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002217; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Duclos S, 2000, J CELL SCI, V113, P3531; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kohler CD, 2011, INT J MED MICROBIOL, V301, P642, DOI 10.1016/j.ijmm.2011.09.006; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Lichtman SM, 2001, J PEDIATR GASTR NUTR, V33, P1, DOI 10.1097/00005176-200107000-00001; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223; Nieuwenhuijzen GAP, 1996, EUR J SURG, V162, P259; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Reddy BS, 2007, CLIN NUTR, V26, P208, DOI 10.1016/j.clnu.2006.10.006; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Seixas E, 2009, EUR J IMMUNOL, V39, P1850, DOI 10.1002/eji.200838403; SHEAR HL, 1989, J IMMUNOL, V143, P2038; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; Stenmark H, 2001, GENOME BIOL, V2; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; URQUHART AD, 1994, CLIN INFECT DIS, V19, P117, DOI 10.1093/clinids/19.1.117; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691	31	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39858	10.1371/journal.pone.0039858	http://dx.doi.org/10.1371/journal.pone.0039858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911692	Green Published, Green Submitted, gold			2022-12-27	WOS:000306644600011
J	Duong, T; Jourdain, G; Ngo-Giang-Huong, N; Le Coeur, S; Kantipong, P; Buranabanjasatean, S; Leenasirimakul, P; Ariyadej, S; Tansuphasawasdikul, S; Thongpaen, S; Lallemant, M				Trinh Duong; Jourdain, Gonzague; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie; Kantipong, Pacharee; Buranabanjasatean, Sudanee; Leenasirimakul, Prattana; Ariyadej, Sriprapar; Tansuphasawasdikul, Somboon; Thongpaen, Suchart; Lallemant, Marc		Program HIV Prevention Treatment P	Laboratory and Clinical Predictors of Disease Progression following Initiation of Combination Therapy in HIV-Infected Adults in Thailand	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TO-CHILD TRANSMISSION; CD4 CELL COUNT; HIV-1-INFECTED PATIENTS; PROGNOSTIC IMPORTANCE; TREATMENT PROGRAMS; EARLY MORTALITY; SEVERE ANEMIA; CARE PROGRAM; SOUTH-AFRICA	Background: Data on determinants of long-term disease progression in HIV-infected patients on antiretroviral therapy (ART) are limited in low and middle-income settings. Methods: Effects of current CD4 count, viral load and haemoglobin and diagnosis of AIDS-defining events (ADEs) after start of combination ART (cART) on death and new ADEs were assessed using Poisson regression, in patient aged >= 18 years within a multi-centre cohort in Thailand. Results: Among 1,572 patients, median follow-up from cART initiation was 4.4 (IQR 3.6-6.3) years. The analysis of death was based on 60 events during 6,573 person-years; 30/50 (60%) deaths with underlying cause ascertained were attributable to infections. Analysis of new ADE included 192 events during 5,865 person-years; TB and Pneumocystis jiroveci pneumonia were the most commonly presented first new ADE (35% and 20% of cases, respectively). In multivariable analyses, low current CD4 count after starting cART was the strongest predictor of death and of new ADE. Even at CD4 above 200 cells/mm 3, survival improved steadily with CD4, with mortality rare at >= 500 cells/mm 3 (rate 1.1 per 1,000 person-years). Haemoglobin had a strong independent effect, while viral load was weakly predictive with poorer prognosis only observed at >= 100,000 copies/ml. Mortality risk increased following diagnosis of ADEs during cART. The decline in mortality rate with duration on cART (from 21.3 per 1,000 person-years within first 6 months to 4.7 per 1,000 person-years at >= 36 months) was accounted for by current CD4 count. Conclusions: Patients with low CD4 count or haemoglobin require more intensive diagnostic and treatment of underlying causes. Maintaining CD4 >= 500 cells/mm(3) minimizes mortality. However, patient monitoring could potentially be relaxed at high CD4 count if resources are limited. Optimal ART monitoring strategies in low-income settings remain a research priority. Better understanding of the aetiology of anaemia in patients on ART could guide prevention and treatment.	[Trinh Duong; Jourdain, Gonzague; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie; Lallemant, Marc] Inst Rech Dev IRD, UMI 174, Paris, France; [Trinh Duong] Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1E 7HT, England; [Jourdain, Gonzague; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie; Lallemant, Marc] Chiang Mai Univ, Fac Associated Med Sci, Chiang Mai 50000, Thailand; [Jourdain, Gonzague; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie; Lallemant, Marc] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Le Coeur, Sophie] Univ Paris Descartes INED IRD, Inst Rech Dev, CEPED, UMR 196, Paris, France; [Kantipong, Pacharee] Chiang Rai Prachanukroh Hosp, Chiang Rai, Thailand; [Buranabanjasatean, Sudanee] Mae Chan Hosp, Chiang Rai, Thailand; [Leenasirimakul, Prattana] Nakornping Hosp, Chiang Mai, Thailand; [Ariyadej, Sriprapar] Rayong Hosp, Rayong, Thailand; [Tansuphasawasdikul, Somboon] Buddhachinaraj Hosp, Phitsanulok, Thailand; [Thongpaen, Suchart] Mahasarakam Hosp, Mahasarakam, Thailand	Institut de Recherche pour le Developpement (IRD); University of London; London School of Hygiene & Tropical Medicine; Chiang Mai University; Harvard University; Harvard T.H. Chan School of Public Health; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD)	Duong, T (corresponding author), Inst Rech Dev IRD, UMI 174, Paris, France.	gonzague.jourdain@phpt.org	Jourdain, Gonzague/F-9117-2017; Ngo-Giang-Huong, Nicole/G-2860-2017	Jourdain, Gonzague/0000-0002-3365-7020; Ngo-Giang-Huong, Nicole/0000-0001-8950-3234	The Global Fund to fight AIDS, Tuberculosis and Malaria Thailand [PR-A-N-008]; Ministry of Public Health, Thailand; Oxfam Great Britain, Thailand; Institut de Recherche pour le Developpement (IRD), France; Institut National d'Etudes Demographiques, France; The Thai International Development Cooperation Agency (TICA), Thailand; Paediatric European Network for the Treatment of AIDS (PENTA)	The Global Fund to fight AIDS, Tuberculosis and Malaria Thailand; Ministry of Public Health, Thailand; Oxfam Great Britain, Thailand; Institut de Recherche pour le Developpement (IRD), France; Institut National d'Etudes Demographiques, France; The Thai International Development Cooperation Agency (TICA), Thailand; Paediatric European Network for the Treatment of AIDS (PENTA)	The treatment, laboratory monitoring and follow up for the patients and data collection are supported by: The Global Fund to fight AIDS, Tuberculosis and Malaria Thailand Grant Round 1 sub recipient PR-A-N-008; Ministry of Public Health, Thailand; Oxfam Great Britain, Thailand; Institut de Recherche pour le Developpement (IRD), France; Institut National d'Etudes Demographiques, France; The Thai International Development Cooperation Agency (TICA), Thailand. TD was funded by the Paediatric European Network for the Treatment of AIDS (PENTA) for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker AG, 2012, CLIN TRIALS IN PRESS; Berhane K, 2004, JAIDS-J ACQ IMM DEF, V37, P1245, DOI 10.1097/01.qai.0000134759.01684.27; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Falster K, 2009, AIDS, V23, P2323, DOI 10.1097/QAD.0b013e328331910c; Fregonese F, 2012, JAIDS-J ACQ IMM DEF, V60, P91, DOI 10.1097/QAI.0b013e31824bd33f; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Harris RJ, 2008, ANTIVIR THER, V13, P959; Hoffmann CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P269, DOI 10.1097/QAI.0b013e31823219d1; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kiragga AN, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-42; Koenig SP, 2012, JAIDS-J ACQ IMM DEF, V59, pE60, DOI 10.1097/QAI.0b013e318245d3c1; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Lanoy E, 2009, AIDS, V23, P2199, DOI 10.1097/QAD.0b013e3283305a00; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lewis DK, 2005, T ROY SOC TROP MED H, V99, P561, DOI 10.1016/j.trstmh.2005.01.002; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Maman D, 2012, 17 INT AIDS C MEX CI, V26, P1393; Mills EJ, 2012, 17 INT AIDS C MEX CI; Mocroft A, 2007, AIDS, V21, P1867, DOI 10.1097/QAD.0b013e328270b877; Mocroft A, 2009, CLIN INFECT DIS, V48, P1138, DOI 10.1086/597468; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Moore DM, 2011, JAIDS-J ACQ IMM DEF, V58, P289, DOI 10.1097/QAI.0b013e3182303716; Phillips A, 2010, LANCET, V375, P96, DOI 10.1016/S0140-6736(09)62103-6; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Russell EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-433; Shah S, 2007, HIV MED, V8, P38, DOI 10.1111/j.1468-1293.2007.00434.x; Tarwater PM, 2004, AIDS, V18, P2419; Thai S, 2009, TROP MED INT HEALTH, V14, P1048, DOI 10.1111/j.1365-3156.2009.02334.x; Walker AS, 2011, CURR OPIN INFECT DIS, V24, P27, DOI 10.1097/QCO.0b013e3283423e0e; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; WHO, 2010, ANT THER HIV INF AD; WHO, 2002, SCAL ANT THER RES LI	38	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43375	10.1371/journal.pone.0043375	http://dx.doi.org/10.1371/journal.pone.0043375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905264	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600074
J	Aldridge, K; Wang, L; Harms, MP; Moffitt, AJ; Cole, KK; Csernansky, JG; Selemon, LD				Aldridge, Kristina; Wang, Lei; Harms, Michael P.; Moffitt, Amanda J.; Cole, Kimberly K.; Csernansky, John G.; Selemon, Lynn D.			A Longitudinal Analysis of Regional Brain Volumes in Macaques Exposed to X-Irradiation in Early Gestation	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; LATERAL GENICULATE-NUCLEUS; PRIMATE VISUAL-CORTEX; PRENATAL EXPOSURE; CEREBRAL-CORTEX; RHESUS-MONKEY; SCHIZOPHRENIA; RISK; MRI; NEURONS	Background: Early gestation represents a period of vulnerability to environmental insult that has been associated with adult psychiatric disease. However, little is known about how prenatal perturbation translates into adult brain dysfunction. Here, we use a longitudinal study design to examine the effects of disruption of early gestational neurogenesis on brain volume in the non-human primate. Methods and Principal Findings: Five Rhesus macaques were exposed to x-irradiation in early gestation (E30-E41), and four control monkeys were sham-irradiated at comparable ages. Whole brain magnetic resonance imaging was performed at 6 months, 12 months, and 3 and 5 years of age. Volumes of whole cerebrum, cortical gray matter, caudate, putamen, and thalamus were estimated using semi-automated segmentation methods and high dimensional brain mapping. Volume reductions spanning all ages were observed in irradiated monkeys in the putamen (15-24%, p = 0.01) and in cortical gray matter (6-15%, p = 0.01). Upon covarying for whole cerebral volume, group differences were reduced to trend levels (putamen: p = 0.07; cortical gray matter: p = 0.08). No group-by-age effects were significant. Conclusions: Due to the small number of observations, the conclusions drawn from this study must be viewed as tentative. Early gestational irradiation may result in non-uniform reduction of gray matter, mainly affecting the putamen and cerebral cortex. This may be relevant to understanding how early prenatal environmental insult could lead to brain morphological differences in neurodevelopmental diseases.	[Aldridge, Kristina; Moffitt, Amanda J.; Cole, Kimberly K.] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Wang, Lei; Csernansky, John G.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Wang, Lei; Csernansky, John G.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Harms, Michael P.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Selemon, Lynn D.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	University of Missouri System; University of Missouri Columbia; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); Yale University	Aldridge, K (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	aldridgek@missouri.edu	Wang, Lei/I-7552-2013	Wang, Lei/0000-0003-3870-3388; Aldridge, Kristina/0000-0003-3924-761X; Harms, Michael/0000-0001-7945-036X	National Institutes of Health [P50-MH071616, RO1-MH59329, P50-MH44866, T32MH17104]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059329, P50MH071616, P50MH044866, T32MH017104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institutes of Health grant numbers P50-MH071616, RO1-MH59329, P50-MH44866, T32MH17104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; Algan O, 1997, J COMP NEUROL, V381, P335, DOI 10.1002/(SICI)1096-9861(19970512)381:3<335::AID-CNE6>3.0.CO;2-3; ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79; Babulas V, 2006, AM J PSYCHIAT, V163, P927, DOI 10.1176/appi.ajp.163.5.927; Ball WS, 2012, CEREB CORTEX, V22, P1, DOI 10.1093/cercor/bhr018; BRAND S, 1979, NEUROSCIENCE, V4, P767, DOI 10.1016/0306-4522(79)90005-8; Braunschweig D, 2008, NEUROTOXICOLOGY, V29, P226, DOI 10.1016/j.neuro.2007.10.010; Brown AS, 2011, FRONT PSYCHIATRY, V2, P1; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; EIDELBERG D, 1982, ARCH NEUROL-CHICAGO, V39, P325, DOI 10.1001/archneur.1982.00510180003001; Friedman HR, 2010, BIOL PSYCHIAT, V68, P108, DOI 10.1016/j.biopsych.2010.02.021; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Hollister JM, 1996, ARCH GEN PSYCHIAT, V53, P19; Insel BJ, 2008, ARCH GEN PSYCHIAT, V65, P1136, DOI 10.1001/archpsyc.65.10.1136; Insel BJ, 2005, SCHIZOPHR RES, V80, P331, DOI 10.1016/j.schres.2005.06.005; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kohn L, 1992, ELECT IMAGING HUMAN, P114; Kruggel F, 2010, NEUROIMAGE, V49, P2123, DOI 10.1016/j.neuroimage.2009.11.006; Langley K, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-26; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Lovanovsky K, 2008, J NEUROPSYCHIATRY CL, V20, P274; Maldova L, 2006, EUR J NEUROSCI, V24, P3204; MATHALON DH, 1993, PSYCHIAT RES-NEUROIM, V50, P121, DOI 10.1016/S0165-1781(05)80006-X; O'Leary CM, 2010, ADDICTION, V105, P74, DOI 10.1111/j.1360-0443.2009.02756.x; OGREN MP, 1981, ANAT EMBRYOL, V162, P1, DOI 10.1007/BF00318090; OTAKE M, 1991, J RADIAT RES, V32, P249, DOI 10.1269/jrr.32.SUPPLEMENT_249; Paxinos G., 2000, RHESUS MONKEY BRAIN; Penner Justin D, 2007, Expert Rev Neurother, V7, P797, DOI 10.1586/14737175.7.7.797; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; RAKIC P, 1977, J COMP NEUROL, V176, P23, DOI 10.1002/cne.901760103; RAKIC P, 1991, P NATL ACAD SCI USA, V88, P2083, DOI 10.1073/pnas.88.6.2083; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rakic P, 1976, NATURE, V176, P23; Rakic P, 1974, SCIENCE, V183, P170; Reig S, 2009, HUM BRAIN MAPP, V30, P355, DOI 10.1002/hbm.20511; ROBB RA, 1989, COMPUT MED IMAG GRAP, V13, P433, DOI 10.1016/0895-6111(89)90285-1; Schindler MK, 2002, BIOL PSYCHIAT, V51, P827, DOI 10.1016/S0006-3223(01)01341-5; Segall JM, 2009, SCHIZOPHRENIA BULL, V35, P82, DOI 10.1093/schbul/sbn150; Selemon LD, 2005, BIOL PSYCHIAT, V57, P83, DOI 10.1016/j.biopsych.2004.10.014; Short SJ, 2010, BIOL PSYCHIAT, V67, P965, DOI 10.1016/j.biopsych.2009.11.026; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; Suner I, 1996, VISUAL NEUROSCI, V13, P585, DOI 10.1017/S0952523800008269; Susser E, 1996, ARCH GEN PSYCHIAT, V53, P25; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037	49	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43109	10.1371/journal.pone.0043109	http://dx.doi.org/10.1371/journal.pone.0043109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905212	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500800046
J	Arriero, MD; Ramis, JM; Perello, J; Monjo, M				del Mar Arriero, Maria; Ramis, Joana M.; Perello, Joan; Monjo, Marta			Inositol Hexakisphosphate Inhibits Osteoclastogenesis on RAW 264.7 Cells and Human Primary Osteoclasts	PLOS ONE			English	Article							KAPPA-B LIGAND; RENAL STONE FORMATION; IN-VITRO; RECEPTOR ACTIVATOR; BONE-RESORPTION; MYOINOSITOL HEXAKISPHOSPHATE; BIOLOGICAL-ACTIVITIES; HUMAN OSTEOBLASTS; DIETARY PHYTATE; GIANT-CELLS	Background: Inoxitol hexakisphosphate (IP6) has been found to have an important role in biomineralization and a direct effect inhibiting mineralization of osteoblasts in vitro without impairing extracellular matrix production and expression of alkaline phosphatase. IP6 has been proposed to exhibit similar effects to those of bisphosphonates on bone resorption, however, its direct effect on osteoclasts (OCL) is presently unknown. Methodology/Principal Findings: The aim of the present study was to investigate the effect of IP6 on the RAW 264.7 monocyte/macrophage mouse cell line and on human primary osteoclasts. On one hand, we show that IP6 decreases the osteoclastogenesis in RAW 264.7 cells induced by RANKL, without affecting cell proliferation or cell viability. The number of TRAP positive cells and mRNA levels of osteoclast markers such as TRAP, calcitonin receptor, cathepsin K and MMP-9 was decreased by IP6 on RANKL-treated cells. On the contrary, when giving IP6 to mature osteoclasts after RANKL treatment, a significant increase of bone resorption activity and TRAP mRNA levels was found. On the other hand, we show that 1 mu M of IP6 inhibits osteoclastogenesis of human peripheral blood mononuclear cells (PBMNC) and their resorption activity both, when given to undifferentiated and to mature osteoclasts. Conclusions/Significance: Our results demonstrate that IP6 inhibits osteoclastogenesis on human PBMNC and on the RAW264.7 cell line. Thus, IP6 may represent a novel type of selective inhibitor of osteoclasts and prove useful for the treatment of osteoporosis.	[del Mar Arriero, Maria; Ramis, Joana M.; Monjo, Marta] Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Dept Fundamental Biol & Hlth Sci, Palma de Mallorca, Spain; [Perello, Joan] ParcBIT, Lab Sanifit, Palma de Mallorca, Spain	Universitat de les Illes Balears	Arriero, MD (corresponding author), Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Dept Fundamental Biol & Hlth Sci, Palma de Mallorca, Spain.	marta.monjo@uib.es	Perello, Joan/A-7387-2019; Ramis, Joana Maria/AAF-4892-2020; Monjo, Marta/GVS-7077-2022	Perello, Joan/0000-0003-2671-3386; Ramis, Joana Maria/0000-0001-9109-8362; Monjo, Marta/0000-0002-2731-9527	INVEST IN SPAIN [C2_10_32]; European Regional Development Fund (ERDF) from the European Union; Eureka-Eurostars Project Application NewBone [E! 5069]; Centre for the Development of Industrial Technology (CDTI) [CIIP20101024]; Ministry of Science and Innovation of Spain (Torres Quevedo contract); Ministry of Science and Innovation of Spain (Ramon y Cajal contract)	INVEST IN SPAIN; European Regional Development Fund (ERDF) from the European Union; Eureka-Eurostars Project Application NewBone; Centre for the Development of Industrial Technology (CDTI); Ministry of Science and Innovation of Spain (Torres Quevedo contract); Ministry of Science and Innovation of Spain (Ramon y Cajal contract)	This work was supported by INVEST IN SPAIN (C2_10_32), European Regional Development Fund (ERDF) from the European Union, Eureka-Eurostars Project Application E! 5069 NewBone, Interempresas Internacional Program (CIIP20101024) from the Centre for the Development of Industrial Technology (CDTI) and the Ministry of Science and Innovation of Spain (Torres Quevedo contract to J.M. Ramis, and Ramon y Cajal contract to M. Monjo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2010, BONE, V46, P1100, DOI 10.1016/j.bone.2010.01.367; Blair HC, 2004, J BONE MINER RES, V19, P1329, DOI 10.1359/JBMR.040403; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BUNCE CM, 1993, BIOCHEM J, V289, P667, DOI 10.1042/bj2890667; Chakraborty A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001958; Conte A, 1999, Arch Esp Urol, V52, P305; Giuliani N, 1998, BONE, V22, P455, DOI 10.1016/S8756-3282(98)00033-7; Giuliani N, 1998, SCAND J RHEUMATOL, V27, P38; Grases F, 2006, FRONT BIOSCI-LANDMRK, V11, P136, DOI 10.2741/1786; Grases F, 2004, LIFE SCI, V75, P11, DOI 10.1016/j.lfs.2003.11.030; Grases F, 2009, J PERIODONTAL RES, V44, P616, DOI 10.1111/j.1600-0765.2008.01168.x; Grases F, 1998, SCAND J UROL NEPHROL, V32, P261; Grases F, 1999, ANTICANCER RES, V19, P3717; Grases F, 2001, J NUTR BIOCHEM, V12, P595, DOI 10.1016/S0955-2863(01)00178-4; Grases F, 2001, BRIT J NUTR, V86, P225, DOI 10.1079/BJN2001389; Grases F, 2000, UROL RES, V28, P136, DOI 10.1007/s002400050152; Grases F, 2000, BIOFACTORS, V11, P171, DOI 10.1002/biof.5520110303; GRASES F, 1994, BRIT J UROL, V74, P298, DOI 10.1111/j.1464-410X.1994.tb16614.x; Grases F, 2008, CARDIOVASC PATHOL, V17, P139, DOI 10.1016/j.carpath.2007.08.005; Grases F, 2007, CIRC J, V71, P1152, DOI 10.1253/circj.71.1152; Grases F, 2007, FRONT BIOSCI-LANDMRK, V12, P2580, DOI 10.2741/2256; Grases F, 2010, J MED FOOD, V13, P1301, DOI 10.1089/jmf.2009.0152; Grases F, 2008, J NEPHROL, V21, P768; Greiner S, 2007, J BIOMED MATER RES A, V80A, P769, DOI 10.1002/jbm.a.30950; Greiner S, 2007, J BIOMED MATER RES A, V83A, P1184, DOI 10.1002/jbm.a.31444; HAWKINS PT, 1993, BIOCHEM J, V294, P929, DOI 10.1042/bj2940929; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Irvine RF, 2005, J PHYSIOL-LONDON, V566, P295, DOI 10.1113/jphysiol.2005.087387; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jilka RL, 1998, J CLIN INVEST, V101, P1942, DOI 10.1172/JCI1039; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Lopez-Gonzalez AA, 2008, J MED FOOD, V11, P747, DOI 10.1089/jmf.2008.0087; Lopez-Gonzalez Angel A, 2010, Front Biosci (Elite Ed), V2, P1093; MAGRILL DS, 1973, J DENT RES, V52, P1342, DOI 10.1177/00220345730520063401; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Parfitt AM, 1996, J BONE MINER RES, V11, P150; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Reinholz GG, 2000, CANCER RES, V60, P6001; Reszka AA, 2004, MINI-REV MED CHEM, V4, P711; Rodan G, 2004, CURR MED RES OPIN, V20, P1291, DOI 10.1185/030079904125004475; Rodan GA, 1996, J CLIN INVEST, V97, P2692, DOI 10.1172/JCI118722; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; SASAKAWA N, 1995, BIOCHEM PHARMACOL, V50, P137, DOI 10.1016/0006-2952(95)00059-9; SHADDUCK RK, 1993, EXP HEMATOL, V21, P515; Shamsuddin AM, 1999, ANTICANCER RES, V19, P3733; Shamsuddin AM, 1997, LIFE SCI, V61, P343, DOI 10.1016/S0024-3205(97)00092-1; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; Susa Mira, 2004, J Transl Med, V2, P6, DOI 10.1186/1479-5876-2-6; Toro EJ, 2012, J BIOL CHEM; VALLEJO M, 1987, NATURE, V330, P656, DOI 10.1038/330656a0; Van Beek ER, 2002, BONE, V30, P64, DOI 10.1016/S8756-3282(01)00655-X; Viereck V, 2002, BIOCHEM BIOPH RES CO, V291, P680, DOI 10.1006/bbrc.2002.6510; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Wittrant Y, 2004, EXP CELL RES, V293, P292, DOI 10.1016/j.yexcr.2003.10.016; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamamoto A, 2002, J BONE MINER RES, V17, P612, DOI 10.1359/jbmr.2002.17.4.612; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zuo J, 2006, J BONE MINER RES, V21, P714, DOI 10.1359/JBMR.060201	67	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43187	10.1371/journal.pone.0043187	http://dx.doi.org/10.1371/journal.pone.0043187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905230	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500800059
J	Feng, P; Zhao, H; Chai, JH; Huang, LQ; Wang, H				Feng, Pu; Zhao, Hang; Chai, Jinghua; Huang, Liquan; Wang, Hong			Expression and Secretion of TNF-alpha in Mouse Taste Buds: A Novel Function of a Specific Subset of Type II Taste Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SIGNALING PATHWAYS; MAMMALIAN SWEET; INNATE IMMUNITY; RECEPTORS; LIPOPOLYSACCHARIDE; INFLAMMATION; GUSTDUCIN; APOPTOSIS; PROTEINS	Taste buds are chemosensory structures widely distributed on the surface of the oral cavity and larynx. Taste cells, exposed to the oral environment, face great challenges in defense against potential pathogens. While immune cells, such as T-cells and macrophages, are rarely found in taste buds, high levels of expression of some immune-response-associated molecules are observed in taste buds. Yet, the cellular origins of these immune molecules such as cytokines in taste buds remain to be determined. Here, we show that a specific subset of taste cells selectively expresses high levels of the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha). Based on immuno-colocalization experiments using taste-cell-type markers, the TNF-alpha-producing cells are predominantly type II taste cells expressing the taste receptor T1R3. These cells can rapidly increase TNF-alpha production and secretion upon inflammatory challenges, both in vivo and in vitro. The lipopolysaccharide (LPS)-induced TNF-alpha expression in taste cells was completely eliminated in TLR2(-/-)/TLR4(-/-) double-gene-knockout mice, which confirms that the induction of TNF-alpha in taste buds by LPS is mediated through TLR signaling pathways. The taste-cell-produced TNF-alpha may contribute to local immune surveillance, as well as regulate taste sensation under normal and pathological conditions.	[Feng, Pu; Chai, Jinghua; Huang, Liquan; Wang, Hong] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Zhao, Hang] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Zhao, Hang] Harvard Univ, Sch Med, Boston, MA USA	Monell Chemical Senses Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Feng, P (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	pfeng@monell.org; hwang@monell.org		Wang, Hong/0000-0003-4130-8741	National Institutes of Health/National Institute of Deafness and Other Communication Disorders grants [DC010012, DC007487, P30 DC011735]; National Science Foundation [DBJ-0216310]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007487, R01DC010012, P30DC011735] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Deafness and Other Communication Disorders grants; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study was supported by National Institutes of Health/National Institute of Deafness and Other Communication Disorders grants DC010012 (H.W.), DC007487 (L.H.), and P30 DC011735 and by a grant from the National Science Foundation DBJ-0216310. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Cannon JG, 2000, NEWS PHYSIOL SCI, V15, P298, DOI 10.1152/physiologyonline.2000.15.6.298; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Cohn ZJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-72; Damak S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-96; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; Feng P, 2010, CHEM SENSES, V35, P501, DOI 10.1093/chemse/bjq040; Feng P, 2009, BRAIN BEHAV IMMUN, V23, P760, DOI 10.1016/j.bbi.2009.02.016; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Ghallab NA, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/847632; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Hoshino K, 1999, J IMMUNOL, V162, P3749; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; JONES GJ, 1986, CANCER, V57, P1709, DOI 10.1002/1097-0142(19860415)57:8+<1709::AID-CNCR2820571315>3.0.CO;2-F; Kim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035588; Kim MR, 2003, BIOCHEM BIOPH RES CO, V312, P500, DOI 10.1016/j.bbrc.2003.10.137; Mann NM, 2002, CLEV CLIN J MED, V69, P329, DOI 10.3949/ccjm.69.4.329; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Moen K, 2005, ORAL SURG ORAL MED O, V100, P433, DOI 10.1016/j.tripleo.2005.05.060; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nadeau S, 2002, J IMMUNOL, V169, P3370, DOI 10.4049/jimmunol.169.6.3370; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Niu YL, 2009, CYTOKINE, V47, P23, DOI 10.1016/j.cyto.2009.04.003; Phillips LM, 1996, AM J PHYSIOL-REG I, V271, pR857, DOI 10.1152/ajpregu.1996.271.4.R857; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Shi LQ, 2012, J NEUROSCI RES, V90, P816, DOI 10.1002/jnr.22798; Sklavounou A, 2000, J ORAL PATHOL MED, V29, P370, DOI 10.1034/j.1600-0714.2000.290802.x; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tomonari H, 2012, CHEM SENSES, V37, P241, DOI 10.1093/chemse/bjr098; WALSH LJ, 1991, P NATL ACAD SCI USA, V88, P4220, DOI 10.1073/pnas.88.10.4220; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; Wang H, 2009, ANN NY ACAD SCI, V1170, P596, DOI 10.1111/j.1749-6632.2009.04480.x; WIEGMANN K, 1992, J BIOL CHEM, V267, P17997; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	43	28	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43140	10.1371/journal.pone.0043140	http://dx.doi.org/10.1371/journal.pone.0043140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905218	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800051
J	Nassini, R; Pedretti, P; Moretto, N; Fusi, C; Carnini, C; Facchinetti, F; Viscomi, AR; Pisano, AR; Stokesberry, S; Brunmark, C; Svitacheva, N; McGarvey, L; Patacchini, R; Damholt, AB; Geppetti, P; Materazzi, S				Nassini, Romina; Pedretti, Pamela; Moretto, Nadia; Fusi, Camilla; Carnini, Chiara; Facchinetti, Fabrizio; Viscomi, Arturo Roberto; Pisano, Anna Rita; Stokesberry, Susan; Brunmark, Charlott; Svitacheva, Naila; McGarvey, Lorcan; Patacchini, Riccardo; Damholt, Anders B.; Geppetti, Pierangelo; Materazzi, Serena			Transient Receptor Potential Ankyrin 1 Channel Localized to Non-Neuronal Airway Cells Promotes Non-Neurogenic Inflammation	PLOS ONE			English	Article							CIGARETTE-SMOKE; ALPHA,BETA-UNSATURATED ALDEHYDES; ION-CHANNEL; CAPSAICIN RECEPTOR; TRPA1; ANTAGONIST; PAIN; ACTIVATION; RELEASE; A1	Background: The transient receptor potential ankyrin 1 (TRPA1) channel, localized to airway sensory nerves, has been proposed to mediate airway inflammation evoked by allergen and cigarette smoke (CS) in rodents, via a neurogenic mechanism. However the limited clinical evidence for the role of neurogenic inflammation in asthma or chronic obstructive pulmonary disease raises an alternative possibility that airway inflammation is promoted by non-neuronal TRPA1. Methodology/Principal Findings: By using Real-Time PCR and calcium imaging, we found that cultured human airway cells, including fibroblasts, epithelial and smooth muscle cells express functional TRPA1 channels. By using immunohistochemistry, TRPA1 staining was observed in airway epithelial and smooth muscle cells in sections taken from human airways and lung, and from airways and lung of wild-type, but not TRPA1-deficient mice. In cultured human airway epithelial and smooth muscle cells and fibroblasts, acrolein and CS extract evoked IL-8 release, a response selectively reduced by TRPA1 antagonists. Capsaicin, agonist of the transient receptor potential vanilloid 1 (TRPV1), a channel co-expressed with TRPA1 by airway sensory nerves, and acrolein or CS (TRPA1 agonists), or the neuropeptide substance P (SP), which is released from sensory nerve terminals by capsaicin, acrolein or CS), produced neurogenic inflammation in mouse airways. However, only acrolein and CS, but not capsaicin or SP, released the keratinocyte chemoattractant (CXCL-1/KC, IL-8 analogue) in bronchoalveolar lavage (BAL) fluid of wild-type mice. This effect of TRPA1 agonists was attenuated by TRPA1 antagonism or in TRPA1-deficient mice, but not by pharmacological ablation of sensory nerves. Conclusions: Our results demonstrate that, although either TRPV1 or TRPA1 activation causes airway neurogenic inflammation, solely TRPA1 activation orchestrates an additional inflammatory response which is not neurogenic. This finding suggests that non-neuronal TRPA1 in the airways is functional and potentially capable of contributing to inflammatory airway diseases.	[Nassini, Romina; Pedretti, Pamela; Fusi, Camilla; Geppetti, Pierangelo; Materazzi, Serena] Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy; [Pedretti, Pamela; Moretto, Nadia; Carnini, Chiara; Facchinetti, Fabrizio; Pisano, Anna Rita; Patacchini, Riccardo] Chiesi Farmaceutici SpA, Dept Pharmacol, Parma, Italy; [Viscomi, Arturo Roberto] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Stokesberry, Susan; McGarvey, Lorcan] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Brunmark, Charlott; Svitacheva, Naila; Damholt, Anders B.] AstraZeneca Res & Dev Innovat Med Resp Inflammat, Molndal, Sweden; [Brunmark, Charlott] Truly Translat Sweden AB, Lund, Sweden; [Svitacheva, Naila] Dis Pharmacol LEO Pharma AS, Ballerup, Denmark; [Damholt, Anders B.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Geppetti, Pierangelo] Univ Florence, Headache Ctr, Florence, Italy	University of Florence; Chiesi Pharmaceuticals Inc; University of Parma; Queens University Belfast; AstraZeneca; University of Copenhagen; University of Florence	Nassini, R (corresponding author), Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy.	geppetti@unifi.it	Nassini, Romina/AAC-5051-2022; Geppetti, Pierangelo/AHA-7897-2022	Nassini, Romina/0000-0002-9223-8395; 	Regione Toscana: "Regional Health Research Program"; FABER - POR CREO [FESR 2007-2013 1.1.C.]; Italian Institute of Technology; Ente Cassa di Risparmio di Firenze; AstraZenca	Regione Toscana: "Regional Health Research Program"(Regione Toscana); FABER - POR CREO; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); AstraZenca	This work was supported by grants from Regione Toscana: "Regional Health Research Program 2009" and "FABER - POR CREO, FESR 2007-2013 1.1.C." and the Italian Institute of Technology, "Project SEED", and Ente Cassa di Risparmio di Firenze. The work was also funded by AstraZenca; this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andre E, 2009, BRIT J PHARMACOL, V158, P1621, DOI 10.1111/j.1476-5381.2009.00438.x; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bang S, 2007, EUR J NEUROSCI, V26, P2516, DOI 10.1111/j.1460-9568.2007.05882.x; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Belvisi MG, 2011, CHEST, V140, P1040, DOI 10.1378/chest.10-3327; Bertrand C, 1996, TRENDS PHARMACOL SCI, V17, P255, DOI 10.1016/S0165-6147(96)10027-4; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bessac BF, 2009, FASEB J, V23, P1102, DOI 10.1096/fj.08-117812; BEVAN S, 1994, TRENDS NEUROSCI, V17, P509, DOI 10.1016/0166-2236(94)90149-X; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bhattacharya MRC, 2008, P NATL ACAD SCI USA, V105, P20015, DOI 10.1073/pnas.0810801105; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Boot JD, 2007, AM J RESP CRIT CARE, V175, P450, DOI 10.1164/rccm.200608-1186OC; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavarra E, 2001, AM J RESP CRIT CARE, V164, P886, DOI 10.1164/ajrccm.164.5.2010032; DELAYGOYET P, 1991, EUR J PHARMACOL, V203, P157, DOI 10.1016/0014-2999(91)90808-4; Dykewicz MS, 2009, J ALLERGY CLIN IMMUN, V123, P519, DOI 10.1016/j.jaci.2009.01.061; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Everaerts W, 2009, N-S ARCH PHARMACOL, V379, P421, DOI 10.1007/s00210-008-0391-7; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; FAHY JV, 1995, AM J RESP CRIT CARE, V152, P879, DOI 10.1164/ajrccm.152.3.7663799; GEPPETTI P, 1995, CAN J PHYSIOL PHARM, V73, P843, DOI 10.1139/y95-115; Geppetti P, 1996, NEUROGENIC INFLAMMAT, P1; Hens G, 2011, AM J RESP CELL MOL, V44, P517, DOI 10.1165/rcmb.2009-0425OC; Hsieh YL, 2008, J NEUROPATH EXP NEUR, V67, P93, DOI 10.1097/nen.0b013e3181630bb8; Joos Guy F., 2001, Current Opinion in Pharmacology, V1, P235, DOI 10.1016/S1471-4892(01)00042-X; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kishimoto E, 2011, AM J PHYSIOL-GASTR L, V301, pG230, DOI 10.1152/ajpgi.00436.2009; LUNDBERG JM, 1983, NATURE, V302, P251, DOI 10.1038/302251a0; Malo JL, 2009, AM J RESP CRIT CARE, V179, P923, DOI 10.1164/rccm.200810-1550OC; Materazzi S, 2008, P NATL ACAD SCI USA, V105, P12045, DOI 10.1073/pnas.0802354105; Moretto N, 2009, AM J PHYSIOL-LUNG C, V296, pL839, DOI 10.1152/ajplung.90570.2008; Mukhopadhyay I, 2011, J RECEPT SIG TRANSD, V31, P350, DOI 10.3109/10799893.2011.602413; Nassini R, 2010, FASEB J, V24, P4904, DOI 10.1096/fj.10-162438; Nilius Bernd, 2007, Bull Mem Acad R Med Belg, V162, P244; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; Oltmanns U, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-74; Pecze L, 2009, CAN J NEUROL SCI, V36, P234, DOI 10.1017/S0317167100006600; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Sawada Y, 2008, EUR J NEUROSCI, V27, P1131, DOI 10.1111/j.1460-9568.2008.06093.x; STEDMAN RL, 1968, CHEM REV, V68, P153, DOI 10.1021/cr60252a002; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; Talavera K, 2009, NAT NEUROSCI, V12, P1293, DOI 10.1038/nn.2379; Taylor-Clark TE, 2008, J PHYSIOL-LONDON, V586, P3447, DOI 10.1113/jphysiol.2008.153585; Taylor-Clark TE, 2009, J PHYSL, V588, P423; Taylor-Clark TE, 2009, AM J RESP CELL MOL, V40, P756, DOI 10.1165/rcmb.2008-0292OC; Tigyi G, 2012, NAT CHEM BIOL, V8, P22, DOI 10.1038/nchembio.738; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104	58	169	173	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42454	10.1371/journal.pone.0042454	http://dx.doi.org/10.1371/journal.pone.0042454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905134	Green Submitted, Green Published, gold			2022-12-27	WOS:000307500800011
J	Shafiq, MI; Steinbrecher, T; Schmid, R				Shafiq, Muhammad Imtiaz; Steinbrecher, Thomas; Schmid, Ralf			FASCAPLYSIN as a Specific Inhibitor for CDK4: Insights from Molecular Modelling	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; DEPENDENT KINASE INHIBITOR; LYMPHOCYTIC-LEUKEMIA CLL; FLAVOPIRIDOL ALVOCIDIB; SELECTIVE INHIBITORS; PROTEIN-LIGAND; CELL-CYCLE; NONNUCLEOSIDE INHIBITORS; BIOMOLECULAR SIMULATIONS; CDK4-SPECIFIC INHIBITORS	Cyclin-dependent kinases (CDKs) play a key role in the cell cycle and are important anti-cancer drug targets. The natural product fascaplysin inhibits CDK4 with surprising selectivity (IC50 = 0.4 mu M) compared to the close homolog CDK2 (IC50 = 500 mu M). Free energy calculations of the positively charged fascaplysin and an uncharged iso-electronic derivative in the CDK2 and CDK4 inhibitor complexes indicate that the positive charge of fascaplysin is crucial for selectivity. This finding will guide further improvements in the design of fascaplysin-based selective inhibitors for CDK4.	[Shafiq, Muhammad Imtiaz; Schmid, Ralf] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Shafiq, Muhammad Imtiaz] Univ Punjab, Inst Chem, Lahore, Pakistan; [Steinbrecher, Thomas] Univ Karlsruhe, Inst Phys Chem, Abt Theoret Chem Biol, Karlsruher Inst Technol, Karlsruhe, Germany	University of Leicester; University of Punjab; Helmholtz Association; Karlsruhe Institute of Technology	Shafiq, MI (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	thomas.steinbrecher@kit.edu; R.Schmid@le.ac.uk	Schmid, Ralf/ABE-1065-2020; Schmid, Ralf/E-6722-2011	Schmid, Ralf/0000-0002-0203-4023; Schmid, Ralf/0000-0002-0203-4023	Higher Education Commission (HEC) Pakistan; Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology	Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	MIS was supported by a PhD studentship provided by the Higher Education Commission (commonly known as HEC) Pakistan (www.hec.gov.pk/). The authors acknowledge support for open access publishing by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; au>Hypercube Inc, 2008, HYPERCHEM TM PROF 8; Aubry C, 2006, ORG BIOMOL CHEM, V4, P787, DOI 10.1039/b518019h; Aubry C, 2004, CHEM COMMUN, P1696, DOI 10.1039/b406076h; Aubry C, 2009, BIOORGAN MED CHEM, V17, P6073, DOI 10.1016/j.bmc.2009.06.070; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Buolamwini JK, 2000, CURR PHARM DESIGN, V6, P379, DOI 10.2174/1381612003400948; Carvajal RD, 2009, PANCREATOLOGY, V9, P404, DOI 10.1159/000187135; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chipot C, 2005, J COMPUT AID MOL DES, V19, P765, DOI 10.1007/s10822-005-9021-3; Darden T, 1998, J CHEM PHYS, V109, P10921, DOI 10.1063/1.477788; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Finn RS, 2011, J CLIN ONCOL S, V29; Foloppe N, 2006, CURR MED CHEM, V13, P3583, DOI 10.2174/092986706779026165; Frisch M.J., 2016, GAUSSIAN16 REV B01; Fry DW, 2004, MOL CANCER THER, V3, P1427; Garcia MD, 2006, ORG BIOMOL CHEM, V4, P4478, DOI 10.1039/b613861f; Gouda H, 2003, BIOPOLYMERS, V68, P16, DOI 10.1002/bip.10270; Grillo M, 2006, BREAST CANCER RES TR, V95, P185, DOI 10.1007/s10549-005-9066-y; Grossfield A, 2003, J AM CHEM SOC, V125, P15671, DOI 10.1021/ja037005r; Harper JW, 2001, CHEM REV, V101, P2511, DOI 10.1021/cr0001030; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Horiuchi T, 2009, BIOORGAN MED CHEM, V17, P7850, DOI 10.1016/j.bmc.2009.10.039; Horn HW, 2004, J CHEM PHYS, V120, P9665, DOI 10.1063/1.1683075; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jenkins PR, 2008, BIOORGAN MED CHEM, V16, P7728, DOI 10.1016/j.bmc.2008.07.002; Jiang YJ, 2005, J MOL MODEL, V11, P509, DOI 10.1007/s00894-005-0263-8; Jorgensen WL, 2008, J CHEM THEORY COMPUT, V4, P869, DOI 10.1021/ct800011m; Jorgensen WL, 2006, BIOORG MED CHEM LETT, V16, P663, DOI 10.1016/j.bmcl.2005.10.038; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kellenberger E, 2004, PROTEINS, V57, P225, DOI 10.1002/prot.20149; Kim JT, 2006, J AM CHEM SOC, V128, P15372, DOI 10.1021/ja066472g; Lacrima K, 2005, ANN ONCOL, V16, P1169, DOI 10.1093/annonc/mdi217; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lazaridis T, 2002, CURR ORG CHEM, V6, P1319, DOI 10.2174/1385272023373491; Li AX, 2008, J MOL STRUC-THEOCHEM, V849, P62, DOI 10.1016/j.theochem.2007.10.015; Lin TS, 2007, BLOOD, V110, p913A, DOI 10.1182/blood.V110.11.3104.3104; Lin TS, 2008, BLOOD, V112, P23; Mahale S, 2006, BIOORG CHEM, V34, P287, DOI 10.1016/j.bioorg.2006.06.004; Mahale S, 2006, BIOORG MED CHEM LETT, V16, P4272, DOI 10.1016/j.bmcl.2006.05.065; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2006, CANCER CELL, V9, P2, DOI 10.1016/j.ccr.2005.12.026; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mascarenhas NM, 2008, J CHEM INF MODEL, V48, P1325, DOI 10.1021/ci8000343; Mascarenhas NM, 2010, J MOL GRAPH MODEL, V28, P695, DOI 10.1016/j.jmgm.2010.01.008; McInnes C, 2004, CHEM BIOL, V11, P525, DOI 10.1016/j.chembiol.2004.03.022; McInnes C, 2008, DRUG DISCOV TODAY, V13, P875, DOI 10.1016/j.drudis.2008.06.012; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Ortega S., 2002, Current Genomics, V3, P245, DOI 10.2174/1389202023350444; Park H, 2004, CHEMBIOCHEM, V5, P1662, DOI 10.1002/cbic.200400214; Plewczynski D, 2011, J COMPUT CHEM, V32, P742, DOI 10.1002/jcc.21643; Reddy MR, 2000, REV COMP CH, V16, P217, DOI 10.1002/9780470125939.ch4; ROLL DM, 1988, J ORG CHEM, V53, P3276, DOI 10.1021/jo00249a025; Rossi KA, 2005, J COMPUT AID MOL DES, V19, P111, DOI 10.1007/s10822-005-1778-x; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shirts MR, 2003, J CHEM PHYS, V119, P5740, DOI 10.1063/1.1587119; Simonson T, 2002, ACCOUNTS CHEM RES, V35, P430, DOI 10.1021/ar010030m; Steinbrecher T, 2006, J MED CHEM, V49, P1837, DOI 10.1021/jm0505720; Steinbrecher T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799191; Steinbrecher T, 2011, J COMPUT CHEM, V32, P3253, DOI 10.1002/jcc.21909; Steinbrecher T, 2010, CURR MED CHEM, V17, P767, DOI 10.2174/092986710790514453; Stembrecher T, 2008, BIOORGAN MED CHEM, V16, P2385, DOI 10.1016/j.bmc.2007.11.070; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; Tsou HR, 2008, J MED CHEM, V51, P3507, DOI 10.1021/jm800072z; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang W, 2001, ANNU REV BIOPH BIOM, V30, P211, DOI 10.1146/annurev.biophys.30.1.211; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Wesierska-Gadek J, 2011, J CELL PHYSIOL, V226, P341, DOI 10.1002/jcp.22426; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zeevaart JG, 2008, J AM CHEM SOC, V130, P9492, DOI 10.1021/ja8019214	86	37	39	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42612	10.1371/journal.pone.0042612	http://dx.doi.org/10.1371/journal.pone.0042612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905154	Green Published, gold			2022-12-27	WOS:000307500800018
J	Wang, YJ; Rao, VK; Kok, WK; Roy, DN; Sethi, S; Ling, BMT; Lee, MBH; Taneja, R				Wang, Yaju; Rao, Vinay Kumar; Kok, Wai Kay; Roy, Dijendra Nath; Sethi, Sumita; Ling, Belinda Mei Tze; Lee, Martin Beng Huat; Taneja, Reshma			SUMO Modification of Stra13 Is Required for Repression of Cyclin D1 Expression and Cellular Growth Arrest	PLOS ONE			English	Article							TRANSCRIPTION FACTOR DEC1; HISTONE DEACETYLASES; INDUCED APOPTOSIS; GENE-EXPRESSION; DIFFERENTIATION; ACTIVATION; HYPOXIA; CANCER; SUMOYLATION; OVEREXPRESSION	Stra13, a basic helix-loop-helix (bHLH) transcription factor is involved in myriad biological functions including cellular growth arrest, differentiation and senescence. However, the mechanisms by which its transcriptional activity and function are regulated remain unclear. In this study, we provide evidence that post-translational modification of Stra13 by Small Ubiquitin-like Modifier (SUMO) dramatically potentiates its ability to transcriptionally repress cyclin D1 and mediate G(1) cell cycle arrest in fibroblast cells. Mutation of SUMO acceptor lysines 159 and 279 located in the C-terminal repression domain has no impact on nuclear localization; however, it abrogates association with the co-repressor histone deacetylase 1 (HDAC1), attenuates repression of cyclin D1, and prevents Stra13-mediated growth suppression. HDAC1, which promotes cellular proliferation and cell cycle progression, antagonizes Stra13 sumoylation-dependent growth arrest. Our results uncover an unidentified regulatory axis between Stra13 and HDAC1 in progression through the G(1)/S phase of the cell cycle, and provide new mechanistic insights into regulation of Stra13-mediated transcriptional repression by sumoylation.	[Wang, Yaju; Rao, Vinay Kumar; Kok, Wai Kay; Roy, Dijendra Nath; Sethi, Sumita; Ling, Belinda Mei Tze; Taneja, Reshma] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Lee, Martin Beng Huat] Natl Univ Hlth Syst, Div Nephrol, Singapore, Singapore	National University of Singapore; National University of Singapore	Wang, YJ (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore.	phsrt@nus.edu.sg	Taneja, Reshma/F-9658-2014	Taneja, Reshma/0000-0002-2151-2094; Lee, Martin/0000-0002-4809-3088; Reshma, Taneja/0000-0001-6214-6177; SETHI, SUMITA/0000-0002-6663-8010	National Medical Research Foundation	National Medical Research Foundation	This work was supported by funds from the National Medical Research Foundation (R.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadling C, 2001, ONCOGENE, V20, P1771, DOI 10.1038/sj.onc.1204212; Bhawal UK, 2011, J PATHOL, V224, P420, DOI 10.1002/path.2878; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Fujimoto K, 2007, INT J MOL MED, V19, P925; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Giatromanolaki A, 2003, J PATHOL, V200, P222, DOI 10.1002/path.1330; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Hayakawa F, 2008, J BIOL CHEM, V283, P24420, DOI 10.1074/jbc.M802217200; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hong YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023046; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Ivanova A, 2005, J MED GENET, V42, P565, DOI 10.1136/jmg.2004.029835; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lee MB, 2005, MOL CELL BIOL, V25, P1879, DOI 10.1128/MCB.25.5.1879-1890.2005; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Ling BMT, 2012, P NATL ACAD SCI USA, V109, P841, DOI 10.1073/pnas.1111628109; Liu JJ, 2010, FEBS LETT, V584, P619, DOI 10.1016/j.febslet.2009.12.011; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Miyazaki K, 2010, J IMMUNOL, V185, P7330, DOI 10.4049/jimmunol.1001381; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Seimiya M, 2002, BIOCHEM BIOPH RES CO, V292, P121, DOI 10.1006/bbrc.2002.6605; Shen M, 2002, J BIOL CHEM, V277, P50112, DOI 10.1074/jbc.M206771200; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Sun H, 2007, J CELL BIOL, V177, P647, DOI 10.1083/jcb.200609007; Sun Hong, 2007, Transl Oncogenomics, V2, P107; Thin TH, 2007, EMBO REP, V8, P401, DOI 10.1038/sj.embor.7400912; Turley H, 2004, J PATHOL, V203, P808, DOI 10.1002/path.1585; Vercherat C, 2009, HUM MOL GENET, V18, P4304, DOI 10.1093/hmg/ddp383; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zheng Y, 2009, OMICS, V13, P301, DOI 10.1089/omi.2009.0014	43	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43137	10.1371/journal.pone.0043137	http://dx.doi.org/10.1371/journal.pone.0043137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905217	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800050
J	Dai, JP; Li, WZ; Zhao, XF; Wang, GF; Yang, JC; Zhang, L; Chen, XX; Xu, YX; Li, KS				Dai, Jian-Ping; Li, Wei-Zhong; Zhao, Xiang-Feng; Wang, Ge-Fei; Yang, Jia-Cai; Zhang, Lin; Chen, Xiao-Xuan; Xu, Yan-Xuan; Li, Kang-Sheng			A Drug Screening Method Based on the Autophagy Pathway and Studies of the Mechanism of Evodiamine against Influenza A Virus	PLOS ONE			English	Article							CELL-GROWTH; ASSAY; REPLICATION; COMPLEXES; H5N1; ACTIVATION; INHIBITORS; INDUCTION; APOPTOSIS; DEATH	In this research, we have established a drug screening method based on the autophagy signal pathway using the bimolecular fluorescence complementation - fluorescence resonance energy transfer (BiFC-FRET) technique to develop novel anti-influenza A virus (IAV) drugs. We selected Evodia rutaecarpa Benth out of 83 examples of traditional Chinese medicine and explored the mechanisms of evodiamine, the major active component of Evodia rutaecarpa Benth, on anti-IAV activity. Our results showed that evodiamine could significantly inhibit IAV replication, as determined by a plaque inhibition assay, an IAV vRNA promoter luciferase reporter assay and the Sulforhodamine B method using cytopathic effect (CPE) reduction. Additionally, evodiamine could significantly inhibit the accumulation of LC3-II and p62, and the dot-like aggregation of EGFP-LC3. This compound also inhibited the formation of the Atg5-Atg12/Atg16 heterotrimer, the expressions of Atg5, Atg7 and Atg12, and the cytokine release of TNF-alpha, IL-1 beta, IL-6 and IL-8 after IAV infection. Evodiamine inhibited IAV-induced autophagy was also dependent on its action on the AMPK/TSC2/mTOR signal pathway. In conclusion, we have established a new drug screening method, and selected evodiamine as a promising anti-IAV compound.	[Dai, Jian-Ping; Zhao, Xiang-Feng; Wang, Ge-Fei; Yang, Jia-Cai; Zhang, Lin; Chen, Xiao-Xuan; Xu, Yan-Xuan; Li, Kang-Sheng] Shantou Univ Med Coll, Dept Microbiol & Immunol, Shantou, Guangdong, Peoples R China; [Li, Wei-Zhong] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Dai, JP (corresponding author), Shantou Univ Med Coll, Dept Microbiol & Immunol, Shantou, Guangdong, Peoples R China.	ksli@stu.edu.cn	Wang, Gefei/A-1206-2013	Li, Kangsheng/0000-0002-6981-9263; Li, Weizhong/0000-0002-8602-8375	The National Natural Science Foundation of China [30972766, 31170852, 81001322, 81172795]; Guangdong Natural Science Foundation [9451503102003499]; Doctoral Program Foundation of Institutions of Higher Education of China [20094402110004]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from The National Natural Science Foundation of China (30972766, 31170852, 81001322, 81172795), Guangdong Natural Science Foundation (9451503102003499), and Doctoral Program Foundation of Institutions of Higher Education of China (20094402110004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai GR, 2009, BIOCHEM BIOPH RES CO, V390, P897, DOI 10.1016/j.bbrc.2009.10.071; Chattopadhyay S, 2011, J VIROL, V85, P3708, DOI 10.1128/JVI.02133-10; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Choi HJ, 2009, PHYTOMEDICINE, V16, P35, DOI 10.1016/j.phymed.2008.10.012; Dai JP, 2009, J ORAL PATHOL MED, V38, P276, DOI 10.1111/j.1600-0714.2008.00738.x; Dreux M, 2009, AUTOPHAGY, V5, P1224, DOI 10.4161/auto.5.8.10219; GIFFIN K, 1995, FEBS LETT, V357, P269, DOI 10.1016/0014-5793(94)01369-C; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Hoelscher M, 2008, EXPERT OPIN DRUG DEL, V5, P1139, DOI 10.1517/17425247.5.10.1139 ; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Itakura E, 2009, AUTOPHAGY, V5, P534, DOI 10.4161/auto.5.4.8062; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Law AHY, 2010, CELL MOL IMMUNOL, V7, P263, DOI 10.1038/cmi.2010.25; Lee H, 2010, BIOCONJUGATE CHEM, V21, P289, DOI 10.1021/bc900342p; Lei H, 2011, CLIN VACCINE IMMUNOL, V18, P1046, DOI 10.1128/CVI.00050-11; Li WZ, 2010, CELL MOL IMMUNOL, V7, P235, DOI 10.1038/cmi.2010.6; Liu AL, 2005, SCI CHINA SER C, V48, P1, DOI 10.1360/062004-69; Ma JH, 2011, J GENET GENOMICS, V38, P533, DOI 10.1016/j.jgg.2011.10.002; Maddry JA, 2011, J BIOMOL SCREEN, V16, P73, DOI 10.1177/1087057110384613; Matarrese P, 2011, J CELL PHYSIOL, V226, P3368, DOI 10.1002/jcp.22696; Meng S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019863; Mueller Barbara, 2009, V189, P1, DOI 10.1007/978-3-540-79086-0_1; Munz C, 2011, VIRUSES-BASEL, V3, P1166, DOI 10.3390/v3071166; Noah JW, 2007, ANTIVIR RES, V73, P50, DOI 10.1016/j.antiviral.2006.07.006; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Shang LB, 2011, AUTOPHAGY, V7, P924, DOI 10.4161/auto.7.8.15860; Shih SR, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-13; Su CY, 2010, P NATL ACAD SCI USA, V107, P19151, DOI 10.1073/pnas.1013592107; Sui YX, 2007, J BIOMOL SCREEN, V12, P229, DOI 10.1177/1087057106296498; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Wang SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028757; Yoon SY, 2008, J VIROL, V82, P11976, DOI 10.1128/JVI.01028-08; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	39	42	47	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42706	10.1371/journal.pone.0042706	http://dx.doi.org/10.1371/journal.pone.0042706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900043	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900060
J	Oeggerli, M; Tian, YM; Ruiz, C; Wijker, B; Sauter, G; Obermann, E; Guth, U; Zlobec, I; Sausbier, M; Kunzelmann, K; Bubendorf, L				Oeggerli, Martin; Tian, Yuemin; Ruiz, Christian; Wijker, Barbara; Sauter, Guido; Obermann, Ellen; Gueth, Uwe; Zlobec, Inti; Sausbier, Matthias; Kunzelmann, Karl; Bubendorf, Lukas			Role of KCNMA1 in Breast Cancer	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ION CHANNELS; POTASSIUM CHANNELS; ANDROGEN RECEPTOR; BK CHANNEL; TISSUE MICROARRAYS; CELL-PROLIFERATION; EXPRESSION; GENE; ACTIVATION	KCNMA1 encodes the a-subunit of the large conductance, voltage and Ca2+-activated (BK) potassium channel and has been reported as a target gene of genomic amplification at 10q22 in prostate cancer. To investigate the prevalence of the amplification in other human cancers, the copy number of KCNMA1 was analyzed by fluorescence-in-situ-hybridization (FISH) in 2,445 tumors across 118 different tumor types. Amplification of KCNMA1 was restricted to a small but distinct fraction of breast, ovarian and endometrial cancer with the highest prevalence in invasive ductal breast cancers and serous carcinoma of ovary and endometrium (3-7%). We performed an extensive analysis on breast cancer tissue microarrays (TMA) of 1,200 tumors linked to prognosis. KCNMA1 amplification was significantly associated with high tumor stage, high grade, high tumor cell proliferation, and poor prognosis. Immunofluorescence revealed moderate or strong KCNMA1 protein expression in 8 out of 9 human breast cancers and in the breast cancer cell line MFM223. KCNMA1-function in breast cancer cell lines was confirmed by whole-cell patch clamp recordings and proliferation assays, using siRNA-knockdown, BK channel activators such as 17 beta-estradiol and the BK-channel blocker paxilline. Our findings revealed that enhanced expression of KCNMA1 correlates with and contributes to high proliferation rate and malignancy of breast cancer.	[Oeggerli, Martin; Ruiz, Christian; Wijker, Barbara; Obermann, Ellen; Bubendorf, Lukas] Univ Basel, Inst Pathol, Basel, Switzerland; [Tian, Yuemin; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, Regensburg, Germany; [Sauter, Guido] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany; [Gueth, Uwe] Univ Basel Hosp, Dept Gynecol & Obstet, CH-4031 Basel, Switzerland; [Zlobec, Inti] Univ Bern, Inst Pathol, Bern, Switzerland; [Sausbier, Matthias] Univ Tubingen, Inst Pharm, Tubingen, Germany	University of Basel; University of Regensburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel; University of Bern; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Oeggerli, M (corresponding author), Univ Basel, Inst Pathol, Basel, Switzerland.	oeggerlim@uhbs.ch	Obermann, Ellen/E-2656-2013; Bubendorf, Lukas/G-5299-2015; Tian, Yuemin/AAE-8827-2021; Bubendorfl, Lukas/H-5880-2011	Bubendorf, Lukas/0000-0001-5970-1803; Zlobec, Inti/0000-0001-6741-3000; Kunzelmann, Karl/0000-0002-4583-7037	Swiss National Science Foundation [31003A_125181]; Deutsche Krebshilfe [109438]; Cancer League of Basel/Baselland [14-2010]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Krebshilfe(Deutsche Krebshilfe); Cancer League of Basel/Baselland	The work was supported by grants from the Swiss National Science Foundation (31003A_125181), Deutsche Krebshilfe (Projekt 109438), and from the Cancer League of Basel/Baselland (14-2010). http://www.snf.ch; http://www.krebshilfe.de; http://www.krebsliga-basel.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basrai D, 2002, NEUROREPORT, V13, P403, DOI 10.1097/00001756-200203250-00008; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Box AH, 2004, CARCINOGENESIS, V25, P2325, DOI 10.1093/carcin/bgh274; Buchanan G, 2005, CANCER RES, V65, P8487, DOI 10.1158/0008-5472.CAN-04-3077; Chen Lie, 2008, V491, P35, DOI 10.1007/978-1-59745-526-8_3; Coiret G, 2005, FEBS LETT, V579, P2995, DOI 10.1016/j.febslet.2005.02.085; Coiret G, 2007, MOL PHARMACOL, V71, P843, DOI 10.1124/mol.106.028290; HACKENBERG R, 1991, CANCER RES, V51, P5722; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kraft R, 2003, PFLUG ARCH EUR J PHY, V446, P248, DOI 10.1007/s00424-003-1012-4; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Liu B, 2009, BBA-BIOMEMBRANES, V1788, P2174, DOI 10.1016/j.bbamem.2009.07.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magklara A, 2002, INT J CANCER, V100, P507, DOI 10.1002/ijc.10520; Marques RB, 2005, INT J CANCER, V117, P221, DOI 10.1002/ijc.21201; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Ouadid-Ahidouch H, 2008, J MEMBRANE BIOL, V221, P1, DOI 10.1007/s00232-007-9080-6; Ousingsawat J, 2008, PFLUG ARCH EUR J PHY, V456, P847, DOI 10.1007/s00424-008-0451-3; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Qian X, 2002, J GEN PHYSIOL, V120, P829, DOI 10.1085/jgp.20028692; Ramirez-Rosas MB, 2011, STEROIDS, V76, P409, DOI 10.1016/j.steroids.2010.12.012; Roger S, 2004, BBA-BIOMEMBRANES, V1667, P190, DOI 10.1016/j.bbamem.2004.10.002; Ruiz C, 2006, INT J CANCER, V118, P2190, DOI 10.1002/ijc.21581; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Spitzner M, 2007, FASEB J, V21, P35, DOI 10.1096/fj.06-6200com; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Zellweger T, 2009, INT J CANCER, V124, P2116, DOI 10.1002/ijc.24174; Zhu N, 2005, FEBS LETT, V579, P4856, DOI 10.1016/j.febslet.2005.07.069	40	68	70	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41664	10.1371/journal.pone.0041664	http://dx.doi.org/10.1371/journal.pone.0041664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899999	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900014
J	Buschmann, AH; Tomova, A; Lopez, A; Maldonado, MA; Henriquez, LA; Ivanova, L; Moy, F; Godfrey, HP; Cabello, FC				Buschmann, Alejandro H.; Tomova, Alexandra; Lopez, Alejandra; Maldonado, Miguel A.; Henriquez, Luis A.; Ivanova, Larisa; Moy, Fred; Godfrey, Henry P.; Cabello, Felipe C.			Salmon Aquaculture and Antimicrobial Resistance in the Marine Environment	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; ANTIBIOTIC-RESISTANCE; OXOLINIC ACID; OXYTETRACYCLINE RESISTANCE; GROWTH PROMOTERS; WILD FISH; TETRACYCLINE; DETERMINANTS; SEDIMENTS; RESIDUES	Antimicrobials used in salmon aquaculture pass into the marine environment. This could have negative impacts on marine environmental biodiversity, and on terrestrial animal and human health as a result of selection for bacteria containing antimicrobial resistance genes. We therefore measured the numbers of culturable bacteria and antimicrobial-resistant bacteria in marine sediments in the Calbuco Archipelago, Chile, over 12-month period at a salmon aquaculture site approximately 20 m from a salmon farm and at a control site 8 km distant without observable aquaculture activities. Three antimicrobials extensively used in Chilean salmon aquaculture (oxytetracycline, oxolinic acid, and florfenicol) were studied. Although none of these antimicrobials was detected in sediments from either site, traces of flumequine, a fluoroquinolone antimicrobial also widely used in Chile, were present in sediments from both sites during this period. There were significant increases in bacterial numbers and antimicrobial-resistant fractions to oxytetracycline, oxolinic acid, and florfenicol in sediments from the aquaculture site compared to those from the control site. Interestingly, there were similar numbers of presumably plasmid-mediated resistance genes for oxytetracycline, oxolinic acid and florfenicol in unselected marine bacteria isolated from both aquaculture and control sites. These preliminary findings in one location may suggest that the current use of large amounts of antimicrobials in Chilean aquaculture has the potential to select for antimicrobial-resistant bacteria in marine sediments.	[Buschmann, Alejandro H.; Lopez, Alejandra; Maldonado, Miguel A.; Henriquez, Luis A.] Univ Los Lagos, Ctr i Mar, Puerto Montt, Chile; [Tomova, Alexandra; Ivanova, Larisa; Cabello, Felipe C.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Moy, Fred; Godfrey, Henry P.] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA	Universidad de Los Lagos; New York Medical College; New York Medical College	Buschmann, AH (corresponding author), Univ Los Lagos, Ctr i Mar, Puerto Montt, Chile.	cabello@nymc.edu	Buschmann, Alejandro H./B-4770-2012	Buschmann, Alejandro H./0000-0003-3246-681X; Godfrey, Henry/0000-0002-7195-6363	Lenfest Ocean Program/Pew Charitable Trusts	Lenfest Ocean Program/Pew Charitable Trusts	This research was supported by a grant from the Lenfest Ocean Program/Pew Charitable Trusts to F.C.C. and A.H.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; Aarestrup Frank M., 2008, Animal Health Research Reviews, V9, P135, DOI 10.1017/S1466252308001503; Akinbowale AL, 2007, INT J ANTIMICROB AG, V30, P177, DOI 10.1016/j.ijantimicag.2007.03.012; Asche Frank, 2008, P271, DOI 10.1007/978-1-4020-6810-2_9; Baquero F, 2009, CLIN MICROBIOL INFEC, V15, P5, DOI 10.1111/j.1469-0691.2008.02677.x; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; BARNES E. M., 1958, British Veterinary Journal, V114, P333; Barrientos M, 2006, THESIS U AUSTRAL CHI; Barton JR, 2010, GLOBAL ENVIRON CHANG, V20, P739, DOI 10.1016/j.gloenvcha.2010.04.001; Bey BS, 2010, BIOTECHNIQUES, V49, P631, DOI 10.2144/000113486; Bissett A, 2006, FEMS MICROBIOL ECOL, V55, P48, DOI 10.1111/j.1574-6941.2005.00012.x; BJORKLUND H, 1990, AQUACULTURE, V86, P359, DOI 10.1016/0044-8486(90)90324-G; Bolton LF, 1999, J CLIN MICROBIOL, V37, P1348, DOI 10.1128/JCM.37.5.1348-1351.1999; Bravo S, 2007, AQUACULTURE, V270, P36, DOI 10.1016/j.aquaculture.2007.06.017; Burridge L, 2010, AQUACULTURE, V306, P7, DOI 10.1016/j.aquaculture.2010.05.020; Buschmann AH, 2006, ICES J MAR SCI, V63, P1338, DOI 10.1016/j.icesjms.2006.04.021; Buschmann AH, 2009, OCEAN COAST MANAGE, V52, P243, DOI 10.1016/j.ocecoaman.2009.03.002; Bustos PA, 2011, AQUACULTURE, V310, P281, DOI 10.1016/j.aquaculture.2010.11.001; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Canton R, 2009, CLIN MICROBIOL INFEC, V15, P20, DOI 10.1111/j.1469-0691.2008.02679.x; Capone DG, 1996, AQUACULTURE, V145, P55, DOI 10.1016/S0044-8486(96)01330-0; Carroll ML, 2003, AQUACULTURE, V226, P165, DOI 10.1016/S0044-8486(03)00475-7; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; Cattoir V, 2007, ANTIMICROB AGENTS CH, V51, P2650, DOI 10.1128/AAC.00070-07; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Costa-Pierce BA, 2010, MAR TECHNOL SOC J, V44, P88, DOI 10.4031/MTSJ.44.3.3; Coyne R, 2001, MARINE ENV HLTH SERI, V3, P28; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; DEPAOLA A, 1995, APPL ENVIRON MICROB, V61, P2335, DOI 10.1128/AEM.61.6.2335-2340.1995; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Fortt A, 2007, REV CHIL INFECTOL, V24, P14; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; GRUMBLES LC, 1948, SCIENCE, V107, P196, DOI 10.1126/science.107.2773.196; Hastings PJ, 2004, TRENDS MICROBIOL, V12, P401, DOI 10.1016/j.tim.2004.07.003; HEKTOEN H, 1995, AQUACULTURE, V133, P175, DOI 10.1016/0044-8486(94)00310-K; Herwig RP, 1997, AQUACULTURE, V149, P263, DOI 10.1016/S0044-8486(96)01455-X; Heuer OE, 2009, CLIN INFECT DIS, V49, P1248, DOI 10.1086/605667; Holten Lutzhoft H-C, 1999, ARCH ENV CONTAM TOXI, V436, P1171; Jacobs L, 2007, INT J FOOD MICROBIOL, V114, P295, DOI 10.1016/j.ijfoodmicro.2006.09.030; JUKES TH, 1950, ARCH BIOCHEM, V26, P324; KAPETANAKI M, 1995, AQUACULTURE, V134, P227, DOI 10.1016/0044-8486(95)00062-7; Kerry J, 1996, AQUACULTURE, V145, P31, DOI 10.1016/S0044-8486(96)01353-1; Kim HK, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.066; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; Millanao A, 2002, THESIS U AUSTRAL CHI; Millanao A, 2011, REV MED CHILE, V139, P107, DOI /S0034-98872011000100015; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Miller RA, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.ARBA-0017-2017; Minarini LAR, 2008, J ANTIMICROB CHEMOTH, V62, P474, DOI 10.1093/jac/dkn237; Miranda CD, 2003, ANTIMICROB AGENTS CH, V47, P883, DOI 10.1128/AAC.47.3.883-888.2003; Miranda CD, 2001, MAR POLLUT BULL, V42, P1096, DOI 10.1016/S0025-326X(01)00093-5; MOORE PR, 1946, J BIOL CHEM, V165, P437; National Research Council, 2010, PREVENTION TREATMENT; Navarro N, 2008, MAR ECOL PROG SER, V361, P47, DOI 10.3354/meps07357; Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363; Pan JC, 2008, ANTIMICROB AGENTS CH, V52, P3829, DOI 10.1128/AAC.00375-08; Pepe MS, 2003, OXFORD STAT SCI SERI, V28, P318; Pouliquen H, 1997, J CHROMATOGR B, V702, P157, DOI 10.1016/S0378-4347(97)00373-3; Rhodes G, 2000, APPL ENVIRON MICROB, V66, P3883, DOI 10.1128/AEM.66.9.3883-3890.2000; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2006, ANTIMICROB AGENTS CH, V50, P2872, DOI 10.1128/AAC.01647-05; Rosewarne CP, 2010, FEMS MICROBIOL ECOL, V72, P35, DOI 10.1111/j.1574-6941.2009.00823.x; Saga T, 2005, ANTIMICROB AGENTS CH, V49, P2144, DOI 10.1128/AAC.49.5.2144-2145.2005; SAMUELSEN OB, 1992, DIS AQUAT ORGAN, V12, P111, DOI 10.3354/dao012111; SAMUELSEN OB, 1992, SCI TOTAL ENVIRON, V114, P25, DOI 10.1016/0048-9697(92)90411-K; Schmidt AS, 2000, APPL ENVIRON MICROB, V66, P4908, DOI 10.1128/AEM.66.11.4908-4915.2000; Schmidt AS, 2001, APPL ENVIRON MICROB, V67, P5675, DOI 10.1128/AEM.67.12.5675-5682.2001; SILVA J, 1987, Revista Latinoamericana de Microbiologia, V29, P165; Singer RS, 2004, ANTIMICROB AGENTS CH, V48, P4047, DOI 10.1128/AAC.48.10.4047-4049.2004; Smith P, 2008, REV SCI TECH OIE, V27, P243, DOI 10.20506/rst.27.1.1799; Smith P, 1996, AQUACULTURE, V146, P157, DOI 10.1016/S0044-8486(96)01382-8; Smith Peter, 1994, Annual Review of Fish Diseases, V4, P273, DOI 10.1016/0959-8030(94)90032-9; Sorensen LK, 2001, J LIQ CHROMATOGR R T, V24, P2469, DOI 10.1081/JLC-100105952; Sorum H, 2003, ANTIMICROB AGENTS CH, V47, P1285, DOI 10.1128/AAC.47.4.1285-1290.2003; Soto D, 2004, J APPL ICHTHYOL, V20, P493, DOI 10.1111/j.1439-0426.2004.00602.x; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tett Paul, 2008, P1, DOI 10.1007/978-1-4020-6810-2_1; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P1892, DOI 10.1128/AAC.01400-08; Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Weston DP, 2000, USE CHEM AQUACULTURE, P20; Xu H, 2007, J BACTERIOL, V189, P6276, DOI 10.1128/JB.00348-07	88	123	129	3	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42724	10.1371/journal.pone.0042724	http://dx.doi.org/10.1371/journal.pone.0042724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905164	Green Published, gold			2022-12-27	WOS:000307331100060
J	Hsieh, TH; Tsai, CF; Hsu, CY; Kuo, PL; Hsi, E; Suen, JL; Hung, CH; Lee, JN; Chai, CY; Wang, SC; Tsai, EM				Hsieh, Tsung-Hua; Tsai, Cheng-Fang; Hsu, Chia-Yi; Kuo, Po-Lin; Hsi, Edward; Suen, Jau-Ling; Hung, Chih-Hsing; Lee, Jau-Nan; Chai, Chee-Yin; Wang, Shao-Chun; Tsai, Eing-Mei			n-Butyl Benzyl Phthalate Promotes Breast Cancer Progression by Inducing Expression of Lymphoid Enhancer Factor 1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR RECEPTOR; STEM-LIKE CELLS; ESTROGEN-RECEPTOR; BETA-CATENIN; SIGNALING PATHWAY; WNT PATHWAY; IN-VITRO; ANGIOGENESIS; INVASION	Environmental hormones play important roles in regulating the expression of genes involved in cell proliferation, drug resistance, and breast cancer risk; however, their precise role in human breast cancer cells during cancer progression remains unclear. To elucidate the effect of the most widely used industrial phthalate, n-butyl benzyl phthalate (BBP), on cancer progression, we evaluated the results of BBP treatment using a whole human genome cDNA microarray and MetaCore software and selected candidate genes whose expression was changed by more than ten-fold by BBP compared with controls to analyze the signaling pathways in human breast cancer initiating cells (R2d). A total of 473 genes were upregulated, and 468 were downregulated. Most of these genes are involved in proliferation, epithelial-mesenchymal transition, and angiogenesis signaling. BBP induced the viability, invasion and migration, and tube formation in vitro, and Matrigel plug angiogenesis in vivo of R2d and MCF-7. Furthermore, the viability and invasion and migration of these cell lines following BBP treatment was reduced by transfection with a small interfering RNA targeting the mRNA for lymphoid enhancer-binding factor 1; notably, the altered expression of this gene consistently differentiated tumors expressing genes involved in proliferation, epithelial-mesenchymal transition, and angiogenesis. These findings contribute to our understanding of the molecular impact of the environmental hormone BBP and suggest possible strategies for preventing and treating human breast cancer.	[Hsieh, Tsung-Hua; Tsai, Cheng-Fang; Hsu, Chia-Yi; Hsi, Edward; Suen, Jau-Ling; Tsai, Eing-Mei] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Kuo, Po-Lin] Kaohsiung Med Univ, Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Kuo, Po-Lin; Lee, Jau-Nan; Chai, Chee-Yin; Tsai, Eing-Mei] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Hung, Chih-Hsing] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Wang, Shao-Chun] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH USA; [Lee, Jau-Nan; Tsai, Eing-Mei] Kaohsiung Med Univ, Dept Obstet & Gynecol, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University System of Ohio; University of Cincinnati; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Hsieh, TH (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.	tsaieing@yahoo.com	Wang, Shao-Chun/P-9904-2019; Hsi, Edward/A-1356-2013; Hsieh, Tsung-Hua/B-2132-2013; Suen, Jan-Ling/C-7293-2009	Wang, Shao-Chun/0000-0002-5477-1682; Hsi, Edward/0000-0002-8272-6707; Hsu, ChiaYi/0000-0001-6809-2165; Chai, Chee-Yin/0000-0003-0486-9742; Suen, Jau-Ling/0000-0002-5146-8354	National Science Council, Taiwan [99-2628-B-037-009-MY3]; Ministry of Education, Taiwan [KMU-EM-99-3]; Kaohsiung Medical University (Hospital) Research Fund [KMUH 97-7R08, KMUH 98-8R19, KMUH 99-9I04, KMUH 99-9R30, KMUER-004]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Kaohsiung Medical University (Hospital) Research Fund	This work was supported in part by the National Science Council, Taiwan [99-2628-B-037-009-MY3]; the Ministry of Education, Taiwan [KMU-EM-99-3]; and the Kaohsiung Medical University (Hospital) Research Fund [KMUH 97-7R08, KMUH 98-8R19, KMUH 99-9I04, KMUH 99-9R30, and KMUER-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alfranca A, 2008, BLOOD, V112, P1120, DOI 10.1182/blood-2007-09-112268; Ao A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018810; Barbieri F, 2012, EXP CELL RES, V318, P847, DOI 10.1016/j.yexcr.2012.02.008; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Buteau-Lozano H, 2008, J ENDOCRINOL, V196, P399, DOI 10.1677/JOE-07-0198; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Gustavson MD, 2004, MOL CARCINOGEN, V41, P125, DOI 10.1002/mc.20049; Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802; Hsieh TH, 2011, FASEB J; Hsieh TH, 2012, TOXICOL SCI; Huang PC, 2010, HUM REPROD, V25, P986, DOI 10.1093/humrep/deq015; Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Kang KS, 1998, MOL CARCINOGEN, V21, P225, DOI 10.1002/(SICI)1098-2744(199804)21:4<225::AID-MC1>3.0.CO;2-J; Kim IY, 2004, J TOXICOL ENV HEAL A, V67, P2025, DOI 10.1080/15287390490514750; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Konno H, 2003, CANCER SCI, V94, P735, DOI 10.1111/j.1349-7006.2003.tb01511.x; Leushacke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023381; Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Ma MY, 2006, TOXICOL SCI, V93, P164, DOI 10.1093/toxsci/kfl036; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marchenko ND, 2004, INT J BIOCHEM CELL B, V36, P942, DOI 10.1016/j.biocel.2003.12.007; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Mei JM, 2000, FASEB J, V14, P1188, DOI 10.1096/fasebj.14.9.1188; Merkle D, 2011, CELL SIGNAL, V23, P507, DOI 10.1016/j.cellsig.2010.08.017; Moore NP, 2000, REPROD TOXICOL, V14, P183, DOI 10.1016/S0890-6238(00)00068-X; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; Nguyen A, 2005, INT J ONCOL, V27, P949; Obermair A, 1997, INT J CANCER, V74, P455, DOI 10.1002/(SICI)1097-0215(19970822)74:4<455::AID-IJC17>3.0.CO;2-8; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ray S, 2008, MOL ENDOCRINOL, V22, P1125, DOI 10.1210/me.2007-0445; Rhodes LV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-295; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Strizzi Luigi, 2008, Breast Dis, V29, P91; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Wang KH, 2010, BIOL CELL, V102, P159, DOI 10.1042/BC20090132; Wang SH, 2009, BIOCHEM BIOPH RES CO, V388, P67, DOI 10.1016/j.bbrc.2009.07.117; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Zhang YS, 2011, BLOOD, V118, P5355, DOI 10.1182/blood-2011-04-350587; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	51	42	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42750	10.1371/journal.pone.0042750	http://dx.doi.org/10.1371/journal.pone.0042750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905168	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100061
J	Yerkes, RW; Khalaily, H; Barkai, R				Yerkes, Richard W.; Khalaily, Hamudi; Barkai, Ran			Form and Function of Early Neolithic Bifacial Stone Tools Reflects Changes in Land Use Practices during the Neolithization Process in the Levant	PLOS ONE			English	Article							HOLOCENE CLIMATE; TRANSITION; VALLEY; MOTZA	For many, climate change is no longer recognized as the primary cause of cultural changes in the Near East. Instead, human landscape degradation, population growth, socioeconomic adjustments, and conflict have been proposed as the mechanisms that shaped the Neolithic Revolution. However, as Bar-Yosef noted, even if there is chronological correlation between climate changes and cultural developments, what is important is to understand how Neolithic societies dealt with these improving or deteriorating environments. Changes in bifacial stone tools provide a framework for examining some of these interactions by focusing on changing land use practices during the Neolithization process. The results of microwear analysis of 40 bifacial artifacts from early Pre-Pottery Neolithic (EPPNB) levels at Motza in the Judean hills document changes during the PPNA-PPNB transition at the onset of the Levantine Moist Period (ca. 8000 cal B.C.) when conditions for agriculture improved. EPPNB villagers added heavy-duty axes to a toolkit they had used for carpentry and began to clear forests for fields and grazing lands. Sustainable forest management continued for the duration of the PPN until the cumulative effects of tree-felling and overgrazing seem to have led to landscape degradation at end of the Pre-Pottery Neolithic C (PPNC), when a cold, dry climatic anomaly (6600-6000 cal B. C.) may have accelerated the reduction of woodlands. Early PPNB components at sites like Motza, with data from nearly five millennia of Neolithic occupations, show how complex hunter-gatherers and early food producers were able to establish sustainable resource management systems even as climate changed, population increased, and social relations were redefined.	[Yerkes, Richard W.] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Khalaily, Hamudi] Israel Antiqu Author, Jerusalem, Israel; [Barkai, Ran] Tel Aviv Univ, Dept Archaeol, IL-69978 Tel Aviv, Israel	University System of Ohio; Ohio State University; Tel Aviv University	Yerkes, RW (corresponding author), Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA.	barkaran@post.tau.ac.il	Barkai, Ran/L-6495-2019; Yerkes, Richard/AAC-9112-2020	BARKAI, RAN/0000-0002-8125-8788				Balee W., 1998, ADV HIST ECOLOGY; Bar-Matthews M, 1999, EARTH PLANET SC LETT, V166, P85, DOI 10.1016/S0012-821X(98)00275-1; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Bar-Yosef O., 2009, ARCHAEOLOGY ENV CHAN, P192; Bar-Yosef Ofer, 2008, HDB LANDSCAPE ARCHAE, P315; Barkai R., 2008, PREHISTORIC TECHNOLO, P159; Barkai R., 2011, STONE AXE STUDIES 3, P39; Barkai Ran, 2008, TIME MIND, V1, P273, DOI DOI 10.2752/175169708X329345; Bocquet-Appel JP, 2011, CURR ANTHROPOL, V52, pS497, DOI 10.1086/659243; BocquetAppel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P1, DOI 10.1007/978-1-4020-8539-0; Enzel Y, 2006, NEW FRONTIERS 33 34; Frumkin A., 1991, HOLOCENE, V1, P191, DOI [DOI 10.1177/095968369100100301, 10.1177/095968369100100301]; Goring-Morris AN, 2011, CURR ANTHROPOL, V52, pS195, DOI 10.1086/658860; HAYDEN B, 1990, J ANTHROPOL ARCHAEOL, V9, P31, DOI 10.1016/0278-4165(90)90005-X; Hill J. Brett, 2009, ARCHAEOLOGY ENV CHAN, P160; Keeley L.H., 1980, EXPT DETERMINATION S; KEELEY LH, 1982, AM ANTIQUITY, V47, P798, DOI 10.2307/280285; Khalaily H, 2007, PALEORIENT, V33, P5, DOI DOI 10.3406/PALE0.2007.5218; Kuijt I, 2002, J WORLD PREHIST, V16, P361, DOI 10.1023/A:1022973114090; Liran R, 2011, ANTIQUITY, V85; Mayer DEBY, 2008, P NATL ACAD SCI USA, V105, P8548, DOI 10.1073/pnas.0709931105; Migowski C, 2006, QUATERNARY RES, V66, P421, DOI 10.1016/j.yqres.2006.06.010; MOORE AMT, 1992, AM ANTIQUITY, V57, P482, DOI 10.2307/280936; Olausson D., 1983, FLINT GROUNDSTONE AX; Parkinson William A., 2002, ARCHAEOLOGY TRIBAL S, P391; Roberts N, 2002, ANTIQUITY, V76, P1002, DOI 10.1017/S0003598X0009181X; ROLLEFSON GO, 1992, J FIELD ARCHAEOL, V19, P443, DOI 10.2307/530427; Rosen AM, 2012, P NATL ACAD SCI USA, V109, P3640, DOI 10.1073/pnas.1113931109; Sapir-Hen L, 2009, J ARCHAEOL SCI, V36, P1538, DOI 10.1016/j.jas.2009.03.015; Semenov S., 1964, PREHISTORIC TECHNOLO; Simmons AH, 2007, NEOLITHIC REVOLUTION; UCKO PJ, 1969, DOMESTICATION EXPLOI; Valla F., 2002, B CTR RECHERCHE FRAN, V10, P71; Weninger B, 2009, DOC PRAEHIST, V36, P7, DOI 10.4312/dp.36.2; Willcox G, 2009, HOLOCENE, V19, P151, DOI 10.1177/0959683608098961; Yasuda Y, 2000, QUATERN INT, V73-4, P127, DOI 10.1016/S1040-6182(00)00069-0; Yerkes RW, 2003, J ARCHAEOL SCI, V30, P1051, DOI 10.1016/S0305-4403(03)00007-4; Yizhaq M, 2005, RADIOCARBON, V47, P193, DOI 10.1017/S003382220001969X; Zeder MA, 2012, J ANTHROPOL ARCHAEOL, V31, P241, DOI 10.1016/j.jaa.2012.03.003	39	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42442	10.1371/journal.pone.0042442	http://dx.doi.org/10.1371/journal.pone.0042442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	986GX	22905133	gold, Green Submitted, Green Published			2022-12-27	WOS:000307331100039
J	Capo-Ramos, DE; Gao, Y; Lubin, JH; Check, DP; Goldin, LR; Pesatori, AC; Consonni, D; Bertazzi, PA; Saxon, AJ; Bergen, AW; Caporaso, NE; Landi, MT				Capo-Ramos, David E.; Gao, Ying; Lubin, Jay H.; Check, David P.; Goldin, Lynn R.; Pesatori, Angela C.; Consonni, Dario; Bertazzi, Pier Alberto; Saxon, Andrew J.; Bergen, Andrew W.; Caporaso, Neil E.; Landi, Maria Teresa			Mood Disorders and Risk of Lung Cancer in the EAGLE Case-Control Study and in the US Veterans Affairs Inpatient Cohort	PLOS ONE			English	Article							BIPOLAR DISORDER; MAJOR DEPRESSION; RECORD-LINKAGE; SEROTONIN; GENETICS; SMOKING; ANTIDEPRESSANTS; SCHIZOPHRENIA; ENVIRONMENT; POPULATION	Background: Mood disorders may affect lung cancer risk. We evaluated this hypothesis in two large studies. Methodology/Principal Findings: We examined 1,939 lung cancer cases and 2,102 controls from the Environment And Genetics in Lung cancer Etiology (EAGLE) case-control study conducted in Italy (2002-2005), and 82,945 inpatients with a lung cancer diagnosis and 3,586,299 person-years without a lung cancer diagnosis in the U. S. Veterans Affairs Inpatient Cohort (VA study), composed of veterans with a VA hospital admission (1969-1996). In EAGLE, we calculated odds ratios (ORs) and 95% confidence intervals (CI), with extensive adjustment for tobacco smoking and multiple lifestyle factors. In the VA study, we estimated lung cancer relative risks (RRs) and 95% CIs with time-dependent Poisson regression, adjusting for attained age, calendar year, hospital visits, time within the study, and related previous medical diagnoses. In EAGLE, we found decreased lung cancer risk in subjects with a personal history of mood disorders (OR: 0.59, 95% CI: 0.44-0.79, based on 121 lung cancer incident cases and 192 controls) and family history of mood disorders (OR: 0.62, 95% CI: 0.50-0.77, based on 223 lung cancer cases and 345 controls). The VA study analyses yielded similar results (RR: 0.74, 95% CI: 0.71-0.77, based on 2,304 incident lung cancer cases and 177,267 non-cancer person-years) in men with discharge diagnoses for mood disorders. History of mood disorders was associated with nicotine dependence, alcohol and substance use and psychometric scales of depressive and anxiety symptoms in controls for these studies. Conclusions/Significance: The consistent finding of a relationship between mood disorders and lung cancer risk across two large studies calls for further research into the complex interplay of risk factors associated with these two widespread and debilitating diseases. Although we adjusted for smoking effects in EAGLE, residual confounding of the results by smoking cannot be ruled out.	[Capo-Ramos, David E.; Gao, Ying; Lubin, Jay H.; Check, David P.; Goldin, Lynn R.; Caporaso, Neil E.; Landi, Maria Teresa] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Pesatori, Angela C.; Consonni, Dario; Bertazzi, Pier Alberto] Univ Milan, Epidemiol Res Ctr, EPOCA, Milan, Italy; [Pesatori, Angela C.; Consonni, Dario; Bertazzi, Pier Alberto] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Epidemiol Unit, Milan, Italy; [Saxon, Andrew J.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; [Saxon, Andrew J.] Addict Psychiat Residency Program, Seattle, WA USA; [Saxon, Andrew J.] Univ Washington, Seattle, WA 98195 USA; [Bergen, Andrew W.] SRI Int, Ctr Hlth Sci, Mol Genet Program, Menlo Pk, CA 94025 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; SRI International	Capo-Ramos, DE (corresponding author), Ctr Dis Control & Prevent, Off Anal & Epidemiol, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA.	landim@mail.nih.gov	bertazzi, pietro alberto/D-5039-2017; Consonni, Dario/K-7943-2016; Consonni, Dario/AAM-2947-2020; Check, David P/J-7184-2015; pesatori, angela/K-5742-2016	bertazzi, pietro alberto/0000-0003-3475-2449; Consonni, Dario/0000-0002-8935-3843; Consonni, Dario/0000-0002-8935-3843; Check, David P/0000-0003-3887-0493; pesatori, angela/0000-0002-0261-3252; Bergen, Andrew/0000-0002-1237-7644	National Institutes of Health, National Cancer Institute (Division of Cancer Epidemiology and Genetics); Region of Lombardy, Milan, Italy (Environmental Epidemiology Program); Center of Excellence in Substance Abuse Treatment and Education at VA Puget Sound Health Care System; NIH [U01DA020830, RC2DA028793]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA033813, RC2DA028793, U01DA020830] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute (Division of Cancer Epidemiology and Genetics)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Region of Lombardy, Milan, Italy (Environmental Epidemiology Program); Center of Excellence in Substance Abuse Treatment and Education at VA Puget Sound Health Care System; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study was provided by the Intramural Research Program of the National Institutes of Health, National Cancer Institute (Division of Cancer Epidemiology and Genetics) and by the Region of Lombardy, Milan, Italy (Environmental Epidemiology Program). Dr. Saxon is supported by the Center of Excellence in Substance Abuse Treatment and Education at VA Puget Sound Health Care System. Dr. Bergen is supported by NIH grants U01DA020830 and RC2DA028793. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst J, 2000, BIOL PSYCHIAT, V48, P445, DOI 10.1016/S0006-3223(00)00909-4; Boyko EJ, 2000, AM J EPIDEMIOL, V151, P307, DOI 10.1093/oxfordjournals.aje.a010207; Brennan C, 2010, J PSYCHOSOM RES, V69, P371, DOI 10.1016/j.jpsychores.2010.04.006; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P161, DOI 10.1001/archpsyc.55.2.161; Breslow N E, 1987, IARC Sci Publ, P1; Brewer JK, 2008, J MOL NEUROSCI, V35, P307, DOI 10.1007/s12031-008-9078-2; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Dalton SO, 2002, AM J EPIDEMIOL, V155, P1088, DOI 10.1093/aje/155.12.1088; de Girolamo G, 2006, SOC PSYCH PSYCH EPID, V41, P853, DOI 10.1007/s00127-006-0097-4; Diaz FJ, 2009, BIPOLAR DISORD, V11, P154, DOI 10.1111/j.1399-5618.2009.00664.x; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Drozdov I, 2009, CANCER-AM CANCER SOC, V115, P4934, DOI 10.1002/cncr.24533; FAWCETT J, 1987, AM J PSYCHIAT, V144, P35; Fidler JA, 2011, ADDICTION, V106, P631, DOI 10.1111/j.1360-0443.2010.03226.x; Fitzgerald Paul J, 2010, Clin Epidemiol, V2, P1; Gelenberg AJ, 2010, J CLIN PSYCHIAT, V71, P6; Goldacre MJ, 2007, SOC PSYCH PSYCH EPID, V42, P683, DOI 10.1007/s00127-007-0211-2; Gross AL, 2010, CANCER CAUSE CONTROL, V21, P191, DOI 10.1007/s10552-009-9449-1; Guo K, 2009, ONCOL REP, V22, P825, DOI 10.3892/or_00000505; Haukka J, 2010, INT J CANCER, V126, P285, DOI 10.1002/ijc.24537; Hippisley-Cox J, 2007, ARCH GEN PSYCHIAT, V64, P1368, DOI 10.1001/archpsyc.64.12.1368; Hooper TI, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-15; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; KAPLAN GA, 1988, J BEHAV MED, V11, P1, DOI 10.1007/BF00846165; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P36; Kessing LV, 1998, EUR PSYCHIAT, V13, P342, DOI 10.1016/S0924-9338(99)80700-7; Knekt P, 1996, AM J EPIDEMIOL, V144, P1096, DOI 10.1093/oxfordjournals.aje.a008887; Landi MT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-203; Lau JYF, 2010, ANNU REV CLIN PSYCHO, V6, P313, DOI 10.1146/annurev.clinpsy.121208.131308; Lieb JL, 2007, MED HYPOTHESES, V69, P684, DOI 10.1016/j.mehy.2007.01.036; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Oerlemans Marjolein Ej, 2007, Clin Pract Epidemiol Ment Health, V3, P29, DOI 10.1186/1745-0179-3-29; Penninx BWJH, 1998, J NATL CANCER I, V90, P1888, DOI 10.1093/jnci/90.24.1888; Pratesi G, 1996, ANTICANCER RES, V16, P3615; Rao ML, 1998, NEUROPSYCHOBIOLOGY, V38, P84, DOI 10.1159/000026522; RICHARDSON C, 2003, VETERANS 2000 CENSUS; Sharma U, 1996, DRUG METAB DISPOS, V24, P669; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; Taioli E, 2008, CARCINOGENESIS, V29, P1467, DOI 10.1093/carcin/bgn062; Toh S, 2007, CANCER CAUSE CONTROL, V18, P1055, DOI 10.1007/s10552-007-9045-1; Van Dam NT, 2010, PSYCHIAT RES; Vicaut E, 2000, ANN MED, V32, P187, DOI 10.3109/07853890008998826; Walker AJ, 2011, BRIT J CANCER, V104, P193, DOI 10.1038/sj.bjc.6605996	44	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42945	10.1371/journal.pone.0042945	http://dx.doi.org/10.1371/journal.pone.0042945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880133	Green Submitted, Green Published, gold			2022-12-27	WOS:000307437900063
J	Boyles, TH; Black, J; Meintjes, G; Mendelson, M				Boyles, Tom H.; Black, John; Meintjes, Graeme; Mendelson, Marc			Failure to Eradicate Isospora belli Diarrhoea Despite Immune Reconstitution in Adults with HIV - A Case Series	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; INTESTINAL PARASITIC INFECTIONS; ANTIRETROVIRAL THERAPY; PROPHYLAXIS; DISEASES	Isospora belli causes diarrhoea in patients with AIDS. Most respond to targeted therapy and recommendations are that secondary prophylaxis can be stopped following immune reconstitution with ART. We report eight cases of chronic isosporiasis that persisted despite standard antimicrobial therapy, secondary prophylaxis, and good immunological and virological response to ART. Median CD4 nadir was 175.5 cells/mm(3) and median highest CD4 while symptomatic was 373 cells/mm(3). Overall 34% of stool samples and 63% of duodenal biopsy specimens were positive for oocytes. Four patients died, two remain symptomatic and two recovered. Possible explanations for persistence of symptoms include host factors such as antigen specific immune deficiency or generalised reduction in gut immunity. Parasite factors may include accumulating resistance to co-trimoxazole. Research is required to determine the optimum dose and duration of co-trimoxazole therapy and whether dual therapy may be necessary. Mortality was high and pending more data we recommend extended treatment with high-dose co-trimoxazole in similar cases.	[Boyles, Tom H.; Black, John; Meintjes, Graeme; Mendelson, Marc] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme] Inst Infect Dis & Mol Med, Cape Town, South Africa; [Meintjes, Graeme] GF Jooste Hosp, Cape Town, South Africa	University of Cape Town; University of Cape Town	Boyles, TH (corresponding author), Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, Groote Schuur Hosp, ZA-7925 Cape Town, South Africa.	tomboyles@yahoo.com		Meintjes, Graeme/0000-0003-1196-4414; Boyles, Tom/0000-0002-5676-8081; Black, John/0000-0002-7845-4972; Mendelson, Marc/0000-0001-6668-3893	PEPFAR/USAID; Wellcome Trust, London, United Kingdom; Fogarty International Center; National Institutes of Health (NIH) [NIH/FIC U2RTW007373-01A1, URTW007370-01A1]	PEPFAR/USAID(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Wellcome Trust, London, United Kingdom(Wellcome Trust); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	TB is funded by, and MM and GM receive support from, a grant from PEPFAR/USAID, administered by ANOVA Healthcare Institute. GM is funded by the Wellcome Trust, London, United Kingdom, and also received SATBAT research training that was funded by the Fogarty International Center and National Institutes of Health (NIH) (NIH/FIC U2RTW007373-01A1 and URTW007370-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assefa S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-155; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; DEHOVITZ JA, 1986, NEW ENGL J MED, V315, P87, DOI 10.1056/NEJM198607103150203; Doumbo O, 1997, AM J TROP MED HYG, V56, P637, DOI 10.4269/ajtmh.1997.56.637; Frenkel JK, 2003, J EUKARYOT MICROBIOL, V50, P682, DOI 10.1111/j.1550-7408.2003.tb00686.x; Heyworth MF, 1996, GASTROENTEROL CLIN N, V25, P691, DOI 10.1016/S0889-8553(05)70269-7; Jongwutiwes S, 2002, SCAND J INFECT DIS, V34, P859, DOI 10.1080/0036554021000026947; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kirk O, 2002, ANN INTERN MED, V137, P239, DOI 10.7326/0003-4819-137-4-200208200-00008; PAPE JW, 1989, NEW ENGL J MED, V320, P1044, DOI 10.1056/NEJM198904203201604; Bachur TPR, 2008, BRAZ J INFECT DIS, V12, P115, DOI 10.1590/S1413-86702008000200004; ten Hove RJ, 2008, DIAGN MICR INFEC DIS, V61, P280, DOI 10.1016/j.diagmicrobio.2008.03.003; Verdier RI, 2000, ANN INTERN MED, V132, P885, DOI 10.7326/0003-4819-132-11-200006060-00006	13	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42844	10.1371/journal.pone.0042844	http://dx.doi.org/10.1371/journal.pone.0042844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880120	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000077
J	Coleman, MD; O'Neil, JD; Woehrling, EK; Ndunge, OBA; Hill, EJ; Menache, A; Reiss, CJ				Coleman, Michael D.; O'Neil, John D.; Woehrling, Elizabeth K.; Ndunge, Oscar Bate Akide; Hill, Eric J.; Menache, Andre; Reiss, Claude J.			A Preliminary Investigation into the Impact of a Pesticide Combination on Human Neuronal and Glial Cell Lines In Vitro	PLOS ONE			English	Article							FIELD APPLICATION; APOPTOSIS; RESIDUES; GRAPES; WINE; TRIMETHYLTIN; FLUDIOXONIL; CYPRODINIL; ASTROCYTES; TOXICITY	Many pesticides are used increasingly in combinations during crop protection and their stability ensures the presence of such combinations in foodstuffs. The effects of three fungicides, pyrimethanil, cyprodinil and fludioxonil, were investigated together and separately on U251 and SH-SY5Y cells, which can be representative of human CNS glial and neuronal cells respectively. Over 48h, all three agents showed significant reductions in cellular ATP, at concentrations that were more than tenfold lower than those which significantly impaired cellular viability. The effects on energy metabolism were reflected in their marked toxic effects on mitochondrial membrane potential. In addition, evidence of oxidative stress was seen in terms of a fall in cellular thiols coupled with increases in the expression of enzymes associated with reactive species formation, such as GSH peroxidase and superoxide dismutase. The glial cell line showed significant responsiveness to the toxin challenge in terms of changes in antioxidant gene expression, although the neuronal SH-SY5Y line exhibited greater vulnerability to toxicity, which was reflected in significant increases in caspase-3 expression, which is indicative of the initiation of apoptosis. Cyprodinil was the most toxic agent individually, although oxidative stress-related enzyme gene expression increases appeared to demonstrate some degree of synergy in the presence of the combination of agents. This report suggests that the impact of some pesticides, both individually and in combinations, merits further study in terms of their impact on human cellular health.	[Coleman, Michael D.; O'Neil, John D.; Woehrling, Elizabeth K.; Ndunge, Oscar Bate Akide; Hill, Eric J.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Menache, Andre; Reiss, Claude J.] Antidote Europe, Perpignan, France	Aston University	Coleman, MD (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	m.d.coleman@aston.ac.uk	Coleman, Michael Damian/AAD-5503-2019	Hill, Eric/0000-0002-9419-1500; Coleman, MIchael D/0000-0002-5510-6852	Marchig Animal Welfare Trust Edinburgh, United Kingdom; Union Belge pour l'Abolition de l'Experimentation sur Animaux Vivants (UBAEAV, Belgium)	Marchig Animal Welfare Trust Edinburgh, United Kingdom; Union Belge pour l'Abolition de l'Experimentation sur Animaux Vivants (UBAEAV, Belgium)	This study received financial support from The Marchig Animal Welfare Trust Edinburgh, United Kingdom (www.marchigtrust.org), as well as the Union Belge pour l'Abolition de l'Experimentation sur Animaux Vivants (UBAEAV, Rue H. van Zuylen 21, 1180 Bruxelles Tel: 02/376 82 83 Bruxelles, Belgium. In addition, Generations Futures, Paris, France (http://www.mdrgf.org) also contributed to the funding of the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavanja MCR, 2003, AM J EPIDEMIOL, V157, P800, DOI 10.1093/aje/kwg040; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Anli E, 2007, J I BREWING, V113, P213, DOI 10.1002/j.2050-0416.2007.tb00278.x; Band PR, 2011, PROSTATE, V71, P168, DOI 10.1002/pros.21232; Brecht S, 2001, MOL BRAIN RES, V94, P25, DOI 10.1016/S0006-8993(01)02767-6; Cabras P, 1997, J AGR FOOD CHEM, V45, P2708, DOI 10.1021/jf960939x; Caceres TP, 2011, ECOTOXICOLOGY, V20, P20, DOI 10.1007/s10646-010-0552-6; Coleman MD, 2000, BIOCHEM PHARMACOL, V60, P1409, DOI 10.1016/S0006-2952(00)00333-6; Coleman MD, 2008, BASIC CLIN PHARMACOL, V102, P25, DOI 10.1111/j.1742-7843.2007.00148.x; Cus F, 2010, FOOD CONTROL, V21, P1512, DOI 10.1016/j.foodcont.2010.04.024; DANIELS A, 1995, PESTIC SCI, V45, P33, DOI 10.1002/ps.2780450106; Engelmeier D, 2006, ADV PHYTOMED, V3, P423; Ensminger M, 2008, ENVIRON MONIT ASSESS, V4, P573; European Food Safety Authority, 2009, 231 EFSA, P1; FAO-WHO, 2005, JOINT M FAO PAN EXP; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; Figiel I, 2002, NEUROTOXICOLOGY, V23, P77, DOI 10.1016/S0161-813X(02)00006-2; Franco R, 2010, CHEM-BIOL INTERACT, V188, P289, DOI 10.1016/j.cbi.2010.06.003; Fritz R, 1997, PESTIC SCI, V49, P40, DOI 10.1002/(SICI)1096-9063(199701)49:1&lt;40::AID-PS470&gt;3.0.CO;2-Y; Gabryel B, 2002, NEUROTOXICOLOGY, V23, P19, DOI 10.1016/S0161-813X(02)00004-9; Gartlon J, 2006, TOXICOL IN VITRO, V20, P1569, DOI 10.1016/j.tiv.2006.07.009; Gradish AE, 2010, PEST MANAG SCI, V66, P142, DOI 10.1002/ps.1846; Holden LJ, 2008, ENVIRON TOXICOL PHAR, V26, P290, DOI 10.1016/j.etap.2008.05.009; Holden LJ, 2007, TOXICOLOGY, V241, P75, DOI 10.1016/j.tox.2007.08.083; Jaworska-Feil L, 2010, NEUROPEPTIDES, V44, P495, DOI 10.1016/j.npep.2010.08.004; Jimenez JJ, 2007, FOOD CHEM, V104, P216, DOI 10.1016/j.foodchem.2006.11.027; Karadag H, 2010, ASIAN J CHEM, V22, P8147; Kimura H, 2010, TOXIN REV, V29, P43, DOI 10.3109/15569543.2010.483533; Koprivica V, 2011, EUR J PHARMACOL, V651, P73, DOI 10.1016/j.ejphar.2010.10.064; Li WJ, 2011, J ZHEJIANG UNIV-SC B, V12, P226, DOI 10.1631/jzus.B0900264; Likas DT, 2011, FOOD ADDIT CONTAM A, V28, P189, DOI 10.1080/19440049.2010.542184; Liu CY, 2011, ENVIRON MONIT ASSESS, V179, P209, DOI 10.1007/s10661-010-1730-y; Lo Curto R, 2004, FOOD CHEM, V84, P71, DOI 10.1016/S0308-8146(03)00168-7; Lorenzin M, 2007, J ENVIRON SCI HEAL B, V42, P823, DOI 10.1080/03601230701555021; Gonzalez-Rodriguez RM, 2009, J CHROMATOGR A, V1216, P6033, DOI 10.1016/j.chroma.2009.06.046; Marin A, 2003, J AGR FOOD CHEM, V51, P4708, DOI 10.1021/jf021222e; Marini AM, 2000, J NEUROSCI RES, V62, P814, DOI 10.1002/1097-4547(20001215)62:6<814::AID-JNR8>3.3.CO;2-6; McConkey DJ, 1998, TOXICOL LETT, V99, P157, DOI 10.1016/S0378-4274(98)00155-6; Oliva J, 2007, J ENVIRON SCI HEAL B, V42, P775, DOI 10.1080/03601230701550964; Pillonel C, 1997, PESTIC SCI, V49, P229, DOI 10.1002/(SICI)1096-9063(199703)49:3&lt;229::AID-PS525&gt;3.0.CO;2-T; Pose-Juan E, 2011, J HAZARD MATER, V193, P288, DOI 10.1016/j.jhazmat.2011.07.074; RAGAN CI, 1987, CURR TOP BIOENERG, V15, P1; Raicevic N, 2005, NEUROPHARMACOLOGY, V48, P720, DOI 10.1016/j.neuropharm.2004.12.003; Ravelo-Perez LM, 2007, ELECTROPHORESIS, V28, P4072, DOI 10.1002/elps.200700251; Ravelo-Perez LM, 2007, ELECTROPHORESIS, V28, P1805, DOI 10.1002/elps.200600526; Reali C, 2005, J NEUROSCI RES, V81, P677, DOI 10.1002/jnr.20584; Reus J, 2002, AGR ECOSYST ENVIRON, V90, P177, DOI 10.1016/S0167-8809(01)00197-9; ROSS RA, 1983, J NATL CANCER I, V71, P741; Rosslenbroich HJ, 2008, J PLANT DIS PROTECT, V115, P208; Schuliga M, 2002, TOXICOL SCI, V70, P183, DOI 10.1093/toxsci/70.2.183; Sidiropoulou E, 2011, TOXICOL LETT, V201, P86, DOI 10.1016/j.toxlet.2010.12.009; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Thrupp L. A., 1990, International Journal of Environmental Studies, V36, P173, DOI 10.1080/00207239008710594; Tsiropoulos NG, 2005, J AGR FOOD CHEM, V53, P10091, DOI 10.1021/jf052162q; Tuzmen MN, 2007, TOXICOL MECH METHOD, V17, P535, DOI 10.1080/15376510701380463; U.S. Environmental Protection Agency, 1998, PEST FACT SHEET CYPR; Wang W, 2011, J NEUROSURG, V114, P689, DOI 10.3171/2010.2.JNS09719; WIKSTRAND CJ, 1981, J NEUROIMMUNOL, V1, P249, DOI 10.1016/0165-5728(81)90029-1; Wing KD, 2000, CROP PROT, V19, P537, DOI 10.1016/S0261-2194(00)00070-3; Yang W, 2010, TOXICOL LETT, V199, P239, DOI 10.1016/j.toxlet.2010.09.005; Zhao Q, 2011, BIRTH DEFECTS RES B, V92, P1, DOI 10.1002/bdrb.20277; Zou DJ, 2011, PHARMAZIE, V66, P44, DOI 10.1692/ph.2011.0618	62	36	36	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42768	10.1371/journal.pone.0042768	http://dx.doi.org/10.1371/journal.pone.0042768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880100	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000307284100166
J	Fu, SM; Feng, CL; Guo, SC; Luo, YJ; Parasuraman, R				Fu, Shimin; Feng, Chunliang; Guo, Shichun; Luo, Yuejia; Parasuraman, Raja			Neural Adaptation Provides Evidence for Categorical Differences in Processing of Faces and Chinese Characters: An ERP Study of the N170	PLOS ONE			English	Article							UNFAMILIAR FACES; DOMAIN SPECIFICITY; TEMPORAL DYNAMICS; HUMAN BRAIN; EXPERTISE; INVERSION; PERCEPTION; OBJECT; ACTIVATION; REPETITION	Whether face perception involves domain-specific or domain-general processing is an extensively debated issue. Relative to non-face objects and alphabetical scripts, Chinese characters provide a good contrast to faces because of their structural configuration, requirement for high level of visual expertise to literate Chinese people, and unique appearance and identity for each individual stimulus. To examine potential categorical differences in their neural processing, event-related potentials (ERPs) were recorded to blocked face and Chinese character stimuli. Fast adaptation method was applied to better control for the low-level stimulus difference between faces and Chinese characters. Participants were required to respond to the color of the outer frame in which these stimuli were presented, at either a fast (ISI 650 ms) or slow (ISI 1300 ms) rate, and with an orientation that was either the same or alternated between upright and inverted. Faces elicited a larger and later N170 relative to characters, but the N170 was more left-lateralized for characters relative to the faces. Adaptation-by-rate and adaptation-by-orientation effects were observed on the amplitude of N170, and both were more pronounced for faces relative to characters. Inverted stimuli elicited a later N170 relative to upright stimuli, without amplitude change, and this inversion effect was more pronounced for faces relative to characters. Moreover, faces elicited a larger and later P1 and a larger adaptation-by-rate effect on P1 relative to characters. The adaptation-by-orientation effect was illustrated by a larger P1 under the same relative to the alternated orientation condition. Therefore, evidence from the amplitude and the lateralization of N170, the stimulus inversion effect on N170 latency, and the neural adaptation between faces and Chinese characters on P1 and N170 components support the notion that the processing of faces and Chinese characters involve categorically different neural mechanisms.	[Fu, Shimin; Guo, Shichun] Tsinghua Univ, Dept Psychol, Beijing 100084, Peoples R China; [Feng, Chunliang; Luo, Yuejia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Parasuraman, Raja] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	Tsinghua University; Beijing Normal University; George Mason University	Fu, SM (corresponding author), Tsinghua Univ, Dept Psychol, Beijing 100084, Peoples R China.	sfu@tsinghua.edu.cn; luoyj@bnu.edu.cn	Fu, Shimin/ABD-7806-2021; Fu, Shimin/A-6438-2008		Tsinghua University, China [20111081107]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [20111021085]; Ministry of Sci & Tech (973 Program) [2011CB711000]; NSF China [30930031, 91132704]; Global Research Initiative Program; United States National Institute of Health [1R01TW007897]; FOGARTY INTERNATIONAL CENTER [R01TW007897] Funding Source: NIH RePORTER	Tsinghua University, China; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Ministry of Sci & Tech (973 Program); NSF China(National Natural Science Foundation of China (NSFC)); Global Research Initiative Program; United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research is supported by the Initiative Scientific Research Program, Tsinghua University, China (20111081107) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (20111021085) to SF, and the Ministry of Sci & Tech (973 Program, 2011CB711000), NSF China (30930031, 91132704), Global Research Initiative Program, and the United States National Institute of Health grants (1R01TW007897) to YL.; This research is supported by the Initiative Scientific Research Program, Tsinghua University, China (20111081107) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry to SF, and the Ministry of Sci & Tech (973 Program, 2011CB711000), NSF China (30930031, 91132704), Global Research Initiative Program, and the United States National Institutes of Health grants (1R01TW007897) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Busey TA, 2005, VISION RES, V45, P431, DOI 10.1016/j.visres.2004.08.021; Caharel S, 2009, NEUROPSYCHOLOGIA, V47, P639, DOI 10.1016/j.neuropsychologia.2008.11.016; Campanella S, 2002, J COGNITIVE NEUROSCI, V14, P210, DOI 10.1162/089892902317236858; Carmel D, 2002, COGNITION, V83, P1, DOI 10.1016/S0010-0277(01)00162-7; Chen YP, 2002, J COGNITIVE NEUROSCI, V14, P1088, DOI 10.1162/089892902320474535; Dalrymple KA, 2011, NEUROPSYCHOLOGIA, V49, P2553, DOI 10.1016/j.neuropsychologia.2011.05.003; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 2011, BRAIN RES, V1376, P76, DOI 10.1016/j.brainres.2010.12.046; Fu SM, 2010, BIOL PSYCHOL, V85, P171, DOI 10.1016/j.biopsycho.2010.06.008; Fu SM, 2002, NEUROIMAGE, V17, P1538, DOI 10.1006/nimg.2002.1155; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Ge LZ, 2006, PSYCHOL SCI, V17, P12, DOI 10.1111/j.1467-9280.2005.01658.x; Harris A, 2008, CEREB CORTEX, V18, P467; Harris A, 2007, CEREB CORTEX, V17, P63, DOI 10.1093/cercor/bhj124; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heisz JJ, 2006, VISION RES, V46, P47, DOI 10.1016/j.visres.2005.09.028; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; Itier RJ, 2006, NEUROIMAGE, V29, P667, DOI 10.1016/j.neuroimage.2005.07.041; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Itier RJ, 2007, J COGNITIVE NEUROSCI, V19, P1815, DOI 10.1162/jocn.2007.19.11.1815; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kikutani M, 2010, PSYCHOL SCI, V21, P865, DOI 10.1177/0956797610371964; Kim KH, 2004, NEUROREPORT, V15, P1099, DOI 10.1097/00001756-200405190-00003; Kovacs G, 2006, CEREB CORTEX, V16, P742, DOI 10.1093/cercor/bhj020; Liu JG, 2009, NEUROREPORT, V20, P273, DOI 10.1097/WNR.0b013e32832000f8; Maurer U, 2008, J COGNITIVE NEUROSCI, V20, P1878, DOI 10.1162/jocn.2008.20125; Maurer U, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.018.2008; Mercure E, 2008, J COGNITIVE NEUROSCI, V20, P2070, DOI 10.1162/jocn.2008.20137; Mercure E, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00006, 10.3389/fnhum.2011.00062]; Noguchi Y, 2004, J NEUROSCI, V24, P6283, DOI 10.1523/JNEUROSCI.0655-04.2004; PARASURAMAN R, 1980, BIOL PSYCHOL, V11, P217, DOI 10.1016/0301-0511(80)90057-5; Prieto E, 2011, FRONTIERS HUMAN NEUR; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rossion B, 2007, J COGNITIVE NEUROSCI, V19, P543, DOI 10.1162/jocn.2007.19.3.543; Sadeh B, 2010, NEUROIMAGE, V53, P782, DOI 10.1016/j.neuroimage.2010.06.029; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Schweinberger SR, 2002, NEUROPSYCHOLOGIA, V40, P2057, DOI 10.1016/S0028-3932(02)00050-7; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Wong ACN, 2005, COGN AFFECT BEHAV NE, V5, P306, DOI 10.3758/CABN.5.3.306; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Zhang JX, 2004, NEUROIMAGE, V23, P975, DOI 10.1016/j.neuroimage.2004.07.008; Zhao JZ, 2010, NEUROSCI LETT, V478, P107, DOI 10.1016/j.neulet.2010.04.075	55	24	25	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41103	10.1371/journal.pone.0041103	http://dx.doi.org/10.1371/journal.pone.0041103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	978NX	22911750	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300023
J	Wang, E; Zhao, YD; Monaco, A; Uccellini, L; Kirkwood, JM; Spyropoulou-Vlachou, M; Panelli, MC; Marincola, FM; Gogas, H				Wang, Ena; Zhao, Yingdong; Monaco, Alessandro; Uccellini, Lorenzo; Kirkwood, John M.; Spyropoulou-Vlachou, Maria; Panelli, Monica C.; Marincola, Francesco M.; Gogas, Helen			A Multi-Factorial Genetic Model for Prognostic Assessment of High Risk Melanoma Patients Receiving Adjuvant Interferon	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; HLA CLASS-I; IMMUNOLOGICAL CONSTANT; CTLA4 GENE; SURVIVAL; POLYMORPHISM; CANCER; SUSCEPTIBILITY; AUTOIMMUNITY; ASSOCIATION	Purpose: IFNa was the first cytokine to demonstrate anti-tumor activity in advanced melanoma. Despite the ability of high-dose IFNa reducing relapse and mortality by up to 33%, large majority of patients experience side effects and toxicity which outweigh the benefits. The current study attempts to identify genetic markers likely to be associated with benefit from IFNa-2b treatment and predictive for survival. Experimental design: We tested the association of variants in FOXP3 microsatellites, CTLA4 SNPs and HLA genotype in 284 melanoma patients and their association with prognosis and survival of melanoma patients who received IFNa adjuvant therapy. Results: Univariate survival analysis suggested that patients bearing either the DRB1*15 or HLA-Cw7 allele suffered worse OS while patients bearing either HLA-Cw6 or HLA-B44 enjoyed better OS. DRB1*15 positive patients suffered also worse RFS and conversely HLA-Cw6 positive patients had better RFS. Multivariate analysis revealed that a five-marker genotyping signature was prognostic of OS independent of disease stage. In the multivariate Cox regression model, HLA-B38 (p = 0.021), HLA-C15 (p = 0.025), HLA-C3 (p = 0.014), DRB1*15 (p = 0.005) and CT60*G/G (0.081) were significantly associated with OS with risk ratio of 0.097 (95% CI, 0.013-0.709), 0.387 (95% CI, 0.169-0.889), 0.449 (95% CI, 0.237-0.851), 1.948 (95% CI, 1.221-3.109) and 1.484 (95% IC, 0.953-2.312) respectively. Conclusion: These results suggest that gene polymorphisms relevant to a biological occurrence are more likely to be informative when studied in concert to address potential redundant or conflicting functions that may limit each gene individual contribution. The five markers identified here exemplify this concept though prospective validation in independent cohorts is needed.	[Wang, Ena; Monaco, Alessandro; Uccellini, Lorenzo; Marincola, Francesco M.] NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Wang, Ena; Monaco, Alessandro; Uccellini, Lorenzo; Marincola, Francesco M.] NIH, Trans NIH Ctr Human Immunol, Bethesda, MD 20892 USA; [Zhao, Yingdong] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; [Kirkwood, John M.; Panelli, Monica C.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA; [Spyropoulou-Vlachou, Maria] Gen Hosp, Natl Tissue Typing Ctr, Dept Immunol, Athens, Greece; [Gogas, Helen] Univ Athens, Sch Med, Dept Med 1, GR-11527 Athens, Greece	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Athens Medical School; National & Kapodistrian University of Athens	Wang, E (corresponding author), NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA.	hgogas@hol.gr	Monaco, Alessandro/O-5338-2015; Monaco, Alessandro/ABH-3887-2020	Monaco, Alessandro/0000-0002-9941-7003; Monaco, Alessandro/0000-0002-9941-7003	CLINICAL CENTER [ZIACL002118] Funding Source: NIH RePORTER	CLINICAL CENTER		American Academy of Dermatology, 2011, MEL FACT SHEET; American Cancer Society, 2010, CANC FACTS FIG 2010; Amundsen SS, 2004, TISSUE ANTIGENS, V64, P593, DOI 10.1111/j.1399-0039.2004.00312.x; Ascierto ML, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-146; Ascierto PA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-62; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Banwell B, 2011, LANCET NEUROL, V10, P436, DOI 10.1016/S1474-4422(11)70045-X; Benhatchi K, 2011, CLIN RHEUMATOL, V30, P1319, DOI 10.1007/s10067-011-1752-z; Bouwhuis MG, 2010, CANCER IMMUNOL IMMUN, V59, P303, DOI 10.1007/s00262-009-0751-2; Breunis WB, 2008, J IMMUNOTHER, V31, P586, DOI 10.1097/CJI.0b013e31817fd8f3; Briggs FBS, 2011, GENES IMMUN, V12, P615, DOI 10.1038/gene.2011.34; Casula M, 2010, ANN ONCOL, V21, P1379, DOI 10.1093/annonc/mdq056; Cheng XL, 2011, HEPATO-GASTROENTEROL, V58, P432; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0; COLOVAI AI, 1994, TISSUE ANTIGENS, V44, P65, DOI 10.1111/j.1399-0039.1994.tb02361.x; COX DR, 1972, J R STAT SOC B, V34, P187; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Garbe C, 2011, ONCOLOGIST, V16, P5, DOI 10.1634/theoncologist.2010-0190; Gogas H, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-108; Gogas H, 2010, CANCER-AM CANCER SOC, V116, P4326, DOI 10.1002/cncr.25211; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hoon DSB, 1998, J CLIN ONCOL, V16, P1430, DOI 10.1200/JCO.1998.16.4.1430; Huang CL, 2005, CANC SKIN, P265; Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370; Kirkwood JM, 2002, CANCER-AM CANCER SOC, V95, P1101, DOI 10.1002/cncr.10775; Kohaar I, 2009, HUM IMMUNOL, V70, P222, DOI 10.1016/j.humimm.2009.01.003; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Li YF, 2011, CLIN CANCER RES, V17, P3830, DOI 10.1158/1078-0432.CCR-10-2877; Lin ZH, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-145; Liu DX, 2005, CLIN CANCER RES, V11, P1237; Liu Y, 2011, DNA CELL BIOL, V30, P1051, DOI 10.1089/dna.2011.1269; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Marsh SGE, 2002, EUR J IMMUNOGENET, V29, P463, DOI 10.1046/j.1365-2370.2002.00359.x; Muto M, 2011, J DERMATOL SCI, V62, P70, DOI 10.1016/j.jdermsci.2010.10.012; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Niu JZ, 2011, CANCER IMMUNOL IMMUN, V60, P1109, DOI 10.1007/s00262-011-1025-3; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Ozdilli K, 2010, J INT MED RES, V38, P1835, DOI 10.1177/147323001003800531; Pectasides D, 2009, J CLIN ONCOL, V27, P939, DOI 10.1200/JCO.2008.16.3121; Rizza P, 2011, EXPERT REV VACCINES, V10, P487, DOI [10.1586/erv.11.9, 10.1586/ERV.11.9]; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Sanderson K, 2005, J CLIN ONCOL, V23, P741, DOI 10.1200/JCO.2005.01.128; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Simon RM, 2011, BRIEF BIOINFORM, V12, P203, DOI 10.1093/bib/bbr001; Sosman JA, 2002, J CLIN ONCOL, V20, P2067, DOI 10.1200/JCO.2002.08.072; Spivey TL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-174; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Ugurel S, 2008, CANCER IMMUNOL IMMUN, V57, P685, DOI 10.1007/s00262-007-0407-z; Wang E, 2008, TRENDS IMMUNOL, V29, P256, DOI 10.1016/j.it.2008.03.002; Yurkovetsky ZR, 2007, CLIN CANCER RES, V13, P2422, DOI 10.1158/1078-0432.CCR-06-1805; Zhang YG, 2011, CANCER-AM CANCER SOC, V117, P4312, DOI 10.1002/cncr.25979	58	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40805	10.1371/journal.pone.0040805	http://dx.doi.org/10.1371/journal.pone.0040805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911710	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300016
J	Angle, MR; Schaefer, AT				Angle, Matthew R.; Schaefer, Andreas T.			Neuronal Recordings with Solid-Conductor Intracellular Nanoelectrodes (SCINEs)	PLOS ONE			English	Article							FOCUSED ION-BEAM; WHOLE-CELL PATCH; DENDRITIC INTEGRATION; MEMBRANE-PROPERTIES; ACTION-POTENTIALS; MICROELECTRODE; PRECURSOR; EXCHANGE; CURRENTS	Direct electrical recording of the neuronal transmembrane potential has been crucial to our understanding of the biophysical mechanisms subserving neuronal computation. Existing intracellular recording techniques, however, limit the accuracy and duration of such measurements by changing intracellular biochemistry and/or by damaging the plasma membrane. Here we demonstrate that nanoengineered electrodes can be used to record neuronal transmembrane potentials in brain tissue without causing these physiological perturbations. Using focused ion beam milling, we have fabricated Solid-Conductor Intracellular NanoElectrodes (SCINEs), from conventional tungsten microelectrodes. SCINEs have tips that are <300 nm in diameter for several micrometers, but can be easily handled and can be inserted into brain tissue. Performing simultaneous whole-cell patch recordings, we show that SCINEs can record action potentials (APs) as well as slower, subthreshold neuronal potentials without altering cellular properties. These results show a key role for nanotechnology in the development of new electrical recording techniques in neuroscience.	[Angle, Matthew R.; Schaefer, Andreas T.] Max Planck Inst Med Res, Heidelberg, Germany	Max Planck Society	Angle, MR (corresponding author), Max Planck Inst Med Res, Heidelberg, Germany.	schaefer@mpimf-heidelberg.mpg.de		Schaefer, Andreas/0000-0002-4677-8788; Angle, Matthew/0000-0002-2601-7631	Max Planck Society, University of Heidelberg; Medical Research Council [MC_UP_1202/5] Funding Source: researchfish; MRC [MC_UP_1202/5] Funding Source: UKRI	Max Planck Society, University of Heidelberg; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Max Planck Society, University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD S, 1995, J NEUROSCI, V15, P7528; Almquist BD, 2010, P NATL ACAD SCI USA, V107, P5815, DOI 10.1073/pnas.0909250107; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BELLES B, 1988, PFLUG ARCH EUR J PHY, V411, P353, DOI 10.1007/BF00587713; Brown KT, 1986, ADV MICROPIPETTE TEC; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; Chorev E, 2009, CURR OPIN NEUROBIOL, V19, P513, DOI 10.1016/j.conb.2009.08.005; de Asis ED, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3247885; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; DOWBEN RM, 1953, SCIENCE, V118, P22, DOI 10.1126/science.118.3053.22; Duan XJ, 2012, NAT NANOTECHNOL, V7, P174, DOI [10.1038/nnano.2011.223, 10.1038/NNANO.2011.223]; Edinger K, 1998, J VAC SCI TECHNOL B, V16, P3311, DOI 10.1116/1.590497; Ferguson JE, 2012, NANOMEDICINE, V8, P427; Forscher P, 1985, BIOPHYS J, V45, P181; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; GRAHAM J, 1946, J CELL COMPAR PHYSL, V28, P99, DOI 10.1002/jcp.1030280106; Grundfest H, 1942, J NEUROPHYSIOL, V5, P275, DOI 10.1152/jn.1942.5.4.275; Hai A, 2010, NAT METHODS, V7, P200, DOI [10.1038/nmeth.1420, 10.1038/NMETH.1420]; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han SW, 2005, BIOCHEM BIOPH RES CO, V332, P633, DOI 10.1016/j.bbrc.2005.04.059; Hanein Y., 2002, SENSORS UPDATE, V10, P47; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; INCE C, 1986, BIOPHYS J, V50, P1203, DOI 10.1016/S0006-3495(86)83563-9; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325, DOI 10.1152/jn.1987.57.1.325; KORN SJ, 1989, J GEN PHYSIOL, V94, P789, DOI 10.1085/jgp.94.5.789; Li H, 2006, FRONTIERS BIOCHIP TE; Li WC, 2004, J NEUROPHYSIOL, V92, P380, DOI 10.1152/jn.01238.2003; LING G, 1949, J CELL COMPAR PHYSL, V34, P383, DOI 10.1002/jcp.1030340304; Lipp S, 1996, J VAC SCI TECHNOL B, V14, P3920, DOI 10.1116/1.588695; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Marty A, 1995, SINGLE CHANNNEL RECO; Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007; MCADAMS ET, 1995, BIOSENS BIOELECTRON, V10, P67, DOI 10.1016/0956-5663(95)96795-Z; MELMED AJ, 1991, J VAC SCI TECHNOL B, V9, P601, DOI 10.1116/1.585467; Obataya I, 2005, NANO LETT, V5, P27, DOI 10.1021/nl0485399; Ogden D, 1994, MICROELECTRODE TECHN; OLIVA C, 1988, BIOPHYS J, V54, P791, DOI 10.1016/S0006-3495(88)83017-0; PENNER R, 1987, BIOSCIENCE REP, V7, P313, DOI 10.1007/BF01121453; PONGRACZ F, 1991, J NEUROPHYSIOL, V65, P747, DOI 10.1152/jn.1991.65.3.747; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Qiao Y, 2005, NANOTECHNOLOGY, V16, P1598, DOI 10.1088/0957-4484/16/9/032; Reccius CH, 2004, LANGMUIR, V20, P11175, DOI 10.1021/la048233h; ROBBLEE LS, 1983, J ELECTROCHEM SOC, V130, P731, DOI 10.1149/1.2119793; Robinson JT, 2012, NAT NANOTECHNOL, V7, P180, DOI [10.1038/nnano.2011.249, 10.1038/NNANO.2011.249]; Sarantopoulos Constantine, 2007, V38, P253; Schrlau MG, 2009, ACS NANO, V3, P563, DOI 10.1021/nn800851d; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Svirskis G, 1997, J NEUROPHYSIOL, V77, P579, DOI 10.1152/jn.1997.77.2.579; Swandulla D, 1992, PRACTICAL ELECTROPHY; Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033; Vervaeke K, 2012, SCIENCE, V335, P1624, DOI 10.1126/science.1215101; Xie C, 2012, NAT NANOTECHNOL, V7, P185, DOI [10.1038/nnano.2012.8, 10.1038/NNANO.2012.8]; Zhang RW, 2010, J PHYSIOL-LONDON, V588, P2557, DOI 10.1113/jphysiol.2010.187088; Zybill CE, 1997, J ORGANOMET CHEM, V547, P167	60	28	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43194	10.1371/journal.pone.0043194	http://dx.doi.org/10.1371/journal.pone.0043194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905231	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600056
J	Aragao, AZB; Belloni, M; Simabuco, FM; Zanetti, MR; Yokoo, S; Domingues, RR; Kawahara, R; Pauletti, BA; Goncalves, A; Agostini, M; Graner, E; Coletta, RD; Fox, JW; Leme, AFP				Aragao, Annelize Z. B.; Belloni, Marilia; Simabuco, Fernando M.; Zanetti, Mariana R.; Yokoo, Sami; Domingues, Romenia R.; Kawahara, Rebeca; Pauletti, Bianca A.; Goncalves, Anderson; Agostini, Michelle; Graner, Edgard; Coletta, Ricardo D.; Fox, Jay W.; Paes Leme, Adriana F.			Novel Processed Form of Syndecan-1 Shed from SCC-9 Cells Plays a Role in Cell Migration	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; INTRACELLULAR DOMAIN; CLEAVAGE; EXPRESSION; REDUCTION; CARCINOMA; RELEASE	The extracellular milieu is comprised in part by products of cellular secretion and cell surface shedding. The presence of such molecules of the sheddome and secretome in the context of the extracellular milieu may have important clinical implications. In cancer they have been hypothesized to play a role in tumor growth and metastasis. The objective of this study was to evaluate whether the sheddome/secretome from two cell lines could be correlated with their potential for tumor development. Two epithelial cell lines, HaCaT and SCC-9, were chosen based on their differing abilities to form tumors in animal models of tumorigenesis. These cell lines when stimulated with phorbol-ester (PMA) showed different characteristics as assessed by cell migration, adhesion and higher gelatinase activity. Proteomic analysis of the media from these treated cells identified interesting, functionally relevant differences in their sheddome/secretome. Among the shed proteins, soluble syndecan-1 was found only in media from stimulated tumorigenic cells (SCC-9) and its fragments were observed in higher amount in the stimulated tumorigenic cells than stimulated non-tumorigenic cells (HaCaT). The increase in soluble syndecan-1 was associated with a decrease in membrane-bound syndecan-1 of SCC-9 cells after PMA stimuli. To support a functional role for soluble syndecan-1 fragments we demonstrated that the synthetic syndecan-1 peptide was able to induce cell migration in both cell lines. Taken together, these results suggested that PMA stimulation alters the sheddome/secretome of the tumorigenic cell line SCC-9 and one such component, the syndecan-1 peptide identified in this study, was revealed to promote migration in these epithelial cell lines.	[Aragao, Annelize Z. B.; Belloni, Marilia; Simabuco, Fernando M.; Zanetti, Mariana R.; Yokoo, Sami; Domingues, Romenia R.; Kawahara, Rebeca; Pauletti, Bianca A.; Goncalves, Anderson; Paes Leme, Adriana F.] Brazilian Biosci Natl Lab CNPEM, Mass Spectrometry Lab, Campinas, SP, Brazil; [Agostini, Michelle; Graner, Edgard; Coletta, Ricardo D.] Univ Estadual Campinas, Piracicaba Sch Dent, Piracicaba, Brazil; [Fox, Jay W.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA	Universidade Estadual de Campinas; University of Virginia	Aragao, AZB (corresponding author), Brazilian Biosci Natl Lab CNPEM, Mass Spectrometry Lab, Campinas, SP, Brazil.	adriana.paesleme@lnbio.org.br	Leme, Adriana F Paes/C-9679-2012; Simabuco, Fernando M/GQA-4176-2022; Simabuco, Fernando M/G-8421-2017; Graner, Edgard/K-4411-2012; Coletta, Ricardo D./B-4909-2015; Agostini, Michelle/AAD-6610-2022; Agostini, Michelle/I-1275-2012; Graner, Edgard/P-4651-2019; Aragão, Annelize Z B/I-6535-2012; Kawahara, Rebeca/B-1532-2015	Leme, Adriana F Paes/0000-0001-7959-147X; Simabuco, Fernando M/0000-0002-1672-9686; Simabuco, Fernando M/0000-0002-1672-9686; Graner, Edgard/0000-0002-4737-7935; Coletta, Ricardo D./0000-0001-5285-3046; Agostini, Michelle/0000-0002-3648-337X; Yokoo, Sami/0000-0003-4658-9319; Kawahara, Rebeca/0000-0002-0292-2637; Rodrigues Zanetti, Mariana/0000-0001-8335-1575	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [470567/2009-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/52833-0, 2009/18301-1, 2010/09642-7, 2010/19278-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (470567/2009-0) and grants and fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2009/52833-0; 2009/18301-1; 2010/09642-7; 2010/19278-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Chen P, 2009, MMP7 SHEDDING SYNDEC; Demidova-Rice TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032146; Doucet A, 2008, MOL CELL PROTEOMICS, V7, P1925, DOI 10.1074/mcp.R800012-MCP200; Eming SA, 2010, J PROTEOME RES, V9, P4758, DOI 10.1021/pr100456d; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Escalante T, 2009, J PROTEOME RES, V8, P5120, DOI 10.1021/pr900489m; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x; Humphries M J, 2001, Curr Protoc Cell Biol, VChapter 9, DOI 10.1002/0471143030.cb0901s00; Jacobs JM, 2008, J PROTEOME RES, V7, P558, DOI 10.1021/pr0704377; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Kurokawa H, 2006, J ORAL PATHOL MED, V35, P301, DOI 10.1111/j.1600-0714.2006.00412.x; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Martinez A, 2009, J ORAL PATHOL MED, V38, P580, DOI 10.1111/j.1600-0714.2009.00761.x; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Leme AFP, 2012, J PROTEOME RES, V11, P279, DOI 10.1021/pr2006439; Leme AFP, 2009, PROTEOMICS, V9, P733, DOI 10.1002/pmic.200800484; Ramani VC, 2012, J BIOL CHEM, V287, P9952, DOI 10.1074/jbc.M111.330803; Ro Y, 2006, INT J ORAL MAX SURG, V35, P252, DOI 10.1016/j.ijom.2005.06.020; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024684; Zong F, 2011, SPECIFIC SYNDECAN 1	37	38	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43521	10.1371/journal.pone.0043521	http://dx.doi.org/10.1371/journal.pone.0043521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905270	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600079
J	Hatzios, SK; Ringgaard, S; Davis, BM; Waldor, MK				Hatzios, Stavroula K.; Ringgaard, Simon; Davis, Brigid M.; Waldor, Matthew K.			Studies of Dynamic Protein-Protein Interactions in Bacteria Using Renilla Luciferase Complementation Are Undermined by Nonspecific Enzyme Inhibition	PLOS ONE			English	Article							ESCHERICHIA-COLI; IN-VIVO; VIBRIO-CHOLERAE; FIREFLY LUCIFERASE; SPLIT-LUCIFERASE; SUICIDE VECTOR; LIVING CELLS; CHEMOTAXIS; CONSTRUCTION; REPORTERS	The luciferase protein fragment complementation assay is a powerful tool for studying protein-protein interactions. Two inactive fragments of luciferase are genetically fused to interacting proteins, and when these two proteins interact, the luciferase fragments can reversibly associate and reconstitute enzyme activity. Though this technology has been used extensively in live eukaryotic cells, split luciferase complementation has not yet been applied to studies of dynamic protein-protein interactions in live bacteria. As proof of concept and to develop a new tool for studies of bacterial chemotaxis, fragments of Renilla luciferase (Rluc) were fused to the chemotaxis-associated response regulator CheY3 and its phosphatase CheZ in the enteric pathogen Vibrio cholerae. Luciferase activity was dependent on the presence of both CheY3 and CheZ fusion proteins, demonstrating the specificity of the assay. Furthermore, enzyme activity was markedly reduced in V. cholerae chemotaxis mutants, suggesting that this approach can measure defects in chemotactic signaling. However, attempts to measure changes in dynamic CheY3-CheZ interactions in response to various chemoeffectors were undermined by nonspecific inhibition of the full-length luciferase. These observations reveal an unexpected limitation of split Rluc complementation that may have implications for existing data and highlight the need for great caution when evaluating small molecule effects on dynamic protein-protein interactions using the split luciferase technology.	[Hatzios, Stavroula K.; Ringgaard, Simon; Davis, Brigid M.; Waldor, Matthew K.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Hatzios, Stavroula K.; Ringgaard, Simon; Davis, Brigid M.; Waldor, Matthew K.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Hatzios, Stavroula K.; Ringgaard, Simon; Davis, Brigid M.; Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Hatzios, SK (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	mwaldor@rics.bwh.harvard.edu		Hatzios, Stavroula/0000-0001-8658-8949; Ringgaard, Simon/0000-0002-4980-5964; Waldor, Matthew/0000-0003-1843-7000	National Institutes of Health [NIH R37 AI-42347]; Howard Hughes Medical Institute; Villum Kann Rasmussen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Villum Kann Rasmussen Foundation(Villum Fonden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the National Institutes of Health (NIH R37 AI-42347) and the Howard Hughes Medical Institute (www.hhmi.org). S. R. was funded by a post-doctoral fellowship from the Villum Kann Rasmussen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; ARMSTRONG JB, 1967, J BACTERIOL, V93, P390, DOI 10.1128/JB.93.1.390-398.1967; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Barak R, 2006, J MOL BIOL, V359, P251, DOI 10.1016/j.jmb.2006.03.033; Boin MA, 2004, FEMS MICROBIOL LETT, V239, P1, DOI 10.1016/j.femsle.2004.08.039; Bouveret E, 2012, METHODS MOL BIOL, V804, P15, DOI 10.1007/978-1-61779-361-5_2; Butler SM, 2006, MOL MICROBIOL, V60, P417, DOI 10.1111/j.1365-2958.2006.05096.x; Butler SM, 2005, NAT REV MICROBIOL, V3, P611, DOI 10.1038/nrmicro1207; Ciruela F, 2008, CURR OPIN BIOTECH, V19, P338, DOI 10.1016/j.copbio.2008.06.003; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; FRETER R, 1981, INFECT IMMUN, V34, P215, DOI 10.1128/IAI.34.1.215-221.1981; Herbst KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005642; Jawhara S, 2004, ANTIMICROB AGENTS CH, V48, P3436, DOI 10.1128/AAC.48.9.3436-3441.2004; Kaihara A, 2003, ANAL CHEM, V75, P4176, DOI 10.1021/ac0300800; Lee SH, 2001, P NATL ACAD SCI USA, V98, P6889, DOI 10.1073/pnas.111581598; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Ringgaard S, 2011, GENE DEV, V25, P1544, DOI 10.1101/gad.2061811; Shimizu TS, 2006, P NATL ACAD SCI USA, V103, P2093, DOI 10.1073/pnas.0510958103; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Stynen B, 2012, MICROBIOL MOL BIOL R, V76, P331, DOI 10.1128/MMBR.05021-11; Thorne N, 2010, CHEM BIOL, V17, P646, DOI 10.1016/j.chembiol.2010.05.012; Thorne N, 2010, CURR OPIN CHEM BIOL, V14, P315, DOI 10.1016/j.cbpa.2010.03.020; TSO WW, 1974, J BACTERIOL, V118, P560, DOI 10.1128/JB.118.2.560-576.1974; Villalobos V, 2007, ANNU REV BIOMED ENG, V9, P321, DOI 10.1146/annurev.bioeng.9.060906.152044; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Wille T, 2012, APPL ENVIRON MICROB, V78, P250, DOI 10.1128/AEM.06670-11; WOOD KV, 1987, ANAL BIOCHEM, V161, P501, DOI 10.1016/0003-2697(87)90480-5	36	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43175	10.1371/journal.pone.0043175	http://dx.doi.org/10.1371/journal.pone.0043175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905225	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600052
J	Xu, GL; Kuster, TM; Gunthardt-Goerg, MS; Dobbertin, M; Li, MH				Xu, Guo-Liang; Kuster, Thomas M.; Guenthardt-Goerg, Madeleine S.; Dobbertin, Matthias; Li, Mai-He			Seasonal Exposure to Drought and Air Warming Affects Soil Collembola and Mites	PLOS ONE			English	Article							BODY-SIZE; FOREST SOIL; LONG-TERM; FOOD WEBS; CLIMATE-CHANGE; ECOSYSTEM; COMMUNITY; DYNAMICS; BIOMASS; GROWTH	Global environmental changes affect not only the aboveground but also the belowground components of ecosystems. The effects of seasonal drought and air warming on the genus level richness of Collembola, and on the abundance and biomass of the community of Collembola and mites were studied in an acidic and a calcareous forest soil in a model oak-ecosystem experiment (the Querco experiment) at the Swiss Federal Research Institute WSL in Birmensdorf. The experiment included four climate treatments: control, drought with a 60% reduction in rainfall, air warming with a seasonal temperature increase of 1.4 degrees C, and air warming + drought. Soil water content was greatly reduced by drought. Soil surface temperature was slightly increased by both the air warming and the drought treatment. Soil mesofauna samples were taken at the end of the first experimental year. Drought was found to increase the abundance of the microarthropod fauna, but reduce the biomass of the community. The percentage of small mites (body length <= 0.20 mm) increased, but the percentage of large mites (body length >0.40 mm) decreased under drought. Air warming had only minor effects on the fauna. All climate treatments significantly reduced the richness of Collembola and the biomass of Collembola and mites in acidic soil, but not in calcareous soil. Drought appeared to have a negative impact on soil microarthropod fauna, but the effects of climate change on soil fauna may vary with the soil type.	[Xu, Guo-Liang] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Kuster, Thomas M.; Guenthardt-Goerg, Madeleine S.; Dobbertin, Matthias; Li, Mai-He] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland	Chinese Academy of Sciences; South China Botanical Garden, CAS; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Xu, GL (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	xugl@scbg.ac.cn	Li, Mai-He/L-6390-2013; Günthardt-Goerg, Madeleine S./L-6461-2013	Li, Mai-He/0000-0002-7029-2841; 	Chinese Academy of Sciences [KSCX2-EW-J-28]; National Natural Science Foundation of China [40801096]; Sino-Swiss Science and Technology Cooperation Program [EG07-092009]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-Swiss Science and Technology Cooperation Program	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KSCX2-EW-J-28) and the National Natural Science Foundation of China (no. 40801096). G. L. Xu's research stay in Switzerland was supported by Sino-Swiss Science and Technology Cooperation Program (project No. EG07-092009) which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez T., 1999, Agricultural and Forest Entomology, V1, P243, DOI 10.1046/j.1461-9563.1999.00032.x; Arend M, 2011, TREE PHYSIOL, V31, P287, DOI 10.1093/treephys/tpr004; BAATH E, 1982, SOIL BIOL BIOCHEM, V14, P353, DOI 10.1016/0038-0717(82)90005-0; BADEJO MA, 1990, BIOTROPICA, V22, P382, DOI 10.2307/2388555; Badejo MA, 2006, EXP APPL ACAROL, V40, P145, DOI 10.1007/s10493-006-9029-y; Blanchard JL, 2011, OIKOS, V120, P481, DOI 10.1111/j.1600-0706.2010.19564.x; BOYCE MS, 1978, OECOLOGIA, V36, P1, DOI 10.1007/BF00344567; BRADY J, 1969, J APPL ECOL, V6, P391, DOI 10.2307/2401506; Bretfeld G, 1999, SYNOPSES PALAEARCTIC, V2; Brussaard L, 1997, AMBIO, V26, P563; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; CH2011, 2011, TECHNICAL REPORT, DOI [10.3929/ethz-a-006720559, DOI 10.3929/ETHZ-A-006720559]; Chahartaghi M, 2006, PEDOBIOLOGIA, V50, P331, DOI 10.1016/j.pedobi.2006.06.001; Chen PY, 2005, STAT SOFTWARE TUTORI; Coulson SJ, 1996, POLAR BIOL, V16, P147; Dallinger R, 1996, COMP BIOCHEM PHYS C, V113, P125, DOI 10.1016/0742-8413(95)02078-0; DANTHANARAYANA W, 1975, AUST J ZOOL, V23, P439, DOI 10.1071/ZO9750439; Digel C, 2011, OIKOS, V120, P503, DOI 10.1111/j.1600-0706.2010.18862.x; Dollery R, 2006, ECOGRAPHY, V29, P111, DOI 10.1111/j.2006.0906-7590.04366.x; DOUCE GK, 1976, OIKOS, V27, P324, DOI 10.2307/3543914; Freckman DW, 1997, AMBIO, V26, P556; Hagvar S, 1998, PEDOBIOLOGIA, V42, P358; Hagvar S, 2009, GLOBAL CHANGE BIOL, V15, P2972, DOI 10.1111/j.1365-2486.2009.01926.x; Haimi J, 2005, APPL SOIL ECOL, V30, P104, DOI 10.1016/j.apsoil.2005.02.006; Harte J, 1996, SOIL BIOL BIOCHEM, V28, P313, DOI 10.1016/0038-0717(95)00139-5; Hodar JA, 1996, ACTA OECOL, V17, P421; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; Huhta V, 2001, PEDOBIOLOGIA, V45, P279, DOI 10.1078/0031-4056-00085; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Janssens F, 2007, CHECKLIST COLLEMBOLA; Johnston D.E., 1982, P111; JONES G, 1987, IBIS, V129, P274, DOI 10.1111/j.1474-919X.1987.tb03208.x; Jucevica E, 2006, PEDOBIOLOGIA, V50, P177, DOI 10.1016/j.pedobi.2005.10.006; Kardol P, 2011, APPL SOIL ECOL, V47, P37, DOI 10.1016/j.apsoil.2010.11.001; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Kuster TM, 2013, PLANT BIOLOGY, V15, P138, DOI 10.1111/j.1438-8677.2011.00552.x; Laakso J, 1999, OIKOS, V87, P57, DOI 10.2307/3546996; Lindberg N, 2002, J APPL ECOL, V39, P924, DOI 10.1046/j.1365-2664.2002.00769.x; Lindberg N., 2003, THESIS SWEDISH U AGR; Maraun M, 1998, PEDOBIOLOGIA, V42, P232; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; Mcgeoch MA, 2006, AUSTRAL ECOL, V31, P719, DOI 10.1111/j.1442-9993.2006.01614.x; Moron-Rios A, 2010, EUR J SOIL BIOL, V46, P91, DOI 10.1016/j.ejsobi.2009.12.008; Norby RJ, 2000, NEW PHYTOL, V147, P3, DOI 10.1046/j.1469-8137.2000.00676.x; Petchey OL, 2010, BIOL LETTERS, V6, P434, DOI 10.1098/rsbl.2010.0240; Pflug A, 2001, EUR J SOIL BIOL, V37, P305, DOI 10.1016/S1164-5563(01)01101-3; Pigino G, 2006, ECOTOX ENVIRON SAFE, V64, P257, DOI 10.1016/j.ecoenv.2005.12.012; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Potapov M, 2001, ISOTOMIDAE SYNOPSES, V3; Rhind SG, 2002, WILDLIFE RES, V29, P235, DOI 10.1071/WR01014; Rusek J, 1998, BIODIVERS CONSERV, V7, P1207, DOI 10.1023/A:1008887817883; Sinclair BJ, 2006, SOIL BIOL BIOCHEM, V38, P3158, DOI 10.1016/j.soilbio.2005.11.035; Sjursen H, 2005, APPL SOIL ECOL, V30, P148, DOI 10.1016/j.apsoil.2005.02.013; SPONCHIADO BN, 1989, EXP AGR, V25, P249, DOI 10.1017/S0014479700016756; Tsiafouli MA, 2005, APPL SOIL ECOL, V29, P17, DOI 10.1016/j.apsoil.2004.10.002; VERHOEF HA, 1983, HOLARCTIC ECOL, V6, P387; WALLWORK JA, 1983, ANNU REV ENTOMOL, V28, P109, DOI 10.1146/annurev.en.28.010183.000545; WIDDEN P, 1986, CAN J BOT, V64, P1424, DOI 10.1139/b86-194; Wolters V, 1998, APPL SOIL ECOL, V9, P221, DOI 10.1016/S0929-1393(98)00079-1; Xu GL, 2009, ENVIRON POLLUT, V157, P2030, DOI 10.1016/j.envpol.2009.02.026	60	33	40	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43102	10.1371/journal.pone.0043102	http://dx.doi.org/10.1371/journal.pone.0043102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905210	Green Published, gold			2022-12-27	WOS:000307823600048
J	Ba, Q; Zhou, NY; Duan, J; Chen, T; Hao, M; Yang, XY; Li, JY; Yin, J; Chu, RA; Wang, H				Ba, Qian; Zhou, Naiyuan; Duan, Juan; Chen, Tao; Hao, Miao; Yang, Xinying; Li, Junyang; Yin, Jun; Chu, Ruiai; Wang, Hui			Dihydroartemisinin Exerts Its Anticancer Activity through Depleting Cellular Iron via Transferrin Receptor-1	PLOS ONE			English	Article							CANCER-CELLS; ARTEMISININ; APOPTOSIS; GROWTH; DERIVATIVES; ACTIVATION; MECHANISMS; EXPRESSION; TRANSPORT; METABOLISM	Artemisinin and its main active metabolite dihydroartemisinin, clinically used antimalarial agents with low host toxicity, have recently shown potent anticancer activities in a variety of human cancer models. Although iron mediated oxidative damage is involved, the mechanisms underlying these activities remain unclear. In the current study, we found that dihydroartemisinin caused cellular iron depletion in time- and concentration-dependent manners. It decreased iron uptake and disturbed iron homeostasis in cancer cells, which were independent of oxidative damage. Moreover, dihydroartemisinin reduced the level of transferrin receptor-1 associated with cell membrane. The regulation of dihydroartemisinin to transferrin receptor-1 could be reversed by nystatin, a cholesterol-sequestering agent but not the inhibitor of clathrin-dependent endocytosis. Dihydroartemisinin also induced transferrin receptor-1 palmitoylation and colocalization with caveolin-1, suggesting a lipid rafts mediated internalization pathway was involved in the process. Also, nystatin reversed the influences of dihydroartemisinin on cell cycle and apoptosis related genes and the siRNA induced downregulation of transferrin receptor-1 decreased the sensitivity to dihydroartemisinin efficiently in the cells. These results indicate that dihydroartemisinin can counteract cancer through regulating cell-surface transferrin receptor-1 in a non-classical endocytic pathway, which may be a new action mechanism of DHA independently of oxidative damage.	[Ba, Qian; Duan, Juan; Chen, Tao; Hao, Miao; Yang, Xinying; Li, Junyang; Yin, Jun; Chu, Ruiai; Wang, Hui] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China; [Zhou, Naiyuan] China Natl Ctr Biotechnol Dev, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Ba, Q (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China.	huiwang@sibs.ac.cn	Ba, Qian/AAZ-2623-2021; hao, miao/HII-4487-2022	Ba, Qian/0000-0002-7253-7566; 	One Hundred Talents Program of the Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715]; Science and Technology Commission of Shanghai Municipality [10391902100]; Science and Technology Commission of Xuhui District of Shanghai Municipality [RCT201001]; Xuhui Central Hospital [CRC2010002, CRC2011001, CRC2011004]; Director Foundation [20090101]; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of the Institute of Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences	One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Commission of Xuhui District of Shanghai Municipality; Xuhui Central Hospital; Director Foundation; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of the Institute of Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences	This study was supported by grants from the One Hundred Talents Program of the Chinese Academy of Sciences, the National Nature Science Foundation (30870513, 31070680 and 91029715), the Science and Technology Commission of Shanghai Municipality (10391902100), the Science and Technology Commission of Xuhui District of Shanghai Municipality (RCT201001), and Xuhui Central Hospital (CRC2010002, CRC2011001 and CRC2011004), Director Foundation (20090101) and the Food Safety Research Center and Key Laboratory of Nutrition and Metabolism of the Institute of Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba Q, 2011, CLIN CANCER RES, V17, P7625, DOI 10.1158/1078-0432.CCR-10-3099; Chaturvedi D, 2010, CHEM SOC REV, V39, P435, DOI 10.1039/b816679j; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Firestone GL, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001239; Graham RM, 2007, WORLD J GASTROENTERO, V13, P4725, DOI 10.3748/wjg.v13.i35.4725; He Y, 2011, RHEUMATOL INT, V31, P53, DOI 10.1007/s00296-009-1218-7; Horonchik L, 2008, CHEM BIOL, V15, P647, DOI 10.1016/j.chembiol.2008.05.011; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Hsu E, 2006, T ROY SOC TROP MED H, V100, P505, DOI 10.1016/j.trstmh.2005.09.020; Huang XJ, 2007, J PHARM PHARMACOL, V59, P849, DOI 10.1211/jpp.59.6.0011; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kasibhatla S, 2005, P NATL ACAD SCI USA, V102, P12095, DOI 10.1073/pnas.0406731102; Kelter G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000798; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lu JJ, 2008, CANCER BIOL THER, V7, P1017, DOI 10.4161/cbt.7.7.6035; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Miller LH, 2011, CELL, V146, P855, DOI 10.1016/j.cell.2011.08.024; Morrissey C, 2010, ANTI-CANCER DRUG, V21, P423, DOI 10.1097/CAD.0b013e328336f57b; NECKERS LM, 1986, CANCER INVEST, V4, P461, DOI 10.3109/07357908609017524; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Ponka P, 1999, INT J BIOCHEM CELL B, V31, P1111, DOI 10.1016/S1357-2725(99)00070-9; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Riganti C, 2009, BRIT J PHARMACOL, V156, P1054, DOI 10.1111/j.1476-5381.2009.00117.x; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SHTERMAN N, 1991, PATHOBIOLOGY, V59, P19, DOI 10.1159/000163611; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wartenberg M, 2003, LAB INVEST, V83, P1647, DOI 10.1097/01.LAB.0000098424.38003.FF	33	60	69	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42703	10.1371/journal.pone.0042703	http://dx.doi.org/10.1371/journal.pone.0042703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900042	Green Published, gold			2022-12-27	WOS:000307380900059
J	Boss, D; Hoffmann, A; Rappaz, B; Depeursinge, C; Magistretti, PJ; Van de Ville, D; Marquet, P				Boss, Daniel; Hoffmann, Annick; Rappaz, Benjamin; Depeursinge, Christian; Magistretti, Pierre J.; Van de Ville, Dimitri; Marquet, Pierre			Spatially-Resolved Eigenmode Decomposition of Red Blood Cells Membrane Fluctuations Questions the Role of ATP in Flickering	PLOS ONE			English	Article							DIGITAL HOLOGRAPHIC MICROSCOPY; ERYTHROCYTE-MEMBRANE; BIOLOGICAL-MEMBRANES; LIPID BILAYERS; ELASTICITY; SHAPE; MECHANICS; CURVATURE; SPECTRIN; SKELETON	Red blood cells (RBCs) present unique reversible shape deformability, essential for both function and survival, resulting notably in cell membrane fluctuations (CMF). These CMF have been subject of many studies in order to obtain a better understanding of these remarkable biomechanical membrane properties altered in some pathological states including blood diseases. In particular the discussion over the thermal or metabolic origin of the CMF has led in the past to a large number of investigations and modeling. However, the origin of the CMF is still debated. In this article, we present an analysis of the CMF of RBCs by combining digital holographic microscopy (DHM) with an orthogonal subspace decomposition of the imaging data. These subspace components can be reliably identified and quantified as the eigenmode basis of CMF that minimizes the deformation energy of the RBC structure. By fitting the observed fluctuation modes with a theoretical dynamic model, we find that the CMF are mainly governed by the bending elasticity of the membrane and that shear and tension elasticities have only a marginal influence on the membrane fluctations of the discocyte RBC. Further, our experiments show that the role of ATP as a driving force of CMF is questionable. ATP, however, seems to be required to maintain the unique biomechanical properties of the RBC membrane that lead to thermally excited CMF.	[Boss, Daniel; Hoffmann, Annick; Rappaz, Benjamin; Magistretti, Pierre J.; Marquet, Pierre] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Vaud, Switzerland; [Depeursinge, Christian] Ecole Polytech Fed Lausanne, Adv Photon Lab, Lausanne, Vaud, Switzerland; [Magistretti, Pierre J.; Marquet, Pierre] DP CHUV, Dept Psychiat, Ctr Neurosci Psychiat, Prilly, Vaud, Switzerland; [Van de Ville, Dimitri] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Vaud, Switzerland; [Van de Ville, Dimitri] Univ Geneva, Dept Radiol & Med Informat, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Boss, D (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Vaud, Switzerland.	daniel.boss@a3.epfl.ch	Van De Ville, Dimitri/A-5364-2008; Rappaz, Benjamin/C-1881-2014	Van De Ville, Dimitri/0000-0002-2879-3861; Rappaz, Benjamin/0000-0002-8744-600X; Magistretti, Pierre Julius/0000-0002-6678-320X	Swiss National Science Foundation [CR32I3132993, PP00P2123438]; Swiss Commission for Technology and Innovation [9389.1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Commission for Technology and Innovation	Funders are in part the Swiss National Science Foundation, grants #CR32I3132993 and #PP00P2123438, URL: http://www.snf.ch; and in part the Swiss Commission for Technology and Innovation, grant #9389.1, URL: http://www.kti.admin.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auth T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051910; Betz T, 2009, P NATL ACAD SCI USA, V106, P15320, DOI 10.1073/pnas.0904614106; BROCHARD F, 1975, J PHYS-PARIS, V36, P1035, DOI 10.1051/jphys:0197500360110103500; Colomb T, 2006, J OPT SOC AM A, V23, P3177, DOI 10.1364/JOSAA.23.003177; DEULING HJ, 1976, J PHYS-PARIS, V37, P1335, DOI 10.1051/jphys:0197600370110133500; Evans J, 2008, BIOPHYS J, V94, P4134, DOI 10.1529/biophysj.107.117952; FEO C, 1977, NATURE, V265, P166, DOI 10.1038/265166a0; FISCHER TM, 1992, BIOPHYS J, V63, P1328, DOI 10.1016/S0006-3495(92)81710-1; Gov N, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.228101; Gov NS, 2005, BIOPHYS J, V88, P1859, DOI 10.1529/biophysj.104.045328; Hale JP, 2009, SOFT MATTER, V5, P3603, DOI 10.1039/b910422d; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Jolliffe Ian, 2011, PRINCIPAL COMPONENT; Jourdain P, 2011, J NEUROSCI, V31, P11846, DOI 10.1523/JNEUROSCI.0286-11.2011; LEVIN S, 1991, BIOPHYS J, V60, P733, DOI 10.1016/S0006-3495(91)82104-X; Lim HWG, 2002, P NATL ACAD SCI USA, V99, P16766, DOI 10.1073/pnas.202617299; Manno S, 2005, J BIOL CHEM, V280, P7581, DOI 10.1074/jbc.M410650200; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; Manno S, 2010, J BIOL CHEM, V285, P33923, DOI 10.1074/jbc.M110.126896; Mark AP, 1992, J PHYS II, V2, P1273; Marquet P, 2005, OPT LETT, V30, P468, DOI 10.1364/OL.30.000468; Mikirova N, 2005, ORTHOMOLECULAR MED, V20, P50; Park Y, 2010, P NATL ACAD SCI US; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; PETERSON MA, 1992, PHYS REV A, V45, P4116, DOI 10.1103/PhysRevA.45.4116; PETERSON MA, 1985, J MATH PHYS, V26, P711, DOI 10.1063/1.526612; Popescu G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218101; Rappaz B, 2008, CYTOM PART A, V73A, P895, DOI 10.1002/cyto.a.20605; Rappaz B, 2009, BLOOD CELL MOL DIS, V42, P228, DOI 10.1016/j.bcmd.2009.01.018; SEIFERT U, 1993, EUROPHYS LETT, V23, P71, DOI 10.1209/0295-5075/23/1/012; SEIFERT U, 1991, PHYS REV A, V44, P1182, DOI 10.1103/PhysRevA.44.1182; SHEETZ MP, 1977, J CELL BIOL, V73, P638, DOI 10.1083/jcb.73.3.638; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; STREY H, 1995, BIOPHYS J, V69, P478, DOI 10.1016/S0006-3495(95)79921-0; Szekely D, 2009, EUR BIOPHYS J BIOPHY, V38, P923, DOI 10.1007/s00249-009-0473-6; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tuvia S, 1998, J CELL BIOL, V141, P1551, DOI 10.1083/jcb.141.7.1551; ZEMAN K, 1990, EUR BIOPHYS J, V18, P203, DOI 10.1007/BF00183373; ZILKER A, 1987, J PHYS-PARIS, V48, P2139, DOI 10.1051/jphys:0198700480120213900; ZILKER A, 1992, PHYS REV A, V46, P7998, DOI 10.1103/PhysRevA.46.7998	40	38	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e40667	10.1371/journal.pone.0040667	http://dx.doi.org/10.1371/journal.pone.0040667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899990	Green Submitted, gold, Green Published			2022-12-27	WOS:000307380900005
J	McNutt, P; Lyman, M; Swartz, A; Tuznik, K; Kniffin, D; Whitten, K; Milhorn, D; Hamilton, T				McNutt, Patrick; Lyman, Megan; Swartz, Adam; Tuznik, Kaylie; Kniffin, Denise; Whitten, Kim; Milhorn, Denise; Hamilton, Tracey			Architectural and Biochemical Expressions of Mustard Gas Keratopathy: Preclinical Indicators and Pathogenic Mechanisms	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; SULFUR MUSTARD; CONFOCAL MICROSCOPY; EPITHELIAL INGROWTH; INJURY; KERATOCYTE; RABBITS; CORNEA; APOPTOSIS; SYSTEM	A subset of victims of ocular sulfur mustard (SM) exposure develops an irreversible, idiotypic keratitis with associated secondary pathologies, collectively referred to as mustard gas keratopathy (MGK). MGK involves a progressive corneal degeneration resulting in chronic ocular discomfort and impaired vision for which clinical interventions have typically had poor outcomes. Using a rabbit corneal vapor exposure model, we previously demonstrated a clinical progression with acute and chronic sequelae similar to that observed in human casualties. However, a better understanding of the temporal changes that occur during the biphasic SM injury is crucial to mechanistic understanding and therapeutic development. Here we evaluate the histopathologic, biochemical and ultrastructural expressions of pathogenesis of the chronic SM injury over eight weeks. We confirm that MGK onset exhibits a biphasic trajectory involving corneal surface regeneration over the first two weeks, followed by the rapid development and progressive degeneration of corneal structure. Preclinical markers of corneal dysfunction were identified, including destabilization of the basal corneal epithelium, basement membrane zone abnormalities and stromal deformation. Clinical sequelae of MGK appeared abruptly three weeks after exposure, and included profound anterior edema, recurring corneal erosions, basement membrane disorganization, basal cell necrosis and stromal degeneration. Unlike resolved corneas, MGK corneas exhibited frustrated corneal wound repair, with significantly elevated histopathology scores. Increased lacrimation, disruption of the basement membrane and accumulation of pro-inflammatory mediators in the aqueous humor provide several mechanisms for corneal degeneration. These data suggest that the chronic injury is fundamentally distinct from the acute lesion, involving injury mechanisms that operate on different time scales and in different corneal tissues. Corneal edema appears to be the principal pathology of MGK, in part resulting from persistent necrosis of the basal corneal epithelium and deterioration of the basement membrane. The findings also provide a potential explanation as to why administration of anti-inflammatories transiently delays, but does not prevent, the development of MGK sequelae.	[McNutt, Patrick; Lyman, Megan; Swartz, Adam; Tuznik, Kaylie; Kniffin, Denise; Whitten, Kim; Hamilton, Tracey] USA, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA; [Milhorn, Denise] USA, Med Res & Mat Command, Ft Detrick, MD USA	Research Institute of Chemical Defense - China	McNutt, P (corresponding author), USA, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA.	patrick.mcnutt@us.army.mil	McNutt, Patrick/AAS-8535-2020	McNutt, Patrick/0000-0002-5703-4565	DTRA - Joint Science and Technology Office, Medical ST Division [2.F0012_08_RC_C, CBM.CUTOC.01.10.RC.003]	DTRA - Joint Science and Technology Office, Medical ST Division	This research was supported by the DTRA - Joint Science and Technology Office, Medical S&T Division (http://www.dtra.mil/Home.aspx), grants 2.F0012_08_RC_C and CBM.CUTOC.01.10.RC.003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004; ABRAMS KL, 1990, AM J VET RES, V51, P1912; Alomar TS, 2011, INVEST OPHTH VIS SCI, V52, P8193, DOI 10.1167/iovs.11-8047; Amir A, 2000, J APPL TOXICOL, V21, pS109; Anumolu SS, 2010, BIOMATERIALS, V31, P964, DOI 10.1016/j.biomaterials.2009.10.010; AXELROD DJ, 1947, AM J PATHOL, V23, P389; Babin MC, 2004, J TOXICOL-CUTAN OCUL, V23, P65, DOI 10.1081/CUS-120027483; Balali-Mood M, 2006, BASIC CLIN PHARMACOL, V99, P273, DOI 10.1111/j.1742-7843.2006.pto_429.x; Benson JM, 2011, WOUND REPAIR REGEN, V19, P348, DOI 10.1111/j.1524-475X.2011.00675.x; Eagle Jr. RC, 1989, T AM OPHTHAL SOC, V87, P119; Eagle R C Jr, 1989, Trans Am Ophthalmol Soc, V87, P107; Feister AJ., 1991, MED DEFENSE MUSTARD; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; Fini ME, 1996, AM J PATHOL, V149, P1287; Foley PL, 2001, COMPARATIVE MED, V51, P239; Fournie PR, 2010, ARCH OPHTHALMOL-CHIC, V128, P426, DOI 10.1001/archophthalmol.2010.23; Graham John S, 2005, J Burns Wounds, V4, pe1; Jain S, 1996, CORNEA, V15, P248, DOI 10.1097/00003226-199605000-00005; Javadi MA, 2005, OPHTHALMOLOGY, V112, P617, DOI 10.1016/j.ophtha.2004.09.027; Kadar T, 2009, TOXICOLOGY, V263, P59, DOI 10.1016/j.tox.2008.10.026; KATAKAMI C, 1991, INVEST OPHTH VIS SCI, V32, P1837; Latkany RA, 2004, J CATARACT REFR SURG, V30, P929, DOI 10.1016/j.jcrs.2003.07.017; Mann I, 1944, P R SOC MED, V35, P229; MATSUBARA M, 1991, DEV BIOL, V147, P425, DOI 10.1016/0012-1606(91)90300-R; McNutt P, 2012, CORNEA, V31, P280, DOI 10.1097/ICO.0B013E31823D02CD; Milhorn D, 2010, ANN NY ACAD SCI, V1194, P72, DOI 10.1111/j.1749-6632.2010.05491.x; Mohan RR, 2000, INVEST OPHTH VIS SCI, V41, P1327; Mousavi B, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-2; Naderi M, 2010, CUTAN OCUL TOXICOL, V29, P234, DOI 10.3109/15569527.2010.491102; Ollivier FJ, 2007, VET OPHTHALMOL, V10, P199, DOI 10.1111/j.1463-5224.2007.00546.x; Pal-Ghosh S, 2011, J CELL SCI, V124, P2666, DOI 10.1242/jcs.085480; Pleyer U, 1999, AM J OPHTHALMOL, V128, P506, DOI 10.1016/S0002-9394(99)00178-6; Safarinejad MR, 2001, MIL MED, V166, P67, DOI 10.1093/milmed/166.1.67; Solberg Y, 1997, SURV OPHTHALMOL, V41, P461, DOI 10.1016/S0039-6257(97)00021-0; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Wilson SE, 1996, INVEST OPHTH VIS SCI, V37, P1582; Wilson SE, 1996, EXP EYE RES, V62, P325, DOI 10.1006/exer.1996.0038; Zieske JD, 2001, EXP EYE RES, V72, P33, DOI 10.1006/exer.2000.0926	38	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42837	10.1371/journal.pone.0042837	http://dx.doi.org/10.1371/journal.pone.0042837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900056	Green Published, gold			2022-12-27	WOS:000307380900074
J	Peruquetti, RL; De Mateo, S; Sassone-Corsi, P				Peruquetti, Rita L.; De Mateo, Sara; Sassone-Corsi, Paolo			Circadian Proteins CLOCK and BMAL1 in the Chromatoid Body, a RNA Processing Granule of Male Germ Cells	PLOS ONE			English	Article							SPERMATOGENESIS; MOUSE; EXPRESSION; RHYTHMS; BODIES; METABOLISM; ORGANELLES; FERTILITY; HOMOLOG; OBESITY	Spermatogenesis is a complex differentiation process that involves genetic and epigenetic regulation, sophisticated hormonal control, and extensive structural changes in male germ cells. RNA nuclear and cytoplasmic bodies appear to be critical for the progress of spermatogenesis. The chromatoid body (CB) is a cytoplasmic organelle playing an important role in RNA post-transcriptional and translation regulation during the late steps of germ cell differentiation. The CB is also important for fertility determination since mutations of genes encoding its components cause infertility by spermatogenesis arrest. Targeted ablation of the Bmal1 and Clock genes, which encode central regulators of the circadian clock also result in fertility defects caused by problems other than spermatogenesis alterations. We show that the circadian proteins CLOCK and BMAL1 are localized in the CB in a stage-specific manner of germ cells. Both BMAL1 and CLOCK proteins physically interact with the ATP-dependent DEAD-box RNA helicase MVH (mouse VASA homolog), a hallmark component of the CB. BMAL1 is differentially expressed during the spermatogenic cycle of seminiferous tubules, and Bmal1 and Clock deficient mice display significant CB morphological alterations due to BMAL1 ablation or low expression. These findings suggest that both BMAL1 and CLOCK contribute to CB assembly and physiology, raising questions on the role of the circadian clock in reproduction and on the molecular function that CLOCK and BMAL1 could potentially have in the CB assembly and physiology.	[Peruquetti, Rita L.; De Mateo, Sara; Sassone-Corsi, Paolo] Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92717 USA	University of California System; University of California Irvine	Peruquetti, RL (corresponding author), Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92717 USA.	psc@uci.edu	de Mateo Lopez, Sara/L-1870-2017	de Mateo Lopez, Sara/0000-0003-4754-6599; Peruquetti, Rita/0000-0003-3153-6599	Sao Paulo State Research Foundation (FAPESP) [2009/14090-6]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	RLP was a postdoctoral fellow supported by Sao Paulo State Research Foundation (FAPESP), grant number 2009/14090-6. http://www.fapesp.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Alvarez JD, 2003, BIOL REPROD, V69, P81, DOI 10.1095/biolreprod.102.011833; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Beyret E, 2011, DEV BIOL, V355, P215, DOI 10.1016/j.ydbio.2011.04.021; Boden MJ, 2006, REPRODUCTION, V132, P379, DOI 10.1530/rep.1.00614; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; CROWLEY WF, 1991, RECENT PROG HORM RES, V47, P27; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Haraguchi CM, 2005, J HISTOCHEM CYTOCHEM, V53, P455, DOI 10.1369/jhc.4A6520.2005; Hess RA, 1999, ENCY REPROD, V4, P1; Kalamvoki M, 2010, P NATL ACAD SCI USA, V107, P17721, DOI 10.1073/pnas.1012991107; Kelly WG, 2007, CHROMOSOME RES, V15, P633, DOI 10.1007/s10577-007-1143-0; Kennaway DJ, 2012, MOL CELL ENDOCRINOL, V349, P56, DOI 10.1016/j.mce.2011.08.013; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Kleene KC, 2011, REPRODUCTION, V142, P383, DOI 10.1530/REP-11-0113; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Kotaja N, 2006, J CELL SCI, V119, P2819, DOI 10.1242/jcs.03022; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee DW, 2003, GENETICS, V164, P821; Lopes SMCDS, 2010, HISTOL HISTOPATHOL, V25, P267, DOI 10.14670/HH-25.267; Morse D, 2003, MOL ENDOCRINOL, V17, P141, DOI 10.1210/me.2002-0184; Nagamori I, 2011, J CELL SCI, V124, P4346, DOI 10.1242/jcs.096461; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; Pek JW, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-6; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Tanaka SS, 2000, GENE DEV, V14, P841; Yokota S, 2008, ACTA HISTOCHEM CYTOC, V41, P65, DOI 10.1267/ahc.08010; Zar JH., 1999, BIOSTATISCICAL ANAL	37	14	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42695	10.1371/journal.pone.0042695	http://dx.doi.org/10.1371/journal.pone.0042695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900038	Green Published, gold			2022-12-27	WOS:000307380900055
J	Valigurova, A				Valigurova, Andrea			Sophisticated Adaptations of Gregarina cuneata (Apicomplexa) Feeding Stages for Epicellular Parasitism	PLOS ONE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; TENEBRIO-MOLITOR LARVAE; MARINE GREGARINES; HOST EPITHELIUM; FINE-STRUCTURE; BLABERAE; CRYPTOSPORIDIUM; POLYMORPHA; EPIMERITE; MYOSIN	Background: Gregarines represent a very diverse group of early emerging apicomplexans, parasitising numerous invertebrates and urochordates, and are considered of little practical significance. Recently, they have gained more attention since some analyses showed that cryptosporidia are more closely related to the gregarines than to coccidia. Methodology/Principal Findings: Using a combined microscopic approach, this study points out the spectacular strategy of Gregarina cuneata for attachment to host tissue and nutrient acquisition while parasitising the intestine of yellow mealworm larvae, and reveals the unusual dynamics of cellular interactions between the host epithelium and parasite feeding stages. Trophozoites of G. cuneata develop epicellularly, attached to the luminal side of the host epithelial cell by an epimerite exhibiting a high degree of morphological variability. The presence of contractile elements in the apical region of feeding stages indicates that trophozoite detachment from host tissue is an active process self-regulated by the parasite. A detailed discussion is provided on the possibility of reversible retraction and protraction of the eugregarine apical end, facilitating eventual reattachment to another host cell in better physiological conditions. The gamonts, found in contact with host tissue via a modified protomerite top, indicate further adaptation of parasite for nutrient acquisition via epicellular parasitism while keeping their host healthy. The presence of eugregarines in mealworm larvae even seems to increase the host growth rate and to reduce the death rate despite often heavy parasitisation. Conclusions/Significance: Improved knowledge about the formation of host-parasite interactions in deep-branching apicomplexans, including gregarines, would offer significant insights into the fascinating biology and evolutionary strategy of Apicomplexa. Gregarines exhibit an enormous diversity in cell architecture and dimensions, depending on their parasitic strategy and the surrounding environment. They seem to be a perfect example of a coevolution between a group of parasites and their hosts.	Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic	Masaryk University Brno	Valigurova, A (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic.	andreav@sci.muni.cz	Valigurová, Andrea/B-4522-2012	Valigurová, Andrea/0000-0001-8313-1580	Czech Science Foundation [GPP506/10/P372]; Ministry of Education, Youth and Sports [MEB021127]; Department of Botany and Zoology, Faculty of Science, Masaryk University	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Department of Botany and Zoology, Faculty of Science, Masaryk University	Financial support was provided by grants from the Czech Science Foundation (GPP506/10/P372). Travel expenses were partially supported by the Ministry of Education, Youth and Sports (MEB021127). The author acknowledges support from the Department of Botany and Zoology, Faculty of Science, Masaryk University, towards the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDOIN J, 1969, Protistologica, V5, P431; Carreno RA, 1999, PARASITOL RES, V85, P899, DOI 10.1007/s004360050655; Cook TJP, 2001, J PARASITOL, V87, P988, DOI 10.2307/3285220; DESPORTES I, 1986, PROTISTOLOGICA, V22, P47; Devauchelle G., 1968, Protistologica, V4, P313; Dyakin Andrey Yu., 2005, Protistology, V4, P97; Dykstra MJ, 1993, MANUAL APPL TECHNIQU; GHAZALI M, 1993, J EUKARYOT MICROBIOL, V40, P345, DOI 10.1111/j.1550-7408.1993.tb04927.x; GHAZALI M, 1989, BIOL CELL, V67, P173, DOI 10.1016/0248-4900(89)90052-X; HARRY OG, 1967, J PROTOZOOL, V14, P539, DOI 10.1111/j.1550-7408.1967.tb02039.x; HARRY OG, 1970, NATURE, V225, P964, DOI 10.1038/225964a0; HARRY OG, 1965, J PROTOZOOL, V12, P296, DOI 10.1111/j.1550-7408.1965.tb01856.x; Heintzelman MB, 2008, J PARASITOL, V94, P158, DOI 10.1645/GE-1339.1; Heintzelman MB, 2004, CELL MOTIL CYTOSKEL, V58, P83, DOI 10.1002/cm.10178; HENRY JE, 1981, ANNU REV ENTOMOL, V26, P49, DOI 10.1146/annurev.en.26.010181.000405; HILDEBRAND HF, 1976, Z PARASITENKD, V49, P193, DOI 10.1007/BF00380590; Kaya, 1993, INSECT PATHOLOGY; Leander BS, 2008, TRENDS PARASITOL, V24, P60, DOI 10.1016/j.pt.2007.11.005; Leander BS, 2006, PROTIST, V157, P45, DOI 10.1016/j.protis.2005.10.002; LIPA JERZY J., 1967, ACTA PROTOZOOL, V5, P97; Lucarotti CJ, 2000, J INVERTEBR PATHOL, V75, P117, DOI 10.1006/jipa.1999.4911; MACMILLAN WG, 1973, PARASITOLOGY, V66, P207, DOI 10.1017/S0031182000044553; ORMIERES R, 1977, Z PARASITENKD, V53, P13, DOI 10.1007/BF00383110; Perkins F. O., 2000, ILLUSTRATED GUIDE PR, V1, P190; RUHNKE TR, 1989, J PROTOZOOL, V36, P428, DOI 10.1111/j.1550-7408.1989.tb05541.x; RUHNKE TR, 1990, J PARASITOL, V76, P519, DOI 10.2307/3282832; SCHREVEL J, 1972, J MICROSC-PARIS, V15, P21; Schrevel J., 1966, Protistologica, V2, P17; SCHREVEL J, 1983, J CELL SCI, V61, P151; Schrevel Joseph, 1993, P133; Sumner R, 1932, SCIENCE, V78, P1; Talluri M.V., 1983, B ZOOL, V50, P247; Templeton TJ, 2010, MOL BIOL EVOL, V27, P235, DOI 10.1093/molbev/msp226; THOMAS D, 1973, J INSECT PHYSIOL, V19, P515, DOI 10.1016/0022-1910(73)90062-0; TRONCHIN G, 1986, PROTISTOLOGICA, V22, P127; TRONCHIN G, 1977, J PROTOZOOL, V24, P67, DOI 10.1111/j.1550-7408.1977.tb05282.x; Valigurova A, 2005, EUR J PROTISTOL, V41, P209, DOI 10.1016/j.ejop.2005.05.005; Valigurova A, 2008, EUR J PROTISTOL, V44, P197, DOI 10.1016/j.ejop.2007.11.006; Valigurova A, 2008, INT J PARASITOL, V38, P913, DOI 10.1016/j.ijpara.2007.11.003; Valigurova A, 2007, J EUKARYOT MICROBIOL, V54, P495, DOI 10.1111/j.1550-7408.2007.00291.x; Valigurova A, 2009, INT J PARASITOL, V39, P1235, DOI 10.1016/j.ijpara.2009.04.009; VIVIER E, 1970, Protistologica, V6, P127	42	23	23	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42606	10.1371/journal.pone.0042606	http://dx.doi.org/10.1371/journal.pone.0042606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900033	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900049
J	Zhou, Y; Pei, ZQ; Su, JQ; Zhang, JL; Zheng, YR; Ni, J; Xiao, CW; Wang, RZ				Zhou, Yong; Pei, Zhiqin; Su, Jiaqi; Zhang, Jingli; Zheng, Yuanrun; Ni, Jian; Xiao, Chunwang; Wang, Renzhong			Comparing Soil Organic Carbon Dynamics in Perennial Grasses and Shrubs in a Saline-Alkaline Arid Region, Northwestern China	PLOS ONE			English	Article							PLANT LITTER DECOMPOSITION; MICROBIAL BIOMASS DYNAMICS; FINE-ROOT DYNAMICS; PATAGONIAN MONTE; NITROGEN; ECOSYSTEMS; PATTERNS; CLIMATE; COMMUNITY; TURNOVER	Background: Although semi-arid and arid regions account for about 40% of terrestrial surface of the Earth and contain approximately 10% of the global soil organic carbon stock, our understanding of soil organic carbon dynamics in these regions is limited. Methodology/Principal Findings: A field experiment was conducted to compare soil organic carbon dynamics between a perennial grass community dominated by Cleistogenes squarrosa and an adjacent shrub community co-dominated by Reaumuria soongorica and Haloxylon ammodendron, two typical plant life forms in arid ecosystems of saline-alkaline arid regions in northwestern China during the growing season 2010. We found that both fine root biomass and necromass in two life forms varied greatly during the growing season. Annual fine root production in the perennial grasses was 45.6% significantly higher than in the shrubs, and fine root turnover rates were 2.52 and 2.17 yr(-1) for the perennial grasses and the shrubs, respectively. Floor mass was significantly higher in the perennial grasses than in the shrubs due to the decomposition rate of leaf litter in the perennial grasses was 61.8% lower than in the shrubs even though no significance was detected in litterfall production. Soil microbial biomass and activity demonstrated a strong seasonal variation with larger values in May and September and minimum values in the dry month of July. Observed higher soil organic carbon stocks in the perennial grasses (1.32 Kg C m(-2)) than in the shrubs (1.12 Kg C m(-2)) might be attributed to both greater inputs of poor quality litter that is relatively resistant to decay and the lower ability of microorganism to decompose these organic matter. Conclusions/Significance: Our results suggest that the perennial grasses might accumulate more soil organic carbon with time than the shrubs because of larger amounts of inputs from litter and slower return of carbon through decomposition.	[Zhou, Yong; Pei, Zhiqin; Su, Jiaqi; Zhang, Jingli; Zheng, Yuanrun; Ni, Jian; Xiao, Chunwang; Wang, Renzhong] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Zhou, Yong; Su, Jiaqi; Zhang, Jingli] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, Y (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	cwxiao@ibcas.ac.cn; wangrz@ibcas.ac.cn	Zhou, Yong/H-9048-2019; Ni, Jian/I-7067-2012; Zhou, Yong/B-9795-2017	Zhou, Yong/0000-0003-2546-8462; Ni, Jian/0000-0001-5411-7050; Zhou, Yong/0000-0003-2546-8462	National Research Program of China (973 Program) [2009CB825103]	National Research Program of China (973 Program)(National Basic Research Program of China)	This study was financially supported by the National Research Program of China (973 Program, no. 2009CB825103). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABER JD, 1985, OECOLOGIA, V66, P317, DOI 10.1007/BF00378292; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Alvarez JA, 2009, PLANT ECOL, V205, P295, DOI 10.1007/s11258-009-9618-z; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Austin AT, 2011, TRENDS ECOL EVOL, V26, P229, DOI 10.1016/j.tree.2011.02.003; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Bao S.-D., 1999, AGR SOIL CHEM ANAL; BERG B, 1993, BIOGEOCHEMISTRY, V20, P127, DOI 10.1007/BF00000785; Campanella MV, 2008, J VEG SCI, V19, P75, DOI 10.3170/2007-8-18333; Canadell J, 1996, OECOLOGIA, V108, P583, DOI 10.1007/BF00329030; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chuyong CB, 2000, NEW PHYTOL, V148, P493, DOI 10.1046/j.1469-8137.2000.00774.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; Descheemaeker K, 2006, FOREST ECOL MANAG, V233, P21, DOI 10.1016/j.foreco.2006.05.061; Fairley R. I., 1985, Ecological interactions in soil: plants, microbes and animals, P37; FAO-UNESCO, 1988, SOIL MAP WORLD; Feng Q, 2002, GEODERMA, V106, P21, DOI 10.1016/S0016-7061(01)00099-4; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Griffiths RI, 2003, APPL ENVIRON MICROB, V69, P6961, DOI 10.1128/AEM.69.12.6961-6968.2003; Hendricks JJ, 2006, J ECOL, V94, P40, DOI 10.1111/j.1365-2745.2005.01067.x; Hipondoka MHT, 2003, J ARID ENVIRON, V54, P319, DOI 10.1006/jare.2002.1093; HOLMES WE, 1994, SOIL SCI SOC AM J, V58, P238, DOI 10.2136/sssaj1994.03615995005800010036x; Hu S, 1997, MICROBIAL ECOL, V33, P134, DOI 10.1007/s002489900015; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Jha P, 2010, PLANT SOIL, V326, P481, DOI 10.1007/s11104-009-0027-9; KINSBURSKY RS, 1989, OECOLOGIA, V80, P498, DOI 10.1007/BF00380072; Liang C, 2002, J APPL ECOL, V39, P584, DOI 10.1046/j.1365-2664.2002.00735.x; Liao JD, 2008, SOIL BIOL BIOCHEM, V40, P1207, DOI 10.1016/j.soilbio.2007.12.018; Liu S, 1996, ARID ZONE RES, V13, P36; LOVELL RD, 1995, SOIL BIOL BIOCHEM, V27, P969, DOI 10.1016/0038-0717(94)00241-R; Maya Y, 1996, J ARID ENVIRON, V34, P23, DOI 10.1006/jare.1996.0090; Mlambo D, 2008, PLANT ECOL, V196, P101, DOI 10.1007/s11258-007-9337-2; Moore TC, 1979, BIOCH PHYSL PLANT HO; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Pavon NP, 2005, J ARID ENVIRON, V60, P1, DOI 10.1016/j.jaridenv.2004.03.004; Phillips DL, 2006, GLOBAL CHANGE BIOL, V12, P61, DOI 10.1111/j.1365-2486.2005.01085.x; Rodriguez MV, 2007, PLANT SOIL, V300, P281, DOI 10.1007/s11104-007-9415-1; SALA OE, 1989, OECOLOGIA, V81, P501, DOI 10.1007/BF00378959; SCHAEFER D, 1985, OECOLOGIA, V65, P382, DOI 10.1007/BF00378913; [盛晋华 Sheng Jinhua], 2004, [草地学报, Acta agrestia sinica], V12, P91; Stone R, 2008, SCIENCE, V320, P1409, DOI 10.1126/science.320.5882.1409; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; Tu C, 2006, SOIL BIOL BIOCHEM, V38, P247, DOI 10.1016/j.soilbio.2005.05.002; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vargas DN, 2006, SOIL BIOL BIOCHEM, V38, P2401, DOI 10.1016/j.soilbio.2006.03.006; [汪诗平 Wang Shiping], 2003, [植物生态学报, Acta Phytoecologica Sinica], V27, P337; Wardle DA, 1995, SOIL BIOL BIOCHEM, V27, P1601, DOI 10.1016/0038-0717(95)00093-T; Weatherly HE, 2003, GLOBAL CHANGE BIOL, V9, P1223, DOI 10.1046/j.1365-2486.2003.00653.x; White DA, 2009, GEODERMA, V150, P214, DOI 10.1016/j.geoderma.2009.02.011; WHITFORD WG, 1986, OECOLOGIA, V68, P512, DOI 10.1007/BF00378764; Wilcox CS, 2004, J ARID ENVIRON, V56, P129, DOI 10.1016/S0140-1963(02)00324-5; Wu Z.Y., 1995, VEGETATION CHINA; Xu Hao, 2005, Acta Botanica Boreali-Occidentalia Sinica, V25, P1309; [许皓 XU Hao], 2007, [生态学报, Acta Ecologica Sinica], V27, P5019; Yahdjian L, 2006, ECOSYSTEMS, V9, P128, DOI 10.1007/s10021-004-0118-7; Zhou GY, 2007, PLANT ECOL, V188, P77, DOI 10.1007/s11258-006-9149-9	59	14	17	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42927	10.1371/journal.pone.0042927	http://dx.doi.org/10.1371/journal.pone.0042927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900067	Green Submitted, gold, Green Published			2022-12-27	WOS:000307380900085
J	Hudson, JL; Dodd, HF				Hudson, Jennifer L.; Dodd, Helen F.			Informing Early Intervention: Preschool Predictors of Anxiety Disorders in Middle Childhood	PLOS ONE			English	Article							BEHAVIORAL-INHIBITION; CHILDREN; TEMPERAMENT; PREVENTION; DEPRESSION; ATTACHMENT; SYMPTOMS; ETIOLOGY	Background: To inform early intervention practice, the present research examines how child anxiety, behavioural inhibition, maternal overinvolvement, maternal negativity, mother-child attachment and maternal anxiety, as assessed at age four, predict anxiety at age nine. Method: 202 children (102 behaviourally inhibited and 100 behaviourally uninhibited) aged 3-4 years were initially recruited and the predictors outlined above were assessed. Diagnostic assessments, using the Anxiety Disorders Interview Schedule, were then conducted five years later. Results: Behavioural inhibition, maternal anxiety, and maternal overinvolvement were significant predictors of clinical anxiety, even after controlling for baseline anxiety (p<.05). No significant effect of negativity or attachment security was found over and above baseline anxiety (p>.1). Conclusions: Preschool children who show anxiety, are inhibited, have overinvolved mothers and mothers with anxiety disorders are at increased risk for anxiety in middle childhood. These factors can be used to identify suitable participants for early intervention and can be targeted within intervention programs.	[Hudson, Jennifer L.; Dodd, Helen F.] Macquarie Univ, Ctr Emot Hlth, Dept Psychol, Sydney, NSW 2109, Australia; [Dodd, Helen F.] Univ E Anglia, Sch Psychol, Norwich NR4 7TJ, Norfolk, England	Macquarie University; University of East Anglia	Hudson, JL (corresponding author), Macquarie Univ, Ctr Emot Hlth, Dept Psychol, Sydney, NSW 2109, Australia.	jennie.hudson@mq.edu.au	Dodd, Helen/L-1430-2019	Hudson, Jennie/0000-0001-5778-2670; Dodd, Helen/0000-0003-1446-5338	Australian Research Council Discovery [DP0342793, DP0878609]	Australian Research Council Discovery(Australian Research Council)	This research was funded by Australian Research Council Discovery grants (DP0342793 and DP0878609). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogels S, 2008, CLIN PSYCHOL REV, V28, P539, DOI 10.1016/j.cpr.2007.07.011; Cassidy J., 1992, ATTACHMENT ORG PRESC; Chronis-Tuscano A, 2009, J AM ACAD CHILD PSY, V48, P928, DOI 10.1097/CHI.0b013e3181ae09df; COLL CG, 1984, CHILD DEV, V55, P1005, DOI 10.2307/1130152; Cooper PJ, 2006, J AFFECT DISORDERS, V93, P205, DOI 10.1016/j.jad.2006.03.017; Degnan KA, 2010, J CHILD PSYCHOL PSYC, V51, P497, DOI 10.1111/j.1469-7610.2010.02228.x; DINARDO PA, 1990, COMORBIDITY OF MOOD AND ANXIETY DISORDERS, P205; Edwards SL, 2010, J CHILD PSYCHOL PSYC, V51, P313, DOI 10.1111/j.1469-7610.2009.02160.x; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; Hirshfeld-Becker DR, 2010, J CONSULT CLIN PSYCH, V78, P498, DOI 10.1037/a0019055; Hudson JL, 2001, BEHAV RES THER, V39, P1411, DOI 10.1016/S0005-7967(00)00107-8; Hudson JL, J AM ACAD C IN PRESS; Hudson JL, J J ABNORM IN PRESS, V39; Hudson JL, 2004, GEN ANXIETY DISORDER, P2051; Kiff CJ, 2011, J ABNORM CHILD PSYCH, V39, P1199, DOI 10.1007/s10802-011-9539-x; Kiff CJ, 2011, CLIN CHILD FAM PSYCH, V14, P251, DOI 10.1007/s10567-011-0093-4; Kochanska G, 1997, J PERS, V65, P387, DOI 10.1111/j.1467-6494.1997.tb00959.x; MAGANA AB, 1986, PSYCHIAT RES, V17, P203, DOI 10.1016/0165-1781(86)90049-1; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; McLeod BD, 2007, CLIN PSYCHOL REV, V27, P155, DOI 10.1016/j.cpr.2006.09.002; McLeod BD, 2011, HANDBOOK OF CHILD AND ADOLESCENT ANXIETY DISORDERS, P213, DOI 10.1007/978-1-4419-7784-7_15; Mian ND, 2011, J ABNORM CHILD PSYCH, V39, P501, DOI 10.1007/s10802-010-9476-0; Moss E, 2006, DEV PSYCHOPATHOL, V18, P425, DOI 10.1017/S0954579406060238; Muris P, 2011, J CHILD FAM STUD, V20, P157, DOI 10.1007/s10826-010-9365-8; Muthen L.K., 1998, MPLUS USERS GUIDE; Pahl KM, 2012, J ANXIETY DISORD, V26, P311, DOI 10.1016/j.janxdis.2011.12.013; Rapee RM, 2005, J CONSULT CLIN PSYCH, V73, P488, DOI 10.1037/0022-006X.73.3.488; Rapee RM, 2010, AM J PSYCHIAT; Rubin DB, 2004, MULTIPLE IMPUTATION; SANSON A, 1987, INFANT BEHAV DEV, V10, P97, DOI 10.1016/0163-6383(87)90009-9; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schwartz OS, 2012, J ABNORM CHILD PSYCH, V40, P59, DOI 10.1007/s10802-011-9542-2; Shamir-Essakow G, 2005, J ABNORM CHILD PSYCH, V33, P131, DOI 10.1007/s10802-005-1822-2; SILVERMAN WK, 1988, J AM ACAD CHILD PSY, V27, P772, DOI 10.1097/00004583-198811000-00019; Sinharay S, 2001, PSYCHOL METHODS, V6, P317, DOI 10.1037//1082-989X.6.4.317; Thomasgard M, 1999, CLIN PEDIATR, V38, P347, DOI 10.1177/000992289903800605; THOMASGARD M, 1995, J DEV BEHAV PEDIATR, V16, P244; Volbrecht MM, 2010, DEV PSYCHOL, V46, P1192, DOI 10.1037/a0020616; Williams LR, 2009, J ABNORM CHILD PSYCH, V37, P1063, DOI 10.1007/s10802-009-9331-3	39	41	42	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42359	10.1371/journal.pone.0042359	http://dx.doi.org/10.1371/journal.pone.0042359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905126	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000307331100035
J	Maruta, C; Saito, Y; Hata, S; Gotoh, N; Suzuki, T; Yamamoto, T				Maruta, Chiaki; Saito, Yuhki; Hata, Saori; Gotoh, Naoya; Suzuki, Toshiharu; Yamamoto, Tohru			Constitutive Cleavage of the Single-Pass Transmembrane Protein Alcadein alpha Prevents Aberrant Peripheral Retention of Kinesin-1	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; AXONAL-TRANSPORT; BINDING PARTNERS; MEMBRANE; CELLS; APP; CALSYNTENIN-1; ABNORMALITIES; SUFFICIENT; METABOLISM	Various membrane proteins are shed by proteinases, constitutively and/or when stimulated by external signals. While the physiological significance of external signal-induced cleavages has been intensely investigated, relatively little is known about the function of constitutive cleavages. Alcadeina (Alc alpha; also called Calsyntenin-1) is an evolutionarily conserved type I single-pass transmembrane protein that binds to kinesin-1 light chain (KLC) to activate kinesin-1's transport of Alc alpha-containing vesicles. We found that Alca was constitutively and efficiently cleaved to liberate its ectodomain into the extracellular space, and that full-length Alca protein was rarely detected on the cell surface. The secretion efficiency of the ectodomain was unaltered by a mutation that both abolished Alc alpha's KLC-binding activity and attenuated its peripheral transport, suggesting that Alc alpha's cleavage occurred, at least partly, en route to the cell surface. We further demonstrated that uncleavable mutant Alca proteins readily accumulated on the cell surface and induced aberrant peripheral recruitment of KLC1 and kinesin heavy chain. Our observations suggest that Alca is efficiently processed in part to minimize the inappropriate peripheral retention of kinesin-1. This role might exemplify the functional relevance of the constitutive cleavage of single-pass transmembrane proteins.	[Maruta, Chiaki; Saito, Yuhki; Hata, Saori; Gotoh, Naoya; Suzuki, Toshiharu; Yamamoto, Tohru] Hokkaido Univ, Fac Pharmaceut Sci, Lab Neurosci, Sapporo, Hokkaido 060, Japan	Hokkaido University	Maruta, C (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Neurosci, Kita 12, Sapporo, Hokkaido 060, Japan.	tsuzuki@pharm.hokudai.ac.jp; yamamoto@pharm.hokudai.ac.jp	Hata, Saori/A-3829-2012; Yamamoto, Tohru/A-3801-2012; Suzuki, Toshiharu/B-5342-2013; Hata, Saori/AAP-9634-2020	Yamamoto, Tohru/0000-0002-1652-0233; 	Ministry of Education, Science, Culture, Sports, and Technology, Japan [20200011, 21113501];  [22590055];  [20390018];  [22659011]; Grants-in-Aid for Scientific Research [23390017, 22590055] Funding Source: KAKEN	Ministry of Education, Science, Culture, Sports, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research 22590055 (T Y), 20390018 (TS), 22659011 (TS) and Grant-in-Aid for Scientific Research on Innovative Areas 20200011 (TY), 21113501 (TS) from the Ministry of Education, Science, Culture, Sports, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fujimura Y, 2006, BRAIN RES, V1101, P12, DOI 10.1016/j.brainres.2006.05.030; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hoerndli FJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004880; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; Kawano T, 2012, TRAFFIC, V13, P834, DOI 10.1111/j.1600-0854.2012.01350.x; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; Kitamura M, 2011, METHOD ENZYMOL, V490, P93, DOI 10.1016/B978-0-12-385114-7.00005-2; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; PAPPOLLA MA, 1995, NEUROSCI LETT, V192, P105, DOI 10.1016/0304-3940(95)11627-9; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Saito Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022108; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Tomita T, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-2; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	27	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e43058	10.1371/journal.pone.0043058	http://dx.doi.org/10.1371/journal.pone.0043058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905201	Green Published, gold			2022-12-27	WOS:000307331100081
J	Robles, P; Micol, JL; Quesada, V				Robles, Pedro; Micol, Jose Luis; Quesada, Victor			Arabidopsis MDA1, a Nuclear-Encoded Protein, Functions in Chloroplast Development and Abiotic Stress Responses	PLOS ONE			English	Article							CHELATASE H-SUBUNIT; GENE-EXPRESSION; ABSCISIC-ACID; RNA-POLYMERASES; TRANSCRIPTION; SUGAR; TERMINATION; ABA; GENOME; FAMILY	Most chloroplast and mitochondrial proteins are encoded by nuclear genes, whose functions remain largely unknown because mutant alleles are lacking. A reverse genetics screen for mutations affecting the mitochondrial transcription termination factor (mTERF) family in Arabidopsis thaliana allowed us to identify 75 lines carrying T-DNA insertions. Two of them were homozygous for insertions in the At4g14605 gene, which we dubbed MDA1 (MTERF DEFECTIVE IN Arabidopsis1). The mda1 mutants exhibited altered chloroplast morphology and plant growth, and reduced pigmentation of cotyledons, leaves, stems and sepals. The mda1 mutations enhanced salt and osmotic stress tolerance and altered sugar responses during seedling establishment, possibly as a result of reduced ABA sensitivity. Loss of MDA1 function caused up-regulation of the RpoTp/SCA3 nuclear gene encoding a plastid RNA polymerase and modified the steady-state levels of chloroplast gene transcripts. Double mutant analyses indicated that MDA1 and the previously described mTERF genes SOLDAT10 and RUG2 act in different pathways. Our findings reveal a new role for mTERF proteins in the response to abiotic stress, probably through perturbed ABA retrograde signalling resulting from a disruption in chloroplast homeostasis.	[Robles, Pedro; Micol, Jose Luis; Quesada, Victor] Univ Miguel Hernandez, Inst Bioingn, Elche, Spain	Universidad Miguel Hernandez de Elche	Robles, P (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Campus Elche, Elche, Spain.	vquesada@umh.es	Robles, Pedro/L-5104-2014; Micol, José Luis/B-4832-2010	Robles, Pedro/0000-0002-4539-5435; Micol, José Luis/0000-0002-0396-1750; quesada, victor/0000-0002-0965-8680	Conselleria d'Educacio of the Generalitat Valenciana [GV/2009/058]; Bancaja-UMH	Conselleria d'Educacio of the Generalitat Valenciana; Bancaja-UMH	This work has been supported by grants from the Conselleria d'Educacio of the Generalitat Valenciana (GV/2009/058) and Bancaja-UMH to V.Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baba K, 2004, PLANT J, V38, P38, DOI 10.1111/j.1365-313X.2004.02022.x; Babiychuk E, 2011, P NATL ACAD SCI USA, V108, P6674, DOI 10.1073/pnas.1103442108; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Berna G, 1999, GENETICS, V152, P729; Binder S, 2003, PHILOS T R SOC B, V358, P181, DOI 10.1098/rstb.2002.1179; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Chan KX, 2010, PLANT SIGNAL BEHAV, V5, P1575, DOI 10.4161/psb.5.12.13758; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Dhaubhadel S, 2008, J PLANT GROWTH REGUL, V27, P297, DOI 10.1007/s00344-008-9056-5; Domagalska MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014012; Emanuel C, 2004, PLANT J, V38, P460, DOI 10.1111/j.0960-7412.2004.02060.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Gazzarrini S, 2001, CURR OPIN PLANT BIOL, V4, P387, DOI 10.1016/S1369-5266(00)00190-4; Giraud E, 2009, PLANT PHYSIOL, V150, P1286, DOI 10.1104/pp.109.139782; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Hajdukiewicz PTJ, 1997, EMBO J, V16, P4041, DOI 10.1093/emboj/16.13.4041; Hricova A, 2006, PLANT PHYSIOL, V141, P942, DOI 10.1104/pp.106.080069; Hyvarinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676; Inan G, 2007, PLANT MOL BIOL, V65, P295, DOI 10.1007/s11103-007-9219-y; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim C, 2009, P NATL ACAD SCI USA, V106, P9920, DOI 10.1073/pnas.0901315106; Kleine T, 2009, TRENDS GENET, V25, P185, DOI 10.1016/j.tig.2009.02.004; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Leon P, 2003, TRENDS PLANT SCI, V8, P110, DOI 10.1016/S1360-1385(03)00011-6; Leroch M, 2005, J BIOL CHEM, V280, P17992, DOI 10.1074/jbc.M412462200; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majeran W, 2012, PLANT PHYSIOL, V158, P156, DOI 10.1104/pp.111.188474; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Meskauskiene R, 2009, PLANT J, V60, P399, DOI 10.1111/j.1365-313X.2009.03965.x; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Narsai R, 2011, PLANT PHYSIOL, V157, P1342, DOI 10.1104/pp.111.183129; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Ponce MR, 1998, PLANT J, V14, P497, DOI 10.1046/j.1365-313X.1998.00146.x; Quesada V, 1999, FEBS LETT, V461, P101, DOI 10.1016/S0014-5793(99)01426-X; Quesada V, 2000, GENETICS, V154, P421; Quesada V, 2011, PLANT J, V68, P738, DOI 10.1111/j.1365-313X.2011.04726.x; Razem FA, 2006, CURR OPIN PLANT BIOL, V9, P454, DOI 10.1016/j.pbi.2006.07.007; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Robles P, 2012, MOL PLANT, V5, P294, DOI 10.1093/mp/sss016; Rook F, 2006, PLANT CELL ENVIRON, V29, P426, DOI 10.1111/j.1365-3040.2005.01477.x; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010; WERNER JE, 1995, PHYSIOL PLANTARUM, V93, P659, DOI 10.1111/j.1399-3054.1995.tb05114.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu FQ, 2009, PLANT PHYSIOL, V150, P1940, DOI 10.1104/pp.109.140731; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhao ZX, 2008, PLANT CELL, V20, P3210, DOI 10.1105/tpc.108.063263	57	54	56	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42924	10.1371/journal.pone.0042924	http://dx.doi.org/10.1371/journal.pone.0042924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905186	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100075
J	Mei, HX; Cheng, L; Tang, J; Fu, ZY; Wang, X; Jen, PHS; Chen, QC				Mei, Hui-Xian; Cheng, Liang; Tang, Jia; Fu, Zi-Ying; Wang, Xin; Jen, Philip H. -S.; Chen, Qi-Cai			Bilateral Collicular Interaction: Modulation of Auditory Signal Processing in Amplitude Domain	PLOS ONE			English	Article							BIG BROWN BAT; INFERIOR COLLICULUS; EPTESICUS-FUSCUS; CORTICOFUGAL MODULATION; CENTRAL NUCLEUS; DESCENDING PROJECTIONS; MERIONES-UNGUICULATUS; NEURONS; FREQUENCY; MIDBRAIN	In the ascending auditory pathway, the inferior colliculus (IC) receives and integrates excitatory and inhibitory inputs from many lower auditory nuclei, intrinsic projections within the IC, contralateral IC through the commissure of the IC and from the auditory cortex. All these connections make the IC a major center for subcortical temporal and spectral integration of auditory information. In this study, we examine bilateral collicular interaction in modulating amplitude-domain signal processing using electrophysiological recording, acoustic and focal electrical stimulation. Focal electrical stimulation of one (ipsilateral) IC produces widespread inhibition (61.6%) and focused facilitation (9.1%) of responses of neurons in the other (contralateral) IC, while 29.3% of the neurons were not affected. Bilateral collicular interaction produces a decrease in the response magnitude and an increase in the response latency of inhibited IC neurons but produces opposite effects on the response of facilitated IC neurons. These two groups of neurons are not separately located and are tonotopically organized within the IC. The modulation effect is most effective at low sound level and is dependent upon the interval between the acoustic and electric stimuli. The focal electrical stimulation of the ipsilateral IC compresses or expands the rate-level functions of contralateral IC neurons. The focal electrical stimulation also produces a shift in the minimum threshold and dynamic range of contralateral IC neurons for as long as 150 minutes. The degree of bilateral collicular interaction is dependent upon the difference in the best frequency between the electrically stimulated IC neurons and modulated IC neurons. These data suggest that bilateral collicular interaction mainly changes the ratio between excitation and inhibition during signal processing so as to sharpen the amplitude sensitivity of IC neurons. Bilateral interaction may be also involved in acoustic-experience-dependent plasticity in the IC. Three possible neural pathways underlying the bilateral collicular interaction are discussed.	[Mei, Hui-Xian; Cheng, Liang; Tang, Jia; Fu, Zi-Ying; Wang, Xin; Chen, Qi-Cai] Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Mei, Hui-Xian; Cheng, Liang; Tang, Jia; Fu, Zi-Ying; Wang, Xin; Chen, Qi-Cai] Cent China Normal Univ, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China; [Jen, Philip H. -S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	Central China Normal University; Central China Normal University; University of Missouri System; University of Missouri Columbia	Mei, HX (corresponding author), Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China.	Jenp@missouri.edu; qcchen2003@yahoo.com.cn	Fu, Ziying/N-7127-2013	Fu, Ziying/0000-0002-0065-8297	National Science Foundation of China [31070971, 30970972, 31000959]; Division of Biological Sciences University of Missouri-Columbia, United States of America	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division of Biological Sciences University of Missouri-Columbia, United States of America	This work was supported by the grants (#31070971, #30970972, #31000959) from the National Science Foundation of China and a fund from the Division of Biological Sciences University of Missouri-Columbia, United States of America, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1979, J COMP NEUROL, V183, P519, DOI 10.1002/cne.901830305; AITKIN LM, 1984, J COMP NEUROL, V228, P210, DOI 10.1002/cne.902280207; Bajo VM, 2005, J COMP NEUROL, V486, P101, DOI 10.1002/cne.20542; Cant NB, 2006, J COMP NEUROL, V495, P511, DOI 10.1002/cne.20888; Casseday JH, 2002, SPR HDB AUD, V15, P238; HERBERT H, 1991, J COMP NEUROL, V304, P103, DOI 10.1002/cne.903040108; Hernandez O, 2006, NEUROREPORT, V17, P1611, DOI 10.1097/01.wnr.0000236857.70715.be; Jen PHS, 1999, J COMP PHYSIOL A, V184, P185, DOI 10.1007/s003590050317; Jen PHS, 2003, HEARING RES, V184, P91, DOI 10.1016/S0378-5955(03)00237-5; Jen PHS, 1998, J COMP PHYSIOL A, V183, P683, DOI 10.1007/s003590050291; Jen PHS, 2002, HEARING RES, V168, P196, DOI 10.1016/S0378-5955(02)00358-1; Jen PHS, 2002, HEARING RES, V168, P139, DOI 10.1016/S0378-5955(02)00369-6; Jen PHS, 2001, EXP BRAIN RES, V137, P292; JEN PHS, 1982, J COMP PHYSIOL, V147, P351, DOI 10.1007/BF00609669; Ji WQ, 2001, J NEUROPHYSIOL, V86, P211, DOI 10.1152/jn.2001.86.1.211; Jia T, 2007, CHINESE J PHYSIOL, V50, P187; KLUG A, 1995, J NEUROPHYSIOL, V74, P1701, DOI 10.1152/jn.1995.74.4.1701; Koch U, 1998, J NEUROPHYSIOL, V80, P71, DOI 10.1152/jn.1998.80.1.71; Lu Y, 2001, EXP BRAIN RES, V141, P331, DOI 10.1007/s002210100885; Malmierca MS, 2009, J COMP NEUROL, V514, P226, DOI 10.1002/cne.21997; Malmierca MS, 2005, NEUROSCIENCE, V136, P883, DOI 10.1016/j.neuroscience.2005.04.040; Malmierca MS, 2005, EUR J NEUROSCI, V21, P2701, DOI 10.1111/j.1460-9568.2005.04103.x; Malmierca MS, 2003, EXP BRAIN RES, V153, P522, DOI 10.1007/s00221-003-1615-1; MALMIERCA MS, 1995, J COMP NEUROL, V357, P124, DOI 10.1002/cne.903570112; Moore DR, 1998, J NEUROPHYSIOL, V80, P2229, DOI 10.1152/jn.1998.80.5.2229; PINHEIRO AD, 1991, J COMP PHYSIOL A, V169, P69; POON PWF, 1990, EXP BRAIN RES, V79, P83; Popelar J, 2003, PHYSIOL RES, V52, P615; SALDANA E, 1992, J COMP NEUROL, V319, P417, DOI 10.1002/cne.903190308; Saldana E, 1996, J COMP NEUROL, V371, P15, DOI 10.1002/(SICI)1096-9861(19960715)371:1<15::AID-CNE2>3.0.CO;2-O; SHNEIDERMAN A, 1989, J COMP NEUROL, V286, P28, DOI 10.1002/cne.902860103; Suga N, 2002, NEURON, V36, P9, DOI 10.1016/S0896-6273(02)00933-9; Suga N, 1997, ENCY ACOUSTICS, P1409; Suga N, 2010, AUDITORY VESTIBULAR, P313; Suga N, 2008, J COMP PHYSIOL A, V194, P169, DOI 10.1007/s00359-007-0274-2; SUN X, 1989, BRAIN RES, V495, P1, DOI 10.1016/0006-8993(89)91212-2; Sun XD, 1996, NEUROSCI LETT, V212, P131, DOI 10.1016/0304-3940(96)12788-9; Wang X, 2007, BRAIN RES, V1167, P80, DOI 10.1016/j.brainres.2007.07.002; Winer JA, 2006, HEARING RES, V212, P1, DOI 10.1016/j.heares.2005.06.014; Winer JA, 1998, J COMP NEUROL, V400, P147; Wu FJ, 2008, CHINESE J PHYSIOL, V51, P13; WU FJ, 2009, CHIN J PHYSL, V52, P1; Wu M, 1991, Chin J Physiol, V34, P145; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; Yan J, 2001, NEUROREPORT, V12, P3313, DOI 10.1097/00001756-200110290-00033; Yan J, 2002, EUR J NEUROSCI, V16, P119, DOI 10.1046/j.1460-9568.2002.02046.x; Yan J, 2005, J NEUROPHYSIOL, V93, P71, DOI 10.1152/jn.00348.2004; Yan J, 1996, SCIENCE, V273, P1100, DOI 10.1126/science.273.5278.1100; Zhang YF, 2000, J NEUROPHYSIOL, V84, P325, DOI 10.1152/jn.2000.84.1.325; Zhang YK, 2005, J NEUROPHYSIOL, V94, P2676, DOI 10.1152/jn.00549.2005; Zhou XM, 2007, J NEUROPHYSIOL, V98, P2509, DOI 10.1152/jn.00613.2007	51	11	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41311	10.1371/journal.pone.0041311	http://dx.doi.org/10.1371/journal.pone.0041311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911778	Green Submitted, Green Published, gold			2022-12-27	WOS:000306751300030
J	Nannyonga, B; Sumpter, DJT; Mugisha, JYT; Luboobi, LS				Nannyonga, Betty; Sumpter, David J. T.; Mugisha, Joseph Y. T.; Luboobi, Livingstone S.			The Dynamics, Causes and Possible Prevention of Hepatitis E Outbreaks	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; DISEASES; MALARIA; PERSISTENCE; INFECTION; EVOLUTION; ECOLOGY	Rapidly spreading infectious diseases are a serious risk to public health. The dynamics and the factors causing outbreaks of these diseases can be better understood using mathematical models, which are fit to data. Here we investigate the dynamics of a Hepatitis E outbreak in the Kitgum region of northern Uganda during 2007 to 2009. First, we use the data to determine that R-0 is approximately 2.25 for the outbreak. Secondly, we use a model to estimate that the critical level of latrine and bore hole coverages needed to eradicate the epidemic is at least 16% and 17% respectively. Lastly, we further investigate the relationship between the co-infection factor for malaria and Hepatitis E on the value of R0 for Hepatitis E. Taken together, these results provide us with a better understanding of the dynamics and possible causes of Hepatitis E outbreaks.	[Nannyonga, Betty; Mugisha, Joseph Y. T.; Luboobi, Livingstone S.] Makerere Univ, Dept Math, Kampala, Uganda; [Sumpter, David J. T.] Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden	Makerere University; Uppsala University	Nannyonga, B (corresponding author), Makerere Univ, Dept Math, Kampala, Uganda.	bnk@math.mak.ac.ug		Luboobi, Livingstone Serwada/0000-0003-0438-9845	International Science Program - ISP; Mathematics Institute of Uppsala University, Sweden	International Science Program - ISP; Mathematics Institute of Uppsala University, Sweden	BN acknowledges the International Science Program - ISP for the funding of this study and the Mathematics Institute of Uppsala University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; ANDERSON R M, 1991; Andrade BB, 2001, PLOS ONE, V6; [Anonymous], 2009, WHO REP; [Anonymous], 2009, MIN HLTH UG WEEKL RE; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Barcus MJ, 2002, AM J TROP MED HYG, V66, P140, DOI 10.4269/ajtmh.2002.66.140; Castillo-Chavez C., 2002, MATH APPROACHES EMER, V1; Centers for disease control and prevention, 2009, HEP E INF HLTH PROF; Cyranoski D, 2001, NATURE, V412, P261, DOI 10.1038/35085715; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Edelstein-Keshet L., 2005, SIAM CLASSICS APPL M, V46; Enserink M, 2004, SCIENCE, V303, P1605, DOI 10.1126/science.303.5664.1605; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; Gold MR, 1996, COST EFFECTIVENESS H; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; GUPTA S, 1994, P ROY SOC B-BIOL SCI, V256, P231, DOI 10.1098/rspb.1994.0075; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Keeling, 2008, MODELLING INFECT DIS; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Klouwenberg PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021013; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Maiwald T, 2008, BIOINFORMATICS, V24, P2037, DOI 10.1093/bioinformatics/btn350; Pasquetto V, 2002, J EXP MED, V192, P529; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Rohani P, 2000, LANCET, V355, P285, DOI 10.1016/S0140-6736(99)04482-7; THURSZ MR, 1995, NAT MED, V1, P374, DOI 10.1038/nm0495-374; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vasco DA, 2007, J THEOR BIOL, V245, P9, DOI 10.1016/j.jtbi.2006.08.015	32	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41135	10.1371/journal.pone.0041135	http://dx.doi.org/10.1371/journal.pone.0041135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911752	Green Published, gold, Green Submitted			2022-12-27	WOS:000306751300025
J	Jarni, K; De Cuyper, B; Brus, R				Jarni, Kristjan; De Cuyper, Bart; Brus, Robert			Genetic Variability of Wild Cherry (Prunus avium L.) Seed Stands in Slovenia as Revealed by Nuclear Microsatellite Loci	PLOS ONE			English	Article							FRAXINUS-EXCELSIOR-L.; HETEROZYGOTE-EXCESS; POPULATIONS; DIFFERENTIATION; SOFTWARE; DISTANCE; TRIALS; DNA	Microsatellite markers were used to describe the genetic variability of four seed stands of wild cherry (Prunus avium L.). One hundred and thirty one individuals were genotyped at ten nuclear microsatellite loci. Total genetic diversity was high (H-E = 0.704), while differences between stands were small but significant (F-ST = 0.053, G(ST)' = 0.234). There was a significant amount of clonal reproduction in one stand, with only 11 genotypes identified among 36 trees. One stand showed a significant excess (F-IS = -0.044) of heterozygosity, and one showed a deficit (F-IS = 0.044). Our results demonstrate the importance of taking into account the biological and genetic characteristics of species in forest management, especially when determining a new seed stand. The small genetic differences found between seed stands indicate that a large number of stands are not required. However, they should be carefully selected and should possess adequate genetic variability to ensure low relatedness between seed trees.	[Jarni, Kristjan; Brus, Robert] Univ Ljubljana, Dept Forestry & Renewable Forest Resources, Biotech Fac, Ljubljana, Slovenia; [De Cuyper, Bart] Res Inst Nat & Forest, Dept Management & Sustainable Use, Geraardsbergen, Belgium	University of Ljubljana; Research Institute for Nature & Forest	Jarni, K (corresponding author), Univ Ljubljana, Dept Forestry & Renewable Forest Resources, Biotech Fac, Ljubljana, Slovenia.	kristjan.jarni@bf.uni-lj.si	Jarni, Kristjan/A-1264-2011		Slovenian Research Agency [L4-4091]; Pahernik Fundation; COST action [2474 EUR]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Pahernik Fundation; COST action(European Cooperation in Science and Technology (COST))	This research was supported by the Slovenian Research Agency (project L4-4091) and the Pahernik Fundation. The authors thank the COST action E42 for its contribution to this work through financing the Short Term Scientific Mission of Kristjan Jarni. Slovenian Research Agency (project L4-4091) (3000 EUR) http://www.arrs.gov.si/en/, COST Action E42 (2474 EUR) http://www.cost.esf.org/domains_actions/fps/Actions/E42, Pahernik Fundation (1000 EUR) http://www.pahernikova-ustanova.si/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], OFFICIAL J EUROPEAN, V11, P17; Balloux F, 2004, EVOLUTION, V58, P1891; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Clarke JB, 2003, MOL ECOL NOTES, V3, P578, DOI 10.1046/j.1471-8286.2003.00517.x; Derory J, 2002, ANN FOREST SCI, V59, P699, DOI 10.1051/forest:2002058; Ducci F, 1997, CAN J FOREST RES, V27, P1998, DOI 10.1139/cjfr-27-12-1998; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Guarino C, 2009, GENOME, V52, P320, DOI [10.1139/G09-007, 10.1139/g09-007]; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heuertz M, 2004, EVOLUTION, V58, P976; Hoebee SE, 2006, FOREST ECOL MANAG, V226, P1, DOI 10.1016/j.foreco.2005.12.024; Jensen JS, 2000, SCAND J FOREST RES, V15, P297, DOI 10.1080/028275800447922; Kobliha J., 2002, Journal of Forest Science (Prague), V48, P202; Lacis G, 2009, SCI HORTIC-AMSTERDAM, V121, P451, DOI 10.1016/j.scienta.2009.03.016; MAGGIONI L, 2006, 6 M 20 21 JUN 2003 B; MCPFE, 1993, 2 MIN C PROT FOR EUR; Mohanty A, 2001, HEREDITY, V87, P421, DOI 10.1046/j.1365-2540.2001.00922.x; Muranty H, 1998, SILVAE GENET, V47, P249; NEI M, 1978, GENETICS, V89, P583; Nepveu G, 1993, ANN SCI FOR S1, V50, P388; Nocetti M, 2010, WOOD SCI TECHNOL, V44, P621, DOI 10.1007/s00226-009-0294-x; Pravilnik o dolocitvi proveniencnih obmocij, 2003, PRAV DOL PROV OBM; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; RUSSELL K, 2003, EUFORGEN TECHNICAL G; Santi F, 2010, SILVAE GENET, V59, P137, DOI 10.1515/sg-2010-0016; Schueler S, 2006, MOL ECOL, V15, P3231, DOI 10.1111/j.1365-294X.2006.03029.x; Stoeckel S, 2006, MOL ECOL, V15, P2109, DOI 10.1111/j.1365-294X.2006.02926.x; Vaughan SP, 2007, HEREDITY, V98, P274, DOI 10.1038/sj.hdy.6800935; Vaughan SP, 2004, MOL ECOL NOTES, V4, P429, DOI 10.1111/j.1471-8286.2004.00673.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Westergren M, 2012, SUMAR LIST, V136, P263	32	10	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41231	10.1371/journal.pone.0041231	http://dx.doi.org/10.1371/journal.pone.0041231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911762	Green Published, Green Submitted, gold			2022-12-27	WOS:000306644600057
J	Mannowetz, N; Wandernoth, PM; Wennemuth, G				Mannowetz, Nadja; Wandernoth, Petra M.; Wennemuth, Gunther			Glucose is a pH-Dependent Motor for Sperm Beat Frequency during Early Activation	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; MITOCHONDRIAL PYRUVATE CARRIER; SOLUBLE ADENYLYL-CYCLASE; MOUSE SPERMATOZOA; DICARBOXYLATE COTRANSPORTER; MAMMALIAN SPERMATOZOA; TYPE-1 HEXOKINASE; CYSTIC-FIBROSIS; TRANSPORT; CAPACITATION	To reach the egg in the ampulla, sperm have to travel along the female genital tract, thereby being dependent on external energy sources and substances to maintain and raise the flagellar beat. The vaginal fluid is rich in lactate, whereas in the uterine fluid glucose is the predominant substrate. This evokes changes in the lactate content of sperm as well as in the intracellular pH (pH(i)) since sperm possess lactate/proton co-transporters. It is well documented that glycolysis yields ATP and that HCO3- is a potent factor in the increase of beat frequency. We here show for the first time a pathway that connects both parts. We demonstrate a doubling of beat frequency in the mere presence of glucose. This effect can reversibly be blocked by 2-deoxy-D-glucose, dichloroacetate and aminooxyacetate, strongly suggesting that it requires both glycolysis and mitochondrial oxidation of glycolytic end products. We show that the glucose-mediated acceleration of flagellar beat and ATP production are hastened by a pH(i) >= 7.1, whereas a pH(i) <= 7.1 leaves both parameters unchanged. Since we observed a diminished rise in beat frequency in the presence of specific inhibitors against carbonic anhydrases, soluble adenylyl cyclase and protein kinase, we suggest that the glucose-mediated effect is linked to CO2 hydration and thus the production of HCO3- by intracellular CA isoforms. In summary, we propose that, in sperm, glycolysis is an additional pH(i)-dependent way to produce HCO3-, thus enhancing sperm beat frequency and contributing to fertility.	[Mannowetz, Nadja; Wandernoth, Petra M.; Wennemuth, Gunther] Univ Saarland, Dept Anat & Cell Biol, D-6650 Homburg, Germany	Saarland University	Mannowetz, N (corresponding author), Univ Saarland, Dept Anat & Cell Biol, D-6650 Homburg, Germany.	gunther.wennemuth@uks.eu		Wennemuth, Gunther/0000-0003-3313-2475				Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Bajpai M, 2006, BIOL REPROD, V74, P109, DOI 10.1095/biolreprod.105.043588; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; BURCKHARDT G, 1984, PFLUG ARCH EUR J PHY, V401, P254, DOI 10.1007/BF00582592; BURGOS C, 1995, BIOL REPROD, V53, P84, DOI 10.1095/biolreprod53.1.84; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; Chen XZ, 1998, J BIOL CHEM, V273, P20972, DOI 10.1074/jbc.273.33.20972; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; Feiden S, 2008, REPROD FERT DEVELOP, V20, P713, DOI 10.1071/RD08004; Florman HM, 2007, P NATL ACAD SCI USA, V104, P11123, DOI 10.1073/pnas.0703626104; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; FRASER LR, 1990, J REPROD FERTIL, P9; GARDNER DK, 1990, J REPROD FERTIL, V88, P361, DOI 10.1530/jrf.0.0880361; Gawlik V, 2008, MOL MEMBR BIOL, V25, P224, DOI 10.1080/09687680701855405; Gomez O, 2006, REPRODUCTION, V131, P63, DOI 10.1530/rep.1.00750; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; HALESTRAP AP, 1978, BIOCHEM J, V172, P377, DOI 10.1042/bj1720377; HALESTRAP AP, 1980, INT J BIOCHEM, V11, P97, DOI 10.1016/0020-711X(80)90241-4; HALPERIN ML, 1969, J BIOL CHEM, V244, P384; Hertz L, 2005, J NEUROSCI RES, V79, P11, DOI 10.1002/jnr.20294; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; HIIPAKKA RA, 1978, BIOL REPROD, V19, P368, DOI 10.1095/biolreprod19.2.368; Hildyard JCW, 2003, BIOCHEM J, V374, P607, DOI 10.1042/BJ20030995; HYNE RV, 1985, J REPROD FERTIL, V73, P59, DOI 10.1530/jrf.0.0730059; KAUPPINEN RA, 1987, BIOCHIM BIOPHYS ACTA, V930, P173, DOI 10.1016/0167-4889(87)90029-2; Kim ST, 2007, REPROD SCI, V14, P445, DOI 10.1177/1933719107306226; Kirichok Y, 2011, MOL HUM REPROD, V17, P478, DOI 10.1093/molehr/gar044; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Mannowetz N, 2010, INT J ANDROL; Markovich D, 2004, PFLUG ARCH EUR J PHY, V447, P594, DOI 10.1007/s00424-003-1128-6; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; MINAKAMI S, 1966, J BIOCHEM, V59, P145, DOI 10.1093/oxfordjournals.jbchem.a128275; MONTAMAT EE, 1988, BIOCHEM J, V255, P1053, DOI 10.1042/bj2551053; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137; Nakamura N, 2008, BIOL REPROD, V79, P537, DOI 10.1095/biolreprod.108.067561; Nakamura N, 2008, MOL REPROD DEV, V75, P632, DOI 10.1002/mrd.20791; Pajor AM, 2000, AM J PHYSIOL-RENAL, V279, pF482, DOI 10.1152/ajprenal.2000.279.3.F482; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PAPA S, 1974, EUR J BIOCHEM, V49, P265, DOI 10.1111/j.1432-1033.1974.tb03831.x; PARKKILA S, 1991, HISTOCHEMISTRY, V95, P477, DOI 10.1007/BF00315743; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; UI M, 1966, BIOCHIM BIOPHYS ACTA, V124, P310, DOI 10.1016/0304-4165(66)90194-2; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wandernoth PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015061; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Welch JE, 2000, J ANDROL, V21, P328; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; WICK AN, 1957, J BIOL CHEM, V224, P963; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Yao XZ, 2002, BIOCHEMISTRY-US, V41, P1083, DOI 10.1021/bi0156761; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044	57	25	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41030	10.1371/journal.pone.0041030	http://dx.doi.org/10.1371/journal.pone.0041030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911736	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600040
J	Schwartze, VU; Hoffmann, K; Nyilasi, I; Papp, T; Vagvolgyi, C; de Hoog, S; Voigt, K; Jacobsen, ID				Schwartze, Volker U.; Hoffmann, Kerstin; Nyilasi, Ildiko; Papp, Tamas; Vagvoelgyi, Csaba; de Hoog, Sybren; Voigt, Kerstin; Jacobsen, Ilse D.			Lichtheimia Species Exhibit Differences in Virulence Potential	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ALTERNATIVE INFECTION MODEL; CRYPTOCOCCUS-NEOFORMANS; MUCORMYCOSIS; SUSCEPTIBILITY; EPIDEMIOLOGY; TEMPERATURE; RHIZOPUS; SURVIVAL; DNA	Although the number of mucormycosis cases has increased during the last decades, little is known about the pathogenic potential of most mucoralean fungi. Lichtheimia species represent the second and third most common cause of mucormycosis in Europe and worldwide, respectively. To date only three of the five species of the genus have been found to be involved in mucormycosis, namely L. corymbifera, L. ramosa and L. ornata. However, it is not clear whether the clinical situation reflects differences in virulence between the species of Lichtheimia or whether other factors are responsible. In this study the virulence of 46 strains of all five species of Lichtheimia was investigated in chicken embryos. Additionally, strains of the closest-related genus Dichotomocladium were tested. Full virulence was restricted to the clinically relevant species while all strains of L. hyalospora, L. sphaerocystis and Dichotomocladium species were attenuated. Although virulence differences were present in the clinically relevant species, no connection between origin (environmental vs clinical) or phylogenetic position within the species was observed. Physiological studies revealed no clear connection of stress resistance and carbon source utilization with the virulence of the strains. Slower growth at 37 degrees C might explain low virulence of L. hyalospora, L. spaherocystis and Dichotomocladium; however, similarly slow growing strains of L. ornata were fully virulent. Thus, additional factors or a complex interplay of factors determines the virulence of strains. Our data suggest that the clinical situation in fact reflects different virulence potentials in the Lichtheimiaceae.	[Schwartze, Volker U.; Jacobsen, Ilse D.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Schwartze, Volker U.; Hoffmann, Kerstin; Voigt, Kerstin] Univ Jena, Inst Microbiol, Dept Microbiol & Mol Biol, Jena, Germany; [Nyilasi, Ildiko; Papp, Tamas; Vagvoelgyi, Csaba] Univ Szeged, Fac Sci & Informat, Dept Microbiol, Szeged, Hungary; [de Hoog, Sybren] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Szeged University; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Schwartze, VU (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany.	Ilse.jacobsen@hki-jena.de	Tamás, Papp/L-8272-2018; Vagvolgyi, Csaba/L-8497-2018; Voigt, Kerstin/AAA-9021-2019; Nyilasi, Ildikó/L-8288-2018; Jacobsen, Ilse/B-3155-2011	Vagvolgyi, Csaba/0000-0003-0009-7773; Nyilasi, Ildikó/0000-0001-7457-067X; Jacobsen, Ilse/0000-0002-6033-9984; Schwartze, Volker U./0000-0003-4429-6360; Papp, Tamas/0000-0001-8211-5431	University of Jena; Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoll Institute)	University of Jena; Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoll Institute)	This study was financially supported by the University of Jena and the Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoll Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastruey-Izquierdo A, 2010, J CLIN MICROBIOL, V48, P2154, DOI 10.1128/JCM.01744-09; [Anonymous], 2007, MICROBE; Aufauvre-Brown A, 1998, EUR J CLIN MICROBIOL, V17, P778, DOI 10.1007/s100960050184; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Brock M, 2009, CURR OPIN MICROBIOL, V12, P371, DOI 10.1016/j.mib.2009.05.004; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Cooney NM, 2008, CURR OPIN MICROBIOL, V11, P511, DOI 10.1016/j.mib.2008.09.018; Cymborowski B, 2000, ACTA BIOCHIM POL, V47, P215, DOI 10.18388/abp.2000_4080; Delgado ACN, 2005, MYCOPATHOLOGIA, V159, P7, DOI 10.1007/s11046-004-9618-4; DETILLEUX PG, 1988, VET PATHOL, V25, P138, DOI 10.1177/030098588802500206; Duran R, 2010, TOXINS, V2, P367, DOI 10.3390/toxins2040367; Ewbank JJ, 2011, DIS MODEL MECH, V4, P300, DOI 10.1242/dmm.006684; Fairley C, 2000, OPHTHALMOLOGY, V107, P555, DOI 10.1016/S0161-6420(99)00142-6; FROMTLING RA, 1989, MYCOPATHOLOGIA, V106, P163, DOI 10.1007/BF00443057; Garcia-Hermoso D, 2009, J CLIN MICROBIOL, V47, P3862, DOI 10.1128/JCM.02094-08; Gomes MZR, 2011, CLIN MICROBIOL REV, V24, P411, DOI 10.1128/CMR.00056-10; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARTL A, 1995, ARZNEIMITTEL-FORSCH, V45-2, P926; Hoffmann K, 2007, MYCOL RES, V111, P1169, DOI 10.1016/j.mycres.2007.07.002; HUSSAIN S, 1995, EUR J RADIOL, V20, P151, DOI 10.1016/0720-048X(95)00644-6; Ibrahim AS, 2005, INFECT IMMUN, V73, P778, DOI 10.1128/IAI.73.2.778-783.2005; Jacobsen ID, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019741; Jacobsen ID, 2010, INFECT IMMUN, V78, P2995, DOI 10.1128/IAI.00268-10; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lamaris GA, 2009, J INFECT DIS, V199, P1399, DOI 10.1086/597615; Lanternier F, 2012, CLIN INFECT DIS, V54, pS35, DOI 10.1093/cid/cir880; Liang KP, 2006, J CLIN MICROBIOL, V44, P892, DOI 10.1128/JCM.44.3.892-898.2006; Liu MF, 2010, J CLIN INVEST, V120, P1914, DOI 10.1172/JCI42164; McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.2307/2406046; Nakagawa Y, 2003, MICROBIOL IMMUNOL, V47, P395, DOI 10.1111/j.1348-0421.2003.tb03376.x; O'Donnell K, 1998, MYCOLOGIA, V90, P624, DOI 10.2307/3761222; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Olias P, 2011, VET MICROBIOL, V148, P348, DOI 10.1016/j.vetmic.2010.08.029; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skiada A, 2011, CLIN MICROBIOL INFEC, V17, P1859, DOI 10.1111/j.1469-0691.2010.03456.x; SUGAR AM, 1992, CLIN INFECT DIS, V14, pS126, DOI 10.1093/clinids/14.Supplement_1.S126; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIEFFENBERG J, 1978, INFECT IMMUN, V19, P481, DOI 10.1128/IAI.19.2.481-485.1978; Tsung Lilian L. Y., 2010, Hong Kong Medical Journal, V16, P137; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WOSTEMEYER J, 1985, EUR J BIOCHEM, V146, P443, DOI 10.1111/j.1432-1033.1985.tb08671.x	47	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40908	10.1371/journal.pone.0040908	http://dx.doi.org/10.1371/journal.pone.0040908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911715	gold, Green Published, Green Submitted			2022-12-27	WOS:000306644600026
J	Guo, XP; Li, XL; Duan, XW; Shen, YY; Xing, Y; Cao, QQ; Qin, L				Guo, Xian-Ping; Li, Xing-Liang; Duan, Xu-Wei; Shen, Yuan-Yue; Xing, Yu; Cao, Qing-Qin; Qin, Ling			Characterization of sck1, a Novel Castanea mollissima Mutant with the Extreme Short Catkins and Decreased Gibberellin	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; THINNING CATKINS; BIOSYNTHESIS; ENCODES; METABOLISM; EXPRESSION; MUTATIONS; INDUCTION; OXIDASE; GENES	A novel Chinese chestnut (Castanea mollissima Bl.) mutant with extreme short catkins, here was named sck1 and has been characterized in the present study. This sck1 caused 6-fold shorter than wild-type catkins. Endogenous gibberellic acids markedly decreased in the mutant, and application of exogenous GA(3) could partially restore the sck1 phenotype to the wild-type phenotype. Paclobutrazol (PP333), an antagonist of GAs biosynthesis, could significantly inhibit the wild-type catkins growth, and lead to a short catkins phenotype similar to the sck1. In addition, compared to the wild-type catkins, the mRNA expression level of ent-kaurenoic acid oxidase (KAO), a gibberellin biosynthsis key gene, was significantly down-regulated (P<0.01) in the sck1. Importantly, transient over-expression of a normal CmKAO gene in short catkins also could partially restore the wild-type phenotype. Real-time PCR and semi-quantitative analysis showed that the mRNA expression level of KAO was significantly up-regulated. In addition, transient RNA interference of CmKAO in wild-type catkins led the mRNA expression level of KAO decrease significantly and inhibited the wild-type catkins elongation strongly. Taken together, our results suggest that the lower gibberellic acids content that is due to decreased CmKAO expression level may contribute to the generation of the extreme short male catkins, sck1.	[Guo, Xian-Ping; Li, Xing-Liang; Duan, Xu-Wei; Shen, Yuan-Yue; Xing, Yu; Qin, Ling] Beijing Agr Univ, Coll Plant Sci & Technol, Key Lab New Technol Agr Applicat Beijing, Beijing 100094, Peoples R China; [Cao, Qing-Qin] Beijing Agr Univ, Coll Biotechnol, Beijing 100094, Peoples R China; [Guo, Xian-Ping] Xinjiang Agr Univ, Coll Forestry & Hort, Urumqi, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture; Xinjiang Agricultural University	Guo, XP (corresponding author), Beijing Agr Univ, Coll Plant Sci & Technol, Key Lab New Technol Agr Applicat Beijing, Beijing 100094, Peoples R China.	qinling@bac.edu.cn	GUO, Xianping/HIR-2072-2022; cao, qingqin/W-5009-2019	GUO, Xianping/0000-0002-3108-1347; Qin, Ling/0000-0002-9814-5771	National Natural Science Foundation of China [30872039]; Beijing Municipal Natural Science Foundation [6092003, 6082004]; Beijing New-Star Program of Science and Technology [2007B031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Beijing New-Star Program of Science and Technology	This work was provided by the National Natural Science Foundation of China (grant no. 30872039) (http://www.nsfc.gov.cn/Portal0/default152.htm), the Beijing Municipal Natural Science Foundation (grant no. 6092003 and 6082004) (http://www.bjnsf.org/), the Beijing New-Star Program of Science and Technology (grant no. 2007B031) (http://www.bjkw.gov.cn/n8785584/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade GM, 2009, PLANT CELL REP, V28, P1385, DOI 10.1007/s00299-009-0738-7; Baluska F, 2001, DEV BIOL, V236, P478, DOI 10.1006/dbio.2001.0333; Bishop GJ, 2002, PLANT CELL, V14, pS97, DOI 10.1105/tpc.001461; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; CECCONI F, 2002, HELIA, V36, P161; Chhun T, 2007, PLANT CELL, V19, P3876, DOI 10.1105/tpc.107.054759; CHIANG HH, 1995, PLANT CELL, V7, P195, DOI 10.1105/tpc.7.2.195; Darley CP, 2001, PLANT MOL BIOL, V47, P179, DOI 10.1023/A:1010687600670; Davidson Sandra E., 2006, Phytochemistry Reviews, V5, P405, DOI 10.1007/s11101-006-9005-5; Davidson SE, 2003, PLANT PHYSIOL, V131, P335, DOI 10.1104/pp.012963; De Schepper S, 2001, ACTA HORTIC, V552, P143; Feng YQ, 2011, SCI HORTIC-AMSTERDAM, V130, P431, DOI 10.1016/j.scienta.2011.07.014; Feng YQ, 2005, J BEIJING AGR COLL, V20, P1; Feng Z.Q., 1995, CHINESE FRUIT; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Freinkel S., 2009, AM CHESTNUT LIFE DEA; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Han XY, 2008, SCI HORTIC-AMSTERDAM, V115, P261, DOI 10.1016/j.scienta.2007.09.003; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; HEDDEN P, 1985, J PLANT GROWTH REGUL, V4, P111, DOI 10.1007/BF02266949; Hedden P, 1999, J EXP BOT, V50, P553, DOI 10.1093/jexbot/50.334.553; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Helliwell CA, 2000, AUST J PLANT PHYSIOL, V27, P1141, DOI 10.1071/PP00079; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; KOORNNEEF M, 1990, THEOR APPL GENET, V80, P852, DOI 10.1007/BF00224204; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Li XingLiang, 2011, Acta Horticulturae Sinica, V38, P1251; Liu K, 1999, ACTA HORTIC, P191, DOI 10.17660/ActaHortic.1999.494.28; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margis-Pinheiro M, 2005, PLANT CELL REP, V23, P819, DOI 10.1007/s00299-004-0896-6; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; PHILLIPS AL, 1995, PLANT PHYSIOL, V108, P1049, DOI 10.1104/pp.108.3.1049; Qin L, 2011, SCI SILVAE SINICAE, V47, P197; Qing Ling, 2011, Scientia Silvae Sinicae, V47, P194; Ross JJ, 1997, PHYSIOL PLANTARUM, V100, P550, DOI 10.1034/j.1399-3054.1997.1000317.x; Sakamoto T, 2004, CURR OPIN BIOTECH, V15, P144, DOI 10.1016/j.copbio.2004.02.003; Sawada Y, 2008, J EXP BOT, V59, P3383, DOI 10.1093/jxb/ern192; Seabra RC, 1998, PLANT CELL REP, V17, P177, DOI 10.1007/s002990050374; Singh DP, 2002, PLANT CELL, V14, P3133, DOI 10.1105/tpc.003046; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Swain SM, 2005, TRENDS PLANT SCI, V10, P123, DOI 10.1016/j.tplants.2005.01.007; Yamaguchi S, 1998, PLANT PHYSIOL, V116, P1271, DOI 10.1104/pp.116.4.1271; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yamaguchi Shinjiro, 2006, Phytochemistry Reviews, V5, P39, DOI 10.1007/s11101-005-4248-0; Yao JL, 2001, P NATL ACAD SCI USA, V98, P1306, DOI 10.1073/pnas.031502498; Zhang Ling, 2007, Journal of Beijing Forestry University, V29, P99; Zhao ZY, 2009, ACTA HORTIC, V844, P457	49	3	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43181	10.1371/journal.pone.0043181	http://dx.doi.org/10.1371/journal.pone.0043181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905227	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600054
J	Galluzzi, L; De Santi, M; Crinelli, R; De Marco, C; Zaffaroni, N; Duranti, A; Brandi, G; Magnani, M				Galluzzi, Luca; De Santi, Mauro; Crinelli, Rita; De Marco, Cinzia; Zaffaroni, Nadia; Duranti, Andrea; Brandi, Giorgio; Magnani, Mauro			Induction of Endoplasmic Reticulum Stress Response by the Indole-3-Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines	PLOS ONE			English	Article							ANTICANCER AGENT; ER STRESS; APOPTOSIS; AUTOPHAGY; PATHWAY; DEATH; XBP1; ACTIVATION; PROTEINS; CAPACITY	Background: Indole-3-carbinol and its metabolic products are considered promising chemopreventive and anticancer agents. Previously we have shown that the indole-3-carbinol cyclic tetrameric derivative CTet induces autophagy and inhibits cell proliferation via inhibition of Akt activity and overexpression of p21/CDKN1A and GADD45A, in both estrogen receptor-positive (MCF-7) and triple negative (MDA-MB-231) breast cancer cell lines. In the present study, we further characterize the autophagic response and investigate the mechanism through which CTet regulates these events. Methodology/Principal Findings: Analysis of gene expression microarray data and subsequent confirmation by quantitative real-time PCR, showed that CTet is able to induce up-regulation of key signaling molecules involved in endoplasmic reticulum (ER) stress response (e. g. DDIT3/CHOP, CHAC1, ATF3, HSPA5/BiP/GRP78, CEBPB, ASNS) and autophagy (e. g. MAP1LC3B), in both MCF-7 and MDA-MB-231 cell lines. Moreover, the monitoring of Xbp-1 splicing confirmed the activation of IRE1/Xbp-1 ER stress response branch after CTet treatment. The role of autophagic processes (known to be induced by ER stress) was investigated further through ATG5 gene silencing and pharmacological inhibition of AVOs formation. CTet was shown to induce an autophagy-related cell death. Moreover, CTet-treated cells stained with Hoechst/PI revealed the presence of necrotic processes without evidence of apoptosis. Conclusions/Significance: The ER stress response was identified as the main upstream molecular mechanism through which CTet acts in both hormone-responsive and triple-negative breast cancer cells. Because of its important role in cancer development, ER stress is a potential target in cancer therapy. The abiltiy of CTet to induce ER stress response and subsequently activate a death program in tumor cells confirms this molecule as a promising anticancer agent.	[Galluzzi, Luca] Univ Urbino Carlo Bo, Dept Biomol Sci, Fano, PU, Italy; [De Santi, Mauro; Crinelli, Rita; Brandi, Giorgio; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy; [De Marco, Cinzia; Zaffaroni, Nadia] Ist Nazl Tumori, Fdn IRCCS, Dept Expt Oncol & Mol Med, I-20133 Milan, Italy; [Duranti, Andrea] Univ Urbino Carlo Bo, Med Chem & Technol Unit, Dept Biomol Sci, Urbino, PU, Italy	University of Urbino; University of Urbino; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Urbino	Galluzzi, L (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Fano, PU, Italy.	luca.galluzzi@uniurb.it	Magnani, Mauro/A-1919-2008; Zaffaroni, Nadia/J-8178-2016; De Marco, Cinzia/Y-7377-2018; Galluzzi, Luca/G-3969-2012; De Santi, Mauro/F-5401-2013	Zaffaroni, Nadia/0000-0002-4669-0890; De Marco, Cinzia/0000-0003-1153-270X; Galluzzi, Luca/0000-0002-1747-526X; De Santi, Mauro/0000-0003-2983-8344; Magnani, Mauro/0000-0001-6456-6626; Crinelli, Rita/0000-0002-1235-8910; Brandi, Giorgio/0000-0003-1380-6137	Italian Association for Cancer Research (AIRC)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by the Italian Association for Cancer Research (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen DZ, 2001, J NUTR, V131, P3294, DOI 10.1093/jn/131.12.3294; Coopman PJ, 1998, CLIN CANCER RES, V4, P507; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; De Santi M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2855; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Gotoh T, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/259462; Guidarelli A, 2010, ANTIOXID REDOX SIGN, V13, P745, DOI 10.1089/ars.2009.2845; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Kagawa S, 2001, CLIN CANCER RES, V7, P1474; Kanemoto S, 2005, BIOCHEM BIOPH RES CO, V331, P1146, DOI 10.1016/j.bbrc.2005.04.039; Li YW, 1999, ONCOGENE, V18, P3166, DOI 10.1038/sj.onc.1202650; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucarini S, 2011, TETRAHEDRON LETT, V52, P2812, DOI 10.1016/j.tetlet.2011.03.117; Lucarini S, 2010, MOLECULES, V15, P4085, DOI 10.3390/molecules15064085; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Paglin S, 2001, CANCER RES, V61, P439; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Samali A., 2010, INT J CELL BIOL, DOI [DOI 10.1155/2010/830307, DOI 10.1109/IJCNN.2010.5596663]; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sun SS, 2004, CELL STRESS CHAPERON, V9, P76; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Weng JR, 2008, CANCER LETT, V262, P153, DOI 10.1016/j.canlet.2008.01.033; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2008, J BIOCHEM, V144, P477, DOI 10.1093/jb/mvn091; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Zhang JY, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-25	35	42	45	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43249	10.1371/journal.pone.0043249	http://dx.doi.org/10.1371/journal.pone.0043249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905241	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800066
J	Kohl, C; Lesnik, R; Brinkmann, A; Ebinger, A; Radonic, A; Nitsche, A; Muhldorfer, K; Wibbelt, G; Kurth, A				Kohl, Claudia; Lesnik, Rene; Brinkmann, Annika; Ebinger, Arnt; Radonic, Aleksandar; Nitsche, Andreas; Muehldorfer, Kristin; Wibbelt, Gudrun; Kurth, Andreas			Isolation and Characterization of Three Mammalian Orthoreoviruses from European Bats	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; POPULATION BIOLOGY; GENOME SEGMENTS; REOVIRUS; SEQUENCE; VIRUS; PATHOGENS; HUMANS; ORIGIN; FAMILY	In recent years novel human respiratory disease agents have been described in South East Asia and Australia. The causative pathogens were classified as pteropine orthoreoviruses with strong phylogenetic relationship to orthoreoviruses of flying foxes inhabiting these regions. Subsequently, a zoonotic bat-to-human transmission has been assumed. We report the isolation of three novel mammalian orthoreoviruses (MRVs) from European bats, comprising bat-borne orthoreovirus outside of South East Asia and Australia and moreover detected in insectivorous bats (Microchiroptera). MRVs are well known to infect a broad range of mammals including man. Although they are associated with rather mild and clinically unapparent infections in their hosts, there is growing evidence of their ability to also induce more severe illness in dogs and man. In this study, eight out of 120 vespertilionid bats proved to be infected with one out of three novel MRV isolates, with a distinct organ tropism for the intestine. One isolate was analyzed by 454 genome sequencing. The obtained strain T3/Bat/Germany/342/08 had closest phylogenetic relationship to MRV strain T3D/04, isolated from a dog. These novel reoviruses provide a rare chance of gaining insight into possible transmission events and of tracing the evolution of bat viruses.	[Kohl, Claudia; Lesnik, Rene; Brinkmann, Annika; Ebinger, Arnt; Radonic, Aleksandar; Nitsche, Andreas; Kurth, Andreas] Robert Koch Inst, Ctr Biol Secur 1, Berlin, Germany; [Muehldorfer, Kristin; Wibbelt, Gudrun] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	Robert Koch Institute; Leibniz Institut fur Zoo und Wildtierforschung	Kohl, C (corresponding author), Robert Koch Inst, Ctr Biol Secur 1, Berlin, Germany.	KohlC@rki.de	Radonić, Aleksandar/AAP-2612-2020	kohl, claudia/0000-0002-1480-8911; Radonic, Aleksandar/0000-0001-6200-9607; Nitsche, Andreas/0000-0001-8185-3176	Konrad Adenauer Foundation; Adolf and Hildegard Isler-Stiftung, Klara Samariter-Stiftung and FAZIT-Stiftung	Konrad Adenauer Foundation; Adolf and Hildegard Isler-Stiftung, Klara Samariter-Stiftung and FAZIT-Stiftung	This study was partially financed by grants provided by the Konrad Adenauer Foundation (fellowship to Dr. Kohl) and by the Adolf and Hildegard Isler-Stiftung, Klara Samariter-Stiftung and FAZIT-Stiftung (Dr. Muhldorfer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2001, BIOCHEM BIOPH RES CO, V287, P583, DOI 10.1006/bbrc.2001.5612; Breun LA, 2001, VIROLOGY, V287, P333, DOI 10.1006/viro.2001.1052; Cheng P, 2009, J CLIN VIROL, V45, P79, DOI 10.1016/j.jcv.2009.03.001; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Chua KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025434; Chua KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003803; Coombs KM, 2006, CURR TOP MICROBIOL, V309, P117; Cutler SJ, 2010, EMERG INFECT DIS, V16, P1, DOI 10.3201/eid1601.081467; Day JM, 2007, VIRUS GENES, V35, P235, DOI 10.1007/s11262-006-0044-1; Day JM, 2009, INFECT GENET EVOL, V9, P390, DOI 10.1016/j.meegid.2009.01.011; Decaro N, 2005, VET MICROBIOL, V109, P19, DOI 10.1016/j.vetmic.2005.05.014; DERMODY TS, 1990, J VIROL, V64, P4842, DOI 10.1128/JVI.64.10.4842-4850.1990; Dermody TS, 2010, REOVIRUSES ORBIVIRUS; Du LF, 2010, ARCH VIROL, V155, P1295, DOI 10.1007/s00705-010-0690-4; Duncan R, 1999, VIROLOGY, V260, P316, DOI 10.1006/viro.1999.9832; GARD GP, 1973, ARCH GES VIRUSFORSCH, V43, P34, DOI 10.1007/BF01249346; Hermann L, 2004, PEDIATR INFECT DIS J, V23, P373, DOI 10.1097/00006454-200404000-00026; HRDY DB, 1979, J VIROL, V31, P104, DOI 10.1128/JVI.31.1.104-111.1979; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiang J, 2006, VIRUS GENES, V33, P193, DOI 10.1007/s11262-005-0046-4; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kohl C, 2012, J VIROL, V86, P1888, DOI 10.1128/JVI.05974-11; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Muhldorfer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029773; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard LI, 2006, ARCH VIROL, V151, P229, DOI 10.1007/s00705-005-0644-4; Song LH, 2008, VIRUS GENES, V37, P392, DOI 10.1007/s11262-008-0283-4; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Thalmann CM, 2010, VIROLOGY, V402, P26, DOI 10.1016/j.virol.2009.11.048; Tyler KL, 2004, J INFECT DIS, V189, P1664, DOI 10.1086/383129; URBANO P, 1994, COMP IMMUNOL MICROB, V17, P151, DOI 10.1016/0147-9571(94)90040-X; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Wellehan JFX, 2009, VET MICROBIOL, V133, P34, DOI 10.1016/j.vetmic.2008.06.011; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9	35	62	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43106	10.1371/journal.pone.0043106	http://dx.doi.org/10.1371/journal.pone.0043106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905211	Green Published, gold			2022-12-27	WOS:000307500800045
J	Li, LZ; Ben, YY; Zhu, ZQ; Li, WH; Xu, JQ; Zhang, XY				Li, Liangzhu; Ben, Yinyin; Zhu, Zhaoqin; Li, Weihua; Xu, Jianqing; Zhang, Xiaoyan			Minocycline Down-Regulates Topical Mucosal Inflammation during the Application of Microbicide Candidates	PLOS ONE			English	Article							HIV-INFECTION; MACROLIDE ANTIBIOTICS; MOUSE MODEL; BIOMARKERS; TOXICITY; SAFETY	An effective anti-human immunodeficiency virus-1 (HIV-1) microbicide should exert its action in the absence of causing aberrant activation of topical immunity that will increase the risk of HIV acquisition. In the present study, we demonstrated that the vaginal application of cellulose sulfate (CS) gel induced topical mucosal inflammatory responses; the addition of minocycline to CS gel could significantly attenuate the inflammation in a mice model. The combined gel of CS plus minocycline not only reduced the production of inflammatory cytokines in cervicovaginal lavages (CVLs), also downregulated the activation of CD4+ T cells and the recruitment of other immune cells including HIV target cells into vaginal tissues. Furthermore, an In vitro HIV-1 pseudovirus infection inhibition assay showed that the combined gel decreased the infection efficacy of different subtypes of HIV-1 pseudoviruses compared with that of CS gel alone. These results implicate that minocycline could be integrated into microbicide formulation to suppress the aberrant activation of topical mucosal immunity and enhance the safety profile during the application of microbicides.	[Li, Liangzhu; Ben, Yinyin; Zhu, Zhaoqin; Xu, Jianqing; Zhang, Xiaoyan] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Li, Liangzhu; Ben, Yinyin; Zhu, Zhaoqin; Xu, Jianqing; Zhang, Xiaoyan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Xu, Jianqing; Zhang, Xiaoyan] Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Xu, Jianqing; Zhang, Xiaoyan] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Li, Weihua] World Hlth Org Collaborating Ctr Res Human Reprod, Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Center for Disease Control & Prevention; World Health Organization	Li, LZ (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	jianqingxu2008@gmail.com; zhang_xycn2002@yahoo.com.cn			National Ministry of Science and Technology of China [2012CB519000]; National Grand Program on Key Infectious Disease Control [2012ZX10001-007-008]; Natural Science Foundation of China [81102282, 81171553]	National Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Grand Program on Key Infectious Disease Control; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Ministry of Science and Technology of China (2012CB519000), National Grand Program on Key Infectious Disease Control (2012ZX10001-007-008), and Natural Science Foundation of China (81102282 and 81171553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg J, 2011, RESPIRATION, V81, P67, DOI 10.1159/000320319; Altenburg J, 2011, RESPIRATION, V81, P75, DOI 10.1159/000320320; BOBBIE RJ, 1980, APPL ENVIRON MICROB, V39, P1212, DOI 10.1128/AEM.39.6.1212-1222.1980; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Cohen PR, 2004, SOUTH MED J, V97, P70, DOI 10.1097/01.SMJ.0000083857.98870.98; Copeland KFT, 2010, J INFECT DIS, V201, P1115, DOI 10.1086/651278; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Doh AS, 2007, CONTRACEPTION, V76, P245, DOI 10.1016/j.contraception.2007.05.083; Fichorova RN, 2004, JAIDS-J ACQ IMM DEF, V37, pS184, DOI 10.1097/00126334-200410013-00010; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Fux R, 2008, Dtsch Med Wochenschr, V133, pF4, DOI 10.1055/s-0028-1082824; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keller MJ, 2006, AM J REPROD IMMUNOL, V56, P356, DOI 10.1111/j.1600-0897.2006.00436.x; Li LZ, 2010, CHINESE MED J-PEKING, V123, P3381, DOI 10.3760/cma.j.issn.0366-6999.2010.23.002; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Maffeis L, 2010, GIORN ITAL DERMAT V, V145, P425; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Morris GC, 2010, CURR OPIN INFECT DIS, V23, P57, DOI 10.1097/QCO.0b013e328334de6d; Nirmalananthan N, 2005, CURR OPIN NEUROL, V18, P712, DOI 10.1097/01.wco.0000187248.21103.c5; ORIEL JD, 1975, J CLIN PATHOL, V28, P403, DOI 10.1136/jcp.28.5.403; Qiu Chao, 2006, Zhonghua Weishengwuxue He Mianyixue Zazhi, V26, P394; Smith K, 2005, CLIN THER, V27, P1329, DOI 10.1016/j.clinthera.2005.09.005; Szeto GL, 2010, J INFECT DIS, V201, P1132, DOI 10.1086/651277; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; Tauber S C, 2008, Curr Mol Pharmacol, V1, P68; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Utari A, 2010, AJIDD-AM J INTELLECT, V115, P433, DOI 10.1352/1944-7558-115.5.433; Wormser GP, 2005, CLIN INFECT DIS, V41, P1368	31	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43211	10.1371/journal.pone.0043211	http://dx.doi.org/10.1371/journal.pone.0043211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905236	Green Submitted, gold, Green Published			2022-12-27	WOS:000307500800061
J	Alkuwaity, K; Taylor, A; Heckels, JE; Doran, KS; Christodoulides, M				Alkuwaity, Khalil; Taylor, Alexander; Heckels, John E.; Doran, Kelly S.; Christodoulides, Myron			Group B Streptococcus Interactions with Human Meningeal Cells and Astrocytes In Vitro	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; BLOOD-BRAIN-BARRIER; LUNG EPITHELIAL-CELLS; BETA-HEMOLYSIN/CYTOLYSIN; NEISSERIA-MENINGITIDIS; BACTERIAL-MENINGITIS; UNITED-STATES; CAPSULAR POLYSACCHARIDE; INFLAMMATORY RESPONSES; NEONATAL MENINGITIS	Background: Streptococcus agalactiae (Group B Streptococcus, GBS) is a leading cause of life-threatening neonatal meningitis and survivors often suffer permanent neurological damage. How this organism interacts with the meninges and subsequently with astrocytes that constitute the underlying cortical glia limitans superficialis is not known. Methodology/Principal Findings: In this paper, we demonstrate dose-dependent adherence of GBS over time to human meningioma cells and fetal astrocytes in vitro, which was not influenced by expression of either beta-haemolysin/cytolysin (beta-h/c) toxin, different capsule serotypes or by absence of capsule (p > 0.05). Internalization of GBS by both cell types was, however, a slow and an infrequent event (only 0.02-0.4% of associated bacteria were internalised by 9 h). Expression of beta-h/c toxin did not play a role in invasion (p > 0.05), whereas capsule expression lead to a reduction (p < 0.05) in the numbers of intracellular bacteria recovered. GBS strains induced cytotoxicity as demonstrated by the measurement of lactate dehydrogenase (LDH) enzyme release by 9 h and by viable staining. Increasing levels of meningioma cell death correlated with bacterial growth and the phenotype of beta-h/c toxin production, i.e. from weakly, to normo- to hyper-haemolytic. However, cytotoxicity was significantly greater (p < 0.05) towards astrocytes, and infection with initial MOI >= 0.003 induced 70-100% LDH release. By comparing wild-type (beta-h/c(+)) and mutant (Delta cylE beta-h/c(-)) strains and beta-h/c toxin extracts and by using the surfactant dipalmitoylphosphatidylcholine in cytotoxicity inhibition experiments, beta-h/c toxin was demonstrated as principally responsible for cell death. Conclusions/Significance: This study has described key events in the interactions of GBS with meningeal cells and astrocytes in vitro and a major virulence role for beta-h/c toxin. Understanding the mechanisms involved will help to identify potential therapies for improving patient survival and for reducing the incidence and severity of neurological sequelae.	[Alkuwaity, Khalil; Taylor, Alexander; Heckels, John E.; Christodoulides, Myron] Univ Southampton, Fac Med, Southampton Gen Hosp, Neisseria Res Grp,Sir Henry Wellcome Labs, Southampton SO9 5NH, Hants, England; [Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	University of Southampton; California State University System; San Diego State University	Alkuwaity, K (corresponding author), King Abdulaziz Univ, Dept Lab Med, Fac Appl Med Sci, Jeddah 21413, Saudi Arabia.	mc4@soton.ac.uk	Christodoulides, Myron/C-6699-2011	Christodoulides, Myron/0000-0002-9663-4731	Ministry of Higher Education, Saudi Arabia; Hope (Wessex Medical Trust); National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01NS051247]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER	Ministry of Higher Education, Saudi Arabia; Hope (Wessex Medical Trust); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	K. Alkuwaity was a PhD student sponsored by the Ministry of Higher Education, Saudi Arabia. The study was supported by an award to M. Christodoulides and J. Heckels from Hope (Wessex Medical Trust) and grant R01NS051247 from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to K. Doran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOLADO R, 1988, NEUROPATH APPL NEURO, V14, P1, DOI 10.1111/j.1365-2990.1988.tb00862.x; Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Bifrare YD, 2003, HIPPOCAMPUS, V13, P481, DOI 10.1002/hipo.10142; Bryan JD, 2009, J BACTERIOL, V191, P1847, DOI 10.1128/JB.01124-08; Chang YC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002082; Charland N, 2000, INFECT IMMUN, V68, P637, DOI 10.1128/IAI.68.2.637-643.2000; Cheng Q, 2002, INFECT IMMUN, V70, P3309; Christodoulides M, 2000, MOL MICROBIOL, V35, P32, DOI 10.1046/j.1365-2958.2000.01694.x; Christodoulides M, 2002, INFECT IMMUN, V70, P4035, DOI 10.1128/IAI.70.8.4035-4044.2002; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Doran KS, 2002, J INFECT DIS, V185, P196, DOI 10.1086/338475; ELSINGHORST EA, 1994, BACT PATH B, V236, P405; Engelhardt B, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-4; FEURER DJ, 1991, NEUROPATH APPL NEURO, V17, P391, DOI 10.1111/j.1365-2990.1991.tb00739.x; Fowler MI, 2006, INFECT IMMUN, V74, P6467, DOI 10.1128/IAI.00644-06; Fowler MI, 2004, CELL MICROBIOL, V6, P555, DOI 10.1111/j.1462-5822.2004.00382.x; GIBSON RL, 1993, INFECT IMMUN, V61, P478, DOI 10.1128/IAI.61.2.478-485.1993; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Hardy SJ, 2000, MOL MICROBIOL, V36, P817, DOI 10.1046/j.1365-2958.2000.01923.x; Heath PGT, 2004, LANCET, V363, P292, DOI 10.1016/S0140-6736(03)15389-5; Hensler ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002446; HULSE ML, 1993, INFECT IMMUN, V61, P4835, DOI 10.1128/IAI.61.11.4835-4841.1993; HUTCHINGS M, 1986, J NEUROSURG, V65, P316, DOI 10.3171/jns.1986.65.3.0316; Iijima S, 2007, PEDIATR INT, V49, P1000, DOI 10.1111/j.1442-200X.2007.02474.x; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kleihues P., 1997, PATHOLOGY GENETICS T; Koedel U, 1999, INFECT DIS CLIN N AM, V13, P549, DOI 10.1016/S0891-5520(05)70094-5; LANCEFIELD RC, 1975, J EXP MED, V142, P165, DOI 10.1084/jem.142.1.165; Lehnardt S, 2007, J IMMUNOL, V179, P6134, DOI 10.4049/jimmunol.179.9.6134; Lembo A, 2010, MOL MICROBIOL, V77, P431, DOI 10.1111/j.1365-2958.2010.07215.x; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; MADOFF LC, 1991, INFECT IMMUN, V59, P204, DOI 10.1128/IAI.59.1.204-210.1991; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; MARCHLEWICZ BA, 1980, INFECT IMMUN, V30, P805; MARTIN TR, 1988, J INFECT DIS, V157, P91, DOI 10.1093/infdis/157.1.91; Maruvada R, 2011, INFECT IMMUN, V79, P4088, DOI 10.1128/IAI.05506-11; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; MCLONE DG, 1980, CHILD BRAIN, V6, P113; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; NOWICKI B, 1986, MICROB PATHOGENESIS, V1, P335, DOI 10.1016/0882-4010(86)90066-5; ODA Y, 1984, J COMP NEUROL, V225, P448, DOI 10.1002/cne.902250310; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; PLATT MW, 1995, CURR MICROBIOL, V31, P5, DOI 10.1007/BF00294625; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Reiss A, 2011, J INFECT DIS, V203, P393, DOI 10.1093/infdis/jiq047; RUBENS CE, 1992, INFECT IMMUN, V60, P5157, DOI 10.1128/IAI.60.12.5157-5163.1992; Schubert A, 2004, INFECT IMMUN, V72, P6197, DOI 10.1128/IAI.72.11.6197-6205.2004; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Shet A, 2004, INDIAN J MED RES, V120, P141; Shin S, 2006, MICROB PATHOGENESIS, V41, P168, DOI 10.1016/j.micpath.2006.07.003; Shin S, 2006, BIOCHEM BIOPH RES CO, V345, P538, DOI 10.1016/j.bbrc.2006.04.130; Stevens JP, 2003, ARCH DIS CHILD-FETAL, V88, P179; TAMURA GS, 1994, INFECT IMMUN, V62, P2450, DOI 10.1128/IAI.62.6.2450-2458.1994; Tazi A, 2012, CURR OPIN MICROBIOL, V15, P44, DOI 10.1016/j.mib.2011.12.002; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; TETI G, 1987, INFECT IMMUN, V55, P3057, DOI 10.1128/IAI.55.12.3057-3064.1987; Truemper E J, 1987, J Perinatol, V7, P267; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; VAUDAUX P, 1979, ANTIMICROB AGENTS CH, V16, P743, DOI 10.1128/AAC.16.6.743; WELLER RO, 1995, GRAYS ANATOMY, P1202; Wells DB, 2001, INFECT IMMUN, V69, P2718, DOI 10.1128/IAI.69.4.2718-2722.2001; Wennekamp J, 2008, IMMUNOL REV, V225, P114, DOI 10.1111/j.1600-065X.2008.00673.x; WILKINSON HW, 1977, J CLIN MICROBIOL, V6, P183; WILLIAMS PA, 1993, J PEDIATR-US, V123, P292, DOI 10.1016/S0022-3476(05)81706-8; Winram SB, 1998, INFECT IMMUN, V66, P4932, DOI 10.1128/IAI.66.10.4932-4941.1998; Yim HH, 1997, ADV EXP MED BIOL, V418, P995; Zweigner J, 2004, J EXP MED, V200, P99, DOI 10.1084/jem.20032100	73	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42660	10.1371/journal.pone.0042660	http://dx.doi.org/10.1371/journal.pone.0042660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900037	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000307380900054
J	Freemantle, E; Lalovic, A; Mechawar, N; Turecki, G				Freemantle, Erika; Lalovic, Aleksandra; Mechawar, Naguib; Turecki, Gustavo			Age and Haplotype Variations within FADS1 Interact and Associate with Alterations in Fatty Acid Composition in Human Male Cortical Brain Tissue	PLOS ONE			English	Article							GENE-CLUSTER; DESATURASE ACTIVITIES; DOCOSAHEXAENOIC ACID; GENOMIC STRUCTURE; CDNA CLONING; METABOLISM; VARIANTS; POLYMORPHISMS; EXPRESSION; OMEGA-6	Fatty acids (FA) play an integral role in brain function and alterations have been implicated in a variety of complex neurological disorders. Several recent genomic studies have highlighted genetic variability in the fatty acid desaturase (FADS1/2/3) gene cluster as an important contributor to FA alterations in serum lipids as well as measures of FA desaturase index estimated by ratios of relevant FAs. The contribution to alterations of FAs within the brain by local synthesis is still a matter of debate. Thus, the impact of genetic variants in FADS genes on gene expression and brain FA levels is an important avenue to investigate. Methods: Analyses were performed on brain tissue from prefrontal cortex Brodmann area 47 (BA47) of 61 male subjects of French Canadian ancestry ranging in age from young adulthood to middle age (18-58 years old), with the exception of one teenager (15 years old). Haplotype tagging SNPs were selected using the publicly available HapMap genotyping dataset in conjunction with Haploview. DNA sequencing was performed by the Sanger method and gene expression was measured by quantitative real-time PCR. FAs in brain tissue were analysed by gas chromatography. Variants in the FADS1 gene region were sequenced and analyzed for their influence on both FADS gene expression and FAs in brain tissue. Results: Our results suggest an association of the minor haplotype with alteration in estimated fatty acid desaturase activity. Analysis of the impact of DNA variants on expression and alternative transcripts of FADS1 and FADS2, however, showed no differences. Furthermore, there was a significant interaction between haplotype and age on certain brain FA levels. Discussion: This study suggests that genetic variability in the FADS genes cluster, previously shown to be implicated in alterations in peripheral FA levels, may also affect FA composition in brain tissue, but not likely by local synthesis.	[Freemantle, Erika; Turecki, Gustavo] McGill Univ, Dept Genet, Montreal, PQ, Canada; [Mechawar, Naguib; Turecki, Gustavo] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Freemantle, Erika; Lalovic, Aleksandra; Mechawar, Naguib; Turecki, Gustavo] Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Freemantle, E (corresponding author), McGill Univ, Dept Genet, Montreal, PQ, Canada.	Gustavo.Turecki@McGill.ca	Turecki, Gustavo/K-5100-2015	Turecki, Gustavo/0000-0003-4075-2736	Fonds de la Recherche en Sante du Quebec (FRSQ) through the Reseau Quebecois de Recherche sur le Suicide; Canadian Institute of Health Research (CIHR) [MOP 53321]; FRSQ	Fonds de la Recherche en Sante du Quebec (FRSQ) through the Reseau Quebecois de Recherche sur le Suicide; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec)	The Quebec Suicide Brain Bank is supported in part by the Fonds de la Recherche en Sante du Quebec (FRSQ) through the Reseau Quebecois de Recherche sur le Suicide. This work was supported in part by the Canadian Institute of Health Research (CIHR) MOP 53321 to GT. EF received a scholarship from FRSQ. NM and GT are both FRSQ chercheur boursier. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basselin M, 2011, BRAIN RES B; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Brenna JT, 2010, PROSTAG LEUKOTR ESS, V82, P281, DOI 10.1016/j.plefa.2010.02.011; Conklin SM, 2007, PSYCHOSOM MED, V69, P932, DOI 10.1097/PSY.0b013e31815aaa42; Conklin SM, 2007, PSYCHIAT RES, V152, P1, DOI 10.1016/j.psychres.2006.10.006; Conklin SM, 2010, PROSTAG LEUKOTR ESS, V82, P111, DOI 10.1016/j.plefa.2009.12.002; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; FOLCH J, 1951, J BIOL CHEM, V191, P833; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fraser T, 2010, NEUROCHEM RES, V35, P503, DOI 10.1007/s11064-009-0087-5; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glaser C, 2011, MATERN CHILD NUTR, V7, P27, DOI 10.1111/j.1740-8709.2011.00319.x; Haiman Christopher A., 2008, V141, P37; Hsieh AT, 2009, PROSTAG LEUKOTR ESS, V81, P105, DOI 10.1016/j.plefa.2009.05.012; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lalovic A, 2007, J PSYCHIATR NEUROSCI, V32, P363; Lassek William D, 2011, Front Evol Neurosci, V3, P5, DOI 10.3389/fnevo.2011.00005; Lattka E, 2010, J LIPID RES, V51, P182, DOI 10.1194/jlr.M900289-JLR200; Lattka E, 2011, AM J CLIN NUTR, V93, P382, DOI 10.3945/ajcn.110.004515; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lattka E, 2009, J NUTRIGENET NUTRIGE, V2, P119, DOI 10.1159/000235559; Liu YH, 2009, SCHIZOPHR RES, V109, P113, DOI 10.1016/j.schres.2008.12.027; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Mathias RA, 2010, J LIPID RES, V51, P2766, DOI 10.1194/jlr.M008359; McNamara RK, 2008, PROSTAG LEUKOTR ESS, V78, P293, DOI 10.1016/j.plefa.2008.04.001; Milte CM, 2009, NUTR REV, V67, P573, DOI 10.1111/j.1753-4887.2009.00229.x; Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017181; Muldoon MF, 2010, J NUTR, V140, P848, DOI 10.3945/jn.109.119578; Nakamura MT, 2002, BIOCHEM SOC T, V30, P1076, DOI 10.1042/BST0301076; Park W.J., 2012, J LIPID RES; Park WJ, 2010, MOL BIOL REP, V37, P2403, DOI 10.1007/s11033-009-9750-9; Park WJ, 2009, GENE, V446, P28, DOI 10.1016/j.gene.2009.06.016; Rao JS, 2007, MOL PSYCHIATR, V12, P151, DOI 10.1038/sj.mp.4001887; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Reardon HT, 2011, J LIPID RES, V52, P2279, DOI 10.1194/jlr.M019653; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Spector AA, 2001, J MOL NEUROSCI, V16, P159, DOI 10.1385/JMN:16:2-3:159; Standl M, 2012, ALLERGY, V67, P83, DOI 10.1111/j.1398-9995.2011.02708.x; Standl M, 2011, CLIN EXP ALLERGY, V41, P1757, DOI 10.1111/j.1365-2222.2011.03833.x; Stohr H, 2000, CYTOGENET CELL GENET, V88, P211, DOI 10.1159/000015552; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Tang B, 2012, PSYCHIAT RES, V196, P201, DOI 10.1016/j.psychres.2011.09.026; Umeda-Sawada R, 2006, BIOSCI BIOTECH BIOCH, V70, P2121, DOI 10.1271/bbb.60057; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Xie L, 2009, J NUTRIGENET NUTRIGE, V2, P243, DOI 10.1159/000255636	47	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42696	10.1371/journal.pone.0042696	http://dx.doi.org/10.1371/journal.pone.0042696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900039	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900056
J	Ito, E; Otsuka, E; Hama, N; Aonuma, H; Okada, R; Hatakeyama, D; Fujito, Y; Kobayashi, S				Ito, Etsuro; Otsuka, Emi; Hama, Noriyuki; Aonuma, Hitoshi; Okada, Ryuichi; Hatakeyama, Dai; Fujito, Yutaka; Kobayashi, Suguru			Memory Trace in Feeding Neural Circuitry Underlying Conditioned Taste Aversion in Lymnaea	PLOS ONE			English	Article							POND SNAIL LYMNAEA; CENTRAL PATTERN GENERATOR; CEREBRAL GIANT-CELLS; SYNAPTIC ENHANCEMENT; TENTACLE NERVES; STAGNALIS; SYSTEM; INTERNEURONS; LIP; EXPRESSION	Background: The pond snail Lymnaea stagnalis can maintain a conditioned taste aversion (CTA) as a long-term memory. Previous studies have shown that the inhibitory postsynaptic potential (IPSP) evoked in the neuron 1 medial (N1M) cell by activation of the cerebral giant cell (CGC) in taste aversion-trained snails was larger and lasted longer than that in control snails. The N1M cell is one of the interneurons in the feeding central pattern generator (CPG), and the CGC is a key regulatory neuron for the feeding CPG. Methodology/Principle Findings: Previous studies have suggested that the neural circuit between the CGC and the N1M cell consists of two synaptic connections: (1) the excitatory connection from the CGC to the neuron 3 tonic (N3t) cell and (2) the inhibitory connection from the N3t cell to the N1M cell. However, because the N3t cell is too small to access consistently by electrophysiological methods, in the present study the synaptic inputs from the CGC to the N3t cell and those from the N3t cell to the N1M cell were monitored as the monosynaptic excitatory postsynaptic potential (EPSP) recorded in the large B1 and B3 motor neurons, respectively. The evoked monosynaptic EPSPs of the B1 motor neurons in the brains isolated from the taste aversion-trained snails were identical to those in the control snails, whereas the spontaneous monosynaptic EPSPs of the B3 motor neurons were significantly enlarged. Conclusion/Significance: These results suggest that, after taste aversion training, the monosynaptic inputs from the N3t cell to the following neurons including the N1M cell are specifically facilitated. That is, one of the memory traces for taste aversion remains as an increase in neurotransmitter released from the N3t cell. We thus conclude that the N3t cell suppresses the N1M cell in the feeding CPG, in response to the conditioned stimulus in Lymnaea CTA.	[Ito, Etsuro; Otsuka, Emi; Okada, Ryuichi; Hatakeyama, Dai; Kobayashi, Suguru] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Funct Biol, Sanuki, Japan; [Hama, Noriyuki] Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido, Japan; [Aonuma, Hitoshi] Hokkaido Univ, Res Inst Elect Sci, Complex Syst Res Grp, Sapporo, Hokkaido, Japan; [Fujito, Yutaka] Sapporo Med Univ, Sch Med, Dept Syst Neurosci, Sapporo, Hokkaido, Japan	Tokushima Bunri University; Hokkaido University; Hokkaido University; Sapporo Medical University	Ito, E (corresponding author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Funct Biol, Sanuki, Japan.	eito@kph.bunri-u.ac.jp	ハタケヤマ, ダイ/HHS-5095-2022; Kobayashi, Suguru/AAN-9001-2021; Aonuma, Hitoshi/D-6540-2012	ハタケヤマ, ダイ/0000-0001-6047-7124; Aonuma, Hitoshi/0000-0001-8380-1820	KAKENHI from Japan Socienty for the Promotion of Science [24657055]	KAKENHI from Japan Socienty for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly funded by KAKENHI from Japan Socienty for the Promotion of Science to EI (24657055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Benjamin PR, 2008, FRONT BIOSCI, V13, P4051, DOI 10.2741/2993; Benjamin PR, 2000, LEARN MEMORY, V7, P124, DOI 10.1101/lm.7.3.124; Bernstein IL, 1999, NUTRITION, V15, P229, DOI 10.1016/S0899-9007(98)00192-0; Brierley MJ, 1997, J NEUROPHYSIOL, V78, P3396, DOI 10.1152/jn.1997.78.6.3396; ELLIOTT CJH, 1992, PHILOS T ROY SOC B, V336, P167, DOI 10.1098/rstb.1992.0054; ELLIOTT CJH, 1985, J NEUROPHYSIOL, V54, P1396, DOI 10.1152/jn.1985.54.6.1396; Ito E, 1999, ZOOL SCI, V16, P711, DOI 10.2108/zsj.16.711; Kawai R, 2004, NEUROBIOL LEARN MEM, V82, P164, DOI 10.1016/j.nlm.2004.06.003; Kawai R, 2011, ZOOL SCI, V28, P517, DOI 10.2108/zsj.28.517; Kemenes I, 2006, CURR BIOL, V16, P1269, DOI 10.1016/j.cub.2006.05.049; Kita S, 2011, BIOL BULL-US, V220, P71, DOI 10.1086/BBLv220n1p71; Kojima S, 1997, NEUROSCI LETT, V230, P179, DOI 10.1016/S0304-3940(97)00507-7; Kojima S, 1996, ZOOL SCI, V13, P803, DOI 10.2108/zsj.13.803; Kojima S, 2001, J NEUROBIOL, V49, P118, DOI 10.1002/neu.1069; Lukowiak K, 2008, J EXP BIOL, V211, P1747, DOI 10.1242/jeb.014886; Marra V, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00161; MCCROHAN CR, 1980, J EXP BIOL, V85, P169; Nakamura H, 1999, NEUROSCI RES, V33, P291, DOI 10.1016/S0168-0102(99)00020-6; Nakamura H, 1999, NEUROSCI RES, V33, P127, DOI 10.1016/S0168-0102(98)00121-7; Nakamura H, 1999, ZOOL SCI, V16, P387, DOI 10.2108/zsj.16.387; ROSE RM, 1979, J EXP BIOL, V80, P137; Sadamoto H, 2004, J NEUROBIOL, V58, P455, DOI 10.1002/neu.10296; Sadamoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020285; Sadamoto H, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00025; Sakakibara M, 2006, BIOL BULL-US, V210, P298, DOI 10.2307/4134566; Silverman-Gavrila LB, 2011, NEUROSCIENCE, V186, P94, DOI 10.1016/j.neuroscience.2011.04.027; Staras K, 1998, J NEUROPHYSIOL, V79, P3030, DOI 10.1152/jn.1998.79.6.3030; Staras K, 1999, J NEUROPHYSIOL, V81, P1261, DOI 10.1152/jn.1999.81.3.1261; Staras K, 2003, CURR BIOL, V13, P116, DOI 10.1016/S0960-9822(02)01435-5; Straub VA, 2007, J NEUROPHYSIOL, V97, P1088, DOI 10.1152/jn.01048.2006; Sugai R, 2006, J EXP BIOL, V209, P826, DOI 10.1242/jeb.02069; Sugai R, 2007, J EXP BIOL, V210, P1225, DOI 10.1242/jeb.02735; Vavoulis DV, 2007, EUR J NEUROSCI, V25, P2805, DOI 10.1111/j.1460-9568.2007.05517.x; Wagatsuma A, 2004, ACTA BIOL HUNG, V55, P149, DOI 10.1556/ABiol.55.2004.1-4.18; Wagatsuma A, 2005, J EXP BIOL, V208, P2389, DOI 10.1242/jeb.01625; Wagatsuma A, 2006, J NEUROSCI RES, V84, P954, DOI 10.1002/jnr.21012; Whelan HA, 1996, J MOLLUS STUD, V62, P483, DOI 10.1093/mollus/62.4.483; Yeoman MS, 1996, J NEUROPHYSIOL, V75, P11, DOI 10.1152/jn.1996.75.1.11	38	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43151	10.1371/journal.pone.0043151	http://dx.doi.org/10.1371/journal.pone.0043151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900097	gold, Green Published, Green Submitted			2022-12-27	WOS:000307380900115
J	Mekhanikova, IV; Andreev, DS; Belozerova, OY; Mikhlin, YL; Lipko, SV; Klimenkov, IV; Akimov, VV; Kargin, VF; Mazurova, YV; Tauson, VL; Likhoshway, YV				Mekhanikova, Irina V.; Andreev, Dmitry S.; Belozerova, Olga Yu.; Mikhlin, Yuri L.; Lipko, Sergey V.; Klimenkov, Igor V.; Akimov, Vladlen V.; Kargin, Valeriy F.; Mazurova, Yelena V.; Tauson, Vladimir L.; Likhoshway, Yelena V.			Specific Features of Mandible Structure and Elemental Composition in the Polyphagous Amphipod Acanthogammarus grewingkii Endemic to Lake Baikal	PLOS ONE			English	Article							ZINC; CUTICLE; HARDNESS; JAWS	Background: In crustaceans, several mechanisms provide for the mechanical strength of the cuticular "tools" (dactyli, claws, jaws), which serve to catch and crush food objects. Studies on the mandibles of the endemic Baikal amphipod Acanthogammarus grewingkii by means of electron microscopy and elemental analysis have revealed specific structural features of these mouthparts. Methodology: The fine structure of the mandible has been studied by means of SEM, TEM, and AFM; methods used to analyze its elemental and phase composition include XEPMA, XPS, SEM-EDS analysis, and XRD. Conclusion: Functional adaptations of the mandible in A. grewingkii provide for the optimum combination of mechanical hardness and fracture resistance, which is achieved due to a complex structure and composition of its cutting parts. Teeth of the mandible are covered by a thin layer of silica (10-20 mu m). Their epicuticle is characterized by a high density, consists of three layers, and increases in thickness toward the tooth apex. The epicuticle is enriched with Br, while the concentrations of Ca and P reach the peak values in the softer internal tissues of the teeth. These data broaden the view of the diversity of adaptation mechanisms providing for the strengthening of cuticular "tools" in crustaceans.	[Mekhanikova, Irina V.; Andreev, Dmitry S.; Klimenkov, Igor V.; Likhoshway, Yelena V.] Russian Acad Sci, Limnol Inst, Siberian Branch, Irkutsk 664003, Russia; [Belozerova, Olga Yu.; Lipko, Sergey V.; Akimov, Vladlen V.; Tauson, Vladimir L.] Russian Acad Sci, AP Vinogradov Inst Geochem, Siberian Branch, Irkutsk 664003, Russia; [Mikhlin, Yuri L.; Kargin, Valeriy F.; Mazurova, Yelena V.] Russian Acad Sci, Inst Chem & Chem Technol, Siberian Branch, Krasnoyarsk, Russia	Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Limnological Institute SB RAS; Irkutsk Science Centre of the Russian Academy of Sciences; A.P. Vinogradov Institute of Geochemistry of the Siberian Branch of the RAS; Russian Academy of Sciences; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Institute of Chemistry & Chemical Technology, Siberian Branch, Russian Academy of Sciences	Mekhanikova, IV (corresponding author), Russian Acad Sci, Limnol Inst, Siberian Branch, Irkutsk 664003, Russia.	irinam@lin.irk.ru; yel@lin.irk.ru	Akimov, Vladlen/O-5124-2015; Klimenkov, Klimen/C-6969-2015; Likhoshway, Yelena V./J-4496-2018; Mikhlin, Yuri/D-6591-2011; Akimov, Vladlen/W-6219-2018	Akimov, Vladlen/0000-0001-6799-6349; Likhoshway, Yelena V./0000-0002-2432-9260; Mikhlin, Yuri/0000-0003-1801-0947; Likhoshway, Yelena/0000-0001-5745-6891; Tauson, Vladimir/0000-0001-8704-6105; Klimenkov, Igor/0000-0002-4732-1501	SB RAS [95]; Russian Foundation for Basic Research [09-05-00511-a]	SB RAS(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This research was funded by the Integration Project of SB RAS No. 95 "Study of Co-Adaptation in the Producer-Consumer System Using the Example of Diatoms and Their Consumers in Freshwater Ecosystems"; additional support was provided by a Russian Foundation for Basic Research grant no. 09-05-00511-a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Bazikalova A.Y., 1945, P BAIKAL LIMNOLOGICA, V11, P1, DOI DOI 10.1016/J.JIP.2016.12.006; Bazikalova AYa, 1954, P BAIKAL LIMNOLOGICA, V14, P312; Bobelmann F, 2007, THERMOCHIM ACTA, V463, P65, DOI 10.1016/j.tca.2007.07.018; Broomell CC, 2006, J EXP BIOL, V209, P3219, DOI 10.1242/jeb.02373; BRYAN GW, 1979, J MAR BIOL ASSOC UK, V59, P969, DOI 10.1017/S0025315400036961; Cribb BW, 2010, ACTA BIOMATER, V6, P3152, DOI 10.1016/j.actbio.2010.02.009; Currey JD, 1999, J EXP BIOL, V202, P3285; DENNELL R., 1960, PHYSIOL CRUSTACEA, V1, P449, DOI DOI 10.1016/B978-0-12-395628-6.50020-8; FALKNER KK, 1991, LIMNOL OCEANOGR, V36, P413, DOI 10.4319/lo.1991.36.3.0413; GOLDBERG WM, 1994, COMP BIOCHEM PHYS B, V107, P633, DOI 10.1016/0305-0491(94)90197-X; Grachev M. A., 2002, CURRENT STATE LAKE B; HALCROW K, 1985, J CRUSTACEAN BIOL, V5, P606, DOI 10.2307/1548238; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hild S, 2009, J STRUCT BIOL, V168, P426, DOI 10.1016/j.jsb.2009.07.017; HILLERTON JE, 1982, J EXP BIOL, V101, P333; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Lupton R, 1993, STAT THEORY PRACTICE; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; Mekhanikova I.V., 2008, Zoologiya Bespozvonochnykh, V5, P17; Mekhanikova IV, 2010, CRUSTACEANA, V83, P865, DOI 10.1163/001121610X504289; MILLER CB, 1990, MAR BIOL, V106, P91, DOI 10.1007/BF02114678; Neues F, 2007, CRYSTENGCOMM, V9, P1245, DOI 10.1039/b710789g; Phedorin MA, 2008, J PALEOLIMNOL, V40, P445, DOI 10.1007/s10933-007-9172-4; Pontin MG, 2007, P NATL ACAD SCI USA, V104, P13559, DOI 10.1073/pnas.0702034104; POPOVSKAYA GI, 2002, DIATOMS PLANKTON LAK; Pryor MGM, 1962, COMP BIOCH, P371; ROER R, 1984, AM ZOOL, V24, P893; Schofield RMS, 2002, NATURWISSENSCHAFTEN, V89, P579, DOI 10.1007/s00114-002-0381-4; Schofield RMS, 2003, J INSECT PHYSIOL, V49, P31, DOI 10.1016/S0022-1910(02)00224-X; Schofield RMS, 2001, SCORPION BIOLOGY AND RESEARCH, P234; Schofield RMS, 2009, J STRUCT BIOL, V166, P272, DOI 10.1016/j.jsb.2009.01.007; Vetrov VA., 1997, TRACE ELEMENTS NATUR; Vinogradov AP, 2001, ELEMENTAL CHEM COMPO; Votintsev KK, 1961, P BAIKAL LIMNOL ST, V20, P1; Warner GF, 1977, BIOL CRABS	36	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43073	10.1371/journal.pone.0043073	http://dx.doi.org/10.1371/journal.pone.0043073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900091	Green Published, gold			2022-12-27	WOS:000307380900109
J	Miyagawa, M; Nishio, S; Usami, S				Miyagawa, Maiko; Nishio, Shin-ya; Usami, Shin-ichi			Prevalence and Clinical Features of Hearing Loss Patients with CDH23 Mutations: A Large Cohort Study	PLOS ONE			English	Article							USHER-SYNDROME; DEAFNESS; JAPANESE; FREQUENCIES; GENES; CADHERINS; MICE; 1D	Screening for gene mutations in CDH23, which has many exons, has lagged even though it is likely to be an important cause for hearing loss patients. To assess the importance of CDH23 mutations in non-syndromic hearing loss, two-step screening was applied and clinical characteristics of the patients with CDH23 mutations were examined in this study. As a first screening, we performed Sanger sequencing using 304 probands compatible with recessive inheritance to find the pathologic mutations. Twenty-six possible mutations were detected to be pathologic in the first screening. For the second screening, using the probes for these 26 mutations, a large cohort of probands (n = 1396) was screened using Taqman amplification-based mutation analysis followed by Sanger sequencing. The hearing loss in a total of 52 families (10 homozygous, 13 compound heterogygous, and 29 heterozygous) was found to be caused by the CDH23 mutations. The majority of the patients showed congenital, high frequency involved, progressive hearing loss. Interestingly, some particular mutations cause late onset moderate hearing loss. The present study is the first to demonstrate the prevalence of CDH23 mutations among non-syndromic hearing loss patients and indicated that mutations of the CDH23 gene are an important cause of non-syndromic hearing loss.	[Miyagawa, Maiko; Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan	Shinshu University	Miyagawa, M (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Ministry of Health, Labour and Welfare of Japan; Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan; Japanese Ministry of Health, Labour and Welfare; Ministry of Education, Science and Culture of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan; Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/) (SU), by the Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/) (SU), by a Health and Labour Sciences Research Grant for Research on Specific Diseases (Vestibular Disorders) from the Japanese Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/) (SU), and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Angst BD, 2001, J CELL SCI, V114, P629; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; de Kok JB, 2002, HUM MUTAT, V19, P554, DOI 10.1002/humu.10076; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mchugh RK, 2006, ANAT REC PART A, V288A, P370, DOI 10.1002/ar.a.20297; Muller U, 2008, CURR OPIN CELL BIOL, V20, P557, DOI 10.1016/j.ceb.2008.06.004; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Oshima A, 2008, Hum Mutat, V29, pE37, DOI 10.1002/humu.20761; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Rowlands TM, 2000, REV REPROD, V5, P53; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Usami S, 2010, AUDIOLOGICAL MED, V8, P28; Usami SI, 2008, ACTA OTO-LARYNGOL, V128, P446, DOI 10.1080/00016480701785046; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; Wagatsuma M, 2007, CLIN GENET, V72, P339, DOI 10.1111/j.1399-0004.2007.00833.x; Zheng QY, 2005, HUM MOL GENET, V14, P103, DOI 10.1093/hmg/ddi010	22	49	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e40366	10.1371/journal.pone.0040366	http://dx.doi.org/10.1371/journal.pone.0040366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899989	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900004
J	Yang, JY; Lan, HT; Huang, XB; Liu, BY; Tong, Y				Yang, Jiyun; Lan, Haitao; Huang, Xiaobing; Liu, Baoyu; Tong, Yu			MicroRNA-126 Inhibits Tumor Cell Growth and Its Expression Level Correlates with Poor Survival in Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							MIR-126; SUPPRESSOR; CARCINOMA; INVASION; GENES	Background: It is controversial whether microRNA-126 is a tumor suppressive or oncogenic miRNA. More experiments are needed to determine whether microRNA-126 is associated with non-small cell lung cancer risk and prognosis. Methods: Over-expression of microRNA-126 was performed to evaluate the cell invasion and tumor growth in non-small cell lung cancer (NSCLC) cell lines and nude mouse xenograft model. Gain-of-function experiments and luciferase assays were performed to reveal the relationship between microRNA-126 and PI3K-Akt signal pathway in A549 cells. We analyzed the associations of the microRNA-126 expression between genetic variants within microRNA-126 and clinical information including smoking status, sex, age, and histological type and the tumor stage. Results: Over-expression of microRNA-126 in NSCLC cell lines decreased cell proliferation in vitro and tumor growth in the nude mouse xenograft model. And microRNA-126 repressed the activity of PI3K-Akt pathway by targeting binding sites in the 3'-untranslated region of PI3KR2 mRNA. The expression level of microRNA-126 was decreased in NSCLC lines and tumor tissues. The patients with low microRNA-126 expression had significantly poorer survival time than those with high microRNA-126 expression (means for survival time (month): 24.392 +/- 1.055 vs. 29.282 +/- 1.140, P = 0.005). However, there was no significant difference in the genotype and allele frequencies of the microRNA-126 variant (G>A, rs4636297) between cases and controls (P = 0.366). In addition, there was no association between SNP rs4636297 and survival time in NSCLC patients (P = 0.992). And microRNA-126 expression had no significant difference among the three genotype groups (P = 0.972). Conclusions: Our data indicate that microRNA-126 is a tumor-suppressor gene in NSCLC and low microRNA-126 expression is a unfavorable prognostic factor in NSCLC patients. However, the regulatory mechanism of microRNA-126 remains to be elucidated in different normal and malignant tissues. Therefore, further research is needed to explore the tumor suppressive functions of microRNA-126 in NSCLC.	[Yang, Jiyun] Sichuan Acad Med Sci, Ctr Human Mol Biol & Genet, Inst Lab Med, Chengdu, Sichuan, Peoples R China; [Yang, Jiyun; Lan, Haitao; Huang, Xiaobing] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Yang, Jiyun] Sichuan Acad Med Sci, Key Lab Human Dis Gene Study Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Tong, Yu] Sichuan Univ, Lab Early Dev & Injuries, W China Inst Woman & Childrens Hlth, Chengdu 610064, Sichuan, Peoples R China; [Tong, Yu] Sichuan Univ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Minist Educ, W China Univ Hosp 2, Chengdu 610064, Sichuan, Peoples R China; [Lan, Haitao] Sichuan Acad Med Sci, Dept Oncol, Chengdu, Sichuan, Peoples R China; [Huang, Xiaobing] Sichuan Acad Med Sci, Dept Hematol, Chengdu, Sichuan, Peoples R China; [Liu, Baoyu] Chengdu Army Gen Hosp, Dept Thorac Surg, Chengdu, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan University; Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Yang, JY (corresponding author), Sichuan Acad Med Sci, Ctr Human Mol Biol & Genet, Inst Lab Med, Chengdu, Sichuan, Peoples R China.	toyuer@gmail.com	Yang, Jiyun/AAS-3937-2020		National Natural Science Foundation of China [30800633]; Sichuan Province Science and Technology Foundation for Youths [09ZQ026-034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province Science and Technology Foundation for Youths	This work was supported by National Natural Science Foundation of China (grant number 30800633) and Sichuan Province Science and Technology Foundation for Youths (grant number 09ZQ026-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2009, EXPERT REV MOL DIAGN, V9, P773, DOI [10.1586/erm.09.57, 10.1586/ERM.09.57]; Cho WCS, 2009, EUR J CANCER, V45, P2197, DOI 10.1016/j.ejca.2009.04.039; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; Donev IS, 2011, CLIN CANCER RES, V17, P2260, DOI 10.1158/1078-0432.CCR-10-1993; Feng R, 2011, CANC LETT, V298, P50; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Hansen TF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-83; Harnprasopwat R, 2010, BIOCHEM BIOPH RES CO, V399, P117, DOI 10.1016/j.bbrc.2010.07.009; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Harris TA, 2010, ARTERIOSCL THROM VAS, V30, P1990, DOI 10.1161/ATVBAHA.110.211706; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hu ZB, 2011, AM J RESP CRIT CARE, V183, P641, DOI 10.1164/rccm.201005-0717OC; Huang ZH, 2011, CANCER RES, V71, P2582, DOI 10.1158/0008-5472.CAN-10-3032; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Lu Y, 2012, CARCINOGENESIS, DOI [10.1093/carcin/bgs1100, DOI 10.1093/CARCIN/BGS1100]; Ma JC, 2009, MOL CELL BIOCHEM, V331, P161, DOI 10.1007/s11010-009-0154-x; Miko E, 2011, FEBS LETT, V585, P1191, DOI 10.1016/j.febslet.2011.03.039; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Otsubo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016617; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Sun YQ, 2010, BIOCHEM BIOPH RES CO, V391, P1483, DOI 10.1016/j.bbrc.2009.12.098; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Toyooka S, 2011, GEN THORAC CARDIOVAS, V59, P527, DOI 10.1007/s11748-010-0743-3; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Yang RX, 2011, BREAST CANCER RES TR, V127, P549, DOI 10.1007/s10549-010-1244-x; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089	39	46	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42978	10.1371/journal.pone.0042978	http://dx.doi.org/10.1371/journal.pone.0042978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900072	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900090
J	Binkowski, TA; Marino, SR; Joachimiak, A				Binkowski, T. Andrew; Marino, Susana R.; Joachimiak, Andrzej			Predicting HLA Class I Non-Permissive Amino Acid Residues Substitutions	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL EPITOPES; MHC CLASS-I; VERSUS-HOST-DISEASE; PEPTIDE-BINDING; STRUCTURAL PREDICTION; COMPUTATIONAL SYSTEM; MOLECULAR-MECHANISM; SIDE-CHAINS; LIGANDS	Prediction of peptide binding to human leukocyte antigen (HLA) molecules is essential to a wide range of clinical entities from vaccine design to stem cell transplant compatibility. Here we present a new structure-based methodology that applies robust computational tools to model peptide-HLA (p-HLA) binding interactions. The method leverages the structural conservation observed in p-HLA complexes to significantly reduce the search space and calculate the system's binding free energy. This approach is benchmarked against existing p-HLA complexes and the prediction performance is measured against a library of experimentally validated peptides. The effect on binding activity across a large set of high-affinity peptides is used to investigate amino acid mismatches reported as high-risk factors in hematopoietic stem cell transplantation.	[Binkowski, T. Andrew; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Binkowski, T. Andrew; Joachimiak, Andrzej] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Marino, Susana R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Chicago	Binkowski, TA (corresponding author), Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, 9700 S Cass Ave, Argonne, IL 60439 USA.	andrzejj@anl.gov		Joachimiak, Andrzej/0000-0003-2535-6209; Marino, Susana G./0000-0003-4369-018X	Office of Science of the U.S. Department of Energy [DE-AC02-06CH11357]; U.S. Department of Energy Office of Science laboratory [DE-AC02-06CH11357]; National Institutes of Health [GM094585]; University of Chicago Comprehensive Cancer Center, Chicago, Illinois [5-31333]; U.S. Department of Energy Office of Biological and Environmental Research [DEAC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy Office of Science laboratory(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center, Chicago, Illinois; U.S. Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research used resources of the Argonne Leadership Computing Facility at Argonne National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-06CH11357. We would like to acknowledge Drs. Devleena Shivakumar, Wei Jiang and Benoit Roux for valuable discussions and support on computational method development and implementation. The submitted manuscript has been created by UChicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne''). Argonne, a U.S. Department of Energy Office of Science laboratory, is operated under Contract No. DE-AC02-06CH11357. The U.S. Government retains for itself, and others acting on its behalf, a paid-up nonexclusive, irrevocable worldwide license in said article to reproduce, prepare derivative works, distribute copies to the public, and perform publicly and display publicly, by or on behalf of the Government.; This work was supported by National Institutes of Health grant GM094585, University of Chicago Comprehensive Cancer Center, Chicago, Illinois (Fund 5-31333) and by the U.S. Department of Energy Office of Biological and Environmental Research contract DEAC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia Y, 2004, METHODS, V34, P454, DOI 10.1016/j.ymeth.2004.06.008; ALTUVIA Y, 1995, J MOL BIOL, V249, P244, DOI 10.1006/jmbi.1995.0293; Ball P, 2008, NATURE, V452, P291, DOI 10.1038/452291a; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; Brusic V, 2002, IMMUNOL CELL BIOL, V80, P280, DOI 10.1046/j.1440-1711.2002.01088.x; Bui HH, 2006, PROTEINS, V63, P43, DOI 10.1002/prot.20870; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui J, 2006, IMMUNOGENETICS, V58, P607, DOI 10.1007/s00251-006-0117-2; DAVENPORT MP, 1995, IMMUNOGENETICS, V42, P392; Doytchinova IA, 2004, METHODS, V34, P444, DOI 10.1016/j.ymeth.2004.06.007; Fagerberg T, 2006, J MOL BIOL, V356, P521, DOI 10.1016/j.jmb.2005.11.059; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Ferrara GB, 2001, BLOOD, V98, P3150, DOI 10.1182/blood.V98.10.3150; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garcia-Sosa AT, 2010, MOL INFORM, V29, P589, DOI 10.1002/minf.201000007; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; Hattotuwagama Channa K., 2007, V409, P227, DOI 10.1007/978-1-60327-118-9_16; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Jacob L, 2008, BIOINFORMATICS, V24, P358, DOI 10.1093/bioinformatics/btm611; Jojic N, 2006, BIOINFORMATICS, V22, pE227, DOI 10.1093/bioinformatics/btl255; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; Kawase T, 2009, BLOOD, V113, P2851, DOI 10.1182/blood-2008-08-171934; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kumar N, 2007, NUCLEIC ACIDS RES, V35, pW549, DOI 10.1093/nar/gkm266; Kumar N, 2010, MOL BIOSYST, V6, P2508, DOI 10.1039/c0mb00013b; Liao WWP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025055; Liao WWP, 2011, AUTOIMMUN REV, V10, P469, DOI 10.1016/j.autrev.2011.02.003; Lim JS, 1996, MOL IMMUNOL, V33, P221, DOI 10.1016/0161-5890(95)00065-8; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Logean A, 2002, J COMPUT AID MOL DES, V16, P229, DOI 10.1023/A:1020244329512; Luo WJ, 2010, J MOL MODEL, V16, P903, DOI 10.1007/s00894-009-0598-7; Mamitsuka H, 1998, PROTEINS, V33, P460, DOI 10.1002/(SICI)1097-0134(19981201)33:4<460::AID-PROT2>3.0.CO;2-M; Marino SR, 2012, BONE MARROW TRANSPL, V47, P217, DOI 10.1038/bmt.2011.56; Michielin O, 2002, J MOL BIOL, V324, P547, DOI 10.1016/S0022-2836(02)00880-X; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Paczesny S, 2010, BONE MARROW TRANSPL, V45, P1, DOI 10.1038/bmt.2009.328; PARKER KC, 1994, J IMMUNOL, V152, P163; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Rognan D, 1999, J MED CHEM, V42, P4650, DOI 10.1021/jm9910775; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SETTE A, 1989, P NATL ACAD SCI USA, V86, P3296, DOI 10.1073/pnas.86.9.3296; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Tong JC, 2004, PROTEIN SCI, V13, P2523, DOI 10.1110/ps.04631204; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW172, DOI 10.1093/nar/gki452; Zhang GL, 2007, J IMMUNOL METHODS, V320, P143, DOI 10.1016/j.jim.2006.12.011; Zhang GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S19; Zoete V, 2010, J MOL RECOGNIT, V23, P142, DOI 10.1002/jmr.1005	54	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41710	10.1371/journal.pone.0041710	http://dx.doi.org/10.1371/journal.pone.0041710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905104	Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100015
J	Ip, CW; Kroner, A; Groh, J; Huber, M; Klein, D; Spahn, I; Diem, R; Williams, SK; Nave, KA; Edgar, JM; Martini, R				Ip, Chi Wang; Kroner, Antje; Groh, Janos; Huber, Marianne; Klein, Dennis; Spahn, Irene; Diem, Ricarda; Williams, Sarah K.; Nave, Klaus-Armin; Edgar, Julia M.; Martini, Rudolf			Neuroinflammation by Cytotoxic T-Lymphocytes Impairs Retrograde Axonal Transport in an Oligodendrocyte Mutant Mouse	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PROTEOLIPID PROTEIN GENE; RETINAL GANGLION-CELLS; GRANZYME-B; MULTIPLE-SCLEROSIS; MYELIN DEGENERATION; AXONOPATHIC CHANGES; NEURONAL APOPTOSIS; NERVOUS-SYSTEM; MOTOR FUNCTION	Mice overexpressing proteolipid protein (PLP) develop a leukodystrophy-like disease involving cytotoxic, CD8+ T-lymphocytes. Here we show that these cytotoxic T-lymphocytes perturb retrograde axonal transport. Using fluorogold stereotactically injected into the colliculus superior, we found that PLP overexpression in oligodendrocytes led to significantly reduced retrograde axonal transport in retina ganglion cell axons. We also observed an accumulation of mitochondria in the juxtaparanodal axonal swellings, indicative for a disturbed axonal transport. PLP overexpression in the absence of T-lymphocytes rescued retrograde axonal transport defects and abolished axonal swellings. Bone marrow transfer from wildtype mice, but not from perforin- or granzyme B-deficient mutants, into lymphocyte-deficient PLP mutant mice led again to impaired axonal transport and the formation of axonal swellings, which are predominantly located at the juxtaparanodal region. This demonstrates that the adaptive immune system, including cytotoxic T-lymphocytes which release perforin and granzyme B, are necessary to perturb axonal integrity in the PLP-transgenic disease model. Based on our observations, so far not attended molecular and cellular players belonging to the immune system should be considered to understand pathogenesis in inherited myelin disorders with progressive axonal damage.	[Ip, Chi Wang; Kroner, Antje; Groh, Janos; Huber, Marianne; Klein, Dennis; Spahn, Irene; Martini, Rudolf] Univ Wurzburg, Dept Neurol, Sect Dev Neurobiol, D-8700 Wurzburg, Germany; [Diem, Ricarda; Williams, Sarah K.] Univ Heidelberg Hosp, Dept Neurooncol, Heidelberg, Germany; [Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, Gottingen, Germany; [Edgar, Julia M.] Univ Glasgow, Appl Neurobiol Grp, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Wurzburg; Ruprecht Karls University Heidelberg; Max Planck Society; University of Glasgow	Ip, CW (corresponding author), Univ Wurzburg, Dept Neurol, Sect Dev Neurobiol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	rudolf.martini@uni-wuerzburg.de	Ip, Chi Wang/HCH-3822-2022; Edgar, Julia M/U-8456-2019	Ip, Chi Wang/0000-0003-0484-385X; Edgar, Julia M/0000-0002-3869-0962; Groh, Janos/0000-0002-7628-0163; Klein, Dennis/0000-0002-0476-445X; Martini, Rudolf/0000-0002-5463-5592	Gemeinnutzige Hertie Stiftung [1.01.1/07/12]; Fritz-Thyssen Foundation [10.07.2.152]; German Research Council [SFB581, TP A3]; University of Wuerzburg (IZKF) [A168]; Roman, Marga and Mareille Sobek Foundation; National Contest for Life (NCL, Hamburg)	Gemeinnutzige Hertie Stiftung; Fritz-Thyssen Foundation; German Research Council(German Research Foundation (DFG)); University of Wuerzburg (IZKF); Roman, Marga and Mareille Sobek Foundation; National Contest for Life (NCL, Hamburg)	This study was funded by the Gemeinnutzige Hertie Stiftung (1.01.1/07/12), Fritz-Thyssen Foundation (10.07.2.152), German Research Council (SFB581, TP A3), local funds of the University of Wuerzburg (IZKF; A168) and by the Roman, Marga and Mareille Sobek Foundation. Other projects of the laboratory of RM are supported by the National Contest for Life (NCL, Hamburg). The funders did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2006, J BIOL CHEM, V281, P8118, DOI 10.1074/jbc.M509361200; Anderson TJ, 1998, J COMP NEUROL, V394, P506, DOI 10.1002/(SICI)1096-9861(19980518)394:4<506::AID-CNE8>3.0.CO;2-5; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Deb C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012478; Deb C, 2009, J NEUROPATH EXP NEUR, V68, P1037, DOI 10.1097/NEN.0b013e3181b5417e; Derfuss T, 2010, J MOL MED, V88, P753, DOI 10.1007/s00109-010-0632-3; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012; Edgar JM, 2010, EMBO MOL MED, V2, P42, DOI 10.1002/emmm.200900057; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gobel K, 2010, GLIA, V58, P469, DOI 10.1002/glia.20938; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Haile Y, 2011, J IMMUNOL, V187, P4861, DOI 10.4049/jimmunol.1100943; Hawkes C, 2003, J COMP NEUROL, V458, P113, DOI 10.1002/cne.10578; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Hobom M, 2004, BRAIN PATHOL, V14, P148, DOI 10.1111/j.1750-3639.2004.tb00047.x; Howe CL, 2007, J NEUROIMMUNOL, V188, P13, DOI 10.1016/j.jneuroim.2007.04.005; Howe CL, 2007, NEUROBIOL DIS, V25, P354, DOI 10.1016/j.nbd.2006.10.001; Ip CW, 2007, NEUROBIOL DIS, V25, P105, DOI 10.1016/j.nbd.2006.08.023; Ip CW, 2006, J NEUROSCI, V26, P8206, DOI 10.1523/JNEUROSCI.1921-06.2006; Kroner A, 2010, AM J PATHOL, V176, P549, DOI 10.2353/ajpath.2010.090722; Kroner A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004405; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Melzer N, 2009, FASEB J, V23, P3659, DOI 10.1096/fj.09-136200; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; Morfini G, 2007, P NATL ACAD SCI USA, V104, P2442, DOI 10.1073/pnas.0611231104; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Muller M, 2007, EXP NEUROL, V203, P55, DOI 10.1016/j.expneurol.2006.07.018; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; SMITH RS, 1980, J NEUROCYTOL, V9, P39, DOI 10.1007/BF01205226; Sobottka B, 2009, AM J PATHOL, V175, P1160, DOI 10.2353/ajpath.2009.090340; TSUKITA S, 1980, J CELL BIOL, V84, P513, DOI 10.1083/jcb.84.3.513; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Williams SK, 2011, AM J PATHOL, V178, P2823, DOI 10.1016/j.ajpath.2011.02.046; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553	44	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42554	10.1371/journal.pone.0042554	http://dx.doi.org/10.1371/journal.pone.0042554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905147	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000307331100048
J	Liss, M; Daubert, D; Brunner, K; Kliche, K; Hammes, U; Leiherer, A; Wagner, R				Liss, Michael; Daubert, Daniela; Brunner, Kathrin; Kliche, Kristina; Hammes, Ulrich; Leiherer, Andreas; Wagner, Ralf			Embedding Permanent Watermarks in Synthetic Genes	PLOS ONE			English	Article							OPTIMIZATION; CELLS	As synthetic biology advances, labeling of genes or organisms, like other high-value products, will become important not only to pinpoint their identity, origin, or spread, but also for intellectual property, classification, bio-security or legal reasons. Ideally information should be inseparably interlaced into expressed genes. We describe a method for embedding messages within open reading frames of synthetic genes by adapting steganographic algorithms typically used for watermarking digital media files. Text messages are first translated into a binary string, and then represented in the reading frame by synonymous codon choice. To aim for good expression of the labeled gene in its host as well as retain a high degree of codon assignment flexibility for gene optimization, codon usage tables of the target organism are taken into account. Preferably amino acids with 4 or 6 synonymous codons are used to comprise binary digits. Several different messages were embedded into open reading frames of T7 RNA polymerase, GFP, human EMG1 and HIV gag, variously optimized for bacterial, yeast, mammalian or plant expression, without affecting their protein expression or function. We also introduced Vigenere polyalphabetic substitution to cipher text messages, and developed an identifier as a key to deciphering codon usage ranking stored for a specific organism within a sequence of 35 nucleotides.	[Liss, Michael; Daubert, Daniela; Brunner, Kathrin; Kliche, Kristina; Wagner, Ralf] Life Technol Geneart AG, Regensburg, Germany; [Hammes, Ulrich] Univ Regensburg, Dept Cell Biol & Plant Physiol, Regensburg, Germany; [Leiherer, Andreas; Wagner, Ralf] Univ Regensburg, Mol Microbiol & Gene Therapy Unit, Inst Med Microbiol & Hyg, Regensburg, Germany	Thermo Fisher Scientific; University of Regensburg; University of Regensburg	Liss, M (corresponding author), Life Technol Geneart AG, Regensburg, Germany.	michael.liss@lifetech.com	Leiherer, Andreas/X-5539-2019	Leiherer, Andreas/0000-0003-3776-5704; Hammes, Ulrich/0000-0002-3663-4908	Bundesministerium fuer Bildung und Forschung [0313687]; Deutsche Forschungsgemeinschaft [HA3468/4-1]	Bundesministerium fuer Bildung und Forschung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Assessment of HIV-1 infectivity and long-term replication kinetics was funded by the Bundesministerium fuer Bildung und Forschung, grant 0313687. Tobacco leaf transfection and analysis was funded by the Deutsche Forschungsgemeinschaft, grant HA3468/4-1. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2004, BIOTECHNOL PROGR, V20, P1605, DOI 10.1021/bp049917i; Bartetzko V, 2009, MOL PLANT MICROBE IN, V22, P655, DOI 10.1094/MPMI-22-6-0655; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Deml L, 2001, J VIROL, V75, P10991, DOI 10.1128/JVI.75.22.10991-11001.2001; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Heider D, 2009, BMC RES NOTES, V2, pe125; Heider D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-40; Heider D, 2008, BIOINFORMATICS, V24, P1961, DOI 10.1093/bioinformatics/btn342; Heider D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-176; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; Maertens B, 2010, PROTEIN SCI, V19, P1312, DOI 10.1002/pro.408; Preuss ML, 2006, J CELL BIOL, V172, P991, DOI 10.1083/jcb.200508116; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; Shimanovsky B, 2003, LECT NOTES COMPUT SC, V2578, P373; Wong PC, 2003, COMMUN ACM, V46, P95, DOI 10.1145/602421.602426	17	46	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42465	10.1371/journal.pone.0042465	http://dx.doi.org/10.1371/journal.pone.0042465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905136	Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100040
J	Natalello, A; Ami, D; Collini, M; D'Alfonso, L; Chirico, G; Tonon, G; Scaramuzza, S; Schrepfer, R; Doglia, SM				Natalello, Antonino; Ami, Diletta; Collini, Maddalena; D'Alfonso, Laura; Chirico, Giuseppe; Tonon, Giancarlo; Scaramuzza, Silvia; Schrepfer, Rodolfo; Doglia, Silvia Maria			Biophysical Characterization of Met-G-CSF: Effects of Different Site-Specific Mono-Pegylations on Protein Stability and Aggregation	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TRANSFORM INFRARED-SPECTROSCOPY; CONFORMATIONAL STABILITY; CIRCULAR-DICHROISM; FLUORESCENCE; CONJUGATION; FILGRASTIM; DYNAMICS; PEG	The limited stability of proteins in vitro and in vivo reduces their conversion into effective biopharmaceuticals. To overcome this problem several strategies can be exploited, as the conjugation of the protein of interest with polyethylene glycol, in most cases, improves its stability and pharmacokinetics. In this work, we report a biophysical characterization of the non-pegylated and of two different site-specific mono-pegylated forms of recombinant human methionyl-granulocyte colony stimulating factor (Met-G-CSF), a protein used in chemotherapy and bone marrow transplantation. In particular, we found that the two mono-pegylations of Met-G-CSF at the N-terminal methionine and at glutamine 135 increase the protein thermal stability, reduce the aggregation propensity, preventing also protein precipitation, as revealed by circular dichroism (CD), Fourier transform infrared (FTIR), intrinsic fluorescence spectroscopies and dynamic light scattering (DLS). Interestingly, the two pegylation strategies were found to drastically reduce the polydispersity of Met-G-CSF, when incubated under conditions favouring protein aggregation, as indicated by DLS measurements. Our in vitro results are in agreement with preclinical studies, underlining that preliminary biophysical analyses, performed in the early stages of the development of new biopharmaceutical variants, might offer a useful tool for the identification of protein variants with improved therapeutic values.	[Natalello, Antonino; Ami, Diletta; Doglia, Silvia Maria] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Natalello, Antonino; Ami, Diletta; Doglia, Silvia Maria] UdR Milano Bicocca, Consorzio Nazl Interuniv Sci Fis Mat CNISM, Milan, Italy; [Collini, Maddalena; D'Alfonso, Laura; Chirico, Giuseppe] Univ Milano Bicocca, Dept Phys, Milan, Italy; [Tonon, Giancarlo] IRCSS Multimed, Milan, Italy; [Scaramuzza, Silvia; Schrepfer, Rodolfo] Bioker Srl, Pula, Italy	University of Milano-Bicocca; University of Milano-Bicocca	Natalello, A (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	diletta.ami@unimib.it	Natalello, Antonino/B-9659-2012; D'Alfonso, Laura/J-4193-2012	Natalello, Antonino/0000-0002-1489-272X; D'Alfonso, Laura/0000-0002-7378-4462; CHIRICO, Giuseppe/0000-0001-6578-6460; Ami, Diletta/0000-0003-4549-8300	FAR (Fondo di Ateneo per la Ricerca) of the University of Milano-Bicocca (Italy); University of Milano-Bicocca	FAR (Fondo di Ateneo per la Ricerca) of the University of Milano-Bicocca (Italy); University of Milano-Bicocca	SMD and GC acknowledge the financial support of the FAR (Fondo di Ateneo per la Ricerca) of the University of Milano-Bicocca (Italy). DA acknowledges a postdoctoral fellowship of the University of Milano-Bicocca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami D, 2012, BIOPHYS J, V102, P1676, DOI 10.1016/j.bpj.2012.02.045; Anderlini P, 1996, BLOOD, V88, P2819, DOI 10.1182/blood.V88.8.2819.bloodjournal8882819; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Bloomfield VA, 1985, DYNAMIC LIGHT SCATTE, P363; Chirico G, 1999, J CHEM PHYS, V110, P2297, DOI 10.1063/1.477883; FRAMPTON JE, 1994, DRUGS, V48, P731, DOI 10.2165/00003495-199448050-00007; Garidel Patrick, 2008, Biotechnology Journal, V3, P1201, DOI 10.1002/biot.200800091; Hao Y, 2006, BIODRUGS, V20, P357, DOI 10.2165/00063030-200620060-00006; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Kazakov AS, 2009, BIOPHYS CHEM, V145, P79, DOI 10.1016/j.bpc.2009.09.003; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; Molineux G, 2004, CURR PHARM DESIGN, V10, P1235, DOI 10.2174/1381612043452613; Natalello A, 2005, BIOCHEM J, V385, P511, DOI 10.1042/BJ20041296; Natalello A, 2008, J MOL BIOL, V381, P1349, DOI 10.1016/j.jmb.2008.06.063; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; PERMYAKOV EA, 1984, BIOPHYS CHEM, V19, P265, DOI 10.1016/0301-4622(84)87009-X; Pozzuolo S, 2008, PROTEIN EXPRES PURIF, V59, P334, DOI 10.1016/j.pep.2008.02.018; Rajan RS, 2006, PROTEIN SCI, V15, P1063, DOI 10.1110/ps.052004006; Salmaso S, 2009, BIOCONJUGATE CHEM, V20, P1179, DOI 10.1021/bc9000432; Seshadri S, 1999, METHOD ENZYMOL, V309, P559; SHIRAFUJI N, 1989, EXP HEMATOL, V17, P116; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Thirumangalathu R, 2006, J PHARM SCI-US, V95, P1480, DOI 10.1002/jps.20619; Vazquez E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-60; Veronese FM, 2007, BIOCONJUGATE CHEM, V18, P1824, DOI 10.1021/bc070123+; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; ZINK T, 1994, BIOCHEMISTRY-US, V33, P8453, DOI 10.1021/bi00194a009	32	25	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42511	10.1371/journal.pone.0042511	http://dx.doi.org/10.1371/journal.pone.0042511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905140	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100044
J	Pelullo, CP; Di Giuseppe, G; Angelillo, IF				Pelullo, Concetta P.; Di Giuseppe, Gabriella; Angelillo, Italo F.			Human Papillomavirus Infection: Knowledge, Attitudes, and Behaviors among Lesbian, Gay Men, and Bisexual in Italy	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ANAL HPV INFECTION; PARENTAL ACCEPTANCE; VACCINATION; SEX; WOMEN; ADOLESCENTS; PREVENTION; CANCER; RISK	Background: This cross-sectional study assess knowledge, attitudes, and behavior towards the human papillomavirus (HPV) and the vaccination among a random sample of 1000 lesbian, gay men, and bisexual women and men. Methods: A face-to-face interview sought information about: socio-demographic characteristics, knowledge about HPV infection, perception of risk towards HPV infection and/or cervical, anal, and oropharyngeal cancers, perception of the benefits of a vaccination to prevent cervical, anal, and oropharyngeal cancers, sexual behaviors, health-promoting behaviors, and willingness to receive the HPV vaccine. Results: Only 60.6% had heard about the HPV infection and this knowledge was significantly higher in female, in those being a member of a homosexual association, in those having had the first sexual experience at a younger age, in those having received information about the HPV infection from physicians, and in those having no need of information about HPV infection. A higher perceived risk of contracting HPV infection has been observed in those younger, lesbian and gay men, who have heard of HPV infection and knew the risk factors and its related diseases, who have received information about HPV infection from physicians, and who need information about HPV infection. Only 1.7% have undergone HPV immunization and 73.3% professed intent to obtain it in the future. The significant predictors of the willingness to receive this vaccine were belief that the vaccination is useful, perception to be at higher risk of contracting HPV infection, and perception to be at higher risk of developing cervical, anal, and oropharyngeal cancers. Conclusions: Information and interventions are strongly needed in order to overcome the lack of knowledge about HPV infection and its vaccination. Inclusion of boys in the national vaccination program and initiate a catch-up program for men who have sex with men up to 26 years may reduce their burden of HPV-related disease.	[Pelullo, Concetta P.; Di Giuseppe, Gabriella; Angelillo, Italo F.] Univ Naples 2, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli	Pelullo, CP (corresponding author), Univ Naples 2, Dept Expt Med, Naples, Italy.	italof.angelillo@unina2.it	Angelillo, Italo Francesco/AAK-1301-2021	Angelillo, Italo Francesco/0000-0003-1213-6602; DI GIUSEPPE, Gabriella/0000-0003-4466-6683	Second University of Naples (Naples, Italy)	Second University of Naples (Naples, Italy)	This study was supported by a research grant from the Second University of Naples (Naples, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brewer NT, 2010, J BEHAV MED, V33, P274, DOI 10.1007/s10865-010-9251-2; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1705; Daley MF, 2010, PEDIATRICS, V126, P425, DOI 10.1542/peds.2009-3500; Davis KC, 2012, HLTH ED BEH IN PRESS; Di Giuseppe G, 2008, BRIT J CANCER, V99, P225, DOI 10.1038/sj.bjc.6604454; Dietz CA, 2011, J AM OSTEOPATH ASSOC, V111, pS19; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; Frisch M, 2003, AM J EPIDEMIOL, V157, P966, DOI 10.1093/aje/kwg067; Gilbert PA, 2011, J LOW GENIT TRACT DI, V15, P83, DOI 10.1097/LGT.0b013e3181f1a960; Gold J, 2011, SEX HEALTH, V8, P234, DOI 10.1071/SH10082; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Heiligenberg M, 2010, SEX TRANSM DIS, V37, P672, DOI 10.1097/OLQ.0b013e3181e71069; Helme DW, 2011, HEALTH COMMUN, V26, P366, DOI 10.1080/10410236.2010.551582; IARC Human papillomaviruses, 2011, IARC MONOGR EVAL C B, V100, P1; Jaspers L, 2011, VACCINE, V29, P7785, DOI 10.1016/j.vaccine.2011.07.107; Kahn JA, 2009, CANCER EPIDEM BIOMAR, V18, P2325, DOI 10.1158/1055-9965.EPI-09-0184; Kim JJ, 2010, LANCET INFECT DIS, V10, P845, DOI 10.1016/S1473-3099(10)70219-X; Lenselink CH, 2008, EUR J OBSTET GYN R B, V137, P103, DOI 10.1016/j.ejogrb.2007.02.012; Lu BB, 2011, CANCER EPIDEM BIOMAR, V20, P990, DOI 10.1158/1055-9965.EPI-10-1160; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Marek E, 2011, VACCINE, V29, P8591, DOI 10.1016/j.vaccine.2011.09.018; McNair R, 2009, AUST NZ J PUBL HEAL, V33, P87, DOI 10.1111/j.1753-6405.2009.00345.x; Miksis S, 2008, JOGNN-J OBST GYN NEO, V37, P329, DOI 10.1111/j.1552-6909.2008.00236.x; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Pitts MK, 2007, SEX TRANSM DIS, V34, P170, DOI 10.1097/01.olq.0000230436.83029.ce; Reiter PL, 2010, SEX TRANSM DIS, V37, P197, DOI 10.1097/OLQ.0b013e3181bf542c; Sam IC, 2009, J ADOLESCENT HEALTH, V44, P610, DOI 10.1016/j.jadohealth.2008.11.014; Simatherai D, 2009, SEX TRANSM INFECT, V85, P148, DOI 10.1136/sti.2008.032581; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Trani F, 2006, J INFECTION, V52, P269, DOI 10.1016/j.jinf.2005.06.010; Trani F, 2005, J PAEDIATR CHILD H, V41, P260, DOI 10.1111/j.1440-1754.2005.00607.x; Vadaparampil ST, 2011, VACCINE, V29, P8634, DOI 10.1016/j.vaccine.2011.09.006; Weiss TW, 2010, J ADOLESCENT HEALTH, V47, P3, DOI 10.1016/j.jadohealth.2010.03.003; Wheldon CW, 2011, VACCINE, V29, P8060, DOI 10.1016/j.vaccine.2011.08.045; Wilson DP, 2010, CLIN TRIALS, V7, P36, DOI 10.1177/1740774509355177; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	36	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42856	10.1371/journal.pone.0042856	http://dx.doi.org/10.1371/journal.pone.0042856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905178	Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100070
J	Simon-Areces, J; Dietrich, MO; Hermes, G; Garcia-Segura, LM; Arevalo, MA; Horvath, TL				Simon-Areces, Julia; Dietrich, Marcelo O.; Hermes, Gretchen; Miguel Garcia-Segura, Luis; Arevalo, Maria-Angeles; Horvath, Tamas L.			Ucp2 Induced by Natural Birth Regulates Neuronal Differentiation of the Hippocampus and Related Adult Behavior	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2 PROTECTS; MECHANISM; SUPEROXIDE; BRAIN; MOUSE; DEATH	Mitochondrial uncoupling protein 2 (UCP2) is induced by cellular stress and is involved in regulation of fuel utilization, mitochondrial bioenergetics, cell proliferation, neuroprotection and synaptogenesis in the adult brain. Here we show that natural birth in mice triggers UCP2 expression in hippocampal neurons. Chemical inhibition or genetic ablation of UCP2 lead to diminished neuronal number and size, dendritic growth and synaptogenezis in vitro and impaired complex behaviors in the adult. These data reveal a critical role for Ucp2 expression in the development of hippocampal neurons and circuits and hippocampus-related adult behaviors.	[Simon-Areces, Julia; Miguel Garcia-Segura, Luis; Arevalo, Maria-Angeles] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Dietrich, Marcelo O.; Hermes, Gretchen; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06510 USA; [Dietrich, Marcelo O.; Horvath, Tamas L.] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Yale University; Universidade Federal do Rio Grande do Sul; Yale University; Yale University	Simon-Areces, J (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	tamas.horvath@yale.edu	Garcia-Segura, Luis M/U-3711-2017; Arevalo, Maria-Angeles/J-7000-2014; Dietrich, Marcelo/A-9928-2009	Garcia-Segura, Luis M/0000-0002-2450-2916; Arevalo, Maria-Angeles/0000-0002-4303-9576; Dietrich, Marcelo/0000-0001-9781-2221	NIH Director's Pioneer Award [DP1OD006850]; NIH [DK080000, DK 060711]; ADA [7-08-MN-25]; Ministerio de Ciencia e Innovacion, Spain [BFU2008-02950-C03-01]; Comunidad de Madrid [CCG08-CSIC/SAL-3617]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060711, R01DK080000] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA(American Diabetes Association); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge support from the NIH Director's Pioneer Award (DP1OD006850), NIH grants DK080000, DK 060711 and ADA 7-08-MN-25 to T.L.H; the Ministerio de Ciencia e Innovacion, Spain (BFU2008-02950-C03-01) and from Comunidad de Madrid (CCG08-CSIC/SAL-3617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Conti B, 2005, J NEUROCHEM, V93, P493, DOI 10.1111/j.1471-4159.2005.03052.x; Deierborg T, 2008, J CEREBR BLOOD F MET, V28, P1186, DOI 10.1038/jcbfm.2008.8; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Dietrich MO, 2008, J NEUROSCI, V28, P10766, DOI 10.1523/JNEUROSCI.2744-08.2008; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Herrera E, 2000, DIABETES-METAB RES, V16, P202, DOI 10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.3.CO;2-R; Horvath B, 2002, BIOCHEM PHARMACOL, V64, P369, DOI 10.1016/S0006-2952(02)01167-X; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Simon-Areces J, 2010, J COMP NEUROL, V518, P1814, DOI 10.1002/cne.22304; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Tsai SY, 2009, P NATL ACAD SCI USA, V106, P22468, DOI 10.1073/pnas.0909089106; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010	20	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42911	10.1371/journal.pone.0042911	http://dx.doi.org/10.1371/journal.pone.0042911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905184	gold, Green Submitted, Green Published			2022-12-27	WOS:000307331100074
J	Swift, DL; Johannsen, NM; Myers, VH; Earnest, CP; Smits, JAJ; Blair, SN; Church, TS				Swift, Damon L.; Johannsen, Neil M.; Myers, Valerie H.; Earnest, Conrad P.; Smits, Jasper A. J.; Blair, Steven N.; Church, Timothy S.			The Effect of Exercise Training Modality on Serum Brain Derived Neurotrophic Factor Levels in Individuals with Type 2 Diabetes	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; CARDIORESPIRATORY FITNESS; AEROBIC EXERCISE; GROWTH-FACTOR; RISK-FACTORS; FACTOR BDNF; RESISTANCE; MEN; MELLITUS; DISEASE	Introduction: Brain derived neurotrophic factor (BDNF) has been implicated in memory, learning, and neurodegenerative diseases. However, the relationship of BDNF with cardiometabolic risk factors is unclear, and the effect of exercise training on BDNF has not been previously explored in individuals with type 2 diabetes. Methods: Men and women (N = 150) with type 2 diabetes were randomized to an aerobic exercise (aerobic), resistance exercise (resistance), or a combination of both (combination) for 9 months. Serum BDNF levels were evaluated at baseline and follow-up from archived blood samples. Results: Baseline serum BDNF was not associated with fitness, body composition, anthropometry, glucose control, or strength measures (all, p>0.05). Similarly, no significant change in serum BDNF levels was observed following exercise training in the aerobic (-1649.4 pg/ml, CI: -4768.9 to 1470.2), resistance (-2351.2 pg/ml, CI: -5290.7 to 588.3), or combination groups (-827.4 pg/ml, CI: -3533.3 to 1878.5) compared to the control group (-2320.0 pg/ml, CI: -5750.8 to 1110.8). However, reductions in waist circumference were directly associated with changes in serum BDNF following training (r = 0.25, p = 0.005). Conclusions: Serum BDNF was not associated with fitness, body composition, anthropometry, glucose control, or strength measures at baseline. Likewise, serum BDNF measures were not altered by 9 months of aerobic, resistance, or combination training. However, reductions in waist circumference were associated with decreased serum BDNF levels. Future studies should investigate the relevance of BDNF with measures of cognitive function specifically in individuals with type-2 diabetes.	[Swift, Damon L.; Johannsen, Neil M.; Church, Timothy S.] Pennington Biomed Res Ctr, Dept Prevent Med, Baton Rouge, LA USA; [Myers, Valerie H.] Pennington Biomed Res Ctr, Behav Med Lab, Baton Rouge, LA USA; [Earnest, Conrad P.] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Smits, Jasper A. J.] So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA; [Blair, Steven N.] Univ S Carolina, Dept Exercise Sci, Columbia, SC 29208 USA; [Blair, Steven N.] Univ S Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Bath; Southern Methodist University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Swift, DL (corresponding author), Pennington Biomed Res Ctr, Dept Prevent Med, Baton Rouge, LA USA.	Damon.Swift@pbrc.edu	Earnest, Conrad P./M-6849-2017; Smits, Jasper AJ/A-4350-2008	Earnest, Conrad P./0000-0002-6546-1268; Smits, Jasper AJ/0000-0001-7128-9807; Smits, Jasper/0000-0003-1633-9693	NIH (NIDDK) [R01 DK068298]; Coca Cola; NIH [T32 DK 64584-9]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK064584, R01DK068298] Funding Source: NIH RePORTER	NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Coca Cola; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH (NIDDK) R01 DK068298, Clinical Trials.gov #: NCT00458133 (http://www2.niddk.nih.gov/). Serum brain derived neurotrophic factor measurements were paid for using unrestricted funding from Coca Cola. The salary and training of Dr. Damon Swift was supported through an NIH T-32 postdoctoral fellowship (T32 DK 64584-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arentoft A, 2009, BRAIN COGNITION, V71, P147, DOI 10.1016/j.bandc.2009.04.009; Castellano V, 2008, J NEUROL SCI, V269, P85, DOI 10.1016/j.jns.2007.12.030; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Currie J, 2009, NEUROSCI LETT, V451, P152, DOI 10.1016/j.neulet.2008.12.043; Erickson KI, 2011, P NATL ACAD SCI; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Fujinami A, 2008, CLIN BIOCHEM, V41, P812, DOI 10.1016/j.clinbiochem.2008.03.003; Goekint M, 2008, MED SCI SPORT EXER, V40, P1990, DOI 10.1249/MSS.0b013e31817eee85; Goekint M, 2010, NEUROSCI LETT, V486, P146, DOI 10.1016/j.neulet.2010.09.032; Gold SM, 2003, J NEUROIMMUNOL, V138, P99, DOI 10.1016/S0165-5728(03)00121-8; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Jung SH, 2011, EUR J APPL PHYSIOL, V111, P303, DOI 10.1007/s00421-010-1658-5; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Karczewska-Kupczewska M, 2011, CLIN BIOCHEM, V44, P817, DOI 10.1016/j.clinbiochem.2011.05.008; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Krabbe KS, 2009, J AM GERIATR SOC, V57, P1447, DOI 10.1111/j.1532-5415.2009.02345.x; Lee BH, 2007, J AFFECT DISORDERS, V101, P239, DOI 10.1016/j.jad.2006.11.005; Levinger I, 2008, MED SCI SPORT EXER, V40, P535, DOI [10.1249/MSS.0b013e31815dd057, 10.1249/mss.0b013e31815dd057]; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nofuji Y, 2008, NEUROSCI LETT, V437, P29, DOI 10.1016/j.neulet.2008.03.057; Schiffer T, 2009, HORM METAB RES, V41, P250, DOI 10.1055/s-0028-1093322; Schulz KH, 2004, J NEUROL SCI, V225, P11, DOI 10.1016/j.jns.2004.06.009; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Strohle A, 2010, PSYCHONEUROENDOCRINO, V35, P364, DOI 10.1016/j.psyneuen.2009.07.013; Suwa M, 2006, METABOLISM, V55, P852, DOI 10.1016/j.metabol.2006.02.012; Zoladz JA, 2008, J PHYSIOL PHARMACOL, V59, P119	30	35	35	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42785	10.1371/journal.pone.0042785	http://dx.doi.org/10.1371/journal.pone.0042785			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880108	Green Published, gold, Green Submitted			2022-12-27	WOS:000307810000070
J	Saito, T; Okada, S; Nohara, A; Tagaya, Y; Osaki, A; Oh-i, S; Takahashi, H; Tsuchiya, T; Hashimoto, K; Satoh, T; Yamada, M; Pessin, JE; Mori, M				Saito, Tsugumichi; Okada, Shuichi; Nohara, Atsushi; Tagaya, Yuko; Osaki, Aya; Oh-i, Shinsuke; Takahashi, Hiroki; Tsuchiya, Takafumi; Hashimoto, Koshi; Satoh, Tetsurou; Yamada, Masanobu; Pessin, Jeffrey E.; Mori, Masatomo			Syntaxin4 Interacting Protein (Synip) Binds Phosphatidylinositol (3,4,5) Triphosphate	PLOS ONE			English	Article							STIMULATED GLUCOSE-TRANSPORT; WW DOMAIN; KINASE-C; GLUT4-CONTAINING VESICLES; INSULIN ACTION; ADIPOCYTES; GLUT4; COMPARTMENTALIZATION; PHOSPHOSERINE; MECHANISM	The insulin responsive Glut4 transport vesicles contain the v-SNARE protein Vamp2 that associate with the plasma membrane t-SNARE protein Syntaxin 4 to drive insulin-stimulated Glut4 translocation in skeletal muscle and adipocytes. The syntaxin 4 interacting protein (Synip) binds to syntaxin 4 in the basal state and dissociates in the insulin-stimulated state allowing for the subsequent binding of Vamp2 containing Glut4 vesicles and fusion with the plasma membrane. In this study, we have found that Synip binds phosphatidylinositol 3,4,5-triphosphate (PIP3), but not phosphatidylinositol 3 phosphate (PIP) or phosphatidylinositol 3,4-biphosphate (PIP2) through the Synip WW domain as deletion of this domain (Synip Delta WW) failed to bind PIP3. Over-expressed Synip Delta WW in 3T3L1 adipocytes reduced the basal levels of Glut4 at the plasma membrane with no effect on the binding to syntaxin 4 in vitro. Subcellular fractionation demonstrated that the amount of Synip Delta WW at the PM was decreased in response to insulin in 3T3L1 adipocytes whereas the amount of Synip WT increased. These data suggest that in the presence of insulin, the dissociated Synip remains anchored to the plasma membrane by binding to PIP3.	[Saito, Tsugumichi; Okada, Shuichi; Nohara, Atsushi; Tagaya, Yuko; Osaki, Aya; Oh-i, Shinsuke; Takahashi, Hiroki; Tsuchiya, Takafumi; Hashimoto, Koshi; Satoh, Tetsurou; Yamada, Masanobu; Mori, Masatomo] Gunma Univ, Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med & Mol Pharmacol, Bronx, NY 10467 USA	Gunma University; Yeshiva University; Albert Einstein College of Medicine	Saito, T (corresponding author), Gunma Univ, Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan.	tsaito@med.gunma-u.ac.jp	Hashimoto, Koshi/AAL-7339-2020	Hashimoto, Koshi/0000-0002-3530-689X	National Institutes of Health [DK082694, DK020541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK082694, P30DK020541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants DK082694 and DK020541. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; FARESE RV, 1984, DIABETES, V33, P648, DOI 10.2337/diabetes.33.7.648; Farese RV, 2005, EXP BIOL MED, V230, P593; He J, 2008, J LIPID RES, V49, P1807, DOI 10.1194/jlr.M800150-JLR200; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; KANDROR KV, 1995, J CELL BIOL, V129, P999, DOI 10.1083/jcb.129.4.999; Lauritzen HPMM, 2008, DIABETES, V57, P13, DOI 10.2337/db07-0516; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Manna P, 2011, J BIOL CHEM, V286, P39848, DOI 10.1074/jbc.M111.270884; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Okada Shuichi, 2003, Methods Mol Med, V83, P93; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; SANDRA A, 1982, HORM METAB RES, V14, P638, DOI 10.1055/s-2007-1019106; SANDRA A, 1985, ENDOCR RES, V11, P95, DOI 10.3109/07435808509035428; Shisheva A, 2008, AM J PHYSIOL-ENDOC M, V295, pE536, DOI 10.1152/ajpendo.90353.2008; Siddle Kenneth, 1992, Progress in Growth Factor Research, V4, P301, DOI 10.1016/0955-2235(92)90013-8; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; WATERS SB, 1995, MOL CELL BIOL, V15, P2791; Watson RT, 2001, EXP CELL RES, V271, P75, DOI 10.1006/excr.2001.5375; WHITE MF, 1994, J BIOL CHEM, V269, P1; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182	25	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42782	10.1371/journal.pone.0042782	http://dx.doi.org/10.1371/journal.pone.0042782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880106	gold, Green Submitted, Green Published			2022-12-27	WOS:000307284100170
J	Vega, CG; Bok, M; Vlasova, AN; Chattha, KS; Fernandez, FM; Wigdorovitz, A; Parreno, VG; Saif, LJ				Vega, Celina G.; Bok, Marina; Vlasova, Anastasia N.; Chattha, Kuldeep S.; Fernandez, Fernando M.; Wigdorovitz, Andres; Parreno, Viviana G.; Saif, Linda J.			IgY Antibodies Protect against Human Rotavirus Induced Diarrhea in the Neonatal Gnotobiotic Piglet Disease Model	PLOS ONE			English	Article							EGG-YOLK IMMUNOGLOBULIN; SECRETING CELL RESPONSES; VIRUS-LIKE PARTICLES; WA HUMAN ROTAVIRUS; IMMUNE-RESPONSES; BOVINE ROTAVIRUS; MATERNAL ANTIBODIES; NASAL IMMUNIZATION; CLINICAL-TRIAL; NEWBORN CALVES	Group A Rotaviruses are the most common cause of severe, dehydrating diarrhea in children worldwide. The aim of the present work was to evaluate protection against rotavirus (RV) diarrhea conferred by the prophylactic administration of specific IgY antibodies (Ab) to gnotobiotic piglets experimentally inoculated with virulent Wa G1P[8] human rotavirus (HRV). Chicken egg yolk IgY Ab generated from Wa HRV hyperimmunized hens specifically recognized (ELISA) and neutralized Wa HRV in vitro. Supplementation of the RV Ab free cow milk diet with Wa HRV-specific egg yolk IgY Ab at a final ELISA Ab titer of 4096 (virus neutralization -VN- titer = 256) for 9 days conferred full protection against Wa HRV associated diarrhea and significantly reduced virus shedding. This protection was dose-dependent. The oral administration of semi-purified passive IgY Abs from chickens did not affect the isotype profile of the pig Ab secreting cell (ASC) responses to Wa HRV infection, but it was associated with significantly fewer numbers of HRV-specific IgA ASC in the duodenum. We further analyzed the pigs immune responses to the passive IgY treatment. The oral administration of IgY Abs induced IgG Ab responses to chicken IgY in serum and local IgA and IgG Ab responses to IgY in the intestinal contents of neonatal piglets in a dose dependent manner. To our knowledge, this is the first study to show that IgY Abs administered orally as a milk supplement passively protect neonatal pigs against an enteric viral pathogen (HRV). Piglets are an animal model with a gastrointestinal physiology and an immune system that closely mimic human infants. This strategy can be scaled-up to inexpensively produce large amounts of polyclonal IgY Abs from egg yolks to be applied as a preventive and therapeutic passive Ab treatment to control RV diarrhea.	[Vega, Celina G.; Bok, Marina; Fernandez, Fernando M.; Wigdorovitz, Andres; Parreno, Viviana G.] CICV & A INTA Castelar, Inst Virol, Buenos Aires, DF, Argentina; [Vlasova, Anastasia N.; Chattha, Kuldeep S.; Saif, Linda J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA	Instituto Nacional de Tecnologia Agropecuaria (INTA); University System of Ohio; Ohio State University	Vega, CG (corresponding author), CICV & A INTA Castelar, Inst Virol, Buenos Aires, DF, Argentina.	vparreno@cnia.inta.gov.ar; saif.2@osu.edu	Saif, Linda/E-4005-2011; Vlasova, Anastasia N/C-2062-2016	Vlasova, Anastasia N/0000-0002-1447-6283; parreno, viviana/0000-0003-0385-5592; Vega, Celina/0000-0002-0644-7263; Bok, Marina/0000-0003-4309-8629	International Research Collaboration - Basic Biomedical-Fogarty International Research Collaboration - Basic Biomedical (FIRCA-BB) [R03]; Fogarty Foundation; National Institutes of Health, USA; FIRCA [60014561]	International Research Collaboration - Basic Biomedical-Fogarty International Research Collaboration - Basic Biomedical (FIRCA-BB); Fogarty Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FIRCA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by an International Research Collaboration - Basic Biomedical-Fogarty International Research Collaboration - Basic Biomedical (FIRCA-BB) (R03); the Fogarty Foundation, National Institutes of Health, USA; and FIRCA grant no. 60014561, PI to LJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita EM, 1999, FOOD AGR IMMUNOL, V11, P191, DOI 10.1080/09540109999861; Anderson EJ, 2010, EXPERT REV ANTI-INFE, V8, P205, DOI [10.1586/eri.10.1, 10.1586/ERI.10.1]; BERNHISELBROADBENT J, 1991, PEDIATRICS, V87, P208; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Carlander D, 1999, UPSALA J MED SCI, V104, P179, DOI 10.3109/03009739909178961; Cornaglia E, 1989, REV LATINOAM MICROBI, P59; Coste A, 2000, J VIROL, V74, P8966, DOI 10.1128/JVI.74.19.8966-8971.2000; Coste A, 2001, VACCINE, V19, P4167, DOI 10.1016/S0264-410X(01)00164-5; Dean KL, 2000, ALTERNATIVE COMPLEME, P118; Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07; Desselberger U, 2011, J INFECT DIS, V203, P188, DOI 10.1093/infdis/jiq031; Dhama K, 2009, VET RES COMMUN, V33, P1, DOI 10.1007/s11259-008-9070-x; El-Merhibi A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/396232; Estes M. K., 2001, FIELDS VIROLOGY; Fernandez FM, 1998, VACCINE, V16, P507, DOI 10.1016/S0264-410X(97)80004-7; Fleming FE, 2007, ARCH VIROL, V152, P1087, DOI 10.1007/s00705-007-0937-x; Franco MA, 2006, VACCINE, V24, P2718, DOI 10.1016/j.vaccine.2005.12.048; Franco MA, 2000, TRENDS MICROBIOL, V8, P50, DOI 10.1016/S0966-842X(99)01682-0; Gonzalez AM, 2010, IMMUNOLOGY, V131, P242, DOI 10.1111/j.1365-2567.2010.03298.x; HATTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1077, DOI 10.1271/bbb.57.1077; Helm RM, 2002, J ALLERGY CLIN IMMUN, V109, P136, DOI 10.1067/mai.2002.120551; Hodgins DC, 1999, J VIROL, V73, P186, DOI 10.1128/JVI.73.1.186-197.1999; Inagaki M, 2010, BIOSCI BIOTECH BIOCH, V74, P680, DOI 10.1271/bbb.90862; Iosef C, 2002, VACCINE, V20, P1741, DOI 10.1016/S0264-410X(02)00031-2; Jacoby H. I., 2001, Journal of Nutraceuticals, Functional & Medical Foods, V3, P47, DOI 10.1300/J133v03n02_05; Jensen AR, 2001, J NUTR, V131, P3259, DOI 10.1093/jn/131.12.3259; Kirkwood CD, 2010, J INFECT DIS, V202, pS43, DOI 10.1086/653548; Littell RC, 1998, J ANIM SCI, V76, P1216; LOSONSKY GA, 1986, J CLIN MICROBIOL, V24, P1041, DOI 10.1128/JCM.24.6.1041-1044.1986; MEYER RC, 1964, APPL MICROBIOL, V12, P295, DOI 10.1128/AEM.12.4.295-300.1964; Mine Yoshinori, 2002, Journal of Medicinal Food, V5, P159, DOI 10.1089/10966200260398198; Mrukowicz J, 2008, J PEDIATR GASTR NUTR, V46, pS32, DOI 10.1097/MPG.0b013e31816f79b0; Mulder IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028279; Munos MK, 2010, INT J EPIDEMIOL, V39, P56, DOI 10.1093/ije/dyq022; Nelson R, 2007, FOOD AGR IMMUNOL, V18, P1, DOI 10.1080/09540100601178623; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parreno V, 2010, VET IMMUNOL IMMUNOP, V136, P12, DOI 10.1016/j.vetimm.2010.01.003; Parreno V, 1999, J GEN VIROL, V80, P1417, DOI 10.1099/0022-1317-80-6-1417; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Patel NC, 2010, NEW ENGL J MED, V362, P314, DOI 10.1056/NEJMoa0904485; Rahman S, 2012, VACCINE, V30, P4661, DOI 10.1016/j.vaccine.2012.04.091; REDMOND MJ, 1993, VACCINE, V11, P273, DOI 10.1016/0264-410X(93)90029-W; Saif L, 1997, ADV EXP MED BIOL, V412, P397; Saif LJ, 1996, ARCH VIROL, P153; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Santosham M, 2010, LANCET, V376, P63, DOI 10.1016/S0140-6736(10)60356-X; Sarker SA, 2001, J PEDIATR GASTR NUTR, V32, P19, DOI 10.1097/00005176-200101000-00009; Sarker SA, 2007, J HEALTH POPUL NUTR, V25, P465; Schade K, 2005, ATLA-ALTERN LAB ANIM, V33, P129, DOI 10.1177/026119290503300208; SCHADE R, 1996, ALTEX, V13, P80; SCHADE R, 1996, ALTEX S, V13, P5; Schade Rudiger, 1994, ALTEX, V11, P75; Sesarman A, 2008, BRIT J DERMATOL, V158, P463, DOI 10.1111/j.1365-2133.2007.08388.x; Stupka JA, 2009, INFECT GENET EVOL, V9, P1225, DOI 10.1016/j.meegid.2009.07.002; Tini M, 2002, COMP BIOCHEM PHYS A, V131, P569, DOI 10.1016/S1095-6433(01)00508-6; Torche AM, 2006, VET IMMUNOL IMMUNOP, V109, P209, DOI 10.1016/j.vetimm.2005.08.016; TOSSER G, 1994, VIROLOGY, V204, P8, DOI 10.1006/viro.1994.1505; Vega C, 2011, VET IMMUNOL IMMUNOP, V142, P156, DOI 10.1016/j.vetimm.2011.05.003; Westfall PH, 1999, MULTIPLE COMP MULTIP; Wolfinger R., 1998, COMP SAS GLM MIXED P; Xu YP, 2006, CELL MOL IMMUNOL, V3, P67; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996; Yuan LJ, 2002, VET IMMUNOL IMMUNOP, V87, P147, DOI 10.1016/S0165-2427(02)00046-6	63	45	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42788	10.1371/journal.pone.0042788	http://dx.doi.org/10.1371/journal.pone.0042788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880110	Green Published, gold, Green Submitted			2022-12-27	WOS:000307284100173
J	Burke, DP; Kelly, DJ				Burke, Darren Paul; Kelly, Daniel John			Substrate Stiffness and Oxygen as Regulators of Stem Cell Differentiation during Skeletal Tissue Regeneration: A Mechanobiological Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MECHANO-REGULATION MODEL; BONE REGENERATION; DISTRACTION OSTEOGENESIS; BIOPHYSICAL STIMULI; GAP SIZE; IN-VIVO; CARTILAGE; TENSION; ANGIOGENESIS	Extrinsic mechanical signals have been implicated as key regulators of mesenchymal stem cell (MSC) differentiation. It has been possible to test different hypotheses for mechano-regulated MSC differentiation by attempting to simulate regenerative events such as bone fracture repair, where repeatable spatial and temporal patterns of tissue differentiation occur. More recently, in vitro studies have identified other environmental cues such as substrate stiffness and oxygen tension as key regulators of MSC differentiation; however it remains unclear if and how such cues determine stem cell fate in vivo. As part of this study, a computational model was developed to test the hypothesis that substrate stiffness and oxygen tension regulate stem cell differentiation during fracture healing. Rather than assuming mechanical signals act directly on stem cells to determine their differentiation pathway, it is postulated that they act indirectly to regulate angiogenesis and hence partially determine the local oxygen environment within a regenerating tissue. Chondrogenesis of MSCs was hypothesized to occur in low oxygen regions, while in well vascularised regions of the regenerating tissue a soft local substrate was hypothesised to facilitate adipogenesis while a stiff substrate facilitated osteogenesis. Predictions from the model were compared to both experimental data and to predictions of a well established computational mechanobiological model where tissue differentiation is assumed to be regulated directly by the local mechanical environment. The model predicted all the major events of fracture repair, including cartilaginous bridging, endosteal and periosteal bony bridging and bone remodelling. It therefore provides support for the hypothesis that substrate stiffness and oxygen play a key role in regulating MSC fate during regenerative events such as fracture healing.	[Burke, Darren Paul; Kelly, Daniel John] Trinity Coll Dublin, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin, Ireland; [Burke, Darren Paul; Kelly, Daniel John] Trinity Coll Dublin, Dept Mech & Mfg Engn, Sch Engn, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Burke, DP (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin, Ireland.	kellyd9@tcd.ie		Kelly, Daniel/0000-0003-4091-0992	Science Foundation Ireland [08/Y15/B1336]; Trinity College Dublin Research Studentship Award	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Trinity College Dublin Research Studentship Award	This study was funded by Science Foundation Ireland under the President of Ireland Young Researcher Award (08/Y15/B1336) and through a Trinity College Dublin Research Studentship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013; Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372; Bian LM, 2012, TISSUE ENG PT A, V18, P715, DOI [10.1089/ten.tea.2011.0455, 10.1089/ten.TEA.2011.0455]; Boccaccio A, 2008, MED BIOL ENG COMPUT, V46, P283, DOI 10.1007/s11517-007-0247-1; Boccaccio A, 2007, ANN BIOMED ENG, V35, P1940, DOI 10.1007/s10439-007-9367-x; Boccaccio A, 2011, J ORTHOP RES, V29, P433, DOI 10.1002/jor.21231; Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108; BRUETON RN, 1990, CLIN ORTHOP RELAT R, P286; Buckley CT, 2010, OSTEOARTHR CARTILAGE, V18, P1345, DOI 10.1016/j.joca.2010.07.004; Byrne DP, 2011, J ORTHOP RES; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; CARTER DR, 1988, J ORTHOP RES, V6, P736, DOI 10.1002/jor.1100060517; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9; Chen G, 2009, J BIOMECH, V42, P2575, DOI 10.1016/j.jbiomech.2009.07.010; Claes L, 2002, J ORTHOP RES, V20, P1099, DOI 10.1016/S0736-0266(02)00044-X; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Cowin SC, 1999, J BIOMECH, V32, P217, DOI 10.1016/S0021-9290(98)00161-4; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Epari DR, 2008, BONE, V43, P734, DOI 10.1016/j.bone.2008.06.007; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; Garcia P, 2012, J BONE JOINT SURG AM, V94A, P49, DOI 10.2106/JBJS.J.00795; Garcia-Aznar JM, 2007, J BIOMECH, V40, P1467, DOI 10.1016/j.jbiomech.2006.06.013; Geris L, 2008, J THEOR BIOL, V251, P137, DOI 10.1016/j.jtbi.2007.11.008; Geris L, 2010, TISSUE ENG PT A, V16, P3353, DOI [10.1089/ten.tea.2010.0130, 10.1089/ten.TEA.2010.0130]; Geris L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000915; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gomez-Benito MJ, 2005, J THEOR BIOL, V235, P105, DOI 10.1016/j.jtbi.2004.12.023; Gomillion CT, 2006, BIOMATERIALS, V27, P6052, DOI 10.1016/j.biomaterials.2006.07.033; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Hayward LN, 2009, BIOMECH MODEL MECHAN; HERSHEY D, 1968, AICHE J, V14, P969, DOI 10.1002/aic.690140628; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11; HORI RY, 1982, J BIOMED MATER RES, V16, P911, DOI 10.1002/jbm.820160615; Isaksson H, 2007, J BIOMECH, V40, P2002, DOI 10.1016/j.jbiomech.2006.09.028; Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Kelly DJ, 2006, TISSUE ENG, V12, P2509, DOI 10.1089/ten.2006.12.2509; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Kelly DJ, 2005, J BIOMECH, V38, P1413, DOI 10.1016/j.jbiomech.2004.06.026; Khayyeri H, 2009, J ORTHOP RES, V27, P1659, DOI 10.1002/jor.20926; Krinner A, 2009, CELL PROLIFERAT, V42, P471, DOI 10.1111/j.1365-2184.2009.00621.x; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Lacroix D, 2002, MED BIOL ENG COMPUT, V40, P14, DOI 10.1007/BF02347690; Lacroix D, 2000, SIMULATION TISSUE DI; Lienau J, 2005, J ORTHOP RES, V23, P639, DOI 10.1016/j.orthres.2004.09.006; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; MENTE PL, 1994, J ORTHOP RES, V12, P637, DOI 10.1002/jor.1100120506; Merceron C, 2010, AM J PHYSIOL-CELL PH, V298, pC355, DOI 10.1152/ajpcell.00398.2009; Meyer EG, 2010, J BIOMECH, V43, P2516, DOI 10.1016/j.jbiomech.2010.05.020; Nagel T, 2010, BIOMECH MODEL MECHAN, V9, P359, DOI 10.1007/s10237-009-0182-1; OCHOA JA, 1992, T 38 ORS, P162; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Pattappa G, 2010, J CELL PHYSL; PAUWELS F, 1960, Z Anat Entwicklungsgesch, V121, P478, DOI 10.1007/BF00523401; Peiffer V, 2011, BIOMECH MODEL MECHAN, V10, P383, DOI 10.1007/s10237-010-0241-7; Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057; Prendergast PJ, 1997, CLIN BIOMECH, V12, P343, DOI 10.1016/S0268-0033(97)00018-1; Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6; ROACH HI, 1995, J CELL BIOL, V131, P483, DOI 10.1083/jcb.131.2.483; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; Savarino L, 2005, J BONE JOINT SURG BR, V87B, P571, DOI 10.1302/0301-620X.87B4.15316; SCHAFFLER MB, 1988, J BIOMECH, V21, P13, DOI 10.1016/0021-9290(88)90186-8; Sheehy EJ, 2012, BIOCHEM BIOPH RES CO, V417, P305, DOI 10.1016/j.bbrc.2011.11.105; Simon U, 2011, COMPUT METHOD BIOMEC, V14, P79, DOI 10.1080/10255842.2010.499865; Steward AJ, 2012, ACTA BIOMATER, V8, P2153, DOI 10.1016/j.actbio.2012.03.016; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Taylor DK, 2009, J BONE MINER RES, V24, P1043, DOI [10.1359/jbmr.090101, 10.1359/JBMR.090101]; Vetter A, 2011, BIOMECH MODEL MECHAN; Vetter A, 2010, J ORTHOP RES, V28, P1440, DOI 10.1002/jor.21175; Vinardell T, 2012, EUR CELLS MATER, V23, P121, DOI 10.22203/eCM.v023a09; Yin M, 2002, J BONE MINER RES, V17, P56, DOI 10.1359/jbmr.2002.17.1.56; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4	78	63	64	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40737	10.1371/journal.pone.0040737	http://dx.doi.org/10.1371/journal.pone.0040737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911707	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300012
J	Udekwu, KI; Levin, BR				Udekwu, Klas I.; Levin, Bruce R.			Staphylococcus aureus in Continuous Culture: A Tool for the Rational Design of Antibiotic Treatment Protocols	PLOS ONE			English	Article							BACTERIAL-CELL DENSITY; IN-VITRO; FUNCTIONAL-RELATIONSHIP; PHARMACODYNAMIC MODEL; ANTIMICROBIAL THERAPY; ESCHERICHIA-COLI; PERSISTER CELLS; GROWTH-RATE; PHARMACOKINETICS; RESISTANCE	In vitro measures of the pharmacodynamics of antibiotics that account for the factors anticipated for bacteria in infected patients are central to the rational design of antibiotic treatment protocols. We consider whether or not continuous culture devices are a way to obtain these measures. Staphylococcus aureus PS80 in high-density continuous cultures were exposed to oxacillin, ciprofloxacin, vancomycin, gentamicin, daptomycin and linezolid. Contrary to results from low density retentostats as well as to predictions of traditional PK/MIC ratios, daily dosing with up to 100x MIC did not clear these cultures. The densities of S. aureus in these cultures oscillated with constant amplitude and never fell below 10(5) CFU per ml. Save for daptomycin "treated" populations, the densities of bacteria in these cultures remained significantly below that of similar antibiotic-free cultures. Although these antibiotics varied in their pharmacodynamic properties there were only modest differences in their mean densities. Mathematical models and experiments suggest that the dominant factor preventing clearance was wall-adhering subpopulations reseeding the planktonic population which can be estimated and corrected for. Continuous cultures provide a way to evaluate the potential efficacy of antibiotic treatment regimes in vitro under conditions that are more clinically realistic and comprehensive than traditional in vitro PK/PD indices.	[Udekwu, Klas I.; Levin, Bruce R.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Udekwu, KI (corresponding author), Swedish Med Nanosci Ctr, Dept Neurosci, Stockholm, Sweden.	klas.udekwu@ki.se	Udekwu, Klas/I-4764-2012		United States National Institutes of Health [GM091875]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091875] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the United States National Institutes of Health (GM091875 to BRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Ambrose PG, 2007, CLIN INFECT DIS, V44, P79, DOI 10.1086/510079; Amsterdam D., 2005, ANTIBIOTICS LAB MED, P61; Andes D, 2004, CLIN LAB MED, V24, P477, DOI 10.1016/j.cll.2004.03.009; Andes D, 2009, ANTIMICROB AGENTS CH, V53, P3003, DOI 10.1128/AAC.01584-08; ANDREW JH, 1987, J ANTIMICROB CHEMOTH, V20, P213, DOI 10.1093/jac/20.2.213; ANWAR H, 1992, CAN J MICROBIOL, V38, P618, DOI 10.1139/m92-102; ANWAR H, 1989, J ANTIMICROB CHEMOTH, V24, P647, DOI 10.1093/jac/24.5.647; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Baudoux P, 2007, J ANTIMICROB CHEMOTH, V59, P246, DOI 10.1093/jac/dkl489; Bigger J, 1944, LANCET, P2497; BILELLO JA, 1994, ANTIMICROB AGENTS CH, V38, P1386, DOI 10.1128/AAC.38.6.1386; Bonapace CR, 2002, ANTIMICROB AGENTS CH, V46, P3574, DOI 10.1128/AAC.46.11.3574-3579.2002; BROWN MRW, 1990, ANTIMICROB AGENTS CH, V34, P1623, DOI 10.1128/AAC.34.9.1623; Craig WA, 1996, PEDIATR INFECT DIS J, V15, P255, DOI 10.1097/00006454-199603000-00015; CRAIG WA, 1993, J ANTIMICROB CHEMOTH, V31, P149, DOI 10.1093/jac/31.suppl_D.149; DAVEY PG, 1987, J ANTIMICROB CHEMOTH, V20, P639, DOI 10.1093/jac/20.5.639; Drusano GL, 2007, CLIN INFECT DIS, V45, pS89, DOI 10.1086/518137; EUCAST, 2000, CLIN MICROBIOL INFEC, V6, P570; FORREST A, 1993, ANTIMICROB AGENTS CH, V37, P1073, DOI 10.1128/AAC.37.5.1073; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; GILBERT P, 1989, APPL ENVIRON MICROB, V55, P1308, DOI 10.1128/AEM.55.5.1308-1311.1989; Gillespie Effie L, 2005, Expert Opin Drug Metab Toxicol, V1, P351, DOI 10.1517/17425255.1.3.351; Institute CaLS, 2005, PERF STAND ANT SUS S; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Leuthner KD, 2006, J ANTIMICROB CHEMOTH, V58, P338, DOI 10.1093/jac/dkl235; Levin BR, 2010, ANTIMICROB AGENTS CH, V54, P3414, DOI 10.1128/AAC.00381-10; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Louie A, 1998, ANTIMICROB AGENTS CH, V42, P1105, DOI 10.1128/AAC.42.5.1105; Lowdin E, 1998, ANTIMICROB AGENTS CH, V42, P2739, DOI 10.1128/AAC.42.10.2739; MACKENZIE FM, 1993, J ANTIMICROB CHEMOTH, V32, P519, DOI 10.1093/jac/32.4.519; Mouton JW, 2002, INT J ANTIMICROB AG, V19, P323, DOI 10.1016/S0924-8579(02)00028-6; Mouton JW, 2001, J ANTIMICROB CHEMOTH, V47, P500, DOI 10.1093/jac/47.4.500; Odenholt I, 2003, CLIN MICROBIOL INFEC, V9, P930, DOI 10.1046/j.1469-0691.2003.00692.x; Odenholt I, 2000, J ANTIMICROB CHEMOTH, V46, P35, DOI 10.1093/jac/46.1.35; Odenholt I, 2007, ANTIMICROB AGENTS CH, V51, P3311, DOI 10.1128/AAC.01470-06; Patel R, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000175714.68624.74; Rang C, 2001, CAN J MICROBIOL, V47, P86, DOI 10.1139/cjm-47-1-86; Regoes RR, 2004, ANTIMICROB AGENTS CH, V48, P3670, DOI 10.1128/AAC.48.10.3670-3676.2004; Safdar N, 2004, ANTIMICROB AGENTS CH, V48, P63, DOI 10.1128/AAC.48.1.63-68.2004; Sakoulas G, 2009, CLIN THER, V31, P1936, DOI 10.1016/j.clinthera.2009.09.012; Sillankorva S, 2008, J APPL MICROBIOL, V105, P196, DOI 10.1111/j.1365-2672.2008.03743.x; Skiest DJ, 2006, J CLIN MICROBIOL, V44, P655, DOI 10.1128/JCM.44.2.655-656.2006; SORIANO F, 1990, J ANTIMICROB CHEMOTH, V25, P621, DOI 10.1093/jac/25.4.621; Soriano F, 2009, J ANTIMICROB CHEMOTH, V63, P1301, DOI 10.1093/jac/dkp112; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; Udekwu KI, 2009, J ANTIMICROB CHEMOTH, V63, P745, DOI 10.1093/jac/dkn554; Wiuff C, 2005, ANTIMICROB AGENTS CH, V49, P1483, DOI 10.1128/AAC.49.4.1483-1494.2005	53	8	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e38866	10.1371/journal.pone.0038866	http://dx.doi.org/10.1371/journal.pone.0038866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911681	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600004
J	Zheng, WY; Zhang, WY; Hu, W; Zhang, C; Yang, Y				Zheng, Wenyun; Zhang, Wenyao; Hu, Wei; Zhang, Chao; Yang, Yi			Exploring the Smallest Active Fragment of HsQSOX1b and Finding a Highly Efficient Oxidative Engine	PLOS ONE			English	Article							QUIESCIN-SULFHYDRYL OXIDASE; EGG-WHITE; QSOX; THIOREDOXIN; PROTEINS; SHUTTLE	Human quiescin-sulfhydryl oxidase 1 isoform b (HsQSOX1b) is a highly efficient, multiple-domain enzyme that directly inserts disulfide bonds into client protein. However, previous studies have focused mainly on the catalytic activity of the whole protein rather than its domain structure. In this research, we dissected the structure and function of HsQSOX1b and explored its mechanism as a highly efficient sulfhydryl oxidase by analyzing the truncated variants. The results showed that the first HsQSOX1b thioredoxin domain was essential for thiol oxidase activity. The smallest active fragment (SAQ) was identified to consist of a helix-rich region (HRR) and an essential for respiration and viability/augmenter of liver regeneration (ERV/ALR) domain, which remained highly active to oxidize an artificial non-thiol substrate but not small molecular and protein thiols. Our study clearly demonstrated that SAQ is a highly efficient oxidative engine, which shows high efficiency in the de novo disulfide formation and oxygen reduction and that this more efficient oxidative engine is necessary for the highly efficient catalysis of QSOXs compared to Erv1 and Erv2. This study will help address the roles of different HsQSOX1b domains in de novo disulfide formation and encourage the engineering of more efficient QSOX variants for the in vitro folding of disulfide-containing proteins.	[Zheng, Wenyun; Zhang, Wenyao; Hu, Wei; Zhang, Chao; Yang, Yi] E China Univ Sci & Technol, Sch Pharm, State Key Lab Bioreactor Engn, Synthet Biol & Biotechnol Lab, Shanghai 200237, Peoples R China	East China University of Science & Technology	Zheng, WY (corresponding author), E China Univ Sci & Technol, Sch Pharm, State Key Lab Bioreactor Engn, Synthet Biol & Biotechnol Lab, Shanghai 200237, Peoples R China.	yiyang@ecust.edu.cn	Yang, Yi/C-1297-2013	Yang, Yi/0000-0001-7896-1184	863 Program [2006AA02Z160]; NSFC (National Nature Science Foundation of China) [90713026, 31071260, 31170815]; Fok Ying Tung Education Foundation [111022]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Dawn Program of Shanghai Education Commission [11SG31]; 111 Project [B07023]; Fundamental Research Funds for the Central Universities	863 Program(National High Technology Research and Development Program of China); NSFC (National Nature Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Dawn Program of Shanghai Education Commission; 111 Project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the 863 Program (Grant No. 2006AA02Z160), NSFC (National Nature Science Foundation of China) (Grant Nos. 90713026, 31071260 and 31170815), the Fok Ying Tung Education Foundation (Grant No. 111022), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Dawn Program of Shanghai Education Commission (Grant No. 11SG31), the 111 Project (Grant No. B07023), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon A, 2010, FEBS LETT, V584, P1521, DOI 10.1016/j.febslet.2010.03.001; Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605; Coppock DL, 2006, ANTIOXID REDOX SIGN, V8, P300, DOI 10.1089/ars.2006.8.300; Faccio G, 2011, APPL MICROBIOL BIOT, V91, P957, DOI 10.1007/s00253-011-3440-y; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Heckler EJ, 2008, BBA-MOL CELL RES, V1783, P567, DOI 10.1016/j.bbamcr.2007.10.002; Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q; Hoober KL, 1999, J BIOL CHEM, V274, P31759, DOI 10.1074/jbc.274.45.31759; Hoober KL, 1999, J BIOL CHEM, V274, P22147, DOI 10.1074/jbc.274.32.22147; Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510; Inaba K, 2010, GENES CELLS, V15, P935, DOI 10.1111/j.1365-2443.2010.01434.x; KIRLEY TL, 1989, ANAL BIOCHEM, V180, P231, DOI 10.1016/0003-2697(89)90422-3; Kodali VK, 2010, BIOCHEMISTRY-US, V49, P2075, DOI 10.1021/bi902222s; Mairet-Coello G, 2004, J COMP NEUROL, V473, P334, DOI 10.1002/cne.20126; Margittai E, 2011, TRAFFIC, V12, P1, DOI 10.1111/j.1600-0854.2010.01108.x; Morel C, 2007, EXP CELL RES, V313, P3971, DOI 10.1016/j.yexcr.2007.09.003; Raje S, 2002, ANAL BIOCHEM, V307, P266, DOI 10.1016/S0003-2697(02)00050-7; Sevier CS, 2012, ANTIOXID REDOX SIGN, V16, P800, DOI 10.1089/ars.2011.4450; Tury A, 2004, J ENDOCRINOL, V183, P353, DOI 10.1677/joe.1.05842; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zheng WY, 2011, J BIOCHEM, V149, P293, DOI 10.1093/jb/mvq143	22	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40935	10.1371/journal.pone.0040935	http://dx.doi.org/10.1371/journal.pone.0040935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911720	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600030
J	Hou, J; Riise, J; Pakkenberg, B				Hou, Jack; Riise, Jesper; Pakkenberg, Bente			Application of Immunohistochemistry in Stereology for Quantitative Assessment of Neural Cell Populations Illustrated in the Gottingen Minipig	PLOS ONE			English	Article							TOTAL NUMBER; GLIAL-CELLS; NEURONS; VALIDATION; ACTIVATION; GROWTH; LAYER; NEUN	Background: Stereology is the study of estimating geometric quantities. When successfully applied, the combination of immunohistochemistry (IHC) and stereology eliminates intra- and interobserver variability for cell type identification. Methodology/Principal Findings: We propose a method to validate existing antibody based cell type markers for stereological application. Comparison was made on the 100-days-old Gottingen minipig (G-mini) neocortex between estimates of total neuron number derived from Giemsa staining using morphological criteria and immunohistochemistry-based cell counting with NeuN. The mean total neuron numbers estimated by the two staining methods were not significantly different. Estimated quantities, including glial cell number, neocortical volume, cell densities and glial-to-neuron ratio were also presented. Additionally, we assessed other commonly used glial markers and discussed how to evaluate the advantages and disadvantages of these markers for stereological estimation of cell number. Conclusion/Significance: The concordance in quantitative estimates of total neuron number derived from NeuN- and Giemsa-stained sections provides evidence for the sensitivity and specificity of NeuN as a neuronal marker in the G-mini. Although time-consuming, quantitative validation of IHC should always be considered in stereological studies if there is doubt of the sensitivity, specificity, or reproducibility of cell type markers. Inaccurate staining may cause both over- and underestimation of the total cell number and inflict considerable limitation when analyzing the results.	[Hou, Jack; Riise, Jesper; Pakkenberg, Bente] Copenhagen Univ Hosp, Res Lab Stereol & Neurosci, Bispebjerg, Denmark	University of Copenhagen	Hou, J (corresponding author), Copenhagen Univ Hosp, Res Lab Stereol & Neurosci, Bispebjerg, Denmark.	forsklab@bbh.regionh.dk		pakkenberg, bente/0000-0003-3851-6494				Andersen K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.013; Bjarkam C R, 2008, Br J Neurosurg, V22 Suppl 1, pS9, DOI 10.1080/02688690802448285; Bjarkam CR, 2008, J NEUROSCI METH, V168, P151, DOI 10.1016/j.jneumeth.2007.09.008; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Boyce RW, 2010, TOXICOL PATHOL, V38, P1011, DOI 10.1177/0192623310385140; Chadi G, 2001, INT J NEUROSCI, V111, P137, DOI 10.3109/00207450108994227; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Fjord-Larsen L, 2010, MOL THER, V18, P2164, DOI 10.1038/mt.2010.154; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Hedreen JC, 1998, ANAT REC, V250, P366; Jelsing J, 2006, J EXP BIOL, V209, P1454, DOI 10.1242/jeb.02141; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Larsen CC, 2006, NEUROSCIENCE, V139, P999, DOI 10.1016/j.neuroscience.2006.01.005; Larsen M, 2004, ANAT EMBRYOL, V208, P239, DOI 10.1007/s00429-004-0395-0; Loesch A, 2010, CELL TISSUE RES, V341, P223, DOI 10.1007/s00441-010-1002-8; Lyck L, 2006, J NEUROSCI METH, V152, P229, DOI 10.1016/j.jneumeth.2005.09.009; Mack AF, 2004, INVEST OPHTH VIS SCI, V45, P3749, DOI 10.1167/iovs.04-0190; Melvin NR, 2010, J HISTOCHEM CYTOCHEM, V58, P577, DOI 10.1369/jhc.2009.954164; Miki Takanori, 2005, Anatomical Science International, V80, P153, DOI 10.1111/j.1447-073x.2005.00121.x; Mikkelsen M, 1999, NEUROTOXICOL TERATOL, V21, P169, DOI 10.1016/S0892-0362(98)00037-3; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Olaussen KA, 2010, CANCER RES, V70, P3851, DOI 10.1158/0008-5472.CAN-09-4352; Opriessnig T, 2010, J VET DIAGN INVEST, V22, P86, DOI 10.1177/104063871002200116; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Papageorgiou IE, 2011, GLIA, V59, P1706, DOI 10.1002/glia.21217; Pelvig DP, 2003, DEMENT GERIATR COGN, V16, P212, DOI 10.1159/000072805; Pilegaard K, 1996, ANAL QUANT CYTOL, V18, P279; Prasad K, 2010, EXP NEUROL, V225, P328, DOI 10.1016/j.expneurol.2010.07.004; Samuelsen GB, 2003, CEREB CORTEX, V13, P115, DOI 10.1093/cercor/13.2.115; Stewart W, 2003, NEUROSCIENCE, V119, P121, DOI 10.1016/S0306-4522(03)00116-7; West MJ, 2004, NEUROBIOL AGING, V25, P1205, DOI 10.1016/j.neurobiolaging.2003.12.005; West MJ, 2002, PROG BRAIN RES, V135, P43; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Widdows K, 2009, PLACENTA, V30, P735, DOI 10.1016/j.placenta.2009.05.007; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Zhang XM, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-26	39	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43556	10.1371/journal.pone.0043556	http://dx.doi.org/10.1371/journal.pone.0043556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905271	gold, Green Published, Green Submitted			2022-12-27	WOS:000307823600080
J	Celik, N; Webb, CT; Leyton, DL; Holt, KE; Heinz, E; Gorrell, R; Kwok, T; Naderer, T; Strugnell, RA; Speed, TP; Teasdale, RD; Likic, VA; Lithgow, T				Celik, Nermin; Webb, Chaille T.; Leyton, Denisse L.; Holt, Kathryn E.; Heinz, Eva; Gorrell, Rebecca; Kwok, Terry; Naderer, Thomas; Strugnell, Richard A.; Speed, Terence P.; Teasdale, Rohan D.; Likic, Vladimir A.; Lithgow, Trevor			A Bioinformatic Strategy for the Detection, Classification and Analysis of Bacterial Autotransporters	PLOS ONE			English	Article							PROTEIN SECRETION SYSTEMS; GRAM-NEGATIVE PATHOGENS; ESCHERICHIA-COLI; OUTER-MEMBRANE; SERINE-PROTEASE; CRYSTAL-STRUCTURE; PASSENGER DOMAIN; CITROBACTER-RODENTIUM; INTERACTIVE TREE; COMMON THEMES	Autotransporters are secreted proteins that are assembled into the outer membrane of bacterial cells. The passenger domains of autotransporters are crucial for bacterial pathogenesis, with some remaining attached to the bacterial surface while others are released by proteolysis. An enigma remains as to whether autotransporters should be considered a class of secretion system, or simply a class of substrate with peculiar requirements for their secretion. We sought to establish a sensitive search protocol that could identify and characterize diverse autotransporters from bacterial genome sequence data. The new sequence analysis pipeline identified more than 1500 autotransporter sequences from diverse bacteria, including numerous species of Chlamydiales and Fusobacteria as well as all classes of Proteobacteria. Interrogation of the proteins revealed that there are numerous classes of passenger domains beyond the known proteases, adhesins and esterases. In addition the barrel-domain-a characteristic feature of autotransporters-was found to be composed from seven conserved sequence segments that can be arranged in multiple ways in the tertiary structure of the assembled autotransporter. One of these conserved motifs overlays the targeting information required for autotransporters to reach the outer membrane. Another conserved and diagnostic motif maps to the linker region between the passenger domain and barrel-domain, indicating it as an important feature in the assembly of autotransporters.	[Celik, Nermin; Webb, Chaille T.; Leyton, Denisse L.; Heinz, Eva; Gorrell, Rebecca; Kwok, Terry; Naderer, Thomas; Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Leyton, Denisse L.; Gorrell, Rebecca; Kwok, Terry] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Holt, Kathryn E.; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Speed, Terence P.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; [Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Likic, Vladimir A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia	Monash University; Monash University; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Queensland; University of Melbourne	Celik, N (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	r.teasdale@uq.edu.au; vlikic@unimelb.edu.au; trevor.lithgow@monash.edu	Lithgow, Trevor J/H-5925-2017; Teasdale, Rohan D/B-2538-2009; Holt, Kathryn E/A-8108-2012; Leyton, Denisse L/A-6915-2015; Gorrell, Rebecca/H-5259-2019; Heinz, Eva/I-2053-2014; Gorrell, Rebecca/J-1454-2012; Teasdale, Rohan/AAD-6698-2019	Lithgow, Trevor J/0000-0002-0102-7884; Teasdale, Rohan D/0000-0001-7455-5269; Holt, Kathryn E/0000-0003-3949-2471; Leyton, Denisse L/0000-0003-4808-9289; Gorrell, Rebecca/0000-0003-0728-3325; Heinz, Eva/0000-0003-4413-3756; Teasdale, Rohan/0000-0001-7455-5269; Strugnell, Richard/0000-0003-0614-5641; Kwok, Terry/0000-0002-5905-3233; Webb, Chaille/0000-0003-0918-0282; Naderer, Thomas/0000-0003-2691-0283	National Health & Medical Research Council (NHMRC) [606788]; Australian Research Council (ARC) [FS110200015]	National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	The project was supported by National Health & Medical Research Council (NHMRC) Program Grant 606788 (to RAS, RT and TL) and Australian Research Council (ARC) Super-Science Fellowships Grant FS110200015 (to RAS and TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp LP, 2010, INFECT IMMUN, V78, P1659, DOI 10.1128/IAI.01010-09; Ashgar SSA, 2007, J BACTERIOL, V189, P1856, DOI 10.1128/JB.01427-06; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Barnard TJ, 2012, J MOL BIOL, V415, P128, DOI 10.1016/j.jmb.2011.10.049; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Bernstein HD, 2007, TRENDS MICROBIOL, V15, P441, DOI 10.1016/j.tim.2007.09.007; Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200; Blanke SR, 2005, TRENDS MICROBIOL, V13, P64, DOI 10.1016/j.tim.2004.12.007; Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb; Brandon LD, 2001, J BACTERIOL, V183, P951, DOI 10.1128/JB.183.3.951-958.2001; Coutte L, 2001, EMBO J, V20, P5040, DOI 10.1093/emboj/20.18.5040; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Dautin N, 2011, J BACTERIOL, V193, P3748, DOI 10.1128/JB.05070-11; deCock H, 1997, J MOL BIOL, V269, P473, DOI 10.1006/jmbi.1997.1069; Desvaux M, 2005, BBA-BIOMEMBRANES, V1713, P92, DOI 10.1016/j.bbamem.2005.05.002; Durand E., 2009, Infectious Disorders - Drug Targets, V9, P518; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FERNANDEZ RC, 1994, INFECT IMMUN, V62, P4727, DOI 10.1128/IAI.62.11.4727-4738.1994; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gangwer KA, 2007, P NATL ACAD SCI USA, V104, P16293, DOI 10.1073/pnas.0707447104; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hodak H, 2007, RES MICROBIOL, V158, P631, DOI 10.1016/j.resmic.2007.08.001; Holland IB, 2010, METHODS MOL BIOL, V619, P1, DOI 10.1007/978-1-60327-412-8_1; Hoopman TC, 2008, J BACTERIOL, V190, P1459, DOI 10.1128/JB.01688-07; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jain S, 2007, J BACTERIOL, V189, P5393, DOI 10.1128/JB.00228-07; Jansen C, 2000, EUR J BIOCHEM, V267, P3792, DOI 10.1046/j.1432-1327.2000.01417.x; Johnson TA, 2009, J MOL BIOL, V389, P559, DOI 10.1016/j.jmb.2009.04.041; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kajava AV, 2006, J STRUCT BIOL, V155, P306, DOI 10.1016/j.jsb.2006.01.015; Khan S, 2011, J MOL BIOL, V413, P985, DOI 10.1016/j.jmb.2011.09.028; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kingsley RA, 2002, MOL MICROBIOL, V43, P895, DOI 10.1046/j.1365-2958.2002.02805.x; Kiselev AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005191; Klemm P, 2006, INT J MED MICROBIOL, V296, P187, DOI 10.1016/j.ijmm.2005.10.002; Kostakioti M, 2006, INFECT IMMUN, V74, P4961, DOI 10.1128/IAI.00103-06; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Leyton DL, 2011, J BIOL CHEM, V286, P42283, DOI 10.1074/jbc.M111.306118; Leyton DL, 2003, INFECT IMMUN, V71, P6307, DOI 10.1128/IAI.71.11.6307-6319.2003; Likic VA, 2010, METHODS MOL BIOL, V619, P271, DOI 10.1007/978-1-60327-412-8_16; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; Mazar J, 2007, TRENDS MICROBIOL, V15, P508, DOI 10.1016/j.tim.2007.10.005; Meng GY, 2011, EMBO J, V30, P3864, DOI 10.1038/emboj.2011.279; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Nishimura K, 2010, J MOL MED, V88, P451, DOI 10.1007/s00109-010-0600-y; Ohnishi Y, 1997, J BIOCHEM, V121, P902; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Rego AT, 2010, BIOCHEM J, V425, P475, DOI 10.1042/BJ20091518; Renn JP, 2011, CHEM BIOL; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rossiter AE, 2011, J BACTERIOL, V193, P4250, DOI 10.1128/JB.00192-11; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Stymest KH, 2008, FEBS J, V275, P3470, DOI 10.1111/j.1742-4658.2008.06493.x; Swanson KA, 2009, INFECT IMMUN, V77, P508, DOI 10.1128/IAI.01173-08; Tajima N, 2010, J MOL BIOL, V402, P645, DOI 10.1016/j.jmb.2010.06.068; Thanassi DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; van Ulsen P, 2011, ADV EXP MED BIOL, V715, P125, DOI 10.1007/978-94-007-0940-9_8; Veiga E, 2004, MOL MICROBIOL, V52, P1069, DOI 10.1111/j.1365-2958.2004.04014.x; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Wells TJ, 2007, FEMS MICROBIOL LETT, V274, P163, DOI 10.1111/j.1574-6968.2007.00833.x; Wells TJ, 2010, MICROBIOL-SGM, V156, P2459, DOI 10.1099/mic.0.039024-0; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yen YT, 2008, TRENDS MICROBIOL, V16, P370, DOI 10.1016/j.tim.2008.05.003; Zhai YJ, 2011, BIOCHEM J, V435, P577, DOI 10.1042/BJ20101548	87	54	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43245	10.1371/journal.pone.0043245	http://dx.doi.org/10.1371/journal.pone.0043245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905239	Green Published, gold, Green Submitted			2022-12-27	WOS:000307500800064
J	Rusine, J; Jurriaans, S; van de Wijgert, J; Cornelissen, M; Kateera, B; Boer, K; Karita, E; Mukabayire, O; de Jong, M; Ondoa, P				Rusine, John; Jurriaans, Suzanne; van de Wijgert, Janneke; Cornelissen, Marion; Kateera, Brenda; Boer, Kimberly; Karita, Etienne; Mukabayire, Odette; de Jong, Menno; Ondoa, Pascale			Molecular and Phylogeographic Analysis of Human Immuno-deficiency Virus Type 1 Strains Infecting Treatment-naive Patients from Kigali, Rwanda	PLOS ONE			English	Article							ANTIRETROVIRAL DRUG-RESISTANCE; SUBTYPE C; GENETIC-ANALYSIS; HIV-INFECTIONS; AVIDITY INDEX; DIVERSITY; FITNESS; AFRICA; INDIVIDUALS; MUTATIONS	This study aimed at describing the genetic subtype distribution of HIV-1 strains circulating in Kigali and their epidemiological link with the HIV-1 strains from the five countries surrounding Rwanda. One hundred and thirty eight pol (RT and PR) sequences from 116 chronically-and 22 recently-infected antiretroviral therapy (ART)-naive patients from Kigali were generated and subjected to HIV drug resistance (HIV-DR), phylogenetic and recombinant analyses in connection with 366 reference pol sequences from Rwanda, Burundi, Kenya, Democratic Republic of Congo, Tanzania and Uganda (Los Alamos database). Among the Rwandan samples, subtype A1 predominated (71.7%), followed by A1/C recombinants (18.1%), subtype C (5.8%), subtype D (2.9%), one A1/D recombinant (0.7%) and one unknown subtype (0.7%). Thirteen unique and three multiple A1/C recombinant forms were identified. No evidence for direct transmission events was found within the Rwandan strains. Molecular characteristics of HIV-1 were similar between chronically and recently-infected individuals and were not significantly associated with demographic or social factors. Our report suggests that the HIV-1 epidemic in Kigali is characterized by the emergence of A1/C recombinants and is not phylogenetically connected with the HIV-1 epidemic in the five neighboring countries. The relatively low level of transmitted HIV-DR mutations (2.9%) reported here indicates the good performance of the ART programme in Rwanda. However, the importance of promoting couples' counseling, testing and disclosure during HIV prevention strategies is highlighted.	[Rusine, John; Mukabayire, Odette] Natl Reference Lab, Kigali, Rwanda; [Jurriaans, Suzanne; Cornelissen, Marion; de Jong, Menno] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Virol,AIGHD, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke; Kateera, Brenda; Boer, Kimberly; Ondoa, Pascale] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, AIGHD, NL-1105 AZ Amsterdam, Netherlands; [Kateera, Brenda; Boer, Kimberly] Infect Dis Network Treatment & Res Africa INTERAC, Kigali, Rwanda; [Kateera, Brenda; Boer, Kimberly] AIGHD, Epidemiol Unit, Royal Trop Inst KIT, Amsterdam, Netherlands; [Karita, Etienne] Projet San Francisco, Kigali, Rwanda	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Rusine, J (corresponding author), Natl Reference Lab, Kigali, Rwanda.	p.ondoa@aighd.org	Asiimwe-Kateera, Brenda/H-3378-2019	van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases (NACCAP) [W 07.05.201.00]; EuropAid [SANTE/2006/105-316]; International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP) [CT_ct_05_33070_001]	Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases (NACCAP); EuropAid; International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP)	The Side Effect and Reproductive Health in a cohort on HAART (SEARCH) study was conducted in the frame of the Infectious diseases Network for Treatment and Research in Africa (INTERACT) program supported by the the Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases (NACCAP grant W 07.05.201.00) and EuropAid (grant SANTE/2006/105-316). Additional funding for the cross-sectional and prospective cohorts of high-risk women at Projet Ubuzima was provided by the International Partnership for Microbicides, Inc. and the European and Developing Countries Clinical Trials Partnership (EDCTP) through a project entitled: "Preparing for Phase III vaginal microbicide trials in Rwanda and Kenya: Preparedness studies, capacity building, and strengthening of medical referral systems" (CT_ct_05_33070_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, HIV AIDS HLTH PROF R; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Bennet DE, 2008, ANTIVIR THER S, V13, P26; Bennett DE, 2008, ANTIVIR THER, V13, P1; Blower S, 2005, AIDS, V19, P1, DOI 10.1097/00002030-200501030-00001; Braunstein L, 2011, PLOS ONE, V6; Brown AJL, 1997, VIROLOGY, V235, P166, DOI 10.1006/viro.1997.8656; Bujingo G, 1988, REV MED RWANDAISE, V20, P37; Calypte Biomedical Corporation, 2005, CAL HIV 1 BED INC EI; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Collinson-Streng AN, 2009, AIDS RES HUM RETROV, V25, P1045, DOI 10.1089/aid.2009.0127; Des Forges A., 1999, LEAVE NO ONE TELL ST; Djoko CF, 2011, AIDS RES HUM RETROV, V27, P323, DOI 10.1089/aid.2010.0201; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Iweriebor BC, 2011, AIDS RES HUM RETROV, V27, P911, DOI [10.1089/aid.2010.0286, 10.1089/AID.2010.0286]; Kayirangwa E, 2006, SEX TRANSM INFECT, V82, pI27, DOI 10.1136/sti.2006.019588; Kelley AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019573; Khoja S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003191; Lee SS, 2009, AIDS, V23, P1753, DOI 10.1097/QAD.0b013e32832dc025; Lukashov VV, 1996, AIDS RES HUM RETROV, V12, P1179, DOI 10.1089/aid.1996.12.1179; Ministry of finance and economic planning national census service, 2003, 3 GEN CENS POP HOUS; Ministry of Health, 2003, GUID PRIS CHARG PERS; Mosha F, 2011, AIDS RES HUM RETROV, V27, P377, DOI 10.1089/aid.2010.0113; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Ndiaye HD, 2009, JAIDS-J ACQ IMM DEF, V52, P249, DOI 10.1097/QAI.0b013e3181af70a4; Njai HF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-40; Ntemgwa M, 2008, AIDS RES HUM RETROV, V24, P655, DOI 10.1089/aid.2007.0282; OSMANOV S, 1994, AIDS RES HUM RETROV, V10, P1327, DOI 10.1089/aid.1994.10.1327; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Prunier G, 1997, RWANDA CRISIS HIST G; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Rodriguez MA, 2009, VIROLOGY, V385, P416, DOI 10.1016/j.virol.2008.12.025; Rwanda Ministry of Health, 2008, TRAC REP EV CLIN IMM; Rwanda Ministry of Local Government, 2010, REP REF REP; Servais J, 2004, AIDS RES HUM RETROV, V20, P279, DOI 10.1089/088922204322996518; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Ssemwanga D, 2012, AIDS RES HUM RETROV, V28, P357, DOI [10.1089/aid.2011.0024, 10.1089/AID.2011.0024]; Stanford University, HIV 1 DRUG RES DAT W; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; Suligoi B, 2002, J CLIN MICROBIOL, V40, P4015, DOI 10.1128/JCM.40.11.4015-4020.2002; VANDEPERRE P, 1984, LANCET, V2, P62; VANDEPERRE P, 1989, LANCET, V1, P941; Veldhuijzen NJ, 2010, AIDS, V24, P2289, DOI 10.1097/QAD.0b013e32833cbb71; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Vidal N, 2007, AIDS RES HUM RETROV, V23, P175, DOI 10.1089/aid.2006.0126; World Bank Global HIV/AIDS Program, 2008, HIV EP HIV RESP AN G; Yirrell DL, 2004, INT J STD AIDS, V15, P103, DOI 10.1258/095646204322764299	53	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42557	10.1371/journal.pone.0042557	http://dx.doi.org/10.1371/journal.pone.0042557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905148	gold, Green Published, Green Submitted			2022-12-27	WOS:000307500800016
J	Canard, E; Mouquet, N; Marescot, L; Gaston, KJ; Gravel, D; Mouillot, D				Canard, Elsa; Mouquet, Nicolas; Marescot, Lucile; Gaston, Kevin J.; Gravel, Dominique; Mouillot, David			Emergence of Structural Patterns in Neutral Trophic Networks	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; ANIMAL MUTUALISTIC NETWORKS; ECOLOGICAL NETWORKS; COMMUNITY ECOLOGY; PHYLOGENETIC CONSTRAINTS; SPECIES ABUNDANCE; NESTEDNESS; NICHE; MODEL; SPECIALIZATION	Interaction networks are central elements of ecological systems and have very complex structures. Historically, much effort has focused on niche-mediated processes to explain these structures, while an emerging consensus posits that both niche and neutral mechanisms simultaneously shape many features of ecological communities. However, the study of interaction networks still lacks a comprehensive neutral theory. Here we present a neutral model of predator-prey interactions and analyze the structural characteristics of the simulated networks. We find that connectance values (complexity) and complexity-diversity relationships of neutral networks are close to those observed in empirical bipartite networks. High nestedness and low modularity values observed in neutral networks fall in the range of those from empirical antagonist bipartite networks. Our results suggest that, as an alternative to niche-mediated processes that induce incompatibility between species ("niche forbidden links"), neutral processes create "neutral forbidden links" due to uneven species abundance distributions and the low probability of interaction between rare species. Neutral trophic networks must be seen as the missing endpoint of a continuum from niche to purely stochastic approaches of community organization.	[Canard, Elsa; Mouquet, Nicolas] Univ Montpellier 2, Inst Sci Evolut, Montpellier, France; [Marescot, Lucile] CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France; [Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Gravel, Dominique] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Exeter; University of Quebec	Canard, E (corresponding author), Univ Montpellier 2, Inst Sci Evolut, Montpellier, France.	elsa.canard@univ-montp2.fr	MOUQUET, Nicolas/AAL-1440-2021	Mouquet, Nicolas/0000-0003-1840-6984; Gaston, Kevin J./0000-0002-7235-7928	Ministry of Higher Education and Research of France; CNRS; NSERC; Canada Research Chair program; French National Game and Wildlife Agency (Office National de la Chasse et de la Faune Sauvage); European Research Council under the European Union's Seventh Framework Programme [268504]; Marie Curie International Outgoing Fellowship (FISHECO) [IOF-GA-2009-236316]; FRB project BIODIVMED; ANR project BIODIVNEK	Ministry of Higher Education and Research of France; CNRS(Centre National de la Recherche Scientifique (CNRS)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); French National Game and Wildlife Agency (Office National de la Chasse et de la Faune Sauvage); European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); Marie Curie International Outgoing Fellowship (FISHECO)(European Commission); FRB project BIODIVMED; ANR project BIODIVNEK(French National Research Agency (ANR))	Dr. Canard was supported by a MENRT grant from Ministry of Higher Education and Research of France. Dr. Mouquet was supported by the CNRS. Dr. Gravel was supported by NSERC and the Canada Research Chair program. Dr. Marescot was supported by a grant from the French National Game and Wildlife Agency (Office National de la Chasse et de la Faune Sauvage). Dr. Gaston was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 268504. Dr. Mouillot was supported by Marie Curie International Outgoing Fellowship (FISHECO) IOF-GA-2009-236316. This study was partially funded by the FRB project BIODIVMED and by the ANR project BIODIVNEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2009, PHILOS T R SOC B, V364, P1781, DOI 10.1098/rstb.2008.0226; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Beckerman AP, 2006, P NATL ACAD SCI USA, V103, P13745, DOI 10.1073/pnas.0603039103; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Bersier LF, 2008, ECOL COMPLEX, V5, P132, DOI 10.1016/j.ecocom.2007.06.013; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Cohen J.E., 1990, COMMUNITY FOOD WEBS; Dorado J, 2011, ECOLOGY, V92, P19, DOI 10.1890/10-0794.1; Dunne JA, 2006, NETWORK STRUCTURE FO; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Gotelli NJ, 2006, ECOGRAPHY, V29, P793, DOI 10.1111/j.2006.0906-7590.04714.x; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Guill C, 2008, J THEOR BIOL, V251, P108, DOI 10.1016/j.jtbi.2007.11.017; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2010, ECOLOGY, V91, P2941, DOI 10.1890/09-1175.1; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; Hubbell Stephen P., 2001, V32, pi; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kondoh M, 2010, ECOLOGY, V91, P3123, DOI 10.1890/09-2219.1; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; MARTINEZ ND, 1992, AM NAT, V139, P1208, DOI 10.1086/285382; May R.M., 1973, STABILITY COMPLEXITY; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Montoya JM, 2003, OIKOS, V102, P614, DOI 10.1034/j.1600-0706.2003.12031.x; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; PIMM SL, 1979, THEOR POPUL BIOL, V16, P144, DOI 10.1016/0040-5809(79)90010-8; Poulin R, 2000, INT J PARASITOL, V30, P1147, DOI 10.1016/S0020-7519(00)00102-8; Rezende EL, 2009, ECOL LETT, V12, P779, DOI 10.1111/j.1461-0248.2009.01327.x; Rickfeld RE, 2003, OIKOS, V100, P185, DOI 10.1034/j.1600-0706.2003.12018.x; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Rossberg AG, 2010, THEOR ECOL-NETH, V3, P13, DOI 10.1007/s12080-009-0049-1; Schmid-Araya JM, 2002, J ANIM ECOL, V71, P1056, DOI 10.1046/j.1365-2656.2002.00668.x; SCHOENLY K, 1991, ECOL MONOGR, V61, P267, DOI 10.2307/2937109; Sole RV, 2002, PHILOS T R SOC B, V357, P667, DOI 10.1098/rstb.2001.0992; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Stouffer DB, 2010, FUNCT ECOL, V24, P44, DOI 10.1111/j.1365-2435.2009.01644.x; Team RDC, 2009, R LANG ENV STAT COMP; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2005, J ANIM ECOL, V74, P946, DOI 10.1111/j.1365-2656.2005.00992.x; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007	57	53	54	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e38295	10.1371/journal.pone.0038295	http://dx.doi.org/10.1371/journal.pone.0038295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899987	Green Published, gold, Green Submitted			2022-12-27	WOS:000307380900002
J	Ishikawa, HO; Xu, AG; Ogura, E; Manning, G; Irvine, KD				Ishikawa, Hiroyuki O.; Xu, Aiguo; Ogura, Eri; Manning, Gerard; Irvine, Kenneth D.			The Raine Syndrome Protein FAM20C Is a Golgi Kinase That Phosphorylates Bio-Mineralization Proteins	PLOS ONE			English	Article							OSTEOSCLEROTIC BONE DYSPLASIA; CASEIN KINASE; GENE-EXPRESSION; MAMMARY-GLAND; POSTTRANSLATIONAL MODIFICATIONS; OSTEOPONTIN; BIOMINERALIZATION; INHIBITION; APPARATUS; BINDING	Raine syndrome is caused by mutations in FAM20C, which had been reported to encode a secreted component of bone and teeth. We found that FAM20C encodes a Golgi-localized protein kinase, distantly related to the Golgi-localized kinase Fourjointed. Drosophila also encode a Golgi-localized protein kinase closely related to FAM20C. We show that FAM20C can phosphorylate secreted phosphoproteins, including both Casein and members of the SIBLING protein family, which modulate biomineralization, and we find that FAM20C phosphorylates a biologically active peptide at amino acids essential for inhibition of biomineralization. We also identify autophosphorylation of FAM20C, and characterize parameters of FAM20C's kinase activity, including its Km, pH and cation dependence, and substrate specificity. The biochemical properties of FAM20C match those of an enzymatic activity known as Golgi casein kinase. Introduction of point mutations identified in Raine syndrome patients into recombinant FAM20C impairs its normal localization and kinase activity. Our results identify FAM20C as a kinase for secreted phosphoproteins and establish a biochemical basis for Raine syndrome.	[Ishikawa, Hiroyuki O.; Ogura, Eri] Chiba Univ, Grad Sch Sci, Chiba, Japan; [Ishikawa, Hiroyuki O.; Xu, Aiguo; Irvine, Kenneth D.] Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ USA; [Ishikawa, Hiroyuki O.; Xu, Aiguo; Irvine, Kenneth D.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA	Chiba University; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Salk Institute	Ishikawa, HO (corresponding author), Chiba Univ, Grad Sch Sci, Chiba, Japan.	irvine@waksman.rutgers.edu	Manning, Gerard/C-8308-2009	Manning, Gerard/0000-0002-5087-9151	Howard Hughes Medical Institute; NHGRI [HG004164]; Special Coordination Funds for Promoting Science and Technology; Japanese Ministry of Education, Culture, Sports and Science; Grants-in-Aid for Scientific Research [23770139] Funding Source: KAKEN; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the Howard Hughes Medical Institute (KDI), NHGRI grant HG004164 (GM), and by Special Coordination Funds for Promoting Science and Technology and Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports and Science (HOI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; BINGHAM EW, 1979, J BIOL CHEM, V254, P4510; BINGHAM EW, 1974, J BIOL CHEM, V249, P3647; Brittle AL, 2010, CURR BIOL, V20, P803, DOI 10.1016/j.cub.2010.03.056; Buckles GR, 2001, DEVELOPMENT, V128, P3533; BURNETT G, 1954, J BIOL CHEM, V211, P969; Deshpande AS, 2011, BIOMACROMOLECULES, V12, P2933, DOI 10.1021/bm2005214; El-Battari A, 2003, GLYCOBIOLOGY, V13, P941, DOI 10.1093/glycob/cwg117; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Fradin M, 2011, CLIN GENET, V80, P177, DOI 10.1111/j.1399-0004.2010.01516.x; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; Hammarsten O., 1883, H-S Z PHYSIOL CHEM, V7, P227; Hao JJ, 2007, J BIOL CHEM, V282, P15357, DOI 10.1074/jbc.M701547200; Hardie DG, 2000, METH MOL B, V99, P191; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Hulskamp G, 2003, CLIN DYSMORPHOL, V12, P153, DOI 10.1097/01.mcd.0000080413.95344.60; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; Jono S, 2000, J BIOL CHEM, V275, P20197, DOI 10.1074/jbc.M909174199; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; Lasa M, 1997, BIOCHEM BIOPH RES CO, V240, P602, DOI 10.1006/bbrc.1997.7702; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; Oh H, 2009, ONCOGENE, V28, P1916, DOI 10.1038/onc.2009.43; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; RAINE J, 1989, J MED GENET, V26, P786, DOI 10.1136/jmg.26.12.786; Rejjal A, 1998, AM J MED GENET, V78, P382, DOI 10.1002/(SICI)1096-8628(19980724)78:4<382::AID-AJMG17>3.0.CO;2-E; Salvi M, 2010, J PROTEOME RES, V9, P3335, DOI 10.1021/pr100058r; Simon MA, 2010, CURR BIOL, V20, P811, DOI 10.1016/j.cub.2010.04.016; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; Simpson MA, 2009, CLIN GENET, V75, P271, DOI 10.1111/j.1399-0004.2008.01118.x; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; WANG XF, 2010, HEALTH TECHNOL ASSES, V14, P957, DOI DOI 10.1369/JHC.2010.9565651; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Wheeler SR, 2006, DEV BIOL, V294, P509, DOI 10.1016/j.ydbio.2006.03.016; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200	47	116	124	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42988	10.1371/journal.pone.0042988	http://dx.doi.org/10.1371/journal.pone.0042988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900076	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900094
J	Liao, XL; Lu, SY; Zhuo, Y; Winter, C; Xu, WF; Wang, YX				Liao, Xiaoling; Lu, Shaoying; Zhuo, Yue; Winter, Christina; Xu, Wenfeng; Wang, Yingxiao			Visualization of Src and FAK Activity during the Differentiation Process from HMSCs to Osteoblasts	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; FOCAL ADHESION KINASE; STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; TYROSINE PHOSPHORYLATION; BONE-FORMATION; ACTIVATION; EXPRESSION; DEXAMETHASONE; MEMBRANE	Non-receptor protein kinases FAK and Src play crucial roles in regulating cellular adhesions, growth, migration and differentiation. However, it remains unclear how the activity of FAK and Src is regulated during the differentiation process from mesenchymal stem cells (MSCs) to bone cells. In this study, we used genetically encoded FAK and Src biosensors based on fluorescence resonance energy transfer (FRET) to monitor the FAK and Src activity in live cells during the differentiation process. The results revealed that the FAK activity increased after the induction of differentiation, which peaked around 20-27 days after induction. Meanwhile, the Src activity decreased continuously for 27 days after induction. Therefore, the results showed significant and differential changes of FAK and Src activity upon induction. This opposite trend between FAK and Src activation suggests novel and un-coupled Src/FAK functions during the osteoblastic differentiation process. These results should provide important information for the biochemical signals during the differentiation process of stem cells toward bone cells, which will advance our understanding of bone repair and tissue engineering.	[Liao, Xiaoling; Xu, Wenfeng] Chongqing Univ Sci & Technol, Biomat & Live Cell Imaging Inst, Sch Met & Mat Engn, Chongqing, Peoples R China; [Lu, Shaoying; Zhuo, Yue; Winter, Christina; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Liao, Xiaoling; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Ctr Biophys & Computat Biol, Inst Genom Biol,Dept Integrat & Mol Physiol, Urbana, IL 61801 USA	Chongqing University of Science & Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Liao, XL (corresponding author), Chongqing Univ Sci & Technol, Biomat & Live Cell Imaging Inst, Sch Met & Mat Engn, Chongqing, Peoples R China.	yingxiao@uiuc.edu	Zhuo, Yue/I-5526-2017	Zhuo, Yue/0000-0002-5739-1896	NIH [HL098472, NS063405]; NSF [CBET0846429]; Research Foundation of University of Illinois; Natural Science Key Foundation Project of CQ in China [CSTC2012JJB0097]; Research Foundation of Chongqing University of Science Technology [CK2010B18, CK2011Z03]; Beckman Graduate Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Research Foundation of University of Illinois; Natural Science Key Foundation Project of CQ in China; Research Foundation of Chongqing University of Science Technology; Beckman Graduate Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from NIH HL098472, NS063405, NSF CBET0846429 (Y.W., S.L. and C.W.), Research Foundation of University of Illinois (S.L.) and the Natural Science Key Foundation Project of CQ in China (CSTC2012JJB0097), and Research Foundation of Chongqing University of Science & Technology (CK2010B18, CK2011Z03) (X.L., W.X.). Y.Z. was supported by the Beckman Graduate Fellowship.	Aicher WK, 2011, ADV DRUG DELIVER REV, V63, P342, DOI 10.1016/j.addr.2010.12.004; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Boufker HI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-298; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gersbach CA, 2007, ANNU REV BIOMED ENG, V9, P87, DOI 10.1146/annurev.bioeng.9.060906.151949; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Hakuno D, 2005, J BIOL CHEM, V280, P39534, DOI 10.1074/jbc.M505575200; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; Hong D, 2009, J STEROID BIOCHEM, V116, P86, DOI 10.1016/j.jsbmb.2009.05.007; Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598; Koukouritaki SB, 1999, MOL MED, V5, P731, DOI 10.1007/BF03402097; Lau E, 2010, BONE, V46, P1508, DOI 10.1016/j.bone.2010.02.031; Liu LY, 2010, BIOMECH MODEL MECHAN, V9, P659, DOI 10.1007/s10237-010-0206-x; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porada CD, 2010, ADV DRUG DELIVER REV, V62, P1156, DOI 10.1016/j.addr.2010.08.010; Salasznyk RM, 2007, J CELL BIOCHEM, V100, P499, DOI 10.1002/jcb.21074; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Seong JY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1414; Seong J, 2011, CELL MOL BIOENG, V4, P138, DOI 10.1007/s12195-011-0161-3; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Sheyn D, 2010, TISSUE ENG PT A, V16, P3679, DOI [10.1089/ten.tea.2009.0786, 10.1089/ten.TEA.2009.0786]; Sheyn D, 2010, ADV DRUG DELIVER REV, V62, P683, DOI 10.1016/j.addr.2010.01.002; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca; Zambuzzi WF, 2010, BIOCHIMIE, V92, P327, DOI 10.1016/j.biochi.2010.01.002; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	47	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42709	10.1371/journal.pone.0042709	http://dx.doi.org/10.1371/journal.pone.0042709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900044	Green Published, Green Submitted, gold			2022-12-27	WOS:000307380900061
J	Conway, ML; Thomas, J; Subramanian, A				Conway, Miriam L.; Thomas, Jennifer; Subramanian, Ahalya			Is the Aligning Prism Measured with the Mallett Unit Correlated with Fusional Vergence Reserves?	PLOS ONE			English	Article							FIXATION DISPARITY; BINOCULAR VISION; VISUAL-ACUITY; HETEROPHORIA; SYMPTOMS; LOCK; ILLUMINATION; DISTANCE; PHORIA	Background: The Mallett Unit is a clinical test designed to detect the fixation disparity that is most likely to occur in the presence of a decompensated heterophoria. It measures the associated phoria, which is the "aligning prism" needed to nullify the subjective disparity. The technique has gained widespread acceptance within professions such as optometry, for investigating suspected cases of decompensating heterophoria; it is, however, rarely used by orthoptists and ophthalmologists. The aim of this study was to investigate whether fusional vergence reserves, measured routinely by both orthoptists and ophthalmologists to detect heterophoria decompensation, were correlated with aligning prism (associated phoria) in a normal clinical population. Methodology/Principal Findings: Aligning prism (using the Mallett Unit) and fusional vergence reserves (using a prism bar) were measured in 500 participants (mean 41.63 years; standard deviation 11.86 years) at 40 cm and 6 m. At 40 cm a strong correlation (p<0.001) between base in aligning prism (Exo FD) and positive fusional reserves was found. Of the participants with zero aligning prism 30% had reduced fusional reserves. At 6 m a weak correlation between base out aligning prism (Eso FD) and negative fusional reserves was found to break (p = 0.01) and to recovery (p = 0.048). Of the participants with zero aligning prism 12% reported reduced fusional reserves. Conclusions/Significance: For near vision testing, the strong inverse correlation between base in aligning prism (Exo FD) and fusional vergence reserves supports the notion that both measures are indicators of decompensation of heterophoria. For distance vision testing and for those patients reporting zero aligning prism further research is required to determine why the relationship appears to be weak/non-existent?	[Conway, Miriam L.; Thomas, Jennifer; Subramanian, Ahalya] City Univ London, Div Optometry & Visual Sci, London EC1V 0HB, England	City University London	Conway, ML (corresponding author), City Univ London, Div Optometry & Visual Sci, London EC1V 0HB, England.	miriam.conway.1@city.ac.uk		Subramanian, Ahalya/0000-0001-8104-5312				Anson AM, 2001, DIAGNOSIS MANAGEMENT; Antona B, 2008, OPHTHAL PHYSL OPT, V28, P475, DOI 10.1111/j.1475-1313.2008.00583.x; Brautaset RL, 1999, OPHTHAL PHYSL OPT, V19, P347, DOI 10.1046/j.1475-1313.1999.00448.x; Evans BJW, 2010, OPTOMETRY TODAY, P40; Evans BJW, 2007, PICKWELLS BINOCULAR; HERAVIANSHANDIZ J, 1993, OPHTHAL PHYSL OPT, V13, P295, DOI 10.1111/j.1475-1313.1993.tb00472.x; JENKINS TCA, 1989, OPHTHAL PHYSL OPT, V9, P121, DOI 10.1111/j.1475-1313.1989.tb00830.x; JENKINS TCA, 1995, OPHTHAL PHYSL OPT, V15, P53, DOI 10.1016/0275-5408(95)92793-E; JENKINS TCA, 1994, OPHTHAL PHYSL OPT, V14, P129, DOI 10.1111/j.1475-1313.1994.tb00100.x; Karania R, 2006, OPHTHAL PHYSL OPT, V26, P507, DOI 10.1111/j.1475-1313.2006.00385.x; Methling D, 1996, OPHTHAL PHYSL OPT, V16, P211, DOI 10.1016/0275-5408(95)00045-3; Millodot M., 2017, DICT OPTOMETRY VISIO; O'Leary CI, 2006, OPHTHAL PHYSL OPT, V26, P555, DOI 10.1111/j.1475-1313.2006.00400.x; Percival AS, 1928, FAULTY TENDENCIES DE; PICKWELL LD, 1991, OPHTHAL PHYSL OPT, V11, P291, DOI 10.1111/j.1475-1313.1991.tb00227.x; PICKWELL LD, 1987, AM J OPTOM PHYS OPT, V64, P513; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Rowe F, 2012, CLIN ORTHOPTICS; SALADIN JJ, 1983, AM J OPTOM PHYS OPT, V60, P933; Sheard C., 1930, AM J OPTOM, V7, P9, DOI [10.1097/00006324-193001000-00001, DOI 10.1097/00006324-193001000-00001]; SHEEDY JE, 1980, J AM OPTOM ASSOC, V51, P1079; SHEEDY JE, 1978, AM J OPTOM PHYS OPT, V55, P670; SHEEDY JE, 1977, AM J OPTOM PHYS OPT, V54, P474; Ukwade MT, 2000, OPTOMETRY VISION SCI, V77, P309, DOI 10.1097/00006324-200006000-00011; Von Noorden G. K., 2002, BINOCULAR VISION OCU, V6th; WILDSOET CF, 1985, OPHTHAL PHYSL OPT, V5, P171, DOI 10.1111/j.1475-1313.1985.tb00653.x; Yekta A, 1986, CLIN EXP OPTOM, V69, P228; YEKTA AA, 1987, OPHTHAL PHYSL OPT, V7, P349, DOI 10.1111/j.1475-1313.1987.tb00759.x	28	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42832	10.1371/journal.pone.0042832	http://dx.doi.org/10.1371/journal.pone.0042832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905174	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000307331100066
J	Kigera, JWM; Straetemans, M; Vuhaka, SK; Nagel, IM; Naddumba, EK; Boer, K				Kigera, James W. M.; Straetemans, Masja; Vuhaka, Simplice K.; Nagel, Ingeborg M.; Naddumba, Edward K.; Boer, Kimberly			Is There an Increased Risk of Post-Operative Surgical Site Infection after Orthopaedic Surgery in HIV Patients? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; TOTAL KNEE REPLACEMENT; TOTAL JOINT ARTHROPLASTY; POSITIVE PATIENTS; HEMOPHILIC ARTHROPATHY; PROPHYLACTIC ANTIBIOTICS; COMPLICATIONS; TUBERCULOSIS; COUNTRIES; DISEASE	Background: There is dilemma as to whether patients infected with the Human Immunodeficiency Virus (HIV) requiring implant orthopaedic surgery are at an increased risk for post-operative surgical site infection (SSI). We conducted a systematic review to determine the effect of HIV on the risk of post-operative SSI and sought to determine if this risk is altered by antibiotic use beyond 24 hours. Methods: We searched electronic databases, manually searched citations from relevant articles, and reviewed conference proceedings. The risk of postoperative SSI was pooled using Mantel-Haenszel method. Results: We identified 18 cohort studies with 16 mainly small studies, addressing the subject. The pooled risk ratio of infection in the HIV patients when compared to non-HIV patients was 1.8 (95% Confidence Interval [CI] 1.3-2.4), in studies in Africa this was 2.3 (95% CI 1.5-3.5). In a sensitivity analysis the risk ratio was reduced to 1.4 (95% CI 0.5-3.8). The risk ratio of infection in patients receiving prolonged antibiotics compared to patients receiving antibiotics for up to 24 hours was 0.7 (95% CI 0.1-4.2). Conclusions: The results may indicate an increased risk in HIV infected patients but these results are not robust and inconclusive after conducting the sensitivity analysis removing poor quality studies. There is need for larger good quality studies to provide conclusive evidence. To better develop surgical protocols, further studies should determine the effect of reduced CD4 counts, viral load suppression and prolonged antibiotics on the risk for infection.	[Kigera, James W. M.; Vuhaka, Simplice K.] Makerere Univ, Coll Hlth Sci, Dept Orthopaed, Kampala, Uganda; [Kigera, James W. M.] PCEA Kikuyu Hosp, Orthopaed Rehabil Ctr, Kikuyu, Kenya; [Straetemans, Masja; Boer, Kimberly] Royal Trop Inst KIT, Dept Biomed Res, Amsterdam, Netherlands; [Nagel, Ingeborg M.] Royal Trop Inst KIT, Dept Informat & Lib Serv, Amsterdam, Netherlands; [Naddumba, Edward K.] Mulago Natl Referral Hosp, Dept Orthopaed, Kampala, Uganda; [Boer, Kimberly] Ctr Poverty Related Communicable Dis AMC CPCD AIG, Acad Med Ctr, Kigali, Rwanda; [Boer, Kimberly] Ctr Poverty Related Communicable Dis AMC CPCD AIG, Acad Med Ctr, Amsterdam, Netherlands	Makerere University; Mulago National Referral Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Kigera, JWM (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Orthopaed, Kampala, Uganda.	jameskigera@yahoo.co.uk			Collaboration for Evidence Based Medicine in East Africa	Collaboration for Evidence Based Medicine in East Africa	The authors received a grant of 2,400 Euros spread over 6 months to cover part of the costs of the study from the "Collaboration for Evidence Based Medicine in East Africa." No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, SCAND J INFECT DIS, V30, P547; Bahebeck J, 2009, INJURY, V40, P1147, DOI 10.1016/j.injury.2008.12.012; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Chapman-Sheath PJ, 2003, J BONE JOINT SURG BR, V85B, P1138, DOI 10.1302/0301-620X.85B8.13986; Chen G, 2010, INT J INJ CONTROL SA, V17, P247, DOI 10.1080/17457300.2010.490920; COHEN B, 1994, J BONE JOINT SURG BR, V76B, P477, DOI 10.1302/0301-620X.76B3.8175859; Cuckler JM, 2005, J ARTHROPLASTY, V20, P33, DOI 10.1016/j.arth.2005.03.004; Devi Pushpa, 2010, Indian J Sex Transm Dis AIDS, V31, P27, DOI 10.4103/0253-7184.68997; Goddard NJ, 2002, HAEMOPHILIA, V8, P382, DOI 10.1046/j.1365-2516.2002.00604.x; Goddard NJ, J BONE JOINT SURG BR, V92, P1085; Govender S, 2001, J BONE JOINT SURG BR, V83B, P864, DOI 10.1302/0301-620X.83B6.11995; Habermann B, 2008, J INFECTION, V57, P41, DOI 10.1016/j.jinf.2008.01.045; Harrison WJ, 2002, J BONE JOINT SURG BR, V84B, P802, DOI 10.1302/0301-620X.84B6.12641; HENLEY MB, 1986, CLIN ORTHOP RELAT R, P249; HOEKMAN P, 1991, J BONE JOINT SURG AM, V73A, P675, DOI 10.2106/00004623-199173050-00005; Jellis JE, 1996, INT ORTHOP, V20, P253, DOI 10.1007/s002640050074; KELLEY SS, 1995, J BONE JOINT SURG AM, V77A, P828, DOI 10.2106/00004623-199506000-00003; Kigera J., 2010, East and Central African Journal of Surgery, V15, P57; Labinjo M, 2009, INJURY PREV, V15, P157, DOI 10.1136/ip.2008.020255; Lehman CR, 2001, J ARTHROPLASTY, V16, P330, DOI 10.1054/arth.2001.21454; Lofqvist T, 1996, ACTA ORTHOP SCAND, V67, P321; Lubega N, 2009, J BONE JOINT SURG BR, V91B, P341, DOI 10.1302/0301-620X.91B3.21706; Mahmud O, 2011, INT J ENV RES PUB HE, V8, P2524, DOI 10.3390/ijerph8062524; Norian JM, 2002, J BONE JOINT SURG AM, V84A, P1138, DOI 10.2106/00004623-200207000-00007; PAIEMENT GD, 1994, J TRAUMA, V37, P545, DOI 10.1097/00005373-199410000-00005; Paiement GD, 1994, J TRAUMA, V37, P550; Parvizi J, 2003, J ARTHROPLASTY, V18, P259, DOI 10.1054/arth.2003.50094; PAVEL A, 1974, J BONE JOINT SURG AM, VA 56, P777, DOI 10.2106/00004623-197456040-00011; Phillips AM, 1997, CLIN ORTHOP RELAT R, P81; Physiotherapy Evidence Database, 1999, PHYSIOTHERAPY EVIDEN; Powell DL, 2005, HAEMOPHILIA, V11, P233, DOI 10.1111/j.1365-2516.2005.01081.x; Prokuski L, 2008, J AM ACAD ORTHOP SUR, V16, P283, DOI 10.5435/00124635-200805000-00007; Rodriguez-Merchan EC, 2007, J BONE JOINT SURG BR, V89B, P186, DOI 10.1302/0301-620X.89B2.18682; Savioz D, 1998, EUR J SURG, V164, P483, DOI 10.1080/110241598750005813; Sheth DS, 2004, J ARTHROPLASTY, V19, P56, DOI 10.1016/j.arth.2003.08.008; Silva M, 2005, J BONE JOINT SURG AM, V87A, P85, DOI 10.2106/JBJS.C.01609; Solimeno LP, 2009, BRIT J HAEMATOL, V145, P227, DOI 10.1111/j.1365-2141.2009.07613.x; UNAIDS, 2008, REP GLOB AIDS AP; *UNAIDS, 2007, AIDS EP UPD; UNGER AS, 1995, J ARTHROPLASTY, V10, P448, DOI 10.1016/S0883-5403(05)80144-5; Vastel L, 1999, REV CHIR ORTHOP, V85, P458; Wells G.A., NEWCASTLE OTTAWA SCA; Winkler H, 2009, INT J MED SCI, V6, P247; Young WF, 2005, SPINE, V30, P256, DOI 10.1097/01.brs.0000151012.15510.57	45	22	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42254	10.1371/journal.pone.0042254	http://dx.doi.org/10.1371/journal.pone.0042254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905120	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100029
J	Scarf, D; Imuta, K; Colombo, M; Hayne, H				Scarf, Damian; Imuta, Kana; Colombo, Michael; Hayne, Harlene			Social Evaluation or Simple Association? Simple Associations May Explain Moral Reasoning in Infants	PLOS ONE			English	Article							COGNITION; NATIVISM	Are we born amoral or do we come into this world with a rudimentary moral compass? Hamlin and colleagues argue that at least one component of our moral system, the ability to evaluate other individuals as good or bad, is present from an early age. In their study, 6- and 10-month-old infants watched two social interactions - in one, infants observed the helper assist the climber achieve the goal of ascending a hill, while in the other, infants observed the hinderer prevent the climber from ascending the hill. When given a choice, the vast majority of infants picked the helper over the hinderer, suggesting that infants evaluated the helper as good and the hinderer as bad. Hamlin and colleagues concluded that the ability to evaluate individuals based on social interaction is innate. Here, we provide evidence that their findings reflect simple associations rather than social evaluations.	[Scarf, Damian; Imuta, Kana; Colombo, Michael; Hayne, Harlene] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago	Scarf, D (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	damianscarf@gmail.com	Imuta, Kana/A-4533-2018	Imuta, Kana/0000-0002-6513-6254; Colombo, Michael/0000-0002-2574-4888; Scarf, Damian/0000-0002-9486-8059				Balter M, 2012, SCIENCE, V335, P1036, DOI 10.1126/science.335.6072.1036; Colombo M., 2010, OXFORD HDB DEV BEHAV, P617, DOI [10.1093/oxfordhb/9780195314731.013.0031, DOI 10.1093/OXFORDHB/9780195314731.013.0031]; DARWIN C, 1982, ORIGIN SPECIES; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Haith M, 1998, INFANT BEHAV DEV, V21, P167, DOI 10.1016/S0163-6383(98)90001-7; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2012, P NATL ACAD SCI USA, V109, pE1427, DOI 10.1073/pnas.1204712109; Hamlin JK, 2011, P NATL ACAD SCI USA, V108, P19931, DOI 10.1073/pnas.1110306108; Hamlin JK, 2011, COGNITIVE DEV, V26, P30, DOI 10.1016/j.cogdev.2010.09.001; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; LABARBERA JD, 1976, CHILD DEV, V47, P535, DOI 10.2307/1128816; Le Pelley ME, 2012, J EXP PSYCHOL LEARN, V38, P686, DOI 10.1037/a0026478; Lewkowicz DJ, 2011, INFANCY, V16, P331, DOI 10.1111/j.1532-7078.2011.00079.x; Perner J, 2005, SCIENCE, V308, P214, DOI 10.1126/science.1111656; Prinz J, 2009, STICH HIS CRITICS, P167; Ruffman T, 2012, BRIT J DEV PSYCHOL, V30, P87, DOI 10.1111/j.2044-835X.2011.02045.x; Scarf D, 2012, P NATL ACAD SCI USA, V109, pE1426, DOI 10.1073/pnas.1204123109; Sirois S, 2007, EUR J DEV PSYCHOL, V4, P46, DOI 10.1080/17405620601047053; Spelke ES, 1998, INFANT BEHAV DEV, V21, P181, DOI 10.1016/S0163-6383(98)90002-9; Sterelny K, 2010, MIND LANG, V25, P279, DOI 10.1111/j.1468-0017.2010.01390.x; van der Vaart E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032904	21	84	85	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42698	10.1371/journal.pone.0042698	http://dx.doi.org/10.1371/journal.pone.0042698			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905161	Green Published, gold, Green Submitted			2022-12-27	WOS:000307331100057
J	Whelan, NV; Johnson, PD; Harris, PM				Whelan, Nathan V.; Johnson, Paul D.; Harris, Phil M.			Rediscovery of Leptoxis compacta (Anthony, 1854) (Gastropoda: Cerithioidea: Pleuroceridae)	PLOS ONE			English	Article							RIVER; REINTRODUCTION	The Mobile River Basin is a hotspot of molluscan endemism, but anthropogenic activities have caused at least 47 molluscan extinctions, 37 of which were gastropods, in the last century. Nine of these suspected extinctions were in the freshwater gastropod genus Leptoxis (Cerithioidea: Pleuroceridae). Leptoxis compacta, a Cahaba River endemic, has not been collected for > 70 years and was formally declared extinct in 2000. Such gastropod extinctions underscore the imperilment of freshwater resources and the current biodiversity crisis in the Mobile River Basin. During a May 2011 gastropod survey of the Cahaba River in central Alabama, USA, L. compacta was rediscovered. The identification of snails collected was confirmed through conchological comparisons to the L. compacta lectotype, museum records, and radulae morphology of historically collected L. compacta. Through observations of L. compacta in captivity, we document for the first time that the species lays eggs in short, single lines. Leptoxis compacta is restricted to a single location in the Cahaba River, and is highly susceptible to a single catastrophic extinction event. As such, the species deserves immediate conservation attention. Artificial propagation and reintroduction of L. compacta into its native range may be a viable recovery strategy to prevent extinction from a single perturbation event.	[Whelan, Nathan V.; Harris, Phil M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Johnson, Paul D.] Alabama Dept Conservat & Nat Resources, Alabama Aquat Biodivers Ctr, Marion, AL USA	University of Alabama System; University of Alabama Tuscaloosa	Whelan, NV (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	nwhelan@crimson.ua.edu		Whelan, Nathan/0000-0002-3542-2102; Harris, Phillip/0000-0003-3215-2167	University of Alabama Department of Biological Sciences and Conchologists of America	University of Alabama Department of Biological Sciences and Conchologists of America	Culturing of L. compacta was done under a State Wildlife Grant Agreement with the U.S. Fish and Wildlife Service and the Alabama Department of Conservation and Natural Resources. The University of Alabama Department of Biological Sciences and Conchologists of America provided grants to N.V. Whelan for fieldwork and SEM work. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEM, 2009, FIN TOT MAX DAIL LOA; AHLSTEDT SA, 1991, AM MALACOL BULL, V8, P139; Anthony JG, 1854, ANN LYCEUM NATURAL H, V6, P122; Bogan AE, 2000, IUCN 2011 RED LIST T; Bogan AE, 1993, SURVEY AQUATIC UNPUB; Burch J. B., 1980, WALKERANA, V3, P1; Fukuda H, 2008, ZOOSYMPOSIA, V1, P15, DOI 10.11646/zoosymposia.1.1.5; George AL, 2009, FISHERIES, V34, P529, DOI 10.1577/1548-8446-34.11.529; Goodrich C., 1941, Occasional Papers of the Museum of Zoology University of Michigan Ann Arbor, VNo. 428, P1; Goodrich C, 1922, U MICHIGAN MUSEUM ZO, V7, P63; GRAF DL, 2001, WALKERANA, V12, P1; Holznagel WE, 1998, AM MALACOL BULL, V14, P181; Howard HS, 2002, CAHABA RUVER BIOL WA; Huryn AD, 1997, FUNCT ECOL, V11, P472, DOI 10.1046/j.1365-2435.1997.00116.x; IUCN, 1998, IUCN GUID REINTR; Johnson PD, 2010, INTERIM REPORT UNPUB; Johnson PD, 2001, STATUS LEPTOXI UNPUB; Johnson PD, 2006, INVENTORY FRES UNPUB; Johnson PD, 2010, PROPOSED REINT UNPUB; Johnson PD, 2012, FISHERIES IN PRESS; Kappes H, 2012, AQUAT SCI, V74, P1, DOI 10.1007/s00027-011-0187-6; LYDEARD C, 1995, CONSERV BIOL, V9, P800, DOI 10.1046/j.1523-1739.1995.09040800.x; Lysne SJ, 2008, J N AM BENTHOL SOC, V27, P463, DOI 10.1899/07-061.1; Minton RL, 2003, P BIOL SOC WASH, V116, P531; Minton RL, 2002, NAUTILUS, V116, P39; MRB Mollusc Recovery Committee, 2010, PLAN POP REST CONS I; NEVES RJ, 1997, AQUATIC FAUNA PERIL; O Foighil Diarmaid, 2011, PLoS One, V6, pe20496, DOI 10.1371/journal.pone.0020496; Regnier C, 2009, CONSERV BIOL, V23, P1214, DOI 10.1111/j.1523-1739.2009.01245.x; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Roberts DL, 2010, CONSERV BIOL, V24, P189, DOI 10.1111/j.1523-1739.2009.01292.x; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Shepard Thomas E., 1994, Geological Survey of Alabama Bulletin, V160, P1; Tolley-Jordan LR, 2008, BIOL PLEUROCERIDAE G; Turgeon D.D., 1998, COMMON SCI NAMES AQU; USFWS, 2010, FED REGISTER, V75, P67512; USFWS, 1998, FED REGISTER, V63, P57610; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Whelan NV, 2012, J MOLLUS STUD, V78, P231, DOI 10.1093/mollus/eys005; Williams JD., 2008, FRESHWATER MUSSELS A	40	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42499	10.1371/journal.pone.0042499	http://dx.doi.org/10.1371/journal.pone.0042499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905139	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100043
J	Zedelius, CM; Veling, H; Bijleveld, E; Aarts, H				Zedelius, Claire M.; Veling, Harm; Bijleveld, Erik; Aarts, Henk			Promising High Monetary Rewards for Future Task Performance Increases Intermediate Task Performance	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; SPEED-ACCURACY TRADEOFF; INCENTIVES; INFORMATION; COMPATIBILITY; FACILITATION; ACTIVATION; MOTIVATION; ATTENTION; FRAMEWORK	In everyday life contexts and work settings, monetary rewards are often contingent on future performance. Based on research showing that the anticipation of rewards causes improved task performance through enhanced task preparation, the present study tested the hypothesis that the promise of monetary rewards for future performance would not only increase future performance, but also performance on an unrewarded intermediate task. Participants performed an auditory Simon task in which they responded to two consecutive tones. While participants could earn high vs. low monetary rewards for fast responses to every second tone, their responses to the first tone were not rewarded. Moreover, we compared performance under conditions in which reward information could prompt strategic performance adjustments (i.e., when reward information was presented for a relatively long duration) to conditions preventing strategic performance adjustments (i.e., when reward information was presented very briefly). Results showed that high (vs. low) rewards sped up both rewarded and intermediate, unrewarded responses, and the effect was independent of the duration of reward presentation. Moreover, long presentation led to a speed-accuracy trade-off for both rewarded and unrewarded tones, whereas short presentation sped up responses to rewarded and unrewarded tones without this trade-off. These results suggest that high rewards for future performance boost intermediate performance due to enhanced task preparation, and they do so regardless whether people respond to rewards in a strategic or non-strategic manner.	[Zedelius, Claire M.; Veling, Harm; Bijleveld, Erik; Aarts, Henk] Univ Utrecht, Dept Social Psychol, Utrecht, Netherlands	Utrecht University	Zedelius, CM (corresponding author), Univ Utrecht, Dept Social Psychol, Utrecht, Netherlands.	c.m.zedelius@uu.nl		Veling, Harm/0000-0002-5648-2980	Netherlands Organization for Scientific Research [VICI-grant 453-06-002]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The work in this paper was supported by VICI-grant 453-06-002 from the Netherlands Organization for Scientific Research (http://www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2004, J PERS SOC PSYCHOL, V87, P23, DOI 10.1037/0022-3514.87.1.23; Bijleveld E, 2012, CURR DIR PSYCHOL SCI, V21, P194, DOI 10.1177/0963721412438463; Bijleveld E, 2010, COGNITION, V115, P330, DOI 10.1016/j.cognition.2009.12.012; Bijleveld E, 2009, PSYCHOL SCI, V20, P1313, DOI 10.1111/j.1467-9280.2009.02443.x; Bonner SE, 2002, ACCOUNT ORG SOC, V27, P303, DOI 10.1016/S0361-3682(01)00052-6; Bosmans A, 2010, J CONSUM RES, V37, P98, DOI 10.1086/648520; BREHM JW, 1989, ANNU REV PSYCHOL, V40, P109, DOI 10.1146/annurev.ps.40.020189.000545; Capa RL, 2011, EXP PSYCHOL, V58, P370, DOI 10.1027/1618-3169/a000104; DECI EL, 1976, ORGAN DYN, V4, P61, DOI 10.1016/0090-2616(76)90036-X; Forster J, 2005, J EXP SOC PSYCHOL, V41, P220, DOI 10.1016/j.jesp.2004.06.009; Gendolla G, 2012, OXFORD HDB MOTIVATIO; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Heitz RP, 2008, PSYCHOPHYSIOLOGY, V45, P119, DOI 10.1111/j.1469-8986.2007.00605.x; Hubner R, 2010, PSYCHON B REV, V17, P821, DOI 10.3758/PBR.17.6.821; Hull C., 1943, PRINCIPLES BEHAV; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Jenkins GD, 1998, J APPL PSYCHOL, V83, P777, DOI 10.1037/0021-9010.83.5.777; Job V, 2010, PSYCHOL SCI, V21, P1686, DOI 10.1177/0956797610384745; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kool W, 2010, J EXP PSYCHOL GEN, V139, P665, DOI 10.1037/a0020198; Kuhl J, 1999, J EXP PSYCHOL GEN, V128, P382, DOI 10.1037/0096-3445.128.3.382; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MCGRAW KO, 1982, J PERS, V50, P58, DOI 10.1111/j.1467-6494.1982.tb00745.x; MILLER J, 1987, J EXP PSYCHOL HUMAN, V13, P425, DOI 10.1037/0096-1523.13.3.425; Min BK, 2007, NEUROSCI LETT, V422, P131, DOI 10.1016/j.neulet.2007.06.013; Min BK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-79; Mir P, 2011, EXP BRAIN RES, V209, P551, DOI 10.1007/s00221-011-2583-5; Monsell S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P3; Morsella E, 2010, SOC COGNITION, V28, P641, DOI 10.1521/soco.2010.28.5.641; Oah S, 1991, J ORGAN BEHAV MANAGE, V12, P85; Osman A, 2000, BIOL PSYCHOL, V51, P173, DOI 10.1016/S0301-0511(99)00045-9; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Pink D., 2009, DRIVE SUPRISING TRUT; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Prendergast C, 1999, J ECON LIT, V37, P7, DOI 10.1257/jel.37.1.7; Roswarski TE, 2000, PSYCHOL RES-PSYCH FO, V63, P148, DOI 10.1007/PL00008173; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Savine AC, 2010, J NEUROSCI, V30, P10294, DOI 10.1523/JNEUROSCI.2052-10.2010; Schneider W., 2002, E PRIME VERSION 20 C; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; SIMON JR, 1969, J APPL PSYCHOL, V53, P433, DOI 10.1037/h0028034; Tandonnet C, 2012, PSYCHOPHYSIOLOGY, V49, P252, DOI 10.1111/j.1469-8986.2011.01301.x; TERBORG JR, 1978, J APPL PSYCHOL, V63, P29, DOI 10.1037/0021-9010.63.1.29; van Steenbergen H, 2009, PSYCHOL SCI, V20, P1473, DOI 10.1111/j.1467-9280.2009.02470.x; Veling H, 2010, MOTIV EMOTION, V34, P184, DOI 10.1007/s11031-010-9160-2; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; Wascher E, 2001, J EXP PSYCHOL HUMAN, V27, P731, DOI 10.1037//0096-1523.27.3.731; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; Zedelius CM, 2011, CONSCIOUS COGN, V20, P355, DOI 10.1016/j.concog.2010.05.001	50	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42547	10.1371/journal.pone.0042547	http://dx.doi.org/10.1371/journal.pone.0042547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905145	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100047
J	Togo, T				Togo, Tatsuru			Cell Membrane Disruption Stimulates NO/PKG Signaling and Potentiates Cell Membrane Repair in Neighboring Cells	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASES; LONG-TERM POTENTIATION; PLASMA-MEMBRANE; CA2+-REGULATED EXOCYTOSIS; REGULATED EXOCYTOSIS; NITRIC-OXIDE; RELEASE; EXPRESSION; MECHANISM	Resealing of a disrupted plasma membrane at the micron-diameter range requires Ca2+-regulated exocytosis. Repeated membrane disruptions reseal more quickly than the initial wound, and this potentiation of membrane resealing persists for at least 24 hours after the initial wound. Long-term potentiation of membrane resealing requires CREB-dependent gene expression, which is activated by the PKC- and p38 MAPK-dependent pathway in a wounded cell. The present study demonstrates that membrane resealing is potentiated in both wounded and neighboring cells in MDCK cells. Wounding of cells expressing CREB133, a mutant variant of CREB, does not show the potentiated response of cell membrane resealing in either wounded or neighboring cells. Furthermore, wounding of cells induces CREB phosphorylation, not only in wounded cells, but also in neighboring cells. Inhibition of the nitric oxide/PKG signaling pathway suppresses CREB phosphorylation in neighboring cells, but not in wounded cells. The potentiation of membrane resealing in neighboring cells is suppressed if the nitric oxide/PKG pathway is inhibited during the initial wound. Together, these results suggest that the nitric oxide/PKG pathway stimulates CREB phosphorylation in neighboring cells so that subsequent cell membrane disruptions of the neighboring cells reseal more quickly.	St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan	Saint Marianna University	Togo, T (corresponding author), St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan.	togot@marianna-u.ac.jp	Togo, Tatsuru/D-5365-2011	Togo, Tatsuru/0000-0003-3015-6367	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Covian-Nares JF, 2010, J CELL SCI, V123, P1884, DOI 10.1242/jcs.066084; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Grembowicz KP, 1999, MOL BIOL CELL, V10, P1247, DOI 10.1091/mbc.10.4.1247; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KITA Y, 1994, EUR J PHARMACOL, V257, P123, DOI 10.1016/0014-2999(94)90703-X; McNeil PL, 2000, J CELL SCI, V113, P1891; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Sammak PJ, 1997, J CELL SCI, V110, P465; Shen SS, 2005, CURR EYE RES, V30, P543, DOI 10.1080/02713680590968574; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; SWANSON JA, 1987, SCIENCE, V238, P548, DOI 10.1126/science.2443981; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Togo T, 2006, J CELL SCI, V119, P2780, DOI 10.1242/jcs.03006; Togo T, 2004, J BIOL CHEM, V279, P44996, DOI 10.1074/jbc.M406327200; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Togo T, 2003, MOL BIOL CELL, V14, P93, DOI 10.1091/mbc.E02-01-0056; Togo T, 1999, J CELL SCI, V112, P719; Togo T, 2000, MOL BIOL CELL, V11, P4339, DOI 10.1091/mbc.11.12.4339; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42885	10.1371/journal.pone.0042885	http://dx.doi.org/10.1371/journal.pone.0042885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880128	gold, Green Submitted, Green Published			2022-12-27	WOS:000307437900058
J	Poethko-Muller, C; Mankertz, A				Poethko-Mueller, Christina; Mankertz, Annette			Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for Seronegativity	PLOS ONE			English	Article							LONG-TERM PERSISTENCE; VACCINATION COVERAGE; VIRUS-ANTIBODIES; MMR VACCINATION; LARGE OUTBREAK; BORN CHILDREN; POPULATION; SEROEPIDEMIOLOGY; IMMUNITY; TITERS	We have undertaken a seroprevalence study with more than 13,000 children, who had been included in the German KIGGS survey, a representative sample of children and adolescents 0-17 years of age. The IgG titres against measles, mumps and rubella were determined in 1 to 17 year olds While 88.8% of the children were MMR-vaccinated at least once, 76.8% of children aged 1 to 17 years showed prevalence of antibodies to MMR. The highest seronegativity was seen with respect to mumps. Gender differences were most pronounced with regard to rubella IgG titres: girls aged 14 to 17 years were best protected, although seronegativity in 6.8% of this vulnerable group still shows the need of improvement. Search for predictors of missing seroprevalence identified young age to be the most important predictor. Children living in the former West and children born outside of Germany had a higher risk of lacking protection against measles and rubella, while children with a migration background but born in Germany were less often seronegative to measles antibodies than their German contemporaries. An association of seronegativity and early vaccination was seen for measles but not for mumps and rubella. A high maternal educational level was associated with seronegativity to measles and rubella. In vaccinated children, seronegativity was highest for mumps and lowest for rubella. For mumps, high differences were observed for seronegativity after one-dose and two-dose vaccination, respectively. Seronegativity increases as time since last vaccination passes thus indicating significant waning effects for all three components of MMR.	[Poethko-Mueller, Christina] Robert Koch Inst, Dept Epidemiol & Hlth Reporting, Berlin, Germany; [Mankertz, Annette] Robert Koch Inst, Div Viral Infect, Natl Reference Ctr, Berlin, Germany; [Mankertz, Annette] Robert Koch Inst, RRL WHO EURO, Berlin, Germany; [Mankertz, Annette] Robert Koch Inst, MMR, Berlin, Germany	Robert Koch Institute; Robert Koch Institute; Robert Koch Institute; Robert Koch Institute	Poethko-Muller, C (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Reporting, Berlin, Germany.	poethko-muellerc@rki.de		Mankertz, Annette/0000-0002-0131-5739	German Federal Ministry of Health; Ministry of Education and Research; Federal Ministry of Food, Agriculture and Consumer Protection	German Federal Ministry of Health; Ministry of Education and Research; Federal Ministry of Food, Agriculture and Consumer Protection	The KiGGS study was funded by the German Federal Ministry of Health (http://www.bmg.bund.de/), the Ministry of Education and Research (http://www.bmbf.de) and the Federal Ministry of Food, Agriculture and Consumer Protection (http://www.bmelv.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P349; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P51; Borras E, 2007, VACCINE, V25, P3240, DOI 10.1016/j.vaccine.2007.01.026; BRISS PA, 1994, J INFECT DIS, V169, P77, DOI 10.1093/infdis/169.1.77; Campbell H, 2007, INT J EPIDEMIOL, V36, P1334, DOI 10.1093/ije/dym207; CHEEK JE, 1995, ARCH PEDIAT ADOL MED, V149, P774, DOI 10.1001/archpedi.1995.02170200064010; Chen MH, 2007, J VIROL METHODS, V146, P414, DOI 10.1016/j.jviromet.2007.08.021; Chu SY, 2004, AM J PUBLIC HEALTH, V94, P973, DOI 10.2105/AJPH.94.6.973; Cohen BJ, 2006, J VIROL METHODS, V131, P209, DOI 10.1016/j.jviromet.2005.08.001; Cortese MM, 2011, J INFECT DIS, V204, P1413, DOI 10.1093/infdis/jir526; Date AA, 2008, J INFECT DIS, V197, P1662, DOI 10.1086/588197; DAVIDKIN I, 1995, VACCINE, V13, P1617, DOI 10.1016/0264-410X(95)00064-8; Davidkin I, 1998, VACCINE, V16, P2052, DOI 10.1016/S0264-410X(98)00081-4; Deeks SL, 2011, CAN MED ASSOC J, V183, P1014, DOI 10.1503/cmaj.101371; ENDERS G, 1988, LANCET, V1, P1445; Galazka AM, 1999, B WORLD HEALTH ORGAN, V77, P3; Gonzalez PP, 2011, ATEN PRIMARIA; Hanna-Wakim R, 2008, J INFECT DIS, V197, P1669, DOI 10.1086/588195; HERSH BS, 1991, J PEDIATR-US, V119, P187, DOI 10.1016/S0022-3476(05)80726-7; Johnson CE, 1996, PEDIATR INFECT DIS J, V15, P687, DOI 10.1097/00006454-199608000-00010; Kalies H, 2006, EUR J PEDIATR, V165, P30, DOI 10.1007/s00431-005-1758-0; Kalies H, 2006, PEDIATR INFECT DIS J, V25, P507, DOI 10.1097/01.inf.0000222413.47344.23; Koch-Institut: R, 2012, SURVSTAT; Kremer JR, 2006, VACCINE, V24, P2594, DOI 10.1016/j.vaccine.2005.12.015; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Kutty PK, 2010, J INFECT DIS, V202, P667, DOI 10.1086/655394; Lee MS, 2001, VACCINE, V19, P4644, DOI 10.1016/S0264-410X(01)00239-0; Mankertz A, 2011, EMERG INFECT DIS, V17, P1396, DOI 10.3201/eid1708.101994; Marin M, 2008, VACCINE, V26, P3601, DOI 10.1016/j.vaccine.2008.04.075; Mauldin J, 2005, J CLIN MICROBIOL, V43, P4847, DOI 10.1128/JCM.43.9.4847-4851.2005; MILLER E, 1982, LANCET, V2, P781; Mitchell LA, 1998, CAN J PUBLIC HEALTH, V89, P325, DOI 10.1007/BF03404484; MOSSONG J, 2009, EURO SURVEILL, V14; Muhsen K, 2011, VACCINE, V29, P3878, DOI 10.1016/j.vaccine.2011.03.047; Nardone A, 2003, EPIDEMIOL INFECT, V131, P691, DOI 10.1017/S0950268803008768; Otto W, 2010, EURO SURVEILL, V15; Pebody RG, 2002, VACCINE, V20, P1134, DOI 10.1016/S0264-410X(01)00435-2; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Poethko-Mueller C, 2007, BUNDESGESUNDHEITSBLA, V50, P851, DOI 10.1007/s00103-007-0248-0; Poethko-Muller C, 2011, VACCINE, V29, P7949, DOI 10.1016/j.vaccine.2011.08.081; Poethko-Muller C, 2009, VACCINE, V27, P2563, DOI 10.1016/j.vaccine.2009.02.009; Quinlisk MP, 2010, J INFECT DIS, V202, P655, DOI 10.1086/655395; Ramsay M, 1999, 010105 EURICDCMDS; Schmid D, 2006, EUROSURVEILLANCE, V11; Siedler A, 2006, Euro Surveill, V11, P131; SULLIVAN KM, 1985, AM J DIS CHILD, V139, P909, DOI 10.1001/archpedi.1985.02140110063030; Sun WY, 1998, PUBLIC HEALTH, V112, P405, DOI 10.1016/S0033-3506(98)00287-X; Theeten H, 2011, EPIDEMIOL INFECT, V139, P494, DOI 10.1017/S0950268810001536; Vaidya SR, 2010, J VIROL METHODS, V163, P153, DOI 10.1016/j.jviromet.2009.09.006; van der Wal MF, 2005, ARCH DIS CHILD, V90, P36, DOI 10.1136/adc.2003.047126; Vandermeulen C, 2004, VACCINE, V22, P2713, DOI 10.1016/j.vaccine.2004.02.001; Vandermeulen C, 2007, VACCINE, V25, P6672, DOI 10.1016/j.vaccine.2007.07.008; Waldhoer T, 1997, EUR J EPIDEMIOL, V13, P145, DOI 10.1023/A:1007359632218; WHARTON M, 1988, J INFECT DIS, V158, P1253, DOI 10.1093/infdis/158.6.1253; Whelan J, 2010, EURO SURVEILL, V15; Whyte D, 2009, EURO SURVEILL, V14	58	77	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42867	10.1371/journal.pone.0042867	http://dx.doi.org/10.1371/journal.pone.0042867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880124	gold, Green Published			2022-12-27	WOS:000307810000079
J	Tarroux, A; Bety, J; Gauthier, G; Berteaux, D				Tarroux, Arnaud; Bety, Joel; Gauthier, Gilles; Berteaux, Dominique			The Marine Side of a Terrestrial Carnivore: Intra-Population Variation in Use of Allochthonous Resources by Arctic Foxes	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; TROPHIC NICHE WIDTH; ALOPEX-LAGOPUS; FOOD-WEB; INDIVIDUAL SPECIALIZATION; LIPID EXTRACTION; CYCLIC DYNAMICS; CARBON ISOTOPES; LEMMING CYCLES; CLIMATE-CHANGE	Inter-individual variation in diet within generalist animal populations is thought to be a widespread phenomenon but its potential causes are poorly known. Inter-individual variation can be amplified by the availability and use of allochthonous resources, i.e., resources coming from spatially distinct ecosystems. Using a wild population of arctic fox as a study model, we tested hypotheses that could explain variation in both population and individual isotopic niches, used here as proxy for the trophic niche. The arctic fox is an opportunistic forager, dwelling in terrestrial and marine environments characterized by strong spatial (arctic-nesting birds) and temporal (cyclic lemmings) fluctuations in resource abundance. First, we tested the hypothesis that generalist foraging habits, in association with temporal variation in prey accessibility, should induce temporal changes in isotopic niche width and diet. Second, we investigated whether within-population variation in the isotopic niche could be explained by individual characteristics (sex and breeding status) and environmental factors (spatiotemporal variation in prey availability). We addressed these questions using isotopic analysis and Bayesian mixing models in conjunction with linear mixed-effects models. We found that: i) arctic fox populations can simultaneously undergo short-term (i.e., within a few months) reduction in both isotopic niche width and inter-individual variability in isotopic ratios, ii) individual isotopic ratios were higher and more representative of a marine-based diet for non-breeding than breeding foxes early in spring, and iii) lemming population cycles did not appear to directly influence the diet of individual foxes after taking their breeding status into account. However, lemming abundance was correlated to proportion of breeding foxes, and could thus indirectly affect the diet at the population scale.	[Tarroux, Arnaud; Bety, Joel; Berteaux, Dominique] Univ Quebec, Chaire Rech Canada Conservat Ecosyst Nord, Rimouski, PQ G5L 3A1, Canada; [Tarroux, Arnaud; Bety, Joel; Berteaux, Dominique] Univ Quebec, Ctr Etud Nord, Rimouski, PQ G5L 3A1, Canada; [Gauthier, Gilles] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Gauthier, Gilles] Univ Laval, Ctr Etud, Quebec City, PQ, Canada	University of Quebec; University of Quebec; Laval University; Laval University	Tarroux, A (corresponding author), Univ Quebec, Chaire Rech Canada Conservat Ecosyst Nord, Rimouski, PQ G5L 3A1, Canada.	arnaud.tarroux@gmail.com; dominique_berteaux@uqar.qc.ca	Tarroux, Arnaud/AAE-5173-2021; Berteaux, Dominique/J-3276-2016	Tarroux, Arnaud/0000-0001-8306-6694; Berteaux, Dominique/0000-0003-2728-5985; Bety, Joel/0000-0002-8775-6411	National Sciences & Engineering Research Council Northern Research Internship; Canada Foundation for Innovation; Canada Research Chairs; Centre d'Etudes Nordiques; Environment Canada; Fonds Quebecois de la Recherche sur la Nature et les Technologies; Indian and Northern Affairs Canada; Natural Sciences and Engineering Research Council of Canada (NSERC); Networks of Centres of Excellence of Canada ArcticNet; Nunavut Wildlife Management Board; Parks Canada; Polar Continental Shelf Program; Universite du Quebec a Rimouski (UQAR); Universite Laval	National Sciences & Engineering Research Council Northern Research Internship; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs(Canada Research ChairsCGIAR); Centre d'Etudes Nordiques; Environment Canada(CGIAR); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT); Indian and Northern Affairs Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Networks of Centres of Excellence of Canada ArcticNet; Nunavut Wildlife Management Board; Parks Canada; Polar Continental Shelf Program; Universite du Quebec a Rimouski (UQAR); Universite Laval	This study was partly funded by an National Sciences & Engineering Research Council Northern Research Internship to A. Tarroux. This study was also supported by (alphabetical order): Canada Foundation for Innovation, Canada Research Chairs, Centre d'Etudes Nordiques, Environment Canada, Fonds Quebecois de la Recherche sur la Nature et les Technologies, Indian and Northern Affairs Canada, Natural Sciences and Engineering Research Council of Canada (NSERC), Networks of Centres of Excellence of Canada ArcticNet, Nunavut Wildlife Management Board, Parks Canada, Polar Continental Shelf Program, Universite du Quebec a Rimouski (UQAR), and Universite Laval. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerbjorn A, 1999, J ANIM ECOL, V68, P34, DOI 10.1046/j.1365-2656.1999.00258.x; ANGERBJORN A, 1994, OECOLOGIA, V99, P226, DOI 10.1007/BF00627734; Araujo MS, 2010, OIKOS, V119, P81, DOI 10.1111/j.1600-0706.2009.17624.x; Audet Alexandra M., 2002, Mammalian Species, V713, P1, DOI 10.1644/1545-1410(2002)713<0001:AL>2.0.CO;2; Bates D., 2010, LINEAR FIXED EFFECTS; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; BenDavid M, 1997, OECOLOGIA, V111, P280, DOI 10.1007/s004420050236; Bety J, 2003, AM NAT, V162, P110, DOI 10.1086/375680; Bety J, 2002, J ANIM ECOL, V71, P88, DOI 10.1046/j.0021-8790.2001.00581.x; Bety J, 2001, OIKOS, V93, P388, DOI 10.1034/j.1600-0706.2001.930304.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cadieux M. - C., 2008, MONITORING ENV ECOLO; Careau V, 2008, ECOSCIENCE, V15, P268, DOI 10.2980/15-2-3097; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Dalerum F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032071; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Dehn LA, 2006, SCI TOTAL ENVIRON, V362, P103, DOI 10.1016/j.scitotenv.2005.11.012; Duchesne D, 2011, OECOLOGIA, V167, P967, DOI 10.1007/s00442-011-2045-6; Elmhagen B, 2000, J ZOOL, V251, P139, DOI 10.1111/j.1469-7998.2000.tb00599.x; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Flaherty EA, 2010, OIKOS, V119, P1409, DOI 10.1111/j.1600-0706.2010.18259.x; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Forero MG, 2004, J ANIM ECOL, V73, P789, DOI 10.1111/j.0021-8790.2004.00852.x; Gagnon CA, 2009, ECOL SOC, V14; Gauthier G, 2011, ECOSCIENCE, V18, P223, DOI 10.2980/18-3-3453; Gilg O, 2003, SCIENCE, V302, P866, DOI 10.1126/science.1087509; Giroux MA, 2012, J ANIM ECOL, V81, P533, DOI 10.1111/j.1365-2656.2011.01944.x; GRANT PR, 1976, P NATL ACAD SCI USA, V73, P257, DOI 10.1073/pnas.73.1.257; Gruyer N, 2008, CAN J ZOOL, V86, P910, DOI 10.1139/Z08-059; Habran S, 2010, MAR MAMMAL SCI, V26, P880, DOI 10.1111/j.1748-7692.2010.00372.x; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Huxel GR, 2002, ECOL RES, V17, P419, DOI 10.1046/j.1440-1703.2002.00501.x; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Jardine TD, 2005, OECOLOGIA, V144, P528, DOI 10.1007/s00442-005-0013-8; Killengreen ST, 2011, J ANIM ECOL, V80, P1049, DOI 10.1111/j.1365-2656.2011.01840.x; Krebs CJ, 2003, CAN J ZOOL, V81, P827, DOI [10.1139/z03-061, 10.1139/Z03-061]; Krebs CJ, 2002, CAN J ZOOL, V80, P1323, DOI 10.1139/Z02-120; Kurle CM, 2002, CAN J ZOOL, V80, P902, DOI 10.1139/Z02-069; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; Legagneux P., 2012, ECOLOGY IN PRESS, DOI [10.1890/11-1973.1, DOI 10.1890/11-1973.1]; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; Morrissette M, 2010, OIKOS, V119, P1181, DOI 10.1111/j.1600-0706.2009.18079.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Pamperin NJ, 2008, POLAR BIOL, V31, P1421, DOI 10.1007/s00300-008-0481-5; Parnell A, 2010, SIAR STABLE ISOTOPE; Pinheiro J, 2001, MIXED EFFECTS MODELS; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Polischuk SC, 2001, CAN J ZOOL, V79, P499, DOI 10.1139/cjz-79-3-499; POND CM, 1995, J ZOOL, V236, P593, DOI 10.1111/j.1469-7998.1995.tb02734.x; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed A, 2002, PATTERNS DISTRIBUTIO, P53; Roth JD, 2003, J ANIM ECOL, V72, P668, DOI 10.1046/j.1365-2656.2003.00739.x; Roth JD, 2002, OECOLOGIA, V133, P70, DOI 10.1007/s00442-002-1004-7; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; SMITH TG, 1976, CAN J ZOOL, V54, P1610, DOI 10.1139/z76-188; Stapp P, 2003, OECOLOGIA, V134, P496, DOI 10.1007/s00442-002-1146-7; Svanback R, 2005, EVOL ECOL RES, V7, P993; Svanback R, 2008, OIKOS, V117, P114, DOI 10.1111/j.2007.0030-1299.16267.x; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Szepanski MM, 1999, OECOLOGIA, V120, P327, DOI 10.1007/s004420050866; Szor G, 2008, POLAR BIOL, V31, P351, DOI 10.1007/s00300-007-0364-1; Tarroux A, 2010, METHODS ECOL EVOL, V1, P231, DOI 10.1111/j.2041-210X.2010.00033.x; Tarroux A, 2010, POLAR BIOL, V33, P1021, DOI 10.1007/s00300-010-0780-5; Therrien JF, 2011, J AVIAN BIOL, V42, P363, DOI 10.1111/j.1600-048X.2011.05330.x; Turner TF, 2010, ECOLOGY, V91, P2227, DOI 10.1890/09-1454.1; Urton EJM, 2005, OECOLOGIA, V145, P317, DOI 10.1007/s00442-005-0124-2; Van VALEN LEIGH, 1965, AMER NATUR, V99, P377, DOI 10.1086/282379; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Willson JD, 2010, OIKOS, V119, P1161, DOI 10.1111/j.1600-0706.2009.17939.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	82	33	33	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42427	10.1371/journal.pone.0042427	http://dx.doi.org/10.1371/journal.pone.0042427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22900021	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100089
J	Tian, XL; Wang, SY; Zhang, Z; Lv, DC				Tian, Xiliang; Wang, Shouyu; Zhang, Zhen; Lv, Decheng			Rat Bone Marrow-Derived Schwann-Like Cells Differentiated by the Optimal Inducers Combination on Microfluidic Chip and Their Functional Performance	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PERIPHERAL-NERVE REGENERATION; STROMAL CELLS; IN-VITRO; NEUROTROPHIC FACTOR; MYELINATION; TRANSPLANTATION; PHENOTYPE; OUTGROWTH; LINEAGE	Numerous researches demonstrated the possibility of derivation of Schwann-like (SC-like) cells in vitro from bone marrow stromal cells (BMSCs). However, the concentration of the induce factors were different in those studies, especially for the critical factors forskolin (FSK) and beta-heregulin (HRG). Here, we used a new and useful method to build an integrated microfluidic chip for rapid analyses of the optimal combination between the induce factors FSK and HRG. The microfluidic device was mainly composed of an upstream concentration gradient generator (CGG) and a downstream cell culture module. Rat BMSCs were cultured in the cell chambers for 11 days at the different concentrations of induce factors generated by CGG. The result of immunofluorescence staining on-chip showed that the group of 4.00 mu M FSK and 250.00 ng/ml HRG presented an optimal effect to promote the derivation of SC-like cells. Moreover, the optimal SC-like cells obtained on-chip were further tested using DRG co-culture and ELISA to detect their functional performance. Our findings demonstrate that SC-like cells could be obtained with high efficiency and functional performance in the optimal inducers combination.	[Tian, Xiliang; Wang, Shouyu; Zhang, Zhen; Lv, Decheng] Dalian Med Univ, Dept Orthoped, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China	Dalian Medical University	Wang, SY (corresponding author), Dalian Med Univ, Dept Orthoped, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China.	wangshouyu666.student@sina.com; lvdecheng88@sina.com			National Nature Science Foundation of China [30901950]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Nature Science Foundation of China (30901950). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao QA, 2011, BIOMATERIALS, V32, P787, DOI 10.1016/j.biomaterials.2010.09.046; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Brohlin M, 2009, NEUROSCI RES, V64, P41, DOI 10.1016/j.neures.2009.01.010; Bunge RP, 1994, J NEUROL S1, V242, pS19; Caddick J, 2006, GLIA, V54, P840, DOI 10.1002/glia.20421; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; De Groot DM, 2006, MOL ENDOCRINOL, V20, P2987, DOI 10.1210/me.2006-0168; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; Dezawa M, 2000, PROG RETIN EYE RES, V19, P171, DOI 10.1016/S1350-9462(99)00010-5; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Hou SY, 2006, NEUROSCIENCE, V140, P101, DOI 10.1016/j.neuroscience.2006.01.066; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kamada T, 2005, J NEUROPATH EXP NEUR, V64, P37, DOI 10.1093/jnen/64.1.37; Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021; Kim C, 2011, LAB CHIP, V11, P874, DOI [10.1039/c0lc00516a, 10.1039/c01c00516a]; Kim HA, 2001, J NEUROSCI, V21, P1110; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Liu L, 2010, BIOMED MICRODEVICES, V12, P505, DOI 10.1007/s10544-010-9407-4; Mahay D, 2008, EXP CELL RES, V314, P2692, DOI 10.1016/j.yexcr.2008.05.013; Mahay D, 2008, BIOTECHNOL APPL BIOC, V51, P167, DOI 10.1042/BA20070212; Ng BK, 2007, J NEUROSCI, V27, P7597, DOI 10.1523/JNEUROSCI.0563-07.2007; Peng JA, 2011, BRAIN RES BULL, V84, P235, DOI 10.1016/j.brainresbull.2010.12.013; Roobrouck VD, 2008, EXP CELL RES, V314, P1937, DOI 10.1016/j.yexcr.2008.03.006; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shimizu S, 2007, BIOCHEM BIOPH RES CO, V359, P915, DOI 10.1016/j.bbrc.2007.05.212; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; Todd KJ, 2007, EUR J NEUROSCI, V25, P1287, DOI 10.1111/j.1460-9568.2007.05385.x; Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077; Tong L, 2010, BIOCHEM BIOPH RES CO, V401, P592, DOI 10.1016/j.bbrc.2010.09.107; Tourovskaia A, 2006, NAT PROTOC, V1, P1092, DOI 10.1038/nprot.2006.123; Wang D, 2008, BRAIN RES, V1188, P44, DOI 10.1016/j.brainres.2007.09.098; Wiberg Mikael, 2003, Surg Technol Int, V11, P303; Zhao FQ, 2005, BIOMED ENVIRON SCI, V18, P326; Zhao LX, 2004, EXP NEUROL, V190, P396, DOI 10.1016/j.expneurol.2004.06.025	38	7	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42804	10.1371/journal.pone.0042804	http://dx.doi.org/10.1371/journal.pone.0042804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880114	gold, Green Published, Green Submitted			2022-12-27	WOS:000307284100174
J	Porritt, MJ; Andersson, HC; Hou, L; Nilsson, A; Pekna, M; Pekny, M; Nilsson, M				Porritt, Michelle J.; Andersson, Helene C.; Hou, Linda; Nilsson, Asa; Pekna, Marcela; Pekny, Milos; Nilsson, Michael			Photothrombosis-Induced Infarction of the Mouse Cerebral Cortex Is Not Affected by the Nrf2-Activator Sulforaphane	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; ACUTE ISCHEMIC-STROKE; GENE-EXPRESSION; RAT; INJURY; BRAIN; PROTECTION; DAMAGE; INDUCTION; OXIDOREDUCTASE-1	Sulforaphane-induced activation of the transcription factor NF-E2 related factor 2 (Nrf2 or the gene Nfe2l2) and subsequent induction of the phase II antioxidant system has previously been shown to exert neuroprotective action in a transient model of focal cerebral ischemia. However, its ability to attenuate functional and cellular deficits after permanent focal cerebral ischemia is not clear. We assessed the neuroprotective effects of sulforaphane in the photothrombotic model of permanent focal cerebral ischemia. Sulforaphane was administered (5 or 50 mg/kg, i.p.) after ischemic onset either as a single dose or as daily doses for 3 days. Sulforaphane increased transcription of Nrf2, Hmox1, GCLC and GSTA4 mRNA in the brain confirming activation of the Nrf2 system. Single or repeated administration of sulforaphane had no effect on the infarct volume, nor did it reduce the number of activated glial cells or proliferating cells when analyzed 24 and 72 h after stroke. Motor-function as assessed by beam-walking, cylinder-test, and adhesive test, did not improve after sulforaphane treatment. The results show that sulforaphane treatment initiated after photothrombosis-induced permanent cerebral ischemia does not interfere with key cellular mechanisms underlying tissue damage.	[Porritt, Michelle J.; Andersson, Helene C.; Hou, Linda; Pekna, Marcela; Pekny, Milos; Nilsson, Michael] Univ Gothenburg, Ctr Brain Repair & Rehabil CBR, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Nilsson, Asa] Sahlgrens Univ Hosp, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Porritt, MJ (corresponding author), Univ Gothenburg, Ctr Brain Repair & Rehabil CBR, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	michael.nilsson@vgregion.se	Pekna, Marcela/AAM-3249-2021; NILSSON, MICHAEL/ABE-7821-2020; Pekna, Marcela/AAM-3261-2021	Pekna, Marcela/0000-0003-2734-8237; NILSSON, MICHAEL/0000-0002-8826-1621; Pekna, Marcela/0000-0003-2734-8237	STENA research foundation; AFA research foundation; ALF Goteborg; Edit Jacobsson Foundation; Rune and Ulla Amlovs Foundation; Swedish Medical Research Council [11548, 20116]; EduGlia ITN EU grant; Free Mason Foundation; Torsten and Ragnar Soderbergs Foundation	STENA research foundation; AFA research foundation; ALF Goteborg; Edit Jacobsson Foundation; Rune and Ulla Amlovs Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); EduGlia ITN EU grant; Free Mason Foundation; Torsten and Ragnar Soderbergs Foundation	Supported by research grants from the STENA and AFA research foundations (to MN, M. Pekny and M. Pekna), by ALF Goteborg (to MN, M. Pekny and M. Pekna), the Edit Jacobsson Foundation (to MN, MJP, M. Pekna and M. Pekny), the Rune and Ulla Amlovs Foundation (MN, M. Pekna and M. Pekny), by the Swedish Medical Research Council (project 11548 to M. Pekny and 20116 to M. Pekna), EduGlia ITN EU grant (to M. Pekny, MN and M. Pekna), the Free Mason Foundation (M. Pekny) and the Torsten and Ragnar Soderbergs Foundation (M. Pekny, MN and M. Pekna). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom P, 2011, NEUROPHARMACOLOGY, V60, P343, DOI 10.1016/j.neuropharm.2010.09.023; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Chang YY, 1999, NEUROSCI LETT, V277, P61, DOI 10.1016/S0304-3940(99)00799-5; Chen G, 2011, J NEUROSCI RES, V89, P515, DOI 10.1002/jnr.22577; Crack PJ, 2003, J CEREBR BLOOD F MET, V23, P19, DOI 10.1097/01.WCB.0000035181.38851.71; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Demougeot C, 2003, J CEREBR BLOOD F MET, V23, P482, DOI 10.1097/01.WCB.0000050066.57184.60; DeRyck M, 1996, J PHARMACOL EXP THER, V279, P748; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; GROME JJ, 1988, J CEREBR BLOOD F MET, V8, P89, DOI 10.1038/jcbfm.1988.11; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Haupt C, 2007, MOL CELL NEUROSCI, V35, P89, DOI 10.1016/j.mcn.2007.02.005; Hoehn B, 2003, STROKE, V34, P2489, DOI 10.1161/01.STR.0000091268.25816.19; Hubbs AF, 2007, AM J PATHOL, V170, P2068, DOI 10.2353/ajpath.2007.060898; JANDER S, 1995, J CEREBR BLOOD F MET, V15, P42, DOI 10.1038/jcbfm.1995.5; Kang KW, 2002, NITRIC OXIDE-BIOL CH, V7, P244, DOI 10.1016/S1089-8603(02)00117-9; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KHARLAMOV A, 1993, J NEUROSCI, V13, P2483, DOI 10.1523/JNEUROSCI.13-06-02483.1993; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; Lee JK, 2007, SURG NEUROL, V67, P620, DOI 10.1016/j.surneu.2006.08.077; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Mattson MP, 2008, CRIT REV TOXICOL, V38, P633, DOI 10.1080/10408440802026406; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Nowicka D, 2008, ACTA NEUROBIOL EXP, V68, P155; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Ping Z, 2010, BRAIN RES, V1343, P178, DOI 10.1016/j.brainres.2010.04.036; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; SCHROETER M, 1994, J NEUROIMMUNOL, V55, P195, DOI 10.1016/0165-5728(94)90010-8; Shah ZA, 2011, NEUROSCIENCE, V180, P248, DOI 10.1016/j.neuroscience.2011.02.031; SNAPE MF, 1993, NEUROSCIENCE, V53, P837, DOI 10.1016/0306-4522(93)90628-S; So HS, 2006, CELL DEATH DIFFER, V13, P1763, DOI 10.1038/sj.cdd.4401863; Son TG, 2009, J NEUROCHEM; Stankowski JN, 2011, ANTIOXID REDOX SIGN, V14, P1841, DOI 10.1089/ars.2010.3292; Talalay P, 2004, METHOD ENZYMOL, V382, P355; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Yu SS, 2011, NEUROCHEM RES, V36, P339, DOI 10.1007/s11064-010-0335-8; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	43	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41090	10.1371/journal.pone.0041090	http://dx.doi.org/10.1371/journal.pone.0041090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911746	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700040
J	Zhang, HF; Ni, B; Zhao, X; Dadzie, I; Du, H; Wang, Q; Xu, HX; Huang, XX				Zhang, Haifang; Ni, Bin; Zhao, Xin; Dadzie, Isaac; Du, Hong; Wang, Qiang; Xu, Huaxi; Huang, Xinxiang			Fis Is Essential for the Stability of Linear Plasmid pBSSB1 and Affects the Motility of Salmonella enterica Serovar Typhi	PLOS ONE			English	Article							ESCHERICHIA-COLI; TERMINAL PROTEINS; DNA-REPLICATION; STREPTOMYCES; CHROMOSOMES; INSTABILITY; BINDING; GENES; CYCLE	pBSSB1 is a 27 kb non-bacteriophage-related linear plasmid first found in Salmonella enterica serovar Typhi (S. Typhi), but the mechanism underlying the replication of pBSSB1 is currently unknown. Previous reports showed that the factor for inversion stimulation (Fis) encoded by fis can affect the replication, transcription and other processes through binding DNA. Here, a fis deletion mutant of S. Typhi (Delta fis) was prepared through the homologous recombination mediated by suicide plasmid and the loss of pBSSB1 in Delta fis was observed surprisingly by pulsed field gel electrophoresis (PFGE). Subsequently, the loss of pBSSB1 was verified by PCR and Southern blot. In addition, the motility of Delta fis was deficient and the flagellin of Dfis could not be detected by 2-dimensional polyacrylamide gel electrophoresis. All these results show that Fis is essential for the stability of pBSSB1 and affects the motility of S. Typhi.	[Zhang, Haifang; Ni, Bin; Zhao, Xin; Dadzie, Isaac; Du, Hong; Xu, Huaxi; Huang, Xinxiang] Jiangsu Univ, Sch Med Technol, Dept Biochem & Mol Biol, Zhenjiang, Jiangsu, Peoples R China; [Wang, Qiang] Nanjing Univ, Dept Biol, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Jiangsu University; Nanjing University	Zhang, HF (corresponding author), Jiangsu Univ, Sch Med Technol, Dept Biochem & Mol Biol, Zhenjiang, Jiangsu, Peoples R China.	huxinx@yahoo.com.hk	Dadzie, Isaac/AAA-6026-2019	Dadzie, Isaac/0000-0002-2146-6796	National Natural Science Foundation of China [31000076]; Natural Science Foundation for colleges and universities in Jiangsu Province [10KJB310001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for colleges and universities in Jiangsu Province	This work was supported by National Natural Science Foundation of China (31000076) and Natural Science Foundation for colleges and universities in Jiangsu Province (10KJB310001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker S, 2007, PLOS PATHOG, V3, P605, DOI 10.1371/journal.ppat.0030059; Baker S, 2007, MOL MICROBIOL, V66, P1207, DOI 10.1111/j.1365-2958.2007.05995.x; Balding C, 2006, PLASMID, V56, P68, DOI 10.1016/j.plasmid.2005.12.001; Blaby IK, 2009, MICROBIOL-SGM, V155, P2676, DOI 10.1099/mic.0.029777-0; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Cameron ADS, 2011, MOL MICROBIOL, V80, P85, DOI 10.1111/j.1365-2958.2011.07560.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Froelich JM, 1996, J BACTERIOL, V178, P6006, DOI 10.1128/jb.178.20.6006-6012.1996; GILLE H, 1991, NUCLEIC ACIDS RES, V19, P4167, DOI 10.1093/nar/19.15.4167; HAYAKAWA T, 1979, J ANTIBIOT, V32, P1348, DOI 10.7164/antibiotics.32.1348; Huang XX, 2004, FEMS MICROBIOL LETT, V234, P239, DOI 10.1016/j.femsle.2004.03.030; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kelly A, 2004, MICROBIOL-SGM, V150, P2037, DOI 10.1099/mic.0.27209-0; Lobry JR, 2003, CURR OPIN MICROBIOL, V6, P101, DOI 10.1016/S1369-5274(03)00024-9; Picardeau M, 2000, GENOME RES, V10, P1594, DOI 10.1101/gr.124000; PLASTERK RHA, 1985, NATURE, V318, P257, DOI 10.1038/318257a0; Ryan VT, 2004, MOL MICROBIOL, V51, P1347, DOI 10.1046/j.1365-2958.2003.03906.x; SUMMERS DK, 1984, CELL, V36, P1097, DOI 10.1016/0092-8674(84)90060-6; SUMMERS DK, 1993, MOL MICROBIOL, V8, P1031, DOI 10.1111/j.1365-2958.1993.tb01648.x; Tsai HH, 2011, NUCLEIC ACIDS RES, V39, P2165, DOI 10.1093/nar/gkq1204; Wold S, 1996, NUCLEIC ACIDS RES, V24, P3527, DOI 10.1093/nar/24.18.3527; Yang CC, 2002, MOL MICROBIOL, V43, P297, DOI 10.1046/j.1365-2958.2002.02760.x; YUAN HS, 1991, P NATL ACAD SCI USA, V88, P9558, DOI 10.1073/pnas.88.21.9558; Zhong L, 2010, J BACTERIOL, V192, P3747, DOI 10.1128/JB.00123-10; Zou X, 2009, MICROBIOL IMMUNOL, V53, P191, DOI 10.1111/j.1348-0421.2009.00106.x	25	10	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e37462	10.1371/journal.pone.0037462	http://dx.doi.org/10.1371/journal.pone.0037462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911678	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700001
J	Bin, JM; Leong, SY; Bull, SJ; Antel, JP; Kennedy, TE				Bin, Jenea M.; Leong, Soo Yuen; Bull, Sarah-Jane; Antel, Jack P.; Kennedy, Timothy E.			Oligodendrocyte Precursor Cell Transplantation into Organotypic Cerebellar Shiverer Slices: A Model to Study Myelination and Myelin Maintenance	PLOS ONE			English	Article							IN-VITRO; CULTURES; DIFFERENTIATION; REMYELINATION	Current in vitro models to investigate the consequence of oligodendrocyte-specific loss-of-function mutations on myelination are primarily limited to co-culture experiments, which do not accurately recapitulate the complex in vivo environment. Here, we describe the development of an in vitro model of myelination and myelin maintenance in which oligodendrocyte precursor cells are transplanted into organotypic cerebellar slice cultures derived from dysmyelinated shiverer mice. Compared to neuron-oligodendrocyte co-cultures, organotypic slices more closely mimic the environment in vivo, while utilizing a genetic background that allows for straight-forward identification of myelin generated by transplanted cells. We show at the ultrastructural level that the myelin generated by wild-type transplanted oligodendrocytes is compact and terminates in cytoplasmic loops that form paranodal junctions with the axon. This myelination results in the appropriate sequestering of axonal proteins into specialized domains surrounding the nodes of Ranvier. We also demonstrate the applicability of this approach for xenograft transplantation of oligodendrocyte precursor cells derived from rat or human sources. This method provides a time-efficient and cost-effective adjunct to conditional knockout mouse lines or in vivo transplantation models to study oligodendrocyte-specific loss-of-function mutations. Furthermore, the approach can be readily used to assess the effect of pharmacological manipulations on myelin, providing a tool to better understand myelination and develop effective therapeutic strategies to treat myelin-related diseases.	[Bin, Jenea M.; Leong, Soo Yuen; Bull, Sarah-Jane; Antel, Jack P.; Kennedy, Timothy E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Bin, JM (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	timothy.kennedy@mcgill.ca		antel, jack/0000-0002-5148-0636	Multiple Sclerosis Society of Canada; Vanier Canada Graduate Scholarship; Fonds de la Recherche en Sante du Quebec	Multiple Sclerosis Society of Canada; Vanier Canada Graduate Scholarship; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This project was supported by operating grants from Multiple Sclerosis Society of Canada (http://mssociety.ca/en/research/default.htm). JMB is supported by a Vanier Canada Graduate Scholarship and SJB is supported by a Multiple Sclerosis Society of Canada Studentship. TEK is a Killam Foundation Scholar and holds a Chercheur National award from the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RC, 1998, METHODS, V16, P282, DOI 10.1006/meth.1998.0685; BILLINGSGAGLIARDI S, 1984, P NATL ACAD SCI-BIOL, V81, P2558, DOI 10.1073/pnas.81.8.2558; BLAKEMORE WF, 1974, NATURE, V249, P577, DOI 10.1038/249577a0; CAMPAGNONI AT, 1988, MOL NEUROBIOL, V2, P41, DOI 10.1007/BF02935632; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Duncan ID, 2011, NEUROTHERAPEUTICS, V8, P607, DOI 10.1007/s13311-011-0080-y; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Jarjour AA, 2008, J NEUROSCI, V28, P11003, DOI 10.1523/JNEUROSCI.3285-08.2008; Jarjour AA, 2012, GLIA, V60, P1, DOI 10.1002/glia.21231; NOTTERPEK LM, 1993, J NEUROSCI RES, V36, P621, DOI 10.1002/jnr.490360603; O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; READHEAD C, 1990, BEHAV GENET, V20, P213, DOI 10.1007/BF01067791; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Zhang H, 2011, EXP NEUROL, V230, P138, DOI 10.1016/j.expneurol.2011.04.009; Zhang PL, 2006, MOL CELL NEUROSCI, V31, P387, DOI 10.1016/j.mcn.2005.10.014	17	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41237	10.1371/journal.pone.0041237	http://dx.doi.org/10.1371/journal.pone.0041237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911763	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600058
J	Engelen, M; Tran, L; Ofman, R; Brennecke, J; Moser, AB; Dijkstra, IME; Wanders, RJA; Poll-The, BT; Kemp, S				Engelen, Marc; Tran, Luc; Ofman, Rob; Brennecke, Josephine; Moser, Ann B.; Dijkstra, Inge M. E.; Wanders, Ronald J. A.; Poll-The, Bwee Tien; Kemp, Stephan			Bezafibrate for X-Linked Adrenoleukodystrophy	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; ACID	X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene and is characterized by impaired beta-oxidation of very-long-chain fatty acids (VLCFA) and subsequent VLCFA accumulation in tissues. In adulthood X-ALD most commonly manifests as a gradually progressive myelopathy, (adrenomyeloneuropathy; AMN) without any curative or disease modifying treatments. We recently showed that bezafibrate (BF), a drug used for the treatment of hyperlipidaemia, reduces VLCFA accumulation in X-ALD fibroblasts by inhibiting ELOVL1, an enzyme involved in the VLCFA synthesis. We therefore designed a proof-of-principal clinical trial to determine whether BF reduces VLCFA levels in plasma and lymphocytes of X-ALD patients. Ten males with AMN were treated with BF for 12 weeks at a dose of 400 mg daily, followed by 12 weeks of 800 mg daily. Every 4 weeks patients were evaluated for side effects and blood samples were taken for analysis. Adherence was good as indicated by a clear reduction in triglycerides. There was no reduction in VLCFA in either plasma or lymphocytes. Plasma levels of BF did not exceed 25 mmol/L. We concluded that BF, at least in the dose given, is unable to lower VLCFA levels in plasma or lymphocytes in X-ALD patients. It is unclear whether this is due to the low levels of BF reached in plasma. Our future work is aimed at the identification of highly-specific inhibitors of ELOVL1 that act at much lower concentrations than BF and are well tolerated. BF appears to have no therapeutic utility in X-ALD.	[Engelen, Marc; Poll-The, Bwee Tien] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Tran, Luc; Ofman, Rob; Brennecke, Josephine; Dijkstra, Inge M. E.; Wanders, Ronald J. A.; Kemp, Stephan] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Engelen, Marc; Poll-The, Bwee Tien; Kemp, Stephan] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Neurol, NL-1105 AZ Amsterdam, Netherlands; [Moser, Ann B.] Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Kennedy Krieger Institute	Engelen, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands.	s.kemp@amc.uva.nl	Engelen, Marc/F-8433-2012; Kemp, Stephan/A-3935-2008	Engelen, Marc/0000-0002-5346-8497; Kemp, Stephan/0000-0003-2023-064X; Poll-The, Bwee Tien/0000-0002-8118-5419	Netherlands Organization for Scientific Research [VIDI-91786328]; European Union [LeukoTreat 241622]; Stop ALD Foundation	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); Stop ALD Foundation	This research was supported by the Netherlands Organization for Scientific Research (VIDI-91786328), the European Union Framework Programme 7 (LeukoTreat 241622) and The Stop ALD Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Engelen M, 2012, J INHERIT METAB DIS, V35, P1137, DOI 10.1007/s10545-012-9471-4; Engelen M, 2010, NEW ENGL J MED, V362, P276, DOI 10.1056/NEJMc0907735; Hubbard WC, 2009, MOL GENET METAB, V97, P212, DOI 10.1016/j.ymgme.2009.03.010; Kemp S, 2012, BBA-MOL BASIS DIS, V1822, P1465, DOI 10.1016/j.bbadis.2012.03.012; Masnatta LD, 1996, J CHROMATOGR B, V687, P437, DOI 10.1016/S0378-4347(96)00254-X; Miller DB, 1998, CLIN PHARMACOKINET, V34, P155, DOI 10.2165/00003088-199834020-00003; Moser HW, 2007, NAT CLIN PRACT NEURO, V3, P140, DOI 10.1038/ncpneuro0421; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Ofman R, 2010, EMBO MOL MED, V2, P90, DOI 10.1002/emmm.201000061; Valianpour F, 2003, MOL GENET METAB, V79, P189, DOI 10.1016/S1096-7192(03)00098-2	10	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41013	10.1371/journal.pone.0041013	http://dx.doi.org/10.1371/journal.pone.0041013			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911730	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600034
J	Estella, C; Herrer, I; Moreno-Moya, JM; Quinonero, A; Martinez, S; Pellicer, A; Simon, C				Estella, Carlos; Herrer, Isabel; Manuel Moreno-Moya, Juan; Quinonero, Alicia; Martinez, Sebastian; Pellicer, Antonio; Simon, Carlos			miRNA Signature and Dicer Requirement during Human Endometrial Stromal Decidualization In Vitro	PLOS ONE			English	Article							BINDING PROTEIN-BETA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CYCLIC-AMP; C/EBP-BETA; CROSS-TALK; KINASE-A; MICRORNAS; CELLS; HOXA10	Decidualization is a morphological and biochemical transformation of endometrial stromal fibroblast into differentiated decidual cells, which is critical for embryo implantation and pregnancy establishment. The complex regulatory networks have been elucidated at both the transcriptome and the proteome levels, however very little is known about the post-transcriptional regulation of this process. miRNAs regulate multiple physiological pathways and their de-regulation is associated with human disorders including gynaecological conditions such as endometriosis and preeclampsia. In this study we profile the miRNAs expression throughout human endometrial stromal (hESCs) decidualization and analyze the requirement of the miRNA biogenesis enzyme Dicer during this process. A total of 26 miRNAs were upregulated and 17 miRNAs downregulated in decidualized hESCs compared to non-decidualized hESCs. Three miRNAs families, miR-181, miR-183 and miR-200, are down-regulated during the decidualization process. Using miRNAs target prediction algorithms we have identified the potential targets and pathways regulated by these miRNAs. The knockdown of Dicer has a minor effect on hESCs during in vitro decidualization. We have analyzed a battery of decidualization markers such as cell morphology, Prolactin, IGFBP-1, MPIF-1 and TIMP-3 secretion as well as HOXA10, COX2, SP1, C/EBP beta and FOXO1 expression in decidualized hESCs with decreased Dicer function. We found decreased levels of HOXA10 and altered intracellular organization of actin filaments in Dicer knockdown decidualized hESCs compared to control. Our results provide the miRNA signature of hESC during the decidualization process in vitro. We also provide the first functional characterization of Dicer during human endometrial decidualization although surprisingly we found that Dicer plays a minor role regulating this process suggesting that alternative biogenesis miRNAs pathways must be involved in human endometrial decidualization.	[Estella, Carlos; Herrer, Isabel; Manuel Moreno-Moya, Juan; Quinonero, Alicia; Martinez, Sebastian; Pellicer, Antonio; Simon, Carlos] Univ Valencia, Inst Univ IVI INCLIVA, FIVI, Valencia, Spain; [Estella, Carlos] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Dept Mol Biol, Madrid, Spain	University of Valencia; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Estella, C (corresponding author), Univ Valencia, Inst Univ IVI INCLIVA, FIVI, Valencia, Spain.	carlos.simon@ivi.es	Estella, Carlos/L-2097-2014; MARTINEZ, ANTONIO PELLICER/C-4832-2015; Pellicer, Antonio/AAA-6005-2020; Simon, Carlos/G-2186-2014	Estella, Carlos/0000-0003-1551-2327; Pellicer, Antonio/0000-0002-8254-863X; Simon, Carlos/0000-0003-0902-9531				Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benson GV, 1996, DEVELOPMENT, V122, P2687; Brar AK, 2001, PHYSIOL GENOMICS, V7, P135, DOI 10.1152/physiolgenomics.00061.2001; Brar AK, 1997, ENDOCRINE, V6, P301, DOI 10.1007/BF02820507; BRUNER KL, 1995, P NATL ACAD SCI USA, V92, P7362, DOI 10.1073/pnas.92.16.7362; Burney RO, 2009, MOL HUM REPROD, V15, P625, DOI 10.1093/molehr/gap068; Chakraborty I, 1996, J MOL ENDOCRINOL, V16, P107, DOI 10.1677/jme.0.0160107; Christian M, 2002, J BIOL CHEM, V277, P20825, DOI 10.1074/jbc.M201018200; Christian Mark, 2002, Reprod Biomed Online, V4 Suppl 3, P24; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Dunn Carolyn L, 2003, Reprod Biomed Online, V7, P151; Garrido-Gomez T, 2010, J CLIN ENDOCRINOL ME; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HIGUCHI T, 1995, ENDOCRINOLOGY, V136, P4973, DOI 10.1210/en.136.11.4973; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Ihnatovych I, 2009, BIOL REPROD, V81, P222, DOI 10.1095/biolreprod.108.074666; Kim JJ, 2007, MOL HUM REPROD, V13, P323, DOI 10.1093/molehr/gam005; Kim JJ, 2003, BIOL REPROD, V68, P24, DOI 10.1095/biolreprod.102.009316; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krikun G, 2000, MOL ENDOCRINOL, V14, P393, DOI 10.1210/me.14.3.393; Lam EW, 2011, J ENDOCRINOL; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lu Z, 2008, MOL HUM REPROD, V14, P357, DOI 10.1093/molehr/gan023; Luo XP, 2003, J CLIN ENDOCR METAB, V88, P4967, DOI 10.1210/jc.2003-030276; Mak IYH, 2002, J CLIN ENDOCR METAB, V87, P2581, DOI 10.1210/jc.87.6.2581; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Petracco R, 2011, J CLIN ENDOCRINOL ME; Piccinni MP, 2010, J REPROD IMMUNOL, V85, P71, DOI 10.1016/j.jri.2010.01.006; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Popovici RM, 1999, J CLIN ENDOCR METAB, V84, P2245, DOI 10.1210/jc.84.6.2245; Qian K, 2009, ENDOCRINOLOGY, V150, P4734, DOI 10.1210/en.2008-1629; Ramathal C, 2011, J BIOL CHEM, V286, P19860, DOI 10.1074/jbc.M110.191759; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; SIMON C, 1994, J CLIN ENDOCR METAB, V78, P675, DOI 10.1210/jc.78.3.675; Singh M, 2008, MODERN PATHOL, V21, P912, DOI 10.1038/modpathol.2008.82; Snowdon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022828; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Stoikos CJ, 2008, HUM REPROD, V23, P1447, DOI 10.1093/humrep/den110; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Teague EMCO, 2010, HUM REPROD UPDATE, V16, P142, DOI 10.1093/humupd/dmp034; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Telgmann R, 1997, ENDOCRINOLOGY, V138, P929, DOI 10.1210/en.138.3.929; Tierney EP, 2003, PHYSIOL GENOMICS, V16, P47, DOI 10.1152/physiolgenomics.00066.2003; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Zhang YQ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.057; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	63	75	79	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41080	10.1371/journal.pone.0041080	http://dx.doi.org/10.1371/journal.pone.0041080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911744	Green Published, gold			2022-12-27	WOS:000306644600044
J	Jewkes, R; Morrell, R; Sikweyiya, Y; Dunkle, K; Penn-Kekana, L				Jewkes, Rachel; Morrell, Robert; Sikweyiya, Yandisa; Dunkle, Kristin; Penn-Kekana, Loveday			Men, Prostitution and the Provider Role: Understanding the Intersections of Economic Exchange, Sex, Crime and Violence in South Africa	PLOS ONE			English	Article							TRANSACTIONAL SEX; MALE CUSTOMERS; PREVALENCE; SAMPLE; PREDICTORS; DYNAMICS; WOMEN; RISK	Background: South African policy makers are reviewing legislation of prostitution, concerned that criminalisation hampers HIV prevention. They seek to understand the relationship between transactional sex, prostitution, and the nature of the involved men. Methods: 1645 randomly-selected adult South African men participated in a household study, disclosing whether they had sex with a woman in prostitution or had had a provider relationship (or sex), participation in crime and violence and completing psychological measures. These became outcomes in multivariable regression models, where the former were exposure variables. Results: 51% of men had had a provider relationship and expected sex in return, 3% had had sex with a woman in prostitution, 15% men had done both of these and 31% neither. Provider role men, and those who had just had sex with a woman in prostitution, were socially conservative and quite violent. Yet the men who had done both (75% of those having sex with a woman in prostitution) were significantly more misogynist, highly scoring on dimensions of psychopathy, more sexually and physically violent to women, and extensively engaged in crime. They had often bullied at school, suggesting that this instrumental, self-seeking masculinity was manifest in childhood. The men who had not engaged in sex for economic exchange expressed a much less violent, more law abiding and gender equitable masculinity; challenging assumptions about the inevitability of intersections of age, poverty, crime and misogyny. Conclusions: Provider role relationships (or sex) are normative for low income men, but not having sex with a woman in prostitution. Men who do the latter operate extensively outside the law and their violence poses a substantial threat to women. Those drafting legislation and policy on the sex industry in South Africa need to distinguish between these two groups to avoid criminalising the normal, and consider measures to protect women.	[Jewkes, Rachel; Sikweyiya, Yandisa] MRC, Gender & Hlth Res Unit, Pretoria, South Africa; [Jewkes, Rachel] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Morrell, Robert] Univ Cape Town, Res Off, ZA-7925 Cape Town, South Africa; [Dunkle, Kristin] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Penn-Kekana, Loveday] Univ Witwatersrand, Fac Hlth Sci, Ctr Hlth Policy, Johannesburg, South Africa	University of Witwatersrand; University of Cape Town; Emory University; Rollins School Public Health; University of Witwatersrand	Jewkes, R (corresponding author), MRC, Gender & Hlth Res Unit, Pretoria, South Africa.	rjewkes@mrc.ac.za	Dunkle, Kristin/AAU-5488-2020	Dunkle, Kristin/0000-0003-3071-5544; Morrell, Robert/0000-0002-6096-486X; Jewkes, Rachel/0000-0002-4330-6267	UK Department For International Development (DFID); National Research Foundation; Novo Foundation; Novo	UK Department For International Development (DFID); National Research Foundation; Novo Foundation; Novo	The main study was funded by the UK Department For International Development (DFID), and the grant was managed by their local partner Human Life Sciences Partnership (HLSP). Robert Morrell was assisted to participate in the project with funding from the National Research Foundation. This analysis was financially supported by the Novo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors recognise that Novo is a funder of a commercial enterprise but Novo had no involvement in the paper apart from providing some funding for writing. They do not own the data and had no financial links to the study at the time of study design or data collection. They have not seen the data, were not involved in shaping the analysis and have not expressed views on the paper. The authors have read the journal's policy on conflict of interest and the funding supplied by Novo in no way compromises or influences the scientific integrity of the paper. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abbey A, 2006, AGGRESSIVE BEHAV, V32, P54, DOI 10.1002/ab.20107; Bolen R.M., 2000, EPIDEMIC RAPE CHILD; Bright Susie, 1997, SEXUAL STATE UNION; BURT MR, 1980, J PERS SOC PSYCHOL, V38, P217, DOI 10.1037/0022-3514.38.2.217; Busch NB, 2002, VIOLENCE AGAINST WOM, V8, P1093, DOI 10.1177/107780102401101755; Church S, 2001, BMJ-BRIT MED J, V322, P524, DOI 10.1136/bmj.322.7285.524; Connell R., 2013, GENDER POWER SOC PER; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; Farley M, 1998, WOMEN HEALTH, V27, P37, DOI 10.1300/J013v27n03_03; Fonagy P., 2003, PSYCHOANALYTIC THEOR; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Gould C., 2008, SELLING SEX CAPE TOW; Guy J, 1990, WOMEN GENDER SO AFRI; Haram L., 2005, RETHINKING SEXUALITI, P211; Hunter Mark., 2010, LOVE TIME AIDS INEQU; Hunter Mark., 2002, AFR STUD-UK, V61, P99, DOI [DOI 10.1080/00020180220140091, 10.1080/00020180220140091]; Jewkes R, 2011, PLOS ONE, V6; Jewkes R, 2011, SOCIAL SCI MED; Jewkes R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-325; KARIM QA, 1995, AM J PUBLIC HEALTH, V85, P1521, DOI 10.2105/AJPH.85.11.1521; Kelly L., 2009, SHIFTING SANDS COMP; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; Leclerc-Madlala S, 2003, SOC DYNAMICS, V29, P213, DOI 10.1080/02533950308628681; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; LEGGETT T., 2001, RAINBOW VICE DRUGS S; Lilienfield S. O., 2005, PSYCHOPATHIC PERSONA; Lilleaas UB, 2007, MEN MASC, V10, P39, DOI 10.1177/1097184X07299329; Machisa M, 2011, WAR HOME; Macleod J., 2008, CHALLENGING MENS DEM; Marcus T, 1995, INDICATOR SA, V13, P80; Mathews S, 2011, BRIT J CRIMINOL, V51, P960, DOI 10.1093/bjc/azr051; McKinnon C., 1979, SEXUAL HARASSMENT WO; Meth P, 2009, GEOFORUM, V40, P853, DOI 10.1016/j.geoforum.2009.07.002; Monto MA, 2005, INT J OFFENDER THER, V49, P505, DOI 10.1177/0306624X04272975; Nkosana J, 2007, SEX HEALTH, V4, P181, DOI 10.1071/SH06070; Paglia Camille, 1994, VAMPS TRAMPS NEW ESS; Pauw I, 1997, AGENDA, V36, P80; Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778; Richter L, 2006, BABA FATHERS FATHERH; Sikweyiya Y, 2007, AGENDA, V74, P48; Silberschmidt M, 2001, SOC SCI MED, V52, P1815, DOI 10.1016/S0277-9536(00)00299-9; South African Law Reform Commission, 2009, 00012009 S AFR LAW R; Talbot K, 2010, MEN MASC, V13; TREMBLAY RE, 1995, J CONSULT CLIN PSYCH, V63, P560, DOI 10.1037/0022-006X.63.4.560; Trotter H, 2007, SUGAR GIRLS SEAMEN J; Wamoyi J, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-6; Wojcicki J, 2002, MED ANTHROPOL Q, V16, P1	48	38	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40821	10.1371/journal.pone.0040821	http://dx.doi.org/10.1371/journal.pone.0040821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977GL	22911711	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600022
J	Koga, T; Ishida, T; Takeda, T; Ishii, Y; Uchi, H; Tsukimori, K; Yamamoto, M; Himeno, M; Furue, M; Yamada, H				Koga, Takayuki; Ishida, Takumi; Takeda, Tomoki; Ishii, Yuji; Uchi, Hiroshi; Tsukimori, Kiyomi; Yamamoto, Midori; Himeno, Masaru; Furue, Masutaka; Yamada, Hideyuki			Restoration of Dioxin-Induced Damage to Fetal Steroidogenesis and Gonadotropin Formation by Maternal Co-Treatment with alpha-Lipoic Acid	PLOS ONE			English	Article							LIPID-PEROXIDATION; ESTROGEN-RECEPTOR; ARYL-HYDROCARBON; VITAMIN-E; N-ACETYLASPARTATE; OXIDATIVE STRESS; EXPRESSION; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; TOXICITY; TCDD	2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), an endocrine disruptor, causes reproductive and developmental toxic effects in pups following maternal exposure in a number of animal models. Our previous studies have demonstrated that TCDD imprints sexual immaturity by suppressing the expression of fetal pituitary gonadotropins, the regulators of gonadal steroidogenesis. In the present study, we discovered that all TCDD-produced damage to fetal production of pituitary gonadotropins as well as testicular steroidogenesis can be repaired by co-treating pregnant rats with alpha-lipoic acid (LA), an obligate co-factor for intermediary metabolism including energy production. While LA also acts as an anti-oxidant, other anti-oxidants; i.e., ascorbic acid, butylated hydroxyanisole and edaravone, failed to exhibit any beneficial effects. Neither wasting syndrome nor CYP1A1 induction in the fetal brain caused through the activation of aryl hydrocarbon receptor (AhR) could be attenuated by LA. These lines of evidence suggest that oxidative stress makes only a minor contribution to the TCDD-induced disorder of fetal steroidogenesis, and LA has a restorative effect by targeting on mechanism(s) other than AhR activation. Following a metabolomic analysis, it was found that TCDD caused a more marked change in the hypothalamus, a pituitary regulator, than in the pituitary itself. Although the components of the tricarboxylic acid cycle and the ATP content of the fetal hypothalamus were significantly changed by TCDD, all these changes were again rectified by exogenous LA. We also provided evidence that the fetal hypothalamic content of endogenous LA is significantly reduced following maternal exposure to TCDD. Thus, the data obtained strongly suggest that TCDD reduces the expression of fetal pituitary gonadotropins to imprint sexual immaturity or disturb development by suppressing the level of LA, one of the key players serving energy production.	[Koga, Takayuki; Ishida, Takumi; Takeda, Tomoki; Ishii, Yuji; Yamada, Hideyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Ishida, Takumi] Sojo Univ, Fac Pharmaceut Sci, Kumamoto, Japan; [Uchi, Hiroshi] Kyushu Univ Hosp, Res & Clin Ctr Yusho & Dioxin, Fukuoka 812, Japan; [Tsukimori, Kiyomi] Fukuoka Childrens Hosp, Dept Obstet, Fukuoka, Japan; [Yamamoto, Midori; Himeno, Masaru] Nagasaki Int Univ, Fac Pharmaceut Sci, Sasebo, Japan; [Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan	Kyushu University; Sojo University; Kyushu University; Nagasaki International University; Kyushu University	Koga, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan.	hyamada@phar.kyushu-u.ac.jp	Ishii, Yuji/AAU-3300-2021; Tsukimori, Kiyomi/L-6228-2019	Tsukimori, Kiyomi/0000-0002-5196-2678; Koga, Takayuki/0000-0001-9782-6746	Ministry of Health, Labour and Welfare, Japan [H21-Kagaku-Ippan-005, H21-Shokuhin-Ippan-014]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was upported by grants from the Ministry of Health, Labour and Welfare, Japan: Research on Risk of Chemical Substances [project No: H21-Kagaku-Ippan-005] and Research on Food Safety [project No: H21-Shokuhin-Ippan-014]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED AE, 1991, FUND APPL TOXICOL, V16, P356, DOI 10.1016/0272-0590(91)90120-S; ALBAYATI ZAF, 1987, ARCH ENVIRON CON TOX, V16, P159, DOI 10.1007/BF01055797; Badawi AF, 2000, CARCINOGENESIS, V21, P1593, DOI 10.1093/carcin/21.8.1593; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; BURKE MD, 1975, DRUG METAB DISPOS, V3, P245; Chng HT, 2009, BRAIN RES, V1251, P80, DOI 10.1016/j.brainres.2008.11.025; COUTURE LA, 1990, TERATOLOGY, V42, P619, DOI 10.1002/tera.1420420606; Coyral-Castel S, 2008, J NEUROENDOCRINOL, V20, P335, DOI 10.1111/j.1365-2826.2007.01643.x; Dungan HM, 2006, ENDOCRINOLOGY, V147, P1154, DOI 10.1210/en.2005-1282; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Funato H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018950; Hassoun EA, 1997, TOXICOLOGY, V124, P27, DOI 10.1016/S0300-483X(97)00127-3; Higashi Y, 2009, EXPERT OPIN PHARMACO, V10, P323, DOI [10.1517/14656560802636888 , 10.1517/14656560802636888]; Ishida T, 2005, J DERMATOL SCI, pS105, DOI 10.1016/j.descs.2005.03.011; Ishida T, 2005, TOXICOL APPL PHARM, V205, P89, DOI 10.1016/j.taap.2004.09.014; Kharat I, 1996, J BIOL CHEM, V271, P10533, DOI 10.1074/jbc.271.18.10533; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kokura S, 2005, CANCER LETT, V229, P223, DOI 10.1016/j.canlet.2005.06.039; Komatsu T, 1996, YAKUBUTSUDOHTAI, V11, P492; Larsen JC, 2006, MOL NUTR FOOD RES, V50, P885, DOI 10.1002/mnfr.200500247; Latchoumycandane C, 2002, ARCH TOXICOL, V76, P113; Latchoumycandane C, 2002, J APPL TOXICOL, V22, P345, DOI 10.1002/jat.866; Madhavarao CN, 2003, J NEUROCHEM, V86, P824, DOI 10.1046/j.1471-4159.2003.01905.x; MARTIN GR, 1961, ARCH BIOCHEM BIOPHYS, V93, P110, DOI 10.1016/0003-9861(61)90321-6; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Murugesan P, 2005, FREE RADICAL RES, V39, P1259, DOI 10.1080/10715760500308154; Mutoh J, 2006, ENDOCRINOLOGY, V147, P927, DOI 10.1210/en.2005-1125; Ogborne RM, 2005, ARTERIOSCL THROM VAS, V25, P2100, DOI 10.1161/01.ATV.0000183745.37161.6e; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Packer L, 1997, Adv Pharmacol, V38, P79; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; PETERSON RE, 1993, CRIT REV TOXICOL, V23, P283, DOI 10.3109/10408449309105013; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Schupke H, 2001, DRUG METAB DISPOS, V29, P855; Schwarz JM, 2008, J STEROID BIOCHEM, V109, P300, DOI 10.1016/j.jsbmb.2008.03.012; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Siman CM, 1997, DIABETOLOGIA, V40, P1416, DOI 10.1007/s001250050844; STOHS SJ, 1983, BIOCHEM BIOPH RES CO, V111, P854, DOI 10.1016/0006-291X(83)91377-3; STOHS SJ, 1984, XENOBIOTICA, V14, P533, DOI 10.3109/00498258409151443; Takeda T, 2012, J BIOL CHEM, V287, P18440, DOI 10.1074/jbc.M111.335158; Takeda T, 2009, J PHARMACOL EXP THER, V329, P1091, DOI 10.1124/jpet.109.151282; Taketoh J, 2007, LIFE SCI, V80, P1259, DOI 10.1016/j.lfs.2006.12.029; TAYLOR MJ, 1984, AGENTS ACTIONS, V15, P454, DOI 10.1007/BF01972387; Terasawa E, 2010, J NEUROENDOCRINOL, V22, P630, DOI 10.1111/j.1365-2826.2010.02027.x; Tian Y, 1998, J STEROID BIOCHEM, V67, P17, DOI 10.1016/S0960-0760(98)00067-3; Wang SJ, 2007, NEUROCHEM INT, V50, P51, DOI 10.1016/j.neuint.2006.06.011; WEBER LWD, 1991, TOXICOLOGY, V66, P133, DOI 10.1016/0300-483X(91)90214-L; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005	54	32	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40322	10.1371/journal.pone.0040322	http://dx.doi.org/10.1371/journal.pone.0040322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911699	Green Published, gold, Green Submitted			2022-12-27	WOS:000306644600017
J	Wu, TS; Chiu, CH; Yang, CH; Leu, HS; Huang, CT; Chen, YC; Wu, TL; Chang, PY; Su, LH; Kuo, AJ; Chia, JH; Lu, CC; Lai, HC				Wu, Ting-Shu; Chiu, Cheng-Hsun; Yang, Chih-Hsun; Leu, Hsieh-Shong; Huang, Ching-Tai; Chen, Yi-Chieh; Wu, Tsu-Lan; Chang, Pi-Yueh; Su, Lin-Hui; Kuo, An-Jing; Chia, Ju-Hsin; Lu, Chia-Chen; Lai, Hsin-Chih			Fish Tank Granuloma Caused by Mycobacterium marinum	PLOS ONE			English	Article							INFECTIONS; SUSCEPTIBILITY; DIAGNOSIS; SKIN	Introduction: Mycobacterium marinum causes skin and soft tissue, bone and joint, and rare disseminated infections. In this study, we aimed to investigate the relationship between treatment outcome and antimicrobial susceptibility patterns. A total of 27 patients with M. marinum infections were enrolled. Methods: Data on clinical characteristics and therapeutic methods were collected and analyzed. We also determined the minimum inhibitory concentrations of 7 antibiotics against 30 isolates from these patients. Results: Twenty-seven patients received antimycobacterial agents with or without surgical debridement. Eighteen patients were cured, 8 failed to respond to treatment, and one was lost to follow-up. The duration of clarithromycin (147 vs. 28; p = 0.0297), and rifampicin (201 vs. 91; p = 0.0266) treatment in the cured patients was longer than that in the others. Surgical debridement was performed in 10 out of the 18 cured patients, and in 1 of another group (p = 0.0417). All the 30 isolates were susceptible to clarithromycin, amikacin, and linezolid; 29 (96.7%) were susceptible to ethambutol; 28 (93.3%) were susceptible to sulfamethoxazole; and 26 (86.7%) were susceptible to rifampicin. However, only 1 (3.3%) isolate was susceptible to doxycycline. Discussion: Early diagnosis of the infection and appropriate antimicrobial therapy with surgical debridement are the mainstays of successful treatment. Clarithromycin and rifampin are supposed to be more effective agents.	[Wu, Ting-Shu; Leu, Hsieh-Shong; Huang, Ching-Tai] Chang Gung Univ, Div Infect Dis, Dept Internal Med, Chang Gung Mem Hosp,Coll Med, Tao Yuan, Taiwan; [Wu, Ting-Shu] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chiu, Cheng-Hsun] Chang Gung Univ, Div Infect Dis, Dept Pediat,Coll Med, Chang Gung Childrens Hosp,Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Yang, Chih-Hsun] Chang Gung Mem Hosp, Dept Dermatol, Tao Yuan, Taiwan; [Chen, Yi-Chieh] Chang Gung Univ, Dept Plast & Reconstruct Surg, Chang Gung Mem Hosp, Coll Med, Tao Yuan, Taiwan; [Wu, Tsu-Lan; Chang, Pi-Yueh; Su, Lin-Hui; Kuo, An-Jing; Chia, Ju-Hsin] Chang Gung Univ, Dept Lab Med, Chang Gung Mem Hosp, Coll Med, Tao Yuan, Taiwan; [Wu, Tsu-Lan; Chang, Pi-Yueh; Su, Lin-Hui; Kuo, An-Jing; Chia, Ju-Hsin; Lai, Hsin-Chih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Chang, Pi-Yueh; Chia, Ju-Hsin; Lai, Hsin-Chih] Chang Gung Univ, Grad Inst Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Lu, Chia-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, New Taipei, Taiwan; [Lai, Hsin-Chih] Chang Gung Univ, Res Ctr Pathogen Bacteria, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Fu Jen Catholic University; Chang Gung University	Wu, TS (corresponding author), Chang Gung Univ, Div Infect Dis, Dept Internal Med, Chang Gung Mem Hosp,Coll Med, Tao Yuan, Taiwan.	hclai@mail.cgu.edu.tw		LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council [NSC99-2321-B-002-022-MY3]; Chang Gung Memorial Hospital [CMRPG381391]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the National Science Council (grant NSC99-2321-B-002-022-MY3), and Chang Gung Memorial Hospital (grant CMRPG381391). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ADAMS RM, 1970, J AMER MED ASSOC, V211, P457, DOI 10.1001/jama.211.3.457; Aubry A, 2002, ARCH INTERN MED, V162, P1746, DOI 10.1001/archinte.162.15.1746; BROWN BA, 1992, ANTIMICROB AGENTS CH, V36, P1987, DOI 10.1128/AAC.36.9.1987; Cheung Jason Pui-yin, 2010, J Orthop Surg (Hong Kong), V18, P98; CLSI/NCCLS, 2003, SUSCEPTIBILITY TESTI; COLLINS CH, 1985, J HYG-CAMBRIDGE, V94, P135, DOI 10.1017/S0022172400061349; Cummins DL, 2005, INT J DERMATOL, V44, P518, DOI 10.1111/j.1365-4632.2005.02204.x; DONTA ST, 1986, ARCH INTERN MED, V146, P902, DOI 10.1001/archinte.146.5.902; Dryden MS, 2011, J ANTIMICROB CHEMOTH, V66, pIV7, DOI 10.1093/jac/dkr072; Feddersen A, 1996, INFECTION, V24, P47, DOI 10.1007/BF01780651; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Holmes GF, 1999, J CLIN MICROBIOL, V37, P3059, DOI 10.1128/JCM.37.9.3059-3061.1999; Kent PT, 1985, GUIDE LEVEL 3 LAB; Lai CC, 2005, CLIN INFECT DIS, V40, P206, DOI 10.1086/426693; Lewis FMT, 2003, CLIN INFECT DIS, V37, P390, DOI 10.1086/376628; LJUNGBERG B, 1987, SCAND J INFECT DIS, V19, P539, DOI 10.3109/00365548709032420; Madan V, 2007, J EUR ACAD DERMATOL, V21, P572, DOI 10.1111/j.1468-3083.2006.01969.x; Osorio Filipa, 2010, Dermatol Online J, V16, P7; Pang HN, 2007, J INFECTION, V54, P584, DOI 10.1016/j.jinf.2006.11.014; PATEL S, 1995, J RHEUMATOL, V22, P1607; Rallis E, 2007, EXPERT OPIN PHARMACO, V8, P2965, DOI 10.1517/14656566.8.17.2965; Rodriguez JC, 2002, INT J ANTIMICROB AG, V20, P464, DOI 10.1016/S0924-8579(02)00239-X; RUNYON EH, 1981, REV INFECT DIS, V3, P819; Schwendiman Mark N, 2009, Dermatol Online J, V15, P11; Sivan M, 2008, JOINT BONE SPINE, V75, P600, DOI 10.1016/j.jbspin.2007.08.011; SWIFT S, 1962, NEW ENGL J MED, V267, P1244, DOI 10.1056/NEJM196212132672408; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; VINCENT V, 2003, MANUAL CLIN MICROBIO, P560; WALLACE RJ, 1986, J CLIN MICROBIOL, V24, P976, DOI 10.1128/JCM.24.6.976-981.1986; Wu Ting-Shu, 2002, Journal of Microbiology Immunology and Infection, V35, P42	30	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41296	10.1371/journal.pone.0041296	http://dx.doi.org/10.1371/journal.pone.0041296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911774	Green Published, Green Submitted			2022-12-27	WOS:000306644600068
J	Knudsen, AK; Overland, S; Hotopf, M; Mykletun, A				Knudsen, Ann Kristin; Overland, Simon; Hotopf, Matthew; Mykletun, Arnstein			Lost Working Years Due to Mental Disorders: An Analysis of the Norwegian Disability Pension Registry	PLOS ONE			English	Article							POPULATION-BASED COHORT; PSYCHIATRIC-DISORDER; SICKNESS ABSENCE; MOOD DISORDERS; HEALTH; DEPRESSION; PREVALENCE; MORTALITY; UNDERTREATMENT; COMORBIDITY	Objectives: Mental disorders are prevalent diagnoses in disability benefit statistics, with awards often granted at younger age than for other diagnoses. We aimed to compare the number of lost working years following disability benefit award for mental disorders versus other diagnostic groups. Methods: Data from the complete Norwegian official registry over disability benefit incidence, including primary diagnoses, were analyzed for the period 2001 to 2003 (N = 77,067), a time-period without any reform in the disability benefit scheme. Lost working years due to disability benefit award before scheduled age retirement at age 67 were calculated. Results: Musculoskeletal disorders were the commonest reason for disability benefit awards (36.3%) with mental disorders in second place (24.0%). However, mental disorders were responsible for the most working years lost (33.8%) compared with musculoskeletal disorders (29.4%). Individuals awarded disability benefit for a mental disorder were on average 8.9 years younger (46.1 years) than individuals awarded for a musculoskeletal disorder (55.0 years), and 6.9 years younger than individuals awarded for any other somatic disorder (53.0 years). Anxiety and depressive disorders were the largest contributors to lost working years within mental disorders. Conclusion: Age at award is highly relevant when the total burden of different diagnoses on disability benefits is considered. There is great disparity in total number of lost working years due to disability benefit award for different diagnostic groups. The high number of lost working years from mental disorders has serious consequences for both the individual and for the wider society and economy.	[Knudsen, Ann Kristin; Overland, Simon; Mykletun, Arnstein] Univ Bergen, Dept Hlth Promot & Dev, Fac Psychol, Bergen, Norway; [Knudsen, Ann Kristin; Overland, Simon; Mykletun, Arnstein] Norwegian Inst Publ Hlth, Dept Publ Mental Hlth, Div Mental Hlth, Bergen, Norway; [Hotopf, Matthew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Mykletun, Arnstein] Univ New S Wales, Fac Med, Sch Psychiat, Sydney, NSW 2052, Australia	University of Bergen; Norwegian Institute of Public Health (NIPH); University of London; King's College London; University of New South Wales Sydney	Knudsen, AK (corresponding author), Univ Bergen, Dept Hlth Promot & Dev, Fac Psychol, Bergen, Norway.	Ann.Knudsen@psych.uib.no	Øverland, Simon/ABF-1289-2020; Knudsen, Ann Kristin/AAB-2465-2019; Hotopf, Matthew/E-4971-2010; Mykletun, Arnstein/L-5004-2015	Øverland, Simon/0000-0001-6967-9355; Mykletun, Arnstein/0000-0002-3878-0079; Hotopf, Matthew/0000-0002-3980-4466; Knudsen, Ann Kristin/0000-0002-1218-798X	Norwegian Institute of Public Health; National Institute for Health Research Biomedical Research Centre for Mental Health at the South London; Maudsley National Health Service Foundations Trust; Institute of Psychiatry, King's College London	Norwegian Institute of Public Health; National Institute for Health Research Biomedical Research Centre for Mental Health at the South London; Maudsley National Health Service Foundations Trust; Institute of Psychiatry, King's College London	The Norwegian Institute of Public Health financed the work with the analyses in the present project. MH is funded by the National Institute for Health Research Biomedical Research Centre for Mental Health at the South London and Maudsley National Health Service Foundations Trust and Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akselsen A, 2009, FD TRYGD DOKUMENTASJ; Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808; Alonso J, 2007, J CLIN PSYCHIAT, V68, P3; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Bratberg B, 2010, DISABILITY WELFARE S; Brown J, 2009, J PUBLIC HEALTH-UK, V31, P74, DOI 10.1093/pubmed/fdn098; Cattrell A, 2011, OCCUP MED-OXFORD, V61, P148, DOI 10.1093/occmed/kqr008; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Cougnard A, 2007, PSYCHIAT SERV, V58, P1427, DOI 10.1176/appi.ps.58.11.1427; Dearing E, 2008, ANN NY ACAD SCI, V1136, P324, DOI 10.1196/annals.1425.006; Gjesdal S, 2003, SCAND J PUBLIC HEALT, V31, P246, DOI 10.1080/14034940210165154; Glozier N, 1998, J OCCUP ENVIRON MED, V40, P793, DOI 10.1097/00043764-199809000-00008; Gravseth HM, 2008, EUR J PUBLIC HEALTH, V18, P650, DOI 10.1093/eurpub/ckn055; HAFNER H, 1993, BRIT J PSYCHIAT, V162, P80, DOI 10.1192/bjp.162.1.80; Harvey SB, 2009, BRIT J PSYCHIAT, V194, P201, DOI 10.1192/bjp.bp.108.055111; Haukenes I, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-406; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Henderson M, 2011, J ROY SOC MED, V104, P198, DOI 10.1258/jrsm.2011.100231; Henderson M, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-37; Hewitt S, 2009, SCAND J PUBLIC HEALT, V37, P280, DOI 10.1177/1403494808101177; Honkonen TI, 2007, J CLIN PSYCHIAT, V68, P1886, DOI 10.4088/JCP.v68n1208; Isometsa ET, 2000, AM J PSYCHIAT, V157, P1869, DOI 10.1176/appi.ajp.157.11.1869; Karlsson NE, 2007, SCAND J PUBLIC HEALT, V35, P341, DOI 10.1080/14034940601159229; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Knudsen AK, 2010, J PSYCHOSOM RES, V69, P59, DOI 10.1016/j.jpsychores.2010.03.007; Kooyman I, 2007, BRIT J PSYCHIAT, V191, pS29, DOI 10.1192/bjp.191.50.s29; Kringlen E, 2001, AM J PSYCHIAT, V158, P1091, DOI 10.1176/appi.ajp.158.7.1091; Lauber C, 2010, INT REV PSYCHIATR, V22, P173, DOI 10.3109/09540261003716405; Layard R, 2006, BRIT MED J, V332, P1030, DOI 10.1136/bmj.332.7548.1030; Lecrubier Y, 2007, J CLIN PSYCHIAT, V68, P36; Mechanic D, 2002, HEALTH AFFAIR, V21, P242, DOI 10.1377/hlthaff.21.5.242; Mechanic D, 2007, J CLIN PSYCHIAT, V68, P20; Moncrieff J, 2000, J PUBLIC HEALTH MED, V22, P59, DOI 10.1093/pubmed/22.1.59; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mykletun A, 2009, 20098 FOLK; Mykletun A, 2006, AM J PSYCHIAT, V163, P1412, DOI 10.1176/appi.ajp.163.8.1412; NAV, 2012, NYE UF ETT KJONN UF; OECD, 2006, SICKN DIS WORK BREAK, V1; Organisation for economic Co-operation and development, 2010, SICKN DIS WORK BREAK; Ostby KA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-12; Overland S, 2007, PSYCHIAT SERV, V58, P1479, DOI 10.1176/appi.ps.58.11.1479; Salminen JK, 1997, ACTA PSYCHIAT SCAND, V95, P242, DOI 10.1111/j.1600-0447.1997.tb09626.x; Sanderson K, 2003, J AFFECT DISORDERS, V77, P109, DOI 10.1016/S0165-0327(03)00134-4; Schneider B, 2011, PSYCHIAT RES; Simon GE, 2001, J OCCUP ENVIRON MED, V43, P2, DOI 10.1097/00043764-200101000-00002; Skogen JC, 2012, ADDICTION, V107, P98, DOI 10.1111/j.1360-0443.2011.03551.x; StataCorp, 2009, STAT 11 BAS REF MAN; The Norwegian Ministry of Labour, 2011, NORW SOC INS SCHEM; Thorlacius S, 2010, J MENT HEALTH, V19, P176, DOI 10.3109/09638230902968316; Upmark M, 1999, SOC PSYCH PSYCH EPID, V34, P533, DOI 10.1007/s001270050172; Vahtera J, 2005, J EPIDEMIOL COMMUN H, V59, P238, DOI 10.1136/jech.2004.021824; Wallman T, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-103; WHO, 1977, ICD 9 INT STAT CLASS; World Health Organization, 1992, ICD 10 INT STAT CLAS	57	61	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42567	10.1371/journal.pone.0042567	http://dx.doi.org/10.1371/journal.pone.0042567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AG	22905150	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600015
J	Challa, AA; Vukmirovic, M; Blackmon, J; Stefanovic, B				Challa, Azariyas A.; Vukmirovic, Milica; Blackmon, John; Stefanovic, Branko			Withaferin-A Reduces Type I Collagen Expression In Vitro and Inhibits Development of Myocardial Fibrosis In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HYPERTENSIVE HEART-DISEASE; HEPATIC STELLATE CELLS; NF-KAPPA-B; LIVER FIBROSIS; MESSENGER-RNA; TGF-BETA; THERAPEUTIC TARGETS; POSTTRANSCRIPTIONAL REGULATION; MOLECULAR-MECHANISMS	Type I collagen is the most abundant protein in the human body. Its excessive synthesis results in fibrosis of various organs. Fibrosis is a major medical problem without an existing cure. Excessive synthesis of type I collagen in fibrosis is primarily due to stabilization of collagen mRNAs. We recently reported that intermediate filaments composed of vimentin regulate collagen synthesis by stabilizing collagen mRNAs. Vimentin is a primary target of Withaferin-A (WF-A). Therefore, we hypothesized that WF-A may reduce type I collagen production by disrupting vimentin filaments and decreasing the stability of collagen mRNAs. This study is to determine if WF-A exhibits anti-fibrotic properties in vitro and in vivo and to elucidate the molecular mechanisms of its action. In lung, skin and heart fibroblasts WF-A disrupted vimentin filaments at concentrations of 0.5-1.5 mu M and reduced 3 fold the half-lives of collagen alpha 1(I) and alpha 2(I) mRNAs and protein expression. In addition, WF-A inhibited TGF-beta 1 induced phosphorylation of TGF-beta 1 receptor I, Smad3 phosphorylation and transcription of collagen genes. WF-A also inhibited in vitro activation of primary hepatic stellate cells and decreased their type I collagen expression. In mice, administration of 4 mg/kg WF-A daily for 2 weeks reduced isoproterenol-induced myocardial fibrosis by 50%. Our findings provide strong evidence that Withaferin-A could act as an anti-fibrotic compound against fibroproliferative diseases, including, but not limited to, cardiac interstitial fibrosis.	[Challa, Azariyas A.; Vukmirovic, Milica; Blackmon, John; Stefanovic, Branko] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Challa, AA (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA.	branko.stefanovic@med.fsu.edu			National Institutes of Health [5R01DK059466-08]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant 5R01DK059466-08 to BS and an American Heart Association grant to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Agocha AE, 1997, MOL CELL BIOCHEM, V172, P195, DOI 10.1023/A:1006848512174; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2010, J BIOL CHEM, V285, P7657, DOI 10.1074/jbc.M109.093765; Bauer M, 2001, FEBS LETT, V502, P1, DOI 10.1016/S0014-5793(01)02655-2; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; BITTERMAN PB, 1991, CHEST, V99, pS81, DOI 10.1378/chest.99.3_Supplement.81S; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; Brilla CG, 2000, CIRCULATION, V102, P1388, DOI 10.1161/01.CIR.102.12.1388; Brooks WW, 2009, COMPARATIVE MED, V59, P339; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Cai L, 2010, J MOL BIOL, V395, P309, DOI 10.1016/j.jmb.2009.11.020; Challa AA, 2011, MOL CELL BIOL, V31, P3773, DOI 10.1128/MCB.05263-11; Cheng K, 2009, MOL PHARMACEUT, V6, P772, DOI 10.1021/mp9000469; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuspidi C, 2006, NEPHROL DIAL TRANSPL, V21, P20, DOI 10.1093/ndt/gfi237; de Gouville AC, 2005, BRIT J PHARMACOL, V145, P166, DOI 10.1038/sj.bjp.0706172; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Diez J, 2002, CIRCULATION, V105, P2512, DOI 10.1161/01.CIR.0000017264.66561.3D; Diez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Diez Javier, 2008, Circ J, V72 Suppl A, pA8, DOI 10.1253/circj.CJ-07-1067; Fallowfield JA, 2011, AM J PHYSIOL-GASTR L, V300, pG709, DOI 10.1152/ajpgi.00451.2010; Faulx MD, 2005, AM J PHYSIOL-HEART C, V289, pH30, DOI 10.1152/ajpheart.00636.2004; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Fritz D, 2011, CURR MED CHEM, V18, P3410, DOI 10.2174/092986711796504691; Ghiassi-Nejad Zahra, 2008, Expert Rev Gastroenterol Hepatol, V2, P803, DOI 10.1586/17474124.2.6.803; Gonzalez A, 2005, CURR OPIN NEPHROL HY, V14, P428, DOI 10.1097/01.mnh.0000174143.30045.bd; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S25; Heling A, 2000, CIRC RES, V86, P846, DOI 10.1161/01.RES.86.8.846; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Holwell TA, 1997, J CELL SCI, V110, P1947; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lee TJ, 2009, FREE RADICAL BIO MED, V46, P1639, DOI 10.1016/j.freeradbiomed.2009.03.022; Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032; Lindquist JN, 2000, AM J PHYSIOL-GASTR L, V279, pG471, DOI 10.1152/ajpgi.2000.279.3.G471; Lindquist JN, 2004, J BIOL CHEM, V279, P23822, DOI 10.1074/jbc.M314060200; Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10; Maitra R, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-15; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Oh JH, 2008, EUR J PHARMACOL, V599, P11, DOI 10.1016/j.ejphar.2008.09.017; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; PENTTINEN RP, 1988, P NATL ACAD SCI USA, V85, P1105, DOI 10.1073/pnas.85.4.1105; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; PICK R, 1989, AM J PATHOL, V134, P365; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Sharada AC, 1996, ACTA ONCOL, V35, P95, DOI 10.3109/02841869609098486; Smaldone S, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-8; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stefanovic B, 1999, MOL CELL BIOL, V19, P4334; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Thaiparambil JT, 2011, INT J CANC; Thompson Alexander James, 2010, Curr Gastroenterol Rep, V12, P23, DOI 10.1007/s11894-009-0080-9; Trojanowska M, 2009, CURR OPIN RHEUMATOL, V21, P623, DOI 10.1097/BOR.0b013e32833038ce; Tsukada S, 2005, J BIOL CHEM, V280, P10055, DOI 10.1074/jbc.M409381200; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yamada NA, 2003, MUTAGENESIS, V18, P277, DOI 10.1093/mutage/18.3.277; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181	68	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42989	10.1371/journal.pone.0042989	http://dx.doi.org/10.1371/journal.pone.0042989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900077	Green Submitted, Green Published, gold			2022-12-27	WOS:000307380900095
J	Lu, HR; Hallstrom, TC				Lu, Huarui; Hallstrom, Timothy C.			Sensitivity to TOP2 Targeting Chemotherapeutics Is Regulated by Oct1 and FILIP1L	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; LUNG-CANCER; DNA; FILAMIN; GENE; ANTICANCER; EXPRESSION; ENDOSTATIN; MUTATIONS; FAMILY	Topoisomerase II (TOP2) targeting drugs like doxorubicin and etoposide are frontline chemotherapeutics for a wide variety of solid and hematological malignancies, including breast and ovarian adenocarcinomas, lung cancers, soft tissue sarcomas, leukemias and lymphomas. These agents cause a block in DNA replication leading to a pronounced DNA damage response and initiation of apoptotic programs. Resistance to these agents is common, however, and elucidation of the mechanisms causing resistance to therapy could shed light on strategies to reduce the frequency of ineffective treatments. To explore these mechanisms, we utilized an unbiased shRNA screen to identify genes that regulate cell death in response to doxorubicin treatment. We identified the Filamin A interacting protein 1-like (FILIP1L) gene as a crucial mediator of apoptosis triggered by doxorubicin. FILIP1L shares significant similarity with bacterial SbcC, an ATPase involved in DNA repair. FILIP1L was originally described as DOC1, or "down-regulated in ovarian cancer" and has since been shown to be down-regulated in a wide variety of human tumors. FILIP1L levels increase markedly through transcriptional mechanisms following treatment with doxorubicin and other TOP2 poisons, including etoposide and mitoxantrone, but not by the TOP2 catalytic inhibitors merbarone or dexrazoxane (ICRF187), or by UV irradiation. This induction requires the action of the OCT1 transcription factor, which relocalizes to the FILIP1L promoter and facilitates its expression following doxorubicin treatment. Our findings suggest that the FILIP1L expression status in tumors may influence the response to anti-TOP2 chemotherapeutics.	[Lu, Huarui; Hallstrom, Timothy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lu, HR (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	halls026@umn.edu			Children's Cancer Research Fund, Minneapolis, MN	Children's Cancer Research Fund, Minneapolis, MN	This work was supported by Children's Cancer Research Fund, Minneapolis, MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Burton ER, 2011, MOL CANCER RES, V9, P1126, DOI 10.1158/1541-7786.MCR-11-0162; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Duncan MB, 2004, BBA-GEN SUBJECTS, V1671, P34, DOI 10.1016/j.bbagen.2003.12.010; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwon M, 2008, CANCER RES, V68, P7332, DOI 10.1158/0008-5472.CAN-08-1087; Liu FJ, 2007, CANCER SCI, V98, P1381, DOI 10.1111/j.1349-7006.2007.00542.x; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mao Y, 1999, BIOCHEMISTRY-US, V38, P10793, DOI 10.1021/bi9909804; Marchese A, 1999, GENOMICS, V56, P12, DOI 10.1006/geno.1998.5655; Martin SA, 2010, CLIN CANCER RES, V16, P5107, DOI 10.1158/1078-0432.CCR-10-0821; Mazzanti CM, 2004, GENOME RES, V14, P1585, DOI 10.1101/gr.2552804; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Schwarze SR, 2002, J BIOL CHEM, V277, P14877, DOI 10.1074/jbc.M200373200; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Tandle AT, 2005, CYTOKINE, V30, P347, DOI 10.1016/j.cyto.2005.01.020; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Tissier A, 2010, DNA REPAIR, V9, P922, DOI 10.1016/j.dnarep.2010.04.010; VERRIJZER CP, 1992, EMBO J, V11, P4993, DOI 10.1002/j.1460-2075.1992.tb05606.x; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702	36	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42921	10.1371/journal.pone.0042921	http://dx.doi.org/10.1371/journal.pone.0042921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900064	gold, Green Published, Green Submitted			2022-12-27	WOS:000307380900082
J	Vigelius, M; Meyer, B				Vigelius, Matthias; Meyer, Bernd			Stochastic Simulations of Pattern Formation in Excitable Media	PLOS ONE			English	Article							REACTION-DIFFUSION; CHEMICAL-SYSTEMS; CALCIUM OSCILLATIONS; COHERENCE RESONANCE; TRAVELING-WAVES; SPIRAL WAVES; NOISE; DYNAMICS; BEHAVIOR; MODEL	We present a method for mesoscopic, dynamic Monte Carlo simulations of pattern formation in excitable reaction-diffusion systems. Using a two-level parallelization approach, our simulations cover the whole range of the parameter space, from the noise-dominated low-particle number regime to the quasi-deterministic high-particle number limit. Three qualitatively different case studies are performed that stand exemplary for the wide variety of excitable systems. We present mesoscopic stochastic simulations of the Gray-Scott model, of a simplified model for intracellular Ca2+ oscillations and, for the first time, of the Oregonator model. We achieve simulations with up to 10(10) particles. The software and the model files are freely available and researchers can use the models to reproduce our results or adapt and refine them for further exploration.	[Vigelius, Matthias; Meyer, Bernd] Monash Univ, FIT Ctr Res Intelligent Syst, Clayton, Vic, Australia	Monash University	Vigelius, M (corresponding author), Monash Univ, FIT Ctr Res Intelligent Syst, Clayton, Vic, Australia.	Matthias.Vigelius@monash.edu			Australian Research Council [ARC DP0879239]	Australian Research Council(Australian Research Council)	This research is funded by the Australian Research Council (http://www.arc.gov.au/) under ARC DP0879239, providing salary support for MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066107; Alonso S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.078302; Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; ATRI A, 1993, BIOPHYS J, V65, P1727, DOI 10.1016/S0006-3495(93)81191-3; Atzberger PJ, 2010, J COMPUT PHYS, V229, P3474, DOI 10.1016/j.jcp.2010.01.012; Bar M, 1994, CHAOS, V4, P499, DOI 10.1063/1.166028; BARKLEY D, 1991, PHYSICA D, V49, P61, DOI 10.1016/0167-2789(91)90194-E; Belousov B, 1985, OSCILLATIONS TRAVELI; Bernstein D, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Biancalani T, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046215; Boon JP, 1996, PHYS REP, V273, P55, DOI 10.1016/0370-1573(95)00080-1; CHOPARD B, 1994, INT J MOD PHYS C, V5, P47, DOI 10.1142/S0129183194000052; Dargan SL, 2003, J PHYSIOL-LONDON, V553, P775, DOI 10.1113/jphysiol.2003.054247; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dupont G, 2003, LECT NOTES PHYS, V623, P131; Elf J, 2003, P SOC PHOTO-OPT INS, V5110, P114, DOI 10.1117/12.497009; Erban R., 2007, ARXIV07041908; Falcke M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/396; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Falcke M, 2003, BIOPHYS J, V84, P42, DOI 10.1016/S0006-3495(03)74831-0; Falcke M, 2009, CHAOS, V19, DOI 10.1063/1.3234259; FIELD RJ, 1974, J CHEM PHYS, V60, P1877, DOI 10.1063/1.1681288; FIELD RJ, 1972, J AM CHEM SOC, V94, P8649, DOI 10.1021/ja00780a001; Fu ZP, 2008, CHINESE PHYS LETT, V25, P1220, DOI 10.1088/0256-307X/25/4/016; Garcia-Ojalvo J, 1999, EUROPHYS LETT, V47, P298, DOI 10.1209/epl/i1999-00388-9; Gardiner C, 2009, SPRINGER SERIES SYNE; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Glatt E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026206; Gong YB, 2011, PHYSICA A, V390, P3662, DOI 10.1016/j.physa.2011.05.038; Gosak M, 2007, BIOPHYS CHEM, V128, P210, DOI 10.1016/j.bpc.2007.04.007; GRAY P, 1985, J PHYS CHEM-US, V89, P22, DOI 10.1021/j100247a009; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; Hempel H, 1999, PHYS REV LETT, V82, P3713, DOI 10.1103/PhysRevLett.82.3713; Hochberg D, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1900092; Izhikevich E.M, 2005, DYNAMICAL SYSTEMS NE; JAHNKE W, 1989, J PHYS CHEM-US, V93, P740, DOI 10.1021/j100339a047; JUNG P, 1995, CHAOS, V5, P458, DOI 10.1063/1.166117; Jung P, 1997, PHYS REV LETT, V78, P1723, DOI 10.1103/PhysRevLett.78.1723; Kadar S, 1998, NATURE, V391, P770, DOI 10.1038/35814; Kapral R, 2004, REV COMP CH, V20, P219, DOI 10.1002/0471678856.ch4; Kapral R, 1996, J PHYS CHEM-US, V100, P18976, DOI 10.1021/jp961247e; Keener J., 2009, INTERDISCIPLINARY AP, V8/I; Keener JP, 2006, MATH MED BIOL, V23, P1, DOI 10.1093/imammb/dql002; Klingbeil G, 2011, BIOINFORMATICS, V27, P1170, DOI 10.1093/bioinformatics/btr068; Koumoutsakos P, 2011, MATH MOD METH APPL S, V21, P955, DOI 10.1142/S021820251100543X; KUHNERT L, 1986, NATURE, V319, P393, DOI 10.1038/319393a0; Kummer U, 2005, BIOPHYS J, V89, P1603, DOI 10.1529/biophysj.104.057216; Lampoudi S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3074302; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Lechleiter JD, 1998, BIOPHYS CHEM, V72, P123, DOI 10.1016/S0301-4622(98)00128-8; Li H, 2010, INT J HIGH PERFORM C, V24, P107, DOI 10.1177/1094342009106066; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Lis M, 2009, BIOINFORMATICS, V25, P2289, DOI 10.1093/bioinformatics/btp387; Ma J, 2008, CHINESE PHYS LETT, V25, P4325, DOI 10.1088/0256-307X/25/12/039; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Mazin W, 1996, MATH COMPUT SIMULAT, V40, P371, DOI 10.1016/0378-4754(95)00044-5; Mikhailov AS, 2006, PHYS REP, V425, P79, DOI 10.1016/j.physrep.2005.11.003; Mott DR, 2001, 20041068 USGS; Muratov CB, 1999, PHYS REV E, V60, P242, DOI 10.1103/PhysRevE.60.242; Muratov CB, 2007, P NATL ACAD SCI USA, V104, P702, DOI 10.1073/pnas.0607433104; Murray JD, 2003, MATH BIOL, V3; Nakata S, 2011, J PHYS CHEM A, V115, P7406, DOI 10.1021/jp2012057; Ouyang Q, 2000, PHYS REV LETT, V84, P1047, DOI 10.1103/PhysRevLett.84.1047; PEARSON JE, 1993, SCIENCE, V261, P189, DOI 10.1126/science.261.5118.189; Perc M, 2007, CHEM PHYS LETT, V437, P143, DOI 10.1016/j.cplett.2007.02.003; Rodriguez JV, 2006, BIOINFORMATICS, V22, P1895, DOI 10.1093/bioinformatics/btl271; Sagues F, 2003, DALTON T, P1201, DOI 10.1039/b210932h; Sagues F, 2007, REV MOD PHYS, V79, P829, DOI 10.1103/RevModPhys.79.829; Schlesner J, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015003; Scott SK, 2004, OSCILLATIONS WAVES C; Sendina-Nadal I, 2000, PHYS REV LETT, V84, P2734, DOI 10.1103/PhysRevLett.84.2734; Si FN, 2007, EUR PHYS J B, V60, P507, DOI 10.1140/epjb/e2008-00009-1; Sneyd J, 2002, P NATL ACAD SCI USA, V99, P2398, DOI 10.1073/pnas.032281999; Solovey G, 2010, PHILOS T R SOC A, V368, P5597, DOI 10.1098/rsta.2010.0273; Stundzia AB, 1996, J COMPUT PHYS, V127, P196, DOI 10.1006/jcph.1996.0168; Swillens S, 1998, CELL CALCIUM, V23, P291, DOI 10.1016/S0143-4160(98)90025-2; TANG YH, 1995, P NATL ACAD SCI USA, V92, P7869, DOI 10.1073/pnas.92.17.7869; Tang YH, 1996, BIOPHYS J, V70, P246, DOI 10.1016/S0006-3495(96)79567-X; Ullner E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.180601; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Vigelius M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033384; Vigelius M, 2011, BIOINFORMATICS, V27, P288, DOI 10.1093/bioinformatics/btq622; Wang HL, 2007, J PHYS CHEM A, V111, P1265, DOI 10.1021/jp0674064; Wang JC, 1999, PHYS REV LETT, V82, P855, DOI 10.1103/PhysRevLett.82.855; Wang WM, 2011, COMMUN NONLINEAR SCI, V16, P2016, DOI 10.1016/j.cnsns.2010.09.002; Winfree Arthur T., 1991, Chaos, V1, P303, DOI 10.1063/1.165844; Woolley TE, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051914; Woolley TE, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046216; Yamasaki-Mann M, 2010, J BIOL CHEM, V285, P25053, DOI 10.1074/jbc.M109.095257; Yang JZ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148302; Yuan GY, 2011, CHAOS SOLITON FRACT, V44, P728, DOI 10.1016/j.chaos.2011.06.013; ZHABOTINSKY AM, 1985, OSCILLATIONS TRAVELL; Zhou LQ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.138301; Zhu CL, 2007, BIOPHYS CHEM, V125, P201, DOI 10.1016/j.bpc.2006.08.001	100	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42508	10.1371/journal.pone.0042508	http://dx.doi.org/10.1371/journal.pone.0042508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900025	gold, Green Published			2022-12-27	WOS:000307380900041
J	Kumar, R; Bose, A; Mallick, BN				Kumar, Rupesh; Bose, Amitabha; Mallick, Birendra Nath			A Mathematical Model towards Understanding the Mechanism of Neuronal Regulation of Wake-NREMS-REMS States	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; BASAL FOREBRAIN STIMULATION; LOCUS-COERULEUS NEURONS; MESENCEPHALIC RETICULAR-FORMATION; ASCENDING AROUSAL SYSTEM; MEDIAL PREOPTIC AREA; FREELY MOVING CATS; BRAIN-STEM; HYPOCRETIN OREXIN; SUPRACHIASMATIC NUCLEUS	In this study we have constructed a mathematical model of a recently proposed functional model known to be responsible for inducing waking, NREMS and REMS. Simulation studies using this model reproduced sleep-wake patterns as reported in normal animals. The model helps to explain neural mechanism(s) that underlie the transitions between wake, NREMS and REMS as well as how both the homeostatic sleep-drive and the circadian rhythm shape the duration of each of these episodes. In particular, this mathematical model demonstrates and confirms that an underlying mechanism for REMS generation is pre-synaptic inhibition from substantia nigra onto the REM-off terminals that project on REM-on neurons, as has been recently proposed. The importance of orexinergic neurons in stabilizing the wake-sleep cycle is demonstrated by showing how even small changes in inputs to or from those neurons can have a large impact on the ensuing dynamics. The results from this model allow us to make predictions of the neural mechanisms of regulation and patho-physiology of REMS.	[Kumar, Rupesh; Mallick, Birendra Nath] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Bose, Amitabha] Jawaharlal Nehru Univ, Sch Phys Sci, New Delhi 110067, India; [Bose, Amitabha] New Jersey Inst Technol, Dept Math Sci, Newark, NJ 07102 USA; [Kumar, Rupesh] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; New Jersey Institute of Technology; Jawaharlal Nehru University, New Delhi	Kumar, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	remsbnm@yahoo.com	Chillale, Rupesh/GYU-9179-2022; Nath, Mallick Birendra/AAF-1781-2020	Kumar, Rupesh/0000-0002-0858-9660; Bose, Amitabha/0000-0002-4812-119X	Council of Scientific and Industrial Research; Department of Biotechnology; Department of Science and Technology; UGC Capacity build-up funds; JC Bose Fellowship; Fulbright-Nehru Program; National Science Foundation, USA [DMS-1122291]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); UGC Capacity build-up funds; JC Bose Fellowship(Department of Science & Technology (India)); Fulbright-Nehru Program; National Science Foundation, USA(National Science Foundation (NSF))	Financial supports from the Council of Scientific and Industrial Research; Department of Biotechnology; Department of Science and Technology; UGC Capacity build-up funds and JC Bose Fellowship to BNM are acknowledged. Financial support from the Fulbright-Nehru Program and from the National Science Foundation DMS-1122291, USA to AB is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, NEUROREPORT, V12, P435, DOI 10.1097/00001756-200102120-00048; ACHERMANN P, 1994, BIOL CYBERN, V71, P115, DOI 10.1007/BF00197314; AKERSTEDT T, 1986, ELECTROEN CLIN NEURO, V64, P119, DOI 10.1016/0013-4694(86)90106-9; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; ASTONJONES G, 1981, J NEUROSCI, V1, P887; Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; Behn CGD, 2010, J NEUROPHYSIOL, V103, P1937, DOI 10.1152/jn.00795.2009; BENINGTON JH, 1994, PROG NEUROBIOL, V44, P433, DOI 10.1016/0301-0082(94)90005-1; BENINGTON JH, 1994, AM J PHYSIOL, V266, pR1992, DOI 10.1152/ajpregu.1994.266.6.R1992; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Bourgin P, 2000, J NEUROSCI, V20, P7760; BREMER F, 1975, BRAIN RES, V96, P71, DOI 10.1016/0006-8993(75)90573-9; BREMER F, 1970, BRAIN RES, V21, P132, DOI 10.1016/0006-8993(70)90028-4; BREMER F, 1973, ARCH ITAL BIOL, V111, P85; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; CHU N, 1973, SCIENCE, V179, P908, DOI 10.1126/science.179.4076.908; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; DEARMOND SJ, 1971, EXP NEUROL, V33, P653, DOI 10.1016/0014-4886(71)90134-8; Dominguez JM, 2005, PHYSIOL BEHAV, V86, P356, DOI 10.1016/j.physbeh.2005.08.006; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Espana RA, 2006, CONTEMPORARY CLIN NE, P189; Espana RA, 2001, NEUROSCIENCE, V106, P699, DOI 10.1016/S0306-4522(01)00319-0; EVERSON CA, 1989, SLEEP, V12, P60; Favale E, 1961, ARCH ITAL BIOL, V99, P1; Fleshner M, 2011, PHILOS T R SOC A, V369, P3855, DOI 10.1098/rsta.2011.0085; GILLILAND MA, 1989, SLEEP, V12, P53, DOI 10.1093/sleep/12.1.53; Guzman-Marin R, 2000, BRAIN RES, V875, P23, DOI 10.1016/S0006-8993(00)02561-0; Gvilia I, 2006, J NEUROSCI, V26, P3037, DOI 10.1523/JNEUROSCI.4827-05.2006; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hernandez Peon R, 1963, ELECTROENCEPHALO S24, V24, P188; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; JACOBS BL, 1986, PROG NEUROBIOL, V27, P183, DOI 10.1016/0301-0082(86)90008-0; Kaur S, 2004, BEHAV BRAIN RES, V151, P185, DOI 10.1016/j.bbr.2003.08.011; Kaur S, 2001, SYNAPSE, V42, P141, DOI 10.1002/syn.1109; KUMAR VM, 1985, EXP NEUROL, V89, P304, DOI 10.1016/0014-4886(85)90091-3; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Magnes J., 1961, ARCH ITAL BIOL, V99, P33; Magni F., 1959, ARCH ITAL BIOL, V97, P33; Mallick B. N., 2011, RAPID EYE MOVEMENT S; Mallick BN, 2011, SLEEP MED REV, V15, P165, DOI 10.1016/j.smrv.2010.11.001; Mallick BN, 2012, PROG NEUROBIOL, V97, P259, DOI 10.1016/j.pneurobio.2012.04.001; Mallick BN, 2005, BEHAV BRAIN RES, V158, P9, DOI 10.1016/j.bbr.2004.08.004; Mallick BN, 2004, J NEUROSCI RES, V75, P133, DOI 10.1002/jnr.10827; MALLICK BN, 1984, BRAIN RES BULL, V13, P353, DOI 10.1016/0361-9230(84)90084-4; Mallick BN, 2004, SYNAPSE, V51, P59, DOI 10.1002/syn.10283; MALLICK BN, 1986, BRAIN RES BULL, V16, P121, DOI 10.1016/0361-9230(86)90019-5; Mallick BN, 2001, NEUROSCIENCE, V104, P467, DOI 10.1016/S0306-4522(01)00062-8; MALLICK BN, 1983, EXP NEUROL, V81, P586, DOI 10.1016/0014-4886(83)90328-X; Mallick BN, 1999, RAPID EYE MOVEMENT S; MANCIA M, 1971, BRAIN RES, V33, P491, DOI 10.1016/0006-8993(71)90123-5; MANCIA M, 1974, BRAIN RES, V80, P41, DOI 10.1016/0006-8993(74)90722-7; MCCARLEY RW, 1975, SCIENCE, V189, P58, DOI 10.1126/science.1135627; MCGINTY D, 1990, TRENDS NEUROSCI, V13, P480, DOI 10.1016/0166-2236(90)90081-K; Methippara MM, 2000, NEUROREPORT, V11, P3423, DOI 10.1097/00001756-200011090-00004; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; MORUZZI G, 1972, ERG PHYSIOL BIOL CH, V64, P1; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; NAUTA WJH, 1946, J NEUROPHYSIOL, V9, P285, DOI 10.1152/jn.1946.9.4.285; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Nishino S, 2006, OREXIN HYPOCRETIN SY; Nishino S, 2007, J CLIN PSYCHIAT, V68, P9; Nishino S, 2007, SLEEP MED, V8, P373, DOI 10.1016/j.sleep.2007.03.008; OKUDZHAVA VM, 1985, ZH VYSSH NERV DEYAT+, V35, P891; Pal D, 2009, NEUROSCIENCE, V164, P404, DOI 10.1016/j.neuroscience.2009.08.025; Pal Dinesh, 2005, Shengli Xuebao, V57, P401; Pal D, 2006, NEUROPHARMACOLOGY, V51, P1, DOI 10.1016/j.neuropharm.2006.02.006; Peyron C, 1998, J NEUROSCI, V18, P9996; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Phillips AJK, 2008, J THEOR BIOL, V255, P413, DOI 10.1016/j.jtbi.2008.08.022; Postnova S, 2009, J BIOL RHYTHM, V24, P523, DOI 10.1177/0748730409346655; Rempe MJ, 2010, J MATH BIOL, V60, P615, DOI 10.1007/s00285-009-0276-5; ROSINA A, 1966, ELECTROEN CLIN NEURO, V21, P157, DOI 10.1016/0013-4694(66)90123-4; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sherin JE, 1998, J NEUROSCI, V18, P4705; Singh S, 1996, NEUROSCI RES, V24, P227, DOI 10.1016/0168-0102(95)00998-1; Skinner F K, 1994, J Comput Neurosci, V1, P69, DOI 10.1007/BF00962719; Steriade M. M., 2005, BRAIN CONTROL WAKEFU; STERMAN MB, 1962, EXP NEUROL, V6, P91, DOI 10.1016/0014-4886(62)90080-8; STERMAN MB, 1962, EXP NEUROL, V6, P103, DOI 10.1016/0014-4886(62)90081-X; Suntsova N, 2002, J PHYSIOL-LONDON, V543, P665, DOI 10.1113/jphysiol.2002.023085; SZYMUSIAK R, 1989, BRAIN RES, V498, P355, DOI 10.1016/0006-8993(89)91116-5; Tamakawa Y, 2006, J NEUROPHYSIOL, V95, P2055, DOI 10.1152/jn.00575.2005; Thankachan S, 2001, BRAIN RES BULL, V55, P43, DOI 10.1016/S0361-9230(01)00486-5; TRACHSEL L, 1986, AM J PHYSIOL, V251, pR1037, DOI 10.1152/ajpregu.1986.251.6.R1037; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859	95	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42059	10.1371/journal.pone.0042059	http://dx.doi.org/10.1371/journal.pone.0042059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905114	Green Submitted, Green Published, gold			2022-12-27	WOS:000307331100024
J	Wang, YQ; Qi, XW; Wang, F; Jiang, J; Guo, QN				Wang, Yong-qiang; Qi, Xiao-wei; Wang, Fan; Jiang, Jun; Guo, Qiao-nan			Association between TGFBR1 Polymorphisms and Cancer Risk: A Meta-Analysis of 35 Case-Control Studies	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; RECEPTOR-TYPE-I; TUMOR SUSCEPTIBILITY ALLELE; COLORECTAL-CANCER; BREAST-CANCER; INT7G24A VARIANT; SPANISH POPULATION; PROSTATE-CANCER; CLINICAL-TRIALS; BLADDER-CANCER	Background: Numerous epidemiological studies have evaluated the association between TGFBR1 polymorphisms and the risk of cancer, however, the results remain inconclusive. To derive a more precise estimation of the relation, we conducted a comprehensive meta-analysis of all available case-control studies relating the TGFBR1*6A and IVS7+24G>A polymorphisms of the TGFBR1 gene to the risk of cancer. Methods: Eligible studies were identified by search of electronic databases. Overall and subgroup analyses were performed. Odds ratio (OR) and 95% confidence interval (CI) were applied to assess the associations between TGFBR1*6A and IVS7+24G>A polymorphisms and cancer risk. Results: A total of 35 studies were identified, 32 with 19,767 cases and 18,516 controls for TGFBR1*6A polymorphism and 12 with 4,195 cases and 4,383 controls for IVS7+24G>A polymorphism. For TGFBR1*6A, significantly elevated cancer risk was found in all genetic models (dominant OR = 1.11, 95% CI = 1.04 similar to 1.18; recessive: OR = 1.36, 95% CI = 1.11 similar to 1.66; additive: OR = 1.13, 95% CI = 1.05 similar to 1.20). In subgroup analysis based on cancer type, increased cancer risk was found in ovarian and breast cancer. For IVS7+24G>A, significant correlation with overall cancer risk (dominant: OR = 1.39, 95% CI = 1.15 similar to 1.67; recessive: OR = 2.23, 95% CI = 1.26 similar to 3.92; additive: OR = 1.43, 95% CI = 1.14 similar to 1.80) was found, especially in Asian population. In the subgroup analysis stratified by cancer type, significant association was found in breast and colorectal cancer. Conclusions: Our investigations demonstrate that TGFBR1*6A and IVS7+24G>A polymorphisms of TGFBR1 are associated with the susceptibility of cancer, and further functional research should be performed to explain the inconsistent results in different ethnicities and cancer types.	[Wang, Yong-qiang; Guo, Qiao-nan] Third Mil Med Univ, Inst Pathol, Southwest Hosp, Chongqing, Peoples R China; [Qi, Xiao-wei; Jiang, Jun] Third Mil Med Univ, Breast Dis Ctr, Southwest Hosp, Chongqing, Peoples R China; [Wang, Fan] Jiangjin Cent Hosp, Dept Oncol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Wang, YQ (corresponding author), Third Mil Med Univ, Inst Pathol, Southwest Hosp, Chongqing, Peoples R China.	jcbd@medmail.com.cn; qiaonan85@263.net	Qi, Xiaowei/O-1338-2018	Qi, Xiaowei/0000-0002-5876-4957	National Natural Science Foundation of China [30971139, 81172554]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants No.30971139 and No.81172554 from National Natural Science Foundation of China. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuli A, 2011, BRIT J CANCER, V105, P870, DOI 10.1038/bjc.2011.296; Baxter SW, 2002, CANCER EPIDEM BIOMAR, V11, P211; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benson JR, 2004, LANCET ONCOL, V5, P229, DOI 10.1016/S1470-2045(04)01426-3; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bredberg A, 2011, CANCER-AM CANCER SOC, V117, P440, DOI 10.1002/cncr.25440; Carvajal-Carmona LG, 2010, P NATL ACAD SCI USA, V107, P7858, DOI 10.1073/pnas.1002816107; Castillejo A, 2009, INT J CANCER, V124, P608, DOI 10.1002/ijc.24013; Castillejo A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-406; Castillejo A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-193; Chen TP, 1999, INT J CANCER, V82, P43; Chen TP, 2006, CLIN CANCER RES, V12, P392, DOI 10.1158/1078-0432.CCR-05-1518; Chen TP, 2004, INT J CANCER, V112, P420, DOI 10.1002/ijc.20419; Colleran G, 2010, BREAST CANCER RES TR, V119, P437, DOI 10.1007/s10549-009-0395-0; Cox DG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-175; Dai LP, 2009, PEDIATR BLOOD CANCER, V52, P819, DOI 10.1002/pbc.21971; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; [董稚明 Dong Zhiming], 2011, [癌变·畸变·突变, Carcinogenesis, Teratogenesis and Mutagenesis], V23, P16; Duan YH, 2011, MOL BIOL REP, V38, P301, DOI 10.1007/s11033-010-0108-0; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Feigelson HS, 2006, CANCER EPIDEM BIOMAR, V15, P1236, DOI 10.1158/1055-9965.EPI-06-0163; Forsti A, 2010, GENE CHROMOSOME CANC, V49, P270, DOI 10.1002/gcc.20738; Galliher Amy J, 2006, Future Oncol, V2, P743, DOI 10.2217/14796694.2.6.743; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hu YS, 2011, MED ONCOL, V28, P622, DOI 10.1007/s12032-010-9483-6; Hu YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-169; Jakubowska A, 2010, BREAST CANCER RES TR, V119, P201, DOI 10.1007/s10549-009-0390-5; Jin QR, 2004, INT J CANCER, V112, P94, DOI 10.1002/ijc.20370; Joshi NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021866; Kaklamani V, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-28; Kaklamani VG, 2005, CANCER RES, V65, P3454, DOI 10.1158/0008-5472.CAN-04-2961; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Liao RY, 2010, MOL BIOL REP, V37, P3227, DOI 10.1007/s11033-009-9906-7; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Lundin JS, 2009, BRIT J CANCER, V100, P1674, DOI 10.1038/sj.bjc.6605054; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martinez-Canto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030812; MOSES HL, 1981, CANCER RES, V41, P2842; Pasche B, 1999, CANCER RES, V59, P5678; Pasche B, 2005, JAMA-J AM MED ASSOC, V294, P1634, DOI 10.1001/jama.294.13.1634; Pasche B, 1998, CANCER RES, V58, P2727; Pasche B, 2004, J CLIN ONCOL, V22, P756, DOI 10.1200/JCO.2004.99.271; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Qi XW, 2010, BREAST CANCER RES TR, V123, P499, DOI 10.1007/s10549-010-0773-7; Qi XW, 2010, BREAST CANCER RES TR, V122, P273, DOI 10.1007/s10549-010-0847-6; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; Samowitz WS, 2001, GENE CHROMOSOME CANC, V32, P381, DOI 10.1002/gcc.1203; Skoglund J, 2007, CLIN CANCER RES, V13, P3748, DOI 10.1158/1078-0432.CCR-06-2865; Song B, 2007, BRIT J CANCER, V97, P1175, DOI 10.1038/sj.bjc.6603961; Spillman MA, 2005, GYNECOL ONCOL, V97, P543, DOI 10.1016/j.ygyno.2005.01.025; Stefanovska AM, 2001, CANCER RES, V61, P8351; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suarez BK, 2005, PROSTATE CANCER P D, V8, P50, DOI 10.1038/sj.pcan.4500765; van Tilborg AAG, 2001, J PATHOL, V194, P76, DOI 10.1002/path.860; You W, 2007, J THORAC ONCOL, V2, P657, DOI 10.1097/JTO.0b013e318070ccd7; Zhang HT, 2005, LUNG CANCER-J IASLC, V49, P419, DOI 10.1016/j.lungcan.2005.03.038; Zhang XL, 2012, MOL BIOL REP, V39, P2567, DOI 10.1007/s11033-011-1009-6; Zhang Y, 2011, BREAST CANCER RES TR, V130, P1073, DOI 10.1007/s10549-011-1806-6; Zhang YJ, 2009, CANCER LETT, V275, P102, DOI 10.1016/j.canlet.2008.10.017	62	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42899	10.1371/journal.pone.0042899	http://dx.doi.org/10.1371/journal.pone.0042899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905183	Green Submitted, gold, Green Published			2022-12-27	WOS:000307331100073
J	Lin, CE; Chen, SU; Lin, CC; Chang, CH; Lin, YC; Tai, YL; Shen, TL; Lee, H				Lin, Chuan-En; Chen, Shee-Uan; Lin, Chu-Cheng; Chang, Chi-Hao; Lin, Yueh-Chien; Tai, Yu-Ling; Shen, Tang-Long; Lee, Hsinyu			Lysophosphatidic Acid Enhances Vascular Endothelial Growth Factor-C Expression in Human Prostate Cancer PC-3 Cells	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; VEGF-C; MAMMARY TUMORIGENESIS; ACTIVATION; AUTOTAXIN; RECEPTOR; AXIS; PROGRESSION; INVASION; LPA(1)	Clinical evidence suggests that lymphangiogenesis and lymphatic metastasis are important processes during the progression of prostate cancer. Vascular endothelial growth factor (VEGF)-C was shown to be a key regulator in these processes. Our previous studies demonstrated that lysophosphatidic acid (LPA), a low-molecular-weight lipid growth factor, enhances VEGF-C expression in human endothelial cells. We previously demonstrated that the LPA receptor plays an important role in lymphatic development in zebrafish embryos. However, the effects of LPA on VEGF-C expression in prostate cancer are not known. Herein, we demonstrate that LPA up-regulated VEGF-C expression in three different human prostate cancer cell lines. In PC-3 human prostate cancer cells, the enhancing effects of LPA were mediated through both LPA1 and LPA3. In addition, reactive oxygen species (ROS) production and lens epithelium-derived growth factor (LEDGF) expression were involved in LPA(1/3)-dependent VEGF-C expression. Furthermore, autotaxin (ATX), an enzyme responsible for LPA synthesis, also participates in regulating VEGF-C expression. By interrupting LPA(1/3) of PC-3, conditioned medium (CM) induced human umbilical vein endothelial cell (HUVEC) lymphatic markers expression was also blocked. In summary, we found that LPA enhances VEGF-C expression through activating LPA(1/3)(-), ROS-, and LEDGF-dependent pathways. These novel findings could potentially shed light on developing new strategies for preventing lymphatic metastasis of prostate cancer.	[Lin, Chuan-En; Chang, Chi-Hao; Lin, Yueh-Chien; Lee, Hsinyu] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Chen, Shee-Uan] Natl Taiwan Univ, Dept Obstet & Gynecol, Taipei 10764, Taiwan; [Lin, Chu-Cheng; Lee, Hsinyu] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Tai, Yu-Ling; Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Shen, Tang-Long; Lee, Hsinyu] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan; [Lee, Hsinyu] Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Lin, CE (corresponding author), Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan.	hsinyu@ntu.edu.tw	Lin, Yueh-Chien/CAA-9333-2022	Lin, Yueh-Chien/0000-0002-8997-2708; Lee, Hsinyu/0000-0002-1477-0183; CHEN, SHEE-UAN/0000-0001-7592-3238; Shen, Tang-Long/0000-0001-6264-3608	National Science Council [NSC97-2311-B-002-002-MY3, NSC 99-2120-M-002-004, NHRI 101-EX101-10130BI]; National Health Research Institutes of the Republic of China	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes of the Republic of China(National Health Research Institutes - Taiwan)	The research was supported by grants (NSC97-2311-B-002-002-MY3, NSC 99-2120-M-002-004 and NHRI 101-EX101-10130BI) from the National Science Council and National Health Research Institutes of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya M, 2006, SURG ONCOL, V15, P117, DOI 10.1016/j.suronc.2006.10.002; Aziziyeh AI, 2009, CELL SIGNAL, V21, P1207, DOI 10.1016/j.cellsig.2009.03.011; Brakenhielm E, 2007, INT J CANCER, V121, P2153, DOI 10.1002/ijc.22900; Burton JB, 2008, CANCER RES, V68, P7828, DOI 10.1158/0008-5472.CAN-08-1488; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Cohen B, 2009, NEOPLASIA, V11, P921, DOI 10.1593/neo.09636; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Enholm B, 1997, ONCOGENE, V14, P2475, DOI 10.1038/sj.onc.1201090; Ferry G, 2008, J PHARMACOL EXP THER, V327, P809, DOI 10.1124/jpet.108.141911; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Hao F, 2007, BBA-MOL CELL BIOL L, V1771, P883, DOI 10.1016/j.bbalip.2007.04.010; Hwang YS, 2006, MOL CARCINOGEN, V45, P518, DOI 10.1002/mc.20183; Jonkers J, 2009, CANCER CELL, V15, P457, DOI 10.1016/j.ccr.2009.05.003; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Lee SJ, 2008, FASEB J, V22, P3706, DOI 10.1096/fj.08-106088; Li JP, 2005, ONCOGENE, V24, P5510, DOI 10.1038/sj.onc.1208693; Lin CI, 2008, CELL MOL LIFE SCI, V65, P2740, DOI 10.1007/s00018-008-8314-9; Lin CI, 2008, CELL SIGNAL, V20, P1804, DOI 10.1016/j.cellsig.2008.06.008; Lin JM, 2005, CANCER RES, V65, P6901, DOI 10.1158/0008-5472.CAN-05-0408; Liu SY, 2009, CELL CYCLE, V8, P3695, DOI 10.4161/cc.8.22.9937; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Nouh MAAM, 2009, CANCER SCI, V100, P1631, DOI 10.1111/j.1349-7006.2009.01234.x; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Park JJ, 2012, PROSTATE; Park SY, 2007, CANCER LETT, V258, P63, DOI 10.1016/j.canlet.2007.08.011; Reinmuth N, 2007, INT J ONCOL, V31, P621; Rhim JH, 2008, J CANCER RES CLIN, V134, P45, DOI 10.1007/s00432-007-0243-8; Rinaldo F, 2007, ONCOGENE, V26, P1731, DOI 10.1038/sj.onc.1209971; Sapoznik S, 2009, CANCER RES, V69, P9306, DOI 10.1158/0008-5472.CAN-09-1213; Sharma P, 2000, BIOCHEM BIOPH RES CO, V276, P1320, DOI 10.1006/bbrc.2000.3606; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Su JL, 2007, BRIT J CANCER, V96, P541, DOI 10.1038/sj.bjc.6603487; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Xie YH, 2004, CELL SIGNAL, V16, P975, DOI 10.1016/j.cellsig.2004.03.005; Xie YH, 2002, J BIOL CHEM, V277, P32516, DOI 10.1074/jbc.M203864200; Zeng YP, 2006, CANCER RES, V66, P9566, DOI 10.1158/0008-5472.CAN-06-1488; Zeng YP, 2004, CLIN CANCER RES, V10, P5137, DOI 10.1158/1078-0432.CCR-03-0434; Zeng YP, 2005, PROSTATE, V65, P222, DOI 10.1002/pros.20288; Zeng Y, 2009, PROSTATE, V69, P283, DOI 10.1002/pros.20879	42	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41096	10.1371/journal.pone.0041096	http://dx.doi.org/10.1371/journal.pone.0041096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911748	Green Submitted, Green Published, gold			2022-12-27	WOS:000306644600047
J	Thornton, E; Vink, R				Thornton, Emma; Vink, Robert			Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease	PLOS ONE			English	Article							NEUROKININ-3 RECEPTORS; BASAL GANGLIA; IN-VIVO; MICROGLIAL ACTIVATION; FUNCTIONAL DEFICITS; OXIDATIVE STRESS; DOPAMINE; DEGENERATION; ASTROCYTES; NIGRA	Neuroinflammation and blood brain barrier (BBB) dysfunction have been implicated in the pathogenesis of Parkinson's disease (PD). The neuropeptide substance P (SP) is an important mediator of both neuroinflammation and BBB dysfunction through its NK1 receptor in a process known as neurogenic inflammation. Increased SP content has previously been reported following 6-OHDA treatment in vitro, with the levels of SP correlating with cell death. The present study used an in vivo 6-OHDA lesion model to determine if dopaminergic degeneration was associated with increased SP in the substantia nigra and whether this degeneration could be prevented by using a SP, NK1 receptor antagonist Unilateral, intrastriatal 6-OHDA lesions were induced and SP (10 mu g/2 mu L) or the NK1 receptor antagonists, N-acetyl-L-tryptophan (2 mu L at 50 nM) or L-333,060 (2 mu L at 100 nM), administered immediately after the neurotoxin. Nigral SP content was then determined using immunohistochemical and ELISA methods, neuroinflammation and barrier integrity was assessed using Iba-1, ED-1, GFAP and albumin immunohistochemistry, while dopaminergic cell loss was assessed with tyrosine hydroxylase immunohistochemistry. Motor function in all animals was assessed using the rotarod task. Intrastriatal 6-OHDA lesioning produced an early and sustained increase in ipsilateral nigral SP content, along with a breakdown of the BBB and activation of microglia and astrocytes. Further exacerbation of SP levels accelerated disease progression, whereas NK1 receptor antagonist treatment protected dopaminergic neurons, preserved barrier integrity, reduced neuroinflammation and significantly improved motor function. We propose that neurogenic inflammation contributes to dopaminergic degeneration in early experimental PD and demonstrate that an NK1 receptor antagonist may represent a novel neuroprotective therapy.	[Thornton, Emma; Vink, Robert] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia	University of Adelaide	Thornton, E (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia.	Robert.Vink@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012; Emery, Kitty/B-5850-2011; Speller, Camilla/D-2830-2014	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Emery, Kitty/0000-0002-4031-1968; Speller, Camilla/0000-0001-7128-9903	Neurosurgical Research Foundation, Adelaide, Australia	Neurosurgical Research Foundation, Adelaide, Australia	This study was funded, in part, by the Neurosurgical Research Foundation, Adelaide, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alves G, 2008, J NEUROL, V255, P18, DOI 10.1007/s00415-008-5004-3; BANNON MJ, 1995, BRAIN RES, V695, P19, DOI 10.1016/0006-8993(95)00791-N; Bartels AL, 2008, J NEURAL TRANSM, V115, P1001, DOI 10.1007/s00702-008-0030-y; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; Bevan MD, 1996, NEUROSCIENCE, V75, P5, DOI 10.1016/0306-4522(96)00377-6; Bishop C, 2004, BRAIN RES, V1023, P126, DOI 10.1016/j.brainres.2004.07.039; Block ML, 2006, FASEB J, V20, P251, DOI 10.1096/fj.05-4553com; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chen LW, 2004, CURR DRUG TARGETS, V5, P197, DOI 10.2174/1389450043490596; Chung YC, 2010, BMB REP, V43, P225, DOI 10.5483/BMBRep.2010.43.4.225; De Ceballos ML, 1999, PEPTIDES, V20, P249, DOI 10.1016/S0196-9781(98)00177-6; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; FERNANDEZ A, 1994, NEUROSCIENCE, V61, P73, DOI 10.1016/0306-4522(94)90061-2; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Helps SC, 2012, APPL IMMUNOHISTO M M, V20, P82, DOI 10.1097/PAI.0b013e31821fc8cd; Hirsch EC, 2000, J NEUROL, V247, P58, DOI 10.1007/PL00007762; Ionov ID, 2008, INT J NEUROSCI, V118, P1763, DOI 10.1080/00207450802330561; Ji KA, 2008, GLIA, V56, P1039, DOI 10.1002/glia.20677; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Lee CS, 1996, NEUROSCIENCE, V72, P641, DOI 10.1016/0306-4522(95)00571-4; Levesque M, 2007, NEUROSCI RES, V57, P362, DOI 10.1016/j.neures.2006.11.002; Lin RCS, 1995, NEUROREPORT, V7, P310, DOI 10.1097/00001756-199512000-00074; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; MANTYH PW, 1989, P NATL ACAD SCI USA, V86, P5193, DOI 10.1073/pnas.86.13.5193; Marriott I, 2004, FRONT BIOSCI-LANDMRK, V9, P2153, DOI 10.2741/1377; Marti M, 2005, J NEUROCHEM, V93, P195, DOI 10.1111/j.1471-4159.2005.03015.x; MAUBORGNE A, 1983, BRAIN RES, V268, P167, DOI 10.1016/0006-8993(83)90403-1; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Mosley RL, 2006, CLIN NEUROSCI RES, V6, P261, DOI 10.1016/j.cnr.2006.09.006; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NISBET AP, 1995, NEUROSCIENCE, V66, P361, DOI 10.1016/0306-4522(94)00606-6; Ogura T, 2005, NEUROSCI RES, V51, P299, DOI 10.1016/j.neures.2004.12.006; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; REID MS, 1990, EXP BRAIN RES, V82, P293; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Rock RB, 2006, J NEUROIMMUNE PHARM, V1, P117, DOI 10.1007/s11481-006-9012-8; Rodriguez MC, 1998, ANN NEUROL, V44, pS175, DOI 10.1002/ana.410440726; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Shults CW, 2004, MITOCHONDRION, V4, P641, DOI 10.1016/j.mito.2004.07.028; SIVAM SP, 1991, NEUROPEPTIDES, V18, P201, DOI 10.1016/0143-4179(91)90148-C; Takagi S, 2007, J NEURAL TRANSM, V114, P1553, DOI 10.1007/s00702-007-0790-9; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; TENOVUO O, 1984, BRAIN RES, V303, P113, DOI 10.1016/0006-8993(84)90217-8; Thornton E, 2010, NEUROSCI LETT, V481, P64, DOI 10.1016/j.neulet.2010.06.057; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; UKAI M, 1995, PHARMACOL BIOCHEM BE, V51, P705, DOI 10.1016/0091-3057(95)00010-T; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Wojtera M, 2005, FOLIA NEUROPATHOL, V43, P311	56	67	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34138	10.1371/journal.pone.0034138	http://dx.doi.org/10.1371/journal.pone.0034138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22905156	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000304780500034
J	Prinja, S; Bahuguna, P; Pinto, AD; Sharma, A; Bharaj, G; Kumar, V; Tripathy, JP; Kaur, M; Kumar, R				Prinja, Shankar; Bahuguna, Pankaj; Pinto, Andrew D.; Sharma, Atul; Bharaj, Gursimer; Kumar, Vishal; Tripathy, Jaya Prasad; Kaur, Manmeet; Kumar, Rajesh			The Cost of Universal Health Care in India: A Model Based Estimate	PLOS ONE			English	Article							POOR	Introduction: As high out-of-pocket healthcare expenses pose heavy financial burden on the families, Government of India is considering a variety of financing and delivery options to universalize health care services. Hence, an estimate of the cost of delivering universal health care services is needed. Methods: We developed a model to estimate recurrent and annual costs for providing health services through a mix of public and private providers in Chandigarh located in northern India. Necessary health services required to deliver good quality care were defined by the Indian Public Health Standards. National Sample Survey data was utilized to estimate disease burden. In addition, morbidity and treatment data was collected from two secondary and two tertiary care hospitals. The unit cost of treatment was estimated from the published literature. For diseases where data on treatment cost was not available, we collected data on standard treatment protocols and cost of care from local health providers. Results: We estimate that the cost of universal health care delivery through the existing mix of public and private health institutions would be INR 1713 (USD 38, 95% CI USD 18-73) per person per annum in India. This cost would be 24% higher, if branded drugs are used. Extrapolation of these costs to entire country indicates that Indian government needs to spend 3.8% (2.1%-6.8%) of the GDP for universalizing health care services. Conclusion: The cost of universal health care delivered through a combination of public and private providers is estimated to be INR 1713 per capita per year in India. Important issues such as delivery strategy for ensuring quality, reducing inequities in access, and managing the growth of health care demand need be explored.	[Prinja, Shankar; Bahuguna, Pankaj; Sharma, Atul; Bharaj, Gursimer; Kumar, Vishal; Tripathy, Jaya Prasad; Kaur, Manmeet; Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Pinto, Andrew D.] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Pinto, Andrew D.] St Michaels Hosp, Ctr Res Inner City Hlth, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Prinja, S (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	dr.rajeshkumar@gmail.com		Pinto, Ameet/0000-0003-1089-5664; Pinto, Andrew/0000-0003-1841-9347; Tripathy, Jaya Prasad/0000-0002-2626-5977; Bahuguna, Pankaj/0000-0001-9952-6077				*AFMC, 2007, STAND TREATM GUID ME; AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Bank W, 2010, WORLD DEV IND; Berman P, 2010, 59886 WORLD BANK HUM, P59886; Chollet D, 1997, PRIVATE INSURANCE PR; Dror DM, 2008, INDIAN J MED RES, V127, P347; Frenk J., 2011, NEW VISION HLTH SYST; Gupta I., 2000, WORLD HLTH POPULATIO, V3; Gupta M, 2010, RATE CONTRACT CONSUM; Hammer J., 2007, Economic and Political Weekly, V42, P4049; Health Do, 2010, SURG CARE PACKAGE; Hotchkiss DR, 1999, HEALTH POLICY, V46, P195, DOI 10.1016/S0168-8510(98)00063-3; Le Grand J., 2003, MOTIVATION AGENCY PU; Levesque JF, 2007, INT J HEALTH PLAN M, V22, P159, DOI 10.1002/hpm.879; Mahal A, 2011, ACHIEVING UNIVERSAL; Mathur Neeta, 2010, Indian J Community Med, V35, P153, DOI 10.4103/0970-0218.62585; Ministry of Health and Family Welfare (MoHFW) Government of India & UNICEF, 2019, NAT POP POL 2000; MOF, 2009, FISC CHALL; MOHFW, 2005, NAT HLTH ACC IND; MOHFW, 2005, NAT COMM MACR HLTH; MOHFW, 2009, NAT HLTH BILL 2009; MOHFW, 2005, BACKGR PAP BURD DIS; MOHFW, 2006, REP WORK GROUP HLTH; MOHFW, 2007, IND PUBL HLTH STAND; MOHFW, 2005, NAT RUR HLTH MISS IM; Moody A, 2011, EC TIMES; National Sample Survey Organisation (NSSO), 2006, MORB HLTH CAR COND A; Palacios R, 2010, NEW APPR PROV HLTH I; Peters D, 2002, BETTER HLTH SYSTEMS, P233; Prinja S, 2011, INDIAN J ME IN PRESS; Rama Baru, 2010, Economic and Political Weekly, V45, P49; Rane W, 1996, EC POLITICAL WE 0824, V24, P2331; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Sengupta A, 2005, BMJ-BRIT MED J, V331, P1157, DOI 10.1136/bmj.331.7526.1157; Singh M, 2006, NEUROL INDIA, V54, P78; Srivastava NM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-61; Sur D, 2009, J HEALTH POPUL NUTR, V27, P725; Suryanarayana M, 2011, IN ADJ HUM DEV IND I; Tancharoensathien V, 2006, ACHIEVING UNIVERSAL; UNDP, 2011, HUM DEV REP 2010; van Doorslaer E, 2005, PAYING OUT OF POCKET; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A, 1999, J HEALTH ECON, V18, P263, DOI 10.1016/S0167-6296(98)00044-7; WHO, 2010, WOR HEALT REP, P1; WHO, 2005, CHOOSING INT AR COST	46	106	108	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30362	10.1371/journal.pone.0030362	http://dx.doi.org/10.1371/journal.pone.0030362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	911GB	22905208	gold, Green Published, Green Submitted			2022-12-27	WOS:000301704200015
J	IJssennagger, N; de Wit, N; Muller, M; van der Meer, R				IJssennagger, Noortje; de Wit, Nicole; Muller, Michael; van der Meer, Roelof			Dietary Heme-Mediated PPAR alpha Activation Does Not Affect the Heme-Induced Epithelial Hyperproliferation and Hyperplasia in Mouse Colon	PLOS ONE			English	Article							ACID-BINDING PROTEIN; RED MEAT; OXIDATIVE STRESS; CANCER; GENE; MICE; CARCINOGENESIS; EXPRESSION; RISK; NRF1	Red meat consumption is associated with an increased colon cancer risk. Heme, present in red meat, injures the colon surface epithelium by luminal cytotoxicity and reactive oxygen species. This surface injury is overcompensated by hyperproliferation and hyperplasia of crypt cells. Transcriptome analysis of mucosa of heme-fed mice showed, besides stress-and proliferation-related genes, many upregulated lipid metabolism-related PPAR alpha target genes. The aim of this study was to investigate the role of PPAR alpha in heme-induced hyperproliferation and hyperplasia. Male PPAR alpha KO and WT mice received a purified diet with or without heme. As PPAR alpha is proposed to protect against oxidative stress and lipid peroxidation, we hypothesized that the absence of PPAR alpha leads to more surface injury and crypt hyperproliferation in the colon upon heme-feeding. Heme induced luminal cytotoxicity and lipid peroxidation and colonic hyperproliferation and hyperplasia to the same extent in WT and KO mice. Transcriptome analysis of colonic mucosa confirmed similar heme-induced hyperproliferation in WT and KO mice. Stainings for alkaline phosphatase activity and expression levels of Vanin-1 and Nrf2-targets indicated a compromised antioxidant defense in heme-fed KO mice. Our results suggest that the protective role of PPAR alpha in antioxidant defense involves the Nrf2-inhibitor Fosl1, which is upregulated by heme in PPAR alpha KO mice. We conclude that PPAR alpha plays a protective role in colon against oxidative stress, but PPAR alpha does not mediate heme-induced hyperproliferation. This implies that oxidative stress of surface cells is not the main determinant of heme-induced hyperproliferation and hyperplasia.	[IJssennagger, Noortje; de Wit, Nicole; Muller, Michael; van der Meer, Roelof] Top Inst Food & Nutr, Wageningen, Netherlands; [IJssennagger, Noortje; Muller, Michael; van der Meer, Roelof] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [de Wit, Nicole; Muller, Michael] Netherlands Nutrigen Ctr, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research	IJssennagger, N (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	noortje.ijssennagger@wur.nl	Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; Kleerebezem, Michiel/AAT-2078-2021; Derrien, Muriel/AAS-6845-2021	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Derrien, Muriel/0000-0001-8841-9153; Kleerebezem, Michiel/0000-0001-8552-2235	program council of TIFN [A-1001]	program council of TIFN	This study was funded by the program council of TIFN (grant A-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeed MA, 2009, FREE RADICAL BIO MED, V47, P767, DOI 10.1016/j.freeradbiomed.2009.06.017; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Anton PM, 2002, DIGEST DIS SCI, V47, P1308, DOI 10.1023/A:1015322514547; Bastide NM, 2011, CANCER PREV RES, V4, P177, DOI 10.1158/1940-6207.CAPR-10-0113; Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Vogel J, 2005, CARCINOGENESIS, V26, P387, DOI 10.1093/carcin/bgh331; de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Harada T, 2003, AM J PHYSIOL-GASTR L, V284, pG255, DOI 10.1152/ajpgi.00244.2002; IJssennagger N, 2012, GUT, V61, P1041, DOI 10.1136/gutjnl-2011-300239; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee SJ, 2010, TOXICOL APPL PHARM, V242, P191, DOI 10.1016/j.taap.2009.10.007; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Pialoux V, 2009, FREE RADICAL BIO MED, V46, P321, DOI 10.1016/j.freeradbiomed.2008.10.047; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Pouyet L, 2010, INFLAMM BOWEL DIS, V16, P96, DOI 10.1002/ibd.21031; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Sesink ALA, 1999, CANCER RES, V59, P5704; Thompson J, 1999, MOL CELL BIOCHEM, V192, P9, DOI 10.1023/A:1006806616963; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang GQ, 2005, HEPATOLOGY, V42, P871, DOI 10.1002/hep.20857; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P2894, DOI 10.1681/ASN.2007010097; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	38	74	75	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43260	10.1371/journal.pone.0043260	http://dx.doi.org/10.1371/journal.pone.0043260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	23239972	gold, Green Submitted, Green Published			2022-12-27	WOS:000307500800068
J	Sun, P; Mantri, N; Lou, HQ; Hu, Y; Sun, D; Zhu, YQ; Dong, TT; Lu, HF				Sun, Peng; Mantri, Nitin; Lou, Heqiang; Hu, Ya; Sun, Dan; Zhu, Yueqing; Dong, Tingting; Lu, Hongfei			Effects of Elevated CO2 and Temperature on Yield and Fruit Quality of Strawberry (Fragaria x ananassa Duch.) at Two Levels of Nitrogen Application	PLOS ONE			English	Article							CARBON-DIOXIDE; ANTIOXIDANT ACTIVITY; LEAF SENESCENCE; ARABIDOPSIS-THALIANA; PHENOLIC METABOLISM; HARVEST INDEX; SEED-SET; GROWTH; STRESS; WHEAT	We investigated if elevated CO2 could alleviate the negative effect of high temperature on fruit yield of strawberry (Fragaria x ananassa Duch. cv. Toyonoka) at different levels of nitrogen and also tested the combined effects of CO2, temperature and nitrogen on fruit quality of plants cultivated in controlled growth chambers. Results show that elevated CO2 and high temperature caused a further 12% and 35% decrease in fruit yield at low and high nitrogen, respectively. The fewer inflorescences and smaller umbel size during flower induction caused the reduction of fruit yield at elevated CO2 and high temperature. Interestingly, nitrogen application has no beneficial effect on fruit yield, and this may be because of decreased sucrose export to the shoot apical meristem at floral transition. Moreover, elevated CO2 increased the levels of dry matter-content, fructose, glucose, total sugar and sweetness index per dry matter, but decreased fruit nitrogen content, total antioxidant capacity and all antioxidant compounds per dry matter in strawberry fruit. The reduction of fruit nitrogen content and antioxidant activity was mainly caused by the dilution effect of accumulated non-structural carbohydrates sourced from the increased net photosynthetic rate at elevated CO2. Thus, the quality of strawberry fruit would increase because of the increased sweetness and the similar amount of fruit nitrogen content, antioxidant activity per fresh matter at elevated CO2. Overall, we found that elevated CO2 improved the production of strawberry (including yield and quality) at low temperature, but decreased it at high temperature. The dramatic fluctuation in strawberry yield between low and high temperature at elevated CO2 implies that more attention should be paid to the process of flower induction under climate change, especially in fruits that require winter chilling for reproductive growth.	[Sun, Peng; Lou, Heqiang; Hu, Ya; Sun, Dan; Zhu, Yueqing; Dong, Tingting; Lu, Hongfei] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Mantri, Nitin] RMIT Univ, Hlth Innovat Res Inst, Sch Appl Sci, Melbourne, Vic, Australia	Zhejiang Normal University; Royal Melbourne Institute of Technology (RMIT)	Sun, P (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China.	luhongfei63@yahoo.com.cn	Lu, Hongfei/F-9526-2013	Lu, Hongfei/0000-0001-9732-0833; Lan, Ruiting/0000-0001-9834-5258; Mantri, Nitin/0000-0002-7621-035X	Project of Scientific and Technological Research Plan of Jinhua [2010-3-078, 2010-3-079]	Project of Scientific and Technological Research Plan of Jinhua	This research was funded by the Project of Scientific and Technological Research Plan of Jinhua (2010-3-078, 2010-3-079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; AHMED FE, 1993, PLANT CELL ENVIRON, V16, P835, DOI 10.1111/j.1365-3040.1993.tb00505.x; American Society for Testing Materials, 2002, STAND TEST METH TOT; AVIGDORIAVIDOV H, 1977, ANN BOT-LONDON, V41, P927, DOI 10.1093/oxfordjournals.aob.a085389; BAKER JT, 1989, CROP SCI, V29, P98, DOI 10.2135/cropsci1989.0011183X002900010024x; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Bernier G., 1981, PHYSL FLOWERING, VI; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Caldwell CR, 2005, J AGR FOOD CHEM, V53, P1125, DOI 10.1021/jf0355351; CASANO LM, 1994, PLANT PHYSIOL, V106, P1033, DOI 10.1104/pp.106.3.1033; Chen K, 1997, J APPL BOT-ANGEW BOT, V71, P195; Chen K, 1997, J APPL BOT-ANGEW BOT, V71, P183; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Datta R, 2001, SEX PLANT REPROD, V14, P127, DOI 10.1007/s00497-001-0105-5; Deng X, 1998, ANN BOT-LONDON, V81, P67, DOI 10.1006/anbo.1997.0535; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; Franzaring J, 2011, ENVIRON EXP BOT, V72, P284, DOI 10.1016/j.envexpbot.2011.04.003; Giorgi A, 2009, FOOD CHEM, V114, P204, DOI 10.1016/j.foodchem.2008.09.039; Goncalves B, 2009, J AGR FOOD CHEM, V57, P265, DOI 10.1021/jf8020199; Grindal G, 1998, J PLANT GROWTH REGUL, V17, P161, DOI 10.1007/PL00007030; Grossman A, 2001, ANNU REV PLANT PHYS, V52, P163, DOI 10.1146/annurev.arplant.52.1.163; Heinonen IM, 1998, J AGR FOOD CHEM, V46, P4107, DOI 10.1021/jf980181c; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hikosaka K, 2011, J EXP BOT, V62, P1523, DOI 10.1093/jxb/erq401; IPCC, 2007, CLIMATE CHANGE 2007, DOI DOI 10.1260/095830507781076194; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Keutgen A, 2007, FOOD CHEM, V105, P1487, DOI 10.1016/j.foodchem.2007.05.033; Konsin M, 2001, J HORTIC SCI BIOTECH, V76, P77, DOI 10.1080/14620316.2001.11511330; Kovacik J, 2007, PLANT SOIL, V297, P255, DOI 10.1007/s11104-007-9346-x; Kumakura H, 1995, JARQ-JPN AGR RES Q, V29, P241; Ledesma NA, 2008, SCI HORTIC-AMSTERDAM, V116, P186, DOI 10.1016/j.scienta.2007.12.010; Levine LH, 2009, ADV SPACE RES, V44, P887, DOI 10.1016/j.asr.2009.06.017; Li WL, 2007, AGR WATER MANAGE, V87, P106, DOI 10.1016/j.agwat.2006.06.027; Lieten F, 1997, ACTA HORTIC, P583, DOI 10.17660/ActaHortic.1997.439.97; Lin YL, 2011, PLANT GROWTH REGUL, V64, P263, DOI 10.1007/s10725-011-9567-0; Lu HF, 2011, J FOOD ENG, V104, P149, DOI 10.1016/j.jfoodeng.2010.12.007; Lu HF, 2010, J AGR FOOD CHEM, V58, P2995, DOI 10.1021/jf903655a; Matsui T, 1997, FIELD CROP RES, V51, P213, DOI 10.1016/S0378-4290(96)03451-X; McConnaughay KDM, 1996, GLOB CHANGE BIOL, V2, P25, DOI 10.1111/j.1365-2486.1996.tb00046.x; MORISHITA M, 1993, J JPN SOC HORTIC SCI, V61, P857, DOI 10.2503/jjshs.61.857; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; NITSCH J. P., 1952, QUART REV BIOL, V27, P33, DOI 10.1086/398643; Porch TG, 2001, PLANT CELL ENVIRON, V24, P723, DOI 10.1046/j.1365-3040.2001.00716.x; Prasad PVV, 2006, AGR FOREST METEOROL, V139, P237, DOI 10.1016/j.agrformet.2006.07.003; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Prasad PVV, 2003, GLOBAL CHANGE BIOL, V9, P1775, DOI [10.1046/j.1365-2486.2003.00708.x, 10.1046/j.1529-8817.2003.00708.x]; Prasad PVV, 2002, GLOBAL CHANGE BIOL, V8, P710, DOI 10.1046/j.1365-2486.2002.00508.x; Pressman E, 2002, ANN BOT-LONDON, V90, P631, DOI 10.1093/aob/mcf240; Quesada MA, 2009, PLANT PHYSIOL, V150, P1022, DOI 10.1104/pp.109.138297; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Reddy KR, 2000, CLIMATE CHANGE AND GLOBAL CROP PRODUCTIVITY, P161, DOI 10.1079/9780851994390.0161; SAINI HS, 1982, ANN BOT-LONDON, V49, P835, DOI 10.1093/oxfordjournals.aob.a086310; Santos BM, 2009, INT J FRUIT SCI, V9, P126, DOI 10.1080/15538360902991337; Sato S, 2000, PLANT CELL ENVIRON, V23, P719, DOI 10.1046/j.1365-3040.2000.00589.x; Su WR, 2001, PLANT PHYSIOL BIOCH, V39, P45, DOI 10.1016/S0981-9428(00)01218-3; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Suzuki K, 2001, J AM SOC HORTIC SCI, V126, P571, DOI 10.21273/JASHS.126.5.571; Taub DR, 2008, J INTEGR PLANT BIOL, V50, P1365, DOI 10.1111/j.1744-7909.2008.00754.x; TAYLOR DR, 1994, PLANT GROWTH REGUL, V15, P235, DOI 10.1007/BF00029896; vanTienderen PH, 1996, AM J BOT, V83, P169, DOI 10.2307/2445934; Wang SY, 2004, J SCI FOOD AGR, V84, P1464, DOI 10.1002/jsfa.1824; Wang SY, 2003, J AGR FOOD CHEM, V51, P4315, DOI 10.1021/jf021172d; Wheeler TR, 1996, J AGR SCI, V127, P37, DOI 10.1017/S0021859600077352; Xiao G., 2009, ACTA ECOL SIN, V29, P205, DOI [10.1016/j.chnaes.2009.08.002, DOI 10.1016/J.CHNAES.2009.08.002]; Xiong W, 2007, CLIMATIC CHANGE, V81, P205, DOI 10.1007/s10584-006-9123-5; Yamasaki A, 2000, J JPN SOC HORTIC SCI, V69, P40, DOI 10.2503/jjshs.69.40; Yoshida H, 2011, FIELD CROP RES, V124, P433, DOI 10.1016/j.fcr.2011.07.016; Zheng H, 2011, J AGR FOOD CHEM, V59, P592, DOI 10.1021/jf1032476; Zheng H, 2010, J FOOD ENG, V101, P402, DOI 10.1016/j.jfoodeng.2010.07.028; Zhu CW, 2009, FUNCT PLANT BIOL, V36, P291, DOI 10.1071/FP08269	71	61	62	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41000	10.1371/journal.pone.0041000	http://dx.doi.org/10.1371/journal.pone.0041000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	23049947	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300020
J	Cheng, J; Khan, MA; Qiu, WM; Li, J; Zhou, H; Zhang, QO; Guo, WW; Zhu, TT; Peng, JH; Sun, FJ; Li, SH; Korban, SS; Han, YP				Cheng, Jun; Khan, Muhammad Awais; Qiu, Wen-Ming; Li, Jing; Zhou, Hui; Zhang, Qiong; Guo, Wenwu; Zhu, Tingting; Peng, Junhua; Sun, Fengjie; Li, Shaohua; Korban, Schuyler S.; Han, Yuepeng			Diversification of Genes Encoding Granule-Bound Starch Synthase in Monocots and Dicots Is Marked by Multiple Genome-Wide Duplication Events	PLOS ONE			English	Article							MALUS X DOMESTICA; PROCESSED PSEUDOGENES; AMYLOPECTIN BIOSYNTHESIS; DEBRANCHING ENZYMES; RICE ENDOSPERM; WAXY LOCUS; 2 ISOFORMS; APPLE; ISOAMYLASE; EXPRESSION	Starch is one of the major components of cereals, tubers, and fruits. Genes encoding granule-bound starch synthase (GBSS), which is responsible for amylose synthesis, have been extensively studied in cereals but little is known about them in fruits. Due to their low copy gene number, GBSS genes have been used to study plant phylogenetic and evolutionary relationships. In this study, GBSS genes have been isolated and characterized in three fruit trees, including apple, peach, and orange. Moreover, a comprehensive evolutionary study of GBSS genes has also been conducted between both monocots and eudicots. Results have revealed that genomic structures of GBSS genes in plants are conserved, suggesting they all have evolved from a common ancestor. In addition, the GBSS gene in an ancestral angiosperm must have undergone genome duplication similar to 251 million years ago (MYA) to generate two families, GBSSI and GBSSII. Both GBSSI and GBSSII are found in monocots; however, GBSSI is absent in eudicots. The ancestral GBSSII must have undergone further divergence when monocots and eudicots split similar to 165 MYA. This is consistent with expression profiles of GBSS genes, wherein these profiles are more similar to those of GBSSII in eudicots than to those of GBSSI genes in monocots. In dicots, GBSSII must have undergone further divergence when rosids and asterids split from each other similar to 126 MYA. Taken together, these findings suggest that it is GBSSII rather than GBSSI of monocots that have orthologous relationships with GBSS genes of eudicots. Moreover, diversification of GBSS genes is mainly associated with genome-wide duplication events throughout the evolutionary course of history of monocots and eudicots.	[Cheng, Jun; Li, Jing; Zhou, Hui; Zhang, Qiong; Zhu, Tingting; Peng, Junhua; Li, Shaohua; Han, Yuepeng] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China; [Khan, Muhammad Awais; Korban, Schuyler S.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Qiu, Wen-Ming; Guo, Wenwu] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Hubei, Peoples R China; [Sun, Fengjie] Georgia Gwinnett Coll, Sch Sci & Technol, Lawrenceville, GA USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; University of Illinois System; University of Illinois Urbana-Champaign; Huazhong Agricultural University; University System of Georgia; Georgia Gwinnett College	Cheng, J (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China.	korban@illinois.edu; yphan@wbgcas.cn	Peng, Junhua/HHZ-2344-2022; Zhu, Tingting/T-9997-2019; Zhu, Tingting/O-6989-2017	Peng, Junhua/0000-0002-8428-3137; Zhu, Tingting/0000-0003-3141-1884; Zhu, Tingting/0000-0003-3141-1884; Leung, Peter/0000-0003-3152-3800; Cheng, Jung-Chien/0000-0002-5399-9327; Khan, Muhammad Awais/0000-0002-0424-7727	National Program on Key Basic Research Project of China (973 Program) [2011CB100600]; CAS [XDA01020304]; Ministry of Agriculture of China	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); CAS(Chinese Academy of Sciences); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This research was jointly supported by National Program on Key Basic Research Project of China (973 Program, grant no. 2011CB100600), the CAS Strategic Priority Research Program (grant no. XDA01020304), and the National 948 Project from the Ministry of Agriculture of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blauth SL, 2001, PLANT PHYSIOL, V125, P1396, DOI 10.1104/pp.125.3.1396; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Carrin ME, 2004, FOOD CHEM, V87, P173, DOI 10.1016/j.foodchem.2003.10.032; Denyer K, 1997, PLANT CELL ENVIRON, V20, P1566, DOI 10.1046/j.1365-3040.1997.d01-48.x; Dian WM, 2003, PLANTA, V218, P261, DOI 10.1007/s00425-003-1101-9; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DRY I, 1992, PLANT J, V2, P193; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards A, 2002, PLANT CELL, V14, P1767, DOI 10.1105/tpc.002907; Ermolaeva MD, 2003, PLANT MOL BIOL, V51, P859, DOI 10.1023/A:1023001130337; Evans RC, 2000, MOL PHYLOGENET EVOL, V17, P388, DOI 10.1006/mpev.2000.0828; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Goncalves I, 2000, GENOME RES, V10, P672, DOI 10.1101/gr.10.5.672; GRAUR D, 1989, J MOL EVOL, V28, P279, DOI 10.1007/BF02103423; Han YP, 2007, PLANTA, V226, P1265, DOI 10.1007/s00425-007-0555-6; Han Y, 2007, MOL PHYLOGENET EVOL, V43, P852, DOI 10.1016/j.ympev.2006.09.001; Han YP, 2011, J EXP BOT, V62, P5117, DOI 10.1093/jxb/err215; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hylton CM, 1996, PLANTA, V198, P230, DOI 10.1007/BF00206248; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kelebek H, 2011, J SCI FOOD AGR, V91, P1855, DOI 10.1002/jsfa.4396; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Korban Schuyler S., 2009, V6, P85, DOI 10.1007/978-0-387-77491-6_5; Kubo A, 1999, PLANT PHYSIOL, V121, P399, DOI 10.1104/pp.121.2.399; Kubo A, 2010, PLANT PHYSIOL, V153, P956, DOI 10.1104/pp.110.155259; Lo Bianco R, 2002, J AM SOC HORTIC SCI, V127, P115, DOI 10.21273/JASHS.127.1.115; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; Magein H., 2000, ACTA HORTIC, V517, P487; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; McIntyre CL, 2008, GENOME, V51, P524, DOI 10.1139/G08-035; NAKAMURA T, 1995, MOL GEN GENET, V248, P253, DOI 10.1007/BF02191591; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Noda T, 2003, CEREAL CHEM, V80, P193, DOI 10.1094/CCHEM.2003.80.2.193; Ophir R, 1997, GENE, V205, P191, DOI 10.1016/S0378-1119(97)00398-3; Pavlicek A, 2006, TRENDS GENET, V22, P69, DOI 10.1016/j.tig.2005.11.005; Rambaut A, 2011, TRACER V1 5 COMPUTER; Sattler SE, 2009, MOL BREEDING, V24, P349, DOI 10.1007/s11032-009-9296-5; Stevenson DG, 2006, CARBOHYD POLYM, V63, P432, DOI 10.1016/j.carbpol.2005.10.009; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vrinten PL, 2000, PLANT PHYSIOL, V122, P255, DOI 10.1104/pp.122.1.255; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; WESSLER SR, 1985, P NATL ACAD SCI USA, V82, P4177, DOI 10.1073/pnas.82.12.4177; WOLFE J A, 1988, Aliso, V12, P177; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	49	43	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30088	10.1371/journal.pone.0030088	http://dx.doi.org/10.1371/journal.pone.0030088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291904	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600014
J	Thomas, MA; Klaper, RD				Thomas, Michael A.; Klaper, Rebecca D.			Psychoactive Pharmaceuticals Induce Fish Gene Expression Profiles Associated with Human Idiopathic Autism	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; SEWAGE-TREATMENT PLANTS; COPY NUMBER VARIATION; WASTE-WATER; PRENATAL EXPOSURE; BIPOLAR DISORDER; SURFACE WATERS; ANTIDEPRESSANTS; BEHAVIOR; DRUGS	Idiopathic autism, caused by genetic susceptibility interacting with unknown environmental triggers, has increased dramatically in the past 25 years. Identifying environmental triggers has been difficult due to poorly understood pathophysiology and subjective definitions of autism. The use of antidepressants by pregnant women has been associated with autism. These and other unmetabolized psychoactive pharmaceuticals (UPPs) have also been found in drinking water from surface sources, providing another possible exposure route and raising questions about human health consequences. Here, we examined gene expression patterns of fathead minnows treated with a mixture of three psychoactive pharmaceuticals (fluoxetine, venlafaxine & carbamazepine) in dosages intended to be similar to the highest observed conservative estimates of environmental concentrations. We conducted microarray experiments examining brain tissue of fish exposed to individual pharmaceuticals and a mixture of all three. We used gene-class analysis to test for enrichment of gene sets involved with ten human neurological disorders. Only sets associated with idiopathic autism were unambiguously enriched. We found that UPPs induce autism-like gene expression patterns in fish. Our findings suggest a new potential trigger for idiopathic autism in genetically susceptible individuals involving an overlooked source of environmental contamination.	[Thomas, Michael A.] Idaho State Univ Sch, Dept Biol Sci, Pocatello, ID 83204 USA; [Klaper, Rebecca D.] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA	Idaho; Idaho State University; University of Wisconsin System; University of Wisconsin Milwaukee	Thomas, MA (corresponding author), Idaho State Univ Sch, Dept Biol Sci, Pocatello, ID 83204 USA.	mthomas@isu.edu	Thomas, Michael A/B-7489-2008	Thomas, Michael A/0000-0003-2982-0291; Klaper, Rebecca/0000-0002-9239-6916; Suh, Mina/0000-0002-9557-4933; harris, mark/0000-0002-9007-1587	PhRMA Foundation Sabbatical Fellowship grant; National Institutes of Health from the INBRE Program of the National Center for Research Resources [P20 RR016454]; University Research Committee of Idaho State University [URC-FY2010-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER	PhRMA Foundation Sabbatical Fellowship grant; National Institutes of Health from the INBRE Program of the National Center for Research Resources; University Research Committee of Idaho State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	MAT was supported by a PhRMA Foundation Sabbatical Fellowship grant, National Institutes of Health Grant Number P20 RR016454 from the INBRE Program of the National Center for Research Resources, and grant number URC-FY2010-05 from the University Research Committee of Idaho State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2006, PROG NEURO-PSYCHOPH, V30, P865, DOI 10.1016/j.pnpbp.2006.01.010; Batt AL, 2008, ANAL CHEM, V80, P5021, DOI 10.1021/ac800066n; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Bromley RL, 2008, NEUROLOGY, V71, P1923, DOI 10.1212/01.wnl.0000339399.64213.1a; Bromley RL, 2009, CURR OPIN NEUROL, V22, P162, DOI 10.1097/WCO.0b013e3283292401; Bruce GM, 2010, ENVIRON SCI TECHNOL, V44, P5619, DOI 10.1021/es1004895; Camacho-Munoz MD, 2010, J HAZARD MATER, V177, P1159, DOI 10.1016/j.jhazmat.2010.01.030; Casper RC, 2003, J PEDIATR-US, V142, P402, DOI 10.1067/mpd.2003.139; Celiz MD, 2009, ENVIRON TOXICOL CHEM, V28, P2473, DOI 10.1897/09-173.1; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Chen M, 2006, WATER QUAL RES J CAN, V41, P351, DOI 10.2166/wqrj.2006.039; Christensen AM, 2009, CHEMOSPHERE, V77, P351, DOI 10.1016/j.chemosphere.2009.07.018; Corcoran J, 2010, CRIT REV TOXICOL, V40, P287, DOI 10.3109/10408440903373590; Croen LA, 2011, ARCH GEN PSYCHIAT AR; Cunningham VL, 2009, REGUL TOXICOL PHARM, V53, P39, DOI 10.1016/j.yrtph.2008.10.006; Currenti SA, 2010, CELL MOL NEUROBIOL, V30, P161, DOI 10.1007/s10571-009-9453-8; DasBanerjee T, 2008, AM J MED GENET B, V147B, P1554, DOI 10.1002/ajmg.b.30877; Dufour-Rainfray D, 2011, NEUROSCI BIOBEHAV R, V35, P1254, DOI 10.1016/j.neubiorev.2010.12.013; Dufour-Rainfray D, 2010, NEUROSCI LETT, V470, P55, DOI 10.1016/j.neulet.2009.12.054; Favreliere S, 2010, ENCEPHALE, V36, pD133, DOI 10.1016/j.encep.2009.06.005; Gentile S, 2010, DEPRESS ANXIETY, V27, P675, DOI 10.1002/da.20706; Gilli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008962; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Alonso SG, 2010, ENVIRON INT, V36, P195, DOI 10.1016/j.envint.2009.11.004; Gros M, 2010, ENVIRON INT, V36, P15, DOI 10.1016/j.envint.2009.09.002; Hadjikhani N, 2010, MED HYPOTHESES, V74, P880, DOI 10.1016/j.mehy.2009.11.015; Hallmayer J, 2011, ARCH GEN PSYCHIAT AR; Hollander E, 2009, PSYCHIAT RES, V170, P43, DOI 10.1016/j.psychres.2008.07.014; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775; Hughes JR, 2009, EPILEPSY BEHAV, V16, P569, DOI 10.1016/j.yebeh.2009.09.023; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; Jjemba PK, 2006, ECOTOX ENVIRON SAFE, V63, P113, DOI 10.1016/j.ecoenv.2004.11.011; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Landrigan PJ, 2010, CURR OPIN PEDIATR, V22, P219, DOI 10.1097/MOP.0b013e328336eb9a; Madureira TV, 2010, SCI TOTAL ENVIRON, V408, P5513, DOI 10.1016/j.scitotenv.2010.07.069; Martins-De-Souza D, 2010, WORLD J BIOL PSYCHIA, V11, P110, DOI 10.3109/15622970903490626; Matigian N, 2007, MOL PSYCHIATR, V12, P815, DOI 10.1038/sj.mp.4001998; McDonald ME, 2010, ENVIRON SCI TECHNOL, V44, P2112, DOI 10.1021/es902057k; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; McNamara IM, 2008, BRAIN RES, V1189, P203, DOI 10.1016/j.brainres.2007.10.063; Mennigen JA, 2010, AQUAT TOXICOL, V100, P128, DOI 10.1016/j.aquatox.2010.07.022; Metcalfe CD, 2003, ENVIRON TOXICOL CHEM, V22, P2881, DOI 10.1897/02-627; Metcalfe CD, 2010, ENVIRON TOXICOL CHEM, V29, P79, DOI 10.1002/etc.27; Nakamura K, 2011, PROG NEURO-PSYCHOPH, V35, P454, DOI 10.1016/j.pnpbp.2010.11.033; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; Oberlander TF, 2010, ARCH PEDIAT ADOL MED, V164, P444, DOI 10.1001/archpediatrics.2010.51; Olver JS, 2004, HUM PSYCHOPHARM CLIN, V19, P9, DOI 10.1002/hup.551; Painter MM, 2009, ENVIRON TOXICOL CHEM, V28, P2677, DOI 10.1897/08-556.1; Pedersen LH, 2010, PEDIATRICS, V125, pE600, DOI 10.1542/peds.2008-3655; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Rasalam AD, 2005, DEV MED CHILD NEUROL, V47, P551, DOI 10.1017/S0012162205001076; Rice C, 2010, DISABIL HEALTH J, V3, P186, DOI 10.1016/j.dhjo.2009.10.008; Santos LHMLM, 2010, J HAZARD MATER, V175, P45, DOI 10.1016/j.jhazmat.2009.10.100; Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011; Schultzt MM, 2008, ANAL CHEM, V80, P1756, DOI 10.1021/ac702154e; Schwab BW, 2005, REGUL TOXICOL PHARM, V42, P296, DOI 10.1016/j.yrtph.2005.05.005; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Simpson KL, 2011, P NATL ACAD SCI USA, V108, P18465, DOI 10.1073/pnas.1109353108; Stackelberg PE, 2007, SCI TOTAL ENVIRON, V377, P255, DOI 10.1016/j.scitotenv.2007.01.095; Stackelberg PE, 2004, SCI TOTAL ENVIRON, V329, P99, DOI 10.1016/j.scitotenv.2004.03.015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Thomas MA, 2012, COMP BIOCHEM PHYS C, V155, P109, DOI 10.1016/j.cbpc.2011.05.014; Thomas MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-66; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110	72	39	39	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e32917	10.1371/journal.pone.0032917	http://dx.doi.org/10.1371/journal.pone.0032917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22905163	Green Submitted, Green Published, gold			2022-12-27	WOS:000305348400001
J	Shen, HN; Lu, CL; Li, CY				Shen, Hsiu-Nien; Lu, Chin-Li; Li, Chung-Yi			Dementia Increases the Risks of Acute Organ Dysfunction, Severe Sepsis and Mortality in Hospitalized Older Patients: A National Population-Based Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; END; PREVALENCE; TAIWAN; STATES; TREND; LIFE	Background: Dementia increases the risk of death in older patients hospitalized for acute illnesses. However, the effect of dementia on the risks of developing acute organ dysfunction and severe sepsis as well as on the risk of hospital mortality in hospitalized older patients remains unknown, especially when treatments for these life-threatening situations are considered. Methods: In this population-based cohort study, we analyzed 41,672 older (>= 65 years) patients, including 3,487 (8.4%) with dementia, from the first-time admission claim data between 2005 and 2007 for a nationally representative sample of one million beneficiaries enrolled in the Taiwan National Health Insurance Research Database. Outcomes included acute organ dysfunction, severe sepsis, and hospital mortality. The effect of dementia on outcomes was assessed using multivariable logistic regression. Results: Dementia was associated with a 32% higher risk of acute organ dysfunction (adjusted odds ratio [aOR] 1.32, 95% confidence interval [CI] 1.19-1.46), a 50% higher risk of severe sepsis (aOR 1.50, 95% CI 1.32-1.69) and a 28% higher risk of hospital mortality (aOR 1.28, 95% CI 1.10-1.48) after controlling age, sex, surgical condition, comorbidity, principal diagnosis, infection status, hospital level, and length of hospital stay. However, the significant adverse effect of dementia on hospital mortality disappeared when life-support treatments, including vasopressor use, hemodialysis, mechanical ventilation, and intensive care, were also controlled. Conclusions: In hospitalized older patients, the presence of dementia increased the risks of acute organ dysfunction, severe sepsis and hospital mortality. However, after intervention using life-support treatments, dementia only exhibited a minor role on short-term mortality.	[Shen, Hsiu-Nien] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Shen, Hsiu-Nien; Lu, Chin-Li; Li, Chung-Yi] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Lu, Chin-Li] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Li, Chung-Yi] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	Chi Mei Hospital; National Cheng Kung University; Chi Mei Hospital; China Medical University Taiwan	Shen, HN (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.	hsiunian@gmail.com	Shen, Hsiu-Nien/H-2803-2019; LI, CHUNG-YI/ABI-1419-2020	LI, CHUNG-YI/0000-0002-0321-8908; Lu, Chin-Li/0000-0002-0818-4823	Chi Mei Medical Center [CMFHR9855]	Chi Mei Medical Center	The study was performed in Chi Mei Medical Center and supported by grant CMFHR9855 from the hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Campbell ML, 2004, CRIT CARE MED, V32, P1839, DOI 10.1097/01.CCM.0000138560.56577.88; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chien IC, 2008, J GERIATR PSYCH NEUR, V21, P142, DOI 10.1177/0891988708316859; Demond DW, 2002, NEUROLOGY, V59, P537, DOI 10.1212/WNL.59.4.537; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Esper AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7717; Foreman MG, 2003, CHEST, V124, P1016, DOI 10.1378/chest.124.3.1016; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Jin P, 2004, NEUROLOGY, V63, P739, DOI 10.1212/01.WNL.0000134604.48018.97; Kimata T, 2008, INT HEART J, V49, P533, DOI 10.1536/ihj.49.533; Laditka James N, 2005, Am J Alzheimers Dis Other Demen, V20, P27, DOI 10.1177/153331750502000109; Marengoni A, 2011, INT J GERIATR PSYCH, V26, P930, DOI 10.1002/gps.2627; Meier DE, 2001, ARCH INTERN MED, V161, P594, DOI 10.1001/archinte.161.4.594; Morrison RS, 2000, JAMA-J AM MED ASSOC, V284, P47, DOI 10.1001/jama.284.1.47; Pisani MA, 2005, CRIT CARE MED, V33, P1371, DOI 10.1097/01.CCM.0000165558.83676.48; Richardson SS, 2007, HEALTH SERV RES, V42, P183, DOI 10.1111/j.1475-6773.2006.00608.x; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Shah SM, 2012, AGE AGEING, V41, P64, DOI 10.1093/ageing/afr135; Shen HN, 2011, PSYCHOSOM MED, V73, P620, DOI 10.1097/PSY.0b013e3182280016; Shen HN, 2010, CHEST, V138, P298, DOI 10.1378/chest.09-2205; Stevenson CG, 2001, CAN MED ASSOC J, V164, P1413; Taylor DH, 2002, J CLIN EPIDEMIOL, V55, P929, DOI 10.1016/S0895-4356(02)00452-3; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca; Wu CS, 2009, AM J GERIAT PSYCHIAT, V17, P614, DOI 10.1097/JGP.0b013e3181a65210	27	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42751	10.1371/journal.pone.0042751	http://dx.doi.org/10.1371/journal.pone.0042751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905169	gold, Green Published, Green Submitted			2022-12-27	WOS:000307331100062
J	IJssennagger, N; Derrien, M; van Doorn, GM; Rijnierse, A; van den Bogert, B; Muller, M; Dekker, J; Kleerebezem, M; van der Meer, R				IJssennagger, Noortje; Derrien, Muriel; van Doorn, Gerdien M.; Rijnierse, Anneke; van den Bogert, Bartholomeus; Muller, Michael; Dekker, Jan; Kleerebezem, Michiel; van der Meer, Roelof			Dietary Heme Alters Microbiota and Mucosa of Mouse Colon without Functional Changes in Host-Microbe Cross-Talk	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; RED MEAT; COLORECTAL-CANCER; HYDROGEN-SULFIDE; RISK; GUT; INHIBITOR; SHOCK; CONSUMPTION; MODULATION	Colon cancer is a major cause of cancer deaths in Western countries and is associated with diets high in red meat. Heme, the iron-porphyrin pigment of red meat, induces cytotoxicity of gut contents which injures surface cells leading to compensatory hyperproliferation of crypt cells. This hyperproliferation results in epithelial hyperplasia which increases the risk of colon cancer. In humans, a high red-meat diet increases Bacteroides spp in feces. Therefore, we simultaneously investigated the effects of dietary heme on colonic microbiota and on the host mucosa of mice. Whole genome microarrays showed that heme injured the colonic surface epithelium and induced hyperproliferation by changing the surface to crypt signaling. Using 16S rRNA phylogenetic microarrays, we investigated whether bacteria play a role in this changed signaling. Heme increased Bacteroidetes and decreased Firmicutes in colonic contents. This shift was most likely caused by a selective susceptibility of Gram-positive bacteria to heme cytotoxic fecal water, which is not observed for Gram-negative bacteria, allowing expansion of the Gram-negative community. The increased amount of Gram-negative bacteria most probably increased LPS exposure to colonocytes, however, there is no appreciable immune response detected in the heme-fed mice. There was no functional change in the sensing of the bacteria by the mucosa, as changes in inflammation pathways and Toll-like receptor signaling were not detected. This unaltered host-microbe cross-talk indicates that the changes in microbiota did not play a causal role in the observed hyperproliferation and hyperplasia.	[IJssennagger, Noortje; Derrien, Muriel; van Doorn, Gerdien M.; Rijnierse, Anneke; van den Bogert, Bartholomeus; Muller, Michael; Dekker, Jan; Kleerebezem, Michiel; van der Meer, Roelof] Top Inst Food & Nutr, Wageningen, Netherlands; [IJssennagger, Noortje; Rijnierse, Anneke; Muller, Michael; van der Meer, Roelof] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Derrien, Muriel; van Doorn, Gerdien M.; van den Bogert, Bartholomeus; Kleerebezem, Michiel] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; NIZO Food Research	Muller, M (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	michiel.kleerebezem@nizo.nl	Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; Kleerebezem, Michiel/AAT-2078-2021; Derrien, Muriel/AAS-6845-2021	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Derrien, Muriel/0000-0001-8841-9153; Kleerebezem, Michiel/0000-0001-8552-2235	program council of Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands [A-1001]	program council of Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands	This study was funded only by the program council of Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands (grant A-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ALJALILI TAR, 1988, CURR MICROBIOL, V17, P13, DOI 10.1007/BF01568812; Attene-Ramos MS, 2010, ENVIRON MOL MUTAGEN, V51, P304, DOI 10.1002/em.20546; Balder HF, 2006, CANCER EPIDEM BIOMAR, V15, P717, DOI 10.1158/1055-9965.EPI-05-0772; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Bovee-Oudenhoven IM, 1999, J NUTR, V129, P607, DOI 10.1093/jn/129.3.607; CARTER RL, 1989, PSYCHOMETRIKA, V54, P9, DOI 10.1007/BF02294446; Collins D, 2011, LANCET ONCOL, V12, P504, DOI 10.1016/S1470-2045(10)70186-8; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Vogel J, 2005, CARCINOGENESIS, V26, P387, DOI 10.1093/carcin/bgh331; de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278; Fund WCR Research AIfC, 2007, FOOD NUTR PHYS ACT P, V1; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Harada T, 2003, AM J PHYSIOL-GASTR L, V284, pG255, DOI 10.1152/ajpgi.00244.2002; Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702; IJssennagger N, 2011, GUT; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; LAPRE JA, 1992, AM J PHYSIOL, V263, pG333, DOI 10.1152/ajpgi.1992.263.3.G333; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee DH, 2004, JNCI-J NATL CANCER I, V96, P403, DOI 10.1093/jnci/djh047; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Lewin MH, 2006, CANCER RES, V66, P1859, DOI 10.1158/0008-5472.CAN-05-2237; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; MAIER BR, 1974, AM J CLIN NUTR, V27, P1470, DOI 10.1093/ajcn/27.12.1470; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Meijerink M, 2010, BENEF MICROBES, V1, P317, DOI 10.3920/BM2010.0029; Nakamura A, 2003, J EXP MED, V197, P669, DOI 10.1084/jem.20021824; NITZAN Y, 1994, CURR MICROBIOL, V29, P125, DOI 10.1007/BF01570752; Nobles CL, 2011, METALLOMICS, V3, P788, DOI 10.1039/c1mt00047k; O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3; Parham NJ, 2000, FEMS MICROBIOL ECOL, V31, P21, DOI 10.1111/j.1574-6941.2000.tb00667.x; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Poelstra K, 1997, AM J PATHOL, V151, P1163; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schepens MAA, 2011, NUTRITION, V27, P590, DOI 10.1016/j.nut.2010.05.002; SCHWARTZ S, 1985, GASTROENTEROLOGY, V89, P19, DOI 10.1016/0016-5085(85)90740-1; Sesink ALA, 1999, CANCER RES, V59, P5704; Si-Tahar M, 2000, GASTROENTEROLOGY, V118, P1061, DOI 10.1016/S0016-5085(00)70359-3; Vaishnava S, 2007, CELL HOST MICROBE, V2, P365, DOI 10.1016/j.chom.2007.11.004; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; YOUNG GP, 1989, J GASTROEN HEPATOL, V4, P537, DOI 10.1111/j.1440-1746.1989.tb00858.x; Zhang XH, 2011, CANCER CAUSE CONTROL, V22, P1627, DOI 10.1007/s10552-011-9839-z; Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141	57	74	75	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49868	10.1371/journal.pone.0049868	http://dx.doi.org/10.1371/journal.pone.0049868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239972	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800010
J	Lichius, A; Yanez-Gutierrez, ME; Read, ND; Castro-Longoria, E				Lichius, Alexander; Yanez-Gutierrez, Mario E.; Read, Nick D.; Castro-Longoria, Ernestina			Comparative Live-Cell Imaging Analyses of SPA-2, BUD-6 and BNI-1 in Neurospora crassa Reveal Novel Features of the Filamentous Fungal Polarisome	PLOS ONE			English	Article							PENICILLIUM-CHRYSOGENUM HYPHAE; CANDIDA-ALBICANS HYPHAE; ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; SEPTAL PORES; ACTIN CYTOSKELETON; POLARIZED GROWTH; FISSION YEAST; FUNCTIONAL-CHARACTERIZATION; ASHBYA-GOSSYPII	A key multiprotein complex involved in regulating the actin cytoskeleton and secretory machinery required for polarized growth in fungi, is the polarisome. Recognized core constituents in budding yeast are the proteins Spa2, Pea2, Aip3/Bud6, and the key effector Bni1. Multicellular fungi display a more complex polarized morphogenesis than yeasts, suggesting that the filamentous fungal polarisome might fulfill additional functions. In this study, we compared the subcellular organization and dynamics of the putative polarisome components BUD-6 and BNI-1 with those of the bona fide polarisome marker SPA-2 at various developmental stages of Neurospora crassa. All three proteins exhibited a yeast-like polarisome configuration during polarized germ tube growth, cell fusion, septal pore plugging and tip repolarization. However, the localization patterns of all three proteins showed spatiotemporally distinct characteristics during the establishment of new polar axes, septum formation and cytokinesis, and maintained hyphal tip growth. Most notably, in vegetative hyphal tips BUD-6 accumulated as a subapical cloud excluded from the Spitzenkorper (Spk), whereas BNI-1 and SPA-2 partially colocalized with the Spk and the tip apex. Novel roles during septal plugging and cytokinesis, connected to the reinitiation of tip growth upon physical injury and conidial maturation, were identified for BUD-6 and BNI-1, respectively. Phenotypic analyses of gene deletion mutants revealed additional functions for BUD-6 and BNI-1 in cell fusion regulation, and the maintenance of Spk integrity. Considered together, our findings reveal novel polarisome-independent functions of BUD-6 and BNI-1 in Neurospora, but also suggest that all three proteins cooperate at plugged septal pores, and their complex arrangement within the apical dome of mature hypha might represent a novel aspect of filamentous fungal polarisome architecture.	[Lichius, Alexander; Yanez-Gutierrez, Mario E.; Castro-Longoria, Ernestina] Ctr Sci Res & Higher Educ Ensenada CICESE, Dept Microbiol, Ensenada, Baja California, Mexico; [Lichius, Alexander; Read, Nick D.] Univ Edinburgh, Inst Cell Biol, Fungal Cell Biol Grp, Edinburgh, Midlothian, Scotland	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; University of Edinburgh	Lichius, A (corresponding author), Ctr Sci Res & Higher Educ Ensenada CICESE, Dept Microbiol, Ensenada, Baja California, Mexico.	ecastro@cicese.mx	Castro-Longoria, Ernestina/GYV-4776-2022; Lichius, Alexander/M-3808-2017	Lichius, Alexander/0000-0002-2971-9604; Read, Nick/0000-0002-2286-2862; Jeffree, Christopher/0000-0002-3838-8720; Lord, Kathryn/0000-0002-2144-6269	SEP-CONACyT [CB-2006-1-61524]; Biotechnology and Biological Sciences Research Council [BB/E010741/1]; CONACyT; BBSRC [BB/E010741/1] Funding Source: UKRI	SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this project was provided by a SEP-CONACyT (www.conacyt.mx) grant (CB-2006-1-61524) to EC-L and a Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) grant (# BB/E010741/1) to NDR. We thank CONACyT for a grant to MEY-G., and a postdoctoral fellowship to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC, 1997, MOL BIOL CELL, V8, P729, DOI 10.1091/mbc.8.4.729; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; Araujo-Palomares CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027148; Araujo-Palomares CL, 2009, FUNGAL GENET BIOL, V46, P551, DOI 10.1016/j.fgb.2009.02.009; Beltran-Aguilar A, 2006, CARACTERIZACION MACR; Berepiki A, 2011, NATURE REV IN PRESS; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Bidlingmaier S, 2004, J CELL BIOL, V164, P207, DOI 10.1083/jcb.200307065; Bornens M, 2008, NAT REV MOL CELL BIO, V9, P874, DOI 10.1038/nrm2524; Buller A.H.R., 1933, RES FUNGI; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Carbo N, 2008, FUNGAL GENET BIOL, V45, P1315, DOI 10.1016/j.fgb.2008.06.010; Chapa-Y-Lazo B, 2011, FUNGAL BIOL-UK, V115, P547, DOI 10.1016/j.funbio.2011.02.001; CHENEVERT J, 1994, GENETICS, V136, P1287; COLLINGE AJ, 1987, FEMS MICROBIOL LETT, V40, P165; COLLINGE AJ, 1985, EXP MYCOL, V9, P80, DOI 10.1016/0147-5975(85)90051-9; Crampin H, 2005, J CELL SCI, V118, P2935, DOI 10.1242/jcs.02414; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Davis RH, 2000, NEUROSPORA CONTRIBUT, P333; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Delgehyr N, 2008, J CELL SCI, V121, P3803, DOI 10.1242/jcs.036269; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Fleissner A, 2005, EUKARYOT CELL, V4, P920, DOI 10.1128/EC.4.5.920-930.2005; Fleissner A, 2007, EUKARYOT CELL, V6, P84, DOI 10.1128/EC.00268-06; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Fujiwara T, 1998, MOL BIOL CELL, V9, P1221, DOI 10.1091/mbc.9.5.1221; Gammie AE, 1998, MOL BIOL CELL, V9, P1395, DOI 10.1091/mbc.9.6.1395; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Harris SD, 2004, FUNGAL GENET BIOL, V41, P391, DOI 10.1016/j.fgb.2003.11.007; Harris SD, 1997, EMBO J, V16, P3474, DOI 10.1093/emboj/16.12.3474; Harris SD, 2006, INT REV CYTOL, V251, P41, DOI 10.1016/S0074-7696(06)51002-2; Harris SD, 2009, MOL MICROBIOL, V73, P733, DOI 10.1111/j.1365-2958.2009.06803.x; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Jedd G, 2000, NAT CELL BIOL, V2, P226, DOI 10.1038/35008652; Jedd G, 2011, TRENDS CELL BIOL, V21, P12, DOI 10.1016/j.tcb.2010.09.001; Jones LA, 2010, EUKARYOT CELL, V9, P1455, DOI 10.1128/EC.00109-10; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167; Koehli M, 2008, J CELL SCI, V121, P3878, DOI 10.1242/jcs.033852; Leeder AC, 2008, FUNGAL GENET BIOL, V45, P897, DOI 10.1016/j.fgb.2007.12.001; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Lichius A., 2010, FUNGAL GENET, V57, P8, DOI [10.4148/1941-4765.1070, DOI 10.4148/1941-4765.1070]; Lichius A, 2010, CELL FUSION NEUROSPO; Lichius A., 2010, DISTINGUISH CONIDIAL, P1; Lichius A, 2011, EUKARYOTIC CEL UNPUB; Lichius A, 2011, FUNGAL BIOL-UK, V115, P518, DOI 10.1016/j.funbio.2011.02.014; Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; MARKHAM P, 1987, FEMS MICROBIOL LETT, V46, P1; MARKHAM P, 1994, MYCOL RES, V98, P1089, DOI 10.1016/S0953-7562(09)80195-0; Martin R, 2005, EUKARYOT CELL, V4, P1712, DOI 10.1128/EC.4.10.1712-1724.2005; MCNALLY MT, 1988, CURR GENET, V14, P545, DOI 10.1007/BF00434079; Meyer V, 2008, FUNGAL GENET BIOL, V45, P152, DOI 10.1016/j.fgb.2007.07.006; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Nolan S, 2006, MOL BIOL CELL, V17, P2439, DOI 10.1091/mbc.E05-11-1015; Ozaki-Kuroda K, 2011, MOL CELL BIOL, V21, P827; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Piel M, 2009, CURR BIOL, V19, pR823, DOI 10.1016/j.cub.2009.08.012; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Ramos-Garcia SL, 2009, EUKARYOT CELL, V8, P1880, DOI 10.1128/EC.00062-09; Rasmussen CG, 2007, EUKARYOT CELL, V6, P1097, DOI 10.1128/EC.00050-07; Rasmussen CG, 2005, EUKARYOT CELL, V4, P1913, DOI 10.1128/EC.4.11.1913-1925.2005; RAYNER ADM, 1991, MYCOLOGIA, V83, P48, DOI 10.2307/3759832; Read ND, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P260; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Roca M. G., 2010, ANAL QUANTIFY CONIDI, P1; Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Sambrook J., 2001, MOL CLONING LAB MANU; Schmitz HP, 2006, MOL BIOL CELL, V17, P130, DOI 10.1091/mbc.e05-06-0479; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Sharpless KE, 2002, MOL BIOL CELL, V13, P469, DOI 10.1091/mbc.01-07-0356; Shaw BD, 2011, FUNGAL BIOL-UK, V115, P541, DOI 10.1016/j.funbio.2011.02.010; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384; Sudbery P, 2011, FUNGAL GENET BIOL, V48, P849, DOI 10.1016/j.fgb.2011.02.004; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Tcheperegine SE, 2005, MOL CELL BIOL, V25, P8567, DOI 10.1128/MCB.25.19.8567-8580.2005; TRINCI APJ, 1973, PROTOPLASMA, V80, P57, DOI 10.1007/BF01666351; TRINCI APJ, 1973, ARCH MIKROBIOL, V91, P113, DOI 10.1007/BF00424755; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Valtz N, 1996, J CELL BIOL, V135, P725, DOI 10.1083/jcb.135.3.725; van Drogen F, 2002, CURR BIOL, V12, P1698, DOI 10.1016/S0960-9822(02)01186-7; Verdin J, 2009, MOL MICROBIOL, V74, P1044, DOI 10.1111/j.1365-2958.2009.06917.x; Virag A, 2006, EUKARYOT CELL, V5, P881, DOI 10.1128/EC.00036-06; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wedlich-Soldner R, 2008, SEMIN CELL DEV BIOL, V19, P224, DOI 10.1016/j.semcdb.2008.01.003	94	42	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30372	10.1371/journal.pone.0030372	http://dx.doi.org/10.1371/journal.pone.0030372			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22900028	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600018
J	Li, Y; Farooq, M; Sheng, DL; Chandramouli, C; Lan, T; Mahajan, NK; Kini, RM; Hong, YH; Lisowsky, T; Ge, RW				Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Lisowsky, Thomas; Ge, Ruowen			Augmenter of Liver Regeneration (alr) Promotes Liver Outgrowth during Zebrafish Hepatogenesis	PLOS ONE			English	Article							HEPATIC STIMULATOR SUBSTANCE; DISULFIDE RELAY SYSTEM; MITOCHONDRIAL SULFHYDRYL OXIDASE; INTERMEMBRANE SPACE; RESPIRATORY-CHAIN; PROTEIN IMPORT; CYTOCHROME-C; GENE; HEPATOPOIETIN; YEAST	Augmenter of Liver Regeneration (ALR) is a sulfhydryl oxidase carrying out fundamental functions facilitating protein disulfide bond formation. In mammals, it also functions as a hepatotrophic growth factor that specifically stimulates hepatocyte proliferation and promotes liver regeneration after liver damage or partial hepatectomy. Whether ALR also plays a role during vertebrate hepatogenesis is unknown. In this work, we investigated the function of alr in liver organogenesis in zebrafish model. We showed that alr is expressed in liver throughout hepatogenesis. Knockdown of alr through morpholino antisense oligonucleotide (MO) leads to suppression of liver outgrowth while overexpression of alr promotes liver growth. The small-liver phenotype in alr morphants results from a reduction of hepatocyte proliferation without affecting apoptosis. When expressed in cultured cells, zebrafish Alr exists as dimer and is localized in mitochondria as well as cytosol but not in nucleus or secreted outside of the cell. Similar to mammalian ALR, zebrafish Alr is a flavin-linked sulfhydryl oxidase and mutation of the conserved cysteine in the CxxC motif abolishes its enzymatic activity. Interestingly, overexpression of either wild type Alr or enzyme-inactive Alr(C131S) mutant promoted liver growth and rescued the liver growth defect of alr morphants. Nevertheless, alr(C131S) is less efficacious in both functions. Meantime, high doses of alr MOs lead to widespread developmental defects and early embryonic death in an alr sequence-dependent manner. These results suggest that alr promotes zebrafish liver outgrowth using mechanisms that are dependent as well as independent of its sulfhydryl oxidase activity. This is the first demonstration of a developmental role of alr in vertebrate. It exemplifies that a low-level sulfhydryl oxidase activity of Alr is essential for embryonic development and cellular survival. The dose-dependent and partial suppression of alr expression through MO-mediated knockdown allows the identification of its late developmental role in vertebrate liver organogenesis.	[Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Farooq, Muhammad] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Lisowsky, Thomas] MultiBIND Biotec GmbH, Cologne, Germany	National University of Singapore; King Saud University; Virginia Commonwealth University	Li, Y (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgerw@nus.edu.sg	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	Singapore Biomedical Research Council [BMRC/01/1/21/18/068]; Ministry of Education [R-154-000-475-112]; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Ministry of Education; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Singapore Biomedical Research Council grant BMRC/01/1/21/18/068 and Ministry of Education grant R-154-000-475-112 to Dr. Ge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen XX, 2003, J BIOL CHEM, V278, P49022, DOI 10.1074/jbc.M304057200; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gandhi CR, 2009, J CELL PHYSL; Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951; GHOSH C, 1994, CELL BIOL TOXICOL, V10, P167, DOI 10.1007/BF00757560; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; HE FH, 1993, HEPATOLOGY, V17, P225, DOI 10.1016/0270-9139(93)90081-W; Hofhaus G, 1999, EUR J CELL BIOL, V78, P349, DOI 10.1016/S0171-9335(99)80069-7; Ilowski M, 2011, BIOCHEM BIOPH RES CO, V404, P148, DOI 10.1016/j.bbrc.2010.11.083; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kondili VG, 2005, DIGEST DIS SCI, V50, P297, DOI 10.1007/s10620-005-1598-9; Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6; LABRECQUE DR, 1975, J PHYSIOL-LONDON, V248, P273, DOI 10.1113/jphysiol.1975.sp010973; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x; Li Y, 2000, J BIOL CHEM, V275, P37443, DOI 10.1074/jbc.M004373200; Liatsos GD, 2003, DIGEST DIS SCI, V48, P1929, DOI 10.1023/A:1026157901805; LISOWSKY T, 1995, GENOMICS, V29, P690, DOI 10.1006/geno.1995.9950; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Lu CR, 2002, FASEB J, V16, P90, DOI 10.1096/fj.01-0506fje; Lu J, 2002, WORLD J GASTROENTERO, V8, P353; McClure KD, 2008, DEV BIOL, V319, P68, DOI 10.1016/j.ydbio.2008.04.004; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Tanigawa K, 2000, J GASTROENTEROL, V35, P112, DOI 10.1007/s005350050023; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Wang CP, 2006, WORLD J GASTROENTERO, V12, P4859; Wang G, 1999, J BIOL CHEM, V274, P11469, DOI 10.1074/jbc.274.17.11469; Wang WZ, 2007, BIOCHEMISTRY-US, V46, P3246, DOI 10.1021/bi602499t; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x; Yang XM, 1997, SCI CHINA SER C, V40, P642, DOI 10.1007/BF02882695	52	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30835	10.1371/journal.pone.0030835	http://dx.doi.org/10.1371/journal.pone.0030835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22905149	gold, Green Published			2022-12-27	WOS:000301703800034
J	Li, YY; Zhu, RN; Qian, Y; Deng, J				Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie			The Characteristics of Blood Glucose and WBC Counts in Peripheral Blood of Cases of Hand Foot and Mouth Disease in China: A Systematic Review	PLOS ONE			English	Review							ENTEROVIRUS 71; OUTBREAK; INFECTIONS; MALAYSIA; TAIWAN; MANIFESTATIONS	Background: Outbreaks of Hand Foot and Mouth Disease (HFMD) have occurred in many parts of the world especially in China. We aimed to summarize the characteristics of the levels of blood glucose and white blood cell (WBC) counts in cases of HFMD in Mainland China and Taiwan, using meta-analysis based on systematic review of published articles. Methods: We systematically reviewed published studies, from the MEDLINE and WANFANG Data, about the levels of blood glucose and WBC counts in cases of HFMD until 15(th) June 2011, and quantitatively summarized the characteristics of them using meta-analysis. Results: In total, 37 studies were included in this review. In Mainland China and Taiwan, generally, the average level of blood glucose, the prevalence of hyperglycemia, WBC counts and the prevalence of leukocytosis increased with the severity of the illness. There was no significant difference in the prevalence of leukocytosis between ANS (autonomic nervous system dysregulation)/PE (pulmonary edema) group and CNS (central nervous system) group, and in the average level of blood glucose between healthy controls and mild cases of HFMD. WBC counts in cases infected by EV71 were less than those in cases infected by CA16. Conclusions: our analyses indicated that blood glucose and WBC counts increased with the severity of HFMD disease, which would help doctors to manage patients efficiently.	[Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, YY (corresponding author), Capital Inst Pediat, Virol Lab, Beijing, Peoples R China.	qybds1129@163.com	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abubakar S, 1999, SCAND J INFECT DIS, V31, P331, DOI 10.1080/00365549950163734; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen JH, 2010, ACTA ACAD MEDICINAE, V32, P363; Chen WB, 2000, 5 DIAGNOSTICS; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Cui LD, 2011, CHINA PRAC MED, V6, P50; Dai W, 2011, CHINESE COMMUNITY DO, V13, P88; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding NZ, 2009, VIRUS RES, V145, P157, DOI 10.1016/j.virusres.2009.06.006; Fan XC, 2009, ANHUI MED J, V30, P253; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsia SH, 2005, PEDIATR INFECT DIS J, V24, P331, DOI 10.1097/01.inf.0000157219.19674.98; Huang S, 2008, ANHUI MED J, V29, P361; Huang YF, 2003, J INFECTION, V46, P238, DOI 10.1053/jinf.2002.1117; Jiang J, 2010, J QILU NURSING, V16, P119; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li CC, 2002, SCAND J INFECT DIS, V34, P104, DOI 10.1080/00365540110077119; Li JM, 2009, CHIN PEDIAT EMERG ME, V16, P142; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li Q., 2010, ANHUI MED J, V31, P1410; Li SH, 2010, CHIN PECIATR EMERG M, V17, P49; Li SH, 2010, CHIN J CLIN INFECT D, V3, P337; [李玉芬 Li Yufen], 2010, [临床儿科杂志, Journal of Chinical Pediatrics], V28, P1011; Liao Y, 2010, JILIN MED J, P4075; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Liu J, 2009, ANHUI MED J, V30, P261; Liu X, 2010, CHIN J MED ULTRASOUN, V7, P1844; Liu Ying-xia, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P475; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Luo LP, 2010, J N CHINA COAL MED U, V12, P356; Mai LL, 2011, CHINESE J NEW CLIN M, V4, P356; MANTEL N, 1959, J NATL CANCER I, V22, P719; [毛国顺 MAO Guoshun], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P387; [毛月燕 MAO Yue-yan], 2009, [中华传染病杂志, Chinese Journal of Infections Diseases], V27, P35; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qian N, 2010, THESIS QINGDAO U, P17; Shen Q, 2011, J MED RES, V40, P93; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Tang LP, 2009, CHIN J M ISDIAGN, V9, P6840; Verbruggen SCAT, 2007, CLIN NUTR, V26, P677, DOI 10.1016/j.clnu.2007.08.012; Wang HC, 2010, CHINA CLIN PRAC MED, V4, P155; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wei XL, 2010, SHANDONG MED J, V50, P70; World Health Organization, 2017, GUID DRINK WAT QUAL, VFourth, DOI 10.1016/S1462-0758(00)00006-6; Yan ZW, 2011, CHIN J GEN PRACT, V10, P343; Yang T, 2010, ACTA MEDCINAE SINICA, V23, P68; Yu LX, 2011, CHIN PEDIAT EMERG ME, V18, P57; [岳保珠 Yue Baozhu], 2010, [中国全科医学, Chinese General Practice], V13, P2239; Zhang GH, 2010, CHINA CLIN PRAC MED, V4, P132; Zhang JH, 2010, CHINESE FOREIGN MED, V8, P12; Zhang Shou-Bin, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P38; Zhao H., 2008, J CLIN PEDIAT, V26, P467; Zheng NH, 2011, CHINA MODERN DOCTOR, V49, P126; Zhou AR, 2000, 5 BIOCH; [周大明 Zhou Daming], 2010, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V35, P1724	63	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29003	10.1371/journal.pone.0029003	http://dx.doi.org/10.1371/journal.pone.0029003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22905149	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400018
J	Li, YQ; He, ZG				Li, Yuqing; He, Zheng-Guo			The Mycobacterial LysR-Type Regulator OxyS Responds to Oxidative Stress and Negatively Regulates Expression of the Catalase-Peroxidase Gene	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATOR; PATHOGENIC MYCOBACTERIA; TUBERCULOSIS; KATG; FURA; SENSITIVITY; SMEGMATIS; MACROPHAGES; RESISTANCE; PROTEINS	Protection against oxidative stress is one of the primary defense mechanisms contributing to the survival of Mycobacterium tuberculosis in the host. In this study, we provide evidence that OxyS, a LysR-type transcriptional regulator functions as an oxidative stress response regulator in mycobacteria. Overexpression of OxyS lowers expression of the catalase-peroxidase (KatG) gene in M. smegmatis. OxyS binds directly with the katG promoter region and a conserved, GC-rich T-N-11-A motif for OxyS binding was successfully characterized in the core binding site. Interestingly, the DNA-binding activity of OxyS was inhibited by H2O2, but not by dithiothreitol. Cys25, which is situated at the DNA-binding domain of OxyS, was found to have a regulatory role for the DNA-binding ability of OxyS in response to oxidative stress. In contrast, the other three cysteine residues in OxyS do not appear to have this function. Furthermore, the mycobacterial strain over-expressing OxyS had a higher sensitivity to H2O2. Thus, OxyS responds to oxidative stress through a unique cysteine residue situated in its DNA-binding domain and negatively regulates expression of the katG gene. These findings uncover a specific regulatory mechanism for mycobacterial adaptation to oxidative stress.	[Li, Yuqing; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	hezhengguo@mail.hzau.edu.cn	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (31025002, 30930003), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (to Z-GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Domenech P, 2001, MICROBES INFECT, V3, P713, DOI 10.1016/S1286-4579(01)01422-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Italiani VCS, 2011, J BACTERIOL, V193, P1734, DOI 10.1128/JB.01339-10; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lee HI, 2010, J BIOCHEM, V147, P511, DOI 10.1093/jb/mvp197; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Master S, 2001, J BACTERIOL, V183, P4033, DOI 10.1128/JB.183.13.4033-4039.2001; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sala C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-33; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Sreevatsan S, 1996, J CLIN MICROBIOL, V34, P2007, DOI 10.1128/JCM.34.8.2007-2010.1996; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	36	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30186	10.1371/journal.pone.0030186	http://dx.doi.org/10.1371/journal.pone.0030186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22905149	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400077
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22808095	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22808095	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808095	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400093
